Psyllid ID: psy14434

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400----
Protein Sequence
MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRLSKGNALDNTLRGHYKIKDAISSKYTSSEKENQQNNNNTAPSYKNVNVNTTESVQRRDKLEVY
Secondary Structure (PSIPRED)
cccccccccccEEEEEEEccccccEEEcccccccccEEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHHccccccEEEEcccccccccccEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHcccccHHHHHHHHHcccccccccccHHHHHccccccccccccccccccccccccEEcccccccccHHHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccEEEEEEEEEEEcccEcccEEEEccccEEEEEccEccccEccEEEEEccccccHHHHHHHHHHHHHHHHHcccccEEEEEHcccccccccEEEEEEcccEEHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHHcccccccccHHHHHccccHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcHHHccHHHccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccccccc
Coil and Loop (DISEMBL)
mtsnttsksgdkvqhnvdgnilaEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKsfqrhpniITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMhrdlkpsnilidkscsikigdlglarslsdSKECLTEYIATrwyrapeilisnrrythhvDIWSLGCILAEMlqskplfpgastshQLQLIVNLvrpnpphadkfyagfknkpEEAVDLLNQILvlnpserpetdqilehnyvskyfpsathvipqvtphtvvldiddnnqleiNDYQDKLYDIVKSCKKkksvkrlskgnaldntlrgHYKIKDAISSKYTSSekenqqnnnntapsyknvnvnttesvqrrdklevy
Flexible Loop (DISEMBL)
mtsnttsksgdkvqhnvdGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILflksfqrhpnIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLglarslsdskECLTEYiatrwyrapeILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSckkkksvkrlskgnaldntlrghyKIKDAISSKYTSSEKenqqnnnntapsyknvnvnttesvqrrdklevy
Low Complexity Region (SEG)
MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVksckkkksvkrlskGNALDNTLRGHYKIKDAISSKYTSSEKEnqqnnnnTAPSYKNVNVNTTESVQRRDKLEVY
Disordered region (IsUnstruct)
****************VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNP*****TDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCK*******************GHY************************************************
Disordered Region (DISOPRED)
****************VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP******AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVK*************************************************************************
Disordered Region (DISEMBL)
***********KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCK********SKGNALDNTLRGHYKIKDAISSK***********NNNTAPSYKNVNVNTTESVQRRDKLEVY
Disordered Region (DISPRO)
********SGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKS******************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRLSKGNALDNTLRGHYKIKDAISSKYTSSEKENQQNNNNTAPSYKNVNVNTTESVQRRDKLEVY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	404	2.2.26 [Sep-21-2011]
Q8TD08	544	Mitogen-activated protein	yes	N/A	0.794	0.590	0.435	1e-84
Q11179	470	Putative serine/threonine	yes	N/A	0.792	0.680	0.448	2e-84
Q9Z2A6	547	Mitogen-activated protein	yes	N/A	0.769	0.568	0.444	4e-83
Q80Y86	549	Mitogen-activated protein	yes	N/A	0.769	0.566	0.447	4e-83
Q54QB1	369	Extracellular signal-regu	yes	N/A	0.764	0.837	0.421	1e-77
Q39024	376	Mitogen-activated protein	yes	N/A	0.707	0.760	0.429	5e-63
Q40353	371	Mitogen-activated protein	N/A	N/A	0.702	0.765	0.403	9e-61
Q39025	376	Mitogen-activated protein	no	N/A	0.688	0.739	0.408	2e-60
Q9LMM5	369	Mitogen-activated protein	no	N/A	0.690	0.756	0.425	5e-60
P28482	360	Mitogen-activated protein	no	N/A	0.707	0.794	0.430	5e-60

>sp|Q8TD08|MK15_HUMAN Mitogen-activated protein kinase 15 OS=Homo sapiens GN=MAPK15 PE=1 SV=1

 Score =  314 bits (804), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 154/354 (43%), Positives = 221/354 (62%), Gaps = 33/354 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           VD  I+  Y + +++G+GAYGIV+KA D+   + VAIKKIF+AFR+KTDAQRT+REI  L
Sbjct: 5   VDPRIVRRYLLRRQLGQGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFREITLL 64

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII++LD+ +A N++D+Y+VFE+M+ DLN VIR   +L+DVH+R I +QL   
Sbjct: 65  QEFGDHPNIISLLDVIRAENDRDIYLVFEFMDTDLNAVIRKGGLLQDVHVRSIFYQLLRA 124

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
             ++H+  V+HRD KPSN+L+D +C++K+ D GLARSL D  E      +TEY+ATRWYR
Sbjct: 125 TRFLHSGHVVHRDQKPSNVLLDANCTVKLCDFGLARSLGDLPEGPEDQAVTEYVATRWYR 184

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+L+S+ RYT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   D  
Sbjct: 185 APEVLLSSHRYTLGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETI-PPPSEEDLL 243

Query: 251 YAG----------FKNKPE-------------EAVDLLNQILVLNPSERPETDQILEHNY 287
             G            ++P              EA+DLL ++LV  P +R    Q L+H Y
Sbjct: 244 ALGSGCRASVLHQLGSRPRQTLDALLPPDTSPEALDLLRRLLVFAPDKRLSATQALQHPY 303

Query: 288 VSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
           V ++   +     +     V     +  QL + +Y+ ++Y ++  C       R
Sbjct: 304 VQRFHCPSDEWAREA---DVRPRAHEGVQLSVPEYRSRVYQMILECGGSSGTSR 354

In vitro, phosphorylates MBP.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q11179|YPC2_CAEEL Putative serine/threonine-protein kinase C05D10.2 OS=Caenorhabditis elegans GN=C05D10.2 PE=2 SV=2

 Score =  312 bits (800), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 161/359 (44%), Positives = 240/359 (66%), Gaps = 39/359 (10%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           +VD +I  ++ + KR+GKGAYGIV+KAYDK +++ VA+KKIF+AFRN TD+QRT+RE++F
Sbjct: 4   DVDTHIHEKFDLQKRLGKGAYGIVWKAYDKRSRETVALKKIFDAFRNPTDSQRTFREVMF 63

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCN 134
           L+ F +HPN+I + +I++A N++D+Y+ FE+ME DL+ VI +  ILKDVH +YIM QL  
Sbjct: 64  LQEFGKHPNVIKLYNIFRADNDRDIYLAFEFMEADLHNVIKKGSILKDVHKQYIMCQLFR 123

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC--------LTEYIAT 186
            + ++H+  V+HRDLKPSN+L+D  C +K+ D GLARSLS  ++         LTEY+AT
Sbjct: 124 AIRFLHSGNVLHRDLKPSNVLLDADCRVKLADFGLARSLSSLEDYPEGQKMPDLTEYVAT 183

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           RWYR+PEIL++ +RYT  VD+WSLGCILAEML  + LFPG+ST +Q++ I+N +   P  
Sbjct: 184 RWYRSPEILLAAKRYTKGVDMWSLGCILAEMLIGRALFPGSSTINQIERIMNTI-AKPSR 242

Query: 247 AD-----KFYAG-----FKNKPEE------------AVDLLNQILVLNPSERPETDQILE 284
           AD       YA         +P +            A+D++ ++L+  P +R   +Q L 
Sbjct: 243 ADIASIGSHYAASVLEKMPQRPRKPLDLIITQSQTAAIDMVQRLLIFAPQKRLTVEQCLV 302

Query: 285 HNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRL 342
           H YV ++  PS   V+     + V   + D+ QL I+DY+D+LY+++   +KK S KR+
Sbjct: 303 HPYVVQFHNPSEEPVL----NYEVYPPLPDHIQLSIDDYRDRLYEMID--EKKASFKRI 355

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9Z2A6|MK15_RAT Mitogen-activated protein kinase 15 OS=Rattus norvegicus GN=Mapk15 PE=1 SV=2

 Score =  308 bits (790), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 153/344 (44%), Positives = 218/344 (63%), Gaps = 33/344 (9%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
            VD ++   Y I +R+GKGAYGIV+KA D+   + VAIKKIF+AFR++TDAQRT+REI+ 
Sbjct: 5   EVDRHVSQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQTDAQRTFREIML 64

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCN 134
           L+ F  HPNII +LD+  A N++D+Y+VFE M+ DLN VI + ++L+D+H R I +QL  
Sbjct: 65  LREFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLEDIHKRCIFYQLLR 124

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWY 189
              +IH+ +V+HRD KP+N+L+D +C +K+ D GLARSLSD  E      LTEY+ATRWY
Sbjct: 125 ATKFIHSGRVIHRDQKPANVLLDAACRVKLCDFGLARSLSDFPEGPGGQALTEYVATRWY 184

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           RAPE+L+S+R YT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   + 
Sbjct: 185 RAPEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILETI-PLPSMEEL 243

Query: 250 FYAGF-----------------------KNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
              G                         + P EA+DLL ++L   P +R   +Q L+H 
Sbjct: 244 QGLGSDYSALILQNLGSRPRQTLDALLPPDTPPEALDLLKRLLAFAPDKRLSAEQALQHP 303

Query: 287 YVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIV 330
           YV ++               V L + + +QL   +Y+++LY ++
Sbjct: 304 YVQRFHCPDRE---WTRGSDVRLPVHEGDQLSAPEYRNRLYQMI 344

Constitutively active kinase which may function as a negative regulator of cell growth. In vitro, phosphorylates FOS.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q80Y86|MK15_MOUSE Mitogen-activated protein kinase 15 OS=Mus musculus GN=Mapk15 PE=1 SV=1

 Score =  308 bits (790), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 154/344 (44%), Positives = 217/344 (63%), Gaps = 33/344 (9%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
            VD ++   Y I +R+GKGAYGIV+KA D+   + VAIKKIF+AFR++ DAQRT+REI+ 
Sbjct: 5   EVDRHVAQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQIDAQRTFREIML 64

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCN 134
           LK F  HPNII +LD+  A N++D+Y+VFE M+ DLN VI + ++LKD+H R I +QL  
Sbjct: 65  LKEFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLKDIHKRCIFYQLLR 124

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWY 189
              +IH+ +V+HRD KP+N+L+D +C +K+ D GLARSL D  E      LTEY+ATRWY
Sbjct: 125 ATKFIHSGRVIHRDQKPANVLLDSACRVKLCDFGLARSLGDLPEGPGGQALTEYVATRWY 184

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD- 248
           RAPE+L+S+R YT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   + 
Sbjct: 185 RAPEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILKTI-PLPSMEEL 243

Query: 249 ----KFYAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
                 Y+                     + P EA+DLL ++L   P +R   +Q L+H 
Sbjct: 244 QDLGSDYSALILQNLGSRPQQTLDALLPPDTPPEALDLLKRLLAFAPDKRLSAEQALQHP 303

Query: 287 YVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIV 330
           YV ++         +     V L + + +QL   +Y+ +LY I+
Sbjct: 304 YVQRFHCPDREWARE---SDVRLPVHEGDQLSAPEYRKRLYQII 344

Constitutively active kinase which may function as a negative regulator of cell growth.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q54QB1|ERK2_DICDI Extracellular signal-regulated kinase 2 OS=Dictyostelium discoideum GN=erkB PE=1 SV=1

 Score =  290 bits (742), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 146/346 (42%), Positives = 220/346 (63%), Gaps = 37/346 (10%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           ++D ++L +Y + ++IGKGAYGIV+KA DK  KQ VA+KKIF+AF+N TDAQRT+REI+F
Sbjct: 5   DIDKHVLRKYEVLQKIGKGAYGIVWKAIDKKTKQTVALKKIFDAFQNATDAQRTFREIMF 64

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
           L+    H NII +L++ KA N++D+Y+VFE+ME DL+ VIR KIL+++H +Y ++QL   
Sbjct: 65  LQELHGHENIIKLLNVIKADNDRDIYLVFEHMETDLHAVIRAKILEEIHKQYTIYQLLKA 124

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR------SLSDSKECLTEYIATRWY 189
           L Y+H+  V+HRD+KPSN+L++  C +K+ D GLAR      S++++   LTEY+ATRWY
Sbjct: 125 LKYMHSANVLHRDIKPSNLLLNSECLVKVADFGLARSITSLESIAEANPVLTEYVATRWY 184

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHAD 248
           RAPEIL+ + +YT  VD+WS+GCIL E+L  K +FPG ST +QL LI+ +  RP+    +
Sbjct: 185 RAPEILLGSTKYTKGVDMWSIGCILGELLGEKAMFPGNSTMNQLDLIIEVTGRPSAEDIE 244

Query: 249 KFYAGFK---------NKPEEAVDLLNQILV-----------LNPSERPETDQILEHNYV 288
              + F          + P    D+     V            NP +R   ++ L H +V
Sbjct: 245 AIKSPFAGTMLESLPPSNPRSLSDMYPSASVDALDLLKKLLQFNPDKRITAEEALAHPFV 304

Query: 289 SKYFPSATHVIPQVTPH---TVVLDIDDNNQLEINDYQDKLY-DIV 330
           +++        P   PH    + + IDD  +  I +Y+++LY DI+
Sbjct: 305 TQFHN------PAEEPHFDRIIKISIDDGQKFPIAEYRNRLYNDII 344

Implicated in the relay of the cAMP chemotactic signal and cell differentiation. Important for receptor-mediated activation of adenylyl cyclase.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  241 bits (616), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 136/317 (42%), Positives = 190/317 (59%), Gaps = 31/317 (9%)

Query: 2   TSNTTSKSGDKVQHNVDGNILA---EYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIF 57
           +    +  G  VQ+NV GN+     +Y    R IG+GAYGIV  A +    + VAIKKI 
Sbjct: 16  SKGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIG 75

Query: 58  EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMENDLNKV 114
            AF N  DA+RT REI  LK    H N+I + DI K     N  D+Y+V+E M+ DL+++
Sbjct: 76  NAFDNIIDAKRTLREIKLLKHMD-HENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQI 134

Query: 115 IR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
           IR ++ L D H R+ ++QL  GL Y+H+  V+HRDLKPSN+L++ +C +K+GD GLAR+ 
Sbjct: 135 IRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTK 194

Query: 174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
           S++ + +TEY+ TRWYRAPE+L++   YT  +DIWS+GCIL E +  +PLFPG    HQL
Sbjct: 195 SET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQL 253

Query: 234 QLIVNL--------------------VRPNPPHADK-FYAGFKNKPEEAVDLLNQILVLN 272
           +LI  L                    VR  P +  + F A F N    AVDLL ++LV +
Sbjct: 254 RLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFD 313

Query: 273 PSERPETDQILEHNYVS 289
           PS R   D+ L H Y++
Sbjct: 314 PSRRITVDEALCHPYLA 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  234 bits (597), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 127/315 (40%), Positives = 193/315 (61%), Gaps = 31/315 (9%)

Query: 4   NTTSKSGDKVQHNVDGNILA---EYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEA 59
              +  G  +Q+N+ GN+     +Y    R +G+GAYGIV  A +   ++ VAIKKI  A
Sbjct: 12  GVPTHGGRYLQYNIYGNLFEVSRKYVPPIRSVGRGAYGIVCAAVNAETREEVAIKKIGNA 71

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL---YVVFEYMENDLNKVIR 116
           F N+ DA+RT REI  L+    H N++++ DI +    ++    Y+V E M+ DL+++IR
Sbjct: 72  FDNRIDAKRTLREIKLLRHMD-HENVMSIKDIIRPPQKENFNHVYIVSELMDTDLHQIIR 130

Query: 117 -DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
            ++ + D H RY ++QL  GL Y+H+  V+HRDLKPSN+L++ +C +KIGD GLAR+ S+
Sbjct: 131 SNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 190

Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
           + + +TEY+ TRWYRAPE+L++   YT  +DIWS+GCIL E++  +PLFPG    HQL+L
Sbjct: 191 T-DFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPGRDYVHQLRL 249

Query: 236 IVNL--------------------VRPNPPHADK-FYAGFKNKPEEAVDLLNQILVLNPS 274
           +  L                    VR  P +  + F A F N    AVDLL ++L+ +PS
Sbjct: 250 VTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPGAVDLLEKMLIFDPS 309

Query: 275 ERPETDQILEHNYVS 289
           +R + D+ L H Y++
Sbjct: 310 KRIKVDEALCHPYMA 324

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  233 bits (595), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 127/311 (40%), Positives = 188/311 (60%), Gaps = 33/311 (10%)

Query: 9   SGDKVQHNVDGNILA---EYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT 64
            G   Q+NV GN+     +Y    R IG+GAYG V  A D    + +AIKKI +AF NK 
Sbjct: 23  GGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIGKAFDNKV 82

Query: 65  DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL---YVVFEYMENDLNKVIR-DKIL 120
           DA+RT REI  L+  + H N++ + DI +    +D    Y+VFE M+ DL+++IR ++ L
Sbjct: 83  DAKRTLREIKLLRHLE-HENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSL 141

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
            D H +Y ++Q+  GL YIH+  V+HRDLKPSN+L++ +C +KI D GLAR+ S++ E +
Sbjct: 142 NDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSET-EYM 200

Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
           TEY+ TRWYRAPE+L+++  YT  +D+WS+GCI AE++  +PLFPG    HQL+LI  L+
Sbjct: 201 TEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELI 260

Query: 241 R----------------------PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE 278
                                  P  P  + F A F +    A+DLL ++LV +P +R  
Sbjct: 261 GSPDGASLEFLRSANARKYVKELPKFPRQN-FSARFPSMNSTAIDLLEKMLVFDPVKRIT 319

Query: 279 TDQILEHNYVS 289
            ++ L + Y+S
Sbjct: 320 VEEALCYPYLS 330

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  232 bits (591), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 132/310 (42%), Positives = 188/310 (60%), Gaps = 31/310 (10%)

Query: 9   SGDKVQHNVDGNILA---EYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT 64
            G  VQ+NV GN+     +Y    R IG+GA GIV  A++    + VAIKKI  AF N  
Sbjct: 20  GGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGNAFGNII 79

Query: 65  DAQRTYREILFLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMENDLNKVIR-DKIL 120
           DA+RT REI  LK    H N+I ++DI +     N  D+++V+E M+ DL+ +IR ++ L
Sbjct: 80  DAKRTLREIKLLKHMD-HDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPL 138

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
            D H R+ ++QL  GL Y+H+  V+HRDLKPSN+L++ +C +KIGD GLAR+ S++ + +
Sbjct: 139 TDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSET-DFM 197

Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL- 239
           TEY+ TRWYRAPE+L++   YT  +DIWS+GCIL E++  +PLFPG     QL+LI  L 
Sbjct: 198 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELI 257

Query: 240 -------------------VRPNPPHADK-FYAGFKNKPEEAVDLLNQILVLNPSERPET 279
                              VR  P +  + F A F N    AVDLL ++LV +P+ R   
Sbjct: 258 GSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITV 317

Query: 280 DQILEHNYVS 289
           D+ L H Y++
Sbjct: 318 DEALCHPYLA 327

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P28482|MK01_HUMAN Mitogen-activated protein kinase 1 OS=Homo sapiens GN=MAPK1 PE=1 SV=3

 Score =  232 bits (591), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82

Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262

Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322

Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
357621464	490	hypothetical protein KGM_08080 [Danaus p	0.769	0.634	0.476	4e-90
187608444	590	mitogen-activated protein kinase 15 [Xen	0.789	0.540	0.466	2e-89
148237882	586	mitogen-activated protein kinase 15 [Xen	0.789	0.544	0.468	2e-89
270010111	467	hypothetical protein TcasGA2_TC009470 [T	0.772	0.668	0.472	1e-88
91085729	488	PREDICTED: similar to MGC99048 protein [	0.772	0.639	0.472	2e-88
242009423	562	mitogen-activated protein kinase ERK-A,	0.797	0.572	0.450	3e-87
313247705	474	unnamed protein product [Oikopleura dioi	0.794	0.677	0.463	8e-87
410911030	614	PREDICTED: mitogen-activated protein kin	0.792	0.521	0.456	5e-86
395512684	579	PREDICTED: mitogen-activated protein kin	0.797	0.556	0.461	2e-85
402879346	544	PREDICTED: mitogen-activated protein kin	0.794	0.590	0.446	1e-84

>gi|357621464|gb|EHJ73286.1| hypothetical protein KGM_08080 [Danaus plexippus]

 Score =  338 bits (866), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 165/346 (47%), Positives = 229/346 (66%), Gaps = 35/346 (10%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           +D +IL  + I KR+GKGAYGIV+KA DK  K  VAIKKIF+AFRN+TDAQRT+REI+FL
Sbjct: 4   IDEHILKRFDIKKRLGKGAYGIVWKAVDKKTKDVVAIKKIFDAFRNQTDAQRTFREIIFL 63

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNG 135
           +SF+ HPNI+ +  I++A+NN+D+Y+ FEYME DL+ VI R  ILKDVH RYIM+Q+   
Sbjct: 64  QSFRNHPNIVKLHSIHRALNNRDIYLGFEYMETDLHNVIKRGNILKDVHKRYIMYQMLKA 123

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--------SKECLTEYIATR 187
             YIH+  V+HRD KPSN+LID +C +K+ D GLARS+S         +  CLT+Y+ATR
Sbjct: 124 TKYIHSGNVIHRDQKPSNVLIDSACRVKLADFGLARSVSSMYSGGEDGADPCLTDYVATR 183

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPH 246
           WYRAPEILI+++ YT  +D+WSLGCIL EML  KPLFPG ST +Q++ ++  L +P+   
Sbjct: 184 WYRAPEILIASKNYTKGIDMWSLGCILGEMLTGKPLFPGTSTVNQIERIMAALPKPSSED 243

Query: 247 ADKFYAGFKNK----------------------PEEAVDLLNQILVLNPSERPETDQILE 284
                +G+ +                       P +A DL+ Q+L+ NP++R   D  L 
Sbjct: 244 ISAVCSGYGSSLIREQAAAHSSSSSLTNQLASAPRDASDLVRQLLLFNPAKRLSADGALH 303

Query: 285 HNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIV 330
           H YV+K+      V     P  V+L + D+ Q+ ++DY++KLY I+
Sbjct: 304 HEYVAKFHREKDEV---TLPSDVLLPLRDDKQMSVDDYRNKLYSIM 346

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|187608444|ref|NP_001120461.1| mitogen-activated protein kinase 15 [Xenopus (Silurana) tropicalis] gi|170284851|gb|AAI61251.1| LOC100145558 protein [Xenopus (Silurana) tropicalis]

 Score =  335 bits (860), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 165/354 (46%), Positives = 243/354 (68%), Gaps = 35/354 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           V+ +I  +Y I KR+GKGAYGIV+KA D+ + + VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct: 6   VEDHISQKYEIKKRLGKGAYGIVWKAIDRKSGEIVAVKKIFDAFRNRTDAQRTFREIMFL 65

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII +L++ +A N+KD+Y+VFE+ME DL+ VI+   +L+D+H+RYI++QL   
Sbjct: 66  QEFGEHPNIIKLLNVIRAQNDKDIYLVFEHMETDLHAVIKKGNLLRDIHMRYILYQLLKA 125

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
             +IH+  V+HRD KPSNIL+D  C +K+ D GLARSL   +E      LTEY+ATRWYR
Sbjct: 126 TKFIHSGNVIHRDQKPSNILLDGDCLVKLCDFGLARSLYQIQEDAGNPALTEYVATRWYR 185

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-- 248
           APEIL+++ RYT  VD+WS+GCIL EML  KPLFPG ST +Q++ I++++ P P H D  
Sbjct: 186 APEILLASHRYTKGVDMWSVGCILGEMLLGKPLFPGTSTINQIERIMSIIEP-PTHEDIL 244

Query: 249 ----KFYAGFKNK-----------------PEEAVDLLNQILVLNPSERPETDQILEHNY 287
               ++ A    +                 P EA+DLL+++LV NP +R   +  LEH Y
Sbjct: 245 AIRSEYGASVIGRMAAKQRVPLAELFPASCPREALDLLSKLLVFNPGKRLTAEGALEHPY 304

Query: 288 VSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
           VS++   A    P +  + V+L +DD+ QL + +Y++KLY+++   ++K +++R
Sbjct: 305 VSRFHSPARE--PALD-YDVILPVDDDTQLSVAEYRNKLYEMI--LERKMNIRR 353

Source: Xenopus (Silurana) tropicalis

Species: Xenopus (Silurana) tropicalis

Genus: Xenopus

Family: Pipidae

Order: Anura

Class: Amphibia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|148237882|ref|NP_001089435.1| mitogen-activated protein kinase 15 [Xenopus laevis] gi|63100234|gb|AAH95915.1| MGC99048 protein [Xenopus laevis]

 Score =  335 bits (860), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 245/354 (69%), Gaps = 35/354 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           V+ +I  +Y I KR+GKGAYGIV+KA D+ + + VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct: 6   VEDHISQKYDIKKRLGKGAYGIVWKAIDRKSGEIVAVKKIFDAFRNRTDAQRTFREIMFL 65

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII +L++ +A N+KD+Y+VFE+ME DL+ VI+   +LKD+H+RYI++QL   
Sbjct: 66  QEFGEHPNIIKLLNVIRAQNDKDIYLVFEHMETDLHAVIKKGNLLKDIHMRYILYQLLKA 125

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
             +IH+  V+HRD KPSNIL+D  C +K+ D GLARSL   +E      LTEY+ATRWYR
Sbjct: 126 TKFIHSGNVIHRDQKPSNILLDGDCLVKLCDFGLARSLYQIQEDVGNPALTEYVATRWYR 185

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-- 248
           APEIL+++ RYT  VD+WS+GCIL EML  KPLFPG ST +Q++ I++++ P P H D  
Sbjct: 186 APEILLASNRYTKGVDMWSVGCILGEMLLGKPLFPGTSTINQIERIMSIIEP-PTHEDIV 244

Query: 249 ----KFYAGFKNK-----------------PEEAVDLLNQILVLNPSERPETDQILEHNY 287
               ++ A   ++                 P EA+DLL+++LV NP +R   ++ LEH Y
Sbjct: 245 SIKSEYGASVISRMSSKHKVPMAELFPASCPREALDLLSKLLVFNPGKRLTAEEALEHPY 304

Query: 288 VSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
           VS++   A    P +  + V+L +DD+ QL + +Y++KLY+++   ++K +++R
Sbjct: 305 VSRFHSPARE--PALD-YDVILPVDDDIQLSVAEYRNKLYEMI--LERKMNIRR 353

Source: Xenopus laevis

Species: Xenopus laevis

Genus: Xenopus

Family: Pipidae

Order: Anura

Class: Amphibia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|270010111|gb|EFA06559.1| hypothetical protein TcasGA2_TC009470 [Tribolium castaneum]

 Score =  333 bits (853), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 164/347 (47%), Positives = 230/347 (66%), Gaps = 35/347 (10%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           +D +I   + I KR+GKGAYGIV+KA D+  K  VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct: 11  IDEHISRRFDIQKRLGKGAYGIVWKAIDRKTKDVVAVKKIFDAFRNQTDAQRTFREIMFL 70

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           +S + HPNI+ +  I++A NN D+Y+ FEYME DL+ VI+  ILKDVH +Y+M+QL   +
Sbjct: 71  QSLKNHPNIVKLFSIHRAANNSDIYLGFEYMETDLHNVIKKGILKDVHKKYVMYQLLKAV 130

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLTEYIATRWY 189
            YIH+  V+HRDLKPSNIL+D  C  KI D GLARSL  S +        LT+Y+ATRWY
Sbjct: 131 KYIHSGNVIHRDLKPSNILLDVMCRCKIADFGLARSLYQSSDSLNETDPTLTDYVATRWY 190

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD- 248
           RAPEILI+NRRYT  +D+WSLGCIL E+   KPLFPG+ST +Q++ I+  + P P   D 
Sbjct: 191 RAPEILIANRRYTKGIDMWSLGCILGEITAGKPLFPGSSTVNQVEKIMASI-PTPSQEDI 249

Query: 249 --KFYAGF---------------------KNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                +G                      KN    ++ L+N++LV NP++R   ++ LEH
Sbjct: 250 SQVCVSGVGISMIKNAASSEKVPLITLLGKNACRSSISLINKLLVFNPNKRLTAEEALEH 309

Query: 286 NYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
           +YVS++      +   V PH +V+  +D+ +L + DY++KLY+I+ +
Sbjct: 310 DYVSQFHNPDEEI---VLPHDIVIPFNDDVRLSVEDYRNKLYEIMST 353

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91085729|ref|XP_973435.1| PREDICTED: similar to MGC99048 protein [Tribolium castaneum]

 Score =  332 bits (852), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 164/347 (47%), Positives = 230/347 (66%), Gaps = 35/347 (10%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           +D +I   + I KR+GKGAYGIV+KA D+  K  VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct: 11  IDEHISRRFDIQKRLGKGAYGIVWKAIDRKTKDVVAVKKIFDAFRNQTDAQRTFREIMFL 70

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           +S + HPNI+ +  I++A NN D+Y+ FEYME DL+ VI+  ILKDVH +Y+M+QL   +
Sbjct: 71  QSLKNHPNIVKLFSIHRAANNSDIYLGFEYMETDLHNVIKKGILKDVHKKYVMYQLLKAV 130

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLTEYIATRWY 189
            YIH+  V+HRDLKPSNIL+D  C  KI D GLARSL  S +        LT+Y+ATRWY
Sbjct: 131 KYIHSGNVIHRDLKPSNILLDVMCRCKIADFGLARSLYQSSDSLNETDPTLTDYVATRWY 190

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD- 248
           RAPEILI+NRRYT  +D+WSLGCIL E+   KPLFPG+ST +Q++ I+  + P P   D 
Sbjct: 191 RAPEILIANRRYTKGIDMWSLGCILGEITAGKPLFPGSSTVNQVEKIMASI-PTPSQEDI 249

Query: 249 --KFYAGF---------------------KNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                +G                      KN    ++ L+N++LV NP++R   ++ LEH
Sbjct: 250 SQVCVSGVGISMIKNAASSEKVPLITLLGKNACRSSISLINKLLVFNPNKRLTAEEALEH 309

Query: 286 NYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
           +YVS++      +   V PH +V+  +D+ +L + DY++KLY+I+ +
Sbjct: 310 DYVSQFHNPDEEI---VLPHDIVIPFNDDVRLSVEDYRNKLYEIMST 353

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242009423|ref|XP_002425485.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212509340|gb|EEB12747.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis]

 Score =  328 bits (841), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 160/355 (45%), Positives = 240/355 (67%), Gaps = 33/355 (9%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           ++D +I   Y + KR+GKGAYGIV+KA DK +++ VA+KKIF+AFRN+TDAQRT+REI+F
Sbjct: 16  DIDDHISKRYEMKKRLGKGAYGIVWKAVDKKSREVVAVKKIFDAFRNQTDAQRTFREIMF 75

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCN 134
           L++F+ HPNII +  ++KA NN+D+Y+VF+YM++DL+ VI +  ILKD+H RYIM+QL  
Sbjct: 76  LQAFKDHPNIIRLRGLHKASNNRDIYLVFDYMDSDLHHVIKKGNILKDIHRRYIMYQLLR 135

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--------SDSKECLTEYIAT 186
              Y+H+  V+HRD KPSNILI+  C IK+ D GLARSL        ++    LT+Y+AT
Sbjct: 136 ATRYLHSGDVIHRDQKPSNILINAECRIKLADFGLARSLANYYTEEETEGPPLLTDYVAT 195

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPP 245
           RWYRAPEIL++++RYT  VD+WSLGCIL EML  KPLFPG+ST +Q++ ++  L +P P 
Sbjct: 196 RWYRAPEILVASKRYTKGVDMWSLGCILGEMLLGKPLFPGSSTVNQIERIMAALPKPTPQ 255

Query: 246 HADKFYAGF-------------------KNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
                  G+                   K+  +EA+DL+ ++L+ +P +R    Q L H 
Sbjct: 256 EISNMCTGYGKSLLEGVIGQKTNLKDMIKSSSQEAIDLVTKLLIFDPGKRLTASQALTHP 315

Query: 287 YVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
           YVSK+   +   +     H+++  ++D+ QL +++Y++KLY+++ + K   S K+
Sbjct: 316 YVSKFCNGSEICL----DHSIIPPLNDDVQLSVSEYRNKLYELIANGKNTISKKQ 366

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|313247705|emb|CBY15845.1| unnamed protein product [Oikopleura dioica]

 Score =  327 bits (837), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 167/360 (46%), Positives = 232/360 (64%), Gaps = 39/360 (10%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           V+ +++  Y I +R+GKGAYGIV+KA ++   + VA+KKIF+AFRN TDAQRT+REILFL
Sbjct: 7   VESHLIERYEIRRRLGKGAYGIVWKANERKTGRVVALKKIFDAFRNPTDAQRTFREILFL 66

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII +L++  A N+KD+Y+VFEYME DL+ VIR   IL+D H RYIM QL   
Sbjct: 67  QEFADHPNIIKLLNVVAAKNDKDIYLVFEYMETDLHAVIRKGGILQDAHQRYIMAQLMRA 126

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-------DSKE----CLTEYI 184
            +++H+  V+HRD KPSN+L+D  C++KI D GLARSLS       DS +     LTEY+
Sbjct: 127 TAFLHSGNVIHRDHKPSNVLLDSDCAVKICDFGLARSLSAIAKRRGDSADTSVPALTEYV 186

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
           ATRWYRAPEIL+S+  YT  VD+WSLGCILAEML  KPLFPG ST  Q++ I+ ++ P P
Sbjct: 187 ATRWYRAPEILLSSPHYTKGVDMWSLGCILAEMLLGKPLFPGDSTFDQIEKIIRVI-PQP 245

Query: 245 PHADKFYAGF-----------------------KNKPEEAVDLLNQILVLNPSERPETDQ 281
              D    G                        K+ P++ +DL+ Q+LV NP +RP  + 
Sbjct: 246 SRLDIDVIGSQYALSVVERAQRKQRVTLEQILPKDSPKDGIDLIKQLLVFNPEKRPSAES 305

Query: 282 ILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
            L H YV+++    T   P    + V+  IDD+ QL +++Y+ KLY +++  K  + ++R
Sbjct: 306 CLSHPYVARF---NTKKEPLDLGYQVIPPIDDDIQLSVDEYRSKLYRMIREKKAARDLER 362

Source: Oikopleura dioica

Species: Oikopleura dioica

Genus: Oikopleura

Family: Oikopleuridae

Class: Appendicularia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|410911030|ref|XP_003968993.1| PREDICTED: mitogen-activated protein kinase 15-like [Takifugu rubripes]

 Score =  324 bits (830), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 163/357 (45%), Positives = 233/357 (65%), Gaps = 37/357 (10%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           V+ +I  +Y I KR+GKGAYGIV+KA D+   + VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct: 13  VEEHISLKYEIKKRLGKGAYGIVWKAIDRKTGEIVAVKKIFDAFRNRTDAQRTFREIMFL 72

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNG 135
           + F  HPNI+ +L++ +A N+KD+Y++FEYM+ DL+ VI +  +LKD+H RY+M+QL   
Sbjct: 73  QEFGDHPNIVKLLNVIRAQNDKDIYLIFEYMDTDLHAVIKKGTLLKDIHKRYVMYQLLKA 132

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
           L Y+H+  V+HRD KPSN+L+D  C +K+ D GLARSL   +E      LTEY+ATRWYR
Sbjct: 133 LKYLHSGNVIHRDQKPSNVLLDTDCVVKLCDFGLARSLKQFQEDSCNPALTEYVATRWYR 192

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN------------ 238
           APEIL+ + RYT  VD+WSLGCIL EMLQ K LFPG ST +Q++ I++            
Sbjct: 193 APEILLGSARYTKGVDMWSLGCILGEMLQGKALFPGTSTINQIEKIMSAIPHPSPEDIMA 252

Query: 239 -------------LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                        L++P  P  D         P +A+DLL  +LV NP +R   +Q L+H
Sbjct: 253 IRSEYGSSLIQRMLLKPQVPLQDLLQPSV---PPDALDLLKGLLVFNPDKRLTAEQALQH 309

Query: 286 NYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRL 342
            YVS++   A    P +  + V+L +DD  QL +  Y++KLY+++   +  +S+ +L
Sbjct: 310 PYVSRFHNPAKE--PALN-YDVILPVDDAVQLSVVQYRNKLYEMMLERRTNQSMLKL 363

Source: Takifugu rubripes

Species: Takifugu rubripes

Genus: Takifugu

Family: Tetraodontidae

Order: Tetraodontiformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|395512684|ref|XP_003760565.1| PREDICTED: mitogen-activated protein kinase 15 [Sarcophilus harrisii]

 Score =  322 bits (825), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 164/355 (46%), Positives = 227/355 (63%), Gaps = 33/355 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           VD ++   Y I +R+GKGAYGIV+KA D+   + VAIKKIF+AFRNKTDAQRT+REI FL
Sbjct: 6   VDEHVAQRYLIKRRLGKGAYGIVWKAVDRRTGEIVAIKKIFDAFRNKTDAQRTFREITFL 65

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII +L++ +A N++D+Y+VFE M+ DL+ VIR   +LKD+H  YI++QL   
Sbjct: 66  QEFDNHPNIIRLLNVIRAENDRDIYLVFESMDTDLHSVIRKGNLLKDIHKCYILYQLLRA 125

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
             +IH+  V+HRD KPSN+L+D  C +K+ D GLARSLS   E      LTEY+ATRWYR
Sbjct: 126 TKFIHSGNVIHRDQKPSNVLLDADCCVKLCDFGLARSLSQLHEEPGNPALTEYVATRWYR 185

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APEIL+S+ RYT  VD+WSLGCIL EML  +PLFPG ST +QL+LI+  + P P   D  
Sbjct: 186 APEILLSSHRYTQGVDMWSLGCILGEMLLGRPLFPGTSTLNQLELILAAI-PAPNKEDFL 244

Query: 251 YAGFK-----------------------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             G +                         P EA+DLL ++LV +P +R   D+ L H Y
Sbjct: 245 AIGSEYSACVLQRMGPRQLVTLDSRLPPTTPPEALDLLQRLLVFDPEKRLTADEALRHPY 304

Query: 288 VSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRL 342
           V ++   A    P +  + ++L +DD  QL + DY+++LY ++   +    ++RL
Sbjct: 305 VRRFHCPAKE--PALE-YEIILPVDDGVQLSVVDYRNRLYKMILDRRVNSQLQRL 356

Source: Sarcophilus harrisii

Species: Sarcophilus harrisii

Genus: Sarcophilus

Family: Dasyuridae

Order: Dasyuromorphia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|402879346|ref|XP_003903304.1| PREDICTED: mitogen-activated protein kinase 15 [Papio anubis]

 Score =  320 bits (819), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 158/354 (44%), Positives = 224/354 (63%), Gaps = 33/354 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           VD  I+  Y + +++G+GAYGIV+KA D+   + VAIKKIF+AFR+KTDAQRT+REI+ L
Sbjct: 5   VDPRIVRRYLLRRQLGQGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFREIMLL 64

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNG 135
           + F  HPNII++LD+ +A N++D+Y+VFE+M+ DLN VIR   +L+DVH+R I +QL   
Sbjct: 65  QEFGDHPNIISLLDVIRAENDRDIYLVFEFMDTDLNAVIRKGGLLQDVHVRSIFYQLLQA 124

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
             ++H+  V+HRD KPSN+L+D +C++K+ D GLARSL D  E      LTEY+ATRWYR
Sbjct: 125 TRFLHSGHVVHRDQKPSNVLLDANCTVKLCDFGLARSLGDLPEGPEDQALTEYVATRWYR 184

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+L+S+ RYT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   D  
Sbjct: 185 APEVLLSSHRYTLGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETI-PPPSKEDLL 243

Query: 251 YAG----------FKNKPE-------------EAVDLLNQILVLNPSERPETDQILEHNY 287
             G            ++P              EA+DLL ++LV  P +R    Q L+H Y
Sbjct: 244 ALGSGCRASVLHRLGSRPRQTLDALLPPDTSPEALDLLRRLLVFTPDKRLSATQALQHPY 303

Query: 288 VSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKR 341
           V ++   +     +V    V L   +  QL   +Y+ ++Y ++  CK      R
Sbjct: 304 VQRFHCPSDEWARKV---HVQLRALEGVQLSAPEYRSRVYQMILECKGSNGTSR 354

Source: Papio anubis

Species: Papio anubis

Genus: Papio

Family: Cercopithecidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
ZFIN|ZDB-GENE-050522-307	533	mapk15 "mitogen-activated prot	0.571	0.433	0.545	9.4e-82
UNIPROTKB|E1BT12	539	E1BT12 "Uncharacterized protei	0.571	0.428	0.546	8.4e-79
UNIPROTKB|E1BYP5	608	E1BYP5 "Uncharacterized protei	0.571	0.379	0.546	8.4e-79
FB|FBgn0052703	916	Erk7 "Extracellularly regulate	0.611	0.269	0.521	5.9e-78
UNIPROTKB|E2RLC0	559	MAPK15 "Uncharacterized protei	0.584	0.422	0.551	2.2e-76
MGI|MGI:2652894	549	Mapk15 "mitogen-activated prot	0.561	0.413	0.559	3.6e-76
RGD|628675	547	Mapk15 "mitogen-activated prot	0.561	0.414	0.559	4.6e-76
GENEDB_PFALCIPARUM|PF14_0294	914	PfMAP1 "mitogen-activated prot	0.611	0.270	0.494	4.6e-76
UNIPROTKB|Q8ILF0	914	PfMAP1 "Mitogen-activated prot	0.611	0.270	0.494	4.6e-76
UNIPROTKB|Q8TD08	544	MAPK15 "Mitogen-activated prot	0.584	0.433	0.543	7.5e-76

ZFIN|ZDB-GENE-050522-307 mapk15 "mitogen-activated protein kinase 15" [Danio rerio (taxid:7955)]

 Score = 694 (249.4 bits), Expect = 9.4e-82, Sum P(2) = 9.4e-82
 Identities = 131/240 (54%), Positives = 182/240 (75%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR--TYREIL 74
             V+ +I ++Y I +R+GKGAYGIV+KA D+ + + VA+KKIF+AFRN+TDAQ   T+REI+
Sbjct:     6 VEEHISSKYEIKRRLGKGAYGIVWKAVDRKSGETVAVKKIFDAFRNRTDAQNEITFREIM 65

Query:    75 FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLC 133
             FL+ F  HPNII +L++ +A N+KD+Y++FE+M+ DL+ VI+   +LKD+H RY+M+QL 
Sbjct:    66 FLQEFGDHPNIIKLLNVIRAQNDKDIYLIFEFMDTDLHAVIKKGNLLKDIHKRYVMYQLL 125

Query:   134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRW 188
                 Y+H+  V+HRD KPSNIL+D  C +K+ D GLARSL   +E      LTEY+ATRW
Sbjct:   126 KATKYLHSGNVIHRDQKPSNILLDSDCFVKLCDFGLARSLYQIQEDAGNPALTEYVATRW 185

Query:   189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
             YRAPEIL+ + RYT  VD+WS+GCILAEML  KPLFPG ST +Q++ I+N++ P+P   D
Sbjct:   186 YRAPEILLGSSRYTKGVDMWSIGCILAEMLLGKPLFPGTSTINQIEKIMNVI-PHPSTED 244

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

UNIPROTKB|E1BT12 E1BT12 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 687 (246.9 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
 Identities = 130/238 (54%), Positives = 175/238 (73%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD  +  ++ + +R+GKGAYGIV+KA ++   + VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct:     6 VDAAVAEKFEMKRRLGKGAYGIVWKAINRRTGEIVAVKKIFDAFRNRTDAQRTFREIMFL 65

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNG 135
             + F  HPNII +LD+ +A NNKD+Y+VFE ME DL+ VI+   +LKD+H  YI++QL   
Sbjct:    66 QEFGEHPNIIKLLDVIRAQNNKDIYLVFESMETDLHAVIKKGNLLKDIHKCYILYQLLKA 125

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-----SDSKECLTEYIATRWYR 190
               +IH+  V+HRD KPSNIL+D  C +K+ D GLARSL       S   LTEY+ATRWYR
Sbjct:   126 TKFIHSGNVIHRDQKPSNILLDADCFVKLCDFGLARSLCQMDEEQSSPALTEYVATRWYR 185

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
             APEIL+S+R YT  VD+WS+GCIL E+L  KPLFPG ST +Q++ I+ ++ P P   D
Sbjct:   186 APEILLSSRSYTKGVDMWSIGCILGELLLGKPLFPGTSTINQIEQILRVI-PAPSSED 242

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1BYP5 E1BYP5 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 687 (246.9 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
 Identities = 130/238 (54%), Positives = 175/238 (73%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD  +  ++ + +R+GKGAYGIV+KA ++   + VA+KKIF+AFRN+TDAQRT+REI+FL
Sbjct:     6 VDAAVAEKFEMKRRLGKGAYGIVWKAINRRTGEIVAVKKIFDAFRNRTDAQRTFREIMFL 65

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNG 135
             + F  HPNII +LD+ +A NNKD+Y+VFE ME DL+ VI+   +LKD+H  YI++QL   
Sbjct:    66 QEFGEHPNIIKLLDVIRAQNNKDIYLVFESMETDLHAVIKKGNLLKDIHKCYILYQLLKA 125

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-----SDSKECLTEYIATRWYR 190
               +IH+  V+HRD KPSNIL+D  C +K+ D GLARSL       S   LTEY+ATRWYR
Sbjct:   126 TKFIHSGNVIHRDQKPSNILLDADCFVKLCDFGLARSLCQMDEEQSSPALTEYVATRWYR 185

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
             APEIL+S+R YT  VD+WS+GCIL E+L  KPLFPG ST +Q++ I+ ++ P P   D
Sbjct:   186 APEILLSSRSYTKGVDMWSIGCILGELLLGKPLFPGTSTINQIEQILRVI-PAPSSED 242

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

FB|FBgn0052703 Erk7 "Extracellularly regulated kinase 7" [Drosophila melanogaster (taxid:7227)]

 Score = 709 (254.6 bits), Expect = 5.9e-78, Sum P(2) = 5.9e-78
 Identities = 134/257 (52%), Positives = 189/257 (73%)

Query:     1 MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
             M +  T+ + ++    +D  + + + + KR+GKGAYGIV+KA D+  K  VA+KK+F+AF
Sbjct:     1 MANYQTAHAQERRIQELDQTVESIFDVRKRMGKGAYGIVWKATDRRTKNTVALKKVFDAF 60

Query:    61 RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKI 119
             R++TDAQRTYRE++FL++F+ HPNI+ ++DI+KA NN D Y+VFE+ME+DL+ VI R  +
Sbjct:    61 RDETDAQRTYREVIFLRAFRCHPNIVRLVDIFKASNNLDFYLVFEFMESDLHNVIKRGNV 120

Query:   120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS----- 174
             LKDVH R++M+QL N + +IH+  V+HRDLKPSNILID  C +K+ D GLAR+LS     
Sbjct:   121 LKDVHKRFVMYQLINAIKFIHSGNVIHRDLKPSNILIDSKCRLKVADFGLARTLSSRRIY 180

Query:   175 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH 231
             D  E    LT+Y+ATRWYRAPEIL+++R YT  +D+W LGCIL EM++ KPLF G ST +
Sbjct:   181 DDLEQDGMLTDYVATRWYRAPEILVASRNYTKGIDMWGLGCILGEMIRQKPLFQGTSTVN 240

Query:   232 QLQLIVNLVRPNPPHAD 248
             Q++ IV  + PN    D
Sbjct:   241 QIEKIVTSL-PNVTKLD 256

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005635 "nuclear envelope" evidence=IDA

GO:0034198 "cellular response to amino acid starvation" evidence=IMP

GO:0050709 "negative regulation of protein secretion" evidence=IMP

GO:0007030 "Golgi organization" evidence=IMP

GO:0045792 "negative regulation of cell size" evidence=IMP

GO:0034389 "lipid particle organization" evidence=IMP

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

UNIPROTKB|E2RLC0 MAPK15 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 695 (249.7 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
 Identities = 134/243 (55%), Positives = 176/243 (72%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD ++   Y + +R+GKGAYGIV+KA D+   + VAIKKIF+AFR+KTDAQRT+REI  L
Sbjct:     6 VDDHVAQRYLLKRRLGKGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFREITLL 65

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNG 135
             +    HPNII +LD+ +A N++D+Y+VFE M+ DLN VI + ++L+DVH RYI +QL   
Sbjct:    66 QELGDHPNIIRLLDVIRAENDRDIYLVFESMDTDLNAVICKGRLLRDVHKRYIFYQLLRA 125

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
               YIH+ +V+HRD KPSNIL+D SC +K+ D GLAR LS   E      LT+Y+ATRWYR
Sbjct:   126 TKYIHSGRVIHRDQKPSNILLDSSCVVKLCDFGLARPLSSLPEEPAGQALTDYVATRWYR 185

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
             APE+L+S+  YT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   D  
Sbjct:   186 APEVLLSSSWYTPGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETIPP-PSKEDLL 244

Query:   251 YAG 253
               G
Sbjct:   245 ALG 247

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

MGI|MGI:2652894 Mapk15 "mitogen-activated protein kinase 15" [Mus musculus (taxid:10090)]

 Score = 689 (247.6 bits), Expect = 3.6e-76, Sum P(2) = 3.6e-76
 Identities = 131/234 (55%), Positives = 175/234 (74%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD ++   Y I +R+GKGAYGIV+KA D+   + VAIKKIF+AFR++ DAQRT+REI+ L
Sbjct:     6 VDRHVAQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQIDAQRTFREIMLL 65

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNG 135
             K F  HPNII +LD+  A N++D+Y+VFE M+ DLN VI + ++LKD+H R I +QL   
Sbjct:    66 KEFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLKDIHKRCIFYQLLRA 125

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
               +IH+ +V+HRD KP+N+L+D +C +K+ D GLARSL D  E      LTEY+ATRWYR
Sbjct:   126 TKFIHSGRVIHRDQKPANVLLDSACRVKLCDFGLARSLGDLPEGPGGQALTEYVATRWYR 185

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
             APE+L+S+R YT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P
Sbjct:   186 APEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILKTI-PLP 238

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001934 "positive regulation of protein phosphorylation" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0008156 "negative regulation of DNA replication" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0023014 "signal transduction by phosphorylation" evidence=ISO

GO:0031398 "positive regulation of protein ubiquitination" evidence=ISO

GO:0032355 "response to estradiol stimulus" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

RGD|628675 Mapk15 "mitogen-activated protein kinase 15" [Rattus norvegicus (taxid:10116)]

 Score = 690 (248.0 bits), Expect = 4.6e-76, Sum P(2) = 4.6e-76
 Identities = 131/234 (55%), Positives = 177/234 (75%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD ++   Y I +R+GKGAYGIV+KA D+   + VAIKKIF+AFR++TDAQRT+REI+ L
Sbjct:     6 VDRHVSQRYLIKRRLGKGAYGIVWKAMDRRTGEVVAIKKIFDAFRDQTDAQRTFREIMLL 65

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNG 135
             + F  HPNII +LD+  A N++D+Y+VFE M+ DLN VI + ++L+D+H R I +QL   
Sbjct:    66 REFGGHPNIIRLLDVIPAKNDRDIYLVFESMDTDLNAVIQKGRLLEDIHKRCIFYQLLRA 125

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
               +IH+ +V+HRD KP+N+L+D +C +K+ D GLARSLSD  E      LTEY+ATRWYR
Sbjct:   126 TKFIHSGRVIHRDQKPANVLLDAACRVKLCDFGLARSLSDFPEGPGGQALTEYVATRWYR 185

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
             APE+L+S+R YT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P
Sbjct:   186 APEVLLSSRWYTPGVDMWSLGCILGEMLRGQPLFPGTSTFHQLELILETI-PLP 238

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0000165 "MAPK cascade" evidence=ISO

GO:0001934 "positive regulation of protein phosphorylation" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0008156 "negative regulation of DNA replication" evidence=IMP

GO:0031398 "positive regulation of protein ubiquitination" evidence=IMP

GO:0032355 "response to estradiol stimulus" evidence=IMP

GO:0045732 "positive regulation of protein catabolic process" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=ISO;ISS;IMP

GENEDB_PFALCIPARUM|PF14_0294 PfMAP1 "mitogen-activated protein kinase 1, PfMAP1" [Plasmodium falciparum (taxid:5833)]

 Score = 675 (242.7 bits), Expect = 4.6e-76, Sum P(2) = 4.6e-76
 Identities = 125/253 (49%), Positives = 182/253 (71%)

Query:    11 DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
             +K   ++D N+L +Y I K++GKGAYG+V+K   K NK  VA+KKIF AF+N TDAQRT+
Sbjct:     9 EKSIDSIDENVLKKYDILKKVGKGAYGVVFKGRCKKNKNIVAVKKIFGAFQNCTDAQRTF 68

Query:    71 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMF 130
             REI+FL     H NII ++D+ KA N+ D+Y++F++ME DL++VI+  +L+++H +YI++
Sbjct:    69 REIIFLYELNGHDNIIKLMDVIKAKNDNDIYLIFDFMETDLHEVIKADLLEEIHKKYIIY 128

Query:   131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS----DSK-ECLTEYIA 185
             QL   L YIH+  ++HRD+KPSNIL++  C IK+ D GLARS+S    ++K   LT+Y+A
Sbjct:   129 QLLRALKYIHSGGLLHRDIKPSNILVNSECHIKVADFGLARSISTHVNENKVPILTDYVA 188

Query:   186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 244
             TRWYRAPEIL+ +  YT  VD+WSLGCI+ E+L  KPLF G ST +QL+ I+ ++ +PN 
Sbjct:   189 TRWYRAPEILLGSTHYTEDVDMWSLGCIMGELLCGKPLFTGNSTMNQLEKIIQVIGKPNK 248

Query:   245 PHADKFYAGFKNK 257
                +   + F  K
Sbjct:   249 KDIEDIRSPFAEK 261

GO:0000165 "MAPK cascade" evidence=ISS

GO:0005575 "cellular_component" evidence=ND

UNIPROTKB|Q8ILF0 PfMAP1 "Mitogen-activated protein kinase 1" [Plasmodium falciparum 3D7 (taxid:36329)]

 Score = 675 (242.7 bits), Expect = 4.6e-76, Sum P(2) = 4.6e-76
 Identities = 125/253 (49%), Positives = 182/253 (71%)

Query:    11 DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
             +K   ++D N+L +Y I K++GKGAYG+V+K   K NK  VA+KKIF AF+N TDAQRT+
Sbjct:     9 EKSIDSIDENVLKKYDILKKVGKGAYGVVFKGRCKKNKNIVAVKKIFGAFQNCTDAQRTF 68

Query:    71 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMF 130
             REI+FL     H NII ++D+ KA N+ D+Y++F++ME DL++VI+  +L+++H +YI++
Sbjct:    69 REIIFLYELNGHDNIIKLMDVIKAKNDNDIYLIFDFMETDLHEVIKADLLEEIHKKYIIY 128

Query:   131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS----DSK-ECLTEYIA 185
             QL   L YIH+  ++HRD+KPSNIL++  C IK+ D GLARS+S    ++K   LT+Y+A
Sbjct:   129 QLLRALKYIHSGGLLHRDIKPSNILVNSECHIKVADFGLARSISTHVNENKVPILTDYVA 188

Query:   186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP 244
             TRWYRAPEIL+ +  YT  VD+WSLGCI+ E+L  KPLF G ST +QL+ I+ ++ +PN 
Sbjct:   189 TRWYRAPEILLGSTHYTEDVDMWSLGCIMGELLCGKPLFTGNSTMNQLEKIIQVIGKPNK 248

Query:   245 PHADKFYAGFKNK 257
                +   + F  K
Sbjct:   249 KDIEDIRSPFAEK 261

GO:0000165 "MAPK cascade" evidence=ISS

GO:0005575 "cellular_component" evidence=ND

UNIPROTKB|Q8TD08 MAPK15 "Mitogen-activated protein kinase 15" [Homo sapiens (taxid:9606)]

 Score = 701 (251.8 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 132/243 (54%), Positives = 180/243 (74%)

Query:    17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
             VD  I+  Y + +++G+GAYGIV+KA D+   + VAIKKIF+AFR+KTDAQRT+REI  L
Sbjct:     5 VDPRIVRRYLLRRQLGQGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFREITLL 64

Query:    77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNG 135
             + F  HPNII++LD+ +A N++D+Y+VFE+M+ DLN VIR   +L+DVH+R I +QL   
Sbjct:    65 QEFGDHPNIISLLDVIRAENDRDIYLVFEFMDTDLNAVIRKGGLLQDVHVRSIFYQLLRA 124

Query:   136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-----CLTEYIATRWYR 190
               ++H+  V+HRD KPSN+L+D +C++K+ D GLARSL D  E      +TEY+ATRWYR
Sbjct:   125 TRFLHSGHVVHRDQKPSNVLLDANCTVKLCDFGLARSLGDLPEGPEDQAVTEYVATRWYR 184

Query:   191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
             APE+L+S+ RYT  VD+WSLGCIL EML+ +PLFPG ST HQL+LI+  + P P   D  
Sbjct:   185 APEVLLSSHRYTLGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETIPP-PSEEDLL 243

Query:   251 YAG 253
               G
Sbjct:   244 ALG 246

GO:0005524 "ATP binding" evidence=IEA

GO:0000122 "negative regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0001934 "positive regulation of protein phosphorylation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0008156 "negative regulation of DNA replication" evidence=IEA

GO:0031398 "positive regulation of protein ubiquitination" evidence=IEA

GO:0032355 "response to estradiol stimulus" evidence=IEA

GO:0045732 "positive regulation of protein catabolic process" evidence=IEA

GO:0017124 "SH3 domain binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005622 "intracellular" evidence=NAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004707 "MAP kinase activity" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q336X9	MPK6_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.4153	0.6930	0.7446	yes	N/A
Q4WSF6	HOG1_ASPFU	2, ., 7, ., 1, 1, ., 2, 4	0.4040	0.6509	0.7185	yes	N/A
Q11179	YPC2_CAEEL	2, ., 7, ., 1, 1, ., 2, 4	0.4484	0.7920	0.6808	yes	N/A
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.4290	0.7079	0.7606	yes	N/A
Q54QB1	ERK2_DICDI	2, ., 7, ., 1, 1, ., 2, 4	0.4219	0.7648	0.8373	yes	N/A
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.3892	0.7277	0.7903	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.824
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	404
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-152
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-117
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-100
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-96
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-95
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-92
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-89
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-88
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-88
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-87
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-83
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-82
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-82
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-80
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-79
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-75
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-74
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-71
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-67
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-67
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-66
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-66
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-65
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-65
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-64
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-64
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-64
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-63
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-62
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-62
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-62
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-61
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-61
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-61
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-61
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-60
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-60
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-59
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-58
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-58
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-57
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-57
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-56
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-55
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-54
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-54
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-53
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-53
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-52
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-47
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-47
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-46
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-46
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-46
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-45
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-45
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-44
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-43
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-43
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-42
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-42
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-41
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-40
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-40
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-39
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-37
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-37
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-36
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-36
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-36
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-36
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-36
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-35
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-34
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-33
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-32
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-32
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-32
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-31
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-30
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-30
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-29
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-29
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-28
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-28
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-27
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-27
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-27
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-27
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-26
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-25
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-25
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-24
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-24
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-23
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-23
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-23
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-22
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-21
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-18
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-18
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-09
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  433 bits (1115), Expect = e-152
 Identities = 162/341 (47%), Positives = 229/341 (67%), Gaps = 31/341 (9%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           +D +IL +Y I +++GKGAYGIV+KA D+  K+ VA+KKIF+AFRN TDAQRT+REI+FL
Sbjct: 1   IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFL 60

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           +    HPNI+ +L++ KA N+KD+Y+VFEYME DL+ VIR  IL+DVH RYIM+QL   L
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-----LTEYIATRWYRA 191
            YIH+  V+HRDLKPSNIL++  C +K+ D GLARSLS+ +E      LT+Y+ATRWYRA
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD--- 248
           PEIL+ + RYT  VD+WS+GCIL EML  KPLFPG ST +QL+ I+ ++   P   D   
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI-GPPSAEDIES 239

Query: 249 -------------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
                                        ++A+DLL ++LV NP++R   ++ LEH YV+
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 290 KYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIV 330
           ++   +      V P+ + + +DDN +L + +Y++KLY+ +
Sbjct: 300 QFHNPSDEP---VLPYPITIPLDDNVKLSVAEYRNKLYEEI 337

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  345 bits (887), Expect = e-117
 Identities = 136/334 (40%), Positives = 187/334 (55%), Gaps = 36/334 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG GAYG+V  A DK   + VAIKKI   F +  DA+R  REI  L+   RH N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 85  IITMLDIYKAVNN---KDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIH 140
           II +LDI +  +     D+Y+V E ME DL+KVI+    L D HI+Y ++Q+  GL Y+H
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL---SDSKECLTEYIATRWYRAPEILIS 197
           +  V+HRDLKPSNIL++ +C +KI D GLAR +    D K  LTEY+ TRWYRAPE+L+S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV----------------- 240
           + RYT  +DIWS+GCI AE+L  KPLFPG     QL LIV ++                 
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 241 -----RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY-FPS 294
                 P  P        F     EA+DLL ++LV +P +R   D+ L H Y+++   P 
Sbjct: 241 NYLKSLPKKPKKP-LSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299

Query: 295 ATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYD 328
                P   P        D+++L   + ++ +Y+
Sbjct: 300 DE---PVAKPPFDFDF-FDDDELTEEELKELIYE 329

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  300 bits (771), Expect = e-100
 Identities = 128/297 (43%), Positives = 183/297 (61%), Gaps = 29/297 (9%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + Y   + IG GAYG+V  A D  + + VAIKKI  AF   T A+RT RE+  L+ F +H
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63

Query: 83  PNIITMLDIYKAVNN--KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYI 139
            NII + DI +      KD+YVV + ME+DL+ +I  D+ L + HIRY ++QL  GL YI
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS----KECLTEYIATRWYRAPEIL 195
           H+  V+HRDLKPSN+L+++ C ++IGD G+AR LS S    K  +TEY+ATRWYRAPE+L
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------AD- 248
           +S   YT  +D+WS+GCI AEML  + LFPG +  HQL+LI++++            +D 
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 249 --KFYAGFKNKP------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             K+      K              EA+DLL+Q+L  +P ER   +Q L+H ++++Y
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  291 bits (748), Expect = 1e-96
 Identities = 131/339 (38%), Positives = 191/339 (56%), Gaps = 38/339 (11%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++   Y     IG+GAYG+V  A  K     VAIKKI   F ++T  QRT REI  L+ F
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRF 60

Query: 80  QRHPNIITMLDIYKAVNN---KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            +H NII +LDI +  +     D+Y+V E ME DL K+I+ + L + HI+Y ++Q+  GL
Sbjct: 61  -KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS---LSDSKECLTEYIATRWYRAPE 193
            YIH+  V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPE
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY-- 251
           I+++++ YT  +DIWS+GCILAEML ++PLFPG    HQL LI+ ++    P  +     
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL--GTPSQEDLNCI 237

Query: 252 ---------------------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                                  F N   +A+DLL+++L  NP +R   ++ L H Y+ +
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Query: 291 YF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYD 328
           Y  PS   V  +  P     D +  + L     ++ +++
Sbjct: 298 YHDPSDEPVAEE--PFP--FDFELFDDLPKEKLKELIFE 332

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  286 bits (734), Expect = 3e-95
 Identities = 117/285 (41%), Positives = 165/285 (57%), Gaps = 25/285 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y    +IG+G YG+VYKA DK   + VAIKKI   F ++   +   REI  LK    HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHAC 142
           II +LD+++     DLY+VFE+M+ DL K+I+D  + L +  I+  ++QL  GL++ H+ 
Sbjct: 60  IIKLLDVFRH--KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            ++HRDLKP N+LI+    +K+ D GLARS        T Y+ TRWYRAPE+L+ ++ Y+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAG-------- 253
             VDIWS+GCI AE+L  +PLFPG S   QL  I   L  P+P    KF +         
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237

Query: 254 -----------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                      F N   +A+DLL+Q+L  +P +R   +Q L H Y
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  278 bits (713), Expect = 1e-92
 Identities = 98/266 (36%), Positives = 149/266 (56%), Gaps = 14/266 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y I +++G+G++G VY A DK   + VAIK I +    K D +R  REI  LK   +HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKL-KHPN 58

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHAC 142
           I+ + D++   +   LY+V EY E  DL  +++ +  L +   R+ + Q+ + L Y+H+ 
Sbjct: 59  IVRLYDVF--EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            ++HRDLKP NIL+D+   +K+ D GLAR L    E LT ++ T  Y APE+ +  + Y 
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEV-LLGKGYG 174

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
             VDIWSLG IL E+L  KP FPG     QL  +   +    P    F     +   EA 
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPG---DDQLLELFKKIGKPKP---PFPPPEWDISPEAK 228

Query: 263 DLLNQILVLNPSERPETDQILEHNYV 288
           DL+ ++LV +P +R   ++ L+H + 
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  274 bits (702), Expect = 1e-89
 Identities = 129/321 (40%), Positives = 187/321 (58%), Gaps = 33/321 (10%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           +  +Y   K IG+GAYGIV  A +    + VAIKKI  AF N+ DA+RT REI  L+   
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61

Query: 81  RHPNIITMLDIYKAVNN---KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGL 136
            H N+I + DI    +     D+Y+V+E M+ DL+++IR  + L D H +Y ++QL  GL
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            YIH+  V+HRDLKPSN+L++ +C +KI D GLAR+ S+  + +TEY+ TRWYRAPE+L+
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------------- 240
           +   YT  +D+WS+GCI AE+L  KPLFPG    HQL+LI  L+                
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241

Query: 241 ------RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK-YFP 293
                  P  P    F   F +    A+DLL ++LV +PS+R   ++ L H Y++  + P
Sbjct: 242 RRYIRSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 294 SATHVIPQVTPHTVVLDIDDN 314
           S   V    TP +   D +++
Sbjct: 301 SDEPVCQ--TPFS--FDFEED 317

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  270 bits (693), Expect = 3e-88
 Identities = 114/294 (38%), Positives = 171/294 (58%), Gaps = 29/294 (9%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
             Y     +G GAYG V  A+D    + VAIKK+   F++   A+RTYRE+  LK    H
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DH 73

Query: 83  PNIITMLDIY---KAVNN-KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            N+I +LD++    ++ + +D+Y+V   M  DLN +++ + L D HI+++++Q+  GL Y
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           IH+  ++HRDLKPSNI +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++ 
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNW 190

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL------------------- 239
             Y   VDIWS+GCI+AE+L  K LFPG+    QL+ I+NL                   
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250

Query: 240 -VRPNPPHADK-FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
            ++  P    K F   F      A+DLL ++LVL+P +R    + L H Y+++Y
Sbjct: 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  267 bits (684), Expect = 9e-88
 Identities = 111/290 (38%), Positives = 158/290 (54%), Gaps = 36/290 (12%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLKS 78
           Y   +++G+G YG+VYKA DK   + VA+KKI      + D +         REI  LK 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKE 54

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGL 136
            + HPNI+ +LD+      + LY+VFEY + DL K +  R   L    I+ IM+QL  GL
Sbjct: 55  LK-HPNIVKLLDVI--HTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           +Y H+ +++HRDLKP NILI++   +K+ D GLAR+        T  + T WYRAPEIL+
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP---------PH 246
            ++ Y+  VDIWS+GCI AEM+  KPLFPG S   QL  I  ++  P           P 
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231

Query: 247 ADKFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNY 287
               +  F  K           E +DLL+++L  NP++R    + L+H Y
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  265 bits (680), Expect = 2e-87
 Identities = 100/266 (37%), Positives = 150/266 (56%), Gaps = 8/266 (3%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + +++G G++G VYKA  K   + VA+K + +        Q   REI  L+    HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPN 59

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+ ++D +   +   LY+V EY E  DL   +     L +   + I  Q+  GL Y+H+ 
Sbjct: 60  IVRLIDAF--EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            ++HRDLKP NIL+D++  +KI D GLA+ L  S   LT ++ T WY APE+L+    Y 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
             VD+WSLG IL E+L  KP F G +   QLQLI  ++ P P   D+    + +  EEA 
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP-PLEFDEPK--WSSGSEEAK 234

Query: 263 DLLNQILVLNPSERPETDQILEHNYV 288
           DL+ + L  +PS+RP  ++IL+H + 
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  254 bits (652), Expect = 6e-83
 Identities = 108/286 (37%), Positives = 163/286 (56%), Gaps = 27/286 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K++G G +G VY A +K   + VAIKK+ + F +  +     RE+  L+    HPN
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPN 59

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           I+ + ++++   N +LY VFEYME +L ++++D   K   +  IR I++Q+  GL++IH 
Sbjct: 60  IVKLKEVFR--ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
               HRDLKP N+L+     +KI D GLAR +  S+   T+Y++TRWYRAPEIL+ +  Y
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYVSTRWYRAPEILLRSTSY 176

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYA-----GFK 255
           +  VDIW+LGCI+AE+   +PLFPG+S   QL  I + L  P      + Y      GF+
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236

Query: 256 --------------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                         N   EA+DL+  +L  +P +RP   Q L+H Y
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  254 bits (650), Expect = 2e-82
 Identities = 104/291 (35%), Positives = 157/291 (53%), Gaps = 33/291 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ---RTY-REILFLKSFQ 80
           Y    +IG+G YG VYKA +K   + VA+KKI    R + + +    T  REI  L+   
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKL- 55

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILK--DVHIRYIMFQLCNGLSY 138
           RHPNI+ + +I  +     +Y+VFEYM++DL  ++    +K  +  I+  M QL  GL Y
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIATRWYRAPEILIS 197
           +H+  ++HRD+K SNILI+    +K+ D GLAR     +    T  + T WYR PE+L+ 
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--------------------V 237
             RY   VD+WS+GCILAE+   KP+F G++   QL+ I                     
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 238 NLVRPNPPHADKFYAGFKNK-PEEAVDLLNQILVLNPSERPETDQILEHNY 287
             ++P  P+  +    FK+     A+DLL+++L L+P +R   DQ L+H Y
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  253 bits (649), Expect = 3e-82
 Identities = 112/286 (39%), Positives = 152/286 (53%), Gaps = 26/286 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQR 81
           Y   K++G+G Y +VYKA DK   + VAIKKI    R +          REI  L+   +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           HPNII +LD++   +N  + +VFE+ME DL KVI+DK  +L    I+  M     GL Y+
Sbjct: 61  HPNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+  ++HRDLKP+N+LI     +K+ D GLARS       +T  + TRWYRAPE+L   R
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR 178

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNP-----------PHA 247
            Y   VD+WS+GCI AE+L   P  PG S   QL  I   L  P                
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238

Query: 248 DKFYAG------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            K +        F    ++A+DLL ++L LNP++R    Q LEH Y
Sbjct: 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  247 bits (633), Expect = 5e-80
 Identities = 110/291 (37%), Positives = 160/291 (54%), Gaps = 34/291 (11%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD--AQRTYREILFLKSFQR 81
            Y I  RIG+GA+GIV+KA D+   + VA+KK+  A R        +  REI  L++ Q 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQ- 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYI 139
           HP ++ +LD++         +V EYM +DL++V+RD  + L +  ++  M  L  G++Y+
Sbjct: 58  HPYVVKLLDVFPH--GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIATRWYRAPEILISN 198
           HA  +MHRDLKP+N+LI     +KI D GLAR  S+ +  L +  +ATRWYRAPE+L   
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNP---------PHAD 248
           R+Y   VD+W++GCI AE+L   PLFPG +   QL ++   L  PN          P  +
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 249 KFYAGFKNKP------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
           K    F                 EA+DLL  +LV +PS+R    + L H Y
Sbjct: 236 KIT--FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  246 bits (630), Expect = 4e-79
 Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 32/298 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           Y + K +G+GAYGIV  A +   + ++ VAIKKI   F  K  A+R  RE+  L+ F+ H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 83  PNIITM--LDIYKAVNNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYI 139
            NI  +  +DI    N  +LY+  E ME DL+++IR  + L D H +  ++Q+  GL YI
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEIL 195
           H+  V+HRDLKP N+L++  C +KI D GLAR  S++       +TEY+ATRWYRAPEI+
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV------------------ 237
           +S + YT  +D+WS+GCILAE+L  KP+F G     QL  I+                  
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241

Query: 238 --NLVR--PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             N +R  PN P    F + F N    A+DLL ++L  +P++R   ++ LEH Y++ +
Sbjct: 242 AQNYIRSLPNIPKK-PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  236 bits (603), Expect = 6e-75
 Identities = 120/292 (41%), Positives = 167/292 (57%), Gaps = 30/292 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y I + IGKG+YG+V  A D +  + VAIKKI + F + +DA R  REI  L+   RHP+
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPD 60

Query: 85  IITMLDIYKAVNN---KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIH 140
           I+ +  I    +    KD+YVVFE ME+DL++VI+ +  L   H ++ ++QL   L YIH
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECL--TEYIATRWYRAPEILIS 197
              V HRDLKP NIL +  C +KI D GLAR + +D+   +  T+Y+ATRWYRAPE+  S
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 198 -NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA------DK- 249
              +YT  +DIWS+GCI AE+L  KPLFPG +  HQL LI +L+    P        +K 
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240

Query: 250 --------------FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                         F   F N    A+ LL ++L  +P +RP  ++ L   Y
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  233 bits (596), Expect = 5e-74
 Identities = 117/292 (40%), Positives = 174/292 (59%), Gaps = 26/292 (8%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           I   Y   + +G GA+G+V  A D+   Q VAIKKI + F     A+RTYRE+  LK   
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL- 66

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           RH NII++ DI+ +   +D+Y V E +  DL++++  + L+   I+Y ++Q+  GL Y+H
Sbjct: 67  RHENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  V+HRDLKPSNILI+++C +KI D GLAR + D +  +T Y++TR+YRAPEI+++ ++
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQ--MTGYVSTRYYRAPEIMLTWQK 182

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP---------------- 244
           Y   VDIWS GCI AEML+ KPLFPG    +Q  +I +L+   P                
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 245 ---PHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              P  +   F   FKN    A+DLL ++LV +P +R    + L H Y++ Y
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  224 bits (572), Expect = 8e-71
 Identities = 102/288 (35%), Positives = 161/288 (55%), Gaps = 28/288 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y +   +G+GAYG+V K  +K   + VAIKK  E+  ++   +   RE+  L+   RH N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+ + + ++      LY+VFEY+E  L +++      L    +R  ++QL   ++Y H+ 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAPEILISNRRY 201
            ++HRD+KP NIL+ +S  +K+ D G AR+L       LT+Y+ATRWYRAPE+L+ +  Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP------HADKFYAGFK 255
              VD+W++GCI+AE+L  +PLFPG S   QL LI   + P PP       ++  +AG  
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 256 ----NKPEE------------AVDLLNQILVLNPSERPETDQILEHNY 287
               ++PE             A+D L   L ++P ER   D++L+H Y
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  216 bits (550), Expect = 4e-67
 Identities = 121/329 (36%), Positives = 190/329 (57%), Gaps = 34/329 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  AYD   +Q VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLD 81

Query: 91  IYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++       N  ++Y+V   M  DLN +++ + L D H++++++QL  GL YIH+  ++H
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIH 141

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C ++I D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 198

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP--------PHADKFYAGFKNK 257
           IWS+GCI+AE+L+ K LFPG     QL+ I+ +V  P+P         HA K+     + 
Sbjct: 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHM 258

Query: 258 PEE------------AVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
           P++            A+DLL ++LVL+  +R    + L H Y S+Y        P+  P+
Sbjct: 259 PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE--PEAEPY 316

Query: 306 TVVLDIDDNNQLEINDYQDKLYDIVKSCK 334
               +  +N +  I ++++  Y+ V S K
Sbjct: 317 D---ESPENKERTIEEWKELTYEEVSSFK 342

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  214 bits (547), Expect = 5e-67
 Identities = 103/296 (34%), Positives = 156/296 (52%), Gaps = 41/296 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TY-REILFLK 77
           EY    RI +G YG+VY+A DK   + VA+KK+      K + ++     T  REI  L 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLREINILL 59

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNG 135
             Q HPNI+T+ ++    N   +Y+V EY+E+DL  ++           ++ +M QL +G
Sbjct: 60  KLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           ++++H   ++HRDLK SN+L++    +KI D GLAR      +  T+ + T WYRAPE+L
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPN----P-----P 245
           +  + Y+  +D+WS+GCI AE+L  KPLFPG S   QL  I  L+  P     P     P
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238

Query: 246 HADKFYAGFKNKP--------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
            A K    F   P              +   DLLN++L  +P++R   +  L+H Y
Sbjct: 239 GAKKKT--FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  212 bits (543), Expect = 2e-66
 Identities = 102/291 (35%), Positives = 151/291 (51%), Gaps = 33/291 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQR- 81
           Y     IG+GAYG VYKA D N  ++VA+KK+        +     T REI  LK  +  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 82  -HPNIITMLDIYKAVNNK---DLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCN 134
            HPNI+ +LD+           L +VFE+++ DL   +       L    I+ +M QL  
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLTEYIATRWYRAPE 193
           G+ ++H+ +++HRDLKP NIL+     +KI D GLAR  S +    LT  + T WYRAPE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPE 176

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPN----PPHAD 248
           +L+    Y   VD+WS+GCI AE+ + +PLF G S + QL  I +++  P+    P +  
Sbjct: 177 VLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235

Query: 249 KFYAGFKNKP------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
              + F +              EE +DLL ++L  NP +R    + L+H Y
Sbjct: 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  211 bits (538), Expect = 8e-66
 Identities = 109/285 (38%), Positives = 158/285 (55%), Gaps = 35/285 (12%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ----RTYREILFLKSFQRHPNI 85
           +IG+G YG+VYKA DK   + VA+KKI    R +T+ +       REI  LK    HPNI
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKEL-NHPNI 60

Query: 86  ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH----IRYIMFQLCNGLSYIHA 141
           + +LD+  + N   LY+VFE+++ DL K + D           I+  ++QL  G++Y H+
Sbjct: 61  VRLLDVVHSENK--LYLVFEFLDLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            +V+HRDLKP N+LID+  ++K+ D GLAR+        T  + T WYRAPEIL+ +R+Y
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-----------VRPNPPHADKF 250
           +  VDIWS+GCI AEM+  +PLFPG S   QL  I              V   P +   F
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237

Query: 251 --------YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                        N  E+ +DLL+++LV +P++R      L+H Y
Sbjct: 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  209 bits (535), Expect = 5e-65
 Identities = 100/308 (32%), Positives = 146/308 (47%), Gaps = 46/308 (14%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L +Y I  ++G+G +G VYKA      + VA+KKI              REI  LK   +
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65

Query: 82  HPNIITMLDIY------KAVNNKDLYVVFEYMENDL-----NKVIRDKILKDVHIRYIMF 130
           HPN++ ++D+              +Y+V  YM++DL     N  ++   L +  I+  M 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYML 122

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--------ECLTE 182
           QL  G++Y+H   ++HRD+K +NILID    +KI D GLAR                  +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 183 Y---IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 239
           Y   + TRWYR PE+L+  RRYT  VDIW +GC+ AEM   +P+  G S   QL LI  L
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242

Query: 240 V-RPNP---------PHADKFYAG----------FKNKPEEAVDLLNQILVLNPSERPET 279
              P           P  +  ++           F     E +DLL+++L L+P +R   
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 280 DQILEHNY 287
              LEH Y
Sbjct: 303 SDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  211 bits (538), Expect = 9e-65
 Identities = 103/288 (35%), Positives = 162/288 (56%), Gaps = 32/288 (11%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           + IG GA+G+V+   D  + + VA+KK+   F+N    +R +RE+  L  F +H N+++ 
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSA 64

Query: 89  LDIYKAVNN---KDLYVVFEYMENDLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           LDI +  +    +++YVV E M++DL+K+I   + L   H++  ++Q+  GL Y+H+  +
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGI 124

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLAR--SLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +HRD+KP N+L++ +C +KI D GLAR     +SK  +T+ + T++YRAPEIL+ +R YT
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYT 183

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG--------- 253
             VDIWS+GCI AE+L  + LF   S   QL LI +L+   P       A          
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG-TPSLEAMRSACEGARAHILR 242

Query: 254 FKNKP--------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
             +KP               EAV LL ++LV +P +R      L H Y
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  210 bits (535), Expect = 1e-64
 Identities = 117/327 (35%), Positives = 178/327 (54%), Gaps = 34/327 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 83

Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 200

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------ADKFYAGFKNK 257
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV               A  +       
Sbjct: 201 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 260

Query: 258 PE------------EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
           P+             AVDLL ++LVL+  +R    Q L H Y ++Y        P   P+
Sbjct: 261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE--PVADPY 318

Query: 306 TVVLDIDDNNQLEINDYQDKLYDIVKS 332
                  ++  L I++++   YD V S
Sbjct: 319 DQSF---ESRDLLIDEWKSLTYDEVIS 342

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  207 bits (529), Expect = 2e-64
 Identities = 93/284 (32%), Positives = 145/284 (51%), Gaps = 24/284 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y I  +IG+G +  V KA  +   +Y AIK + + F++        REI  L+    HPN
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHAC 142
           I+ ++++        L +VFE M+ +L ++I+ +   L +  ++  M+QL   L ++H  
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            + HRD+KP NILI     +K+ D G  R +  SK   TEYI+TRWYRAPE L+++  Y 
Sbjct: 120 GIFHRDIKPENILIKDDI-LKLADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTDGYYG 177

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFK------ 255
             +DIW++GC+  E+L   PLFPG +   Q+  I +++  P+     KF           
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237

Query: 256 ------------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                       N   E +DLL ++L  +P ER    Q L H Y
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  208 bits (531), Expect = 4e-64
 Identities = 118/333 (35%), Positives = 181/333 (54%), Gaps = 35/333 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K++G GAYG V  A DK   + VAIKK+   F+++  A+R YRE+  LK  Q H N
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HEN 75

Query: 85  IITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I +LD++ +       +D Y+V  YM+ DL K++    L +  ++Y+++Q+  GL YIH
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP-LSEDKVQYLVYQMLCGLKYIH 134

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  ++HRDLKP N+ +++ C +KI D GLAR  +D++  +T Y+ TRWYRAPE++++   
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-ADAE--MTGYVVTRWYRAPEVILNWMH 191

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADK---------- 249
           Y   VDIWS+GCI+AEML  K LF G     QL  I+ +   P P    K          
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251

Query: 250 ----------FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVI 299
                     F   F     +AVDLL ++L L+  +R    + LEH Y   +        
Sbjct: 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF-----RDA 306

Query: 300 PQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
            + T      D  +N +L +++++  +Y  VKS
Sbjct: 307 DEETEQQPYDDSLENEKLSVDEWKKHIYKEVKS 339

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  203 bits (519), Expect = 7e-64
 Identities = 81/259 (31%), Positives = 123/259 (47%), Gaps = 49/259 (18%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+G +G VY A DK   + VAIK I +   +    +   REI  LK    HPNI+ +  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN-HPNIVKLYG 58

Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
           +++  +   LY+V EY E   L  ++++    L +  I  I+ Q+  GL Y+H+  ++HR
Sbjct: 59  VFE--DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 148 DLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           DLKP NIL+D     +K+ D GL++ L+  K  L   + T  Y APE+L+    Y+   D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLN 266
           IWSLG IL E+                                          E  DL+ 
Sbjct: 177 IWSLGVILYEL-----------------------------------------PELKDLIR 195

Query: 267 QILVLNPSERPETDQILEH 285
           ++L  +P +RP   +ILEH
Sbjct: 196 KMLQKDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  205 bits (524), Expect = 3e-63
 Identities = 106/304 (34%), Positives = 148/304 (48%), Gaps = 48/304 (15%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTY-----------REILFL 76
             +G+G YG V KAYD    + VAIKK+      N     R             RE+  +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNG 135
              + H NI+ ++D+Y  V    + +V + M +DL KV+  KI L +  ++ I+ Q+ NG
Sbjct: 75  NEIK-HENIMGLVDVY--VEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--------------SDSKECLT 181
           L+ +H    MHRDL P+NI I+     KI D GLAR                   +E +T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV- 240
             + T WYRAPE+L+   +Y   VD+WS+GCI AE+L  KPLFPG +   QL  I  L+ 
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Query: 241 RPNP---PHADK--------------FYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
            PN    P A K                  F N  ++A+DLL  +L LNP ER    + L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 284 EHNY 287
           +H Y
Sbjct: 312 KHEY 315

Length = 335

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  204 bits (520), Expect = 2e-62
 Identities = 113/321 (35%), Positives = 174/321 (54%), Gaps = 32/321 (9%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
             Y   K++G GAYG V  A D+     VAIKK++  F+++  A+R YRE+  LK   +H
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KH 73

Query: 83  PNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            N+I +LD++    +     D Y+V  +M  DL K+++ + L +  I+++++Q+  GL Y
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           IHA  ++HRDLKP N+ +++ C +KI D GLAR  +DS+  +T Y+ TRWYRAPE++++ 
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSE--MTGYVVTRWYRAPEVILNW 190

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--------------------N 238
             YT  VDIWS+GCI+AEML  KPLF G     QL  I+                    N
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 239 LVRPNPPHADK-FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
            V+  P    K F +   N    AV++L ++LVL+   R    + L H Y  ++      
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310

Query: 298 VIPQVTPHTVVLDIDDNNQLE 318
              +  P+    D + +  LE
Sbjct: 311 --TEAPPYDDSFD-EVDQSLE 328

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  202 bits (517), Expect = 2e-62
 Identities = 105/297 (35%), Positives = 160/297 (53%), Gaps = 41/297 (13%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILF 75
           + E+    RIG+G YGIVY+A D  + + VA+KK+      + D +R      + REI  
Sbjct: 6   VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITL 59

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLC 133
           L +  RHPNI+ + ++    +   +++V EY E DL  ++ +      +  ++ +M QL 
Sbjct: 60  LLNL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 134 NGLSYIHACKVMHRDLKPSNILI-DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
            GL Y+H   ++HRDLK SN+L+ DK C +KI D GLAR+     + +T  + T WYRAP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP------- 244
           E+L+    YT  +D+W++GCILAE+L  KPL PG S   QL LI+ L+  PN        
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237

Query: 245 --PHADKFYAGFKNKP------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
             P   KF      +P            E  + LLN +L+ +P +R   ++ LE +Y
Sbjct: 238 DLPLVGKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  201 bits (513), Expect = 4e-62
 Identities = 98/282 (34%), Positives = 156/282 (55%), Gaps = 30/282 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+G+YG+V K   K   Q VAIKK  E+  +K   +   REI  LK   RH N++ +++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIE 67

Query: 91  IYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           +++    K LY+VFE+++    +DL K      L +  +R  +FQ+  G+ + H+  ++H
Sbjct: 68  VFR--RKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RD+KP NIL+ +S  +K+ D G AR+L+   E  T+Y+ATRWYRAPE+L+ + +Y   VD
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIV-----------NLVRPNPP---------- 245
           IW++GC++ EML  +PLFPG S   QL  I+            + + NP           
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             +     F       +DL  Q L ++P +RP + Q+L H +
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  199 bits (508), Expect = 1e-61
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 19/270 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y I K+IGKG++G VY    K++ +   +K+I  +  ++ + +    E+  LK    HPN
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK-LNHPN 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIR-----YIMFQLCNGLSY 138
           II   + +       L +V EY +  DL++ I+ +  +              QLC  L Y
Sbjct: 61  IIKYYESF--EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H+ K++HRD+KP NI +  +  +K+GD G+++ LS + +     + T +Y +PE+   N
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL-CQN 177

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           + Y +  DIWSLGC+L E+   K  F G +    L+L + +++   P     Y       
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPPIPSQY------S 228

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
            E  +L++ +L  +P ERP   QIL+  ++
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  200 bits (511), Expect = 1e-61
 Identities = 104/293 (35%), Positives = 143/293 (48%), Gaps = 30/293 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
            Y   ++IG+G YG VYKA DKN  + VA+KK       +       REI  L+      
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 84  NIITMLDIYKAVNNK---DLYVVFEYMENDLNKVIRDKILKDVH------IRYIMFQLCN 134
            I+ +LD+           LY+VFEY+++DL K +               I+  M+QL  
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           G+++ H   VMHRDLKP N+L+DK    +KI DLGL R+ S   +  T  I T WYRAPE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------------- 239
           +L+ +  Y+  VDIWS+GCI AEM + +PLFPG S   QL  I  L              
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241

Query: 240 -----VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                  P     D   A   +   E +DLL ++L  +P++R      L H Y
Sbjct: 242 LRDWHEFPQWKPQDLSRA-VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  199 bits (509), Expect = 2e-61
 Identities = 96/283 (33%), Positives = 156/283 (55%), Gaps = 30/283 (10%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+YG+V+K  ++   Q VAIKK  E+  +    +   REI  LK   +HPN++ ++
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLI 66

Query: 90  DIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           ++++    + L++VFEY +    N+L K    + + +  I+ I++Q    +++ H    +
Sbjct: 67  EVFR--RKRKLHLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRD+KP NILI K   IK+ D G AR L+   +  T+Y+ATRWYRAPE+L+ + +Y   V
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN---------------------LVRPNP 244
           D+W++GC+ AE+L  +PL+PG S   QL LI                       L  P P
Sbjct: 183 DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEP 242

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
              +   + F N    A+  L   L ++P+ER   +++LEH Y
Sbjct: 243 ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  201 bits (513), Expect = 3e-61
 Identities = 113/315 (35%), Positives = 173/315 (54%), Gaps = 51/315 (16%)

Query: 23  AEYTIHKR------IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           + +T+ KR      IG GA GIV  AYD    Q VAIKK+   F+N T A+R YRE++ +
Sbjct: 10  STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM 69

Query: 77  KSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQL 132
           K    H NII +L+++    +    +D+Y+V E M+ +L +VI+   L    + Y+++Q+
Sbjct: 70  KLV-NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MDLDHERMSYLLYQM 127

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             G+ ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAP
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAP 186

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH--------------------Q 232
           E+ I    Y  +VDIWS+GCI+ EM++   LFPG  T H                    +
Sbjct: 187 EV-ILGMGYKENVDIWSVGCIMGEMIRGTVLFPG--TDHIDQWNKIIEQLGTPSDEFMSR 243

Query: 233 LQLIV-NLVRPNPPHA----------DKFYAG----FKNKPEEAVDLLNQILVLNPSERP 277
           LQ  V N V   P +A            F        K K  +A DLL+++LV++P +R 
Sbjct: 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303

Query: 278 ETDQILEHNYVSKYF 292
             D  L+H Y++ ++
Sbjct: 304 SVDDALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  198 bits (505), Expect = 1e-60
 Identities = 102/292 (34%), Positives = 152/292 (52%), Gaps = 35/292 (11%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G +G V+KA  K  KQ VA+KK+      +       REI  L+   +H N++ ++
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLI 77

Query: 90  DI----YKAVNNK--DLYVVFEYMENDLNKVIRDKILK--DVHIRYIMFQLCNGLSYIHA 141
           +I        N      Y+VFE+ E+DL  ++ +K +K     I+ +M  L NGL YIH 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILIS 197
            K++HRD+K +NILI K   +K+ D GLAR+ S SK       T  + T WYR PE+L+ 
Sbjct: 138 NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------VRPNP------ 244
            R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L       V P        
Sbjct: 198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF 257

Query: 245 -----PHADKFYAGFKNKP----EEAVDLLNQILVLNPSERPETDQILEHNY 287
                P   K     + KP      A+DL++++LVL+P++R + D  L H++
Sbjct: 258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  198 bits (505), Expect = 3e-60
 Identities = 106/299 (35%), Positives = 154/299 (51%), Gaps = 39/299 (13%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           + +G G+ G+V+ A D +  + VA+KKI     +    +   REI  ++    H NI+ +
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLD-HDNIVKV 67

Query: 89  LDIYKAVNNKD------------LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            ++     +              +Y+V EYME DL  V+    L + H R  M+QL  GL
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 137 SYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAP 192
            YIH+  V+HRDLKP+N+ I+ +   +KIGD GLAR +      K  L+E + T+WYR+P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI---VNLVRPNP----- 244
            +L+S   YT  +D+W+ GCI AEML  KPLF GA    Q+QLI   V +VR        
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247

Query: 245 ---PHADKFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              P   +   G   +P          EA+D L QIL  NP +R   ++ L H Y+S Y
Sbjct: 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  194 bits (495), Expect = 1e-59
 Identities = 105/289 (36%), Positives = 153/289 (52%), Gaps = 41/289 (14%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ----RTYREILFLKSFQRHPN 84
           ++IG+G YG+VYKA +K   + VA+KKI    R  T+ +       REI  LK    HPN
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELN-HPN 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           I+ +LD+        LY+VFE++  DL K +    L  +    I+  +FQL  GL++ H+
Sbjct: 61  IVKLLDVIH--TENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            +V+HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP-- 258
           +  VDIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P  
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSLPDY 234

Query: 259 --------------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
                               E+  DLL+Q+L  +P++R      L H +
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 1e-58
 Identities = 100/319 (31%), Positives = 161/319 (50%), Gaps = 61/319 (19%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTD--AQRTYREILFLKSFQ 80
           Y I   IG+G YG VYKA  KN K  +  AIKK F+  + +    +Q   REI  L+  +
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVH---IRYIMFQLCN 134
            H N++++++++    +K +Y++F+Y E+DL ++I   R      +    ++ +++Q+ N
Sbjct: 61  -HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 135 GLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSL-SDSKECLTE--YIATR 187
           G+ Y+H+  V+HRDLKP+NIL+     +   +KIGDLGLAR   +  K        + T 
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVN 238
           WYRAPE+L+  R YT  +DIW++GCI AE+L  +P+F G              QL+ I  
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 239 LVRPNPPHADKFYAGFKNKPE------------------------------EAVDLLNQI 268
           ++    P     +   K  PE                              +  DLL ++
Sbjct: 240 VL--GTPTEKD-WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 269 LVLNPSERPETDQILEHNY 287
           L  +P++R   ++ LEH Y
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  190 bits (486), Expect = 2e-58
 Identities = 83/273 (30%), Positives = 131/273 (47%), Gaps = 27/273 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           E+T  + +G+G++G VY A DK+  + +A+K +  +  ++ + +   REI  L S Q HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HP 59

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
           NI+      +      L +  EY+    L+ +++    L +  IR    Q+  GL+Y+H+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISNR 199
             ++HRD+K +NIL+D    +K+ D G A+ L D    E       T ++ APE +I   
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGE 178

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP- 258
            Y    DIWSLGC + EM   KP +              L   NP  A          P 
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWS------------EL--GNPMAALYKIGSSGEPPE 224

Query: 259 ------EEAVDLLNQILVLNPSERPETDQILEH 285
                 EEA D L + L  +P +RP  D++L+H
Sbjct: 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  191 bits (487), Expect = 3e-58
 Identities = 107/287 (37%), Positives = 157/287 (54%), Gaps = 26/287 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y   ++IG+G YG+VYKA D+   + +A+KKI     ++       REI  LK  Q H 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HG 61

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVH-IRYIMFQLCNGLSYIH 140
           NI+ + D+    + K LY+VFEY++ DL K +       K+   I+  ++Q+  G++Y H
Sbjct: 62  NIVRLQDVVH--SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 141 ACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           + +V+HRDLKP N+LID+   ++K+ D GLAR+        T  + T WYRAPEIL+ +R
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPN----------PPHAD 248
            Y+  VDIWS+GCI AEM+  KPLFPG S   +L  I  ++  PN          P +  
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239

Query: 249 KF--------YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            F                   VDLL+++L L+PS+R      LEH Y
Sbjct: 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  189 bits (483), Expect = 1e-57
 Identities = 93/287 (32%), Positives = 147/287 (51%), Gaps = 37/287 (12%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TYREILFLKSFQRHP 83
           +++G+G Y  VYK  ++   + VA+K+I        DA+        REI  +K   +H 
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKEL-KHE 58

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHIRYIMFQLCNGLSYI 139
           NI+ + D+     NK L +VFEYM+ DL K +        L    ++   +QL  G+++ 
Sbjct: 59  NIVRLHDVIH-TENK-LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +V+HRDLKP N+LI+K   +K+ D GLAR+        +  + T WYRAP++L+ +R
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-----------------RP 242
            Y+  +DIWS+GCI+AEM+  +PLFPG +   QL  I  ++                 +P
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236

Query: 243 NPPHAD--KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             P          F +     +DLL+++L LNP  R      L+H +
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  189 bits (481), Expect = 2e-57
 Identities = 101/287 (35%), Positives = 149/287 (51%), Gaps = 26/287 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +YT  ++IG+G YG+VYK  +K   Q VA+KKI      +       REI  LK  Q HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HP 59

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHIRYIMFQLCNGLSYI 139
           NI+ + D+    +   LY++FE++  DL K +    + + +    ++  ++Q+  G+ + 
Sbjct: 60  NIVCLQDVLMQESR--LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+ +V+HRDLKP N+LID    IK+ D GLAR+        T  + T WYRAPE+L+ + 
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPN--------------- 243
           RY+  VDIWS+G I AEM   KPLF G S   QL  I   L  P                
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237

Query: 244 --PPHADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             P           KN  E+ +DLL ++L+ +P++R    + L H Y
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  187 bits (476), Expect = 2e-56
 Identities = 99/307 (32%), Positives = 153/307 (49%), Gaps = 50/307 (16%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILF 75
           + ++ I  +IG+G YG VYKA DK+  + VA+KK+      + D ++        REI  
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKI 59

Query: 76  LKSFQRHPNIITMLDIYKAVNNKD-----------LYVVFEYMENDLNKVIRDKIL--KD 122
           L+    H NI+ + +I   V +K             Y+VFEYM++DL  ++   ++   +
Sbjct: 60  LRQLN-HRNIVNLKEI---VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 123 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLT 181
            HI+  M QL  GL+Y H    +HRD+K SNIL++    IK+ D GLAR   S+     T
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----- 236
             + T WYR PE+L+   RY   +D+WS GCIL E+   KP+F       QL+LI     
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Query: 237 ---------------VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQ 281
                           N ++P   +  +    F   P  A+DLL+ +L L+PS+R   ++
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295

Query: 282 ILEHNYV 288
            L   ++
Sbjct: 296 ALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  182 bits (464), Expect = 6e-55
 Identities = 93/281 (33%), Positives = 145/281 (51%), Gaps = 27/281 (9%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G YG V+KA ++   + VA+K++     ++       REI  LK   +H NI+ + 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLY 65

Query: 90  DIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           D+  +  +K L +VFEY + DL K        I  ++ ++  MFQL  GL++ H+  V+H
Sbjct: 66  DVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-VKSFMFQLLKGLAFCHSHNVLH 122

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+LI+K+  +K+ D GLAR+      C +  + T WYR P++L   + Y+  +D
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 182

Query: 207 IWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR-------PNPPHA--DKFYAGFK- 255
           +WS GCI AE+  + +PLFPG     QL+ I  L+        P        K Y  +  
Sbjct: 183 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPA 242

Query: 256 ---------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                           DLL  +LV NP +R   ++ L+H Y
Sbjct: 243 TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  184 bits (468), Expect = 1e-54
 Identities = 117/344 (34%), Positives = 190/344 (55%), Gaps = 45/344 (13%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K   
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 81  RHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G+
Sbjct: 82  -HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGI 139

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVIL 198

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF----- 250
               Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P P    K      
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257

Query: 251 --------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQILE 284
                   YAG+                  K K  +A DLL+++LV++ S+R   D+ L+
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317

Query: 285 HNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 318 HPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  178 bits (454), Expect = 9e-54
 Identities = 87/269 (32%), Positives = 139/269 (51%), Gaps = 25/269 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
            + I ++IGKG +G VYKA  K   + VAIK I     +K   ++   EI  LK   +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILK-KCKHP 57

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           NI+     Y  +   +L++V E+       DL K   ++ L +  I Y+  +L  GL Y+
Sbjct: 58  NIVKYYGSY--LKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYL 114

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+  ++HRD+K +NIL+     +K+ D GL+  LSD+K   T  + T ++ APE+ I+ +
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPYWMAPEV-INGK 172

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK-- 257
            Y +  DIWSLG    E+ + KP +   S    ++ +  +    PP       G +N   
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPP-------GLRNPEK 222

Query: 258 -PEEAVDLLNQILVLNPSERPETDQILEH 285
             +E  D L + L  NP +RP  +Q+L+H
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  181 bits (461), Expect = 1e-53
 Identities = 117/343 (34%), Positives = 190/343 (55%), Gaps = 43/343 (12%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K   
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 81  RHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            H NII++L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G+
Sbjct: 75  -HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGI 132

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVIL 191

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF----- 250
               Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K      
Sbjct: 192 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 251 --------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQILE 284
                   YAG                   K K  +A DLL+++LV++P++R   D+ L+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310

Query: 285 HNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           H Y++ ++  A    P   P  +     D  +  I ++++ +Y
Sbjct: 311 HPYINVWYDPAEVEAP---PPQIYDKQLDEREHTIEEWKELIY 350

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  177 bits (450), Expect = 9e-53
 Identities = 95/300 (31%), Positives = 144/300 (48%), Gaps = 53/300 (17%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQRTYREILF 75
           Y    ++G+G+Y  VYK   K   Q VA+K+I         F A R          E   
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----------EASL 56

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLC 133
           LK   +H NI+T+ DI      K L +VFEY++ DL + + D    L   ++R  +FQL 
Sbjct: 57  LKDL-KHANIVTLHDIIHT--KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            GL+Y H  +V+HRDLKP N+LI +   +K+ D GLAR+ S   +  +  + T WYR P+
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPD 173

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNL-----------VR 241
           +L+ +  Y+  +D+W +GCI  EM   +PLFPG++    QL  I  +           V 
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 242 PNP---PHADKFYAGFKNKP-----------EEAVDLLNQILVLNPSERPETDQILEHNY 287
            NP   P++  FY     +P               +L  + L   P +R    + ++H Y
Sbjct: 234 SNPEFKPYSFPFY---PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  175 bits (445), Expect = 5e-52
 Identities = 90/265 (33%), Positives = 139/265 (52%), Gaps = 17/265 (6%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+GA G VYKA D+   + VAIKK+    R +   +    EIL +K   +HPNI+  
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNK-ELIINEILIMKDC-KHPNIVDY 80

Query: 89  LDIYKAVNNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVM 145
            D Y      +L+VV EYM+   L  +I      + +  I Y+  ++  GL Y+H+  V+
Sbjct: 81  YDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRD+K  NIL+ K  S+K+ D G A  L+  K      + T ++ APE +I  + Y   V
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE-VIKRKDYGPKV 197

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           DIWSLG +  EM + +P +        L LI     P   + +K+   FK       D L
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK-------DFL 250

Query: 266 NQILVLNPSERPETDQILEHNYVSK 290
           N+ LV +P +RP  +++L+H ++ K
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  171 bits (435), Expect = 7e-50
 Identities = 104/316 (32%), Positives = 170/316 (53%), Gaps = 40/316 (12%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           +L  Y   K IG GA GIV  A+D      VA+KK+   F+N+T A+R YRE++ LK   
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78

Query: 81  RHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            H NII++L+++    +    +D+Y+V E M+ +L +VI  + L    + Y+++Q+  G+
Sbjct: 79  -HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGI 136

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            ++H+  ++HRDLKPSNI++   C++KI D GLAR+   +   +T Y+ TR+YRAPE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRYYRAPEVIL 195

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV------------------- 237
               Y  +VDIWS+GCI+ E+++   +F G     Q   ++                   
Sbjct: 196 G-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254

Query: 238 NLVRPNPP-HADKFYAGF------------KNKPEEAVDLLNQILVLNPSERPETDQILE 284
           N V   P      F   F            K K  +A DLL+++LV++P +R   D+ L 
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314

Query: 285 HNYVSKYFPSATHVIP 300
           H Y++ ++  A    P
Sbjct: 315 HPYITVWYDPAEAEAP 330

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  163 bits (413), Expect = 2e-47
 Identities = 95/281 (33%), Positives = 156/281 (55%), Gaps = 31/281 (11%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GAYG+V K   K  K+ VAIKK  ++  N+   + T RE+  L++ ++  NI+ + +
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE-NIVELKE 67

Query: 91  IYKAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
            ++      LY+VFEY+E ++ +++ +    +  +  +R  ++QL   + + H   ++HR
Sbjct: 68  AFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKNDIVHR 124

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAPEILISNRRYTHHVD 206
           D+KP N+LI  +  +K+ D G AR+LS+      TEY+ATRWYR+PE+L+    Y   VD
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVD 183

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF------YAGFK----N 256
           +WS+GCIL E+   +PLFPG S   QL  I  ++ P P    K       + G +    N
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN 243

Query: 257 KPEE------------AVDLLNQILVLNPSERPETDQILEH 285
            P+              +DL+  +L LNP++R  T+Q L H
Sbjct: 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  161 bits (409), Expect = 7e-47
 Identities = 101/287 (35%), Positives = 147/287 (51%), Gaps = 37/287 (12%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ----RTYREILFLKSFQR--HPN 84
           IG GAYG VYKA D ++  +VA+K +    R +T+       T RE+  LK  +   HPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 85  IITMLDIYKAVNNK---DLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLS 137
           I+ ++D+           + +VFE+++ DL +   DK+    L    I+ +M Q   GL 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDL-RTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++HA  ++HRDLKP NIL+     +K+ D GLAR  S  +  LT  + T WYRAPE+L+ 
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVLLQ 181

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI---------------VNLVRP 242
           +  Y   VD+WS+GCI AEM + KPLF G S + QL  I               V L R 
Sbjct: 182 S-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240

Query: 243 N-PPHADKFYAGFKNKPEE-AVDLLNQILVLNPSERPETDQILEHNY 287
              P   +       + EE    LL ++L  NP +R    + L+H +
Sbjct: 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 9e-47
 Identities = 83/266 (31%), Positives = 134/266 (50%), Gaps = 19/266 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR-EILFLKSFQRH 82
            Y +   IG+GA+G+VYK  +     +VAIK+I    + K +A ++   EI  LK+ + H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLK-H 58

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYI 139
           PNI+  +   +   +  LY++ EY EN  L ++I+      + +   Y+ +Q+  GL+Y+
Sbjct: 59  PNIVKYIGSIE--TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-YQVLQGLAYL 115

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   V+HRD+K +NIL  K   +K+ D G+A  L+D  +     + T ++ APE+ I   
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV-IEMS 174

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
             +   DIWSLGC + E+L   P +   +    L  IV    P  P         +    
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP---------EGISP 225

Query: 260 EAVDLLNQILVLNPSERPETDQILEH 285
           E  D L Q    +P+ RP   Q+L+H
Sbjct: 226 ELKDFLMQCFQKDPNLRPTAKQLLKH 251

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 87/340 (25%), Positives = 148/340 (43%), Gaps = 23/340 (6%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLKSFQRH 82
            Y I +++G+G++G VY A D+   + VA+K + +   +K+   +R  REI  L S    
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGLS 137
           PNI+ + D +   +   LY+V EY++       L K+ R   L +    +I+ Q+ + L 
Sbjct: 58  PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 138 YIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKE------CLTEYIATRWYR 190
           Y+H+  ++HRD+KP NIL+D+    +K+ D GLA+ L D           +  + T  Y 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 191 APEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           APE+L  +S    +   DIWSLG  L E+L   P F G   S      + ++   P  + 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 249 KF---YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
                 +  +   + A DLL ++L  +P  R  +   L H+ ++      + +   + P 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 306 TVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRLSKG 345
                                   +     K      SK 
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335

Length = 384

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  159 bits (405), Expect = 2e-46
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 30/272 (11%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
           T+ K++G+GA+G VYK          +  VA+K + E   + ++ Q     RE   ++  
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKL 58

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIR---YIMFQLCNG 135
             HPNI+ +L +      + L +V EYM   DL   +R    K++ +        Q+  G
Sbjct: 59  D-HPNIVKLLGV--CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPE 193
           + Y+ +   +HRDL   N L+ ++  +KI D GL+R L D          +  RW  APE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APE 174

Query: 194 ILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
             +   ++T   D+WS G +L E+    +  +PG S +  L+ +    R   P       
Sbjct: 175 S-LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP------ 227

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
              N P E   L+ Q    +P +RP   +++E
Sbjct: 228 ---NCPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  160 bits (406), Expect = 2e-46
 Identities = 103/291 (35%), Positives = 156/291 (53%), Gaps = 30/291 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +     T RE+  L+  +  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLC 133
            HPN++ + D+   V+  D    L +VFE+++ DL   +    +  +    I+ +MFQL 
Sbjct: 62  EHPNVVRLFDVC-TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S  +  LT  + T WYRAPE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAPE 179

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           +L+ +  Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++  P      +  A
Sbjct: 180 VLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 253 ----GFKNKPEEAV------------DLLNQILVLNPSERPETDQILEHNY 287
                F +K  + +            DLL + L  NP++R      L H Y
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 3e-46
 Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 39/276 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
           T+ K++G+GA+G VYK          K  VA+K + E   + ++ Q     RE   ++  
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE---DASEQQIEEFLREARIMRKL 58

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HPN++ +L +      + LY+V EYME  DL   +R     L    +     Q+  G+
Sbjct: 59  D-HPNVVKLLGV--CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+ +   +HRDL   N L+ ++  +KI D GL+R L D      +Y          RW 
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-----DDYYRKRGGKLPIRWM 170

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
            APE  +   ++T   D+WS G +L E+    +  +PG S    L+ + N  R   P   
Sbjct: 171 -APES-LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP-- 226

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                  N P E  DL+ Q    +P +RP   +++E
Sbjct: 227 -------NCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  159 bits (403), Expect = 6e-46
 Identities = 96/287 (33%), Positives = 141/287 (49%), Gaps = 35/287 (12%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQRHPNI 85
           +++G+G+Y  VYK   + N Q VA+K I      KT+    +   RE   LK   +H NI
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGL-KHANI 65

Query: 86  ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACK 143
           + + DI      + L  VFEYM  DL + +      L   ++R  MFQL  GL+YIH   
Sbjct: 66  VLLHDIIHT--KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           ++HRDLKP N+LI     +K+ D GLAR+ S   +  +  + T WYR P++L+    Y+ 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLV---------------------- 240
            +DIW  GCI  EMLQ +P FPG S    QL+ I  ++                      
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            P  P   +      ++P +A DL +Q+L++ P +R      L H Y
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  159 bits (402), Expect = 1e-45
 Identities = 95/303 (31%), Positives = 159/303 (52%), Gaps = 29/303 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 80
           +  Y   +++G+G Y  V+K   K  +  VA+K+I     ++  A  T  RE+  LK   
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDL- 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 138
           +H NI+T+ DI     +K L +VFEY++ DL + + D   I+   +++  ++Q+  GL+Y
Sbjct: 62  KHANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H  KV+HRDLKP N+LI++   +K+ D GLAR+ S   +  +  + T WYR P++L+ +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKF- 250
             Y+  +D+W +GCI  EM   +PLFPG++   +L LI  L+        P     D+F 
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239

Query: 251 -YAGFKNKPE-----------EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
            Y   K KP+           E ++LL + L     +R   ++ ++H Y         H 
Sbjct: 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR-IHS 298

Query: 299 IPQ 301
           +P+
Sbjct: 299 LPE 301

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  157 bits (398), Expect = 4e-45
 Identities = 92/289 (31%), Positives = 153/289 (52%), Gaps = 28/289 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 80
           L  Y    ++G+G Y  V+K   K  +  VA+K+I     ++  A  T  RE+  LK+  
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNL- 60

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVH-IRYIMFQLCNGLSY 138
           +H NI+T+ DI      + L +VFEY+++DL + + +   L  +H ++  MFQL  GLSY
Sbjct: 61  KHANIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H  K++HRDLKP N+LI++   +K+ D GLAR+ S   +  +  + T WYR P++L+ +
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-----------VRPNPPHA 247
             Y+  +D+W +GCIL EM   +P+FPG++   +L LI  L           +  N    
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238

Query: 248 DKFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNY 287
              +  ++ +P          + +DLL+ +L+     R   +  L H+Y
Sbjct: 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  153 bits (390), Expect = 4e-44
 Identities = 83/279 (29%), Positives = 141/279 (50%), Gaps = 28/279 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQR 81
           +Y + + IGKG++G V K   K++ + +  K+I   + N T+ ++     E+  L+   +
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILREL-K 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI------RDKILKDVHIRYIMFQLCN 134
           HPNI+   D     +N+ LY+V EY E  DL ++I      R  I ++   R I+ QL  
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR-ILTQLLL 116

Query: 135 GLSYIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            L   H        V+HRDLKP+NI +D + ++K+GD GLA+ L         Y+ T +Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            +PE  +++  Y    DIWSLGC++ E+    P F   +   QLQL   +          
Sbjct: 177 MSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKFRRIPY 232

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            Y+       E  +++  +L ++P +RP T+++L+   +
Sbjct: 233 RYS------SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  152 bits (386), Expect = 3e-43
 Identities = 91/289 (31%), Positives = 149/289 (51%), Gaps = 28/289 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQ 80
           L  Y    ++G+G Y  VYK   K     VA+K+I     ++  A  T  RE+  LK   
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDL- 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 138
           +H NI+T+ DI      K L +VFEY++ DL + + D    +   +++  +FQL  GL+Y
Sbjct: 62  KHANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H  KV+HRDLKP N+LI++   +K+ D GLAR+ S   +  +  + T WYR P+IL+ +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKF- 250
             Y+  +D+W +GCI  EM   +PLFPG++   QL  I  ++        P     ++F 
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239

Query: 251 ---YAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNY 287
              Y  ++             +  +LL+++L     +R   ++ ++H Y
Sbjct: 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  151 bits (383), Expect = 7e-43
 Identities = 87/291 (29%), Positives = 135/291 (46%), Gaps = 44/291 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQ 80
           ++   K IG+G++  V  A +K   +  AIK   K       K    +  +E+L   +  
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-- 59

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSY 138
            HP II +   Y   + ++LY V EY  N +L + IR     D    R+   ++   L Y
Sbjct: 60  GHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS------KECLTE---------- 182
           +H+  ++HRDLKP NIL+DK   IKI D G A+ L  +      K   T           
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 183 ----YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
               ++ T  Y +PE L++ +      D+W+LGCI+ +ML  KP F G++     Q I+ 
Sbjct: 178 RFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236

Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP----ETDQILEH 285
           L    PP          N P +A DL+ ++LVL+P +R       D++  H
Sbjct: 237 LEYSFPP----------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 2e-42
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 26/266 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYRE--ILFLKSFQRHPNII 86
           +GKG++G V     K+  +  A+K +   +  + K + + T  E  IL   S   HP I+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNIL---SRINHPFIV 56

Query: 87  TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKV 144
            +   Y     + LY+V EY    +L   +       +   R+   ++   L Y+H+  +
Sbjct: 57  KL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           ++RDLKP NIL+D    IK+ D GLA+ LS        +  T  Y APE+ +  + Y   
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV-LLGKGYGKA 173

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL 264
           VD WSLG +L EML  KP F     +   + I   +  +P    +F         EA DL
Sbjct: 174 VDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPEF------LSPEARDL 223

Query: 265 LNQILVLNPSER---PETDQILEHNY 287
           ++ +L  +P++R      ++I  H +
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  149 bits (377), Expect = 3e-42
 Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 39/279 (13%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
            +IG G +G VY A + +  + +A+K+I  +    KT  +    E+  L+   +HPN++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNLVK 63

Query: 88  MLDIYKAVNNKDLYVVFEY-MENDLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVM 145
              +   V+ + +Y+  EY     L +++    + D H IR    QL  GL+Y+H+  ++
Sbjct: 64  YYGV--EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSK----ECLTEYIATRWYRAPEILISNRRY 201
           HRD+KP+NI +D +  IK+GD G A  L ++     E +     T  Y APE+ I+  + 
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV-ITGGKG 180

Query: 202 THH---VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             H    DIWSLGC++ EM   K  +       Q+                F+ G  +KP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---------------FHVGAGHKP 225

Query: 259 ---------EEAVDLLNQILVLNPSERPETDQILEHNYV 288
                     E  D L++ L  +P +RP   ++L+H +V
Sbjct: 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  147 bits (373), Expect = 1e-41
 Identities = 90/273 (32%), Positives = 140/273 (51%), Gaps = 23/273 (8%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSF 79
           L  + I K+IGKG + +VYKA    + + VA+KK  IFE    K   Q   +EI  LK  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA-RQDCLKEIDLLKQL 59

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLC 133
             HPN+I  L  +  + N +L +V E  +  DL+++I+      +++ +  I     QLC
Sbjct: 60  D-HPNVIKYLASF--IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           + L ++H+ ++MHRD+KP+N+ I  +  +K+GDLGL R  S         + T +Y +PE
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
             I    Y    DIWSLGC+L EM  LQS       +     + I     P P  AD + 
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHY- 233

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                  EE  DL+++ +  +P +RP+   +L+
Sbjct: 234 ------SEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 1e-40
 Identities = 85/276 (30%), Positives = 139/276 (50%), Gaps = 28/276 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYREILFLKSFQR 81
            +T+ + IGKG++G VYKA DK   Q VAIK I   EA     D Q+   EI FL S  R
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFL-SQCR 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
            P I      +  +    L+++ EY       DL   ++   L + +I +I+ ++  GL 
Sbjct: 58  SPYITKYYGSF--LKGSKLWIIMEYCGGGSCLDL---LKPGKLDETYIAFILREVLLGLE 112

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+H    +HRD+K +NIL+ +   +K+ D G++  L+ +      ++ T ++ APE+ I 
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV-IK 171

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKFYAGFK 255
              Y    DIWSLG    E+ + +P     S  H ++++  + + NPP    +KF   FK
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFLIPKNNPPSLEGNKFSKPFK 228

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                  D ++  L  +P ERP   ++L+H ++ K 
Sbjct: 229 -------DFVSLCLNKDPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  143 bits (364), Expect = 2e-40
 Identities = 89/272 (32%), Positives = 135/272 (49%), Gaps = 28/272 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I +++G+G+YG VYKA  K   Q VAIK +      + D Q   +EI  LK     P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQ-CDSPY 59

Query: 85  IITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I+     Y    N DL++V EY      +D+ K I +K L +  I  I++Q   GL Y+H
Sbjct: 60  IVKYYGSY--FKNTDLWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           + K +HRD+K  NIL+++    K+ D G++  L+D+       I T ++ APE+ I    
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV-IQEIG 175

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE- 259
           Y +  DIWSLG    EM + KP +        + +I N     PP          + PE 
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPP------PTLSD-PEK 224

Query: 260 ---EAVDLLNQILVLNPSERPETDQILEHNYV 288
              E  D + + LV +P ERP   Q+L+H ++
Sbjct: 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  144 bits (365), Expect = 2e-40
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 25/272 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K +G+G+ G+VYK   K   +  A+KKI     ++   ++  RE+  L+S    P ++  
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRS-CESPYVVKC 64

Query: 89  LDIYKAV-NNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC- 142
              Y A     ++ +V EYM+     DL K  +   + +  + YI  Q+  GL Y+H   
Sbjct: 65  ---YGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            ++HRD+KPSN+LI+    +KI D G+++ L ++ +    ++ T  Y +PE  I    Y+
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178

Query: 203 HHVDIWSLGCILAEMLQSK-PLFPGASTS--HQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
           +  DIWSLG  L E    K P  P    S    +Q I +   P+ P         +    
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA--------EEFSP 230

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           E  D ++  L  +P +RP   ++L+H ++ K 
Sbjct: 231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  146 bits (370), Expect = 9e-40
 Identities = 97/308 (31%), Positives = 165/308 (53%), Gaps = 42/308 (13%)

Query: 3   SNTTSKSGDK---VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA 59
           +N   +  D+   + ++++ +    Y +   IG G++G+VY+A   +  + VAIKK+ + 
Sbjct: 43  NNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ- 101

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIY------KAVNNKDLYVVFEYMENDLNK 113
                D Q   RE+L +K+   H NII + D Y      K   N  L VV E++   ++K
Sbjct: 102 -----DPQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155

Query: 114 VIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDL 167
            ++     +  L    ++   +QLC  L+YIH+  + HRDLKP N+LID  + ++K+ D 
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215

Query: 168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 227
           G A++L   +  ++ YI +R+YRAPE+++    YT H+D+WSLGCI+AEM+   P+F G 
Sbjct: 216 GSAKNLLAGQRSVS-YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274

Query: 228 STSHQLQLIVNLVRP---------NPPHADKFYAGFKNK----------PEEAVDLLNQI 268
           S+  QL  I+ ++           NP +AD  +   K K          P++A++ ++Q 
Sbjct: 275 SSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQF 334

Query: 269 LVLNPSER 276
           L   P +R
Sbjct: 335 LKYEPLKR 342

Length = 440

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (358), Expect = 1e-39
 Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 51/284 (17%)

Query: 29  KRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHP 83
           K++G+GA+G VYK            VA+K + E   + ++ +R    +E   +K    HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE---DASEEERKDFLKEARVMKKL-GHP 56

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR----------DKILKDVHIRYIMFQL 132
           N++ +L +      + LY+V EYME  DL   +R             L    +     Q+
Sbjct: 57  NVVRLLGV--CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------ 186
             G+ Y+ + K +HRDL   N L+ +   +KI D GL+R + D       Y         
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKKTGGKLP 170

Query: 187 -RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR-P 242
            RW  APE  + +  +T   D+WS G +L E+  L + P +PG S    L+ +    R P
Sbjct: 171 IRWM-APE-SLKDGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRKGYRLP 227

Query: 243 NPPHA-DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            P +  D+ Y           +L+     L+P +RP   +++E 
Sbjct: 228 KPEYCPDELY-----------ELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (357), Expect = 2e-39
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 40/278 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
            + K++G+GA+G VYK       +  +  VA+K + E     ++ +R     E   +K  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE---GASEEEREEFLEEASIMKKL 58

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGL 136
             HPNI+ +L +      + LY+V EYM   DL   +R     L    +  +  Q+  G+
Sbjct: 59  S-HPNIVRLLGV--CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+ +   +HRDL   N L+ ++  +KI D GL+R + +       Y          +W 
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED----DYYRKRGGGKLPIKWM 171

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
            APE  + + ++T   D+WS G +L E+  L  +P +PG S    L+L+ +  R   P  
Sbjct: 172 -APE-SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLEDGYRLPRP-- 226

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                  +N P+E  +L+ Q    +P +RP   +++E 
Sbjct: 227 -------ENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 5e-38
 Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 27/270 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +G GA+G VYKA  K    + A K I  E+     D      EI  L    +HPNI+ + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSEC-KHPNIVGLY 68

Query: 90  DIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           + Y       L+++ E+ +    D   +  ++ L +  IRY+  Q+   L+++H+ KV+H
Sbjct: 69  EAY--FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI----SNRRYT 202
           RDLK  NIL+     +K+ D G++     + +    +I T ++ APE++      +  Y 
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD---KFYAGFKNKPE 259
           +  DIWSLG  L E+ Q +P  P     + +++++ +++  PP  D   K+ + F     
Sbjct: 187 YKADIWSLGITLIELAQMEP--PHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFN---- 239

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
              D L   LV +P +RP   ++L+H +VS
Sbjct: 240 ---DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  134 bits (340), Expect = 4e-37
 Identities = 86/269 (31%), Positives = 130/269 (48%), Gaps = 25/269 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQRH 82
           + + K++GKG+YG VYK    ++ Q+ A+K++     + +  +R     EI  L S   H
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVN-H 58

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGL 136
           PNII+  + +   N   L +V EY    DL+K I       K++ +  I  I  QL  GL
Sbjct: 59  PNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
             +H  K++HRDLK +NIL+  +  +KIGDLG+++ L   K      I T  Y APE+  
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVW- 173

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             R Y++  DIWSLGC+L EM    P F   S       +     P  P           
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP---------I 224

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEH 285
             ++  + +  +L + P  RP  D+IL  
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 4e-37
 Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 30/278 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + + IG+G YG VYKA  K   Q VAIK +      + + +    E   L+ +  HPN
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPN 64

Query: 85  IITMLDIYKA----VNNKDLYVVFEYMEN----DLNKVIRD--KILKDVHIRYIMFQLCN 134
           I T    +       N+  L++V E        DL K +R   K LK+  I YI+ +   
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           GL+Y+H  KV+HRD+K  NIL+ K+  +K+ D G++  L  +      +I T ++ APE+
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 195 LISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---HA 247
           +  +      Y    D+WSLG    E+   KP        H ++ +  + R  PP     
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNPPPTLKSP 241

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           + +   F        D +++ L+ N  +RP  +++LEH
Sbjct: 242 ENWSKKF-------NDFISECLIKNYEQRPFMEELLEH 272

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  135 bits (340), Expect = 1e-36
 Identities = 96/295 (32%), Positives = 140/295 (47%), Gaps = 31/295 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   +++G+G+Y  VYK   K N + VA+K I       T      RE   LK   +H N
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT-AIREASLLKGL-KHAN 64

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           I+ + DI      + L +VFEY+  DL + + DK    +H   ++  +FQL  GLSYIH 
Sbjct: 65  IVLLHDIIHT--KETLTLVFEYVHTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             ++HRDLKP N+LI  +  +K+ D GLAR+ S      +  + T WYR P++L+ +  Y
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 202 THHVDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLI-VNLVRPNPPHADKFYAGFKNKPE 259
           +  +D+W +GCI  EM+Q    FPG      QL+ I + L  PN       ++    KPE
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241

Query: 260 E---------------------AVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                                 A DL +++L   P  R      L H Y S   P
Sbjct: 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  133 bits (336), Expect = 3e-36
 Identities = 86/272 (31%), Positives = 135/272 (49%), Gaps = 32/272 (11%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNIIT 87
           I KGAYG V+ A  K+     AIK I +A    +N+ D   T R+IL   S  + P ++ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL---SQAQSPYVVK 57

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   ++   N  LY+V EY+   DL  ++ +   L +   R  + ++   L Y+H+  ++
Sbjct: 58  LYYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLAR---------SLSDSKECLTEYIATRWYRAPEILI 196
           HRDLKP NILID +  +K+ D GL++            D KE     + T  Y APE+++
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDYIAPEVIL 174

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             + ++  VD WSLGCIL E L   P F G +     Q I+N     P            
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--------DVE 225

Query: 257 KPEEAVDLLNQILVLNPSERPET---DQILEH 285
             +EA+DL++++LV +P +R      ++I  H
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  132 bits (334), Expect = 4e-36
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 21/265 (7%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ---RTYREILFLKSFQRHPNIIT 87
           +G G++G VY+  + ++  + A+K++  A   +T  +   +  +EI  L   Q HPNI+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQ 66

Query: 88  MLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVM 145
            L   +  +N  LY+  E +    L K+++      +  IR    Q+  GL Y+H    +
Sbjct: 67  YLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRD+K +NIL+D +  +K+ D G+A+ + +     + +  + ++ APE++     Y    
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGGYGLAA 183

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN--PPHADKFYAGFKNKPEEAVD 263
           DIWSLGC + EM   KP +   S    +  +  + R    PP  D           EA D
Sbjct: 184 DIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLSD-------EAKD 233

Query: 264 LLNQILVLNPSERPETDQILEHNYV 288
            + + L  +PS RP   ++LEH +V
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  133 bits (336), Expect = 6e-36
 Identities = 92/314 (29%), Positives = 163/314 (51%), Gaps = 61/314 (19%)

Query: 30  RIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           ++G+G YG VYKA  K+ K  +  A+K+I         +    REI  L+   +HPN+I+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLREL-KHPNVIS 62

Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH----------IRYIMFQLCNGLS 137
           +  ++ +  ++ ++++F+Y E+DL  +I+       +          ++ +++Q+ +G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 138 YIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYR 190
           Y+HA  V+HRDLKP+NIL+     +   +KI D+G AR  +   + L +    + T WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF----PGASTSH-----QLQLIVNL-- 239
           APE+L+  R YT  +DIW++GCI AE+L S+P+F        TS+     QL  I N+  
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 240 ---------VRPNPPHAD----------------KFYAGFKNKPE-EAVDLLNQILVLNP 273
                    ++  P H+                 K+    K KP+ +A  LL ++L ++P
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302

Query: 274 SERPETDQILEHNY 287
            +R  ++Q ++  Y
Sbjct: 303 IKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  131 bits (332), Expect = 6e-36
 Identities = 89/271 (32%), Positives = 147/271 (54%), Gaps = 21/271 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +Y   K+IG+G++G       K + KQYV IK+I  +  +  + + + +E+  L S  +H
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVL-SNMKH 58

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLCNGLSY 138
           PNI+   + ++   N +LY+V +Y E  DL K I   R  +  +  I     Q+C  L +
Sbjct: 59  PNIVQYQESFE--ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H  K++HRD+K  NI + K  +IK+GD G+AR L+ + E     I T +Y +PEI   N
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CEN 175

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGFKNK 257
           R Y +  DIW+LGC+L EM   K  F   +  +   L++ ++R + PP +  +    +N 
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LVLKIIRGSYPPVSSHYSYDLRN- 231

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                 L++Q+   NP +RP  + ILE N++
Sbjct: 232 ------LVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  133 bits (336), Expect = 7e-36
 Identities = 94/314 (29%), Positives = 162/314 (51%), Gaps = 61/314 (19%)

Query: 30  RIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           ++G+G YG VYKA  K+ K  +  A+K+I         +    REI  L+   +HPN+I 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLREL-KHPNVIA 62

Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVIR----------DKILKDVHIRYIMFQLCNGLS 137
           +  ++ + +++ ++++F+Y E+DL  +I+             L    ++ +++Q+ +G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 138 YIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYR 190
           Y+HA  V+HRDLKP+NIL+     +   +KI D+G AR  +   + L +    + T WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF----PGASTSH-----QLQLIVNL-- 239
           APE+L+  R YT  +DIW++GCI AE+L S+P+F        TS+     QL  I ++  
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242

Query: 240 ---------VRPNPPHAD----------------KFYAGFKNKPEEAVDLLNQ-ILVLNP 273
                    +R  P +                  K+    K KP+  V LL Q +L ++P
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302

Query: 274 SERPETDQILEHNY 287
           ++R  ++Q L+  Y
Sbjct: 303 TKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  129 bits (327), Expect = 3e-35
 Identities = 77/265 (29%), Positives = 138/265 (52%), Gaps = 19/265 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ I  +IGKG++G+V+K   K +K+  A+K+I  +  N+ + +    E   L       
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SS 59

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            II   + +  ++   L +V EY EN     L K+ R + L +  +     Q+  GL+++
Sbjct: 60  YIIRYYESF--LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+ K++HRD+K  N+ +D   ++KIGDLG+A+ LSD+       + T +Y +PE L  ++
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDK 176

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGFKNKP 258
            Y    D+W+LG +L E    K  F     ++Q  LI+ ++R   PP +  +        
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPF---DANNQGALILKIIRGVFPPVSQMYSQ------ 227

Query: 259 EEAVDLLNQILVLNPSERPETDQIL 283
            +   L++Q L  +  +RP+T Q+L
Sbjct: 228 -QLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  128 bits (324), Expect = 1e-34
 Identities = 69/276 (25%), Positives = 131/276 (47%), Gaps = 29/276 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + IG GA  +VY A    N + VAIK+I +  + +T      +E+  +     HPN
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCN-HPN 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN----DLNK-VIRDKILKDVHIRYIMFQLCNGLSYI 139
           ++     +  V   +L++V  Y+      D+ K       L +  I  ++ ++  GL Y+
Sbjct: 61  VVKYYTSF--VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWYRAPEIL 195
           H+   +HRD+K  NIL+ +  S+KI D G++ SL+D  +        ++ T  + APE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------K 249
                Y    DIWS G    E+      +   S    +++++  ++ +PP  +      K
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPSLETGADYKK 235

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           +   F+        +++  L  +PS+RP  +++L+H
Sbjct: 236 YSKSFR-------KMISLCLQKDPSKRPTAEELLKH 264

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 77/273 (28%), Positives = 136/273 (49%), Gaps = 24/273 (8%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF-----LKSFQRHP 83
            +IG+G+ GIV  A DK+  + VA+KK+     +    QR  RE+LF     ++ +Q HP
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQR--RELLFNEVVIMRDYQ-HP 76

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           NI+ M   Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS++HA 
Sbjct: 77  NIVEMYSSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            V+HRD+K  +IL+     +K+ D G    +S         + T ++ APE +IS   Y 
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VISRLPYG 193

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
             VDIWSLG ++ EM+  +P +        ++ I + + P   +  K             
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP-------RLR 246

Query: 263 DLLNQILVLNPSERPETDQILEHNYVSKYFPSA 295
             L+++LV +P++R    ++L H +++K  P +
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  127 bits (320), Expect = 3e-34
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 22/271 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y I K+IG+G++G +Y A  K++ ++  IK+I        + + + +E++ L    +HPN
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPN 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLCNGLSYIH 140
           I+T    ++   N  L++V EY +  DL K I   R  +  +  I     Q+  GL +IH
Sbjct: 61  IVTFFASFQ--ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 141 ACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
             K++HRD+K  NI + K+  + K+GD G+AR L+DS E     + T +Y +PEI   NR
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNR 177

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNK 257
            Y +  DIWSLGC+L E+   K  F G +  HQL L +      P  P+  +        
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVLKICQGYFAPISPNFSR-------- 228

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             +   L++Q+  ++P +RP    IL+  ++
Sbjct: 229 --DLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  127 bits (320), Expect = 8e-34
 Identities = 79/279 (28%), Positives = 143/279 (51%), Gaps = 14/279 (5%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAIK++    + +   +    EIL ++ 
Sbjct: 15  GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRE 72

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             +HPNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 73  -NKHPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 129

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 188

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 246

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
                D LN+ L ++  +R    ++L+H ++    P ++
Sbjct: 247 -----DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  126 bits (318), Expect = 1e-33
 Identities = 88/277 (31%), Positives = 128/277 (46%), Gaps = 34/277 (12%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
             +G G  G+V K   +   + +A+K I     N+   ++  RE+  L      P I+  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCN-SPYIVGF 64

Query: 89  LDIYKA-VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY-------IMFQLCNGLSYIH 140
              Y A  NN D+ +  EYM    +    DKILK+V  R        I   +  GL+Y+H
Sbjct: 65  ---YGAFYNNGDISICMEYM----DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 141 AC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
              K++HRD+KPSNIL++    IK+ D G++  L +S      ++ T  Y APE  I   
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPE-RIQGN 174

Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTS----HQLQLIVNLVRPNPPHADKFYAGF 254
            Y+   DIWSLG  L E+     P  P           LQ IVN   P  P + KF    
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-SGKF---- 229

Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                +  D +N  L+ +P ERP   ++LEH ++ KY
Sbjct: 230 ---SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 2e-33
 Identities = 81/279 (29%), Positives = 134/279 (48%), Gaps = 35/279 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSF 79
           +Y + +RIG G YG VYKA D    + VAIK I      K +    +    +EI  LK  
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQEISMLKEC 57

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNG 135
            RHPNI+     Y  +    L++V EY       D+ +V R   L ++ I Y+  +   G
Sbjct: 58  -RHPNIVAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKG 113

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L+Y+H    +HRD+K +NIL+ +   +K+ D G++  L+ +      +I T ++ APE+ 
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 196 ISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN--PPH---AD 248
              R+  Y    DIW+LG    E+ +   L P     H ++ +  + + N  PP     +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAE---LQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           K+   F        D + + L  +P +RP   ++L+H +
Sbjct: 231 KWSPVFH-------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  122 bits (306), Expect = 4e-32
 Identities = 83/272 (30%), Positives = 143/272 (52%), Gaps = 21/272 (7%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSF 79
           LA + I K+IG+G +  VY+A    +++ VA+KK  IFE    K   Q   +EI  LK  
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA-RQDCVKEIDLLKQL 59

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVI-----RDKILKDVHIRYIMFQLC 133
             HPN+I  LD +  + + +L +V E  +  DL+++I     + +++ +  +     QLC
Sbjct: 60  N-HPNVIKYLDSF--IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           + + ++H+ +VMHRD+KP+N+ I  +  +K+GDLGL R  S         + T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYA 252
            +  N  Y    DIWSLGC+L EM   +  F G    +   L   + + + PP   + Y+
Sbjct: 177 RIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                 E+  +L++  +  +P +RP+   + +
Sbjct: 235 ------EKLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  122 bits (307), Expect = 5e-32
 Identities = 80/284 (28%), Positives = 146/284 (51%), Gaps = 16/284 (5%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 74  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 189

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 247

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVI 299
                D LN+ L ++  +R    ++L+H +  ++K   S T +I
Sbjct: 248 -----DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 8e-32
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 48/282 (17%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR----EILFLKSFQRHPN 84
           K +G+GA+G VY  YD +  + +A+K+      +  + ++       EI  LK+ Q H  
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQ-VPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYI 139
           I+      +  +++ L +  EYM       ++D++     L +   R    Q+  G+ Y+
Sbjct: 66  IVQYYGCLR--DDETLSIFMEYMPGG---SVKDQLKAYGALTETVTRKYTRQILEGVEYL 120

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILI 196
           H+  ++HRD+K +NIL D + ++K+GD G ++ L     S   +     T ++ +PE+ I
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV-I 179

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKP----------LFPGASTSHQLQLIVNLVRPNPPH 246
           S   Y    D+WS+GC + EML  KP          +F  A+     QL        P H
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL--------PSH 231

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                        +A + L +  V N  +RP  +++L H +V
Sbjct: 232 VS----------PDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  121 bits (305), Expect = 1e-31
 Identities = 76/271 (28%), Positives = 140/271 (51%), Gaps = 14/271 (5%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT +++IG+GA G V+ A D    Q VAIK+I    + +   +    EIL +K 
Sbjct: 15  GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKE 72

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD +  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 73  L-KNPNIVNFLDSF--LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALE 129

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++HA +V+HRD+K  N+L+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 188

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K    F+  
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR-- 246

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                D LN+ L ++  +R    ++L+H ++
Sbjct: 247 -----DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  120 bits (302), Expect = 2e-31
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 31/263 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------AQRTYREILFLKS 78
           + + + IGKGA+G V     ++ K+  A+K +     NK         +    E   L+ 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM-----NKQKCVEKGSVRNVLNERRILQE 56

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGL 136
              HP ++ +   Y   + +++Y+V + +   DL   + +     +  +++ + ++   L
Sbjct: 57  L-NHPFLVNLW--YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+H+  ++HRD+KP NIL+D+   + I D  +A  ++      T    T  Y APE+L 
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPEVLC 172

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRPNPPHADKFYAG 253
             + Y+  VD WSLG    E L+ K  + G S                  P         
Sbjct: 173 R-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT------- 224

Query: 254 FKNKPEEAVDLLNQILVLNPSER 276
                 EA+D +N++L  +P +R
Sbjct: 225 ---WSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  119 bits (300), Expect = 2e-31
 Identities = 79/265 (29%), Positives = 131/265 (49%), Gaps = 20/265 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + + +G+G++G        N+ Q  A+K+I    ++ +  + + +E + L +  +HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLL-AKMKHP 58

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYI 139
           NI+   + ++A  +  LY+V EY +  DL + I+    K+  +  I     Q+C G+ +I
Sbjct: 59  NIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +V+HRD+K  NI + ++  +K+GD G AR L+        Y+ T +Y  PEI   N 
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-ENM 175

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAGFKNKP 258
            Y +  DIWSLGCIL E+   K  F   S  +  L++     +P P H            
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSY--------- 226

Query: 259 EEAVDLLNQILVLNPSERPETDQIL 283
            E   L+ Q+   NP  RP    IL
Sbjct: 227 -ELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  119 bits (298), Expect = 1e-30
 Identities = 76/271 (28%), Positives = 139/271 (51%), Gaps = 14/271 (5%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAIK++    + +   +    EIL ++ 
Sbjct: 15  GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRE 72

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 73  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALD 129

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 188

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + ++  A F+  
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR-- 246

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                D LN+ L ++   R    ++L+H ++
Sbjct: 247 -----DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  117 bits (294), Expect = 2e-30
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 41/276 (14%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +GKG YGIVY A D + +  +AIK+I E  R+    Q  + EI  L S+ +H NI+  L 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIA-LHSYLKHRNIVQYLG 72

Query: 91  IYKAVNNKDLYVVFEYMEN----DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHAC 142
              + +    + +F  ME      L+ ++R K       +  I +   Q+  GL Y+H  
Sbjct: 73  ---SDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 143 KVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR- 200
           +++HRD+K  N+L++  S  +KI D G ++ L+    C   +  T  Y APE++    R 
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG-FKNKPE 259
           Y    DIWSLGC + EM   KP F       +L           P A  F  G FK  PE
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF------IELG---------EPQAAMFKVGMFKIHPE 232

Query: 260 -------EAVDLLNQILVLNPSERPETDQILEHNYV 288
                  EA + + +    +P +R     +L+  ++
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 88/276 (31%), Positives = 129/276 (46%), Gaps = 31/276 (11%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITM 88
           R+G+GA G V K   KN     A+K I        D Q+   RE+   KS +  P I+  
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITT--DPNPDLQKQILRELEINKSCK-SPYIVKY 64

Query: 89  LDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIR----------YIMFQLCNGLS 137
              +   ++  + +  EY E   L     D I K V  R           I   +  GLS
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+H+ K++HRD+KPSNIL+ +   +K+ D G++  L +S      +  T +Y APE  I 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPE-RIQ 176

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-----LQLIVNLVRPNPPHADKFYA 252
            + Y+   D+WSLG  L E+ Q++  FP            L  IVN+  PNP   D+   
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--PNPELKDEPGN 234

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           G K   EE  D + Q L  +P+ RP    +LEH ++
Sbjct: 235 GIK-WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  116 bits (292), Expect = 3e-30
 Identities = 72/264 (27%), Positives = 133/264 (50%), Gaps = 17/264 (6%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   + +GKGA+G         +   V  K++     ++ + +    EI+ L   Q HPN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPN 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYME--NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
           II   + +  +++  L +  EY       +K++R   ++ ++  + + +FQ+ + +SYIH
Sbjct: 61  IIAYYNHF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
              ++HRD+K  NI + K+  IK+GD G+++ L          + T +Y +PE L    +
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQGVK 177

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           Y    DIW+LGC+L E+L  K  F     ++ L L+V +V+ N       Y+       E
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDA---TNPLNLVVKIVQGNYTPVVSVYS------SE 228

Query: 261 AVDLLNQILVLNPSERPETDQILE 284
            + L++ +L  +P +RP  D++L+
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  115 bits (289), Expect = 1e-29
 Identities = 80/261 (30%), Positives = 131/261 (50%), Gaps = 21/261 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GA+GIV+    K +++ V IK+I      K +      E   LK    HPNII   +
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYE 66

Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMH 146
            +  + +K L +V EY     L + I+ +   +L +  I +   Q+   L ++H   ++H
Sbjct: 67  NF--LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124

Query: 147 RDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           RDLK  NIL+DK   + KIGD G+++ LS SK      + T  Y +PE L   + Y    
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPE-LCEGKPYNQKS 182

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADKFYAGFKNKPEEAVDL 264
           DIW+LGC+L E+   K  F  A+      L++ ++     P +D++         +   L
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLP---ALVLKIMSGTFAPISDRY-------SPDLRQL 232

Query: 265 LNQILVLNPSERPETDQILEH 285
           +  +L L+PS+RP+  QI+  
Sbjct: 233 ILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 74/276 (26%), Positives = 131/276 (47%), Gaps = 34/276 (12%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTY------REILFLKSFQRHP 83
           IG G++G VY   + ++ + +A+K++   +    +  ++        REI  LK  Q H 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HE 66

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHA 141
           NI+  L    +++   L +  EY+       + +     ++  +R  + Q+  GL+Y+H 
Sbjct: 67  NIVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT------EYIATRWYRAPEIL 195
             ++HRD+K +NIL+D    IKI D G+++ L  +               + ++ APE+ 
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV- 183

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV---NLVRPNPPHADKFYA 252
           +    YT   DIWSLGC++ EML  K  FP  +   QLQ I        P  P       
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIP------- 233

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
              N   EA+D L +   ++ ++RP   ++L+H ++
Sbjct: 234 --SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  115 bits (289), Expect = 1e-29
 Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 28/277 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSF 79
           E+   +++G GA+   Y+A D      +A+K++       ++ +       +EI  +   
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVF-EYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNG 135
             HP+II M     A      + +F E+M    ++ ++       + V I Y   QL  G
Sbjct: 61  N-HPHIIRM---LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-QLLRG 115

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCS-IKIGDLG----LARSLSDSKECLTEYIATRWYR 190
           LSY+H  +++HRD+K +N+LID +   ++I D G    LA   + + E   + + T  + 
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN--PPHAD 248
           APE+L    +Y    D+WS+GC++ EM  +KP +     S+ L LI  +      P   +
Sbjct: 176 APEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
               G +       D+  + L L P +RP + ++L+H
Sbjct: 235 HLSPGLR-------DVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  114 bits (288), Expect = 2e-29
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 24/254 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHPNIITML 89
           +G G +G V     K+  +  A+K + +    +T  Q   + E   L+    HP I+ + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59

Query: 90  DIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             +K  + K +Y++ EY    +L  ++RD+ +  +   R+ +  +     Y+H   +++R
Sbjct: 60  RTFK--DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLKP N+L+D +  +K+ D G A+ L   ++  T +  T  Y APEI I N+ Y   VD 
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEI-ILNKGYDFSVDY 175

Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-----PPHADKFYAGFKNKPEEAV 262
           WSLG +L E+L  +P F G      +++  ++++ N     P + DK           A 
Sbjct: 176 WSLGILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDK----------AAK 224

Query: 263 DLLNQILVLNPSER 276
           DL+ Q+L  NP ER
Sbjct: 225 DLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  114 bits (286), Expect = 4e-29
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 34/278 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQ-YVAIKKIF---EAFR-NKTDAQRTYR----EIL 74
           EY + + +G GA+G VYK   KNN Q  +A+K+I     AF  +K +  ++      E+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI--LKDVHIRY----- 127
            +K   RHPNI+     +  + N  LY+V + +E      + +    LK+   R+     
Sbjct: 61  IIKEQLRHPNIVRYYKTF--LENDRLYIVMDLIEG---APLGEHFNSLKEKKQRFTEERI 115

Query: 128 --IMFQLCNGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 184
             I  Q+   L Y+H  K ++HRDL P+NI++ +   + I D GLA+      + LT  +
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVV 174

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
            T  Y  PEI + N  Y    D+W+ GCIL +M   +P F   +       IV  V    
Sbjct: 175 GTILYSCPEI-VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY--E 231

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
           P  +  Y+      E+  D++   L  +   RP+  Q+
Sbjct: 232 PLPEGMYS------EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  113 bits (284), Expect = 5e-29
 Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 20/271 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFLKSFQR 81
            Y   + +GKG+YG V    +  + KQYV IKK+    RN +  +R   E    L S  +
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYV-IKKL--NLRNASRRERKAAEQEAQLLSQLK 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLS 137
           HPNI+   + ++  +   LY+V  + E  DL   +++   K+L +  +     Q+   L 
Sbjct: 58  HPNIVAYRESWEGEDGL-LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+H   ++HRDLK  N+ + ++  IK+GDLG+AR L +  +  +  I T +Y +PE L S
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFS 175

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           N+ Y +  D+W+LGC + EM   K  F     +  +  I+    P  P         K+ 
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP---------KDY 226

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             E  +L+  +L   P +RP    IL   Y+
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 3e-28
 Identities = 72/254 (28%), Positives = 130/254 (51%), Gaps = 22/254 (8%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K I KGA+G VY A  ++   Y AIK + ++    +N+    +  R I+ ++     P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES--PYV 59

Query: 86  ITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC 142
             +   Y +  +KD LY+V EY+   D   +I+    L +   +  + ++  G+  +H  
Sbjct: 60  AKL---YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            ++HRD+KP N+LID++  +K+ D GL+R+  ++K    +++ T  Y APE ++      
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGVGD-D 171

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
              D WSLGC++ E L   P F   +       I++     P    +F +       EAV
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCS------PEAV 225

Query: 263 DLLNQILVLNPSER 276
           DL+N++L ++P++R
Sbjct: 226 DLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  111 bits (279), Expect = 4e-28
 Identities = 82/293 (27%), Positives = 141/293 (48%), Gaps = 33/293 (11%)

Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           + V+ ++D N + E  I   +G GA+G VYKA +K      A K I    +++ + +   
Sbjct: 2   EHVRRDLDPNEVWE--IIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYM 57

Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRY 127
            EI  L +   HP I+ +L  +    +  L+++ E+      D   +  D+ L +  I+ 
Sbjct: 58  VEIEILATCN-HPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
           I  Q+   L Y+H+ K++HRDLK  N+L+     IK+ D G++     + +    +I T 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 188 WYRAPEIL----ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLV 240
           ++ APE++    + +  Y +  DIWSLG  L EM Q +P        H+L   ++++ + 
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------PHHELNPMRVLLKIA 228

Query: 241 RPNPPHAD---KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           +  PP      K+   F+       D L   L  +P  RP   Q+LEH +VS 
Sbjct: 229 KSEPPTLSQPSKWSMEFR-------DFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  111 bits (280), Expect = 4e-28
 Identities = 81/283 (28%), Positives = 143/283 (50%), Gaps = 32/283 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLKSFQRHP 83
           +T  + IG G++G VY A D    + VAIKK+  + +   +  Q   +E+ FL+   RHP
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHP 75

Query: 84  NIITMLDIYKAVNNKD--LYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           N I     YK    ++   ++V EY     +D+ +V + K L++V I  I      GL+Y
Sbjct: 76  NTIE----YKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAY 130

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS- 197
           +H+ + +HRD+K  NIL+ +  ++K+ D G A  +S +      ++ T ++ APE++++ 
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPYWMAPEVILAM 186

Query: 198 -NRRYTHHVDIWSLG--CI-LAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
              +Y   VD+WSLG  CI LAE  +  PLF   + S    +  N    + P        
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAE--RKPPLFNMNAMSALYHIAQN----DSPTLSS---- 236

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
             +  +   + ++  L   P +RP ++++L+H +V +  P   
Sbjct: 237 -NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  111 bits (278), Expect = 6e-28
 Identities = 73/272 (26%), Positives = 140/272 (51%), Gaps = 15/272 (5%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  K++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 83

Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 84  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIW 200

Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKG-------FLDRL 253

Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           LV +P++R    ++L+H +++K  P +  ++P
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAGPPSC-IVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  110 bits (275), Expect = 1e-27
 Identities = 73/268 (27%), Positives = 140/268 (52%), Gaps = 15/268 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  +RIGKG++G VYK  D   K+ VAIK I +    + + +   +EI  L      P 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PY 63

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           I      Y  +    L+++ EY+       +++   L++ +I  I+ ++  GL Y+H+ +
Sbjct: 64  ITRYYGSY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDF 180

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +P     S  H ++++  + + +PP  +    G  +KP +  +
Sbjct: 181 KADIWSLGITAIELAKGEPPN---SDLHPMRVLFLIPKNSPPTLE----GQYSKPFK--E 231

Query: 264 LLNQILVLNPSERPETDQILEHNYVSKY 291
            +   L  +P  RP   ++L+H ++++Y
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  111 bits (279), Expect = 1e-27
 Identities = 80/311 (25%), Positives = 142/311 (45%), Gaps = 26/311 (8%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           S+++S S            L+E     RIG GA G VYK   +   +  A+K I+    N
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG---N 110

Query: 63  KTDAQRTY--REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRD 117
             D  R    REI  L+    HPN++   D++   +N ++ V+ E+M+    +   +  +
Sbjct: 111 HEDTVRRQICREIEILRDVN-HPNVVKCHDMFD--HNGEIQVLLEFMDGGSLEGTHIADE 167

Query: 118 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
           + L DV       Q+ +G++Y+H   ++HRD+KPSN+LI+ + ++KI D G++R L+ + 
Sbjct: 168 QFLADV-----ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222

Query: 178 ECLTEYIATRWYRAPEIL---ISNRRYTHHV-DIWSLGCILAEMLQSKPLFPGASTSHQL 233
           +     + T  Y +PE +   +++  Y  +  DIWSLG  + E    +  F         
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282

Query: 234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
            L+  +    PP A            E    ++  L   P++R    Q+L+H ++ +  P
Sbjct: 283 SLMCAICMSQPPEAP------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336

Query: 294 SATHVIPQVTP 304
                 P +  
Sbjct: 337 GQGQGGPNLHQ 347

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  109 bits (276), Expect = 2e-27
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 36/264 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQR 81
           ++   K +G G++G V     K + +Y A+K     +  + K   +    E   L+S  R
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK-QVEHVLNEKRILQSI-R 59

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HP ++ +   ++  ++ +LY+V EY     + + L K  R     +   R+   Q+   L
Sbjct: 60  HPFLVNLYGSFQ--DDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLAL 114

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAPE 193
            Y+H+  +++RDLKP N+L+D    IKI D G A+ +       C T EY+      APE
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYL------APE 168

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-KFYA 252
           I I ++ Y   VD W+LG ++ EML   P F   +     + I+            +F +
Sbjct: 169 I-ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------GKVRFPS 219

Query: 253 GFKNKPEEAVDLLNQILVLNPSER 276
            F     +A DL+  +L ++ ++R
Sbjct: 220 FFSP---DAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  108 bits (272), Expect = 3e-27
 Identities = 83/267 (31%), Positives = 134/267 (50%), Gaps = 23/267 (8%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLKSF 79
           LA + I K+IG+G +  VY+A    +   VA+KK  IF+    K       +EI  LK  
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQL 59

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLC 133
             HPN+I     +  + + +L +V E  +  DL+++I+      +++ +  +     QLC
Sbjct: 60  N-HPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           + L ++H+ +VMHRD+KP+N+ I  +  +K+GDLGL R  S         + T +Y +PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +  N  Y    DIWSLGC+L EM  LQS P +      + L   +      P  +D + 
Sbjct: 177 RIHEN-GYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLYSLCKKIEQCDYPPLPSDHY- 233

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPE 278
                  EE   L+N  +  +P +RP+
Sbjct: 234 ------SEELRQLVNMCINPDPEKRPD 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  108 bits (272), Expect = 5e-27
 Identities = 77/280 (27%), Positives = 129/280 (46%), Gaps = 26/280 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GAYG+V K         +A+K+I    R   ++Q   R ++ L    R  +    + 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI----RATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 91  IYKAV-NNKDLYVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGLSYIHA-CK 143
            Y A+    D+++  E M+  L+K  +    K + I       I   +   L Y+H+   
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNRR 200
           V+HRD+KPSN+LI+++  +K+ D G++  L DS    T     + Y APE +   ++ + 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKG 183

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH--ADKFYAGFKNKP 258
           Y    D+WSLG  + E+   +  FP  S     Q +  +V    P   A+KF   F    
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF---- 237

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
               D +N+ L  N  ERP   ++L+H +   +    T V
Sbjct: 238 ---QDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (270), Expect = 6e-27
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI----------FEAFRNKTDAQRTYREILFLKSFQ 80
           IGKG YG VY A +    + +A+K++              ++   A R+  EI  LK   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS--EIETLKDLD 66

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLS 137
            H NI+  L        + L +  EY+    +   +R   +  + + +R+   Q+  GL+
Sbjct: 67  -HLNIVQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-VRFFTEQVLEGLA 122

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEIL 195
           Y+H+  ++HRDLK  N+L+D     KI D G+++   D    +       + ++ APE++
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 196 ISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL--VRPNPPHADKFYA 252
            S  + Y+  VDIWSLGC++ EM   +  +   S    +  +  L   R  PP       
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSM 239

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              N    A+D LN    +NP  RP   ++L+H
Sbjct: 240 ---NLSPVALDFLNACFTINPDNRPTARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 8e-27
 Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 56/301 (18%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQ 80
           ++ + K IG+GA+G V+   DK+  Q  A+K + ++    RN+    R  R+IL   +  
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL---ADA 58

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSY 138
             P I+ +   Y   + + LY+V EYM   DL N +IR  +  +   R+ + +L   L  
Sbjct: 59  DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------------CLTEYIA 185
           +H    +HRD+KP NILID    IK+ D GL + ++ +K+                  + 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 186 TRW----------------YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 229
            R                 Y APE+L     Y    D WSLG IL EML   P F   + 
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 230 SHQLQLIVN----LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER-PETDQILE 284
                 I+N    L  P  P              EA+DL+ + L+ +P +R    ++I  
Sbjct: 236 QETYNKIINWKESLRFPPDPPV----------SPEAIDLICR-LLCDPEDRLGSFEEIKS 284

Query: 285 H 285
           H
Sbjct: 285 H 285

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (267), Expect = 1e-26
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 21/272 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL--FLKSFQRH 82
           Y + +R+GKG++G VY   DK       +K + E    + +   T +      L S   H
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGL 136
           P I+     +  +      ++ EY E  DL+  + +     K L +  +     QL  G+
Sbjct: 62  PAIVKFHASF--LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+H  +++HRDLK  NI +  +  +KIGD G++R L  S +  T +  T +Y +PE L 
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL- 177

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
            ++ Y    DIWSLGCIL EM      F G    + L +++ +V    P   + Y     
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLRIVEGPTPSLPETY----- 229

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
              +   ++  +L  +PS RP   +IL + ++
Sbjct: 230 -SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  107 bits (267), Expect = 2e-26
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 31/278 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L S   HPN
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCD-HPN 63

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +LD +   NN  L+++ E+      D   +  ++ L +  IR +  Q    L+Y+H 
Sbjct: 64  IVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI----S 197
            K++HRDLK  NIL      IK+ D G++   + + +    +I T ++ APE+++     
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP---HADKFY 251
           +R Y +  D+WSLG  L EM Q +P        H+L   ++++ + +  PP      ++ 
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRWS 235

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           + FK       D L + L  N   R  T Q+L+H +V+
Sbjct: 236 SEFK-------DFLKKCLEKNVDARWTTTQLLQHPFVT 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (267), Expect = 2e-26
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 47/279 (16%)

Query: 29  KRIGKGAYGIVYKA-YDKNNKQ---YVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRH 82
           K++G+G +G V    YD         VA+K +     +  +  R+   REI  L++   H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLD-H 65

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            NI+    + +    + L ++ EY+      D  +  RD+I     + +   Q+C G+ Y
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQICKGMDY 124

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT----EYIATRWYRAPEI 194
           + + + +HRDL   NIL++    +KI D GLA+ L + K+             WY APE 
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQ---------SKPLFPGASTSHQLQL--IVNLVRPN 243
           L    +++   D+WS G  L E+           ++ L        Q+ +  ++ L++  
Sbjct: 184 L-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 244 -----PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
                PP            P+E  DL+       P +RP
Sbjct: 243 ERLPRPPSC----------PDEVYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  105 bits (263), Expect = 5e-26
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 20/275 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR----EILFLKSF 79
           E+T  + +GKGAYG VY     N  Q +A+K++     N   A++ Y     E+  LKS 
Sbjct: 1   EWTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            +H NI+  L      N   +++ F    +  + + R   L +        Q+ +G++Y+
Sbjct: 60  -KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-----SLSDSK-ECLTEYIATRWYRAPE 193
           H   V+HRD+K +N+++  +  IK+ D G AR      L  +    L     T ++ APE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           + I+   Y    DIWS+GC + EM   KP          +  I       P   D F   
Sbjct: 179 V-INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF--- 234

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                  A+D +   L  +  ERP   Q+L H+++
Sbjct: 235 ----SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (263), Expect = 5e-26
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 41/269 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           E+T+ +++G G +G V++   KN  + VAIK +     +    Q   +E+  LK   RH 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSD--DLLKQQDFQKEVQALKRL-RHK 62

Query: 84  NIITMLDIYKAVNNKD--LYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLS 137
           ++I++     AV +    +Y++ E ME   L   +R    ++L    +  +  Q+  G++
Sbjct: 63  HLISLF----AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-------SLSDSKECLTEYIATRWYR 190
           Y+     +HRDL   NIL+ +    K+ D GLAR         SD K      I  +W  
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK------IPYKW-T 171

Query: 191 APEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVR-PNPPHAD 248
           APE   S+  ++   D+WS G +L EM    +  +PG +       I    R P P    
Sbjct: 172 APEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC- 229

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERP 277
                    P+E   ++ +     P +RP
Sbjct: 230 ---------PQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  105 bits (264), Expect = 6e-26
 Identities = 73/261 (27%), Positives = 132/261 (50%), Gaps = 16/261 (6%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A +K++ + VA+K +    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQ-HQNVVEM- 83

Query: 90  DIYK-AVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             YK  +  ++L+V+ E+++   L  ++    L +  I  +   +   L Y+H+  V+HR
Sbjct: 84  --YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           D+K  +IL+     +K+ D G    +S         + T ++ APE+ IS   Y   VDI
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-ISRTPYGTEVDI 200

Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ 267
           WSLG ++ EM+  +P  P  S S  +Q +  L    PP     +   K  P    D L +
Sbjct: 201 WSLGIMVIEMVDGEP--PYFSDS-PVQAMKRLRDSPPPKLKNAH---KISP-VLRDFLER 253

Query: 268 ILVLNPSERPETDQILEHNYV 288
           +L   P ER    ++L+H ++
Sbjct: 254 MLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  105 bits (263), Expect = 7e-26
 Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G G YG VYK       Q  AIK + +   ++ +  +   EI  LK +  H NI T   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKL--EINMLKKYSHHRNIATYYG 80

Query: 91  IY----KAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
            +       ++  L++V E+       DL K  +   LK+  I YI  ++  GL+++HA 
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-- 200
           KV+HRD+K  N+L+ ++  +K+ D G++  L  +      +I T ++ APE++  +    
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 201 --YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y +  DIWSLG    EM +  P        H ++ +  + R  PP         K   
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPPKLKS-----KKWS 252

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
           ++ +D +   LV N   RP T+Q+L+H ++
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 8e-26
 Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 9/224 (4%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-- 82
           Y   + IG+GAYG VY+       + VA+K I        D     RE+  L   ++   
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           PNI      Y  +    L+++ EY E   +  +++   + + +I  I+ ++   L YIH 
Sbjct: 62  PNITKYYGSY--LKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             V+HRD+K +NIL+  + ++K+ D G+A  L+ +    + ++ T ++ APE++   + Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 245
               DIWSLG  + EM    P +        + LI    +  PP
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKSKPP 220

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  105 bits (263), Expect = 9e-26
 Identities = 71/272 (26%), Positives = 135/272 (49%), Gaps = 15/272 (5%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A +K+  + VA+KK+    R +   +  + E++ ++ +  H N++ M 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYH-HENVVDMY 85

Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LSY+H   V+HRD
Sbjct: 86  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     IK+ D G    +S         + T ++ APE+ IS   Y   VDIW
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV-ISRLPYGTEVDIW 202

Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        ++ I + + P    + K  +  +         L+ +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG-------FLDLM 255

Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           LV  PS+R    ++L+H ++    P +  ++P
Sbjct: 256 LVREPSQRATAQELLQHPFLKLAGPPSC-IVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  104 bits (261), Expect = 9e-26
 Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 27/271 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYRE--ILFLKSFQRHPNI 85
           K +G+GA+G VY  YD +  + +A K++ F+    +T  + +  E  I  LK+  +H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERI 66

Query: 86  ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIH 140
           +      +    K L +  EYM       ++D++     L +   R    Q+  G+SY+H
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGG---SVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILIS 197
           +  ++HRD+K +NIL D + ++K+GD G ++ L     S   +     T ++ +PE+ IS
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV-IS 182

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-NPPHADKFYAGFKN 256
              Y    D+WSLGC + EML  KP  P A       +     +P NP           +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP--PWAEYEAMAAIFKIATQPTNPQLP-------SH 233

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             E A D L  I V     RP  +++L H +
Sbjct: 234 ISEHARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  104 bits (261), Expect = 2e-25
 Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 23/284 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG+GA+G V K   K +   +A+K+I  +  ++ + +R   ++  +      P I+    
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF-- 68

Query: 91  IYKAV-NNKDLYVVFEYMENDLNK-------VIRDKILKDVHIRYIMFQLCNGLSYI-HA 141
            Y A+    D ++  E M+  L+K       V++  I +++ +  I       L+Y+   
Sbjct: 69  -YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEI-LGKIAVATVKALNYLKEE 126

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR- 200
            K++HRD+KPSNIL+D++ +IK+ D G++  L DS    T     R Y APE +  + R 
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARD 185

Query: 201 -YTHHVDIWSLGCILAEMLQSKPLFPG-ASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
            Y    D+WSLG  L E+   K  +P   S   QL  +V    P   ++++         
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER-----EFS 240

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
              V+ +N  L+ + S+RP+  ++LEH ++  Y      V   V
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYV 284

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  103 bits (259), Expect = 2e-25
 Identities = 78/271 (28%), Positives = 136/271 (50%), Gaps = 21/271 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYREILFLKSFQRH 82
           +T  +RIGKG++G V+K  D   +Q VAIK I   EA     D Q+   EI  L      
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDS- 61

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           P +      Y  +    L+++ EY+       ++R     +  I  ++ ++  GL Y+H+
Sbjct: 62  PYVTKYYGSY--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            K +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IQQSAY 178

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFYAGFKNKPEE 260
               DIWSLG    E+ + +P  P  S  H ++++  + + NPP    +F   FK     
Sbjct: 179 DSKADIWSLGITAIELAKGEP--PN-SDMHPMRVLFLIPKNNPPTLTGEFSKPFK----- 230

Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + ++  L  +PS RP   ++L+H ++ K 
Sbjct: 231 --EFIDACLNKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  103 bits (257), Expect = 5e-25
 Identities = 71/265 (26%), Positives = 135/265 (50%), Gaps = 15/265 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  ++IGKG++G V+K  D   ++ VAIK I +    + + +   +EI  L      P 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PY 63

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           +      Y  + +  L+++ EY+       ++    L +  I  I+ ++  GL Y+H+ K
Sbjct: 64  VTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDS 180

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +   P  S  H ++++  + + NPP  +  Y+    KP +  +
Sbjct: 181 KADIWSLGITAIELAKGE---PPHSELHPMKVLFLIPKNNPPTLEGNYS----KPLK--E 231

Query: 264 LLNQILVLNPSERPETDQILEHNYV 288
            +   L   PS RP   ++L+H ++
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  103 bits (258), Expect = 5e-25
 Identities = 77/274 (28%), Positives = 139/274 (50%), Gaps = 28/274 (10%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           + IG G++G VY A D  N + VAIKK+ +   ++    Q   +E+ FL+   RHPN I 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79

Query: 88  MLDIYKAVNNKDLYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
               Y  +     ++V EY     +DL +V   K L++V I  +      GL+Y+H+  +
Sbjct: 80  YRGCY--LREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--NRRYT 202
           +HRD+K  NIL+ +   +K+GD G A  ++ +      ++ T ++ APE++++    +Y 
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYD 192

Query: 203 HHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPP--HADKFYAGFKNKPE 259
             VD+WSLG    E+ + K PLF      + +  + ++ +   P   +  +   F+N   
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPALQSGHWSEYFRN--- 245

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                ++  L   P +RP ++ +L+H +V +  P
Sbjct: 246 ----FVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  103 bits (257), Expect = 8e-25
 Identities = 77/275 (28%), Positives = 136/275 (49%), Gaps = 22/275 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLKSFQRHP 83
           +T  + IG G++G VY A D    + VAIKK+  + +   +  Q   +E+ FL+  + HP
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HP 85

Query: 84  NIITMLDIYKAVNNKDLYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           N I     Y  +     ++V EY     +DL +V   K L++V I  I      GL+Y+H
Sbjct: 86  NSIEYKGCY--LREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH 142

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--N 198
           +  ++HRD+K  NIL+ +   +K+ D G A   S +      ++ T ++ APE++++   
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAMDE 198

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
            +Y   VD+WSLG    E+ + KP     +    L  I     P    ++++   F+N  
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-LQSNEWSDYFRN-- 255

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                 ++  L   P +RP ++++L+H +V +  P
Sbjct: 256 -----FVDSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  101 bits (253), Expect = 1e-24
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 33/279 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYRE--ILFLKSFQR 81
           + + K +G+GA+G VY  YD +  + +A+K++ F+    +T  +    E  I  LK+   
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL- 62

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGL 136
           H  I+      +    + L +  E+M       I+D++     L +   R    Q+  G+
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGG---SIKDQLKSYGALTENVTRKYTRQILEGV 119

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPE 193
           SY+H+  ++HRD+K +NIL D   ++K+GD G ++ L     S   +     T ++ +PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN----PPHADK 249
           + IS   Y    DIWS+GC + EML  KP  P A       +     +P     PPH   
Sbjct: 180 V-ISGEGYGRKADIWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTNPVLPPHVS- 235

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                    +   D L +I V     RP  D++L H +V
Sbjct: 236 ---------DHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 20/214 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFLKSFQ 80
           ++ I  ++G+G YG V+ A  K+  + VA+K++ ++   K +  R   T R+IL   +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL---TTT 58

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSY 138
           +   ++ +L  Y   +++ LY+  EY+   D   ++ +  +L + H R+ M ++   +  
Sbjct: 59  KSEWLVKLL--YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA 116

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEIL 195
           +H    +HRDLKP N LID S  IK+ D GL      SK  +T     + +  Y APE+L
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPEVL 170

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 229
              + Y   VD WSLGC+L E L   P F G++ 
Sbjct: 171 -RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  101 bits (252), Expect = 2e-24
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 23/270 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G G YG VYK       Q  AIK + +      + +   +EI  LK +  H NI T   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIK-VMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 91  IYKAVN----NKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
            +   N    +  L++V E+       DL K  +   LK+  I YI  ++  GLS++H  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-- 200
           KV+HRD+K  N+L+ ++  +K+ D G++  L  +      +I T ++ APE++  +    
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190

Query: 201 --YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y    D+WSLG    EM +  P          L LI     P P    K ++      
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWS------ 242

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
           ++    +   LV N S+RP T+Q+++H ++
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 26/279 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFLKSFQRHPNIITML 89
           IG G  G VYK   K     +A+K++     NK + +R   ++ + LKS    P I+   
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVVLKSHD-CPYIVKCY 80

Query: 90  DIYKAVNNKDLYVVFEYME---NDLNKVIRDKILKDVHIRYIMFQLCNGLSYI---HACK 143
             +  + + D+++  E M    + L K I+  I +D+ +  +   +   L Y+   H   
Sbjct: 81  GYF--ITDSDVFICMELMSTCLDKLLKRIQGPIPEDI-LGKMTVAIVKALHYLKEKHG-- 135

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNRR 200
           V+HRD+KPSNIL+D S ++K+ D G++  L DSK   T       Y APE +     N +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPK 194

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAGFKNKPE 259
           Y    D+WSLG  L E+   +  +    T  + L  I+    P+ P  + F   F     
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC---- 250

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
                ++  L  +  +RP+  ++L+H ++ +Y  +   V
Sbjct: 251 ---SFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 31/281 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I + IGKG YG V+K  +K N    A+K +        + +  Y     LK+   HPN
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN---ILKALSDHPN 76

Query: 85  IITMLDIY--KAVNNKD-LYVVFEYME----NDLNK--VIRDKILKDVHIRYIMFQLCNG 135
           ++    +Y  K V N D L++V E        DL K  + R + +++  I YI+ +   G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L ++H  K +HRD+K +NIL+     +K+ D G++  L+ ++      + T ++ APE++
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 196 ISNRR----YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
              ++    Y    D+WSLG    E+    P  P A   H ++ +  + R  PP      
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDP--PLADL-HPMRALFKIPRNPPPTL---- 249

Query: 252 AGFKNKPE----EAVDLLNQILVLNPSERPETDQILEHNYV 288
               ++PE    E  D + + L  +  +RP    +L+H ++
Sbjct: 250 ----HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 76/283 (26%), Positives = 133/283 (46%), Gaps = 38/283 (13%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFLKSFQRHPNIITML 89
           +G G  G VYKAY    ++ +A+K I      +   Q  +  EIL+       P II   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD---SPYIIGFY 65

Query: 90  DIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
             +  V N+ + +  E+M+    D+ + I + +L  + +  +      GL+Y+ + K++H
Sbjct: 66  GAF-FVENR-ISICTEFMDGGSLDVYRKIPEHVLGRIAVAVV-----KGLTYLWSLKILH 118

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RD+KPSN+L++    +K+ D G++  L +S      Y+ T  Y APE  IS  +Y  H D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPE-RISGEQYGIHSD 175

Query: 207 IWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNPP------HADKFYAGFKN 256
           +WSLG    E+   +  +P    +      LQL+  +V  +PP       ++KF      
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF------ 229

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVI 299
                V  + Q +   P ERP  + +++H ++ +Y      V+
Sbjct: 230 -----VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 71/259 (27%), Positives = 115/259 (44%), Gaps = 32/259 (12%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQRHPNI 85
           K +GKG++G V  A  K   +  A+K + +    + D      T + +L L    +HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACK 143
             +   ++  +   L+ V EY+   DL   I R     +   R+   ++  GL ++H   
Sbjct: 59  TQLHSCFQTKDR--LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILIS 197
           +++RDLK  N+L+D    IKI D G+       KE +   + T        Y APEIL S
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGM------CKEGILGGVTTSTFCGTPDYIAPEIL-S 169

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VD W+LG +L EML  +  F G       Q I+     +     ++ +     
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE----DEVRYPRWLS----- 220

Query: 258 PEEAVDLLNQILVLNPSER 276
            +EA  +L   L  NP +R
Sbjct: 221 -KEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 97.8 bits (243), Expect = 6e-23
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 26/271 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           IG G++G VY A + +  + VA+KK+ +   +     Q   +E+ FL+   +HPN I   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIE-- 85

Query: 90  DIYKAVNNKD--LYVVFEYM---ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             YK    K+   ++V EY     +DL +V   K L++V I  I      GL+Y+H+  +
Sbjct: 86  --YKGCYLKEHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--NRRYT 202
           +HRD+K  NIL+ +   +K+ D G A   S +      ++ T ++ APE++++    +Y 
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQYD 198

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
             VD+WSLG    E+ + KP     +    L  I     P    ++++   F+      V
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT-LQSNEWTDSFRG----FV 253

Query: 263 DLLNQILVLNPSERPETDQILEHNYVSKYFP 293
           D   Q +   P ERP + ++L H++V +  P
Sbjct: 254 DYCLQKI---PQERPASAELLRHDFVRRDRP 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 37/277 (13%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYRE-------ILFLKSFQ 80
           K +G+GA+G VY  YD +  + +A+K++ F+      D+Q T +E       I  LK+  
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDP-----DSQETSKEVNALECEIQLLKNL- 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI------LKDVHIRYIMFQLCN 134
           RH  I+      +    K L +  EYM       I+D++       ++V  RY   Q+  
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGG---SIKDQLKAYGALTENVTRRYTR-QILQ 117

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRA 191
           G+SY+H+  ++HRD+K +NIL D + ++K+GD G ++ +     S   +     T ++ +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+ IS   Y    D+WS+ C + EML  KP  P A       +     +P  P      
Sbjct: 178 PEV-ISGEGYGRKADVWSVACTVVEMLTEKP--PWAEYEAMAAIFKIATQPTKPMLP--- 231

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                  +   D L QI V     RP  + +L H +V
Sbjct: 232 ---DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 65/250 (26%), Positives = 110/250 (44%), Gaps = 17/250 (6%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIIT 87
           +G+G +G V  A  K   +  AIK + +     R++ ++    + I    + +RHP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           +   ++      +  V EY    DL   I   +  +    +    +  GL Y+H  K+++
Sbjct: 67  LFACFQT--EDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVY 124

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLK  N+L+D    +KI D GL +      +  + +  T  + APE+L +   YT  VD
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL-TETSYTRAVD 183

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLN 266
            W LG ++ EML  +  FPG         IVN     P               EA+ ++ 
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL----------SREAISIMR 233

Query: 267 QILVLNPSER 276
           ++L  NP  R
Sbjct: 234 RLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 22/258 (8%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSFQ 80
            +    K +G G +G V+   D+ ++ Y A+K   I E  R K + Q  + E   LK   
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEV- 58

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSY 138
            HP II +           LY++ EY+   +L   +R+     +    +   ++   L Y
Sbjct: 59  SHPFIIRLFWTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H+ ++++RDLKP NIL+DK   IK+ D G A+ L D    L     T  Y APE+ I +
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---GTPEYLAPEV-IQS 172

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           + +   VD W+LG ++ EML   P F   +     + I+      P H D +        
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY-------- 224

Query: 259 EEAVDLLNQILVLNPSER 276
             A DL+ ++LV++ + R
Sbjct: 225 --AKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 75/281 (26%), Positives = 135/281 (48%), Gaps = 31/281 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I + IGKG YG VYK  +K +    A+K I +   +  +       IL  +S   HPN
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNIL--QSLPNHPN 80

Query: 85  IITMLDI-YKA--VNNKDLYVVFEYME----NDLNK--VIRDKILKDVHIRYIMFQLCNG 135
           ++    + YKA  +    L++V E        +L K  +I  + L +  I YI++    G
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L ++H  +++HRD+K +NIL+     +K+ D G++  L+ ++      + T ++ APE++
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 196 ISNRRYTH----HVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPP---HA 247
              ++Y +      D+WSLG    E+     PLF      H ++ +  + R  PP   H 
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF----DMHPVKTLFKIPRNPPPTLLHP 256

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           +K+   F +        ++Q L+ +   RP    +LEH ++
Sbjct: 257 EKWCRSFNH-------FISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 18/270 (6%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ + +RIG G YG VYKA + N  +  AIK I        D     +EI+ +K   +H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDC-KHS 66

Query: 84  NIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           NI+     Y  +    L++  E+       D+  V     L +  I Y+  +   GL Y+
Sbjct: 67  NIVAYFGSY--LRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYL 122

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+   MHRD+K +NIL+  +  +K+ D G++  ++ +      +I T ++ APE+    R
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 200 R--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  Y    DIW++G    E+ + +P          L L+       P   DK    + N 
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM--KWSNS 240

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY 287
               V +    L  NP +RP  +++L+H +
Sbjct: 241 FHHFVKM---ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 45/288 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ K +G+GA+G V KA      + N    VA+K + +    + D      E+  +K   
Sbjct: 15  TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG 73

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-----------------MEN--DLNKVIRDKILK 121
           +H NII +L +        LYVV EY                      D  +   +  L 
Sbjct: 74  KHKNIINLLGV--CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET-LT 130

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KE 178
              +    +Q+  G+ ++ + K +HRDL   N+L+ +   +KI D GLAR +      ++
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 191 TTNGRLPVKWM-APEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSP-YPGIPVEELFKLL 247

Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R   P          N  +E   L+       PS+RP   Q++E
Sbjct: 248 KEGYRMEKPQ---------NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.0 bits (231), Expect = 1e-21
 Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 44/265 (16%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K++G G +G V+  Y   + + VAIK + +        +    E   +K  Q HP ++ +
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTK-VAIKSLKQG---SMSPEAFLAEANLMKQLQ-HPRLVRL 66

Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
              Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 67  ---YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAPEILIS 197
           +HRDL+ +NIL+ ++   KI D GLAR + D+     EY A        +W  APE  I+
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN-----EYTAREGAKFPIKW-TAPEA-IN 176

Query: 198 NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR----PNPPHADKFYA 252
              +T   D+WS G +L E++   +  +PG +     ++I NL R    P P        
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGYRMPRP-------- 225

Query: 253 GFKNKPEEAVDLLNQILVLNPSERP 277
              N PEE  +L+       P ERP
Sbjct: 226 --DNCPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 22/272 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +R+G G YG VYKA + +  +  A+K I        D     +EI  +K   +H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVKEC-KHC 66

Query: 84  NIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           NI+     Y  ++ + L++  EY       D+  V     L ++ I Y+  +   GL+Y+
Sbjct: 67  NIVAYFGSY--LSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYL 122

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI--LIS 197
           H+   MHRD+K +NIL+  +  +K+ D G+A  ++ +      +I T ++ APE+  +  
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPPHADKFYAGFK 255
           N  Y    DIW++G    E+ + +P          L L+   N   P      K+ + F 
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           N        +   L  NP +RP  +++L H +
Sbjct: 243 N-------FVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 71/263 (26%), Positives = 117/263 (44%), Gaps = 39/263 (14%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +++G G +G V+     N    VA+K +     +        +E   +K   RH  ++ +
Sbjct: 12  RKLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKL-RHDKLVQL 66

Query: 89  LDIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIR---YIMFQLCNGLSYIHACK 143
              Y   + ++ +Y+V EYM    L   ++    K + +     +  Q+  G++Y+ +  
Sbjct: 67  ---YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAPEILI 196
            +HRDL   NIL+ ++   KI D GLAR + D      EY A        +W  APE   
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD-----EYTAREGAKFPIKW-TAPEAAN 177

Query: 197 SNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGF 254
              R+T   D+WS G +L E++   +  +PG +    L+ +    R P PP         
Sbjct: 178 YG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP--------- 227

Query: 255 KNKPEEAVDLLNQILVLNPSERP 277
            N PEE  DL+ Q    +P ERP
Sbjct: 228 -NCPEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 71/288 (24%), Positives = 132/288 (45%), Gaps = 52/288 (18%)

Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
           T+ + +G+G++G+VY+   K       +  VAIK + E   N +  +R     E   +K 
Sbjct: 9   TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLNEASVMKE 65

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRYIM-------- 129
           F  H +++ +L +      +   VV E M + DL   +R +  +  +   +         
Sbjct: 66  FNCH-HVVRLLGV--VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 130 ---FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--- 183
               ++ +G++Y+ A K +HRDL   N ++ +  ++KIGD G+ R + +     T+Y   
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-----TDYYRK 177

Query: 184 -----IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  RW  APE L  +  +T   D+WS G +L EM  L  +P + G S    L+ +
Sbjct: 178 GGKGLLPVRWM-APESL-KDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSNEEVLKFV 234

Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           ++    + P         +N P++ ++L+      NP  RP   +I+ 
Sbjct: 235 IDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 78/253 (30%), Positives = 119/253 (47%), Gaps = 20/253 (7%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG++G V+ A  K   Q+ AIK +  +      D + T  E   L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV-HIRYIMFQLCNGLSYIHACKVM 145
           +   ++   N  L+ V EY+   DL   I+     D+    +   ++  GL ++H+  ++
Sbjct: 61  LYCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARS--LSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           +RDLK  NIL+D    IKI D G+ +   L D+K C   +  T  Y APEIL+  ++Y  
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TFCGTPDYIAPEILLG-QKYNT 175

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
            VD WS G +L EML  +  F G       Q I    R + P     Y  +  +  EA D
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI----RMDNP----CYPRWLTR--EAKD 225

Query: 264 LLNQILVLNPSER 276
           +L ++ V  P  R
Sbjct: 226 ILVKLFVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 91.4 bits (227), Expect = 7e-21
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           ++  GL  +H  ++++RDLKP NIL+D    I+I DLGLA  + +  E +   + T  Y 
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYM 168

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HADK 249
           APE+ + N RYT   D W LGC++ EM++ K  F       + + +   V+ +   +++K
Sbjct: 169 APEV-VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER 276
           F        E A  +  Q+L  +P  R
Sbjct: 228 F-------SEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 27/238 (11%)

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-----LKDVHIRYIMFQLCN 134
            H  I+   D +K+  +  L ++ EY    DLNK I+ ++      ++  +  + +Q+  
Sbjct: 123 DHFGIVKHFDDFKS--DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL 180

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAP 192
            L  +H+ K+MHRDLK +NI +  +  IK+GD G ++  SDS   +  + +  T +Y AP
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV-NLVRPNP-PHADKF 250
           E L   +RY+   D+WSLG IL E+L     F G S    +Q ++     P P P +   
Sbjct: 241 E-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH---NYVSKYFPSATHVIPQVTPH 305
            A           LL+ +L  NP+ RP T Q+L      YV+  F         ++PH
Sbjct: 300 KA-----------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPH 346

Length = 478

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 42/217 (19%)

Query: 31  IGKGAYGIVYKA-----YDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           +G+GA+G V+         +N+K+ VA+K + E   N  DA++ + RE   L +FQ H N
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQ-HEN 69

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR---------------DKILKDVHIRYI 128
           I+    +          +VFEYME+ DLNK +R                  L    +  I
Sbjct: 70  IVKFYGV--CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----- 183
             Q+ +G+ Y+ +   +HRDL   N L+     +KIGD G++R +       T+Y     
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----TDYYRVGG 182

Query: 184 ---IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 217
              +  RW   PE ++  R++T   D+WS G +L E+
Sbjct: 183 HTMLPIRWM-PPESIMY-RKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 34/272 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           E T  K +G G +G+V+    +     VAIK I E   ++ D      E   +     HP
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDD---FIEEAKVMMKLS-HP 59

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLSYIH 140
           N++ +  +      + +++V EYM N  L   +R+    L    +  +   +C  + Y+ 
Sbjct: 60  NLVQLYGV--CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
           +   +HRDL   N L+ +   +K+ D GLAR + D      +Y ++       +W   PE
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-----QYTSSQGTKFPVKW-APPE 171

Query: 194 ILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           +   + R++   D+WS G ++ E+  + K  +   S S  ++ +    R   P       
Sbjct: 172 VFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL----- 225

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                P E   ++       P +RP   ++L 
Sbjct: 226 ----APTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 52/290 (17%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFE---AFRNKTDAQRTYREILFLKSFQRHPNI 85
           K I  GAYG VY    K  +Q  A+KKI +     RN+       R+IL   +F  +P +
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL---TFAENPFV 63

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMF-QLCNGLSYIHACK 143
           ++M   ++    + L +V EY+E  D   ++++     V +  + F +    L Y+H   
Sbjct: 64  VSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGL--------------------ARSLSDSKECLT-E 182
           ++HRDLKP N+LI     IK+ D GL                     R   D + C T E
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LV 240
           YI      APE+ I  + Y   VD W++G IL E L     F G +       +++  + 
Sbjct: 182 YI------APEV-ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD---QILEHNY 287
            P    A          P +A DL++++L  NP ER  T    ++ +H +
Sbjct: 235 WPEGDEA---------LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 14/208 (6%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSF 79
           L+++ + + +G G++G V  A  K   +Y AIK  K  E  + K   Q   +E   L   
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK-QVQHVAQEKSILMEL 75

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIRD--KILKDVHIRYIMFQLCNGL 136
             HP I+ M+  ++  +   +Y + E+ +  +L   +R   +   DV  ++   +L    
Sbjct: 76  S-HPFIVNMMCSFQ--DENRVYFLLEFVVGGELFTHLRKAGRFPNDVA-KFYHAELVLAF 131

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+H+  +++RDLKP N+L+D    +K+ D G A+ + D    L     T  Y APE+ I
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---GTPEYLAPEV-I 187

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLF 224
            ++ +   VD W++G +L E +   P F
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 70/251 (27%), Positives = 119/251 (47%), Gaps = 16/251 (6%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG++G V  A  K   ++ AIK +  +      D + T  E   L     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKVM 145
           +   ++    + L+ V EY+   DL   I+     D    R+   ++  GL ++H   ++
Sbjct: 61  LFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLK  N+L+DK   IKI D G+ +   + +   + +  T  Y APEI +  ++Y   V
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQKYNESV 177

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D WS G +L EML  +  F G         I+N    + PH  ++ +      +EA D L
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN----DRPHFPRWIS------KEAKDCL 227

Query: 266 NQILVLNPSER 276
           +++   +P++R
Sbjct: 228 SKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 6/213 (2%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K IGKG++G V  A  K + ++ A+K +  +A   K + +    E   L    +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y       LY V +Y+        + R++   +   R+   ++ + L Y+H+  ++
Sbjct: 61  LH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLKP NIL+D    + + D GL +   +  +  + +  T  Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL-RKQPYDRTV 177

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
           D W LG +L EML   P F    T+     I+N
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 68/254 (26%), Positives = 110/254 (43%), Gaps = 22/254 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFLKSFQRHPNIIT 87
           +GKG +G V     K   +  A KK+ +    K   ++     ++IL   S      I++
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS---SRFIVS 57

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACK 143
           +   Y      DL +V   M   DL   I +       +    +   Q+  GL ++H  +
Sbjct: 58  L--AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           +++RDLKP N+L+D   +++I DLGLA  L   K+ +     T  Y APE+L     Y  
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRAGTPGYMAPEVLQ-GEVYDF 173

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHADKFYAGFKNKPEEAV 262
            VD ++LGC L EM+  +  F       + + +          + DKF         EA 
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF-------SPEAK 226

Query: 263 DLLNQILVLNPSER 276
           DL   +L  +P +R
Sbjct: 227 DLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.0 bits (218), Expect = 8e-20
 Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 37/277 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQ 80
           + T+  ++G G YG VY+   K     VA+K +      K D        +E   +K   
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI- 59

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGL 136
           +HPN++ +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + +
Sbjct: 60  KHPNLVQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPE 193
            Y+     +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPE 175

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            L  N +++   D+W+ G +L E+      P +PG   S   +L+    R   P      
Sbjct: 176 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKGYRMERP------ 227

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEH 285
              +  P +  +L+      NPS+RP   E  Q  E 
Sbjct: 228 ---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 28/269 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
             E  +   IGKG +G V     +  K  VA+K +     + T AQ    E   + +  R
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLK---DDSTAAQAFLAEASVMTTL-R 58

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPN++ +L +   +    LY+V EYM        L    R  I     + + +  +C G+
Sbjct: 59  HPNLVQLLGV--VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL-DVCEGM 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GLA+  S  ++  +  +  +W  APE L 
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKW-TAPEAL- 171

Query: 197 SNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
             ++++   D+WS G +L E+    +  +P       +  +    R   P         +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP---------E 222

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILE 284
             P E   ++     L+P++RP   Q+ E
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 75/268 (27%), Positives = 119/268 (44%), Gaps = 33/268 (12%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IGKG +G VYK   K N + VA+K            ++  +E   LK +  HPNI+ +
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTL-PPDLKRKFLQEAEILKQY-DHPNIVKL 57

Query: 89  LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVM 145
           + +   V  + +Y+V E +    L   +R K   L    +  +      G+ Y+ +   +
Sbjct: 58  IGV--CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLAR-------SLSDSKECLTEYIATRWYRAPEILISN 198
           HRDL   N L+ ++  +KI D G++R       ++SD      + I  +W  APE L + 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG----LKQIPIKW-TAPEAL-NY 169

Query: 199 RRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
            RYT   D+WS G +L E   L   P +PG S     + I +  R   P         + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTP-YPGMSNQQTRERIESGYRMPAP---------QL 219

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILE 284
            PEE   L+ Q    +P  RP   +I  
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 51/284 (17%)

Query: 31  IGKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---- 80
           +G GA+G VY+          +    VA+K +    +  TD ++      FLK       
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEK----KEFLKEAHLMSN 55

Query: 81  -RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMF 130
             HPNI+ +L +   + N+  Y++ E ME  DL   +RD         +L    +  I  
Sbjct: 56  FNHPNIVKLLGV--CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILI---DKSCS--IKIGDLGLARSLSDSKECLTE--- 182
            +  G  Y+     +HRDL   N L+          +KIGD GLAR +  S     E   
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLV 240
            +  RW  APE L+   ++T   D+WS G ++ E+L    +P +P  +    LQ +    
Sbjct: 174 LLPVRWM-APESLLDG-KFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTAGG 230

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           R   P         +N P++   L+      +PSERP  D+I E
Sbjct: 231 RLQKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 17/194 (8%)

Query: 37  GIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN 96
            IV+ A  K     VA+KKI     +K D +   +EI+  +  Q HPNI+  +  +  + 
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSF--IV 70

Query: 97  NKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS 152
           + +LYVV   M      DL K    + L ++ I +I+  + N L YIH+   +HR +K S
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKAS 130

Query: 153 NILIDKSCSIKIGDLGLARSLSDSKE------CLTEYIAT--RWYRAPEILISNRR-YTH 203
           +IL+     + +  L  + S+    +         +       W  +PE+L  N + Y  
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQGYNE 189

Query: 204 HVDIWSLGCILAEM 217
             DI+S+G    E+
Sbjct: 190 KSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 66/263 (25%), Positives = 124/263 (47%), Gaps = 30/263 (11%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T+ + IG G +G+V+  Y    K+ VAIK I E   ++ D     + ++ L     H
Sbjct: 4   SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS----H 58

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +        + +VFE+ME+  L+  +R +        +  +   +C G++Y+
Sbjct: 59  PKLVQLYGV--CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
            +  V+HRDL   N L+ ++  +K+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEV-F 173

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  +Y+   D+WS G ++ E      +F    T ++        R N    +   AGF+ 
Sbjct: 174 SFSKYSSKSDVWSFGVLMWE------VFSEGKTPYE-------NRSNSEVVETINAGFRL 220

Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + +++     ERPE
Sbjct: 221 YKPRLASQSVYELMQHCWKERPE 243

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 67/289 (23%)

Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHP 83
           +++GKG +G V    Y     N  + VA+KK+  +     +  R + REI  LKS Q H 
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HD 65

Query: 84  NIITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDV----HIRYIMF--QLC 133
           NI+     YK V      ++L +V EY+       +RD + K      H + +++  Q+C
Sbjct: 66  NIVK----YKGVCYSAGRRNLRLVMEYLPYG---SLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR------ 187
            G+ Y+ + + +HRDL   NIL++    +KIGD GL + L   K    EY   R      
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESP 174

Query: 188 --WYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQL------QLIV 237
             WY APE L  + +++   D+WS G +L E+     K   P A     +      Q+IV
Sbjct: 175 IFWY-APESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232

Query: 238 ----NLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
                L++     P PP            P E   ++ +    +PS+RP
Sbjct: 233 YHLIELLKNNGRLPAPPGC----------PAEIYAIMKECWNNDPSQRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 44/232 (18%)

Query: 95  VNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYIH-ACKVMH 146
            ++ ++ +  E+M+   L++V++      + IL  + I  +      GL+Y+    K+MH
Sbjct: 69  YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVL-----RGLTYLREKHKIMH 123

Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L     YT   D
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGT-HYTVQSD 180

Query: 207 IWSLGCILAEML------------QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           IWSLG  L EM             + + +F    +  + +     V  +PP + +  A F
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240

Query: 255 K------NKP----------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           +      N+P          +E  D +++ L  NP ER +  ++ +H ++ +
Sbjct: 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 75/257 (29%), Positives = 118/257 (45%), Gaps = 25/257 (9%)

Query: 29  KRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRHP 83
           K +GKG YG V+   K    +  +  A+K + +A   RN+ D   T  E   L++ + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
            I+ +  IY       LY++ EY+        + R+ I  +    + + ++   L ++H 
Sbjct: 61  FIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             +++RDLKP NIL+D    +K+ D GL +           +  T  Y APEIL+   R 
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM---RS 175

Query: 202 THH--VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
            H   VD WSLG ++ +ML   P F   +    +  I+      PP+             
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT----------P 225

Query: 260 EAVDLLNQILVLNPSER 276
           EA DLL ++L  NPS R
Sbjct: 226 EARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (216), Expect = 4e-19
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 9/193 (4%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRT-YREILFLKSFQRHPNIIT 87
           IGKG +G VY+   K+ ++  A+K +   E    K  A     R IL        P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   ++   + DLY+V +YM        + ++    +   ++ + +L   L ++H   ++
Sbjct: 61  LKFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           +RDLKP NIL+D +  I + D GL+++ L+D+K   T +  T  Y APE+L+  + YT H
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKH 177

Query: 205 VDIWSLGCILAEM 217
           VD WSLG ++ EM
Sbjct: 178 VDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.5 bits (222), Expect = 4e-19
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 34/208 (16%)

Query: 49  QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR---------HPNIITMLDIYKAVNNKD 99
             VAIK +      +TDA     +      F+R         HPNI+ +LD  +A     
Sbjct: 4   HEVAIKLL------RTDAPEEEHQR---ARFRRETALCARLYHPNIVALLDSGEAPPGL- 53

Query: 100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI- 156
           L+ VFEY+    L +V+  D  L       +M Q+ + L+  H   ++HRDLKP NI++ 
Sbjct: 54  LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113

Query: 157 ---DKSCSIKIGDLGLARSLSDSKECL-------TEYIATRWYRAPEILISNRRYTHHVD 206
               +  + K+ D G+   L   ++         TE + T  Y APE L      T + D
Sbjct: 114 QTGVRPHA-KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSD 171

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQ 234
           +++ G I  E L  + +  GAS +  L 
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILY 199

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 88.6 bits (219), Expect = 6e-19
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 52/308 (16%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQ 80
           L EY + K+IG G +G V+    K  +++   K I +   + +  +Q    E+  ++   
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMREL- 69

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD--KILKDVH---IRYIMFQLCN 134
           +H NI+  +D +    N+ LY++ E+ +  DL++ I+   K+   +    I  I  QL +
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 135 GLSYIHACK-------VMHRDLKPSNILIDKSCS-----------------IKIGDLGLA 170
            L+Y H  K       V+HRDLKP NI +                       KIGD GL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 171 RSL---SDSKECLTEYIATRWYRAPEILI-SNRRYTHHVDIWSLGCILAEMLQSKPLFPG 226
           +++   S +  C    + T +Y +PE+L+   + Y    D+W+LGCI+ E+   K  F  
Sbjct: 190 KNIGIESMAHSC----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 227 ASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           A+     QLI  L R P+ P         K K +E   L+  +L L+  ERP   Q L +
Sbjct: 246 ANNFS--QLISELKRGPDLP--------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295

Query: 286 NYVSKYFP 293
             +    P
Sbjct: 296 QIIKNVGP 303

Length = 1021

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 26/271 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K + +Y A+K +  E    K +   T  E   LK+  RHP + +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y       L  V EY+        + R+++  +   R+   ++ + L Y+H+ K++
Sbjct: 60  LK--YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLK  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAV 176

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVD 263
           D W LG ++ EM+  +  F         +LI+  ++  P    AD            A  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSAD------------AKS 224

Query: 264 LLNQILVLNPSER-----PETDQILEHNYVS 289
           LL+ +L+ +P++R      +  +I+ H++ +
Sbjct: 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 80/292 (27%), Positives = 136/292 (46%), Gaps = 39/292 (13%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +GKG YG VYK   +     +A+K+I    R + D +  + +I+             ++D
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI----RLELD-ESKFNQIIMELDILHKAVSPYIVD 63

Query: 91  IYKAVNNKD-LYVVFEYME-NDLNKV----IRDKILKDVHIRYIMFQLCNGLSYI-HACK 143
            Y A   +  +Y+  EYM+   L+K+    +  + + +  +R I + +  GL ++     
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLG----LARSLSDSKECLTEYIATRWYRAPEILIS-- 197
           ++HRD+KP+N+L++ +  +K+ D G    L  SL+ +       I  + Y APE + S  
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSGG 177

Query: 198 ---NRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFY 251
              N  YT   D+WSLG  + EM L   P  P    +   QL  IV+    +PP     Y
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD---GDPPTLPSGY 234

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
           +       +A D + + L   P+ RP   Q+LEH ++ KY  +   +   VT
Sbjct: 235 SD------DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVT 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 9e-19
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 10/147 (6%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           ++C GL  +H  ++++RDLKP NIL+D    I+I DLGLA  + +  + +   + T  Y 
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYM 168

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-PHADK 249
           APE+ + N RYT   D W+LGC+L EM+  +  F       + + +  LV+     +++K
Sbjct: 169 APEV-VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER 276
           F         +A  L   +L  +P ER
Sbjct: 228 F-------SPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 9/221 (4%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K IGKG++G V  A  K  +++ A+K +  +A   K + +    E   L    +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   ++  +   LY V +Y+        + R++   +   R+   ++ + L Y+H+  ++
Sbjct: 61  LHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLKP NIL+D    I + D GL +   +     + +  T  Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTV 177

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN---LVRPN 243
           D W LG +L EML   P F   +T+     I+N    ++PN
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 69/254 (27%), Positives = 122/254 (48%), Gaps = 21/254 (8%)

Query: 29  KRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           K +G+G++G V+   K    +  Q  A+K + +A     D  RT  E   L     HP I
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFI 60

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           + +   Y       LY++ +++   DL  ++ ++ +  +  +++ + +L   L ++H+  
Sbjct: 61  VKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR-YT 202
           +++RDLKP NIL+D+   IK+ D GL++   D ++    +  T  Y APE++  NRR +T
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--NRRGHT 176

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
              D WS G ++ EML     F G      + +I+      P    +F +       EA 
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSP------EAQ 226

Query: 263 DLLNQILVLNPSER 276
            LL  +   NP+ R
Sbjct: 227 SLLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---TYREILFLKSFQRHPNI 85
           K IGKG++G V  A  K++  + A+K + +    K   Q      R +L LK+  +HP +
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LKNL-KHPFL 58

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           + +   Y     + LY V +Y+        + R++   +   R+   ++ + + Y+H+  
Sbjct: 59  VGLH--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           +++RDLKP NIL+D    + + D GL +   + +E  + +  T  Y APE+L     Y  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-RKEPYDR 175

Query: 204 HVDIWSLGCILAEMLQSKPLF 224
            VD W LG +L EML   P F
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 82/310 (26%), Positives = 138/310 (44%), Gaps = 68/310 (21%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIV 66

Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 67  GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 119

Query: 140 -HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 176

Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLV------------RPNPP 245
             Y+   DIWS+G  L EM   + P+ P    + +L+L+                RP PP
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAESETSPRPRPP 234

Query: 246 HADKFYAGFKNKPEEAV-------------------------DLLNQILVLNPSERPETD 280
                  G  ++P  A+                         D +N+ L+ NP+ER +  
Sbjct: 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK 294

Query: 281 QILEHNYVSK 290
           Q++ H ++ +
Sbjct: 295 QLMVHAFIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 22/278 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ +   +G+G +G V    +K      A+K + ++     +    + E   + S    P
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
            I  +   Y   +  +LY+V EY    DL  ++   +    +   ++ + +L   +  +H
Sbjct: 62  WIPQLQ--YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEILI--- 196
               +HRD+KP N+LID++  IK+ D G A  L+ +K   ++  + T  Y APE+L    
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 197 --SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
                 Y    D WSLG I  EM+  +  F   +++     I+N  R         +  F
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---------FLKF 230

Query: 255 KNKPEEAVDLLNQI--LVLNPSERPETDQILEHNYVSK 290
              P+ + D L+ I  L+    ER   + +  H + SK
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 26  TIHKRIGKGAYGIVYKA-YDKNNKQY--VAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
           TI K IG G +G V +       K+   VAIK +       +D QR     E   +  F 
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD 63

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HPNII +  +      + + ++ EYMEN  L+K +R  D       +  ++  + +G+ 
Sbjct: 64  -HPNIIRLEGVVTKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYRAPEI 194
           Y+     +HRDL   NIL++ +   K+ D GL+R L DS+   T     I  RW  APE 
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA 179

Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R++T   D+WS G ++ E++
Sbjct: 180 -IAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 10/147 (6%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           +LC GL  +   ++++RDLKP NIL+D    I+I DLGLA  + +  E +   + T  Y 
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYM 168

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHADK 249
           APE+ I+N +YT   D W LGC++ EM+Q +  F       + + +   V+ +   +++K
Sbjct: 169 APEV-INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER 276
           F        E+A  +   +L  NP ER
Sbjct: 228 F-------SEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 29  KRIGKGAYGIVYKA--YDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + +G+GA+G VYK      N +     VAIK + E    +   Q+ +R+   L S  +HP
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE--NAEPKVQQEFRQEAELMSDLQHP 68

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNK-VIRDKILKDVHIR--------------- 126
           NI+ +L +      +   ++FEY+ + DL++ ++R+    DV                  
Sbjct: 69  NIVCLLGV--CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 127 -YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SD-----SKE 178
            +I  Q+  G+ Y+ +   +HRDL   N L+ +  ++KI D GL+R +  +D     SK 
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 217
            L      RW   PE ++   ++T   DIWS G +L E+
Sbjct: 187 LL----PVRWM-PPEAILYG-KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 85.0 bits (210), Expect = 6e-18
 Identities = 82/328 (25%), Positives = 140/328 (42%), Gaps = 67/328 (20%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL-KSFQRHP 83
           + I   +G+G +G V +A+D+  K+Y A+K +    +   DA+    EI F+ K  Q  P
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK---IEIQFMEKVRQADP 187

Query: 84  -NIITMLDIYKAVNNKDLY---VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            +   ++ I +   N+  +   V+ +Y    L+ +++       H+  I+FQ    L Y 
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF 247

Query: 140 HA-CKVMHRDLKPSNILIDKS----------------CSIKIGDLGLARSLSDSKECLTE 182
           H    +MH DLKP NIL++ S                C ++I DLG      D +   T 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG---GCCDERHSRTA 304

Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP----------------- 225
            ++TR YR+PE+++    + +  D+WS+GCI+ E+   K L+                  
Sbjct: 305 IVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363

Query: 226 ---------GASTSHQLQLIVNLVRP--NPPHADKFYAGFKNKPEEAV-------DLLNQ 267
                    G   +  L      +RP  +P H  +     + +P   V       DL+  
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIA---RARPVREVIRDDLLCDLIYG 420

Query: 268 ILVLNPSERPETDQILEHNYVSKYFPSA 295
           +L  +  +R    Q+  H YV KY+P  
Sbjct: 421 LLHYDRQKRLNARQMTTHPYVLKYYPEC 448

Length = 467

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.0 bits (205), Expect = 8e-18
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 51/291 (17%)

Query: 31  IGKGAYGIVYKAYDKNNKQY-----VAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           IG+GA+G V++A       Y     VA+K + E      D Q  + RE   +  F  HPN
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-HPN 69

Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-----------------------L 120
           I+ +L +      K + ++FEYM   DLN+ +R +                        L
Sbjct: 70  IVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
                  I  Q+  G++Y+   K +HRDL   N L+ ++  +KI D GL+R++  +    
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 181 ---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 237
               + I  RW   PE +  N RYT   D+W+ G +L E+  S  + P    +H+ ++I 
Sbjct: 188 ASENDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIF-SYGMQPYYGMAHE-EVIY 243

Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEH 285
            +   N        +   N P E  +L+       PS+RP     ++IL+ 
Sbjct: 244 YVRDGN------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 6/199 (3%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K IGKG++G V  A  K + +  A+K +  +   N+ + +    E   L    +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y     + LY V +++        + R++   +   R+   ++ + L Y+H+  ++
Sbjct: 61  LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLKP NIL+D    + + D GL +      +  T +  T  Y APE+ I  + Y + V
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPYDNTV 177

Query: 206 DIWSLGCILAEMLQSKPLF 224
           D W LG +L EML   P F
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 36/264 (13%)

Query: 29  KRIGKGAYGIVYKAY--DKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           K +G G +G V K     K+ K+  VA+K   +        +   RE   +     HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVK-TLKQEHIAAGKKEFLREASVMAQLD-HPCI 58

Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACK 143
           + ++ + K    + L +V E      L K ++ +  +    ++ +  Q+  G++Y+ +  
Sbjct: 59  VRLIGVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIAT-------RWYRAPEIL 195
            +HRDL   N+L+      KI D G++R+L + S      Y AT       +WY APE  
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWY-APEC- 169

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           I+  +++   D+WS G  L E     +KP +     +  + ++ +  R   P        
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKP-YGEMKGAEVIAMLESGERLPRP-------- 220

Query: 254 FKNKPEEAVDLLNQILVLNPSERP 277
            +  P+E   ++       P +RP
Sbjct: 221 -EECPQEIYSIMLSCWKYRPEDRP 243

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 24/284 (8%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 60  LK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAV 176

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNK---- 257
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K    
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236

Query: 258 -----PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
                P +A +++     L+         +++   +  + P  T
Sbjct: 237 RLGGGPSDAKEVMEHRFFLS----INWQDVVQKKLLPPFKPQVT 276

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K++G G +G V+  Y  NN   VA+K +          Q    E   +K+ Q H  ++ +
Sbjct: 12  KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQ-HDKLVRL 66

Query: 89  LDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNGLSYIHACK 143
              Y  V  ++ +Y++ EYM     L+ +  D+  K +  + I F  Q+  G++YI    
Sbjct: 67  ---YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRY 201
            +HRDL+ +N+L+ +S   KI D GLAR + D++    E      +W  APE  I+   +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEA-INFGSF 181

Query: 202 THHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKPE 259
           T   D+WS G +L E++   K  +PG S S  +  +    R P            +N P+
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM----------ENCPD 231

Query: 260 EAVDLLNQILVLNPSERPETDQI 282
           E  D++         ERP  D +
Sbjct: 232 ELYDIMKTCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 38/266 (14%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           ++G+G +G V+     N    VAIK +    +  T     + +   +    RH  ++ + 
Sbjct: 13  KLGQGCFGEVWMG-TWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPL- 66

Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             Y  V+ + +Y+V E+M      D  K    K LK   +  +  Q+ +G++YI     +
Sbjct: 67  --YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAPEILISN 198
           HRDL+ +NIL+  +   KI D GLAR + D+     EY A        +W  APE  +  
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDN-----EYTARQGAKFPIKW-TAPEAALYG 178

Query: 199 RRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E++ + +  +PG      L+ +    R P P          + 
Sbjct: 179 -RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP----------QG 227

Query: 257 KPEEAVDLLNQILVLNPSERPETDQI 282
            PE   +L+      +P ERP  + I
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 32/274 (11%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+C V+
Sbjct: 60  LK--YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           +RDLK  N+++DK   IKI D GL +  +SD     T +  T  Y APE+L  N  Y   
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN-DYGRA 175

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           VD W LG ++ EM+  +   P  +  H    +L L+  +  P            +    E
Sbjct: 176 VDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRFP------------RTLSPE 221

Query: 261 AVDLLNQILVLNPSER----PE-TDQILEHNYVS 289
           A  LL  +L  +P +R    PE   +I+EH + +
Sbjct: 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 50/284 (17%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           K +GKG  G V+    K   +  A+K   K     RNK     T +EIL   +   HP +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL---ATLDHPFL 63

Query: 86  ITMLDIYKAVNNKDLYVVFEY-MENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHA 141
            T+   ++      L +V +Y    +L ++++    K L +   R+   ++   L Y+H 
Sbjct: 64  PTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-----------------KECLTEYI 184
             +++RDLKP NIL+ +S  I + D  L++                          +E  
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 185 A------------TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 232
           +            T  Y APE+ IS   +   VD W+LG +L EML     F G++    
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
              I+          +  + G       A DL+ ++LV +PS+R
Sbjct: 241 FSNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 66/277 (23%), Positives = 126/277 (45%), Gaps = 26/277 (9%)

Query: 29  KRIGKGAYGIVY---KAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + +G GAYG V+   K    +  +  A+K   K     + KT A+ T  E   L++ +R 
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKT-AEHTRTERQVLEAVRRC 64

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           P ++T+   Y    +  L+++ +Y+        + + +   +  +R  + ++   L ++H
Sbjct: 65  PFLVTLH--YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEILISNR 199
              +++RD+K  NIL+D    + + D GL++  L++ +E    +  T  Y APE++    
Sbjct: 123 QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 200 R-YTHHVDIWSLGCILAEMLQSKPLFP--GASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             +   VD WSLG +  E+L     F   G   S Q ++   +++  PP      A    
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKSKPPFPKTMSA---- 237

Query: 257 KPEEAVDLLNQILVLNPSER---PETDQILEHNYVSK 290
              EA D + ++L  +P +R      D+I  H +   
Sbjct: 238 ---EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 38/210 (18%)

Query: 31  IGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNK-TDAQRT---YREILFLKSFQRHP 83
           IGKG +G VY          K + A+K +     N+ TD +      +E + +K F  HP
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFS-HP 56

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMF--QLCNGL 136
           N++++L I        L VV  YM++ DL   IR +     +KD+    I F  Q+  G+
Sbjct: 57  NVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDL----IGFGLQVAKGM 111

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+ + K +HRDL   N ++D+S ++K+ D GLAR + D      EY +   +   ++ +
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK-----EYYSVHNHTGAKLPV 166

Query: 197 --------SNRRYTHHVDIWSLGCILAEML 218
                     +++T   D+WS G +L E++
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 53/275 (19%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHP 83
           +++G G +G V++    NN   VA+K +     +  D         FL   Q     RHP
Sbjct: 12  RKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKD---------FLAEAQIMKKLRHP 61

Query: 84  NIITMLDIYKAVNNKD--LYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
            +I +     AV   +  +Y+V E M+     +  +    + LK   +  +  Q+ +G++
Sbjct: 62  KLIQLY----AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+ A   +HRDL   N+L+ ++   K+ D GLAR + +       Y A        +W  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-----IYEAREGAKFPIKW-T 171

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHAD 248
           APE  + N R++   D+WS G +L E++   +  +PG + +  LQ +    R P PP   
Sbjct: 172 APEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP--- 227

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERP--ETDQ 281
                    P+E  D++      +P +RP  ET Q
Sbjct: 228 -------GCPKELYDIMLDCWKEDPDDRPTFETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 52/282 (18%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIF------EAFRNKTDAQRTYREILFLKSFQRHP 83
           ++G+G +G V+     N    VAIK +       EAF  +    +  R          H 
Sbjct: 13  KLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR----------HE 61

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            ++ +   Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+
Sbjct: 62  KLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAP 192
                +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A        +W  AP
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKW-TAP 172

Query: 193 EILISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
           E  +   R+T   D+WS G +L E+  + +  +PG      L  +    R P PP     
Sbjct: 173 EAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--- 228

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
                  PE   DL+ Q     P ERP  + +    ++  YF
Sbjct: 229 -------PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF 261

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)

Query: 26  TIHKRIGKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 18  TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEY-----------------MEN--DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                 ME   D+ +V  +++ 
Sbjct: 78  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +Q+  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 136 FKD--LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 194 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 250

Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS RP   Q++E
Sbjct: 251 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 45/289 (15%)

Query: 26  TIHKRIGKGAYGIVYKA----YDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKS 78
            + K +G+G +G V +A     DK+       VA+K + +   +K D      E+  +K 
Sbjct: 15  VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKL 73

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKI---------LKDVHIRYI 128
             +H NII +L +        LYV+ EY  + +L + +R +          +  V    +
Sbjct: 74  IGKHKNIINLLGV--CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 129 MF--------QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SK 177
            F        Q+  G+ Y+ + + +HRDL   N+L+ +   +KI D GLAR + D    K
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQL 235
           +     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +L
Sbjct: 192 KTSNGRLPVKWM-APEALF-DRVYTHQSDVWSFGILMWEIFTLGGSP-YPGIPVEELFKL 248

Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           +    R + P          N   E   L+ +     P++RP   Q++E
Sbjct: 249 LREGHRMDKP---------SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 31/224 (13%)

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLS 137
           R P I++    +  +N  ++ +  E+M+   L+++ +    I  ++ +  I   +  GL+
Sbjct: 61  RSPYIVSFYGAF--LNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLT 117

Query: 138 YIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           Y++   ++MHRD+KPSNIL++    IK+ D G++  L +S      ++ T  Y +PE  I
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPE-RI 174

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFP----------GASTSHQLQLIVNLVRPNPPH 246
              +YT   D+WSLG  + E+   K  FP                 L L+  +V+  PP 
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232

Query: 247 --ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             +  F       PE+  D ++  L+ +P+ERP   Q+      
Sbjct: 233 LPSSDF-------PEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 79.6 bits (196), Expect = 7e-17
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 28/209 (13%)

Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
           T  K IG G +G V++   K     +  VAIK +   +   T+ QR     E   +  F 
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFS 64

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCN------ 134
            H NII +  +      K   ++ EYMEN       DK L+D    +  +QL        
Sbjct: 65  -HHNIIRLEGVVTKF--KPAMIITEYMENG----ALDKYLRDHDGEFSSYQLVGMLRGIA 117

Query: 135 -GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----IATRWY 189
            G+ Y+     +HRDL   NIL++ +   K+ D GL+R L D  E         I  RW 
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW- 176

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML 218
            APE  I+ R++T   D+WS G ++ E++
Sbjct: 177 TAPEA-IAYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 18/252 (7%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG++G V  A  K   +Y A+K +  +      D + T  E   L     +P    
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP---F 57

Query: 88  MLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHACKV 144
           +  +Y     K+ L+ V E++   DL   I+DK   D++   +   ++  GL ++H+  +
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           ++RDLK  N+++D+   IKI D G+ +         + +  T  Y APEIL    +YT  
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL-QGLKYTFS 176

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL 264
           VD WS G +L EML  +  F G       + I    R + PH  ++        +E+ D+
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDELFESI----RVDTPHYPRWIT------KESKDI 226

Query: 265 LNQILVLNPSER 276
           L ++   +P+ R
Sbjct: 227 LEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--- 80
           I + IG G +G V +   K     + +VAIK +   +   T+ QR  R+ L   S     
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQR--RDFLSEASIMGQF 62

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HPNII +  +     ++ + ++ E+MEN  L+  +R  D     + +  ++  +  G+ 
Sbjct: 63  DHPNIIHLEGV--VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE------CLTEYIATRWYRA 191
           Y+     +HRDL   NIL++ +   K+ D GL+R L D          L   I  RW  A
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TA 179

Query: 192 PEILISNRRYTHHVDIWSLGCILAEML 218
           PE  I+ R++T   D+WS G ++ E++
Sbjct: 180 PEA-IAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 41/287 (14%)

Query: 26  TIHKRIGKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK NK      K+ +      D      E+  +K  
Sbjct: 15  TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI 74

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILK 121
            +H NII +L       +  LYV+ EY  + +L + +R                 ++ L 
Sbjct: 75  GKHKNIINLLG--ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
              +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR + +    K+
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIV 237
                +  +W  APE L  +R YTH  D+WS G +L E+       +PG       +L+ 
Sbjct: 193 TTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250

Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
              R + P          N   E   ++ +     PS+RP   Q++E
Sbjct: 251 EGHRMDKP---------ANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 43/285 (15%)

Query: 29  KRIGKGAYGIVYKA------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           K +G+G +G V  A       +K N+      K+ ++   + D      E+  +K   +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILKDVH 124
            NII +L       +  LYV+ EY  + +L + +R                 ++ L    
Sbjct: 84  KNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLT 181
           +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+   
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+   
Sbjct: 202 GRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLKEG 258

Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
            R + P          N   E   ++       PS+RP   Q++E
Sbjct: 259 HRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 24/257 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +RIG+G +G V+    + +   VA+K   E       A +  +E   LK +  HPNI+ +
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYS-HPNIVRL 58

Query: 89  LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVM 145
           + +      + +Y+V E ++  D    +R +   LK   +  ++     G+ Y+ +   +
Sbjct: 59  IGV--CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEILISNRRYT 202
           HRDL   N L+ +   +KI D G++R   D     T   + I  +W  APE L +  RY+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL-NYGRYS 174

Query: 203 HHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
              D+WS G +L E   L + P +   S     + I   VR   P         +  P+ 
Sbjct: 175 SESDVWSFGILLWEAFSLGAVP-YANLSNQQTREAIEQGVRLPCP---------ELCPDA 224

Query: 261 AVDLLNQILVLNPSERP 277
              L+ +    +P +RP
Sbjct: 225 VYRLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 59/284 (20%)

Query: 29  KRIGKGAYGIVYKA--YDKNNKQY-VAIK--------KIFEAFRNKTDAQRTYREILFLK 77
           K++G G++G+V +        K   VA+K         I + F          +E   + 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL---------KEAAIMH 51

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQL 132
           S   H N+I +   Y  V    L +V E        + L K      L      Y + Q+
Sbjct: 52  SLD-HENLIRL---YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV-QI 106

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR-- 190
            NG+ Y+ + + +HRDL   NIL+     +KIGD GL R+L  +++    Y+     +  
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---YVMEEHLKVP 163

Query: 191 ----APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLI----VNLV 240
               APE L   R ++H  D+W  G  L EM     +P + G S S  L+ I      L 
Sbjct: 164 FAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQILKKIDKEGERLE 221

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           RP            +  P++  +++ Q    NP++RP    + E
Sbjct: 222 RP------------EACPQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 9e-17
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +E T  K +G G +G+V+    K   Q  VAIK I E   ++ D     + ++ L     
Sbjct: 4   SELTFMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLS---- 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LN--KVIRDKILKDVHIRYIMFQLCNGLS 137
           HP ++ +  +      K LY+V E+MEN   LN  +  + K+ KD+ +  +   +C G+ 
Sbjct: 58  HPKLVQLYGV--CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEGME 114

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+     +HRDL   N L+  +  +K+ D G+ R + D      EY ++       +W  
Sbjct: 115 YLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKW-S 168

Query: 191 APEILISNRRYTHHVDIWSLGCILAEM 217
            PE+   + +Y+   D+WS G ++ E+
Sbjct: 169 PPEVFNFS-KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 42/218 (19%)

Query: 31  IGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           +G+GA+G V+ A   N     +K  VA+K + EA  +++  Q   RE   L   Q H +I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQ-HQHI 69

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KIL---KDV--------HIRYI 128
           +    +      + L +VFEYM + DLN+ +R      KIL   +DV         +  I
Sbjct: 70  VRFYGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----- 183
             Q+ +G+ Y+ +   +HRDL   N L+ +   +KIGD G++R +       T+Y     
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVGG 182

Query: 184 ---IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
              +  RW     IL   R++T   DIWS G +L E+ 
Sbjct: 183 RTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 37/272 (13%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           T+ + IG+G +G VY+      +N K  VA+K   +   + +  ++  +E   ++ F  H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQF-DH 66

Query: 83  PNIITMLDIYKAVNNKDLYVVFE-YMENDLNKVIRDKILKDVHIRYIMF--QLCNGLSYI 139
           P+I+ ++ +   +    +++V E     +L   ++           I++  QL   L+Y+
Sbjct: 67  PHIVKLIGV---ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR------WYRAPE 193
            + + +HRD+   N+L+     +K+GD GL+R L D     + Y A++      W  APE
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE----SYYKASKGKLPIKWM-APE 178

Query: 194 ILISNRRYTHHVDIWSLGCILAE--MLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
             I+ RR+T   D+W  G  + E  ML  KP F G   +  +  I N  R P PP     
Sbjct: 179 S-INFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRIENGERLPMPP----- 231

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                N P     L+ +    +PS+RP   ++
Sbjct: 232 -----NCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 16/251 (6%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG++G V  A  K   +  AIK +  +      D   T  E   L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   ++  +   L+ V EY+   DL  ++ R +   +   R+   ++   L ++H   V+
Sbjct: 61  LHCCFQTKDR--LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RDLK  NIL+D     K+ D G+ +    +    T +  T  Y APEIL     Y   V
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL-QELEYGPSV 177

Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D W+LG ++ EM+  +P F   +     + I+        H D  Y  + +K  EAV +L
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESIL--------HDDVLYPVWLSK--EAVSIL 227

Query: 266 NQILVLNPSER 276
              +  NP++R
Sbjct: 228 KAFMTKNPNKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 61/261 (23%)

Query: 69  TYREILFLKSFQRHPNIITMLD--IYKAVN-------NKDLYVVFEYMENDLNKVIRDKI 119
           T  E + L++   HP++I M D  +  A+        + DLY    Y+      +  D+ 
Sbjct: 104 TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYSSDLYT---YLTKRSRPLPIDQA 159

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 179
           L       I  Q+  GL Y+HA +++HRD+K  NI I+    + IGDLG A+    +   
Sbjct: 160 L------IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213

Query: 180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML----------QSKPLFPGAST 229
           L     T    APE+L +  +Y    DIWS G +L EML           S P     S 
Sbjct: 214 LG-LAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSC 271

Query: 230 SHQLQLIVNLVRPNPPHADKF--------------YAGFKNKP-------------EEAV 262
              L  I++ ++ +P   ++F              YA  + +P              +  
Sbjct: 272 HSHLLKIISTLKVHP---EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGE 328

Query: 263 DLLNQILVLNPSERPETDQIL 283
            L++++L  + + RP  ++IL
Sbjct: 329 FLVHKMLTFDAAMRPSAEEIL 349

Length = 357

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 8/146 (5%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           ++  GL  +H    ++RDLKP NIL+D    I+I DLGLA  + +  E +   + T  Y 
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYM 168

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+ ++N+RYT   D W LGC++ EM++ +  F G     + + +   V       + +
Sbjct: 169 APEV-LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET---EEVY 224

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
            A F    EEA  +   +L  +P +R
Sbjct: 225 SAKFS---EEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 68/237 (28%), Positives = 106/237 (44%), Gaps = 12/237 (5%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP  +T
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP-FLT 58

Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK-V 144
            L  Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+ K V
Sbjct: 59  ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           ++RDLK  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRA 176

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNK 257
           VD W LG ++ EM+  +  F         +LI    +   R   P A    +G   K
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 29/269 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           +GKG++G V  A  K   +  AIK   K      +  +     + +L L      P  +T
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG---KPPFLT 64

Query: 88  MLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKV 144
            L  +      D LY V EY+   DL   I+     K+ H  +   ++  GL ++H+  +
Sbjct: 65  QL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           ++RDLK  N+++D    IKI D G+ + ++   K   T +  T  Y APEI I+ + Y  
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEI-IAYQPYGK 180

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
            VD W+ G +L EML  +P F G       Q I+      P          K+  +EAV 
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----------KSLSKEAVS 230

Query: 264 LLNQILVLNPSER----PETDQ-ILEHNY 287
           +   +L  +P++R    P  ++ I EH +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAF 259

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 71/262 (27%), Positives = 125/262 (47%), Gaps = 38/262 (14%)

Query: 29  KRIGKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K++G G +G V+   ++ N K  VA+K +    +  T +  ++ E   +    RH  ++ 
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTK--VAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 88  MLDIYKAVNNKDLYVVFEYM-ENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACK 143
           +   Y  V+ + +Y+V EYM +  L   ++D   + LK  ++  +  Q+  G++YI    
Sbjct: 66  L---YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-------TRWYRAPEILI 196
            +HRDL+ +NIL+      KI D GLAR + D+     EY A        +W  APE  +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDN-----EYTARQGAKFPIKW-TAPEAAL 176

Query: 197 SNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
              R+T   D+WS G +L E++ + +  +PG +    L+ +    R   P         +
Sbjct: 177 YG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP---------Q 226

Query: 256 NKPEEAVDLLNQILVLNPSERP 277
           + P    +L+ Q    +P ERP
Sbjct: 227 DCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 9e-16
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
            I K IG G +G V     K     +  VAIK +   +   T+ QR     E   +  F 
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFD 63

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+ 
Sbjct: 64  -HPNIIHLEGV--VTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----IATRWYRAPE 193
           Y+     +HRDL   NIL++ +   K+ D GL+R L D  E         I  RW  APE
Sbjct: 121 YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPE 179

Query: 194 ILISNRRYTHHVDIWSLGCILAEML 218
             I+ R++T   D+WS G ++ E++
Sbjct: 180 A-IAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 23/231 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD--AQRTYREILFLKSF 79
           L + T+ + IG+G +G V +   +   Q VA+K I      K D  AQ    E   +   
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI------KCDVTAQAFLEETAVMTKL 56

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-IRYIMFQL--CNG 135
             H N++ +L +   + +  LY+V E M + +L   +R +    V  I+ + F L    G
Sbjct: 57  H-HKNLVRLLGV---ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + Y+ + K++HRDL   NIL+ +    K+ D GLAR    S       +  +W  APE L
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKW-TAPEAL 169

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 245
             +++++   D+WS G +L E+    +  +P  S     + +    R  PP
Sbjct: 170 -KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 74/267 (27%), Positives = 125/267 (46%), Gaps = 22/267 (8%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITML 89
           IGKG++G V +   ++ ++  A+K I +A   ++++   T  E   L      P I+ + 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 90  DIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             +++   + LY+V  ++      + + R+        R+   +L   L  +H   V++R
Sbjct: 60  FSFQS--PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117

Query: 148 DLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           DLKP NIL+D    I + D GL + ++ D  +  T +  T  Y APE L+    YT  VD
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPE-LLLGHGYTKAVD 175

Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLN 266
            W+LG +L EML   P F   + +   + I  L  P      +F  GF     +A DLL 
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPL-----RFPDGFD---RDAKDLLI 225

Query: 267 QILVLNPSER---PETDQILEHNYVSK 290
            +L  +P+ R       +I  H + S+
Sbjct: 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 70/243 (28%), Positives = 112/243 (46%), Gaps = 35/243 (14%)

Query: 23  AEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---F 75
            E    K +G GA+G VYK       +  K  VAIK +    R +T  +   +EIL   +
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL----REETSPK-ANKEILDEAY 61

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQ 131
           + +   HP+++ +L I  +     + ++ + M      D  +  +D I    ++     Q
Sbjct: 62  VMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNI-GSQYLLNWCVQ 117

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 186
           +  G+SY+   +++HRDL   N+L+     +KI D GLA+ L D  E   EY A      
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDE--KEYHAEGGKVP 174

Query: 187 -RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-P 242
            +W  A E  I +R YTH  D+WS G  + E++   +KP + G        L+    R P
Sbjct: 175 IKWM-ALES-ILHRIYTHKSDVWSYGVTVWELMTFGAKP-YEGIPAVEIPDLLEKGERLP 231

Query: 243 NPP 245
            PP
Sbjct: 232 QPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 50/274 (18%)

Query: 23  AEYTIHKRIGKGAYGIVYKA-YDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILF 75
               + K++G G +G V+ A Y+K+ K  VA+K +       EAF  + +          
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEAN---------V 54

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--Q 131
           +K+ Q H  ++ +   +  V  + +Y++ E+M     L+ +  D+  K    + I F  Q
Sbjct: 55  MKTLQ-HDKLVKL---HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA------ 185
           +  G+++I     +HRDL+ +NIL+  S   KI D GLAR + D+     EY A      
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-----EYTAREGAKF 165

Query: 186 -TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPN 243
             +W  APE  I+   +T   D+WS G +L E++   +  +PG S    ++ +    R  
Sbjct: 166 PIKW-TAPEA-INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-- 221

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
            P  +       N PEE  +++ +     P ERP
Sbjct: 222 MPRPE-------NCPEELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 25/270 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +GKG++G V  A  K   +  AIK +  +      D + T  E   L    + P +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 90  DIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++ V+   LY V EY+   DL   I+     K+    +   ++  GL ++H   +++R
Sbjct: 68  SCFQTVDR--LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+++D    IKI D G+ +           +  T  Y APEI I+ + Y   VD 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI-IAYQPYGKSVDW 184

Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           W+ G +L EML  +P F G       Q I+  N+  P            K+  +EAV + 
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP------------KSLSKEAVSIC 232

Query: 266 NQILVLNPSER----PETDQ-ILEHNYVSK 290
             ++  +PS+R    PE ++ I EH +  +
Sbjct: 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 65/263 (24%), Positives = 125/263 (47%), Gaps = 20/263 (7%)

Query: 24  EYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLK 77
            + + K +G GAYG V+   K    +  +  A+K + +A    + KT  + T  E   L+
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKT-VEHTRTERNVLE 59

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
             ++ P ++T+   Y       L+++ +Y+        + +     +  +R+   ++   
Sbjct: 60  HVRQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEI 194
           L ++H   +++RD+K  NIL+D    + + D GL++  LS+ KE    +  T  Y APEI
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +     +   VD WSLG ++ E+L  + P       + Q ++   +++ +PP       G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI--G 235

Query: 254 FKNKPEEAVDLLNQILVLNPSER 276
                 EA DLL+++L  +P +R
Sbjct: 236 P-----EAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 11/211 (5%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQRHPNII 86
           IG+G +G VY     +  +  A+K   +  R K     T     R +L L S    P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
            M   Y       L  + + M   DL+  + +  +  +  +R+   ++  GL ++H   V
Sbjct: 61  CM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           ++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T  Y APE+L     Y   
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSS 176

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
            D +SLGC+L ++L+    F    T  + ++
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---REILFLKSFQRHPNIIT 87
           +GKG +G V     KN  +  A KK+ +    K   ++     +EIL   +    P I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN---SPFIVN 57

Query: 88  MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMF---QLCNGLSYIHACK 143
           +   Y   +   L +V   M   DL   I +   + + +  ++    Q+  G+ ++H+  
Sbjct: 58  L--AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           +++RD+KP N+L+D   + ++ DLGLA  L D K  +T+   T  Y APEIL     Y++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRAGTNGYMAPEIL-KEEPYSY 173

Query: 204 HVDIWSLGCILAEMLQSKPLF 224
            VD +++GC + EM+  +  F
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 6/197 (3%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           IG+G+Y  V     K N Q  A+K +  E   +  D      E    +    +P ++ + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 90  DIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++  +   L++V EY+     +  + R + L + H R+   ++C  L+++H   +++R
Sbjct: 63  SCFQTTSR--LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL     Y   VD 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDW 179

Query: 208 WSLGCILAEMLQSKPLF 224
           W+LG ++ EM+  +  F
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYREILFLKSFQR 81
           +Y + K IG+GA+G V     K++++  A+K +  FE  + ++D+   + E   + +F  
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIM-AFAN 101

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            P ++ +   ++  ++K LY+V EYM   DL  ++ +  + +   ++   ++   L  IH
Sbjct: 102 SPWVVQLFCAFQ--DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILIS- 197
           +  ++HRD+KP N+L+DK   +K+ D G    + ++    C T  + T  Y +PE+L S 
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQ 218

Query: 198 --NRRYTHHVDIWSLGCILAEML 218
             +  Y    D WS+G  L EML
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.2 bits (182), Expect = 6e-15
 Identities = 79/296 (26%), Positives = 121/296 (40%), Gaps = 60/296 (20%)

Query: 28  HKR-------IGKGAYG-IVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRT---YREI 73
           HKR       +G+G +G +    YD  N    + VA+K      + +   Q T    +EI
Sbjct: 2   HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVK----TLKRECGQQNTSGWKKEI 57

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQL 132
             LK+   H NI+           K L ++ EY+    L   +    L    +     Q+
Sbjct: 58  NILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI 116

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----- 187
           C G++Y+H+   +HRDL   N+L+D    +KIGD GLA+++ +      EY   R     
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDS 172

Query: 188 ---WYRAPEILISNRRYTHHVDIWSLGCILAEML------QSKP------LFPGASTSHQ 232
              WY A E L  N ++++  D+WS G  L E+L      QS P      + P       
Sbjct: 173 PVFWY-AVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230

Query: 233 LQLIVNLVR----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           ++LI  L R    P P          KN P+E   L+          RP    ++ 
Sbjct: 231 VRLIELLERGMRLPCP----------KNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 49/233 (21%)

Query: 27  IHKRIGKGAYGIVYKA--YD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + + +G+GA+G V+ A  Y+     +K  VA+K    A ++ T A R        K FQR
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAAR--------KDFQR 56

Query: 82  HPNIITMLD------IYKAVNNKD-LYVVFEYMEN-DLNKVIRDK-----ILKDVHIR-- 126
              ++T L        Y    + D L +VFEYM++ DLNK +R       IL D   R  
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 127 ----------YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
                     +I  Q+ +G+ Y+ +   +HRDL   N L+  +  +KIGD G++R +  +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176

Query: 177 KECLT---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLF 224
                     +  RW   P   I  R++T   D+WS G IL E+     +P F
Sbjct: 177 DYYRVGGHTMLPIRW--MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHP 83
           Y I + IGKG  G VY AYD    + VA+KKI E    N    +R  RE   + +   HP
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAK-IAADLIHP 62

Query: 84  NIITMLDIYKAVNNKDL-YVVFEYMENDLNKVI------RDKILKDVHIRY-------IM 129
            I+ +  I    ++ D  Y    Y+E    K +      ++ + K++  +        I 
Sbjct: 63  GIVPVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------- 181
            ++C  + Y+H+  V+HRDLKP NIL+     + I D G A      +E L         
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 182 ----------EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
                     + + T  Y APE L+     +   DI++LG IL +ML
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 1/94 (1%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           Q+ +GL ++H  ++++RDLKP N+L+D   +++I DLGLA  L D +     Y  T  + 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           APE+L     Y   VD ++LG  L EM+ ++  F
Sbjct: 165 APELL-QGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 40/220 (18%)

Query: 27  IHKRIGKGAYGIVYKA--YD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + + +G+GA+G V+ A  Y+   + +K  VA+K + +A  N    +  +RE   L + Q 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQ- 65

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR----DKIL----------KDVHIR 126
           H +I+    +   V    L +VFEYM++ DLNK +R    D +L              + 
Sbjct: 66  HEHIVKFYGV--CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--- 183
           +I  Q+  G+ Y+ +   +HRDL   N L+ ++  +KIGD G++R +       T+Y   
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-----TDYYRV 178

Query: 184 -----IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
                +  RW   P   I  R++T   D+WSLG +L E+ 
Sbjct: 179 GGHTMLPIRW--MPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 42/276 (15%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 57

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDK---ILKDVHIRYIMFQLCNGLS 137
           H N++ +L +        LY+V EYM +  L   +R +   +L    +      +C  + 
Sbjct: 58  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+ A   +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE L  
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL-R 172

Query: 198 NRRYTHHVDIWSLGCILAEMLQ----SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            ++++   D+WS G +L E+        P  P       L+ +V       P  +K   G
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVV-------PRVEK---G 215

Query: 254 FKNK-----PEEAVDLLNQILVLNPSERPETDQILE 284
           +K       P    D++ Q   L+ + RP   Q+ E
Sbjct: 216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 33/190 (17%)

Query: 51  VAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFE 105
           VA+K +      + D  +T R   FLK  +     ++PNII +L +   V++  L ++ E
Sbjct: 47  VAVKML------RADVTKTARND-FLKEIKIMSRLKNPNIIRLLGV--CVSDDPLCMITE 97

Query: 106 YMEN-DLNKV-----IRDKILKDVHIR--------YIMFQLCNGLSYIHACKVMHRDLKP 151
           YMEN DLN+      I        +I         Y+  Q+ +G+ Y+ +   +HRDL  
Sbjct: 98  YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157

Query: 152 SNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILISNRRYTHHVDIW 208
            N L+    +IKI D G++R+L        +    +  RW     IL+   ++T   D+W
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVW 215

Query: 209 SLGCILAEML 218
           + G  L EM 
Sbjct: 216 AFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 25/267 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +GKG++G V  A  K   +  AIK +  +      D + T  E   L    + P +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 90  DIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++ ++   LY V EY+   DL   I+     K+ H  +   ++  GL ++H+  +++R
Sbjct: 68  SCFQTMDR--LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+++D    IKI D G+ +           +  T  Y APEI I+ + Y   VD 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDW 184

Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           W+ G +L EML  +  F G       Q I+  N+  P            K+  +EAV + 
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------KSMSKEAVAIC 232

Query: 266 NQILVLNPSER----PETDQ-ILEHNY 287
             ++  +P +R    PE ++ I EH +
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAF 259

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 49/253 (19%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K IG+GA+G V     K+     A+KK+ ++    + +    R  R+IL   +   +P +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL---AEADNPWV 63

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           + +   Y   +   LY++ EY+   D+   +++     +   R+ + +    +  IH   
Sbjct: 64  VKLY--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLS---------------------------DS 176
            +HRD+KP N+L+D    IK+ D GL   L                             S
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 177 KECLTEY-----------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP 225
           K     +           + T  Y APE+ +    Y    D WSLG I+ EML   P F 
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 226 GASTSHQLQLIVN 238
             +     + I+N
Sbjct: 241 SDNPQETYRKIIN 253

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 16/224 (7%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQRHPNII 86
           IG+G +G VY     +  +  A+K   +  R K     T     R +L L S    P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
            M   Y       L  + + M   DL+  + +  +  +  +R+   ++  GL ++H   V
Sbjct: 61  CM--TYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           ++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T  Y APE+L     Y   
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSS 176

Query: 205 VDIWSLGCILAEMLQSKPLFPGASTSHQ-----LQLIVNLVRPN 243
            D +SLGC+L ++L+    F    T  +     + L VN+  P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 76/315 (24%), Positives = 132/315 (41%), Gaps = 76/315 (24%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIV 66

Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD------KILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V+++      +IL  V I  +      GL+Y+
Sbjct: 67  GFYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL-----RGLAYL 119

Query: 140 -HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               ++MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 176

Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFP-----------------GASTSHQLQLIVNLV 240
             Y+   DIWS+G  L E+   + P+ P                      H +       
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS-----P 231

Query: 241 RPNPPHADKFYAGFKNKPEEAV-------------------------DLLNQILVLNPSE 275
           RP PP       G  ++P  A+                         + +N+ L+ NP+E
Sbjct: 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291

Query: 276 RPETDQILEHNYVSK 290
           R +   ++ H ++ +
Sbjct: 292 RADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 65/224 (29%), Positives = 113/224 (50%), Gaps = 14/224 (6%)

Query: 4   NTTSKSGDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF 60
           N  ++  D +    D  + AE Y + K IG+GA+G V     K+ ++  A+K +  FE  
Sbjct: 23  NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
           + ++D+   + E   + +F   P ++ +   Y   +++ LY+V EYM   DL  ++ +  
Sbjct: 83  K-RSDSAFFWEERDIM-AFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 177
           + +   R+   ++   L  IH+   +HRD+KP N+L+DKS  +K+ D G    ++     
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198

Query: 178 ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEML 218
            C T  + T  Y +PE+L S   +  Y    D WS+G  L EML
Sbjct: 199 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 62/259 (23%), Positives = 110/259 (42%), Gaps = 44/259 (16%)

Query: 51  VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN- 109
           VA+K +     +    +   +E+  L      PNI  +L +     +  L ++ EYMEN 
Sbjct: 49  VAVKVLRPD-ASDNAREDFLKEVKILSRLS-DPNIARLLGV--CTVDPPLCMIMEYMENG 104

Query: 110 DLNKVIRDKILKDVHIR------------YIMFQLCNGLSYIHACKVMHRDLKPSNILID 157
           DLN+ ++  + +   +             Y+  Q+ +G+ Y+ +   +HRDL   N L+ 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164

Query: 158 KSCSIKIGDLGLARSLSDSKECLTEYIAT---RWYRAPEILISNRRYTHHVDIWSLGCIL 214
           K+ +IKI D G++R+L  S     +  A    RW     +L+   ++T   D+W+ G  L
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTL 222

Query: 215 AEMLQSKPLFPGASTSHQLQLIVNLVR-----------PNPPHADKFYAGFKNKPEEAVD 263
            E+L      P    + Q Q+I N              P PP          N P++  +
Sbjct: 223 WEILTLCREQPYEHLTDQ-QVIENAGHFFRDDGRQIYLPRPP----------NCPKDIYE 271

Query: 264 LLNQILVLNPSERPETDQI 282
           L+ +    +  +RP   +I
Sbjct: 272 LMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 35/274 (12%)

Query: 25  YTIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +T+ + +GKG +G V +A    +  + Q VA+K +     + +D +   RE   +K F  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD- 59

Query: 82  HPNIITMLDIYKAVNNKDL----YVVFEYMEN-DLNKVIRDKILKD--------VHIRYI 128
           HPN+I ++ +      K       V+  +M++ DL+  +    + +          +R+ 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF- 118

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
           M  + +G+ Y+ +   +HRDL   N +++++ ++ + D GL++ +      ++     + 
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAE-MLQSKPLFPGASTSHQLQLIVNLVR-PN 243
            +W  A E L  N  YT H D+W+ G  + E M + +  + G   S     ++   R   
Sbjct: 179 VKWL-ALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
           PP             E+  +L+ Q     P  RP
Sbjct: 237 PPDC----------LEDVYELMCQCWSPEPKCRP 260

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 67/288 (23%), Positives = 135/288 (46%), Gaps = 54/288 (18%)

Query: 26  TIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREIL----FL 76
           T+ + +G+G++G+VY+   K       +  VAIK +     N+  + R   E L     +
Sbjct: 9   TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-----NEAASMRERIEFLNEASVM 63

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRY 127
           K F  H +++ +L +      +   V+ E M   DL   +R        + +     ++ 
Sbjct: 64  KEFNCH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 128 IM---FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLT 181
           ++    ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++   
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++  
Sbjct: 181 GLLPVRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVME- 236

Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                        G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 237 ------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 82/288 (28%), Positives = 123/288 (42%), Gaps = 64/288 (22%)

Query: 29  KRI---GKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           KRI   G+G +G V    Y     N  + VA+K +         A    +EI  L++   
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLY- 64

Query: 82  HPNIITMLDIYKAVNNKD------LYVVF-------EYMENDLNKVIRDKILKDVHIRYI 128
           H NI+     YK +  +D      L + F       EY+  + NK+     LK    +Y 
Sbjct: 65  HENIVK----YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN----LKQQL-KYA 115

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----I 184
           + Q+C G+ Y+ + + +HRDL   N+L++    +KIGD GL +++   KE  T       
Sbjct: 116 V-QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-----QSKPL---FPGASTSHQLQLI 236
              WY APE LI ++ Y    D+WS G  L E+L     +S P+         +H    +
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232

Query: 237 VNLVR--------PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
             LVR        P PP          N PEE   L+ +     PS+R
Sbjct: 233 TRLVRVLEEGKRLPRPP----------NCPEEVYQLMRKCWEFQPSKR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 6/197 (3%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           IG+G+Y  V     K  ++  A+K I  E   +  D      E    ++   HP ++ + 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 90  DIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++  +   L+ V E++   DL   + R + L + H R+   ++   L+++H   +++R
Sbjct: 63  SCFQTESR--LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL     Y   VD 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDW 179

Query: 208 WSLGCILAEMLQSKPLF 224
           W+LG ++ EM+  +  F
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 73/271 (26%), Positives = 117/271 (43%), Gaps = 42/271 (15%)

Query: 9   SGDKVQHNVDGNILAEYTIHKRIGKGAYGIVY----KAY-----------DKNNKQYVAI 53
           +  K++H  D   LA + +   +  GA+G ++    +A              N  +    
Sbjct: 136 AQAKLKH--DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCE 193

Query: 54  KKIFEAFRNKTD-AQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLN 112
           + I +  +  +  A +   EIL L     H NI+ + +I ++  N   Y++ +  + DL 
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALG-RLNHENILKIEEILRSEANT--YMITQKYDFDLY 250

Query: 113 KVIRDKIL--KDV----HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD 166
             + D+    KD       R IM QL   + YIH  K++HRD+K  NI ++    I +GD
Sbjct: 251 SFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGD 310

Query: 167 LGLARSLSDSKECLTEY--IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
            G A      +E   +Y  + T    +PEIL  +  Y    DIWS G IL +ML S    
Sbjct: 311 FGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDML-SHDFC 367

Query: 225 P----GASTSHQLQLIVNLVR------PNPP 245
           P    G     QL  I++ +       P+PP
Sbjct: 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398

Length = 501

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 56/281 (19%), Positives = 115/281 (40%), Gaps = 35/281 (12%)

Query: 26  TIHKRIGKGAYGIVYKA---YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
            + K +G+G +G V +     D  ++  VA+K +       ++ +    E   +K F  H
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-H 60

Query: 83  PNIITMLDIYKAVNNKDL------YVVFEYMEN-DLNKVIRDKILKDVHIRY-------I 128
           PN++ ++ +        L       V+  +M++ DL+  +    L  +  +         
Sbjct: 61  PNVMKLIGV--CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA--- 185
           M  +  G+ Y+     +HRDL   N ++ +  ++ + D GL++ +          IA   
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNP 244
            +W  A E L ++R YT   D+W+ G  + E+  + +  +PG         + +  R   
Sbjct: 179 VKWI-AIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           P         ++  +E  DL+      +P +RP   ++ E 
Sbjct: 237 P---------EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 37/238 (15%)

Query: 24  EYTIHKRIGKGAYGIVY--KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +Y I   +  G+ G V+    +    ++ V +K +       T  +   REI  LK+   
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTIS- 144

Query: 82  HPNIITMLDIYKAVN---------NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQ 131
           H  II ++  Y+  +           DL+   +      L + I            I  +
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI-----------TIQRR 193

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWY 189
           L   L+Y+H   ++HRD+K  NI +D+  +  +GD G A  L    +    Y    T   
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLF--PGASTSHQLQLIVNLVRPNP 244
            +PE+L  +  Y    DIWS G +L EM  ++  LF     S+S QL+ I+  ++ +P
Sbjct: 254 NSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310

Length = 392

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 72/295 (24%), Positives = 134/295 (45%), Gaps = 66/295 (22%)

Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREIL----FL 76
           T+ + +G+G++G+VY+   ++      +  VA+K +     N++ + R   E L     +
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-----NESASLRERIEFLNEASVM 63

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-------------KILKD 122
           K F  H +++ +L +      +   VV E M + DL   +R                L++
Sbjct: 64  KGFTCH-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 123 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
             +  +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + +     T+
Sbjct: 121 --MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TD 173

Query: 183 Y--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQ 232
           Y        +  RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    
Sbjct: 174 YYRKGGKGLLPVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQV 230

Query: 233 LQLIVN---LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+ +++   L +P+            N PE   DL+      NP  RP   +I+ 
Sbjct: 231 LKFVMDGGYLDQPD------------NCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 26/260 (10%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +GKG +G V+K   K+ K  VA+K   E    +    +   E   LK +  HPNI+ ++ 
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKI-KFLSEARILKQYD-HPNIVKLIG 59

Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHR 147
           +      + +Y+V E +   D    +R K   LK   +         G++Y+ +   +HR
Sbjct: 60  V--CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSD---SKECLTEYIATRWYRAPEILISNRRYTHH 204
           DL   N L+ ++  +KI D G++R   D   S   L + I  +W  APE L +  RY+  
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-IPIKW-TAPEAL-NYGRYSSE 174

Query: 205 VDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
            D+WS G +L E   L   P +PG +     + +    R + P         +  P++  
Sbjct: 175 SDVWSYGILLWETFSLGVCP-YPGMTNQQAREQVEKGYRMSCP---------QKCPDDVY 224

Query: 263 DLLNQILVLNPSERPETDQI 282
            ++ +     P  RP+  ++
Sbjct: 225 KVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 28/267 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     KN  Q  A+K +  +E   R +T   R  R++L     +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIR---DKILKDVHIRYIMFQLCNGL 136
                IT L  Y   +  +LY+V +Y +  DL  ++    D++ +D+  R+ + ++   +
Sbjct: 62  ----WITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVLAI 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLG-LARSLSDSKECLTEYIATRWYRAPEIL 195
             +H    +HRD+KP N+L+DK+  I++ D G   R L+D        + T  Y +PEIL
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 196 ISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +      RY    D WSLG  + EML  +  F   S       I+N       H + F 
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HKEHFQ 228

Query: 252 --AGFKNKPEEAVDLLNQILVLNPSER 276
                 +  EEA DL+ + L+ +P  R
Sbjct: 229 FPPDVTDVSEEAKDLIRR-LICSPETR 254

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 26/205 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H
Sbjct: 5   DLTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS----H 58

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLSYI 139
             ++ +  +      + +Y+V EYM N  L   +R+  K  +   +  +   +C G++Y+
Sbjct: 59  EKLVQLYGV--CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAP 192
            + + +HRDL   N L+D    +K+ D GL+R + D      EY ++       RW   P
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRW-SPP 170

Query: 193 EILISNRRYTHHVDIWSLGCILAEM 217
           E+L+ + +++   D+W+ G ++ E+
Sbjct: 171 EVLLYS-KFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 6/197 (3%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITML 89
           IG+G+Y  V     K  ++  A+K + +   N   D      E    +    HP ++ + 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 90  DIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++      L+ V EY+     +  + R + L + H R+   ++   L+Y+H   +++R
Sbjct: 63  SCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL     Y   VD 
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDW 179

Query: 208 WSLGCILAEMLQSKPLF 224
           W+LG ++ EM+  +  F
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 17/213 (7%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTY--REILFLK 77
             ++ + K IG+GA+G V     K++KQ  A+K +  FE  + ++D+   +  R+I+   
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIM--- 97

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGL 136
           +      I+ +   Y   ++K LY+V EYM   DL  ++ +  + +   R+   ++   L
Sbjct: 98  AHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLAL 155

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEI 194
             IH+   +HRD+KP N+L+DKS  +K+ D G    +  +    C T  + T  Y +PE+
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEV 214

Query: 195 LISNR---RYTHHVDIWSLGCILAEMLQSKPLF 224
           L S      Y    D WS+G  L EML     F
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 48/230 (20%)

Query: 26  TIHKRIGKGAYGIVY--------KAYDK--------NNKQYVAIKKIFEAFRNKTDAQRT 69
           T  +++G+G +G V+        K  DK        N    VA+K +      + DA + 
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML------REDANKN 61

Query: 70  YREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI------RD 117
            R   FLK  +     + PNII +L +   + +  L ++ EYMEN DLN+ +        
Sbjct: 62  ARND-FLKEIKIMSRLKDPNIIRLLAV--CITSDPLCMITEYMENGDLNQFLSRHEPQEA 118

Query: 118 KILKDV------HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 171
               DV       + ++  Q+ +G+ Y+ +   +HRDL   N L+ K+ +IKI D G++R
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 172 SLSDSKECLTEYIAT---RWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
           +L        +  A    RW     IL+   ++T   D+W+ G  L E+L
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 27/260 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     KN  +  A+K +  +E   R +T   R  R++L      
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV----N 57

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGL 136
                IT L  Y   +  +LY+V +Y +  DL  ++    D++ +D+  R+ + ++   +
Sbjct: 58  GDNQWITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVIAI 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEIL 195
             +H    +HRD+KP NIL+D +  I++ D G    L +     +   + T  Y +PEIL
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 196 ISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +      +Y    D WSLG  + EML  +  F   S       I+N       H ++F 
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HKERFQ 228

Query: 252 --AGFKNKPEEAVDLLNQIL 269
             A   +  E+A DL+ +++
Sbjct: 229 FPAQVTDVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 12/169 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQ 80
           E+ I K I +GA+G VY    KNN +  A+K + +A    +N     +  R+ L L    
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL---S 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKV--IRDKILKDVHIRYIMFQLCNGLS 137
           + P I+ +    ++ NN  +Y+V EY+   D+  +  I     +++ ++YI  ++   L 
Sbjct: 62  KSPFIVHLYYSLQSANN--VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALD 118

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
           Y+H   ++HRDLKP N+LI     IK+ D GL++   + +  + + + T
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 37/274 (13%)

Query: 31  IGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V +A  K    K   AIK + E F ++ D +    E+  L     HPNII +
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 89  LDIYKAVNNKDLYVVFEYME--NDLNKVIRDKILK----------------DVHIRYIMF 130
           L   +  N   LY+  EY    N L+ + + ++L+                   +     
Sbjct: 69  LGACE--NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
            +  G+ Y+   + +HRDL   N+L+ ++ + KI D GL+R      +     +  RW  
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 191 APEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
              +  S   YT   D+WS G +L E+  L   P + G + +   + +    R   P   
Sbjct: 187 IESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRMEKP--- 240

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                 +N  +E  +L+ Q     P ERP   QI
Sbjct: 241 ------RNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 16/249 (6%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +GKG++G V  A  K + +  A+K +  +      D + T  E   L   + HP +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 90  DIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++  +   L+ V E++   DL   + + +   +   R+   ++ + L ++H   +++R
Sbjct: 63  CCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           DLK  N+L+D     K+ D G+ +    + +  + +  T  Y APEIL     Y   VD 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL-QEMLYGPSVDW 179

Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ 267
           W++G +L EML     F   +     + I+N         +  Y  + +  ++AVD+L  
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DEVVYPTWLS--QDAVDILKA 229

Query: 268 ILVLNPSER 276
            +  NP+ R
Sbjct: 230 FMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 20/234 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + IH+ +  G+ G V+++   +  Q V +K  + A         +  E   L+    HP 
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA--------SSVHEARLLRRLS-HPA 221

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHAC 142
           ++ +LD+ + V      V+ +Y  +DL   +  R + L    +  +  QL + + YIH  
Sbjct: 222 VLALLDV-RVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE 279

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IA-TRWYRAPEILISNRR 200
            ++HRD+K  N+L++    I +GD G A     S      Y IA T    APE+L  +  
Sbjct: 280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-P 338

Query: 201 YTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQL---IVNLVRPNPPHADKF 250
           YT  VDIWS G ++ E  + +  LF  +    +      I+ ++R    H D+F
Sbjct: 339 YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392

Length = 461

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 29/239 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 62

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQL 132
            +   +P++  +L I        + ++ + M      D  +  +D I    ++     Q+
Sbjct: 63  MASVDNPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-YLLNWCVQI 118

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L +D KE   E   +  +W 
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
               IL  +R YTH  D+WS G  + E++   SKP + G   S    ++    R P PP
Sbjct: 179 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 27/260 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     K+ ++  A+K +  +E   R +T   R  R +L     Q
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGL 136
                IT L  Y   +   LY+V +Y +  DL  ++    D++ +D+  R+ + ++   +
Sbjct: 62  ----WITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIAEMVLAI 115

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEIL 195
             IH    +HRD+KP N+L+D +  I++ D G    ++      +   + T  Y +PEIL
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 196 ISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +      +Y    D WSLG  + EML  +  F   S       I+N       H ++F 
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HEERFQ 228

Query: 252 --AGFKNKPEEAVDLLNQIL 269
             +   +  EEA DL+ +++
Sbjct: 229 FPSHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 58/277 (20%), Positives = 110/277 (39%), Gaps = 43/277 (15%)

Query: 31  IGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTY----REILFLKSFQR 81
           +G+G +G V+ A  K       +  V +K +      KT  +       RE+   +    
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-----QKTKDENLQSEFRRELDMFRKLS- 66

Query: 82  HPNIITMLDIYKAVNNKD-LYVVFEYME-NDLNKVIRDKILKD----------VHIRYIM 129
           H N++ +L +       +  Y++ EY +  DL + +R    KD               + 
Sbjct: 67  HKNVVRLLGL---CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATR 187
            Q+  G+ ++   + +HRDL   N L+     +K+  L L++ + +S+        I  R
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPPH 246
           W  APE +  +  ++   D+WS G ++ E+     L F G S    L  +       P  
Sbjct: 184 WL-APEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                   +  P     L+ +   +NP +RP   +++
Sbjct: 242 --------EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 37/274 (13%)

Query: 31  IGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     HPNII +
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 89  LDIYKAVNNKDLYVVFEYME--NDLNKVIRDKILK----------------DVHIRYIMF 130
           L   +  +   LY+  EY    N L+ + + ++L+                   + +   
Sbjct: 62  LGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
            +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R      +     +  RW  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 191 APEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
              +  S   YT + D+WS G +L E+  L   P + G + +   + +    R   P   
Sbjct: 180 IESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLEKP--- 233

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                  N  +E  DL+ Q     P ERP   QI
Sbjct: 234 ------LNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 62/283 (21%), Positives = 135/283 (47%), Gaps = 28/283 (9%)

Query: 25  YTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLK 77
           + + K +G GAYG V+   K    ++ +  A+K + +A        T+  RT R++L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL--E 59

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
             ++ P ++T+   Y    +  L+++ +Y+        + + +  K+  ++    ++   
Sbjct: 60  HIRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA 117

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEI 194
           L ++H   +++RD+K  NIL+D +  + + D GL++    D  E    +  T  Y AP+I
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 195 LISNRR-YTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           +      +   VD WS+G ++ E+L  + P       + Q ++   +++  PP+  +  A
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 253 GFKNKPEEAVDLLNQILVLNPSER-----PETDQILEHNYVSK 290
             K       D++ ++L+ +P +R      + D+I +H +  K
Sbjct: 238 LAK-------DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 79/313 (25%), Positives = 125/313 (39%), Gaps = 70/313 (22%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K IG GA+G V      +     A+K + +A    RN+    +  R+IL   +   +  +
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL---AEADNEWV 63

Query: 86  ITMLDIYKAVNNKD-LYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           + +   Y +  +KD LY V +Y+   D+ + +IR  I ++   R+ + +L   +  +H  
Sbjct: 64  VKL---YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSL----------------SDSKECLTEY--- 183
             +HRD+KP NILID+   IK+ D GL                     DS E   E+   
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 184 ------------------------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ 219
                                   + T  Y APE+L+    YT   D WS+G IL EML 
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLV 239

Query: 220 SKPLFPGASTSHQLQLIVNLVRP--NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER- 276
            +P F   + +     ++N       P  A            EA DL+ + L     +R 
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQA--------KLSREASDLILR-LCCGAEDRL 290

Query: 277 --PETDQILEHNY 287
                D+I  H +
Sbjct: 291 GKNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 21  ILAEYTIHKR--IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---F 75
           IL E  + K   +G GA+G VYK     + + V I    +  R  T + +  +EIL   +
Sbjct: 3   ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAY 61

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ 131
           + +    P +  +L I        + +V + M      D  +  +D+I     + + + Q
Sbjct: 62  VMAGVGSPYVCRLLGI---CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV-Q 117

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY------IA 185
           +  G+SY+   +++HRDL   N+L+     +KI D GLAR L D  E  TEY      + 
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDE--TEYHADGGKVP 174

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
            +W     IL  +RR+TH  D+WS G  + E++
Sbjct: 175 IKWMALESIL--HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 46/277 (16%)

Query: 29  KRIGKGAYGIVYKAYDKN-NKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G V +A     +K    +K   K+ +   + ++ +    E+  +     H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 85  IITMLDIYKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           I+ +L          + V+ EY     + N L +  R+  L    +    +Q+  G++++
Sbjct: 101 IVNLLG--ACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFL 157

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECL--TEYIATRWYRAPEILI 196
            +   +HRDL   N+L+     +KI D GLAR  ++DS   +     +  +W  APE + 
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APESIF 216

Query: 197 SNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           +   YT   D+WS G +L E+  L S P +PG        + V+          KFY   
Sbjct: 217 NC-VYTFESDVWSYGILLWEIFSLGSNP-YPG--------MPVD---------SKFYKLI 257

Query: 255 KN---------KPEEAVDLLNQILVLNPSERPETDQI 282
           K           P E  D++      +P +RP   QI
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 34/185 (18%)

Query: 63  KTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR 116
           + DA +  R   FLK  +     + PNII +L +   V+   L ++ EYMEN DLN+ + 
Sbjct: 55  RPDANKNARND-FLKEVKILSRLKDPNIIRLLGV--CVDEDPLCMITEYMENGDLNQFLS 111

Query: 117 DKILKD---------------VHIRYIMF-----QLCNGLSYIHACKVMHRDLKPSNILI 156
              L D                 I Y        Q+ +G+ Y+ +   +HRDL   N L+
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171

Query: 157 DKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILISNRRYTHHVDIWSLGCI 213
            ++ +IKI D G++R+L        +    +  RW     IL+   ++T   D+W+ G  
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVT 229

Query: 214 LAEML 218
           L E+L
Sbjct: 230 LWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 68/294 (23%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K +G GA+G V  A   +     A+K + +     RN+    +  R+IL     +     
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE----- 61

Query: 86  ITMLDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
             ++ +Y +  +KD LY V +Y+     ++ +IR ++  +V  R+ + +L   +  +H  
Sbjct: 62  -WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLA-------------------------------- 170
             +HRD+KP NILID    IK+ D GL                                 
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 171 --------------RSLSDSKECLTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILA 215
                         R+    + CL    + T  Y APE+L+  + YT   D WS+G IL 
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239

Query: 216 EMLQSKPLFPGAS-TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           EML  +P F   + T  QL++I      N  +        K  P EAVDL+ ++
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVI------NWENTLHIPPQVKLSP-EAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 68/249 (27%), Positives = 103/249 (41%), Gaps = 60/249 (24%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K +G GA+G V  A   + K   A+K + +     RN+    +  R+IL     +     
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE----- 61

Query: 86  ITMLDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
             ++ +Y +  +KD LY V +Y+     ++ +IR  I  +   R+ + +L   +  +H  
Sbjct: 62  -WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLA---RSLSDSK---------------------- 177
             +HRD+KP NILID+   IK+ D GL    R   DSK                      
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 178 ---------------------ECLTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILA 215
                                 CL    + T  Y APE+L+    YT   D WS+G IL 
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239

Query: 216 EMLQSKPLF 224
           EML  +P F
Sbjct: 240 EMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 52/289 (17%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G GA+G VY+           +  VA+K + E+   + ++     E L +  F 
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKF- 66

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH--------IRYIMFQ 131
            H NI+ ++ +      +  +++ E M   DL   +R+   +           + +    
Sbjct: 67  NHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEY--- 183
           +  G  Y+     +HRD+   N L+  +C       KI D G+AR +  +      Y   
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLL--TCKGPGRVAKIADFGMARDIYRA-----SYYRK 177

Query: 184 -----IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W   PE  +    +T   D+WS G +L E+  L   P +PG +    ++ +
Sbjct: 178 GGRAMLPIKWM-PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVMEFV 234

Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
               R +PP         K  P     ++       P +RP    ILE 
Sbjct: 235 TGGGRLDPP---------KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 24/258 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
             +G G +G V K   K  K  + VA+K +     +        RE   ++    +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIV 59

Query: 87  TMLDIYKAVNNKDLYVVFEYME-NDLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 144
            M+ I +A +     +V E  E   LNK + ++K + + +I  ++ Q+  G+ Y+     
Sbjct: 60  RMIGICEAES---WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRY 201
           +HRDL   N+L+      KI D GL+++L   +         +W   + APE + +  ++
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKF 175

Query: 202 THHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
           +   D+WS G ++ E      KP + G   +   Q+I +  R   P            P 
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP-YKGMKGNEVTQMIESGERMECPQR---------CPP 225

Query: 260 EAVDLLNQILVLNPSERP 277
           E  DL+         ERP
Sbjct: 226 EMYDLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 42/221 (19%)

Query: 29  KRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQRH 82
           + +G+ A+G +YK +      ++ Q VAIK +    ++  + Q+   +++   L +   H
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTL----KDINNPQQWGEFQQEASLMAELHH 66

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH----------------- 124
           PNI+ +L +      + + ++FEY+ + DL++ +   I++  H                 
Sbjct: 67  PNIVCLLGV--VTQEQPVCMLFEYLNQGDLHEFL---IMRSPHSDVGCSSDEDGTVKSSL 121

Query: 125 ----IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
                 +I  Q+  G+ Y+ +   +H+DL   NILI +   +KI DLGL+R +  +    
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181

Query: 181 TE---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
            +    +  RW   PE ++   +++   DIWS G +L E+ 
Sbjct: 182 VQPKSLLPIRWM-PPEAIMYG-KFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 27/233 (11%)

Query: 29  KRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G VYK       +  K  VAIK + E    K + +    E L + S   HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPH 70

Query: 85  IITMLDIYKAVNNKDLY------VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           ++ +L +  +   + +        + +Y+        +D I   + + + + Q+  G+ Y
Sbjct: 71  LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEH-----KDNIGSQLLLNWCV-QIAKGMMY 124

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLTE--YIATRWYRAPEIL 195
           +   +++HRDL   N+L+     +KI D GLAR L  D KE   +   +  +W       
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 182

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
           I  R++TH  D+WS G  + E++    KP + G  T     L+    R P PP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEKGERLPQPP 234

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 65/289 (22%), Positives = 107/289 (37%), Gaps = 60/289 (20%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHP 83
           K +G+G +G V KA     K       +      +  +    R++L    F       HP
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL--SEFNLLKQVNHP 63

Query: 84  NIITMLDIYKAVNNKDLYVVFEYME----------------------------NDLNKVI 115
           ++I +        +  L ++ EY +                               N   
Sbjct: 64  HVIKLYG--ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 116 RDKILKDVHIRYIMF--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
           R   + D+    I F  Q+  G+ Y+   K++HRDL   N+L+ +   +KI D GL+R +
Sbjct: 122 RALTMGDL----ISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 174 SDSKECLTEY---IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAS 228
            +    +      I  +W  A E L  +  YT   D+WS G +L E+  L   P +PG +
Sbjct: 178 YEEDSYVKRSKGRIPVKWM-AIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPGIA 234

Query: 229 TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
                 L+    R   P         +N  EE  +L+       P +RP
Sbjct: 235 PERLFNLLKTGYRMERP---------ENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 61/280 (21%), Positives = 123/280 (43%), Gaps = 36/280 (12%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
            + K +G+G +G V +    N       VA+K +  A   +++ +    E + +K F  H
Sbjct: 2   ALGKTLGEGEFGSVMEG-QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-H 59

Query: 83  PNIITMLDIYKAVNNKDLY----VVFEYMEN-DLNKVIRDKILKDVHIRY-------IMF 130
           PN++ ++ +       + Y    V+  +M++ DL+  +    L D             M 
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---TR 187
            + +G+ Y+ +   +HRDL   N +++++ ++ + D GL++ + +        IA    +
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIV--NLVRPNP 244
           W  A E L ++R YT   D+WS G  + E+  + +  +PG   S     +   N ++  P
Sbjct: 180 WI-AIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
              D  Y+           L++   +LNP +RP  + +  
Sbjct: 238 DCLDGLYS-----------LMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 29/228 (12%)

Query: 29  KRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + +G+  +G VYK +          Q VAIK + +  + +   +  ++    ++S  +HP
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD--KAEGPLREEFKHEAMMRSRLQHP 68

Query: 84  NIITMLD----------IYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDV----HIRY 127
           NI+ +L           I+   ++ DL  ++V     +D+     DK +K         +
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           I+ Q+  G+ ++ +  V+H+DL   N+L+    ++KI DLGL R +  +   K      +
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 232
             RW  +PE ++   +++   DIWS G +L E+  S  L P    S+Q
Sbjct: 189 PIRWM-SPEAIMYG-KFSIDSDIWSYGVVLWEVF-SYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 52/307 (16%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---------- 74
           Y I + +G GA G V  A   ++ +  A+K +     ++ D  R   E+           
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 75  ------FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIR- 126
                 F K   R+P  + M+ +           V +Y    DL + I+ +   +   R 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIAL-----------VLDYANAGDLRQEIKSRAKTNRTFRE 142

Query: 127 ----YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECL 180
                +  Q+   + ++H+  ++HRD+K +NIL+  +  +K+GD G ++  +   S +  
Sbjct: 143 HEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202

Query: 181 TEYIATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIV 237
             +  T +Y APEI    RR  Y+   D++SLG +L E+L  K  F G +    +   + 
Sbjct: 203 RTFCGTPYYVAPEIW---RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259

Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
               P PP              E  +++  +L  +P  RP + ++L    + K F S   
Sbjct: 260 GRYDPLPPSISP----------EMQEIVTALLSSDPKRRPSSSKLLNMP-ICKLFISGLL 308

Query: 298 VIPQVTP 304
            I Q  P
Sbjct: 309 EIVQTQP 315

Length = 496

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 41/277 (14%)

Query: 31  IGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     HPNII +
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 89  LDIYKAVNNKDLYVVFEY---------------MENDLNKVIRDKI---LKDVHIRYIMF 130
           L   +  +   LY+  EY               +E D    I +     L    + +   
Sbjct: 74  LGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
            +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R      +     +  RW  
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 191

Query: 191 APEILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPNPPH 246
              +  S   YT + D+WS G +L E+  L   P      A    +L     L +P    
Sbjct: 192 IESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---- 245

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    N  +E  DL+ Q     P ERP   QIL
Sbjct: 246 --------LNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 24  EYTIHKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFR----NKTDAQRTYREILFLKS 78
           ++   + +G G++G ++   Y   +   VAIK+ FE  +     + D   + R+IL   +
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR-FEKSKIIKQKQVDHVFSERKIL---N 86

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIR--DKILKDVHIRYIMFQLCNG 135
           +  HP  + +   +K  +   LY+V E+ +  +    +R   +   DV   Y   Q+   
Sbjct: 87  YINHPFCVNLYGSFK--DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA-QIVLI 143

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
             Y+ +  +++RDLKP N+L+DK   IK+ D G A+ +      L     T  Y APEIL
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---GTPEYIAPEIL 200

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           + N  +    D W+LG  + E+L   P F
Sbjct: 201 L-NVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 16/197 (8%)

Query: 31  IGKGAYGIVYKA-YDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +G G +G V K  Y    KQ  VAIK + +    K+      RE   +     +P I+ M
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLD-NPYIVRM 60

Query: 89  LDIYKAVNNKDLYVVFEYME-NDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + + +A     L +V E      LNK +   +D+I    ++  +M Q+  G+ Y+     
Sbjct: 61  IGVCEAEA---LMLVMEMASGGPLNKFLSGKKDEITVS-NVVELMHQVSMGMKYLEGKNF 116

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISNRRY 201
           +HRDL   N+L+      KI D GL+++L           A +W   + APE  I+ R++
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC-INFRKF 175

Query: 202 THHVDIWSLGCILAEML 218
           +   D+WS G  + E  
Sbjct: 176 SSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---T 186
           FQ+  G+ ++ + K +HRDL   NIL+ ++  +KI D GLAR +    + + +  A    
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNP 244
           +W  APE  I ++ YT   D+WS G +L E+  L + P +PG             V+ + 
Sbjct: 240 KWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPG-------------VQIDE 283

Query: 245 PHADKFYAGFK-NKPEEAVDLLNQILVL----NPSERPETDQILEH 285
               +   G +   PE A   +  I++     NP +RP   +++E 
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECL--TEYIATR 187
           Q+  G+SY+H   V+H+D+   N +ID+   +KI D  L+R L      CL   E    +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEM 217
           W  A E L+ N+ Y+   D+WS G +L E+
Sbjct: 185 WM-ALESLV-NKEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 38/204 (18%)

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-----LCNGLS 137
           PN++ +      V+   +++V ++ E      +   I K ++I     +     +   L 
Sbjct: 45  PNMVCLHKYI--VSEDSVFLVLQHAEGG---KLWSHISKFLNIPEECVKRWAAEMVVALD 99

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI-LI 196
            +H   ++ RDL P+NIL+D    I++        + DS  C  E +    Y APE+  I
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAV-ENMYCAPEVGGI 156

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLF----PGASTSHQLQLIVNLVRPNPPHADKFYA 252
           S    T   D WSLG IL E+L  K L      G +T   L +        P        
Sbjct: 157 SEE--TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI--------PEWVS---- 202

Query: 253 GFKNKPEEAVDLLNQILVLNPSER 276
                 EEA  LL Q+L  NP+ER
Sbjct: 203 ------EEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 26/165 (15%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL---TEYIAT 186
           FQ+  G+ ++ + K +HRDL   NIL+ ++  +KI D GLAR +    + +   +  +  
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNP 244
           +W  APE  I ++ YT   D+WS G +L E+  L + P +PG             V+ N 
Sbjct: 241 KWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPG-------------VQINE 284

Query: 245 PHADKFYAGFKNK-PEEAVDLLNQILVL----NPSERPETDQILE 284
               +   G + + PE A   + +I++     +P ERP    ++E
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 8/102 (7%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 186
           FQ+  G+ ++ + K +HRDL   NIL+ ++  +KI D GLAR +    + + +    +  
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPG 226
           +W  APE  I +R YT   D+WS G +L E+  L + P +PG
Sbjct: 246 KWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 67/292 (22%)

Query: 29  KRIGKGAYGIVY--KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----R 81
             IG G +G V   +A+   +K  V +K++         +     ++LFL+  Q      
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-------RASATPDEQLLFLQEVQPYRELN 53

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKIL-------KDVHIRYIMFQLC 133
           HPN++  L   + + +    +V E+    DL   +R           KDV  R +  ++ 
Sbjct: 54  HPNVLQCLG--QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR-MACEVA 110

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------- 186
           +GL ++H    +H DL   N  +    S+KIGD GLA  L    E   +Y  T       
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPE---DYYITKDCHAVP 165

Query: 187 -RWYRAPEIL------ISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIV 237
            RW  APE++      +  +  T   +IWSLG  + E+     +P +P  S    L+ +V
Sbjct: 166 LRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVV 223

Query: 238 -----NLVRPN--PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                 L +P     ++D++Y             + Q   L+P  RP  +++
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYE------------VMQFCWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 55/251 (21%), Positives = 105/251 (41%), Gaps = 48/251 (19%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K IG+GA+G V     K+     A+K + +A    + +    R  R+IL         + 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV------EADS 60

Query: 86  ITMLDIYKAVNNK-DLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           + ++ ++ +  +K +LY++ E++     +  +++   L +   ++ + +    +  IH  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLA------------RSLSDS-------------- 176
             +HRD+KP N+L+D    +K+ D GL             R+L+ S              
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 177 ---------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 227
                    ++     + T  Y APE+ +    Y    D WSLG I+ EML   P F   
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 228 STSHQLQLIVN 238
           +     + ++N
Sbjct: 240 TPQETYKKVMN 250

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 52/188 (27%)

Query: 24  EYTIHKRIGKGAYGIVYKAY---DKNNKQ--YVAIKKI-----FEAFRNKTDAQRTYREI 73
           ++ + K++G+GA+G+VYKA     ++ K+  YV +KK       E + N+   +R     
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEYGAVEIWMNER-VRRACPNS 190

Query: 74  L--FLKSFQRHPNIITMLDIYKAVNNKD---LYVVFEYMEND-LNKVIRDK--------- 118
              F+  F             + V++K     ++V+ Y     L  +++ K         
Sbjct: 191 CADFVYGF------------LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238

Query: 119 ILKDVH------------IRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIG 165
           +L  V             I+ IM Q+   L  +H+  ++HRD+KP NI+    S S KI 
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKII 298

Query: 166 DLGLARSL 173
           DLG A  L
Sbjct: 299 DLGAAADL 306

Length = 566

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI----LFLKSFQRHPN 84
           K +G G +G V+K         + I    +  ++++  ++T++EI    L + S   H  
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLD-HAY 70

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I+ +L I    +   L +V +        D  +  RD +     + + + Q+  G+ Y+ 
Sbjct: 71  IVRLLGICPGAS---LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV-QIAKGMYYLE 126

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTEYIAT--RWYRAPEILIS 197
             +++HR+L   NIL+     ++I D G+A  L  D K+       T  +W     IL  
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF- 185

Query: 198 NRRYTHHVDIWSLGCILAEML 218
             RYTH  D+WS G  + EM+
Sbjct: 186 -GRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 26/148 (17%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 186
           +Q+ NG+ ++ +   +HRDL   N+LI +   +KI D GLAR +      +++   ++  
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           +W  APE  I N  YT   D+WS G +L E      +F    T +          P  P 
Sbjct: 306 KWM-APES-IFNNLYTTLSDVWSFGILLWE------IFTLGGTPY----------PELPM 347

Query: 247 ADKFYAGFKN-----KPEEAVDLLNQIL 269
            ++FY   K      KP  A D + +I+
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIM 375

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 34/207 (16%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR--TYREILFLKSFQ 80
           A ++I +    GA G  +   D    ++V IK            QR  T  E   L++  
Sbjct: 92  AGFSILETFTPGAEGFAFACIDNKTCEHVVIKA----------GQRGGTATEAHILRAIN 141

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYI 139
            HP+II +   +    NK   ++    + DL   +  K  +    I  I   +   + Y+
Sbjct: 142 -HPSIIQLKGTF--TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYL 198

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYIATRWY--------R 190
           H  +++HRD+K  NI I+    + +GD G A        C   +  A ++Y         
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGAA--------CFPVDINANKYYGWAGTIATN 250

Query: 191 APEILISNRRYTHHVDIWSLGCILAEM 217
           APE+L  +  Y   VDIWS G +L EM
Sbjct: 251 APELLARD-PYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 34/169 (20%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECL--TEYIAT 186
           +Q+  G+S++ +   +HRDL   NIL+      KI D GLAR + +DS   +     +  
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNP 244
           +W  APE  I N  YT   D+WS G +L E+  L S P +PG                  
Sbjct: 281 KWM-APES-IFNCVYTFESDVWSYGILLWEIFSLGSSP-YPGM----------------- 320

Query: 245 PHADKFYAGFKN---------KPEEAVDLLNQILVLNPSERPETDQILE 284
           P   KFY   K           P E  D++      +P +RP   QI++
Sbjct: 321 PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 32/166 (19%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECL--TEYIAT 186
            Q+  G+ ++ +   +HRD+   N+L+      KI D GLAR  ++DS   +     +  
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 245
           +W  APE  I +  YT   D+WS G +L E+    K  +PG        ++VN       
Sbjct: 279 KWM-APES-IFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG--------ILVN------- 321

Query: 246 HADKFYAGFKN---------KPEEAVDLLNQILVLNPSERPETDQI 282
              KFY   K           P E   ++     L P+ERP   QI
Sbjct: 322 --SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 50/252 (19%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREILFLKSFQRHPNI 85
           K IG+GA+G V     K+     A+K + +A    + +    R  R+IL          +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD---GAWV 63

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           + M   Y   + ++LY++ E++     +  +++   L +   ++ + +    +  IH   
Sbjct: 64  VKMF--YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-------------------- 183
            +HRD+KP N+L+D    +K+ D GL   L  +    TE+                    
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR--TEFYRNLTHNPPSDFSFQNMNSK 179

Query: 184 -----------------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 226
                            + T  Y APE+ +    Y    D WSLG I+ EML   P F  
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 227 ASTSHQLQLIVN 238
            +     + ++N
Sbjct: 239 ETPQETYRKVMN 250

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 60/263 (22%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQ-RTYREILFLKSFQRHPNI 85
           K IGKGA+G V     K+  +  A+K +   E F+    A  +  R++L   +    P +
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL---AESDSPWV 63

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           +++   Y   + + LY++ E++   DL   +I+     +   R+ M +    +  +H   
Sbjct: 64  VSLY--YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGL---------------------ARSLSDSKECLT- 181
            +HRD+KP NILID+   IK+ D GL                      ++  D++  +  
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 182 ----------EYIATRW----------------YRAPEILISNRRYTHHVDIWSLGCILA 215
                     + IAT W                Y APEI +  + Y    D WSLG I+ 
Sbjct: 182 DSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMF 239

Query: 216 EMLQSKPLFPGASTSHQLQLIVN 238
           E L   P F   ++    + I+N
Sbjct: 240 ECLIGWPPFCSENSHETYRKIIN 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 24/157 (15%)

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIAT 186
           +Q+  G+ ++ +   +HRDL   N+L+ +   +KI D GLAR +      +++   ++  
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP 245
           +W  APE +  N  YT   D+WS G +L E+       +PG        +IV+    N  
Sbjct: 304 KWM-APESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPG--------MIVDSTFYN-- 351

Query: 246 HADKFYAGFK-NKPEEAVDLLNQILVL----NPSERP 277
              K  +G++  KP+ A   +  I+V      P +RP
Sbjct: 352 ---KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 38/141 (26%), Positives = 70/141 (49%), Gaps = 12/141 (8%)

Query: 82  HPNIITMLDIYKAVNN-KDLYVVFEYM-ENDLNKVIR-DKILKDVHIRYIMFQLCNGLSY 138
           +PN I +   Y +V   K   ++ +Y+ + DL  +++ +  L +  ++ I+ QL   L+ 
Sbjct: 68  NPNFIKL---YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALND 124

Query: 139 IHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +H   ++H D+K  N+L D++   I + D GL +    +  C   Y  T  Y +PE  I 
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSC---YDGTLDYFSPE-KIK 179

Query: 198 NRRYTHHVDIWSLGCILAEML 218
              Y    D W++G +  E+L
Sbjct: 180 GHNYDVSFDWWAVGVLTYELL 200

Length = 267

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 38/225 (16%)

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCN--- 134
           +HPNI+  L   + V      +VFEY E  DL   +       ++  +  +    C    
Sbjct: 53  QHPNILQCLG--QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRA 191
           G++++H    +H DL   N  +    ++K+GD G+  S        TE    +  RW  A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169

Query: 192 PEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI-----VNL 239
           PE++            T   ++W+LG  L E+ + +   +   S    L  +     V L
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229

Query: 240 VRPN--PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
            +P    P+++++Y           ++L Q   L+P +R   +++
Sbjct: 230 FKPQLELPYSERWY-----------EVL-QFCWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 36/168 (21%)

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRA 191
           GL ++H    +H DL   N L+    ++KIGD GL+ +       +T    ++  RW  A
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-A 170

Query: 192 PE--------ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIV---N 238
           PE        +L+ ++  T   ++WSLG  + E+ +  S+P +   S    L   V    
Sbjct: 171 PELVDEVHGNLLVVDQ--TKESNVWSLGVTIWELFELGSQP-YRHLSDEQVLTYTVREQQ 227

Query: 239 LVRPNP----PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
           L  P P    P +D++Y             + Q   L P +RP  +++
Sbjct: 228 LKLPKPRLKLPLSDRWYE------------VMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 65/286 (22%), Positives = 119/286 (41%), Gaps = 44/286 (15%)

Query: 23  AEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKS 78
               I + +G G +G + +   K     +  VAI  +     +K   +R +  E L L  
Sbjct: 5   KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAEALTLGQ 62

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR--DKILKDVHIRYIMFQLCNG 135
           F  H NI+ +  +    N   + +V EYM N  L+  +R  +  L    +  ++  L +G
Sbjct: 63  FD-HSNIVRLEGVITRGNT--MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR---WYRAP 192
           + Y+     +H+ L    +L++     KI   G  R   D  E +   ++ +    + AP
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAP 177

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQ--LQLIVNLVRPNPPHAD 248
           E  I    ++   D+WS G ++ E++    +P +     S Q  ++ + +  R   P   
Sbjct: 178 EA-IQYHHFSSASDVWSFGIVMWEVMSYGERPYW---DMSGQDVIKAVEDGFRLPAP--- 230

Query: 249 KFYAGFKNKPEEAVDLLNQILV----LNPSERPETDQILEHNYVSK 290
                 +N P     LL+Q+++        ERP   QI  H+ +SK
Sbjct: 231 ------RNCPN----LLHQLMLDCWQKERGERPRFSQI--HSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIM 129
           + L  F RHPNI+T   ++       L+V+  +M     N L K    + + +  I  I+
Sbjct: 50  VVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNIL 107

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILI 156
           F    GL+Y+H    +HR++K S+ILI
Sbjct: 108 FGALRGLNYLHQNGYIHRNIKASHILI 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           IL+       I +G  G  YK     N     +K+I     N  ++  +  EI  +   Q
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI-----NDVNSIPS-SEIADMGKLQ 741

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            HPNI+ ++ + ++   K  Y++ EY+E  +L++V+R+  L     R I   +   L ++
Sbjct: 742 -HPNIVKLIGLCRS--EKGAYLIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFL 796

Query: 140 HA-C--KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           H  C   V+  +L P  I+ID      +  L L   L    +C      +  Y APE   
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKC----FISSAYVAPETR- 850

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSK 221
             +  T   DI+  G IL E+L  K
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 78/332 (23%), Positives = 130/332 (39%), Gaps = 73/332 (21%)

Query: 31  IGKGAYGI--VYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           IG+G   +  V  A  K   +YV +++I  EA  N  +     +  L +     HPNI+ 
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVP 63

Query: 88  MLDIYKA--VNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
               Y+A  + + +L+VV  +M      DL        + ++ I YI+  +   L YIH 
Sbjct: 64  ----YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT------EY-IATRWYRAPEI 194
              +HR +K S+ILI     + +  L    S+ +  + L       +Y +    + +PE+
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179

Query: 195 LISNRR-YTHHVDIWSLG-------------------------------CIL------AE 216
           L  N + Y    DI+S+G                               C+L      AE
Sbjct: 180 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239

Query: 217 MLQSKPLFPGASTSHQLQLIVNLVRP-NP-----PHADKFYAGFKNKPEEAVDLLNQILV 270
            L  KP   GA++       V+  RP N      P+   F   F +        + Q L 
Sbjct: 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH-------FVEQCLQ 292

Query: 271 LNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
            NP  RP    +L H++  +    A+  +P++
Sbjct: 293 RNPDARPSASTLLNHSFFKQIKRRASEALPEL 324

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 1/51 (1%)

Query: 121 KDVH-IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 170
           +D++ I+ +M Q+  GL  +H   ++HRD+KP N+L+     +KI D G A
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 29/164 (17%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDK-------SCSIKIGDLGLARSLSDSKECLTEY 183
           QL + LSY+    ++H ++   NIL+ +       S  IK+ D G++ + + S+E   E 
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT-ALSREERVER 183

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           I   W  APE +      +   D WS G  L E+      F G          V L    
Sbjct: 184 IP--WI-APECVPGGNSLSTAADKWSFGTTLLEIC-----FDGE---------VPLKERT 226

Query: 244 PPHADKFYAGFKNKPE----EAVDLLNQILVLNPSERPETDQIL 283
           P   ++FY      PE    E   L++Q L   P++RP    IL
Sbjct: 227 PSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 29/158 (18%)

Query: 131 QLCNGLSYIHACKVMHRDLKPSNIL-----IDKSCS--IKIGDLGLARSLSDSKECLTEY 183
           QL + LSY+    ++H ++   NIL     ID  C   IK+ D G+  ++   +EC+ E 
Sbjct: 113 QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV-ER 171

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           I   W  APE +  ++  +   D WS G  L E+      + G        L        
Sbjct: 172 IP--WI-APECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKTLA------- 216

Query: 244 PPHADKFYAG----FKNKPEEAVDLLNQILVLNPSERP 277
               ++FY G         +E  DL+   +  +P++RP
Sbjct: 217 --EKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	404
KOG0660|consensus	359		100.0
KOG0593|consensus	396		100.0
KOG0588|consensus	786		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0661|consensus	538		100.0
KOG0659|consensus	318		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0663|consensus	419		100.0
KOG0600|consensus	560		100.0
KOG0592|consensus	604		100.0
KOG0605|consensus	550		100.0
KOG0595|consensus	429		100.0
KOG0033|consensus	355		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
KOG0591|consensus	375		100.0
KOG0594|consensus	323		100.0
KOG0658|consensus	364		100.0
KOG0597|consensus	808		100.0
KOG0694|consensus	694		100.0
KOG0585|consensus	576		100.0
KOG0611|consensus	668		100.0
KOG0578|consensus	550		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0599|consensus	411		100.0
KOG0582|consensus	516		100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0610|consensus	459		100.0
KOG0198|consensus	313		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667|consensus	586		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0032|consensus	382		100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4717|consensus	864		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580|consensus	281		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0662|consensus	292		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0589|consensus	426		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0201|consensus	467		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0666|consensus	438		100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0604|consensus	400		100.0
KOG0665|consensus	369		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0192|consensus	362		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0596|consensus	677		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0690|consensus	516		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607|consensus	463		100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0577|consensus	948		100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0612|consensus	1317		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0586|consensus	596		100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574|consensus	502		100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4236|consensus	888		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0579|consensus	1187		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0983|consensus	391		100.0
KOG0197|consensus	468		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG1989|consensus	738		100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0696|consensus	683		100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986|consensus	591		100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4279|consensus	1226		100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0669|consensus	376		100.0
KOG0668|consensus	338		100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0671|consensus	415		100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0584|consensus	632		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG2345|consensus	302		100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0664|consensus	449		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0193|consensus	678		100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG1035|consensus	1351		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4645|consensus	1509		100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0603|consensus	612		100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG4721|consensus	904		100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0695|consensus	593		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG1006|consensus	361		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0670|consensus	752		100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0608|consensus	1034		100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1151|consensus	775		100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG1290|consensus	590		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0587|consensus	953		100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0194|consensus	474		100.0
KOG1187|consensus	361		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1026|consensus	774		100.0
KOG4250|consensus	732		100.0
KOG1095|consensus	1025		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0196|consensus	996		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257|consensus	974		100.0
KOG1027|consensus	903		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167|consensus	418		100.0
KOG0199|consensus	1039		100.0
KOG0984|consensus	282		100.0
KOG4278|consensus	1157		100.0
KOG1094|consensus	807		100.0
KOG0200|consensus	609		100.0
KOG1152|consensus	772		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576|consensus	829		100.0
KOG2052|consensus	513		100.0
KOG1025|consensus	1177		100.0
KOG3653|consensus	534		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345|consensus	378		100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590|consensus	601		99.96
KOG1024|consensus	563		99.96
KOG1163|consensus	341		99.96
KOG1164|consensus	322		99.95
KOG1165|consensus	449		99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
KOG0603|consensus	612		99.93
KOG1240|consensus	1431		99.93
KOG0606|consensus	1205		99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG4158|consensus	598		99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0195|consensus	448		99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1033|consensus	516		99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG1166|consensus	974		99.83
KOG0590|consensus	601		99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1023|consensus	484		99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG0601|consensus	524		99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG1243|consensus	690		99.6
KOG0606|consensus	1205		99.59
KOG1266|consensus	458		99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG0601|consensus	524		99.44
KOG3741|consensus	655		99.33
KOG2137|consensus	700		99.3
KOG3087|consensus	229		99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
COG4248	637	Uncharacterized protein with protein kinase and he	99.09
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.01
PRK09902	216	hypothetical protein; Provisional	99.0
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.94
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
KOG0576|consensus	829		98.37
KOG1035|consensus	1351		98.35
KOG1235|consensus	538		98.29
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.29
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.21
KOG1826|consensus	2724		98.12
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.98
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
KOG1093|consensus	725		97.91
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.81
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.65
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
PRK10593	297	hypothetical protein; Provisional	97.62
KOG2268|consensus	465		97.59
PRK12396	409	5-methylribose kinase; Reviewed	97.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
PRK05231	319	homoserine kinase; Provisional	97.35
PLN02236	344	choline kinase	97.21
PLN02756	418	S-methyl-5-thioribose kinase	97.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.11
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
KOG2270|consensus	520		96.9
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.78
PTZ00384	383	choline kinase; Provisional	96.65
KOG1236|consensus	565		95.69
PTZ00296	442	choline kinase; Provisional	95.67
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.65
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.5
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.44
PRK06148	1013	hypothetical protein; Provisional	95.26
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.01
PHA03111	444	Ser/Thr kinase; Provisional	94.99
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.6
KOG2269|consensus	531		94.47

>KOG0660|consensus

Probab=100.00  E-value=3.9e-64  Score=452.77  Aligned_cols=310  Identities=42%  Similarity=0.754  Sum_probs=276.0

Q ss_pred             cccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         14 QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      -....+.+...|..++.||+|+||+||.|.++.+|+.||||++...+.+...+++.+||+++|+.++ |+||+.+.+++.
T Consensus        13 ~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~   91 (359)
T KOG0660|consen   13 VFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFR   91 (359)
T ss_pred             eeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecc
Confidence            3445677888899999999999999999999999999999999999999999999999999999998 999999999986


Q ss_pred             e---ccCCeEEEEEeccCCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         94 A---VNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        94 ~---~~~~~~~lv~E~~~~~L~~~l~~~~-l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      .   .+...+|+|+|+|+.+|..+++.+. |++.+++.+++||+.||+|+|+.+|+||||||.|+|++.++.+||||||+
T Consensus        92 p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   92 PPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             cccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence            4   3567899999999999999999877 99999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC--CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--
Q psy14434        170 ARSLSD--SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--  245 (404)
Q Consensus       170 a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  245 (404)
                      |+....  ....++.++.|.||+|||++.+...|+.+.||||+|||+.||++|++.|+|.+..+++..|....+....  
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998753  2345688999999999999998999999999999999999999999999999999999999888774333  


Q ss_pred             -------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCc
Q psy14434        246 -------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT  306 (404)
Q Consensus       246 -------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~  306 (404)
                                         ....+...+++.++.+.+|+.+||.+||.+|+|++++|.||||..+..+.+   +++++..
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d---EP~~~~~  328 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED---EPVCQPI  328 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc---CCCCCCC
Confidence                               444566778899999999999999999999999999999999999988777   3433322


Q ss_pred             ccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        307 VVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      +..  .+. ..+.++|++.+++++
T Consensus       329 ~~~--~~~-~~~~~~~r~~i~~e~  349 (359)
T KOG0660|consen  329 FDS--FEH-ELTEEELRELIYKEI  349 (359)
T ss_pred             Ccc--ccc-cccHHHHHHHHHHHH
Confidence            222  233 388999999999987

>KOG0593|consensus

Probab=100.00  E-value=5.7e-62  Score=427.61  Aligned_cols=269  Identities=33%  Similarity=0.672  Sum_probs=244.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++.|+.+..+|.|+||+||+|+++.||+.||||++.....+....+-.+||+++|++++ |||+|.+.++|.  ....++
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFr--rkrklh   77 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFR--RKRKLH   77 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHH--hcceeE
Confidence            35799999999999999999999999999999999877666777778899999999997 999999999998  678899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +|+|||+-++.+.+..  ..+++..++.+++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.+..+...
T Consensus        78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            9999999877666664  44999999999999999999999999999999999999999999999999999999877788


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------------  245 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  245 (404)
                      .+.++.|.||+|||.+.+...|+.++||||+||++.||++|.+.|++.++.+++..|...++...+              
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            899999999999999998899999999999999999999999999999999999999887664333              


Q ss_pred             -------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        246 -------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       246 -------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                             ....+...+++++..+.||+.+||+.||.+|++.+++|.||||..+..
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence                   445555666778889999999999999999999999999999976543

>KOG0588|consensus

Probab=100.00  E-value=2.6e-61  Score=461.72  Aligned_cols=353  Identities=28%  Similarity=0.383  Sum_probs=300.8

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..+.++-|++.+.||.|+.|.|-+|.+..||+.+|||++.+. .........+.+||.+|+-+. ||||+.+|++++  +
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe--~   83 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWE--N   83 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeec--c
Confidence            456788999999999999999999999999999999999766 556666778899999999987 999999999987  7


Q ss_pred             CCeEEEEEeccCC-cHH-HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~-~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ..++|+|.||+.| .|. .+++++++++.++..+++||+.|+.|||..+||||||||+|+|++..+++||+|||+|..- 
T Consensus        84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-  162 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-  162 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-
Confidence            8899999999995 454 5556889999999999999999999999999999999999999999999999999999654 


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .++..+.+.||+|.|+|||++.+..+.+.++||||+|||||.|++|+.||++.+....+.++..+....|          
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----------  232 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----------  232 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----------
Confidence            4557788999999999999998888889999999999999999999999999888888888888776555          


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCC-CCCCCCCCcccccCCCCCcCCHHHHHHHHHHHHHhh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH-VIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSC  333 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (404)
                      ..+|+++++||.+||..||.+|+|.+++++|||+.++...... ..+..  ..+....-+..+.-.....+.|.-++|..
T Consensus       233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~--~~~~i~s~ps~~~IDp~Il~~l~iLwc~~  310 (786)
T KOG0588|consen  233 SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPP--VSVPILSIPSIQEIDPLILQHLCILWCGR  310 (786)
T ss_pred             CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCC--cccceeecCCcccCCHHHHhhhhheeecC
Confidence            4569999999999999999999999999999999987543321 11111  11111111222222345667777777777


Q ss_pred             hccchhhhcccCCCCCCccccceeeecccccCCCCChhhhhhcC-----CCCCCcccccc
Q psy14434        334 KKKKSVKRLSKGNALDNTLRGHYKIKDAISSKYTSSEKENQQNN-----NNTAPSYKNVN  388 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  388 (404)
                      ...+-.++|....  +|.+++.|+++..++.++++..++.+++.     ++.++++|+++
T Consensus       311 d~~kl~~kLls~~--~n~EK~~Y~LLl~~k~r~~~~~~~~~~~kk~~~~s~~~~p~k~~~  368 (786)
T KOG0588|consen  311 DPEKLVEKLLSPD--DNDEKTLYFLLLRRKRRDSSQLDDFDENKKDLLGSAADPPRKRVD  368 (786)
T ss_pred             ChHHHHHHHcCCC--cchhHHHHHHHHHhhccchhhhhhhhhhhhhhhccccCCchhhhh
Confidence            7888888888777  89999999999999999999999888888     78899999998

>KOG0615|consensus

Probab=100.00  E-value=4e-60  Score=431.67  Aligned_cols=263  Identities=34%  Similarity=0.575  Sum_probs=225.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-----hHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----TDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.....     .......+|+++|++|. |||||+++++|+
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence            346677999999999999999999999999999999998764333     12334569999999997 999999999998


Q ss_pred             eccCCeEEEEEeccCC-cHHH-HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---CceEEeccc
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNK-VIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLG  168 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~-~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---~~vkl~Dfg  168 (404)
                        .....||||||++| +|.+ ++..+.+.+..-+.+++||+.|+.|||+.||+||||||+|||++.+   ..+||+|||
T Consensus       247 --~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  247 --VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             --cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence              56678999999995 6655 4567889999999999999999999999999999999999999766   789999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCC
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPP  245 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  245 (404)
                      +|+..+ ....+.+.||||.|.|||++.+.+  .+..++|+|||||+||-+++|.+||.+..... ..++|..+.....+
T Consensus       325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            999876 456778999999999999995432  34568999999999999999999998876554 67777776664443


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                            ..|..+++++.+||.+||..||++|||++|+|+||||+..
T Consensus       404 ------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  404 ------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                  2246789999999999999999999999999999999853

>KOG0575|consensus

Probab=100.00  E-value=1.7e-58  Score=440.56  Aligned_cols=254  Identities=31%  Similarity=0.585  Sum_probs=233.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+|...+.||+|||+.||.+.+..+|+.||+|++.+. ........++.+||++.++|. |||||+++++|+  +...+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FE--Ds~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFE--DSNNVY   94 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEee--cCCceE
Confidence            5699999999999999999999999999999999765 445667788999999999997 999999999999  577899


Q ss_pred             EEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||+|+|. ++|..+++ .+.++|.+++++++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+..+...
T Consensus        95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            9999999 68888887 466999999999999999999999999999999999999999999999999999999887777


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      ..+.||||.|.|||++ .....+..+||||+||++|.|++|+|||...+-.+.+..|.......|.          .++.
T Consensus       175 k~TlCGTPNYIAPEVl-~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----------~ls~  243 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVL-NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----------HLSA  243 (592)
T ss_pred             cceecCCCcccChhHh-ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----------ccCH
Confidence            8899999999999998 4777899999999999999999999999999999999988877665543          5689


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ++++||.+||+.||.+|||++++|.|+||+.
T Consensus       244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            9999999999999999999999999999954

>KOG0661|consensus

Probab=100.00  E-value=1e-59  Score=435.83  Aligned_cols=271  Identities=37%  Similarity=0.683  Sum_probs=241.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|.++++||.|.||.||+|+.+.+|+.||||.+.+.+....+. ..+||+..|+++..||||+++.+++.+.+. .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~-~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR-I   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc-e
Confidence            46679999999999999999999999999999999998877665444 456999999999889999999999985333 8


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+|||||+.+|+++++.  +.|++..++.|++||++||+|+|.+|+.|||+||||||++....|||+|||+|+..... 
T Consensus        85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence            999999999999999985  45999999999999999999999999999999999999998889999999999988754 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC-C-----------
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-P-----------  245 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----------  245 (404)
                      ...+.++.|.||+|||+++....|+.++||||+|||++|+.+-++.|+|.+..+++.+|...++... .           
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            4568899999999999999999999999999999999999999999999999999999999887322 2           


Q ss_pred             --------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        246 --------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       246 --------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                              ....+...+++.++++.+||.+||..||.+||||.++|+||||+....
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                    122233445668899999999999999999999999999999986543

>KOG0659|consensus

Probab=100.00  E-value=2e-58  Score=398.68  Aligned_cols=266  Identities=39%  Similarity=0.698  Sum_probs=240.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|...+.||+|.||+||+|++..+|+.||||++......+.......|||+.|+.++ |+||+.+.++|.  ....+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~--~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFP--HKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhhcc--CCCceEE
Confidence            5789999999999999999999999999999999877666666777889999999998 999999999987  5777999


Q ss_pred             EEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      |+|||+.+|+.+++.+  .++..+++.|+.++++||+|||++.|+||||||.|+||+++|.+||+|||+++.+.......
T Consensus        79 VfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   79 VFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             EEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            9999999999999864  59999999999999999999999999999999999999999999999999999998877766


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-Cc------------
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HA------------  247 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------------  247 (404)
                      +..+.|.||+|||.+.+...|+..+||||.|||+.||+.|.+.|+|.++-+++..+...++...+ .+            
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            66789999999999999999999999999999999999999999999999999999998884333 11            


Q ss_pred             -----chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 -----DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 -----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                           ......++.++.++.||+.+||.+||.+|+|+.++|+|+||+..
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                 11112455678899999999999999999999999999999974

>KOG0598|consensus

Probab=100.00  E-value=5.6e-58  Score=414.45  Aligned_cols=263  Identities=29%  Similarity=0.499  Sum_probs=235.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-.++|++++.||+|+||+||+++.+.+++.||+|++.+...- ..+......|..+|..+. ||.||+++..|+  +..
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQ--t~~   98 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQ--TEE   98 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecc--cCC
Confidence            4467999999999999999999999999999999999876443 347788889999999986 999999999988  688


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+|+||+.| .|...++ ++.+++..++.|+.+|+.||.|||++||+||||||+|||++.+|+++|+|||+|+.....
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            89999999996 8888887 678999999999999999999999999999999999999999999999999999976666


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .....+.|||+.|||||++. +..|+.++|+||||+++|+|++|.+||.+.+.....+.+.....+.++         ..
T Consensus       179 ~~~t~tfcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---------~~  248 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---------GY  248 (357)
T ss_pred             CCccccccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---------cc
Confidence            66667789999999999985 568999999999999999999999999999998888888776643333         23


Q ss_pred             CCHHHHHHHHhccccCCCCCC----CHHHHHhccCCCCcCCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERP----ETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rp----t~~~ll~hp~~~~~~~~~  295 (404)
                      ++.++++||+++|..||++|.    ++.++.+||||....|..
T Consensus       249 ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            689999999999999999996    789999999999877654

>KOG0581|consensus

Probab=100.00  E-value=6.7e-58  Score=414.05  Aligned_cols=260  Identities=28%  Similarity=0.478  Sum_probs=224.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ....+.+.++.||+|..|+||+|+|+.|++.+|+|++. ...+....+++.+|+.++++.+ ||+||.+|+.|..... .
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~-~  152 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE-E  152 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc-e
Confidence            44558889999999999999999999999999999994 3456677889999999999996 9999999999984322 6


Q ss_pred             EEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ++|+||||+ |+|..++.. ++++|..+..++.++++||.|||. ++|+||||||+||||+..|.|||||||.+..+.+.
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999 589998874 779999999999999999999995 99999999999999999999999999999988664


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-----STSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                        ...+++||..|||||.+ .+..|+.++||||||++++||.+|+.||...     +..+.+..|.....+..+   .  
T Consensus       233 --~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP---~--  304 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP---E--  304 (364)
T ss_pred             --hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC---c--
Confidence              56789999999999998 5778999999999999999999999999774     333444444433222222   1  


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                         ..+|+++++||..||++||.+|||+.+++.|||+.++..
T Consensus       305 ---~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  305 ---GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             ---ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence               137999999999999999999999999999999997644

>KOG0663|consensus

Probab=100.00  E-value=7.4e-58  Score=406.60  Aligned_cols=272  Identities=35%  Similarity=0.619  Sum_probs=242.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +-++.|+.+..|+.|+||+||+|+|+.|++.||+|+++.......---..+|||.+|.+.+ |||||.+-++....+-..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccce
Confidence            5677899999999999999999999999999999999776655555566789999999998 999999999998778888


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|||||||+.||..++..  .+|+..+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++.+.
T Consensus       152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999999999999973  579999999999999999999999999999999999999999999999999999998877


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-----------
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-----------  246 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  246 (404)
                      ...+..+.|.||+|||++.+...|+.++||||+|||+.||+++++.|+|.+..+++..|...++.....           
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            778889999999999999999999999999999999999999999999999999999999887733321           


Q ss_pred             ---------cchhhcccCC--CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 ---------ADKFYAGFKN--KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 ---------~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                               ...+...|..  +++...+|++.+|.+||.+|.||+++|+|+||....
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                     1111122222  458899999999999999999999999999998743

>KOG0600|consensus

Probab=100.00  E-value=2.9e-57  Score=422.49  Aligned_cols=268  Identities=37%  Similarity=0.634  Sum_probs=240.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|++......+.......|||.+|++|. ||||+++.+.........+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceEE
Confidence            45689999999999999999999999999999999877777777888889999999997 99999999998765578999


Q ss_pred             EEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-C
Q psy14434        102 VVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-E  178 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~  178 (404)
                      ||+|||+-||..++...  .|++.++++|+.||+.||.|||++||+|||||.+||||+.+|.+||+|||+|+.+.... .
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence            99999999999999865  59999999999999999999999999999999999999999999999999999765543 3


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------------  246 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  246 (404)
                      ..+..+.|.||+|||++++...|+.++|+||+||||.||+.|++.|++.+..+++..|.+..+...+.            
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            47788999999999999999999999999999999999999999999999999999999887743331            


Q ss_pred             -------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        247 -------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       247 -------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                             ...+...+..+++.+.+|+..||..||.+|.||.++|.|+||..
T Consensus       355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                   22222334557889999999999999999999999999999943

>KOG0592|consensus

Probab=100.00  E-value=4.7e-55  Score=410.78  Aligned_cols=264  Identities=31%  Similarity=0.516  Sum_probs=235.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      -.-..+|.+.+.||.|+|++|++|.++.+++.||||++.+... .+.....+.+|-..|.+|.+||.|++||..|.  +.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cc
Confidence            4567799999999999999999999999999999999976643 33445556688889999988999999999988  68


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+|+||++ |+|.++|++ +.|++..+++++.||+.||+|||++|||||||||+|||++++|++||+|||.|+.+.+
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            88999999999 689888874 7899999999999999999999999999999999999999999999999999987654


Q ss_pred             CC-----------Cc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        176 SK-----------EC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       176 ~~-----------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ..           ..  ..+++||..|.+||++ .....++++|+|+||||+|.|+.|.+||.+.+.-..+++|+.....
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            21           11  1458999999999998 6778899999999999999999999999999999999999988776


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                      .++          ++++.+.|||.++|..||.+|+|+.+|..||||...-+..
T Consensus       306 fp~----------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  306 FPE----------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             CCC----------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            653          5689999999999999999999999999999999876544

>KOG0605|consensus

Probab=100.00  E-value=3.8e-54  Score=404.85  Aligned_cols=268  Identities=28%  Similarity=0.476  Sum_probs=228.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -+++|++++.||+|+||.||+|+.+.||+.||+|++.+..+ ..........|-.+|.... +|+||++|..|.  +..+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQ--D~~~  215 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQ--DKEY  215 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEec--CCCe
Confidence            46799999999999999999999999999999999987643 3455666778888888864 999999999998  6888


Q ss_pred             EEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC--
Q psy14434        100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--  175 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~--  175 (404)
                      +||||||++| |+..++. .+.|++..++.++.+++.|+..||+.|+|||||||+|+||+..|++||+|||+|..+..  
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999995 8888876 56799999999999999999999999999999999999999999999999999853311  


Q ss_pred             --------------------CC-C------------------------cccccccccccccccccccCCCCCchhhHHHH
Q psy14434        176 --------------------SK-E------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSL  210 (404)
Q Consensus       176 --------------------~~-~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  210 (404)
                                          .. .                        ...+.+|||.|||||++. +..|+..+|+|||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHH
Confidence                                00 0                        012457999999999996 5569999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC--CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC---HHHHHhc
Q psy14434        211 GCILAEMLQSKPLFPGASTSHQLQLIVNLVR--PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE---TDQILEH  285 (404)
Q Consensus       211 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~h  285 (404)
                      |||+|||+.|.+||.+.+..+.+.+|.+...  ..|..        ..++.+++|||.+||. ||++|..   ++||.+|
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            9999999999999999999999999988764  22221        3457999999999999 9999985   8999999


Q ss_pred             cCCCCcCCCCCCCCCC
Q psy14434        286 NYVSKYFPSATHVIPQ  301 (404)
Q Consensus       286 p~~~~~~~~~~~~~~~  301 (404)
                      |||...-|......++
T Consensus       446 PfF~~v~W~~l~~~~a  461 (550)
T KOG0605|consen  446 PFFKGVDWDHLREMPA  461 (550)
T ss_pred             CccccCCcchhhcCCC
Confidence            9999988766544443

>KOG0595|consensus

Probab=100.00  E-value=5.6e-54  Score=391.86  Aligned_cols=262  Identities=31%  Similarity=0.536  Sum_probs=230.9

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .....++|.+.+.||+|+||+||+|+++.++..||||.+.+.........-+..|+.+|+.++ |||||.++++++  ..
T Consensus         5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~--~~   81 (429)
T KOG0595|consen    5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIE--DD   81 (429)
T ss_pred             cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEe--cC
Confidence            356778999999999999999999999999999999999887777778888899999999998 999999999987  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC------CceEEecccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS------CSIKIGDLGL  169 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~------~~vkl~Dfg~  169 (404)
                      ..+|+|||||. |||..+++.. .+++..++.++.||+.||++||+++|+||||||+|||++..      -.+||+|||+
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            78999999999 6999999854 79999999999999999999999999999999999999765      4589999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      |+.+... ....+.||+|.|||||++ ...+|+.++|+||+|+|+|+|++|++||+..+..+.+..+.......+...  
T Consensus       162 AR~L~~~-~~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~--  237 (429)
T KOG0595|consen  162 ARFLQPG-SMAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP--  237 (429)
T ss_pred             hhhCCch-hHHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh--
Confidence            9998754 456788999999999998 477899999999999999999999999999999888776655443222211  


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                           ..++....+|+...|+.+|..|.+..+-+.|+++...
T Consensus       238 -----~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  238 -----AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             -----hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence                 2346677899999999999999999999999998754

>KOG0033|consensus

Probab=100.00  E-value=5.3e-56  Score=379.36  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=232.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.+.|++.+.||+|.|++|+++.+..+|+.+|+|+++.........+++.+|+.+.+.|+ ||||+++++.+.  ..+..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~--~~~~~   85 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFH   85 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhc--cccee
Confidence            445799999999999999999999999999999999877677778899999999999998 999999999976  67889


Q ss_pred             EEEEeccCC-cH-HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEeccccccccCC
Q psy14434        101 YVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSD  175 (404)
Q Consensus       101 ~lv~E~~~~-~L-~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg~a~~~~~  175 (404)
                      |||+|+|.| +| .+++++-.++|..+..++.||++||.|||.+||+|||+||+|+++-+   ..-+||+|||++..++ 
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997 55 45666667899999999999999999999999999999999999943   3569999999999888 


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      +.....+.+|||.|||||++ ....|+..+|||+.|||||-|+.|.+||.+.+....++.|+.+....++      +.|+
T Consensus       165 ~g~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~------~~w~  237 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS------PEWD  237 (355)
T ss_pred             CccccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC------cccC
Confidence            45566788999999999998 5678999999999999999999999999999999999999888765444      2358


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ++++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus       238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            89999999999999999999999999999999975

>KOG0583|consensus

Probab=100.00  E-value=1.5e-53  Score=406.82  Aligned_cols=260  Identities=30%  Similarity=0.467  Sum_probs=228.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC---hhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ....+.|.+.+.||+|+||+|++|.+..+++.||+|++.+....   ......+.+|+.+++.+..||||+++++++.. 
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-   91 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-   91 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence            46678999999999999999999999999999999987664221   23455666899999999889999999999984 


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARS  172 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~  172 (404)
                       ...+|+|||||.| +|.+.+.. ++++|.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++..
T Consensus        92 -~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   92 -PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             -CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence             4559999999996 88888875 789999999999999999999999999999999999999999 9999999999998


Q ss_pred             cCCCCCcccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .........+.|||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+.......+.......+       
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p-------  243 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP-------  243 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-------
Confidence            744456678899999999999996655 557999999999999999999999999888887777665544333       


Q ss_pred             cccCCC-CHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        252 AGFKNK-PEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       252 ~~~~~~-~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ..+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus       244 ---~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  244 ---SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ---CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence               234 899999999999999999999999999999997

>KOG0616|consensus

Probab=100.00  E-value=6.9e-54  Score=375.76  Aligned_cols=259  Identities=28%  Similarity=0.472  Sum_probs=230.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-+++|++++.||.|+||.|.+++++.+|..||+|++.+. .......+...+|..+|+.+. ||.++++++.|.  +..
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~--d~~  117 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFK--DNS  117 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeec--cCC
Confidence            3467899999999999999999999999999999999665 234455666778999999997 999999999977  688


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+||||||++| .|..+++ .+++++..++.++.||+.||.|||+++|++|||||+|||++++|.+||+|||+|+...+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999996 6877776 478999999999999999999999999999999999999999999999999999987653


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                         ..+.||||.|+|||++ ....|+.++|+|||||++|||+.|.+||.+.+....+++|.++.-..|.          .
T Consensus       198 ---T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----------~  263 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----------Y  263 (355)
T ss_pred             ---EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----------c
Confidence               4678999999999998 5778999999999999999999999999999999999999887665553          4


Q ss_pred             CCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~~~  295 (404)
                      +++++++||.++|+.|-.+|.     ...++..||||+...|..
T Consensus       264 fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  264 FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            589999999999999999993     568999999999876544

>KOG0591|consensus

Probab=100.00  E-value=1.2e-55  Score=384.10  Aligned_cols=251  Identities=32%  Similarity=0.567  Sum_probs=224.1

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEee-EEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD-IYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~-~~~~~~   96 (404)
                      .-....+|++++.||+|+||.||++.+..+|..+|.|.+.-...+....+....|+.+|++|+ |||||++++ .|. .+
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~-~~   91 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFI-ED   91 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhh-cc
Confidence            445667899999999999999999999999999999999877888888999999999999997 999999998 443 24


Q ss_pred             CCeEEEEEeccC-CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCcEEEccCCceEEec
Q psy14434         97 NKDLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA--CK--VMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~--~~--i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      ...++||||||+ |||..+++     .+.++|..+|.++.|++.||..||+  .+  |+||||||.||+++.+|.|||+|
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            556999999999 79999886     3469999999999999999999998  55  99999999999999999999999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||+++.+........+++|||.||+||.+ ....|+.++||||+||++|||+.-.+||.+.+..+...+|.++..+..+.
T Consensus       172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  172 FGLGRFLSSKTTFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             chhHhHhcchhHHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            99999998887888899999999999998 57789999999999999999999999999998888888887764432221


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCH
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPET  279 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  279 (404)
                              ..+|..+..+|..|+..||+.||+.
T Consensus       251 --------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 --------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             --------HHhhhHHHHHHHHHccCCcccCCCc
Confidence                    3458899999999999999999986

>KOG0594|consensus

Probab=100.00  E-value=2.6e-53  Score=383.92  Aligned_cols=271  Identities=37%  Similarity=0.658  Sum_probs=235.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC-cceEeeEEEecc----
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVN----   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-Iv~l~~~~~~~~----   96 (404)
                      ...|+.++.||+|+||+||+|+++.+|+.||+|++......+..-....+|+.+++.+. |+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            56788899999999999999999999999999999766554445566789999999997 999 999999987432    


Q ss_pred             CCeEEEEEeccCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      ...+++||||++.+|..++..     ..++...++.++.||+.||+|||++||+||||||+||||+++|.+||+|||+|+
T Consensus        89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence            248999999999999999975     247788999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-----
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-----  246 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  246 (404)
                      ...-+....+..++|.||+|||++.+...|+..+||||+|||++||+++++.|++.++.+++..|...++.....     
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            877565667778899999999999988899999999999999999999999999999999999999888743321     


Q ss_pred             ---------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        247 ---------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       247 ---------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                                     ...+....+..++++.+++.+||+.+|.+|+|+..+|.||||.....
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                           11222222334468999999999999999999999999999987643

>KOG0658|consensus

Probab=100.00  E-value=2.1e-53  Score=383.94  Aligned_cols=266  Identities=35%  Similarity=0.656  Sum_probs=228.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC---
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK---   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~---   98 (404)
                      .=.|+-.+.+|+|+||.||+|....+++.||||++-...      .---+|+.+|+.+. |||||++..+|....+.   
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchh
Confidence            336899999999999999999999999999999984221      12237899999886 99999999998754444   


Q ss_pred             eEEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccc
Q psy14434         99 DLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~  172 (404)
                      ++.+|||||+.+|...++     +..++...++-+++||++||+|||+.||+||||||.|||+|.+ |.+||||||.|+.
T Consensus        96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            455899999999999998     4669999999999999999999999999999999999999986 9999999999998


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      +..+.. ..++.-|..|+|||.+.+...|+.+.||||.||++.||+-|.+.|+|.+..+++..|.+.++.+..       
T Consensus       176 L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  176 LVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            876544 477889999999999999999999999999999999999999999999999999999988774322       


Q ss_pred             -----------Ccchhhc-ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        246 -----------HADKFYA-GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       246 -----------~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                                 ....+.. .....++++.+|+.++|.++|.+|.++.+++.||||+..+.+.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                       0011111 3355789999999999999999999999999999999888764

>KOG0597|consensus

Probab=100.00  E-value=1.8e-53  Score=400.86  Aligned_cols=259  Identities=34%  Similarity=0.603  Sum_probs=234.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+....+.+.+.+.+|+++++.++ ||||+.+++.|+  ...+++
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfE--t~~~~~   77 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFE--TSAHLW   77 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhc--ccceEE
Confidence            36899999999999999999999999999999999999889999999999999999997 999999999998  577899


Q ss_pred             EEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        102 VVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       102 lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      +|+|||.|+|..++. ++.++|+.++.++++++.||.|||+++|+|||+||.|||+.+.|.+|+||||+|+.+.......
T Consensus        78 vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             EEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            999999999999997 5779999999999999999999999999999999999999999999999999999988877777


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      +..-|||.|||||++ .+..|+..+|+||||||+|||++|++||-..+.......|..--...+          ...+..
T Consensus       158 tsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----------~~~S~~  226 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----------STASSS  226 (808)
T ss_pred             eeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----------ccccHH
Confidence            888999999999998 588899999999999999999999999977666655555543222111          356899


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      +.+||..+|.+||.+|+|..+++.|||.++...-
T Consensus       227 f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  227 FVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             HHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence            9999999999999999999999999999875543

>KOG0694|consensus

Probab=100.00  E-value=2.1e-52  Score=403.24  Aligned_cols=262  Identities=26%  Similarity=0.489  Sum_probs=234.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -+++|.+++.||+|+||+|++|..+.+++.||||++++. .....+....+.|-+++....+||.++.++.+|.  ...+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~~~  443 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TKEH  443 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cCCe
Confidence            456899999999999999999999999999999999775 4556677888899999998888999999999998  5778


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|+||||+.| ++..+.+.+.|++..++.|+..|+.||+|||++||||||||.+|||++.+|++||+|||+++.......
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9999999996 655555568899999999999999999999999999999999999999999999999999998765556


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ...++||||.|||||++ .+..|+.++|+|||||+||||+.|..||++.+..+....|.+.....|          ..+|
T Consensus       524 ~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----------~~ls  592 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----------RFLS  592 (694)
T ss_pred             ccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----------Cccc
Confidence            77889999999999998 678899999999999999999999999999999999998877544333          3468


Q ss_pred             HHHHHHHHhccccCCCCCCCH-----HHHHhccCCCCcCCCC
Q psy14434        259 EEAVDLLNQILVLNPSERPET-----DQILEHNYVSKYFPSA  295 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~~~~  295 (404)
                      .++.++++++|..+|++|..+     .++..||||..+.|..
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            999999999999999999864     7899999999876644

>KOG0585|consensus

Probab=100.00  E-value=2.9e-52  Score=386.05  Aligned_cols=268  Identities=28%  Similarity=0.433  Sum_probs=228.5

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------------hhHHHHHHHHHHHHHhccCCCCcc
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------------KTDAQRTYREILFLKSFQRHPNII   86 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~hpnIv   86 (404)
                      -..+++|++.+.||+|.||+|.+|++..+++.||||++.+....            ....++..+||.+|+++. |||||
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV  171 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVV  171 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCee
Confidence            45778999999999999999999999999999999999654211            123457889999999997 99999


Q ss_pred             eEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         87 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        87 ~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~-l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      +|+++..++....+|||+|||.. .+...-..+. +++.+++.|+.+++.||.|||..||+||||||+|+||+++|+|||
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99999998889999999999994 4433333455 999999999999999999999999999999999999999999999


Q ss_pred             ecccccccc-----CCCCCcccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q psy14434        165 GDLGLARSL-----SDSKECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI  236 (404)
Q Consensus       165 ~Dfg~a~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  236 (404)
                      +|||.+...     .+....+...+|||.|+|||...++   ...+.+.||||+||+||-|+.|+.||-+....+...+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999999866     2333444557899999999998652   34578999999999999999999999999998888888


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                      ++.--..+.        .+.+.+.++|||.+||++||++|+++.++..|||........
T Consensus       332 vn~pL~fP~--------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  332 VNDPLEFPE--------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             hcCcccCCC--------cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            775443333        234678999999999999999999999999999998765443

>KOG0611|consensus

Probab=100.00  E-value=2.1e-52  Score=379.82  Aligned_cols=256  Identities=31%  Similarity=0.545  Sum_probs=233.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +..-+|++.+.||+|.||.|-+|++..+|+.||||.|.+. ..++.+...+.+||.+|..|+ ||||+.+|++|+  +..
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFE--Nkd  126 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFE--NKD  126 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhc--CCc
Confidence            3456899999999999999999999999999999999765 456678889999999999997 999999999998  778


Q ss_pred             eEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+.|||||.. |.|++++. .+.|++.+++.+|.||..|+.|||.++++|||||.+|||++.++++||+|||++..+.. 
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-  205 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-  205 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence            8999999999 58999997 56799999999999999999999999999999999999999999999999999988765 


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      ...++++||+|.|.+||++.+..+-++.+|.||||++||.|+.|..||++.+......+|.++....++           
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----------  274 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----------  274 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----------
Confidence            466789999999999999966677789999999999999999999999999999999998887664433           


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .|.++.-||+.||..||++|.|++++..|.|++=
T Consensus       275 ~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  275 TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            3678999999999999999999999999999873

>KOG0578|consensus

Probab=100.00  E-value=4.8e-52  Score=393.49  Aligned_cols=260  Identities=32%  Similarity=0.557  Sum_probs=232.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ++....|.....||+|+.|.||.|....+++.||||.+...  ......-++.|+.+|+.+. |+|||.+++.|.  ...
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Syl--v~d  343 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLH-HPNIVNFLDSYL--VGD  343 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhcc-chHHHHHHHHhc--ccc
Confidence            56677899999999999999999999999999999999654  3445566889999999997 999999999987  357


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+++|||||+| +|.+++....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+....
T Consensus       344 eLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            79999999995 89999999899999999999999999999999999999999999999999999999999999988777


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ....+.+|||.|||||++ ....|+.++||||||+++.||+-|.+||-..+....+..|.....+....       ...+
T Consensus       424 ~KR~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-------~~kl  495 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-------PEKL  495 (550)
T ss_pred             CccccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-------cccc
Confidence            677888999999999998 67889999999999999999999999998877777777766544443322       2567


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      |+.+++||.+||+.|+.+|+++.+||.||||+..
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999999643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-50  Score=376.98  Aligned_cols=263  Identities=33%  Similarity=0.658  Sum_probs=220.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|.+..++..||+|++.... .........+|+.+++.+. ||||+++++++.  .....|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLK-HANIVTLHDIIH--TERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCC-CCCEeeEEEEEc--CCCeEE
Confidence            568999999999999999999999999999999985432 2223345678999999996 999999999986  566899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+.++|...+..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        80 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9999999999888864  34789999999999999999999999999999999999999999999999999765443333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA------------  247 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------  247 (404)
                      .....|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.......+...            
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            44567899999999986667789999999999999999999999999888777776665544222110            


Q ss_pred             --------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 --------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                              .........++.++.+||.+||+.||.+|||++++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                    00111124568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0599|consensus

Probab=100.00  E-value=1.8e-52  Score=362.80  Aligned_cols=268  Identities=29%  Similarity=0.468  Sum_probs=233.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc------ChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------NKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..-..|.-.+.||+|..++|-++.++.+|..+|+|++.....      .........+|+.+|+++.+||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            345678889999999999999999999999999999854311      11223445689999999999999999999998


Q ss_pred             eccCCeEEEEEeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         94 AVNNKDLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                        ....+++|+|.|+ |.|.+++... .+++.+.+.|+.||++|+.|||.++|+||||||+|||++++-++||+|||+++
T Consensus        94 --s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   94 --SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             --CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence              5777999999999 7899999854 59999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILI-----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      .+..+ ......||||+|.|||.+.     +...|+..+|+|++|||+|.|+.|.+||......-.+..|+.+...... 
T Consensus       172 ~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s-  249 (411)
T KOG0599|consen  172 QLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS-  249 (411)
T ss_pred             ccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC-
Confidence            88764 5678899999999999973     3467899999999999999999999999998888888888888765544 


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                           +.|.+++.+..|||.+||+.||.+|+|++++|.||||.++.-...
T Consensus       250 -----peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~  294 (411)
T KOG0599|consen  250 -----PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA  294 (411)
T ss_pred             -----cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence                 335788999999999999999999999999999999976654433

>KOG0582|consensus

Probab=100.00  E-value=2.9e-50  Score=370.47  Aligned_cols=270  Identities=27%  Similarity=0.413  Sum_probs=225.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .-.++|++.+.||.|..++||+|+...+++.||||++.....+.. ...+.+|+..|..+. ||||++++..|.  .+..
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~-HPNIv~~~~sFv--v~~~   98 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLID-HPNIVTYHCSFV--VDSE   98 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcC-CCCcceEEEEEE--ecce
Confidence            456789999999999999999999999999999999987655554 788999999999996 999999999998  5778


Q ss_pred             EEEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        100 LYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      +|+||.||. |++.++++.   ..+.|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999 688888874   3499999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCcc----ccccccccccccccc-ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        176 SKECL----TEYIATRWYRAPEIL-ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       176 ~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .....    .+++|||+|||||++ .....|+.++||||||++..||.+|..||........+-...+...+.+.....-
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            33221    556899999999994 4456899999999999999999999999988777655444333332222111111


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .......+..++.+|..||+.||.+|||++++|+|+||+....
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            1122446778999999999999999999999999999997554

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-49  Score=383.43  Aligned_cols=306  Identities=36%  Similarity=0.656  Sum_probs=240.0

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--   95 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--   95 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++..............+|+.+++.+. ||||+++++++...  
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~   97 (364)
T cd07875          19 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence            345788999999999999999999999999999999999766666666778889999999996 99999999987532  


Q ss_pred             --cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         96 --NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        96 --~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                        ....+|+||||++++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875          98 LEEFQDVYIVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             ccccCeEEEEEeCCCCCHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence              2346899999999998887764 4889999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc-c----
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA-D----  248 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~----  248 (404)
                      ... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+....+...+.. .    
T Consensus       177 ~~~-~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         177 GTS-FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCC-CcccCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            432 223456799999999998 466789999999999999999999999998887776666655433211100 0    


Q ss_pred             ---------------hhh------------cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCC
Q psy14434        249 ---------------KFY------------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQ  301 (404)
Q Consensus       249 ---------------~~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~  301 (404)
                                     .+.            ......+..+++||.+||+.||.+|||+.++|+||||..+..+.....++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~  334 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP  334 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCC
Confidence                           000            00011346789999999999999999999999999998776554422111


Q ss_pred             CCCCcccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        302 VTPHTVVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                        |..... ..+..+...++|++.+++++
T Consensus       335 --~~~~~~-~~~~~~~~~~~~~~~~~~~~  360 (364)
T cd07875         335 --PKIPDK-QLDEREHTIEEWKELIYKEV  360 (364)
T ss_pred             --CCCCCc-cchhhhccHHHHHHHHHHHH
Confidence              111111 12234566777777776655

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-49  Score=379.58  Aligned_cols=270  Identities=43%  Similarity=0.765  Sum_probs=221.5

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---CCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---~~~~  100 (404)
                      +|++.+.||+|+||.||+|.+..++..||||++...........++.+|+.+++.+. ||||+++++++...+   ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceE
Confidence            699999999999999999999999999999998765545556667889999999997 999999999875322   2458


Q ss_pred             EEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        101 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      |+|||||+++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            99999999999888864 469999999999999999999999999999999999999999999999999997643221  


Q ss_pred             -Cccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----------
Q psy14434        178 -ECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----------  245 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  245 (404)
                       ......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+.......+....+..+.          
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence             11234679999999999743 256899999999999999999999999887766555544433322111          


Q ss_pred             -----------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        246 -----------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       246 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                                 ....+...++.+++.+.+||.+||+.||++|||++++++||||+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence                       0111223345678899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0610|consensus

Probab=100.00  E-value=2.5e-50  Score=368.02  Aligned_cols=262  Identities=26%  Similarity=0.388  Sum_probs=226.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ...|++++.||+|.-|+||+|....++..+|+|++.+.... .....+...|-.||..+. ||.++.+|..|+  .....
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fe--t~~~~  152 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFE--TDKYS  152 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheee--cccee
Confidence            34688999999999999999999999999999999876544 566778888999999996 999999999998  57789


Q ss_pred             EEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC-
Q psy14434        101 YVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-  175 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  175 (404)
                      |++||||.| +|..++++   +.|++..++.|+.+++.||+|||-.|||+|||||+||||-++|+|.|+||.++..... 
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999995 89888874   4599999999999999999999999999999999999999999999999998743210 


Q ss_pred             ----------------------------------C---------------------CCcccccccccccccccccccCCC
Q psy14434        176 ----------------------------------S---------------------KECLTEYIATRWYRAPEILISNRR  200 (404)
Q Consensus       176 ----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  200 (404)
                                                        .                     +.....++||-.|.|||++ .+..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI-~G~G  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI-RGEG  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee-ecCC
Confidence                                              0                     0112346799999999998 5667


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC--
Q psy14434        201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE--  278 (404)
Q Consensus       201 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt--  278 (404)
                      .+.++|||+||+++|||++|..||.|.+....+..+.......+.        .+.++..++|||+++|.+||.+|..  
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~--------~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE--------EPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC--------CCcchhHHHHHHHHHhccChhhhhccc
Confidence            899999999999999999999999999999888877654332222        1356799999999999999999998  


Q ss_pred             --HHHHHhccCCCCcCCCC
Q psy14434        279 --TDQILEHNYVSKYFPSA  295 (404)
Q Consensus       279 --~~~ll~hp~~~~~~~~~  295 (404)
                        +.||-+||||.+..|..
T Consensus       384 rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  384 RGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             cchHHhhcCccccCCChhh
Confidence              99999999999988765

>KOG0198|consensus

Probab=100.00  E-value=9.3e-51  Score=373.27  Aligned_cols=261  Identities=29%  Similarity=0.506  Sum_probs=213.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ...|...+.||+|+||.||++.+..+|..+|+|.+...  +....+.+.+|+.+|.+++ |||||++++.....+...++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence            45799999999999999999999999999999998554  2223777899999999998 99999999975432223789


Q ss_pred             EEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCC--
Q psy14434        102 VVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSD--  175 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~--  175 (404)
                      |+|||+. |+|.+++...  .|++..++.++.||++||+|||++||+||||||+|||++. ++.+||+|||++.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999 5899999853  6999999999999999999999999999999999999999 79999999999987663  


Q ss_pred             -CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 -SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                       .........||+.|||||++..+.....++|||||||++.||+||++||... .....+-.+.... ..|.       .
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~-------i  244 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPE-------I  244 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCC-------C
Confidence             1122345789999999999854333446999999999999999999999873 3222222222111 1111       1


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ...+|.++++||.+||..||.+||||.++|.|||.....+
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            1457999999999999999999999999999999986444

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-49  Score=372.96  Aligned_cols=268  Identities=32%  Similarity=0.578  Sum_probs=215.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++..... ........+|+.+++.+. ||||+++++++.  +....|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCC-CCCcCeEEEEEe--cCCeEE
Confidence            4689999999999999999999999999999999864422 223345678999999996 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+.++|.+.+..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            9999999998888764  45899999999999999999999999999999999999999999999999999765443333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCC-C-----------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPP-H-----------  246 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-~-----------  246 (404)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... ..+..+......... .           
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            455678999999999865667899999999999999999999999876443 333333332221100 0           


Q ss_pred             --------cchhhccc--CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        247 --------ADKFYAGF--KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       247 --------~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                              ...+...+  ...+..+.+||.+||+.||.+|||+.++|+||||....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                    00000001  124578999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0667|consensus

Probab=100.00  E-value=5.1e-50  Score=386.50  Aligned_cols=264  Identities=33%  Similarity=0.568  Sum_probs=225.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-----CcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-----NIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-----nIv~l~~~~~~   94 (404)
                      .+..+|.+.+.||+|+||.|-+|.|..|++.||||+++.   ...-..+...|+.+|..++.|.     |||+++++|. 
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-  258 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-  258 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-
Confidence            455589999999999999999999999999999999953   4556777789999999997543     8999999987 


Q ss_pred             ccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC--CceEEecccc
Q psy14434         95 VNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGL  169 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~--~~vkl~Dfg~  169 (404)
                       -..++|||+|+++.+|+++++..   .|+...++.++.||+.||.+||+.||||+||||||||+...  ..|||+|||+
T Consensus       259 -fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  259 -FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             -cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence             57789999999999999999864   48899999999999999999999999999999999999654  4799999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----  245 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  245 (404)
                      |+.....   ..+++.+..|+|||+++ +..|+.+.||||||||++||++|.+.|+|.+..+++..|++.++..+.    
T Consensus       338 Sc~~~q~---vytYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  338 SCFESQR---VYTYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccCCc---ceeeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9875432   34789999999999996 678999999999999999999999999999999999999998885444    


Q ss_pred             -------Ccch------------------------------hhcccC------------CCCHHHHHHHHhccccCCCCC
Q psy14434        246 -------HADK------------------------------FYAGFK------------NKPEEAVDLLNQILVLNPSER  276 (404)
Q Consensus       246 -------~~~~------------------------------~~~~~~------------~~~~~~~~li~~~L~~dp~~R  276 (404)
                             ....                              .....+            .-...+.|||.+||..||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                   0000                              000001            012357899999999999999


Q ss_pred             CCHHHHHhccCCCCcC
Q psy14434        277 PETDQILEHNYVSKYF  292 (404)
Q Consensus       277 pt~~~ll~hp~~~~~~  292 (404)
                      +|+.++|+||||....
T Consensus       494 ~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTS  509 (586)
T ss_pred             CCHHHHhcCccccccc
Confidence            9999999999998643

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-49  Score=378.60  Aligned_cols=273  Identities=36%  Similarity=0.683  Sum_probs=222.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++..............+|+.+++.+. ||||++++++|....   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence            5788999999999999999999999999999999999766556666778889999999997 999999999986322   


Q ss_pred             -CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         97 -NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        97 -~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                       ...+|+||||++++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          97 EFQDVYLVMELMDANLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             ccceeEEEEeCCCcCHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence             245899999999988877654 488999999999999999999999999999999999999999999999999976533


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------  246 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------  246 (404)
                      . .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+..........         
T Consensus       176 ~-~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         176 N-FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             C-ccCCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            2 233456789999999998 46678999999999999999999999999887665554444332211100         


Q ss_pred             -----------cchhhc------------ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        247 -----------ADKFYA------------GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       247 -----------~~~~~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                                 ...+..            .....++.+.+||.+||+.||++|||+.++|.||||..++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  326 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE  326 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence                       000000            01123678999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032|consensus

Probab=100.00  E-value=2.4e-49  Score=377.61  Aligned_cols=265  Identities=30%  Similarity=0.506  Sum_probs=232.2

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ....+...|++.+.||+|.||+||+|+++.+|+.+|+|++.+.... ........+|+.+|+++.+||||+.++++|+  
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e--  106 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE--  106 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE--
Confidence            4466778899999999999999999999999999999999766443 3356778899999999988999999999998  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC----CceEEeccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLA  170 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~----~~vkl~Dfg~a  170 (404)
                      +...+++|||+|.| .|.+.+....+++..+..++.||+.|++|||+.||+||||||+|+|+...    +.+|++|||++
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            46689999999995 77777665469999999999999999999999999999999999999543    57999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ..... .......+||+.|+|||++ ....|+..+||||+||++|.|++|.+||.+.........+.........     
T Consensus       187 ~~~~~-~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~-----  259 (382)
T KOG0032|consen  187 KFIKP-GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS-----  259 (382)
T ss_pred             eEccC-CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC-----
Confidence            98876 5667889999999999998 5578999999999999999999999999999888777766665442222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ..|+.++..+.+||.+||..||.+|+|+.++|+|||+...
T Consensus       260 -~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  260 -EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence             3357889999999999999999999999999999998864

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-49  Score=378.47  Aligned_cols=305  Identities=38%  Similarity=0.715  Sum_probs=241.1

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec-
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV-   95 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~-   95 (404)
                      ..+.+.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||++++++|... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT   87 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence            4456788999999999999999999999999999999999765544555667789999999997 99999999987532 


Q ss_pred             ---cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 ---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ---~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                         .....|++|++++++|..++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence               22457999999999999998888899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      ....   ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.........       
T Consensus       168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            5432   345679999999999865567899999999999999999999999888776666655544332111       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI  311 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  311 (404)
                                    ....+...+...++.+.+||.+||..||.+|||+.++|.||||..+..+....  ...+   ....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~--~~~~---~~~~  319 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEP--EAEP---YDES  319 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcccc--ccCc---cccc
Confidence                          00111122345677899999999999999999999999999999865543211  1111   1112


Q ss_pred             CCCCcCCHHHHHHHHHHHH
Q psy14434        312 DDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~  330 (404)
                      .......+.++.+..+...
T Consensus       320 ~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07878         320 PENKERTIEEWKELTYEEV  338 (343)
T ss_pred             hhhhhccHHHHHHHHHHHH
Confidence            2233445566666665544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-48  Score=376.61  Aligned_cols=304  Identities=37%  Similarity=0.680  Sum_probs=235.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec----
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~----   95 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..............+|+.+++.+. ||||++++++|...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence            5678999999999999999999999999999999999776666667778889999999996 99999999998632    


Q ss_pred             cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ....+|+||||++++|...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~lv~e~~~~~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          93 EFQDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             ccceeEEEhhhhcccHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            2246899999999988877754 489999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-c-------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-A-------  247 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-------  247 (404)
                      . .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+........+. .       
T Consensus       172 ~-~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         172 S-FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             c-cccCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            2 233456799999999998 46678999999999999999999999999887666555444433211100 0       


Q ss_pred             --------------------chh----hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCC
Q psy14434        248 --------------------DKF----YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT  303 (404)
Q Consensus       248 --------------------~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~  303 (404)
                                          ...    .......+..+.+||.+||..||.+|||+.++|+||||..+........++  
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~--  327 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPP--  327 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCC--
Confidence                                000    000112356789999999999999999999999999998776543322111  


Q ss_pred             CCcccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        304 PHTVVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      +...... .+......++|.+.+.+.+
T Consensus       328 ~~~~~~~-~~~~~~~~~~~~~~~~~~~  353 (355)
T cd07874         328 PQIYDKQ-LDEREHTIEEWKELIYKEV  353 (355)
T ss_pred             ccccccc-hhhhhccHHHHHHHHHHHh
Confidence            1111111 1223345666776666554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-49  Score=367.40  Aligned_cols=262  Identities=35%  Similarity=0.647  Sum_probs=215.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++..............+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFR--RRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEe--cCCEEEE
Confidence            4799999999999999999999999999999999765444555667789999999997 999999999987  5678999


Q ss_pred             EEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-Cc
Q psy14434        103 VFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-EC  179 (404)
Q Consensus       103 v~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~~  179 (404)
                      ||||+.+++...+.  .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            99999986555554  2458999999999999999999999999999999999999999999999999998764322 22


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc-----------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-----------  248 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------  248 (404)
                      .....||+.|+|||++. +..++.++|+|||||++|+|++|++||.+.+.......+.....+.+....           
T Consensus       158 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 YTEYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            33467999999999984 556899999999999999999999999987766655555443332211000           


Q ss_pred             ----------h-hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        249 ----------K-FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       249 ----------~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                                . .......++.++.+||.+||+.||.+|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      0 001112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-48  Score=376.29  Aligned_cols=267  Identities=37%  Similarity=0.680  Sum_probs=221.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---CCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---~~~~  100 (404)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........++.+|+.+++.++ ||||+++++++...+   ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            478999999999999999999999999999998765555556678889999999997 999999999986322   1268


Q ss_pred             EEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-C
Q psy14434        101 YVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-E  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~  178 (404)
                      |+||||+.++|...+. .+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            9999999999888776 4569999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      ......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+...++..+....+....             
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  239 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH  239 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence            2334568999999999866566899999999999999999999999998877777666554331111             


Q ss_pred             ---------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        246 ---------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       246 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                               ............++++.+||.+||+.||.+|||+.++|.||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                     1111112224568899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4717|consensus

Probab=100.00  E-value=9.3e-50  Score=371.94  Aligned_cols=275  Identities=29%  Similarity=0.482  Sum_probs=246.7

Q ss_pred             cccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         14 QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ++-..|.|.+-|.+.+.||+|.|++|.+|++--+|+.||||++.+...+......+++|++.|+..+ |||||++|++..
T Consensus         9 g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViD   87 (864)
T KOG4717|consen    9 GHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVID   87 (864)
T ss_pred             ccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhc
Confidence            3345688999999999999999999999999999999999999999999989999999999999997 999999999976


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-ccCCceEEecccc
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-DKSCSIKIGDLGL  169 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll-~~~~~vkl~Dfg~  169 (404)
                        ....+|||+|+-++ +|.++|-  ...+.+.-++.||.||+.|+.|||+..++||||||+||.+ .+-|-|||.|||+
T Consensus        88 --TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   88 --TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             --ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccc
Confidence              56789999999995 9999885  3569999999999999999999999999999999999776 5578999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      +..+.++ ....+.||+..|-|||++++..+..+++||||||||||-|++|.+||...++.+.+..|+......|     
T Consensus       166 SNkf~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-----  239 (864)
T KOG4717|consen  166 SNKFQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-----  239 (864)
T ss_pred             cccCCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-----
Confidence            9988765 5578899999999999999888888999999999999999999999999999999999998876544     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCC
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV  302 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~  302 (404)
                           ..++.++++||..||..||.+|.+.+++..|+|++..-+.....+|.+
T Consensus       240 -----shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLv  287 (864)
T KOG4717|consen  240 -----SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLV  287 (864)
T ss_pred             -----hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCcee
Confidence                 456899999999999999999999999999999998765544334433

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-48  Score=364.89  Aligned_cols=264  Identities=36%  Similarity=0.617  Sum_probs=216.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC-CCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEe---cc
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKA---VN   96 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~---~~   96 (404)
                      .+|++.+.||+|+||.||+|.+.. ++..||+|.+..............+|+.+++.+.  .||||+++++++..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 5788999998655444444455667777777663  49999999998752   23


Q ss_pred             CCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ...+++||||+.++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            457899999999999888864   34899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc------
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA------  247 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  247 (404)
                      ... .......||+.|+|||.+ .+..++.++|||||||++|+|++|++||.+......+..+........+..      
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            433 233456799999999998 456789999999999999999999999999888888777776544221100      


Q ss_pred             -----------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 -----------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 -----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                                 ..+....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                       01112234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580|consensus

Probab=100.00  E-value=4.8e-50  Score=341.98  Aligned_cols=254  Identities=30%  Similarity=0.511  Sum_probs=227.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -+++|++.+.||+|-||.||+|+.+.++-.||+|++.+... ......++.+|+.+...|+ ||||+++|++|.  +...
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh--d~~r   96 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH--DSKR   96 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee--ccce
Confidence            45789999999999999999999999999999999987643 3345567789999999997 999999999998  6788


Q ss_pred             EEEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        100 LYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      +|+++||.. |.+...+..   +.+++...+.++.|++.|+.|||.++++||||||+|+|++..|.+||+|||.+.... 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999998 688888873   459999999999999999999999999999999999999999999999999997643 


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .....+.|||..|.+||+. .+..++..+|+|++|++.||++.|.+||......+.++.|.+.....+          .
T Consensus       176 -~~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----------~  243 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----------S  243 (281)
T ss_pred             -CCCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----------c
Confidence             3445788999999999997 677889999999999999999999999999998888888877655443          4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .++.++.|||.+||.++|.+|.+..+++.|||+..
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            66899999999999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.9e-49  Score=386.25  Aligned_cols=266  Identities=34%  Similarity=0.626  Sum_probs=215.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec-----
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV-----   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~-----   95 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.+. ||||++++++|...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence            3467999999999999999999999999999999884321      22347999999997 99999999987421     


Q ss_pred             -cCCeEEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccc
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLG  168 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg  168 (404)
                       ....+++||||++++|..++.     ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             123577999999998877764     34689999999999999999999999999999999999998765 69999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---  245 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  245 (404)
                      +++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..+....+....   
T Consensus       217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            998765432 2345678999999999866667999999999999999999999999998887777776655432111   


Q ss_pred             ---------------Ccchhhccc-CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        246 ---------------HADKFYAGF-KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       246 ---------------~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                                     ....+...+ ...+.++.+||.+||++||.+|||+.++|.||||......
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence                           000111111 2367899999999999999999999999999999876554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-49  Score=366.91  Aligned_cols=254  Identities=27%  Similarity=0.403  Sum_probs=216.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.  +...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEH--DQRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhc--cCCeEE
Confidence            479999999999999999999999999999999865422 2234556778999999997 999999999876  567899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+. ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence            9999998 489888864 56899999999999999999999999999999999999999999999999999866432   


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..+++
T Consensus       155 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~  223 (291)
T cd05612         155 TWTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----------RHLDL  223 (291)
T ss_pred             cccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----------ccCCH
Confidence            2345799999999998 466789999999999999999999999988877666666554322211          34578


Q ss_pred             HHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        260 EAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      .+.+||.+||+.||.+||+     +++++.||||....+
T Consensus       224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            9999999999999999995     999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0662|consensus

Probab=100.00  E-value=1.4e-49  Score=325.42  Aligned_cols=267  Identities=34%  Similarity=0.660  Sum_probs=235.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .|.-.+.||+|.||+||+|+.+.+++.||+|.+.....++..-...++|+-+++.++ |.||++++++..  .+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlh--sdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhc--cCceeEEe
Confidence            566778999999999999999999999999999877777777778899999999997 999999999975  57789999


Q ss_pred             EeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        104 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       104 ~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      +|||..+|.++..  .+.+..+.++.++.|+++||.+||++++.|||+||.|+||+.+|.+||+|||+++.++-+-.+..
T Consensus        80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            9999999998887  57799999999999999999999999999999999999999999999999999998887766667


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCC--------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH--------------  246 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  246 (404)
                      ..+.|.||++|.++.+..-|+.+.|+||.|||+.|+.. |++.|++.+..+++..|...++.....              
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            77899999999999888899999999999999999984 899999999999999999887733221              


Q ss_pred             -----cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        247 -----ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       247 -----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                           ...+....+.++...+||+.++|.-+|..|++++++|+||||.++.+
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~  291 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP  291 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence                 11222223444567899999999999999999999999999987643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.6e-49  Score=372.12  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=212.9

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.++.+|+.||+|++.+... .........+|+.+++.+. ||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQ--THDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEE--cCCEEEEEEeCC
Confidence            469999999999999999999999999975432 3345567788999999997 999999999987  567899999999


Q ss_pred             CC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence            85 78777764 56999999999999999999999999999999999999999999999999999764333334455789


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..+++++.+||
T Consensus       158 t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----------~~~~~~~~~li  226 (323)
T cd05571         158 TPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----------RTLSPEAKSLL  226 (323)
T ss_pred             CccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 466789999999999999999999999988776665555443221111          35689999999


Q ss_pred             HhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      .+||..||.+||     ++.++++||||....+
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         227 AGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             HHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999999999     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.6e-48  Score=364.58  Aligned_cols=269  Identities=31%  Similarity=0.633  Sum_probs=222.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|.+..... ........+|+.+++.+. ||||+++++++.  .+..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~   78 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIVH--TDKS   78 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCC-CCCcceEEEEEe--eCCe
Confidence            345789999999999999999999999999999999864422 223345668999999997 999999999987  4678


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .|+||||+.++|...+..  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            999999999998887764  348999999999999999999999999999999999999999999999999997654433


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-----------
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-----------  246 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  246 (404)
                      .......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+.....           
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            333455789999999998666678999999999999999999999999888777666665544322110           


Q ss_pred             ---------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 ---------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 ---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                               ........+.+++++.+||.+||..||.+|||+.+++.||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                     0011122345788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-48  Score=370.44  Aligned_cols=256  Identities=23%  Similarity=0.403  Sum_probs=218.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .-..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.+. ||||+++++++.  +.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~   90 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQ--DE   90 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--cC
Confidence            345678999999999999999999999999999999996543 23344566789999999996 999999999987  56


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.+ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            789999999985 88887764 5689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .   ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          .
T Consensus       171 ~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----------~  236 (329)
T PTZ00263        171 R---TFTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----------N  236 (329)
T ss_pred             C---cceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----------C
Confidence            2   2346799999999998 456689999999999999999999999988776665555544322111          2


Q ss_pred             CCCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKY  291 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~  291 (404)
                      .++..+.+||.+||+.||.+||+     +.+++.||||...
T Consensus       237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            35789999999999999999997     7999999999874

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-48  Score=368.15  Aligned_cols=261  Identities=25%  Similarity=0.466  Sum_probs=219.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++..+. ||||+++++++.  ....+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQ--DDEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEE--cCCEEE
Confidence            4799999999999999999999999999999999755322 234566788999999997 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence            9999998 489998864 5689999999999999999999999999999999999999999999999999986543   2


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      ....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.........  .........++.
T Consensus       155 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~s~  231 (333)
T cd05600         155 ANSVVGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--PVYDDPRFNLSD  231 (333)
T ss_pred             cCCcccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC--CCCCccccccCH
Confidence            34567999999999984 557899999999999999999999999988777666655543221110  000000135689


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ++.+||.+||..+|.+||++.++++||||....
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            999999999999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.4e-48  Score=367.47  Aligned_cols=309  Identities=52%  Similarity=0.939  Sum_probs=252.4

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+++.+|+|++..............+|+.+++++.+||||+++++++...+.
T Consensus         2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            34677899999999999999999999999999999999876555555666778899999999449999999999875556


Q ss_pred             CeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         98 KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        98 ~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ..+|+||||+.++|..++..+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             ceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            67899999999999999987788999999999999999999999999999999999999999999999999998654322


Q ss_pred             -----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        178 -----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       178 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                           .......|++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.........+.........       
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                 22334678999999998866667889999999999999999999999887776665554443321110       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI  311 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  311 (404)
                                    .........+.++.++.+||.+||+.||.+|||+.+++.||||.++..+..   .+..+......+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~---~~~~~~~~~~~~  318 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD---EPVLPYPITIPL  318 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC---CCCCCCCccCCc
Confidence                          111112223457889999999999999999999999999999998755443   223334445567


Q ss_pred             CCCCcCCHHHHHHHHHHH
Q psy14434        312 DDNNQLEINDYQDKLYDI  329 (404)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~  329 (404)
                      +++...+..+++.+++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~  336 (337)
T cd07852         319 DDNVKLSVAEYRNKLYEE  336 (337)
T ss_pred             cccceeeHHHHHhhhhhc
Confidence            888999999999998864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.6e-48  Score=365.75  Aligned_cols=254  Identities=25%  Similarity=0.439  Sum_probs=214.8

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHH---hccCCCCcceEeeEEEeccCCeE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLK---SFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~---~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      |++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.++.   .+. ||||+++++++.  ....+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~--~~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQ--TEDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEE--cCCEE
Confidence            7899999999999999999999999999999975432 2334455666766654   444 999999999987  56789


Q ss_pred             EEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        101 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |+||||+.+ +|...+..+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence            999999995 8888888888999999999999999999999999999999999999999999999999998764433334


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      ....+|++.|+|||.+ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..++.
T Consensus       158 ~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----------~~~~~  226 (324)
T cd05589         158 TSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----------RFLSR  226 (324)
T ss_pred             ccccccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------CCCCH
Confidence            4567899999999998 466789999999999999999999999998877766666554322211          34688


Q ss_pred             HHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        260 EAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      .+.+||.+||+.||.+||     ++.++++||||....
T Consensus       227 ~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         227 EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999999999999     799999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-47  Score=370.79  Aligned_cols=261  Identities=23%  Similarity=0.357  Sum_probs=214.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+.++..+. ||||+++++++.  +...+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~--~~~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQ--DKLNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCCeEE
Confidence            479999999999999999999999999999999965432 2334456778999999996 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        102 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      +||||+.| +|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            99999985 8888886 4679999999999999999999999999999999999999999999999999987543210  


Q ss_pred             ---------------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        178 ---------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       178 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                                                       ......+||+.|+|||++. +..++.++|||||||++|+|++|+.||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                             0112457999999999984 567899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCC---CCCCHHHHHhccCCCCcCCC
Q psy14434        225 PGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPS---ERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .+.........+.........      +....+++++.+||.+|+. +|.   .||+++++++||||....+.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~------p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIF------PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccC------CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            988877766666543221100      0012468899999999775 444   46899999999999976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-47  Score=357.03  Aligned_cols=263  Identities=36%  Similarity=0.617  Sum_probs=213.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEec---cCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAV---NNK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~---~~~   98 (404)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+..............+|+.+++.+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            599999999999999999999999999999998654333333344556777776653  499999999998632   245


Q ss_pred             eEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+++||||+.++|..++..   ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            6899999999999888864   3489999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----------  245 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  245 (404)
                      . .......||+.|+|||++. +..++.++|||||||++|+|++|.+||.+......+..+.........          
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             c-ccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            2 2234457899999999984 566899999999999999999999999888777766666554331111          


Q ss_pred             -------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 -------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 -------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                             .........+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   0011112234578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.5e-48  Score=365.08  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.++.+++.||+|++.+.. ...........|+.++..+..||||+++++++.  ....+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999999999999999996543 233455667788899888867999999999987  567899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            85 8888776 456999999999999999999999999999999999999999999999999998764433333455679


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..++.++.+||
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~li  227 (320)
T cd05590         159 TPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----------TWLSQDAVDIL  227 (320)
T ss_pred             CccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 466789999999999999999999999998887776666554322111          34688999999


Q ss_pred             HhccccCCCCCCCH------HHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERPET------DQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rpt~------~~ll~hp~~~~~~~  293 (404)
                      .+||+.||.+||++      ++++.||||....+
T Consensus       228 ~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         228 KAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             HHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99999999999998      99999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-47  Score=366.48  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=218.8

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCC-eEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      .....++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. ........+.+|+.+++.+. ||||+++++++.  
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--  101 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFK--  101 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEE--
Confidence            3446678999999999999999999877654 789999986543 23345566788999999997 999999999987  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      +...+|+||||+. |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            5678999999997 589888864 56999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ...   ....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+         
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p---------  248 (340)
T PTZ00426        182 DTR---TYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP---------  248 (340)
T ss_pred             CCC---cceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC---------
Confidence            432   2456799999999998 456689999999999999999999999998877666666554332211         


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                       ..+++.+.++|++||+.||.+|+     +++++++||||....+
T Consensus       249 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        249 -KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence             34588999999999999999995     8999999999987543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-47  Score=363.80  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=216.5

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+... ..........|+.++..+..|++|+.+++++.  ....+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence            58999999999999999999999999999999975432 33455667889999999975567889999987  4678999


Q ss_pred             EEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+. |+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            999998 588888764 568999999999999999999999999999999999999999999999999987543333334


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..++.+
T Consensus       159 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~  227 (324)
T cd05587         159 RTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----------KSLSKE  227 (324)
T ss_pred             eeecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHH
Confidence            556799999999998 456789999999999999999999999998887776666654322211          346889


Q ss_pred             HHHHHHhccccCCCCCCCH-----HHHHhccCCCCcC
Q psy14434        261 AVDLLNQILVLNPSERPET-----DQILEHNYVSKYF  292 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~  292 (404)
                      +.+||.+||..||.+|++.     .++++||||....
T Consensus       228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         228 AVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999999986     8999999998743

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-47  Score=370.76  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ...+|++++.||+|+||.||+|.+..+++.||+|...        .....+|+.+++.+. ||||++++++|.  .....
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~  158 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAIN-HPSIIQLKGTFT--YNKFT  158 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCC-CCCCCCEeEEEE--ECCee
Confidence            3468999999999999999999999999999999753        234578999999997 999999999987  46779


Q ss_pred             EEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-CC
Q psy14434        101 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-KE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-~~  178 (404)
                      ++|||++.++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus       159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            99999999998887764 56999999999999999999999999999999999999999999999999999754321 22


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHhhCCCCCCc----
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-------TSHQLQLIVNLVRPNPPHA----  247 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~----  247 (404)
                      .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||....       ...++..+....+..+...    
T Consensus       239 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            23456899999999998 45678999999999999999999997764322       2233444443333211100    


Q ss_pred             ---------------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 ---------------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ---------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                           .........++.++.+||.+||+.||.+|||+.++|+||||....
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                                 000011123567899999999999999999999999999998753

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-47  Score=370.05  Aligned_cols=261  Identities=26%  Similarity=0.372  Sum_probs=219.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  +...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~--~~~~~  118 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQ--DDKYL  118 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCCEE
Confidence            4689999999999999999999999999999999965422 2334455678999999996 999999999987  57789


Q ss_pred             EEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        101 YVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      |+||||+. |+|..++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999998 5899999888899999999999999999999999999999999999999999999999999986543221 


Q ss_pred             cccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        179 CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .....+||+.|+|||++.+.   ..++.++|||||||++|+|++|++||.+.+.......+.........      +...
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~  272 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF------PDDI  272 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC------CCcC
Confidence            22356799999999998532   34789999999999999999999999988877666666543221110      1113


Q ss_pred             CCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCc
Q psy14434        256 NKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKY  291 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~  291 (404)
                      .++.++.+||.+||..+|.+  |+|++++++||||...
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            46899999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=363.32  Aligned_cols=247  Identities=27%  Similarity=0.440  Sum_probs=209.9

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      ||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++++. ||||+++++++.  ....+|+||||+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQ--SPEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEe--cCCeEEEEEcCCCC
Confidence            799999999999999999999999996543 23445667788999999996 999999999987  56789999999985


Q ss_pred             -cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccccc
Q psy14434        110 -DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR  187 (404)
Q Consensus       110 -~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~  187 (404)
                       +|.+.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence             8888775 45699999999999999999999999999999999999999999999999999986443333345568999


Q ss_pred             ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHh
Q psy14434        188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ  267 (404)
Q Consensus       188 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  267 (404)
                      .|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......          ...+++.+.+||.+
T Consensus       158 ~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~  226 (312)
T cd05585         158 EYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF----------PDGFDRDAKDLLIG  226 (312)
T ss_pred             ccCCHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC----------CCcCCHHHHHHHHH
Confidence            99999998 46678999999999999999999999998877766555544321111          13568999999999


Q ss_pred             ccccCCCCCC---CHHHHHhccCCCCc
Q psy14434        268 ILVLNPSERP---ETDQILEHNYVSKY  291 (404)
Q Consensus       268 ~L~~dp~~Rp---t~~~ll~hp~~~~~  291 (404)
                      ||..||.+||   ++.+++.||||...
T Consensus       227 ~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         227 LLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            9999999997   57999999999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589|consensus

Probab=100.00  E-value=9.9e-49  Score=368.73  Aligned_cols=259  Identities=30%  Similarity=0.535  Sum_probs=235.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+.|..++.+|+|+||.+++++++.++..|++|.+...............|+.++.+++ |||||.+.+.|.. ++..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~-~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEE-DGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhc-CCceEE
Confidence            56899999999999999999999999999999999888888888888999999999997 9999999999973 344499


Q ss_pred             EEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||+||+| ++.+.+..   ..++++.+..|+.||+.|+.|||+++|+|||||+.|||+++++.|||+|||+|+.+....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999995 89888864   349999999999999999999999999999999999999999999999999999998776


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ....+++|||.||+||++ .+..|+.++|||||||++|||++-+++|.+.+......++........+         ..+
T Consensus       161 ~~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---------~~y  230 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---------SMY  230 (426)
T ss_pred             hhhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---------ccc
Confidence            677889999999999997 7889999999999999999999999999999999988888887743322         456


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      +.+++.+|..||..+|..||++.++|.+|.+....
T Consensus       231 s~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  231 SSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             cHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            89999999999999999999999999999887543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-47  Score=370.33  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=215.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||++++++|.  +...+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQ--DENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCeEE
Confidence            47999999999999999999999999999999996543 22344556778999999997 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+..... 
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999998 488888764 5699999999999999999999999999999999999999999999999999875432110 


Q ss_pred             -------------------------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q psy14434        179 -------------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK  221 (404)
Q Consensus       179 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  221 (404)
                                                           .....+||+.|+|||++ ....++.++|||||||++|+|++|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                 11134699999999998 4667899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC---HHHHHhccCCCCcC
Q psy14434        222 PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE---TDQILEHNYVSKYF  292 (404)
Q Consensus       222 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~hp~~~~~~  292 (404)
                      +||.+.+.......+.........      .....+++++.+||.+||. +|.+|++   +.+++.||||....
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQF------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCC------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            999988776666555543221110      0112468999999999997 9999998   99999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-47  Score=356.22  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=212.1

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.++..+. |+||+++++++.  ....+++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~--~~~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYE--TKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEc--cCCeEEE
Confidence            388999999999999999999999999999998654322 233445678999999996 999999999987  5668999


Q ss_pred             EEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||+. |+|...+..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~  156 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E  156 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence            999998 478777643   35899999999999999999999999999999999999999999999999999875432 2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.........+.........      .....++
T Consensus       157 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~s  229 (285)
T cd05631         157 TVRGRVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE------EYSEKFS  229 (285)
T ss_pred             eecCCCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc------cCCccCC
Confidence            23456799999999998 4667899999999999999999999999876654333333332221111      1114568


Q ss_pred             HHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~  292 (404)
                      .++.+||.+||+.||.+||+     ++++++||||....
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            99999999999999999997     89999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-48  Score=369.95  Aligned_cols=260  Identities=28%  Similarity=0.445  Sum_probs=219.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++..+. ||||+++++++.  +...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQ--DEEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhee--cCCeEE
Confidence            4799999999999999999999999999999999765332 245566778999999997 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      +||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999998 489888875 479999999999999999999999999999999999999999999999999998655432  


Q ss_pred             ---------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q psy14434        178 ---------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS  230 (404)
Q Consensus       178 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  230 (404)
                                                 .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       1233467999999999984 567899999999999999999999999988876


Q ss_pred             HHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC-HHHHHhccCCCCcCC
Q psy14434        231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE-TDQILEHNYVSKYFP  293 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~hp~~~~~~~  293 (404)
                      .....+.........      +....+++++.+||.+||. ||.+||+ +.++++||||....+
T Consensus       237 ~~~~~i~~~~~~~~~------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         237 ETYNKIINWKESLRF------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHHhccCCcccC------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            666665542221110      1112368999999999998 9999999 999999999987644

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0201|consensus

Probab=100.00  E-value=7e-50  Score=367.69  Aligned_cols=255  Identities=29%  Similarity=0.526  Sum_probs=222.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ..|+.++.||+|+||.||+|.+..+++.||||++... ..+.+...+.+|+.+|.++. ++||.++|+.|-  .+..+++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~-~~~it~yygsyl--~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCD-SPNITEYYGSYL--KGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcC-cchHHhhhhhee--ecccHHH
Confidence            4688889999999999999999999999999999654 34456777889999999997 899999999987  5778999


Q ss_pred             EEeccCC-cHHHHHHhcCC-CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMEN-DLNKVIRDKIL-KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l-~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      +||||.| ++.+.++.+.+ .+.++..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+.......
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            9999995 88899987665 999999999999999999999999999999999999999999999999999887766666


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      .+++|||.|||||++. ...|+.++||||||++.+||.+|.+|+........+..|-   ...|+...      ..+++.
T Consensus       169 ~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---k~~PP~L~------~~~S~~  238 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---KSAPPRLD------GDFSPP  238 (467)
T ss_pred             ccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---CCCCCccc------cccCHH
Confidence            8899999999999995 7789999999999999999999999998877743322222   22222211      356899


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +++|+..||.+||+.||+|.+||+|+|++..
T Consensus       239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999999999873

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-47  Score=364.24  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=211.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+.. ..........+|+.+++.+. ||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQ--TKDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCEEEEEEeCC
Confidence            46999999999999999999999999997543 23445667788999999996 999999999987  577899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence            85 7877775 456999999999999999999999999999999999999999999999999998764333333445689


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......          ...+++++.+||
T Consensus       158 t~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------p~~~~~~~~~li  226 (328)
T cd05593         158 TPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF----------PRTLSADAKSLL  226 (328)
T ss_pred             CcCccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC----------CCCCCHHHHHHH
Confidence            9999999998 45678999999999999999999999998877665554443221111          135689999999


Q ss_pred             HhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      .+||..||.+|+     ++.++++||||....
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         227 SGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             HHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999997     899999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-47  Score=362.81  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=211.7

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+|..||+|++..... .........+|+.+++.+. ||||++++++|.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCEEEEEEeCC
Confidence            469999999999999999999999999975432 3345566778999999996 999999999987  567899999999


Q ss_pred             CC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence            85 78877764 56999999999999999999999999999999999999999999999999998764333333445679


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..+++++.+||
T Consensus       158 t~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----------~~~~~~~~~li  226 (323)
T cd05595         158 TPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----------RTLSPEAKSLL  226 (323)
T ss_pred             CcCcCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 456789999999999999999999999988777666555543221111          35689999999


Q ss_pred             HhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      .+||..||.+|+     ++.++++||||....
T Consensus       227 ~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         227 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             HHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999998     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=359.70  Aligned_cols=306  Identities=41%  Similarity=0.724  Sum_probs=238.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---c
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---N   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---~   96 (404)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++... ..........+|+.+++++. ||||+++++++...   .
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            3567999999999999999999999999999999998532 22344566778999999997 99999999987532   2


Q ss_pred             CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         97 NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ...+|+||||+.++|...+..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          80 FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             cceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            24689999999999999998888999999999999999999999999999999999999999999999999998765432


Q ss_pred             CC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------
Q psy14434        177 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------  245 (404)
Q Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  245 (404)
                      ..   ......||+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.........        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            11   2234578999999998755567899999999999999999999999887766555544443332111        


Q ss_pred             -------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCC
Q psy14434        246 -------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDID  312 (404)
Q Consensus       246 -------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (404)
                                   ....+....+..+.++.+||.+||+.+|.+|||+.+++.||||..+..+..   .+..+.....+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~---~~~~~~~~~~~~~  316 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD---EPVAEEPFPFDFE  316 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC---cccCCCCCChhhc
Confidence                         001111123456788999999999999999999999999999998876533   2222223344444


Q ss_pred             CCCcCCHHHHHHHHHHHH
Q psy14434        313 DNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~  330 (404)
                      .-.....+.+++.+...+
T Consensus       317 ~~~~~~~~~~~~~~~~~~  334 (336)
T cd07849         317 LFDDLPKEKLKELIFEEI  334 (336)
T ss_pred             cccccCHHHHHHHHHHHh
Confidence            445555556666655443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.4e-47  Score=367.56  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=217.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  ++..
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--~~~~  117 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQ--DDKY  117 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCE
Confidence            34689999999999999999999999999999999865322 2334455678888888886 999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|+||||+. |+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999998 5899999888899999999999999999999999999999999999999999999999999987643222


Q ss_pred             -cccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        179 -CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                       .....+||+.|+|||++.+.   ..++.++|||||||++|+|++|..||.+.+.......+.........      +..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------p~~  271 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF------PED  271 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC------CCc
Confidence             22456799999999998532   24789999999999999999999999988877666666543321110      011


Q ss_pred             CCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~  291 (404)
                      ..++..+.++|.+||..++.+  |+|+.++++||||...
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            346889999999999866654  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-47  Score=362.59  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=213.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.++.+++.||+|++.+... ..........|..++..+.+||||++++++|.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence            469999999999999999999999999965432 33445567788888888767999999999987  567899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            85 8887775 456999999999999999999999999999999999999999999999999999765433344455679


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..++.++.+||
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~~~~~~~ll  227 (321)
T cd05591         159 TPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----------VWLSKEAVSIL  227 (321)
T ss_pred             CccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 466789999999999999999999999998887777666654322211          23588999999


Q ss_pred             HhccccCCCCCC-------CHHHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERP-------ETDQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rp-------t~~~ll~hp~~~~~~  292 (404)
                      .+||+.||.+||       ++.++++||||....
T Consensus       228 ~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             HHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            999999999999       999999999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-46  Score=354.67  Aligned_cols=268  Identities=32%  Similarity=0.615  Sum_probs=221.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      -.++|++.+.||.|+||.||+|.+..+++.||+|.+..... ........+|+.+++.+. ||||+++++++.  ....+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~--~~~~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcC-CCCcceEEEEEe--cCCeE
Confidence            46789999999999999999999999999999999854322 223345668999999997 999999999987  56789


Q ss_pred             EEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.++|...+..  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999999999888764  4589999999999999999999999999999999999999999999999999976544333


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-cch--------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADK--------  249 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~--------  249 (404)
                      ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.......... ...        
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            33445689999999998666668899999999999999999999999888777766665544322110 000        


Q ss_pred             -----------hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        250 -----------FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       250 -----------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                 .......+++.+.+||.+||+.||.+|||+.++|+||||..+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                       0011135688999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-46  Score=361.69  Aligned_cols=303  Identities=36%  Similarity=0.668  Sum_probs=238.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---   95 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+..........+.+|+.+++.+. ||||++++++|...   
T Consensus        12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence            35778999999999999999999999999999999998766555566677889999999996 99999999998632   


Q ss_pred             -cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       +....|+||||+.++|...+... +++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~~~lv~e~~~~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          91 EEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cccCcEEEEEeccCCCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             22467999999999998888755 9999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc-------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA-------  247 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  247 (404)
                      .. .......+++.|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+.......+....+..+...       
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TS-FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CC-CCCCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            42 223445689999999998 466789999999999999999999999988877666655554433221100       


Q ss_pred             -------------chhhcc-------------cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCC
Q psy14434        248 -------------DKFYAG-------------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQ  301 (404)
Q Consensus       248 -------------~~~~~~-------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~  301 (404)
                                   ..+...             ....+..+.+||.+||+.||.+|||+.++|.||||..++.......|.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~  327 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPP  327 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCC
Confidence                         000000             112456789999999999999999999999999999888765543333


Q ss_pred             CCCCcccccCCCCCcCCHHHHHHHHHH
Q psy14434        302 VTPHTVVLDIDDNNQLEINDYQDKLYD  328 (404)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (404)
                      ..+..  -.. +......++|.+.++.
T Consensus       328 ~~~~~--~~~-~~~~~~~~~~~~~~~~  351 (353)
T cd07850         328 PAPYD--HSI-DEREHTVEEWKELIYK  351 (353)
T ss_pred             CCccc--ccc-ccccccHHHHHHHHHh
Confidence            22211  111 2335556667665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.2e-47  Score=360.89  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=217.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+..|++|+.+++++.  ....+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence            58999999999999999999999999999999975432 23344556778888888877899999999987  4678999


Q ss_pred             EEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+. |+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            999998 588877764 569999999999999999999999999999999999999999999999999997644333334


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..++.+
T Consensus       159 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s~~  227 (323)
T cd05616         159 KTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------KSMSKE  227 (323)
T ss_pred             ccCCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------CcCCHH
Confidence            556799999999998 466789999999999999999999999998887776666654332211          346899


Q ss_pred             HHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        261 AVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      +.+|+.+||+.||.+|++     ..+++.||||....+
T Consensus       228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         228 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999999998     489999999986543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.4e-47  Score=368.10  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=212.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.+. ||||+++++++.  +...+|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~--~~~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEe--cCCEEEE
Confidence            6999999999999999999999999999999996543 33445667889999999996 999999999987  5678999


Q ss_pred             EEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC---
Q psy14434        103 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK---  177 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~---  177 (404)
                      ||||+.| +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++.......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999984 88888864 569999999999999999999999999999999999999999999999999975331100   


Q ss_pred             --------------------------------------------CcccccccccccccccccccCCCCCchhhHHHHHHH
Q psy14434        178 --------------------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI  213 (404)
Q Consensus       178 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  213 (404)
                                                                  ......+||+.|+|||++. +..++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhH
Confidence                                                        0112357999999999984 5678999999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhcccc--CCCCCCCHHHHHhccCCCCc
Q psy14434        214 LAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVL--NPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       214 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +|+|++|..||...+.......+.........      .....+++++.+||.+|+..  +|..|+++.+++.||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHI------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCC------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999999887766555544432211110      11135689999999996654  55559999999999999876


Q ss_pred             CC
Q psy14434        292 FP  293 (404)
Q Consensus       292 ~~  293 (404)
                      .+
T Consensus       312 ~~  313 (381)
T cd05626         312 DF  313 (381)
T ss_pred             Ch
Confidence            44

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0666|consensus

Probab=100.00  E-value=1.3e-48  Score=344.37  Aligned_cols=270  Identities=37%  Similarity=0.683  Sum_probs=225.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      +....|++++.||+|.||.||+|..+.++.    .+|||++.-............||+.+++.++ |||++.+..+|-. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~-   98 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLS-   98 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhc-
Confidence            455689999999999999999997766543    6899999655444455667789999999997 9999999999864 


Q ss_pred             cCCeEEEEEeccCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC----CceEEe
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIG  165 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~----~~vkl~  165 (404)
                      .+..+++++||.+-+|..+|+-      +.++...++.|++||+.|+.|||++-|+||||||.||||..+    |.|||+
T Consensus        99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            3788999999999999999962      348999999999999999999999999999999999999888    899999


Q ss_pred             ccccccccCCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------cHHHH
Q psy14434        166 DLGLARSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---------TSHQL  233 (404)
Q Consensus       166 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---------~~~~~  233 (404)
                      |||+++.+.+.-.   .....+.|.||+|||.+++...|+.+.|||+.|||+.||++-.+.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9999998765422   23456889999999999999999999999999999999999999997643         34677


Q ss_pred             HHHHHhhCCCCCC---------------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        234 QLIVNLVRPNPPH---------------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       234 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      ..|.+.++.....                           ...++.....-++.+.+||.+||.+||.+|+|++++|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            7888877633221                           1111222233456699999999999999999999999999


Q ss_pred             CCCCc
Q psy14434        287 YVSKY  291 (404)
Q Consensus       287 ~~~~~  291 (404)
                      ||..-
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            99864

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-46  Score=351.05  Aligned_cols=262  Identities=37%  Similarity=0.681  Sum_probs=215.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|++|.||+|.+..++..||+|.+............+.+|+.+++.+. ||||+++++++.  ++..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLM--QESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEe--eCCeEEEE
Confidence            589999999999999999999999999999998655444444567788999999997 999999999987  46789999


Q ss_pred             EeccCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+.++|.+++..    +.+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++.........
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          78 FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             EecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            99999988888753    45899999999999999999999999999999999999999999999999999765443333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------------  245 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  245 (404)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.........+.........              
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            334467899999999865566789999999999999999999999887665544443332221100              


Q ss_pred             -----CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 -----HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 -----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ...........+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                 0011112234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.7e-47  Score=359.34  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.++.+|+.||+|++.+... ..........|..++..+.+||||+++++++.  +...+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence            469999999999999999999999999975432 23345566778888887767999999999987  567899999999


Q ss_pred             CC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            85 88877764 56999999999999999999999999999999999999999999999999998754333334456789


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..++.++.+||
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~li  227 (316)
T cd05620         159 TPDYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----------RWITKESKDIL  227 (316)
T ss_pred             CcCccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 466789999999999999999999999988777665555433221111          23588999999


Q ss_pred             HhccccCCCCCCCH-HHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERPET-DQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rpt~-~~ll~hp~~~~~~  292 (404)
                      .+||+.||.+||++ +++++||||....
T Consensus       228 ~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         228 EKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            99999999999998 5888999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-47  Score=362.02  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=209.9

Q ss_pred             CeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +|++.+.||+|+||.||+|.+.   .+++.||+|++.+...  ..........|+.+++.+..||||+++++++.  ...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence            5899999999999999999874   5789999999865422  23345567789999999977999999999987  567


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            89999999985 8888775 456999999999999999999999999999999999999999999999999999765332


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh-CCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  254 (404)
                      . ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.... ...+.       ..
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~  231 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-------FP  231 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-------CC
Confidence            2 223356799999999998554567899999999999999999999997543221111121111 11111       11


Q ss_pred             CCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      ..++..+.+||.+||..||.+||     +++++++||||....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            34688999999999999999999     889999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-47  Score=368.60  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.+. ||||++++++|.  +...+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQ--DAQYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCeeE
Confidence            479999999999999999999999999999999865422 3344566778999999996 999999999987  567899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +||||+. |+|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999997 589888764 5689999999999999999999999999999999999999999999999999863211000 


Q ss_pred             ----------------------------------------------cccccccccccccccccccCCCCCchhhHHHHHH
Q psy14434        179 ----------------------------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGC  212 (404)
Q Consensus       179 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  212 (404)
                                                                    .....+||+.|+|||++ .+..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEecch
Confidence                                                          00125799999999998 4667899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCC---CCHHHHHhccCCC
Q psy14434        213 ILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER---PETDQILEHNYVS  289 (404)
Q Consensus       213 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~~ll~hp~~~  289 (404)
                      ++|+|++|.+||.+.+....+..+.........      +....++.++.+||.+||. +|.+|   +++.+++.||||.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYF------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999999999999887776666655543221110      1113468899999999998 66665   6999999999998


Q ss_pred             CcC
Q psy14434        290 KYF  292 (404)
Q Consensus       290 ~~~  292 (404)
                      ...
T Consensus       310 ~~~  312 (377)
T cd05629         310 GVD  312 (377)
T ss_pred             CCC
Confidence            754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-47  Score=368.71  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=212.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||++++++|.  +...+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~--~~~~~~   77 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQ--DKDNLY   77 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEE--eCCEEE
Confidence            369999999999999999999999999999999965432 2344566778999999996 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC---
Q psy14434        102 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---  176 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~---  176 (404)
                      +|||||.+ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+...   
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999985 88888764 56899999999999999999999999999999999999999999999999997532100   


Q ss_pred             --------------------------------------------CCcccccccccccccccccccCCCCCchhhHHHHHH
Q psy14434        177 --------------------------------------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGC  212 (404)
Q Consensus       177 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  212 (404)
                                                                  .......+||+.|+|||++ .+..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEechH
Confidence                                                        0001235799999999998 4567899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC---HHHHHhccCCC
Q psy14434        213 ILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE---TDQILEHNYVS  289 (404)
Q Consensus       213 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~hp~~~  289 (404)
                      ++|+|++|.+||.+.+.......+.........      +....+++++.+||.+|+ .+|.+|++   +++++.||||.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  309 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK  309 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence            999999999999887766555554432221111      111356899999999986 59999997   99999999998


Q ss_pred             CcCC
Q psy14434        290 KYFP  293 (404)
Q Consensus       290 ~~~~  293 (404)
                      ...+
T Consensus       310 ~~~~  313 (382)
T cd05625         310 TIDF  313 (382)
T ss_pred             CcCh
Confidence            7543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.1e-47  Score=358.96  Aligned_cols=252  Identities=28%  Similarity=0.421  Sum_probs=212.5

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+.. ..........+|+.+++.+..||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999999999999999997553 233445667788899988867999999999987  567899999999


Q ss_pred             CC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            84 88877764 47999999999999999999999999999999999999999999999999998754333333445679


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|+|||||++|+|++|..||.+.+.......+.......+          ..++..+.+||
T Consensus       159 ~~~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~li  227 (318)
T cd05570         159 TPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----------RWLSKEAKSIL  227 (318)
T ss_pred             CccccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----------CcCCHHHHHHH
Confidence            9999999998 466789999999999999999999999988877666555543221111          34688999999


Q ss_pred             HhccccCCCCCCCH-----HHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERPET-----DQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~~  293 (404)
                      .+||..||.+||++     .+++.||||....+
T Consensus       228 ~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             HHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999999     99999999987543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.9e-47  Score=357.94  Aligned_cols=256  Identities=33%  Similarity=0.620  Sum_probs=200.5

Q ss_pred             eeeecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         28 HKRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      .+.||+|+||.||+|.++  .+++.||+|.+....    ......+|+.+++.+. ||||++++++|.......+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEe
Confidence            467999999999999976  467889999985432    2334678999999997 999999999987656778999999


Q ss_pred             ccCCcHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----ccCCceEEecccccc
Q psy14434        106 YMENDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLAR  171 (404)
Q Consensus       106 ~~~~~L~~~l~~----------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----~~~~~vkl~Dfg~a~  171 (404)
                      |+.++|..++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            999998887752          148899999999999999999999999999999999999    456789999999998


Q ss_pred             ccCCCC---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHh
Q psy14434        172 SLSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVNL  239 (404)
Q Consensus       172 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~  239 (404)
                      ......   ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+...         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322   1234567899999999986656789999999999999999999999975432         2333333333


Q ss_pred             hCCCCCCcc----------------------------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        240 VRPNPPHAD----------------------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       240 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+.......                            .........+..+.+||.+||+.||.+|||++++|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            221111000                            0000011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-46  Score=359.44  Aligned_cols=305  Identities=41%  Similarity=0.768  Sum_probs=239.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      .+..+|.+.+.||.|+||.||+|.+..+++.||||.+..............+|+.+++.+. ||||+++++++....   
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            4567899999999999999999999999999999998765445555667788999999996 999999999876322   


Q ss_pred             CCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         97 NKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ...+|+||||+.++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            245899999999999888864 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------  246 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------  246 (404)
                      .........++..|+|||.+.....++.++|+|||||++|+|++|.+||.+.+.......+....+.....         
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            33334456789999999998555568999999999999999999999998877665555554443321110         


Q ss_pred             ------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCC
Q psy14434        247 ------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDN  314 (404)
Q Consensus       247 ------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (404)
                                  ...+....+.+++.+.+||.+||+.+|.+|||+.++++||||.........   ++.+..+..++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~---~~~~~~~~~~~~~~  317 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE---PVCQTPFSFDFEED  317 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC---ccCCCccchhhhhh
Confidence                        011112235678999999999999999999999999999999987555442   22223334444433


Q ss_pred             CcCCHHHHHHHHHHH
Q psy14434        315 NQLEINDYQDKLYDI  329 (404)
Q Consensus       315 ~~~~~~~~~~~~~~~  329 (404)
                      . ....+..+.++..
T Consensus       318 ~-~~~~~~~~~~~~~  331 (337)
T cd07858         318 A-LTEEDIKELIYNE  331 (337)
T ss_pred             h-cCHHHHHHHHHHH
Confidence            3 4445555555544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.4e-47  Score=358.43  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=209.3

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++..... ..........|..++..+..||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            469999999999999999999999999975432 23345556677777777667999999999987  567899999999


Q ss_pred             C-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      . |+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            8 488888764 56999999999999999999999999999999999999999999999999999865443344455689


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..++.++.+||
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~ll  227 (316)
T cd05592         159 TPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----------RWISKEAKDCL  227 (316)
T ss_pred             CccccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHHHHHHH
Confidence            9999999998 456689999999999999999999999998877666555543221111          34688999999


Q ss_pred             HhccccCCCCCCCH-HHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERPET-DQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rpt~-~~ll~hp~~~~~~  292 (404)
                      .+||+.||.+||++ .+++.||||....
T Consensus       228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         228 SKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             HHHccCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999999986 4888999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.9e-47  Score=359.84  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=205.9

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|..++..+.+||||++++++|.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence            4699999999999999999999999999765432 3445667789999999977999999999987  567899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++............+|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            85 8887775 467999999999999999999999999999999999999999999999999998754333333456789


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------cHH-HHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS--------TSH-QLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      |+.|+|||++ .+..++.++|+|||||++|+|++|+.||....        ... ..+.+......          ....
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~p~~  227 (329)
T cd05588         159 TPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------IPRS  227 (329)
T ss_pred             CccccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------CCCC
Confidence            9999999998 46678999999999999999999999996321        111 11112111111          1134


Q ss_pred             CCHHHHHHHHhccccCCCCCCC------HHHHHhccCCCCcC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPE------TDQILEHNYVSKYF  292 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt------~~~ll~hp~~~~~~  292 (404)
                      ++..+.+||.+||..||.+|++      +.++++||||....
T Consensus       228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            6889999999999999999987      78999999997643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-46  Score=362.28  Aligned_cols=262  Identities=27%  Similarity=0.472  Sum_probs=210.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+. |+||+++++++.  ....
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~  146 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVN-HPNVVKCHDMFD--HNGE  146 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCC-CCCcceeeeEec--cCCe
Confidence            34678999999999999999999999999999999985432 3344567789999999997 999999999986  5778


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|+||||+.+ +|..   .....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       147 ~~lv~e~~~~~~L~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        147 IQVLLEFMDGGSLEG---THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEEecCCCCcccc---cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999999995 5643   23367788899999999999999999999999999999999999999999999987654333


Q ss_pred             ccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        179 CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ......||..|+|||.+..    +...+.++|||||||++|+|++|+.||...........+..........      ..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~  297 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE------AP  297 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC------CC
Confidence            3345679999999998732    2345678999999999999999999997544332222222221111110      11


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      ..++.++.+||.+||..||++|||+.++++||||.+....
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            3568899999999999999999999999999999986544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-46  Score=353.45  Aligned_cols=272  Identities=35%  Similarity=0.637  Sum_probs=224.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +.+++|++.+.||.|+||.||+|.+..+|+.||+|.+..............+|+.+++++. |+||+++++++.......
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCe
Confidence            4567899999999999999999999999999999998644333333344568999999997 999999999987545567


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+.++|..++..  ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            899999999998888874  568999999999999999999999999999999999999999999999999998765443


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc----------
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA----------  247 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  247 (404)
                      .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+..+....+......          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            3334445688999999986556789999999999999999999999999888887777766543211100          


Q ss_pred             ----------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 ----------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                ..+...+...++.+.+||.+||+.||++|||+.+++.||||.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                      011111233588999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.8e-47  Score=368.69  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=211.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||+++++.|.  ++..+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCEEE
Confidence            479999999999999999999999999999999865422 2234556778999999996 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC---
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---  176 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~---  176 (404)
                      +||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...   
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999998 589888864 56899999999999999999999999999999999999999999999999997532100   


Q ss_pred             ----------------------------------------CCcccccccccccccccccccCCCCCchhhHHHHHHHHHH
Q psy14434        177 ----------------------------------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAE  216 (404)
Q Consensus       177 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~  216 (404)
                                                              .......+||+.|+|||++ .+..++.++|||||||++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeee
Confidence                                                    0001235799999999998 46678999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCC---CHHHHHhccCCCCc
Q psy14434        217 MLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEHNYVSKY  291 (404)
Q Consensus       217 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~hp~~~~~  291 (404)
                      |++|+.||.+.........+.........      .....+++++.+||.+|+ .+|.+|+   ++.++++||||...
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHI------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccC------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999999888766555544332211110      112356899999999976 5999999   99999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.2e-47  Score=361.97  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=217.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.  +...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~--~~~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQ--DKDNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCeEE
Confidence            479999999999999999999999999999999976543 2334555678888888885 999999999987  567899


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||++ ++|.+++..  +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999997 589998875  4699999999999999999999999999999999999999999999999999987654322


Q ss_pred             -ccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        179 -CLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                       ......||+.|+|||++..     ...++.++|||||||++|+|++|..||.+......+..+.........      +
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------~  231 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF------P  231 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC------C
Confidence             2233579999999999842     456789999999999999999999999888777666665543221100      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ....+++.+.+||.+||. +|.+|||+.+++.||||....+
T Consensus       232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence            113568999999999998 9999999999999999987543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.1e-47  Score=362.07  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=211.1

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+|+.||+|++.+... .........+|+.+++.+. ||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~--~~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--THDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--cCCEEEEEEeCC
Confidence            469999999999999999999999999975432 3344566778999999996 999999999987  567899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      .+ +|...+. .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++.............+
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence            85 7877776 4569999999999999999999997 8999999999999999999999999999876443333345567


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..+++++.+|
T Consensus       158 gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~~~~~~~l  226 (325)
T cd05594         158 GTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----------RTLSPEAKSL  226 (325)
T ss_pred             CCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----------CCCCHHHHHH
Confidence            99999999998 466789999999999999999999999988777655555433221111          3468899999


Q ss_pred             HHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        265 LNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       265 i~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      |.+||+.||.+|+     ++.++++||||....+
T Consensus       227 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         227 LSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             HHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999997     9999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-46  Score=356.54  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=216.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.+... ..........|+.++..+..|++|+++++++.  ....+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEE
Confidence            47889999999999999999999999999999975432 33445567788889988876788999999987  4668999


Q ss_pred             EEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+. |+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            999998 588888865 569999999999999999999999999999999999999999999999999997654333334


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+          ..++.+
T Consensus       159 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----------~~~~~~  227 (323)
T cd05615         159 RTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----------KSLSKE  227 (323)
T ss_pred             cCccCCccccCHHHH-cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------ccCCHH
Confidence            456799999999998 456789999999999999999999999998877766666654322211          346889


Q ss_pred             HHHHHHhccccCCCCCCC-----HHHHHhccCCCCcC
Q psy14434        261 AVDLLNQILVLNPSERPE-----TDQILEHNYVSKYF  292 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~  292 (404)
                      +.+++.+||+.+|.+|++     ..++++||||....
T Consensus       228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         228 AVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            999999999999999997     57899999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-46  Score=362.92  Aligned_cols=262  Identities=25%  Similarity=0.379  Sum_probs=217.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.+. ||||+++++++.  +...
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--~~~~  117 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ--DDRY  117 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--cCCE
Confidence            3478999999999999999999999999999999986532 22334455678888888886 999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        100 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      +|+||||++ |+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999998 589999988889999999999999999999999999999999999999999999999999998764322 


Q ss_pred             CcccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 ECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ......+||+.|+|||++...   ..++.++|||||||++|+|++|..||.+.+.......+.........      +..
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~  271 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF------PDD  271 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC------CCc
Confidence            122456799999999998532   23789999999999999999999999988877666666543321111      112


Q ss_pred             CCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~  291 (404)
                      ..++..+.+||.+||..++.+  |+++.++++||||...
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            457899999999999854443  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0604|consensus

Probab=100.00  E-value=1.2e-47  Score=336.67  Aligned_cols=258  Identities=28%  Similarity=0.507  Sum_probs=220.1

Q ss_pred             cccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--cc
Q psy14434         20 NILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--VN   96 (404)
Q Consensus        20 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~~   96 (404)
                      .+.++|++. +.||-|-.|.|..+.++.||+.+|+|++.       +..+..+|+..-....+|||||.++++|+.  ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            477889986 67999999999999999999999999983       445566888888888889999999999972  24


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEecccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGL  169 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg~  169 (404)
                      ...+.+|||.|+| .|...+++   ..++|.++..|+.||..|+.|||+.+|.||||||+|+|.+.   +..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            5678899999996 78888874   34999999999999999999999999999999999999965   45799999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHhhCCCCC
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS----TSHQLQLIVNLVRPNPP  245 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~  245 (404)
                      |+..... ..+.+.|-||.|.|||++ +...|+...|+||+||++|.|++|.+||....    ......+|..+...++.
T Consensus       211 AK~t~~~-~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  211 AKETQEP-GDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             ccccCCC-ccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            9876543 445677899999999997 77889999999999999999999999997643    23445566666555554


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                            ..|..+|+.+.|+|+++|..+|.+|.|+.+++.|||+++..
T Consensus       289 ------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  289 ------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                  33577899999999999999999999999999999998754

>KOG0665|consensus

Probab=100.00  E-value=8.3e-48  Score=340.92  Aligned_cols=308  Identities=34%  Similarity=0.621  Sum_probs=257.5

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--   94 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--   94 (404)
                      ..+++..+|.-++.+|.|.- .|..|.|..++++||+|++..++.+.....+..+|..++..+. |+||++++.+|..  
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK   88 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence            56788899999999999998 9999999999999999999888888899999999999999997 9999999999952  


Q ss_pred             --ccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 --VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 --~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                        .....+|+|||+|..+|...+. -.+..+.+.++++|+++|++|||+.||+||||||+||+++.++.+||.|||+++.
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence              1235689999999999998888 3488899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC-CCCc----
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPHA----  247 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~----  247 (404)
                      .... ...+.++.|..|+|||++.+.+ |...+||||+||++.||++|+..|+|.+.-++..++.+.++.. +...    
T Consensus       168 e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            6554 5678899999999999997655 9999999999999999999999999999999988888877632 2200    


Q ss_pred             ---------------chhhcccCC------------CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCC
Q psy14434        248 ---------------DKFYAGFKN------------KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP  300 (404)
Q Consensus       248 ---------------~~~~~~~~~------------~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~  300 (404)
                                     ..+...+++            -+..+++|+.+||..||++|.+++++|.|||++-|+.+...  +
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev--~  323 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV--E  323 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc--c
Confidence                           111111111            23468999999999999999999999999999976555443  2


Q ss_pred             CCCCCcccccCCCCCcCCHHHHHHHHHHHHHh
Q psy14434        301 QVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS  332 (404)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (404)
                      .+.|. .-....+..+.+.++|++++++++..
T Consensus       324 ap~pe-~~d~~~d~~~~t~~e~ke~If~ev~~  354 (369)
T KOG0665|consen  324 APPPE-IYDKQLDEREHTIEEWKELIFKEVQR  354 (369)
T ss_pred             CCCCc-hhhhhcccccCCHHHHHHHHHHHHHh
Confidence            22232 22233445566799999999998843

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-46  Score=350.46  Aligned_cols=262  Identities=34%  Similarity=0.646  Sum_probs=214.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++++. ||||+++++++.  +...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLH--SDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhc--cCCceEEE
Confidence            589999999999999999999999999999998654333333455678999999996 999999999987  56789999


Q ss_pred             EeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        104 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       104 ~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      +||++++|...+.  .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            9999999888775  35689999999999999999999999999999999999999999999999999986654433334


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCC---------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPP---------------  245 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~---------------  245 (404)
                      ...+++.|+|||.+.+...++.++|||||||++|+|++|..| |.+.+....+..+.........               
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            456889999999986556679999999999999999998877 5555555555555443321111               


Q ss_pred             ----CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 ----HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 ----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                          ....+....+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                0111122234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-46  Score=372.98  Aligned_cols=266  Identities=26%  Similarity=0.467  Sum_probs=209.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc-----CCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~l~~~~~~~~   96 (404)
                      .++|++++.||+|+||+||+|.+..+++.||||++....   ........|+.+++.+.     .|.+++.++++|.. +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-C
Confidence            468999999999999999999999999999999985321   12233445666666654     24568899998864 4


Q ss_pred             CCeEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCC--------------
Q psy14434         97 NKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSC--------------  160 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~--------------  160 (404)
                      ...+|+|||+++++|.+++. .+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++              
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            56799999999988888775 4579999999999999999999998 5999999999999998765              


Q ss_pred             --ceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q psy14434        161 --SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       161 --~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  238 (404)
                        .+||+|||.+....   ......+||+.|+|||++. +..++.++|||||||++|||++|++||.+.+....+..+..
T Consensus       284 ~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        284 PCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CceEEECCCCccccCc---cccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              49999999886432   2234568999999999984 66789999999999999999999999998887777666655


Q ss_pred             hhCCCCCCcch---------hhcc---------------------c--CCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        239 LVRPNPPHADK---------FYAG---------------------F--KNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       239 ~~~~~~~~~~~---------~~~~---------------------~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      ..+..+.....         +...                     .  ...++.+.|||.+||++||.+|||+.++|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            54432211000         0000                     0  00145678999999999999999999999999


Q ss_pred             CCCCcCCCC
Q psy14434        287 YVSKYFPSA  295 (404)
Q Consensus       287 ~~~~~~~~~  295 (404)
                      ||..+++..
T Consensus       440 ~~~~~~~~~  448 (467)
T PTZ00284        440 YVLKYYPEC  448 (467)
T ss_pred             cccccCCcc
Confidence            999876644

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-46  Score=354.83  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=209.8

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++..... ..........|..++.....||||+++++++.  +...+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence            469999999999999999999999999976532 23344556678888877656999999999987  467899999999


Q ss_pred             C-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      . |+|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            8 589888875 56899999999999999999999999999999999999999999999999998754333333455679


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.... +..+         ..++.++.+||
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~---------~~~~~~~~~li  227 (316)
T cd05619         159 TPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYP---------RWLTREAKDIL  227 (316)
T ss_pred             CccccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC---------ccCCHHHHHHH
Confidence            9999999998 45678999999999999999999999998877666555543221 1111         23578999999


Q ss_pred             HhccccCCCCCCCHH-HHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERPETD-QILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rpt~~-~ll~hp~~~~~~~  293 (404)
                      .+||+.||.+||++. +++.||||....+
T Consensus       228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         228 VKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             HHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            999999999999996 8999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-46  Score=356.44  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=210.0

Q ss_pred             eeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         28 HKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++.||+|+||.||+|.+.   .+++.||+|++.+...  ..........|+.+++.+. ||||++++++|.  .+..+|+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~l   77 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQ--TGGKLYL   77 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEe--cCCeEEE
Confidence            368999999999999874   4688999999965422  2334456678999999997 999999999987  5678999


Q ss_pred             EEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+.+ +|...+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence            9999985 8888876 4568999999999999999999999999999999999999999999999999987544333334


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..+++.
T Consensus       158 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~  226 (323)
T cd05584         158 HTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----------PYLTPE  226 (323)
T ss_pred             cccCCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHH
Confidence            456799999999998 456688999999999999999999999988877666655544322211          345889


Q ss_pred             HHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        261 AVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      +.+||.+||..||.+||     ++.+++.||||....
T Consensus       227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999999999999     899999999998643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.5e-47  Score=364.10  Aligned_cols=261  Identities=23%  Similarity=0.371  Sum_probs=214.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.++..+. ||+|+++++.+.  +...+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~--~~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQ--DKRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCEEE
Confidence            47999999999999999999999999999999996543 23344566778999999996 999999999987  577899


Q ss_pred             EEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        102 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      +||||+.| +|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999985 8988886 4569999999999999999999999999999999999999999999999999987542210  


Q ss_pred             ---------------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        178 ---------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       178 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                                                       ......+||+.|+|||++ .+..++.++|||||||++|+|++|++||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCCCC
Confidence                                             011245799999999998 4667899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCC---CHHHHHhccCCCCcCCC
Q psy14434        225 PGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEHNYVSKYFPS  294 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~hp~~~~~~~~  294 (404)
                      .+.........+.........      +....+++++.+||.+|+. ||.+|+   ++.++++||||.+..+.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~------p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVF------PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceec------CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            888777666665542211100      0012368899999999874 999998   48999999999986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-46  Score=348.68  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      ||+|+||+||+|.+..+++.||+|++.+.... ......+..|+.+++.+. ||||+++++++.  ....+|+||||+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQ--TKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEc--CCCeEEEEEeCCCC
Confidence            79999999999999999999999998654322 233456678999999996 999999999987  56779999999984


Q ss_pred             -cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccc
Q psy14434        110 -DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY  183 (404)
Q Consensus       110 -~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~  183 (404)
                       +|...+.     ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.............
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence             8877663     2458999999999999999999999999999999999999999999999999998765544444456


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHH
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      .||+.|+|||++. +..++.++|+|||||++|+|++|+.||...........+.......+.      .....++..+.+
T Consensus       158 ~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~  230 (280)
T cd05608         158 AGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------TYPDKFSPASKS  230 (280)
T ss_pred             CCCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC------CCcccCCHHHHH
Confidence            7999999999984 567889999999999999999999999875543222222222211111      111356899999


Q ss_pred             HHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        264 LLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       264 li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      ++.+||+.||.+||     +++++++||||+...+
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            99999999999999     8899999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-46  Score=357.26  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=208.2

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHH-HhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFL-KSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l-~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||+||+|.+..+|+.||+|++.+... .......+..|...+ +.+. ||||+++++++.  +...+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~--~~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQ--TADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEE--eCCEEEEEEcC
Confidence            469999999999999999999999999965432 233445566666654 5564 999999999987  56789999999


Q ss_pred             cCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      +.+ +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence            985 88877764 5699999999999999999999999999999999999999999999999999876443333445567


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......          .+.++..+.+|
T Consensus       158 gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------~~~~~~~~~~l  226 (323)
T cd05575         158 GTPEYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----------KPNISVSARHL  226 (323)
T ss_pred             CChhhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----------CCCCCHHHHHH
Confidence            99999999998 46678999999999999999999999998887766655554332111          14568999999


Q ss_pred             HHhccccCCCCCCCH----HHHHhccCCCCcCC
Q psy14434        265 LNQILVLNPSERPET----DQILEHNYVSKYFP  293 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~----~~ll~hp~~~~~~~  293 (404)
                      |.+||+.||.+||++    .++++||||....+
T Consensus       227 i~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             HHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999999999987    69999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0192|consensus

Probab=100.00  E-value=2.1e-46  Score=354.52  Aligned_cols=250  Identities=30%  Similarity=0.478  Sum_probs=210.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC-eE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK-DL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~-~~  100 (404)
                      .....+.+.||+|+||+||++....+.. ||+|++.....+......+.+|+.+|.+++ |||||+++|++..  .. .+
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~--~~~~~  115 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTS--PPGSL  115 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC--CCCce
Confidence            4456677779999999999998764322 999999776655555888999999999997 9999999999863  33 69


Q ss_pred             EEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCcEEEccCC-ceEEeccccccccC
Q psy14434        101 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSNILIDKSC-SIKIGDLGLARSLS  174 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~-i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~  174 (404)
                      +|||||++ |+|..++..   +.++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            99999999 689999965   57999999999999999999999999 99999999999999998 99999999998766


Q ss_pred             CCCCccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HhhCCCCCCcchhhc
Q psy14434        175 DSKECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV-NLVRPNPPHADKFYA  252 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  252 (404)
                      ......+...||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+.........+. ...++..+       
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p-------  268 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP-------  268 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-------
Confidence            43334455789999999999953 4679999999999999999999999999988855444443 33333333       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        ..+++.+..|+.+||..||.+||+..+++.
T Consensus       269 --~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  269 --KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence              236899999999999999999999998864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-47  Score=361.39  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=207.7

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      ||+|+||+||+|.+..+++.||+|++.+.. ...........|..++....  +||||++++++|.  ....+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence            799999999999999999999999986532 22334455566777776654  6999999999987  567899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            84 7877775 456999999999999999999999999999999999999999999999999999764433334456789


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      |+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.......+.         ..++.++.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~li  229 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---------NVLSDEGRQFV  229 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---------ccCCHHHHHHH
Confidence            999999999865566899999999999999999999999887766655554433221111         23588999999


Q ss_pred             HhccccCCCCCC----CHHHHHhccCCCCcC
Q psy14434        266 NQILVLNPSERP----ETDQILEHNYVSKYF  292 (404)
Q Consensus       266 ~~~L~~dp~~Rp----t~~~ll~hp~~~~~~  292 (404)
                      .+||..||.+||    ++.++++||||....
T Consensus       230 ~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         230 KGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            999999999998    799999999998654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-46  Score=345.07  Aligned_cols=258  Identities=35%  Similarity=0.664  Sum_probs=215.0

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++++. ||||+++++++.  ....+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQ--DDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEE--ESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-cccccccccccc--ccccccccc
Confidence            89999999999999999999999999999999766554555555567999999995 999999999987  477899999


Q ss_pred             eccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        105 EYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       105 E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      |++.+ +|.+++. .+.+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+............
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99997 8999997 678999999999999999999999999999999999999999999999999999764333344556


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      ..+++.|+|||++..+..++.++|+||||+++|+|++|..||...........+............   ......+..+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  234 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---QQSREKSEELR  234 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---TSHTTSHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---cccchhHHHHH
Confidence            789999999999843678999999999999999999999999887444443333332221111000   00011237899


Q ss_pred             HHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        263 DLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ++|.+||+.||++|||+.++++||||
T Consensus       235 ~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-46  Score=356.10  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=205.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++.++.+||||+++++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence            469999999999999999999999999976533 33455667789999888867999999999987  467899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++............+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            94 7877775 456999999999999999999999999999999999999999999999999999764333333455689


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-----SHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||.....     ......+.........      .....++..
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~~~~~  231 (329)
T cd05618         159 TPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRSLSVK  231 (329)
T ss_pred             CccccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCCCCCHH
Confidence            9999999998 466789999999999999999999999953110     0011111111111100      011356889


Q ss_pred             HHHHHHhccccCCCCCCC------HHHHHhccCCCCcC
Q psy14434        261 AVDLLNQILVLNPSERPE------TDQILEHNYVSKYF  292 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt------~~~ll~hp~~~~~~  292 (404)
                      +.+||.+||..||.+||+      +.++++||||....
T Consensus       232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            999999999999999998      58999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-46  Score=355.24  Aligned_cols=305  Identities=38%  Similarity=0.710  Sum_probs=246.3

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..+.+.++|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++...+
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPAS   87 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccc
Confidence            3466788999999999999999999999999999999998665444555677789999999996 999999999875321


Q ss_pred             ----CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         97 ----NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        97 ----~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                          ...+|+|+||++++|.+++....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        88 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          88 SLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cccccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                2358999999999999999988899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      ....   .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+......+..+.+.....++       
T Consensus       168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            5432   345578999999999855557889999999999999999999999988777766666555432211       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI  311 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  311 (404)
                                    ....+...+...+..+.+||.+||..||.+|||+.+++.||||.++..+......+    ....+ 
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~----~~~~~-  319 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP----PYDQS-  319 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc----ccCcc-
Confidence                          00111222345688999999999999999999999999999999887665422211    11111 


Q ss_pred             CCCCcCCHHHHHHHHHHHH
Q psy14434        312 DDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~  330 (404)
                      -++.+..+++|+..++..+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07851         320 FESRDLTVDEWKELVYKEI  338 (343)
T ss_pred             hhhhhcCHHHHHHHhHHHH
Confidence            2345677888888888766

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0596|consensus

Probab=100.00  E-value=5.6e-47  Score=356.55  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=209.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ...|+++++||+||.+.||++.... ...||+|++.....+...+.-...|+..|.+|++|.+|+++++|  ...++.+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY--Ev~d~~lY  436 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY--EVTDGYLY  436 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee--eccCceEE
Confidence            3469999999999999999997643 45678888776667788888899999999999999999999998  44689999


Q ss_pred             EEEeccCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||||-+.||..+++++.  ++.-.++.+..|||.|+.++|..||||.||||.|+|+- .|.+||+|||.|..+......
T Consensus       437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            999999999999998764  44448999999999999999999999999999999984 568999999999987664332


Q ss_pred             --ccccccccccccccccccC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        180 --LTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       180 --~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                        ..+.+||+.|||||.+...          -..+.++||||||||||+|++|++||..-  ...+.++.....+...  
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI~~P~~~--  591 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAITDPNHE--  591 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhhcCCCcc--
Confidence              2456899999999998421          13578999999999999999999999442  2233444333333211  


Q ss_pred             chhhcccCCC--CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 DKFYAGFKNK--PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 ~~~~~~~~~~--~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..    |+.+  ..++.++++.||..||.+|||+.++|+|||+..+
T Consensus       592 Ie----fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  592 IE----FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             cc----ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            01    1222  2349999999999999999999999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-45  Score=352.37  Aligned_cols=263  Identities=24%  Similarity=0.411  Sum_probs=212.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.+. ||||+++++++.  ....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECCEEE
Confidence            468999999999999999999999999999999986432 3344567889999999997 999999999987  467899


Q ss_pred             EEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+.+ +|.+++.. +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999995 89988875 5689999999999999999999986 6999999999999999999999999999765432  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------------  246 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  246 (404)
                      ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...+.......+..........            
T Consensus       158 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             ccccCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence            23456799999999998 45678999999999999999999999997765543322211100000000            


Q ss_pred             ----------c----------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        247 ----------A----------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       247 ----------~----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                .                .........+++++.+||.+||+.||++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                      0                00000012357899999999999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-45  Score=351.54  Aligned_cols=304  Identities=38%  Similarity=0.694  Sum_probs=242.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---   95 (404)
                      +.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+..........+.+|+.++++++ ||||+++++++...   
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccc
Confidence            55678999999999999999999999999999999999765444445667789999999997 99999999988632   


Q ss_pred             -cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       .....|+++++++++|.+++..+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++....
T Consensus        92 ~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          92 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             2245789999998899999888889999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc-------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA-------  247 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  247 (404)
                      .   ......|++.|+|||.+.+...++.++|||||||++|+|++|++||...+.......+.......++..       
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2   224457899999999975546688999999999999999999999988776665555444332111100       


Q ss_pred             --------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCC
Q psy14434        248 --------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD  313 (404)
Q Consensus       248 --------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (404)
                                    ..+...+...++.+.+||.+||+.||.+||++.+++.||||.++..+.....+...+.+     ..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~~~~~-----~~  323 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQS-----FE  323 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCCccCc-----ch
Confidence                          00111123457889999999999999999999999999999987765543322222211     23


Q ss_pred             CCcCCHHHHHHHHHHHHH
Q psy14434        314 NNQLEINDYQDKLYDIVK  331 (404)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~  331 (404)
                      ..++.++++-+..++++.
T Consensus       324 ~~~~~~~~~~~~~~~~~~  341 (345)
T cd07877         324 SRDLLIDEWKSLTYDEVI  341 (345)
T ss_pred             hcccCHHHHHHHHHHHHH
Confidence            346777888888888774

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.5e-46  Score=353.72  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=207.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++.++..||||+.+++++.  ....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence            469999999999999999999999999976533 33455667789999999977999999999987  467899999999


Q ss_pred             CC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            85 8887776 457999999999999999999999999999999999999999999999999999754333333455789


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS------TSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      |+.|+|||++ .+..++.++|||||||++|+|++|..||....      ................         ...++.
T Consensus       159 t~~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------p~~~~~  228 (327)
T cd05617         159 TPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI---------PRFLSV  228 (327)
T ss_pred             CcccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC---------CCCCCH
Confidence            9999999998 46678999999999999999999999996422      1111111111111111         134688


Q ss_pred             HHHHHHHhccccCCCCCCC------HHHHHhccCCCCcCC
Q psy14434        260 EAVDLLNQILVLNPSERPE------TDQILEHNYVSKYFP  293 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt------~~~ll~hp~~~~~~~  293 (404)
                      .+.++|.+||..||.+|++      +.+++.||||....+
T Consensus       229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence            9999999999999999998      579999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-46  Score=353.23  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=213.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|+.++..+. |+||++++++|.  +...+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQ--DENNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEe--cCCeEE
Confidence            47999999999999999999999999999999996532 23334555678888888886 999999999987  567899


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. ++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999997 589988864  4699999999999999999999999999999999999999999999999999876543322


Q ss_pred             -ccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        179 -CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                       .....+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+.......+........     +...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~  232 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-----FPPD  232 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-----CCCc
Confidence             2223569999999999842    24578899999999999999999999988776666555543322111     1111


Q ss_pred             cCCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCcCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKYFP  293 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~~~  293 (404)
                      ...++..+.+||.+||..++.+  |+++.++++||||....+
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            2347899999999999765544  889999999999987543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-46  Score=356.78  Aligned_cols=250  Identities=27%  Similarity=0.464  Sum_probs=211.8

Q ss_pred             eeeecccCceeEEEEEE---cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         28 HKRIGKGAYGIVYKAYD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      ++.||+|+||.||++.+   ..+|+.||+|++.+............+|+.+++++. ||||+++++++.  ....+|+||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv~   77 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQ--TEGKLYLIL   77 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEE--cCCEEEEEE
Confidence            36799999999999976   357899999999765544455566778999999996 999999999987  567899999


Q ss_pred             eccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        105 EYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       105 E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      ||+. ++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++............
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            9998 588888864 46999999999999999999999999999999999999999999999999999866544334455


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      .+||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..+++.+.
T Consensus       158 ~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----------~~~~~~~~  226 (318)
T cd05582         158 FCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----------QFLSPEAQ  226 (318)
T ss_pred             ccCChhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCCHHHH
Confidence            6899999999998 456678999999999999999999999988877666655543322111          34688999


Q ss_pred             HHHHhccccCCCCCCC-----HHHHHhccCCCCc
Q psy14434        263 DLLNQILVLNPSERPE-----TDQILEHNYVSKY  291 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~  291 (404)
                      +||.+||+.||.+||+     +.+++.||||...
T Consensus       227 ~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         227 SLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999999999     7789999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.5e-46  Score=369.47  Aligned_cols=264  Identities=21%  Similarity=0.372  Sum_probs=221.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++..............+|+..+..+. |+||+++++.+...+. 
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccccc
Confidence            34557999999999999999999999999999999999766666677778889999999996 9999999988753221 


Q ss_pred             -----CeEEEEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         98 -----KDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        98 -----~~~~lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                           ..+++||||+. |+|.+.+..     ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                 24789999999 589888863     3589999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCC--CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        167 LGLARSLSDS--KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       167 fg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      ||+++.....  .......+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            9999765432  1223456799999999998 456789999999999999999999999988877666555544322111


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                               ...+++++.+|+.+||+.||.+||++.+++.|||++.+..
T Consensus       266 ---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        266 ---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             ---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence                     1456899999999999999999999999999999876543

>KOG0690|consensus

Probab=100.00  E-value=1.5e-47  Score=339.48  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=231.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|..++.||+|.||+|-+++.+.+++.||||++++.. ....+....+.|-++|+..+ ||.+..+-..|+  ...
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQ--t~d  241 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQ--TQD  241 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhc--cCc
Confidence            35678999999999999999999999999999999997763 34455666778999999997 999999988887  577


Q ss_pred             eEEEEEeccCC-cHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l-~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||..| .|.-.+ +.+.+++...+.+...|+.||.|||+++|++||||.+|+|++++|++||+|||+++.....
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            89999999996 565444 4567999999999999999999999999999999999999999999999999999987666


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .....++||||.|.|||++ ....|+.++|+|.+||++|||++|+.||...+....+..|.-..-..|          ..
T Consensus       322 g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----------r~  390 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----------RT  390 (516)
T ss_pred             cceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----------cc
Confidence            7778899999999999998 678899999999999999999999999999999988888765443333          45


Q ss_pred             CCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~~~  295 (404)
                      +++++..||..+|.+||.+|.     .+.|+..|+||....|..
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            699999999999999999997     578999999999876644

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-46  Score=355.04  Aligned_cols=250  Identities=25%  Similarity=0.431  Sum_probs=206.7

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHH-HhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFL-KSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l-~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|.+..+|+.||+|++.+... .......+..|...+ +.+ +||||+++++++.  ....+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~--~~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQ--TTEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEe--cCCEEEEEEcC
Confidence            469999999999999999999999999965432 333445566666654 455 5999999999987  56789999999


Q ss_pred             cCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      +.+ +|...+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.............+
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence            985 7877765 45699999999999999999999999999999999999999999999999999876443333445678


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......          .+..+..+.++
T Consensus       158 gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l  226 (325)
T cd05604         158 GTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----------RPGASLTAWSI  226 (325)
T ss_pred             CChhhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----------CCCCCHHHHHH
Confidence            99999999998 46678999999999999999999999998887766655554422111          13568899999


Q ss_pred             HHhccccCCCCCCCH----HHHHhccCCCCcC
Q psy14434        265 LNQILVLNPSERPET----DQILEHNYVSKYF  292 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~----~~ll~hp~~~~~~  292 (404)
                      |.+||..+|.+||++    .++++||||....
T Consensus       227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             HHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999976    5899999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-45  Score=380.08  Aligned_cols=267  Identities=29%  Similarity=0.495  Sum_probs=221.0

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ......++|++++.||.|+||.||+|.+..++..||+|++............+..|+.+++.+. ||||++++++|....
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence            3456778999999999999999999999999999999999766556667778889999999997 999999999987656


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCCcEEEcc-----
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-------KVMHRDLKPSNILIDK-----  158 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~-------~i~HrDlkp~NIll~~-----  158 (404)
                      ...+||||||+. ++|..++..     +.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            678999999998 589888864     4699999999999999999999984       4999999999999964     


Q ss_pred             ------------CCceEEeccccccccCCCCCccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy14434        159 ------------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFP  225 (404)
Q Consensus       159 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~  225 (404)
                                  .+.+||+|||++...... ......+||+.|+|||++.. ...++.++||||||||||+|++|..||.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                        234899999999866432 22345679999999999853 3458899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        226 GASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .......+..........+         ....+.++.+||..||..+|.+||++.++|.|||+....++
T Consensus       245 ~~~~~~qli~~lk~~p~lp---------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        245 KANNFSQLISELKRGPDLP---------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             cCCcHHHHHHHHhcCCCCC---------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            7665544333322211111         13458899999999999999999999999999999876543

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.6e-45  Score=343.77  Aligned_cols=267  Identities=38%  Similarity=0.654  Sum_probs=216.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---CCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---~~~   99 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+..||||+++++++...+   ...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999986554444445667889999999976899999999986322   124


Q ss_pred             EEEEEeccCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccc
Q psy14434        100 LYVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARS  172 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~  172 (404)
                      .|+||||++++|.+++..      ..+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999998887753      24799999999999999999999999999999999999998 88999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------  246 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  246 (404)
                      ............+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+..........      
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            54332223344678999999988655668999999999999999999999999887766665555433211100      


Q ss_pred             ------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        247 ------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       247 ------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                                  ........+.++..+.+||.+||..||.+||++.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                        0011112245789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-45  Score=342.97  Aligned_cols=262  Identities=38%  Similarity=0.660  Sum_probs=216.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .|++++.||.|++|.||+|.+..+++.||||.+............+.+|+.+++++. ||||+++++++.  +....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcc--cCCcEEEE
Confidence            489999999999999999999999999999998654434444467788999999997 999999999986  56789999


Q ss_pred             EeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        104 FEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       104 ~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      |||+.++|..++..   ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++..........
T Consensus        78 ~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          78 FEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             eeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            99999888888763   458999999999999999999999999999999999999999999999999987665433333


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC--------------
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH--------------  246 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  246 (404)
                      ....+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+.......+..........              
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            445678999999988655567889999999999999999999998877666555554433322110              


Q ss_pred             -----cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 -----ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 -----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ...+....+.+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                 011112234568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.1e-46  Score=352.72  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=206.8

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHH-HHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILF-LKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~-l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+..|... ++.+ .||||+++++++.  ....+|+||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~--~~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQ--TADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEE--cCCeEEEEEeC
Confidence            469999999999999999999999999965422 22333445555554 4556 4999999999987  56789999999


Q ss_pred             cCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      +.+ +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence            995 88888764 5689999999999999999999999999999999999999999999999999976443333345678


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+......          ..+.++..+.++
T Consensus       158 gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----------~~~~~~~~~~~l  226 (325)
T cd05602         158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----------LKPNITNSARHL  226 (325)
T ss_pred             CCccccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----------CCCCCCHHHHHH
Confidence            99999999998 4667899999999999999999999999988777666655442211          114568999999


Q ss_pred             HHhccccCCCCCCCHH----HHHhccCCCCcCC
Q psy14434        265 LNQILVLNPSERPETD----QILEHNYVSKYFP  293 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~~----~ll~hp~~~~~~~  293 (404)
                      |.+||+.||.+|+++.    ++++|+||....+
T Consensus       227 i~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            9999999999999875    8999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-45  Score=340.02  Aligned_cols=263  Identities=36%  Similarity=0.710  Sum_probs=215.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+............+.+|+.+++.+. ||||+++++++.  ....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFR--RKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEe--eCCEEEE
Confidence            4799999999999999999999999999999998644333333445678999999997 999999999987  4678999


Q ss_pred             EEeccCCc-HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~~-L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||++++ |..++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            99999974 5555543 459999999999999999999999999999999999999999999999999998765543333


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC-----------------
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-----------------  243 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  243 (404)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+....+....+.......                 
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            445688999999998655678899999999999999999999999877665555444322211                 


Q ss_pred             ----CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        244 ----PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       244 ----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                          +.........++.++..+.+||.+||+.+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                111111222345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-45  Score=342.72  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=212.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .|++.+.||+|+||.||++.+..+++.||+|++...... ........+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeec--CCCeEEE
Confidence            489999999999999999999999999999998654322 223345678999999996 999999999987  4568999


Q ss_pred             EEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||+. ++|...+..   ..+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999998 478877743   358999999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+|++.|+|||++. +..++.++||||+||++|+|++|..||.+.........+..........      ....++
T Consensus       157 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  229 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE------YSEKFS  229 (285)
T ss_pred             ccccccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc------cCcccC
Confidence            223457899999999984 5668999999999999999999999998876554444443332211111      113468


Q ss_pred             HHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      ..+.+||.+||..||.+||     ++.++++||||....
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            8999999999999999999     899999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-45  Score=350.23  Aligned_cols=300  Identities=43%  Similarity=0.778  Sum_probs=240.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---CCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---NKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---~~~~  100 (404)
                      +|++.+.||.|++|.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++....   ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccce
Confidence            689999999999999999999999999999999765544566678889999999997 999999999986422   2478


Q ss_pred             EEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        101 YVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      |++|||+.++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......  
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999999999888875 469999999999999999999999999999999999999999999999999998765432  


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC----------
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH----------  246 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  246 (404)
                       .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+........+.          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence             223455789999999998554478999999999999999999999999988877777766654422211          


Q ss_pred             -----------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCCC
Q psy14434        247 -----------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNN  315 (404)
Q Consensus       247 -----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (404)
                                 ...+....+.++..+.+||.+||+.+|.+|||+.+++.||||.....+.....+.   ....+...++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  316 (330)
T cd07834         240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAK---PPFDFDFFDDD  316 (330)
T ss_pred             hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCC---Ccccccccchh
Confidence                       1111222345788999999999999999999999999999999876654421111   11122225556


Q ss_pred             cCCHHHHHHHHH
Q psy14434        316 QLEINDYQDKLY  327 (404)
Q Consensus       316 ~~~~~~~~~~~~  327 (404)
                      ....+++++.++
T Consensus       317 ~~~~~~~~~~~~  328 (330)
T cd07834         317 ELTEEELKELIY  328 (330)
T ss_pred             hcCHHHHhHHhh
Confidence            666677766654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-44  Score=346.79  Aligned_cols=275  Identities=37%  Similarity=0.712  Sum_probs=227.0

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.+.++|++++.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.+. ||||+++++++.....
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcc
Confidence            456788999999999999999999999999999999998655444445567789999999996 9999999999863221


Q ss_pred             ----CeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         98 ----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        98 ----~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                          ...++||||++++|..++....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          89 LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence                3568999999889999998888999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------  245 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  245 (404)
                      ...   .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+.......+.        
T Consensus       169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            432   234568999999999855456889999999999999999999999887766555554443221110        


Q ss_pred             -------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        246 -------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       246 -------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                                   ....+......++..+.++|.+||..||.+|||+.+++.||||..+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence                         001112233567889999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-45  Score=348.03  Aligned_cols=302  Identities=37%  Similarity=0.687  Sum_probs=235.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--   96 (404)
                      +.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.+. ||||+++++++....  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~   89 (342)
T cd07879          11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSG   89 (342)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccC
Confidence            45668999999999999999999999999999999998765444444566789999999996 999999999986322  


Q ss_pred             --CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 --NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 --~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                        ....|+||||+..+|...+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        90 ~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          90 DEFQDFYLVMPYMQTDLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             CCCceEEEEecccccCHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence              23579999999988876653 468999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---------  245 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  245 (404)
                      .   ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+...+         
T Consensus       169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            2   2234578999999999855556899999999999999999999999988766665555543321111         


Q ss_pred             ------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCC
Q psy14434        246 ------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD  313 (404)
Q Consensus       246 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (404)
                                  ....+...++..+..+.+||.+||+.||.+||++.+++.||||..+.+......    +.....+. +
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~----~~~~~~~~-~  320 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE----QQPYDDSL-E  320 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCC----CCcccchh-h
Confidence                        011122233467888999999999999999999999999999998765433211    11111111 2


Q ss_pred             CCcCCHHHHHHHHHHHH
Q psy14434        314 NNQLEINDYQDKLYDIV  330 (404)
Q Consensus       314 ~~~~~~~~~~~~~~~~~  330 (404)
                      +...+.+++...+++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~  337 (342)
T cd07879         321 NEKLSVDEWKKHIYKEV  337 (342)
T ss_pred             hhhCCHHHHHHHhhhhh
Confidence            22445566666666554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-45  Score=350.48  Aligned_cols=250  Identities=27%  Similarity=0.452  Sum_probs=205.1

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHH-HHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREIL-FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+. +++.+. ||||+++++++.  +...+|+||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~--~~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQ--TAEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEE--cCCEEEEEEcC
Confidence            469999999999999999999999999965432 2334445566665 456665 999999999987  56789999999


Q ss_pred             cCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      +.+ +|...+. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.............+
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence            985 7877765 45689999999999999999999999999999999999999999999999999876433333345568


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......          ....+..+.++
T Consensus       158 gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----------~~~~~~~~~~l  226 (321)
T cd05603         158 GTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----------PGGKTVAACDL  226 (321)
T ss_pred             CCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----------CCCCCHHHHHH
Confidence            99999999998 45678999999999999999999999998887666555544322111          13457899999


Q ss_pred             HHhccccCCCCCCCH----HHHHhccCCCCcC
Q psy14434        265 LNQILVLNPSERPET----DQILEHNYVSKYF  292 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~----~~ll~hp~~~~~~  292 (404)
                      |.+||+.||.+||++    .++++|+||....
T Consensus       227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             HHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            999999999999875    5999999998644

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.7e-45  Score=349.70  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=214.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+... .......+..|+.++..+. |++|+++++++.  +...+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQ--DENNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEe--cCCEEE
Confidence            479999999999999999999999999999999865322 2233444667888888885 999999999987  567899


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. |+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999998 589999875  5689999999999999999999999999999999999999999999999999876543222


Q ss_pred             -ccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        179 -CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                       .....+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+.......+........     +...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~p~~  232 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-----FPAQ  232 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc-----CCCc
Confidence             2234579999999999842    34678999999999999999999999998877776666554322111     1112


Q ss_pred             cCCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCcCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKYFP  293 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~~~  293 (404)
                      ...++.++.+||.+||..++.+  |++++++++||||....+
T Consensus       233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            2457899999999999775554  789999999999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-45  Score=339.43  Aligned_cols=263  Identities=39%  Similarity=0.697  Sum_probs=220.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.+. ||||+++++++.  ....+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP--HGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCeeEEE
Confidence            589999999999999999999999999999998765444555667889999999997 999999999987  57789999


Q ss_pred             EeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-cc
Q psy14434        104 FEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CL  180 (404)
Q Consensus       104 ~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~  180 (404)
                      |||++++|.+++..  +.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus        78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            99997799988864  4589999999999999999999999999999999999999999999999999987654321 22


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---------------
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---------------  245 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  245 (404)
                      ....|+..|+|||.+.+...++.++|||||||++|+|++|.+||.+......+..+.........               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            34568999999999865666799999999999999999999999888777666665554332111               


Q ss_pred             -----CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        246 -----HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       246 -----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                           ....+...++..+..+.+||.+||..+|++|||+++++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 00011223345678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.5e-45  Score=332.93  Aligned_cols=253  Identities=29%  Similarity=0.551  Sum_probs=214.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|++|.||++.++.+++.||+|.+............+.+|+.+++++. |||++++++.+.. ....+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEG-EDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecC-CCCEEEEE
Confidence            599999999999999999999999999999999765555556667888999999996 9999999988753 34568999


Q ss_pred             EeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+.+ +|.+.+..   ..+++.+++.++.||+.||.+||++|++||||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            999984 88888864   34899999999999999999999999999999999999999999999999999876544334


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|++.|+|||++ .+..++.++|+|||||++|+|++|+.||...+.......+.....+..+         ..+++
T Consensus       159 ~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  228 (257)
T cd08223         159 ASTLIGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP---------KDYSP  228 (257)
T ss_pred             cccccCCcCccChhHh-cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc---------cccCH
Confidence            4456789999999997 4567889999999999999999999999877766555544443322111         34688


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+.+||.+||+.||.+|||+.+++.||||
T Consensus       229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         229 ELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-45  Score=338.80  Aligned_cols=261  Identities=34%  Similarity=0.631  Sum_probs=215.0

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||.|+||.||+|.+..++..||+|.+....... ......+|+..++++.+||||+++++++.....+.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            788999999999999999999999999999986543333 2334568999999997799999999998854447899999


Q ss_pred             eccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        105 EYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       105 E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      ||+.++|.+.+..  +.+++..++.++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++........ ...
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~  157 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTE  157 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCC
Confidence            9999988888764  45899999999999999999999999999999999999999 9999999999987654322 234


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-----------------
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-----------------  245 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------  245 (404)
                      ..+++.|+|||.+..+..++.++|+|||||++|+|++|.+||.+.+.......+.........                 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            568999999998755666789999999999999999999999988776666655544332211                 


Q ss_pred             --CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 --HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 --~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                        ....+......++..+.+||.+||..+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              0000111123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-45  Score=342.60  Aligned_cols=267  Identities=36%  Similarity=0.655  Sum_probs=220.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|.+..............+|+.+++++. ||||+++++++...+...+
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcE
Confidence            346899999999999999999999999999999998655444444455678999999997 9999999999875545889


Q ss_pred             EEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.++|.+++..  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999999999888864  3489999999999999999999999999999999999999999999999999987655433


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...........+.........             
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            3344568899999999865556789999999999999999999999988777666665544331111             


Q ss_pred             -------CcchhhcccCC--CCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 -------HADKFYAGFKN--KPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 -------~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                             ....+...++.  +++.+.+||.+||+.+|++|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                   00111122333  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-45  Score=346.30  Aligned_cols=255  Identities=33%  Similarity=0.629  Sum_probs=198.0

Q ss_pred             eeecccCceeEEEEEEcC--CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      ..||+|+||.||+|.+..  ++..||+|.+....    ......+|+.+++.+. ||||+++++++.......+|+||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEee
Confidence            579999999999999764  56789999885432    2335678999999997 9999999999876567789999999


Q ss_pred             cCCcHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----ccCCceEEeccccccc
Q psy14434        107 MENDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARS  172 (404)
Q Consensus       107 ~~~~L~~~l~~----------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----~~~~~vkl~Dfg~a~~  172 (404)
                      ++++|..++..          ..+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||+++.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            99988877742          137889999999999999999999999999999999999    4567899999999986


Q ss_pred             cCCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHhh
Q psy14434        173 LSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVNLV  240 (404)
Q Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~  240 (404)
                      ......   ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.....         ..+...+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            643221   223457899999999986556789999999999999999999999975432         12222222222


Q ss_pred             CCCCC-Cc-------------c--------------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        241 RPNPP-HA-------------D--------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       241 ~~~~~-~~-------------~--------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +.... ..             .              .........+..+.+||.+||+.||.+|||+.++|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            21100 00             0              0000011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9e-45  Score=340.69  Aligned_cols=266  Identities=41%  Similarity=0.706  Sum_probs=219.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC---hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+......   ......+..|+.+++.+. |+||+++++++.  +...+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFG--HKSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheee--cCCEE
Confidence            589999999999999999999999999999999654333   233455678999999997 999999999987  46789


Q ss_pred             EEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.++|..++...  .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        78 ~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          78 NLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             EEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999999988999999764  499999999999999999999999999999999999999999999999999987655433


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+......+..+.........             
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            3344567889999999865567899999999999999999999999887776665555443321110             


Q ss_pred             -----CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        246 -----HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       246 -----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                           ........+...+..+.+||.+||..||++|||+.+++.||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                 00011112344578899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-44  Score=339.46  Aligned_cols=261  Identities=28%  Similarity=0.511  Sum_probs=219.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +....+|++.+.||.|++|.||+|.+..+++.||+|.+...  .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~   89 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELK-NPNIVNFLDSFL--VGD   89 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcC-CCceeeeeeeEe--cCc
Confidence            34456799999999999999999999999999999998543  2334566788999999996 999999999987  567


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+|+||||+.+ +|..++....+++.++..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            89999999985 89888888889999999999999999999999999999999999999999999999999988665443


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......|++.|+|||.+ .+..++.++|+|||||++|+|++|..||.+.+.......+.....+..       .....+
T Consensus       170 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~  241 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-------QNPEKL  241 (296)
T ss_pred             ccCCCcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-------CCcccC
Confidence            333445789999999997 456688999999999999999999999988776555444332211111       112456


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ++.+.+||.+||..||.+|||+.++++||||....
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            88999999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.9e-45  Score=348.95  Aligned_cols=275  Identities=45%  Similarity=0.809  Sum_probs=226.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--cCC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--~~~   98 (404)
                      +..+|++.+.||.|++|.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||++++++|...  ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            447899999999999999999999999999999999765444455677788999999997 99999999987632  345


Q ss_pred             eEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+|+||||+.++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            789999999999988886 4558999999999999999999999999999999999999999999999999997654322


Q ss_pred             C----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------
Q psy14434        178 E----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------  245 (404)
Q Consensus       178 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  245 (404)
                      .    ......|+.+|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+....+..+.        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1    1234578999999999855566899999999999999999999999988776665555444332111        


Q ss_pred             -------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        246 -------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       246 -------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                                   ....+...++..+..+.++|.+||+.+|++|||+.+++.||||.+...+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence                         001111223556899999999999999999999999999999998765544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-44  Score=343.29  Aligned_cols=299  Identities=38%  Similarity=0.688  Sum_probs=232.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCC--CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--ccCCe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--VNNKD   99 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~~~~~   99 (404)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+..............+|+.+++++.+||||++++++...  .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  89999999865444444566778899999999779999999987542  23356


Q ss_pred             EEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        100 LYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      +|++|||++++|...+. ...+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence            89999999999988886 4568999999999999999999999999999999999999999999999999998654321 


Q ss_pred             ---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---------
Q psy14434        178 ---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---------  245 (404)
Q Consensus       178 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  245 (404)
                         .......||+.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+.......+....+..+.         
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP  240 (332)
T ss_pred             cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence               11234578999999998755567899999999999999999999999887766666555554432111         


Q ss_pred             ------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCC
Q psy14434        246 ------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD  313 (404)
Q Consensus       246 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (404)
                                  ....+....+..+..+.+|+.+||+.||.+|||+.+++.||||..+..+..   .+.+..+..  .+-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~---~~~~~~~~~--~~~  315 (332)
T cd07857         241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD---EPVCQKPFD--FSF  315 (332)
T ss_pred             hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc---ccccccccc--CCc
Confidence                        011122233456889999999999999999999999999999988765443   222222222  222


Q ss_pred             CCcCCHHHHHHHHH
Q psy14434        314 NNQLEINDYQDKLY  327 (404)
Q Consensus       314 ~~~~~~~~~~~~~~  327 (404)
                      ..+.+.++.++.+.
T Consensus       316 ~~~~~~~~~~~~~~  329 (332)
T cd07857         316 ESEDSMEELRDMII  329 (332)
T ss_pred             cccccHHHHHHHHh
Confidence            33445556665553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=338.41  Aligned_cols=264  Identities=33%  Similarity=0.610  Sum_probs=211.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .+++|++.+.||+|++|.||+|.++.+++.||+|.+...... .......+|+.+++.+. ||||+++++++.  +....
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~   78 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLK-HANIVTLHDIIH--TKKTL   78 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCC-CcceeeEEEEEe--cCCeE
Confidence            357899999999999999999999999999999998643222 22234568999999996 999999999987  56789


Q ss_pred             EEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.++|.+++..  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999999999888864  3589999999999999999999999999999999999999999999999999876433222


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCCC-----------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLVRPNPPH-----------  246 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~-----------  246 (404)
                      ......++..|+|||.+.+...++.++||||+||++|+|++|..||.+.. ..+....+.+........           
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            22334578899999998655668899999999999999999999997765 334444333332211100           


Q ss_pred             ---------cchhhcccCCCC--HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 ---------ADKFYAGFKNKP--EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 ---------~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                               ..........++  ..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     011111122344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-44  Score=339.31  Aligned_cols=260  Identities=28%  Similarity=0.508  Sum_probs=217.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +....+|++.+.||+|++|.||+|.+..+++.||+|.+....  ........+|+.+++.+. ||||+++++.+.  ...
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~--~~~   90 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENK-NPNIVNYLDSYL--VGD   90 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCC-CCCEeeEEEEEE--eCC
Confidence            566789999999999999999999999999999999985432  234566778999999986 999999999987  467


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ..|+||||+.+ +|..++..+.+++.++..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            89999999985 89999988889999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......|++.|+|||.+ .+..++.++|+|||||++|+|++|+.||...........+.....+..       .....+
T Consensus       171 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~  242 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------QNPEKL  242 (296)
T ss_pred             cccCcccCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-------CCcccc
Confidence            333445789999999997 456678999999999999999999999987665443332221111111       111346


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +..+.+||.+||..+|.+|||+.+++.||||...
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            7889999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-44  Score=338.92  Aligned_cols=267  Identities=38%  Similarity=0.690  Sum_probs=217.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++.+.||.|++|.||+|.++.+|+.||+|.+............+.+|+.+++.+. ||||+++++++.  +....|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH--SEKRLY   77 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEe--cCCeEE
Confidence            36899999999999999999999999999999998655444444556778999999996 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCCCC
Q psy14434        102 VVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||++++|...+...   .+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.......
T Consensus        78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            99999998888777542   2578889999999999999999999999999999999985 5679999999997654433


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc----------
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA----------  247 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  247 (404)
                      .......+++.|+|||.+.+...++.++|||||||++|+|++|.+||...........+...........          
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            3334456789999999986556688999999999999999999999988776665555544332111100          


Q ss_pred             ---------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 ---------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 ---------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                               .......+.+++.+.+++.+||+.+|++||++.++++||||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                     01111234578899999999999999999999999999999864

>KOG0607|consensus

Probab=100.00  E-value=2.3e-46  Score=331.33  Aligned_cols=271  Identities=26%  Similarity=0.452  Sum_probs=225.5

Q ss_pred             cccccccccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         14 QHNVDGNILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ..+..|.+.+-|++. +.||+|+|+.|--+....+|..||||++.+.  ..-...+.++|++++.+.++|+||+.++++|
T Consensus        68 ~ss~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   68 TSSLSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             cccccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            344556677778885 7799999999999999999999999999665  4556778999999999999999999999999


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---ceEEecc
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDL  167 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l-~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---~vkl~Df  167 (404)
                      +  ++..+|||||-|.| .|...| +.+.|++.++..++.+|+.||+|||.+||.||||||+|||.....   -||||||
T Consensus       146 E--dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  146 E--DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             c--ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecc
Confidence            8  67889999999996 555555 567799999999999999999999999999999999999997664   4899999


Q ss_pred             ccccccCCC-------CCcccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Q psy14434        168 GLARSLSDS-------KECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS--------  228 (404)
Q Consensus       168 g~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------  228 (404)
                      .+...+...       .+...+.+|+..|||||+..    ....|+.+.|.||||||+|.|++|.+||.|.-        
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            987654322       12334568999999999962    13468999999999999999999999997632        


Q ss_pred             -------cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        229 -------TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       229 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                             ....+..|.++...+|.      ..|..+|.++.|||+.+|..|+..|.++.+++.|||+....+.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYeFPd------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYEFPD------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCcCCh------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                   23345555555555554      3457789999999999999999999999999999999987665

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.4e-44  Score=340.73  Aligned_cols=299  Identities=39%  Similarity=0.722  Sum_probs=237.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|++.+..........+.+|+.+++.+. ||||++++++|.. ....
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFIS-PLED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEec-CCCc
Confidence            4677899999999999999999999999999999998655444555677789999999997 9999999999863 3557


Q ss_pred             EEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        100 LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      .|++|||++++|..++....+++..+..++.||+.||+|||++|++||||+|.||+++.++.++|+|||.+.....   .
T Consensus        85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            8999999999999999888899999999999999999999999999999999999999999999999999975432   2


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------------  245 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  245 (404)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.........+.+..+..+.              
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            234568899999998755567899999999999999999999999887765544444433322111              


Q ss_pred             -------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCCCcCC
Q psy14434        246 -------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLE  318 (404)
Q Consensus       246 -------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (404)
                             .........+.++..+.++|.+||+.+|++|||+++++.||||..+..+...   +.......++ +++..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~  317 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE---PVAEEKFDWS-FNDADLP  317 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc---cCchhhcCCc-hhcccCC
Confidence                   0011112234578899999999999999999999999999999877654432   2222233333 3345567


Q ss_pred             HHHHHHHHH
Q psy14434        319 INDYQDKLY  327 (404)
Q Consensus       319 ~~~~~~~~~  327 (404)
                      ++.|+-.++
T Consensus       318 ~~~~~~~~~  326 (328)
T cd07856         318 VDTWKVMMY  326 (328)
T ss_pred             HHHHHHHhc
Confidence            777776654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.9e-44  Score=330.55  Aligned_cols=252  Identities=29%  Similarity=0.509  Sum_probs=216.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|.+.+.||+|++|.||+|.++.+++.|++|.+..............+|+.+++.+. ||||+++++++.  .....|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFL--DKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeec--cCCEEEEE
Confidence            588999999999999999999999999999998765555667778889999999996 999999999987  56789999


Q ss_pred             EeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+. ++|.+++..   ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99998 489988865   35899999999999999999999999999999999999999999999999999876554333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|++.|+|||++. +..++.++|+|||||++|+|++|+.||...+.......+.....+..+         ..++.
T Consensus       158 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  227 (256)
T cd08529         158 ANTIVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---------QMYSQ  227 (256)
T ss_pred             hhccccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---------cccCH
Confidence            34557899999999984 556889999999999999999999999887766555554443322211         24578


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+.++|.+||+.+|++||++.+++.|||+
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         228 QLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.7e-45  Score=361.71  Aligned_cols=254  Identities=28%  Similarity=0.489  Sum_probs=213.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC-CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..|.+.+.||+|++|.||+|.+..+ +..||+|.+..  ........+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~--~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACD-HFGIVKHFDDFK--SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE--ECCEEE
Confidence            3499999999999999999998877 78899997733  23344556678999999996 999999999987  467899


Q ss_pred             EEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        102 VVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      |||||+. |+|.+.+..     ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999998 589877642     3589999999999999999999999999999999999999999999999999987643


Q ss_pred             CC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ..  ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+........+        
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--------  292 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP--------  292 (478)
T ss_pred             ccccccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--------
Confidence            32  123456799999999998 4667899999999999999999999999887776666655543322111        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ..++.++.+||.+||..||.+||++.+++.|+|+...
T Consensus       293 -~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        293 -CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence             3468899999999999999999999999999998753

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.7e-45  Score=338.94  Aligned_cols=263  Identities=36%  Similarity=0.710  Sum_probs=216.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+. ||||+++++++.  .....|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFR--RKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcc--cCCeEEE
Confidence            4799999999999999999999999999999998655444444556778999999996 999999999986  5778999


Q ss_pred             EEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+.+ .|..+... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            9999997 55555543 358999999999999999999999999999999999999999999999999998765544444


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC----------------
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP----------------  244 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  244 (404)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|++||...........+........                
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            5567899999999986556678999999999999999999999987776555444443222111                


Q ss_pred             -----CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        245 -----PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       245 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ..........+.++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                 01111112235678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0577|consensus

Probab=100.00  E-value=1.3e-46  Score=355.76  Aligned_cols=257  Identities=28%  Similarity=0.507  Sum_probs=225.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..|.-++.||.|+||.||-|++..+.+.||||++.-. .......+.+++|+..|+++. |||++.+-++|-  .+.+.+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyL--re~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYL--REHTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceee--ccchHH
Confidence            4588899999999999999999999999999999544 455677889999999999997 999999999987  577889


Q ss_pred             EEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +|||||-|+-.+++.  ++++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.+....+    
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            999999998777775  67799999999999999999999999999999999999999999999999999977644    


Q ss_pred             cccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 LTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ..+++|||.|||||+++.  .+.|+-++||||||++..||.-.++|+-..+....+..|.....|....        ..+
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs--------~eW  250 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--------NEW  250 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--------chh
Confidence            357899999999999853  5679999999999999999999999988888777777665544443331        345


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      +..+++|+..||++-|.+|||.+++|+|+|+..-.|+
T Consensus       251 S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  251 SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            7889999999999999999999999999999875543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-44  Score=340.52  Aligned_cols=269  Identities=36%  Similarity=0.641  Sum_probs=215.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--   96 (404)
                      +..+++|++.+.||+|+||.||+|.+..+++.||+|.+..............+|+.+++++. ||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATP   86 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence            46677899999999999999999999999999999998654333334445668999999996 999999999876322  


Q ss_pred             ----CCeEEEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         97 ----NKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        97 ----~~~~~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                          ....|+||||+.++|.+.+...  .+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          87 YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                2457999999999998888754  6899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        171 RSLSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       171 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      .......    .......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+.......+....+..+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            7654322    112335678899999987555567899999999999999999999998877666555554443321110


Q ss_pred             cch--------------------hhc--ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 ADK--------------------FYA--GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 ~~~--------------------~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ...                    ...  .....+..+.+||.+||..||.+|||++++|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000                    000  001135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-45  Score=354.58  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...+|++++.||.|+||.||+|...  .++..||+|.+...       ....+|+.+++.+. ||||++++++|.  ...
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTIS-HRAIINLIHAYR--WKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcC-CCCccceeeeEe--eCC
Confidence            3457999999999999999999764  35678999988532       22457999999997 999999999987  467


Q ss_pred             eEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+|+|||++.++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus       160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            899999999999888885 4569999999999999999999999999999999999999999999999999997654432


Q ss_pred             C--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHhhCCCCCCcch---
Q psy14434        178 E--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---SHQLQLIVNLVRPNPPHADK---  249 (404)
Q Consensus       178 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~---  249 (404)
                      .  ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+...   ...+..+....+..+.....   
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            1  22346799999999998 466789999999999999999999999976542   33334443333211110000   


Q ss_pred             -------------------hhc--ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        250 -------------------FYA--GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       250 -------------------~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                         ...  ....++.++.+||.+||..||++|||+.++|.||||.+..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                               000  0023467899999999999999999999999999998743

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-45  Score=345.93  Aligned_cols=263  Identities=25%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.+. ||||++++++|.  ....+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCC-CCcccceeEEEE--ECCEEE
Confidence            368999999999999999999999999999999886432 3344567889999999997 999999999987  467899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. ++|.+++.. +.+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999998 489988874 5689999999999999999999975 7999999999999999999999999998765332  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      ......|++.|+|||.+ .+..++.++|+|||||++|+|++|+.||...........+.........             
T Consensus       158 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             ccccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence            22345799999999998 4567899999999999999999999999765543332111100000000             


Q ss_pred             --------C---c----------chhhc--ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        246 --------H---A----------DKFYA--GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       246 --------~---~----------~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                              .   .          .....  .....+.++.+||.+||+.||++|||+.+++.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                    0   0          00000  001256789999999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0612|consensus

Probab=100.00  E-value=1.4e-46  Score=378.34  Aligned_cols=271  Identities=26%  Similarity=0.371  Sum_probs=225.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .++|.+++.||+|+||.|.+++++.+++.||+|++.+-.+- ..+..-+..|-.+|..- +.+.|+.++..|.  ++.++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQ--D~~~L  150 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQ--DERYL  150 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhc--Cccce
Confidence            46899999999999999999999999999999999764333 33444444455555544 5899999999987  68899


Q ss_pred             EEEEeccCC-cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        101 YVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      |+||||+.| ||..++.+- .+++..+++|+..|+.||+-||+.|+|||||||+|||++..|++||+|||.|..+...+ 
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            999999995 899999754 59999999999999999999999999999999999999999999999999998877443 


Q ss_pred             Cccccccccccccccccccc---C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC--CCCCCcchhh
Q psy14434        178 ECLTEYIATRWYRAPEILIS---N-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR--PNPPHADKFY  251 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~---~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  251 (404)
                      -.....+|||.|.|||++..   + +.|+..+|+||+||++|||++|..||...+-...+.+|++...  .+|.      
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~------  304 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD------  304 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc------
Confidence            34456789999999999843   3 5789999999999999999999999999999999999987632  2221      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCC---HHHHHhccCCCCcCCCC-CCCCCCCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPE---TDQILEHNYVSKYFPSA-THVIPQVTP  304 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~hp~~~~~~~~~-~~~~~~~~~  304 (404)
                        ...+|+++.+||.+++. +|+.|..   ++++-.||||.+.-|.. ....||..|
T Consensus       305 --~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP  358 (1317)
T KOG0612|consen  305 --ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP  358 (1317)
T ss_pred             --ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence              13479999999999886 5677877   99999999999887744 333444444

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.8e-45  Score=346.81  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=213.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|+.++..+. |++|+.+++++.  +....|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~--~~~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQ--DENYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--cCCEEE
Confidence            47999999999999999999999999999999986532 22334445667888888886 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. |+|..++..  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999998 589998874  5689999999999999999999999999999999999999999999999999976644322


Q ss_pred             c-ccccccccccccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        179 C-LTEYIATRWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       179 ~-~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      . ....+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+.......+.......+     +...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~p~~  232 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ-----FPSH  232 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc-----CCCc
Confidence            1 2235799999999997431    4578899999999999999999999988777666555544321110     1112


Q ss_pred             cCCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCcC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKYF  292 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~~  292 (404)
                      ...++.++.+||.+||..++.+  |++++++++||||....
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            2456899999999999976655  57999999999998643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-44  Score=340.06  Aligned_cols=262  Identities=29%  Similarity=0.507  Sum_probs=217.6

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +....+|++++.||.|+||.||+|.+..+++.||+|.+....  ......+.+|+.+++.+. ||||+++++++.  ...
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~   89 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENK-NPNIVNYLDSYL--VGD   89 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCC
Confidence            556689999999999999999999999999999999985432  234456778999999986 999999999987  567


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ..|+||||+++ +|.+++....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            89999999985 89999988889999999999999999999999999999999999999999999999999997655433


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......+++.|+|||.+ .+..++.++|+|||||++|+|++|..||.+.+.......+.....+...       ....+
T Consensus       170 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~  241 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-------NPERL  241 (297)
T ss_pred             cCcCcccCCccccCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCC-------Ccccc
Confidence            333455789999999998 4567889999999999999999999999776554332222111111100       11345


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      +..+.+|+.+||..+|.+||++.++++||||....+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            788999999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-44  Score=334.66  Aligned_cols=261  Identities=33%  Similarity=0.671  Sum_probs=215.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|++|.||+|.+..+|..||+|++..... ........+|+.+++++. ||||+++++++.  .....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELK-HENIVRLHDVIH--TENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhc-CCCEeeeeeeEe--eCCcEEEE
Confidence            58999999999999999999999999999999864432 223455678999999996 999999999987  46678999


Q ss_pred             EeccCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+.++|.+++..    ..+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++.........
T Consensus        77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          77 FEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             EecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            99999999888764    34899999999999999999999999999999999999999999999999999765443333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-------------  246 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  246 (404)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+.+........             
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            3445678999999998665667899999999999999999999999888777666655443211110             


Q ss_pred             ------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 ------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 ------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                            ........+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  001111123457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.7e-44  Score=343.30  Aligned_cols=271  Identities=37%  Similarity=0.664  Sum_probs=217.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      .+.++|++.+.||.|+||.||+|.+..+|+.||+|.+...  .........+|+.+++.+. ||||+++++++....   
T Consensus         2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            3467999999999999999999999999999999998543  2244566778999999996 999999998875321   


Q ss_pred             ---------CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEec
Q psy14434         97 ---------NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGD  166 (404)
Q Consensus        97 ---------~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~D  166 (404)
                               ...+|+||||++++|.+.+..+.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+|
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                     13579999999999999988888999999999999999999999999999999999999975 56789999


Q ss_pred             cccccccCCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q psy14434        167 LGLARSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN  243 (404)
Q Consensus       167 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  243 (404)
                      ||++........   ......|+..|+|||.+.+...++.++|||||||++|+|++|+.||.+.........+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999976532211   11234578899999987556678899999999999999999999998877655554443322110


Q ss_pred             C--------------------CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        244 P--------------------PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       244 ~--------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .                    ..........+.++.++.+||.+||+.||.+|||+.+++.||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            0                    0011111223457889999999999999999999999999999987644

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0586|consensus

Probab=100.00  E-value=1.3e-45  Score=352.60  Aligned_cols=263  Identities=30%  Similarity=0.461  Sum_probs=234.1

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ...-++.|.+.+.||+|.|+.|.+|++..++..||||.+.+...+....+.+.+|+.+|+.+. |||||+++.+.+  ..
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~--t~  127 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIE--TE  127 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeeee--ec
Confidence            345677899999999999999999999999999999999999999888888999999999997 999999999987  46


Q ss_pred             CeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.+ .+.+++. .++..+..++.++.|++.|++|||+++|+|||||++|||++.+-.+||+|||++..+..
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence            789999999985 6777765 57788899999999999999999999999999999999999999999999999998874


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .....++||++.|+|||++.+..+.++.+|+||+|+++|.|+.|.+||++.+..........+....+          -
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----------~  276 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----------F  276 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc----------c
Confidence             46678899999999999997777789999999999999999999999999887766555544433222          2


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      -++.++.++|+++|..+|.+|++.+++.+|.|.......
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            247899999999999999999999999999999876654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-44  Score=347.52  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++++.||+|+||.||+|.+..++..||+|+....        ....|+.+++.+. ||||+++++++.  .....++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVN-HPSVIRMKDTLV--SGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCC-CCCCcChhheEE--eCCeeEE
Confidence            4699999999999999999999999999999985322        2246899999997 999999999987  4667899


Q ss_pred             EEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      |||++.++|..++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  213 (357)
T PHA03209        135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAF  213 (357)
T ss_pred             EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccc
Confidence            999999999888763  46899999999999999999999999999999999999999999999999999754322 223


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcH---------HHHHHHHHhhCCCCCCcc--
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTS---------HQLQLIVNLVRPNPPHAD--  248 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~---------~~~~~~~~~~~~~~~~~~--  248 (404)
                      ....||+.|+|||++. +..++.++|||||||++|+|+++. ++|......         ..+..+.......+....  
T Consensus       214 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            4567999999999984 567899999999999999999854 444432211         122222222221111000  


Q ss_pred             ---hh-------------------hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        249 ---KF-------------------YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       249 ---~~-------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ..                   ......++.++.+||.+||+.||.+|||+.++|+||||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence               00                   0011245778889999999999999999999999999985

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=333.47  Aligned_cols=255  Identities=28%  Similarity=0.499  Sum_probs=216.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++.  ++..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFL--KGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEE--ECCeEEE
Confidence            47999999999999999999999999999999986442 2344566778999999997 999999999987  4678999


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      |+||+.+ +|.+++....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            9999985 899999888899999999999999999999999999999999999999999999999999987765433344


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...|++.|+|||.+. +..++.++|||||||++|+|++|..||...+.......+.....+....        ..++..+
T Consensus       157 ~~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  227 (274)
T cd06609         157 TFVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--------NKFSKPF  227 (274)
T ss_pred             cccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--------cccCHHH
Confidence            567899999999984 5558999999999999999999999998766544444333332221110        1268899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .++|.+||..+|++|||++++++||||..
T Consensus       228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         228 KDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence            99999999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-44  Score=354.43  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|...        .....+|+.+++++. ||||+++++++.  .....+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~-HpnIv~l~~~~~--~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLS-HPAVLALLDVRV--VGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCC-CCCCCcEEEEEE--ECCEEE
Confidence            457999999999999999999999999999999642        123458999999997 999999999976  467899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +|||++.++|..++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... 
T Consensus       237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9999999999888764  3599999999999999999999999999999999999999999999999999976543221 


Q ss_pred             -cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCC------cHHHHHHHHHhhCCC----CCC
Q psy14434        179 -CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF-PGAS------TSHQLQLIVNLVRPN----PPH  246 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~------~~~~~~~~~~~~~~~----~~~  246 (404)
                       .....+||+.|+|||++ .+..++.++|||||||++|||++|..++ ....      ...++..+.......    +..
T Consensus       317 ~~~~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence             12345799999999998 4567899999999999999999987543 3221      122233332222110    000


Q ss_pred             ---------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        247 ---------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       247 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                                           .......+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                 00000111245678999999999999999999999999999974

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6e-44  Score=328.48  Aligned_cols=254  Identities=31%  Similarity=0.537  Sum_probs=217.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|+||.||+|.+..++..||+|.+...........++..|+.+++.+. ||||+++++++.......+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998765556666778889999999997 9999999998865567788999


Q ss_pred             EeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        104 FEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH-----~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |||+.+ +|.+++..     ..+++..++.++.||+.||+|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999984 88888863     46899999999999999999999     89999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ............|++.|+|||.+ ....++.++|+||||+++|+|++|..||...+.......+.....+..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI--------  230 (265)
T ss_pred             ccCCcccccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC--------
Confidence            76544334456789999999998 455688999999999999999999999988775555444443322111        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                       ....+..+.+++.+||..+|.+|||+.++++|||+
T Consensus       231 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         231 -PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence             13567899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=334.70  Aligned_cols=261  Identities=40%  Similarity=0.716  Sum_probs=214.2

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.+. |||++++++++.  +....|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~--~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVH--SENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheec--cCCeEEEEE
Confidence            67889999999999999999999999999998654433444456778999999997 999999999986  567899999


Q ss_pred             eccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        105 EYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       105 E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||++++|.+++...   .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++...........
T Consensus        78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          78 EFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             eccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence            99998999888754   489999999999999999999999999999999999999999999999999976543322223


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----------------  245 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  245 (404)
                      ...+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+.........                
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            3457889999998755556789999999999999999999999887766555544443221110                


Q ss_pred             ---CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 ---HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 ---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                         ...........++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               0001112235577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0574|consensus

Probab=100.00  E-value=1.2e-47  Score=336.93  Aligned_cols=257  Identities=28%  Similarity=0.488  Sum_probs=220.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .-+-|.+++.||.|+||.||+|.++.+|+.+|||.+.    -+.+++++.+|+.++++.. .|++|++|+.|-  ....+
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~-S~yVVKYYGSYF--K~sDL  103 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCK-SKYVVKYYGSYF--KHSDL  103 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcC-Cchhhhhhhhhc--cCCce
Confidence            4455999999999999999999999999999999984    3568899999999999997 999999999876  57789


Q ss_pred             EEEEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||||+ |+..++++  ++.|++.++..++...++||.|||...-+|||||..|||++.+|..||+|||.+..+.+.-
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            99999999 79999887  5679999999999999999999999999999999999999999999999999998877655


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  256 (404)
                      ....+.+|||.|||||++ ..-.|+..+||||||++..||.-|++||.+-.....   |.-.-. +.+....     ...
T Consensus       184 AKRNTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~K-----PE~  254 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKK-----PEE  254 (502)
T ss_pred             HhhCccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCC-----hHh
Confidence            556778999999999998 566799999999999999999999999976554322   211111 2222111     123


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .|.++.||+++||.+.|++|.|+-++++|||++....
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            5788999999999999999999999999999987543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=335.23  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=215.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+..  ........+.+|+.+++++. ||||+++++++.  .....|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECK-HPNIVGLYEAYF--YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEe--cCCeEE
Confidence            4579999999999999999999998999999999853  24455667889999999997 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+++ +|..++..  +.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999995 88888864  4699999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        179 CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ......|++.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+.......+.....+...       ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~  231 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-------QP  231 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-------Cc
Confidence            3445678999999998742    345678999999999999999999999877655544444322211111       11


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..++.++.++|.+||+.+|.+||++.++++||||...
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            3467899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.9e-44  Score=334.35  Aligned_cols=261  Identities=29%  Similarity=0.467  Sum_probs=213.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..+.|++++.||.|+||.||+|.+..++..+|+|.+...  .......+.+|+.+++.+. ||||+++++++.  ....+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   84 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCN-HPYIVKLLGAFY--WDGKL   84 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEE--eCCeE
Confidence            346799999999999999999999999999999998532  4455677788999999997 999999999987  46689


Q ss_pred             EEEEeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |+||||+.+ +|..++.  ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999999996 6776664  3458999999999999999999999999999999999999999999999999987644333


Q ss_pred             Cccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        178 ECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .......+++.|+|||.+..    ...++.++|+|||||++|+|++|.+||...+.......+.....+...       .
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~  237 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS-------Q  237 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC-------C
Confidence            33345678999999998742    345688999999999999999999999776654443333222111111       1


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ...++.++.++|.+||..+|++||++.++++||||....+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            1356789999999999999999999999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-43  Score=332.39  Aligned_cols=263  Identities=36%  Similarity=0.622  Sum_probs=207.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||.||+|.+..+|..||+|.+..... ........+|+.+++.+. |+||+++++++.  .....|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEe--cCCeEE
Confidence            3689999999999999999999999999999999854322 222345568999999996 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+.++|...+..  +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          80 FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             EEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            9999999888776653  45788899999999999999999999999999999999999999999999998765433333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCC-----------Cc
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPP-----------HA  247 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-----------~~  247 (404)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.... ..+..+.........           ..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            344567999999999855556788999999999999999999999765542 222222221111100           00


Q ss_pred             ---------chhhcccC--CCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 ---------DKFYAGFK--NKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 ---------~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                               ......+.  ..+..+.+++.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                     00000011  125789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-44  Score=328.01  Aligned_cols=254  Identities=26%  Similarity=0.489  Sum_probs=209.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC---hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+......   ......+.+|+.+++++. ||||+++++++.  ....
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLR--DDET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEc--cCCe
Confidence            4699999999999999999999999999999998644322   223456788999999996 999999999987  4568


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+.+ +|.+.+.. +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            9999999985 88888764 568999999999999999999999999999999999999999999999999987654321


Q ss_pred             Ccc---cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 ECL---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ...   ....|+..|+|||.+. +..++.++|||||||++|+|++|+.||...+.......+......  .      ...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~------~~~  229 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--P------QLP  229 (263)
T ss_pred             cccccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--C------CCC
Confidence            111   2356889999999984 556899999999999999999999999776555444333222111  1      011


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..++..+.++|.+||..+|.+|||+.++++||||
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            3568899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-44  Score=344.16  Aligned_cols=250  Identities=25%  Similarity=0.422  Sum_probs=199.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++.+.||+|+||.||+|.+.     .++..||+|++... ........+.+|+.++..+..||||+++++++.. ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence            57999999999999999999752     44578999998643 2334456788999999999669999999998753 35


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-----------------------------------------------------------
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-----------------------------------------------------------  117 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-----------------------------------------------------------  117 (404)
                      ..+++||||++ |+|.+++..                                                           
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            56899999999 589888763                                                           


Q ss_pred             ----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--ccccccccccccc
Q psy14434        118 ----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRA  191 (404)
Q Consensus       118 ----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~a  191 (404)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......+++.|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                1367788899999999999999999999999999999999999999999999986533221  1122345678999


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH-HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhcc
Q psy14434        192 PEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQIL  269 (404)
Q Consensus       192 PE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  269 (404)
                      ||++ .+..++.++|||||||++|+|++ |..||.+....... ..+........         ...+++.+.+|+.+||
T Consensus       245 PE~~-~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl  314 (338)
T cd05102         245 PESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA---------PENATPEIYRIMLACW  314 (338)
T ss_pred             cHHh-hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHc
Confidence            9998 45678999999999999999997 99999876543332 22222211111         1356889999999999


Q ss_pred             ccCCCCCCCHHHHHh
Q psy14434        270 VLNPSERPETDQILE  284 (404)
Q Consensus       270 ~~dp~~Rpt~~~ll~  284 (404)
                      +.||.+|||+.++++
T Consensus       315 ~~dp~~RPs~~el~~  329 (338)
T cd05102         315 QGDPKERPTFSALVE  329 (338)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.9e-44  Score=333.12  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=201.2

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhccCh-hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      ||+|+||.||++.++.+|+.||+|.+....... ........|+.+++.+. ||||+++++++.  ....+|+||||+.|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~--~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFE--SKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEe--cCCeEEEEEecCCC
Confidence            799999999999999999999999986543222 23344567999999996 999999999987  56789999999985


Q ss_pred             -cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        110 -DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       110 -~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                       +|...+..   ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....... ......|
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence             88877753   248889999999999999999999999999999999999999999999999997665432 2234568


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-hCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ++.|+|||++. +..++.++|+|||||++|+|++|..||.+.........+... ......      .....++.++.+|
T Consensus       157 ~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l  229 (277)
T cd05607         157 TNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK------FEHQNFTEESKDI  229 (277)
T ss_pred             CCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc------cccccCCHHHHHH
Confidence            99999999984 555899999999999999999999999765432221122111 111111      0113568999999


Q ss_pred             HHhccccCCCCCCCH----HHHHhccCCCCcC
Q psy14434        265 LNQILVLNPSERPET----DQILEHNYVSKYF  292 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~----~~ll~hp~~~~~~  292 (404)
                      |.+||+.||.+||++    .+++.||||....
T Consensus       230 i~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         230 CRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            999999999999999    6788999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=336.38  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=217.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+..|+.+++.+. ||||+++++++.  .....|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQ--TETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeee--cCCEEE
Confidence            4799999999999999999999999999999999655333 245667889999999997 999999999986  567899


Q ss_pred             EEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+.+ +|.+++..   ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999985 89888874   358999999999999999999999999999999999999999999999999987543211


Q ss_pred             C-----------------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy14434        178 E-----------------------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS  228 (404)
Q Consensus       178 ~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  228 (404)
                      .                             ......||..|+|||++ .+..++.++|||||||++|+|++|..||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1                             11234688999999998 45668999999999999999999999998887


Q ss_pred             cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC----HHHHHhccCCCCcCCCC
Q psy14434        229 TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE----TDQILEHNYVSKYFPSA  295 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~~ll~hp~~~~~~~~~  295 (404)
                      .......+.......+.        ....+..+.++|.+||..||.+|||    ++++|.||||+...++.
T Consensus       237 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         237 RDETFSNILKKEVTFPG--------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             hHHHHHHHhcCCccCCC--------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            76665554432211111        1236899999999999999999999    99999999999865444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-44  Score=334.61  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=208.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...... ........+|+.+++.+. |++|+.+++.+.  ....+|+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~l   77 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCL   77 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEe--cCCEEEE
Confidence            478899999999999999999999999999998654322 223445678999999996 999999999987  4668999


Q ss_pred             EEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||+. ++|.+.+..   ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... 
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999998 589887753   348999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......|++.|+|||++ .+..++.++|+||+||++|+|++|..||.....................      .....++
T Consensus       157 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  229 (285)
T cd05630         157 TIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE------EYSEKFS  229 (285)
T ss_pred             cccCCCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh------hcCccCC
Confidence            22345799999999998 4567899999999999999999999999875432211111111111000      1124568


Q ss_pred             HHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCc
Q psy14434        259 EEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKY  291 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~  291 (404)
                      +++.+|+.+||+.||.+|||     +.++++||||...
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            89999999999999999999     9999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.9e-44  Score=331.06  Aligned_cols=256  Identities=29%  Similarity=0.497  Sum_probs=209.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc----C
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~----~   97 (404)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|.+....   .....+..|+.+++.+.+||||+++++++....    .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            457999999999999999999999999999999985432   234567789999999866999999999986432    2


Q ss_pred             CeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ..+|++|||+.+ +|.+++..   ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            468999999985 88888874   35899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        174 SDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ...........|++.|+|||++.+    ...++.++|+||+||++|+|++|..||...........+....  ...    
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~----  235 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APR----  235 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCC----
Confidence            433333345679999999999842    3357889999999999999999999997665544333322211  111    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                        .....++..+.+||.+||..+|.+|||+.+++.||||
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 --LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             --CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence              0113467899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.7e-44  Score=340.16  Aligned_cols=273  Identities=36%  Similarity=0.610  Sum_probs=221.2

Q ss_pred             cccccCCeEE-eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhH------------HHHHHHHHHHHHhccCCCC
Q psy14434         18 DGNILAEYTI-HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------------AQRTYREILFLKSFQRHPN   84 (404)
Q Consensus        18 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~E~~~l~~l~~hpn   84 (404)
                      ..++.++|.. .+.||.|+||+||+|.+..+++.||+|++.........            ...+.+|+.+++.+. |||
T Consensus         3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~   81 (335)
T PTZ00024          3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN   81 (335)
T ss_pred             ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence            3456778875 47799999999999999999999999998544222110            124678999999997 999


Q ss_pred             cceEeeEEEeccCCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceE
Q psy14434         85 IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        85 Iv~l~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vk  163 (404)
                      |+++++++.  .....|+||||+.++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++
T Consensus        82 iv~~~~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         82 IMGLVDVYV--EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eeeeeEEEe--cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence            999999987  5678999999999999988864 4689999999999999999999999999999999999999999999


Q ss_pred             EeccccccccCC--------------CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy14434        164 IGDLGLARSLSD--------------SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST  229 (404)
Q Consensus       164 l~Dfg~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  229 (404)
                      |+|||++.....              .........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976541              112223345788999999986555679999999999999999999999998887


Q ss_pred             HHHHHHHHHhhCCCCCC------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        230 SHQLQLIVNLVRPNPPH------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ...+..+..........                  ...+.......+..+.+||.+||+.+|.+|||++++|.||||...
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            77776666544321110                  111122234568889999999999999999999999999999876


Q ss_pred             CC
Q psy14434        292 FP  293 (404)
Q Consensus       292 ~~  293 (404)
                      ..
T Consensus       320 ~~  321 (335)
T PTZ00024        320 PL  321 (335)
T ss_pred             CC
Confidence            43

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.8e-44  Score=326.76  Aligned_cols=252  Identities=32%  Similarity=0.584  Sum_probs=215.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.+. ||||+++++++.  .....|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFE--ENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeec--CCCeEEEE
Confidence            599999999999999999999999999999998765445556677889999999997 999999999987  56789999


Q ss_pred             EeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+.+ +|.+.+...   .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            999985 888888642   4789999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|++.|+|||.+ .+..++.++|+|||||++|+|++|..||...+.......+.....+..+         ..++.
T Consensus       158 ~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  227 (256)
T cd08218         158 ARTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS---------SHYSY  227 (256)
T ss_pred             hhhccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc---------ccCCH
Confidence            3345688999999997 4566888999999999999999999999887776665555443322111         34588


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ++.++|.+||+.+|.+||++.++++||||
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-44  Score=342.10  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             Eeeeeccc--CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         27 IHKRIGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        27 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      +++.||+|  +||+||++.++.+|+.||+|.+............+.+|+.+++.+. ||||+++++++.  .+...|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~--~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFI--ADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--ECCEEEEEE
Confidence            56889999  7789999999999999999999765555555667778999999996 999999999987  467899999


Q ss_pred             eccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--
Q psy14434        105 EYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--  178 (404)
Q Consensus       105 E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--  178 (404)
                      ||+. ++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9998 588888863   3489999999999999999999999999999999999999999999999987654322111  


Q ss_pred             -----cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        179 -----CLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       179 -----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                           ......++..|+|||++.+. ..++.++|||||||++|+|++|..||.................+...       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 11223567889999998543 46899999999999999999999999865544332222211110000       


Q ss_pred             -----------------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        246 -----------------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       246 -----------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                                   ...........+++.+.+||.+||+.||++|||++++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                         0000000112356789999999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.6e-44  Score=337.02  Aligned_cols=267  Identities=36%  Similarity=0.673  Sum_probs=216.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc----
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~----   96 (404)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|.+..............+|+.+++.+. ||||+++++++....    
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            368999999999999999999999999999999998654333333345678999999996 999999999875322    


Q ss_pred             --CCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         97 --NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        97 --~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                        ...+|+||||+.++|...+..  ..+++..++.++.||++||.|||++|++|+||||+||++++++.++|+|||++..
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              346899999999988877763  4699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCC-----------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC
Q psy14434        173 LSDSKE-----------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       173 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      ......           ......|++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            543211           112346788999999886556689999999999999999999999998888777666655443


Q ss_pred             CCCCC--------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        242 PNPPH--------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       242 ~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ...+.                    .......+...++.+.+||.+||..||.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            21110                    001111223456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.6e-44  Score=332.24  Aligned_cols=256  Identities=30%  Similarity=0.479  Sum_probs=211.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      -|++.+.||.|+||.||+|.+..++..+|+|.+...  .........+|+.+++.+. ||||+++++++.  .....|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~--~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCD-HPNIVKLLDAFY--YENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEe--eCCEEEEE
Confidence            378999999999999999999999999999998432  3445667788999999996 999999999987  46789999


Q ss_pred             EeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        104 FEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       104 ~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      |||+.+ +|...+.  .+.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999985 7777665  3568999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        181 TEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      ....|++.|+|||++.    .+..++.++|+|||||++|+|++|.+||...+.......+.....+...       ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  233 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-------QPSR  233 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-------Cccc
Confidence            4567899999999873    2345778999999999999999999999877665544444333221111       1134


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ++..+.+||.+||..||.+||++.++++||||...
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            67899999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-44  Score=332.14  Aligned_cols=263  Identities=37%  Similarity=0.708  Sum_probs=216.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.+. |+||+++++++.  .....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFR--RKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEE--ECCEEEE
Confidence            4799999999999999999999999999999998765555555677889999999997 999999999987  4678999


Q ss_pred             EEeccCCcHHHH-HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-c
Q psy14434        103 VFEYMENDLNKV-IRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-C  179 (404)
Q Consensus       103 v~E~~~~~L~~~-l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~  179 (404)
                      ||||+++++... ... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            999999765444 333 4589999999999999999999999999999999999999999999999999987655432 3


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-------------  246 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  246 (404)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.........+.......++.             
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            3456789999999998655478999999999999999999999998877665555544433211110             


Q ss_pred             --------cchhhcccC-CCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 --------ADKFYAGFK-NKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 --------~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                              .......++ .++.++.+||.+||..+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                    000111122 248899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4236|consensus

Probab=100.00  E-value=4.9e-46  Score=347.89  Aligned_cols=273  Identities=27%  Similarity=0.476  Sum_probs=228.3

Q ss_pred             CCCCCCCCcccccccccccCCeEE--eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccC
Q psy14434          4 NTTSKSGDKVQHNVDGNILAEYTI--HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR   81 (404)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~   81 (404)
                      .+.|.++.+++.+++..  .-|++  .+.||+|.||+||-|.++.+|+.||||+|.+.........++..|+.+|+.+. 
T Consensus       545 ~s~s~s~~qiqe~vd~s--tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-  621 (888)
T KOG4236|consen  545 QSISVSNCQIQENVDIS--TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-  621 (888)
T ss_pred             CCccccchhhhhhhhHH--HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-
Confidence            34444555556555443  34555  58999999999999999999999999999887666667788899999999997 


Q ss_pred             CCCcceEeeEEEeccCCeEEEEEeccCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         82 HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        82 hpnIv~l~~~~~~~~~~~~~lv~E~~~~~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ||.||.+.-.|+  ..+.+++|||-+.|+....|-   .++|++...+.++.||+.||.|||-++|+|+||||+|||+..
T Consensus       622 HPGiV~le~M~E--T~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas  699 (888)
T KOG4236|consen  622 HPGIVNLECMFE--TPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLAS  699 (888)
T ss_pred             CCCeeEEEEeec--CCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeecc
Confidence            999999999988  466799999999999766663   578999999999999999999999999999999999999965


Q ss_pred             C---CceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q psy14434        159 S---CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 ~---~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  235 (404)
                      .   ..+||||||+|+.+... ....+.+|||.|.|||++ ....|+.+.|+||+|||+|--+.|..||....+  .-.+
T Consensus       700 ~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQ  775 (888)
T KOG4236|consen  700 ASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQ  775 (888)
T ss_pred             CCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccc--hhHH
Confidence            4   47999999999988754 455678999999999998 577899999999999999999999999965433  2334


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      |.+.....++.      -|..+++++.|||+.+|+..-++|.|.+..|.|||++++
T Consensus       776 IQNAaFMyPp~------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  776 IQNAAFMYPPN------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             hhccccccCCC------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            44443333331      246789999999999999999999999999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.2e-44  Score=330.72  Aligned_cols=256  Identities=26%  Similarity=0.481  Sum_probs=208.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~--~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYL--RRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--eCCEEE
Confidence            35899999999999999999999999999999998543  2234455678999999996 999999999986  567899


Q ss_pred             EEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+++ +|.+++. .+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999985 8988886 456999999999999999999999999999999999999999999999999998765443333


Q ss_pred             ccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 LTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .....|++.|+|||++.  ....++.++|+|||||++|+|++|..||.................. ++..    .....+
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~  237 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKL----KDKMKW  237 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC-CCcc----cccCCC
Confidence            34567999999999873  2345788999999999999999999998665544333222221111 1110    111246


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNY  287 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~  287 (404)
                      +..+.+||.+||..+|++|||++++++|||
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-43  Score=330.34  Aligned_cols=264  Identities=24%  Similarity=0.440  Sum_probs=213.1

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ...+...++|++.+.||+|+||.||+|.+..+++.+|+|++...   ......+.+|+.+++++.+|||++++++++...
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455678999999999999999999999999999999998532   123345668899999996699999999998643


Q ss_pred             c---CCeEEEEEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         96 N---NKDLYVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        96 ~---~~~~~lv~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      +   ...+|+||||+.+ +|.+++.     ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence            2   3568999999985 8888775     24689999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ||++..............|+..|+|||.+....    .++.++|+|||||++|+|++|++||...........+.....+
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            999986654333333456899999999974332    3678999999999999999999999877655444443322111


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ...       .....+..+.+||.+||+.+|++||++.+++.||||.
T Consensus       252 ~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 TLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            110       0123567899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-44  Score=337.21  Aligned_cols=264  Identities=36%  Similarity=0.673  Sum_probs=209.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcC--CCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKN--NKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+.... ..........+|+.+++.+. ||||+++++++.......+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            58999999999999999999988  89999999986532 12333456678999999997 9999999999986545789


Q ss_pred             EEEEeccCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc----CCceEEeccccc
Q psy14434        101 YVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK----SCSIKIGDLGLA  170 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~----~~~vkl~Dfg~a  170 (404)
                      |+||||++++|..++..      ..+++..++.++.||+.||.|||+.|++||||||+||+++.    ++.+||+|||++
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999999888776642      25889999999999999999999999999999999999999    899999999999


Q ss_pred             cccCCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHHHH
Q psy14434        171 RSLSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH---------QLQLIVN  238 (404)
Q Consensus       171 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~~~~  238 (404)
                      ........   .....++++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.....         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543221   22345789999999988665678999999999999999999999997654322         1222222


Q ss_pred             hhCCCCC---------------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        239 LVRPNPP---------------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       239 ~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .......                           ........+...+..+.++|.+||+.||.+|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            2111000                           0001111112567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-43  Score=323.42  Aligned_cols=252  Identities=27%  Similarity=0.507  Sum_probs=217.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++++.||.|+||.||.+.+..+++.+++|.+............+.+|+.+++++. |+||+++++++.  +...++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFM--DDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEe--cCCeEEEE
Confidence            599999999999999999999999999999998766556666777889999999996 999999999987  56789999


Q ss_pred             EeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||+. ++|.+.+...   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            99998 4899888753   5899999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|++.|+|||.+. +..++.++|+|||||++|+|++|..||...........+........         ...++.
T Consensus       158 ~~~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  227 (256)
T cd08221         158 AETVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---------VSVYSS  227 (256)
T ss_pred             ccccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---------ccccCH
Confidence            44567899999999974 55678999999999999999999999988777666655543322111         145688


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+.++|.+||..+|.+||++.++++|||+
T Consensus       228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         228 ELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-44  Score=336.01  Aligned_cols=264  Identities=26%  Similarity=0.491  Sum_probs=219.9

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+...+.|.....||.|+||.||++.+..++..||||.+...  .......+.+|+..++.+. ||||+++++.+.  ..
T Consensus        17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~--~~   91 (292)
T cd06658          17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYH-HENVVDMYNSYL--VG   91 (292)
T ss_pred             cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCC-CCcHHHHHHhee--cC
Confidence            345556677788899999999999999999999999998532  2344566789999999996 999999999987  56


Q ss_pred             CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ...|+||||+.+ +|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        92 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          92 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            789999999985 7888888778999999999999999999999999999999999999999999999999998765443


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      ........|++.|+|||.+ .+..++.++|+|||||++|+|++|..||...+.......+.....+...       ....
T Consensus       172 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  243 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-------DSHK  243 (292)
T ss_pred             cccCceeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-------cccc
Confidence            3333456789999999997 4567889999999999999999999999887765555444333222111       1134


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .+..+.++|.+||..||.+|||+.++++||||....++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            57889999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-43  Score=331.39  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=215.4

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++.  +...+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQ--DDSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEE--cCCeEE
Confidence            479999999999999999999999999999999865432 2344567789999999997 999999999987  567899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+. ++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......   
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999996 689888864 56999999999999999999999999999999999999999999999999999876543   


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      ....+|++.|+|||.+. +...+.++|+||||+++|+|++|..||...+.......+.......+          ...+.
T Consensus       155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~  223 (290)
T cd05580         155 TYTLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----------SFFSP  223 (290)
T ss_pred             CCCCCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----------ccCCH
Confidence            23457899999999984 55678999999999999999999999987775544444442221111          33578


Q ss_pred             HHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        260 EAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      .+.++|.+||..||.+|+     +++++++||||....+
T Consensus       224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             HHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence            999999999999999999     9999999999987553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-43  Score=329.88  Aligned_cols=258  Identities=24%  Similarity=0.397  Sum_probs=212.6

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .|+..+.||.|+||.||+|.+..+++.||+|.+...... ........+|+.+++.+. |+||+.+++++.  .+..+++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~l   77 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYE--TKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEe--cCCEEEE
Confidence            478899999999999999999999999999998654322 223445678999999996 999999999987  5678999


Q ss_pred             EEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||+.+ +|...+..   ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~  156 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E  156 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence            9999995 78777653   35999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......|++.|+|||.+ .+..++.++|+|||||++|+|++|..||.+.........+..........      ....++
T Consensus       157 ~~~~~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  229 (285)
T cd05632         157 SIRGRVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV------YSAKFS  229 (285)
T ss_pred             cccCCCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc------cCccCC
Confidence            22445799999999998 45678999999999999999999999998876654444443333221111      114568


Q ss_pred             HHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~  292 (404)
                      .++.+|+.+||+.||.+||+     +.+++.|+||....
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            89999999999999999999     88999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0579|consensus

Probab=100.00  E-value=8.9e-46  Score=352.38  Aligned_cols=259  Identities=28%  Similarity=0.511  Sum_probs=220.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..+-|.|+..||-|+||.||+|..+.++-..|.|+|  ...+...+...+-||.+|.... ||+|+++++.|.  -++.+
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI--etkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy--~enkL  104 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI--ETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYY--FENKL  104 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhh--cccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHh--ccCce
Confidence            345699999999999999999999999988899998  3446778888999999999997 999999999876  36679


Q ss_pred             EEEEeccCCc-HHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYMEND-LNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~~~-L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+.|||+|+ ...++-  .+.|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.......
T Consensus       105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999999975 444443  5679999999999999999999999999999999999999999999999999997655444


Q ss_pred             Ccccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        178 ECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ....+++|||.|||||++.    ...+|++++||||||++|.||..+.+|-...+....+-++.+...|....       
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-------  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-------  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-------
Confidence            5556789999999999973    35689999999999999999999999988777766655554433322211       


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ...++..+.|||.+||.+||+.||+++++|+||||...
T Consensus       258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            14567899999999999999999999999999999853

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=328.07  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=210.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc----C
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~----~   97 (404)
                      .++|++.+.||.|++|.||+|.++.+++.+++|++....   .....+.+|+.+++++..||||+++++++....    .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            468999999999999999999999999999999985432   234567799999999967999999999987422    4


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      ..+|+||||+.+ +|.+++..     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            568999999995 78877753     468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .............|++.|+|||.+..    ...++.++|||||||++|+|++|..||...........+.....+...  
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  239 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK--  239 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC--
Confidence            65443333445678999999998743    235678899999999999999999999766554444443332211110  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ....++..+.+||.+||..||++|||+.++++|||+
T Consensus       240 -----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 -----SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                 112357899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-43  Score=325.89  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=213.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||.|+||.||+|....++..+|+|++....... ....+.+|+..++.+. |+||+++++.+.  .....|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCN-HPNVVKYYTSFV--VGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcC-CCCEEEEEEEEe--eCCEEEE
Confidence            47999999999999999999999999999999986543333 6677889999999996 999999999886  5678999


Q ss_pred             EEeccCC-cHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        103 VFEYMEN-DLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||++.+ +|.+.+..    ..+++..++.++.||+.||+|||+.|++||||+|+||++++++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999985 88888864    358999999999999999999999999999999999999999999999999997665432


Q ss_pred             Cc----ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        178 EC----LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       178 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ..    .....|+..|+|||.+.....++.++|+|||||++|+|++|..||...+.............+...    ....
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~  232 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE----TGAD  232 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcC----Cccc
Confidence            22    234568999999999855547899999999999999999999999876655444333332111111    1111


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +..+++.+.+|+.+||..||++|||+.+++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            24668899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.7e-44  Score=328.29  Aligned_cols=258  Identities=27%  Similarity=0.481  Sum_probs=208.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++.  ....
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~--~~~~   80 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECK-HCNIVAYFGSYL--SREK   80 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcC-CCCeeeeeEEEE--eCCE
Confidence            3456899999999999999999999999999999998533  2233455778999999996 999999999987  4678


Q ss_pred             EEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+++ +|.+++. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999995 8888776 4568999999999999999999999999999999999999999999999999998764333


Q ss_pred             Cccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 ECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .......|++.|+|||.+..  ...++.++|+||+||++|+|++|..||...........+..... .++..    ....
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~  235 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKL----KDKT  235 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCC----cccc
Confidence            33344578999999998742  34467899999999999999999999865543322222211111 11100    1113


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNY  287 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~  287 (404)
                      .++..+.+||.+||..+|++|||++++++|+|
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            46789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-43  Score=330.28  Aligned_cols=258  Identities=28%  Similarity=0.492  Sum_probs=210.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec----
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~----   95 (404)
                      ...+.|++.+.||.|+||.||+|.+..+++.+|+|++...   ......+..|+.+++.+.+||||+++++++...    
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3557899999999999999999999999999999997432   234456778999999997799999999998521    


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      ....+|++|||+++ +|.+++..   ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            34678999999985 88888864   348888899999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .............|++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+........   
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---  246 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL---  246 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC---
Confidence            65433223345678999999998742    34578899999999999999999999976655443333222111110   


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ....++..+.+||.+||+.||.+|||+.++++||||
T Consensus       247 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 -----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                 113468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.1e-44  Score=331.92  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=212.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++++.||+|+||.||+|.+..++..||+|.+... ........+.+|+.+++++. ||||+++++++.  ....+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAV-SPYIVDFYGAFF--IEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhhee--cCCeEEE
Confidence            4799999999999999999999999999999988543 23444567889999999996 999999999987  4678999


Q ss_pred             EEeccCC-cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        103 VFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ||||+.+ +|..++..+    .+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999996 788888764    69999999999999999999996 59999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        177 KECLTEYIATRWYRAPEILISN-----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                        ......|++.|+|||.+.+.     ..++.++|+|||||++|+|++|..||...........+.......+..     
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  229 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-----  229 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-----
Confidence              22345688999999997432     235789999999999999999999997765544443333322221111     


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                       ....++.++.+||.+||..+|.+||++.+++.||||.....
T Consensus       230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         230 -LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             -CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence             11346899999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-44  Score=331.02  Aligned_cols=261  Identities=43%  Similarity=0.771  Sum_probs=218.8

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+++.+. ||||+++++++.  ....+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFR--HKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhc--cCCCEEEEE
Confidence            67889999999999999999999999999998765545455677888999999997 999999999976  467899999


Q ss_pred             eccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        105 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       105 E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      ||++++|...+...  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence            99999988888753  7899999999999999999999999999999999999999999999999999876554323344


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-Ccc-------------
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HAD-------------  248 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-------------  248 (404)
                      ..++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+........+ ...             
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            568899999999865547899999999999999999999999988877766666554332111 000             


Q ss_pred             ------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        249 ------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       249 ------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                            ......+.++..+.+||.+||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                  0111223568899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-43  Score=324.88  Aligned_cols=252  Identities=28%  Similarity=0.551  Sum_probs=208.6

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-------hHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-------TDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+.......       .....+.+|+.+++.+. ||||+++++++.  .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL--D   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--e
Confidence            5888999999999999999999999999999885442221       22355678999999996 999999999986  4


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ....++||||+.+ +|..++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++...
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            6789999999985 89888875 568999999999999999999999999999999999999999999999999988664


Q ss_pred             CCC------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        175 DSK------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       175 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ...      .......|+..|+|||.+ .+..++.++|+|||||++|+|++|..||.+.........+.....+..+   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  233 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP---  233 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC---
Confidence            211      111234688999999998 4556788999999999999999999999876655444443332222111   


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                            ..++..+.++|.+||+.||.+||++.++++||||
T Consensus       234 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 ------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                  3468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0983|consensus

Probab=100.00  E-value=1e-44  Score=314.74  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=216.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++.+.+..||+|+.|.|++++.+.+|...|||.+.+.. +.++.++++..+.++....+.|.||+.+++|.  .+..++|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi--~n~dV~I  168 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI--TNTDVFI  168 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe--eCchHHH
Confidence            34566788999999999999999999999999997653 56677888888988887777899999999998  4667899


Q ss_pred             EEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      .||.|..-++.+++  .++++|..+-.+..-++.||.||. .+||+|||+||+|||+++.|.+||||||++..+.+.. .
T Consensus       169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-A  247 (391)
T KOG0983|consen  169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-A  247 (391)
T ss_pred             HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-c
Confidence            99999976777665  467999999999999999999997 5789999999999999999999999999998776542 2


Q ss_pred             cccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        180 LTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .+...|.+.|||||.+.-  ...|+.++||||||++++||.||..||.+.+ +.+.+..+.+...   +...    .-.+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---P~L~----~~~g  320 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---PLLP----GHMG  320 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---CCCC----cccC
Confidence            345679999999999832  3578999999999999999999999999854 4455555555322   2221    1134


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      +|+.+++|+..||.+|+.+||...++|+|||+..+.
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            799999999999999999999999999999998653

>KOG0197|consensus

Probab=100.00  E-value=2.5e-44  Score=340.11  Aligned_cols=243  Identities=26%  Similarity=0.485  Sum_probs=207.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .+++++.||+|.||.||.|....+ ..||+|.+.....   ....+.+|+.+|++|. |++||++++++.  .+..+|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~--~~~piyIV  279 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM---SPEAFLREAQIMKKLR-HEKLVKLYGVCT--KQEPIYIV  279 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc---ChhHHHHHHHHHHhCc-ccCeEEEEEEEe--cCCceEEE
Confidence            467788999999999999988644 3589999865432   2345569999999997 999999999987  44579999


Q ss_pred             EeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||. |+|.++++.   +.+...+...++.||++|++||.++++|||||-..||||++++.+||+|||+|+...++...
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            99999 799999985   45899999999999999999999999999999999999999999999999999965443221


Q ss_pred             c-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 L-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      . .+.--..-|.|||.+ ....++.+||||||||+||||+| |+.||++.+..+.+..+.++.+...+         ..+
T Consensus       360 ~~~~~kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---------~~C  429 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---------EGC  429 (468)
T ss_pred             ecCCCCCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---------CCC
Confidence            1 111223459999998 57789999999999999999997 99999999999999999998885554         678


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHH
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQIL  283 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll  283 (404)
                      |+++-+++..||..+|++|||.+.+.
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            99999999999999999999998664

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4e-43  Score=327.49  Aligned_cols=263  Identities=24%  Similarity=0.431  Sum_probs=210.6

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe-
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA-   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~-   94 (404)
                      +-.....++|++.+.||+|+||.||+|.+..+++.+|+|++...   ......+.+|+.+++.+.+||||+++++++.. 
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            44456778999999999999999999999999999999987532   12234566899999999669999999998742 


Q ss_pred             --ccCCeEEEEEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         95 --VNNKDLYVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        95 --~~~~~~~lv~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                        ..+..+|+||||+++ +|.+++.     ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence              245679999999985 8887764     24588999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ||++..............|++.|+|||.+..    +..++.++|||||||++|+|++|..||...........+.....+
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            9999876543333344579999999998742    245788999999999999999999999776554433322211111


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..       .....++..+.+||.+||+.||++|||+.++++|+||
T Consensus       248 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            00       0112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-43  Score=331.83  Aligned_cols=268  Identities=35%  Similarity=0.628  Sum_probs=218.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      ...++|++.+.||.|+||.||+|.++.+|+.||+|.+............+.+|+.+++.+. ||||+++++++....   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            4567899999999999999999999999999999998654333344456678999999996 999999999986422   


Q ss_pred             -----CCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         97 -----NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        97 -----~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                           ...+|+||||+++++...+..  ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                 347899999999988887764  3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-Cc
Q psy14434        170 ARSLSDSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-HA  247 (404)
Q Consensus       170 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  247 (404)
                      +........ ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+........+ ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            986643321 1223356888999998865556789999999999999999999999888777776666665432211 00


Q ss_pred             -------------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        248 -------------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       248 -------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                                         ......+..++..+.++|.+||..||.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                               01112234568999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=323.03  Aligned_cols=255  Identities=29%  Similarity=0.513  Sum_probs=211.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++...  .......+.+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECR-HPNIVAYFGSYL--RRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCC-CCChhceEEEEE--eCCEEEE
Confidence            5899999999999999999999999999999998543  2235677889999999996 999999999986  5678999


Q ss_pred             EEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +|||+++ +|..++..  ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            9999995 88888764  46999999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 LTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .....++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+.......+..     .....+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL-----KDKEKW  232 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccc-----cchhhh
Confidence            3456789999999997432  267889999999999999999999998776555444333221111110     011235


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNY  287 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~  287 (404)
                      +.++.+||.+||..+|..|||+.+++.|+|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-43  Score=327.74  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=206.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+....... ...+...|+..+.+..+||||+++++++.  ....+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEE
Confidence            47999999999999999999999999999999986543332 34456667776555556999999999987  5667999


Q ss_pred             EEeccCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        103 VFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       103 v~E~~~~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|||++++|.+++..     ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999988877753     3589999999999999999999997 9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      . ......|+..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ....+..+.....+..+       
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  229 (283)
T cd06617         158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP-------  229 (283)
T ss_pred             c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC-------
Confidence            1 12334688999999987432   446889999999999999999999996532 22333333222111111       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ...+|.++.+||.+||..+|.+||++.++++||||...
T Consensus       230 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         230 -AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence             12368899999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG1989|consensus

Probab=100.00  E-value=5.3e-44  Score=355.06  Aligned_cols=248  Identities=28%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeE-EE--ecc--CC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI-YK--AVN--NK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~-~~--~~~--~~   98 (404)
                      ++++.+.|.+|||+.||+|.+...|..||+|++...  ++..+..+.+||.+|+.|.+|+|||.+++. ..  ..+  .-
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            588899999999999999999988889999998544  778888899999999999999999999993 22  112  24


Q ss_pred             eEEEEEeccC-CcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .++|+||||. |+|-+++.   +..|++.++++||+|+++||++||...  |||||||-|||||+.+|.+||||||.+..
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            6789999999 58988887   345999999999999999999999988  99999999999999999999999999975


Q ss_pred             cCCCCCccc---------ccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC
Q psy14434        173 LSDSKECLT---------EYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       173 ~~~~~~~~~---------~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      .........         ....|+.|+|||++.  ++...+.++|||+|||+||-||+...||.+....    .|.++..
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y  271 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNY  271 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccc
Confidence            433221111         124699999999972  4567899999999999999999999999776443    3444444


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..|+        ++.++..+.+||+.||+.||++||++-+++.+
T Consensus       272 ~~P~--------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  272 SFPP--------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             cCCC--------CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            3333        25668899999999999999999999998865

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-43  Score=327.50  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=214.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+.|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.+. ||||+++++++.  +....|
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   78 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KGTKLW   78 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCEEE
Confidence            356889999999999999999999999999999985432 2345667888999999996 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        102 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      +||||+++ +|.+++..+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        79 lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          79 IIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            99999985 89999988889999999999999999999999999999999999999999999999999997665433333


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ....++..|+|||.+. +..++.++|+|||||++|+|++|..||...........+.....+.         ....++..
T Consensus       159 ~~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~  228 (277)
T cd06640         159 NTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT---------LTGEFSKP  228 (277)
T ss_pred             ccccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC---------CchhhhHH
Confidence            4456888999999974 5568999999999999999999999998766554433322111111         11345788


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +.+++.+||+.+|.+||++.++++|+||..
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         229 FKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence            999999999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-43  Score=326.12  Aligned_cols=263  Identities=38%  Similarity=0.679  Sum_probs=217.6

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+++.+. |||++++++++........++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEe
Confidence            78899999999999999999999999999999765434445566778999999997 99999999998743237899999


Q ss_pred             eccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-ccc
Q psy14434        105 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CLT  181 (404)
Q Consensus       105 E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-~~~  181 (404)
                      ||++++|..++...  .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            99999998888754  699999999999999999999999999999999999999999999999999987654321 123


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------------  246 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  246 (404)
                      ...++..|+|||.+.+...++.++|||||||++|+|++|+.||...........+..........               
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            34678899999987655668999999999999999999999998888776666665543321110               


Q ss_pred             -----cchhhcccCC-CCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 -----ADKFYAGFKN-KPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 -----~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ...+...+.. ++..+.++|.+||+.+|.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                 0011112223 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-43  Score=326.43  Aligned_cols=254  Identities=25%  Similarity=0.482  Sum_probs=204.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++. ||||+++++++.  .....++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCD-SPYIIGFYGAFF--VENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--ECCEEEE
Confidence            47899999999999999999999999999999985432 2334566788999999996 999999999987  4667899


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||||+++ +|...   ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......  ...
T Consensus        77 v~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~  151 (279)
T cd06619          77 CTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAK  151 (279)
T ss_pred             EEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--ccc
Confidence            9999996 55433   35788999999999999999999999999999999999999999999999999765432  234


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHhh-CCCCCCcchhhcccCCC
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ---LQLIVNLV-RPNPPHADKFYAGFKNK  257 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~  257 (404)
                      ..+||+.|+|||.+. +..++.++|+|||||++|+|++|..||........   ........ .......     .....
T Consensus       152 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  225 (279)
T cd06619         152 TYVGTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-----PVGQF  225 (279)
T ss_pred             CCCCChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-----CCCcC
Confidence            467999999999984 56689999999999999999999999965332110   00111111 1111100     01345


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ++++.+||.+||+.+|.+||++.+++.||||...
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            7899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-43  Score=326.56  Aligned_cols=257  Identities=26%  Similarity=0.488  Sum_probs=214.5

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEeccCCeEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+.  .|||++++++++.  .+...|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEE
Confidence            5888999999999999999999999999999986432 3344566778999999886  5999999999986  567899


Q ss_pred             EEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        102 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      +||||+.+ +|.+++..+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        79 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            99999985 89999888889999999999999999999999999999999999999999999999999998765544334


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ....|+..|+|||.+.++..++.++|+|||||++|+|++|..||.+.........+...   .++...     ....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~-----~~~~~~~  230 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KPPRLE-----DNGYSKL  230 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CCCCCC-----cccCCHH
Confidence            45578999999999865666789999999999999999999999876654433222211   111100     0126789


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +.+++.+||..||.+||++.+++.|+||...
T Consensus       231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         231 LREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            9999999999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-43  Score=324.68  Aligned_cols=251  Identities=25%  Similarity=0.459  Sum_probs=211.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+..... .....+.+|+.+++++. ||||+++++++.  +...+|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQ--DEENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhc--CCCeEEE
Confidence            5899999999999999999999999999999997553332 45677889999999996 999999999986  5778999


Q ss_pred             EEeccCC-cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        103 VFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      ||||+.| +|...+... .+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence            9999985 899888765 79999999999999999999999999999999999999999999999999998765432 23


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ....|+..|+|||.+ .+..++.++|+||||+++|+|++|..||...+..  ..+...........         ...++
T Consensus       157 ~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  226 (258)
T cd05578         157 TSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY---------PATWS  226 (258)
T ss_pred             cccCCChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccC---------cccCc
Confidence            445688999999998 4556899999999999999999999999877642  22222111111111         13457


Q ss_pred             HHHHHHHHhccccCCCCCCCH--HHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPET--DQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~--~~ll~hp~~  288 (404)
                      ..+.++|.+||+.||.+||++  .++++||||
T Consensus       227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         227 TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.4e-43  Score=319.67  Aligned_cols=251  Identities=30%  Similarity=0.493  Sum_probs=213.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+............+.+|+.+++.+. ||||+++++.+.  .....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFL--EDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEe--cCCEEEEE
Confidence            599999999999999999999999999999999766555666778889999999997 999999999986  56789999


Q ss_pred             EeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCCCCC
Q psy14434        104 FEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~~~~  178 (404)
                      |||+.+ +|.+++...   .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            999985 899988753   389999999999999999999999999999999999998654 58999999998765432 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......|+..|+|||.+ .+..++.++|+||||+++|+|++|..||.+.+.......+........+         ..++
T Consensus       157 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~  226 (256)
T cd08220         157 KAYTVVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---------DRYS  226 (256)
T ss_pred             cccccccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---------CCcC
Confidence            22345689999999998 4566889999999999999999999999887766555554433222111         3468


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..+.+++.+||..+|.+|||+.++++||||
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.2e-44  Score=332.06  Aligned_cols=256  Identities=27%  Similarity=0.492  Sum_probs=212.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.  .....|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYITRYYGSYL--KGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCC-CCccHhhhcccc--cCCceEE
Confidence            46788899999999999999999999999999985432 2334567889999999996 999999999987  5667999


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||||+++ +|.+++..+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            9999995 898888888899999999999999999999999999999999999999999999999999976654332233


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...|+..|+|||.+ .+..++.++|+|||||++|+|++|..||...........+.....+.         ....++..+
T Consensus       160 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  229 (277)
T cd06642         160 TFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---------LEGQYSKPF  229 (277)
T ss_pred             cccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---------CCcccCHHH
Confidence            45688999999998 45678899999999999999999999997655444333222211111         112457889


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      .++|.+||+.+|++||++.++++||||..+.
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         230 KEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.6e-43  Score=322.74  Aligned_cols=256  Identities=27%  Similarity=0.506  Sum_probs=207.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..|++.+.||+|+||.||+|.+..++..||+|++.....   .......+.+|+.+++.+. ||||+++++++.......
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence            368999999999999999999999999999998854422   2234556788999999996 999999999987545678


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-  176 (404)
                      ++++|||+.+ +|.+.+.. +.+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            8999999985 89888864 56899999999999999999999999999999999999999999999999998765321 


Q ss_pred             --CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 --KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                        ........++..|+|||.+ .+..++.++|+||+||++|+|++|+.||...........+...  ...+..      .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~------~  231 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTNPQL------P  231 (266)
T ss_pred             ccCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCCCCC------c
Confidence              1112234588999999998 4567889999999999999999999999876554433332211  111111      1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ..+++.+.+|| +||..+|.+||++++++.||||+
T Consensus       232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            23578889999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.4e-43  Score=329.53  Aligned_cols=261  Identities=25%  Similarity=0.427  Sum_probs=210.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.... ......++.+|+.+++++. ||||+++++++.  .+..+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECN-SPYIVGFYGAFY--SDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCCEEEE
Confidence            47999999999999999999999999999999985432 2344566889999999996 999999999987  5678999


Q ss_pred             EEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||+.+ +|.+++.. +.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++......  .
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~  154 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  154 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence            9999985 89988864 568999999999999999999997 69999999999999999999999999998765332  2


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-------------  246 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  246 (404)
                      ....+|++.|+|||.+ .+..++.++|+|||||++|+|++|+.||...+.......+..........             
T Consensus       155 ~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2456789999999997 45668899999999999999999999997665433222221110000000             


Q ss_pred             ----------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        247 ----------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       247 ----------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                      .... .....++.++.+|+.+||..+|++|||+.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                            0000 0001257789999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.1e-43  Score=321.75  Aligned_cols=251  Identities=33%  Similarity=0.569  Sum_probs=209.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||.|+||.||+|.+..++..+|+|.+...    .....+.+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCD-SPYIVKYYGSYF--KNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCC-CCcEeeeeeeee--cCCcEEE
Confidence            5799999999999999999999998999999998533    22667889999999995 999999999987  4678999


Q ss_pred             EEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ++||+.+ +|.+++..  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999995 89888863  45899999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|+..|+|||.+ .+..++.++|||||||++|+|++|+.||...........+........       .....++.
T Consensus       156 ~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~  227 (256)
T cd06612         156 RNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL-------SDPEKWSP  227 (256)
T ss_pred             cccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC-------CchhhcCH
Confidence            3445688999999997 456789999999999999999999999987655443322221111100       11134578


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+.++|.+||+.||.+|||+.++|.||||
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            89999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-43  Score=331.37  Aligned_cols=261  Identities=25%  Similarity=0.474  Sum_probs=217.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +.....|.....||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.+. ||||+++++++.  .+.
T Consensus        17 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~   91 (297)
T cd06659          17 GDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYL--VGE   91 (297)
T ss_pred             ccchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCC-CCchhhhhhhee--eCC
Confidence            34555677788999999999999999999999999998543  2234456778999999996 999999999987  467


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ..|+||||+++ +|..++....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            89999999995 88888888789999999999999999999999999999999999999999999999999997654433


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......|++.|+|||.+ .+..++.++|+|||||++|+|++|..||...........+........       .....+
T Consensus       172 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~  243 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-------KNAHKI  243 (297)
T ss_pred             ccccceecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCc-------cccCCC
Confidence            333456799999999998 455689999999999999999999999987766555444332211111       112456


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      +..+.++|.+||+.+|.+||++.++++||||.+..
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            88999999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0696|consensus

Probab=100.00  E-value=1.6e-44  Score=329.24  Aligned_cols=264  Identities=26%  Similarity=0.404  Sum_probs=228.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      -.-..+|..+..||+|+||.|.+|..+.+.+.||||++.+... ...+..--+.|-++|.....-|.+++++.+|..  -
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--m  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--M  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--h
Confidence            3455789999999999999999999999999999999977532 233344445666777666667899999999984  5


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.| +|-..+++ +.+.+..+..++.+|+.||-+||++||++||||.+|||++.+|++||+|||+++.-.-
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            579999999995 88777764 7799999999999999999999999999999999999999999999999999997666


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      ......++||||.|+|||++ ...+|+.++|+||+||+||||+.|.+||++.+..+.++.|++..-..+          .
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----------K  571 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----------K  571 (683)
T ss_pred             CCcceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----------c
Confidence            66667889999999999998 578899999999999999999999999999999999999987654333          4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCH-----HHHHhccCCCCcCCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPET-----DQILEHNYVSKYFPSA  295 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~~~~  295 (404)
                      .+|.++.++...+|.+.|.+|...     .++-.||||...-|..
T Consensus       572 slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  572 SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            568999999999999999999754     6899999998766543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-42  Score=324.73  Aligned_cols=258  Identities=27%  Similarity=0.529  Sum_probs=215.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ..|...+.||.|++|.||++.+..+++.+|+|++...  .......+.+|+.+++.+. ||||+++++++.  .....++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~--~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYL--VGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcC-CCChheEEEEEE--cCCeEEE
Confidence            3566678999999999999999999999999988432  3334456789999999996 999999999987  4677999


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ++||+.+ +|.+++..+.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+...........
T Consensus        94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          94 VMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             EEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            9999985 899998888899999999999999999999999999999999999999999999999998876544333334


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...|++.|+|||.+ .+..++.++|+|||||++|+|++|..||...+.......+.....+...       ....++..+
T Consensus       174 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l  245 (285)
T cd06648         174 SLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-------NLHKVSPRL  245 (285)
T ss_pred             cccCCccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-------ccccCCHHH
Confidence            45789999999997 4556889999999999999999999999877665555544433211111       112367899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+||.+||+.+|++|||+.++++||||....+
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.9e-43  Score=329.91  Aligned_cols=262  Identities=29%  Similarity=0.518  Sum_probs=217.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +...++|.+.+.||+|+||.||++.+..++..||+|.+...  .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~   89 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENK-HPNIVNYLDSYL--VGD   89 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcC-CCCeeehhheee--eCC
Confidence            45568999999999999999999999989999999998532  3334566788999999996 999999999987  466


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ..|+|+||+.+ +|.+++....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            79999999984 89999988889999999999999999999999999999999999999999999999999987665443


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......|++.|+|||.+ ....++.++|+|||||++|+|++|..||...+.......+.....+..       .....+
T Consensus       170 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~  241 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-------QNPEKL  241 (293)
T ss_pred             cccccccCChhhcCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCC-------CCcccc
Confidence            334455789999999997 455688999999999999999999999987665443322221111110       111345


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      +..+.++|.+||..+|.+||++.+++.|+||....+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            788999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.8e-43  Score=328.99  Aligned_cols=262  Identities=26%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++.+||||+++++++.  .....++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWI   80 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEE
Confidence            4677888999999999999999999999999998654322 445667889999999977999999999876  4667899


Q ss_pred             EEeccCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        103 VFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       103 v~E~~~~~L~~~l~------~~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      +|||+.+++..+..      .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            99999976654432      35699999999999999999999974 999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ... .....|++.|+|||.+.+.  ..++.++|||||||++|+|++|+.||.....  ....+.......++....  ..
T Consensus       161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~--~~  235 (288)
T cd06616         161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSN--SE  235 (288)
T ss_pred             CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCC--cC
Confidence            221 2334688999999998544  3689999999999999999999999976542  222222222211111110  11


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ...++.++.+||.+||+.+|.+|||+.+++.||||..+.
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            134788999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-42  Score=320.67  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=207.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc----ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR----NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|.+.....    .......+.+|+.+++.+. |+||+++++++.  +...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCL--DDNT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEee--cCCe
Confidence            588999999999999999986 4788899998854321    2233456788999999996 999999999987  4678


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-  176 (404)
                      ++++|||+.+ +|.+++.. +.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999985 89988875 56899999999999999999999999999999999999999999999999998754211 


Q ss_pred             -----CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        177 -----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       177 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                           ........|+..|+|||.+ .+..++.++|+|||||++|+|++|..||...+.......+.......+..     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  230 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL-----  230 (265)
T ss_pred             ccccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCC-----
Confidence                 1122345689999999998 45668899999999999999999999998766554443333322221111     


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                        ...++.++.+||.+||+.+|.+||++.++++||||
T Consensus       231 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         231 --PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              13468899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=326.51  Aligned_cols=261  Identities=40%  Similarity=0.725  Sum_probs=218.6

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||+|++|.||+|....+++.||+|++...............|+.+++.+. |+||+++++++.  .....++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIH--TERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhh--cCCceEEEe
Confidence            67889999999999999999999999999999765444445566778999999997 999999999986  457899999


Q ss_pred             eccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        105 EYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       105 E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      ||++++|.+++...  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++............
T Consensus        78 e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          78 EYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             cCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence            99999999999865  6999999999999999999999999999999999999999999999999999876544333344


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC----------------
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH----------------  246 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------  246 (404)
                      ..++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+......+..+..........                
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            5678889999998655578999999999999999999999998887776666655543311110                


Q ss_pred             ---cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 ---ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 ---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                         .......++..+..+.++|.+||..||++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence               001112234457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986|consensus

Probab=100.00  E-value=2.6e-44  Score=331.29  Aligned_cols=275  Identities=25%  Similarity=0.388  Sum_probs=223.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .+.|+.-+.||+||||.||-++.+.||+-||+|++.+..... ......+.|-.+|.++. .+.||.+-..|+  ....+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfe--Tkd~L  260 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFE--TKDAL  260 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeec--CCCce
Confidence            356888999999999999999999999999999996554333 33344578888999886 899999998888  46679


Q ss_pred             EEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ++||..|.| ||.-.|.+   ..|++..+..++.+|+.||.+||+.+|++|||||+|||+|+.|+++|+|.|+|..+...
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            999999995 88766642   35999999999999999999999999999999999999999999999999999988765


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      . ...+.+||.+|||||++. ...|+.+.|+|||||++|+|+.|..||...........+.......+....      ..
T Consensus       341 ~-~~~~rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~------~k  412 (591)
T KOG0986|consen  341 K-PIRGRVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS------DK  412 (591)
T ss_pred             C-ccccccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc------cc
Confidence            4 345568999999999984 555999999999999999999999999776554444344443332222111      45


Q ss_pred             CCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCCCC---CCCCCCCCCCcc
Q psy14434        257 KPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFPSA---THVIPQVTPHTV  307 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~~~---~~~~~~~~~~~~  307 (404)
                      +|+++++|.+.+|+.||.+|.     .+.++-+||||+...+..   ....||..|++.
T Consensus       413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~  471 (591)
T KOG0986|consen  413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG  471 (591)
T ss_pred             cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence            699999999999999999997     567999999999865432   334455555543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-43  Score=351.89  Aligned_cols=268  Identities=25%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCC-eEEEEE--------------Ecch-hccChhHHHHHHHHHHHHHhccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAIK--------------KIFE-AFRNKTDAQRTYREILFLKSFQRH   82 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK--------------~~~~-~~~~~~~~~~~~~E~~~l~~l~~h   82 (404)
                      ..+.++|++++.||+|+||.||+|..+... ...++|              .+.+ ..........+.+|+.+|+.+. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            346688999999999999999998765332 222222              1111 1122334556779999999997 9


Q ss_pred             CCcceEeeEEEeccCCeEEEEEeccCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         83 PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        83 pnIv~l~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~------l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                      |||+++++++.  .....|+||+++.++|..++....      .....++.++.||+.||.|||++||+||||||+|||+
T Consensus       223 pnIv~l~~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        223 ENILKIEEILR--SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CCcCcEeEEEE--ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            99999999987  466789999999988887775432      3456788899999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCCC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCC--CcHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP-LFPGA--STSHQ  232 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~-pf~~~--~~~~~  232 (404)
                      +.++.+||+|||++..+..... .....+||+.|+|||++ .+..++.++|||||||++|+|++|.. ||...  .....
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987654322 22346799999999998 45678999999999999999999875 44332  22233


Q ss_pred             HHHHHHhhCCC----CC-------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        233 LQLIVNLVRPN----PP-------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       233 ~~~~~~~~~~~----~~-------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      +..+.......    +.                   ....+.. ...++..+.++|.+||++||.+|||+.|+|.||||.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR-NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH-hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            33333222110    00                   0000000 123567788999999999999999999999999997


Q ss_pred             Cc
Q psy14434        290 KY  291 (404)
Q Consensus       290 ~~  291 (404)
                      ..
T Consensus       459 ~~  460 (501)
T PHA03210        459 AE  460 (501)
T ss_pred             cC
Confidence            63

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-42  Score=325.68  Aligned_cols=259  Identities=28%  Similarity=0.410  Sum_probs=212.4

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++.+.  .+..+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFE--TKRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEe--cCCEEE
Confidence            379999999999999999999999999999999865432 2334567778999999996 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        102 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      +||||+.| +|..++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......  
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999985 89988864 568999999999999999999999999999999999999999999999999986321100  


Q ss_pred             -------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        178 -------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       178 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                                   .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||.+.........+.......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                         0111245788999999974 56689999999999999999999999988776655555444322211


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCC---HHHHHhccCCCCcC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE---TDQILEHNYVSKYF  292 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~hp~~~~~~  292 (404)
                      ..       ...++..+.++|.+||+.||++||+   +.++|+||||....
T Consensus       237 ~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         237 EG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             Cc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            11       1246889999999999999999998   79999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4279|consensus

Probab=100.00  E-value=3.9e-44  Score=344.28  Aligned_cols=250  Identities=28%  Similarity=0.536  Sum_probs=213.6

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      .||+|.||+||.|+|..+...+|||-+.  ..+....+.+..||.+-+.|+ |.|||+++|.+.  +++.+-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIp--ekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~s--enGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIP--EKDSREVQPLHEEIALHSTLR-HKNIVRYLGSVS--ENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecc--cccchhhccHHHHHHHHHHHh-hHhHHHHhhccC--CCCeEEEEeecCCC
Confidence            4999999999999999999999999984  446677888899999999997 999999999965  67888999999995


Q ss_pred             -cHHHHHHh--cCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCCCCCccccc
Q psy14434        110 -DLNKVIRD--KIL--KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEY  183 (404)
Q Consensus       110 -~L~~~l~~--~~l--~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~  183 (404)
                       +|..+++.  +++  .+..+.++.+||++||+|||.+.|+|||||-+||||+. .|.+||+|||-++.+..-+++..++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence             89999986  456  78889999999999999999999999999999999976 7999999999999988878888889


Q ss_pred             ccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        184 IATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      .||..|||||++..+ ..|+.++|||||||++.||.||++||.........--.......-|+.       ...++.+++
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~i-------Peelsaeak  809 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPI-------PEELSAEAK  809 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCC-------cHHHHHHHH
Confidence            999999999999543 579999999999999999999999997665543221111111111111       134578899


Q ss_pred             HHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        263 DLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .||.+|+.+||.+||++.++|..||++..
T Consensus       810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  810 NFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHcCCCcccCccHHHhccCcccccC
Confidence            99999999999999999999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-42  Score=318.42  Aligned_cols=252  Identities=33%  Similarity=0.574  Sum_probs=211.0

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|.+.+.||+|+||.||+|.++.+|..+|+|.+............+.+|+.+++.+. |+||+++++.+.  .....|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQ--ENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheec--cCCeEEEE
Confidence            589999999999999999999999999999998665444455667779999999996 999999999976  56789999


Q ss_pred             EeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc-eEEeccccccccCCCCC
Q psy14434        104 FEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSDSKE  178 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~-vkl~Dfg~a~~~~~~~~  178 (404)
                      +||+.+ +|.+++...   .+++..+..++.||+.||.|||+.+++|+||||+||++++++. ++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999985 888888642   4789999999999999999999999999999999999998864 69999999987655433


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......|++.|+|||.+ ....++.++|+|||||++|+|++|..||...........+......         ...+..+
T Consensus       158 ~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~  227 (257)
T cd08225         158 LAYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---------PISPNFS  227 (257)
T ss_pred             cccccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---------CCCCCCC
Confidence            33445689999999987 4556889999999999999999999999876655544433322111         1113567


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..+.++|.+||..+|++|||+.++++||||
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         228 RDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-42  Score=322.98  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=197.3

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhccChhH-HHHHHHHHHHHHhc--cCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREILFLKSF--QRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l--~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      .||+|+||.||++.+..+++.+|+|.+.+....... .....+|..+++.+  ..||||+.+++++.  .....|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence            489999999999999999999999998654333222 22233444333332  25999999999987  46679999999


Q ss_pred             cCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      +.+ +|..++. .+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.......  .....
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcC
Confidence            995 8887776 4569999999999999999999999999999999999999999999999999987654322  23356


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      |++.|+|||.+.++..++.++|+||+||++|+|++|..||......... .+.........      .....++.++.++
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~l  229 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNV------ELPDSFSPELKSL  229 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCc------CCccccCHHHHHH
Confidence            9999999999855566899999999999999999999999764332211 11111111110      0113568899999


Q ss_pred             HHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        265 LNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       265 i~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      |.+||..||.+||     |+.++++||||.....
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence            9999999999999     6999999999998554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.4e-42  Score=318.78  Aligned_cols=256  Identities=27%  Similarity=0.496  Sum_probs=208.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+.....   .......+.+|+.+++.+. ||||+++++++.......
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            579999999999999999999999999999998853321   2234567788999999996 999999999987544567


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++++|||+++ +|.+++.. +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999985 89888865 568999999999999999999999999999999999999999999999999987653211


Q ss_pred             ---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 ---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                         .......|+..|+|||.+. +..++.++|+|||||++|+|++|+.||...........+...  +..+..      .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~------~  231 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVL------P  231 (265)
T ss_pred             ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCC------c
Confidence               1123356889999999984 566889999999999999999999999776544443332211  111100      1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ...+..+.++|.+|+. +|.+||+++++++|||+.
T Consensus       232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            3457789999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-42  Score=322.81  Aligned_cols=255  Identities=26%  Similarity=0.491  Sum_probs=213.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +-|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.++..+. ||||+++++++.  .+...|+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEE--eCCeEEE
Confidence            35888999999999999999999999999999875332 2334566778999999996 999999999987  5678999


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||||+++ +|..++..+.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            9999985 888888888899999999999999999999999999999999999999999999999999876654332333


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...|+..|+|||.+ .+...+.++|+|||||++|+|++|..||...........+.....+.         ....++.++
T Consensus       160 ~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  229 (277)
T cd06641         160 TFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---------LEGNYSKPL  229 (277)
T ss_pred             cccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---------CCcccCHHH
Confidence            45688999999997 45567889999999999999999999997766544444332221111         113468899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .++|.+||+.+|.+||++.++++||||...
T Consensus       230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         230 KEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-42  Score=317.88  Aligned_cols=248  Identities=30%  Similarity=0.542  Sum_probs=209.1

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.... .........+|+.+++.+. ||||+++++++.  ....+|++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFE--ADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEEEEE
Confidence            5899999999999999999999999999999985432 2345567778999999996 999999999987  56789999


Q ss_pred             EeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      |||++ ++|.+.+..   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99998 488887753   34899999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....|++.|+|||++ .+..++.++|+||||+++|+|++|..||...+.......+........+         ..++.
T Consensus       157 ~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  226 (255)
T cd08219         157 ACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---------SHYSY  226 (255)
T ss_pred             cccccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---------cccCH
Confidence            4456789999999997 4566899999999999999999999999887766555544433222111         34578


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+.+||.+||+.||++|||+.+++.-
T Consensus       227 ~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         227 ELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            89999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-42  Score=317.06  Aligned_cols=253  Identities=28%  Similarity=0.521  Sum_probs=209.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.....   .......+.+|+.+++.+. ||||+++++++.  +...+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTER--EEDNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEe--cCCeE
Confidence            58888999999999999999998999999999854321   2345567889999999996 999999999976  56789


Q ss_pred             EEEEeccCC-cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |++|||+++ +|.+++... .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            999999985 899888754 48999999999999999999999999999999999999999999999999987654432 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......|++.|+|||.+.....++.++|+|||||++|+|++|..||...........+..... .+.       ....++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~-------~~~~~~  228 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPP-------IPDHLS  228 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-CCC-------cCCCcC
Confidence            234566899999999984333489999999999999999999999977664443333322111 111       113468


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +.+.+|+.+||+.+|.+||++.+++.|||+
T Consensus       229 ~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         229 DEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.2e-42  Score=318.15  Aligned_cols=255  Identities=28%  Similarity=0.498  Sum_probs=214.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+..+..+. |+||+++++++.  ....+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCE-SPYVVKCYGAFY--KEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc--cCCeEEE
Confidence            3689999999999999999999999999999998654322 45677889999999997 999999999987  4678999


Q ss_pred             EEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||+. ++|.+++.. ..+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.........
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            999999 589999875 679999999999999999999999 99999999999999999999999999999876554443


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .....++..|+|||.+ ....++.++|+||||+++|+|++|..||....   .......+.   .......      ...
T Consensus       157 ~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~------~~~  226 (264)
T cd06623         157 CNTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPPPSL------PAE  226 (264)
T ss_pred             ccceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCCCCC------Ccc
Confidence            3456789999999997 45678999999999999999999999997774   222222222   2111111      123


Q ss_pred             -CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 -KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 -~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ++..+.++|.+||..+|++||++.++++||||+.+
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence             68899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-42  Score=321.87  Aligned_cols=261  Identities=29%  Similarity=0.447  Sum_probs=208.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.... ......++.+|+.+++.+. ||||++++++|.......+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence            47999999999999999999999999999999986432 2345667889999999996 999999999987556668999


Q ss_pred             EEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        103 VFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       103 v~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ||||+++ +|.+++.     ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999985 8877664     245889999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHhhCCCCCCcchhh
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-----SHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .  .....++..|+|||.+ .+..++.++|+|||||++|+|++|..||.....     .+....+.....+...   ...
T Consensus       159 ~--~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  232 (287)
T cd06621         159 L--AGTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK---DEP  232 (287)
T ss_pred             c--cccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc---cCC
Confidence            2  2244678899999987 466789999999999999999999999976622     2222222221111110   000


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..-...++.+.+||.+||..+|.+|||+.+++.||||...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            0001246789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.4e-43  Score=323.33  Aligned_cols=257  Identities=28%  Similarity=0.540  Sum_probs=210.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||.|++|.||+|.++.+++.+|+|.+..... .....++.+|+.+++.+. ||||+++++++.  ....+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCN-SPYIVGFYGAFY--NNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCC-CCchhhhheeee--cCCEEEE
Confidence            468899999999999999999999999999999865432 345567789999999997 999999999987  4578999


Q ss_pred             EEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|||+. ++|.+++..  ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999 589998874  568999999999999999999999 9999999999999999999999999999876543221


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                        ....++..|+|||.+ .+..++.++|+|||||++|+|++|..||.....  ......+........+....     ..
T Consensus       157 --~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  228 (265)
T cd06605         157 --KTFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-----GK  228 (265)
T ss_pred             --hcccCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-----hh
Confidence              226788999999998 456789999999999999999999999976521  11112222222211111100     11


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ++..+.++|.+||..||.+|||+.+++.||||+.+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            68899999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-42  Score=315.49  Aligned_cols=252  Identities=32%  Similarity=0.595  Sum_probs=216.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|++|.||++.+..++..||+|++............+.+|+.+++.+. |||++++++.+.  .....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~--~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFE--EKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEe--cCCEEEEE
Confidence            589999999999999999999999999999999766555567778889999999997 999999999987  45789999


Q ss_pred             EeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        104 FEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||+++ +|.+.+..     ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999985 89888864     569999999999999999999999999999999999999999999999999998765544


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      .......|++.|+|||.+ .+..++.++|+||+|+++|+|++|..||...+................+         ..+
T Consensus       158 ~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  227 (258)
T cd08215         158 DLAKTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---------SQY  227 (258)
T ss_pred             ceecceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---------CCC
Confidence            344456789999999987 4556889999999999999999999999887765554444332221111         256


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +..+.+++.+||..+|++|||+.++|+||||
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            7899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0669|consensus

Probab=100.00  E-value=1.9e-45  Score=315.87  Aligned_cols=269  Identities=36%  Similarity=0.663  Sum_probs=224.0

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe------
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------   94 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~------   94 (404)
                      .++.|.-...||+|.||.||+|+.+.+|+.||+|++........--...++|+.+|..++ |+|++.+++++..      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcc
Confidence            456788889999999999999999999999999988655444555567789999999997 9999999887642      


Q ss_pred             ccCCeEEEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+...+|+||.+|+.+|..++...  +++..++..++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.
T Consensus        94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            134569999999999999999754  699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        173 LSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       173 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      +....    ...+..+.|.||++||.+.+...|+++.|||..|||+.+|++|.+.+.+.....++..|....+......+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            64322    22455678999999999999999999999999999999999999999999999888887665543222100


Q ss_pred             h------hhccc-------------C------CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        249 K------FYAGF-------------K------NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       249 ~------~~~~~-------------~------~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +      ++...             +      .-++++.+|+.+||..||.+|++++++|.|.||..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            0      00000             0      01358999999999999999999999999999974

>KOG0668|consensus

Probab=100.00  E-value=3.6e-44  Score=303.99  Aligned_cols=268  Identities=31%  Similarity=0.551  Sum_probs=222.5

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+-..++|++++.+|+|-|+.||.|....+++.++||+++     ....+.+.+|+.+|+.|.+||||++++++..++..
T Consensus        33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            3445678999999999999999999999999999999984     45677889999999999999999999999998888


Q ss_pred             CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~~~~  175 (404)
                      ....+|+||+.. ++..+..  .|+.-+++.++.+|+.||.|||++||.|||+||.|++|+.. -.++|+|+|+|.....
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             cCchhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            899999999996 5554443  38889999999999999999999999999999999999865 5699999999987765


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCC---------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPP---------  245 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~---------  245 (404)
                      +. .....+.+..|--||.+..-+.|+.+.|+|||||++..|+..+.| |.|.+..+++-+|...++....         
T Consensus       186 ~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  186 GK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             Cc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            42 234456788899999998888999999999999999999998755 5778888887777665442111         


Q ss_pred             -------------Ccchhhcc-----cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        246 -------------HADKFYAG-----FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       246 -------------~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                                   ....+...     -.-+++++.|||.++|..|..+|+|+.|++.||||.....
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence                         00111100     0124689999999999999999999999999999986443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-42  Score=324.44  Aligned_cols=258  Identities=26%  Similarity=0.508  Sum_probs=215.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ..|.....||+|+||.||++....+++.||+|++...  .......+.+|+.+++.+. |+||+++++++.  .....++
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   94 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDELWV   94 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcC-CcchhheeeEEE--eCCEEEE
Confidence            3455567899999999999999999999999987432  3344566788999999996 999999999987  4678999


Q ss_pred             EEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        103 VFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||||+.+ +|.+++..+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657          95 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            9999985 788888877899999999999999999999999999999999999999999999999999876544333334


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...|++.|+|||.+ .+..++.++|+||+||++|+|++|..||.+.........+.........       ....++..+
T Consensus       175 ~~~~~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l  246 (292)
T cd06657         175 SLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-------NLHKVSPSL  246 (292)
T ss_pred             ccccCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-------CcccCCHHH
Confidence            45789999999987 4566789999999999999999999999877666555444333221111       124568899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+++.+||+.+|.+||++.+++.||||....+
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999999999998664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.1e-42  Score=315.94  Aligned_cols=256  Identities=29%  Similarity=0.550  Sum_probs=211.0

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.+. |+||+++++++.  +...+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEV--HREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEe--cCCEEEEE
Confidence            699999999999999999999999999999998765544557788899999999996 999999999875  57789999


Q ss_pred             EeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc-
Q psy14434        104 FEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-  180 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-  180 (404)
                      +||+. ++|.+++..+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99998 5899988764 58899999999999999999999999999999999999999999999999998765432221 


Q ss_pred             ---cccccccccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        181 ---TEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       181 ---~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                         ....+++.|+|||.+....  .++.++||||||+++|+|++|..||...+........... ...+. .    +...
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-~----~~~~  231 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP-I----PDSL  231 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC-C----Cccc
Confidence               1356889999999984332  3788999999999999999999999766443332222221 11111 1    1123


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+++.+.+||.+||+.+|.+|||+.+++.|||+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            458899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0671|consensus

Probab=100.00  E-value=2.7e-44  Score=325.54  Aligned_cols=265  Identities=27%  Similarity=0.484  Sum_probs=215.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-C----CcceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-P----NIITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p----nIv~l~~~~~   93 (404)
                      +.+.++|.++..+|+|.||.|..+.|..++..||||+++.-   ..-.....-|+.+|.++..+ |    -++.+.++|.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            34578999999999999999999999999999999998422   12234455789999999533 3    3777877776


Q ss_pred             eccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc------------
Q psy14434         94 AVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK------------  158 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~------------  158 (404)
                        -.+..|||+|.++-++.++++.+   +++..+++.+++||+.++++||+.+++|-||||+|||+.+            
T Consensus       162 --yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  162 --YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             --ccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence              47789999999998999999864   4889999999999999999999999999999999999831            


Q ss_pred             --------CCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q psy14434        159 --------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS  230 (404)
Q Consensus       159 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  230 (404)
                              +..|+|+|||.|......   ....+.|..|+|||+++ +-.++.++||||+||||+||++|...|+..++.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    345899999999865433   25678999999999996 667999999999999999999999999999988


Q ss_pred             HHHHHHHHhhCCCCCCcchhh---------------------------------cccCCCC---HHHHHHHHhccccCCC
Q psy14434        231 HQLQLIVNLVRPNPPHADKFY---------------------------------AGFKNKP---EEAVDLLNQILVLNPS  274 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~---~~~~~li~~~L~~dp~  274 (404)
                      +.+..+...+++.|.....-.                                 ..+...+   ..+.|||++||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            888777777776555111000                                 0000111   3588999999999999


Q ss_pred             CCCCHHHHHhccCCCCcC
Q psy14434        275 ERPETDQILEHNYVSKYF  292 (404)
Q Consensus       275 ~Rpt~~~ll~hp~~~~~~  292 (404)
                      +|+|+.|+|.||||+...
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998753

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-42  Score=321.10  Aligned_cols=252  Identities=26%  Similarity=0.366  Sum_probs=204.7

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      ||+|+||+||+|.+..+|+.||+|.+...... ......+..|+.+++.++ ||||+++++++.  .....|+||||+.+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFE--TKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEe--cCCeEEEEEecCCC
Confidence            69999999999999999999999998654322 233445578999999997 999999999987  46789999999994


Q ss_pred             -cHHHHHHh-c--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        110 -DLNKVIRD-K--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       110 -~L~~~l~~-~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                       +|.+.+.. +  .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||.+...... .......+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence             89888864 3  5899999999999999999999999999999999999999999999999998765432 22334568


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      +..|+|||.+. +..++.++|+|||||++|+|++|+.||...........+.......+.      .....+++.+.++|
T Consensus       157 ~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li  229 (277)
T cd05577         157 TPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV------EYPDKFSPEAKDLC  229 (277)
T ss_pred             CCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc------cCCccCCHHHHHHH
Confidence            88999999984 455889999999999999999999999776543222222222211111      11134589999999


Q ss_pred             HhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      .+||+.||.+||     ++.+++.||||..+.+
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            999999999999     8999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-42  Score=322.17  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=206.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC-----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.+... ........+.+|+.++..+. ||||+++++++.  +
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT--K   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcC-CcccceEEEEEc--C
Confidence            458999999999999999999886655     67999998643 23344556789999999996 999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ....|++|||+. ++|.+++..                 ..+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            667899999998 589888864                 34788899999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14434        159 SCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  235 (404)
                      ++.++|+|||++.......  .......+++.|+|||.+. +..++.++|||||||++|+|++ |..||.+.........
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999997653322  1223345788999999874 5668999999999999999998 9999988777666555


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +........         ...++.++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            544322211         14578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=317.44  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=204.2

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +.||.|+||.||+|.+..+++.||+|.+.+.... .........|..++....+||||+++++++.  ....+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence            5799999999999999999999999998654221 2233344556665555556999999999987  567899999999


Q ss_pred             CC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc
Q psy14434        108 EN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA  185 (404)
Q Consensus       108 ~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g  185 (404)
                      .+ +|..++.. +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....    .....|
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCC
Confidence            85 89988875 5689999999999999999999999999999999999999999999999999876433    233468


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      ++.|+|||.+. +..++.++|+||||+++|+|++|..||...+.......+.......+..      ....++..+.++|
T Consensus       156 ~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~i  228 (260)
T cd05611         156 TPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE------VKEFCSPEAVDLI  228 (260)
T ss_pred             CcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCc------ccccCCHHHHHHH
Confidence            89999999985 4458999999999999999999999998877766555544332211111      1135689999999


Q ss_pred             HhccccCCCCCCC---HHHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERPE---TDQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rpt---~~~ll~hp~~~~~~~  293 (404)
                      .+||+.+|++||+   +++++.||||....|
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            9999999999995   579999999987544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.1e-42  Score=323.78  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC----------------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN----------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI   85 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   85 (404)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+... ........+.+|+.++.++. ||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLK-DPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcC-CCCe
Confidence            4589999999999999999997532                3457999998643 23344567889999999996 9999


Q ss_pred             ceEeeEEEeccCCeEEEEEeccC-CcHHHHHHhc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy14434         86 ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK--------------------ILKDVHIRYIMFQLCNGLSYIHACKV  144 (404)
Q Consensus        86 v~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~--------------------~l~~~~~~~i~~qil~al~~LH~~~i  144 (404)
                      +++++++.  +....++||||+. ++|.+++...                    .+++..+..++.||+.||.|||+.||
T Consensus        82 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          82 IRLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             eEEEEEEe--cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999987  4567999999998 4898888542                    25677889999999999999999999


Q ss_pred             ccCCCCCCcEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh--C
Q psy14434        145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--S  220 (404)
Q Consensus       145 ~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g  220 (404)
                      +||||||+|||++.++.+||+|||+++.......  ......++..|+|||++. ...++.++|||||||++|+|++  |
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999986543221  112234578899999974 5568999999999999999986  5


Q ss_pred             CCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        221 KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       221 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..||.+.+.......+..........  ......+.++..+.+|+.+||+.||.+|||+.++..
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQ--VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhcccc--ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            67887766655554443322211100  001112456889999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=321.30  Aligned_cols=260  Identities=39%  Similarity=0.745  Sum_probs=214.4

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |++.+.||+|++|.||+|....+++.||||.+...... .......+|+..++++.+||||+++++++.  .+...|+||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEE
Confidence            78899999999999999999999999999998654332 233345578999999977999999999987  477899999


Q ss_pred             eccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        105 EYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       105 E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||+.++|.+.+...   .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~  156 (283)
T cd07830          78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYT  156 (283)
T ss_pred             ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcC
Confidence            99988998887643   58999999999999999999999999999999999999999999999999998665432 234


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------------  246 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  246 (404)
                      ...++..|+|||.+.+...++.++|+||||+++++|++|.+||+..........+..........               
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            46689999999998666678999999999999999999999998887776666555443322110               


Q ss_pred             -----cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        247 -----ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       247 -----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                           ...........+..+.+||.+||+.+|++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                 001111123346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-42  Score=324.69  Aligned_cols=257  Identities=28%  Similarity=0.499  Sum_probs=213.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ......|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++++.  ..
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~--~~   87 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYL--RE   87 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEE--eC
Confidence            345567999999999999999999999999999999985432 23344567889999999996 999999999987  46


Q ss_pred             CeEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ...|+||||+.|++.+.+.  .+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            6789999999998877775  35689999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .    ....+++.|+|||++.+  ...++.++||||||+++|+|++|.+||.+.+.......+.....+...        
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  235 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS--------  235 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC--------
Confidence            2    34568899999998742  356788999999999999999999999877665544433222111111        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ...++..+.++|.+||..+|.+||++.+++.||||..
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            1235788999999999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0584|consensus

Probab=100.00  E-value=1e-43  Score=340.06  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=221.6

Q ss_pred             cccccccCCe-EEeeeecccCceeEEEEEEcCCCeEEEEEEcch--hccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         16 NVDGNILAEY-TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE--AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        16 ~~~~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      .+.....++| +....||+|+|-+||+|.|..+|..||.-.+..  -.......++++.|+.+|+.|+ ||||+++|+++
T Consensus        32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW  110 (632)
T KOG0584|consen   32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSW  110 (632)
T ss_pred             ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeehe
Confidence            3444555665 456889999999999999999999998865533  3456677899999999999997 99999999999


Q ss_pred             EeccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccC-CceEEecc
Q psy14434         93 KAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKS-CSIKIGDL  167 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~-~~vkl~Df  167 (404)
                      .+..+..+-+|+|++. |+|..++++ +.++...++.|++||++||.|||++.  |||||||-+||+|+.+ |.|||+|+
T Consensus       111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  111 VDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             ecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence            9878888999999998 799998875 66999999999999999999999986  9999999999999875 89999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHhhCCCCCC
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPH  246 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~  246 (404)
                      |+|.......  ....+|||.|||||++  ...|+..+||||||+++.||+|+..||.......++ +++..+..|..-.
T Consensus       191 GLAtl~r~s~--aksvIGTPEFMAPEmY--EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  191 GLATLLRKSH--AKSVIGTPEFMAPEMY--EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             hHHHHhhccc--cceeccCccccChHHH--hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence            9999876543  3458999999999998  467999999999999999999999999877666554 4455544432211


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                              .--.+++++||.+||.. ...|+|+.|||.||||..-
T Consensus       267 --------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 --------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             --------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                    11278999999999999 8999999999999999863

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-42  Score=318.96  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=207.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .|+..+.||+|++|.||+|.+..+++.||+|++......    ......+.+|+..++.++ ||||+++++++.  +...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATC--EDSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceec--cCCe
Confidence            488899999999999999999999999999998643321    224567889999999997 999999999986  5678


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~~  176 (404)
                      +++||||+.+ +|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            9999999995 89888864 5689999999999999999999999999999999999998776 5999999998766432


Q ss_pred             CC----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchhh
Q psy14434        177 KE----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY  251 (404)
Q Consensus       177 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  251 (404)
                      ..    ......|+..|+|||.+ .+..++.++|+|||||++|+|++|..||...........+..... .....     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  231 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS-----  231 (268)
T ss_pred             cccCCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC-----
Confidence            11    11234688999999997 456788999999999999999999999976554333333322211 11110     


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                       ....+++.+.+++.+||..+|.+|||+.++++||||.
T Consensus       232 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         232 -IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence             1134578999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.8e-42  Score=320.05  Aligned_cols=242  Identities=22%  Similarity=0.245  Sum_probs=200.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhH-HHHHHHHHHHHHhccCCCCcceEeeEEEe--ccCCeEEEEEe
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREILFLKSFQRHPNIITMLDIYKA--VNNKDLYVVFE  105 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~~~~~~~lv~E  105 (404)
                      ..||+|++|.||+|..  +|+.||+|.+......... ...+.+|+.+|+++. ||||+++++++..  .....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999977  6889999999765433322 456779999999997 9999999999865  33467899999


Q ss_pred             ccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        106 YMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       106 ~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      |+.+ +|.+++.. +.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......   ..
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence            9995 89998874 458999999999999999999998 499999999999999999999999999998654322   23


Q ss_pred             ccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        183 YIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ..|++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.......+.        ...+++.+
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------~~~~~~~l  251 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--------PLDCPLEI  251 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--------CCcCcHHH
Confidence            568999999999843 257899999999999999999999999988766665555433221111        12568899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHh
Q psy14434        262 VDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+|+.+||+.||++|||+.+++.
T Consensus       252 ~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        252 KCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.2e-42  Score=317.49  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=203.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+.... .......+.+|+..++.+. ||||+++++++.  ....
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFD-HSNIVRLEGVIT--RGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEe--cCCC
Confidence            46999999999999999999765   446789999986542 2334456789999999996 999999999987  5678


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .++||||+++ +|.+++..  +.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999995 78888864  36899999999999999999999999999999999999999999999999987654322


Q ss_pred             CCc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KEC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ... .....++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.+.......+........         .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~  230 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA---------P  230 (266)
T ss_pred             chhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---------C
Confidence            111 1122356789999997 45678999999999999999775 9999988877766666544322211         1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..++..+.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-42  Score=321.23  Aligned_cols=253  Identities=32%  Similarity=0.564  Sum_probs=213.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++++.+||||+++++++.  .....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence            479999999999999999999999999999999866432 33445667789999999966999999999986  567899


Q ss_pred             EEEeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        102 VVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      +||||+. ++|.+++... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            9999995 6899888754 79999999999999999999999999999999999999999999999999988654322  


Q ss_pred             ------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q psy14434        178 ------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL  239 (404)
Q Consensus       178 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  239 (404)
                                        .......++..|+|||.+ ....++.++|+||||+++++|++|..||...........+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                              112234578999999987 4556889999999999999999999999887765554444432


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCH----HHHHhccCC
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPET----DQILEHNYV  288 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~hp~~  288 (404)
                      ....+          ..+++.+.+||.+||+.+|.+||++    .++++||||
T Consensus       238 ~~~~~----------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            22211          3458899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=319.77  Aligned_cols=262  Identities=38%  Similarity=0.660  Sum_probs=210.6

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEeccC---Ce
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNN---KD   99 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~~~---~~   99 (404)
                      |++.+.||.|+||.||+|.++.+++.||+|.+..............+|+.+++.+.  .||||+++++++...+.   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999989999999999654433333445567877777664  49999999999874222   24


Q ss_pred             EEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ++++|||+.++|.+++..   ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            899999999988887764   24899999999999999999999999999999999999999999999999999776433


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-----------
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-----------  245 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  245 (404)
                      . ......++..|+|||.+. +..++.++|+|||||++|+|++|.+||.+.........+.........           
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             c-ccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2 223445888999999984 566889999999999999999999999988877776666553321100           


Q ss_pred             ------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        246 ------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       246 ------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                            .........+.++..+.++|.+||+.||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                  0011111123456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=311.69  Aligned_cols=252  Identities=31%  Similarity=0.557  Sum_probs=214.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++.++. |||++++++++.  +....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIE--TSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEE--eCCEEEEE
Confidence            589999999999999999999999999999999766555566778889999999996 999999999986  46789999


Q ss_pred             EeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        104 FEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      |||+.+ +|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999985 89888864 5799999999999999999999999999999999999999999999999999987765444334


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ...++..|+|||.+. +..++.++|+||||+++|+|++|..||.................+..         ...++..+
T Consensus       158 ~~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~  227 (254)
T cd06627         158 SVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL---------PEGISPEL  227 (254)
T ss_pred             ccccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC---------CCCCCHHH
Confidence            567899999999974 45588999999999999999999999987665444333322111111         14568899


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .+++.+||..+|++|||+.+++.||||
T Consensus       228 ~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         228 KDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.1e-42  Score=317.83  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             ccCCeEEeeee--cccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         21 ILAEYTIHKRI--GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        21 ~~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.|++.+.+  |.|+||.||++.++.++..+|+|.+.......       .|+.....+.+||||++++++|.  ...
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~--~~~   82 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT--TLK   82 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe--cCC
Confidence            45677887776  99999999999999999999999985432211       12222333346999999999987  456


Q ss_pred             eEEEEEeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~  175 (404)
                      ..|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            8999999998 5999998764 799999999999999999999999999999999999999998 999999999876543


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCCCcchhhccc
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .    ....|+..|+|||++ .+..++.++|+|||||++|+|++|..||........ ...+........       ...
T Consensus       163 ~----~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~  230 (267)
T PHA03390        163 P----SCYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL-------PFI  230 (267)
T ss_pred             C----ccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC-------Ccc
Confidence            2    234689999999998 456688999999999999999999999976543321 122222111111       112


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCC-HHHHHhccCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPE-TDQILEHNYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~hp~~~  289 (404)
                      +..++.+.+||.+||+.+|.+||+ ++++|+||||.
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            357899999999999999999996 59999999996

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.1e-42  Score=317.17  Aligned_cols=258  Identities=28%  Similarity=0.495  Sum_probs=206.6

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC--------hhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--------KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+......        ......+.+|+.+++.+. ||||+++++++.  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFET--   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEec--
Confidence            589999999999999999999999999999988532111        112345678999999996 999999999976  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      .....++||||+.+ +|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          79 TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            46789999999984 89888865 56899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC--CcccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        174 SDSK--ECLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       174 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ....  .......|+..|+|||.+.... .++.++|+||||+++|+|++|..||...........+..... ......  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~--  235 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-APPIPP--  235 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-CCcCCc--
Confidence            4321  1123456889999999985433 478999999999999999999999976554433332221111 111111  


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                       .....++..+.++|.+||..+|.+|||+.++++||||
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 -DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence             1124568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.7e-42  Score=315.59  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=207.0

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC-
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-  108 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-  108 (404)
                      ||.|++|.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  ++..+|++|||+. 
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFK--DKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEE--cCCccEEEEecCCC
Confidence            7999999999999999999999999965433 2344567889999999996 999999999987  5678999999998 


Q ss_pred             CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccccc
Q psy14434        109 NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR  187 (404)
Q Consensus       109 ~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~  187 (404)
                      ++|.+++.. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence            589988875 458999999999999999999999999999999999999999999999999998765432 223457899


Q ss_pred             ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHH
Q psy14434        188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS--TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL  265 (404)
Q Consensus       188 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (404)
                      .|+|||.+ ....++.++|+||||+++|+|++|..||....  .......+...... .. .      ....+.++.++|
T Consensus       157 ~~~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~-~------~~~~~~~~~~~i  227 (262)
T cd05572         157 EYVAPEII-LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LE-F------PNYIDKAAKDLI  227 (262)
T ss_pred             CccChhHh-cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-CC-C------CcccCHHHHHHH
Confidence            99999997 45668899999999999999999999997766  33333333321111 10 0      023478999999


Q ss_pred             HhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        266 NQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       266 ~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      .+||+.+|++||+     +.++++||||+.+.+
T Consensus       228 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         228 KQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             HHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            9999999999999     999999999997643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.8e-42  Score=315.19  Aligned_cols=249  Identities=29%  Similarity=0.501  Sum_probs=200.9

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      ...||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.+. |+||+++++++.  .+...++||||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDS--ENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeec--cCCEEEEEEecC
Confidence            35799999999999999999999999988533  3345667889999999996 999999999976  567899999999


Q ss_pred             C-CcHHHHHHh--cCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCCCCCccc
Q psy14434        108 E-NDLNKVIRD--KIL--KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       108 ~-~~L~~~l~~--~~l--~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      . ++|.+.+..  ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            8 489998875  345  78889999999999999999999999999999999976 67999999999976644333334


Q ss_pred             ccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        182 EYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...|++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||...................+.       ....++++
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~  240 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE-------IPESLSAE  240 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC-------CCcccCHH
Confidence            45689999999997433 34789999999999999999999999765433221111111111111       11346789


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +.+|+.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         241 AKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8e-42  Score=313.02  Aligned_cols=250  Identities=34%  Similarity=0.566  Sum_probs=214.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+............+.+|+.+++.+. ||||+++++++.  .....|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL--DGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhc--cCCEEEEE
Confidence            589999999999999999999999999999999766556666777889999999997 999999999987  46789999


Q ss_pred             EeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        104 FEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||+++ +|..++..     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999985 89888765     45899999999999999999999999999999999999999999999999999876543 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                       ......+++.|+|||.+ .+..++.++|+||||+++|+|++|+.||...+.......+.....+..+         ...
T Consensus       157 -~~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  225 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---------PIY  225 (256)
T ss_pred             -CcccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---------hhh
Confidence             22345689999999998 4667888999999999999999999999887766554444332222111         245


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      +.++.++|.+||..+|++|||+.++++||++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            7889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-42  Score=334.01  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=199.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+..+     +..||+|++.... .......+.+|+.+++.+.+||||+++++++.  .
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT--H  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec--C
Confidence            45799999999999999999986443     3579999996442 23345667899999999955999999999986  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh----------------------------------------------------------
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD----------------------------------------------------------  117 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~----------------------------------------------------------  117 (404)
                      ...+|+|||||. |+|.+++..                                                          
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            667999999998 588887753                                                          


Q ss_pred             -------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--cccc
Q psy14434        118 -------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTE  182 (404)
Q Consensus       118 -------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~  182 (404)
                                   .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ....
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                         1367788999999999999999999999999999999999999999999999976543221  1112


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhh-CCCCCCcchhhcccCCCCHH
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV-RPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ..+++.|+|||++ .+..++.++|||||||++|+|++ |+.||................ ....+         ..++++
T Consensus       274 ~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  343 (374)
T cd05106         274 ARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP---------DFAPPE  343 (374)
T ss_pred             CCCccceeCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC---------CCCCHH
Confidence            2355679999998 45678999999999999999997 999998765544333333221 11111         235789


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHh
Q psy14434        261 AVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +.+++.+||+.||.+|||+.++++
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-41  Score=314.45  Aligned_cols=252  Identities=31%  Similarity=0.561  Sum_probs=204.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++++.  .....
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   77 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFI--EDNEL   77 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEE--ECCeE
Confidence            368999999999999999999999999999999875432 33444566788999999996 999999999987  45689


Q ss_pred             EEEEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        101 YVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      +++|||+++ +|.+++.     ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999995 8887774     2348899999999999999999999999999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCCCcchhhc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ..........|++.|+|||.+. +..++.++|+||+|+++|+|++|..||......  .....+.....+...       
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  229 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP-------  229 (267)
T ss_pred             chhHHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC-------
Confidence            4333334456889999999984 566889999999999999999999998654322  222222211111110       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ....+..+.++|.+||..+|++||++.++++.
T Consensus       230 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         230 -TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence             12357889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.6e-42  Score=332.59  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=199.4

Q ss_pred             CCeEEeeeecccCceeEEEEEE-----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++.... .......+.+|+.+++.+..||||+++++++.  ..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~  111 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT--VG  111 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cC
Confidence            4799999999999999999964     3567789999986432 23445677899999999956999999999986  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc----------------------------------------------------------
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK----------------------------------------------------------  118 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~----------------------------------------------------------  118 (404)
                      ...|+|||||. |+|.+++...                                                          
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            67999999999 5888877531                                                          


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc-
Q psy14434        119 ------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-  179 (404)
Q Consensus       119 ------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-  179 (404)
                                        .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                              3677888999999999999999999999999999999999999999999999865432211 


Q ss_pred             -ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH-HHHhhCCCCCCcchhhcccCC
Q psy14434        180 -LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL-IVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       180 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  256 (404)
                       .....++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+......... +........+         ..
T Consensus       272 ~~~~~~~~~~y~aPE~~-~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  341 (375)
T cd05104         272 VKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP---------EC  341 (375)
T ss_pred             ccCCCCCCcceeChhHh-cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC---------CC
Confidence             1123346679999998 45678999999999999999998 8899987654433333 3222221111         23


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+.++.+||.+||+.||++|||+.++++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            47899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-41  Score=313.49  Aligned_cols=248  Identities=24%  Similarity=0.470  Sum_probs=206.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+...   ......+.+|+.+++.+. ||||+++++++.  ....++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCC-CCChhheEEEEc--CCCCcE
Confidence            35799999999999999999999999999999998532   334567789999999996 999999999976  566789


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||+. ++|.+++..   ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999998 589988864   248899999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 ECL-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      ... ....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||++.+.......+........         ..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  228 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER---------PE  228 (263)
T ss_pred             eeccCCCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---------CC
Confidence            111 112345679999987 46678899999999999999998 9999988777666555544332211         14


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .++.++.++|.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            568999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG2345|consensus

Probab=100.00  E-value=5.4e-43  Score=300.16  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=200.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE---eccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK---AVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~---~~~~~   98 (404)
                      .++|++.+.||.|||+.||+++...+++.||+|++...  ..++.+..++|+...++++ |||+++++++.-   .....
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCce
Confidence            46899999999999999999999999999999999554  4677888999999999997 999999998742   11345


Q ss_pred             eEEEEEeccC-CcHHHHHHh----c-CCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCceEEeccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD----K-ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~----~-~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ..||+++|.. |+|.+.++.    + .+++.++.+|+.+|++||++||+..  ++||||||.|||+++++.++|.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            6899999998 788888862    2 5999999999999999999999999  999999999999999999999999998


Q ss_pred             cccCCCCCc------c---cccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH
Q psy14434        171 RSLSDSKEC------L---TEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH--QLQLIV  237 (404)
Q Consensus       171 ~~~~~~~~~------~---~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~  237 (404)
                      ....-.-..      .   ..-.-|..|+|||.+.  .+...+.++|||||||+||+|+.|..||.......  ..-.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~  256 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ  256 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence            754321100      0   1123478899999983  23456889999999999999999999994321100  000001


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.....        +.-..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       257 n~q~s~--------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 NAQISI--------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccccc--------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            100001        1113468999999999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=311.66  Aligned_cols=255  Identities=26%  Similarity=0.511  Sum_probs=209.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc---cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....   ........+.+|+.+++++. ||||+++++++.......
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            47999999999999999999999999999999874321   22345567788999999997 999999999987655677


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-  176 (404)
                      ++++|||+.+ +|.+.+.. +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++..... 
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999985 88888764 56899999999999999999999999999999999999999999999999999865321 


Q ss_pred             --CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 --KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                        ........|+..|+|||.+. +..++.++|+|||||++|+|++|++||...........+..  .+..+..      .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~------p  231 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPML------P  231 (264)
T ss_pred             ccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCC------C
Confidence              11223456899999999984 55688999999999999999999999987655544433321  1111111      1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..++..+.++|.+||. +|.+||++.+++.|||.
T Consensus       232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            4568899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-41  Score=316.63  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=196.7

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhccChhH-HHHHHHHHH---HHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD-AQRTYREIL---FLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~---~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      .||+|+||.||+|.+..+++.||+|.+.+....... ......|..   .++.. .||+|+.+++++.  ....+|+|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFH--TPDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeee--cCCEEEEEEe
Confidence            489999999999999999999999998654322221 112223333   33333 4999999999987  4678999999


Q ss_pred             ccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccc
Q psy14434        106 YMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY  183 (404)
Q Consensus       106 ~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~  183 (404)
                      |+.| +|..++. .+.+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......  ....
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  155 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS  155 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCc
Confidence            9985 7887775 4568999999999999999999999999999999999999999999999999987654322  2345


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHH
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      +|+..|+|||.+.++..++.++|+||+||++|+|++|+.||.+...................       ....++..+.+
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~  228 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------LPDSFSPELRS  228 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC-------CCCcCCHHHHH
Confidence            79999999999865556899999999999999999999999776322211111111111111       01345889999


Q ss_pred             HHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        264 LLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       264 li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      +|.+||..+|.+||     ++.++++||||....+
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            99999999999999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-41  Score=318.44  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCe--EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ++|++.+.||.|+||.||+|.++.++.  .+++|.+.. .........+.+|+.++.++..||||+++++++.  ....+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcc
Confidence            589999999999999999999887764  468887752 2333445677889999999966999999999986  46679


Q ss_pred             EEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCce
Q psy14434        101 YVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI  162 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~v  162 (404)
                      |++|||+. ++|.+++...                 .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence            99999998 5899888642                 37888999999999999999999999999999999999999999


Q ss_pred             EEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhC
Q psy14434        163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      ||+|||++........ ......+..|+|||.+ ....++.++|||||||++|+|++ |..||.+.........+.....
T Consensus       159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             EECCcCCCccccceec-cCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999999864322111 1112235579999987 45668999999999999999997 9999988877666555544322


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+         ..++..+.+||.+||..+|.+|||++++++.
T Consensus       237 ~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 MEKP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2111         3468899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-41  Score=314.36  Aligned_cols=251  Identities=24%  Similarity=0.444  Sum_probs=202.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++... ........+.+|+.+++.+. ||||+++++++.  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~--   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc--
Confidence            3467999999999999999999865     24567999998543 22334556789999999996 999999999976  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceE
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~~-----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vk  163 (404)
                      .....++||||+. ++|.+++...           .++...+..++.|++.||.|||+.|++||||||+||++++++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            5678999999998 5899888642           246778899999999999999999999999999999999999999


Q ss_pred             EeccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhh
Q psy14434        164 IGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV  240 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  240 (404)
                      |+|||++.........  .....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998755432211  1123457889999998 45668999999999999999998 789998877666555444332


Q ss_pred             CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ....+         ..++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22111         3467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.6e-41  Score=307.20  Aligned_cols=250  Identities=32%  Similarity=0.572  Sum_probs=210.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+..++.+. ||||+++++++.  .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCK-HPNIVKYYGSYL--KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCC-CCCEeEEEEEEe--cCCeEEEE
Confidence            58999999999999999999999999999999864432  45677889999999997 999999999987  45789999


Q ss_pred             EeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc
Q psy14434        104 FEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL  180 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~  180 (404)
                      +||++ ++|.+++...  .+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  154 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R  154 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence            99999 5899988764  799999999999999999999999999999999999999999999999999987654322 3


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ....|+..|+|||.+. ...++.++|+||||+++|+|++|..||...+.............+....       ...++..
T Consensus       155 ~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~  226 (253)
T cd05122         155 NTMVGTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-------PEKWSDE  226 (253)
T ss_pred             cceecCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCc-------ccccCHH
Confidence            4567899999999984 5558899999999999999999999998775544444333311111110       1223788


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHhccC
Q psy14434        261 AVDLLNQILVLNPSERPETDQILEHNY  287 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~hp~  287 (404)
                      +.++|.+||+.||.+|||+.++++|||
T Consensus       227 ~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-41  Score=349.33  Aligned_cols=253  Identities=28%  Similarity=0.405  Sum_probs=201.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...... .....++.+|+.+++.+. ||||+++++++.  +....
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~--d~~~l   77 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICS--DGDPV   77 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEe--eCCEE
Confidence            47899999999999999999999999999999999654332 334567889999999997 999999999987  56789


Q ss_pred             EEEEeccCC-cHHHHHHh------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecc
Q psy14434        101 YVVFEYMEN-DLNKVIRD------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                      |+||||++| +|.+++..            ..++...+..++.||+.||+|||++||+||||||+||+++.+|.++|+||
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence            999999985 88888753            12455678889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q psy14434        168 GLARSLSDSK------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST  229 (404)
Q Consensus       168 g~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  229 (404)
                      |++.......                  ......+||+.|+|||.+ .+..++.++|||||||++|+|++|..||.....
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            9997652110                  111235799999999997 466789999999999999999999999977554


Q ss_pred             HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ......  ... ..+...    ..+..+++.+.+++.+||..||++|++..+.+.+
T Consensus       237 ~ki~~~--~~i-~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        237 RKISYR--DVI-LSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhh--hhc-cChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332211  111 111111    1124678999999999999999999887666544

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-41  Score=317.34  Aligned_cols=259  Identities=34%  Similarity=0.582  Sum_probs=216.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +...+.|++.+.||.|++|.||+|.+..++..||+|++.....   ....+.+|+..++.+. |+||+++++++.  ...
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~   88 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCK-HPNIVDYYDSYL--VGD   88 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCC-CCCeeEEEEEEE--ECC
Confidence            4566679999999999999999999998999999999854322   4566788999999996 999999999987  457


Q ss_pred             eEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..|+|+||++ ++|.+++...  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            8999999999 5999999865  799999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .........+++.|+|||.+ .+..++.++|+|||||++|+|++|..||...........+.....+...       ...
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~  240 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-------NPE  240 (286)
T ss_pred             chhhhccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-------chh
Confidence            33333345688999999987 4566899999999999999999999999877665544443322111111       113


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .++..+.+||.+||+.+|.+|||+.+++.|+||...
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            368899999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-41  Score=318.03  Aligned_cols=263  Identities=25%  Similarity=0.417  Sum_probs=210.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|++|.||+|.+..+++.||+|.+.+... ......+.+|+.++....+||||+++++++.  ....
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~   88 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSD   88 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCe
Confidence            455789999999999999999999999999999999865432 2344566778887777777999999999987  5678


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|++|||+.++|..++..  +.+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus        89 ~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          89 VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999999999888777753  568999999999999999999997 59999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KECLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .. .....+++.|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... ..+..+.....+..+       
T Consensus       169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  240 (296)
T cd06618         169 KA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-------  240 (296)
T ss_pred             Cc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-------
Confidence            22 2334578899999998433   24788999999999999999999999764332 222222222111111       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ....++.++.+||.+||..||.+||++.+++.||||..+..
T Consensus       241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            11246889999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0664|consensus

Probab=100.00  E-value=2.3e-44  Score=312.58  Aligned_cols=276  Identities=38%  Similarity=0.712  Sum_probs=233.1

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      +..+.....+.+-.+.||.|+||+||.+.|..+|+.||+|++...+.+-...++.++|+++|..++ |.|++..+++...
T Consensus        45 h~h~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQP  123 (449)
T KOG0664|consen   45 HYHPPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQP  123 (449)
T ss_pred             CCCCccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCC
Confidence            344444555677789999999999999999999999999999888888888999999999999997 9999999988753


Q ss_pred             cc---CCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         95 VN---NKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        95 ~~---~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ..   ...+|+++|+|..+|.++|-. ..++...++-+++||++||+|||+.||.||||||.|+|+++++.+||||||++
T Consensus       124 ph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  124 ANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             CCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence            22   235789999999999998864 56999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----
Q psy14434        171 RSLSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----  245 (404)
Q Consensus       171 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  245 (404)
                      +...... ..++..+.|..|+|||++.+...|+.++||||+|||+.||+-.+..|...+..++++.|.+.++....    
T Consensus       204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence            9765433 23455678999999999999999999999999999999999999999999999999998887663221    


Q ss_pred             ------------------CcchhhcccC--CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        246 ------------------HADKFYAGFK--NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       246 ------------------~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                        ....++..-.  ....++.+++.+||.+||++|++..+++.|+|....
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                              1111111111  223468899999999999999999999999999764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-41  Score=321.44  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..+|++.+.||+|+||.||+|.+..+++    .||+|++... .......++.+|+.+++.+. ||||+++++++..   
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~---   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT---   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC---
Confidence            3579999999999999999999876655    3899998532 23345567788999999996 9999999998763   


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...++++||+. |+|.+.+...  .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            35789999998 5888888753  58899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .....  .....++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+........       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------  232 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------  232 (316)
T ss_pred             CCCcceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC-------
Confidence            43221  1223346789999998 45678999999999999999997 9999987765544333322222111       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ...++..+.+++.+||..+|.+||++.+++.+
T Consensus       233 --~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         233 --PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              13457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.7e-41  Score=314.09  Aligned_cols=256  Identities=24%  Similarity=0.437  Sum_probs=203.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+.... .......+.+|+.+++.+. ||||+++++++.  .
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFT-CHHVVRLLGVVS--K   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc--C
Confidence            4689999999999999999997652     35579999885432 2233455678999999996 999999999976  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~-----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      ....|+||||+. |+|.+++...           .++...+..++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            567899999998 5899888631           2456778899999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhC
Q psy14434        165 GDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      +|||+++........  .....++..|+|||.+ .+..++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHh-ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998755332211  1223456789999997 45668999999999999999998 7899988776665554433222


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh------ccCCCCc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE------HNYVSKY  291 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~------hp~~~~~  291 (404)
                      ...         ...+++.+.+++.+||+.||++|||+.++++      ||||...
T Consensus       240 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         240 LDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            111         1345789999999999999999999999986      8988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.2e-41  Score=318.87  Aligned_cols=256  Identities=28%  Similarity=0.490  Sum_probs=212.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .+...|...+.||+|+||.||+|.+..++..+|+|.+.... ........+.+|+.+++.+. |||++++++++.  ...
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~   98 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYL--REH   98 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--eCC
Confidence            34456999999999999999999999999999999986442 23344567889999999996 999999999987  466


Q ss_pred             eEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..|+||||+.|+|.+.+.  ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        99 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635          99 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            789999999998877774  356899999999999999999999999999999999999999999999999998754332


Q ss_pred             CCcccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                          ....|++.|+|||.+.  ....++.++|+|||||++|+|++|..||...........+.....+...        .
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~  246 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------S  246 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--------C
Confidence                3456899999999974  2356788999999999999999999999776655555544433221111        1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..++..+.+||.+||+.+|.+||++.++++|+|+..
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            345788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.5e-41  Score=315.00  Aligned_cols=247  Identities=27%  Similarity=0.436  Sum_probs=202.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+|.+.+.||.|+||.||++.+.     .++..+|+|.+...  .......+.+|+.+++++. ||||+++++++.  ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cC
Confidence            36999999999999999999863     35677999988543  3445667889999999997 999999999986  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCce
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK--------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI  162 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~--------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~v  162 (404)
                      ..+++||||+. ++|.+++...              .+++..+..++.||+.||+|||++|++||||||+||+++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            78999999998 5898888632              38999999999999999999999999999999999999999999


Q ss_pred             EEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHh
Q psy14434        163 KIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNL  239 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  239 (404)
                      +|+|||++........  ......+++.|+|||.+ .+..++.++|+|||||++|+|++ |.+||...........+...
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999976543221  11223457789999998 45678999999999999999998 99999887766665555443


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .....         ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 RVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            32111         1346889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.2e-41  Score=306.93  Aligned_cols=255  Identities=31%  Similarity=0.548  Sum_probs=212.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|++|.||+|.+..++..|++|++............+.+|+..++++. ||||+++++.+.......++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999998765544566778889999999997 9999999999874323789999


Q ss_pred             EeccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--c
Q psy14434        104 FEYME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--C  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~  179 (404)
                      |||+. ++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99996 5899888754 799999999999999999999999999999999999999999999999999987655432  1


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchhhcccCCCC
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKP  258 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  258 (404)
                      .....++..|+|||.+ .....+.++|+||||+++|+|++|..||........  ....... ....      ......+
T Consensus       160 ~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~------~~~~~~~  230 (260)
T cd06606         160 TGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGSSGEPP------EIPEHLS  230 (260)
T ss_pred             ccCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccccCCCc------CCCcccC
Confidence            3445689999999997 455689999999999999999999999987762222  1111111 0111      1113458


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..+.+||.+||..+|++||++.+++.||||
T Consensus       231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         231 EEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=325.26  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=200.3

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++.+.||.|+||.||+|.+..     +++.||+|++.... .......+.+|+.+++++..|+||+++++++.. .+
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK-PG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CC
Confidence            479999999999999999997543     45789999986432 334456678899999999669999999998753 45


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-----------------------------------------------------------
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-----------------------------------------------------------  117 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-----------------------------------------------------------  117 (404)
                      ..++++|||+.+ +|.+++..                                                           
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            678999999995 88887742                                                           


Q ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--cccccccccccccc
Q psy14434        118 ---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAP  192 (404)
Q Consensus       118 ---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aP  192 (404)
                         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....  ......++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2578888999999999999999999999999999999999999999999999987543221  11233456789999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH-HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccc
Q psy14434        193 EILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILV  270 (404)
Q Consensus       193 E~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  270 (404)
                      |++ .+..++.++|||||||++|+|++ |..||.+........ .+........         ....++++.+++.+||+
T Consensus       245 E~~-~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~~cl~  314 (337)
T cd05054         245 ESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---------PEYATPEIYSIMLDCWH  314 (337)
T ss_pred             HHh-cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---------CccCCHHHHHHHHHHcc
Confidence            987 45678999999999999999997 999998754433322 2222222111         13457899999999999


Q ss_pred             cCCCCCCCHHHHHhc
Q psy14434        271 LNPSERPETDQILEH  285 (404)
Q Consensus       271 ~dp~~Rpt~~~ll~h  285 (404)
                      .+|++||++.++++|
T Consensus       315 ~~p~~RPs~~ell~~  329 (337)
T cd05054         315 NNPEDRPTFSELVEI  329 (337)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-41  Score=310.29  Aligned_cols=241  Identities=24%  Similarity=0.411  Sum_probs=198.5

Q ss_pred             eecccCceeEEEEEE--cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         30 RIGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      +||+|+||.||+|.+  ..++..+|+|++............+.+|+.+++.+. ||||+++++++.   ....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE---AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc---CCCcEEEEecC
Confidence            689999999999965  456789999998655444556677889999999996 999999999874   44679999999


Q ss_pred             C-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc---ccc
Q psy14434        108 E-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---LTE  182 (404)
Q Consensus       108 ~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~---~~~  182 (404)
                      . ++|.+++.. +.+++..+..++.||+.||.|||++|++||||||.||+++.++.+||+|||++.........   ...
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9 579888864 56899999999999999999999999999999999999999999999999999876443221   122


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHH
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA  261 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (404)
                      ..+++.|+|||.+ ....++.++|+|||||++|+|++ |..||.+.........+.....+..+         ..+++++
T Consensus       158 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l  227 (257)
T cd05116         158 GKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP---------QRCPPEM  227 (257)
T ss_pred             CCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---------CCCCHHH
Confidence            2346789999987 45678899999999999999997 99999887766665555543322211         3568999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHh
Q psy14434        262 VDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++|.+||+.||.+||+++++..
T Consensus       228 ~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         228 YDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHhccCchhCcCHHHHHH
Confidence            99999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-41  Score=317.70  Aligned_cols=256  Identities=27%  Similarity=0.484  Sum_probs=212.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...+.|...+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. |||++++++++.  +..
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~   94 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYL--KEH   94 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEE--eCC
Confidence            344458888999999999999999999999999999864422 3344567788999999996 999999999987  467


Q ss_pred             eEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..|+||||+.+++...+..  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..... 
T Consensus        95 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633          95 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            7999999999988877753  4589999999999999999999999999999999999999999999999999865322 


Q ss_pred             CCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                         .....|+..|+|||.+..  ...++.++|+|||||++|+|++|.+||...+.......+.....+...        .
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~  242 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ--------S  242 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------c
Confidence               234568999999999742  356788999999999999999999999887665555544332221111        1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..++..+.+|+.+||+.+|.+||++.+++.||||..
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            345778999999999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-41  Score=315.29  Aligned_cols=249  Identities=27%  Similarity=0.464  Sum_probs=204.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.  .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQ-HENIVKFYGVCT--E   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcC-CCCchheeeEEe--c
Confidence            3569999999999999999998753     46789999986432 2334567889999999997 999999999987  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK---------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC  160 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~---------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~  160 (404)
                      ....++||||+. ++|.+++...               .+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            578999999998 4898888632               378889999999999999999999999999999999999999


Q ss_pred             ceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q psy14434        161 SIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIV  237 (404)
Q Consensus       161 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  237 (404)
                      .++|+|||++.......  .......+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999997543221  112233467889999998 45678999999999999999998 999998877776666555


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .......+         ..++..+.+++.+||..||++||++.++++
T Consensus       239 ~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33322221         346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=310.36  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++|++.+.||+|+||.||+|..+.+   ...||+|.+.... .......+.+|+.+++.+. ||||+++++++.  ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVT--KSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEe--cCCc
Confidence            5799999999999999999988654   4579999885432 3344566788999999996 999999999986  5677


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .++||||+.+ +|.+++..  +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999985 89998864  46899999999999999999999999999999999999999999999999999876522


Q ss_pred             CCcc--cccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        177 KECL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       177 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ....  ....+++.|+|||.+ .+..++.++||||||+++|+|++ |..||...........+........+        
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  230 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP--------  230 (266)
T ss_pred             ccceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence            2211  122346789999997 45678999999999999999997 99999877766655555443222111        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ..++..+.+|+.+||+.+|++||++.+++++
T Consensus       231 -~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         231 -MDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             3468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-41  Score=315.82  Aligned_cols=257  Identities=25%  Similarity=0.439  Sum_probs=208.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECR-SPYIVSFYGAFL--NENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcC-CCCcceEeeeEe--cCCEEEE
Confidence            57999999999999999999999999999999885432 2344567889999999996 999999999987  4578999


Q ss_pred             EEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||+++ +|..++.. +.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            9999995 78888765 568999999999999999999997 699999999999999999999999999987543221  


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHhhCCCCCCcchhh
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--------HQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ....+|+..|+|||++. +..++.++|+|||||++|+|++|..||......        .....+.......+....   
T Consensus       159 ~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  234 (284)
T cd06620         159 ADTFVGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP---  234 (284)
T ss_pred             cCccccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC---
Confidence            23457899999999984 557889999999999999999999999765432        111222222221111110   


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                        ...++..+.+||.+||+.||.+|||+.++++|+||.+.
T Consensus       235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence              01257889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0193|consensus

Probab=100.00  E-value=8.1e-43  Score=332.07  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++..+.+.||+|+||+||+|.+..+   ||||++..........+.+..|+..+++-+ |.||+-+.|++.   +..+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~---~p~~  462 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACM---NPPL  462 (678)
T ss_pred             CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhc---CCce
Confidence            446678899999999999999988654   999999888888889999999999999998 999999999986   3335


Q ss_pred             EEEEeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC--C
Q psy14434        101 YVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--D  175 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~--~  175 (404)
                      .||+.+|+| +|+.++.  +..|.......|+.||++|+.|||.++|||||||..||++.+++.|||+|||++..-.  .
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence            999999998 7998886  4458899999999999999999999999999999999999999999999999986421  2


Q ss_pred             CCCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .........|...|||||+++.  ...|+..+|||||||++|||++|..||........+-.+-.+.. .    ......
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l-~----pd~s~~  617 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL-M----PDLSKI  617 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-C----ccchhh
Confidence            2223334457888999999853  34789999999999999999999999984443322222222211 1    122233


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+++.++.+|+..||.+++++||...+||.
T Consensus       618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            4677889999999999999999999999887

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-41  Score=312.62  Aligned_cols=250  Identities=21%  Similarity=0.396  Sum_probs=201.7

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCe--EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec----cCC
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNK   98 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~----~~~   98 (404)
                      +.+.+.||+|+||.||+|.+..++.  .+|+|.+............+.+|+.+++.+. ||||+++++++...    ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCC
Confidence            3567899999999999999887765  6899998765556666778889999999996 99999999976421    123


Q ss_pred             eEEEEEeccC-CcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ..+++|||+. |+|...+..       ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            5789999998 588877631       23789999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        171 RSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       171 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      +........  .....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---  235 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---  235 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            876432211  1122456789999997 46678999999999999999999 8999988776655555443322111   


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                            ...++..+.++|.+||+.||.+|||+.+++++
T Consensus       236 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                  13567889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-41  Score=312.54  Aligned_cols=249  Identities=32%  Similarity=0.524  Sum_probs=207.9

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      ||.|+||.||+|.+..+|+.+|+|++..... .......+.+|+.+++.+. ||||+++++.+.  .....|++|||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQ--GKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhee--cCcEEEEEEecCCC
Confidence            6899999999999999999999999854422 2345667788999999997 999999999986  57789999999985


Q ss_pred             -cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--------c
Q psy14434        110 -DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--------C  179 (404)
Q Consensus       110 -~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--------~  179 (404)
                       +|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........        .
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence             89988875 5689999999999999999999999999999999999999999999999999876443211        2


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                      .....++..|+|||.+. ...++.++|+||||+++|+|++|..||...........+.......+..        ..++.
T Consensus       158 ~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  228 (265)
T cd05579         158 DKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--------VEVSD  228 (265)
T ss_pred             ccCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--------ccCCH
Confidence            23456888999999984 4558899999999999999999999998887766655554422211110        12488


Q ss_pred             HHHHHHHhccccCCCCCCCH---HHHHhccCCCCc
Q psy14434        260 EAVDLLNQILVLNPSERPET---DQILEHNYVSKY  291 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~---~~ll~hp~~~~~  291 (404)
                      .+.+|+.+||+.+|.+|||+   .++|+||||+..
T Consensus       229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.7e-41  Score=313.93  Aligned_cols=250  Identities=24%  Similarity=0.431  Sum_probs=202.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..+|++.+.||+|+||.||+|...    .++..+|+|.+... ........+.+|+.+++.+. ||||+++++++.  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~   79 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVT--QE   79 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe--cC
Confidence            467999999999999999999853    45678999998643 22344566788999999996 999999999986  46


Q ss_pred             CeEEEEEeccC-CcHHHHHHh------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~------------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ...|+||||+. ++|.+++..                  ..+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            67899999998 589888852                  23778889999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14434        159 SCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  235 (404)
                      ++.+||+|||++.......  .......++..|+|||.+ .+..++.++|+|||||++|+|++ |..||.+.........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999997654321  112334467789999998 45668999999999999999998 9999987766554444


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.......         ....+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            43322111         124568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-41  Score=312.55  Aligned_cols=246  Identities=25%  Similarity=0.451  Sum_probs=206.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++.+.||.|+||.||+|.+.. +..+|+|++...  .......+.+|+.+++.+. ||||+++++++.  .....++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLR-HKHLISLFAVCS--VGEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCC-CcchhheeeeEe--cCCCeEE
Confidence            479999999999999999999988 888999998543  2334556788999999996 999999999986  5667999


Q ss_pred             EEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        103 VFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||+++ +|.+++..   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999985 99999874   3589999999999999999999999999999999999999999999999999987654332


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......++..|+|||.+ ....++.++|+|||||++|+|++ |..||.+.+.......+........         ...+
T Consensus       160 ~~~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~  229 (261)
T cd05148         160 LSSDKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---------PAKC  229 (261)
T ss_pred             cccCCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---------CCCC
Confidence            23344567789999997 45678899999999999999998 8999988777666666654332211         1456


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ++.+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         230 PQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=308.76  Aligned_cols=243  Identities=30%  Similarity=0.512  Sum_probs=205.4

Q ss_pred             eeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         29 KRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +.||+|+||.||+|.+...   +..||+|.+....... ....+.+|+..++.+. |+||+++++++.  ....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLG-HPNVVRLLGVCT--EEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcC-CCChheeeeeec--CCCceEEEEE
Confidence            4699999999999999866   8899999996554333 5677889999999997 999999999987  4778999999


Q ss_pred             ccC-CcHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        106 YME-NDLNKVIRD----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       106 ~~~-~~L~~~l~~----------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      |+. ++|.+++..          ..+++..++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            996 689999875          458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...  .......+++.|+|||.+. ...++.++|||||||++|+|++ |..||...........+........       
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  228 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-------  228 (262)
T ss_pred             cccccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            432  2233456788999999984 4578999999999999999999 6999988877666666554322211       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ...++.++.+++.+||..+|.+|||+.+++++
T Consensus       229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         229 --PEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --CccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              13458999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG1035|consensus

Probab=100.00  E-value=2.7e-42  Score=350.16  Aligned_cols=261  Identities=31%  Similarity=0.532  Sum_probs=208.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--   96 (404)
                      .++..+|+.++.||+||||.||+|+.+-+|..||||+|.... +.....++.+|+..|.+|. |||||++|..+....  
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCc
Confidence            468889999999999999999999999999999999997666 7778888999999999997 999999984431000  


Q ss_pred             --------------------------------------------------------------------------------
Q psy14434         97 --------------------------------------------------------------------------------   96 (404)
Q Consensus        97 --------------------------------------------------------------------------------   96 (404)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------C--------CeEEEEEeccCC-cHHHHHHhcCCC--HHHHHHHHHHHHHHHHH
Q psy14434         97 ---------------------------N--------KDLYVVFEYMEN-DLNKVIRDKILK--DVHIRYIMFQLCNGLSY  138 (404)
Q Consensus        97 ---------------------------~--------~~~~lv~E~~~~-~L~~~l~~~~l~--~~~~~~i~~qil~al~~  138 (404)
                                                 +        ..+||-||||+. .+.++++.+.+.  ...+|++|.||++||+|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence                                       0        247999999996 567777776664  78899999999999999


Q ss_pred             HHhCCCccCCCCCCcEEEccCCceEEeccccccccC------------------CCCCcccccccccccccccccccCC-
Q psy14434        139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS------------------DSKECLTEYIATRWYRAPEILISNR-  199 (404)
Q Consensus       139 LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~-  199 (404)
                      +|+.|||||||||.||++++++.|||+|||++....                  .+....++.+||..|+|||++.+.. 
T Consensus       713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            999999999999999999999999999999998621                  0112456789999999999986555 


Q ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC
Q psy14434        200 -RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE  278 (404)
Q Consensus       200 -~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  278 (404)
                       .|+.++||||||+|++||+.   ||..  ..+....+.+......+....+   +.+--+.-..+|++||+.||.+|||
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~~~f---~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEPADF---FDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCCccc---ccccchHHHHHHHHHhcCCCccCCC
Confidence             69999999999999999985   4533  3333333333333222221111   1222355678999999999999999


Q ss_pred             HHHHHhccCCC
Q psy14434        279 TDQILEHNYVS  289 (404)
Q Consensus       279 ~~~ll~hp~~~  289 (404)
                      |.++|++.||.
T Consensus       865 A~eLL~s~llp  875 (1351)
T KOG1035|consen  865 ATELLNSELLP  875 (1351)
T ss_pred             HHHHhhccCCC
Confidence            99999999986

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-41  Score=323.30  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=201.6

Q ss_pred             eeeeccc--CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         28 HKRIGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        28 ~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      ...||+|  +||+||+|.+..+|+.||+|++............+.+|+.+++.+. ||||++++++|.  .+...++|||
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~--~~~~~~~v~e   79 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFT--TGSWLWVISP   79 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEe--cCCceEEEEe
Confidence            3457776  9999999999999999999998765545555677788998888886 999999999997  4667999999


Q ss_pred             ccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc-
Q psy14434        106 YMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-  180 (404)
Q Consensus       106 ~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-  180 (404)
                      |+.+ +|.+++..   ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+.......... 
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9994 88888874   348999999999999999999999999999999999999999999999998654332111100 


Q ss_pred             ------cccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc------
Q psy14434        181 ------TEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA------  247 (404)
Q Consensus       181 ------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  247 (404)
                            ....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.................+...      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                  112346679999998543 4578999999999999999999999987765544333222111000000      


Q ss_pred             ------------------------------chh-hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 ------------------------------DKF-YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ------------------------------~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                                    ... ......++..+.+||.+||+.||++|||+.++|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                          000 001123567899999999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-41  Score=311.80  Aligned_cols=250  Identities=30%  Similarity=0.548  Sum_probs=204.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||+|++|.||+|.+..++..+|+|.+.... ........+.+|+.+++.+. ||||+++++++.  .....+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI--EDNELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeE--eCCeEE
Confidence            57999999999999999999999999999999885432 23345567789999999996 999999999987  466899


Q ss_pred             EEEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        102 VVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ++|||+.+ +|.+++.     ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999985 8888775     24589999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .........|+..|+|||.+ .+..++.++|+||||+++|+|++|..||.+....  .....+.....+..+        
T Consensus       159 ~~~~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  229 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------  229 (267)
T ss_pred             CCcccccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC--------
Confidence            43333456789999999997 4566889999999999999999999999765432  222222211111110        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ...++..+.++|.+||..||++|||+.++++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            1346789999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.8e-41  Score=318.02  Aligned_cols=250  Identities=28%  Similarity=0.388  Sum_probs=200.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeE--EEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .++|++.+.||+|+||.||+|.+..++..  +|+|.+... ........+.+|+.++.++.+||||+++++++.  ....
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~   82 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGY   82 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCC
Confidence            45899999999999999999998877754  577776422 233455677789999999966999999999986  5677


Q ss_pred             EEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434        100 LYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                      +|+||||+. ++|.+++...                 .+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999998 5899888632                 4788999999999999999999999999999999999999999


Q ss_pred             eEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhh
Q psy14434        162 IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLV  240 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  240 (404)
                      +||+|||++....... ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         163 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EEeCccccCcccchhh-hcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            9999999986432111 11112346679999987 45668899999999999999998 999998776655544432221


Q ss_pred             CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ....         ...+++.+.+||.+||+.+|++||++.+++.+
T Consensus       241 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 RLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111         13467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.6e-41  Score=307.17  Aligned_cols=242  Identities=24%  Similarity=0.419  Sum_probs=195.5

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME  108 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~  108 (404)
                      +.||+|+||.||+|.+..+++.+|+|.+... ........+.+|+.+++.+. ||||+++++++.  .....|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCT--QKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc--CCCCeEEEEeecc
Confidence            4699999999999999999999999987543 23344567889999999996 999999999986  4667999999998


Q ss_pred             C-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc--ccc
Q psy14434        109 N-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEY  183 (404)
Q Consensus       109 ~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~  183 (404)
                      + +|.+++..  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........  ...
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            5 89888864  348999999999999999999999999999999999999999999999999987644321111  111


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      .++..|+|||.+ .+..++.++|+|||||++|+|++ |..||...........+........         ...++..+.
T Consensus       157 ~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  226 (252)
T cd05084         157 QIPVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---------PELCPDAVY  226 (252)
T ss_pred             CCceeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---------cccCCHHHH
Confidence            234569999997 45668999999999999999997 8899977665544444433222111         134588999


Q ss_pred             HHHHhccccCCCCCCCHHHHHh
Q psy14434        263 DLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +|+.+||+.+|++|||+.++++
T Consensus       227 ~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         227 RLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.2e-41  Score=318.33  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=212.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ......|...+.||.|+||.||+|.+..+++.+|+|.+... ........++.+|+.+++.+. |+|++++++++.  ..
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   87 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--RE   87 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEE--cC
Confidence            34455688999999999999999999999999999998543 223344567788999999996 999999999987  46


Q ss_pred             CeEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ...++||||+.|++...+.  ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            7789999999998877764  34589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .    ....|++.|+|||.+.+  ...++.++|||||||++|+|++|..||...........+.....+...        
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  235 (308)
T cd06634         168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------  235 (308)
T ss_pred             c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC--------
Confidence            2    34568899999999742  345788999999999999999999999776554444433332221111        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ...++..+.+||.+||..+|.+||++.+++.|||+...
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            13457889999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-41  Score=311.16  Aligned_cols=250  Identities=20%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             eEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc----C
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----N   97 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~----~   97 (404)
                      |++.+.||+|+||.||+|....+   +..||+|.+............+.+|+..++.+. ||||+++++++....    .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccC
Confidence            67889999999999999987653   478999998765555566778889999999996 999999999875321    1


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      ...+++|||+. ++|..++..       ..+++..+..++.||+.||.|||++|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence            34799999998 588877742       2488999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        170 ARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       170 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ++........  .....++..|+|||.+ .+..++.++|||||||++|+|++ |.+||.+.........+........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  236 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ--  236 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            9865433211  1112346789999987 56678999999999999999999 8999988776665555544322211  


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                             ...++..+.+++.+||..||.+|||+.+++++
T Consensus       237 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 -------PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   14568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.1e-41  Score=314.48  Aligned_cols=251  Identities=29%  Similarity=0.487  Sum_probs=205.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||++.+...     ...+|+|.+.... .......+.+|+.+++++.+||||+++++++.  .
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~   87 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--Q   87 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--C
Confidence            35799999999999999999987643     3789999986442 33455668899999999956999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ...++++|||+. ++|..++..                 +.+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence            667999999998 589888853                 34788999999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14434        159 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  235 (404)
                      ++.+||+|||+++.......  ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            99999999999986543221  11222345779999987 46678999999999999999997 9999988777666655


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +........+         ..++..+.+|+.+||..||++|||+.+++++
T Consensus       247 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGYRMEKP---------QNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCCcCCCC---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5443322211         3457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.1e-41  Score=319.13  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=197.5

Q ss_pred             CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC-CcHHH
Q psy14434         35 AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNK  113 (404)
Q Consensus        35 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-~~L~~  113 (404)
                      ++|.||.+.+..+++.||+|++............+.+|+.+++.++ ||||++++++|.  +....|++|||+. ++|.+
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFI--VDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhheee--cCCeEEEEEeccCCCCHHH
Confidence            4566777777779999999999765455667788999999999997 999999999987  5677999999999 58888


Q ss_pred             HHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-------ccccc
Q psy14434        114 VIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLTEY  183 (404)
Q Consensus       114 ~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~  183 (404)
                      ++..   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+........       .....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            8874   3588999999999999999999999999999999999999999999999998875432211       12234


Q ss_pred             ccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC----------------
Q psy14434        184 IATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH----------------  246 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------  246 (404)
                      .++..|+|||++... ..++.++|+||+||++|+|++|..||.................+....                
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            577889999998543 457899999999999999999999998765443322111111000000                


Q ss_pred             --------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 --------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 --------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                              ..........++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                    0000000112346789999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9e-41  Score=306.65  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=201.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||+|..+. +..+|+|.+....   .....+.+|+.+++.+. ||||+++++++.  .....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA---MSEEDFIEEAKVMMKLS-HPKLVQLYGVCT--QQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC---ccHHHHHHHHHHHHHCC-CCCceeEEEEEc--cCCCEEE
Confidence            579999999999999999998754 5579999875332   22356778999999997 999999999986  4667999


Q ss_pred             EEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||+. |+|.+++..  +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999998 589888864  45899999999999999999999999999999999999999999999999998765432211


Q ss_pred             -ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 -LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                       .....++..|+|||.+ .+..++.++|+|||||++|+|++ |+.||...+.......+........+         ...
T Consensus       157 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~~  226 (256)
T cd05114         157 SSSGAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---------KLA  226 (256)
T ss_pred             ccCCCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------CCC
Confidence             1222355679999997 45678999999999999999999 89999888777666666554332211         234


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +..+.+++.+||..+|.+||++.++++
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-40  Score=307.35  Aligned_cols=250  Identities=32%  Similarity=0.586  Sum_probs=204.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++++. |+||+++++++.  .....+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~--~~~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFI--ENNELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeee--cCCeEE
Confidence            58999999999999999999999999999999886432 23344667889999999996 999999999987  467799


Q ss_pred             EEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        102 VVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      +||||+.+ +|..++..     ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999985 89888753     3489999999999999999999999999999999999999999999999999886654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS--HQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      .........+++.|+|||.+ .+..++.++|+|||||++|+|++|..||......  .....+.....+..+        
T Consensus       159 ~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  229 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP--------  229 (267)
T ss_pred             CCcccceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC--------
Confidence            33333445789999999997 4666889999999999999999999999654322  222222221111111        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ...++..+.++|.+||..+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1245789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.6e-41  Score=313.30  Aligned_cols=260  Identities=22%  Similarity=0.406  Sum_probs=207.7

Q ss_pred             CeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++.....  .........+|+.+++.+.+|+||+.++++|.  .+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence            4899999999999999999875   4788999999864322  22334566789999999977999999999987  467


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.+ +|.+.+. .+.+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            89999999995 8888776 456899999999999999999999999999999999999999999999999999765432


Q ss_pred             C-CcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchhhcc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG  253 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  253 (404)
                      . .......|+..|+|||.+... ..++.++||||||+++|+|++|..||...........+..... ..++.       
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  231 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-------  231 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC-------
Confidence            2 122345689999999998432 3467899999999999999999999975433222222222211 11111       


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      ...+++.+.+|+.+||+.||.+||     ++.+++.||||....
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            134578999999999999999997     899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.4e-41  Score=315.68  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=202.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .++|.+.+.||+|+||.||+|.+..       +...+|+|.+... ........+.+|+.+++.+.+||||+++++++. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence            3689999999999999999998643       2356999998643 234456678889999999966999999999987 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                       .....|+||||+. ++|.+++...                 .++...+..++.||+.||+|||++|++||||||+||++
T Consensus        95 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          95 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             -cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence             4667999999998 5899888642                 37888999999999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL  233 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  233 (404)
                      +.++.+||+|||++.........  .....+++.|+|||.+. +..++.++|+|||||++|+|++ |..||.+.......
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999998765432111  11223456899999874 5668999999999999999998 88999776665544


Q ss_pred             HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+........         ...++.++.+||.+||..+|.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44433222111         13568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4645|consensus

Probab=100.00  E-value=1.2e-43  Score=361.58  Aligned_cols=259  Identities=28%  Similarity=0.486  Sum_probs=218.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++.-+|+-...||.|.||.||-|.+..+|+..|+|-+.-..........+.+|..++..+. |||+|++|++  ......
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGV--EvHRek 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGV--EVHREK 1308 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCce--eecHHH
Confidence            3445899999999999999999999999999999988655445556667789999999997 9999999998  446788


Q ss_pred             EEEEEeccC-CcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~~-l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|.||||. |+|.++++.+. .++...+.+..|++.|++|||+.||+||||||+||+++-+|-+|++|||.|..+.+..
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999 58999998765 5666677788999999999999999999999999999999999999999998876543


Q ss_pred             ----CcccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hhCCCCCCcchh
Q psy14434        178 ----ECLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKF  250 (404)
Q Consensus       178 ----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~  250 (404)
                          .......|||.|||||++.+.  .....++|||||||++.||+||+.||...+..-++--.+. +..|..+     
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----- 1463 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP----- 1463 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-----
Confidence                223567899999999999653  3567899999999999999999999988776655433332 2223333     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                          ..++++.++||..||..||.+|.++.++|.|.|-+.
T Consensus      1464 ----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1464 ----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             ----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                336899999999999999999999999999998654

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.6e-41  Score=310.51  Aligned_cols=249  Identities=23%  Similarity=0.433  Sum_probs=201.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      +.|++.+.||+|++|.||+|.+..     ++..||+|.+... ........+.+|+.+++.+. |+||+++++++.  +.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSF--ER   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cC
Confidence            579999999999999999999987     7788999988533 22334456788999999996 999999999876  45


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---ceEEe
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIG  165 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~--------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---~vkl~  165 (404)
                      ...++||||+. ++|.+++...        .+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            66899999997 5899888643        488899999999999999999999999999999999998765   59999


Q ss_pred             ccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        166 DLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       166 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      |||+++........  .....++..|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHH-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999866332111  1122335679999998 45668999999999999999997 99999887776655544332222


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..         ...++..+.+++.+||+.+|++|||+.++++|
T Consensus       241 ~~---------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DP---------PKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11         13568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.9e-41  Score=307.47  Aligned_cols=246  Identities=26%  Similarity=0.442  Sum_probs=202.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|++|.||+|.+. ++..||+|.+...   ......+.+|+.+++.+. |+||+++++++.  .....+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVT--KEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCC-CCCeeeEEEEEc--CCCCcE
Confidence            457999999999999999999875 4566999987532   234567788999999997 999999999976  566789


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||+. ++|.+++..   ..++...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999997 589888864   358889999999999999999999999999999999999999999999999998764322


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......++..|+|||.+ ....++.++|+|||||++|+|++ |..||.+.........+.......         ...
T Consensus       158 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~  227 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---------RME  227 (261)
T ss_pred             eeccCCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---------CCC
Confidence            1 11223456789999997 45668899999999999999998 999998877666555554432211         114


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++.++.+++.+||..+|++||+++++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            56889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0603|consensus

Probab=100.00  E-value=3.2e-42  Score=331.08  Aligned_cols=245  Identities=30%  Similarity=0.458  Sum_probs=205.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..+.|.+...+|.|+||+|-.+.+..+++.+++|++.+.      .....+|+.++....+||||+++++++.  ++...
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~  391 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEI  391 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceec--CCcee
Confidence            567899999999999999999999999999999999654      2223367777777888999999999987  68889


Q ss_pred             EEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-ccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-DKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll-~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+|||++.| -+.+.+...+....++..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....  
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            999999997 34444444443338888999999999999999999999999999999 68899999999999877543  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                       ..+.|-|..|.|||++ ....|+.++||||||++||+|++|..||......   ..+...++.....        ..+|
T Consensus       470 -~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------~~vS  536 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------ECVS  536 (612)
T ss_pred             -hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc--------cccC
Confidence             3445778999999998 5788999999999999999999999999877665   2233333321110        4679


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..+++||++||++||.+|+++.+++.||||
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999999999

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=309.73  Aligned_cols=250  Identities=25%  Similarity=0.455  Sum_probs=203.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... .......+.+|+.+++.+. ||||+++++++.  .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--T   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc--C
Confidence            45799999999999999999988643     4789999985432 2334556778999999996 999999999987  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK-----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~-----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      ....|+||||+. ++|.+++...           .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            677999999998 5899888632           2677889999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhC
Q psy14434        165 GDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      +|||+++.......  ......++..|+|||.+ ....++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHH-hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            99999876543221  12334567889999997 45568999999999999999998 9999988777666555542222


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+         ..++..+.++|.+||+.+|++|||+.++++.
T Consensus       240 ~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         240 LDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            1111         3358899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-40  Score=307.17  Aligned_cols=245  Identities=24%  Similarity=0.417  Sum_probs=199.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|.+..++ .||+|++.....   ....+.+|+.+++.+. ||||+++++++.   ....|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCC-CCCcceEEEEEC---CCCcE
Confidence            367999999999999999999887665 499999864322   2345778999999996 999999999864   44579


Q ss_pred             EEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+.+ +|.+++..   ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999984 89998874   347899999999999999999999999999999999999999999999999997654332


Q ss_pred             Cc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 EC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .. .....++..|+|||.. .+..++.++|+|||||++|+|++ |..||.+.........+........         ..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  226 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---------PP  226 (262)
T ss_pred             cccccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---------cc
Confidence            21 1233466789999987 45668999999999999999999 8899988776655554433221111         13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++..+.+++.+||+.+|.+||++.+++.
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            56889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.9e-41  Score=309.71  Aligned_cols=251  Identities=30%  Similarity=0.527  Sum_probs=204.5

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc---cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +|.+.+.||+|+||.||++.+..++..+++|++....   ..........+|+.+++.+. ||||+++++++.  +....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFL--ERDAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHh--cCCce
Confidence            6899999999999999999998887777777764432   22334556678999999996 999999999976  45678


Q ss_pred             EEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ++||||+.+ +|...+..     ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999985 88877752     45899999999999999999999999999999999999975 579999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ..........|++.|+|||.+ .+..++.++|+||||+++|+|++|..||.+.........+.....+..         .
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  226 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---------P  226 (260)
T ss_pred             CCcccccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---------c
Confidence            443333445688999999987 456678899999999999999999999977665544444332221111         1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ..++.++.++|.+||..+|++||++.+++.||||
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            3567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.8e-41  Score=306.58  Aligned_cols=247  Identities=22%  Similarity=0.408  Sum_probs=201.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.... +..+|+|.+.....   ....+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLS-HEKLVQLYGVCT--KQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCC-CCCeeeEEEEEc--cCCCcE
Confidence            3579999999999999999997754 44599998854322   2345778999999997 999999999986  456789


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. ++|.+++..  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++.......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999998 489888864  3589999999999999999999999999999999999999999999999999876543321


Q ss_pred             c-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        179 C-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       179 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      . .....++..|+|||.+ .+..++.++|+|||||++|+|++ |..||...........+........+         ..
T Consensus       156 ~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  225 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---------HL  225 (256)
T ss_pred             eecCCCccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---------CC
Confidence            1 1122355779999998 45568999999999999999998 99999877766655555544332221         23


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            57899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-41  Score=309.35  Aligned_cols=245  Identities=30%  Similarity=0.529  Sum_probs=198.5

Q ss_pred             EEeeeecccCceeEEEEEEc----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         26 TIHKRIGKGAYGIVYKAYDK----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+.+.||.|+||.||+|...    ..+..|+||.+.. .........+.+|+..+++++ ||||+++++++.  .....+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~--~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCI--ENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEE--SSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccc-cccccccccccc--cccccc
Confidence            57889999999999999987    4567899999943 344456788899999999995 999999999987  566699


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+. |+|.+++...   .+++..+..++.||+.||.|||+++++|++|+|+||+++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999998 6899999865   69999999999999999999999999999999999999999999999999998763221


Q ss_pred             --CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 --ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                        .......+...|+|||.+. ...++.++||||||+++|||++ |+.||...+.......+.+......+         
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------  227 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---------  227 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---------
T ss_pred             ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccceec---------
Confidence              1123345677899999984 5558999999999999999999 78999888777766666544443222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..++..+.++|.+||..||.+|||+.++++
T Consensus       228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            456889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-40  Score=311.82  Aligned_cols=248  Identities=26%  Similarity=0.441  Sum_probs=201.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|.+.+.||+|+||.||+|.+.     .++..+++|.+...  .......+.+|+.+++.+. ||||+++++++.  .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQ-HEHIVKFYGVCG--D   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEc--c
Confidence            357999999999999999999864     34567899987432  2334456778999999996 999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ....++||||+. ++|.+++...                 .+++..++.++.||+.||+|||++|++||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            667999999998 5899988642                 3788999999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14434        159 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  235 (404)
                      ++.++|+|||++........  ......+++.|+|||.+ .+..++.++|||||||++|+|++ |..||...+.......
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999976543221  12234567889999987 45678899999999999999998 9999988777665555


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +.........         ...+..+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            4433222111         345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0614|consensus

Probab=100.00  E-value=5.2e-43  Score=326.45  Aligned_cols=267  Identities=22%  Similarity=0.386  Sum_probs=233.4

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ......+++.+++..||-||||.|=++........+|+|++++. ..+......++.|-.+|.... .|.||++|..|. 
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfr-  490 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFR-  490 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhc-
Confidence            33445667889999999999999999988776667999999765 445566677889999999997 999999999998 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       +..++|++||-|- |.|..+++ ++.|.+..+++++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+.
T Consensus       491 -d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  491 -DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             -cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence             6889999999998 48999887 46799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      +..+ ....++||||.|.|||+++ +...+.++|.||||+++|||++|.+||.+.+....+..|.+++....        
T Consensus       570 i~~g-~KTwTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--------  639 (732)
T KOG0614|consen  570 IGSG-RKTWTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--------  639 (732)
T ss_pred             hccC-CceeeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--------
Confidence            8765 4457899999999999986 55679999999999999999999999999999999999988765211        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCCCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPSA  295 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~~~  295 (404)
                      ....++..+.+||+++-..+|.+|..     +.++-+|-||..+.|..
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence            11456889999999999999999986     78999999999987754

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-41  Score=313.08  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+|++.+.||.|+||.||+|.+..+     +..||+|++.... .......+.+|+.++..+. ||||+++++++.  ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVT--KE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CC
Confidence            4688999999999999999987543     5789999986432 2334456778999999996 999999999986  45


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      ...++++||+. ++|..++..                 ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            67899999998 478888742                 247888899999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI  236 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  236 (404)
                      +.+||+|||+++.......  ......+++.|+|||.+. +..++.++|||||||++|+|++ |..||.+.........+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999886543221  112334678899999984 5568999999999999999998 88899887776665555


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ........         ...++..+.+|+.+||+.+|.+||++.+++..
T Consensus       240 ~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            44332211         14568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=305.03  Aligned_cols=246  Identities=24%  Similarity=0.405  Sum_probs=201.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|++|.||+|.+.. +..||+|.+....   .....+.+|+.+++++. ||||+++++++.  ....+|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---MDPKDFLAEAQIMKKLR-HPKLIQLYAVCT--LEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---ccHHHHHHHHHHHHHCC-CCCccceeEEEe--cCCCee
Confidence            3579999999999999999998754 4679999986432   23456778999999997 999999999976  566789


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+. ++|.+++...   .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999995 6899998753   48999999999999999999999999999999999999999999999999998765321


Q ss_pred             Cc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 EC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .. ......+..|+|||.+ .+..++.++|+|||||++|+|++ |+.||.+.........+........         ..
T Consensus       158 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  227 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC---------PP  227 (261)
T ss_pred             ccccCCCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---------CC
Confidence            11 1112234579999987 45678999999999999999999 9999988776665555543322111         13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++..+.+++.+||+.+|.+||++.++++
T Consensus       228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         228 GCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             cCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            46789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=310.81  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=198.5

Q ss_pred             CCe-EEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEY-TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+.... .......+.+|+.+++.+. ||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCC
Confidence            466 999999999999998864    34567889999985432 2234556778999999996 9999999998875556


Q ss_pred             CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..+++||||+.+ +|.+++....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            678999999994 8999998888999999999999999999999999999999999999999999999999999865432


Q ss_pred             CCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC--CC-----
Q psy14434        177 KEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP--PH-----  246 (404)
Q Consensus       177 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~-----  246 (404)
                      ...   .....++..|+|||.+ ....++.++|||||||++|+|++|..||.......  ...........  ..     
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhhh
Confidence            211   1223456779999987 45668999999999999999999999986533210  00000000000  00     


Q ss_pred             -cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        247 -ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       247 -~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                       ..........++..+.+++.+||+.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             00000112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-40  Score=308.57  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..+|++.+.||.|+||+||+|.+..+++    .||+|++... ........+.+|+.++..+. ||||+++++++.   .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~---~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVG-SPYVCRLLGICL---T   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEc---C
Confidence            4579999999999999999999877765    4899988543 23344566778999999986 999999999875   3


Q ss_pred             CeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...+++|||+. |+|.+.+..  +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            45789999998 588888864  358999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .....  .....+++.|+|||.+ .+..++.++|||||||++|||++ |..||...........+........       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------  232 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ-------  232 (279)
T ss_pred             cccceeecCCCccchhhCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-------
Confidence            32221  1122356789999997 45678999999999999999998 8999987666554444433222211       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ...++..+.+++.+||..||++||++.+++..
T Consensus       233 --~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         233 --PPICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             --CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              13468899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-40  Score=324.67  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|++... ........+.+|+.+++++..||||+++++++.  .
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~  112 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--K  112 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--c
Confidence            4578999999999999999998743     2457999998543 233445678899999999966999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh----------------------------------------------------------
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD----------------------------------------------------------  117 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~----------------------------------------------------------  117 (404)
                      ...+|||||||. |+|.+++..                                                          
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            678999999998 588877643                                                          


Q ss_pred             ---------------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434        118 ---------------------------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus       118 ---------------------------------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                                                             ..+++..+..++.||+.||+|||+.||+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                   13677788899999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH-
Q psy14434        159 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ-  234 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~-  234 (404)
                      ++.+||+|||+++.......  ......+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.......... 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            99999999999986543221  12234567889999998 45668999999999999999997 999998765433332 


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+........         ...++..+.+++.+||+.||++|||+.++.+
T Consensus       352 ~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYRMAK---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCCCCC---------CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            2222211111         1356889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-40  Score=314.01  Aligned_cols=250  Identities=27%  Similarity=0.463  Sum_probs=202.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc-------CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .++|.+.+.||+|+||.||+|.+.       .....+|+|.+... ........+.+|+.+++.+.+||||+++++++. 
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCT-   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence            358999999999999999999763       23457999988643 233456677889999999966999999999986 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                       ....+|++|||+. ++|.+++..                 ..+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus        89 -~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          89 -QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             -cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence             4667999999998 589988864                 237888999999999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL  233 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  233 (404)
                      +.++.+||+|||+++........  .....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.......
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHH-ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999865432211  1122345679999998 45678999999999999999999 89999887766665


Q ss_pred             HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+........         ...++.++.+++.+||..+|.+|||+.++++
T Consensus       247 ~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 KLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            55543322111         1456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=306.37  Aligned_cols=246  Identities=25%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++.+...   ....+.+|+.+++.+. ||||+++++++.  .....|+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLS-HPNLVQLYGVCT--KQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCC-CCCEEEEEEEEc--CCCceEE
Confidence            46899999999999999999876 456799999854322   2345678999999996 999999999976  5667999


Q ss_pred             EEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        103 VFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ||||+++ +|.+++..  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999975 89988864  35899999999999999999999999999999999999999999999999998765432211


Q ss_pred             -ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 -LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                       .....++..|+|||.+. +..++.++|+|||||++|+|++ |..||...+.......+........+         ..+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  226 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP---------KLA  226 (256)
T ss_pred             ccCCCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC---------CCC
Confidence             11122345799999974 5678999999999999999998 89999877766655554433222111         346


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +..+.+++.+||..+|++|||+.++++.
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-40  Score=306.38  Aligned_cols=245  Identities=25%  Similarity=0.427  Sum_probs=200.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+......   ...+.+|+.+++++. ||||+++++++.   ....|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLR-HDKLVQLYAVVS---EEPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcC-CCceEEEEeEEC---CCCcE
Confidence            458999999999999999999776 4556999998643322   345778999999996 999999999864   34589


Q ss_pred             EEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||+.+ +|.+++..   ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999984 89988864   348999999999999999999999999999999999999999999999999998654322


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......++..|+|||.+ .+..++.++|+||||+++|+|++ |.+||.+.+.......+........         ..
T Consensus       157 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  226 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---------PQ  226 (260)
T ss_pred             cccccCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---------CC
Confidence            1 11223456689999987 45678899999999999999999 8999988777666665543322211         13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+..+.+|+.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            56889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-40  Score=305.67  Aligned_cols=245  Identities=26%  Similarity=0.456  Sum_probs=201.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.+. ||||+++++++.   ....+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQ-HPRLVRLYAVVT---QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcC-CcCeeeEEEEEc---cCCcE
Confidence            357999999999999999999865 466799999864332   3456778999999997 999999999864   45689


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||+. ++|.+.+..   ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999998 589888763   358899999999999999999999999999999999999999999999999997665222


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .......++..|+|||.+ ....++.++|+||||+++|+|++ |++||.+.+.......+........         ..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  226 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR---------PD  226 (260)
T ss_pred             cccccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---------CC
Confidence             112233466789999987 45668899999999999999998 9999988877666555544332211         13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+.++.++|.+||..+|++|||+++++.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         227 NCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            45789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-40  Score=308.12  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ++|++.+.||.|+||.||+|.+..+++    .+++|.+... .......++..|+..+..+. ||||+++++++.   ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~---~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP---GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC---CC
Confidence            579999999999999999999877776    4677776422 22234456677888888886 999999999864   44


Q ss_pred             eEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..++++||+. |+|.+++..  +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            5789999998 689998864  4689999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        176 SKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...  ......++..|+|||.+. +..++.++|||||||++|||++ |..||.+.........+........+       
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  233 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP-------  233 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC-------
Confidence            221  122345677899999984 5568999999999999999998 99999887665544444333222211       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ..++..+.+++.+||..||.+|||+.++++.
T Consensus       234 --~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         234 --QICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              2357789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=304.15  Aligned_cols=241  Identities=21%  Similarity=0.370  Sum_probs=196.0

Q ss_pred             eeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         29 KRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +.||+|+||.||+|....++   ..+|+|.+...... .....+.+|+.+++.+. ||||+++++++.   ....++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLD-HPCIVRLIGVCK---GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc---CCceEEEEE
Confidence            47999999999999876554   78999998654333 45567889999999996 999999999875   446899999


Q ss_pred             ccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc--
Q psy14434        106 YME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT--  181 (404)
Q Consensus       106 ~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~--  181 (404)
                      |+. ++|.+++... .+++..+..++.|++.||+|||..|++|+||||+||+++.++.+||+|||+++..........  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            998 5899988754 499999999999999999999999999999999999999999999999999986644332211  


Q ss_pred             -ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCH
Q psy14434        182 -EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE  259 (404)
Q Consensus       182 -~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (404)
                       ...++..|+|||.+ .+..++.++|||||||++|+|++ |.+||...+.......+.......         ....++.
T Consensus       156 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  225 (257)
T cd05060         156 TAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---------RPEECPQ  225 (257)
T ss_pred             cCccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---------CCCCCCH
Confidence             11234679999998 45678999999999999999998 999998776655544443322211         1145688


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        260 EAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       260 ~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+.++|.+||..+|++||++.++++
T Consensus       226 ~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         226 EIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-40  Score=308.17  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=201.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+|++.++||+|+||.||+|...     .++..+|+|.+...  .......+.+|+.+++.+. |+||+++++++.  ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQ-HQHIVRFYGVCT--EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEe--cC
Confidence            47899999999999999999753     35678999987533  3455667889999999996 999999999976  46


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC  160 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~  160 (404)
                      ...+++|||+. ++|.+++...                .+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            67899999998 5898888642                378899999999999999999999999999999999999999


Q ss_pred             ceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q psy14434        161 SIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIV  237 (404)
Q Consensus       161 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  237 (404)
                      .+||+|||++........  ......+++.|+|||.+ .+..++.++|||||||++|+|++ |.+||...........+.
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999875533211  11223456789999987 45668999999999999999998 999998777666555554


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .......+         ..+++.+.+||.+||+.||.+||++.+++.
T Consensus       239 ~~~~~~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRELERP---------RTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCccCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43322111         356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-40  Score=305.91  Aligned_cols=249  Identities=26%  Similarity=0.413  Sum_probs=203.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+.||+|+||.||+|.+..++   ..+|+|.+.... .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCC
Confidence            357999999999999999999886544   479999986432 2344567788999999996 999999999986  566


Q ss_pred             eEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..|+||||+++ +|.+++..  +.++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            79999999984 89988874  3589999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc---cccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        176 SKECL---TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       176 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .....   ....++..|+|||.+ .+..++.++|+|||||++|++++ |..||.+.........+.+......       
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  230 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-------  230 (267)
T ss_pred             ccceeeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC-------
Confidence            32211   112235679999998 45678999999999999999886 9999988776665555544322111       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        ...+++.+.+++.+||+.+|.+||++.++++
T Consensus       231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         231 --PMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence              1346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-40  Score=311.51  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=204.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc-------CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ...+|.+.+.||+|+||.||+|.+.       .++..||+|.+... ........+.+|+.+++.+.+||||+++++++.
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            3567999999999999999999752       23457999988643 234456678899999999966999999999987


Q ss_pred             eccCCeEEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         94 AVNNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                        .....|+||||+. ++|.+++...                 .++...+..++.||+.||.|||++|++||||||+||+
T Consensus        92 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          92 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence              4667899999998 5899888642                 3677888999999999999999999999999999999


Q ss_pred             EccCCceEEeccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14434        156 IDKSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ  232 (404)
Q Consensus       156 l~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  232 (404)
                      ++.++.+||+|||+++........  .....+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+......
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999866432211  1223456789999997 45668999999999999999998 7899988776666


Q ss_pred             HHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+........         ...++..+.+||.+||..+|.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            555543322111         13568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-40  Score=310.96  Aligned_cols=256  Identities=22%  Similarity=0.388  Sum_probs=203.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC----------------eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK----------------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI   85 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   85 (404)
                      .++|++++.||+|+||.||+|.+..++                ..||+|.+.... .......+.+|+.+++++. ||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcC-CCCE
Confidence            458999999999999999999876543                568999986442 2345667789999999997 9999


Q ss_pred             ceEeeEEEeccCCeEEEEEeccC-CcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy14434         86 ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS  152 (404)
Q Consensus        86 v~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~  152 (404)
                      +++++++.  .+...+++||++. ++|..++...            .+++..++.++.||+.||+|||++|++||||||+
T Consensus        82 ~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          82 ARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             eEEEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999986  4578999999998 4898888643            4889999999999999999999999999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGAS  228 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~  228 (404)
                      ||+++.++.++|+|||++.......  .......+++.|+|||.+. +..++.++|||||||++|+|++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999997654322  1122345678899999974 5568999999999999999998  678887776


Q ss_pred             cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        229 TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ....+............  .........++.++.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGR--QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccc--cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66655555443211100  0000112346789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-40  Score=318.41  Aligned_cols=252  Identities=25%  Similarity=0.449  Sum_probs=199.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEE-----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||++.... .......+.+|+.++.++..||||+++++++.. .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-P   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec-C
Confidence            35899999999999999999985     3467899999986432 234456788999999999769999999998753 4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc---------------------------------------------------------
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK---------------------------------------------------------  118 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~---------------------------------------------------------  118 (404)
                      +..++++|||+. |+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            557899999999 5888887531                                                         


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--ccccccc
Q psy14434        119 -----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIA  185 (404)
Q Consensus       119 -----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~g  185 (404)
                                 .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                       257778889999999999999999999999999999999999999999999976533211  1122335


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH-HHHHHhhCCCCCCcchhhcccCCCCHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      ++.|+|||.+. +..++.++|||||||++|+|++ |..||.+....... ..+........+         ...++++.+
T Consensus       244 ~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  313 (343)
T cd05103         244 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------DYTTPEMYQ  313 (343)
T ss_pred             CcceECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC---------CCCCHHHHH
Confidence            67799999974 5678999999999999999997 99999876543322 222222221111         234788999


Q ss_pred             HHHhccccCCCCCCCHHHHHhc
Q psy14434        264 LLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       264 li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ++.+||+.||.+|||+.++++|
T Consensus       314 ~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=302.66  Aligned_cols=244  Identities=29%  Similarity=0.487  Sum_probs=205.5

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC-
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-  108 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-  108 (404)
                      ||.|+||.||++.+..+++.+|+|.+.+.... ......+..|+.+++.+. ||||+++++.+.  .+...|+||||+. 
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQ--TEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHee--cCCeeEEEEecCCC
Confidence            69999999999999989999999998654332 335667788999999997 999999999986  5778999999995 


Q ss_pred             CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccccc
Q psy14434        109 NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR  187 (404)
Q Consensus       109 ~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~  187 (404)
                      ++|.+++... .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++.
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            6899888754 689999999999999999999999999999999999999999999999999987654333344567899


Q ss_pred             ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHh
Q psy14434        188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ  267 (404)
Q Consensus       188 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  267 (404)
                      .|+|||.+. +...+.++|+||||+++|+|++|..||...+.......+... ....         ....+..+.++|.+
T Consensus       158 ~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------~~~~~~~l~~~i~~  226 (250)
T cd05123         158 EYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRF---------PEFLSPEARDLISG  226 (250)
T ss_pred             cccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCC---------CCCCCHHHHHHHHH
Confidence            999999974 556788999999999999999999999877765444444331 1111         12347899999999


Q ss_pred             ccccCCCCCCCH---HHHHhccCC
Q psy14434        268 ILVLNPSERPET---DQILEHNYV  288 (404)
Q Consensus       268 ~L~~dp~~Rpt~---~~ll~hp~~  288 (404)
                      ||..||++||++   .++++||||
T Consensus       227 ~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         227 LLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhcCCHhhCCCcccHHHHHhCCCC
Confidence            999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3e-40  Score=308.89  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=200.0

Q ss_pred             CeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+... ........+.+|+.+++.+. ||||+++++.+.  ...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVN-HPHVIKLYGACS--QDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEe--cCC
Confidence            58899999999999999998753     2356888887543 23344567889999999996 999999999986  466


Q ss_pred             eEEEEEeccC-CcHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-------------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS  152 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-------------------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~  152 (404)
                      ..+++|||+. ++|.+++..                         ..+++..+..++.|++.||.|||++|++||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            7899999999 588888753                         23678889999999999999999999999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAST  229 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  229 (404)
                      |||++.++.+||+|||+++.......  ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+...
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999976533221  11223456789999987 46678999999999999999998 9999988776


Q ss_pred             HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ......+........+         ..++.++.+|+.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLLKTGYRMERP---------ENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHhCCCCCCCC---------CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6655544433222211         346889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.1e-40  Score=303.53  Aligned_cols=240  Identities=23%  Similarity=0.400  Sum_probs=194.6

Q ss_pred             eecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         30 RIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      .||+|+||.||+|...  .++..||+|++... ........+.+|+.+++++. ||||+++++++.   ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~---~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE---AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc---CCCeEEEEEeC
Confidence            4899999999999765  44567999998543 23344566889999999996 999999999875   45689999999


Q ss_pred             C-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc---c
Q psy14434        108 E-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL---T  181 (404)
Q Consensus       108 ~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~---~  181 (404)
                      + ++|.+++..  ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..........   .
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            8 589888863  468999999999999999999999999999999999999999999999999997654322111   1


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...+++.|+|||.+ ....++.++|||||||++|+|++ |..||.+.........+........+         ..++++
T Consensus       157 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  226 (257)
T cd05115         157 AGKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP---------AECPPE  226 (257)
T ss_pred             CCCCCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------CCCCHH
Confidence            12235789999987 45668999999999999999996 99999887776655555443322211         456899


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHh
Q psy14434        261 AVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +.++|.+||..+|++||++.++.+
T Consensus       227 l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         227 MYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4721|consensus

Probab=100.00  E-value=3.9e-42  Score=324.30  Aligned_cols=237  Identities=30%  Similarity=0.456  Sum_probs=199.8

Q ss_pred             EEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      .-++.||+|+-|.||+|+..  ++.||||+++..         -..+|+-|++|+ ||||+.+.+++.  ....+|||||
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLk-H~NII~FkGVCt--qsPcyCIiME  192 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLK-HPNIITFKGVCT--QSPCYCIIME  192 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhcc-CcceeeEeeeec--CCceeEEeee
Confidence            34677999999999999654  778999998421         124688899997 999999999986  6788999999


Q ss_pred             ccC-CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccc
Q psy14434        106 YME-NDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY  183 (404)
Q Consensus       106 ~~~-~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~  183 (404)
                      ||. |.|..+++.+ .++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++....- .....+
T Consensus       193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSF  271 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSF  271 (904)
T ss_pred             ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhh
Confidence            999 7899999864 5899999999999999999999999999999999999999999999999999987654 445678


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHH
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      +||..|||||++ .....+.++|||||||+||||+||..||.+-+...    |+-+++.....    ......+|..+.-
T Consensus       272 aGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsNsL~----LpvPstcP~Gfkl  342 (904)
T KOG4721|consen  272 AGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSNSLH----LPVPSTCPDGFKL  342 (904)
T ss_pred             hhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEeccCCccc----ccCcccCchHHHH
Confidence            999999999998 57788999999999999999999999998766543    22233321111    1222567889999


Q ss_pred             HHHhccccCCCCCCCHHHHHhcc
Q psy14434        264 LLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       264 li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      ||+.||+-.|..||++.++|.|-
T Consensus       343 L~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  343 LLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHhcCCCCCccHHHHHHHH
Confidence            99999999999999999999984

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.2e-40  Score=303.01  Aligned_cols=242  Identities=24%  Similarity=0.438  Sum_probs=199.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..+|++.+.||+|+||.||++...  |..+|+|.+..    ......+.+|+.+++.+. |+|++++++++.. .....|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC----CchHHHHHHHHHHHHhCC-CCCeeeEEEEEEc-CCCceE
Confidence            357999999999999999999664  67799998743    233456788999999996 9999999997643 456789


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||++ ++|.+++...   .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999998 5899888743   37889999999999999999999999999999999999999999999999987654322


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                         ....++..|+|||++ ....++.++|||||||++|+|++ |+.||...........+........         ...
T Consensus       157 ---~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~  223 (256)
T cd05082         157 ---DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---------PDG  223 (256)
T ss_pred             ---CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---------CCC
Confidence               233456789999987 46678999999999999999997 9999987766555554443322111         145


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +++.+.+++.+||+.+|++|||+.++++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            6899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.8e-40  Score=339.17  Aligned_cols=147  Identities=29%  Similarity=0.477  Sum_probs=131.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.++..+. ||||+++++++.  ....+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQ--SANNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEE--ECCEE
Confidence            578999999999999999999999999999999996543 33444567788999999886 999999999876  56789


Q ss_pred             EEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        101 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      ||||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999997 589988864 568999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0695|consensus

Probab=100.00  E-value=1.7e-41  Score=302.34  Aligned_cols=263  Identities=24%  Similarity=0.412  Sum_probs=220.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-+.+|++++.||+|+|++|.+++.+.|.+.||+|++++... ++++..-...|-.+..+..+||.+|-++.+|.  .+.
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tes  324 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TES  324 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccc
Confidence            345789999999999999999999999999999999987754 44555556678888888889999999999998  578


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+++|.||+.| +|--.++ ++.++++.++.+...|+.||.|||++||++||||.+|||++..|++||+|+|+++..-.+
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            89999999995 7755554 567999999999999999999999999999999999999999999999999999987666


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCcHH-HHHHHHHhhCCCCCCcc
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG-------ASTSH-QLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-------~~~~~-~~~~~~~~~~~~~~~~~  248 (404)
                      .....++||||.|.|||++ .+..|+.++|+|+|||+++||+.|+.||+-       .+..+ .++.|.+.....|    
T Consensus       405 gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----  479 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----  479 (593)
T ss_pred             CcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----
Confidence            6777889999999999998 578899999999999999999999999962       12222 2233322211111    


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCC------CHHHHHhccCCCCcCCCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERP------ETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------t~~~ll~hp~~~~~~~~~  295 (404)
                            ..+|-.+..+++..|.+||.+|.      ...++..|+||...-|..
T Consensus       480 ------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  480 ------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             ------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence                  34567788999999999999996      458999999999665544

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-40  Score=301.73  Aligned_cols=243  Identities=25%  Similarity=0.454  Sum_probs=202.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||.|+||.||+|...  |+.||+|.+.....   ...++.+|+.+++.+. |+||+++++++.  +....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLR-HPNLVQLLGVVL--QGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcC-CcceeeeEEEEc--CCCCeE
Confidence            457999999999999999999764  78899999864422   5677889999999997 999999999976  467899


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+. ++|.+++...   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999 5999988743   58999999999999999999999999999999999999999999999999998763322


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                         ....++..|+|||.+. ...++.++|+|||||++|+|++ |..||...........+........         ...
T Consensus       157 ---~~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~  223 (256)
T cd05039         157 ---DSGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA---------PEG  223 (256)
T ss_pred             ---ccCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC---------ccC
Confidence               1233566799999874 5568899999999999999997 9999987766555444433222111         134


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +++.+.++|.+||..+|.+|||+.++++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            58899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-40  Score=308.72  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=201.1

Q ss_pred             CCeEEeeeecccCceeEEEEEE-----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|.+.+.||+|+||.||+|.+     ..++..+|+|++.... .......+.+|+.+++++.+||||+++++++.  ..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~  111 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACT--IG  111 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--cC
Confidence            4799999999999999999975     3356689999886432 23345667899999999956999999999986  46


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ..+|+||||+. ++|.+++...   .+++.++..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++...
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            67999999998 5899888743   3899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        174 SDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .....  ......+++.|+|||.+ ....++.++||||+||++|+|++ |..||.+..................      
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------  264 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA------  264 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC------
Confidence            43221  11223457789999987 45568999999999999999998 9999987765544433332111110      


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        .....++.+.+|+.+||..+|++|||+.++++
T Consensus       265 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         265 --QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence              01345789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-40  Score=313.99  Aligned_cols=250  Identities=28%  Similarity=0.453  Sum_probs=202.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC-------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN-------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      .+|++.+.||+|+||.||+|.+...       +..||+|.+... ........+.+|+.+++++.+||||+++++++.  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            3699999999999999999986432       246899987532 234456778899999999966999999999986  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID  157 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~  157 (404)
                      ....+|++|||+. ++|.+++...                 .++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            4667999999998 4899888642                 367788899999999999999999999999999999999


Q ss_pred             cCCceEEeccccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14434        158 KSCSIKIGDLGLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ  234 (404)
Q Consensus       158 ~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  234 (404)
                      .++.+||+|||+++........  .....++..|+|||++ .+..++.++|||||||++|+|++ |..||.+........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999865432211  1222345679999998 45678899999999999999998 889998887766655


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+........         ...++.++.+|+.+||+.+|.+|||+.+++.+
T Consensus       248 ~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         248 LLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5544322211         13457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.5e-40  Score=301.69  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=199.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|++|.||+|.+..++ .+|+|.+....   .....+.+|+.+++.+. |||++++++++.   ....|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~   76 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT---MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS---EEPIY   76 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC---ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc---CCCcE
Confidence            367999999999999999999887654 58999875332   22355678999999996 999999999874   34579


Q ss_pred             EEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|||+.+ +|.+++...   .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            99999985 899888642   37889999999999999999999999999999999999999999999999997654322


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......++..|+|||.+ .+..++.++|+|||||++|+|++ |..||.+.........+........         ..
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  226 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC---------PQ  226 (260)
T ss_pred             ccccCCCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------Cc
Confidence            1 11223466789999987 45668999999999999999999 8999988777666555543322111         13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+..+.+++.+||..||.+||++.++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         227 GCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            46889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-40  Score=301.34  Aligned_cols=246  Identities=26%  Similarity=0.451  Sum_probs=202.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+.. +..+|+|.+....   .....+.+|+.+++.+. ||||+++++++.  .....+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT---MSPEAFLQEAQIMKKLR-HDKLVQLYAVCS--EEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc---cCHHHHHHHHHHHhhCC-CCCEeeeeeeee--cCCceE
Confidence            4689999999999999999998764 5679999986432   23456788999999997 999999999976  457799


Q ss_pred             EEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+.+ +|.+++..   ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999985 89988864   358999999999999999999999999999999999999999999999999987664321


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......++..|+|||.+. +..++.++|+|||||++|+|++ |+.||.+.........+........+         .
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~  227 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP---------P  227 (261)
T ss_pred             hhhhhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------C
Confidence            1 111223456899999984 5668999999999999999998 99999887776666665543322111         3


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+..+.+++.+||..+|.+||++.+++.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            45789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=304.65  Aligned_cols=243  Identities=29%  Similarity=0.393  Sum_probs=194.4

Q ss_pred             eeecccCceeEEEEEEcCCCe--EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQ--YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|.++.++.  .+|+|.+... ........+.+|+.++.++..||||+++++++.  ....+|+||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEe
Confidence            468999999999999988775  4688887532 233445677889999999966999999999987  45678999999


Q ss_pred             cC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccc
Q psy14434        107 ME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG  168 (404)
Q Consensus       107 ~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg  168 (404)
                      +. ++|.+++...                 .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence            98 5899888642                 37888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ++....... .......+..|+|||.+ ....++.++|+|||||++|+|++ |..||.+.+.......+........   
T Consensus       158 l~~~~~~~~-~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---  232 (270)
T cd05047         158 LSRGQEVYV-KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK---  232 (270)
T ss_pred             Cccccchhh-hccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC---
Confidence            986432111 11112345679999987 46678999999999999999997 9999987776655554433222111   


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                            ...++.++.+|+.+||..+|.+|||+.+++..
T Consensus       233 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         233 ------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             ------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                  13457899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1006|consensus

Probab=100.00  E-value=1.4e-42  Score=300.28  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=214.4

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +..+-+..||.|+||+|++..++.+|+..|||.+.... .+.+.++++.|.....+-.+.||||++||..-  .++..+|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~EGdcWi  140 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SEGDCWI  140 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cCCceee
Confidence            34556778999999999999999999999999996443 35677888889988888888999999999854  6788999


Q ss_pred             EEeccCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        103 VFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       103 v~E~~~~~L~~~l~------~~~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .||+|+-+|..+.+      +..++|..+-.|....+.||.||. ...|||||+||+|||++..|.|||||||.+..+.+
T Consensus       141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99999987655443      456999999999999999999997 46899999999999999999999999999987765


Q ss_pred             CCCcccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        176 SKECLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .-. .+.-.|...|||||.+.... .|+.++|+||||++|||+.||+.||.+.+.  .+.++.......++.... ....
T Consensus       221 SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~-~~~~  296 (361)
T KOG1006|consen  221 SIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF-DKEC  296 (361)
T ss_pred             HHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC-cccc
Confidence            322 23346889999999985544 489999999999999999999999877544  444444444433332111 1112


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      -+++..+..||..||.+|-+.||...+++++||+..+..
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            346889999999999999999999999999999987643

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.2e-40  Score=307.56  Aligned_cols=262  Identities=23%  Similarity=0.392  Sum_probs=206.2

Q ss_pred             CeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +|++.+.||+|++|.||+|.+.   .++..||+|++.+...  .......+.+|+.++..+.+||||+++++.+.  ...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence            4899999999999999999864   4678899999865422  22344567789999999977999999999986  567


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.+ +|...+.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            89999999985 88887764 56899999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-hCCCCCCcchhhcc
Q psy14434        177 KE-CLTEYIATRWYRAPEILISNR-RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAG  253 (404)
Q Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  253 (404)
                      .. ......|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+... ....++       .
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~  231 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-------F  231 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC-------C
Confidence            21 122346899999999974332 3688999999999999999999999644322111122111 111111       1


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCC---HHHHHhccCCCCcCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPE---TDQILEHNYVSKYFPS  294 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~hp~~~~~~~~  294 (404)
                      ...++..+.++|.+||+.||++|||   +.++|+||||+...++
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            1345789999999999999999998   5678999999886553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-39  Score=301.25  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=202.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCe---EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+|+..+.||+|+||.||+|.++.++.   .+|+|.+.... .......+..|+.+++.+. ||||+++++++.  ....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVT--KFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEc--cCCC
Confidence            478999999999999999999876554   79999885432 3344567789999999996 999999999986  5667


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .|+||||+++ +|..++..  +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            8999999995 89888864  45899999999999999999999999999999999999999999999999999765432


Q ss_pred             CCccc---ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KECLT---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .....   ....++.|+|||.+ ....++.++|||||||++|+|++ |..||...+.......+........        
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~--------  231 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA--------  231 (268)
T ss_pred             cccceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC--------
Confidence            21111   11234579999998 45668999999999999999997 9999988777666665544322111        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ...++..+.+++.+||..+|++||++.++++.
T Consensus       232 -~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         232 -PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             13468899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.8e-40  Score=302.28  Aligned_cols=250  Identities=24%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe---EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+.||+|+||.||+|.++.++.   .||+|.+... ........+..|+.+++.+. ||||+++++++.  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEEC--CCC
Confidence            4579999999999999999999887664   6999998643 23445677889999999996 999999999976  567


Q ss_pred             eEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..++||||+.+ +|.+++..  +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            78999999985 89888864  4589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc--ccccc---cccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        176 SKEC--LTEYI---ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       176 ~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ....  .....   ++..|+|||.+ .+..++.++|||||||++|||++ |..||...+.......+........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-----  232 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-----  232 (269)
T ss_pred             CccccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-----
Confidence            2211  11111   24579999998 46678999999999999999886 9999988776655555533222111     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ...++..+.+++.+||..+|.+||++.+++..
T Consensus       233 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         233 ----PMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                13568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-40  Score=307.01  Aligned_cols=255  Identities=23%  Similarity=0.405  Sum_probs=199.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC--------------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN--------------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      .+|++.+.||+|+||.||+|.+..+              ...||+|.+... ........+.+|+.+++.+. ||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~-h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLK-NPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCC-CCCcCeE
Confidence            4899999999999999999987543              235899998643 23344566889999999997 9999999


Q ss_pred             eeEEEeccCCeEEEEEeccCC-cHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q psy14434         89 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI  154 (404)
Q Consensus        89 ~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~-------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NI  154 (404)
                      ++++.  .....++||||+.+ +|.+++...             .+++..+..++.||+.||+|||++|++||||||+||
T Consensus        83 ~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99986  56779999999985 898888542             267888999999999999999999999999999999


Q ss_pred             EEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcH
Q psy14434        155 LIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTS  230 (404)
Q Consensus       155 ll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~  230 (404)
                      +++.++.+||+|||++........  ......+++.|+|||.+. ...++.++|+|||||++|+|++  |..||......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999999976543221  112234567899999874 5568999999999999999998  66788776665


Q ss_pred             HHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .....+.........  ..+....+..++.+.+|+.+||+.||.+||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGR--QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccc--cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            555444332211000  0000112346789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-39  Score=299.11  Aligned_cols=246  Identities=30%  Similarity=0.526  Sum_probs=204.1

Q ss_pred             eEEeeeecccCceeEEEEEEcCCC----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++.+.||.|+||.||+|.+..++    ..+|+|.+.... .......+..|+..++.+. |+||+++++++.  .....
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLD-HPNIVKLLGVCT--EEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcC-CCchheEEEEEc--CCCee
Confidence            357889999999999999998766    889999985432 2225667889999999995 999999999987  45789


Q ss_pred             EEEEeccCC-cHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~~---l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |++|||+.+ +|.+++....   +++..+..++.||+.||++||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999985 8998887432   899999999999999999999999999999999999999999999999999866543


Q ss_pred             CCccc-ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLT-EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ..... ...+++.|+|||.+ ....++.++|+|||||++|+|++ |.+||...+.......+........+         
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  226 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---------  226 (258)
T ss_pred             cccccccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------
Confidence            21111 12367889999997 56678999999999999999998 88999887776666655544332211         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..++..+.+++.+||..||++|||+.++++
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            336889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.3e-40  Score=305.22  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=200.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.  .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~--~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-HPNIVKLLGVCA--V   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcC-CCchheEEEEEc--C
Confidence            3579999999999999999998753     67889999986432 2334566778999999996 999999999976  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK-----------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS  152 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~-----------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~  152 (404)
                      +...++||||+. ++|.+++...                       .+++..++.++.||+.||.|||++|++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            667899999999 4898888632                       3678889999999999999999999999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAST  229 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  229 (404)
                      ||+++.++.++|+|||++........  ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+...
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999875432211  11223356679999987 45678999999999999999997 8889987776


Q ss_pred             HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ......+.......         ....++.++.+||.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66555444322211         11346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-39  Score=302.51  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=202.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|.+.. .........+.+|+.+++.+. ||||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~-~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLS-HQNILPILHVCIE-DG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-CC
Confidence            3579999999999999999999876    357899998753 234455677889999999996 9999999998653 35


Q ss_pred             CeEEEEEeccC-CcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~---------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                      ...++++||+. ++|..++..         ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            67899999998 689888864         34889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCc--ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        168 GLARSLSDSKEC--LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       168 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      |+++.+......  .....++..|+|||.+ .+..++.++|||||||++|++++ |++||...+.......+........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            999865432211  1223456779999998 45668999999999999999998 9999987766554443333221111


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                               ...+++++.+++.+||..||++|||+.+++.
T Consensus       241 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         241 ---------PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                     1345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-39  Score=302.90  Aligned_cols=254  Identities=25%  Similarity=0.448  Sum_probs=196.7

Q ss_pred             CCeEEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .+|++.+.||+|+||.||+|.    +..++..||+|.+...  .......+.+|+.+++.+. ||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCC
Confidence            479999999999999999997    4567889999998533  3445667789999999997 99999999987655566


Q ss_pred             eEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+++||||+. ++|.+++..  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            7999999997 589998864  3589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------------HHHHHHhh
Q psy14434        176 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ------------LQLIVNLV  240 (404)
Q Consensus       176 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------------~~~~~~~~  240 (404)
                      ....   .....++..|+|||.+ .+..++.++|+|||||++|+|++|..++........            ...+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211   1112234569999997 456789999999999999999998776543221100            00000100


Q ss_pred             CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ....     .......++..+.+|+.+||..+|++|||+.+++..
T Consensus       240 ~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         240 KNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             hcCC-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            0000     001124568899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-40  Score=305.35  Aligned_cols=254  Identities=23%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             CeEEeeeecccCceeEEEEEE----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -|++++.||+|+||.||+|..    ..++..||+|.+... ........+.+|+.+++.+. ||||+++++++...+...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCc
Confidence            378999999999999999974    457889999998543 23344567889999999996 999999999987544577


Q ss_pred             EEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .++||||++ ++|.+++...  .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            899999997 5899988643  4899999999999999999999999999999999999999999999999999866432


Q ss_pred             CC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----------HHHHHHHHhhCC
Q psy14434        177 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-----------HQLQLIVNLVRP  242 (404)
Q Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~  242 (404)
                      ..   ......++..|+|||.+. +..++.++|||||||++|+|+++..|+......           ............
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            21   112345677899999974 556889999999999999999987654221100           000111111100


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..     .......++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       242 ~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GK-----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             Cc-----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            00     001124568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-39  Score=300.99  Aligned_cols=248  Identities=24%  Similarity=0.437  Sum_probs=201.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+|.+.+.||.|+||.||+|.+...   ...||+|..... ........+.+|+.+++.+. ||||+++++++.   ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~---~~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFD-HPHIVKLIGVIT---ENP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCC-CCchhceeEEEc---CCC
Confidence            4699999999999999999987644   456899987533 22445567888999999996 999999999876   345


Q ss_pred             EEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .|+||||+. ++|.+++...  .+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999998 5899998753  4899999999999999999999999999999999999999999999999999765443


Q ss_pred             CCc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KEC-LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ... .....++..|+|||.+ ....++.++|||||||++|+|++ |..||.+.........+........         .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~  230 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---------P  230 (270)
T ss_pred             cceecCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---------C
Confidence            211 1122345679999987 45678999999999999999986 9999988877666555544332211         1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..++..+.++|.+||..+|.+|||+.+++..
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4568899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0670|consensus

Probab=100.00  E-value=1.2e-41  Score=318.12  Aligned_cols=262  Identities=31%  Similarity=0.549  Sum_probs=221.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-----CCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-----PNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----pnIv~l~~~~~~~   95 (404)
                      +-++|.+....|+|-||+|.+|.|..-|..||||+|..   ++.-.+.-++|+.+|++|...     -|+++++..|.  
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--
Confidence            44689999999999999999999999999999999953   455566778999999999742     38999998887  


Q ss_pred             cCCeEEEEEeccCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccc
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLA  170 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a  170 (404)
                      ...++|||+|.+.-+|..+++.    -.|....++.|+.||+.||+.|...||+|.||||+||||++. ..+||||||.|
T Consensus       505 hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            5778999999999999999974    238889999999999999999999999999999999999875 57999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-----
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-----  245 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  245 (404)
                      ......  ..+.+..+..|.|||+++ +-.|++..|+||+||+||||.||+..|+|.....++...+...+..+.     
T Consensus       585 ~~~~en--eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  585 SFASEN--EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             cccccc--cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            776543  357788999999999986 678999999999999999999999999999999999988887766554     


Q ss_pred             -----------------------------------CcchhhcccCC---CC-------HHHHHHHHhccccCCCCCCCHH
Q psy14434        246 -----------------------------------HADKFYAGFKN---KP-------EEAVDLLNQILVLNPSERPETD  280 (404)
Q Consensus       246 -----------------------------------~~~~~~~~~~~---~~-------~~~~~li~~~L~~dp~~Rpt~~  280 (404)
                                                         ....+...+..   ++       ..+.+||.+||..||.+|+|+.
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                               00011111111   11       3588999999999999999999


Q ss_pred             HHHhccCCCC
Q psy14434        281 QILEHNYVSK  290 (404)
Q Consensus       281 ~ll~hp~~~~  290 (404)
                      ++|.||||+.
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-39  Score=304.76  Aligned_cols=255  Identities=24%  Similarity=0.406  Sum_probs=197.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC----------------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcc
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN----------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII   86 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv   86 (404)
                      ++|++.+.||+|+||.||+|.+..                ++..+|+|++... ........+.+|+.+++.+. |+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~-~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLK-DPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCcc
Confidence            579999999999999999986432                3457999998543 23344567889999999996 99999


Q ss_pred             eEeeEEEeccCCeEEEEEeccC-CcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q psy14434         87 TMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN  153 (404)
Q Consensus        87 ~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~N  153 (404)
                      ++++++.  .....++||||+. ++|.+++...            .+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        83 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999986  4567899999998 5898888643            25677899999999999999999999999999999


Q ss_pred             EEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCc
Q psy14434        154 ILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGAST  229 (404)
Q Consensus       154 Ill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~  229 (404)
                      ||++.++.++|+|||++..+.....  ......+++.|+|||... ...++.++|+|||||++|+|++  |..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999976543221  112233467899999874 4568999999999999999998  7788877666


Q ss_pred             HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ................  .........+++.+.+|+.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFFRDQGR--QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHHhhccc--cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5544433222111000  0001112346789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-39  Score=296.60  Aligned_cols=246  Identities=24%  Similarity=0.472  Sum_probs=200.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+|++.+.||.|+||.||+|.+.. +..+|+|.+.....   ....+.+|+.+++.+. ||||+++++++.  .....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM---SEEDFIEEAQVMMKLS-HPKLVQLYGVCT--ERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC---CHHHHHHHHHHHHhCC-CCCeeeEEEEEc--cCCceEE
Confidence            589999999999999999998864 56799998864332   2345678999999996 999999999976  4667899


Q ss_pred             EEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        103 VFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      ||||+.+ +|.+++..  +.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999985 78888864  4589999999999999999999999999999999999999999999999999876543211 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......++..|+|||.+. +..++.++|+|||||++|+|++ |..||...........+........+         ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  226 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---------RLA  226 (256)
T ss_pred             ccCCCccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---------CCC
Confidence            111233567899999884 5678899999999999999998 99999887766666555443222211         234


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +..+.+|+.+||..+|.+|||+.+++++
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            7899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=301.06  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++|++.+.||+|+||.||+|.++.+|+    .+|+|.+.... .......+.+|+..++.+. ||||+++++++..   
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVD-HPHVVRLLGICLS---   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec---
Confidence            4689999999999999999999876654    58999875442 2345567789999999996 9999999999863   


Q ss_pred             CeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...++||||+. |+|.+.+..  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            67899999998 589988875  358999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccc--ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSKECLT--EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .......  ...++..|+|||.+ ....++.++|+|||||++|+|++ |..||.+.........+........+      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  233 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP------  233 (279)
T ss_pred             CcccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC------
Confidence            3322111  12235679999987 45678999999999999999998 99999887766655555433221111      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                         ...+..+.+++.+||..+|.+||++.++++
T Consensus       234 ---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         234 ---PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               335788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-39  Score=304.77  Aligned_cols=259  Identities=19%  Similarity=0.205  Sum_probs=190.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhH---------HHHHHHHHHHHHhccCCCCcce
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTD---------AQRTYREILFLKSFQRHPNIIT   87 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~~hpnIv~   87 (404)
                      ...++|++.+.||+|+||.||+|.+..+   +..+|+|+..........         ......+...+..+. |++|++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence            3446899999999999999999998877   667788864322111000         011223334455565 999999


Q ss_pred             EeeEEEeccC--CeEEEEEeccCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         88 MLDIYKAVNN--KDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        88 l~~~~~~~~~--~~~~lv~E~~~~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      ++++......  ...+++||++..++.+.+... ..++..++.++.||+.||+|||+.+|+||||||+|||++.++.++|
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            9987653222  245788998887777776643 3788889999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH
Q psy14434        165 GDLGLARSLSDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLI  236 (404)
Q Consensus       165 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~  236 (404)
                      +|||+|+......       .......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.... ......
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999998653221       111234699999999997 5677899999999999999999999999877432 222111


Q ss_pred             H-HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        237 V-NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      . ..........    ...+..+..+.+++..|+..+|++||++.++++
T Consensus       247 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGK----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhh----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1 1111000000    012456889999999999999999999999875

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=297.01  Aligned_cols=241  Identities=27%  Similarity=0.448  Sum_probs=196.3

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME  108 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~  108 (404)
                      +.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++++. ||||+++++++.  .....++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYD-HPNIVKLIGVCV--QKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCC-CCCeEEEEEEEe--cCCCeEEEEEcCC
Confidence            469999999999999887 899999988654332 35567788999999997 999999999986  5677999999997


Q ss_pred             -CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc--ccc
Q psy14434        109 -NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEY  183 (404)
Q Consensus       109 -~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~  183 (404)
                       ++|.+++..  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..........  ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence             478888864  358899999999999999999999999999999999999999999999999997654221111  112


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      .++..|+|||.+ .+..++.++|+|||||++|+|++ |..||...........+........         ...++..+.
T Consensus       156 ~~~~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~  225 (251)
T cd05041         156 QIPIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---------PQLCPEEIY  225 (251)
T ss_pred             cceeccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC---------CccCCHHHH
Confidence            335679999997 45678999999999999999999 8899987776555444433222111         134578999


Q ss_pred             HHHHhccccCCCCCCCHHHHHh
Q psy14434        263 DLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +++.+||..+|.+|||+.++++
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0608|consensus

Probab=100.00  E-value=8.6e-41  Score=318.54  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=208.6

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      -|..++.||-|+||.|+++....|...||+|.+.+.. ...........|-.||.... .+.||+||..|.  +...+|+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQ--DkdnLYF  706 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQ--DKDNLYF  706 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEec--cCCceEE
Confidence            5888999999999999999999999999999996652 33344555567888898886 899999999988  6778999


Q ss_pred             EEeccCC-cHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC------
Q psy14434        103 VFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS------  174 (404)
Q Consensus       103 v~E~~~~-~L~~~l-~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~------  174 (404)
                      ||+|+.| ++-.++ +.+.|.|.-+++++.++.+|+++.|..|+|||||||+||||+.+|+|||+|||+|..+.      
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            9999995 766554 67889999999999999999999999999999999999999999999999999996431      


Q ss_pred             ---CCC---------------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q psy14434        175 ---DSK---------------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML  218 (404)
Q Consensus       175 ---~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  218 (404)
                         .++                                 ......+||+.|+|||++. ...|+..+|+||.|||||||+
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHh
Confidence               100                                 0112457999999999984 667899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCC---CHHHHHhccCCCCcCC
Q psy14434        219 QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEHNYVSKYFP  293 (404)
Q Consensus       219 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~hp~~~~~~~  293 (404)
                      .|++||..........++++......      .....+++.++.+||.++. -+++.|.   .++++-.||||+.+-.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~------~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLH------IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccc------cccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            99999988776655555444322110      0112567999999998854 4677776   4678999999997644

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.7e-39  Score=295.97  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+...   ......+.+|+.+++.+. |+||+++++++..   ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~   75 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EPI   75 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC---CCe
Confidence            3568999999999999999999765 4556999987532   233456778999999996 9999999999763   668


Q ss_pred             EEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |++|||+. ++|.+++..   ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99999998 589998864   24788889999999999999999999999999999999999999999999999765432


Q ss_pred             CC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......++..|+|||.+ ....++.++|+|||||++|++++ |..||.+.+.......+........         .
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~  225 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------P  225 (260)
T ss_pred             CcccccCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC---------c
Confidence            21 11223456779999998 45668999999999999999998 9999988777666555543322111         1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ...+.++.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            356889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-39  Score=315.36  Aligned_cols=250  Identities=23%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|.+.+.||+|+||.||+|.+.     .++..||+|++.... .......+.+|+.++..+..||||+++++++.  ..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--~~  113 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT--KG  113 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--cC
Confidence            46899999999999999999864     355789999996543 23334567899999999966999999999986  45


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc----------------------------------------------------------
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK----------------------------------------------------------  118 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~----------------------------------------------------------  118 (404)
                      ..+++||||+. |+|.+++...                                                          
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            67999999999 5898887532                                                          


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q psy14434        119 -----------------------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID  157 (404)
Q Consensus       119 -----------------------------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~  157 (404)
                                                               .++...+..++.||+.||.|||+.|++||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                     256667888999999999999999999999999999999


Q ss_pred             cCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q psy14434        158 KSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQ  234 (404)
Q Consensus       158 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  234 (404)
                      .++.+||+|||+++.......  ......+++.|+|||.+ ....++.++|||||||++|||++ |..||..........
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            999999999999976432211  11234578889999998 45668999999999999999998 889998766554433


Q ss_pred             HHHH-hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        235 LIVN-LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .... ......         ...++.++.+|+.+||..+|.+||++.+++..
T Consensus       353 ~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         353 NAIKRGYRMAK---------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3322 211111         13468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-39  Score=294.09  Aligned_cols=242  Identities=24%  Similarity=0.440  Sum_probs=194.9

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME  108 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~  108 (404)
                      +.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++.  .....++||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYD-HPNIVKLIGVCT--QRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEe--cCCccEEEEECCC
Confidence            46899999999999865 67789999986443 2333456778999999996 999999999986  4567999999998


Q ss_pred             -CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcc-cccc
Q psy14434        109 -NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-TEYI  184 (404)
Q Consensus       109 -~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~  184 (404)
                       ++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence             588888764  358899999999999999999999999999999999999999999999999987543321111 1123


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      ++..|+|||.+ ....++.++|+|||||++|+|++ |..||.+.........+........         ...++..+.+
T Consensus       156 ~~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  225 (250)
T cd05085         156 IPIKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---------PQKCPDDVYK  225 (250)
T ss_pred             CcccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC---------CCCCCHHHHH
Confidence            46679999997 45678999999999999999998 9999988766655444433222111         1346899999


Q ss_pred             HHHhccccCCCCCCCHHHHHhc
Q psy14434        264 LLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       264 li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ++.+||..+|++||++.++++.
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHHH
Confidence            9999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.3e-39  Score=297.04  Aligned_cols=244  Identities=26%  Similarity=0.458  Sum_probs=191.4

Q ss_pred             eeecccCceeEEEEEEcC---CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         29 KRIGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +.||+|+||.||+|.+..   .+..+|+|.+... ........+.+|+.+++.+. ||||+++++++.. .+...+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLP-SEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeec-CCCCcEEEEe
Confidence            468999999999998653   3467999987532 23345667788999999996 9999999997643 3456889999


Q ss_pred             ccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC----C
Q psy14434        106 YME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK----E  178 (404)
Q Consensus       106 ~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~----~  178 (404)
                      |+. ++|.+++...  .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++......    .
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            998 5899998753  46778888999999999999999999999999999999999999999999997653321    1


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......+++.|+|||.+ .+..++.++|||||||++|+|++ |.+||...+.......+........+         ..+
T Consensus       158 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  227 (262)
T cd05058         158 NHTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---------EYC  227 (262)
T ss_pred             ccccCcCCccccChhHh-ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------CcC
Confidence            11233467789999987 45678999999999999999999 56778776655544443332221111         235


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +..+.+++.+||..+|++||++.+++..
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-39  Score=295.56  Aligned_cols=242  Identities=25%  Similarity=0.393  Sum_probs=197.9

Q ss_pred             eeecccCceeEEEEEEcC-CC--eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         29 KRIGKGAYGIVYKAYDKN-NK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +.||+|++|.||+|.+.. ++  ..||+|.+...... .....+.+|+..++++. ||||+++++++..   ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEEE
Confidence            468999999999998865 33  36999999655433 56677889999999997 9999999999863   77999999


Q ss_pred             ccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc--
Q psy14434        106 YME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC--  179 (404)
Q Consensus       106 ~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~--  179 (404)
                      |+. ++|.+.+...   .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.........  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            997 5899888753   4899999999999999999999999999999999999999999999999999876442211  


Q ss_pred             -ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        180 -LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       180 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                       .....++..|+|||.+ ....++.++|||||||++|+|++ |..||...........+..... ...       .....
T Consensus       156 ~~~~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~-------~~~~~  226 (257)
T cd05040         156 MEEHLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-RLE-------RPEAC  226 (257)
T ss_pred             cccCCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-cCC-------CCccC
Confidence             1124567889999987 45678999999999999999998 9999987776665555443111 111       01345


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +..+.+++.+||..+|.+||++.+++.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.9e-39  Score=296.26  Aligned_cols=240  Identities=26%  Similarity=0.480  Sum_probs=197.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||++.  .+++.||+|.+...    .....+.+|+.+++.+. ||||+++++++..   ...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLH-HKNLVRLLGVILH---NGLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---CCcE
Confidence            4679999999999999999985  46788999998532    23456778999999996 9999999999752   3479


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||+. ++|.+++...   .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999998 5899888743   4789999999999999999999999999999999999999999999999998764322 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                        ......+..|+|||.+ .+..++.++|+|||||++|+|++ |.+||...+.......+.......+.         ..
T Consensus       154 --~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  221 (254)
T cd05083         154 --VDNSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP---------EG  221 (254)
T ss_pred             --CCCCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC---------Cc
Confidence              1223346789999987 45678899999999999999997 99999887776655554433222211         35


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ++..+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-39  Score=303.93  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++|+..+.||+|+||.||+|.+..++.    .+|+|.+.... .......+.+|+.+++.+. ||||+++++++..   
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~---   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMD-HPHLVRLLGVCLS---   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC---
Confidence            3578999999999999999999887775    46888875332 2333446778999999996 9999999998752   


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...++++||+. |+|.+.+...  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence            34679999998 5888888643  58899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ....  ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+........       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------  232 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ-------  232 (303)
T ss_pred             CcccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC-------
Confidence            3221  12233457789999997 46678999999999999999997 8999987665444443332222111       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ...++..+.+++.+||..+|++||++.++++.
T Consensus       233 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         233 --PPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              13457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-39  Score=298.01  Aligned_cols=250  Identities=29%  Similarity=0.515  Sum_probs=204.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcC-CCeEEEEEEcchhc--------cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAF--------RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....        .......++.+|+.++.+..+||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            48899999999999999999987 78899999885321        223345667789998887556999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEecc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                       .....+++|||+.+ +|.+++.     ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence             56789999999985 7877763     2358999999999999999999996 78999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      |.+....... ......|+..|+|||.+. +..++.++|+||||+++|+|++|.+||...........+.........  
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  234 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--  234 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--
Confidence            9998765432 344567899999999984 556899999999999999999999999877666555544443322111  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                            ...+++.+.++|.+||+.||++||++.++..+
T Consensus       235 ------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         235 ------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                  12457899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1151|consensus

Probab=100.00  E-value=2.7e-41  Score=310.52  Aligned_cols=267  Identities=26%  Similarity=0.489  Sum_probs=215.0

Q ss_pred             cccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-----hHHHHHHHHHHHHHhccCCCCcceE
Q psy14434         14 QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----TDAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      ++.-+....++|-++..||+|||+.||+|.|...+++||+|+-.......     .-.+...+|..+-+.|. ||.||++
T Consensus       454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKl  532 (775)
T KOG1151|consen  454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKL  532 (775)
T ss_pred             hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeee
Confidence            34445677889999999999999999999999999999999864332222     22344568999999996 9999999


Q ss_pred             eeEEEeccCCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCCcEEEcc---CCc
Q psy14434         89 LDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC--KVMHRDLKPSNILIDK---SCS  161 (404)
Q Consensus        89 ~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~--~i~HrDlkp~NIll~~---~~~  161 (404)
                      |++|.- +...+|-|+|||+| +|.-++++ +.+++.+++.|+.||+.||.||...  -|||-||||.|||+..   -|.
T Consensus       533 YDyfsl-DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  533 YDYFSL-DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeee-ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            999964 67789999999998 78888875 5589999999999999999999865  4999999999999943   488


Q ss_pred             eEEeccccccccCCCCC-------cccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q psy14434        162 IKIGDLGLARSLSDSKE-------CLTEYIATRWYRAPEILISN---RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH  231 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  231 (404)
                      +||+|||+++.+.+...       ......||.||++||.|.-+   +..+.++||||+|||+|.+++|+.||...-...
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            99999999998865432       22346799999999998543   467899999999999999999999995543222


Q ss_pred             HH---HHHHHhhC-CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        232 QL---QLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       232 ~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .+   ..|.+... .+|+        -+-+++++.+||++||.+.-+.|+...++.+||||..
T Consensus       692 dILqeNTIlkAtEVqFP~--------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  692 DILQENTILKATEVQFPP--------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHhhhchhcceeccCCC--------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            11   11222221 1111        2567999999999999999999999999999999975

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-39  Score=297.44  Aligned_cols=237  Identities=18%  Similarity=0.287  Sum_probs=186.2

Q ss_pred             eeecccCceeEEEEEEcC------------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKN------------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +.||+|+||.||+|....            ....+|+|++...  .......+.+|+.++..+. ||||+++++++.  .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~--~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVS-HKHIVLLYGVCV--R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--c
Confidence            468999999999997532            2335889987543  2334456778888999996 999999999976  4


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc-------eEEec
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-------IKIGD  166 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~-------vkl~D  166 (404)
                      ....++||||+++ +|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            5678999999995 67777753  45899999999999999999999999999999999999987664       89999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPP  245 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~  245 (404)
                      ||++......    ....++..|+|||.+..+..++.++|||||||++|+|+ .|..||.......... .......   
T Consensus       156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~---  227 (262)
T cd05077         156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM---  227 (262)
T ss_pred             CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc---
Confidence            9998765322    23468889999998855677899999999999999998 5888887655433221 1111111   


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                             .....+.++.+||.+||+.||++||++.+++.+
T Consensus       228 -------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 -------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                   012335789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.9e-39  Score=298.39  Aligned_cols=250  Identities=22%  Similarity=0.392  Sum_probs=199.5

Q ss_pred             eEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC----
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----   97 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~----   97 (404)
                      |++.+.||+|+||.||+|.+.   .+++.||||++...........++.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence            678899999999999999865   35789999999766556666778889999999996 9999999998753222    


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      ...++++||+. ++|..++..       ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence            23478899998 588777642       1378889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        170 ARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       170 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ++.......  ......+++.|++||.+ ....++.++|||||||++|+|++ |.+||.+.+.......+........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  236 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ--  236 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC--
Confidence            986543221  11223456789999987 45667899999999999999999 8999987766554444433221111  


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                             ....+..+.+++.+||..+|++||++.+++.+
T Consensus       237 -------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 -------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   13457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=299.32  Aligned_cols=237  Identities=17%  Similarity=0.305  Sum_probs=187.1

Q ss_pred             eeecccCceeEEEEEEcCCCe-------EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQ-------YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +.||+|+||.||+|.+...+.       .+|+|.+...  .......+..|+.+++.+. ||||+++++++.  .....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLS-HKHLVLNYGVCV--CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCC-CCChhheeeEEE--eCCCcE
Confidence            469999999999998866544       3788877432  2334456778889999886 999999999987  456689


Q ss_pred             EEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc--------eEEeccccc
Q psy14434        102 VVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--------IKIGDLGLA  170 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~--------vkl~Dfg~a  170 (404)
                      +||||+.+ +|..++...  .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999984 898888743  4899999999999999999999999999999999999987765        699999998


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ......    ....+++.|+|||.+.+...++.++|||||||++|+|++|. +||...+........ ......+     
T Consensus       156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~-----  225 (258)
T cd05078         156 ITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQLP-----  225 (258)
T ss_pred             cccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccCC-----
Confidence            755432    23568889999999865566899999999999999999994 666555444332221 1111111     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                           ...+.++.+||.+||+.||++|||++++++.
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         226 -----APKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                 2345789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-39  Score=296.98  Aligned_cols=250  Identities=21%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++++.||.|+||.||+|..+.     +...+|+|.+... ........+.+|+.+++++. ||||+++++++.  +.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLS-HKNVVRLLGLCR--EA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcC-CcceeeeEEEEC--CC
Confidence            579999999999999999998754     3467999987532 12234567889999999996 999999999876  46


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      ...|+||||+. ++|.+++...          .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            67899999998 5899988742          489999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        167 LGLARSLSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       167 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      ||++....... .......++..|+|||.+. +..++.++|||||||++|+|++ |..||.+.........+.......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            99987543211 1223345678899999874 5567899999999999999998 8889977666555444432221111


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                              ....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       240 --------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 --------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                    113568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.5e-39  Score=295.71  Aligned_cols=247  Identities=21%  Similarity=0.354  Sum_probs=189.1

Q ss_pred             eeecccCceeEEEEEEcC--CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|....  ....+|+|.+... ........+.+|+..++.+. ||||+++++.+.  ....+|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~--~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCI--ESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCC-CCCcceEEEEEC--CCCceEEEEEe
Confidence            369999999999996543  4457888887533 23344556778999999986 999999999976  56679999999


Q ss_pred             cC-CcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        107 ME-NDLNKVIRDKI------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       107 ~~-~~L~~~l~~~~------l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +. |+|.+++....      .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            98 58999886432      45777889999999999999999999999999999999999999999999865432211 


Q ss_pred             -ccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        179 -CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                       ......+++.|+|||++..      ...++.++|||||||++|+|++ |..||....................+..   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---  233 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP---  233 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC---
Confidence             1122345678999998732      2356889999999999999999 7899987766655444433322111110   


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                       .....++..+.+++..|+ .||.+|||++++++
T Consensus       234 -~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         234 -QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence             111356788899999998 59999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG1290|consensus

Probab=100.00  E-value=3.4e-39  Score=300.04  Aligned_cols=264  Identities=31%  Similarity=0.559  Sum_probs=207.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-------CcceEeeEEE--
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-------NIITMLDIYK--   93 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-------nIv~l~~~~~--   93 (404)
                      ++|-+++.||.|.|++||+|.|..+.+.||+|+.+.+   ..-.+..+.||++|+++..+.       +||+|++.|.  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            7899999999999999999999999999999998533   334566779999999986443       7999999996  


Q ss_pred             eccCCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccC----------
Q psy14434         94 AVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKS----------  159 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~----------  159 (404)
                      .+++.++|+|+|+++.+|..+|..   +.++...++.|++|||.||.|||. .||||-||||+|||+..+          
T Consensus       155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~  234 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE  234 (590)
T ss_pred             CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence            678899999999999999998874   459999999999999999999995 699999999999998200          


Q ss_pred             --------------------------------------------------------------------------------
Q psy14434        160 --------------------------------------------------------------------------------  159 (404)
Q Consensus       160 --------------------------------------------------------------------------------  159 (404)
                                                                                                      
T Consensus       235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~  314 (590)
T KOG1290|consen  235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES  314 (590)
T ss_pred             hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CceE
Q psy14434        160 ----------------------------------------------------------------------------CSIK  163 (404)
Q Consensus       160 ----------------------------------------------------------------------------~~vk  163 (404)
                                                                                                  -++|
T Consensus       315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK  394 (590)
T KOG1290|consen  315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK  394 (590)
T ss_pred             chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence                                                                                        0145


Q ss_pred             EeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHH
Q psy14434        164 IGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA------STSHQLQLIV  237 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~------~~~~~~~~~~  237 (404)
                      |+|||.|+...   ...+.-+.|..|+|||++. +..|+..+||||++|++|||+||..+|...      .+.+.+..|+
T Consensus       395 IaDlGNACW~~---khFT~DIQTRQYRapEVll-GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  395 IADLGNACWVH---KHFTEDIQTRQYRAPEVLL-GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             Eeeccchhhhh---hhhchhhhhhhccCcceee-cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            55555554422   1123345688899999996 667999999999999999999999888532      3567778888


Q ss_pred             HhhCCCCCC-------cchhhc---------------------ccCCCC----HHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        238 NLVRPNPPH-------ADKFYA---------------------GFKNKP----EEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       238 ~~~~~~~~~-------~~~~~~---------------------~~~~~~----~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.++..|..       ...|+.                     ..-.+|    .++.+||.-||+++|++||||.++|+|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            877755440       000000                     000112    357899999999999999999999999


Q ss_pred             cCCCCcCC
Q psy14434        286 NYVSKYFP  293 (404)
Q Consensus       286 p~~~~~~~  293 (404)
                      ||++....
T Consensus       551 PwLn~~~~  558 (590)
T KOG1290|consen  551 PWLNPVAG  558 (590)
T ss_pred             ccccCCCC
Confidence            99987544

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.1e-39  Score=298.60  Aligned_cols=254  Identities=22%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEc----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDK----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .+|++.+.||+|+||.||+|...    .++..+|+|++...... .....+.+|+.+++.+. ||||+++++++......
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCC
Confidence            46889999999999999999864    34789999998654332 35667889999999996 99999999998755567


Q ss_pred             eEEEEEeccC-CcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+++|||+. ++|.+++....  +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            8999999998 58999987544  99999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHHHHHhhC
Q psy14434        176 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-----------QLQLIVNLVR  241 (404)
Q Consensus       176 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~  241 (404)
                      ....   .....++..|+|||.+ .+..++.++|+|||||++|+|++|..||.......           ....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHH-ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2211   1122345679999987 45578899999999999999999998886543221           0111111111


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .....     .....++.++.+|+.+||..+|.+|||+.+++.
T Consensus       241 ~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERL-----PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcC-----CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11100     011345788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0587|consensus

Probab=100.00  E-value=1.6e-39  Score=320.72  Aligned_cols=270  Identities=26%  Similarity=0.470  Sum_probs=224.9

Q ss_pred             CCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEe
Q psy14434         10 GDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML   89 (404)
Q Consensus        10 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~   89 (404)
                      +.-...+......+-|++.+.||.|.+|.||++..+.+++..|+|++..   ......++..|.++|+.+..|||++.+|
T Consensus         6 ~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fy   82 (953)
T KOG0587|consen    6 LMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFY   82 (953)
T ss_pred             ccccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEE
Confidence            3344555556667789999999999999999999999999999999854   3344556668899999999999999999


Q ss_pred             eEEEe---ccCCeEEEEEeccC-CcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCce
Q psy14434         90 DIYKA---VNNKDLYVVFEYME-NDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI  162 (404)
Q Consensus        90 ~~~~~---~~~~~~~lv~E~~~-~~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~v  162 (404)
                      ++|.-   ..++.++||||||+ |+..++++   ..++.|..+.+|++.++.|+.+||.+.++|||||-.|||++.+|.|
T Consensus        83 g~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   83 GAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE
Confidence            99862   35678999999999 47777776   4569999999999999999999999999999999999999999999


Q ss_pred             EEeccccccccCCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q psy14434        163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  238 (404)
                      ||+|||++..+........+.+|||.|||||++..    ...|+..+|+||||++..||--|.+|+-+.-....   +..
T Consensus       163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~  239 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFL  239 (953)
T ss_pred             EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hcc
Confidence            99999999988776666778899999999999843    24578899999999999999999999866555433   333


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ..+..++..    ..+...+.++.+||..||.+|..+||+..++|.|||++
T Consensus       240 IpRNPPPkL----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  240 IPRNPPPKL----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             CCCCCCccc----cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            333222221    11245688999999999999999999999999999987

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.7e-39  Score=296.18  Aligned_cols=242  Identities=29%  Similarity=0.499  Sum_probs=193.7

Q ss_pred             eeecccCceeEEEEEEcCCC------eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNK------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      +.||+|+||.||+|.+....      ..+|+|.+.... .......+.+|+.+++.+. ||||+++++++.  .....++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCL--LNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcC-CCCeeeEeeeec--CCCCeEE
Confidence            46999999999999876443      789999885432 2244567788999999996 999999999986  4667999


Q ss_pred             EEeccC-CcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-----ceEEeccc
Q psy14434        103 VFEYME-NDLNKVIRD--------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-----SIKIGDLG  168 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~--------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-----~vkl~Dfg  168 (404)
                      ||||+. ++|.+++..        ..+++..+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999998 588888863        2378899999999999999999999999999999999999887     89999999


Q ss_pred             cccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCC
Q psy14434        169 LARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPP  245 (404)
Q Consensus       169 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  245 (404)
                      ++........  ......++..|+|||.+ .+..++.++|||||||++|+|++ |..||...+.......+........ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK-  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHH-ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC-
Confidence            9976533211  11223456789999998 45668999999999999999998 9999987776655444432221111 


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                              ...+|..+.++|.+||..+|.+||++.++++
T Consensus       235 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 --------PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                    1346889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.7e-39  Score=296.38  Aligned_cols=236  Identities=19%  Similarity=0.292  Sum_probs=185.2

Q ss_pred             eecccCceeEEEEEEcCC------------------------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCc
Q psy14434         30 RIGKGAYGIVYKAYDKNN------------------------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI   85 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   85 (404)
                      .||+|+||.||+|....+                        ...||+|++...  .......+.+|+.+++.+. ||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~-h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVS-HIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCC-CCCe
Confidence            599999999999974321                        245889988543  2233456778888888886 9999


Q ss_pred             ceEeeEEEeccCCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC--
Q psy14434         86 ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC--  160 (404)
Q Consensus        86 v~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~--  160 (404)
                      +++++++.  .....++||||+++ +|..++..  +.+++..+..++.||+.||+|||++||+||||||+|||++..+  
T Consensus        79 v~~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          79 AFVHGVCV--RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eeEEEEEE--eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            99999976  46678999999995 78887753  5689999999999999999999999999999999999997653  


Q ss_pred             -----ceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHH
Q psy14434        161 -----SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQ  234 (404)
Q Consensus       161 -----~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~  234 (404)
                           .+|++|||++......    ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||.+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence                 4899999998654322    22357888999998865567899999999999999985 6899998766544332


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...... ..+          ...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~-~~~----------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FYEKKH-RLP----------EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHhcc-CCC----------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222111 111          1235689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-38  Score=293.61  Aligned_cols=247  Identities=20%  Similarity=0.307  Sum_probs=188.5

Q ss_pred             eeecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||+|...  .++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++.  +....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCT--EVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--CCCCcEEEEEC
Confidence            46999999999999764  345779999885443 2233456778999999996 999999999976  45668999999


Q ss_pred             cC-CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        107 ME-NDLNKVIRDK------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       107 ~~-~~L~~~l~~~------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +. |+|.+++...      .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            98 5898888642      356677888999999999999999999999999999999999999999999875433221 


Q ss_pred             -cccccccccccccccccccC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        179 -CLTEYIATRWYRAPEILISN------RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                       ......|++.|+|||++...      ..++.++|+|||||++|+|++ |..||...................... .. 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-  234 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK-PR-  234 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC-Cc-
Confidence             11234578889999997421      135789999999999999996 999998776655433322221111110 00 


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        .....+..+.+++.+|+ .+|++|||+++++.
T Consensus       235 --~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 --LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             --cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence              01235778999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0194|consensus

Probab=100.00  E-value=1.6e-39  Score=312.02  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=208.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCe---E-EEEEEcch-hccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQ---Y-VAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~-~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..++-.+.+.||+|+||.||+|..+..+.   . ||+|.... .........++++|.++|++++ ||||+++||+..  
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~--  231 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAV--  231 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc--
Confidence            34556677999999999999998765422   3 89998865 3466788899999999999997 999999999965  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ...-+|||||+|.| +|.+++++..  ++..+...++++.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            57779999999995 9999998654  99999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH-HHhhCCCCCCcchh
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI-VNLVRPNPPHADKF  250 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~  250 (404)
                      ...........--...|+|||.+. ...|+.++||||+||++||+++ |..||++.........+ .+..+...+     
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~-----  385 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP-----  385 (474)
T ss_pred             CcceeeccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC-----
Confidence            432111111122456799999984 5589999999999999999998 88999999988888887 434443332     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                          ...|.++..++.+|+..+|+.|||+.++.+
T Consensus       386 ----~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  386 ----SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ----CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                245788999999999999999999998864

>KOG1187|consensus

Probab=100.00  E-value=4e-39  Score=306.92  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=195.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC-e
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK-D   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~-~   99 (404)
                      ..+.|.-...||+|+||.||+|....+ ..||||.+.......  ..++..|+.++.++. |||+++++||+.  +.+ .
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~--e~~~~  146 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLR-HPNLVKLLGYCL--EGGEH  146 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCC-CcCcccEEEEEe--cCCce
Confidence            345788888999999999999987655 789999875432221  455899999999998 999999999987  444 6


Q ss_pred             EEEEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        100 LYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACK---VMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~---i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+||+|||. |+|.+.+..+   .++|.....|+.+++.||+|||...   |+||||||+|||+|++...||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            999999999 7999998743   7899999999999999999999854   99999999999999999999999999965


Q ss_pred             cCCCCCccccc-ccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHhhCC--CCCC
Q psy14434        173 LSDSKECLTEY-IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRP--NPPH  246 (404)
Q Consensus       173 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~--~~~~  246 (404)
                      ........... .||.+|+|||.+. .+..+.++|||||||++.||++|+.+.+...   ......+.......  ....
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            54311222222 7999999999984 5678999999999999999999998876532   21222322221111  1111


Q ss_pred             cchhhcccCCCC-----HHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        247 ADKFYAGFKNKP-----EEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       247 ~~~~~~~~~~~~-----~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .++-... ...+     ..+..+..+|++.+|.+||++.++++.
T Consensus       306 iD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  306 VDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             eCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            1110000 1112     236678899999999999999997543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-39  Score=293.74  Aligned_cols=227  Identities=25%  Similarity=0.319  Sum_probs=183.0

Q ss_pred             cCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC-cHH
Q psy14434         34 GAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN  112 (404)
Q Consensus        34 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~  112 (404)
                      |.+|.||+|.+..+++.||+|.+....       ...+|...+.... ||||+++++++.  +....|+||||+.+ +|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~-~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHC-VPNMVCLHKYIV--SEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcC-CCceeehhhhee--cCCeEEEEEecCCCCCHH
Confidence            889999999999999999999986432       1223444444554 999999999987  56789999999995 888


Q ss_pred             HHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccccccccc
Q psy14434        113 KVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA  191 (404)
Q Consensus       113 ~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~a  191 (404)
                      +.+.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||.+......   .....++..|+|
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a  150 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA  150 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence            87754 46999999999999999999999999999999999999999999999999988665432   233456788999


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhcccc
Q psy14434        192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVL  271 (404)
Q Consensus       192 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  271 (404)
                      ||.+ ....++.++|+||+||++|+|++|..||.......     ......         .....+++.+.+||.+||+.
T Consensus       151 PE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~li~~~l~~  215 (237)
T cd05576         151 PEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NTHTTL---------NIPEWVSEEARSLLQQLLQF  215 (237)
T ss_pred             Cccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cccccc---------CCcccCCHHHHHHHHHHccC
Confidence            9987 45667899999999999999999998875432110     000000         01134688999999999999


Q ss_pred             CCCCCCCH-----HHHHhccCC
Q psy14434        272 NPSERPET-----DQILEHNYV  288 (404)
Q Consensus       272 dp~~Rpt~-----~~ll~hp~~  288 (404)
                      ||.+||++     +++++||||
T Consensus       216 dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         216 NPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CHHHhcCCCccchHHHHcCCCC
Confidence            99999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-38  Score=291.26  Aligned_cols=234  Identities=21%  Similarity=0.326  Sum_probs=186.5

Q ss_pred             eeecccCceeEEEEEEcCCC----------eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         29 KRIGKGAYGIVYKAYDKNNK----------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +.||+|+||.||+|.+..++          ..+++|.+....   .....+.+|+.+++.+. ||||+++++++..   .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLS-HKHLVKLYGVCVR---D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCC-CcchhheeeEEec---C
Confidence            46999999999999998776          357888764322   12567788999999996 9999999998763   5


Q ss_pred             eEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-------ceEEeccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-------SIKIGDLG  168 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-------~vkl~Dfg  168 (404)
                      ..++||||+. ++|..++...  .++...+..++.||+.||+|||++||+||||||+||+++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            5799999999 5898888743  489999999999999999999999999999999999999887       79999999


Q ss_pred             cccccCCCCCcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ++.....    .....++..|+|||.+... ..++.++|+|||||++|+|++ |..||...+.......... ....+  
T Consensus       154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~--  226 (259)
T cd05037         154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP--  226 (259)
T ss_pred             ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC--
Confidence            9986543    1234577889999998544 378999999999999999999 5788876654333222221 11100  


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                              ......+.++|.+||..+|.+|||+.++++
T Consensus       227 --------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 --------MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                    111378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-38  Score=319.81  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=179.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCC----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE---
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNN----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK---   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~---   93 (404)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|.+.....    ......+  .++... +.++..+...|.   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            457899999999999999999999988    89999998753211    1111111  112221 233333222211   


Q ss_pred             -eccCCeEEEEEeccCC-cHHHHHHhcCC---------------------CHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q psy14434         94 -AVNNKDLYVVFEYMEN-DLNKVIRDKIL---------------------KDVHIRYIMFQLCNGLSYIHACKVMHRDLK  150 (404)
Q Consensus        94 -~~~~~~~~lv~E~~~~-~L~~~l~~~~l---------------------~~~~~~~i~~qil~al~~LH~~~i~HrDlk  150 (404)
                       ......+++||||+++ +|.+++....+                     ....+..++.||+.||.|||++||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             1346679999999995 78888864321                     134467899999999999999999999999


Q ss_pred             CCcEEEcc-CCceEEeccccccccCCC-CCcccccccccccccccccccCC---------------------CCCchhhH
Q psy14434        151 PSNILIDK-SCSIKIGDLGLARSLSDS-KECLTEYIATRWYRAPEILISNR---------------------RYTHHVDI  207 (404)
Q Consensus       151 p~NIll~~-~~~vkl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Di  207 (404)
                      |+|||++. ++.+||+|||+++.+... .......+||+.|+|||.+....                     .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 579999999999865432 22335678999999999753211                     23446699


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC-----------C-CCCcchhhcccCCCCHHHHHHHHhccccCCCC
Q psy14434        208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP-----------N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSE  275 (404)
Q Consensus       208 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  275 (404)
                      |||||++|||+++..++.  +....+.........           . ..........+...+..+++||.+||++||.+
T Consensus       363 wSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             HHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            999999999999765543  222222222111110           0 00000011111223445779999999999999


Q ss_pred             CCCHHHHHhccCCCCcCC
Q psy14434        276 RPETDQILEHNYVSKYFP  293 (404)
Q Consensus       276 Rpt~~~ll~hp~~~~~~~  293 (404)
                      |||+.++|+||||.....
T Consensus       441 R~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        441 RISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCCHHHHhCCcCcCCCCc
Confidence            999999999999987544

>KOG1026|consensus

Probab=100.00  E-value=2.6e-39  Score=320.43  Aligned_cols=248  Identities=28%  Similarity=0.482  Sum_probs=210.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ...+-+..+.||+|+||+||+|+-.     .....||||.++.. .+....+++.||+.++..|+ |||||+++|++.  
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~--  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQ-HPNIVRLLGVCR--  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEc--
Confidence            3456788899999999999999754     23467999998643 34447788999999999997 999999999987  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRDK---------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~~---------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      ++.-+|+|+|||. |||.++++..               +|+..+...|+.||+.||.||-++.++||||-.+|+||+++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            6778999999999 8999999621               27889999999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI  236 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  236 (404)
                      ..|||+|||+++..-..+  .......-...|||||.+. .+.++.+|||||+||+|||+++ |+.||.+.++.+.++.+
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            999999999998653321  1111223456799999995 6789999999999999999996 99999999999998888


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHH
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI  282 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l  282 (404)
                      .++.-..-         ..++|.++.+|+..||+.+|.+||++.||
T Consensus       719 ~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            77654222         26789999999999999999999999987

>KOG4250|consensus

Probab=100.00  E-value=1.6e-39  Score=315.13  Aligned_cols=202  Identities=31%  Similarity=0.507  Sum_probs=177.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc----CC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~----~~   98 (404)
                      .-|...+.||+|+||.||+++++.+|+.||||.+.... .........+|+.+|++++ |||||+++++-++..    ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccc
Confidence            56889999999999999999999999999999997653 5566778889999999998 999999999865433    44


Q ss_pred             eEEEEEeccC-CcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--cCC--ceEEecccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSC--SIKIGDLGL  169 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~--~~~--~vkl~Dfg~  169 (404)
                      ...+|||||. |+|...+++    ..|++.++..++.++..||.|||++||+||||||.||++-  ++|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            5689999999 599999974    3599999999999999999999999999999999999983  334  479999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA  227 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  227 (404)
                      |+.+.++. ...+.+||+.|.+||++.....|+..+|.||+||++|+++||..||-..
T Consensus       171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99987654 6788999999999999955688999999999999999999999998543

>KOG1095|consensus

Probab=100.00  E-value=2.3e-38  Score=324.25  Aligned_cols=251  Identities=27%  Similarity=0.473  Sum_probs=212.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCC-----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .-...-++.+.||+|.||.||.|....-.     ..||||.+.+. .+..+...+++|..+|..+. |||||+++|+.. 
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l-  765 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCL-  765 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeec-
Confidence            33456788999999999999999875432     34899998643 56778889999999999997 999999999965 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEe
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG  165 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~~--------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~  165 (404)
                       +....+|++|||. |||..++++.        .++..+...++.||++|+.||+++++|||||-.+|+|++....|||+
T Consensus       766 -~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  766 -DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             -CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence             5778899999999 5999999854        38999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCCcccc--cccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        166 DLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       166 Dfg~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      |||+|+.+-........  ..-...|||||.+. .+.++.++|||||||++||+++ |..||++.+..+.+......-+.
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99999954332211111  12345699999984 5789999999999999999997 89999999998887766666554


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++         ..+|..+.+++..||+.+|++||++..+++
T Consensus       924 ~~P---------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPP---------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCC---------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            444         578999999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-37  Score=286.38  Aligned_cols=247  Identities=19%  Similarity=0.309  Sum_probs=187.4

Q ss_pred             eeecccCceeEEEEEEcCCC--eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      +.||+|+||.||++....++  ..+++|.+... ........+.+|+..++.+. ||||+++++.+.  .....|+||||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~~~~~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCV--EAIPYLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccC-CcchhheEEEec--CCCccEEEEec
Confidence            36999999999999754433  34667766432 22344567889999999996 999999999987  46678999999


Q ss_pred             cC-CcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--C
Q psy14434        107 ME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--E  178 (404)
Q Consensus       107 ~~-~~L~~~l~~~-----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--~  178 (404)
                      +. |+|.+++...     .+++..++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.......  .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99 5899888642     35667788999999999999999999999999999999999999999999986432211  1


Q ss_pred             ccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        179 CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .....+|+..|+|||++..      ...++.++|||||||++|+|++ |..||...........+......... ...  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~--  233 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF-KPQ--  233 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC-CCc--
Confidence            1234568899999998732      1235788999999999999996 57889777766555554333221110 000  


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                       ....+++.+.+++..|| .+|++||++.++++
T Consensus       234 -~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         234 -LELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence             11345788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0196|consensus

Probab=100.00  E-value=6.4e-38  Score=305.53  Aligned_cols=249  Identities=26%  Similarity=0.437  Sum_probs=219.5

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ....|.+.||.|.||.||+|+.+..|   ..||||.++.. ..+.....++.|..+|-++. ||||++|.++..  ...-
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVT--ks~P  704 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVT--KSKP  704 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEe--cCce
Confidence            35678899999999999999988766   46999998643 45667778999999999997 999999999976  5677


Q ss_pred             EEEEEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +.||+|||+ |+|..+++  ++.|+..++.-.++.|+.|++||.++|++||||-..||||+.+...|++|||+++.+.++
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            899999999 79999998  467999999999999999999999999999999999999999999999999999988765


Q ss_pred             CCccccccc---ccccccccccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KECLTEYIA---TRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .+...+..|   ...|.|||.+ ...+++.++||||+|+++||.+ .|..||.+.++.+.+..+....+..++       
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------  856 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------  856 (996)
T ss_pred             CCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-------
Confidence            533333333   3569999998 6788999999999999999977 599999999999999999999886666       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        .++|..+.+|+..||++|-.+||.+.+++.+
T Consensus       857 --mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  857 --MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence              6789999999999999999999999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-36  Score=272.41  Aligned_cols=241  Identities=38%  Similarity=0.664  Sum_probs=198.6

Q ss_pred             CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC-cHHH
Q psy14434         35 AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK  113 (404)
Q Consensus        35 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~  113 (404)
                      +||.||+|.+..+++.+|+|++........ ...+.+|+..++++. |+||+++++++.  .....+++|||+++ +|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLK-HPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCC-CCcHHHHHhhee--eCCEEEEEEeCCCCCCHHH
Confidence            589999999999999999999865433222 577889999999995 999999999976  45789999999997 9999


Q ss_pred             HHHhcC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccc
Q psy14434        114 VIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP  192 (404)
Q Consensus       114 ~l~~~~-l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP  192 (404)
                      ++.... ++...++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p  155 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP  155 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence            987654 8999999999999999999999999999999999999999999999999998765432 33456789999999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhcccc
Q psy14434        193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVL  271 (404)
Q Consensus       193 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  271 (404)
                      |.+. ...++.++|+||||+++++|++|..||... ........+..........       ...++..+.+++.+||..
T Consensus       156 E~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      156 EVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-------EWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             HHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-------cccCCHHHHHHHHHHccC
Confidence            9974 566788999999999999999999999773 3333333332222211110       011678999999999999


Q ss_pred             CCCCCCCHHHHHhccCC
Q psy14434        272 NPSERPETDQILEHNYV  288 (404)
Q Consensus       272 dp~~Rpt~~~ll~hp~~  288 (404)
                      +|++||++.++++||||
T Consensus       228 ~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      228 DPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CchhccCHHHHhhCCCC
Confidence            99999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257|consensus

Probab=100.00  E-value=3.1e-37  Score=293.99  Aligned_cols=243  Identities=27%  Similarity=0.485  Sum_probs=204.1

Q ss_pred             eEEeeeecccCceeEEEEEEcC----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..+.+.||.|.||-||.|....    ..-.||||..+.. ......+.++.|..+|+.+. ||||++++|++.   ..-.
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfd-HphIikLIGv~~---e~P~  465 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCV---EQPM  465 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCC-Ccchhheeeeee---ccce
Confidence            3445679999999999997643    2346899987643 34455888999999999997 999999999986   4568


Q ss_pred             EEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||++. |.|..+++.+  .|+......+++||+.||+|||+.+++||||-..||||.+..-|||+|||+++.+.+..
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999 8899999854  48889999999999999999999999999999999999999999999999999887643


Q ss_pred             Ccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 ECL-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .-. +...-..-|||||.+ +...++.++|||.|||++||++ .|..||.+-...+.+-.+.++.+..-+         +
T Consensus       546 yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---------~  615 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---------P  615 (974)
T ss_pred             hhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---------C
Confidence            211 112234559999998 6788999999999999999987 599999998888777777777664333         6


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHH
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQI  282 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~l  282 (404)
                      ++|+.+..|+.+||.++|.+||+..++
T Consensus       616 nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  616 NCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             CCChHHHHHHHHHhccCcccCCcHHHH
Confidence            889999999999999999999998665

>KOG1027|consensus

Probab=100.00  E-value=1.5e-37  Score=305.54  Aligned_cols=246  Identities=29%  Similarity=0.426  Sum_probs=192.5

Q ss_pred             eEEeeeecccCcee-EEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         25 YTIHKRIGKGAYGI-VYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        25 y~~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      |.-.+.+|.|+-|+ ||+|..  .|+.||||.+-.     .....+.+|+..|+.-..|||||++|+.  +.+...+||.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEE
Confidence            33356789999875 799965  578999998842     3344667999999999999999999987  5578899999


Q ss_pred             EeccCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---C--CceEEecccccccc
Q psy14434        104 FEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---S--CSIKIGDLGLARSL  173 (404)
Q Consensus       104 ~E~~~~~L~~~l~~~~-----l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~--~~vkl~Dfg~a~~~  173 (404)
                      .|+|..+|.+++....     ......+..+.|++.||++||+.+|+||||||.||||+.   +  .+++|+|||+++.+
T Consensus       582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9999999999998631     122446788999999999999999999999999999976   3  47999999999988


Q ss_pred             CCCCCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        174 SDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       174 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ..+...   ..+..||.+|+|||++. ...-..++|||||||++|+.++| ..||......  ...|..........   
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L---  735 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHL---  735 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHh-ccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeee---
Confidence            764432   34567999999999985 44457799999999999999986 8999553322  22333322211110   


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                          -+....++.|||.+||.++|..||+|.++|.||+|=
T Consensus       736 ----~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  736 ----EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ----ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                011122899999999999999999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=295.47  Aligned_cols=268  Identities=19%  Similarity=0.303  Sum_probs=184.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc----------------CCCeEEEEEEcchhccCh------------hHHHHHHHH
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK----------------NNKQYVAIKKIFEAFRNK------------TDAQRTYRE   72 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~------------~~~~~~~~E   72 (404)
                      ..++|++.+.||+|+||+||+|.+.                ..++.||||.+.......            ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                345679999985321110            011223346


Q ss_pred             HHHHHhccCCCC-----cceEeeEEEe------ccCCeEEEEEeccCC-cHHHHHHhc----------------------
Q psy14434         73 ILFLKSFQRHPN-----IITMLDIYKA------VNNKDLYVVFEYMEN-DLNKVIRDK----------------------  118 (404)
Q Consensus        73 ~~~l~~l~~hpn-----Iv~l~~~~~~------~~~~~~~lv~E~~~~-~L~~~l~~~----------------------  118 (404)
                      +..+.++. |.+     +++++++|..      ......++||||+++ +|.+++...                      
T Consensus       223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            67777775 443     4667776642      124568999999994 888777531                      


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc-ccccccccccccccc
Q psy14434        119 ---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC-LTEYIATRWYRAPEI  194 (404)
Q Consensus       119 ---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~  194 (404)
                         .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               1345678889999999999999999999999999999999999999999999765432111 112235899999999


Q ss_pred             cccCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCcHH-HH---HHHHHhhCCCCCCcc
Q psy14434        195 LISNRR-------------------Y--THHVDIWSLGCILAEMLQSKP-LFPGASTSH-QL---QLIVNLVRPNPPHAD  248 (404)
Q Consensus       195 ~~~~~~-------------------~--~~~~DiwslG~il~~l~~g~~-pf~~~~~~~-~~---~~~~~~~~~~~~~~~  248 (404)
                      +.....                   +  ....|+||+||++|+|++|.. ||.+..... ..   ......+........
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            743211                   1  124799999999999999974 665422111 00   111111110000011


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCC---CCCCCHHHHHhccCCCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNP---SERPETDQILEHNYVSK  290 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~~ll~hp~~~~  290 (404)
                      .+ ..+...++.++||+.+||..+|   .+|+|+.++|+||||..
T Consensus       462 ~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             Cc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            11 2345678999999999999866   68999999999999964

>KOG1167|consensus

Probab=100.00  E-value=2.3e-37  Score=284.19  Aligned_cols=263  Identities=30%  Similarity=0.510  Sum_probs=204.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcC---CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .+.+.|.+++.||.|.|++||++.+..   ..+.||+|.+...    ..-.++..|+++|..+.++.||+++.+++.  +
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r--n  106 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFR--N  106 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhc--c
Confidence            456789999999999999999999887   7889999998543    344568899999999999999999999987  7


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~  174 (404)
                      ++...+||||++- ...++...  ++..+++.+++.++.||+++|.+||+||||||.|+|.+. .++-.|+|||++....
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            8889999999995 66666654  678899999999999999999999999999999999986 4788999999996110


Q ss_pred             C----------------C----------------------------CCcccccccccccccccccccCCCCCchhhHHHH
Q psy14434        175 D----------------S----------------------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSL  210 (404)
Q Consensus       175 ~----------------~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  210 (404)
                      .                .                            ....-...||++|+|||++..-+.-+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            0                0                            0000134689999999999877778999999999


Q ss_pred             HHHHHHHHhCCCCCCC-CCcHHHHHHHHHhhC------------C----C--C-C-----------C-cchhh-------
Q psy14434        211 GCILAEMLQSKPLFPG-ASTSHQLQLIVNLVR------------P----N--P-P-----------H-ADKFY-------  251 (404)
Q Consensus       211 G~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~------------~----~--~-~-----------~-~~~~~-------  251 (404)
                      |||+..+++++.||-. .++...+..+....+            .    .  . +           . .....       
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999988743 222222222211110            0    0  0 0           0 00000       


Q ss_pred             ---cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        252 ---AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       252 ---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ......+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               111223558999999999999999999999999999984

>KOG0199|consensus

Probab=100.00  E-value=1.7e-36  Score=292.25  Aligned_cols=253  Identities=24%  Similarity=0.396  Sum_probs=211.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++.++.+.||+|+||+|++|.+...+   ..||||++....... ....+++|+.+|.+|+ |||++++||+..   +.
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~-H~hliRLyGvVl---~q  183 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQ-HPHLIRLYGVVL---DQ  183 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhcc-CcceeEEeeeec---cc
Confidence            356888999999999999999886432   469999996554333 6778999999999998 999999999976   35


Q ss_pred             eEEEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      -+.+|||++. |+|.+.+++   ..|....+..|+.||+.||.||.++++|||||-..|||+-....|||||||+.+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            6899999999 688888765   347788888999999999999999999999999999999999999999999999887


Q ss_pred             CCCCccc---ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        175 DSKECLT---EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       175 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .......   ..-....|+|||.+ ....++.++|||++||++|||++ |..||.|......++.+....+...+     
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP-----  337 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP-----  337 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC-----
Confidence            5433211   11234569999998 67889999999999999999997 78999999999888888766554333     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                          +.+++++.+++..||..+|.+|||+..|...-+..
T Consensus       338 ----k~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  338 ----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ----CCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                56799999999999999999999999886554443

>KOG0984|consensus

Probab=100.00  E-value=3.5e-36  Score=251.77  Aligned_cols=211  Identities=27%  Similarity=0.433  Sum_probs=177.4

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +..-+..||+|+||.|-+.++..+|...|+|.+... .+....++.++|+.+..+...+|.+|.+|+.+.  ....++|.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwIc  123 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWIC  123 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEEe
Confidence            455577899999999999999999999999999654 346677788899999988888999999999865  67889999


Q ss_pred             EeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        104 FEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       104 ~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ||.|..+|..+.+     .+.++|..+-+|+.-++.||.|||+ ..++|||+||.||||+.+|+||+||||.+-.+.+.-
T Consensus       124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            9999998876654     3459999999999999999999996 589999999999999999999999999998876542


Q ss_pred             Cccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHH
Q psy14434        178 ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVN  238 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~  238 (404)
                      . .+.-.|...|||||.+..   ...|+.++||||||+++.||.+++.||+... ..+++.++..
T Consensus       204 A-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  204 A-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             H-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            2 222468889999999842   3478999999999999999999999997654 4445554443

>KOG4278|consensus

Probab=100.00  E-value=9e-36  Score=283.80  Aligned_cols=241  Identities=25%  Similarity=0.500  Sum_probs=209.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +......||.|.||.||.+.++.-.-.||||.++.   +.-...+++.|..+|+.++ |||+|++++++.  .+.-+|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT--~EpPFYIi  341 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--HEPPFYII  341 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhc-CccHHHHhhhhc--cCCCeEEE
Confidence            34556789999999999999998888899999854   3456788999999999997 999999999986  56779999


Q ss_pred             EeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        104 FEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +|||. |+|.++++.   ..++...+.+++.||..|+.||..+++|||||-..|.||.++..||++|||+++.+..+.. 
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-  420 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-  420 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence            99998 889888874   3477778889999999999999999999999999999999999999999999998865432 


Q ss_pred             ccccccc---cccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        180 LTEYIAT---RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       180 ~~~~~gt---~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       +...|.   .-|.|||.+ ....++.++|||+|||+|||+.| |..||++-+-...+..+.+..+...+         .
T Consensus       421 -TAHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P---------e  489 (1157)
T KOG4278|consen  421 -TAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP---------E  489 (1157)
T ss_pred             -ecccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC---------C
Confidence             333443   459999997 57788999999999999999986 89999999998888888777765444         6


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHH
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQI  282 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~l  282 (404)
                      +|++.+..|++.||+..|..||++.++
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            889999999999999999999999887

>KOG1094|consensus

Probab=100.00  E-value=5.7e-35  Score=276.87  Aligned_cols=256  Identities=22%  Similarity=0.366  Sum_probs=205.8

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..+...+.+.||+|.||.|.+|.-.. +..||+|.++.. ........+.+|+++|.+++ ||||+.+++++.  .++.+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~--~DePi  610 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD-ATKNARNDFLKEIKILSRLK-HPNIVELLGVCV--QDDPL  610 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcc-cchhHHHHHHHHHHHHhccC-CCCeeEEEeeee--cCCch
Confidence            34567889999999999999997643 688999998644 33444678899999999996 999999999976  56679


Q ss_pred             EEEEeccC-CcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~~---l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ++|||||+ |+|..++....   +.......++.||+.||+||.+.+++||||.+.|+|+++++++||+|||+++.+-.+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999 79999998653   244556679999999999999999999999999999999999999999999965433


Q ss_pred             C--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 K--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      +  ..-...+-...|||||.+. .++++.++|+|++|+++||+++  ...||....+.................  .+..
T Consensus       691 ~yy~vqgr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~--~~l~  767 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ--VVLS  767 (807)
T ss_pred             CceeeecceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc--eecc
Confidence            2  1112234567899999986 5679999999999999999874  678998887777666655554432221  1222


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ...-++..+.+++.+||..+..+||+.+++-.
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            23457889999999999999999999999844

>KOG0200|consensus

Probab=100.00  E-value=7.1e-34  Score=289.36  Aligned_cols=247  Identities=31%  Similarity=0.509  Sum_probs=206.7

Q ss_pred             eEEeeeecccCceeEEEEEEc----C---CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDK----N---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..+.+.||.|.||.|++|.-.    .   ....||+|.+...... .+...+..|+.+|+.+..||||+.+++++.  ..
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t--~~  374 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACT--QD  374 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeec--cC
Confidence            356779999999999999643    1   1457999998765544 788899999999999999999999999976  47


Q ss_pred             CeEEEEEeccC-CcHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDKI-----------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~~-----------------l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      +.+++|+||+. |+|.++++..+                 ++..+...+++||+.|++||++..++||||-.+|||+.++
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence            88999999999 79999998766                 8999999999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCCCcc-ccccc--ccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-cHHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSKECL-TEYIA--TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAS-TSHQLQ  234 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~-~~~~~~  234 (404)
                      ..+||+|||+|+.......-. ....|  ...|||||.+. ...|+.++||||+|++|||+++ |..||++.. ....+.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            999999999998654332211 22222  34499999984 5889999999999999999997 789999865 555566


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+..+.+...+         ..++.++.+++..||+.+|.+||+..++..
T Consensus       534 ~l~~G~r~~~P---------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 FLKEGNRMEQP---------EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHhcCCCCCCC---------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66666664444         567899999999999999999999998865

>KOG1152|consensus

Probab=100.00  E-value=2.5e-35  Score=278.98  Aligned_cols=201  Identities=27%  Similarity=0.444  Sum_probs=177.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc------cChhHHHHHHHHHHHHHhcc--CCCCcceEeeEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF------RNKTDAQRTYREILFLKSFQ--RHPNIITMLDIY   92 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~   92 (404)
                      ...+|..++.||.|+||.|++|.++.....|+||.|.+..      ..+..+-.+--||.+|..++  .|+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4456999999999999999999999999999999997653      22333444567999999886  489999999999


Q ss_pred             EeccCCeEEEEEeccC-C-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         93 KAVNNKDLYVVFEYME-N-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~-~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      +  +++++||+||--+ | +|.++|.. ..++|.++..|+.|++.|+++||+.||+|||||-+||.++.+|-+||+|||.
T Consensus       639 E--ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  639 E--DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             e--cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            8  6888999999887 4 89999984 4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP  225 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  225 (404)
                      +.....+  ....++||..|+|||++.+..+.+..-|||+||++||.++....||.
T Consensus       717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9877654  34678999999999999766777999999999999999999998884

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=310.53  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=184.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ...|...+.||+|+||.||+|.+..++..||+|.+.....      ....|+..+++++ ||||+++++++.  +....|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~-HpnIv~~~~~~~--~~~~~~  759 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQ-HPNIVKLIGLCR--SEKGAY  759 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCC-CCCcceEEEEEE--cCCCCE
Confidence            4567777899999999999999999999999999854321      1124578888996 999999999987  456789


Q ss_pred             EEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH---ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH---~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||++ |+|.++++.  +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||........ 
T Consensus       760 lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            9999998 589998864  889999999999999999999   6799999999999999998887775 6655433221 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCC--CCcchhh-c
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNP--PHADKFY-A  252 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~--~~~~~~~-~  252 (404)
                         ....||+.|+|||++ .+..++.++|||||||++|||++|+.||.....  ...............  ....... .
T Consensus       836 ---~~~~~t~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ---TKCFISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCccccccccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               234689999999997 466789999999999999999999999854321  111111111100000  0000000 0


Q ss_pred             c---cCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 G---FKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~---~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .   ......++.+++.+||+.||++|||+.++++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0   00112357789999999999999999999875

>KOG0576|consensus

Probab=100.00  E-value=5.4e-36  Score=287.74  Aligned_cols=262  Identities=27%  Similarity=0.494  Sum_probs=216.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +...+|.++..+|+|.||-||+|+++.+++..|+|+++..  ...+..-+..|+.+++..+ ||||+.+++.|.  ....
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~-h~nivay~gsyl--r~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYL--RRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCC-CcChHHHHhhhh--hhcC
Confidence            4556899999999999999999999999999999999543  3445666778999999997 999999999986  4667


Q ss_pred             EEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ++|.||||+| +|.+... .+++++.++.+.++..+.|++|||+.|-+|||||-.|||++..|.+|++|||.+..+...-
T Consensus        87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999995 7877766 5789999999999999999999999999999999999999999999999999998877665


Q ss_pred             Ccccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 ECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      ....++.|||.|||||+..  ....|...+|+|++|+...||---.+|--..-....+. ++......++...+    -.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-LmTkS~~qpp~lkD----k~  241 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LMTKSGFQPPTLKD----KT  241 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-HhhccCCCCCcccC----Cc
Confidence            6667899999999999852  24578999999999999999876666643333333322 23333333332221    13


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..++.+.+|++.+|.++|.+|||++.+|.|||...-
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            467889999999999999999999999999999764

>KOG2052|consensus

Probab=100.00  E-value=1.8e-33  Score=259.54  Aligned_cols=265  Identities=25%  Similarity=0.386  Sum_probs=198.7

Q ss_pred             CCCCCCCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHH--hccCC
Q psy14434          5 TTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK--SFQRH   82 (404)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~--~l~~h   82 (404)
                      +.|.|+.....-+.-++..+.++++.||+|.||.||+|...  |+.||||++.     ..+....++|.++.+  .|+ |
T Consensus       193 ~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~-----srdE~SWfrEtEIYqTvmLR-H  264 (513)
T KOG2052|consen  193 ETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS-----SRDERSWFRETEIYQTVMLR-H  264 (513)
T ss_pred             ccCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEec-----ccchhhhhhHHHHHHHHHhc-c
Confidence            35566666666777889999999999999999999999876  7789999994     234444556655554  455 9


Q ss_pred             CCcceEeeEEEec--cCCeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCC
Q psy14434         83 PNIITMLDIYKAV--NNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKP  151 (404)
Q Consensus        83 pnIv~l~~~~~~~--~~~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~--------~i~HrDlkp  151 (404)
                      +||+.+++.-...  .-.+++||++|.+ |+|.+++....++.+...+++.-++.||++||..        .|+|||||.
T Consensus       265 ENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  265 ENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             chhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            9999999874321  1247899999999 8999999999999999999999999999999942        499999999


Q ss_pred             CcEEEccCCceEEeccccccccCCCC----CcccccccccccccccccccCCCC-----CchhhHHHHHHHHHHHHh---
Q psy14434        152 SNILIDKSCSIKIGDLGLARSLSDSK----ECLTEYIATRWYRAPEILISNRRY-----THHVDIWSLGCILAEMLQ---  219 (404)
Q Consensus       152 ~NIll~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~---  219 (404)
                      .||||.++|..-|+|+|+|.......    ......+||..|||||++......     -..+||||||.++||+..   
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999999998665432    223457899999999998433211     246899999999999975   


Q ss_pred             --C-----CCCCCCCC----cHHHHHHHH--HhhCCCCCCcchhhcccCCCC--HHHHHHHHhccccCCCCCCCHHHHH
Q psy14434        220 --S-----KPLFPGAS----TSHQLQLIV--NLVRPNPPHADKFYAGFKNKP--EEAVDLLNQILVLNPSERPETDQIL  283 (404)
Q Consensus       220 --g-----~~pf~~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~~ll  283 (404)
                        |     .+||.+.-    ..+....+.  +..+|..+...      ...+  ..+..+++.||..||.-|.|+-.+-
T Consensus       425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW------~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW------KSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence              2     47775432    222222222  22233333221      2111  2467889999999999999986553

>KOG1025|consensus

Probab=100.00  E-value=1.5e-33  Score=276.09  Aligned_cols=245  Identities=24%  Similarity=0.410  Sum_probs=205.4

Q ss_pred             eEEeeeecccCceeEEEEEEcCCC----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .+..++||+|+||+||+|..--.|    .+||||++.. +........+++|+.+|.++. |||+++++++..   ...+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~---~s~~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLD-HPNLLRLLGVCM---LSTL  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcc---cchH
Confidence            555778999999999999885444    4688998753 344555678889999999997 999999999976   3348


Q ss_pred             EEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .||++|++ |.|.++++.  ..+.......|.+||++||.|||.++++||||-.+||||.+...+||.|||+++.+....
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            89999999 689999874  458999999999999999999999999999999999999999999999999999876544


Q ss_pred             Cccccc--ccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 ECLTEY--IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 ~~~~~~--~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ......  ...+-|||-|.+ ....|+.++||||+||++|||+| |..||.+....+.-..+....+...+         
T Consensus       853 ~ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP---------  922 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP---------  922 (1177)
T ss_pred             ccccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---------
Confidence            332222  234568999988 46789999999999999999997 89999999888877777766663333         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +.++.++..++.+||..|+..||+++++..
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            567899999999999999999999988754

>KOG3653|consensus

Probab=100.00  E-value=2.2e-32  Score=254.10  Aligned_cols=250  Identities=22%  Similarity=0.335  Sum_probs=184.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHH--hccCCCCcceEeeEEEec--cC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK--SFQRHPNIITMLDIYKAV--NN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~--~l~~hpnIv~l~~~~~~~--~~   97 (404)
                      ....++.+.||+|.||.||+|..  +++.||||++.     ..+.+....|-.+..  .++ |+||+++++.-+..  ..
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~-h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMK-HENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCcc-chhHHHhhchhccCCccc
Confidence            56788999999999999999965  46899999994     334444444444443  454 99999999885421  24


Q ss_pred             CeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh---------CCCccCCCCCCcEEEccCCceEEecc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA---------CKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~---------~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                      ..++||++|.+ |+|.+++....+++....+++.-+++||+|||+         ..|+|||||..||||..|+...|+||
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            47899999998 899999999999999999999999999999995         35999999999999999999999999


Q ss_pred             ccccccCCCC--CcccccccccccccccccccCCCCC-----chhhHHHHHHHHHHHHhCCC------------CCCC--
Q psy14434        168 GLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYT-----HHVDIWSLGCILAEMLQSKP------------LFPG--  226 (404)
Q Consensus       168 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~l~~g~~------------pf~~--  226 (404)
                      |+|..+....  ....+.+||..|||||++.+.-...     .+.||||+|.++|||++...            ||..  
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9998776432  2233478999999999985543333     46899999999999997432            2221  


Q ss_pred             --CCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHH
Q psy14434        227 --ASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQ  281 (404)
Q Consensus       227 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~  281 (404)
                        ....+..+...-..+..|.....+...  .....+.+.+..||+.||+-|.|+.=
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHH
Confidence              011122222222222111111111111  12356889999999999999999843

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.1e-31  Score=235.14  Aligned_cols=211  Identities=38%  Similarity=0.699  Sum_probs=182.7

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC-C
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-N  109 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-~  109 (404)
                      ||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+. |++|+++++++.  .....+++||++. +
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN-HPNIVKLYGVFE--DENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcC-CCCeeeEeeeee--cCCeEEEEEecCCCC
Confidence            689999999999998889999999986432221 3567889999999997 899999999986  4578999999999 6


Q ss_pred             cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCCCCCcccccccc
Q psy14434        110 DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIAT  186 (404)
Q Consensus       110 ~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~gt  186 (404)
                      +|..++...  .++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            899998865  6999999999999999999999999999999999999999 8999999999998765432223345688


Q ss_pred             cccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHH
Q psy14434        187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLN  266 (404)
Q Consensus       187 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  266 (404)
                      ..|++||.+.....++.+.|+|++|+++++|                                         ..+.+++.
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~~~~l~  195 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------PELKDLIR  195 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------HHHHHHHH
Confidence            8999999984333788999999999999999                                         35789999


Q ss_pred             hccccCCCCCCCHHHHHhcc
Q psy14434        267 QILVLNPSERPETDQILEHN  286 (404)
Q Consensus       267 ~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      +|+..+|.+||++.++++|+
T Consensus       196 ~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         196 KMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345|consensus

Probab=100.00  E-value=1e-33  Score=245.96  Aligned_cols=261  Identities=22%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeE-EEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI-YKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~-~~~~~~~   98 (404)
                      ++.+.|.+.++||.|.||.+.+|.++.++..+++|.+.++.   .....+.+|...--.|..|.||+.-|++ |+  ..+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq--t~d   95 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ--TSD   95 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhh--cCc
Confidence            45678999999999999999999999999999999997653   4566778888887778889999999877 44  345


Q ss_pred             eEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc--CCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~~~~  175 (404)
                      .+++++||++ |+|...+....+.|...+.++.|++.|+.|+|+++++|||||.+||||-.  ..+|||||||..+..+.
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            7789999999 89999998888999999999999999999999999999999999999943  35899999999876543


Q ss_pred             CCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHhhCCCCCCcchh
Q psy14434        176 SKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPHADKF  250 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  250 (404)
                      .   ....--+-.|.+||....    .-...+.+|+|.||+++|.+++|++||+.....+.-. ......+...+   ..
T Consensus       176 t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---~~  249 (378)
T KOG1345|consen  176 T---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---AL  249 (378)
T ss_pred             e---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---cC
Confidence            2   122224566899998632    1235678999999999999999999997543322211 11222221111   11


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCC---CCHHHHHhccCCCCc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSER---PETDQILEHNYVSKY  291 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~~ll~hp~~~~~  291 (404)
                      -..+..+++.+..+.++-|..+|++|   -++......-|....
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            23346679999999999999999999   677777777776543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.1e-30  Score=232.20  Aligned_cols=202  Identities=37%  Similarity=0.658  Sum_probs=173.1

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.+. |+|++++++++.  .....++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~--~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLK-HPNIVKLYGVFE--DPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCC-CCChhhheeeee--cCCceEEEE
Confidence            67889999999999999999988999999998654322 25667888999999996 999999999976  457799999


Q ss_pred             eccCC-cHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-Ccc
Q psy14434        105 EYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-ECL  180 (404)
Q Consensus       105 E~~~~-~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~~~  180 (404)
                      |++.+ +|.+++....  +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99997 9999987543  8999999999999999999999999999999999999999999999999998765432 123


Q ss_pred             cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCcH
Q psy14434        181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG-ASTS  230 (404)
Q Consensus       181 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~  230 (404)
                      ....++..|++||.+.+...++.++|+||||+++++|++|+.||.. .+..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            4457888999999874455677899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=6.7e-32  Score=284.96  Aligned_cols=197  Identities=15%  Similarity=0.220  Sum_probs=145.8

Q ss_pred             CCcceEeeEEEe-----ccCCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         83 PNIITMLDIYKA-----VNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        83 pnIv~l~~~~~~-----~~~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                      +||.+++++|..     .....++++||+++++|.+++..  ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL  112 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV  112 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence            578888887621     12346788999999999999974  45999999999999999999999999999999999999


Q ss_pred             EccC-------------------CceEEeccccccccCCCC----------------CcccccccccccccccccccCCC
Q psy14434        156 IDKS-------------------CSIKIGDLGLARSLSDSK----------------ECLTEYIATRWYRAPEILISNRR  200 (404)
Q Consensus       156 l~~~-------------------~~vkl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~  200 (404)
                      |+..                   +.+|++|||+++......                ......+||++|||||++. +..
T Consensus       113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~  191 (793)
T PLN00181        113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN-GSS  191 (793)
T ss_pred             EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc-cCC
Confidence            9654                   445666666665321100                0011246899999999984 566


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHH
Q psy14434        201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD  280 (404)
Q Consensus       201 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  280 (404)
                      ++.++|||||||+||||++|.+|+.....  ....+.....+...         ....+.+.+++.+||+.+|.+||++.
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI---------LLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh---------hhcCHHHHHHHHHhCCCChhhCcChH
Confidence            89999999999999999999888753221  11222211111100         11245677999999999999999999


Q ss_pred             HHHhccCCCCc
Q psy14434        281 QILEHNYVSKY  291 (404)
Q Consensus       281 ~ll~hp~~~~~  291 (404)
                      ++|+||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4e-29  Score=216.12  Aligned_cols=164  Identities=20%  Similarity=0.302  Sum_probs=128.2

Q ss_pred             CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccccc
Q psy14434        109 NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT  186 (404)
Q Consensus       109 ~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt  186 (404)
                      |+|.+++..  +.+++.+++.++.||+.||.|||+.+      ||+|||++.++.+|+  ||++......     ...||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            678888874  45999999999999999999999998      999999999999999  9999765432     22689


Q ss_pred             cccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCCCcchhhcccCCCCH--HHHH
Q psy14434        187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAGFKNKPE--EAVD  263 (404)
Q Consensus       187 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  263 (404)
                      +.|||||++ .+..++.++|||||||++|+|++|..||...... ..+..+........+...   .....++.  .+.+
T Consensus        68 ~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  143 (176)
T smart00750       68 PYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR---SNLESVSAARSFAD  143 (176)
T ss_pred             ccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc---ccHHHHHhhhhHHH
Confidence            999999998 4667899999999999999999999999765432 233333333222211100   00012233  6999


Q ss_pred             HHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        264 LLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       264 li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      +|.+||..+|.+||++.+++.|+|+.
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHH
Confidence            99999999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590|consensus

Probab=99.96  E-value=2.9e-30  Score=259.90  Aligned_cols=268  Identities=24%  Similarity=0.322  Sum_probs=202.0

Q ss_pred             ccCCe-EEeeeecccCceeEEEEEEcCCCeEEEEEEcch---hccChhHHHH-HHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEY-TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE---AFRNKTDAQR-TYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~-~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..+.| ...+.+|.|++|.|+.+......+.++.|.+..   .......... +..|..+-..+. |||++.....+.  
T Consensus       315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~--  391 (601)
T KOG0590|consen  315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQ--  391 (601)
T ss_pred             cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHh--
Confidence            34556 567889999999999888877777677665532   1112222222 455666666776 999988777654  


Q ss_pred             cCCeEEEEEeccCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      +....+-+||||++||..++... .++..++..++.||+.||+|||+.||.|||+||+|+++..+|.+||+|||.+..+.
T Consensus       392 ~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  392 EIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            23334444999999998888865 89999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        175 DSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       175 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .+.    ....+.+|+..|+|||++.+........||||.|+++..|++|+.||.-....+....-...... .......
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~-~~~~~~~  550 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ-RNIFEGP  550 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc-cccccCh
Confidence            432    33567899999999999965555667899999999999999999999765443322111111111 1111122


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ...+..++.+.+.+|.+||+.||.+|+|+++|++.+||+...
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            233455688999999999999999999999999999998754

>KOG1024|consensus

Probab=99.96  E-value=2.4e-28  Score=222.25  Aligned_cols=249  Identities=21%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCC-----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++++...+-+|.||.||.|......     +.|-+|.+. ...+.-....++.|...+..+. |||++++.++... +.
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie-~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE-DY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEee-cc
Confidence            46888888999999999999776433     335555553 2344556677888999999997 9999999998754 56


Q ss_pred             CeEEEEEeccC-CcHHHHHH-----h----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecc
Q psy14434         98 KDLYVVFEYME-NDLNKVIR-----D----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~-----~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                      ...++++.+++ |+|..++.     +    +.++..++...+.|++.|++|||+.|++|.||-..|.+|++..+|||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            77889999998 78988887     1    23777888899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCC-cccc-cccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        168 GLARSLSDSKE-CLTE-YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       168 g~a~~~~~~~~-~~~~-~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      .+++.+-+.+. +... --....|||||.+ ....|+.++|+|||||++|||+| |+.||..-++.+....++++.+...
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ  519 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ  519 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence            99986543321 1111 1134569999998 57789999999999999999997 8999999999999888888887555


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +         -++|.++..++..||...|++||+.+++..
T Consensus       520 P---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  520 P---------FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             C---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            4         578999999999999999999999999864

>KOG1163|consensus

Probab=99.96  E-value=7.2e-28  Score=206.42  Aligned_cols=253  Identities=19%  Similarity=0.234  Sum_probs=202.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.+.|++++.||+|+||-+|+|....+|+.||||+-.    +.....++..|..+.+.|++-..|+.+..+..  +..
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es----~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~   84 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES----SKAKHPQLLYESKVYRILQGGVGIPHIRHYGT--EKD   84 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeec----ccCCCcchhHHHHHHHHhccCCCCchhhhhcc--ccc
Confidence            456788999999999999999999999999999999863    22334456788999999987788888888765  677


Q ss_pred             eEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---CceEEecccccccc
Q psy14434         99 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---~~vkl~Dfg~a~~~  173 (404)
                      +-.+||++++.+|+++..  .+.++...+..++-|++.-++|+|.++++||||||+|+|..-+   ..+.|+|||+|+..
T Consensus        85 ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   85 YNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            789999999999998886  6779999999999999999999999999999999999998533   56999999999876


Q ss_pred             CCCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        174 SDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       174 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      .+..       .......||..|++-.... +..-+.+.|+-|+|.+|.++..|..||++.......++.......... 
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-  242 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-  242 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-
Confidence            5422       1224567999999987763 445688899999999999999999999998776665554443331111 


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHH
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD  280 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  280 (404)
                       ........+.|.++.-.|.-|-..--++-|...
T Consensus       243 -~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  243 -TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             -CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence             122334567788999999988777767777764

>KOG1164|consensus

Probab=99.95  E-value=1.6e-26  Score=219.14  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=195.1

Q ss_pred             cccccC-CeEEeeeecccCceeEEEEEEcCCC-eEEEEEEcchhccChhHHHHHHHHHHHHHhcc---CCCCcceEeeEE
Q psy14434         18 DGNILA-EYTIHKRIGKGAYGIVYKAYDKNNK-QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---RHPNIITMLDIY   92 (404)
Q Consensus        18 ~~~~~~-~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---~hpnIv~l~~~~   92 (404)
                      ...... +|.+.+.||+|+||.||.|.+..++ ..+|+|+..........  .+..|..++..+.   +.+++..+++..
T Consensus        12 ~~~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   12 DNDKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             hhcccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            334444 8999999999999999999998775 67899987543222211  4557788888876   246899999886


Q ss_pred             EeccCCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-----CceEE
Q psy14434         93 KAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-----CSIKI  164 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-----~~vkl  164 (404)
                      . .....-||||+.++.+|.++...   +.++...+..++.|++.+|.+||+.|++||||||.|+++...     ..+.|
T Consensus        90 ~-~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   90 R-STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             c-CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence            3 35677899999999999998852   569999999999999999999999999999999999999765     35999


Q ss_pred             ecccccc--ccCCCC--------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14434        165 GDLGLAR--SLSDSK--------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ  234 (404)
Q Consensus       165 ~Dfg~a~--~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  234 (404)
                      .|||+++  ......        .....+.||..|+++.+. .+...+.+.|+||++.++.+|+.|..||.+........
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~  247 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS  247 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence            9999998  321111        112345699999999997 57778999999999999999999999997766443333


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .............     .....+..+..+...+-..+...+|....+...
T Consensus       248 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  248 KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            3322221111000     112345677788888777888999988777554

>KOG1165|consensus

Probab=99.95  E-value=5.6e-27  Score=209.50  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.-.|++.+.||+|+||+++.|...-++++||||.-.+    ..++-++..|....+.|.+.++|...|.+  ..++.+-
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~N   99 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYN   99 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeee--ccccchh
Confidence            34469999999999999999999999999999998632    24455667788888888889999999866  4467777


Q ss_pred             EEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-----ceEEecccccccc
Q psy14434        101 YVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-----SIKIGDLGLARSL  173 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-----~vkl~Dfg~a~~~  173 (404)
                      .||||+++.+|+++..  .+.|+...+..++.|++.-+.|+|++.+|.|||||+|+||...+     .|.|+|||+|+..
T Consensus       100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8999999999998886  56799999999999999999999999999999999999997543     5999999999987


Q ss_pred             CCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHhhCCC
Q psy14434        174 SDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH---QLQLIVNLVRPN  243 (404)
Q Consensus       174 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  243 (404)
                      .++..       ...+..||..||+-...+ +..-+.+.|+-|||-++++.+.|.+||.+.....   .+++|-...+..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            65432       234567999999988875 5567899999999999999999999999865443   333433322222


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHH
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD  280 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  280 (404)
                      +     +.....++|.++...+.-.-..+-.+-|..+
T Consensus       259 ~-----i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  259 P-----IEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             C-----HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            1     2233355677777777666666666666653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.1e-25  Score=211.83  Aligned_cols=260  Identities=32%  Similarity=0.594  Sum_probs=205.5

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChh-HHHHHHHHHHHHHhccCCC-CcceEeeEEEeccCCeEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHP-NIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~~hp-nIv~l~~~~~~~~~~~~~l  102 (404)
                      |.+.+.||.|+||.||++.+.   ..+++|.+........ ....+.+|+..+..+. |+ +|+++++++.  .....++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~--~~~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQ--DEGSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEe--cCCEEEE
Confidence            889999999999999999887   7789999977655554 6777889999999998 55 8999999985  4555899


Q ss_pred             EEeccCC-cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCCC
Q psy14434        103 VFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDS  176 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~~  176 (404)
                      +++++.+ ++..++...    .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+......
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999996 677666654    699999999999999999999999999999999999999988 7999999999865443


Q ss_pred             CC------cccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCC-C
Q psy14434        177 KE------CLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRP-N  243 (404)
Q Consensus       177 ~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~-~  243 (404)
                      ..      .....+||..|+|||.+...  ..+....|+||+|++++++++|..||.....    ......+.....+ .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            21      34667899999999998543  5789999999999999999999999877764    2333333322222 1


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      .........  ......+.+++..++..+|..|.+..+...++|.....
T Consensus       236 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         236 ASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             ccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            111000000  11125789999999999999999999999987666543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.8e-27  Score=221.62  Aligned_cols=172  Identities=17%  Similarity=0.191  Sum_probs=132.6

Q ss_pred             cccccccccccCCeEEeeeecccCceeEEEEEEcC-CCeEEEEEEcchhcc---ChhHHHHHHHHHHHHHhccCCCCcce
Q psy14434         12 KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIIT   87 (404)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~   87 (404)
                      +...+...-+.++|++.+.||+|+||+||+|++.. +++.+|||++.....   .......+.+|+.+|+.+. |+|++.
T Consensus         7 ~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~   85 (365)
T PRK09188          7 PLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVP   85 (365)
T ss_pred             CCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCc
Confidence            33444555677889999999999999999999876 688889998753211   2334556789999999997 999885


Q ss_pred             -EeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEccCCceEE
Q psy14434         88 -MLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL-KPSNILIDKSCSIKI  164 (404)
Q Consensus        88 -l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDl-kp~NIll~~~~~vkl  164 (404)
                       +++.      ...|+||||+.| +|.. +..  ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||
T Consensus        86 ~l~~~------~~~~LVmE~~~G~~L~~-~~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         86 QLLAT------GKDGLVRGWTEGVPLHL-ARP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             EEEEc------CCcEEEEEccCCCCHHH-hCc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEE
Confidence             4432      347999999996 5652 211  11   2467899999999999999999999 999999999999999


Q ss_pred             eccccccccCCCCC--------cccccccccccccccccc
Q psy14434        165 GDLGLARSLSDSKE--------CLTEYIATRWYRAPEILI  196 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~  196 (404)
                      +|||+|+.+.....        .....++++.|+|||.+.
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999987654321        123557888899999973

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=2.1e-26  Score=209.47  Aligned_cols=236  Identities=20%  Similarity=0.319  Sum_probs=154.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccC---------CCCcceEeeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQR---------HPNIITMLDIYK   93 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~---------hpnIv~l~~~~~   93 (404)
                      .....+.||.|++|.||.+.|..||+.+|+|++.... ........+.+|......+.+         |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            5677889999999999999999999999999985433 233455566666555544332         223333333322


Q ss_pred             ---------ec-cCC-----eEEEEEeccCCcHHHHHH---hcC-----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q psy14434         94 ---------AV-NNK-----DLYVVFEYMENDLNKVIR---DKI-----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLK  150 (404)
Q Consensus        94 ---------~~-~~~-----~~~lv~E~~~~~L~~~l~---~~~-----l~~~~~~~i~~qil~al~~LH~~~i~HrDlk  150 (404)
                               .. ...     ..+++|+-+.++|..++.   ...     +.......+..|+++.+++||+.|++|+||+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                     11 111     236889999999888765   211     2233334566899999999999999999999


Q ss_pred             CCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccC-------CCCCchhhHHHHHHHHHHHHhCCCC
Q psy14434        151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-------RRYTHHVDIWSLGCILAEMLQSKPL  223 (404)
Q Consensus       151 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~l~~g~~p  223 (404)
                      |+|++++++|.++|+||+.....+....   ....+..|.+||.....       -.++.+.|.|+||+++|.|+||+.|
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            9999999999999999998876543211   13456779999986322       2478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCC
Q psy14434        224 FPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER  276 (404)
Q Consensus       224 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  276 (404)
                      |...........             .+..+- ++|+.+++||..+|+.||.+|
T Consensus       250 f~~~~~~~~~~~-------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW-------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG-------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc-------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            976543211110             333333 789999999999999999987

>KOG0603|consensus

Probab=99.93  E-value=1e-27  Score=231.33  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=196.9

Q ss_pred             eecccCceeEEEEEE---cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         30 RIGKGAYGIVYKAYD---KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      .+|.|+||.|+++..   ...+..||+|+..+.............|..++....+||.+++++..|+  ....+++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhh
Confidence            379999999998743   3557889999997764443333355567788888888999999999987  57789999999


Q ss_pred             cCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccc
Q psy14434        107 MEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI  184 (404)
Q Consensus       107 ~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  184 (404)
                      ..| +|...+. ...+.+..+..+...++.|++++|+.|++|||+|++||+++.+|++++.|||+++.......    .|
T Consensus        79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c  154 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC  154 (612)
T ss_pred             cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence            996 6655554 45588889999999999999999999999999999999999999999999999987654322    29


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHH
Q psy14434        185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDL  264 (404)
Q Consensus       185 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (404)
                      ||..|||||++.   ....++|+||+|+++++|++|..||.+    +....|.......+          ...+..++++
T Consensus       155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----------~~l~~~a~~~  217 (612)
T KOG0603|consen  155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----------RELSAEARSL  217 (612)
T ss_pred             cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----------hhhhHHHHHH
Confidence            999999999983   568899999999999999999999977    34444444322222          2347889999


Q ss_pred             HHhccccCCCCCCCH-----HHHHhccCCCCcCCC
Q psy14434        265 LNQILVLNPSERPET-----DQILEHNYVSKYFPS  294 (404)
Q Consensus       265 i~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~~~  294 (404)
                      +..++..+|..|...     .++++|+||...-+.
T Consensus       218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            999999999999754     789999999886654

>KOG1240|consensus

Probab=99.93  E-value=1.6e-26  Score=233.50  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=185.6

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh--ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +|...+.||++.|=+|++|++.+ |. |+||++.+.  ..+-....+.++|++ ...+ ++||++++.-+..  .....|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~--t~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLV--TDKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHH--hhHHHH
Confidence            89999999999999999998764 43 899998554  344556667777777 4445 4999999987744  566789


Q ss_pred             EEEeccCCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc--CCCC-
Q psy14434        102 VVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSK-  177 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~~~-l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~--~~~~-  177 (404)
                      ||-+|...+|++.+..++ +...+.++|+.||+.||..||..||+|||||.+||||+.-+.+.|+||..-+..  ..++ 
T Consensus        98 lvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen   98 LVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            999999999999998665 788899999999999999999999999999999999999999999999876542  1111 


Q ss_pred             Cccc----ccccccccccccccccCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        178 ECLT----EYIATRWYRAPEILISNR----------RYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       178 ~~~~----~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ...+    +...-.+|.|||.|....          ..+++.||||+||+++||++ |++||.    ..++-....+.. 
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~-  252 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA-  252 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc-
Confidence            1111    122345799999986421          25689999999999999997 789983    122211111110 


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        .....+.....  +..++.||..|++.||.+|.++++.|+.
T Consensus       253 --~~~e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 --DDPEQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             --cCHHHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence              00011111111  4578999999999999999999999975

>KOG0606|consensus

Probab=99.92  E-value=2.5e-25  Score=224.81  Aligned_cols=226  Identities=29%  Similarity=0.398  Sum_probs=173.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -...+|..++.|..|+||.||+++|+.+.+.+|+| +++..       .+      +      .||+.+-+.        
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------li------l------Rnilt~a~n--------  131 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LI------L------RNILTFAGN--------  131 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hh------h------hccccccCC--------
Confidence            34568999999999999999999999999999994 43221       01      1      122222211        


Q ss_pred             EEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        100 LYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      .+.|     ||-...++. +.++...        +.+++|||+-||+|||+||+|++|+.-|++|++|||+++...... 
T Consensus       132 pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  132 PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence            1222     554445543 3344333        789999999999999999999999999999999999987432210 


Q ss_pred             --------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q psy14434        178 --------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN  243 (404)
Q Consensus       178 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  243 (404)
                                    -.....||||.|+|||++. ...|+..+|||++|+|+|+.+.|+.||.+...++.+..++......
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhh-hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                          0113468999999999984 6679999999999999999999999999999999888887766544


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCC---CHHHHHhccCCCCcCCC
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP---ETDQILEHNYVSKYFPS  294 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~hp~~~~~~~~  294 (404)
                      ++..       ...+++++++|.++|+.+|..|.   .+-++.+|+||...-+.
T Consensus       278 pE~d-------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  278 PEED-------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccC-------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            4432       45689999999999999999995   56788899999986654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.6e-24  Score=191.59  Aligned_cols=174  Identities=16%  Similarity=0.177  Sum_probs=133.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHH-HH------HHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QR------TYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~------~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      +-++|++.+.||.|+||.||++.+  ++..+|+|++.......... ..      ..+|+..+.++. ||+|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence            457899999999999999999755  46679999997654433332 22      468889999996 999999999876


Q ss_pred             ecc------CCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         94 AVN------NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        94 ~~~------~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      ...      ....+|+|||++| +|.++..   +++    ....+++.+|..||+.|++|||++|.||+++.+| ++|+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            432      2457999999997 7876632   333    2456999999999999999999999999999988 99999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML  218 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  218 (404)
                      ||.........             |-+.+.-...++.++|+||||+++..+.
T Consensus       178 fg~~~~~~e~~-------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRK-------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchh-------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            99887653221             1111223445678999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=7.8e-24  Score=184.79  Aligned_cols=140  Identities=21%  Similarity=0.247  Sum_probs=108.5

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhH------------------------HHHHHHHHHHHHhccCCC
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD------------------------AQRTYREILFLKSFQRHP   83 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~~hp   83 (404)
                      .+.||+|++|.||+|.+. +|+.||+|++.........                        .....+|+..+..+. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            468999999999999987 8999999999654221111                        112245999999996 77


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccCC-cHHHH-HHhcCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEccCC
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV-IRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSNILIDKSC  160 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~-l~~~~l~~~~~~~i~~qil~al~~L-H~~~i~HrDlkp~NIll~~~~  160 (404)
                      ++.....+..  ..  .+|||||++| ++... +..+.++...+..++.||+.+|.+| |+.||+||||||+|||++ ++
T Consensus        80 ~v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          80 GIPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence            7644333221  12  3899999997 44333 4567799999999999999999999 799999999999999998 57


Q ss_pred             ceEEeccccccccC
Q psy14434        161 SIKIGDLGLARSLS  174 (404)
Q Consensus       161 ~vkl~Dfg~a~~~~  174 (404)
                      .++|+|||+|....
T Consensus       155 ~v~LiDFG~a~~~~  168 (190)
T cd05147         155 KLYIIDVSQSVEHD  168 (190)
T ss_pred             cEEEEEccccccCC
Confidence            89999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4e-23  Score=178.91  Aligned_cols=189  Identities=14%  Similarity=0.080  Sum_probs=139.9

Q ss_pred             EEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh--hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK--TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .+...|++|+||+|+.+..  .+.+++.+.+.......  .....+.+|+.+|+++.+|++|++++++.      ..|++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv   76 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD   76 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence            4567899999999998755  67778877764332211  12234678999999998779999999862      26999


Q ss_pred             EeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEccCCceEEeccccccccCCCCCc--
Q psy14434        104 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDL-KPSNILIDKSCSIKIGDLGLARSLSDSKEC--  179 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDl-kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~--  179 (404)
                      |||+.| +|...+..     . ...++.|++.+|.+||+.||+|||| ||+|||++.+|.++|+|||++.........  
T Consensus        77 meyI~G~~L~~~~~~-----~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         77 RSYLAGAAMYQRPPR-----G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             EeeecCccHHhhhhh-----h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            999997 56543321     1 2357889999999999999999999 799999999999999999999865443210  


Q ss_pred             --c---------cccccccccccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q psy14434        180 --L---------TEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGAS  228 (404)
Q Consensus       180 --~---------~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~  228 (404)
                        .         .-...++.|++|+...--...+ .+.++++.|+-+|.++|+..++.+..
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence              0         0012477788887642222233 66799999999999999998875543

>KOG4158|consensus

Probab=99.90  E-value=8.3e-24  Score=193.41  Aligned_cols=254  Identities=24%  Similarity=0.300  Sum_probs=176.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCe-----------------------------------EEEEEEcchhccCh
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQ-----------------------------------YVAIKKIFEAFRNK   63 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----------------------------------~vaiK~~~~~~~~~   63 (404)
                      +-.+++|++.+.||+|....||.|.-..+|.                                   +.|||.+..-....
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            3456789999999999999999986543211                                   24666664322221


Q ss_pred             hH---HHHHHHHHH------HH---------------HhccCCCCcceEeeEEEe-------------------------
Q psy14434         64 TD---AQRTYREIL------FL---------------KSFQRHPNIITMLDIYKA-------------------------   94 (404)
Q Consensus        64 ~~---~~~~~~E~~------~l---------------~~l~~hpnIv~l~~~~~~-------------------------   94 (404)
                      ..   .+...+|..      .+               .+|..|||||.+..+|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            11   122222221      11               123469999999988742                         


Q ss_pred             ccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--cC--CceEEeccccc
Q psy14434         95 VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KS--CSIKIGDLGLA  170 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~--~~--~~vkl~Dfg~a  170 (404)
                      ....++|+||.....+|..++..+..+.....-++.|+++|+.|||++||.|||+|.+|||+.  .|  -.+.|+|||.+
T Consensus       313 g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence            124578999999999999999988888888999999999999999999999999999999994  33  35899999987


Q ss_pred             cccCCC------CCcccccccccccccccccccCCCC-----CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q psy14434        171 RSLSDS------KECLTEYIATRWYRAPEILISNRRY-----THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL  239 (404)
Q Consensus       171 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  239 (404)
                      -.-..-      ....-..-|...-||||+....+..     -.++|.|+.|.+.||++....||.+......-..-...
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            432210      0111223477889999997432211     24789999999999999999999774332211111111


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHH
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD  280 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  280 (404)
                      ..  .+      .....+++.+++|+..+|+.||.+|+++.
T Consensus       473 ~q--LP------alp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  473 SQ--LP------ALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hh--CC------CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            00  01      11256789999999999999999999874

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=9.8e-23  Score=178.33  Aligned_cols=142  Identities=20%  Similarity=0.179  Sum_probs=112.0

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChh------------------------HHHHHHHHHHHHHhccCC
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT------------------------DAQRTYREILFLKSFQRH   82 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~~h   82 (404)
                      +.+.||+|++|.||+|.+. +|+.||||++........                        ......+|...+.++. |
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence            3578999999999999987 899999999865421100                        0122357889999997 8


Q ss_pred             CCcceEeeEEEeccCCeEEEEEeccCCc-H-HHHHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccC
Q psy14434         83 PNIITMLDIYKAVNNKDLYVVFEYMEND-L-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        83 pnIv~l~~~~~~~~~~~~~lv~E~~~~~-L-~~~l~~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~  159 (404)
                      +++.....+..  ..  .|+||||++|. + ...+....++...+..++.|++.+|.+||+ .||+||||||+||+++ +
T Consensus        79 ~~i~~p~~~~~--~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          79 AGVPVPEPILL--KK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCCCceEEEe--cC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence            88755444432  12  48999999973 3 344566678899999999999999999999 9999999999999999 8


Q ss_pred             CceEEeccccccccCC
Q psy14434        160 CSIKIGDLGLARSLSD  175 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~  175 (404)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195|consensus

Probab=99.88  E-value=8.2e-23  Score=178.33  Aligned_cols=257  Identities=18%  Similarity=0.288  Sum_probs=200.6

Q ss_pred             CCCCCCCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC
Q psy14434          5 TTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN   84 (404)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn   84 (404)
                      +++++++.......|.-.++..+...|.....|..|+|+...+  .+++|++............+..|.-.|+-+. |||
T Consensus       172 tktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifs-hpn  248 (448)
T KOG0195|consen  172 TKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFS-HPN  248 (448)
T ss_pred             ccccccccccccccCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeec-CCc
Confidence            4566777777888888889999999999999999999988643  4677887655555555566667888888886 999


Q ss_pred             cceEeeEEEeccCCeEEEEEeccC-CcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcc
Q psy14434         85 IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDK  158 (404)
Q Consensus        85 Iv~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~~---l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~  158 (404)
                      |+.+++.+.  ....+.++..||+ |+|+.++..+.   ....++.+++.+|+.|++|||+..  |.---|....++|++
T Consensus       249 ilpvlgacn--sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide  326 (448)
T KOG0195|consen  249 ILPVLGACN--SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE  326 (448)
T ss_pred             hhhhhhhcc--CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc
Confidence            999999976  4577999999999 79999998653   678889999999999999999864  444468899999999


Q ss_pred             CCceEE--eccccccccCCCCCcccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q psy14434        159 SCSIKI--GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ  234 (404)
Q Consensus       159 ~~~vkl--~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  234 (404)
                      +...+|  +|--++...       .+..-.|.||+||.+...+.  --.++|+|||++++|||.|...||.+.+..+.--
T Consensus       327 dltarismad~kfsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm  399 (448)
T KOG0195|consen  327 DLTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM  399 (448)
T ss_pred             hhhhheecccceeeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence            876555  444333221       22345789999999854332  2367999999999999999999998877765433


Q ss_pred             H-HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHH
Q psy14434        235 L-IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI  282 (404)
Q Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l  282 (404)
                      + ..++++...+         ++++..+..|++-|+..||.+||..+.+
T Consensus       400 kialeglrv~ip---------pgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  400 KIALEGLRVHIP---------PGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             hhhhccccccCC---------CCccHHHHHHHHHHhcCCCCcCCCccee
Confidence            3 3445554433         6778999999999999999999988765

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.6e-21  Score=171.94  Aligned_cols=137  Identities=17%  Similarity=0.211  Sum_probs=107.8

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc----CCCCcceEeeEEEeccC-CeEE-
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----RHPNIITMLDIYKAVNN-KDLY-  101 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~l~~~~~~~~~-~~~~-  101 (404)
                      .+.||+|+||.||.  +..++.. +||++....  ......+.+|+.+++.+.    .||||+++++++++..+ +.++ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            56899999999995  7777665 799885432  234566889999999994    38999999999985332 3434 


Q ss_pred             EEEeccC---CcHHHHHHhcCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCcEEEccC----CceEEecccccc
Q psy14434        102 VVFEYME---NDLNKVIRDKILKDVHIRYIMFQLCNGL-SYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLAR  171 (404)
Q Consensus       102 lv~E~~~---~~L~~~l~~~~l~~~~~~~i~~qil~al-~~LH~~~i~HrDlkp~NIll~~~----~~vkl~Dfg~a~  171 (404)
                      +||||++   ++|.+++.++.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+.
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            7899955   599999987767666  35688888887 99999999999999999999743    479999955443

>KOG1033|consensus

Probab=99.84  E-value=1.4e-21  Score=185.58  Aligned_cols=245  Identities=29%  Similarity=0.445  Sum_probs=163.7

Q ss_pred             CeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccCh-hHHHHHHHHHHHHHhccCCCCcceEee-------EE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLD-------IY   92 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~l~~-------~~   92 (404)
                      .+.+.+..+.++++.+.......+   .+-++-+..   ..+. .......+++..+.....|+.. -+.+       .+
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~---~~d~~~~~~~~~r~~~~l~~~~~~~~s-~~~d~~~s~~~~~  320 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRA---DVDSLCACKYTFRQLGVLVDSSHSNRS-ILEDLRPSLFESS  320 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhh---hccchhhhhhhhhhhhheeccccCCcc-cccCCCCchhhhc
Confidence            455555566666666655433322   122222221   1222 4455566777777666534433 3322       11


Q ss_pred             E---eccCCeEEEEEeccC-CcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         93 K---AVNNKDLYVVFEYME-NDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        93 ~---~~~~~~~~lv~E~~~-~~L~~~l~~~~----l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      .   .....++||.|++|. .+|.+++..+.    .+......++.|+..|++|   +|.+|+|+||.||++..++.+||
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence            1   112346899999999 58999997543    5667788999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCC------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q psy14434        165 GDLGLARSLSDSK------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIV  237 (404)
Q Consensus       165 ~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~  237 (404)
                      .|||+........      ...+..+||.+||+||.+ .+..|+.++||||||+||+||++-   |...... .....+.
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~~---f~T~~er~~t~~d~r  473 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLIQ---FSTQFERIATLTDIR  473 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHHH---hccHHHHHHhhhhhh
Confidence            9999987665432      234567899999999998 577899999999999999999972   2111111 1111122


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      ++..+  +.   +   +.+ .+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus       474 ~g~ip--~~---~---~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  474 DGIIP--PE---F---LQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cCCCC--hH---H---hhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            11111  00   0   011 3456799999999999999988887777775

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=1.5e-20  Score=169.62  Aligned_cols=143  Identities=16%  Similarity=0.110  Sum_probs=110.6

Q ss_pred             CeEEeeeecccCceeEEEEE-EcCCCeEEEEEEcchhccCh--------------------h--HHHHHHHHHHHHHhcc
Q psy14434         24 EYTIHKRIGKGAYGIVYKAY-DKNNKQYVAIKKIFEAFRNK--------------------T--DAQRTYREILFLKSFQ   80 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~--------------------~--~~~~~~~E~~~l~~l~   80 (404)
                      .|.+.+.||.|++|.||+|. +..+|+.||+|++.......                    .  ......+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67789999999986432110                    0  1123468999999996


Q ss_pred             CCC--CcceEeeEEEeccCCeEEEEEeccCC-cHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCcEE
Q psy14434         81 RHP--NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSNIL  155 (404)
Q Consensus        81 ~hp--nIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l-~~~~l~~~~~~~i~~qil~al~~LH~~~-i~HrDlkp~NIl  155 (404)
                       +.  .++++++.      ...++||||++| +|.... ....+....+..++.||+.+|.+||+.| ++||||||+||+
T Consensus       109 -~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 -EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             -hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence             42  23444432      124899999998 454443 3445667778899999999999999999 999999999999


Q ss_pred             EccCCceEEeccccccccC
Q psy14434        156 IDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       156 l~~~~~vkl~Dfg~a~~~~  174 (404)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>KOG1166|consensus

Probab=99.83  E-value=2.5e-20  Score=192.13  Aligned_cols=191  Identities=23%  Similarity=0.337  Sum_probs=149.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChh-HHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..|.|.+.||.|+||.||.|.+.. |+.||+|+-..+...+- -..+++..++ . ++  -+.|..+..++..  ....+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~-~~--~~~~~~~~~a~~~--~~~S~  770 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-P-QM--LPSIMHISSAHVF--QNASV  770 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-h-hh--hcchHHHHHHHcc--CCcce
Confidence            469999999999999999999877 99999998754432221 1122222222 1 11  2556666655442  34478


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-------CCceEEeccccccc
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------SCSIKIGDLGLARS  172 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-------~~~vkl~Dfg~a~~  172 (404)
                      +|+||.+ |+|.+++.. +.+++.-+..++.|++..|++||..+|||+||||+|.||..       .-.++|+|||.+.-
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            9999999 899999984 55889999999999999999999999999999999999942       23599999999864


Q ss_pred             cC--CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q psy14434        173 LS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK  221 (404)
Q Consensus       173 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  221 (404)
                      +.  .........++|-.+-.+|+. .+..+++.+|.|.|+-+++-|+.|+
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHH
Confidence            32  233556778899999999997 7889999999999999999999997

>KOG0590|consensus

Probab=99.82  E-value=1.4e-21  Score=197.25  Aligned_cols=261  Identities=27%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcC-CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ....|.+.+.||.|+|+.|-.+.... ....+|.|.+............+-.|..+-+.+.+|+|++.+++...  +...
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~   95 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRS   95 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCcc
Confidence            45579999999999999999887744 34567777776554445555556667777777877999999999865  6777


Q ss_pred             EEEEEeccCC-cHHHHH-Hh-c-CCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEccCC-ceEEecccccccc
Q psy14434        100 LYVVFEYMEN-DLNKVI-RD-K-ILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSL  173 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l-~~-~-~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~  173 (404)
                      .+++++|..| ++...+ .. . ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|...
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            8999999775 566555 32 2 4677888999999999999999 99999999999999999999 9999999999876


Q ss_pred             CC-C--CCccccccc-ccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHhhCCCCCCc
Q psy14434        174 SD-S--KECLTEYIA-TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL--QLIVNLVRPNPPHA  247 (404)
Q Consensus       174 ~~-~--~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  247 (404)
                      .. .  .......+| ++.|+|||.+.+........|+||+|+++..+++|..|+.........  ..+...       .
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-------~  248 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-------G  248 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-------c
Confidence            55 2  233455688 999999999865567789999999999999999999998765543311  111110       0


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ......+..++..+.+++.+++..+|..|.+.+++-.+||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            0012334677889999999999999999999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.6e-18  Score=154.38  Aligned_cols=136  Identities=21%  Similarity=0.241  Sum_probs=108.9

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh------hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK------TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++.||+|++|.||+|..  .|..+++|+........      ....+..+|+.++..+. |++|+....++.  .....+
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~~~~~~   75 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFV--DPENFI   75 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEE--eCCCCE
Confidence            36799999999999977  56779999764322111      12345678999999997 888876666654  345679


Q ss_pred             EEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        102 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ++|||++| +|.+++....  . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        76 lv~e~~~G~~L~~~~~~~~--~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSNG--M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhcc--H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999986 8888876532  2 7888999999999999999999999999999999 78999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7.7e-19  Score=154.83  Aligned_cols=138  Identities=22%  Similarity=0.202  Sum_probs=105.7

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh--------------------hHHHHHHHHHHHHHhccCCCC
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK--------------------TDAQRTYREILFLKSFQRHPN   84 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~~hpn   84 (404)
                      |.+.+.||+|+||.||++... +|+.||||++.......                    .......+|..++..+. |++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            888999999999999999875 78999999875322100                    01122467888888886 663


Q ss_pred             --cceEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434         85 --IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus        85 --Iv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                        ++..++      ....++||||++| +|..+..     ......++.+|+.++.++|+.|++||||||+||++++++.
T Consensus        95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~-----~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          95 FPVPKPID------WNRHAVVMEYIDGVELYRVRV-----LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCCceee------cCCceEEEEEeCCcchhhccc-----cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence              444433      2335899999997 6655432     1345678899999999999999999999999999999999


Q ss_pred             eEEeccccccccCC
Q psy14434        162 IKIGDLGLARSLSD  175 (404)
Q Consensus       162 vkl~Dfg~a~~~~~  175 (404)
                      ++|+|||++.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999966543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.5e-18  Score=150.71  Aligned_cols=132  Identities=23%  Similarity=0.292  Sum_probs=100.9

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhc-cC-----hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RN-----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-----~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .||+|++|.||+|..  ++..+++|+..... ..     .....+..+|+.++..+. |+++.....++.  .....++|
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~~~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDV--DPDNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEE--ECCCCEEE
Confidence            489999999999974  56789999864321 11     112355678999999997 665443333332  34456899


Q ss_pred             EeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434        104 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      |||++| +|.+.+.....      .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus        76 ~e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999986 78777654321      7899999999999999999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023|consensus

Probab=99.75  E-value=4.2e-18  Score=164.87  Aligned_cols=202  Identities=23%  Similarity=0.372  Sum_probs=151.3

Q ss_pred             HhccCCCCcceEeeEEEeccCCeEEEEEeccC-CcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCC
Q psy14434         77 KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKV-MHRDLKPS  152 (404)
Q Consensus        77 ~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i-~HrDlkp~  152 (404)
                      +.+. |.|+.++++...  ++...++|.+||. |+|.+.+....  ++......++++|+.||.|||...| .|+.+++.
T Consensus         2 ~~l~-h~n~~~f~g~~~--~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASV--DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             cccc-hhhhhhheeeEe--cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            4565 999999999976  5688999999999 79999998643  6677788899999999999998766 99999999


Q ss_pred             cEEEccCCceEEeccccccccCCC--CCcccccccccccccccccccC--C----CCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISN--R----RYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~--~----~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                      |.+++....+||+|||+.......  ........-...|.|||.+...  .    ..+.+.|+||+|++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998765321  1111122245569999998542  1    1467799999999999999999999


Q ss_pred             CCCCc----HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        225 PGAST----SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       225 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +....    .+....+.+  ....+..+..... ...++++..++.+||..+|..||+++.+-.
T Consensus       159 ~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK--GGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHh--cCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            76322    233333333  1111112222111 145668999999999999999999988744

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=8e-18  Score=146.85  Aligned_cols=138  Identities=22%  Similarity=0.236  Sum_probs=98.1

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHH----------------------HHHHHHHHHhccCC-CC
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR----------------------TYREILFLKSFQRH-PN   84 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~~h-pn   84 (404)
                      .+.||+|+||.||+|.+. +++.||||++............                      ...|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999887 7889999988643222111111                      13456666666422 22


Q ss_pred             cceEeeEEEeccCCeEEEEEeccCC-cHH-HHHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCc
Q psy14434         85 IITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus        85 Iv~l~~~~~~~~~~~~~lv~E~~~~-~L~-~~l~~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~  161 (404)
                      +.+.+++      ...++||||+++ ++. ..+...... .+++.++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            4445443      125999999997 211 122211111 6678899999999999999 9999999999999999 899


Q ss_pred             eEEeccccccccC
Q psy14434        162 IKIGDLGLARSLS  174 (404)
Q Consensus       162 vkl~Dfg~a~~~~  174 (404)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=2.3e-17  Score=166.89  Aligned_cols=138  Identities=21%  Similarity=0.296  Sum_probs=106.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcc-hhcc-----ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFR-----NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..|...+.||+|+||.||++......  +++|+.. +...     ......+..+|+.+++.+. |++++....+..  .
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~  407 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDV--D  407 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEE--e
Confidence            34566789999999999999765443  4444321 1111     1123456778999999997 999887766544  3


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ....++||||++| +|.+++.       ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            4457899999986 8887775       356789999999999999999999999999999 6789999999999753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=6.9e-17  Score=146.08  Aligned_cols=137  Identities=15%  Similarity=0.205  Sum_probs=104.4

Q ss_pred             eeec-ccCceeEEEEEEcCCCeEEEEEEcchhc------c-----ChhHHHHHHHHHHHHHhccCCCCc--ceEeeEEEe
Q psy14434         29 KRIG-KGAYGIVYKAYDKNNKQYVAIKKIFEAF------R-----NKTDAQRTYREILFLKSFQRHPNI--ITMLDIYKA   94 (404)
Q Consensus        29 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~E~~~l~~l~~hpnI--v~l~~~~~~   94 (404)
                      ..|| .||.|+||.+...  +..+++|.+.+..      .     ......+..+|+.++..+. |++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4577 7888888888664  6678999774321      1     1233456788999999997 7774  667766432


Q ss_pred             ccCC--eEEEEEeccCC--cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         95 VNNK--DLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        95 ~~~~--~~~lv~E~~~~--~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ....  ..++|||+++|  +|.+++....+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            1111  23599999996  788888877676653    568999999999999999999999999999999999999988


Q ss_pred             cc
Q psy14434        171 RS  172 (404)
Q Consensus       171 ~~  172 (404)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>KOG0601|consensus

Probab=99.71  E-value=7.1e-18  Score=163.36  Aligned_cols=255  Identities=24%  Similarity=0.291  Sum_probs=204.0

Q ss_pred             ccCCeEEeeeecc--cCceeEEEEEE--cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGK--GAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ....+.+.+.+|.  |++|.||.+..  ..++..+|+|.-...........+-++|....+.+..|++.++.+..++  .
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~  189 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--G  189 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--c
Confidence            3456888999999  99999999988  8889999999865555555566666788888888888999999888876  6


Q ss_pred             CCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCcEEEccC-CceEEecccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCN----GLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGL  169 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~----al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~  169 (404)
                      .+.+|+-+|+|+.+|..+...  ..+++..++..+.+...    ||.++|+.+++|-|+||.||+...+ ...+++|||+
T Consensus       190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            788999999999988888764  44899999999999999    9999999999999999999999999 8899999999


Q ss_pred             ccccCCCCCccccc-----ccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHhhCC
Q psy14434        170 ARSLSDSKECLTEY-----IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA--STSHQLQLIVNLVRP  242 (404)
Q Consensus       170 a~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~  242 (404)
                      ...+.+.+......     .|..-|++||..  ..-++...|++++|.++.+..+|..+....  +...++....     
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----  342 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----  342 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----
Confidence            99887654222222     577889999986  566899999999999999999887555433  2211111111     


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .+.      ....+.+.++...+..|++.+|..|+++..++.|+++..
T Consensus       343 ip~------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPL------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             Cch------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            000      011344667777999999999999999999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2e-16  Score=132.32  Aligned_cols=132  Identities=24%  Similarity=0.268  Sum_probs=107.5

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEEeccCCeEEEEEe
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +++.||.|.++.||++....  ..+++|.+.....    ...+.+|+..++.+..+ .++++++.++.  ..+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEE
Confidence            46789999999999998754  6799999854322    45677899999999744 68899888765  3467899999


Q ss_pred             ccCCc-HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        106 YMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC---KVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       106 ~~~~~-L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~---~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |+.|. +..+      +......++.+++.++++||..   +++|+|++|+||++++.+.++++|||.+..
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99873 3322      5566677899999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243|consensus

Probab=99.60  E-value=1.4e-14  Score=141.98  Aligned_cols=184  Identities=21%  Similarity=0.389  Sum_probs=135.5

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      |.+ +..+-++.+..-.|..+.++.+|.+.+......  .......+-++.|+.++ ||||+++++.++  ..+.+|||+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e--~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLR-HPNILSYLDTTE--EEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhcc-Cchhhhhhhhhc--ccCceEEEe
Confidence            444 334444444333566778888888888754322  44556677888899997 999999999987  567899999


Q ss_pred             eccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccc
Q psy14434        105 EYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY  183 (404)
Q Consensus       105 E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~  183 (404)
                      |.+.. |..+++.  ++...+...+.||+.||.||| ..+++|++|.-..|+|+..|.+||++|.++.............
T Consensus        89 ErV~P-l~~~lk~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~  165 (690)
T KOG1243|consen   89 ERVRP-LETVLKE--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL  165 (690)
T ss_pred             ecccc-HHHHHHH--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc
Confidence            99975 4444443  347788899999999999997 6789999999999999999999999999886554332212222


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q psy14434        184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS  220 (404)
Q Consensus       184 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  220 (404)
                      ..--.|..|+.+. .  -....|.|.|||++++++.|
T Consensus       166 ~~~~s~~~P~~~~-~--s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  166 YLIESFDDPEEID-P--SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhcccChhhcC-c--cccchhhhhHHHHHHHHhCc
Confidence            2233466777652 1  12567999999999999998

>KOG0606|consensus

Probab=99.59  E-value=5.3e-16  Score=157.94  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=196.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-...+.+.+-+-+|++|.++.+.-..+|...++|+...... ...+...+..+-.++-.-. +|.++.....|  ....
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~--~~rs  877 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSF--PCRS  877 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCC--CCCC
Confidence            355678888899999999999998888887777776543211 1112222222222221111 34444443332  2456


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC-
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  175 (404)
                      -.+++++|..+ +|...+.. +..+.+..+.++..+..++.+||+..+.|+|++|.|+++..+|+.++.|||......- 
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            68999999984 78777764 4578888888999999999999999999999999999999999999999984322110 


Q ss_pred             -----C--C-----------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy14434        176 -----S--K-----------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP  225 (404)
Q Consensus       176 -----~--~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  225 (404)
                           .  .                       .......||+.|.+||... +...+..+|+|++|+++++.++|.+||.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                 0  0                       0012346899999999984 6667889999999999999999999999


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHH---HHHhccCCCCcCCCC
Q psy14434        226 GASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD---QILEHNYVSKYFPSA  295 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---~ll~hp~~~~~~~~~  295 (404)
                      .......++.+.+...+.+...       ...+.++++++..+|..+|.+|..+.   ++-.|+||+...+..
T Consensus      1037 a~tpq~~f~ni~~~~~~~p~g~-------~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPWPEGP-------EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CcchhhhhhccccCCCCCCCCc-------cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            9888887777766555443321       34578999999999999999999887   888999999876644

>KOG1266|consensus

Probab=99.51  E-value=5.3e-15  Score=133.09  Aligned_cols=199  Identities=21%  Similarity=0.289  Sum_probs=137.8

Q ss_pred             HHhccCCCCcceEeeEEEec---cCCeEEEEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q psy14434         76 LKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACK--V  144 (404)
Q Consensus        76 l~~l~~hpnIv~l~~~~~~~---~~~~~~lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~--i  144 (404)
                      |.++. |.||++++.++.+.   +.....+++|||. |++..++++     ..+.....++|+.||+.||.|||+..  |
T Consensus       121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            44554 99999999998632   3456789999999 688887763     34888889999999999999999875  9


Q ss_pred             ccCCCCCCcEEEccCCceEEeccccccccC--CCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q psy14434        145 MHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS  220 (404)
Q Consensus       145 ~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~--~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  220 (404)
                      +|+.+..+.|++..+|-+|+.--.-.....  ...  .....-.+-++|.|||.= .....+.++|||++|+...+|..|
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHh
Confidence            999999999999988888875321111100  000  001112367889999973 344567889999999999999988


Q ss_pred             CCCC-CCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        221 KPLF-PGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       221 ~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ..-- .+.+....-..+.+.....             -...-++++.+||+..|..||++.+++.||.+-
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~l-------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGL-------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeec-------------cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            6432 2221111111111111100             012345789999999999999999999999764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=3.3e-13  Score=117.04  Aligned_cols=140  Identities=17%  Similarity=0.251  Sum_probs=102.8

Q ss_pred             eeeecccCceeEEEEEEcC------CCeEEEEEEcchhc----------------c----ChhHHHHH----HHHHHHHH
Q psy14434         28 HKRIGKGAYGIVYKAYDKN------NKQYVAIKKIFEAF----------------R----NKTDAQRT----YREILFLK   77 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~----------------~----~~~~~~~~----~~E~~~l~   77 (404)
                      ...||.|-=+.||.|....      .+..+|||+..-..                .    .......+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997654      35789999764210                0    01112222    37999999


Q ss_pred             hccCC-CCcceEeeEEEeccCCeEEEEEeccCCc-H-HHHHHhcCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCc
Q psy14434         78 SFQRH-PNIITMLDIYKAVNNKDLYVVFEYMEND-L-NKVIRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSN  153 (404)
Q Consensus        78 ~l~~h-pnIv~l~~~~~~~~~~~~~lv~E~~~~~-L-~~~l~~~~l~~~~~~~i~~qil~al~~L-H~~~i~HrDlkp~N  153 (404)
                      ++... -+++..+++.      .-+|||||++++ + ...+++..+++..+..++.+++.+|..| |+.|++|+||+|.|
T Consensus        82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            88643 4677777652      249999999863 2 2234444566677788899999999999 89999999999999


Q ss_pred             EEEccCCceEEeccccccccC
Q psy14434        154 ILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       154 Ill~~~~~vkl~Dfg~a~~~~  174 (404)
                      ||+. ++.+.|+|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9996 5689999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.5e-13  Score=133.31  Aligned_cols=142  Identities=19%  Similarity=0.233  Sum_probs=93.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccCh---------------------------hH-----H------HHHH
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK---------------------------TD-----A------QRTY   70 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------~~-----~------~~~~   70 (404)
                      +.||+|++|.||+|..+ +|+.||||+........                           ..     .      ..+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 68899999975321000                           00     0      0122


Q ss_pred             HHHHHHHhcc----CCCCcceEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q psy14434         71 REILFLKSFQ----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCN-GLSYIHACKV  144 (404)
Q Consensus        71 ~E~~~l~~l~----~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~-al~~LH~~~i  144 (404)
                      +|...+..+.    ++++ +.+-.+|.. -....+|||||++| +|.+......... ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~~-~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPG-VYVPEVYWD-RTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCC-EEeCCEehh-hcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCc
Confidence            3444444442    2333 333333322 12346999999997 6666554221111 23345556655 4678899999


Q ss_pred             ccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        145 MHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       145 ~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      +|+|++|.||+++.+|+++|+|||++..+.
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=3e-14  Score=141.52  Aligned_cols=146  Identities=18%  Similarity=0.259  Sum_probs=96.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC---------------------------h-----hHHHH
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---------------------------K-----TDAQR   68 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~-----~~~~~   68 (404)
                      +...|.. +.||+|++|.||+|..+.+|+.||||+.......                           .     +....
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            4456776 7899999999999999988999999998643100                           0     01111


Q ss_pred             H------HHHHHHHHhcc---CCCCcceEeeEEEeccCCeEEEEEeccCC-cHHHH--HHh-c----CCCHHHHHHHHHH
Q psy14434         69 T------YREILFLKSFQ---RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV--IRD-K----ILKDVHIRYIMFQ  131 (404)
Q Consensus        69 ~------~~E~~~l~~l~---~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~--l~~-~----~l~~~~~~~i~~q  131 (404)
                      +      .+|...+.++.   .+...+.+-.+|.+ -....+|||||+.| .+.++  +.. +    .+.+..+..++.|
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            2      23443333332   13333444444432 13446899999997 66553  222 2    2444555556666


Q ss_pred             HHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEeccccccccCC
Q psy14434        132 LCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLARSLSD  175 (404)
Q Consensus       132 il~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Dfg~a~~~~~  175 (404)
                      ++       ..|++|+|++|.||+++.+|    +++++|||++..+..
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            55       58999999999999999988    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2.1e-13  Score=116.86  Aligned_cols=128  Identities=15%  Similarity=0.068  Sum_probs=93.7

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      ++.|+.|.++.||++...  +..|++|.......   ......+|..+++.+.....+++++.+..    ...++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence            467899999999999764  77899998743321   12234678888888863333456665432    2348999999


Q ss_pred             CC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        108 EN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV-----MHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       108 ~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i-----~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      +| ++...       ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        74 ~G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            97 44322       11123457899999999999985     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.44  E-value=8.6e-14  Score=135.20  Aligned_cols=254  Identities=20%  Similarity=0.268  Sum_probs=189.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEc-CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDK-NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      -....+|.++..||.|.|+.|+.+.-. .++..|++|-+.+...........+.|+.+...+..|.+++.++..+.  ..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~  338 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QL  338 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--cc
Confidence            346778999999999999999987654 677889999887766666666667788888888888999999988876  45


Q ss_pred             CeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccccC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~~~  174 (404)
                      ...||=.|||.+ ++...+. ...+.+...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||.+..+.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            567799999985 4332222 3347888999999999999999999999999999999999886 788999999886532


Q ss_pred             CCCCcccccccccccc-cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        175 DSKECLTEYIATRWYR-APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      -..   ....++-+++ .+|++.....+..+.|++|||..+.+.++|.+.-.....   ...+.....+.          
T Consensus       419 ~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~----------  482 (524)
T KOG0601|consen  419 FSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPN----------  482 (524)
T ss_pred             eec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccC----------
Confidence            211   1222344444 356555677789999999999999999998743322211   12222221111          


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .++....++.+...++..++..|+.+.++..|.-|..
T Consensus       483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            1333467889999999999999999999988876643

>KOG3741|consensus

Probab=99.33  E-value=4.9e-11  Score=113.99  Aligned_cols=212  Identities=17%  Similarity=0.233  Sum_probs=156.0

Q ss_pred             CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--ccCCeEEEEEeccCC--c
Q psy14434         35 AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--VNNKDLYVVFEYMEN--D  110 (404)
Q Consensus        35 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~~~~~~~lv~E~~~~--~  110 (404)
                      --.+.|+|....+|..|++|.++....  ........-+..++++. |+|||++.++|..  ..+..+++|++|.++  +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            346789999999999999999932211  11112223467788897 9999999999862  345678999999985  6


Q ss_pred             HHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        111 LNKVIRD----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       111 L~~~l~~----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      |.+..-.                ...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+-+++|+.+|....+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            7665521                136789999999999999999999999999999999999999999999999887765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCCCcchhhc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .+.       +       |.+.    --.+-|.=.||.+++.|.||..--...+.  ...+..+.               
T Consensus       445 ~d~-------~-------~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------------  491 (655)
T KOG3741|consen  445 EDP-------T-------EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------------  491 (655)
T ss_pred             CCC-------C-------cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------------
Confidence            442       0       1111    12356888999999999999633111111  11122221               


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ..++.+++++|.-+...++++ -++.+++.|
T Consensus       492 --~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  492 --TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence              345789999999999999987 678888776

>KOG2137|consensus

Probab=99.30  E-value=1.1e-12  Score=129.21  Aligned_cols=154  Identities=21%  Similarity=0.350  Sum_probs=113.5

Q ss_pred             HHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc---------ccccccccccccccccccCCC
Q psy14434        131 QLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---------LTEYIATRWYRAPEILISNRR  200 (404)
Q Consensus       131 qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~  200 (404)
                      +.+.|+.|+|. .+++|+.|.|++|.++..|.+||+.|+++....++...         ..-......|.|||.+. +..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-GTT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-ccc
Confidence            34489999995 68999999999999999999999999998765442110         01112356799999984 567


Q ss_pred             CCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCH
Q psy14434        201 YTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPET  279 (404)
Q Consensus       201 ~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  279 (404)
                      .+.++|+||+||++|.+. .|+..+.+.........-.........      ..-.++|+++++=|.++|..++..||++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~------~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAF------GYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccc------cccccCcHHHHHHHHHHhcCCcccCcch
Confidence            789999999999999998 566666554433222222111111000      0115679999999999999999999999


Q ss_pred             HHHHhccCCCCc
Q psy14434        280 DQILEHNYVSKY  291 (404)
Q Consensus       280 ~~ll~hp~~~~~  291 (404)
                      ..++..|||.+.
T Consensus       260 ~~l~~~~ff~D~  271 (700)
T KOG2137|consen  260 DLLLSIPFFSDP  271 (700)
T ss_pred             hhhhcccccCCc
Confidence            999999999874

>KOG3087|consensus

Probab=99.21  E-value=3e-10  Score=95.11  Aligned_cols=141  Identities=21%  Similarity=0.252  Sum_probs=100.7

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcc-hhcc-----ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFR-----NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .+..+-+|+-+.|+++..  .|+.+.||.=. +...     ..-...+..+|++.|.++. --.|.--.-+|.  +...-
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~--D~~~~   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFI--DTYGG   85 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEE--ecCCC
Confidence            667888999999999955  57777787532 2221     1223455678999888875 334433333343  34445


Q ss_pred             EEEEeccCC--cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eEEeccccccc
Q psy14434        101 YVVFEYMEN--DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARS  172 (404)
Q Consensus       101 ~lv~E~~~~--~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vkl~Dfg~a~~  172 (404)
                      .|+|||++|  ++.+++...   ...+.....++.+|-+.+.-||.++|||+||..+||++..+|.   +.++|||++..
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            889999998  788877642   2333334788999999999999999999999999999977653   58999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1e-10  Score=104.53  Aligned_cols=142  Identities=15%  Similarity=0.199  Sum_probs=99.7

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEEecc-CCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVN-NKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~~~~-~~~~~lv~E~  106 (404)
                      +.||.|..+.||++.... |..+++|+....... .......+|..+++.+..+ ..+++++.+..... .+..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            678999999999997743 578999997543221 2344667899999998632 34677776643211 1356899999


Q ss_pred             cCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q psy14434        107 MEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--------------------------------------------  141 (404)
Q Consensus       107 ~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~--------------------------------------------  141 (404)
                      ++| ++...+....+++.+...++.+++.+|..||+                                            
T Consensus        82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            997 44433322345666666667777777777763                                            


Q ss_pred             ------------CCCccCCCCCCcEEEcc--CCceEEeccccccc
Q psy14434        142 ------------CKVMHRDLKPSNILIDK--SCSIKIGDLGLARS  172 (404)
Q Consensus       142 ------------~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~  172 (404)
                                  ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        24699999999999998  56789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=4.2e-10  Score=94.69  Aligned_cols=131  Identities=23%  Similarity=0.317  Sum_probs=93.0

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEE-cchhccChhH-----HHHHHHHHHHHHhccCC-CCcceEeeEEEeccCCeEE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKK-IFEAFRNKTD-----AQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~-~~~~~~~~~~-----~~~~~~E~~~l~~l~~h-pnIv~l~~~~~~~~~~~~~  101 (404)
                      ..+++|+-+.++.+...  |..+++|. +.+....+.-     ..+..+|..++.++..- =+.+-++++    +.....
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----D~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----DPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCE
Confidence            35788999999998553  33456663 3333333322     33456788888887622 244555554    344578


Q ss_pred             EEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        102 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |+|||++| .|.+.+...      ...++..+-..+.-||.+||+|+||.++||+++.++ +.++|||++..
T Consensus        76 I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998 466677655      245667777788889999999999999999998775 99999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=2.3e-10  Score=98.95  Aligned_cols=128  Identities=23%  Similarity=0.253  Sum_probs=83.2

Q ss_pred             EEEEEEcCCCeEEEEEEcchhc--------------c--------C--hhHHHHHHHHHHHHHhccCC-CCcceEeeEEE
Q psy14434         39 VYKAYDKNNKQYVAIKKIFEAF--------------R--------N--KTDAQRTYREILFLKSFQRH-PNIITMLDIYK   93 (404)
Q Consensus        39 V~~~~~~~~~~~vaiK~~~~~~--------------~--------~--~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~   93 (404)
                      ||.|.. .+|..+|+|+.....              .        .  ........+|...|.++... -++++.+++- 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            788876 456789999764210              0        0  11123456899999999744 2577877652 


Q ss_pred             eccCCeEEEEEeccC--CcHHHHHHhcCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         94 AVNNKDLYVVFEYME--NDLNKVIRDKILKDVHIRYIMFQLCNGLSY-IHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~--~~L~~~l~~~~l~~~~~~~i~~qil~al~~-LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                        .   -+|||||++  |.....+....++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+
T Consensus        80 --~---~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 --R---NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             --T---TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             --C---CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence              2   389999999  632233333333456677788888886655 589999999999999999887 8999999998


Q ss_pred             cccC
Q psy14434        171 RSLS  174 (404)
Q Consensus       171 ~~~~  174 (404)
                      ....
T Consensus       154 v~~~  157 (188)
T PF01163_consen  154 VDSS  157 (188)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            7654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.9e-09  Score=97.57  Aligned_cols=132  Identities=13%  Similarity=0.078  Sum_probs=90.4

Q ss_pred             eEEEEEEcCCCeEEEEEEcchhccCh---------hHHHHHHHHHHHHHhccCCCC--cceEeeEEEecc---CCeEEEE
Q psy14434         38 IVYKAYDKNNKQYVAIKKIFEAFRNK---------TDAQRTYREILFLKSFQRHPN--IITMLDIYKAVN---NKDLYVV  103 (404)
Q Consensus        38 ~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~~hpn--Iv~l~~~~~~~~---~~~~~lv  103 (404)
                      .|.++.  -.|+.|.||.........         .......+|...+..+. .-+  .+....+.+...   ....+||
T Consensus        37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEE
Confidence            355553  356789999663221100         11113557777777664 222  233344443211   3357899


Q ss_pred             EeccCC--cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-------CCceEEecccccc
Q psy14434        104 FEYMEN--DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------SCSIKIGDLGLAR  171 (404)
Q Consensus       104 ~E~~~~--~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-------~~~vkl~Dfg~a~  171 (404)
                      ||++++  +|.+++..   ...+......++.+++..+.-||.+||+|+|++|.|||++.       ++.+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999997  68888753   44667778899999999999999999999999999999975       4689999999885


Q ss_pred             c
Q psy14434        172 S  172 (404)
Q Consensus       172 ~  172 (404)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            3

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.09  E-value=3e-09  Score=99.65  Aligned_cols=249  Identities=10%  Similarity=0.098  Sum_probs=156.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEe----eEEEeccC-C
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML----DIYKAVNN-K   98 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~----~~~~~~~~-~   98 (404)
                      -....+.||+|+-+.+|-.-.-.   ..+.|+.+.+--  ....   +.+..|...-.||-+-.-+    ......+. .
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp--a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP--AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             ccCCCccccCCccceeeecchhh---chhheeecCCCc--hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            34567889999999999763222   245677654321  1111   1223344444455432211    11112233 3


Q ss_pred             eEEEEEeccCC--cHHHHHH----hc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         99 DLYVVFEYMEN--DLNKVIR----DK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        99 ~~~lv~E~~~~--~L~~~l~----~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      .+.++|..+.|  ....+..    ..   ...+..+.+.+..|+.+.+.||..|..-+|+.++|+||+.++.|.|+|=..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            37889999986  3444443    11   266788999999999999999999999999999999999999999998655


Q ss_pred             ccccCCCCCcccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCc----HHHHH-HHHHh
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQS-KPLFPGAST----SHQLQ-LIVNL  239 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~----~~~~~-~~~~~  239 (404)
                      -... ......-..+|.+.|.+||.-.    .+-.-+...|.|.||+++|+|+.| +.||.+-..    ..-.+ .|..+
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            4332 2333344557899999999852    123446788999999999999987 899976321    11111 22222


Q ss_pred             hCCCCC------CcchhhcccCCCCHHHHHHHHhcccc--CCCCCCCHHH
Q psy14434        240 VRPNPP------HADKFYAGFKNKPEEAVDLLNQILVL--NPSERPETDQ  281 (404)
Q Consensus       240 ~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~~  281 (404)
                      .....+      ...+..--+.-+++.++.|..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            110000      00011112244688999999999976  3678999854

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=6e-09  Score=92.21  Aligned_cols=107  Identities=22%  Similarity=0.280  Sum_probs=80.9

Q ss_pred             HHHHHHHHHHHHhccC-CCCcceEeeEEEecc--CCeEEEEEeccCC--cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Q psy14434         66 AQRTYREILFLKSFQR-HPNIITMLDIYKAVN--NKDLYVVFEYMEN--DLNKVIRD-KILKDVHIRYIMFQLCNGLSYI  139 (404)
Q Consensus        66 ~~~~~~E~~~l~~l~~-hpnIv~l~~~~~~~~--~~~~~lv~E~~~~--~L~~~l~~-~~l~~~~~~~i~~qil~al~~L  139 (404)
                      ..+..+|...+..+.. .=.+++.+++.+...  ....++|||++++  +|.+++.. ...+......++.+++..++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3455566666665541 123455555544211  1345899999997  68888875 3367777889999999999999


Q ss_pred             HhCCCccCCCCCCcEEEccCC---ceEEeccccccc
Q psy14434        140 HACKVMHRDLKPSNILIDKSC---SIKIGDLGLARS  172 (404)
Q Consensus       140 H~~~i~HrDlkp~NIll~~~~---~vkl~Dfg~a~~  172 (404)
                      |.+||+|+|++|.|||++.++   .+.|+||+.++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.00  E-value=1.1e-08  Score=89.05  Aligned_cols=139  Identities=12%  Similarity=0.104  Sum_probs=100.4

Q ss_pred             ecccCceeEEEEEEcCCCeEEEEEEcch----hccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEE---eccCCeEEE
Q psy14434         31 IGKGAYGIVYKAYDKNNKQYVAIKKIFE----AFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYK---AVNNKDLYV  102 (404)
Q Consensus        31 lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~---~~~~~~~~l  102 (404)
                      -|+||.|.|+.....  |..+-+|.-..    ...-.-....+.+|...|..+... -.+++.. ++.   ......-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            577999999998543  33577886531    111123456677888888877521 1244444 222   122344689


Q ss_pred             EEeccCC--cHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc--eEEeccccccc
Q psy14434        103 VFEYMEN--DLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLARS  172 (404)
Q Consensus       103 v~E~~~~--~L~~~l~~~~---l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~--vkl~Dfg~a~~  172 (404)
                      |+|-++|  +|.+++.+..   .+......++.+++.+++-||+.|+.|+|+-+.||+++.+|.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9999985  8999887654   467777899999999999999999999999999999987777  99999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.94  E-value=6.1e-09  Score=92.88  Aligned_cols=139  Identities=23%  Similarity=0.213  Sum_probs=101.7

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcch------------hc------cC--hhHHHHHHHHHHHHHhccCC-C
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE------------AF------RN--KTDAQRTYREILFLKSFQRH-P   83 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~------~~--~~~~~~~~~E~~~l~~l~~h-p   83 (404)
                      +.+...||-|--|.||.|.+. .|..+|||.=..            ..      .+  ........+|..+|.+|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            557789999999999999887 567799994210            00      00  11233456899999999633 2


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccCCc-HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCce
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI  162 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~~~-L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~v  162 (404)
                      .+++.+++      +...+|||+++|- |..+    +++......++..|++-+.-+-..|++|+|+++-||+++++|.+
T Consensus       172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            56666654      3469999999983 3222    23455667777888888888889999999999999999999999


Q ss_pred             EEeccccccccC
Q psy14434        163 KIGDLGLARSLS  174 (404)
Q Consensus       163 kl~Dfg~a~~~~  174 (404)
                      .++||--+....
T Consensus       242 ~vIDwPQ~v~~~  253 (304)
T COG0478         242 VVIDWPQAVPIS  253 (304)
T ss_pred             EEEeCcccccCC
Confidence            999997765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.4e-07  Score=82.53  Aligned_cols=141  Identities=16%  Similarity=0.182  Sum_probs=89.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----------hhHHHHHHHHHHHHHhccCCCCcceEee
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----------KTDAQRTYREILFLKSFQRHPNIITMLD   90 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~~hpnIv~l~~   90 (404)
                      +-++|.+.+.+-......|.+..  .+|..+++|........          .....++......++... ......++.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g-~~~~~~~yl  105 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG-FTEPADPYL  105 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC-cccccccee
Confidence            34578999999888887787773  45788999987543211          122222233333333321 333344333


Q ss_pred             EEEec---cCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         91 IYKAV---NNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        91 ~~~~~---~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      +.+-.   -....+++|||++| .|.+...   +++    .+...|.+++.-||+.|++|+|..|.|++++.+ .++++|
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence            33211   12345689999998 4543321   222    244567788999999999999999999999865 499999


Q ss_pred             cccccc
Q psy14434        167 LGLARS  172 (404)
Q Consensus       167 fg~a~~  172 (404)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.60  E-value=5.6e-07  Score=79.67  Aligned_cols=137  Identities=19%  Similarity=0.188  Sum_probs=94.0

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhccC--------------------hhHHHH--HHHHHHHHHhccC-CCCcc
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--------------------KTDAQR--TYREILFLKSFQR-HPNII   86 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~~--~~~E~~~l~~l~~-hpnIv   86 (404)
                      .|+.|--+.||+|.. .++..+|+|++......                    ......  ..+|..-|+++.. +=.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            455666668999865 45788999987432111                    111111  2367777777642 34456


Q ss_pred             eEeeEEEeccCCeEEEEEeccCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceE
Q psy14434         87 TMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        87 ~l~~~~~~~~~~~~~lv~E~~~~~--L~~~l~~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vk  163 (404)
                      +-+.++.      -.|||||++..  -.-.++.-.+...++..+..++++.+.-|-. .|++|+||+.=|||+. ++.+.
T Consensus       134 ~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         134 EPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            6666543      38999999853  1112233334555788889999999999866 9999999999999999 88999


Q ss_pred             EeccccccccC
Q psy14434        164 IGDLGLARSLS  174 (404)
Q Consensus       164 l~Dfg~a~~~~  174 (404)
                      |+|||-|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.5e-06  Score=77.95  Aligned_cols=133  Identities=16%  Similarity=0.168  Sum_probs=80.4

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEEEeccCCeEEEEEecc
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      ..||+|..+.||+.    .+..+++|......    ....+.+|..+++.+.... .+++.+++..  .....++|||++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeec
Confidence            57899999999984    24457889875322    2344578999998886332 2567777654  455578999999


Q ss_pred             CCc--HHHHHH---------------------hc---CCCHHH-HHHHHHH----------HHHH-HHHHH----hCCCc
Q psy14434        108 END--LNKVIR---------------------DK---ILKDVH-IRYIMFQ----------LCNG-LSYIH----ACKVM  145 (404)
Q Consensus       108 ~~~--L~~~l~---------------------~~---~l~~~~-~~~i~~q----------il~a-l~~LH----~~~i~  145 (404)
                      +|.  +...+.                     .-   ...... ...+..+          +... ..+|.    ...++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            983  111110                     00   001000 0011000          1111 12222    12478


Q ss_pred             cCCCCCCcEEEccCCceEEeccccccc
Q psy14434        146 HRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       146 HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |+|+.|.||++++++ +.|+||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=8.4e-07  Score=88.15  Aligned_cols=142  Identities=18%  Similarity=0.307  Sum_probs=86.6

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhcc---------------------------ChhH-----HHH------HH
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---------------------------NKTD-----AQR------TY   70 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~-----~~~------~~   70 (404)
                      +.|++++-|.||+|+.+. |+.||||+.+....                           +...     ...      ..
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            579999999999998865 89999998652210                           0000     011      12


Q ss_pred             HHHHHHHhcc----CCCCcceEeeEEEeccCCeEEEEEeccCC-cHHHH--HHhcCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy14434         71 REILFLKSFQ----RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACK  143 (404)
Q Consensus        71 ~E~~~l~~l~----~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~--l~~~~l~~~~~~~i~~qil~al~~LH~~~  143 (404)
                      +|...+.++.    +.|++ .+=.+|.+ -...-.|+|||++| .+.+.  ++...++...+...+.++.  +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence            3444444332    22332 22222221 13345899999998 44444  3444455333332222211  22233489


Q ss_pred             CccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       144 i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ++|.|..|.||+++.+|++.+.|||+...+..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999977654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=3.8e-06  Score=75.35  Aligned_cols=139  Identities=23%  Similarity=0.273  Sum_probs=80.8

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEE-eccCCeEEEEEe
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYK-AVNNKDLYVVFE  105 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~-~~~~~~~~lv~E  105 (404)
                      ++.|+.|..+.||++.... + .+++|.....    .....+.+|..+++.+..+ ..+++++.... .......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            5789999999999998765 3 7899987432    4556667888888888644 23567776432 223445799999


Q ss_pred             ccCC-cHHH----------------HHH---hc--C---CCHHH------HHH---H------------HHHHHH-HHHH
Q psy14434        106 YMEN-DLNK----------------VIR---DK--I---LKDVH------IRY---I------------MFQLCN-GLSY  138 (404)
Q Consensus       106 ~~~~-~L~~----------------~l~---~~--~---l~~~~------~~~---i------------~~qil~-al~~  138 (404)
                      ++.| .+..                .+.   ..  .   +....      ...   .            ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            9997 3433                110   00  0   01000      000   0            111222 2333


Q ss_pred             HH-------hCCCccCCCCCCcEEEc-cCCceEEeccccccc
Q psy14434        139 IH-------ACKVMHRDLKPSNILID-KSCSIKIGDLGLARS  172 (404)
Q Consensus       139 LH-------~~~i~HrDlkp~NIll~-~~~~vkl~Dfg~a~~  172 (404)
                      ++       ...++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33       24599999999999999 667778999987743

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=3.7e-06  Score=76.42  Aligned_cols=133  Identities=16%  Similarity=0.101  Sum_probs=80.2

Q ss_pred             eecccCc-eeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC
Q psy14434         30 RIGKGAY-GIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME  108 (404)
Q Consensus        30 ~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~  108 (404)
                      .|..|.+ +.||++...  +..+.+|......     .....+|+.+++.+..+--+++++++..  ..+..++|||+++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~e~i~   75 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLTSAVP   75 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEEEeeC
Confidence            3445555 789999543  3678888874321     3356689999988876655667777654  3456789999998


Q ss_pred             C-cHHHHH----------------Hh-cCCCH----------HHHHHH---HH----------------HHHHHHHHHH-
Q psy14434        109 N-DLNKVI----------------RD-KILKD----------VHIRYI---MF----------------QLCNGLSYIH-  140 (404)
Q Consensus       109 ~-~L~~~l----------------~~-~~l~~----------~~~~~i---~~----------------qil~al~~LH-  140 (404)
                      | .+....                .. ..++.          ......   +.                .+...+..|- 
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            7 343221                00 00110          000000   00                0111122221 


Q ss_pred             ------hCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        141 ------ACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       141 ------~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                            ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                  2348999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576|consensus

Probab=98.37  E-value=9.4e-08  Score=94.11  Aligned_cols=245  Identities=18%  Similarity=0.142  Sum_probs=162.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC-cceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-Iv~l~~~~~~~~~~~~  100 (404)
                      ..-|.....+++|+++++++.+...+...+ .+.+...       ....-++.+|.+++ ||| .+..++-+.  .+...
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n-~P~~~v~~~~d~~--~E~~~  309 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVN-NPNPVVRYLEDYD--GEDYL  309 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHcc-CCCCcccccccCC--ccccc
Confidence            345777888999999999999877666554 5555322       23335778889997 999 444444432  46677


Q ss_pred             EEEEeccCCc--HHHHH--HhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEND--LNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~~--L~~~l--~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +++|+++.+.  ....+  ..-.+.+-+...+...-+++++++|+.-=+|+|    ||+.++ +..+..||+....+...
T Consensus       310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence            8999999853  11111  111244555666777888999999998778998    777655 67999999998877543


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      . ...+..+|+.++|||+. ....+....|+|++|+-..++.-|.+|-..  ......  .-...+..+..... ..+. 
T Consensus       385 ~-~~~t~~~~~~~~~pev~-~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~--~~g~~p~s~~L~~~-~aw~-  456 (829)
T KOG0576|consen  385 M-KPRTAIGTPEPLAPEVI-QENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLP--MIGNGPNSPMLTDK-SAWS-  456 (829)
T ss_pred             c-ccccCCCCCCCCCchhh-cccccccCCCccCCCcchhhcCCCCCCCCC--CccccC--CCCCCCCccccchh-hhcC-
Confidence            2 34567899999999987 466788889999999877777777766433  100000  00000000000000 0000 


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       +..-.++...|+..-|..|+....++.|.+|+.-
T Consensus       457 -~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  457 -PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             -cccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence             1112257788999999999999999999999864

>KOG1035|consensus

Probab=98.35  E-value=1.5e-06  Score=91.28  Aligned_cols=205  Identities=21%  Similarity=0.272  Sum_probs=138.5

Q ss_pred             hHHHHHHHHHHHHHhccCCCCcceEeeEEEe-ccCC-eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Q psy14434         64 TDAQRTYREILFLKSFQRHPNIITMLDIYKA-VNNK-DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYI  139 (404)
Q Consensus        64 ~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~-~~~~-~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~L  139 (404)
                      .+......|...+.... |+|++.++.+--. ...+ .+.+..++|.+ ++...+.. +.++...++.+..++++|++|+
T Consensus       224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence            44555667888888887 9999999987431 1111 22345567775 66666664 5688999999999999999999


Q ss_pred             HhCCCccCCCCCC---cEEEccCCceEEe--ccccccccCCCCCcccccccccccccccccccCCCC--CchhhHHHHHH
Q psy14434        140 HACKVMHRDLKPS---NILIDKSCSIKIG--DLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY--THHVDIWSLGC  212 (404)
Q Consensus       140 H~~~i~HrDlkp~---NIll~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~  212 (404)
                      |+..+.|.-+...   +-.++..+.+.++  ||+.+......... .....+..+.|||... ...+  ....|+|++|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~-~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLK-ENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccc-cccchhhhhhHHHHHHH
Confidence            9986666555444   3444556677777  99988876554322 2233455677788752 2222  34469999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        213 ILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       213 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ....+..|..+-...      ........             ........+++.+|+.-++++|+++.+++.|+|...
T Consensus       381 l~~~~~~~~~i~~~~------~~~~~~l~-------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKS------AVPVSLLD-------------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             HHhhhhhcCcccccc------cchhhhhc-------------cccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            999999876432111      11111111             001126789999999999999999999999999864

>KOG1235|consensus

Probab=98.29  E-value=8.7e-06  Score=80.81  Aligned_cols=138  Identities=22%  Similarity=0.254  Sum_probs=87.5

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccC-----------------------------hhHHHHHHHHHHHHH--
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-----------------------------KTDAQRTYREILFLK--   77 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------~~~~~~~~~E~~~l~--   77 (404)
                      +.||.-+.|.|++|+.+. |+.||||+-+.....                             ++-.+.+..|+..++  
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999998876 999999975422110                             011111222222222  


Q ss_pred             --------hccCCCC------cceEeeEEEeccCCeEEEEEeccCC----cHHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Q psy14434         78 --------SFQRHPN------IITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI  139 (404)
Q Consensus        78 --------~l~~hpn------Iv~l~~~~~~~~~~~~~lv~E~~~~----~L~~~l~~~~l~~~~~~~i~~qil~al~~L  139 (404)
                              .+. |-+      |+++|-.+    ...-.|+||||+|    ++ +.+.+..++...+...+.++..  .-|
T Consensus       246 ~Nae~~~~~f~-~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~gi~~~~i~~~l~~~~~--~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFK-DFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRGISPHDILNKLVEAYL--EQI  317 (538)
T ss_pred             HhHHHHHHHHH-hcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcCCCHHHHHHHHHHHHH--HHH
Confidence                    222 333      44444332    2346899999997    45 5555555776655443333222  112


Q ss_pred             HhCCCccCCCCCCcEEEcc----CCceEEeccccccccCC
Q psy14434        140 HACKVMHRDLKPSNILIDK----SCSIKIGDLGLARSLSD  175 (404)
Q Consensus       140 H~~~i~HrDlkp~NIll~~----~~~vkl~Dfg~a~~~~~  175 (404)
                      =..|++|+|-.|.||++..    ++.+.+-|||+...+..
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3578999999999999984    67899999999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.29  E-value=2.2e-05  Score=68.50  Aligned_cols=130  Identities=21%  Similarity=0.321  Sum_probs=90.9

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhc--------------cChhHHHHHHHHHHHHHhcc-----CCCCcceE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--------------RNKTDAQRTYREILFLKSFQ-----RHPNIITM   88 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~-----~hpnIv~l   88 (404)
                      ...||+|+.-.||.-  . .....+||++....              .......+..+|+.....+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999865  2 23346889886543              11223445556666555553     37899999


Q ss_pred             eeEEEeccCCeEEEEEeccC---C----cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-
Q psy14434         89 LDIYKAVNNKDLYVVFEYME---N----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-  160 (404)
Q Consensus        89 ~~~~~~~~~~~~~lv~E~~~---~----~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-  160 (404)
                      +|+.++  +..+.+|+|.+.   |    +|.+++..+.+++ .+..   .+-+-..||-+.+|+.+|++|.||++...+ 
T Consensus        83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999874  555788888874   2    6899998887877 3333   344556778899999999999999995432 


Q ss_pred             ---ceEEec
Q psy14434        161 ---SIKIGD  166 (404)
Q Consensus       161 ---~vkl~D  166 (404)
                         .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence               577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=8.1e-06  Score=68.59  Aligned_cols=129  Identities=16%  Similarity=0.164  Sum_probs=90.7

Q ss_pred             EEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEe
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      +..+.||+|.+|.||++...  |..+|+|+-.    .+.....+..|.++|..+.+----.++|.+-+      -++.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhh
Confidence            45678999999999999765  4478999753    34455667789999999985555566776522      255699


Q ss_pred             ccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCcEEEccCCceEEeccccccc
Q psy14434        106 YMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK-PSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       106 ~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlk-p~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |+.| .|.++-...  +..    -+..++++---|-..||-|+.|. |...+|..++.+.|+||..|..
T Consensus        93 ~i~G~~L~~~~~~~--~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG--DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc--cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998 676554432  222    33345555444677899999885 5556666666999999998873

>PLN02876 acyl-CoA dehydrogenase

Probab=98.22  E-value=1.6e-05  Score=84.89  Aligned_cols=83  Identities=14%  Similarity=0.179  Sum_probs=56.2

Q ss_pred             EeeeecccCceeEEEEEEcCCC--eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCc--ceEeeEEEec-cCCeEE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI--ITMLDIYKAV-NNKDLY  101 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI--v~l~~~~~~~-~~~~~~  101 (404)
                      -++.|+.|.++.+|+......+  ..+++|+..... .......+.+|..+++.+..|+++  ++++.++.+. ..+..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            3677899999999998765433  467888763321 112234677999999999655654  7777765421 124678


Q ss_pred             EEEeccCCc
Q psy14434        102 VVFEYMEND  110 (404)
Q Consensus       102 lv~E~~~~~  110 (404)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.21  E-value=4.4e-05  Score=66.26  Aligned_cols=130  Identities=18%  Similarity=0.196  Sum_probs=89.8

Q ss_pred             CCeEEeeeecccCc-eeEEEEEEcCCCeEEEEEEcch---h--------ccC-h-------hHHHHHHHHHHHHHhccC-
Q psy14434         23 AEYTIHKRIGKGAY-GIVYKAYDKNNKQYVAIKKIFE---A--------FRN-K-------TDAQRTYREILFLKSFQR-   81 (404)
Q Consensus        23 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~---~--------~~~-~-------~~~~~~~~E~~~l~~l~~-   81 (404)
                      .+++.++.||.|.- |.||++.-  .|+.||+|++..   .        ... .       .....+..|.+..-+|+. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999954  577999999321   0        000 0       112234566666666652 


Q ss_pred             -CCCc--ceEeeEEEec----------------cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC
Q psy14434         82 -HPNI--ITMLDIYKAV----------------NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC  142 (404)
Q Consensus        82 -hpnI--v~l~~~~~~~----------------~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~  142 (404)
                       +.++  +++++++.-.                ......||.||+...-       .++...    +.+|++-|..+|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~~~~~----~~~~~~dl~~~~k~  183 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PLQIRD----IPQMLRDLKILHKL  183 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------ccchhH----HHHHHHHHHHHHHC
Confidence             4455  9999987421                1123468888887532       233333    45677778889999


Q ss_pred             CCccCCCCCCcEEEccCCceEEeccccc
Q psy14434        143 KVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus       143 ~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ||+-+|+++.|..     .=||+|||.+
T Consensus       184 gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CeeeccCcccccc-----CCEEEecccC
Confidence            9999999999987     3489999864

>KOG1826|consensus

Probab=98.12  E-value=2.4e-07  Score=98.93  Aligned_cols=218  Identities=17%  Similarity=0.086  Sum_probs=145.5

Q ss_pred             ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccC-CcHHHHHHhc-----CCCHHHHHHHHHHHHHH
Q psy14434         62 NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNG  135 (404)
Q Consensus        62 ~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~~-----~l~~~~~~~i~~qil~a  135 (404)
                      .+...+....|...++... |+++...+.=.........|..++|+. |.+.+++-++     .+....+.....+.+.+
T Consensus      1269 sePlkemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred             hhHHHHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhc
Confidence            3444445555666666666 998887776665556677899999998 5777777543     24444454444554777


Q ss_pred             HHHHHhC-----CCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHH
Q psy14434        136 LSYIHAC-----KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL  210 (404)
Q Consensus       136 l~~LH~~-----~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  210 (404)
                      ..-+|+.     -.+|+++|+-|.+|..+..++++++|+.+............++++.|++|+.. +.-.++.++|+|..
T Consensus      1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRR 1426 (2724)
T ss_pred             cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHH
Confidence            7777753     27999999999999999999999999998444444455667788999999986 56678888999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        211 GCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       211 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      |+.+|.+..|..+|     ....+.+.++.-....    +...-.-.|.++-.....+|-..-..||.-...+.-+.|..
T Consensus      1427 s~~ly~rs~~n~~f-----i~flq~~Lkgiidn~t----f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF-----IFFLQPALKGIIDNHT----FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHHHHHHhcccHHH-----HHHHHHHHcCcccccc----cccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            99999999888776     2222333322221110    00000111333334444444455578888888888777754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.08  E-value=6.2e-05  Score=67.88  Aligned_cols=73  Identities=18%  Similarity=0.236  Sum_probs=47.7

Q ss_pred             eeeecccCceeEEEEEEcC-CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         28 HKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      ++.|+.|-...+|++.... ++..|++|+.....   .......+|+.+++.+..+.-.+++++.+.   .   .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence            4678889999999996543 35678899764321   111233478888888864444566655432   2   479999


Q ss_pred             cCC
Q psy14434        107 MEN  109 (404)
Q Consensus       107 ~~~  109 (404)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            986

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.98  E-value=0.00016  Score=69.95  Aligned_cols=78  Identities=18%  Similarity=0.232  Sum_probs=54.9

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-----ChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEeccCCeE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-----NKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~~~~~~~  100 (404)
                      .+.||.|.+..||++.+..+++.++||.-.....     ..-...+...|...|+.+..+  .++++++.+    +....
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----D~~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----DEELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE----CCCCC
Confidence            4679999999999999865546799998532111     022455667788888876433  467888876    34557


Q ss_pred             EEEEeccCC
Q psy14434        101 YVVFEYMEN  109 (404)
Q Consensus       101 ~lv~E~~~~  109 (404)
                      ++|||++++
T Consensus       107 ~lVME~L~~  115 (401)
T PRK09550        107 VTVMEDLSD  115 (401)
T ss_pred             EEEEecCCC
Confidence            899999875

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=5.6e-05  Score=68.28  Aligned_cols=73  Identities=12%  Similarity=0.140  Sum_probs=43.6

Q ss_pred             eeeecccCce-eEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC--CcceEeeEEEeccC-CeEEEE
Q psy14434         28 HKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP--NIITMLDIYKAVNN-KDLYVV  103 (404)
Q Consensus        28 ~~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--nIv~l~~~~~~~~~-~~~~lv  103 (404)
                      ++.|+.|+.. .||+..     ..+++|.....    .....+.+|...+..+..+-  .+..+++.....+. ...+++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            4567877776 599872     24777875321    22346778999998886431  34444443221111 245889


Q ss_pred             EeccCC
Q psy14434        104 FEYMEN  109 (404)
Q Consensus       104 ~E~~~~  109 (404)
                      |++++|
T Consensus        73 ~~~i~G   78 (235)
T cd05155          73 YRWLEG   78 (235)
T ss_pred             EEeecC
Confidence            999887

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=2.9e-05  Score=67.39  Aligned_cols=97  Identities=20%  Similarity=0.126  Sum_probs=78.1

Q ss_pred             HHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC-cHHH----HHHhcCCCHHHHHHHHHHHHHHHHHHHh---C
Q psy14434         71 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK----VIRDKILKDVHIRYIMFQLCNGLSYIHA---C  142 (404)
Q Consensus        71 ~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~----~l~~~~l~~~~~~~i~~qil~al~~LH~---~  142 (404)
                      .|..+++.+.+.+++++++|++.      -++|+||.+. ++..    +.+-...++.....++.++++.+.+|+.   .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57888888986689999999964      2778999983 4432    1111236888999999999999999986   4


Q ss_pred             CCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434        143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       143 ~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      .+.-.|++|+|+-++++|++|++|.+.+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093|consensus

Probab=97.91  E-value=3.6e-05  Score=74.76  Aligned_cols=175  Identities=24%  Similarity=0.343  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy14434         65 DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV  144 (404)
Q Consensus        65 ~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i  144 (404)
                      ...+++-...+++.+. |+|...++++-+. ......+|||++..+|++.+..+.+-.....              .+|+
T Consensus        25 ~s~~ilgr~~~lktl~-~~~l~~yl~~~r~-~~~r~IVV~e~~~~Sled~~~~~~l~~~s~~--------------~~~~   88 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQ-HDNLCQYLDFSRG-KHERVIVVMEHYTMSLEDILKTGNLKDESLL--------------AHGV   88 (725)
T ss_pred             cHHHHhhhhHHHHhhc-CccceeeEeeecC-ccceEEEEehhhccchHHHHHhcccchhhhc--------------cccc
Confidence            4455667778888997 9999999988654 3455889999999999999886653222211              2222


Q ss_pred             ccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       145 ~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                      .|-     |+       ++.+| .+   ....               |-..      ++++||||+|.++.++.-|...+
T Consensus        89 ~~~-----~~-------~~~td-~~---~t~~---------------~~~~------~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   89 LHL-----NI-------IYITD-HF---LTKY---------------PSPI------GPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             cee-----hh-------hhccc-cc---cccC---------------CCCC------CcchhhhhHHHHHHHHHHhhHHH
Confidence            221     22       23333 00   0000               1111      24999999999999999999888


Q ss_pred             CCCCcHHHHHHHHHhhCCCCCCcc--hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        225 PGASTSHQLQLIVNLVRPNPPHAD--KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ......+....+............  .+.-..-.++....+++.+|+-..|..||...++.+++-|....
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            777777666666554432221000  00011123567788999999999999999999999999987653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.81  E-value=0.00027  Score=67.05  Aligned_cols=77  Identities=17%  Similarity=0.296  Sum_probs=53.1

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhc-----cChhHHHHHHHHHHHHHhccCC-C-CcceEeeEEEeccCCeEE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-----RNKTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~E~~~l~~l~~h-p-nIv~l~~~~~~~~~~~~~  101 (404)
                      +.||.|....||++.+..+++.++||.-....     ...-...+...|...|+..... | .++++|.+    +.....
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~~   76 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMAV   76 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----ccccce
Confidence            35899999999999986544679999653211     1244556666788888776543 3 57777765    455567


Q ss_pred             EEEeccCC
Q psy14434        102 VVFEYMEN  109 (404)
Q Consensus       102 lv~E~~~~  109 (404)
                      +|||+++.
T Consensus        77 ~vMEdL~~   84 (370)
T TIGR01767        77 TVMEDLSH   84 (370)
T ss_pred             ehHhhCcc
Confidence            99999963

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.74  E-value=0.00019  Score=65.72  Aligned_cols=132  Identities=11%  Similarity=0.138  Sum_probs=76.1

Q ss_pred             eecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC
Q psy14434         30 RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        30 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~  109 (404)
                      .+..|-.+.+|++.  .++..+++|.........  .....+|..+++.+..+.-.++++....      -++||||++|
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccC
Confidence            46678888999886  456678888754321111  0123578888888864433455554421      2689999987


Q ss_pred             -cHH--------------HHHH---hc-----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCCccCC
Q psy14434        110 -DLN--------------KVIR---DK-----ILKD-VHIRYIMFQL---------CNGLSYIHA--------CKVMHRD  148 (404)
Q Consensus       110 -~L~--------------~~l~---~~-----~l~~-~~~~~i~~qi---------l~al~~LH~--------~~i~HrD  148 (404)
                       .+.              ..+.   .-     .++. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence             221              1111   10     1111 1222222222         111222221        2589999


Q ss_pred             CCCCcEEEccCCceEEeccccccc
Q psy14434        149 LKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       149 lkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      +.|.||++++++ +.|+||+.+..
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999877 89999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.65  E-value=0.00045  Score=64.64  Aligned_cols=139  Identities=14%  Similarity=0.076  Sum_probs=80.7

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEE----EeccCCeEE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIY----KAVNNKDLY  101 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~----~~~~~~~~~  101 (404)
                      -++.|..|....+|++..  ++..+++|+...     .....+..|+.++..+..+- .+++++..-    .....+..+
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            366788888889999854  334689998743     22345667777777775321 244444320    001234568


Q ss_pred             EEEeccCC-cH-----------HHHHH---h--cCCCH--------H--H--HH--------HHHHHHHHHHHHHHh---
Q psy14434        102 VVFEYMEN-DL-----------NKVIR---D--KILKD--------V--H--IR--------YIMFQLCNGLSYIHA---  141 (404)
Q Consensus       102 lv~E~~~~-~L-----------~~~l~---~--~~l~~--------~--~--~~--------~i~~qil~al~~LH~---  141 (404)
                      +|+++++| .+           ...+.   .  ..+..        .  .  ..        .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            99999986 21           01110   0  00100        0  0  00        011112334444443   


Q ss_pred             ----CCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        142 ----CKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       142 ----~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                          .++||+|+.|.||++++++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                4799999999999999887778999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00037  Score=65.45  Aligned_cols=73  Identities=15%  Similarity=0.168  Sum_probs=47.4

Q ss_pred             eeeecccCceeEEEEEEcC------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         28 HKRIGKGAYGIVYKAYDKN------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ++.|..|-...+|++....      .++.+++|+.....   .......+|..++..+..+--.+++++++.   +   .
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---~---~   73 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP---N---G   73 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC---C---C
Confidence            4567788888999987543      25789999864322   223345678888888764443456666543   2   3


Q ss_pred             EEEeccCC
Q psy14434        102 VVFEYMEN  109 (404)
Q Consensus       102 lv~E~~~~  109 (404)
                      +|+||++|
T Consensus        74 ~v~e~i~G   81 (302)
T cd05156          74 RIEEFIPS   81 (302)
T ss_pred             chhheeCC
Confidence            57888876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.62  E-value=0.0011  Score=62.16  Aligned_cols=79  Identities=11%  Similarity=0.100  Sum_probs=54.0

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEe-ccCCeEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKA-VNNKDLY  101 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~-~~~~~~~  101 (404)
                      -.-.+.||.|..+.||+..... + .+++|... .   ......+..|...|+.+..+  -.++++++++.. ...+..+
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMAR-S---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC-C-CEEEEEec-c---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            3446789999999999985432 3 36677642 2   11234667888888888654  367888877643 1245689


Q ss_pred             EEEeccCC
Q psy14434        102 VVFEYMEN  109 (404)
Q Consensus       102 lv~E~~~~  109 (404)
                      ||||+++|
T Consensus        90 LVmE~i~G   97 (297)
T PRK10593         90 LLLERLRG   97 (297)
T ss_pred             EEEeccCC
Confidence            99999986

>KOG2268|consensus

Probab=97.59  E-value=5.4e-05  Score=69.68  Aligned_cols=139  Identities=19%  Similarity=0.226  Sum_probs=95.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh---c---cChh--------------HHHHHHHHHHHHHhccCCC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---F---RNKT--------------DAQRTYREILFLKSFQRHP   83 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~---~~~~--------------~~~~~~~E~~~l~~l~~hp   83 (404)
                      -|.+.++||-|--+-||.+-+. .|.+.++|.=...   +   .+..              ......+|...|+.|..|-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3667889999999999999775 4666888842111   0   0001              1122357888898887543


Q ss_pred             C-cceEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434         84 N-IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus        84 n-Iv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                      . +++.++      ....++|||++.| .|..+..     ...+..+...+..-+.-|..+|+||+|..-=||+|.+++.
T Consensus       172 fpVPkpiD------~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  172 FPVPKPID------HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCccc------ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence            3 344443      3447999999987 4433321     1123445666777777889999999999999999999999


Q ss_pred             eEEeccccccccC
Q psy14434        162 IKIGDLGLARSLS  174 (404)
Q Consensus       162 vkl~Dfg~a~~~~  174 (404)
                      ++++||--+....
T Consensus       241 i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  241 IVVIDFPQMVSTS  253 (465)
T ss_pred             EEEeechHhhccC
Confidence            9999997665443

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.55  E-value=0.00063  Score=65.33  Aligned_cols=81  Identities=19%  Similarity=0.207  Sum_probs=56.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh----ccChhHHHHHHHHHHHHHhccCC-C-CcceEeeEEEeccC
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA----FRNKTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNN   97 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~~E~~~l~~l~~h-p-nIv~l~~~~~~~~~   97 (404)
                      .+. .+.||.|.-..||++.+..++..++||.-...    ....-...+...|...|+..... | .++++|.+    +.
T Consensus        31 ~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~  105 (409)
T PRK12396         31 GLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DS  105 (409)
T ss_pred             cce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----Cc
Confidence            344 67799999999999988544567899865321    12244567777788888876432 3 57778766    45


Q ss_pred             CeEEEEEeccCC
Q psy14434         98 KDLYVVFEYMEN  109 (404)
Q Consensus        98 ~~~~lv~E~~~~  109 (404)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            567899999863

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.00098  Score=62.78  Aligned_cols=141  Identities=14%  Similarity=0.109  Sum_probs=79.6

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEE----EeccCCe
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIY----KAVNNKD   99 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~----~~~~~~~   99 (404)
                      ...++.++.|....+|++.. .+| .+++|+.....    ....+..|..++..|..+- .+++++..-    .....+.
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            34466778888889999864 233 57888764321    1223445666776664221 244444321    0112456


Q ss_pred             EEEEEeccCCc-H-----H------HHHH---h--cCCCH-------HHHHH----------------HHHHHHHHHHHH
Q psy14434        100 LYVVFEYMEND-L-----N------KVIR---D--KILKD-------VHIRY----------------IMFQLCNGLSYI  139 (404)
Q Consensus       100 ~~lv~E~~~~~-L-----~------~~l~---~--~~l~~-------~~~~~----------------i~~qil~al~~L  139 (404)
                      .+++|+|++|. +     .      ..+.   .  ..++.       ...+.                ....+...+.++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999861 1     1      1111   0  01100       01000                011123345555


Q ss_pred             H-------hCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        140 H-------ACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       140 H-------~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      .       ..++||+|+.+.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3       2689999999999999998877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.35  E-value=0.0063  Score=57.55  Aligned_cols=31  Identities=26%  Similarity=0.239  Sum_probs=26.3

Q ss_pred             CCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .|+||+|+.|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4899999999999998665568999998753

>PLN02236 choline kinase

Probab=97.21  E-value=0.0039  Score=59.68  Aligned_cols=137  Identities=19%  Similarity=0.148  Sum_probs=80.2

Q ss_pred             EeeeecccCceeEEEEEEcC----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKN----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      -++.|..|-...+|++....    +++.|++|+.....   ...-...+|..+++.+..+.--+++++.+.   ++   .
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~---~g---~  110 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFP---NG---R  110 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEEC---Cc---e
Confidence            44566678889999986432    24678999875431   122223578888888865544566777653   22   5


Q ss_pred             EEeccCC-cHH-----------HH---HH---hcC-------CCHHHHHHHHHHH-----------------HHHHHHH-
Q psy14434        103 VFEYMEN-DLN-----------KV---IR---DKI-------LKDVHIRYIMFQL-----------------CNGLSYI-  139 (404)
Q Consensus       103 v~E~~~~-~L~-----------~~---l~---~~~-------l~~~~~~~i~~qi-----------------l~al~~L-  139 (404)
                      |.+|++| ++.           .+   +.   ...       .....+..++.++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7888875 321           11   11   101       1122333333221                 1111122 


Q ss_pred             ---H----hCCCccCCCCCCcEEEcc-CCceEEeccccccc
Q psy14434        140 ---H----ACKVMHRDLKPSNILIDK-SCSIKIGDLGLARS  172 (404)
Q Consensus       140 ---H----~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~  172 (404)
                         .    ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               1    235899999999999986 46899999988753

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.20  E-value=0.0068  Score=58.70  Aligned_cols=77  Identities=19%  Similarity=0.284  Sum_probs=52.2

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-----ChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEeccCCe
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-----NKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKD   99 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~~~~~~   99 (404)
                      ..+.||.|....||++.+.  +..++||.-.....     ..-...+...|...|+.+...  ..+++++.+..    ..
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TM  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CC
Confidence            4678999999999999873  44588997642211     112455666777777766422  47888887733    44


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                      .+++||++++
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            6889999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.11  E-value=0.0051  Score=58.53  Aligned_cols=136  Identities=15%  Similarity=0.178  Sum_probs=77.1

Q ss_pred             eeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      ++.|..|-...+|++.....   +..|++|+.....   .......+|..+++.+..+.--+++++++.   ++   +|.
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~---~G---~i~   89 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG---NG---MIQ   89 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC---Cc---Eee
Confidence            45566688889999865432   2378899874321   122233478888888864433456666642   22   478


Q ss_pred             eccCC-cHH--------------HHHH---hcCC-------CHHHHHHHHHHH----------------------HHHHH
Q psy14434        105 EYMEN-DLN--------------KVIR---DKIL-------KDVHIRYIMFQL----------------------CNGLS  137 (404)
Q Consensus       105 E~~~~-~L~--------------~~l~---~~~l-------~~~~~~~i~~qi----------------------l~al~  137 (404)
                      +|+.| .+.              ..++   ...+       ....+..++.++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            88875 221              1111   1111       122233332222                      11122


Q ss_pred             HHH----hCC----CccCCCCCCcEEEcc-CCceEEeccccccc
Q psy14434        138 YIH----ACK----VMHRDLKPSNILIDK-SCSIKIGDLGLARS  172 (404)
Q Consensus       138 ~LH----~~~----i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~  172 (404)
                      .+.    ..+    ++|.|+.|.|||+++ ++.++++||..|..
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            221    122    799999999999975 57899999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.0082  Score=56.26  Aligned_cols=147  Identities=15%  Similarity=0.130  Sum_probs=85.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEEeccCCeEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~~~~~~~~~l  102 (404)
                      ...+++.+..|-...+|...+.  ++.+++. ...............+|..+++.+..- --+...++++....-+..|.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            4556666655555566666554  7778888 332233345566667888888888531 12333344433211246799


Q ss_pred             EEeccCC-c------------------HHHHHHh-------c-C-------CCHHHHHHHHHH--------------HHH
Q psy14434        103 VFEYMEN-D------------------LNKVIRD-------K-I-------LKDVHIRYIMFQ--------------LCN  134 (404)
Q Consensus       103 v~E~~~~-~------------------L~~~l~~-------~-~-------l~~~~~~~i~~q--------------il~  134 (404)
                      ||+|+.| .                  |.+.+..       + .       ....++..+..+              +..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            9999987 1                  1111110       0 0       011112222222              223


Q ss_pred             HHHHHHhC--------CCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434        135 GLSYIHAC--------KVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       135 al~~LH~~--------~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ...+|+.+        .++|+|+.+.||+|+.++.+=|.||+++...
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            34555532        4899999999999999988999999999754

>KOG2270|consensus

Probab=96.90  E-value=0.0074  Score=56.93  Aligned_cols=139  Identities=22%  Similarity=0.275  Sum_probs=92.4

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhc----------------------cChhHHHH--HHHHHHHHHhccCCC
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----------------------RNKTDAQR--TYREILFLKSFQRHP   83 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~--~~~E~~~l~~l~~hp   83 (404)
                      -..|..|--+-||.|.. .+|..+|||++.-..                      .+.....+  ...|++-|+++. ..
T Consensus       149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~a  226 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NA  226 (520)
T ss_pred             ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hc
Confidence            34466677778999865 456669999764210                      11222222  236777777775 33


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEccCC
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSNILIDKSC  160 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~~~--L~~~l~~~~l~~~~~~~i~~qil~al~~L-H~~~i~HrDlkp~NIll~~~~  160 (404)
                      .|+----+.-    ....|||++++.+  -.-.++.-.++...+..+-.|++.-+.-| |..+++|.||.-=|+|+ -+|
T Consensus       227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG  301 (520)
T KOG2270|consen  227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG  301 (520)
T ss_pred             CCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence            4322221111    1248999999853  22344555688888888888888888877 67899999999999998 456


Q ss_pred             ceEEecccccccc
Q psy14434        161 SIKIGDLGLARSL  173 (404)
Q Consensus       161 ~vkl~Dfg~a~~~  173 (404)
                      .+.|+|.+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999999887654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.013  Score=54.21  Aligned_cols=30  Identities=33%  Similarity=0.498  Sum_probs=25.4

Q ss_pred             CCccCCCCCCcEEEccCCc-eEEeccccccc
Q psy14434        143 KVMHRDLKPSNILIDKSCS-IKIGDLGLARS  172 (404)
Q Consensus       143 ~i~HrDlkp~NIll~~~~~-vkl~Dfg~a~~  172 (404)
                      .++|+|+.|.|||++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.78  E-value=0.0072  Score=56.98  Aligned_cols=30  Identities=20%  Similarity=0.145  Sum_probs=27.6

Q ss_pred             CCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        143 KVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       143 ~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ++||+|+.++|||+++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.65  E-value=0.011  Score=57.29  Aligned_cols=75  Identities=17%  Similarity=0.165  Sum_probs=46.9

Q ss_pred             EEeeeecccCceeEEEEEEcCC-CeE-----EEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNN-KQY-----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++.|..|-...+|++..... +..     |.++...   ......-...+|+.+++.+..+.--.++++.|.   +  
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---~--  124 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---D--  124 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC---C--
Confidence            3455676788999999965433 222     3333321   111222233578889999876666678887764   2  


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                       ++|.||++|
T Consensus       125 -g~l~efIeG  133 (383)
T PTZ00384        125 -FTIQEWVEG  133 (383)
T ss_pred             -EEEEEEecc
Confidence             699999986

>KOG1236|consensus

Probab=95.69  E-value=0.044  Score=52.58  Aligned_cols=59  Identities=22%  Similarity=0.273  Sum_probs=43.1

Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEcc
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYI-HACKVMHRDLKPSNILIDK  158 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~L-H~~~i~HrDlkp~NIll~~  158 (404)
                      ..++-+|..| ++..++.....++.-.+.++.-...|+.-+ ---+++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            3566677777 788888877677766666666666665443 3568999999999999943

>PTZ00296 choline kinase; Provisional

Probab=95.67  E-value=0.096  Score=51.80  Aligned_cols=74  Identities=11%  Similarity=0.113  Sum_probs=45.4

Q ss_pred             EeeeecccCceeEEEEEEcCC--------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNN--------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      -++.|..|-.-.+|++.....        ++.|.+++.....   ...-....|..+++.+..+---.++++.+.   + 
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---g-  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIAPQLLNTFS---G-  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCCCceEEEeC---C-
Confidence            567788888889999875422        4678888874321   122233457777776653333345666653   2 


Q ss_pred             eEEEEEeccCC
Q psy14434         99 DLYVVFEYMEN  109 (404)
Q Consensus        99 ~~~lv~E~~~~  109 (404)
                        +.|.||++|
T Consensus       182 --g~I~efi~g  190 (442)
T PTZ00296        182 --GRIEEWLYG  190 (442)
T ss_pred             --CEEEEeeCC
Confidence              557888875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.65  E-value=0.064  Score=47.24  Aligned_cols=84  Identities=20%  Similarity=0.208  Sum_probs=57.8

Q ss_pred             HHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh--CCCcc
Q psy14434         69 TYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--CKVMH  146 (404)
Q Consensus        69 ~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~--~~i~H  146 (404)
                      ...+..++.++.   .|+++..   + ++..+.++.|+|..-          .... ..++.-=+.+|.-.|+  .+.+|
T Consensus       105 y~nky~v~Armh---GilrL~N---D-n~~~yGvIlE~Cy~~----------~i~~-~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  105 YFNKYRVFARMH---GILRLKN---D-NNYKYGVILERCYKI----------KINF-SNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhHHHHhh---heeEeec---C-CCceeEEEEeeccCc----------ccch-hHHHHHhHHHHHHhhccCCCeec
Confidence            356777777663   5677762   2 566778999999731          0000 1111112466777884  46999


Q ss_pred             CCCCCCcEEEccCCceEEeccccc
Q psy14434        147 RDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus       147 rDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      +|..|+||+-++.|-+||.|-+..
T Consensus       167 GD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  167 GDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             CCCChhheeecCCCCEEecChhhh
Confidence            999999999999999999997754

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.50  E-value=0.051  Score=51.40  Aligned_cols=73  Identities=22%  Similarity=0.286  Sum_probs=57.7

Q ss_pred             cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      +..+.|++|++-++.+.-.   +.....++..|+++.+..++-+.. -..-||++...||||+ +|.|-|+||-+++.
T Consensus       297 e~~y~yl~~kdhgt~is~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHGTPISII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCCceeeee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            4567789999988765322   224567788888888887777764 4689999999999999 99999999999984

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.44  E-value=0.3  Score=45.37  Aligned_cols=75  Identities=13%  Similarity=0.144  Sum_probs=43.7

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEeccCCeEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      -+-.+.+|.|....+|+..  .+++.+.+|+-.     ......+..|..-|+.|.  .--.+++.+.+...  ...-||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fL   89 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFL   89 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceE
Confidence            3446779999999999985  677889999864     222234456666666662  23457788887653  334599


Q ss_pred             EEeccC
Q psy14434        103 VFEYME  108 (404)
Q Consensus       103 v~E~~~  108 (404)
                      ||||++
T Consensus        90 lle~l~   95 (288)
T PF03881_consen   90 LLEFLE   95 (288)
T ss_dssp             EEE---
T ss_pred             EEEeec
Confidence            999987

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.26  E-value=0.26  Score=54.09  Aligned_cols=31  Identities=35%  Similarity=0.475  Sum_probs=26.7

Q ss_pred             CCCccCCCCCCcEEEccCC--ceE-Eeccccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSC--SIK-IGDLGLARS  172 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~--~vk-l~Dfg~a~~  172 (404)
                      .++||+|+.+.|||++.++  ++. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  565 999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.01  E-value=0.042  Score=51.66  Aligned_cols=29  Identities=21%  Similarity=0.290  Sum_probs=25.6

Q ss_pred             CCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.99  E-value=0.062  Score=50.11  Aligned_cols=74  Identities=22%  Similarity=0.243  Sum_probs=47.5

Q ss_pred             EEEEEeccCCc-----HHHHHHhcCCC-HHHHHHHHHHHHHHHHHHH----hCCCccCCCCCCcEEEccCC---------
Q psy14434        100 LYVVFEYMEND-----LNKVIRDKILK-DVHIRYIMFQLCNGLSYIH----ACKVMHRDLKPSNILIDKSC---------  160 (404)
Q Consensus       100 ~~lv~E~~~~~-----L~~~l~~~~l~-~~~~~~i~~qil~al~~LH----~~~i~HrDlkp~NIll~~~~---------  160 (404)
                      -.||++++.++     +....+.|..+ .+-++.++.||+.-.-.+-    ..+.+|-||||+||||-...         
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  329 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD  329 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence            35888887753     33344444444 3346778889876553332    35699999999999983322         


Q ss_pred             ---------ceEEecccccccc
Q psy14434        161 ---------SIKIGDLGLARSL  173 (404)
Q Consensus       161 ---------~vkl~Dfg~a~~~  173 (404)
                               +.+|.||.+++..
T Consensus       330 ~~~vF~Epi~~~LnDFDfSqv~  351 (444)
T PHA03111        330 ATYVFNEPIKACLNDFDFSQVA  351 (444)
T ss_pred             eEEEeccchhhhhcccCHHHHc
Confidence                     3566777777643

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.60  E-value=0.057  Score=50.58  Aligned_cols=74  Identities=20%  Similarity=0.280  Sum_probs=46.4

Q ss_pred             EEEEeccCCc-----HHHHHHhcCCC-HHHHHHHHHHHHHHHHHH---H-hCCCccCCCCCCcEEEccC-----------
Q psy14434        101 YVVFEYMEND-----LNKVIRDKILK-DVHIRYIMFQLCNGLSYI---H-ACKVMHRDLKPSNILIDKS-----------  159 (404)
Q Consensus       101 ~lv~E~~~~~-----L~~~l~~~~l~-~~~~~~i~~qil~al~~L---H-~~~i~HrDlkp~NIll~~~-----------  159 (404)
                      .||++++.++     +....+-|..+ .+-++.++.||+.-.--+   - ..+.+|-||||+||||-..           
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            5899988753     23333333322 334677788876543112   1 3569999999999998322           


Q ss_pred             -------CceEEeccccccccC
Q psy14434        160 -------CSIKIGDLGLARSLS  174 (404)
Q Consensus       160 -------~~vkl~Dfg~a~~~~  174 (404)
                             -+.+|.||.+|+..+
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             EEEecccceeeecccCHHHhcc
Confidence                   246788888886543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG2269|consensus

Probab=94.47  E-value=0.075  Score=49.49  Aligned_cols=136  Identities=20%  Similarity=0.320  Sum_probs=89.7

Q ss_pred             EeeeecccCceeEEEEEE-------cC---CCeEEEEEEcchhc----------------------cChhHHHHHH--HH
Q psy14434         27 IHKRIGKGAYGIVYKAYD-------KN---NKQYVAIKKIFEAF----------------------RNKTDAQRTY--RE   72 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~-------~~---~~~~vaiK~~~~~~----------------------~~~~~~~~~~--~E   72 (404)
                      |...|..|--++|+-|+-       ..   .-..+|||+++-..                      .+......++  +|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            345677788888887743       11   12357898764211                      1222333333  45


Q ss_pred             HHHHHhccCC----CCcceEeeEEEeccCCeEEEEEeccCC--cHHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HhCCCc
Q psy14434         73 ILFLKSFQRH----PNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYI-HACKVM  145 (404)
Q Consensus        73 ~~~l~~l~~h----pnIv~l~~~~~~~~~~~~~lv~E~~~~--~L~~~l~~~~l~~~~~~~i~~qil~al~~L-H~~~i~  145 (404)
                      ..-|.+++.|    |-+|.+-         ...|||-+++.  .-.--++...|+..+.+..-.|++.++.-| |..-++
T Consensus       336 mhNL~RMq~~GlpcP~vV~lk---------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LV  406 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLK---------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLV  406 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeee---------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhhee
Confidence            5555555433    3444333         24789999983  222233445599999999999999999888 678899


Q ss_pred             cCCCCCCcEEEccCCceEEeccccccc
Q psy14434        146 HRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       146 HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      |.|+.--|+|...+ .+.++|..-+..
T Consensus       407 HADlSEyN~Lw~~g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  407 HADLSEYNLLWTPG-KVWVIDVSQSVE  432 (531)
T ss_pred             ecchhhhhheecCC-ceEEEechhccC
Confidence            99999999999776 899999876643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	404
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-73
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-62
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-61
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-61
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-61
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-61
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-61
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-61
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-61
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-61
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-61
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-61
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-61
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-61
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-61
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-60
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-60
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-60
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-60
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-60
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-59
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-59
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-59
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-59
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-59
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-58
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-58
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-57
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-56
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-55
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-55
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-54
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-54
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-53
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-53
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-53
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-53
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-53
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-53
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-53
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-53
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-53
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-53
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-53
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-53
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-53
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-53
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-53
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-53
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-53
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-53
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-53
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-53
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-53
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-53
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-53
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-53
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-53
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-53
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-53
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-53
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-53
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-53
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-53
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-53
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-53
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-53
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-53
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-53
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-53
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-53
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-53
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-53
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-53
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-53
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-53
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-52
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-52
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-52
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-52
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-52
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-52
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-52
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-52
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-52
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-52
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-52
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-52
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-52
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-52
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-52
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-52
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-50
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-49
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-49
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-49
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-49
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-48
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-48
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-48
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-48
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-48
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-48
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-48
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-48
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-48
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-48
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-48
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-48
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-47
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-47
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-47
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-47
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-47
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-47
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-47
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-47
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-47
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-47
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-47
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-47
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-47
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-47
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-46
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-46
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-46
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-46
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-46
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-46
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-46
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-45
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-44
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-44
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-44
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-44
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-44
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-44
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-44
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-44
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-44
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-43
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-43
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-43
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-43
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-43
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-43
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-43
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-43
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-43
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-43
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-43
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-43
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-43
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-42
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-42
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-41
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-41
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-40
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-40
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-39
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-39
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-39
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-39
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-38
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-38
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-38
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-38
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-38
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-38
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-37
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-37
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-37
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-34
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-33
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-32
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-32
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-32
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-32
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-32
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-32
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-32
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-32
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-32
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-32
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-32
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-31
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-31
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-31
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-31
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-31
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-31
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-31
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-31
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-31
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-30
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-29
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-29
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-29
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-29
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-28
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-28
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-28
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-28
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-28
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-28
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-27
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-27
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-27
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-27
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-27
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-27
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-27
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-27
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-27
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-26
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-26
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-26
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-26
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-26
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-26
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-26
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-26
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-26
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-26
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-26
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-25
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-25
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-25
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-25
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-25
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-25
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-25
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-25
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-25
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-25
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-25
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-25
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-24
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-24
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-24
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-24
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-24
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-24
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-24
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-24
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-24
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-24
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-24
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-24
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-24
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-24
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-24
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-24
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-24
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-24
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-24
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-24
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-24
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-24
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-24
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-24
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-24
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-24
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-24
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-23
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-23
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-23
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-23
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-23
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-23
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-23
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-23
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-23
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-22
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-22
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-22
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-22
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-22
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-22
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-22
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-21
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-21
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-21
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-21
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-21
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-20
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-20
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-19
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-19
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-19
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-18
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-18
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-18
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-18
3soa_A	444	Full-Length Human Camkii Length = 444		5e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-18
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-17
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-17
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-17
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-17
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-17
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-17
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-17
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-17
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-17
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-17
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-16
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-16
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-15
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-15
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-15
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-15
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-15
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-15
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-15
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-15
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-15
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-15
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-15
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-15
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-15
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-15
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-14
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-14
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-14
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-12
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		9e-12
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		5e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  271 bits (694), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 142/372 (38%), Positives = 218/372 (58%), Gaps = 67/372 (18%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           VD ++L +Y + K++GKGAYGIV+K+ D+   + VA+KKIF+AF+N TDAQRT+REI+ L
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
                H NI+ +L++ +A N++D+Y+VF+YME DL+ VIR  IL+ VH +Y+++QL   +
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS---------------------LSD 175
            Y+H+  ++HRD+KPSNIL++  C +K+ D GL+RS                       D
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
            +  LT+Y+ATRWYRAPEIL+ + +YT  +D+WSLGCIL E+L  KP+FPG+ST +QL+ 
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 236 IVNLV---------RPNPPHADKFYAGFKNKP---------------------------- 258
           I+ ++             P A       K K                             
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP---HTVVLDIDDNN 315
           EEA+DLL+++L  NP++R   +  L+H +VS +        P   P   H + + I+DN 
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN------PNEEPNCDHIITIPINDNV 356
Query: 316 QLEINDYQDKLY 327
           +  I+DY++ +Y
Sbjct: 357 KHSIDDYRNLVY 368

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  234 bits (596), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 193/316 (61%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L +F RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLAF-RHEN 84
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 264
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+++Y+  +  
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDE 324
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 325 PIAE-APFKFDMELDD 339

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 90
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 270
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 271 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 330
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 331 PIAE-APFKFDMELDD 345

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 84
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 264
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 324
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 325 PIAE-APFKFDMELDD 339

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 87
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 267
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 327
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 328 PIAE-APFKFDMELDD 342

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 88
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 268
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 269 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 328
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 329 PIAE-APFKFDMELDD 343

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 79
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 259
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 260 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 319
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 320 PIAE-APFKFDMELDD 334

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/321 (42%), Positives = 193/321 (60%), Gaps = 30/321 (9%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++   YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF 98
Query: 80  QRHPNIITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            RH NII + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL
Sbjct: 99  -RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPE 193
            YIH+  V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPE
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVN 238
           I+++++ YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+N
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 239 LVRPN----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
           L   N     PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+
Sbjct: 278 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 293 PSATHVIPQVTPHTVVLDIDD 313
             +   I +  P    +++DD
Sbjct: 338 DPSDEPIAE-APFKFDMELDD 357

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 80
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 260
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 261 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 320
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 321 PIAE-APFKFDMELDD 335

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  231 bits (589), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAI+KI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  231 bits (588), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 80
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+     L  I+NL   N
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARN 260
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 261 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 320
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 321 PIAE-APFKFDMELDD 335

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  231 bits (588), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 136/316 (43%), Positives = 191/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 134/316 (42%), Positives = 192/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L +F RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLAF-RHEN 84
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP------------- 244
           + YT  +DIWS+GCILAEML ++P+FPG     QL  I+ ++  P+              
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARN 264
Query: 245 -----PHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+++Y+  +  
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDE 324
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 325 PIAE-APFKFDMELDD 339

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  228 bits (580), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 82
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 262
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 323 PIAE-APFKFDMELDD 337

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  227 bits (578), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 135/316 (42%), Positives = 190/316 (60%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYXQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 134/316 (42%), Positives = 189/316 (59%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 86
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    L E +ATRWYRAPEI++++
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 327 PIAE-APFKFDMELDD 341

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 134/316 (42%), Positives = 189/316 (59%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 87
Query: 85  IITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V + ME DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +C +KI D GLAR      D    L E +ATRWYRAPEI++++
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 267
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 327
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 328 PIAE-APFKFDMELDD 342

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  224 bits (572), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 128/321 (39%), Positives = 189/321 (58%), Gaps = 30/321 (9%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++   YT  + IG+GAYG+V  AYD   K  VAIKKI   F ++T  QRT REI  L  F
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLREIQILLRF 98
Query: 80  QRHPNIITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            RH N+I + DI +A      +D+Y+V + ME DL K+++ + L + HI Y ++Q+  GL
Sbjct: 99  -RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGL 157
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPE 193
            YIH+  V+HRDLKPSN+LI+ +C +KI D GLAR      D    LTE +ATRWYRAPE
Sbjct: 158 KYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVN 238
           I+++++ YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+N
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 239 LVRPN-----PPHADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
           +   N     P      +A  F     +A+DLL+++L  NP++R   ++ L H Y+ +Y+
Sbjct: 278 MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYY 337
Query: 293 PSATHVIPQVTPHTVVLDIDD 313
                 + +  P T  +++DD
Sbjct: 338 DPTDEPVAE-EPFTFAMELDD 357

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  224 bits (570), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 125/306 (40%), Positives = 183/306 (59%), Gaps = 31/306 (10%)
Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           +V  ++  EY I + IG GAYG+V  A  +   Q VAIKKI  AF   T+A+RT RE+  
Sbjct: 47  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 76  LKSFQRHPNIITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMF 130
           LK F +H NII + DI +        K +YVV + ME+DL+++I   + L   H+RY ++
Sbjct: 107 LKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 165
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIAT 186
           QL  GL Y+H+ +V+HRDLKPSN+L++++C +KIGD G+AR L  S       +TEY+AT
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPP 245
           RWYRAPE+++S   YT  +D+WS+GCI  EML  + LFPG +  HQLQLI+ ++  P+P 
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 246 -----HADKFYAGFKNKP---------------EEAVDLLNQILVLNPSERPETDQILEH 285
                 A++  A  ++ P                +A+ LL ++L   PS R      L H
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345
Query: 286 NYVSKY 291
            +++KY
Sbjct: 346 PFLAKY 351

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 134/316 (42%), Positives = 188/316 (59%), Gaps = 30/316 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F RH N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF-RHEN 102
Query: 85  IITMLDIYKAVN---NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           II + DI +A      KD+Y+V   M  DL K+++ + L + HI Y ++Q+  GL YIH+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS---DSKECLTEYIATRWYRAPEILISN 198
             V+HRDLKPSN+L++ +  +KI D GLAR      D    LTEY+ATRWYRAPEI++++
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFP---------------GASTSHQLQLIVNLVRPN 243
           + YT  +DIWS+GCILAEML ++P+FP               G+ +   L  I+NL   N
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 282
Query: 244 ----PPHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
                PH +K  +   F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+  +  
Sbjct: 283 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 342
Query: 298 VIPQVTPHTVVLDIDD 313
            I +  P    +++DD
Sbjct: 343 PIAE-APFKFDMELDD 357

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  223 bits (568), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 125/306 (40%), Positives = 183/306 (59%), Gaps = 31/306 (10%)
Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           +V  ++  EY I + IG GAYG+V  A  +   Q VAIKKI  AF   T+A+RT RE+  
Sbjct: 48  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 76  LKSFQRHPNIITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMF 130
           LK F +H NII + DI +        K +YVV + ME+DL+++I   + L   H+RY ++
Sbjct: 108 LKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 166
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIAT 186
           QL  GL Y+H+ +V+HRDLKPSN+L++++C +KIGD G+AR L  S       +TEY+AT
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNPP 245
           RWYRAPE+++S   YT  +D+WS+GCI  EML  + LFPG +  HQLQLI+ ++  P+P 
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 246 -----HADKFYAGFKNKP---------------EEAVDLLNQILVLNPSERPETDQILEH 285
                 A++  A  ++ P                +A+ LL ++L   PS R      L H
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 346
Query: 286 NYVSKY 291
            +++KY
Sbjct: 347 PFLAKY 352

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  218 bits (554), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 172/286 (60%), Gaps = 29/286 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  AYD   +Q VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL-KHENVIGLLD 86
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     ++Y+V   M  DLN +++ + L D H++++++QL  GL YIH+  ++H
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIH 146
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C ++I D GLAR    + E +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 147 RDLKPSNVAVNEDCELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNWMHYNQTVD 203
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP--------PHADKFYAGFKNK 257
           IWS+GCI+AE+LQ K LFPG+    QL+ I+ +V  P+P         HA  +       
Sbjct: 204 IWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM 263
Query: 258 PEE------------AVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           P++            A+DLL ++LVL+  +R    + L H Y S+Y
Sbjct: 264 PQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 309

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 171/286 (59%), Gaps = 29/286 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  AYD   +Q VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     ++Y+V   M  DLN +++ + L D H++++++QL  GL YIH+  ++H
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   ++I D GLAR    + E +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP--------PHADKFYAGFKNK 257
           IWS+GCI+AE+LQ K LFPG+    QL+ I+ +V  P+P         HA  +       
Sbjct: 212 IWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM 271
Query: 258 PEE------------AVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           P++            A+DLL ++LVL+  +R    + L H Y S+Y
Sbjct: 272 PQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  214 bits (544), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 171/286 (59%), Gaps = 29/286 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  AYD   +Q VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     ++Y+V   M  DLN +++ + L D H++++++QL  GL YIH+  ++H
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   ++I D GLAR    + E +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLARQ---ADEEMTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP--------PHADKFYAGFKNK 257
           IWS+GCI+AE+LQ K LFPG+    QL+ I+ +V  P+P         HA  +       
Sbjct: 212 IWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM 271
Query: 258 PEE------------AVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           P++            A+DLL ++LVL+  +R    + L H Y S+Y
Sbjct: 272 PQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  211 bits (536), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 116/309 (37%), Positives = 177/309 (57%), Gaps = 41/309 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           NI +++ +   +G+GAYG+V  A  K   + VAIKKI E F     A RT REI  LK F
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHF 66
Query: 80  QRHPNIITMLDIYKA---VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            +H NIIT+ +I +     N  ++Y++ E M+ DL++VI  ++L D HI+Y ++Q    +
Sbjct: 67  -KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS----------KECLTEYIAT 186
             +H   V+HRDLKPSN+LI+ +C +K+ D GLAR + +S          +  +TEY+AT
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           RWYRAPE+++++ +Y+  +D+WS GCILAE+   +P+FPG    HQL LI  ++    PH
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII--GTPH 243
Query: 247 AD---------------KFYAGFKNKPEE---------AVDLLNQILVLNPSERPETDQI 282
           +D               K    +   P E          +DLL ++LV +P++R    + 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 283 LEHNYVSKY 291
           LEH Y+  Y
Sbjct: 304 LEHPYLQTY 312

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 115/309 (37%), Positives = 176/309 (56%), Gaps = 41/309 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           NI +++ +   +G+GAYG+V  A  K   + VAIKKI E F     A RT REI  LK F
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHF 66
Query: 80  QRHPNIITMLDIYKA---VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            +H NIIT+ +I +     N  ++Y++ E M+ DL++VI  ++L D HI+Y ++Q    +
Sbjct: 67  -KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS----------KECLTEYIAT 186
             +H   V+HRDLKPSN+LI+ +C +K+ D GLAR + +S          +  +TE +AT
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           RWYRAPE+++++ +Y+  +D+WS GCILAE+   +P+FPG    HQL LI  ++    PH
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII--GTPH 243
Query: 247 AD---------------KFYAGFKNKPEE---------AVDLLNQILVLNPSERPETDQI 282
           +D               K    +   P E          +DLL ++LV +P++R    + 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 283 LEHNYVSKY 291
           LEH Y+  Y
Sbjct: 304 LEHPYLQTY 312

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 114/309 (36%), Positives = 176/309 (56%), Gaps = 41/309 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           NI +++ +   +G+GAYG+V  A  K   + VAIKKI E F     A RT REI  LK F
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHF 66
Query: 80  QRHPNIITMLDIYKA---VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            +H NIIT+ +I +     N  ++Y++ E M+ DL++VI  ++L D HI+Y ++Q    +
Sbjct: 67  -KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS----------KECLTEYIAT 186
             +H   V+HRDLKPSN+LI+ +C +K+ D GLAR + +S          +  + E++AT
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           RWYRAPE+++++ +Y+  +D+WS GCILAE+   +P+FPG    HQL LI  ++    PH
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII--GTPH 243
Query: 247 AD---------------KFYAGFKNKPEE---------AVDLLNQILVLNPSERPETDQI 282
           +D               K    +   P E          +DLL ++LV +P++R    + 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 283 LEHNYVSKY 291
           LEH Y+  Y
Sbjct: 304 LEHPYLQTY 312

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 165/288 (57%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 95
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR  +D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 270
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 165/288 (57%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 95
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR  +D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 270
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 108
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 283
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 107
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 282
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 165/288 (57%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 95
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR  +D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 270
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 98
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 158
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 159 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 215
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 216 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 273
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 274 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNAMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 212 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 269
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/325 (36%), Positives = 180/325 (55%), Gaps = 34/325 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  +YD  +   +A+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 117
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 177
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 178 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNMTVD 234
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP-------------------PHA 247
           IWS+GCI+AE+L  + LFPG    +QLQ I+ L    P                   P  
Sbjct: 235 IWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQM 294
Query: 248 DK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
            K  F   F      AVDLL ++LVL+  +R    + L H Y S+Y        P+  P+
Sbjct: 295 PKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE--PESEPY 352
Query: 306 TVVLDIDDNNQLEINDYQDKLYDIV 330
                  ++ QLEI +++   Y+ V
Sbjct: 353 DQSF---ESRQLEIEEWKRLTYEEV 374

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 165/288 (57%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+ + F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 100
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 217
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 218 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 275
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 84
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 201
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 259
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 212 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 269
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 107
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 282
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 100
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 217
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 218 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 275
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 100
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 217
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 218 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 275
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 99
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 160 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 216
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 217 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 274
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 95
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 270
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 108
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 283
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 111
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 228
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 229 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 286
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 90
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 207
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 208 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 265
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 90
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 207
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 208 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 265
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 93
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 210
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 211 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 268
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 90
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 207
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 208 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 265
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 87
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 147
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 148 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 204
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 205 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 262
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 263 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 212 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 269
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 93
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 210
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 211 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 268
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 86
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 147 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 203
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 204 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 261
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 262 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 84
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++   L D H++++++Q+  GL YIH+  ++H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 201
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 259
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 85
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 202
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 203 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 260
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 85
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 202
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 203 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 260
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  205 bits (521), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 84
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 201
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 259
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  204 bits (520), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDAGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDYGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDRGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  204 bits (518), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 164/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDGGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 111
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +  Y+ATRWYRAPEI+++   Y   VD
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGYVATRWYRAPEIMLNWMHYNQTVD 228
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 229 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 286
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +  ++ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +  ++ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI   GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILGFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 84
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +  ++ATRWYRAPEI+++   Y   VD
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRAPEIMLNWMHYNQTVD 201
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 259
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +T  +ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGXVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  202 bits (513), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  202 bits (513), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D  LAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDCELKILDFYLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 94
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 155 RDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 212 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 269
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 90
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 151 RDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 207
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 208 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 265
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  201 bits (511), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 93
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 210
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 211 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 268
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  201 bits (511), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 162/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 108
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++ C +KI D GLAR   D    +   +ATRWYRAPEI+++   Y   VD
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGXVATRWYRAPEIMLNWMHYNQTVD 225
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLA 283
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  201 bits (510), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 99
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 160 RDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 216
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 217 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 274
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  201 bits (510), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 162/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 88
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GL R   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCRHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 205
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 206 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 263
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  201 bits (510), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 163/288 (56%), Gaps = 33/288 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK   +H N+I +LD
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLD 93
Query: 91  IYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++    +     D+Y+V   M  DLN +++ + L D H++++++Q+  GL YIH+  ++H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKPSN+ +++   +KI D GLAR   D    +T Y+ATRWYRAPEI+++   Y   VD
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVD 210
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------------------ 248
           IWS+GCI+AE+L  + LFPG     QL+LI+ LV    P A+                  
Sbjct: 211 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLKKISSESARNYIQSLT 268
Query: 249 -----KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                 F   F      AVDLL ++LVL+  +R    Q L H Y ++Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 112/314 (35%), Positives = 172/314 (54%), Gaps = 31/314 (9%)
Query: 1   MTSNTTSKSGDKVQH--NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE 58
           M+S   ++SG   Q        + A Y   + +G GAYG V  A D      VAIKK++ 
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 59  AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKV 114
            F+++  A+R YRE+  LK   RH N+I +LD++          D Y+V  +M  DL K+
Sbjct: 61  PFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL 119
Query: 115 IRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 174
           ++ + L +  I+++++Q+  GL YIHA  ++HRDLKP N+ +++ C +KI D GLAR  +
Sbjct: 120 MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-A 178
Query: 175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
           DS+  +   + TRWYRAPE++++  RYT  VDIWS+GCI+AEM+  K LF G+    QL+
Sbjct: 179 DSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 235 LIVNLVRPNP-------------------PHADK--FYAGFKNKPEEAVDLLNQILVLNP 273
            I+ +    P                   P  +K  F +   N    AV+LL ++LVL+ 
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296
Query: 274 SERPETDQILEHNY 287
            +R    + L H Y
Sbjct: 297 EQRVTAGEALAHPY 310

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 109/287 (37%), Positives = 160/287 (55%), Gaps = 32/287 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G GAYG V  A DK + + VAIKK+   F+++  A+R YRE+L LK  Q H N+I +LD
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLD 90
Query: 91  IYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           ++       N  D Y+V  +M+ DL K++  K  ++  I+Y+++Q+  GL YIH+  V+H
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-KIQYLVYQMLKGLKYIHSAGVVH 149
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+ +++ C +KI D GLAR  +D++  +T Y+ TRWYRAPE+++S   Y   VD
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARH-ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR----------------------PNP 244
           IWS+GCI+AEML  K LF G     QL  I+ +                        P  
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           P  D F   F     +A DLL ++L L+  +R    Q L H +   +
Sbjct: 267 PRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 109/293 (37%), Positives = 161/293 (54%), Gaps = 32/293 (10%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y     +G GAYG V  A DK + + VAIKK+   F+++  A+R YRE+L LK  Q H N
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HEN 102
Query: 85  IITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I +LD++       N  D Y+V  +M+ DL K++  +  ++  I+Y+++Q+  GL YIH
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEE-KIQYLVYQMLKGLKYIH 161
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  V+HRDLKP N+ +++ C +KI D GLAR  +D++  +T Y+ TRWYRAPE+++S   
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAE--MTGYVVTRWYRAPEVILSWMH 218
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR------------------- 241
           Y   VDIWS+GCI+AEML  K LF G     QL  I+ +                     
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 242 ---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              P  P  D F   F     +A DLL ++L L+  +R    Q L H +   +
Sbjct: 279 QSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  192 bits (487), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 192/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  191 bits (484), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 191/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 82  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 139
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 198
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P P    K     
Sbjct: 199 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 318 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 358

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 116/345 (33%), Positives = 191/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 116/345 (33%), Positives = 191/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 116/345 (33%), Positives = 191/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 119 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 176
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 235
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 236 L-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 355 QHPYINVWYDPA 366

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 82  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 139
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 198
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 199 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 318 QHPYINVWYDPA 329

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 85
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 86  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 143
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 202
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VD+WS+GCI+ EM+  K LFPG     Q  ++I  L  P P    K     
Sbjct: 203 L-GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 262 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 321
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 322 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 362

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 167/296 (56%), Gaps = 26/296 (8%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            ++ +Y   +++G+G YG+VYKA D   +  VA+K+I     ++       REI  LK  
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLS 137
             HPNI++++D+  +   + L +VFE+ME DL KV+ +    L+D  I+  ++QL  G++
Sbjct: 77  H-HPNIVSLIDVIHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           + H  +++HRDLKP N+LI+   ++K+ D GLAR+        T  + T WYRAP++L+ 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP---PHADKF--- 250
           +++Y+  VDIWS+GCI AEM+  KPLFPG +   QL  I +++  PNP   P   +    
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 251 ----YAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
               +  F+ KP         +E +DLL+ +L  +P++R      + H Y     P
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 317 QHPYINVWYDPA 328

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 82  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 139
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 198
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 199 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 318 QHPYINVWYDPA 329

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 317 QHPYINVWYDPA 328

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 75  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 132
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 191
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VD+WS+GCI+ EM+  K LFPG     Q  ++I  L  P P    K     
Sbjct: 192 LG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 251 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 310
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 311 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 351

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 119 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 176
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 235
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 236 L-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 355 QHPYINVWYDPA 366

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 75  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 132
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 191
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 192 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 311 QHPYINVWYDPA 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 79
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 80  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 137
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 196
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 197 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 256 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 315
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 316 QHPYINVWYDPA 327

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 75  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 132
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 191
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 192 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 311 QHPYINVWYDPA 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 115/345 (33%), Positives = 189/345 (54%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 82
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 83  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 140
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +  ++ TR+YRAPE++
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMVPFVVTRYYRAPEVI 199
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P P    K     
Sbjct: 200 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 259 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 318
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 319 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 359

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 167/296 (56%), Gaps = 26/296 (8%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            ++ +Y   +++G+G YG+VYKA D   +  VA+K+I     ++       REI  LK  
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLS 137
             HPNI++++D+  +   + L +VFE+ME DL KV+ +    L+D  I+  ++QL  G++
Sbjct: 77  H-HPNIVSLIDVIHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           + H  +++HRDLKP N+LI+   ++K+ D GLAR+        T  + T WYRAP++L+ 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP---PHADKF--- 250
           +++Y+  VDIWS+GCI AEM+  KPLFPG +   QL  I +++  PNP   P   +    
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 251 ----YAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
               +  F+ KP         +E +DLL+ +L  +P++R      + H Y     P
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 176/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 74  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 131
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 190
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 310 QHPYINVWYDPA 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 115/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+G I+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 115/345 (33%), Positives = 188/345 (54%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T  + TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPEVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++   LFPG     Q  ++I  L  P P    K     
Sbjct: 198 L-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGFKN------------------KPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                    K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 113/324 (34%), Positives = 178/324 (54%), Gaps = 40/324 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYFPSATHVIPQVTPHTV 307
           +H Y++ ++  A         HT+
Sbjct: 317 QHPYINVWYDPAXXXXXDEREHTI 340

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 115/345 (33%), Positives = 190/345 (55%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L++VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+G I+ EM++   LFPG     Q  ++I  L  P+P    K     
Sbjct: 198 L-GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 175/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 317 QHPYINVWYDPA 328

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  184 bits (467), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 175/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 317 QHPYINVWYDPA 328

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 175/312 (56%), Gaps = 40/312 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 74  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXG 131
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 190
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 284 EHNYVSKYFPSA 295
           +H Y++ ++  A
Sbjct: 310 QHPYINVWYDPA 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 117/345 (33%), Positives = 188/345 (54%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S     E + TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-VVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM+  K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 174/309 (56%), Gaps = 40/309 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++    ++KI D GLAR+   S   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VDIWS+GCI+ EM++ K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG                   K K  +A DLL+++LV++P++R   D  L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 284 EHNYVSKYF 292
           +H Y++ ++
Sbjct: 317 QHPYINVWY 325

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 116/345 (33%), Positives = 188/345 (54%), Gaps = 45/345 (13%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD   ++ VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII +L+++    +    +D+Y+V E M+ +L +VI+ + L    + Y+++Q+  G
Sbjct: 81  N-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S     E + TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-VVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF---- 250
           +    Y  +VD+WS+GCI+ EM+  K LFPG     Q  ++I  L  P P    K     
Sbjct: 198 L-GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 251 ---------YAGF------------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
                    YAG+                  K K  +A DLL+++LV++ S+R   D+ L
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 284 EHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
           +H Y++ ++ PS     P   P   +    D  +  I ++++ +Y
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQL----DEREHTIEEWKELIY 357

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 105/287 (36%), Positives = 160/287 (55%), Gaps = 25/287 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +Y   ++IG+G YG+VYKA + N  +  A+KKI     ++     T REI  LK   +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYI 139
           H NI+ + D+      K L +VFE+++ DL K++   +  L+ V  +  + QL NG++Y 
Sbjct: 59  HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +V+HRDLKP N+LI++   +KI D GLAR+        T  I T WYRAP++L+ ++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKFYA 252
           +Y+  +DIWS+GCI AEM+   PLFPG S + QL  I  ++        PN     K+  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 253 GF------------KNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            F            K   E  +DLL+++L L+P++R    Q LEH Y
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 160/287 (55%), Gaps = 25/287 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +Y   ++IG+G YG+VYKA + N  +  A+KKI     ++     T REI  LK   +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYI 139
           H NI+ + D+      K L +VFE+++ DL K++   +  L+ V  +  + QL NG++Y 
Sbjct: 59  HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +V+HRDLKP N+LI++   +KI D GLAR+        T  + T WYRAP++L+ ++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKFYA 252
           +Y+  +DIWS+GCI AEM+   PLFPG S + QL  I  ++        PN     K+  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 253 GF------------KNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            F            K   E  +DLL+++L L+P++R    Q LEH Y
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 160/287 (55%), Gaps = 25/287 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +Y   ++IG+G YG+VYKA + N  +  A+KKI     ++     T REI  LK   +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYI 139
           H NI+ + D+      K L +VFE+++ DL K++   +  L+ V  +  + QL NG++Y 
Sbjct: 59  HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +V+HRDLKP N+LI++   +KI D GLAR+        T  + T WYRAP++L+ ++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKFYA 252
           +Y+  +DIWS+GCI AEM+   PLFPG S + QL  I  ++        PN     K+  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 253 GF------------KNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
            F            K   E  +DLL+++L L+P++R    Q LEH Y
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/299 (33%), Positives = 157/299 (52%), Gaps = 35/299 (11%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +++G G Y  VYK  +K    YVA+K++       T +    REI  +K   +H NI+ +
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-AIREISLMKEL-KHENIVRL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH-------IRYIMFQLCNGLSYIHA 141
            D+    N   L +VFE+M+NDL K +  + + +         ++Y  +QL  GL++ H 
Sbjct: 69  YDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            K++HRDLKP N+LI+K   +K+GD GLAR+        +  + T WYRAP++L+ +R Y
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------PNPPHADKFYAGF 254
           +  +DIWS GCILAEM+  KPLFPG +   QL+LI +++        P+     K+    
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 255 KNKPEE-----------------AVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
           + +P                    +D L+ +L LNP  R    Q L H + ++Y+  A+
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 106/284 (37%), Positives = 149/284 (52%), Gaps = 30/284 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--KTDAQRT-YREILFLKSFQRHPNIIT 87
           +G+G +  VYKA DKN  Q VAIKKI    R+  K    RT  REI  L+    HPNII 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 76
Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +LD +   +N  L  VF++ME DL  +I+D   +L   HI+  M     GL Y+H   ++
Sbjct: 77  LLDAFGHKSNISL--VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP+N+L+D++  +K+ D GLA+S           + TRWYRAPE+L   R Y   V
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGV 194
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF--------YAGFKNK 257
           D+W++GCILAE+L   P  PG S   QL  I   +    P  +++        Y  FK+ 
Sbjct: 195 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL--GTPTEEQWPDMCSLPDYVTFKSF 252
Query: 258 P------------EEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           P            ++ +DL+  + + NP  R    Q L+  Y S
Sbjct: 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GLS+ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 74
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 75  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 192
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 248
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 304

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 69  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 242
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 298

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 71
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 72  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 245
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 301

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 74
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 75  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 192
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 248
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 304

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 115/341 (33%), Positives = 171/341 (50%), Gaps = 80/341 (23%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---- 80
           Y I   IG+G+YG VY AYDKN ++ VAIKK+   F +  D +R  REI  L   +    
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 81  -RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSY 138
            R  ++I   D+ K     +LY+V E  ++DL K+ +  I L + HI+ I++ L  G ++
Sbjct: 88  IRLYDLIIPDDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC------------------- 179
           IH   ++HRDLKP+N L+++ CS+K+ D GLAR+++  K+                    
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 180 ---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAE---MLQSK--------PLFP 225
              LT ++ TRWYRAPE+++    YT  +DIWS GCI AE   MLQS         PLFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 226 GAST-----------------SHQLQLIVNLVRP---------NPPHADKFYAGFKN-KP 258
           G+S                    QL +I N++           N P   K+   F + KP
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 259 -----------EEAVDLLNQILVLNPSERPETDQILEHNYV 288
                      ++ ++LL  +L  NP++R   DQ L+H Y+
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 106/317 (33%), Positives = 174/317 (54%), Gaps = 40/317 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  A+D      VA+KK+   F+N+T A+R YRE++ LK  
Sbjct: 19  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 78
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI  + L    + Y+++Q+  G
Sbjct: 79  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCG 136
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+ S +   +T Y+ TR+YRAPE++
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS-TNFMMTPYVVTRYYRAPEVI 195
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLF------------------PGASTSHQLQLIV 237
           +    Y  +VDIWS+GCI+ E+++   +F                  P A     LQ  V
Sbjct: 196 L-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 238 -NLVRPNPPHA----DKFYAGF---------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
            N V   P +     ++ +  +         K K  +A DLL+++LV++P +R   D+ L
Sbjct: 255 RNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314
Query: 284 EHNYVSKYFPSATHVIP 300
            H Y++ ++  A    P
Sbjct: 315 RHPYITVWYDPAEAEAP 331

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+ KI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+ KI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 69  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 242
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 298

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 69
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 70  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 243
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 299

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 71
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 72  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 245
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 301

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 69
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 70  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 128 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 243
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 299

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 69  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 242
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 298

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 69  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 242
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 298

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 69
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 70  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 243
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 299

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 68
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 69  LDVIHTENK--LYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 242
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 298

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 110/320 (34%), Positives = 161/320 (50%), Gaps = 49/320 (15%)
Query: 16  NVDG-NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           N+ G ++ + Y   K +G G  G+V+ A D +  + VAIKKI     +    +   REI 
Sbjct: 3   NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIK 60
Query: 75  FLKSFQRHPNIITMLDIYKAVNNK------------DLYVVFEYMENDLNKVIRDKILKD 122
            ++    H NI+ + +I     ++             +Y+V EYME DL  V+    L +
Sbjct: 61  IIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119
Query: 123 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLS---DSKE 178
            H R  M+QL  GL YIH+  V+HRDLKP+N+ I+ +   +KIGD GLAR +      K 
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV- 237
            L+E + T+WYR+P +L+S   YT  +D+W+ GCI AEML  K LF GA    Q+QLI+ 
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 238 -----------------------NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPS 274
                                  ++  P+ P   +   G      EAVD L QIL  +P 
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISR---EAVDFLEQILTFSPM 295
Query: 275 ERPETDQILEHNYVSKY-FP 293
           +R   ++ L H Y+S Y FP
Sbjct: 296 DRLTAEEALSHPYMSIYSFP 315

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 108/317 (34%), Positives = 173/317 (54%), Gaps = 40/317 (12%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  A+D      VA+KK+   F+N+T A+R YRE++ LK  
Sbjct: 21  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 80
Query: 80  QRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI  + L    + Y+++Q+  G
Sbjct: 81  N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCG 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+ + +   +T Y+ TR+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVI 197
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLF------------------PGASTSHQLQLIV 237
           +    Y  +VDIWS+GCI+ E+++   +F                  P A     LQ  V
Sbjct: 198 L-GMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 238 -NLVRPNPPHAD-KFYAGF------------KNKPEEAVDLLNQILVLNPSERPETDQIL 283
            N V   P +   KF   F            K K  +A DLL+++LV++P +R   D+ L
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 284 EHNYVSKYFPSATHVIP 300
            H Y++ ++  A    P
Sbjct: 317 RHPYITVWYDPAEAEAP 333

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 155/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE+++ DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 149/285 (52%), Gaps = 33/285 (11%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL K +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNY 287
                           E+   LL+Q+L  +P++R      L H +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 66
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL   +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 67  LDVIHTENK--LYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y+  V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 240
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 153/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL   +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 153/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 67
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL   +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 68  LDVIHTENK--LYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 126 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 241
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 297

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 153/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 70
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL   +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 71  LDVIHTENK--LYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 244
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 300

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 153/300 (51%), Gaps = 37/300 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPNI+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL 69
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVM 145
           LD+    N   LY+VFE++  DL   +    L  + +  I   +FQL  GL++ H+ +V+
Sbjct: 70  LDVIHTENK--LYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLKP N+LI+   +IK+ D GLAR+           + T WYRAPEIL+  + Y+  V
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKNKP------ 258
           DIWSLGCI AEM+  + LFPG S   QL ++   L  P+    +  + G  + P      
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTSMPDYKPSF 243
Query: 259 ----------------EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                           E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 299

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 111/354 (31%), Positives = 166/354 (46%), Gaps = 86/354 (24%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
           D  I   Y I   IG G+YG V +AYDK  K+ VAIKKI   F +  D +R  REI  L 
Sbjct: 48  DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 78  SFQRHPNIITMLDIY--KAVNNKD-LYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLC 133
               H +++ +LDI   K V   D LYVV E  ++D  K+ R  + L ++HI+ +++ L 
Sbjct: 108 RLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-------------------- 173
            G+ Y+H+  ++HRDLKP+N L+++ CS+K+ D GLAR++                    
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 174 -------SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ------- 219
                   + K  LT ++ TRWYRAPE+++    YT  +D+WS+GCI AE+L        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 220 ----SKPLFPGAST--------------------SHQLQLIVNLVRPNPPHAD------- 248
                 PLFPG+S                       QL +I N++   P   D       
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG-TPSEEDIEALEKE 345
Query: 249 ---------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                               F     +A+ LL ++LV NP++R   ++ L H +
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 160/288 (55%), Gaps = 42/288 (14%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+G+YG+V K  +K+  + VAIKK  E+  +K   +   REI  LK   RH N++ +L+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLE 91
Query: 91  IYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH----------IRYIMFQLCNGLSYIH 140
           + K    K  Y+VFE++++         IL D+           ++  +FQ+ NG+ + H
Sbjct: 92  VCK--KKKRWYLVFEFVDH--------TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  ++HRD+KP NIL+ +S  +K+ D G AR+L+   E   + +ATRWYRAPE+L+ + +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKF-----YAGF 254
           Y   VD+W++GC++ EM   +PLFPG S   QL  +++ L    P H + F     +AG 
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 255 K------NKP---------EEAVDLLNQILVLNPSERPETDQILEHNY 287
           +       +P         E  +DL  + L ++P +RP   ++L H++
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 164/345 (47%), Gaps = 85/345 (24%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---- 80
           Y I   IG+G+YG VY AYDKN  + VAIKK+   F +  D +R  REI  L   +    
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 81  -RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSY 138
            R  ++I   D+ K     +LY+V E  ++DL K+ +  I L + H++ I++ L  G  +
Sbjct: 90  IRLHDLIIPEDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC------------------- 179
           IH   ++HRDLKP+N L+++ CS+KI D GLAR+++  K+                    
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 180 ------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-----------P 222
                 LT ++ TRWYRAPE+++    YT+ +DIWS GCI AE+L              P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 223 LFPGAST-----------------SHQLQLIVNLVRPNPPHAD----------KFYAGFK 255
           LFPG+S                    QL +I N++   PP  D          K+   F 
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVI-GTPPEEDLKCITKQEVIKYIKLFP 325
Query: 256 NK------------PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +             +E +DLL  +L  N  +R   D+ L H Y+
Sbjct: 326 TRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYL 370

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 159/290 (54%), Gaps = 26/290 (8%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           ++ +Y    +IG+G+YG+V+K  +++  Q VAIKK  E+  +    +   REI  LK   
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL- 59
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR-DKILKDVHIRYIMFQLCNGLSY 138
           +HPN++ +L++++    + L++VFEY ++  L+++ R  + + +  ++ I +Q    +++
Sbjct: 60  KHPNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H    +HRD+KP NILI K   IK+ D G AR L+   +   + +ATRWYR+PE+L+ +
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR----------------- 241
            +Y   VD+W++GC+ AE+L   PL+PG S   QL LI   +                  
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 242 ----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
               P+P   +     F N    A+ LL   L ++P+ER   +Q+L H Y
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 158/292 (54%), Gaps = 32/292 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +     T RE+  L+  +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ + D+   V+  D    L +VFE+++ DL   + DK+    +    I+ +MFQL
Sbjct: 72  EHPNVVRLFDVC-TVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S  +  LT  + T WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAP 188
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++  P      +  
Sbjct: 189 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 252 A----GFKNKPEEAV------------DLLNQILVLNPSERPETDQILEHNY 287
           A     F +K  + +            DLL + L  NP++R      L H Y
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 158/292 (54%), Gaps = 32/292 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +     T RE+  L+  +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ + D+   V+  D    L +VFE+++ DL   + DK+    +    I+ +MFQL
Sbjct: 72  EHPNVVRLFDVC-TVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S  +  LT  + T WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAP 188
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++  P      +  
Sbjct: 189 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 252 A----GFKNKPEEAV------------DLLNQILVLNPSERPETDQILEHNY 287
           A     F +K  + +            DLL + L  NP++R      L H Y
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 158/292 (54%), Gaps = 32/292 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +     T RE+  L+  +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ + D+   V+  D    L +VFE+++ DL   + DK+    +    I+ +MFQL
Sbjct: 72  EHPNVVRLFDVC-TVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S  +  LT  + T WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAP 188
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++  P      +  
Sbjct: 189 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 252 A----GFKNKPEEAV------------DLLNQILVLNPSERPETDQILEHNY 287
           A     F +K  + +            DLL + L  NP++R      L H Y
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 150/295 (50%), Gaps = 27/295 (9%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +Y   ++IG+G YG V+KA ++   + VA+K++     ++       REI  LK   +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSY 138
           H NI+ + D+  +  +K L +VFE+ + DL K   D    D+    ++  +FQL  GL +
Sbjct: 60  HKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H+  V+HRDLKP N+LI+++  +K+ D GLAR+      C +  + T WYR P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 199 RRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV----------------- 240
           + Y+  +D+WS GCI AE+   ++PLFPG     QL+ I  L+                 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 241 RPNP--PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
           +P P  P                 DLL  +L  NP +R   ++ L+H Y S + P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 147/305 (48%), Gaps = 41/305 (13%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---------AQRTYREILF 75
           YT+ + I  G+YG V    D      VAIK++F    +             +R  REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 76  LKSFQRHPNIITMLDIYKAVNNK---DLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMF 130
           L  F  HPNI+ + DI+          LY+V E M  DL +VI D+  ++   HI+Y M+
Sbjct: 83  LNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWY 189
            +  GL  +H   V+HRDL P NIL+  +  I I D  LAR   +D+ +  T Y+  RWY
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWY 199
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------- 241
           RAPE+++  + +T  VD+WS GC++AEM   K LF G++  +QL  IV +V         
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259
Query: 242 --PNPPHADKFYAGFKNKPEE------------AVDLLNQILVLNPSERPETDQILEHNY 287
              +P   D       N P              A+DL+ ++L  NP  R  T+Q L H Y
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 288 VSKYF 292
               F
Sbjct: 320 FESLF 324

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 147/305 (48%), Gaps = 41/305 (13%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---------AQRTYREILF 75
           YT+ + I  G+YG V    D      VAIK++F    +             +R  REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 76  LKSFQRHPNIITMLDIYKAVNNK---DLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMF 130
           L  F  HPNI+ + DI+          LY+V E M  DL +VI D+  ++   HI+Y M+
Sbjct: 83  LNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWY 189
            +  GL  +H   V+HRDL P NIL+  +  I I D  LAR   +D+ +  T Y+  RWY
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWY 199
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-------- 241
           RAPE+++  + +T  VD+WS GC++AEM   K LF G++  +QL  IV +V         
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259
Query: 242 --PNPPHADKFYAGFKNKPEE------------AVDLLNQILVLNPSERPETDQILEHNY 287
              +P   D       N P              A+DL+ ++L  NP  R  T+Q L H Y
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 288 VSKYF 292
               F
Sbjct: 320 FESLF 324

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 90/212 (42%), Positives = 122/212 (57%), Gaps = 13/212 (6%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           ++G+G YG VYKA D    + VAIK+I      +       RE+  LK  Q H NII + 
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELK 99
Query: 90  DIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSYIHACKVMH 146
            +    +N  L+++FEY ENDL K +      DV +R I   ++QL NG+++ H+ + +H
Sbjct: 100 SVIH--HNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLH 155
Query: 147 RDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
           RDLKP N+L+  S +     +KIGD GLAR+        T  I T WYR PEIL+ +R Y
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHY 215
Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
           +  VDIWS+ CI AEML   PLFPG S   QL
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 150/295 (50%), Gaps = 27/295 (9%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +Y   ++IG+G YG V+KA ++   + VA+K++     ++       REI  LK   +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSY 138
           H NI+ + D+  +  +K L +VFE+ + DL K   D    D+    ++  +FQL  GL +
Sbjct: 60  HKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H+  V+HRDLKP N+LI+++  +K+ + GLAR+      C +  + T WYR P++L   
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 199 RRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLV----------------- 240
           + Y+  +D+WS GCI AE+  + +PLFPG     QL+ I  L+                 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 241 RPNP--PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
           +P P  P                 DLL  +L  NP +R   ++ L+H Y S + P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 161/300 (53%), Gaps = 35/300 (11%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +++Y    +IG+G +G V+KA  +   Q VA+KK+      +       REI  L+   +
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-K 75
Query: 82  HPNIITMLDIYKAVNN------KDLYVVFEYMENDLNKVIRDKILKDV--HIRYIMFQLC 133
           H N++ +++I +   +        +Y+VF++ E+DL  ++ + ++K     I+ +M  L 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWY 189
           NGL YIH  K++HRD+K +N+LI +   +K+ D GLAR+ S +K          + T WY
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------VRP 242
           R PE+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L       V P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 243 NPPHAD-----KFYAGFKNKPEE----------AVDLLNQILVLNPSERPETDQILEHNY 287
           N  + +     +   G K K ++          A+DL++++LVL+P++R ++D  L H++
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 161/300 (53%), Gaps = 35/300 (11%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +++Y    +IG+G +G V+KA  +   Q VA+KK+      +       REI  L+   +
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 82  HPNIITMLDIYKAVNN------KDLYVVFEYMENDLNKVIRDKILKDV--HIRYIMFQLC 133
           H N++ +++I +   +        +Y+VF++ E+DL  ++ + ++K     I+ +M  L 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWY 189
           NGL YIH  K++HRD+K +N+LI +   +K+ D GLAR+ S +K          + T WY
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------VRP 242
           R PE+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L       V P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 243 NPPHAD-----KFYAGFKNKPEE----------AVDLLNQILVLNPSERPETDQILEHNY 287
           N  + +     +   G K K ++          A+DL++++LVL+P++R ++D  L H++
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 161/300 (53%), Gaps = 35/300 (11%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +++Y    +IG+G +G V+KA  +   Q VA+KK+      +       REI  L+   +
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 82  HPNIITMLDIYKAVNN------KDLYVVFEYMENDLNKVIRDKILKDV--HIRYIMFQLC 133
           H N++ +++I +   +        +Y+VF++ E+DL  ++ + ++K     I+ +M  L 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWY 189
           NGL YIH  K++HRD+K +N+LI +   +K+ D GLAR+ S +K          + T WY
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------VRP 242
           R PE+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L       V P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 243 NPPHAD-----KFYAGFKNKPEE----------AVDLLNQILVLNPSERPETDQILEHNY 287
           N  + +     +   G K K ++          A+DL++++LVL+P++R ++D  L H++
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 161/300 (53%), Gaps = 35/300 (11%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +++Y    +IG+G +G V+KA  +   Q VA+KK+      +       REI  L+   +
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 74
Query: 82  HPNIITMLDIYKAVNN------KDLYVVFEYMENDLNKVIRDKILKDV--HIRYIMFQLC 133
           H N++ +++I +   +        +Y+VF++ E+DL  ++ + ++K     I+ +M  L 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----LTEYIATRWY 189
           NGL YIH  K++HRD+K +N+LI +   +K+ D GLAR+ S +K          + T WY
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-------VRP 242
           R PE+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L       V P
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 243 NPPHAD-----KFYAGFKNKPEE----------AVDLLNQILVLNPSERPETDQILEHNY 287
           N  + +     +   G K K ++          A+DL++++LVL+P++R ++D  L H++
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 33/296 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           + Y     IG GAYG VYKA D ++  +VA+K +      +     T RE+  L+  +  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ ++D+  A +  D    + +VFE+++ DL   + DK     L    I+ +M Q 
Sbjct: 64  EHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYL-DKAPPPGLPAETIKDLMRQF 121
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++HA  ++HRDLKP NIL+    ++K+ D GLAR  S  +  L   + T WYRAP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALAPVVVTLWYRAP 180
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD---- 248
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G S + QL  I +L+   PP  D    
Sbjct: 181 EVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPRD 238
Query: 249 -----KFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                  +     +P         E    LL ++L  NP +R    + L+H+Y+ K
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 33/296 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           + Y     IG GAYG VYKA D ++  +VA+K +      +     T RE+  L+  +  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ ++D+  A +  D    + +VFE+++ DL   + DK     L    I+ +M Q 
Sbjct: 64  EHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYL-DKAPPPGLPAETIKDLMRQF 121
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++HA  ++HRDLKP NIL+    ++K+ D GLAR  S  +  L   + T WYRAP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALDPVVVTLWYRAP 180
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD---- 248
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G S + QL  I +L+   PP  D    
Sbjct: 181 EVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPRD 238
Query: 249 -----KFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                  +     +P         E    LL ++L  NP +R    + L+H+Y+ K
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 33/296 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           + Y     IG GAYG VYKA D ++  +VA+K +      +     T RE+  L+  +  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 81  RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQL 132
            HPN++ ++D+  A +  D    + +VFE+++ DL   + DK     L    I+ +M Q 
Sbjct: 64  EHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYL-DKAPPPGLPAETIKDLMRQF 121
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL ++HA  ++HRDLKP NIL+    ++K+ D GLAR  S  +  L   + T WYRAP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALFPVVVTLWYRAP 180
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD---- 248
           E+L+ +  Y   VD+WS+GCI AEM + KPLF G S + QL  I +L+   PP  D    
Sbjct: 181 EVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPRD 238
Query: 249 -----KFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                  +     +P         E    LL ++L  NP +R    + L+H+Y+ K
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 124/214 (57%), Gaps = 8/214 (3%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITM 88
           ++G+G Y  VYK   K     VA+K+I     ++  A  T  RE+  LK   +H NI+T+
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDL-KHANIVTL 65
Query: 89  LDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMH 146
            DI      K L +VFEY++ DL + + D   I+   +++  +FQL  GL+Y H  KV+H
Sbjct: 66  HDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+LI++   +K+ D GLAR+ S   +     + T WYR P+IL+ +  Y+  +D
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 207 IWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
           +W +GCI  EM   +PLFPG++   QL  I  ++
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 102/299 (34%), Positives = 153/299 (51%), Gaps = 36/299 (12%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ---RTYREILFLKSF 79
           + Y     IG GAYG VYKA D ++  +VA+K +               T RE+  L+  
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 80  Q--RHPNIITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI----LKDVHIRYIM 129
           +   HPN++ ++D+  A +  D    + +VFE+++ DL   + DK     L    I+ +M
Sbjct: 69  EAFEHPNVVRLMDVC-ATSRTDREIKVTLVFEHVDQDLRTYL-DKAPPPGLPAETIKDLM 126
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            Q   GL ++HA  ++HRDLKP NIL+    ++K+ D GLAR  S  +  LT  + T WY
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALTPVVVTLWY 185
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD- 248
           RAPE+L+ +  Y   VD+WS+GCI AEM + KPLF G S + QL  I +L+   PP  D 
Sbjct: 186 RAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDW 243
Query: 249 --------KFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                     +     +P         E    LL ++L  NP +R    + L+H+Y+ K
Sbjct: 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 100/335 (29%), Positives = 168/335 (50%), Gaps = 53/335 (15%)
Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-- 58
           M+ N  + + ++ +  +D      + + +  G+G +G V    +K+    VAIKK+ +  
Sbjct: 6   MSLNAAAAADERSRKEMD-----RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP 60
Query: 59  AFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAVNNKD-----LYVVFEYMENDL 111
            FRN        RE+  ++      HPNI+ +   +  +  +D     L VV EY+ + L
Sbjct: 61  RFRN--------RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL 112
Query: 112 NKVIRDKILKDVH-----IRYIMFQLCNGLSYIH--ACKVMHRDLKPSNILIDKS-CSIK 163
           ++  R+   + V      I+  +FQL   +  +H  +  V HRD+KP N+L++++  ++K
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172
Query: 164 IGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL 223
           + D G A+ LS S+  +  YI +R+YRAPE++  N+ YT  VDIWS+GCI AEM+  +P+
Sbjct: 173 LCDFGSAKKLSPSEPNVA-YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231
Query: 224 FPGASTSHQLQLIVNLV---------RPNPPHADKFYAGFKNKP-------------EEA 261
           F G +++ QL  IV ++         + NP H D      K  P             +EA
Sbjct: 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEA 291
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
            DLL+ +L   P ER +  + L H Y  +    AT
Sbjct: 292 YDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 154/294 (52%), Gaps = 41/294 (13%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE--AFRNKTDAQRTYREILFLKSFQRH 82
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  AF+N        RE+  ++    H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLD-H 72
Query: 83  PNIITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLC 133
            NI+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAP
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAP 191
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPN 243
           E++     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 244 PPHADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           P + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 153/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 102
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 221
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 281
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 282 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 333

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 153/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 153
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 272
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 332
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 333 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 384

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 154/294 (52%), Gaps = 41/294 (13%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE--AFRNKTDAQRTYREILFLKSFQRH 82
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  AF+N        RE+  ++    H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLD-H 72
Query: 83  PNIITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLC 133
            NI+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAP
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAP 191
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPN 243
           E++     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 244 PPHADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           P + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 153/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 112
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 231
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 232 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 291
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 292 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 343

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 153/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 110
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 229
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 289
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 290 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 341

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 153/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 108
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 227
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 152/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 79
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 198
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 258
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 259 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 310

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 152/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 87
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 206
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 266
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 267 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 318

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 152/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 74
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 193
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 155/297 (52%), Gaps = 48/297 (16%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+V++A    + + VAIKK+ +  R K       RE+  ++   +HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMR-IVKHPN 93
Query: 85  IITMLDIYKAVNNKD----LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           ++ +   + +  +K     L +V EY+   + +  R      + +  + I+  M+QL   
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 136 LSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D  S  +K+ D G A+ L  + E     I +R+YRAPE+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSXICSRYYRAPEL 212
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL--------------- 239
           +     YT ++DIWS GC++AE++Q +PLFPG S   QL  I+ +               
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 240 --------VRPNPPHADKFYAGFKNK-PEEAVDLLNQILVLNPSERPETDQILEHNY 287
                   +RP+P     F   F+ + P +A+DL++++L   PS R    + L H +
Sbjct: 273 YMEHKFPQIRPHP-----FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 153/294 (52%), Gaps = 41/294 (13%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE--AFRNKTDAQRTYREILFLKSFQRH 82
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  AF+N        RE+  ++    H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLD-H 72
Query: 83  PNIITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLC 133
            NI+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAP
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAP 191
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPN 243
           E++     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 244 PPHADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           P + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 152/292 (52%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 108
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 227
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRP--------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL ++I  L  P        NP 
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 86
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 205
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 265
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 266 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 86
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 205
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 265
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 266 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 82
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 201
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 261
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 262 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 313

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 93
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 212
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 272
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 273 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 324

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 74
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 193
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 75
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 194
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 254
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 255 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 306

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 74
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 193
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 74
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 193
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 151/292 (51%), Gaps = 37/292 (12%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+ +  R K       RE+  ++    H N
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLD-HCN 78
Query: 85  IITM-LDIYKAVNNKD---LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNG 135
           I+ +    Y +   KD   L +V +Y+   + +V R      + L  ++++  M+QL   
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++  I +R+YRAPE+
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRYYRAPEL 197
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------RPNPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 257
Query: 246 HADKFYAGFK----------NKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
           + +  +   K            P EA+ L +++L   P+ R    +   H++
Sbjct: 258 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 147/284 (51%), Gaps = 16/284 (5%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 74  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +E + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEV-VT 189
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 247
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVI 299
                D LN+ L ++  +R    ++L+H +  ++K   S T +I
Sbjct: 248 -----DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 93/314 (29%), Positives = 162/314 (51%), Gaps = 61/314 (19%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYV--AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           ++G+G YG VYKA  K+ K     A+K+I         +    REI  L+   +HPN+I+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLREL-KHPNVIS 82
Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVIR----------DKILKDVHIRYIMFQLCNGLS 137
           +  ++ +  ++ ++++F+Y E+DL  +I+             L    ++ +++Q+ +G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 138 YIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEY---IATRWYR 190
           Y+HA  V+HRDLKP+NIL+     +   +KI D+G AR  +   + L +    + T WYR
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF----PGASTSH-----QLQLIVNL-- 239
           APE+L+  R YT  +DIW++GCI AE+L S+P+F        TS+     QL  I N+  
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 240 ---------VRPNPPHAD----------------KFYAGFKNKPE-EAVDLLNQILVLNP 273
                    ++  P H+                 K+    K KP+ +A  LL ++L ++P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 274 SERPETDQILEHNY 287
            +R  ++Q ++  Y
Sbjct: 323 IKRITSEQAMQDPY 336

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 157/325 (48%), Gaps = 69/325 (21%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y++ K +G G++GIV + +D  + +  A+KK+ +  R K       RE+  +K    H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------RELDIMKVLD-HV 60
Query: 84  NIITMLDIY------------------------KAVN------------NKDLYVVFEYM 107
           NII ++D +                          VN            NK L V+ EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 108 ENDLNKVIRDKIL--KDVHIRYI---MFQLCNGLSYIHACKVMHRDLKPSNILID-KSCS 161
            + L+KV++  I   + + +  I   ++QL   + +IH+  + HRD+KP N+L++ K  +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 162 IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK 221
           +K+ D G A+ L  S+  +   I +R+YRAPE+++    YT  +D+WS+GC+  E++  K
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAX-ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 222 PLFPGASTSHQLQLIV---------NLVRPNPPHADKFYAGFKNK----------PEEAV 262
           PLF G ++  QL  I+          ++R NP + +  +   K K          P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 263 DLLNQILVLNPSERPETDQILEHNY 287
           DLL QIL   P  R    + + H +
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPF 324

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 146/284 (51%), Gaps = 16/284 (5%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 74  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV-VT 189
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 247
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVI 299
                D LN+ L ++  +R    ++L+H +  ++K   S T +I
Sbjct: 248 -----DFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 146/284 (51%), Gaps = 16/284 (5%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 74  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 189
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 247
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVI 299
                D LN+ L ++  +R    ++L+H +  ++K   S T +I
Sbjct: 248 -----DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 151/303 (49%), Gaps = 22/303 (7%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 17  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 74
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 75  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 131
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 132 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV-VT 190
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 248
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVIPQVTPHTVVLDIDDNN 315
                D LN+ L ++  +R    ++++H +  ++K   S T +I      T       NN
Sbjct: 249 -----DFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEAT------KNN 297
Query: 316 QLE 318
            LE
Sbjct: 298 HLE 300

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 150/275 (54%), Gaps = 21/275 (7%)
Query: 22  LAEYTIHKRIGKGAYG--IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           + +Y   ++IG+G++G  I+ K+ + + +QYV IK+I  +  +  + + + RE+  L + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTE-DGRQYV-IKEINISRMSSKEREESRREVAVLANM 80
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI---RDKILKDVHIRYIMFQLCNG 135
            +HPNI+   + ++   N  LY+V +Y E  DL K I   +  + ++  I     Q+C  
Sbjct: 81  -KHPNIVQYRESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L ++H  K++HRD+K  NI + K  ++++GD G+AR L+ + E     I T +Y +PEI 
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI- 196
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
             N+ Y +  DIW+LGC+L E+   K  F   S  +   L++ ++  + P     Y+   
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIISGSFPPVSLHYS--- 250
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
               +   L++Q+   NP +RP  + ILE  +++K
Sbjct: 251 ---YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 131/233 (56%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    +NK       
Sbjct: 25  DYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK----- 79
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
           REI  L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 140/278 (50%), Gaps = 17/278 (6%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G     Y I   +GKG++G V K  D+  +Q  A+K I +A     D     RE+  LK 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
              HPNI+ + +I +  ++   Y+V E Y   +L +++I+ K   +     I+ Q+ +G+
Sbjct: 78  LD-HPNIMKLFEILE--DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           +Y+H   ++HRDLKP NIL+   +K C IKI D GL+     + + + + I T +Y APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +L     Y    D+WS G IL  +L   P F G +       I+  V       D     
Sbjct: 194 VLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFD--LPQ 245
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           ++   ++A DL+ ++L  +PS R    Q LEH ++ KY
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 137/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   TE   T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TELCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 151/303 (49%), Gaps = 22/303 (7%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 17  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 74
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 75  -NKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 131
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HR++K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 132 FLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 190
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+  
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-- 248
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVIPQVTPHTVVLDIDDNN 315
                D LN+ L ++  +R    ++++H +  ++K   S T +I      T       NN
Sbjct: 249 -----DFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEAT------KNN 297
Query: 316 QLE 318
            LE
Sbjct: 298 HLE 300

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 140/278 (50%), Gaps = 17/278 (6%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G     Y I   +GKG++G V K  D+  +Q  A+K I +A     D     RE+  LK 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
              HPNI+ + +I +  ++   Y+V E Y   +L +++I+ K   +     I+ Q+ +G+
Sbjct: 78  LD-HPNIMKLFEILE--DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           +Y+H   ++HRDLKP NIL+   +K C IKI D GL+     + + + + I T +Y APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +L     Y    D+WS G IL  +L   P F G +       I+  V       D     
Sbjct: 194 VLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFD--LPQ 245
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           ++   ++A DL+ ++L  +PS R    Q LEH ++ KY
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 140/278 (50%), Gaps = 17/278 (6%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G     Y I   +GKG++G V K  D+  +Q  A+K I +A     D     RE+  LK 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
              HPNI+ + +I +  ++   Y+V E Y   +L +++I+ K   +     I+ Q+ +G+
Sbjct: 78  LD-HPNIMKLFEILE--DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           +Y+H   ++HRDLKP NIL+   +K C IKI D GL+     + + + + I T +Y APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +L     Y    D+WS G IL  +L   P F G +       I+  V       D     
Sbjct: 194 VLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFD--LPQ 245
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           ++   ++A DL+ ++L  +PS R    Q LEH ++ KY
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 138/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +KN+K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +   ++  +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFH--DSTRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ KV+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA--ALCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 72  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T+   T  Y  PE +I 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPE-MIE 184
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 236 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 68  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T+   T  Y  PE +I 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPE-MIE 180
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 231
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 232 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T+   T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T+   T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 84  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 196
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 247
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 248 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 278

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 93  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 205
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 256
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 257 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 72  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 184
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 236 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 72  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE  I 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPEX-IE 184
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 236 -EGARDLISRLLKHNPSQRPXLREVLEHPWIT 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TXLCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 71  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 183
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 234
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 235 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 66  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 178
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 229
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 230 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 68  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR--TTLSGTLDYLPPE-MIE 180
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 231
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 232 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K  K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 64  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I 
Sbjct: 120 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 176
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 227
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 228 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 258

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 135/273 (49%), Gaps = 23/273 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-----DLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   +       +Y++ EY        +L K+   K  +     YI  +L N L
Sbjct: 72  HPNILRLYGYFHDATR--VYLILEYAPRGEVYKELQKL--SKFDEQRTATYIT-ELANAL 126
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           SY H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MI 183
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             R +   VD+WSLG +  E L  KP F   +     + I  +    P            
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT-------- 235
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
             E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 236 --EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 93  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+    +   T  Y  PE +I 
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DDLCGTLDYLPPE-MIE 205
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 256
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 257 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 141/280 (50%), Gaps = 20/280 (7%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFL 76
           DG  +  Y I K +G+G++G V  AY     Q VA+K I +    K+D Q R  REI +L
Sbjct: 9   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 68
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCN 134
           +   RHP+II + D+ K+    ++ +V EY  N+L   I  RDK + +   R    Q+ +
Sbjct: 69  R-LLRHPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIIS 124
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
            + Y H  K++HRDLKP N+L+D+  ++KI D GL+  ++D    L     +  Y APE+
Sbjct: 125 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 183
Query: 195 LISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            IS + Y    VD+WS G IL  ML  +  F   S     + I N V   P       AG
Sbjct: 184 -ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 242
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                     L+ ++L++NP  R    +I++ ++     P
Sbjct: 243 ----------LIKRMLIVNPLNRISIHEIMQDDWFKVDLP 272

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 141/280 (50%), Gaps = 20/280 (7%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFL 76
           DG  +  Y I K +G+G++G V  AY     Q VA+K I +    K+D Q R  REI +L
Sbjct: 8   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 67
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCN 134
           +   RHP+II + D+ K+    ++ +V EY  N+L   I  RDK + +   R    Q+ +
Sbjct: 68  R-LLRHPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIIS 123
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
            + Y H  K++HRDLKP N+L+D+  ++KI D GL+  ++D    L     +  Y APE+
Sbjct: 124 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV 182
Query: 195 LISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            IS + Y    VD+WS G IL  ML  +  F   S     + I N V   P       AG
Sbjct: 183 -ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG 241
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                     L+ ++L++NP  R    +I++ ++     P
Sbjct: 242 ----------LIKRMLIVNPLNRISIHEIMQDDWFKVDLP 271

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 93/280 (33%), Positives = 143/280 (51%), Gaps = 20/280 (7%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFL 76
           DG  +  Y I K +G+G++G V  AY     Q VA+K I +    K+D Q R  REI +L
Sbjct: 3   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 62
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCN 134
           +   RHP+II + D+ K+    ++ +V EY  N+L   I  RDK + +   R    Q+ +
Sbjct: 63  R-LLRHPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIIS 118
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
            + Y H  K++HRDLKP N+L+D+  ++KI D GL+  ++D    L     +  Y APE+
Sbjct: 119 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 177
Query: 195 LISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            IS + Y    VD+WS G IL  ML  +  F   S     + I N V   P    KF + 
Sbjct: 178 -ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLS- 231
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                  A  L+ ++L++NP  R    +I++ ++     P
Sbjct: 232 -----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 266

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--AALCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 69  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI + G +     S+   T    T  Y  PE +I 
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 181
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 232
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 233 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 69  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPE-MIE 181
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 232
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 233 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+    +   T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DDLCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA--ALCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI + G +     S+   T    T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR--TTLCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 67  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPE-MIE 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 231 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 68  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPE-MIE 180
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 231
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 232 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 21/272 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMF--QLCNGLS 137
           HPNI+ +   +       +Y++ EY    L  V R+  K+ K    R   +  +L N LS
Sbjct: 70  HPNILRLYGYFHDATR--VYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLCGTLDYLPPE-MIE 182
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +   VD+WSLG +  E L  KP F   +     + I  +    P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT--------- 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 234 -EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 135/271 (49%), Gaps = 26/271 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + +++G+G+YG VYKA  K   Q VAIK++      ++D Q   +EI  ++     P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCD-SPH 85
Query: 85  IITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHA 141
           ++     Y    N DL++V EY     ++ +IR  +K L +  I  I+     GL Y+H 
Sbjct: 86  VVKYYGSY--FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            + +HRD+K  NIL++     K+ D G+A  L+D        I T ++ APE+ I    Y
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEV-IQEIGY 202
Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE-- 259
               DIWSLG    EM + KP +   +  H ++ I  ++  NPP   +       KPE  
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIF-MIPTNPPPTFR-------KPELW 251
Query: 260 --EAVDLLNQILVLNPSERPETDQILEHNYV 288
                D + Q LV +P +R    Q+L+H +V
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-----DLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   +       +Y++ EY        +L K+   K  +     YI  +L N L
Sbjct: 72  HPNILRLYGYFHDATR--VYLILEYAPRGEVYKELQKL--SKFDEQRTATYIT-ELANAL 126
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           SY H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--XXLXGTLDYLPPE-MI 183
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             R +   VD+WSLG +  E L  KP F   +     + I  +    P            
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT-------- 235
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
             E A DL++++L  NPS+RP   ++LEH +++
Sbjct: 236 --EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAIK I        + R    A     EI  LK
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 77  KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 132
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 191
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 238
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 239 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 141/283 (49%), Gaps = 27/283 (9%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G I   +   +++G GA+G V+   ++++     IK I +  R++   ++   EI  LKS
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKS 76
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVI----RDKILKDVHIRYIMFQL 132
              HPNII + ++++  +N  +Y+V E  E    L +++    R K L + ++  +M Q+
Sbjct: 77  LD-HPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            N L+Y H+  V+H+DLKP NIL   +     IKI D GLA  L  S E  T    T  Y
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAAGTALY 192
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            APE+    R  T   DIWS G ++  +L     F G S   ++Q       PN      
Sbjct: 193 MAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-EVQQKATYKEPN------ 243
Query: 250 FYAGFKNKP--EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            YA  + +P   +AVDLL Q+L  +P  RP   Q+L H +  +
Sbjct: 244 -YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 141/276 (51%), Gaps = 20/276 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFLKSFQ 80
           +  Y I K +G+G++G V  AY     Q VA+K I +    K+D Q R  REI +L+   
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LL 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSY 138
           RHP+II + D+ K+    ++ +V EY  N+L   I  RDK + +   R    Q+ + + Y
Sbjct: 62  RHPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIISAVEY 118
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H  K++HRDLKP N+L+D+  ++KI D GL+  ++D    L     +  Y APE+ IS 
Sbjct: 119 CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV-ISG 176
Query: 199 RRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           + Y    VD+WS G IL  ML  +  F   S     + I N V   P    KF +     
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLS----- 227
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
              A  L+ ++L++NP  R    +I++ ++     P
Sbjct: 228 -PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 262

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAIK I        + R    A     EI  LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 71  KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 185
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 232
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAIK I        + R    A     EI  LK
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 70  KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 125
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 184
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 231
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 232 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 138/276 (50%), Gaps = 24/276 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + IG G+Y +  +   K      A+K I ++ R+ T+      EI  L  + +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILLRYGQHPN 77
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           IIT+ D+Y   + K +YVV E M+    L+K++R K   +     ++F +   + Y+HA 
Sbjct: 78  IITLKDVYD--DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 143 KVMHRDLKPSNIL-IDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            V+HRDLKPSNIL +D+S    SI+I D G A+ L      L     T  + APE+L   
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ER 194
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF--YAGFKN 256
           + Y    DIWSLG +L  ML     F         +++  +       + KF    G+ N
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI------GSGKFSLSGGYWN 248
Query: 257 K-PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              + A DL++++L ++P +R     +L H ++  +
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAIK I        + R    A     EI  LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 71  KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 185
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 232
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAIK I        + R    A     EI  LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 71  KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 185
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 232
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 139/275 (50%), Gaps = 17/275 (6%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G++   Y   K++G GAYG V    DK      AIK I +   + +   +   E+  LK 
Sbjct: 33  GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
              HPNI+ + D ++  + ++ Y+V E Y   +L +++I      +V    I+ Q+ +G+
Sbjct: 93  LD-HPNIMKLYDFFE--DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           +Y+H   ++HRDLKP N+L+   +K   IKI D GL+    + K+ + E + T +Y APE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPE 208
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +L   ++Y    D+WS+G IL  +L   P F G +     Q I+  V       D     
Sbjct: 209 VL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEKGKYTFDS--PE 260
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           +KN  E A DL+ Q+L  +   R    Q LEH ++
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 14/270 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 94
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 95  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 211
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 264
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHV 298
           LV +P++R    ++L+H +++K  P A+ V
Sbjct: 265 LVRDPAQRATAAELLKHPFLAKAGPPASIV 294

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 14/270 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 92
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 93  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 209
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 262
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHV 298
           LV +P++R    ++L+H +++K  P A+ V
Sbjct: 263 LVRDPAQRATAAELLKHPFLAKAGPPASIV 292

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 26/277 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHP 83
           Y   + +GKG++G V    DK   Q  A+K I +   + KTD +   RE+  LK    HP
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 110
Query: 84  NIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + + ++  +    Y+V E Y   +L +++I  K   +V    I+ Q+ +G++Y+H 
Sbjct: 111 NIMKLYEFFE--DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 142 CKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            K++HRDLKP N+L++   K  +I+I D GL+     SK+ + + I T +Y APE+L  +
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPEVL--H 225
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGF 254
             Y    D+WS G IL  +L   P F GA+    L+ +         P           +
Sbjct: 226 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ----------W 275
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           K   E A DL+ ++L   PS R      L+H ++  Y
Sbjct: 276 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 312

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 14/270 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 214
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 215 NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 331
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 384
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHV 298
           LV +P++R    ++L+H +++K  P A+ V
Sbjct: 385 LVRDPAQRATAAELLKHPFLAKAGPPASIV 414

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 14/270 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 83
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 84  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 200
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 253
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHV 298
           LV +P++R    ++L+H +++K  P A+ V
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAGPPASIV 283

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 141/272 (51%), Gaps = 15/272 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 87
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 88  NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 204
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 257
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           LV +P++R    ++L+H +++K  P A+ ++P
Sbjct: 258 LVRDPAQRATAAELLKHPFLAKAGPPAS-IVP 288

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAI+ I        + R    A     EI  LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 196 KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 310
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 357
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 26/277 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHP 83
           Y   + +GKG++G V    DK   Q  A+K I +   + KTD +   RE+  LK    HP
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 109
Query: 84  NIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + + ++  +    Y+V E Y   +L +++I  K   +V    I+ Q+ +G++Y+H 
Sbjct: 110 NIMKLYEFFE--DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 142 CKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            K++HRDLKP N+L++   K  +I+I D GL+     SK+ + + I T +Y APE+L  +
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPEVL--H 224
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGF 254
             Y    D+WS G IL  +L   P F GA+    L+ +         P           +
Sbjct: 225 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ----------W 274
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           K   E A DL+ ++L   PS R      L+H ++  Y
Sbjct: 275 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 311

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 140/286 (48%), Gaps = 39/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           EY + K +G GA G V  A+++   + VAI+ I        + R    A     EI  LK
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
               HP II + + + A   +D Y+V E ME     +KV+ +K LK+   +   +Q+   
Sbjct: 210 KLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 265
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  Y AP
Sbjct: 266 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAP 324
Query: 193 EILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           E+L+S     Y   VD WSLG IL   L   P F    + H+ Q+ +          D+ 
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQVSLK---------DQI 371
Query: 251 YAG--------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +G        +    E+A+DL+ ++LV++P  R  T++ L H ++
Sbjct: 372 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 139/270 (51%), Gaps = 14/270 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A  +++ + VA+KK+    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 137
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
           + Y  +   +L+VV E++E   L  ++    + +  I  +   +   LS +HA  V+HRD
Sbjct: 138 NSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE LIS   Y   VDIW
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIW 254
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        +++I + + P   +  K     K         L+++
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG-------FLDRL 307
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHV 298
           LV +P++R    ++L+H +++K  P A+ V
Sbjct: 308 LVRDPAQRATAAELLKHPFLAKAGPPASIV 337

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 26/277 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHP 83
           Y   + +GKG++G V    DK   Q  A+K I +   + KTD +   RE+  LK    HP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + + ++  +    Y+V E Y   +L +++I  K   +V    I+ Q+ +G++Y+H 
Sbjct: 87  NIMKLYEFFE--DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 142 CKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            K++HRDLKP N+L++   K  +I+I D GL+     SK+ + + I T +Y APE+L  +
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPEVL--H 201
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGF 254
             Y    D+WS G IL  +L   P F GA+    L+ +         P           +
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ----------W 251
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           K   E A DL+ ++L   PS R      L+H ++  Y
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 136/270 (50%), Gaps = 23/270 (8%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKK--IFEAFRNKTDAQRTYREILFLK 77
           N LA + I K+IG+G +  VY+A    +   VA+KK  IF+    K  A    +EI  LK
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLK 87
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR-----DKILKDVHIRYIMFQ 131
               HPN+I     +  + + +L +V E  +  DL+++I+      +++ +  +     Q
Sbjct: 88  QLN-HPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
           LC+ L ++H+ +VMHRD+KP+N+ I  +  +K+GDLGL R  S         + T +Y +
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 192 PEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           PE +  N  Y    DIWSLGC+L EM  LQS P +      + L   +      P  +D 
Sbjct: 205 PERIHEN-GYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPET 279
           +        EE   L+N  +  +P +RP+ 
Sbjct: 263 Y-------SEELRQLVNMCINPDPEKRPDV 285

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 142/290 (48%), Gaps = 28/290 (9%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDA------- 66
           +G I   Y   +++G GAYG V    +KN     AIK I    F+  R   D        
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVH 124
           +  Y EI  LKS   HPNII + D+++  + K  Y+V E+ E      ++I      +  
Sbjct: 91  EEIYNEISLLKSLD-HPNIIKLFDVFE--DKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLT 181
              IM Q+ +G+ Y+H   ++HRD+KP NIL++   S   IKI D GL+   S   + L 
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LR 206
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
           + + T +Y APE+L   ++Y    D+WS G I+  +L   P F G +     Q I+  V 
Sbjct: 207 DRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVE 260
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
               + D  +  +KN  +EA +L+  +L  + ++R   ++ L   ++ KY
Sbjct: 261 KGKYYFD--FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 138/275 (50%), Gaps = 24/275 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + IG G+Y    +   K      A+K I ++ R+ ++      EI  L  + +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE------EIEILLRYGQHPN 82
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           IIT+ D+Y   + K +Y+V E M     L+K++R K   +    +++  +   + Y+H+ 
Sbjct: 83  IITLKDVYD--DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 143 KVMHRDLKPSNIL-IDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            V+HRDLKPSNIL +D+S +   ++I D G A+ L      L     T  + APE+L   
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-KR 199
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY---AGFK 255
           + Y    DIWSLG +L  ML     F    +    +++  +       + KF      + 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI------GSGKFTLSGGNWN 253
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
              E A DL++++L ++P +R    Q+L+H +V++
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 138/275 (50%), Gaps = 24/275 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + IG G+Y    +   K      A+K I ++ R+ ++      EI  L  + +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE------EIEILLRYGQHPN 82
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           IIT+ D+Y   + K +Y+V E M     L+K++R K   +    +++  +   + Y+H+ 
Sbjct: 83  IITLKDVYD--DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 143 KVMHRDLKPSNIL-IDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            V+HRDLKPSNIL +D+S +   ++I D G A+ L      L     T  + APE+L   
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-KR 199
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY---AGFK 255
           + Y    DIWSLG +L  ML     F    +    +++  +       + KF      + 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI------GSGKFTLSGGNWN 253
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
              E A DL++++L ++P +R    Q+L+H +V++
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGGP 87
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 146
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 147 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 205
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 206 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 265
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 266 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLMGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGGP 107
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 166
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 167 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 225
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 226 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLE 285
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 286 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 147/293 (50%), Gaps = 29/293 (9%)
Query: 10  GDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQ 67
           G  VQH+    I ++ Y   + +GKG++G V    DK   Q  A+K I +   + KTD +
Sbjct: 20  GMFVQHST--AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 68  RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHI 125
              RE+  LK    HPNI+ + + ++  +    Y+V E Y   +L +++I  K   +V  
Sbjct: 78  SLLREVQLLKQLD-HPNIMKLYEFFE--DKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 134
Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTE 182
             I+ Q+ +G++Y+H  K++HRDLKP N+L++   K  +I+I D GL+     SK+ + +
Sbjct: 135 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKD 193
Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VN 238
            I T +Y APE+L  +  Y    D+WS G IL  +L   P F GA+    L+ +      
Sbjct: 194 KIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 251
Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              P           +K   E A DL+ ++L   PS R      L+H ++  Y
Sbjct: 252 FELPQ----------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 141/268 (52%), Gaps = 15/268 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T   RIGKG++G VYK  D + K+ VAIK I +    + + +   +EI  L      P 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCD-SPY 78
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           I      Y  + +  L+++ EY+       +++   L++ +I  I+ ++  GL Y+H+ +
Sbjct: 79  ITRYFGSY--LKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 136
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV-IKQSAYDF 195
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +   P  S  H ++++  + + +PP  +    G  +KP +  +
Sbjct: 196 KADIWSLGITAIELAKGE---PPNSDLHPMRVLFLIPKNSPPTLE----GQHSKPFK--E 246
Query: 264 LLNQILVLNPSERPETDQILEHNYVSKY 291
            +   L  +P  RP   ++L+H ++++Y
Sbjct: 247 FVEACLNKDPRFRPTAKELLKHKFITRY 274

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGGP 87
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 146
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 147 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 205
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 206 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 265
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 266 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGGP 88
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 147
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 148 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 206
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 207 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 266
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 267 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++  + NN +     K           ++  REI  L++    P
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           NI+ +LDI +  ++K   ++FEY+ N   KV+    L D  IRY +++L   L Y H+  
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQG 145
Query: 144 VMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +MHRD+KP N++ID     +++ D GLA      KE     +A+R+++ PE+L+  + Y 
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQDYD 204
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNL--------------VRPNPP-- 245
           + +D+WSLGC+ A M+ + +P F G     QL  I  +              +  +P   
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLE 264
Query: 246 -----HADKFYAGFKNK------PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                H+ K +  F N         EA+D L+++L  +  ER    + + H Y  +
Sbjct: 265 ALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 148/317 (46%), Gaps = 49/317 (15%)
Query: 4   NTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE----- 58
            ++  SGD VQ N       +YT+   IGKG+YG+V  AY++N+  Y A+K + +     
Sbjct: 1   GSSGSSGDCVQLN-------QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIR 53
Query: 59  -------------------AFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD 99
                                + +   ++ Y+EI  LK    HPN++ ++++    N   
Sbjct: 54  QAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDH 112
Query: 100 LYVVFEYM-ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 158
           LY+VFE + +  + +V   K L +   R+    L  G+ Y+H  K++HRD+KPSN+L+ +
Sbjct: 113 LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 159 SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY--THHVDIWSLGCILAE 216
              IKI D G++     S   L+  + T  + APE L   R+      +D+W++G  L  
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 217 MLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP---EEAVDLLNQILVLNP 273
            +  +  F       ++  + + ++            F ++P   E+  DL+ ++L  NP
Sbjct: 233 FVFGQCPF----MDERIMCLHSKIKSQALE-------FPDQPDIAEDLKDLITRMLDKNP 281
Query: 274 SERPETDQILEHNYVSK 290
             R    +I  H +V++
Sbjct: 282 ESRIVVPEIKLHPWVTR 298

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 129/233 (55%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + VA+K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N+LID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 143/293 (48%), Gaps = 29/293 (9%)
Query: 10  GDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQ 67
           G  VQH+    I ++ Y   + +GKG++G V    DK   Q  A+K I +   + KTD +
Sbjct: 14  GXFVQHST--AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 68  RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHI 125
              RE+  LK    HPNI  + + ++  +    Y+V E Y   +L +++I  K   +V  
Sbjct: 72  SLLREVQLLKQLD-HPNIXKLYEFFE--DKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTE 182
             I+ Q+ +G++Y H  K++HRDLKP N+L++   K  +I+I D GL+     SK+   +
Sbjct: 129 ARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-XKD 187
Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VN 238
            I T +Y APE+L  +  Y    D+WS G IL  +L   P F GA+    L+ +      
Sbjct: 188 KIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              P           +K   E A DL+ + L   PS R      L+H ++  Y
Sbjct: 246 FELPQ----------WKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTY 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 135/276 (48%), Gaps = 24/276 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + IG G+Y +  +   K      A+K I ++ R+ T+      EI  L  + +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE------EIEILLRYGQHPN 77
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           IIT+ D+Y   + K +YVV E  +    L+K++R K   +     ++F +   + Y+HA 
Sbjct: 78  IITLKDVYD--DGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 143 KVMHRDLKPSNIL-IDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            V+HRDLKPSNIL +D+S    SI+I D G A+ L      L     T  + APE+L   
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL-ER 194
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF--YAGFKN 256
           + Y    DIWSLG +L   L     F         +++  +       + KF    G+ N
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARI------GSGKFSLSGGYWN 248
Query: 257 K-PEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              + A DL+++ L ++P +R     +L H ++  +
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y +   IG G+YG   K   K++ + +  K++      + + Q    E+  L+   +HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-----RDKILKDVHIRYIMFQLCNGLS 137
           NI+   D      N  LY+V EY E  DL  VI       + L +  +  +M QL   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 138 YIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             H        V+HRDLKP+N+ +D   ++K+GD GLAR L+  ++   E++ T +Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSP 185
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E + +   Y    DIWSLGC+L E+    P F   S   Q +L           A K   
Sbjct: 186 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKEL-----------AGKIRE 230
Query: 253 G-FKNKPEEAVDLLNQILV----LNPSERPETDQILEH 285
           G F+  P    D LN+I+     L    RP  ++ILE+
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 128/232 (55%), Gaps = 9/232 (3%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMF 130
                L++ +  PNIIT+ DI K   ++   +VFE++ N   K +R + L D  IR+ M+
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLR-QTLTDYDIRFYMY 138
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
           ++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R++
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYF 197
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           + PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 138/269 (51%), Gaps = 19/269 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  +RIGKG++G V+K  D   +Q VAIK I +    + + +   +EI  L   Q   +
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEITVLS--QCDSS 81
Query: 85  IITMLDIYKA-VNNKDLYVVFEYMENDLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
            +T    Y + +    L+++ EY+       ++R     +  I  ++ ++  GL Y+H+ 
Sbjct: 82  YVT--KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           K +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y 
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IQQSAYD 198
Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-ADKFYAGFKNKPEEA 261
              DIWSLG    E+ + +P  P  S  H ++++  + + NPP     F   FK      
Sbjct: 199 SKADIWSLGITAIELAKGEP--PN-SDMHPMRVLFLIPKNNPPTLVGDFTKSFK------ 249
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSK 290
            + ++  L  +PS RP   ++L+H ++ K
Sbjct: 250 -EFIDACLNKDPSFRPTAKELLKHKFIVK 277

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 38/294 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++A +  N +     ++          ++  RE+  L++ +   
Sbjct: 39  DYQLVRKLGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGT 93
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           NII ++D  K   +K   +VFEY+ N D  ++   +IL D  IR+ M++L   L Y H+ 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY--QILTDFDIRFYMYELLKALDYCHSK 151
Query: 143 KVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            +MHRD+KP N++ID +   +++ D GLA     ++E     +A+R+++ PE+L+  + Y
Sbjct: 152 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDYQMY 210
Query: 202 THHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNP---------------- 244
            + +D+WSLGC+LA M+ + +P F G     QL  I  ++                    
Sbjct: 211 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 270
Query: 245 -----PHADKFYAGF---KNK---PEEAVDLLNQILVLNPSERPETDQILEHNY 287
                 H+ K +  F   +N+     EA+DLL+++L  +  +R    + +EH Y
Sbjct: 271 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 150/294 (51%), Gaps = 38/294 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + +++G+G Y  V++A +  N +     ++          ++  RE+  L++ +   
Sbjct: 44  DYQLVRKLGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGT 98
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           NII ++D  K   +K   +VFEY+ N D  ++   +IL D  IR+ M++L   L Y H+ 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY--QILTDFDIRFYMYELLKALDYCHSK 156
Query: 143 KVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            +MHRD+KP N++ID +   +++ D GLA     ++E     +A+R+++ PE+L+  + Y
Sbjct: 157 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDYQMY 215
Query: 202 THHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNP---------------- 244
            + +D+WSLGC+LA M+ + +P F G     QL  I  ++                    
Sbjct: 216 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 275
Query: 245 -----PHADKFYAGF---KNK---PEEAVDLLNQILVLNPSERPETDQILEHNY 287
                 H+ K +  F   +N+     EA+DLL+++L  +  +R    + +EH Y
Sbjct: 276 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 138/278 (49%), Gaps = 31/278 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L S   HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCD-HPN 95
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +LD +   NN  L+++ E+      D   +  ++ L +  I+ +  Q  + L+Y+H 
Sbjct: 96  IVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS---- 197
            K++HRDLK  NIL      IK+ D G++   + + +    +I T ++ APE+++     
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP---HADKFY 251
           +R Y +  D+WSLG  L EM + +P        H+L   ++++ + +  PP      ++ 
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           + FK       D L + L  N   R  T Q+L+H +V+
Sbjct: 268 SNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 123/231 (53%), Gaps = 15/231 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRH 82
           Y I   IGKG++G V KAYD+  +++VAIK I   +AF N+   +    E++     +  
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHI---RYIMFQLCNGLSYI 139
             I+ +   +   N+  L +VFE +  +L  ++R+   + V +   R    Q+C  L ++
Sbjct: 97  YYIVHLKRHFMFRNH--LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 140 HA--CKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
                 ++H DLKP NIL+   K  +IKI D G +  L      + + I +R+YR+PE+L
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQXIQSRFYRSPEVL 211
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           +    Y   +D+WSLGCIL EM   +PLF GA+   Q+  IV ++   P H
Sbjct: 212 LG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 261

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 123/231 (53%), Gaps = 15/231 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRH 82
           Y I   IGKG++G V KAYD+  +++VAIK I   +AF N+   +    E++     +  
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHI---RYIMFQLCNGLSYI 139
             I+ +   +   N+  L +VFE +  +L  ++R+   + V +   R    Q+C  L ++
Sbjct: 116 YYIVHLKRHFMFRNH--LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 140 HA--CKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
                 ++H DLKP NIL+   K  +IKI D G +  L      + + I +R+YR+PE+L
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQXIQSRFYRSPEVL 230
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           +    Y   +D+WSLGCIL EM   +PLF GA+   Q+  IV ++   P H
Sbjct: 231 LG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 144/287 (50%), Gaps = 15/287 (5%)
Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           +++  +SG     N+  +    +T  ++IGKG++G V+K  D   ++ VAIK I +    
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEA 60
Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLN-KVIRDKILK 121
           + + +   +EI  L      P +      Y  + +  L+++ EY+       ++    L 
Sbjct: 61  EDEIEDIQQEITVLSQCDS-PYVTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 181
           +  I  I+ ++  GL Y+H+ K +HRD+K +N+L+ +   +K+ D G+A  L+D++    
Sbjct: 118 ETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
            ++ T ++ APE+ I    Y    DIWSLG    E+ + +P     S  H ++++  + +
Sbjct: 178 XFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPK 233
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            NPP  +  Y+    KP +  + +   L   PS RP   ++L+H ++
Sbjct: 234 NNPPTLEGNYS----KPLK--EFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A +K++ + VA+K +    R +   +  + E++ ++ +Q H N++ M 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMY 108
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
             Y  +  ++L+V+ E+++   L  ++    L +  I  +   +   L+Y+HA  V+HRD
Sbjct: 109 KSY--LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     +K+ D G    +S         + T ++ APE+ IS   Y   VDIW
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEV-ISRSLYATEVDIW 225
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +   S    ++ +    R +PP   K     K  P    D L ++
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRL----RDSPP--PKLKNSHKVSP-VLRDFLERM 278
Query: 269 LVLNPSERPETDQILEHNYV 288
           LV +P ER    ++L+H ++
Sbjct: 279 LVRDPQERATAQELLDHPFL 298

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 35/290 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           + IG G++G VY A D  N + VAIKK+ +   ++    Q   +E+ FL+   RHPN I 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 118
Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
               Y  +     ++V EY     + +  +  K L++V I  +      GL+Y+H+  ++
Sbjct: 119 YRGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--NRRYTH 203
           HRD+K  NIL+ +   +K+GD G A  ++ +      ++ T ++ APE++++    +Y  
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP--NPPHADKFYAGFKNKPEEA 261
            VD+WSLG    E+ + KP     +    L  I     P     H  +++  F       
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF------- 285
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI 311
              ++  L   P +RP ++ +L+H +V +             P TV++D+
Sbjct: 286 ---VDSCLQKIPQDRPTSEVLLKHRFVLRE-----------RPPTVIMDL 321

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 137/278 (49%), Gaps = 31/278 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L S   HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCD-HPN 95
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +LD +   NN  L+++ E+      D   +  ++ L +  I+ +  Q  + L+Y+H 
Sbjct: 96  IVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS---- 197
            K++HRDLK  NIL      IK+ D G++   +   +    +I T ++ APE+++     
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP---HADKFY 251
           +R Y +  D+WSLG  L EM + +P        H+L   ++++ + +  PP      ++ 
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           + FK       D L + L  N   R  T Q+L+H +V+
Sbjct: 268 SNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 137/278 (49%), Gaps = 31/278 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L S   HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCD-HPN 95
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +LD +   NN  L+++ E+      D   +  ++ L +  I+ +  Q  + L+Y+H 
Sbjct: 96  IVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS---- 197
            K++HRDLK  NIL      IK+ D G++   +   +    +I T ++ APE+++     
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRPNPP---HADKFY 251
           +R Y +  D+WSLG  L EM + +P        H+L   ++++ + +  PP      ++ 
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           + FK       D L + L  N   R  T Q+L+H +V+
Sbjct: 268 SNFK-------DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 24/272 (8%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           + IG G++G VY A D  N + VAIKK+ +   ++    Q   +E+ FL+   RHPN I 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
               Y  +     ++V EY     + +  +  K L++V I  +      GL+Y+H+  ++
Sbjct: 80  YRGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS--NRRYTH 203
           HRD+K  NIL+ +   +K+GD G A  ++ +      ++ T ++ APE++++    +Y  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP--NPPHADKFYAGFKNKPEEA 261
            VD+WSLG    E+ + KP     +    L  I     P     H  +++  F       
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF------- 246
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
              ++  L   P +RP ++ +L+H +V +  P
Sbjct: 247 ---VDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 123/231 (53%), Gaps = 15/231 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQRH 82
           Y I   IGKG++G V KAYD+  +++VAIK I   +AF N+   +    E++     +  
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHI---RYIMFQLCNGLSYI 139
             I+ +   +   N+  L +VFE +  +L  ++R+   + V +   R    Q+C  L ++
Sbjct: 116 YYIVHLKRHFMFRNH--LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 140 HA--CKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
                 ++H DLKP NIL+   K  +IKI D G +  L      + + I +R+YR+PE+L
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQR---IYQXIQSRFYRSPEVL 230
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           +    Y   +D+WSLGCIL EM   +PLF GA+   Q+  IV ++   P H
Sbjct: 231 LG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 136/275 (49%), Gaps = 26/275 (9%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-------TYREILFLKSFQRHP 83
           IG+G   +V +   +      A+K I E    +   ++       T RE   L+    HP
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVK-IMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 84  NIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHA 141
           +IIT++D Y++  +  +++VF+ M + +L   + +K+ L +   R IM  L   +S++HA
Sbjct: 161 HIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             ++HRDLKP NIL+D +  I++ D G +  L +  E L E   T  Y APEIL  +   
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 202 TH-----HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV-NLVRPNPPHADKFYAGFK 255
           TH      VD+W+ G IL  +L   P F        L++I+    + + P  D   +  K
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                  DL++++L ++P  R   +Q L+H +  +
Sbjct: 338 -------DLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 24  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 82
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 83  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 136
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 195
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 23  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 81
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 82  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 135
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 136 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 194
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 22/278 (7%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLK 77
           G  + ++ +   +GKG++  VY+A   +    VAIK I  +A       QR   E+  + 
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK-IH 65
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCN 134
              +HP+I+ + + ++  N   +Y+V E   N ++N+ +++++    +   R+ M Q+  
Sbjct: 66  CQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           G+ Y+H+  ++HRDL  SN+L+ ++ +IKI D GLA  L    E       T  Y +PEI
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 195 LISNRRYTHHV--DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
                R  H +  D+WSLGC+   +L  +P F   +  + L  +V         AD    
Sbjct: 184 AT---RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--------LADYEMP 232
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            F +   EA DL++Q+L  NP++R     +L+H ++S+
Sbjct: 233 SFLSI--EAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 30  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 88
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 89  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 142
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 143 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 201
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 202 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 143/302 (47%), Gaps = 27/302 (8%)
Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           M S++ ++S D++  +   +    + + + +G G YG VYK       Q  AIK + +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDV- 59
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN----NKDLYVVFEYME----NDLN 112
               + +   +EI  LK +  H NI T    +   N    +  L++V E+       DL 
Sbjct: 60  -TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 113 KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
           K  +   LK+  I YI  ++  GLS++H  KV+HRD+K  N+L+ ++  +K+ D G++  
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 173 LSDSKECLTEYIATRWYRAPEILISNRR----YTHHVDIWSLGCILAEMLQSKPLFPGAS 228
           L  +      +I T ++ APE++  +      Y    D+WSLG    EM +  P      
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---C 235
Query: 229 TSHQLQLIVNLVRPNPPH--ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
             H ++ +  + R   P   + K+   F++        +   LV N S+RP T+Q+++H 
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQS-------FIESCLVKNHSQRPATEQLMKHP 288
Query: 287 YV 288
           ++
Sbjct: 289 FI 290

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 24  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 82
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 83  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 136
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 195
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 128/233 (54%), Gaps = 11/233 (4%)
Query: 11  DKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           D   H V+     +Y + +++G+G Y  V++A +  N + V +K +    + K   +   
Sbjct: 25  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK- 83
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIM 129
                L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L D  IR+ M
Sbjct: 84  ----ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYM 137
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+
Sbjct: 138 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY 196
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
           ++ PE+L+  + Y + +D+WSLGC+LA M+ + +P F G     QL  I  ++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHP 83
           Y + K IGKG++G V KAYD    Q+VA+K +    RN+    R    EI  L+  ++  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 84  -----NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNG 135
                N+I ML+ +   N+  + + FE +  +L ++I+    +      +R     +   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L  +H  +++H DLKP NIL+ +     I  +    S  + +   T  I +R+YRAPE++
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTX-IQSRFYRAPEVI 271
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
           +  R Y   +D+WSLGCILAE+L   PL PG     QL  ++ L+
Sbjct: 272 LGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 146/300 (48%), Gaps = 33/300 (11%)
Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           S   S+  + V+ ++D N + E  I   +G GA+G VYKA +K      A K I    ++
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWE--IVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKS 56
Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---DKI 119
           + + +    EI  L +   HP I+ +L  Y   ++  L+++ E+        I    D+ 
Sbjct: 57  EEELEDYIVEIEILATCD-HPYIVKLLGAY--YHDGKLWIMIEFCPGGAVDAIMLELDRG 113
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 179
           L +  I+ +  Q+   L+++H+ +++HRDLK  N+L+     I++ D G++     + + 
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 180 LTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-- 233
              +I T ++ APE+++     +  Y +  DIWSLG  L EM Q +P        H+L  
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------PHHELNP 227
Query: 234 -QLIVNLVRPNPP---HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            ++++ + + +PP      K+   F+       D L   L  NP  RP   Q+LEH +VS
Sbjct: 228 MRVLLKIAKSDPPTLLTPSKWSVEFR-------DFLKIALDKNPETRPSAAQLLEHPFVS 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 147/323 (45%), Gaps = 34/323 (10%)
Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
            N+ +   D+  H      +  Y + K IGKG +  V  A      + VAIK I +   N
Sbjct: 1   GNSIASCADEQPH------IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN 54
Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKIL 120
            T  Q+ +RE+  +K    HPNI+ + ++ +    K LY++ EY       + ++    +
Sbjct: 55  PTSLQKLFREVRIMKILN-HPNIVKLFEVIE--TEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
           K+   R    Q+ + + Y H  +++HRDLK  N+L+D   +IKI D G +   +   + L
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-L 170
Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
             +     Y APE+    +     VD+WSLG IL  ++     F G +     + ++   
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH--- 297
              P     FY        +  +LL + LVLNP +R   +QI++  ++     +A H   
Sbjct: 231 YRIP-----FYMS-----TDCENLLKRFLVLNPIKRGTLEQIMKDRWI-----NAGHEED 275
Query: 298 -VIPQVTPHTVVLDIDDNNQLEI 319
            + P V P    LDI D  +++I
Sbjct: 276 ELKPFVEPE---LDISDQKRIDI 295

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 142/304 (46%), Gaps = 28/304 (9%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VAIK I +   N T  Q+ +RE+  +K    
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN- 69
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY++ EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 70  HPNIVKLFEVIE--TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 127
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  +++HRDLK  N+L+D   +IKI D G +   +   + L  +  +  Y APE+    +
Sbjct: 128 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQGKK 186
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 236
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH----VIPQVTPHTVVLDIDDNN 315
           +  +LL + LVLNP +R   +QI++  ++     +A H    + P V P    LDI D  
Sbjct: 237 DCENLLKRFLVLNPIKRGTLEQIMKDRWI-----NAGHEEDELKPFVEPE---LDISDQK 288
Query: 316 QLEI 319
           +++I
Sbjct: 289 RIDI 292

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHP 83
           Y + K IGKG++G V KAYD    Q+VA+K +    RN+    R    EI  L+  ++  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 84  -----NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNG 135
                N+I ML+ +   N+  + + FE +  +L ++I+    +      +R     +   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L  +H  +++H DLKP NIL+ +     I  +    S  + +   T  I +R+YRAPE++
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTX-IQSRFYRAPEVI 271
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
           +  R Y   +D+WSLGCILAE+L   PL PG     QL  ++ L+
Sbjct: 272 LGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 135/265 (50%), Gaps = 15/265 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  ++IGKG++G V+K  D   ++ VAIK I +    + + +   +EI  L      P 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PY 86
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           +      Y  + +  L+++ EY+       ++    L +  I  I+ ++  GL Y+H+ K
Sbjct: 87  VTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDS 203
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +   P  S  H ++++  + + NPP  +  Y+    KP +  +
Sbjct: 204 KADIWSLGITAIELARGE---PPHSELHPMKVLFLIPKNNPPTLEGNYS----KPLK--E 254
Query: 264 LLNQILVLNPSERPETDQILEHNYV 288
            +   L   PS RP   ++L+H ++
Sbjct: 255 FVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 40/291 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ I + +GKG +G VY A +K NK  +A+K +F++   K   +   R  + ++S  RHP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV--HIRY-------IMFQLCN 134
           NI+ M + +   + K +Y++ E+         R ++ K++  H R+        M +L +
Sbjct: 76  NILRMYNYFH--DRKRIYLMLEF-------APRGELYKELQKHGRFDEQRSATFMEELAD 126
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL---ARSLSDSKECLTEYIATRWYRA 191
            L Y H  KV+HRD+KP N+L+     +KI D G    A SL     C      T  Y  
Sbjct: 127 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-----GTLDYLP 181
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE +I  + +   VD+W  G +  E L   P F   S +   + IVN+    PP      
Sbjct: 182 PE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS--- 237
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                  + + DL++++L  +P +R     ++EH +V     ++  V+P V
Sbjct: 238 -------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA---NSRRVLPPV 278

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y +   IG G+YG   K   K++ + +  K++      + + Q    E+  L+   +HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-----RDKILKDVHIRYIMFQLCNGLS 137
           NI+   D      N  LY+V EY E  DL  VI       + L +  +  +M QL   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 138 YIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             H        V+HRDLKP+N+ +D   ++K+GD GLAR L+        ++ T +Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E + +   Y    DIWSLGC+L E+    P F   S   Q +L           A K   
Sbjct: 186 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKEL-----------AGKIRE 230
Query: 253 G-FKNKPEEAVDLLNQILV----LNPSERPETDQILEH 285
           G F+  P    D LN+I+     L    RP  ++ILE+
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y +   IG G+YG   K   K++ + +  K++      + + Q    E+  L+   +HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-----RDKILKDVHIRYIMFQLCNGLS 137
           NI+   D      N  LY+V EY E  DL  VI       + L +  +  +M QL   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 138 YIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             H        V+HRDLKP+N+ +D   ++K+GD GLAR L+        ++ T +Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E + +   Y    DIWSLGC+L E+    P F   S   Q +L           A K   
Sbjct: 186 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKEL-----------AGKIRE 230
Query: 253 G-FKNKPEEAVDLLNQILV----LNPSERPETDQILEH 285
           G F+  P    D LN+I+     L    RP  ++ILE+
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 135/265 (50%), Gaps = 15/265 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  ++IGKG++G V+K  D   ++ VAIK I +    + + +   +EI  L      P 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PY 66
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           +      Y  + +  L+++ EY+       ++    L +  I  I+ ++  GL Y+H+ K
Sbjct: 67  VTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV-IKQSAYDS 183
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +   P  S  H ++++  + + NPP  +  Y+    KP +  +
Sbjct: 184 KADIWSLGITAIELARGE---PPHSELHPMKVLFLIPKNNPPTLEGNYS----KPLK--E 234
Query: 264 LLNQILVLNPSERPETDQILEHNYV 288
            +   L   PS RP   ++L+H ++
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 135/265 (50%), Gaps = 15/265 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +T  ++IGKG++G V+K  D   ++ VAIK I +    + + +   +EI  L      P 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS-PY 66
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLN-KVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           +      Y  + +  L+++ EY+       ++    L +  I  I+ ++  GL Y+H+ K
Sbjct: 67  VTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
            +HRD+K +N+L+ +   +K+ D G+A  L+D++     ++ T ++ APE+ I    Y  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV-IKQSAYDS 183
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
             DIWSLG    E+ + +   P  S  H ++++  + + NPP  +  Y+    KP +  +
Sbjct: 184 KADIWSLGITAIELARGE---PPHSELHPMKVLFLIPKNNPPTLEGNYS----KPLK--E 234
Query: 264 LLNQILVLNPSERPETDQILEHNYV 288
            +   L   PS RP   ++L+H ++
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 23/272 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A ++ +K  +A+K +F+    K   +   R  + ++S  R
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   +       +Y++ EY        +L K+ R     +      + +L N L
Sbjct: 71  HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANAL 125
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           SY H+ +V+HRD+KP N+L+  +  +KI D G +     S+   T    T  Y  PE +I
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--TTLCGTLDYLPPE-MI 182
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             R +   VD+WSLG +  E L   P F   +     + I  +    P            
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVT-------- 234
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             E A DL++++L  N S+R    ++LEH ++
Sbjct: 235 --EGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 142/290 (48%), Gaps = 33/290 (11%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE 72
           V+ ++D N + E  I   +G GA+G VYKA +K      A K I    +++ + +    E
Sbjct: 3   VRRDLDPNEVWE--IVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVE 58
Query: 73  ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIM 129
           I  L +   HP I+ +L  Y   ++  L+++ E+        I    D+ L +  I+ + 
Sbjct: 59  IEILATCD-HPYIVKLLGAY--YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 115
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            Q+   L+++H+ +++HRDLK  N+L+     I++ D G++     + +    +I T ++
Sbjct: 116 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 175
Query: 190 RAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLVRP 242
            APE+++     +  Y +  DIWSLG  L EM Q +P        H+L   ++++ + + 
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------PHHELNPMRVLLKIAKS 229
Query: 243 NPP---HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +PP      K+   F+       D L   L  NP  RP   Q+LEH +VS
Sbjct: 230 DPPTLLTPSKWSVEFR-------DFLKIALDKNPETRPSAAQLLEHPFVS 272

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 117/227 (51%), Gaps = 21/227 (9%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-TYREILFLKSFQRHP 83
           Y + K IGKG +G V KAYD    Q+VA+K +    RN+    R    EI  L+  ++  
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 84  -----NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNG 135
                N+I ML+ +   N+  + + FE +  +L ++I+    +      +R     +   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 136 LSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L  +H  +++H DLKP NIL+ +     IK+ D G   S     + +   I +R+YRAPE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPE 269
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
           +++  R Y   +D+WSLGCILAE+L   PL PG     QL  ++ L+
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 19/287 (6%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI 73
           Q +  G+I   YT+   IG+G++G V  A  K  +   A KKI + F    D  R  +EI
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEI 74
Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQ 131
             +KS   HPNII + + ++  +N D+Y+V E         +V+  ++ ++     IM  
Sbjct: 75  EIMKSLD-HPNIIRLYETFE--DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 132 LCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           + + ++Y H   V HRDLKP N L         +K+ D GLA      K   T+ + T +
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPY 190
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           Y +P++L     Y    D WS G ++  +L   P F  A T  ++ L +       P  D
Sbjct: 191 YVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-SAPTDXEVMLKIREGTFTFPEKD 247
Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA 295
                + N   +A  L+ ++L  +P +R  + Q LEH +  K   S+
Sbjct: 248 -----WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 40/291 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ I + +GKG +G VY A +K NK  +A+K +F++   K   +   R  + ++S  RHP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV--HIRY-------IMFQLCN 134
           NI+ M + +   + K +Y++ E+         R ++ K++  H R+        M +L +
Sbjct: 75  NILRMYNYFH--DRKRIYLMLEF-------APRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL---ARSLSDSKECLTEYIATRWYRA 191
            L Y H  KV+HRD+KP N+L+     +KI D G    A SL     C      T  Y  
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-----GTLDYLP 180
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE +I  + +   VD+W  G +  E L   P F   S +   + IVN+    PP      
Sbjct: 181 PE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS--- 236
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                  + + DL++++L  +P +R     ++EH +V     ++  V+P V
Sbjct: 237 -------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA---NSRRVLPPV 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +GKG YGIVY   D +N+  +AIK+I E  R+   +Q  + EI   K   +H NI+  L 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHL-KHKNIVQYLG 86
Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVH--IRYIMFQLCNGLSYIHACKVM 145
            +    N  + +  E +    L+ ++R K   LKD    I +   Q+  GL Y+H  +++
Sbjct: 87  SFS--ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 146 HRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-RRYTH 203
           HRD+K  N+LI+  S  +KI D G ++ L+    C   +  T  Y APEI+    R Y  
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
             DIWSLGC + EM   KP F            V + + +P
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 132/272 (48%), Gaps = 15/272 (5%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +IG+G+ GIV  A +K+  + VA+KK+    R +   +  + E++ ++ +  H N++ M 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYH-HDNVVDMY 108
Query: 90  DIYKAVNNKDLYVVFEYMEND-LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
             Y  +   +L+VV E++E   L  ++    + +  I  +   +   LSY+H   V+HRD
Sbjct: 109 SSY--LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIW 208
           +K  +IL+     IK+ D G    +S         + T ++ APE+ IS   Y   VDIW
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV-ISRLPYGTEVDIW 225
Query: 209 SLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQI 268
           SLG ++ EM+  +P +        ++ I + + P      K  +  +         L+ +
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRG-------FLDLM 278
Query: 269 LVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           LV  PS+R    ++L H ++    P +  ++P
Sbjct: 279 LVREPSQRATAQELLGHPFLKLAGPPSC-IVP 309

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +GKG YGIVY   D +N+  +AIK+I E  R+   +Q  + EI   K   +H NI+  L 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHL-KHKNIVQYLG 72
Query: 91  IYKAVNNKDLYVVFEYMEND-LNKVIRDKI--LKDVH--IRYIMFQLCNGLSYIHACKVM 145
            +    N  + +  E +    L+ ++R K   LKD    I +   Q+  GL Y+H  +++
Sbjct: 73  SFS--ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 146 HRDLKPSNILIDK-SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-RRYTH 203
           HRD+K  N+LI+  S  +KI D G ++ L+    C   +  T  Y APEI+    R Y  
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
             DIWSLGC + EM   KP F            V + + +P
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 231

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + ++ +HK +GKG++G V+ A  K   Q+ AIK +  +      D + T  E   L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV-HIRYIMFQLCNGLSY 138
            HP +  M   ++   N  L+ V EY+   DL   I+     D+    +   ++  GL +
Sbjct: 77  EHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS--LSDSKECLTEYIATRWYRAPEILI 196
           +H+  +++RDLK  NIL+DK   IKI D G+ +   L D+K    E+  T  Y APEIL+
Sbjct: 135 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NEFCGTPDYIAPEILL 192
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             ++Y H VD WS G +L EML  +  F G       +L  ++   NP     FY  +  
Sbjct: 193 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNP-----FYPRWLE 243
Query: 257 KPEEAVDLLNQILVLNPSER 276
           K  EA DLL ++ V  P +R
Sbjct: 244 K--EAKDLLVKLFVREPEKR 261

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 129/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA++ I +   N +  Q+ +RE+  +K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L E+  +  Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 268

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 23/272 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A ++ +K  +A+K +F+    K   +   R  + ++S  R
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   +       +Y++ EY        +L K+ R     +      + +L N L
Sbjct: 71  HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANAL 125
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           SY H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE +I
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPE-MI 182
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             R +   VD+WSLG +  E L   P F   +     + I  +    P            
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVT-------- 234
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             E A DL++++L  N S+R    ++LEH ++
Sbjct: 235 --EGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 19/285 (6%)
Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           +  G+I   YT+   IG+G++G V  A  K  +   A KKI + F    D  R  +EI  
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEI 59
Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLC 133
           +KS   HPNII + + ++  +N D+Y+V E         +V+  ++ ++     IM  + 
Sbjct: 60  MKSLD-HPNIIRLYETFE--DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 134 NGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           + ++Y H   V HRDLKP N L         +K+ D GLA      K   T+ + T +Y 
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYV 175
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           +P++L     Y    D WS G ++  +L   P F  A T  ++ L +       P  D  
Sbjct: 176 SPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-SAPTDXEVMLKIREGTFTFPEKD-- 230
Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA 295
              + N   +A  L+ ++L  +P +R  + Q LEH +  K   S+
Sbjct: 231 ---WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA+K I +   N +  Q+ +RE+  +K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +  +  Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA+K I +   N +  Q+ +RE+  +K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +  +  Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 268

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA+K I +   N +  Q+ +RE+  +K    
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN- 64
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 65  HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +  +  Y APE+    +
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKK 181
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 231
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 232 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 261

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 133/273 (48%), Gaps = 17/273 (6%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y + + +GKGA+ +V +   K   Q  A K I     +  D Q+  RE    +   +HP
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICR-LLKHP 90
Query: 84  NIITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           NI+ + D   +++ +   Y+VF+ +        ++  +   +    + + Q+   +++IH
Sbjct: 91  NIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 141 ACKVMHRDLKPSNILIDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
              ++HRDLKP N+L+   C   ++K+ D GLA  +   ++    +  T  Y +PE+L  
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  Y   VDIW+ G IL  +L   P F      H+L   +     + P  +     +   
Sbjct: 208 D-PYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKAGAYDFPSPE-----WDTV 260
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             EA +L+NQ+L +NP++R   DQ L+H +V +
Sbjct: 261 TPEAKNLINQMLTINPAKRITADQALKHPWVCQ 293

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA+K I +   N +  Q+ +RE+  +K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIE--TEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +     Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 137/276 (49%), Gaps = 21/276 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIIT 87
           K++G GAYG V    DK      AIK I ++    T ++     E+  LK    HPNI+ 
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HPNIMK 68
Query: 88  MLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           + + ++  + ++ Y+V E Y   +L +++I  +   +V    IM Q+ +G +Y+H   ++
Sbjct: 69  LYEFFE--DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 126
Query: 146 HRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           HRDLKP N+L++   +   IKI D GL+       + + E + T +Y APE+L   ++Y 
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVL--RKKYD 183
Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV-NLVRPNPPHADKFYAGFKNKPEEA 261
              D+WS G IL  +L   P F G +    L+ +       +PP        +    +EA
Sbjct: 184 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPD-------WTQVSDEA 236
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
             L+  +L   PS+R   ++ L H ++ K F S  H
Sbjct: 237 KQLVKLMLTYEPSKRISAEEALNHPWIVK-FCSQKH 271

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 25/276 (9%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQRTYREILFLKSFQRHP 83
           +G+G   +V +   K   +  A+K I       F A   +   + T +E+  L+    HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHA 141
           NII + D Y+   N   ++VF+ M+  +L   + +K+ L +   R IM  L   +  +H 
Sbjct: 85  NIIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR- 200
             ++HRDLKP NIL+D   +IK+ D G +  L D  E L E   T  Y APEI+  +   
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 201 ----YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFK 255
               Y   VD+WS G I+  +L   P F        L++I++   +   P  D +    K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                  DL+++ LV+ P +R   ++ L H +  +Y
Sbjct: 262 -------DLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 16/270 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA++ I +   N +  Q+ +RE+  +K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++    +K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +  +  Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYMS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           +  +LL + L+LNPS+R   +QI++  +++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMN 268

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + ++ +HK +GKG++G V+ A  K   Q+ AIK +  +      D + T  E   L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV-HIRYIMFQLCNGLSY 138
            HP +  M   ++   N  L+ V EY+   DL   I+     D+    +   ++  GL +
Sbjct: 76  EHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS--LSDSKECLTEYIATRWYRAPEILI 196
           +H+  +++RDLK  NIL+DK   IKI D G+ +   L D+K     +  T  Y APEIL+
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NXFCGTPDYIAPEILL 191
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
             ++Y H VD WS G +L EML  +  F G       +L  ++   NP     FY  +  
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNP-----FYPRWLE 242
Query: 257 KPEEAVDLLNQILVLNPSER 276
           K  EA DLL ++ V  P +R
Sbjct: 243 K--EAKDLLVKLFVREPEKR 260

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 25/276 (9%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQRTYREILFLKSFQRHP 83
           +G+G   +V +   K   +  A+K I       F A   +   + T +E+  L+    HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHA 141
           NII + D Y+   N   ++VF+ M+  +L   + +K+ L +   R IM  L   +  +H 
Sbjct: 72  NIIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR- 200
             ++HRDLKP NIL+D   +IK+ D G +  L D  E L E   T  Y APEI+  +   
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 201 ----YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFK 255
               Y   VD+WS G I+  +L   P F        L++I++   +   P  D +    K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                  DL+++ LV+ P +R   ++ L H +  +Y
Sbjct: 249 -------DLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 20/270 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIIT 87
           K++G GAYG V    DK      AIK I ++    T ++     E+  LK    HPNI+ 
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HPNIMK 85
Query: 88  MLDIYKAVNNKDLYVVFE-YMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           + + ++  + ++ Y+V E Y   +L +++I  +   +V    IM Q+ +G +Y+H   ++
Sbjct: 86  LYEFFE--DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 143
Query: 146 HRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           HRDLKP N+L++   +   IKI D GL+       + + E + T +Y APE+L   ++Y 
Sbjct: 144 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVL--RKKYD 200
Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI-VNLVRPNPPHADKFYAGFKNKPEEA 261
              D+WS G IL  +L   P F G +    L+ +       +PP        +    +EA
Sbjct: 201 EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPD-------WTQVSDEA 253
Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKY 291
             L+  +L   PS+R   ++ L H ++ K+
Sbjct: 254 KQLVKLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K +G+G++ I  K   K + Q  A+K I     +K     T +EI  LK  + HPNI+ +
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 89  LDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
            +++   +    ++V E +       ++ + K   +    YIM +L + +S++H   V+H
Sbjct: 72  HEVFH--DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 147 RDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           RDLKP N+L    + +  IKI D G AR      + L     T  Y APE+L  N  Y  
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDE 188
Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG--FKNKPEEA 261
             D+WSLG IL  ML  +  F     S      V +++      D  + G  +KN  +EA
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFSFEGEAWKNVSQEA 247
Query: 262 VDLLNQILVLNPSER 276
            DL+  +L ++P++R
Sbjct: 248 KDLIQGLLTVDPNKR 262

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 23/270 (8%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ I + +GKG +G VY A +K +   VA+K +F++   K   +   R  + +++   HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 84  NIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-IRYIMFQLCNGLSYIHA 141
           NI+ + + +   + + +Y++ EY    +L K ++     D      IM +L + L Y H 
Sbjct: 84  NILRLYNYF--YDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGL---ARSLSDSKECLTEYIATRWYRAPEILISN 198
            KV+HRD+KP N+L+     +KI D G    A SL     C      T  Y  PE +I  
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC-----GTLDYLPPE-MIEG 195
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           R +   VD+W +G +  E+L   P F  AS +   + IV +         KF A     P
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------DLKFPASV---P 245
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
             A DL++++L  NPSER    Q+  H +V
Sbjct: 246 TGAQDLISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 26/294 (8%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILF 75
           VD   +  Y   + +GKG +   Y+  D + K+  A K + ++   K    ++   EI  
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ 131
            KS   +P+++     ++  ++  +YVV E        +L+K  R K + +   RY M Q
Sbjct: 96  HKSLD-NPHVVGFHGFFE--DDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQ 150
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
              G+ Y+H  +V+HRDLK  N+ ++    +KIGD GLA  +    E   +   T  Y A
Sbjct: 151 TIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 210
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+L   + ++  VDIWSLGCIL  +L  KP F  +        I       P H +   
Sbjct: 211 PEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV- 268
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPSATHVIP 300
                    A  L+ ++L  +P+ RP      TD+     Y     P++   +P
Sbjct: 269 ---------ASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVP 313

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 26/294 (8%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILF 75
           VD   +  Y   + +GKG +   Y+  D + K+  A K + ++   K    ++   EI  
Sbjct: 20  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 79
Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ 131
            KS   +P+++     ++  ++  +YVV E        +L+K  R K + +   RY M Q
Sbjct: 80  HKSLD-NPHVVGFHGFFE--DDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQ 134
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
              G+ Y+H  +V+HRDLK  N+ ++    +KIGD GLA  +    E   +   T  Y A
Sbjct: 135 TIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 194
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+L   + ++  VDIWSLGCIL  +L  KP F  +        I       P H +   
Sbjct: 195 PEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV- 252
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPSATHVIP 300
                    A  L+ ++L  +P+ RP      TD+     Y     P++   +P
Sbjct: 253 ---------ASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVP 297

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHP 83
           Y     +G GA+  V  A DK  ++ VAIK I  EA   K  +     EI  L    +HP
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKI-KHP 76
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + DIY++  +  LY++ + +      ++++      +     ++FQ+ + + Y+H 
Sbjct: 77  NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 142 CKVMHRDLKPSNIL---IDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HRDLKP N+L   +D+   I I D GL++ + D    L+    T  Y APE+L + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQ 192
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNK 257
           + Y+  VD WS+G I   +L   P F   + +   + I+      + P+ D         
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI------- 245
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            + A D +  ++  +P +R   +Q L+H +++
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHP 83
           Y     +G GA+  V  A DK  ++ VAIK I  EA   K  +     EI  L    +HP
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKI-KHP 76
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + DIY++  +  LY++ + +      ++++      +     ++FQ+ + + Y+H 
Sbjct: 77  NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 142 CKVMHRDLKPSNIL---IDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HRDLKP N+L   +D+   I I D GL++ + D    L+    T  Y APE+L + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQ 192
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNK 257
           + Y+  VD WS+G I   +L   P F   + +   + I+      + P+ D         
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI------- 245
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            + A D +  ++  +P +R   +Q L+H +++
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHP 83
           Y     +G GA+  V  A DK  ++ VAIK I  EA   K  +     EI  L    +HP
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EIAVLHKI-KHP 76
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + DIY++  +  LY++ + +      ++++      +     ++FQ+ + + Y+H 
Sbjct: 77  NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 142 CKVMHRDLKPSNIL---IDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HRDLKP N+L   +D+   I I D GL++ + D    L+    T  Y APE+L + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQ 192
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNK 257
           + Y+  VD WS+G I   +L   P F   + +   + I+      + P+ D         
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI------- 245
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            + A D +  ++  +P +R   +Q L+H +++
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 6/205 (2%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFLKSFQ 80
           +  Y I + +G+G++G V  A     +Q VA+K I      K+D   R  REI +LK   
Sbjct: 8   IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LL 66
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           RHP+II + D+       D+ +V EY   +L + ++  K + +   R    Q+   + Y 
Sbjct: 67  RHPHIIKLYDV--ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H  K++HRDLKP N+L+D + ++KI D GL+  ++D    L     +  Y APE++    
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVINGKL 183
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLF 224
                VD+WS G +L  ML  +  F
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 26/294 (8%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILF 75
           VD   +  Y   + +GKG +   Y+  D + K+  A K + ++   K    ++   EI  
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ 131
            KS   +P+++     ++  ++  +YVV E        +L+K  R K + +   RY M Q
Sbjct: 96  HKSLD-NPHVVGFHGFFE--DDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQ 150
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
              G+ Y+H  +V+HRDLK  N+ ++    +KIGD GLA  +    E       T  Y A
Sbjct: 151 TIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIA 210
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+L   + ++  VDIWSLGCIL  +L  KP F  +        I       P H +   
Sbjct: 211 PEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV- 268
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPSATHVIP 300
                    A  L+ ++L  +P+ RP      TD+     Y     P++   +P
Sbjct: 269 ---------ASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVP 313

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQRTYREILFLKSFQRHP 83
           +G+G   +V +   K   +  A+K I       F A   +   + T +E+  L+    HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCNGLSYIHA 141
           NII + D Y+   N   ++VF+ M+  +L   + +K+ L +   R IM  L   +  +H 
Sbjct: 85  NIIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR- 200
             ++HRDLKP NIL+D   +IK+ D G +  L D  E L     T  Y APEI+  +   
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 201 ----YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFK 255
               Y   VD+WS G I+  +L   P F        L++I++   +   P  D +    K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                  DL+++ LV+ P +R   ++ L H +  +Y
Sbjct: 262 -------DLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 26/294 (8%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILF 75
           VD   +  Y   + +GKG +   Y+  D + K+  A K + ++   K    ++   EI  
Sbjct: 36  VDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI 95
Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ 131
            KS   +P+++     ++  ++  +YVV E        +L+K  R K + +   RY M Q
Sbjct: 96  HKSLD-NPHVVGFHGFFE--DDDFVYVVLEICRRRSLLELHK--RRKAVTEPEARYFMRQ 150
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
              G+ Y+H  +V+HRDLK  N+ ++    +KIGD GLA  +    E       T  Y A
Sbjct: 151 TIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIA 210
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+L   + ++  VDIWSLGCIL  +L  KP F  +        I       P H +   
Sbjct: 211 PEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV- 268
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPSATHVIP 300
                    A  L+ ++L  +P+ RP      TD+     Y     P++   +P
Sbjct: 269 ---------ASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTSCLTVP 313

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQRTYREILFLKSFQRHP 83
           Y     +G GA+  V  A DK  ++ VAIK I + A   K  +     EI  L    +HP
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN--EIAVLHKI-KHP 76
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + DIY++  +  LY++ + +      ++++      +     ++FQ+ + + Y+H 
Sbjct: 77  NIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 142 CKVMHRDLKPSNIL---IDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HRDLKP N+L   +D+   I I D GL++ + D    L+    T  Y APE+L + 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQ 192
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNK 257
           + Y+  VD WS+G I   +L   P F   + +   + I+      + P+ D         
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI------- 245
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            + A D +  ++  +P +R   +Q L+H +++
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++L  Y IH+ +G GA+G+V++  ++      A K  F    +++D +   +EI  + S 
Sbjct: 48  HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRKEIQTM-SV 104
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNG 135
            RHP ++ + D ++  ++ ++ +++E+M   +L + + D   K+ +D  + Y M Q+C G
Sbjct: 105 LRHPTLVNLHDAFE--DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCKG 161
Query: 136 LSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L ++H    +H DLKP NI+    +S  +K+ D GL   L D K+ +     T  + APE
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPE 220
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +    +   ++ D+WS+G +   +L     F G +    L+   N+   +    D  ++G
Sbjct: 221 V-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKSCDWNMDDSAFSG 276
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
                E+  D + ++L+ +P+ R    Q LEH +++
Sbjct: 277 IS---EDGKDFIRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++L  Y IH+ +G GA+G+V++  ++      A K  F    +++D +   +EI  + S 
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRKEIQTM-SV 210
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNG 135
            RHP ++ + D ++  ++ ++ +++E+M   +L + + D   K+ +D  + Y M Q+C G
Sbjct: 211 LRHPTLVNLHDAFE--DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCKG 267
Query: 136 LSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L ++H    +H DLKP NI+    +S  +K+ D GL   L D K+ +     T  + APE
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPE 326
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +    +   ++ D+WS+G +   +L     F G +    L+   N+   +    D  ++G
Sbjct: 327 V-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKSCDWNMDDSAFSG 382
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
                E+  D + ++L+ +P+ R    Q LEH +++
Sbjct: 383 IS---EDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 23/287 (8%)
Query: 17  VDGNILAE--YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YRE 72
            D ++L E  Y + + IGKGA+ +V +  ++   Q  A+K +  A    +    T   + 
Sbjct: 16  ADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 73  ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-----ILKDVHIR 126
              +    +HP+I+ +L+ Y   ++  LY+VFE+M+  DL   I  +     +  +    
Sbjct: 76  EASICHMLKHPHIVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 183
           + M Q+   L Y H   ++HRD+KP N+L+   + S  +K+GD G+A  L +S       
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           + T  + APE+ +    Y   VD+W  G IL  +L     F G        +I    + N
Sbjct: 194 VGTPHFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           P         + +  E A DL+ ++L+L+P+ER    + L H ++ +
Sbjct: 253 PRQ-------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 30/284 (10%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG+GAYG V K   K + Q +A+K+I    R+  D +   + ++ L    R  +   ++ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI----RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 91  IYKAV-NNKDLYVVFEYMENDLNKV------IRDKILKDVHIRYIMFQLCNGLSYIHA-C 142
            Y A+    D ++  E M    +K       + D ++ +  +  I       L+++    
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNR 199
           K++HRD+KPSNIL+D+S +IK+ D G++  L DS    T     R Y APE +    S +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQ 204
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-----KFYAGF 254
            Y    D+WSLG  L E+   +  FP    +     +  +V+ +PP        +F   F
Sbjct: 205 GYDVRSDVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
                  ++ +N  L  + S+RP+  ++L+H ++  Y   A  V
Sbjct: 263 -------INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 16/268 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  Y + K IGKG +  V  A      + VA+K I +   N +  Q+ +RE+   K    
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLN- 71
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ + ++ +    K LY+V EY       + ++     K+   R    Q+ + + Y 
Sbjct: 72  HPNIVKLFEVIET--EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYC 129
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H   ++HRDLK  N+L+D   +IKI D G +   +   + L  +     Y APE+    +
Sbjct: 130 HQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKK 188
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
                VD+WSLG IL  ++     F G +     + ++      P     FY        
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-----FYXS-----T 238
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNY 287
           +  +LL + L+LNPS+R   +QI +  +
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 143/308 (46%), Gaps = 25/308 (8%)
Query: 18  DGNI-LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILF 75
           DG + +  Y +   +G G +G V     +     VA+K +  +  R+     +  REI  
Sbjct: 10  DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN 69
Query: 76  LKSFQRHPNIITMLDIYKAVNN-KDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL 132
           LK F RHP+II +   Y+ ++   D+++V EY+      + + ++  L +   R +  Q+
Sbjct: 70  LKLF-RHPHIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
            +G+ Y H   V+HRDLKP N+L+D   + KI D GL+  +SD  E L     +  Y AP
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAP 184
Query: 193 EILISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           E+ IS R Y    VDIWS G IL  +L     F         + I + +         FY
Sbjct: 185 EV-ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------FY 234
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI 311
                 P   + LL  +L ++P +R     I EH +  +  P   ++ P+   ++  + I
Sbjct: 235 TPQYLNP-SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK--YLFPEDPSYSSTM-I 290
Query: 312 DDNNQLEI 319
           DD    E+
Sbjct: 291 DDEALKEV 298

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 114/217 (52%), Gaps = 13/217 (5%)
Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
           G I+ E Y I  ++G G    VY A D      VAIK IF   R K +  + +   +   
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 78  SFQRHPNIITMLDIYKAVNNKD--LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQL 132
           S   H NI++M+D    V+ +D   Y+V EY+E   L++ I     +  D  I +   Q+
Sbjct: 66  SQLSHQNIVSMID----VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF-TNQI 120
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI-ATRWYRA 191
            +G+ + H  +++HRD+KP NILID + ++KI D G+A++LS++    T ++  T  Y +
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
           PE            DI+S+G +L EML  +P F G +
Sbjct: 181 PE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 132/258 (51%), Gaps = 20/258 (7%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ I + +G G++G V+    ++N +Y A+K +  E        + T  E L L S  
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML-SIV 63
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSY 138
            HP II M   ++  + + ++++ +Y+E  +L  ++R  +   +   ++   ++C  L Y
Sbjct: 64  THPFIIRMWGTFQ--DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H+  +++RDLKP NIL+DK+  IKI D G A+ + D    L     T  Y APE+ +S 
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC---GTPDYIAPEV-VST 177
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           + Y   +D WS G ++ EML     F  ++T    + I+N     PP  +          
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN---------- 227
Query: 259 EEAVDLLNQILVLNPSER 276
           E+  DLL++++  + S+R
Sbjct: 228 EDVKDLLSRLITRDLSQR 245

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 24/279 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GAYG+V K     + Q +A+K+I    R   ++Q   R ++ L    R  +    + 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI----RATVNSQEQKRLLMDLDISMRTVDCPFTVT 114
Query: 91  IYKAV-NNKDLYVVFEYMENDLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHA-CK 143
            Y A+    D+++  E M+  L+K  +  I K   I       I   +   L ++H+   
Sbjct: 115 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNRR 200
           V+HRD+KPSN+LI+    +K+ D G++  L DS    T     + Y APE +   ++ + 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKG 233
Query: 201 YTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
           Y+   DIWSLG  + E+ +   P     +   QL+ +V    P  P ADKF A F     
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-ADKFSAEF----- 287
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
             VD  +Q L  N  ERP   ++++H + + +    T V
Sbjct: 288 --VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 324

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 18/294 (6%)
Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           MT       G +   N        Y + + +GKGA+ +V +   K      A K I    
Sbjct: 7   MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRD 117
            +  D Q+  RE    +  Q HPNI+ + D   ++  +   Y+VF+ +        ++  
Sbjct: 67  LSARDFQKLEREARICRKLQ-HPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 118 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLS 174
           +   +    + + Q+   ++Y H+  ++HR+LKP N+L+    K  ++K+ D GLA  ++
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
           DS E    +  T  Y +PE+L  +  Y+  VDIW+ G IL  +L   P F      H+L 
Sbjct: 183 DS-EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLY 239
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             +     + P  +     +     EA  L++ +L +NP +R   DQ L+  ++
Sbjct: 240 AQIKAGAYDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 12/226 (5%)
Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
            N+ + + D+  H      +  Y + K IGKG +  V  A      + VA+K I +   N
Sbjct: 1   GNSITSATDEQPH------IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLN 54
Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKIL 120
            T  Q+ +RE+  +K    HPNI+ + ++ +    K LY+V EY       + ++    +
Sbjct: 55  PTSLQKLFREVRIMKILN-HPNIVKLFEVIET--EKTLYLVMEYASGGEVFDYLVAHGRM 111
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
           K+   R    Q+ + + Y H   ++HRDLK  N+L+D   +IKI D G +   +   + L
Sbjct: 112 KEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-L 170
Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 226
             +  +  Y APE+    +     VD+WSLG IL  ++     F G
Sbjct: 171 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 132/283 (46%), Gaps = 22/283 (7%)
Query: 18  DGNI-LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILF 75
           DG + +  Y +   +G G +G V     +     VA+K +  +  R+     +  REI  
Sbjct: 5   DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN 64
Query: 76  LKSFQRHPNIITMLDIYKAVNN-KDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL 132
           LK F RHP+II +   Y+ ++   D ++V EY+      + + +   ++++  R +  Q+
Sbjct: 65  LKLF-RHPHIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
            + + Y H   V+HRDLKP N+L+D   + KI D GL+  +SD  E L +   +  Y AP
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAP 179
Query: 193 EILISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           E+ IS R Y    VDIWS G IL  +L     F         + I   V   P + ++  
Sbjct: 180 EV-ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
           A           LL  +L ++P +R     I EH +  +  PS
Sbjct: 239 A----------TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITML 89
           +G+GA+G V KA +  + +Y AIKKI    R+  +   T   E++ L S   H  ++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLN-HQYVVRYY 68
Query: 90  DIY----------KAVNNKD-LYVVFEYMEND-LNKVIRDKILKDVHIRY--IMFQLCNG 135
             +           AV  K  L++  EY EN  L  +I  + L      Y  +  Q+   
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR--------------SLSDSKECLT 181
           LSYIH+  ++HRDLKP NI ID+S ++KIGD GLA+              +L  S + LT
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
             I T  Y A E+L     Y   +D++SLG I  EM+   P   G    + L+ + ++  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSI 246
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             PP  D       NK +    ++  ++  +P++RP    +L   ++
Sbjct: 247 EFPPDFD------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 36/272 (13%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIV 70
Query: 87  TMLDIYKAVNNKDLYVVFEYMEND-LNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 71  GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 123
Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L D  E   E++ TR Y +PE L   
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--EMANEFVGTRSYMSPERL-QG 180
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y+   DIWS+G  L EM   +   P  +    L  IVN   P  P A  F   F+   
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSA-VFSLEFQ--- 236
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
               D +N+ L+ NP+ER +  Q++ H ++ +
Sbjct: 237 ----DFVNKCLIKNPAERADLKQLMVHAFIKR 264

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITML 89
           +G+GA+G V KA +  + +Y AIKKI    R+  +   T   E++ L S   H  ++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLN-HQYVVRYY 68
Query: 90  DIY----------KAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRY--IMFQLCNG 135
             +           AV  K  L++  EY EN  L  +I  + L      Y  +  Q+   
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR--------------SLSDSKECLT 181
           LSYIH+  ++HRDLKP NI ID+S ++KIGD GLA+              +L  S + LT
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
             I T  Y A E+L     Y   +D++SLG I  EM+   P   G    + L+ + ++  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSI 246
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             PP  D       NK +    ++  ++  +P++RP    +L   ++
Sbjct: 247 EFPPDFD------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 84  GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEV 198
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 248
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 249 QKMLQTDPTARPTINELLNDEFFTSGYIPA 278

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 34/273 (12%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECN-SPYIV 86
Query: 87  TMLDIYKAVNNKDLYVVFEYMEND-LNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 87  GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 139
Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 140 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 196
Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
             Y+   DIWS+G  L EM   + P+  G+ +    +L+  +V   PP   K  +G  + 
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPP---KLPSGVFSL 253
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             E  D +N+ L+ NP+ER +  Q++ H ++ +
Sbjct: 254 --EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 84  GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEV 198
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 248
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 249 QKMLQTDPTARPTINELLNDEFFTSGYIPA 278

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 88  GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEV 202
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 203 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 252
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 253 QKMLQTDPTARPTINELLNDEFFTSGYIPA 282

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 25  YTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSF 79
           + + + +GKG YG V+   K    N  +  A+K + +A   RN  D   T  E   L+  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
            +HP I+ +  IY       LY++ EY+       ++ R+ I  +    + + ++   L 
Sbjct: 79  -KHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H   +++RDLKP NI+++    +K+ D GL +           +  T  Y APEIL+ 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  +   VD WSLG ++ +ML   P F G +    +  I+      PP+           
Sbjct: 196 S-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT--------- 245
Query: 258 PEEAVDLLNQILVLNPSER 276
            +EA DLL ++L  N + R
Sbjct: 246 -QEARDLLKKLLKRNAASR 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 25  YTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSF 79
           + + + +GKG YG V+   K    N  +  A+K + +A   RN  D   T  E   L+  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
            +HP I+ +  IY       LY++ EY+       ++ R+ I  +    + + ++   L 
Sbjct: 79  -KHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H   +++RDLKP NI+++    +K+ D GL +           +  T  Y APEIL+ 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR 195
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  +   VD WSLG ++ +ML   P F G +    +  I+      PP+           
Sbjct: 196 S-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT--------- 245
Query: 258 PEEAVDLLNQILVLNPSER 276
            +EA DLL ++L  N + R
Sbjct: 246 -QEARDLLKKLLKRNAASR 263

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 22/283 (7%)
Query: 18  DGNI-LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILF 75
           DG + +  Y +   +G G +G V     +     VA+K +  +  R+     +  REI  
Sbjct: 5   DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN 64
Query: 76  LKSFQRHPNIITMLDIYKAVNN-KDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL 132
           LK F RHP+II +   Y+ ++   D ++V EY+      + + +   ++++  R +  Q+
Sbjct: 65  LKLF-RHPHIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
            + + Y H   V+HRDLKP N+L+D   + KI D GL+  +SD  E L     +  Y AP
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAP 179
Query: 193 EILISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           E+ IS R Y    VDIWS G IL  +L     F         + I   V   P + ++  
Sbjct: 180 EV-ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
           A           LL  +L ++P +R     I EH +  +  PS
Sbjct: 239 A----------TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + +R+G G +G V +   ++  + VAIK+  +    K + +R   EI  +K    HPN
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLN-HPN 74
Query: 85  IITMLDI----YKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNG 135
           +++  ++     K   N    +  EY E       LN+      LK+  IR ++  + + 
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI---KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           L Y+H  +++HRDLKP NI++         KI DLG A+ L D  E  TE++ T  Y AP
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLAP 193
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQS-KPLFP 225
           E L+  ++YT  VD WS G +  E +   +P  P
Sbjct: 194 E-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKN-NKQYVAI---KKIFEAFRNKTDAQRTYREILFLKSFQ 80
           Y + + +G G + IV K   K   K+Y A    K+   + R     +   RE+  L+   
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI- 65
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           RHPNIIT+ DI++  N  D+ ++ E +      + +   + L +      + Q+ +G+ Y
Sbjct: 66  RHPNIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 139 IHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H+ ++ H DLKP NI L+DK+     IK+ D G+A  +    E       T  + APEI
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEI 182
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   N    +++   F
Sbjct: 183 -VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNISAVNYDFDEEY---F 235
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            N  E A D + ++LV +P  R    Q LEH+++
Sbjct: 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + +R+G G +G V +   ++  + VAIK+  +    K + +R   EI  +K    HPN
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLN-HPN 73
Query: 85  IITMLDI----YKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNG 135
           +++  ++     K   N    +  EY E       LN+      LK+  IR ++  + + 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI---KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           L Y+H  +++HRDLKP NI++         KI DLG A+ L D  E  TE++ T  Y AP
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLAP 192
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQS-KPLFP 225
           E L+  ++YT  VD WS G +  E +   +P  P
Sbjct: 193 E-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKN-NKQYVAI---KKIFEAFRNKTDAQRTYREILFLKSFQ 80
           Y + + +G G + IV K   K   K+Y A    K+   + R     +   RE+  L+   
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI- 72
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLS 137
           RHPNIIT+ DI++  N  D+ ++ E +   +L   + +K  + +D   +++  Q+ +G+ 
Sbjct: 73  RHPNIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QILDGVH 129
Query: 138 YIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           Y+H+ ++ H DLKP NI L+DK+     IK+ D G+A  +    E       T  + APE
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPE 188
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           I ++        D+WS+G I   +L     F G +    L    N+   N    +++   
Sbjct: 189 I-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNISAVNYDFDEEY--- 241
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           F N  E A D + ++LV +P  R    Q LEH+++
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 106 GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEV 220
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 221 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 270
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 271 QKMLQTDPTARPTINELLNDEFFTSGYIPA 300

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 108 GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEV 222
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 272
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 23/275 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKN-NKQYVAI---KKIFEAFRNKTDAQRTYREILFLKSFQ 80
           Y + + +G G + IV K   K   K+Y A    K+   + R     +   RE+  L+   
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI- 86
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLS 137
           RHPNIIT+ DI++  N  D+ ++ E +   +L   + +K  + +D   +++  Q+ +G+ 
Sbjct: 87  RHPNIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QILDGVH 143
Query: 138 YIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           Y+H+ ++ H DLKP NI L+DK+     IK+ D G+A  +    E       T  + APE
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPE 202
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           I ++        D+WS+G I   +L     F G +    L    N+   N    +++   
Sbjct: 203 I-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNISAVNYDFDEEY--- 255
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           F N  E A D + ++LV +P  R    Q LEH+++
Sbjct: 256 FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT-DAQRTYREILFLKSFQRHPNIITML 89
           +GKG +   ++  D + K+  A K + ++   K    ++   EI   +S   H +++   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
             ++  +N  ++VV E        +L+K  R K L +   RY + Q+  G  Y+H  +V+
Sbjct: 82  GFFE--DNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE+L S + ++  V
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEV 196
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLL 265
           D+WS+GCI+  +L  KP F  +        I       P H +            A  L+
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV----------AASLI 246
Query: 266 NQILVLNPSERPETDQIL-EHNYVSKYFPS 294
            ++L  +P+ RP  +++L +  + S Y P+
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTSGYIPA 276

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 24/280 (8%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
            +G+GAYG+V K     + Q +A+K+I    R   ++Q   R ++ L    R  +    +
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI----RATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 90  DIYKAV-NNKDLYVVFEYMENDLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHA-C 142
             Y A+    D+++  E M+  L+K  +  I K   I       I   +   L ++H+  
Sbjct: 70  TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNR 199
            V+HRD+KPSN+LI+    +K+ D G++  L D      +    + Y APE +   ++ +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPERINPELNQK 188
Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
            Y+   DIWSLG  + E+ +   P     +   QL+ +V    P  P ADKF A F    
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-ADKFSAEF---- 243
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
              VD  +Q L  N  ERP   ++++H + + +    T V
Sbjct: 244 ---VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 24/277 (8%)
Query: 23  AEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           +++ + K +G+G++G V+   K    + +Q  A+K + +A     D  RT  E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
             HP I+ +   Y       LY++ +++       ++ ++ +  +  +++ + +L   L 
Sbjct: 84  N-HPFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+  +++RDLKP NIL+D+   IK+ D GL++   D ++    +  T  Y APE+ ++
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VN 199
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +T   D WS G ++ EML     F G      + +I+      P    +F +     
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLS----- 250
Query: 258 PEEAVDLLNQILVLNPSER----PE-TDQILEHNYVS 289
             EA  LL  +   NP+ R    P+  ++I  H++ S
Sbjct: 251 -PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 24/277 (8%)
Query: 23  AEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           +++ + K +G+G++G V+   K    + +Q  A+K + +A     D  RT  E   L   
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
             HP I+ +   Y       LY++ +++       ++ ++ +  +  +++ + +L   L 
Sbjct: 85  N-HPFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+  +++RDLKP NIL+D+   IK+ D GL++   D ++    +  T  Y APE+ ++
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VN 200
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +T   D WS G ++ EML     F G      + +I+      P    +F +     
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLS----- 251
Query: 258 PEEAVDLLNQILVLNPSER----PE-TDQILEHNYVS 289
             EA  LL  +   NP+ R    P+  ++I  H++ S
Sbjct: 252 -PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 287

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 24/277 (8%)
Query: 23  AEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           +++ + K +G+G++G V+   K    + +Q  A+K + +A     D  RT  E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
             HP I+ +   Y       LY++ +++       ++ ++ +  +  +++ + +L   L 
Sbjct: 84  N-HPFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+  +++RDLKP NIL+D+   IK+ D GL++   D ++    +  T  Y APE+ ++
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VN 199
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R +T   D WS G ++ EML     F G      + +I+      P    +F +     
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLS----- 250
Query: 258 PEEAVDLLNQILVLNPSER----PE-TDQILEHNYVS 289
             EA  LL  +   NP+ R    P+  ++I  H++ S
Sbjct: 251 -PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           EY + + +GKGA+ +V +       Q  A K I     +  D Q+  RE    +   +HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICR-LLKHP 63
Query: 84  NIITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           NI+ + D   +++ +   Y+VF+ +        ++  +   +    + + Q+   +++ H
Sbjct: 64  NIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 141 ACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
              ++HRDLKP N+L+    K  ++K+ D GLA  +   ++    +  T  Y +PE+L  
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  Y   VD+W+ G IL  +L   P F      H+L   +     + P  +     +   
Sbjct: 181 DP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDFPSPE-----WDTV 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             EA DL+N++L +NP++R    + L+H ++ +
Sbjct: 234 TPEAKDLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + +GKGA+ +V +   K      A K I     +  D Q+  RE    +  Q HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN 66
Query: 85  IITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ + D   ++  +   Y+VF+ +        ++  +   +    + + Q+   ++Y H+
Sbjct: 67  IVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 142 CKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HR+LKP N+L+    K  ++K+ D GLA  ++DS E    +  T  Y +PE+L  +
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y+  VDIW+ G IL  +L   P F      H+L   +     + P  +     +    
Sbjct: 183 -PYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYPSPE-----WDTVT 235
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
            EA  L++ +L +NP +R   DQ L+  ++
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + +GKGA+ +V +   K      A K I     +  D Q+  RE    +  Q HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN 66
Query: 85  IITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ + D   ++  +   Y+VF+ +        ++  +   +    + + Q+   ++Y H+
Sbjct: 67  IVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 142 CKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HR+LKP N+L+    K  ++K+ D GLA  ++DS E    +  T  Y +PE+L  +
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y+  VDIW+ G IL  +L   P F      H+L   +     + P  +     +    
Sbjct: 183 -PYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYPSPE-----WDTVT 235
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
            EA  L++ +L +NP +R   DQ L+  ++
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + +GKGA+ +V +   K      A K I     +  D Q+  RE    +  Q HPN
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPN 65
Query: 85  IITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ + D   ++  +   Y+VF+ +        ++  +   +    + + Q+   ++Y H+
Sbjct: 66  IVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 142 CKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HR+LKP N+L+    K  ++K+ D GLA  ++DS E    +  T  Y +PE+L  +
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y+  VDIW+ G IL  +L   P F      H+L   +     + P  +     +    
Sbjct: 182 -PYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYPSPE-----WDTVT 234
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
            EA  L++ +L +NP +R   DQ L+  ++
Sbjct: 235 PEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 52/264 (19%)
Query: 19  GNIL-AEYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIK------KIFEAFR--------- 61
           G++L A Y I   +G+GA+G V +  D K   ++VA+K      +  EA R         
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL 68
Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILK 121
           N TD   T+R +  L+ F+ H +I  + ++   ++  D      ++   L+         
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD--------- 118
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-------------------CSI 162
             HIR + +Q+C  ++++H+ K+ H DLKP NIL  +S                     I
Sbjct: 119 --HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 222
           K+ D G   S +   E  +  ++TR YRAPE++++   ++   D+WS+GCIL E      
Sbjct: 177 KVVDFG---SATYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232
Query: 223 LFPGASTSHQLQLIVNLVRPNPPH 246
           +FP   +   L ++  ++ P P H
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKH 256

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           EY + + +GKGA+ +V +       Q  A K I     +  D Q+  RE    +   +HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICR-LLKHP 63
Query: 84  NIITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           NI+ + D   +++ +   Y+VF+ +        ++  +   +    + + Q+   +++ H
Sbjct: 64  NIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 141 ACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
              ++HRDLKP N+L+    K  ++K+ D GLA  +   ++    +  T  Y +PE+L  
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +  Y   VD+W+ G IL  +L   P F      H+L   +     + P  +     +   
Sbjct: 181 DP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDFPSPE-----WDTV 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             EA DL+N++L +NP++R    + L+H ++ +
Sbjct: 234 TPEAKDLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 124/259 (47%), Gaps = 19/259 (7%)
Query: 23  AEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           + + + K +G+G++G V+   K    ++    A+K + +A     D  RT  E   L   
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLS 137
             HP ++ +   Y       LY++ +++       ++ ++ +  +  +++ + +L  GL 
Sbjct: 88  N-HPFVVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+  +++RDLKP NIL+D+   IK+ D GL++   D ++    +  T  Y APE+ ++
Sbjct: 145 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV-VN 203
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + ++H  D WS G ++ EML     F G      + LI+      P    +F +     
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP----QFLS----- 254
Query: 258 PEEAVDLLNQILVLNPSER 276
             EA  LL  +   NP+ R
Sbjct: 255 -TEAQSLLRALFKRNPANR 272

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 17/273 (6%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           EY +++ IGKGA+ +V +          A K I     +  D Q+  RE    +   +H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL-KHS 63
Query: 84  NIITMLDIYKAVNNKDL-YVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           NI+ + D   +++ +   Y+VF+ +        ++  +   +    + + Q+   + + H
Sbjct: 64  NIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 120
Query: 141 ACKVMHRDLKPSNILIDKSC---SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
              V+HRDLKP N+L+   C   ++K+ D GLA  +   ++    +  T  Y +PE+L  
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-R 179
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
              Y   VDIW+ G IL  +L   P F      H+L   +     + P  +     +   
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKAGAYDFPSPE-----WDTV 233
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             EA +L+NQ+L +NP++R    + L+H +V +
Sbjct: 234 TPEAKNLINQMLTINPAKRITAHEALKHPWVCQ 266

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 23/287 (8%)
Query: 17  VDGNILAE--YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YRE 72
            D ++L E  Y + + IGKG + +V +  ++   Q  A+K +  A    +    T   + 
Sbjct: 16  ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 73  ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-----ILKDVHIR 126
              +    +HP+I+ +L+ Y   ++  LY+VFE+M+  DL   I  +     +  +    
Sbjct: 76  EASICHMLKHPHIVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 183
           + M Q+   L Y H   ++HRD+KP  +L+   + S  +K+G  G+A  L +S       
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           + T  + APE+ +    Y   VD+W  G IL  +L     F G        +I    + N
Sbjct: 194 VGTPHFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           P         + +  E A DL+ ++L+L+P+ER    + L H ++ +
Sbjct: 253 PRQ-------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 23/287 (8%)
Query: 17  VDGNILAE--YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YRE 72
            D ++L E  Y + + IGKG + +V +  ++   Q  A+K +  A    +    T   + 
Sbjct: 18  ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 77
Query: 73  ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-----ILKDVHIR 126
              +    +HP+I+ +L+ Y   ++  LY+VFE+M+  DL   I  +     +  +    
Sbjct: 78  EASICHMLKHPHIVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 135
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 183
           + M Q+   L Y H   ++HRD+KP  +L+   + S  +K+G  G+A  L +S       
Sbjct: 136 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           + T  + APE+ +    Y   VD+W  G IL  +L     F G        +I    + N
Sbjct: 196 VGTPHFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 254
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           P         + +  E A DL+ ++L+L+P+ER    + L H ++ +
Sbjct: 255 PRQ-------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 125/270 (46%), Gaps = 15/270 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + + +GKGA+ +V +       Q  A K I     +  D Q+  RE    +   +HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICR-LLKHPN 82
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+ + D      +   Y++F+ +        ++  +   +    + + Q+   + + H  
Sbjct: 83  IVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 143 KVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
            V+HRDLKP N+L+    K  ++K+ D GLA  +   ++    +  T  Y +PE+L  + 
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
            Y   VD+W+ G IL  +L   P F      H+L   +     + P  +     +     
Sbjct: 201 -YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDFPSPE-----WDTVTP 253
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVS 289
           EA DL+N++L +NPS+R    + L+H ++S
Sbjct: 254 EAKDLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NIIT+L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIITLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 47/296 (15%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--- 80
           +Y + + IG GA  +V  AY    K+ VAIK+I     N    Q +  E+L  K  Q   
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELL--KEIQAMS 68
Query: 81  --RHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVI------RDKILKDVHIRYI 128
              HPNI++    +  V   +L++V + +      D+ K I      +  +L +  I  I
Sbjct: 69  QCHHPNIVSYYTSF--VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-----TEY 183
           + ++  GL Y+H    +HRD+K  NIL+ +  S++I D G++  L+   +         +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ---LQLIVNLV 240
           + T  + APE++   R Y    DIWS G    E      L  GA+  H+   +++++  +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE------LATGAAPYHKYPPMKVLMLTL 240
Query: 241 RPNPPHADKFYAGFKNKP------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           + +PP  +    G ++K       +    +++  L  +P +RP   ++L H +  K
Sbjct: 241 QNDPPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 6/219 (2%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE-AFRNKTDAQRTYREILFLKSFQR 81
           +++   K IGKG++G V  A  K  + + A+K + + A   K + +    E   L    +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HP ++ +   ++  +   LY V +Y+        + R++   +   R+   ++ + L Y+
Sbjct: 98  HPFLVGLHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+  +++RDLKP NIL+D    I + D GL +   +     + +  T  Y APE+L   +
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL-HKQ 214
Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
            Y   VD W LG +L EML   P F   +T+     I+N
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 139/297 (46%), Gaps = 33/297 (11%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K +G+G + +V +   K+  Q  A K + +  R +        EI  L+  +  P +I +
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 89  LDIYKAVNNKDLYVVFEYMEN---------DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            ++Y+  N  ++ ++ EY            +L +++ +    DV IR I  Q+  G+ Y+
Sbjct: 95  HEVYE--NTSEIILILEYAAGGEIFSLCLPELAEMVSEN---DV-IRLIK-QILEGVYYL 147
Query: 140 HACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           H   ++H DLKP NIL+        IKI D G++R +  + E L E + T  Y APEIL 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEIL- 205
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
           +    T   D+W++G I   +L     F G       +  +N+ + N  ++++    F +
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQVNVDYSEE---TFSS 259
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSK------YFPSATHVIPQVTPHTV 307
             + A D +  +LV NP +RP  +  L H+++ +      + P  T    Q   H+V
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSV 316

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 15/274 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG G +G+     DK + + VA+K I    R +  A    REI+  +S  RHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSL-RHPN 76
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++   +    L +V EY        ++       +   R+   QL +G+SY HA 
Sbjct: 77  IVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +V HRDLK  N L+D S +  +KI D G ++S S         + T  Y APE+L+    
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 193
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
                D+WS G  L  ML     F         +  ++ +  N  +A   Y        E
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-NVQYAIPDYVHIS---PE 249
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              L+++I V +P++R    +I  H +  K  P+
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 47/296 (15%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--- 80
           +Y + + IG GA  +V  AY    K+ VAIK+I     N    Q +  E+L  K  Q   
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELL--KEIQAMS 63
Query: 81  --RHPNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVI------RDKILKDVHIRYI 128
              HPNI++    +  V   +L++V + +      D+ K I      +  +L +  I  I
Sbjct: 64  QCHHPNIVSYYTSF--VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL-----TEY 183
           + ++  GL Y+H    +HRD+K  NIL+ +  S++I D G++  L+   +         +
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ---LQLIVNLV 240
           + T  + APE++   R Y    DIWS G    E      L  GA+  H+   +++++  +
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE------LATGAAPYHKYPPMKVLMLTL 235
Query: 241 RPNPPHADKFYAGFKNKP------EEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           + +PP  +    G ++K       +    +++  L  +P +RP   ++L H +  K
Sbjct: 236 QNDPPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 52/264 (19%)
Query: 19  GNIL-AEYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIK------KIFEAFR--------- 61
           G++L A Y I   +G+GA+G V +  D K   ++VA+K      +  EA R         
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL 68
Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILK 121
           N TD   T+R +  L+ F+ H +I  + ++   ++  D      ++   L+         
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD--------- 118
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-------------------CSI 162
             HIR + +Q+C  ++++H+ K+ H DLKP NIL  +S                     I
Sbjct: 119 --HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 222
           K+ D G   S +   E  +  +  R YRAPE++++   ++   D+WS+GCIL E      
Sbjct: 177 KVVDFG---SATYDDEHHSTLVXXRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232
Query: 223 LFPGASTSHQLQLIVNLVRPNPPH 246
           +FP   +   L ++  ++ P P H
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKH 256

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEY-----------------MEN--DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                 ME   D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 151/315 (47%), Gaps = 40/315 (12%)
Query: 24  EYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +Y + K++ G G  G V + + +   Q  A+K ++++ + + +    ++           
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA-------SGG 81
Query: 83  PNIITMLDIYKAVNN--KDLYVVFEYMEN-DLNKVIR---DKILKDVHIRYIMFQLCNGL 136
           P+I+ +LD+Y+ +++  + L ++ E ME  +L   I+   D+   +     IM  +   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            ++H+  + HRD+KP N+L    +K   +K+ D G A+    ++  L     T +Y APE
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPE 199
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQLIVNLVR---PNPPHA 247
           +L    +Y    D+WSLG I+  +L   P F    G + S  ++  + L +   PNP   
Sbjct: 200 VL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-- 256
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
                 +    E+A  L+  +L  +P+ER    Q + H ++++     + V+PQ   HT 
Sbjct: 257 ------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ-----SMVVPQTPLHTA 305
Query: 308 -VLDIDDNNQLEIND 321
            VL  D ++  E+ +
Sbjct: 306 RVLQEDKDHWDEVKE 320

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 52/311 (16%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLK 77
           G  L ++   + +G+G +G+V++A +K +    AIK+I     N+  A ++  RE+  L 
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALA 58
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYV-----VFEYMENDLNKVIRDKILKD-------VHI 125
             + HP I+   + +   N  +        V+ Y++  L    R + LKD       +  
Sbjct: 59  KLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQL---CRKENLKDWMNGRCTIEE 114
Query: 126 R------YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE- 178
           R      +I  Q+   + ++H+  +MHRDLKPSNI       +K+GD GL  ++   +E 
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 179 --CLTEY---------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 227
              LT           + T+ Y +PE +  N  Y+H VDI+SLG IL E+     L+P +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL-----LYPFS 228
Query: 228 STSHQLQLIVNLVRPNPPHADKFYAGFKNK-PEEAVDLLNQILVLNPSERPETDQILEHN 286
           +   +++ + ++         KF   F  K P E V ++  +L  +P ERPE   I+E+ 
Sbjct: 229 TQMERVRTLTDV------RNLKFPPLFTQKYPCEYV-MVQDMLSPSPMERPEAINIIENA 281
Query: 287 YVSKY-FPSAT 296
                 FP  T
Sbjct: 282 VFEDLDFPGKT 292

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 191 KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 242
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 243 -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 406
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQXQP 448

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 274 KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 325
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 326 -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 439
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 440 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 489
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 490 -PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQXQP 531

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPAFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 151/315 (47%), Gaps = 40/315 (12%)
Query: 24  EYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +Y + K++ G G  G V + + +   Q  A+K ++++ + + +    ++           
Sbjct: 10  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA-------SGG 62
Query: 83  PNIITMLDIYKAVNN--KDLYVVFEYMEN-DLNKVIR---DKILKDVHIRYIMFQLCNGL 136
           P+I+ +LD+Y+ +++  + L ++ E ME  +L   I+   D+   +     IM  +   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 137 SYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            ++H+  + HRD+KP N+L    +K   +K+ D G A+    ++  L     T +Y APE
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPE 180
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQLIVNLVR---PNPPHA 247
           +L    +Y    D+WSLG I+  +L   P F    G + S  ++  + L +   PNP   
Sbjct: 181 VL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-- 237
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
                 +    E+A  L+  +L  +P+ER    Q + H ++++     + V+PQ   HT 
Sbjct: 238 ------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ-----SMVVPQTPLHTA 286
Query: 308 -VLDIDDNNQLEIND 321
            VL  D ++  E+ +
Sbjct: 287 RVLQEDKDHWDEVKE 301

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 191 KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 242
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 243 -QLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 406
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQXQP 448

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 5   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 61  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 176
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 177 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 232
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 233 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 191 KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 242
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 243 -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 356
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 406
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 448

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 5   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 61  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 176
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 177 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 232
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 233 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSC---SIKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 15/274 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG G +G+     DK + + VA+K I    R +   +   REI+  +S  RHPN
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSL-RHPN 75
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++   +    L +V EY        ++       +   R+   QL +G+SY HA 
Sbjct: 76  IVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 133
Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +V HRDLK  N L+D S +  +KI D G ++S S         + T  Y APE+L+    
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 192
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
                D+WS G  L  ML     F         +  ++ +  N  +A   Y        E
Sbjct: 193 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-NVQYAIPDYVHIS---PE 248
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              L+++I V +P++R    +I  H +  K  P+
Sbjct: 249 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 282

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+ ++   K+ D GLAR + D++    +      +W  APE  +   R+T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYG-RFT 193
Query: 203 HHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEE 260
              D+WS G +L E+  + +  +PG      L  +    R P PP            PE 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------PES 243
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
             DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 244 LHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           EY + + +GKGA+ +V +       Q  A   I     +  D Q+  RE    +   +HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR-LLKHP 70
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + D      +   Y++F+ +        ++  +   +    + + Q+   + + H 
Sbjct: 71  NIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 142 CKVMHRDLKPSNILID---KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             V+HR+LKP N+L+    K  ++K+ D GLA  +   ++    +  T  Y +PE+L  +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y   VD+W+ G IL  +L   P F      H+L   +     + P  +     +    
Sbjct: 189 P-YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDFPSPE-----WDTVT 241
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            EA DL+N++L +NPS+R    + L+H ++S
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHPNIITML 89
           +G+GA+G V KA +  + +Y AIKKI    R+  +   T   E+  L S   H  ++   
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLN-HQYVVRYY 68
Query: 90  DIY----------KAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRY--IMFQLCNG 135
             +           AV  K  L++  EY EN  L  +I  + L      Y  +  Q+   
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR--------------SLSDSKECLT 181
           LSYIH+  ++HR+LKP NI ID+S ++KIGD GLA+              +L  S + LT
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
             I T  Y A E+L     Y   +D +SLG I  E +   P   G    + L+ + ++  
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSVSI 246
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             PP  D       NK +    ++  ++  +P++RP    +L   ++
Sbjct: 247 EFPPDFD------DNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K      +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KNTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           ++G+G +G V+     N    VAIK +          +   +E   +K   RH  ++   
Sbjct: 192 KLGQGCFGEVWMG-TWNGTTRVAIKTLKPG---NMSPEAFLQEAQVMKKL-RHEKLV--- 243
Query: 90  DIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
            +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     +
Sbjct: 244 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISNR 199
           HRDL+ +NIL+ ++   K+ D GL R + D+     EY A +       + APE  +   
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDN-----EYTARQGAKFPIKWTAPEAALYG- 357
Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNK 257
           R+T   D+WS G +L E+  + +  +PG      L  +    R P PP            
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---------- 407
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
           PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 408 PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQXQP 449

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 13  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 66
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 67  V---QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEIL 195
              +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAA 178
Query: 196 ISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           +   R+T   D+WS G +L E+  + +  +PG      L  +    R P PP        
Sbjct: 179 LYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------ 231
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
               PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 232 ----PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 273

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG G +G+     DK   + VA+K I    R +   +   REI+  +S  RHPN
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENVKREIINHRSL-RHPN 76
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++   +    L +V EY        ++       +   R+   QL +G+SY HA 
Sbjct: 77  IVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +V HRDLK  N L+D S +  +KI D G +++ S         + T  Y APE+L+    
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPKSAVGTPAYIAPEVLLKKEY 193
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
                D+WS G  L  ML     F         +  ++ +  N  +A   Y        E
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-NVQYAIPDYVHIS---PE 249
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              L+++I V +P++R    +I  H +  K  P+
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + + +  
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINAML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIIHLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 11  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 64
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 65  V---QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEIL 195
              +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAA 176
Query: 196 ISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           +   R+T   D+WS G +L E+  + +  +PG      L  +    R P PP        
Sbjct: 177 LYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------ 229
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
               PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 230 ----PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 271

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 15  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 68
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 69  V---QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEIL 195
              +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAA 180
Query: 196 ISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           +   R+T   D+WS G +L E+  + +  +PG      L  +    R P PP        
Sbjct: 181 LYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------ 233
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
               PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 234 ----PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 275

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 37/292 (12%)
Query: 31  IGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +G+GAY  V  A   +N K+Y    KI E     + + R +RE+  L   Q + NI+ ++
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAV--KIIEKQAGHSRS-RVFREVETLYQCQGNKNILELI 77
Query: 90  DIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
           + ++  ++   Y+VFE ++    L  + + K   +     ++  +   L ++H   + HR
Sbjct: 78  EFFE--DDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHR 135
Query: 148 DLKPSNILI---DKSCSIKIGDLGLARSLSDSKEC-------LTEYIATRWYRAPEI--L 195
           DLKP NIL    +K   +KI D  L   +  +  C       LT    +  Y APE+  +
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 196 ISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSH------------QLQLIVNLVR 241
            +++   Y    D+WSLG +L  ML   P F G   +             Q +L  ++  
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 255
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                 DK +A   +   EA DL++++LV +  +R    Q+L+H +V    P
Sbjct: 256 GKYEFPDKDWAHISS---EAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRT 69
           Q NVD      Y   + +G G + +V K  +K+   QY A    K+  ++ R     +  
Sbjct: 6   QENVDDY----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRY 127
            RE+  LK  Q HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +     
Sbjct: 62  EREVSILKEIQ-HPNVITLHEVYE--NKTDVILIGELVAGGELFDFLAEKESLTEEEATE 118
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEY 183
            + Q+ NG+ Y+H+ ++ H DLKP NI L+D++     IKI D GLA  +    E     
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T  + APEI ++        D+WS+G I   +L     F G +    L    N+   N
Sbjct: 178 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVN 233
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               D++   F N    A D + ++LV +P +R      L+H ++
Sbjct: 234 YEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  ++I D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKI-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 40/279 (14%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIV 67
Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 68  GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 120
Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 177
Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQ------LQLIVNLVRPNPPHADKFY 251
             Y+   DIWS+G  L EM   + P+ P  +           +L+  +V   PP   K  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPP---KLP 234
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           +G  +   E  D +N+ L+ NP+ER +  Q++ H ++ +
Sbjct: 235 SGVFSL--EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 60
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 223
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 224 TYLNPWKKIDSAPLALLHKILVENPSAR 251

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 62
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 225
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSAR 253

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 89
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 90  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 146
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE- 205
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 260
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 261 -----KARDLVEKLLVLDATKR 277

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 19  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 72
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 73  V---QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEIL 195
              +HRDL+ +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAA 184
Query: 196 ISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           +   R+T   D+WS G +L E+  + +  +PG      L  +    R P PP        
Sbjct: 185 LYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------ 237
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
               PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 238 ----PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 279

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GAYG V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N  L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +  +   D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 86
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 87  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 143
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 202
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 257
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 258 -----KARDLVEKLLVLDATKR 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 89
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 90  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 146
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 205
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 260
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 261 -----KARDLVEKLLVLDATKR 277

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 27  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 86
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 87  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 145 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 203 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 259
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 260 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 30  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 89
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 90  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 148 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 206 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 262
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 263 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITM 88
           ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  ++  
Sbjct: 25  KLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKLV-- 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+     
Sbjct: 77  -QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAPEILISN 198
           +HRDL  +NIL+ ++   K+ D GLAR + D+     EY A +       + APE  +  
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKWTAPEAALYG 190
Query: 199 RRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
            R+T   D+WS G +L E+  + +  +PG      L  +    R P PP           
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC--------- 240
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            PE   DL+ Q    +P ERP  + +    ++  YF   T   PQ  P
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYL--QAFLEDYF---TSTEPQYQP 282

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 86
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 87  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 143
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE- 202
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 257
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 258 -----KARDLVEKLLVLDATKR 274

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 93
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 94  LDHPFFVKLYFCFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 150
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 151 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 209
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 264
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 265 -----KARDLVEKLLVLDATKR 281

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 135/268 (50%), Gaps = 27/268 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 85
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 86  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 142
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE- 201
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 256
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQI 282
                +A DL+ ++LVL+ ++R   +++
Sbjct: 257 -----KARDLVEKLLVLDATKRLGCEEM 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 86
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 87  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 143
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 202
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 257
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 258 -----KARDLVEKLLVLDATKR 274

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 65
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 66  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 122
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLT-EYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 123 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 181
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 236
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 237 -----KARDLVEKLLVLDATKR 253

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 25  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 84
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 85  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 143 FKD--LVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 201 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 257
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 258 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 135/268 (50%), Gaps = 27/268 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 85
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 86  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 142
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 201
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 256
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQI 282
                +A DL+ ++LVL+ ++R   +++
Sbjct: 257 -----KARDLVEKLLVLDATKRLGCEEM 279

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+G +G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+ EY                      D+N+V  +++ 
Sbjct: 144 GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 202 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 260 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 316
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 317 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 63
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 64  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 120
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 121 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 179
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 234
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 235 -----KARDLVEKLLVLDATKR 251

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 64
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 65  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 121
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 180
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 235
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 236 -----KARDLVEKLLVLDATKR 252

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 66
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 67  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 123
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKECLT-EYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 124 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 182
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 237
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 238 -----KARDLVEKLLVLDATKR 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 70
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 71  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 127
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 128 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 186
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+   
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP-- 241
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 242 -----KARDLVEKLLVLDATKR 258

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 15/274 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG G +G+     DK + + VA+K I    R +   +   REI+  +S  RHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSL-RHPN 76
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++   +    L +V EY        ++       +   R+   QL +G+SY HA 
Sbjct: 77  IVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +V HRDLK  N L+D S +  +KI   G ++S S       + + T  Y APE+L+    
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKDTVGTPAYIAPEVLLKKEY 193
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
                D+WS G  L  ML     F         +  ++ +  N  +A   Y        E
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-NVQYAIPDYVHIS---PE 249
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              L+++I V +P++R    +I  H +  K  P+
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+  Y                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 3   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 52
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 53  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 112
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 113 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 171
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LTE   T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 172 NSLTEPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 230
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP         +    EE   L+  +L   P++R    + + H ++ + 
Sbjct: 231 TRIRMGQYEFPNPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 281
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 282 ----STKVPQTPLHTSRVLKEDKERWE 304

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 35/287 (12%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 19  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 72
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 73  V---QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNR 199
              +HRDL+ +NIL+ ++   K+ D GLAR + D++    +      +W  APE  +   
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW-TAPEAALYG- 187
Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNK 257
           R+T   D+WS G +L E+  + +  +PG      L  +    R P PP            
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---------- 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
           PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 238 PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 279

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGRAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K  + 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK- 245
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 246 -----QRLGGGPSDAKE---VMEHRF 263

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGRAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K  + 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK- 245
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 246 -----QRLGGGPSDAKE---VMEHRF 263

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 116/267 (43%), Gaps = 22/267 (8%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGRAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAG-FKNKPEE 260
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG  K  P  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP-- 244
Query: 261 AVDLLNQILVLNPSERPETDQILEHNY 287
                 Q L   PS+  E   ++EH +
Sbjct: 245 -----KQRLGGGPSDAKE---VMEHRF 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K  + 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK- 245
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 246 -----QRLGGGPSDAKE---VMEHRF 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 72
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 73  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAV 189
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K  + 
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK- 248
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 249 -----QRLGGGPSDAKE---VMEHRF 266

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAV 186
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K  + 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK- 245
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 246 -----QRLGGGPSDAKE---VMEHRF 263

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 137/298 (45%), Gaps = 43/298 (14%)
Query: 15  HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           H VD     ++   + IG G +G V+KA  + + +   IK++      K + ++  RE+ 
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVK 56
Query: 75  FLKSFQRHPNIITMLDIYKAVN--------------NKDLYVVFEYME-NDLNKVI---R 116
            L     H NI+     +   +               K L++  E+ +   L + I   R
Sbjct: 57  ALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SD 175
            + L  V    +  Q+  G+ YIH+ K+++RDLKPSNI +  +  +KIGD GL  SL +D
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
            K   ++   T  Y +PE  IS++ Y   VD+++LG ILAE+L          T+ +   
Sbjct: 176 GKRXRSK--GTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHV------CDTAFETSK 226
Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
               +R      D   +   +K E+   LL ++L   P +RP T +IL    V K  P
Sbjct: 227 FFTDLR------DGIISDIFDKKEKT--LLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           T+ K +G+GA+G V  A       DK  +      K+ +    + D      E+  +K  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------------------DLNKVIRDKI- 119
            +H NII +L       +  LYV+  Y                      D+N+V  +++ 
Sbjct: 98  GKHKNIINLLG--ACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---S 176
            KD  +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++    
Sbjct: 156 FKD--LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
           K+     +  +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG       +
Sbjct: 214 KKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           L+    R + P          N   E   ++       PS+RP   Q++E
Sbjct: 271 LLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 20/266 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  RHP +  
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 74
Query: 88  MLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVM 145
           +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y+H+  V+
Sbjct: 75  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHV 205
           +RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  N  Y   V
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGRAV 191
Query: 206 DIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAGFKNKPEEA 261
           D W LG ++ EM+  +  F         +LI    +   R   P A    AG   K    
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP-- 249
Query: 262 VDLLNQILVLNPSERPETDQILEHNY 287
                Q L   PS+  E   ++EH +
Sbjct: 250 ----KQRLGGGPSDAKE---VMEHRF 268

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +       I+ L    P   +KF+   
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSY 138
           HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L Y
Sbjct: 89  HPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEY 145
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEILI 196
           +H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE L+
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 204
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
           + +      D+W+LGCI+ +++   P F   +     Q I+ L    P   +KF+     
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFP---- 257
Query: 257 KPEEAVDLLNQILVLNPSER 276
              +A DL+ ++LVL+ ++R
Sbjct: 258 ---KARDLVEKLLVLDATKR 274

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + K IG G +G+     DK + + VA+K I    R +   +   REI+  +S  RHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSL-RHPN 76
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++   +    L +V EY        ++       +   R+   QL +G+SY HA 
Sbjct: 77  IVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +V HRDLK  N L+D S +  +KI   G ++S S         + T  Y APE+L+    
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 193
Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
                D+WS G  L  ML     F         +  ++ +  N  +A   Y        E
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-NVQYAIPDYVHIS---PE 249
Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              L+++I V +P++R    +I  H +  K  P+
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 27/262 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 88
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGL 136
             HP  + +   ++  +++ LY    Y +N +L K IR KI    +   R+   ++ + L
Sbjct: 89  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSAL 145
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEI 194
            Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           L++ +      D+W+LGCI+ +++   P F   +       I+ L    P   +KF+   
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP---EKFFP-- 259
Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +A DL+ ++LVL+ ++R
Sbjct: 260 -----KARDLVEKLLVLDATKR 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNK-QYVAI---KKIFEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+   +Y A    K+   A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HPNIIT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  -HPNIITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITAVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
               E A D + ++LV    +R    + L H +++
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 24/280 (8%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
            +G+GAYG+V K     + Q  A+K+I    R   ++Q   R +  L    R  +    +
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRI----RATVNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 90  DIYKAV-NNKDLYVVFEYMENDLNKVIRDKILKDVHI-----RYIMFQLCNGLSYIHA-C 142
             Y A+    D+++  E  +  L+K  +  I K   I       I   +   L ++H+  
Sbjct: 97  TFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL---ISNR 199
            V+HRD+KPSN+LI+    +K  D G++  L D      +    + Y APE +   ++ +
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKPYXAPERINPELNQK 215
Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
            Y+   DIWSLG    E+ +   P     +   QL+ +V    P  P ADKF A F    
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-ADKFSAEF---- 270
Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
              VD  +Q L  N  ERP   ++ +H + + +    T V
Sbjct: 271 ---VDFTSQCLKKNSKERPTYPELXQHPFFTLHESKGTDV 307

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 27  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 78
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 79  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 196
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 244
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 245 EELYQLMRLCWKERPEDRPTFD 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 25/286 (8%)
Query: 15  HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREI 73
           +N+D   L ++     +GKG++G V  A  K  ++  AIK +  +      D + T  E 
Sbjct: 11  NNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQ 131
             L    + P +  +   ++ V+   LY V EY+   DL   I+     K+    +   +
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDR--LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
           +  GL ++H   +++RDLK  N+++D    IKI D G+ +          E+  T  Y A
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIA 188
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHADK 249
           PEI I+ + Y   VD W+ G +L EML  +P F G       Q I+  N+  P       
Sbjct: 189 PEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP------- 240
Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER----PETDQ-ILEHNYVSK 290
                K+  +EAV +   ++  +P++R    PE ++ + EH +  +
Sbjct: 241 -----KSLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRR 281

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 25  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 77  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 194
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 242
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 243 EELYQLMRLCWKERPEDRPTFD 264

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 25/261 (9%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLKSF 79
           ++   K +G+G++  V  A +    +  AIK I E       NK       R+++   S 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVM---SR 91
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLS 137
             HP  + +   ++  +++ LY    Y +N +L K IR      +   R+   ++ + L 
Sbjct: 92  LDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 149
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-DSKEC-LTEYIATRWYRAPEIL 195
           Y+H   ++HRDLKP NIL+++   I+I D G A+ LS +SK+     ++ T  Y +PE L
Sbjct: 150 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-L 208
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
           ++ +      D+W+LGCI+ +++   P F   +     Q I+ L    P       A F 
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP-------AAFF 261
Query: 256 NKPEEAVDLLNQILVLNPSER 276
            K   A DL+ ++LVL+ ++R
Sbjct: 262 PK---ARDLVEKLLVLDATKR 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 19  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 70
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 188
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 236
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 237 EELYQLMRLCWKERPEDRPTFD 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 28  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 79
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 80  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 197
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 245
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 246 EELYQLMRLCWKERPEDRPTFD 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 69
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 70  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTFTAHAGAKFPIKWTAPESLAYN 185
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 186 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP---------EGC 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 131/285 (45%), Gaps = 52/285 (18%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQRTYREI 73
           +E  +  RIG G++G VYK     +   VA+K +         F+AFRN+    R     
Sbjct: 36  SEVMLSTRIGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRK---- 88
Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHI---RYIMF 130
                  RH NI+  +     +   +L +V ++ E          + K +H+   ++ MF
Sbjct: 89  ------TRHVNILLFMGY---MTKDNLAIVTQWCEGS-------SLYKHLHVQETKFQMF 132
Query: 131 QL-------CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLT 181
           QL         G+ Y+HA  ++HRD+K +NI + +  ++KIGD GLA  +S     + + 
Sbjct: 133 QLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 182 EYIATRWYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 239
           +   +  + APE+  +  N  ++   D++S G +L E++  +   P +  +++ Q+I  +
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE--LPYSHINNRDQIIFMV 250
Query: 240 VRP-NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
            R    P   K Y   KN P+    L+   +     ERP   QIL
Sbjct: 251 GRGYASPDLSKLY---KNCPKAMKRLVADCVKKVKEERPLFPQIL 292

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D  + + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 72
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ + D  +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 190 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 69
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 70  VQLLGV--CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPESLAYN 185
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 186 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP---------EGC 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 19  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 70
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 188
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 236
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 237 EELYQLMRLCWKERPEDRPTFD 258

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 21  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 72
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 73  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 190
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 238
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 239 EELYQLMRLCWKERPEDRPTFD 260

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D  + + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 72
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ + D  +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 190 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 20  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 71
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 72  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYGTFT 189
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 237
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 238 EELYQLMRLCWKERPEDRPTFD 259

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 72
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 73  VQLLGV--CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPESLAYN 188
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 189 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 238
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 77  VQLLGV--CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 192
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 193 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 242
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 29  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 80
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 81  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 198
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 246
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 247 EELYQLMRLCWKERPEDRPTFD 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 19  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 68
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 69  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 128
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 129 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 187
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 188 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 246
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 247 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 297
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 298 ----STKVPQTPLHTSRVLKEDKERWE 320

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 35/287 (12%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNI 85
           +  ++G+G +G V+     N    VAIK +    +  T +   + +E   +K   RH  +
Sbjct: 12  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKL-RHEKL 65
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +    +Y  V+ + + +V EYM      D  K    K L+   +  +  Q+ +G++Y+  
Sbjct: 66  V---QLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNR 199
              +HRDL+ +NIL+ ++   K+ D GLAR + D++    +      +W  APE  +   
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYG- 180
Query: 200 RYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNK 257
           R+T   D+WS G +L E+  + +  +PG      L  +    R P PP            
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---------- 230
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
           PE   DL+ Q     P ERP  + +    ++  YF   T   PQ  P
Sbjct: 231 PESLHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 272

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 130/272 (47%), Gaps = 21/272 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           +   + +G GA+  V  A +K   +  A+K I  +A + K  +     EI  L+   +H 
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN--EIAVLRKI-KHE 80
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           NI+ + DIY++ N+  LY+V + +      ++++      +     ++ Q+ + + Y+H 
Sbjct: 81  NIVALEDIYESPNH--LYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR 138
Query: 142 CKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
             ++HRDLKP N+L    D+   I I D GL++ +    + ++    T  Y APE+L + 
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEVL-AQ 196
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNK 257
           + Y+  VD WS+G I   +L   P F   + S   + I+      + P+ D         
Sbjct: 197 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDI------- 249
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            + A D +  ++  +P++R   +Q   H +++
Sbjct: 250 SDSAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 25  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 76
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 77  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 194
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 242
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 243 EELYQLMRLCWKERPEDRPTFD 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 77  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 192
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 193 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 242
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 77  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 192
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 193 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 242
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 73
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 74  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 189
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 190 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 239
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 44/279 (15%)
Query: 2   TSNTTSKS--GDKVQHNVD--GNILAE-YTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKK 55
           +S  +S+S   DK  H V   G+ L E Y I   +G+G +G V +  D    K  VA+K 
Sbjct: 2   SSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI 61
Query: 56  IFEAFRNKTDAQRTYR-EILFLKSFQRHPN-----IITMLDIYKAVNNKDLYVVFEYMEN 109
           I    RN    +   R EI  LK  +          + M D +    +  + + FE +  
Sbjct: 62  I----RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELLGK 115
Query: 110 DLNKVIRDKILKDV---HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---------- 156
           +  + +++   +     H+R++ +QLC+ L ++H  ++ H DLKP NIL           
Sbjct: 116 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 175
Query: 157 -DKSC--------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
             KSC        SI++ D G   S +   E  T  +ATR YR PE+++    +    D+
Sbjct: 176 EHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDV 231
Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           WS+GCIL E  +   LF        L ++  ++ P P H
Sbjct: 232 WSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSH 270

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 44/279 (15%)
Query: 2   TSNTTSKS--GDKVQHNVD--GNILAE-YTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKK 55
           +S  +S+S   DK  H V   G+ L E Y I   +G+G +G V +  D    K  VA+K 
Sbjct: 25  SSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI 84
Query: 56  IFEAFRNKTDAQRTYR-EILFLKSFQRHPN-----IITMLDIYKAVNNKDLYVVFEYMEN 109
           I    RN    +   R EI  LK  +          + M D +    +  + + FE +  
Sbjct: 85  I----RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELLGK 138
Query: 110 DLNKVIRDKILKDV---HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---------- 156
           +  + +++   +     H+R++ +QLC+ L ++H  ++ H DLKP NIL           
Sbjct: 139 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 198
Query: 157 -DKSC--------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
             KSC        SI++ D G   S +   E  T  +ATR YR PE+++    +    D+
Sbjct: 199 EHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDV 254
Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           WS+GCIL E  +   LF        L ++  ++ P P H
Sbjct: 255 WSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSH 293

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 14  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 65
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 66  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 183
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 231
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 232 EELYQLMRLCWKERPEDRPTFD 253

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 24  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 75
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 76  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 193
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 241
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 242 EELYQLMRLCWKERPEDRPTFD 263

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 73
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 74  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 189
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 190 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 239
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 5   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 54
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 55  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 173
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 174 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 232
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 233 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 283
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 284 ----STKVPQTPLHTSRVLKEDKERWE 306

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 4   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 53
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 54  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 113
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 114 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 172
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 173 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 231
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 232 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 282
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 283 ----STKVPQTPLHTSRVLKEDKERWE 305

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 84
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 85  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 200
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 201 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 250
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 11  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 60
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 61  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 120
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 121 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 179
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 180 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 238
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 239 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 289
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 290 ----STKVPQTPLHTSRVLKEDKERWE 312

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 49  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 98
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 99  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 217
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 218 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 277 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 327
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 328 ----STKVPQTPLHTSRVLKEDKERWE 350

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
            + ++ + + +G+GA G V  A ++  ++ VA+K +    +   D     ++ + +    
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKML 61
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            H N++      +  N + L++ +       +++  D  + +   +    QL  G+ Y+H
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYIATRWYRAPEILISN 198
              + HRD+KP N+L+D+  ++KI D GLA     ++ +  L +   T  Y APE+L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK- 257
             +   VD+WS G +L  ML  +  +   S S Q                  Y+ +K K 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----------------YSDWKEKK 224
Query: 258 ----PEEAVD-----LLNQILVLNPSER 276
               P + +D     LL++ILV NPS R
Sbjct: 225 TYLNPWKKIDSAPLALLHKILVENPSAR 252

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 9   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 58
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 59  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 118
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 119 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 177
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 178 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 236
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 237 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 287
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 288 ----STKVPQTPLHTSRVLKEDKERWE 310

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 10  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 59
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 60  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 119
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 120 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 178
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 179 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 237
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 238 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 288
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 289 ----STKVPQTPLHTSRVLKEDKERWE 311

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 77  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPESLAYN 192
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 193 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 242
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 77  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 192
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 193 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 242
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 19  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 70
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 188
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 236
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 237 EELYQLMRLCWKERPEDRPTFD 258

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 151/327 (46%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 5   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 54
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 55  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 173
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 174 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 232
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 233 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 283
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 284 ----STKVPQTPLHTSRVLKEDKERWE 306

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 75
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 76  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 192 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 241
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 150/327 (45%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 55  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 104
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 105 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 164
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 165 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 223
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 224 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 282
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP         +    EE   L+  +L   P++R    + + H ++ + 
Sbjct: 283 TRIRMGQYEFPNPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 333
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 334 ----STKVPQTPLHTSRVLKEDKERWE 356

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 72  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 187
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 188 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 237
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 150/327 (45%), Gaps = 41/327 (12%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 3   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 52
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 53  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 112
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 113 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 171
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
             LT    T +Y APE+L    +Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 172 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 230
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP         +    EE   L+  +L   P++R    + + H ++ + 
Sbjct: 231 TRIRMGQYEFPNPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 281
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 282 ----STKVPQTPLHTSRVLKEDKERWE 304

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   +           
Sbjct: 91  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS---LSDSKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR    +   K+
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 209 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 265
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 266 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 116/258 (44%), Gaps = 40/258 (15%)
Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYR-EILF 75
           G+ L E Y I   +G+G +G V +  D    K  VA+K I    RN    +   R EI  
Sbjct: 14  GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII----RNVGKYREAARLEINV 69
Query: 76  LKSFQRHPN-----IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV---HIRY 127
           LK  +          + M D +    +  + + FE +  +  + +++   +     H+R+
Sbjct: 70  LKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH 127
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILI-----------DKSC--------SIKIGDLG 168
           + +QLC+ L ++H  ++ H DLKP NIL             KSC        SI++ D G
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
              S +   E  T  +ATR YR PE+++    +    D+WS+GCIL E  +   LF    
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 229 TSHQLQLIVNLVRPNPPH 246
               L ++  ++ P P H
Sbjct: 244 NREHLVMMEKILGPIPSH 261

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 54/283 (19%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           + + + +G +  VY+A D  + +  A+K++      K  A    +E+ F+K    HPNI+
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA--IIQEVCFMKKLSGHPNIV 89
Query: 87  TMLDIYKA------VNNKDLYVVFEYMENDLNKVIR----------DKILKDVHIRYIMF 130
                             +  ++ E  +  L + ++          D +LK      I +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK------IFY 143
Query: 131 QLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLAR--------SLSDSKECL 180
           Q C  + ++H  K  ++HRDLK  N+L+    +IK+ D G A         S S  +  L
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 181 TEYIATR----WYRAPEI--LISNRRYTHHVDIWSLGCILAEM-LQSKPLFPGASTSHQL 233
            E   TR     YR PEI  L SN       DIW+LGCIL  +  +  P   GA      
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260
Query: 234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
             IVN     PPH D  Y  F +       L+  +L +NP ER
Sbjct: 261 --IVNGKYSIPPH-DTQYTVFHS-------LIRAMLQVNPEER 293

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 27  IHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K   
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY------------ 127
           +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y            
Sbjct: 133 KHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 128 -----IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKEC 179
                  +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+ 
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIV 237
               +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+ 
Sbjct: 251 TNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLK 307
Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
              R + P          N   E   ++       PS+RP   Q++E
Sbjct: 308 EGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 140/329 (42%), Gaps = 72/329 (21%)
Query: 23  AEYTIHKR----------IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYRE 72
            +YT+ KR          IG G +G V+KA  + + +   I+++      K + ++  RE
Sbjct: 2   TKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV------KYNNEKAERE 55
Query: 73  ILFLKSFQRHPNIITMLDIYKAVN---------------------------NKDLYVVFE 105
           +  L     H NI+     +   +                            K L++  E
Sbjct: 56  VKALAKLD-HVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 106 YME-NDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS 161
           + +   L + I   R + L  V    +  Q+  G+ YIH+ K++HRDLKPSNI +  +  
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ 174
Query: 162 IKIGDLGLARSL-SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS 220
           +KIGD GL  SL +D K   T    T  Y +PE  IS++ Y   VD+++LG ILAE+L  
Sbjct: 175 VKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHV 231
Query: 221 KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD 280
                   T+ +       +R      D   +   +K E+   LL ++L   P +RP T 
Sbjct: 232 ------CDTAFETSKFFTDLR------DGIISDIFDKKEKT--LLQKLLSKKPEDRPNTS 277
Query: 281 QILEHNYVSKYFPSATHVIPQVTPHTVVL 309
           +IL    V K  P           HT VL
Sbjct: 278 EILRTLTVWKKSPEKNE------RHTCVL 300

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G  G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 19  ERLGAGQAGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 70
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HRDL+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW-TAPEA-INYGTFT 188
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 236
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 237 EELYQLMRLCWKERPEDRPTFD 258

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 14/244 (5%)
Query: 4   NTTSKSGDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF 60
           N  S+  D +    D  + AE Y + K IG+GA+G V     K+ ++  A+K +  FE  
Sbjct: 54  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
           + ++D+   + E   + +F   P ++ +   Y   +++ LY+V EYM   DL  ++ +  
Sbjct: 114 K-RSDSAFFWEERDIM-AFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 177
           + +   R+   ++   L  IH+   +HRD+KP N+L+DKS  +K+ D G    ++     
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 178 ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
            C T  + T  Y +PE+L S   +  Y    D WS+G  L EML     F   S      
Sbjct: 230 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 288
Query: 235 LIVN 238
            I+N
Sbjct: 289 KIMN 292

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 23  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 82
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y           
Sbjct: 83  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 141 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 201 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 257
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 258 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 14/244 (5%)
Query: 4   NTTSKSGDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF 60
           N  S+  D +    D  + AE Y + K IG+GA+G V     K+ ++  A+K +  FE  
Sbjct: 49  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
           + ++D+   + E   + +F   P ++ +   Y   +++ LY+V EYM   DL  ++ +  
Sbjct: 109 K-RSDSAFFWEERDIM-AFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYD 164
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 177
           + +   R+   ++   L  IH+   +HRD+KP N+L+DKS  +K+ D G    ++     
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 178 ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
            C T  + T  Y +PE+L S   +  Y    D WS+G  L EML     F   S      
Sbjct: 225 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283
Query: 235 LIVN 238
            I+N
Sbjct: 284 KIMN 287

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 131/304 (43%), Gaps = 19/304 (6%)
Query: 12  KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTY 70
           K +H V  N   E+   K +GKG +G V    +K   +Y A+K +  E    K +   T 
Sbjct: 143 KPKHRVTMN---EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 199
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYI 128
            E   L++  RHP  +T L  Y    +  L  V EY         + R+++  +   R+ 
Sbjct: 200 TENRVLQN-SRHP-FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 256
Query: 129 MFQLCNGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
             ++ + L Y+H+ K V++RDLK  N+++DK   IKI D GL +        +  +  T 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPN 243
            Y APE+L  N  Y   VD W LG ++ EM+  +  F         +LI    +   R  
Sbjct: 317 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 375
Query: 244 PPHADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
            P A    +G  K  P++ +   ++        R     + +H Y  K  P      PQV
Sbjct: 376 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK---PQV 432
Query: 303 TPHT 306
           T  T
Sbjct: 433 TSET 436

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 14/244 (5%)
Query: 4   NTTSKSGDKVQHNVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF 60
           N  S+  D +    D  + AE Y + K IG+GA+G V     K+ ++  A+K +  FE  
Sbjct: 54  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
           + ++D+   + E   + +F   P ++ +   Y   +++ LY+V EYM   DL  ++ +  
Sbjct: 114 K-RSDSAFFWEERDIM-AFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYD 169
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-- 177
           + +   R+   ++   L  IH+   +HRD+KP N+L+DKS  +K+ D G    ++     
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 178 ECLTEYIATRWYRAPEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
            C T  + T  Y +PE+L S   +  Y    D WS+G  L EML     F   S      
Sbjct: 230 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 288
Query: 235 LIVN 238
            I+N
Sbjct: 289 KIMN 292

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 28/298 (9%)
Query: 5   TTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT 64
           TT      + H+ D      Y   K IG G +G+     DK  K+ VA+K I    R   
Sbjct: 7   TTGPLDMPIMHDSD-----RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAA 58
Query: 65  DAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKD 122
             +   REI+  +S  RHPNI+   ++   +    L ++ EY        ++       +
Sbjct: 59  IDENVQREIINHRSL-RHPNIVRFKEVI--LTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 123 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECL 180
              R+   QL +G+SY H+ ++ HRDLK  N L+D S +  +KI D G ++S S      
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQP 174
Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ----LQLI 236
              + T  Y APE+L+         D+WS G  L  ML     F            +Q I
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
           +++    P          +  P E   L+++I V +P+ R    +I  H++  K  P+
Sbjct: 235 LSVKYSIP-------DDIRISP-ECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D  + + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 72
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ + D  +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NILI  + ++K+ D G+AR+++DS   + +    I T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 190 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E ME   DL   I ++  L++   R   +Q+  
Sbjct: 68  VSSGFSGVIRLLDWFERPDS--FVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 183
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 228
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 229 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+     A K I      A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            H N+IT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  HH-NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITSVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            +  E A D + ++LV    +R    + L H +++
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 131/304 (43%), Gaps = 19/304 (6%)
Query: 12  KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTY 70
           K +H V  N   E+   K +GKG +G V    +K   +Y A+K +  E    K +   T 
Sbjct: 140 KPKHRVTMN---EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYI 128
            E   L++  RHP  +T L  Y    +  L  V EY         + R+++  +   R+ 
Sbjct: 197 TENRVLQN-SRHP-FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 129 MFQLCNGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
             ++ + L Y+H+ K V++RDLK  N+++DK   IKI D GL +        +  +  T 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPN 243
            Y APE+L  N  Y   VD W LG ++ EM+  +  F         +LI    +   R  
Sbjct: 314 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372
Query: 244 PPHADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
            P A    +G  K  P++ +   ++        R     + +H Y  K  P      PQV
Sbjct: 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK---PQV 429
Query: 303 TPHT 306
           T  T
Sbjct: 430 TSET 433

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 16  NVDGNI---LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-- 70
           NV+ NI   + ++++H+ IG+G +G VY     +  +  A+K   +  R K     T   
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLAL 237
Query: 71  --REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIR 126
             R +L L S    P I+ M   Y       L  + + M   DL+  + +  +  +  +R
Sbjct: 238 NERIMLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
           +   ++  GL ++H   V++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGT 353
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
             Y APE+L     Y    D +SLGC+L ++L+    F
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 8/146 (5%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           ++C GL  +H  ++++RDLKP NIL+D    I+I DLGLA  + + +  +   + T  Y 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYM 352
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+ + N RYT   D W+LGC+L EM+  +  F       + + +  LV+  P    + 
Sbjct: 353 APEV-VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
           ++       +A  L +Q+L  +P+ER
Sbjct: 412 FS------PQARSLCSQLLCKDPAER 431

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y           
Sbjct: 91  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 209 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 265
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 266 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 16  NVDGNI---LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-- 70
           NV+ NI   + ++++H+ IG+G +G VY     +  +  A+K   +  R K     T   
Sbjct: 178 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLAL 236
Query: 71  --REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIR 126
             R +L L S    P I+ M   Y       L  + + M   DL+  + +  +  +  +R
Sbjct: 237 NERIMLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 294
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
           +   ++  GL ++H   V++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T
Sbjct: 295 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGT 352
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
             Y APE+L     Y    D +SLGC+L ++L+    F
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQRHPNIIT 87
           ++G+G +G+VYK Y  N    VA+KK+       T+   Q+  +EI  +   Q H N++ 
Sbjct: 38  KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVE 94
Query: 88  MLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHAC 142
           +L    + +  DL +V+ YM N    D    +        H+R  + Q   NG++++H  
Sbjct: 95  LLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATRWYRAPEILISNRR 200
             +HRD+K +NIL+D++ + KI D GLAR+     + +  +  + T  Y APE L     
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGE 210
Query: 201 YTHHVDIWSLGCILAEMLQSKP 222
            T   DI+S G +L E++   P
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLP 232

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 317
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 318 VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HR+L   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 433
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 434 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 483
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 20  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 79
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y           
Sbjct: 80  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 138 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 198 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 254
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 255 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y           
Sbjct: 91  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 209 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 265
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 266 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 24  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 83
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVHIRY----------- 127
            +H NII +L       +  LYV+ EY  + +L + ++ +    +   Y           
Sbjct: 84  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 128 ------IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
                   +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 142 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 202 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 258
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 259 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 20/280 (7%)
Query: 19  GNILAEYTIHKR--IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           G + + YT+ K   +G G +G V+K  +      +A K I    R   D +    EI  +
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVM 140
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKI-LKDVHIRYIMFQLC 133
                H N+I + D +++ N  D+ +V EY++     +++I +   L ++     M Q+C
Sbjct: 141 NQLD-HANLIQLYDAFESKN--DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 134 NGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
            G+ ++H   ++H DLKP NIL     +  IKI D GLAR     +E L     T  + A
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLA 256
Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE+ ++    +   D+WS+G I   +L     F G + +  L  I+          D   
Sbjct: 257 PEV-VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------RWDLED 309
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             F++  EEA + ++++L+   S R    + L+H ++S +
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G +G VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 69
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 70  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPESLAYN 185
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 186 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP---------EGC 235
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 18/287 (6%)
Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G++   Y I + +G GA+G+V++  +K   +    K I   +    D      EI  +  
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQ 104
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVI-RDKILKDVHIRYIMFQLCNG 135
              HP +I + D ++  +  ++ ++ E++      +++   D  + +  +   M Q C G
Sbjct: 105 LH-HPKLINLHDAFE--DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 136 LSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L ++H   ++H D+KP NI+ +  K+ S+KI D GLA  L +  E +    AT  + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPE 220
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           I +       + D+W++G +   +L     F G      LQ   N+ R +    +     
Sbjct: 221 I-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRCDWEFDED---A 273
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           F +   EA D +  +L   P +R      LEH ++     + T  IP
Sbjct: 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 16  NVDGNI---LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-- 70
           NV+ NI   + ++++H+ IG+G +G VY     +  +  A+K   +  R K     T   
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLAL 237
Query: 71  --REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIR 126
             R +L L S    P I+ M   Y       L  + + M   DL+  + +  +  +  +R
Sbjct: 238 NERIMLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
           +   ++  GL ++H   V++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGT 353
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
             Y APE+L     Y    D +SLGC+L ++L+    F
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 16  NVDGNI---LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-- 70
           NV+ NI   + ++++H+ IG+G +G VY     +  +  A+K   +  R K     T   
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLAL 237
Query: 71  --REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN-KVIRDKILKDVHIR 126
             R +L L S    P I+ M   Y       L  + + M   DL+  + +  +  +  +R
Sbjct: 238 NERIMLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
           +   ++  GL ++H   V++RDLKP+NIL+D+   ++I DLGLA   S  K   +  + T
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGT 353
Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
             Y APE+L     Y    D +SLGC+L ++L+    F
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D    + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 72
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ + D  +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 190 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 278
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+  
Sbjct: 279 VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HR+L   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  N
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYN 394
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 395 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 444
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 445 PEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+     A K I      A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            H N+IT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  HH-NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITSVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            +  E A D + ++LV    +R    + L H +++
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 8/146 (5%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           ++C GL  +H  ++++RDLKP NIL+D    I+I DLGLA  + + +  +   + T  Y 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYM 352
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+ + N RYT   D W+LGC+L EM+  +  F       + + +  LV+  P    + 
Sbjct: 353 APEV-VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
           ++       +A  L +Q+L  +P+ER
Sbjct: 412 FS------PQARSLCSQLLCKDPAER 431

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+     A K I      A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            H N+IT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  HH-NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITSVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            +  E A D + ++LV    +R    + L H +++
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+     A K I      A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            H N+IT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  HH-NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITAVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
               E A D + ++LV    +R    + L H +++
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 16/294 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + E+   K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-S 65
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           RHP +  +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y
Sbjct: 66  RHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 139 IHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +H+ K V++RDLK  N+++DK   IKI D GL +        +  +  T  Y APE+L  
Sbjct: 124 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 183
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAG 253
           N  Y   VD W LG ++ EM+  +  F         +LI    +   R   P A    +G
Sbjct: 184 N-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 242
Query: 254 -FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT 306
             K  P++ +   ++        R     + +H Y  K  P      PQVT  T
Sbjct: 243 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK---PQVTSET 293

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 16/294 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + E+   K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-S 66
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           RHP +  +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y
Sbjct: 67  RHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 139 IHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +H+ K V++RDLK  N+++DK   IKI D GL +        +  +  T  Y APE+L  
Sbjct: 125 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 184
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAG 253
           N  Y   VD W LG ++ EM+  +  F         +LI    +   R   P A    +G
Sbjct: 185 N-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 243
Query: 254 -FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT 306
             K  P++ +   ++        R     + +H Y  K  P      PQVT  T
Sbjct: 244 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK---PQVTSET 294

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +R+G G +G V+  Y  N    VA+K + +             E   +K  Q       +
Sbjct: 15  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQ----RL 66
Query: 89  LDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           + +Y  V  + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I     
Sbjct: 67  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRYT 202
           +HR+L+ +NIL+  + S KI D GLAR + D++    E      +W  APE  I+   +T
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEA-INYGTFT 184
Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLI---VNLVRPNPPHADKFYAGFKNKP 258
              D+WS G +L E++   +  +PG +    +Q +     +VRP+            N P
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------------NCP 232
Query: 259 EEAVDLLNQILVLNPSERPETD 280
           EE   L+       P +RP  D
Sbjct: 233 EELYQLMRLCWKERPEDRPTFD 254

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSFQ 80
           Y I + +G G + IV K  +K+     A K I      A R     +   RE+  L+   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            H N+IT+ D+Y+  N  D+ ++ E +      + + + + L +      + Q+ +G++Y
Sbjct: 74  HH-NVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 139 IHACKVMHRDLKPSNI-LIDKSCS---IKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           +H  K+ H DLKP NI L+DK+     IK+ D GLA  + D  E       T  + APEI
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            ++        D+WS+G I   +L     F G +    L    N+   +    ++F   F
Sbjct: 190 -VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITAVSYDFDEEF---F 242
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
               E A D + ++LV    +R    + L H +++
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 16/294 (5%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + E+   K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-S 67
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           RHP +  +   Y    +  L  V EY         + R+++  +   R+   ++ + L Y
Sbjct: 68  RHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 139 IHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +H+ K V++RDLK  N+++DK   IKI D GL +        +  +  T  Y APE+L  
Sbjct: 126 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 185
Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI----VNLVRPNPPHADKFYAG 253
           N  Y   VD W LG ++ EM+  +  F         +LI    +   R   P A    +G
Sbjct: 186 N-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 244
Query: 254 -FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT 306
             K  P++ +   ++        R     + +H Y  K  P      PQVT  T
Sbjct: 245 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFK---PQVTSET 295

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 73
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 74  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T     ++   + APE L  N
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPESLAYN 189
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 190 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 239
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 72
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESL-T 190
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK-----KIFE-AFRNKTDAQRTYR 71
           +G    +Y+    +G GA+G V+ A DK   + V +K     K+ E  +       +   
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 72  EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNK---VIRDKILKDVHIRYI 128
           EI  L   + H NII +LDI++  N     +V E   + L+    + R   L +    YI
Sbjct: 79  EIAILSRVE-HANIIKVLDIFE--NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
             QL + + Y+    ++HRD+K  NI+I +  +IK+ D G A  L   K   T +  T  
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIE 194
Query: 189 YRAPEILISNRRYTHHVDIWSLG-------------CILAEMLQSKPLFPGASTSHQLQL 235
           Y APE+L+ N      +++WSLG             C L E +++    P   +   + L
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254
Query: 236 IVNLVRPNP 244
           +  L++P P
Sbjct: 255 VSGLLQPVP 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 72
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           + +L +         Y++ E+M   +L   +R+   ++V+   + Y+  Q+ + + Y+  
Sbjct: 73  VQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILISN 198
              +HRDL   N L+ ++  +K+ D GL+R ++   +  T     ++   + APE L  N
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPESLAYN 188
Query: 199 RRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  
Sbjct: 189 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGC 238
Query: 258 PEEAVDLLNQILVLNPSERPETDQI 282
           PE+  +L+      NPS+RP   +I
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-- 81
           E  + + +G+GA+G+V KA  K   + VAIK+I      +++++R    I+ L+   R  
Sbjct: 10  EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI------ESESERKAF-IVELRQLSRVN 60
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   Y A  N  + +V EY E     N L+           H      Q   G+
Sbjct: 61  HPNIVKL---YGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 137 SYIHACK---VMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           +Y+H+ +   ++HRDLKP N+L+    ++ KI D G A    D +  +T    +  + AP
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAP 173
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFP--GASTSHQLQLIVNLVRPNPPHADKF 250
           E+      Y+   D++S G IL E++  +  F   G      +  + N  RP        
Sbjct: 174 EVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-------- 224
Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE-HNYVSKYFPSA 295
               KN P+    L+ +    +PS+RP  ++I++   ++ +YFP A
Sbjct: 225 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 269

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-- 81
           E  + + +G+GA+G+V KA  K   + VAIK+I      +++++R    I+ L+   R  
Sbjct: 9   EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI------ESESERKAF-IVELRQLSRVN 59
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGL 136
           HPNI+ +   Y A  N  + +V EY E     N L+           H      Q   G+
Sbjct: 60  HPNIVKL---YGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 137 SYIHACK---VMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           +Y+H+ +   ++HRDLKP N+L+    ++ KI D G A    D +  +T    +  + AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAP 172
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFP--GASTSHQLQLIVNLVRPNPPHADKF 250
           E+      Y+   D++S G IL E++  +  F   G      +  + N  RP        
Sbjct: 173 EVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-------- 223
Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE-HNYVSKYFPSA 295
               KN P+    L+ +    +PS+RP  ++I++   ++ +YFP A
Sbjct: 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 31  IGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           +G GA G IVY+    N    VA+K+I     +  D     RE+  L+    HPN+I   
Sbjct: 32  LGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYF 84
Query: 90  DIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHACKVMHR 147
              K  + +  Y+  E     L + +  K    + +  I    Q  +GL+++H+  ++HR
Sbjct: 85  CTEK--DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 148 DLKPSNILI---DKSCSIK--IGDLGLARSLSDSKECLTE---YIATRWYRAPEILISNR 199
           DLKP NILI   +    IK  I D GL + L+  +   +       T  + APE+L  + 
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 200 RY--THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           +   T+ VDI+S GC+   ++       G S   Q  +++     +  H +      K++
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE------KHE 256
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY 287
              A +L+ +++ ++P +RP    +L+H +
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQRHPNIIT 87
           ++G+G +G+VYK Y  N    VA+KK+       T+   Q+  +EI  +   Q H N++ 
Sbjct: 38  KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVE 94
Query: 88  MLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHAC 142
           +L    + +  DL +V+ YM N    D    +        H+R  + Q   NG++++H  
Sbjct: 95  LLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATRWYRAPEILISNRR 200
             +HRD+K +NIL+D++ + KI D GLAR+     + +     + T  Y APE L     
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGE 210
Query: 201 YTHHVDIWSLGCILAEMLQSKP 222
            T   DI+S G +L E++   P
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLP 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 131/289 (45%), Gaps = 21/289 (7%)
Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           ++ +Y +   +G+G+YG V +  D     ++ V I K  +  R         +EI  L+ 
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKV---IRDKILKDVHIRYIMFQLCNG 135
             RH N+I ++D+      + +Y+V EY    + ++   + +K            QL +G
Sbjct: 63  L-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL---SDSKECLTEYIATRWYRAP 192
           L Y+H+  ++H+D+KP N+L+    ++KI  LG+A +L   +    C T    +  ++ P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPP 180
Query: 193 EILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           EI      ++   VDIWS G  L  +      F G +     +L  N+ + +       Y
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGKGS-------Y 230
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
           A   +      DLL  +L   P++R    QI +H++  K  P A   +P
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 75
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 193
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILK 121
            +H NII +L       +  LYV+ EY  + +L + ++                 ++ L 
Sbjct: 76  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
              +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 194 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 250
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 251 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 26  TIHKRIGKGAYGIVYKAY------DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            + K +G+GA+G V  A       DK N+      K+ ++   + D      E+  +K  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR-----------------DKILK 121
            +H NII +L       +  LYV+ EY  + +L + ++                 ++ L 
Sbjct: 91  GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD---SKE 178
              +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +      K+
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLI 236
                +  +W  APE L  +R YTH  D+WS G +L E+  L   P +PG       +L+
Sbjct: 209 TTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 265
Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               R + P          N   E   ++       PS+RP   Q++E
Sbjct: 266 KEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D    + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 89
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ + D  +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 207 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 240

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 89/350 (25%), Positives = 149/350 (42%), Gaps = 72/350 (20%)
Query: 1   MTSNTTSKSGDKVQHNVDGNILA---EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--- 54
           M  +    SG +  +   G++L    +Y +   IG+G+YG+V  A +   +   AIK   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 55  --KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE-----YM 107
             KI +   N  D +R   E+  +K    HPNI  + ++Y+  + + + +V E     ++
Sbjct: 61  KNKIRQI--NPKDVERIKTEVRLMKKLH-HPNIARLYEVYE--DEQYICLVMELCHGGHL 115
Query: 108 ENDLNKVIRDKILK-----------------------DVH--------------IRYIMF 130
            + LN  I D   K                        +H              I  IM 
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSL----SDSKECLTEYI 184
           Q+ + L Y+H   + HRD+KP N L   +KS  IK+ D GL++      +     +T   
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 185 ATRWYRAPEIL-ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVR 241
            T ++ APE+L  +N  Y    D WS G +L  +L     FPG + +  +  ++N  L  
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
            NP         +      A DLL+ +L  N  ER +  + L+H ++S++
Sbjct: 296 ENP--------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 29  KRIGKGAYGIVYKA-YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           KR+G G +G V+   ++ N K  VAIK +    +  T +  ++ E   +    +H  ++ 
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTK--VAIKTL----KPGTMSPESFLEEAQIMKKLKHDKLV- 67
Query: 88  MLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
              +Y  V+ + +Y+V EYM      D  K    + LK  ++  +  Q+  G++YI    
Sbjct: 68  --QLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRY 201
            +HRDL+ +NIL+      KI D GLAR + D++    +      +W  APE  +   R+
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYG-RF 183
Query: 202 THHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKPE 259
           T   D+WS G +L E++ + +  +PG +    L+ +    R P P          ++ P 
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP----------QDCPI 233
Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
              +L+      +P ERP  + +   +++  YF   T   PQ  P
Sbjct: 234 SLHELMIHCWKKDPEERPTFEYL--QSFLEDYF---TATEPQYQP 273

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 118/250 (47%), Gaps = 37/250 (14%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           + I + IGKG++G V      + K+  A+K +  +    + + +  ++E+  ++  + HP
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HP 75
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH-----IRYIMFQLCNGLSY 138
            ++ +   Y   + +D+++V + +   L   +R  + ++VH     ++  + +L   L Y
Sbjct: 76  FLVNLW--YSFQDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +   +++HRD+KP NIL+D+   + I D  +A  L    + +T    T+ Y APE+  S 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSR 189
Query: 199 R--RYTHHVDIWSLGCILAEMLQSKP----------------------LFPGASTSHQLQ 234
           +   Y+  VD WSLG    E+L+ +                        +P A +   + 
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249
Query: 235 LIVNLVRPNP 244
           L+  L+ PNP
Sbjct: 250 LLKKLLEPNP 259

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 72
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 190
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 90
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 208
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 103
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 221
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 76
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 194
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 195 ESKFSVASDVWSFGVVLYELF 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 75
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 193
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 71
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L  
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE 190
Query: 198 NRRYTHHVDIWSLGCILAEML 218
           + +++   D+WS G +L E+ 
Sbjct: 191 S-KFSVASDVWSFGVVLYELF 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 77
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 195
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 196 ESKFSVASDVWSFGVVLYELF 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 70
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 188
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 189 ESKFSVASDVWSFGVVLYELF 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 79
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 197
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 198 ESKFSVASDVWSFGVVLYELF 218

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 75
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ E++    L + ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE 194
Query: 198 NRRYTHHVDIWSLGCILAEML 218
           + +++   D+WS G +L E+ 
Sbjct: 195 S-KFSVASDVWSFGVVLYELF 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 78
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 196
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 197 ESKFSVASDVWSFGVVLYELF 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 72
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 190
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS----H 61
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +VFE+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 62  PKLVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 120 EEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 176
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 223
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 224 YKPRLASTHVYQIMNHCWKERPE 246

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQRHPNIIT 87
           ++G+G +G+VYK Y  N    VA+KK+       T+   Q+  +EI  +   Q H N++ 
Sbjct: 32  KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVE 88
Query: 88  MLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHAC 142
           +L    + +  DL +V+ YM N    D    +        H+R  + Q   NG++++H  
Sbjct: 89  LLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 146
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATRWYRAPEILISNRR 200
             +HRD+K +NIL+D++ + KI D GLAR+     + +     + T  Y APE L     
Sbjct: 147 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGE 204
Query: 201 YTHHVDIWSLGCILAEMLQSKP 222
            T   DI+S G +L E++   P
Sbjct: 205 ITPKSDIYSFGVVLLEIITGLP 226

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 96  NNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN 153
           +N +LY+V EYM      + + R     + H R+   Q+     Y+H+  +++RDLKP N
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 154 ILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 213
           +LID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+LG +
Sbjct: 172 LLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWALGVL 227
Query: 214 LAEMLQSKPLF 224
           + EM    P F
Sbjct: 228 IYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 96  NNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSN 153
           +N +LY+V EYM      + + R     + H R+   Q+     Y+H+  +++RDLKP N
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 154 ILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCI 213
           +LID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+LG +
Sbjct: 172 LLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWALGVL 227
Query: 214 LAEMLQSKPLF 224
           + EM    P F
Sbjct: 228 IYEMAAGYPPF 238

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 90
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPEILIS 197
            + +HRDL   NIL++    +KIGD GL + L   KE             WY APE L +
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESL-T 208
Query: 198 NRRYTHHVDIWSLGCILAEML 218
             +++   D+WS G +L E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 19  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 78
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 79  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEXXSVHNKTG 195
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 196 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
           T  K IG G +G VYK   K +       VAIK +   +   T+ QR     E   +  F
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQF 103
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGL 136
             H NII +  +      K + ++ EYMEN  L+K +R+K      + +  ++  +  G+
Sbjct: 104 SHH-NIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NIL++ +   K+ D GL+R L D  E         I  RW  AP
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TAP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  IS R++T   D+WS G ++ E++
Sbjct: 220 EA-ISYRKFTSASDVWSFGIVMWEVM 244

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS----H 61
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +VFE+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 62  PKLVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 120 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 176
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 223
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 224 YKPRLASTHVYQIMNHCWKERPE 246

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           + +G G++G V     K    + A+K I +  + K    +     L  K  Q+  N   +
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMK-ILD--KQKVVKLKQIEHTLNEKRIQQAVNFPFL 104
Query: 89  LDI-YKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           + + +   +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+ 
Sbjct: 105 VKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL 161
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            +++RDLKP N+LID+   IK+ D G A+ +      L     T  Y APEI++S + Y 
Sbjct: 162 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYN 217
Query: 203 HHVDIWSLGCILAEMLQSKPLF 224
             VD W+LG ++ EM    P F
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS----H 59
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +VFE+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 60  PKLVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 174
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 221
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPE 244

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 103 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 218
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 263
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 69  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 184
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 229
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 230 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 97  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 212
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 257
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 258 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 38  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 97
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 98  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 155
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 214
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 215 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 261

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 84  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 199
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 244
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 245 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 130/277 (46%), Gaps = 25/277 (9%)
Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE--AFRNKTDAQRTYREILFLK 77
           NI   +   + +G GA+  V+    +   +  A+K I +  AFR+ +       EI  LK
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS----LENEIAVLK 61
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
              +H NI+T+ DIY++  +   Y+V + +      ++++   +  +     ++ Q+ + 
Sbjct: 62  KI-KHENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 136 LSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           + Y+H   ++HRDLKP N+L    +++  I I D GL++   +    ++    T  Y AP
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAP 176
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI-VNLVRPNPPHADKFY 251
           E+L + + Y+  VD WS+G I   +L   P F   + S   + I         P  D   
Sbjct: 177 EVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD--- 232
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               +  E A D +  +L  +P+ER   ++ L H ++
Sbjct: 233 ----DISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 83  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 198
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 243
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 244 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 42/271 (15%)
Query: 27  IHKRIGKGAYGIVYKA-YDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSF 79
           + K++G G +G V+ A Y+K+ K  VA+K +       EAF  + +  +T +    +K  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK-- 247
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNG 135
                      ++  V  + +Y++ E+M     L+ +  D+  K    + I F  Q+  G
Sbjct: 248 -----------LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPE 193
           +++I     +HRDL+ +NIL+  S   KI D GLAR + D++    E      +W  APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE 355
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
             I+   +T   D+WS G +L E++   +  +PG S    ++ +    R P P       
Sbjct: 356 A-INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP------- 407
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              +N PEE  +++ +     P ERP  + I
Sbjct: 408 ---ENCPEELYNIMMRCWKNRPEERPTFEYI 435

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 68  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 183
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 228
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 229 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 39  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 98
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 99  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 156
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 215
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 216 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 262

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 84  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 199
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 244
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 245 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 97  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 212
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 257
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 258 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 10  SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS----H 64
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +VFE+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 65  PKLVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 122
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 123 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 179
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 226
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 227 YKPRLASTHVYQIMNHCWRERPE 249

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 96  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 211
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 256
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 257 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 111 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 226
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 271
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 272 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 83  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 198
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 243
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 244 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 20  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 79
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 80  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 196
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 197 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 96  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 211
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 256
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 257 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 19  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 78
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 79  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 195
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 196 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 69  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 184
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 229
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 230 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 49/290 (16%)
Query: 28  HKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
            K +G G+ G +V++   +     VA+K++   F           EI  L     HPN+I
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRP--VAVKRMLIDF-----CDIALMEIKLLTESDDHPNVI 90
Query: 87  TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY--------IMFQLCNGLSY 138
                     ++ LY+  E    +L  ++  K + D +++         ++ Q+ +G+++
Sbjct: 91  RY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 139 IHACKVMHRDLKPSNILIDKSC-------------SIKIGDLGLARSLSDSKECLTEYI- 184
           +H+ K++HRDLKP NIL+  S               I I D GL + L   +      + 
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 185 ---ATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQL 235
               T  +RAPE+L   + RR T  +DI+S+GC+   +L SK   P        S+ ++ 
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL-SKGKHPFGDKYSRESNIIRG 267
Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           I +L      H     A       EA DL++Q++  +P +RP   ++L H
Sbjct: 268 IFSLDEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 17  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 76
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 77  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 193
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 194 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 96  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 211
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 256
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 257 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 18  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 77
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 78  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 194
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 195 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 241

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 69  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 184
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 229
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 230 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 97  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 212
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 257
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 258 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 20  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 79
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 80  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 196
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 197 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 97  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 212
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 257
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 258 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAFRNKTDAQRTYREILFLKSFQR 81
           +Y + K IG+GA+G V     K +++  A+K +  FE  + ++D+   + E   + +F  
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIK-RSDSAFFWEERDIM-AFAN 133
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            P ++ +   ++  ++K LY+V EYM   DL  ++ +  + +   ++   ++   L  IH
Sbjct: 134 SPWVVQLFCAFQ--DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILIS- 197
           +  ++HRD+KP N+L+DK   +K+ D G    + ++    C T  + T  Y +PE+L S 
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISPEVLKSQ 250
Query: 198 --NRRYTHHVDIWSLGCILAEML 218
             +  Y    D WS+G  L EML
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEML 273

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 49/290 (16%)
Query: 28  HKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
            K +G G+ G +V++   +     VA+K++   F           EI  L     HPN+I
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRP--VAVKRMLIDF-----CDIALMEIKLLTESDDHPNVI 90
Query: 87  TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY--------IMFQLCNGLSY 138
                     ++ LY+  E    +L  ++  K + D +++         ++ Q+ +G+++
Sbjct: 91  RY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 139 IHACKVMHRDLKPSNILIDKSC-------------SIKIGDLGLARSLSDSKECLTEYI- 184
           +H+ K++HRDLKP NIL+  S               I I D GL + L   +      + 
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 185 ---ATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS----TSHQLQL 235
               T  +RAPE+L   + RR T  +DI+S+GC+   +L SK   P        S+ ++ 
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL-SKGKHPFGDKYSRESNIIRG 267
Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           I +L      H     A       EA DL++Q++  +P +RP   ++L H
Sbjct: 268 IFSLDEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 25/282 (8%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + +   +G+GA  IVY+   K  ++  A+K      +   D +    EI  L     HPN
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALK----VLKKTVDKKIVRTEIGVLLRLS-HPN 109
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           II + +I++      L +         ++++      +      + Q+   ++Y+H   +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 145 MHRDLKPSNILIDKS---CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
           +HRDLKP N+L         +KI D GL++ + + +  +     T  Y APEIL     Y
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCAPEIL-RGCAY 227
Query: 202 THHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVN----LVRPNPPHADKFYAGFKN 256
              VD+WS+G I   +L   +P +         + I+N     + P           +  
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP----------WWDE 277
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
               A DL+ +++VL+P +R  T Q L+H +V+    +  H+
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM 319

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 15  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 74
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 75  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 191
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 192 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 29  KRIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +++GKG +G V    Y     N  + VA+KK+  +   +   +   REI  LKS Q H N
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDN 73
Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMF--QLCNGLSYIHA 141
           I+    +  +   ++L ++ EY+    L   ++    +  HI+ + +  Q+C G+ Y+  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------WYRAPE 193
            + +HR+L   NIL++    +KIGD GL + L   K    EY   +        WY APE
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWY-APE 188
Query: 194 ILISNRRYTHHVDIWSLGCILAEML 218
            L  + +++   D+WS G +L E+ 
Sbjct: 189 SLTES-KFSVASDVWSFGVVLYELF 212

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 96  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 211
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR- 256
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 257 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 116 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 173
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 231
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 276
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 277 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 42/271 (15%)
Query: 27  IHKRIGKGAYGIVYKA-YDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSF 79
           + K++G G +G V+ A Y+K+ K  VA+K +       EAF  + +  +T +        
Sbjct: 19  LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQ-------- 68
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNG 135
             H  ++ +   +  V  + +Y++ E+M     L+ +  D+  K    + I F  Q+  G
Sbjct: 69  --HDKLVKL---HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPE 193
           +++I     +HRDL+ +NIL+  S   KI D GLAR + D++    E      +W  APE
Sbjct: 124 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE 182
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
             I+   +T   D+WS G +L E++   +  +PG S    ++ +    R P P       
Sbjct: 183 A-INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP------- 234
Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              +N PEE  +++ +     P ERP  + I
Sbjct: 235 ---ENCPEELYNIMMRCWKNRPEERPTFEYI 262

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 12  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 71
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 72  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 129
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTG 188
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 189 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 235

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 91  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 148
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 206
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 251
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 252 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGL 136
                  +I +LD ++  ++  L +       DL   I ++  L++   R   +Q+   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 137 SYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
            + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWI 181
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
             +R +     +WSLG +L +M+     F      H  ++I   V         F+   +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQV---------FFR--Q 225
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               E   L+   L L PS+RP  ++I  H ++
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGL 136
                  +I +LD ++  ++  L +       DL   I ++  L++   R   +Q+   +
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 137 SYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
            + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE +
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWI 228
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
             +R +     +WSLG +L +M+     F      H  ++I   V         F+   +
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR--Q 272
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
               E   L+   L L PS+RP  ++I  H ++
Sbjct: 273 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 67  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 124
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 182
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 227
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 228 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 27  SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLS----H 81
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +VFE+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 82  PKLVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 139
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 140 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 196
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 243
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 244 YKPRLASTHVYQIMNHCWKERPE 266

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D    + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 72
Query: 84  NIITMLDIYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDVHIR-----YIMFQLCNGL 136
            I+ +    +A        Y+V EY++      +RD +  +  +       ++   C  L
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPE 193
           ++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               +       D++SLGC+L E+L  +P F G S
Sbjct: 190 QARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 64  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 179
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 224
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 225 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D GLA+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 33/299 (11%)
Query: 2   TSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAF 60
           T+NT SK  +    N D   L ++     +GKG++G V  +  K   +  A+K +  +  
Sbjct: 1   TTNTVSKFDN--NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 58
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVI 115
               D + T  E   L    + P +  +   ++ ++   LY V EY+        + +V 
Sbjct: 59  IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVG 116
Query: 116 RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
           R    K+ H  +   ++  GL ++ +  +++RDLK  N+++D    IKI D G+ +    
Sbjct: 117 R---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
                  +  T  Y APEI I+ + Y   VD W+ G +L EML  +  F G       Q 
Sbjct: 174 DGVTTKXFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
Query: 236 IV--NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER----PETDQ-ILEHNY 287
           I+  N+  P            K+  +EAV +   ++  +P +R    PE ++ I EH +
Sbjct: 233 IMEHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +  +   L     T  Y APEI++S + Y   VD W+L
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGATWTLC---GTPEYLAPEIILS-KGYNKAVDWWAL 245
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 53/294 (18%)
Query: 28  HKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
            K +G G+ G +V++   +     VA+K++   F           EI  L     HPN+I
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRP--VAVKRMLIDF-----CDIALMEIKLLTESDDHPNVI 72
Query: 87  TMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY--------IMFQLCNGLSY 138
                     ++ LY+  E    +L  ++  K + D +++         ++ Q+ +G+++
Sbjct: 73  RY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 139 IHACKVMHRDLKPSNILIDKSC-------------SIKIGDLGLARSLSDSKECLTEYI- 184
           +H+ K++HRDLKP NIL+  S               I I D GL + L   +      + 
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 185 ---ATRWYRAPEI------LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS----TSH 231
               T  +RAPE+      L + RR T  +DI+S+GC+   +L SK   P        S+
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL-SKGKHPFGDKYSRESN 249
Query: 232 QLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            ++ I +L      H     A       EA DL++Q++  +P +RP   ++L H
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 79  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 139 TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 255
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 256 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 20  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 79
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 80  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 196
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 197 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 20  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 79
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 80  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 196
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 197 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 18  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 77
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 78  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 194
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 195 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 241

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 35/300 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GA+  V    +    Q  A+K I E       + R +RE+  L   Q H N++ +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK-IIEKQPGHIRS-RVFREVEMLYQCQGHRNVLELIE 78
Query: 91  IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
            ++  +    Y+VFE M     L+ + + +   ++    ++  + + L ++H   + HRD
Sbjct: 79  FFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 149 LKPSNILID---KSCSIKIGDLGLARSLSDSKEC-------LTEYIATRWYRAPEILISN 198
           LKP NIL +   +   +KI D GL   +  + +C       L     +  Y APE++ + 
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 199 RR----YTHHVDIWSLGCILAEMLQSKPLFPG------------ASTSHQLQLIVNLVRP 242
                 Y    D+WSLG IL  +L   P F G            A  + Q  L  ++   
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                DK +A        A DL++++LV +  +R    Q+L+H +V    P  T   P V
Sbjct: 257 KYEFPDKDWAHISCA---AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 25  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 84
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 85  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 142
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 201
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 202 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 248

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 21  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 80
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 81  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTG 197
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 198 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 120/260 (46%), Gaps = 27/260 (10%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           KR+G G +G V+  Y  NN   VA+K +          Q    E   +K+ Q       +
Sbjct: 19  KRLGAGQFGEVWMGY-YNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHD----KL 70
Query: 89  LDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNGLSYIHACK 143
           + +Y  V  ++ +Y++ EYM     L+ +  D+  K +  + I F  Q+  G++YI    
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRY 201
            +HRDL+ +N+L+ +S   KI D GLAR + D++    E      +W  APE  I+   +
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEA-INFGCF 188
Query: 202 THHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           T   D+WS G +L E++   K  +PG + +  +  +    R   P  +       N P+E
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYR--MPRVE-------NCPDE 239
Query: 261 AVDLLNQILVLNPSERPETD 280
             D++         ERP  D
Sbjct: 240 LYDIMKMCWKEKAEERPTFD 259

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKA--YDKNNKQYVAIKKIFEAFRNKTDAQRTY 70
           VQH V G        ++ IG+G +G VY     D + K+     K      +  +  +  
Sbjct: 21  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 80
Query: 71  REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            E + +K F  HPN++++L I        L VV  YM+  DL   IR++         I 
Sbjct: 81  TEGIIMKDFS-HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 130 F--QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY---- 183
           F  Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D KE  + +    
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLD-KEFDSVHNKTG 197
Query: 184 --IATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGAST 229
             +  +W       +  +++T   D+WS G +L E++ +  P +P  +T
Sbjct: 198 AKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 22  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 80
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 81  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 198 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 249
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 250 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 84  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H C V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 199
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 244
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L P +RP  ++I  H ++
Sbjct: 245 -QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 30/223 (13%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-----RTYREILFL 76
            AE T+ + IG G +G VY+A+   ++  VA+K    A R+  D          R+   L
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDE--VAVK----AARHDPDEDISQTIENVRQEAKL 59
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK-ILKDVHIRYIMFQLCN 134
            +  +HPNII +  +   +   +L +V E+     LN+V+  K I  D+ + + + Q+  
Sbjct: 60  FAMLKHPNIIALRGV--CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAV-QIAR 116
Query: 135 GLSYIH---ACKVMHRDLKPSNILIDKSCS--------IKIGDLGLARSLSDSKECLTEY 183
           G++Y+H      ++HRDLK SNILI +           +KI D GLAR    + + ++  
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAA 175
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG 226
            A  W  APE+ I    ++   D+WS G +L E+L  +  F G
Sbjct: 176 GAYAWM-APEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 13  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 71
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 72  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 128
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 129 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 189 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 240
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 241 --------GGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 12/138 (8%)
Query: 92  YKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           Y   +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVD 220
Query: 207 IWSLGCILAEMLQSKPLF 224
            W+LG ++ EM    P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 12/138 (8%)
Query: 92  YKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           Y   +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVD 220
Query: 207 IWSLGCILAEMLQSKPLF 224
            W+LG ++ EM    P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 12/138 (8%)
Query: 92  YKAVNNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMH 146
           Y   +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVD 206
           RDLKP N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVD 220
Query: 207 IWSLGCILAEMLQSKPLF 224
            W+LG ++ EM    P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 33/299 (11%)
Query: 2   TSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAF 60
           T+NT SK  +    N D   L ++     +GKG++G V  +  K   +  A+K +  +  
Sbjct: 322 TANTISKFDN--NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 379
Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVI 115
               D + T  E   L    + P +  +   ++ ++   LY V EY+        + +V 
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVG 437
Query: 116 RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
           R    K+ H  +   ++  GL ++ +  +++RDLK  N+++D    IKI D G+ +    
Sbjct: 438 R---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494
Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
                  +  T  Y APEI I+ + Y   VD W+ G +L EML  +  F G       Q 
Sbjct: 495 DGVTTKXFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 236 IV--NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER----PETDQ-ILEHNY 287
           I+  N+  P            K+  +EAV +   ++  +P +R    PE ++ I EH +
Sbjct: 554 IMEHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 66/308 (21%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYIV 129
Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 130 GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 182
Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 183 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 239
Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL------------------ 239
             Y+   DIWS+G  L EM   + P+ P    + +L+L+                     
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELMFGCQVEGDAAETPPRPRTPGR 297
Query: 240 ------VRPNPPHAD-KFYAGFKNKPE----------EAVDLLNQILVLNPSERPETDQI 282
                 +   PP A  +      N+P           E  D +N+ L+ NP+ER +  Q+
Sbjct: 298 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQL 357
Query: 283 LEHNYVSK 290
           + H ++ +
Sbjct: 358 MVHAFIKR 365

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 53/293 (18%)
Query: 29  KRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           K +G G+ G +V++   +     VA+K++   F           EI  L     HPN+I 
Sbjct: 21  KILGYGSSGTVVFQGSFQGRP--VAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIR 73
Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY--------IMFQLCNGLSYI 139
                    ++ LY+  E    +L  ++  K + D +++         ++ Q+ +G++++
Sbjct: 74  Y--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 140 HACKVMHRDLKPSNILIDKSC-------------SIKIGDLGLARSLSDSKECLTEYI-- 184
           H+ K++HRDLKP NIL+  S               I I D GL + L   +      +  
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 185 --ATRWYRAPEI------LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS----TSHQ 232
              T  +RAPE+      L + RR T  +DI+S+GC+   +L SK   P        S+ 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL-SKGKHPFGDKYSRESNI 250
Query: 233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           ++ I +L      H     A       EA DL++Q++  +P +RP   ++L H
Sbjct: 251 IRGIFSLDEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 118/256 (46%), Gaps = 53/256 (20%)
Query: 9   SGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNK 63
           SG  VQH    +I+    + + +G+GA+G V+ A   N     +K  VA+K    A ++ 
Sbjct: 5   SGIHVQHIKRRDIV----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDP 56
Query: 64  TDAQRTYREILFLKSFQRHPNIIT------MLDIYKAVNNKD-LYVVFEYME-NDLNKVI 115
           T A R        K FQR   ++T      ++  Y    + D L +VFEYM+  DLNK +
Sbjct: 57  TLAAR--------KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 116 RDK-----ILKDVHIR------------YIMFQLCNGLSYIHACKVMHRDLKPSNILIDK 158
           R       IL D   R            +I  Q+ +G+ Y+ +   +HRDL   N L+  
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 168
Query: 159 SCSIKIGDLGLARSLSDS---KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILA 215
           +  +KIGD G++R +  +   +      +  RW   P   I  R++T   D+WS G IL 
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW--MPPESIMYRKFTTESDVWSFGVILW 226
Query: 216 EMLQ--SKPLFPGAST 229
           E+     +P F  ++T
Sbjct: 227 EIFTYGKQPWFQLSNT 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   IK+ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 139/310 (44%), Gaps = 70/310 (22%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECN-SPYIV 94
Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSYI 139
                +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y+
Sbjct: 95  GFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYL 147
Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
               K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L   
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QG 204
Query: 199 RRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL-VRPNPPHA--------- 247
             Y+   DIWS+G  L EM   + P+ P    + +L+L+    V  +             
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 248 --DKFYAGFKNKPEEAV-------------------------DLLNQILVLNPSERPETD 280
             +KF  G  ++P  A+                         D +N+ L+ NP+ER +  
Sbjct: 263 PLNKF--GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 281 QILEHNYVSK 290
           Q++ H ++ +
Sbjct: 321 QLMVHAFIKR 330

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   I++ D GLA+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 21  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 79
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 80  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 197 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 248
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 249 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 66/309 (21%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYI 66
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR------DKILKDVHIRYIMFQLCNGLSY 138
           +     +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y
Sbjct: 67  VGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTY 119
Query: 139 IHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +    K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-Q 176
Query: 198 NRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL----------------- 239
              Y+   DIWS+G  L EM   + P+ P    + +L+L+                    
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 240 -------VRPNPPHAD-KFYAGFKNKPE----------EAVDLLNQILVLNPSERPETDQ 281
                  +   PP A  +      N+P           E  D +N+ L+ NP+ER +  Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 282 ILEHNYVSK 290
           ++ H ++ +
Sbjct: 295 LMVHAFIKR 303

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 86
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 87  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 143
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 204 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 255
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 256 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 86
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 87  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 204 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 255
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 256 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GLAR L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 137/309 (44%), Gaps = 66/309 (21%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYI 66
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSY 138
           +     +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y
Sbjct: 67  VGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTY 119
Query: 139 IHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +    K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-Q 176
Query: 198 NRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL----------------- 239
              Y+   DIWS+G  L EM   + P+ P    + +L+L+                    
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 240 -------VRPNPPHAD-KFYAGFKNKPE----------EAVDLLNQILVLNPSERPETDQ 281
                  +   PP A  +      N+P           E  D +N+ L+ NP+ER +  Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 282 ILEHNYVSK 290
           ++ H ++ +
Sbjct: 295 LMVHAFIKR 303

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 98  DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEYLAPEIILS-KGYNKAVDWWAL 210
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 211 GVLIYEMAAGYPPF 224

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 141/282 (50%), Gaps = 39/282 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQ-----YVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           +Y I + +G+G +GIV++  + ++K+     +V +K         TD     +EI  L +
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--------TDQVLVKKEISIL-N 56
Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNG 135
             RH NI+ + + ++++  ++L ++FE++   D+ + I      L +  I   + Q+C  
Sbjct: 57  IARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 136 LSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L ++H+  + H D++P NI+    +S +IKI + G AR L         + A  +Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-APE 173
Query: 194 ILISNRRYTHHV-----DIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           +      + H V     D+WSLG ++  +L    + P  + ++Q Q+I N++       +
Sbjct: 174 V------HQHDVVSTATDMWSLGTLVYVLLSG--INPFLAETNQ-QIIENIMNAEYTFDE 224
Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           +    FK    EA+D ++++LV     R    + L+H ++ +
Sbjct: 225 E---AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 18  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 76
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 77  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 133
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 134 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 194 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 245
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 246 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 122/271 (45%), Gaps = 31/271 (11%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY    K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 90
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           + +L +         Y+V EYM      + L +  R+++   V + Y+  Q+ + + Y+ 
Sbjct: 91  VQLLGV--CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV-LLYMATQISSAMEYLE 147
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILIS 197
               +HRDL   N L+ ++  +K+ D GL+R ++   +  T +   ++   + APE L  
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAY 205
Query: 198 NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
           N  ++   D+W+ G +L E+       +PG   S    L+    R   P         + 
Sbjct: 206 N-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQP---------EG 255
Query: 257 KPEEAVDLLNQILVLNPSERP---ETDQILE 284
            P +  +L+      +P++RP   ET Q  E
Sbjct: 256 CPPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 88/172 (51%), Gaps = 26/172 (15%)
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEY 183
           +I  Q+   + ++H+  +MHRDLKPSNI       +K+GD GL  ++   +E    LT  
Sbjct: 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 184 ---------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
                    + T+ Y +PE +  N  Y+H VDI+SLG IL E+L S       ST  +  
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYS------FSTQMERV 280
Query: 235 LIVNLVRPNPPHADKFYAGFKNK-PEEAVDLLNQILVLNPSERPETDQILEH 285
            I+  VR       KF   F  K P+E + ++  +L  +P+ERPE   I+E+
Sbjct: 281 RIITDVR-----NLKFPLLFTQKYPQEHM-MVQDMLSPSPTERPEATDIIEN 326

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 15  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 74  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 191 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 242
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 243 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 245
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FAEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 22  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 80
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 81  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 198 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 249
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 250 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 133 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 245
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 42/304 (13%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS--- 78
           + +Y I + + +G +  +    +K+NK Y   K        K D  ++  + + +KS   
Sbjct: 30  INDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 79  -FQRHPNIIT------MLDIYKAVNNKD-LYVVFEYMEND-----------LNKVIRDKI 119
            F+    IIT       L     + N D +Y+++EYMEND           L+K     I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 120 LKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
              V I+ I+  + N  SYIH  K + HRD+KPSNIL+DK+  +K+ D G +  + D K 
Sbjct: 149 PIQV-IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206
Query: 179 CLTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 237
            +     T  +  PE   +   Y    VDIWSLG  L  M  +  + P +     ++L  
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN--VVPFSLKISLVELFN 263
Query: 238 NLVRPN---PPHADKFYAGFKNKPE---------EAVDLLNQILVLNPSERPETDQILEH 285
           N+   N   P   + F     NK           E +D L   L  NP+ER  ++  L+H
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 286 NYVS 289
            +++
Sbjct: 324 EWLA 327

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 21  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 79
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 80  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 197 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 248
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 249 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 29/271 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFE----AFRNKTDAQRTYREILFL-- 76
           AEY +   +GKG +G V+  +   ++  VAIK I       +   +D+     E+  L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 77  -KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCN 134
             +   HP +I +LD ++      L +       DL   I +K  L +   R    Q+  
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 135 GLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
            + + H+  V+HRD+K  NILID  + C+ K+ D G    L D  E  T++  TR Y  P
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHD--EPYTDFDGTRVYSPP 207
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E +  ++ +     +WSLG +L +M+     F       + Q I+      P H      
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHVSP--- 258
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                  +   L+ + L   PS RP  ++IL
Sbjct: 259 -------DCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 19  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 77
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 78  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 134
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 135 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 195 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 246
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 247 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   I++ D G A+ +      L     T  Y APEI+IS + Y   VD W+L
Sbjct: 169 PENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIIIS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 217
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 50  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 108
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 109 CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 165
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + ++   ++     + 
Sbjct: 166 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 226 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 277
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 278 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 217
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 107 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 163
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 164 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 219
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 220 GVLIYEMAAGYPPF 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYI 66
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSY 138
           +     +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y
Sbjct: 67  VGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTY 119
Query: 139 IHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +    K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-Q 176
Query: 198 NRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL----------------- 239
              Y+   DIWS+G  L EM   + P+ P  +   +L     +                 
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 240 -----VRPNPPHAD-KFYAGFKNKPE----------EAVDLLNQILVLNPSERPETDQIL 283
                +   PP A  +      N+P           E  D +N+ L+ NP+ER +  Q++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 284 EHNYVSK 290
            H ++ +
Sbjct: 297 VHAFIKR 303

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            +G G  G+V+K   K +   +A K    +I  A RN+       RE+  L      P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLHECNS-PYI 66
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR------DKILKDVHIRYIMFQLCNGLSY 138
           +     +   ++ ++ +  E+M+   L++V++      ++IL  V I  I      GL+Y
Sbjct: 67  VGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTY 119
Query: 139 IHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +    K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L  
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-Q 176
Query: 198 NRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL----------------- 239
              Y+   DIWS+G  L EM   + P+ P  +   +L     +                 
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 240 -----VRPNPPHAD-KFYAGFKNKPE----------EAVDLLNQILVLNPSERPETDQIL 283
                +   PP A  +      N+P           E  D +N+ L+ NP+ER +  Q++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 284 EHNYVSK 290
            H ++ +
Sbjct: 297 VHAFIKR 303

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 31  IGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP+I+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFD-HPHIVK 455
Query: 88  MLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ + + 
Sbjct: 456 LIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEILISNR 199
           +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  I+ R
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES-INFR 567
Query: 200 RYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
           R+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP          N
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP----------N 616
Query: 257 KPEEAVDLLNQILVLNPSERPETDQI 282
            P     L+ +    +PS RP   ++
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 27  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 79
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 80  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 128
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 129 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 245
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 246 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQRTYRE- 72
            + T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R  R  
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 73  -ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ 131
            IL    +   P +     + +      LY     +E     +   K++       I  Q
Sbjct: 93  NILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID------IARQ 140
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYIATRWY 189
              G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +   +  +
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 200
Query: 190 RAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPH 246
            APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R    P 
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPD 258
Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
             K  +   N P+    L+ + L     ERP   QIL
Sbjct: 259 LSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 12  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 65  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 113
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 114 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 230
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 231 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G G  G V+K   +     +A+K++  +  NK + +R   ++  +      P I+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 91  IYKAVNNKDLYVVFEYMENDLNKV-------IRDKILKDVHIRYIMFQLCNGLSYI---H 140
            +  + N D+++  E M     K+       I ++IL  + +  +       L Y+   H
Sbjct: 92  TF--ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV-----KALYYLKEKH 144
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL----I 196
              V+HRD+KPSNIL+D+   IK+ D G++  L D K           Y APE +     
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDP 201
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
           +   Y    D+WSLG  L E+   +  FP  +     +++  +++  PP       G   
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ--FPYKNCKTDFEVLTKVLQEEPP----LLPGHMG 255
Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
              +    +   L  +  +RP+ +++LEH+++ +Y
Sbjct: 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 34  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 86
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 87  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 135
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 136 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 195 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 252
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 253 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 291

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQRTYRE- 72
            + T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R  R  
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 73  -ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ 131
            IL    +   P +     + +      LY     +E     +   K++       I  Q
Sbjct: 93  NILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID------IARQ 140
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYIATRWY 189
              G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +   +  +
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 200
Query: 190 RAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN-PPH 246
            APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R    P 
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPD 258
Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
             K  +   N P+    L+ + L     ERP   QIL
Sbjct: 259 LSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 12  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 65  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 113
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 114 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 230
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 231 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 99  DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 155
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 156 PENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 211
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 212 GVLIYEMAAGYPPF 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 31  IGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           +G+GA+G V+ A   N     +K  VA+K + EA  +++  Q   RE   L   Q H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQ-HQHI 105
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KIL---KDV--------HIRYI 128
           +    +      + L +VFEYM   DLN+ +R      K+L   +DV         +  +
Sbjct: 106 VRFFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             Q+  G+ Y+     +HRDL   N L+ +   +KIGD G++R +  +   +      + 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
            RW     IL   R++T   D+WS G +L E+ 
Sbjct: 224 IRWMPPESILY--RKFTTESDVWSFGVVLWEIF 254

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 9   DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 61
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 62  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 110
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 111 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 170 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 227
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 228 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA--QRTYREILFLKSFQRHPNIIT 87
           + G+G +G+VYK Y  N    VA+KK+       T+   Q+  +EI      Q H N++ 
Sbjct: 29  KXGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVXAKCQ-HENLVE 85
Query: 88  MLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHAC 142
           +L    + +  DL +V+ Y  N    D    +        H R  + Q   NG++++H  
Sbjct: 86  LLGF--SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN 143
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATRWYRAPEILISNRR 200
             +HRD+K +NIL+D++ + KI D GLAR+     + +  +  + T  Y APE L     
Sbjct: 144 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGE 201
Query: 201 YTHHVDIWSLGCILAEMLQSKP 222
            T   DI+S G +L E++   P
Sbjct: 202 ITPKSDIYSFGVVLLEIITGLP 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N++ID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           A Y + +++G G +  V+ A D  N  +VA+K I    +  T+A     EI  L+     
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAED--EIKLLQRVNDA 75
Query: 83  PN----------IITMLDIY--KAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRY 127
            N          I+ +LD +  K  N   + +VFE +  +L  +I+    + +  ++++ 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 128 IMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS------IKIGDLGLARSLSDSKECL 180
           I  QL  GL Y+H  C ++H D+KP N+L++   S      IKI DLG A       E  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHY 192
Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           T  I TR YR+PE+L+    +    DIWS  C++ E++    LF
Sbjct: 193 TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLF 235

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 7   DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 60  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 108
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 109 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 225
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 226 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 31  IGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP+I+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFD-HPHIVK 455
Query: 88  MLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ + + 
Sbjct: 456 LIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEILISNR 199
           +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  I+ R
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES-INFR 567
Query: 200 RYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
           R+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP          N
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP----------N 616
Query: 257 KPEEAVDLLNQILVLNPSERPETDQI 282
            P     L+ +    +PS RP   ++
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           A Y + +++G G +  V+ A D  N  +VA+K I    +  T+A     EI  L+     
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAED--EIKLLQRVNDA 75
Query: 83  PN----------IITMLDIY--KAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRY 127
            N          I+ +LD +  K  N   + +VFE +  +L  +I+    + +  ++++ 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 128 IMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS------IKIGDLGLARSLSDSKECL 180
           I  QL  GL Y+H  C ++H D+KP N+L++   S      IKI DLG A       E  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHY 192
Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           T  I TR YR+PE+L+    +    DIWS  C++ E++    LF
Sbjct: 193 TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLF 235

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 41/273 (15%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQ 80
           + + IG+G +G V++      +N    VAIK      +N T     ++  +E L ++ F 
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQEALTMRQFD 69
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLS 137
            HP+I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+
Sbjct: 70  -HPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAP 192
           Y+ + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + AP
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAP 181
Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADK 249
           E  I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP    
Sbjct: 182 ES-INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP---- 235
Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                 N P     L+ +    +PS RP   ++
Sbjct: 236 ------NCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/333 (24%), Positives = 143/333 (42%), Gaps = 53/333 (15%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 49  KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL-------QDC 98
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 99  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAF 158
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     I   +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  + S 
Sbjct: 159 TEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 217
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---------PGAS 228
             LT    T +Y APE+L    +Y    D WSLG I   +L   P F         PG  
Sbjct: 218 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXK 276
Query: 229 T---SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           T     Q +       PNP         +    EE   L+  +L   P++R    +   H
Sbjct: 277 TRIRXGQYEF------PNPE--------WSEVSEEVKXLIRNLLKTEPTQRXTITEFXNH 322
Query: 286 NYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLE 318
            ++ +     +  +PQ   HT  +  +D  + E
Sbjct: 323 PWIXQ-----STKVPQTPLHTSRVLKEDKERWE 350

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 30/263 (11%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           +E T  + IG G +G+V+  Y   NK  VAIK I E   ++ D       ++ L     H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS----H 62
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           P ++ +  +   +    + +V E+ME+  L+  +R +  +     +  +   +C G++Y+
Sbjct: 63  PKLVQLYGV--CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEILI 196
               V+HRDL   N L+ ++  IK+ D G+ R + D +   T    T++   + +PE+  
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF- 177
Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK- 255
           S  RY+   D+WS G ++ E+  S+   P  +            R N    +    GF+ 
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVF-SEGKIPYEN------------RSNSEVVEDISTGFRL 224
Query: 256 NKPEEAVDLLNQILVLNPSERPE 278
            KP  A   + QI+     ERPE
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPE 247

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 7   DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 60  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 108
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 109 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 225
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 226 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 7   DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY     +E     +   K++      
Sbjct: 60  KTRHVNILLFMGYSTAPQLAI---VTQWCEGSSLYHHLHIIETKFEMI---KLID----- 108
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 109 -IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 185 ATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE++    +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRG 225
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              P   K  +   N P+    L+ + L     ERP   QIL
Sbjct: 226 YLSPDLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 36  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 90
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 91  FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 149 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 207
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 208 EA-IAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 46  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 100
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 101 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 159 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 217
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 218 EA-IAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 71
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 72  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 183
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 235
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 236 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 31  IGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           +G+GA+G V+ A   N     +K  VA+K + EA  +++  Q   RE   L   Q H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQ-HQHI 76
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KIL---KDV--------HIRYI 128
           +    +      + L +VFEYM   DLN+ +R      K+L   +DV         +  +
Sbjct: 77  VRFFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             Q+  G+ Y+     +HRDL   N L+ +   +KIGD G++R +  +   +      + 
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
            RW     IL   R++T   D+WS G +L E+ 
Sbjct: 195 IRWMPPESILY--RKFTTESDVWSFGVVLWEIF 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 6/212 (2%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A+K +  E   +  D      E    +   
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +   ++  +   L+ V EY+     +  + R + L + H R+   ++   L+Y
Sbjct: 68  NHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H   +++RDLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL   
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-RG 184
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
             Y   VD W+LG ++ EM+  +  F    +S
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 31  IGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           +G+GA+G V+ A   N     +K  VA+K + EA  +++  Q   RE   L   Q H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQ-HQHI 82
Query: 86  ITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----KIL---KDV--------HIRYI 128
           +    +      + L +VFEYM   DLN+ +R      K+L   +DV         +  +
Sbjct: 83  VRFFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             Q+  G+ Y+     +HRDL   N L+ +   +KIGD G++R +  +   +      + 
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
            RW     IL   R++T   D+WS G +L E+ 
Sbjct: 201 IRWMPPESILY--RKFTTESDVWSFGVVLWEIF 231

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 73
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V EYMEN  L+  +R  D     + +  ++  + +G+
Sbjct: 74  FDHPNIIRLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 190
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 191 E-AIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ +M    P F
Sbjct: 225 GVLIYQMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 6/212 (2%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A+K +  E   +  D      E    +   
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +   ++  +   L+ V EY+     +  + R + L + H R+   ++   L+Y
Sbjct: 64  NHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H   +++RDLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL   
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-RG 180
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
             Y   VD W+LG ++ EM+  +  F    +S
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 42  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 99
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 100 HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 211
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 212 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 263
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 264 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 133/284 (46%), Gaps = 46/284 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           T+ + +G+G++G+VY+   K       +  VAIK + EA   +   +    E   +K F 
Sbjct: 15  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFN 73
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIR--------DKILKDVHIRYIM-- 129
            H +++ +L +      +   V+ E M   DL   +R        + +L    +  ++  
Sbjct: 74  CH-HVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 130 -FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIA 185
             ++ +G++Y++A K +HRDL   N  + +  ++KIGD G+ R + ++   ++     + 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            RW  +PE L  +  +T + D+WS G +L E+  L  +P + G S    L+ ++      
Sbjct: 191 VRWM-SPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME----- 242
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVL----NPSERPETDQIL 283
                    G  +KP+   D+L +++ +    NP  RP   +I+
Sbjct: 243 --------GGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 16  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 73
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 74  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 185
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 237
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 238 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 6/212 (2%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A+K +  E   +  D      E    +   
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +   ++  +   L+ V EY+     +  + R + L + H R+   ++   L+Y
Sbjct: 79  NHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H   +++RDLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL   
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-RG 195
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
             Y   VD W+LG ++ EM+  +  F    +S
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 227

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 48/269 (17%)
Query: 27  IHKRIGKGAYGIVYKA-YDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLKSF 79
           + K++G G +G V+ A Y+K+ K  VA+K +       EAF  + +  +T +    +K  
Sbjct: 186 LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK-- 241
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNG 135
                      ++  V  + +Y++ E+M     L+ +  D+  K    + I F  Q+  G
Sbjct: 242 -----------LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           +++I     +HRDL+ +NIL+  S   KI D GLAR        +      +W  APE  
Sbjct: 291 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--------VGAKFPIKW-TAPEA- 340
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           I+   +T   D+WS G +L E++   +  +PG S    ++ +    R P P         
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP--------- 391
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQI 282
            +N PEE  +++ +     P ERP  + I
Sbjct: 392 -ENCPEELYNIMMRCWKNRPEERPTFEYI 419

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 76
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 77  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 188
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 240
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 241 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 74
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 75  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 186
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 238
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 239 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   +++G+G +  V      ++  + A+K+I      + D +   RE    + F  HPN
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFN-HPN 87
Query: 85  IITMLD--IYKAVNNKDLYVVFEYME-----NDLNKVIRDK--ILKDVHIRYIMFQLCNG 135
           I+ ++   + +     + +++  + +     N++ + ++DK   L +  I +++  +C G
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER-LKDKGNFLTEDQILWLLLGICRG 146
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS----LSDSKECLT--EYIATRW- 188
           L  IHA    HRDLKP+NIL+       + DLG        +  S++ LT  ++ A R  
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 189 --YRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLF-----PGASTSHQLQLIVNL 239
             YRAPE+    S+       D+WSLGC+L  M+  +  +      G S +  +Q  +++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
            + +P H+   +            LLN ++ ++P +RP    +L
Sbjct: 267 PQ-SPRHSSALW-----------QLLNSMMTVDPHQRPHIPLLL 298

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 71
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 72  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 183
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 235
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 236 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 68
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 69  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
           + + +HRD+   N+L+  +  +K+GD GL+R + DS    T Y A++      + APE  
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPES- 180
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS--KPLFPGASTSHQLQLIVNLVR-PNPPHADKFYA 252
           I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP       
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP------- 232
Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              N P     L+ +    +PS RP   ++
Sbjct: 233 ---NCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 31  IGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           IGKG +G+VY         N+   AIK +          +   RE L ++    HPN++ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLN-HPNVLA 86
Query: 88  MLDIYKAVNNKDLYVVFEYM-ENDLNKVIR----DKILKDVHIRYIMFQLCNGLSYIHAC 142
           ++ I         +V+  YM   DL + IR    +  +KD+ I + + Q+  G+ Y+   
Sbjct: 87  LIGIMLPPEGLP-HVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGL-QVARGMEYLAEQ 143
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI------ 196
           K +HRDL   N ++D+S ++K+ D GLAR + D      EY + + +R   + +      
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDR-----EYYSVQQHRHARLPVKWTALE 198
Query: 197 --SNRRYTHHVDIWSLGCILAEML 218
                R+T   D+WS G +L E+L
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 13  VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQ 67
           VQH    NI+    + + +G+GA+G V+ A   N     +K  VA+K + +A  N    +
Sbjct: 7   VQHIKRHNIV----LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--K 60
Query: 68  RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR----DKIL-- 120
             +RE   L + Q H +I+    +   V    L +VFEYM+  DLNK +R    D +L  
Sbjct: 61  DFHREAELLTNLQ-HEHIVKFYGV--CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 121 --------KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
                       + +I  Q+  G+ Y+ +   +HRDL   N L+ ++  +KIGD G++R 
Sbjct: 118 EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177
Query: 173 LSDS---KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
           +  +   +      +  RW   P   I  R++T   D+WSLG +L E+ 
Sbjct: 178 VYSTDYYRVGGHTMLPIRW--MPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I K IG G +G V     K     +  VAIK +   +   TD QR     E   +  F  
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY---TDKQRRDFLSEASIMGQFD- 88
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPNII +  +      K + ++ EYMEN  L+  +R  D     + +  ++  + +G+ Y
Sbjct: 89  HPNIIHLEGV--VTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAPEI 194
           +     +HRDL   NIL++ +   K+ D G++R L D  E         I  RW  APE 
Sbjct: 147 LSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT-APE- 204
Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R++T   D+WS G ++ E++
Sbjct: 205 AIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 6/206 (2%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A++ +  E   +  D      E    +   
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +   ++  +   L+ V EY+     +  + R + L + H R+   ++   L+Y
Sbjct: 111 NHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H   +++RDLK  N+L+D    IK+ D G+ +      +  + +  T  Y APEIL   
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-RG 227
Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLF 224
             Y   VD W+LG ++ EM+  +  F
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--- 80
           I + IG G +G V +   K     +  VAIK +   +   T+ QR  RE L   S     
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY---TERQR--REFLSEASIMGQF 74
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HPNII +  +    N+  + ++ E+MEN  L+  +R  D     + +  ++  + +G+ 
Sbjct: 75  EHPNIIRLEGV--VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMR 132
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY------IATRWYRA 191
           Y+     +HRDL   NIL++ +   K+ D GL+R L ++    TE       I  RW  A
Sbjct: 133 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT-A 191
Query: 192 PEILISNRRYTHHVDIWSLGCILAEML 218
           PE  I+ R++T   D WS G ++ E++
Sbjct: 192 PEA-IAFRKFTSASDAWSYGIVMWEVM 217

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 137/283 (48%), Gaps = 28/283 (9%)
Query: 25  YTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF----RNKTDAQRTYREILFLK 77
           + + K +G GAYG V+   K    +  +  A+K + +A        T+  RT R++L  +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL--E 113
Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNG 135
             ++ P ++T+   Y       L+++ +Y+        + + +   +  ++  + ++   
Sbjct: 114 HIRQSPFLVTLH--YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKECLTEYIATRWYRAPEI 194
           L ++H   +++RD+K  NIL+D +  + + D GL++  ++D  E   ++  T  Y AP+I
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 195 L-ISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           +   +  +   VD WSLG ++ E+L  + P       + Q ++   +++  PP+  +  A
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 253 GFKNKPEEAVDLLNQILVLNPSER-----PETDQILEHNYVSK 290
                   A DL+ ++L+ +P +R      + D+I EH +  K
Sbjct: 292 -------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/331 (24%), Positives = 131/331 (39%), Gaps = 75/331 (22%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR-EILFLKSFQRHP 83
           + + +++G G +G V      +NK+Y A+K +    RN     R+ + E   LK  Q   
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDD 92
Query: 84  NIITMLDIY--KAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYI---MFQLCNGLSY 138
                +  Y  K +    + ++FE +   L ++I        HI  I     ++   L+Y
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 139 IHACKVMHRDLKPSNILID-------------------------KSCSIKIGDLGLARSL 173
           +    + H DLKP NIL+D                         KS  IK+ D G A   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
           SD    +   I TR YRAPE+++ N  +    D+WS GC+LAE+     LF        L
Sbjct: 213 SDYHGSI---INTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 234 QLIVNLVRPNP-----------------------------------PHADKFYAGFK-NK 257
            ++ ++++P P                                    H  K    +K  K
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            E   D L  IL ++P+ RP   ++L+H ++
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 35/300 (11%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           +G+GA+  V    +    Q  A+K I E       + R +RE+  L   Q H N++ +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVK-IIEKQPGHIRS-RVFREVEMLYQCQGHRNVLELIE 78
Query: 91  IYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD 148
            ++  +    Y+VFE M     L+ + + +   ++    ++  + + L ++H   + HRD
Sbjct: 79  FFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 149 LKPSNILID---KSCSIKIGDLGLARSLSDSKEC-------LTEYIATRWYRAPEILISN 198
           LKP NIL +   +   +KI D  L   +  + +C       L     +  Y APE++ + 
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 199 RR----YTHHVDIWSLGCILAEMLQSKPLFPG------------ASTSHQLQLIVNLVRP 242
                 Y    D+WSLG IL  +L   P F G            A  + Q  L  ++   
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                DK +A        A DL++++LV +  +R    Q+L+H +V    P  T   P V
Sbjct: 257 KYEFPDKDWAHISCA---AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 80  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 195 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP+ RP   +I+
Sbjct: 252 DQP---------DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 70/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T  Y AP I++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEYLAPAIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 11  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 63
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY    ++     K    K++      
Sbjct: 64  KTRHVNILLFMGYSTKPQLAI---VTQWCEGSSLY---HHLHASETKFEMKKLID----- 112
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 113 -IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 185 ATRWYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE+  +  +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRG 229
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           +  P   K  +   N P+    L+ + L     ERP   +IL
Sbjct: 230 SLSPDLSKVRS---NCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 23  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +  +    +  +      ++ ++     K    K++      
Sbjct: 76  KTRHVNILLFMGYSTKPQLAIVTQWCEGSS------LYHHLHASETKFEMKKLID----- 124
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 125 -IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 185 ATRWYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE+  +  +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRG 241
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           +  P   K  +   N P+    L+ + L     ERP   +IL
Sbjct: 242 SLSPDLSKVRS---NCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 122/267 (45%), Gaps = 29/267 (10%)
Query: 27  IHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + + IG+G +G V++      +N    VAIK       +    ++  +E L ++ F  HP
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD-HP 71
Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I+ ++ +   +    ++++ E     +L     +R   L    +    +QL   L+Y+ 
Sbjct: 72  HIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISN 198
           + + +HRD+   N+L+  +  +K+GD GL+R + DS   +     +  +W  APE  I+ 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APES-INF 186
Query: 199 RRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFK 255
           RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP          
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP---------- 235
Query: 256 NKPEEAVDLLNQILVLNPSERPETDQI 282
           N P     L+ +    +PS RP   ++
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 80  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 195 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP  RP   +I+
Sbjct: 252 DQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 40/275 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 17  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 76
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 77  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 131
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 132 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 192 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 248
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
           + P          N PE   DL+      NP  RP
Sbjct: 249 DQP---------DNCPERVTDLMRMCWQFNPKMRP 274

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---------FEAFRNKTDAQR 68
           DG I    T+ +RIG G++G VYK     +   VA+K +          +AF+N+    R
Sbjct: 23  DGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 69  TYRE--ILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIR 126
             R   IL    +   P +     + +      LY    ++     K    K++      
Sbjct: 76  KTRHVNILLFMGYSTAPQLAI---VTQWCEGSSLY---HHLHASETKFEMKKLID----- 124
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA--RSLSDSKECLTEYI 184
            I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA  +S         +  
Sbjct: 125 -IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 185 ATRWYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            +  + APE+  +  +  Y+   D+++ G +L E++  +   P ++ +++ Q+I  + R 
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRG 241
Query: 243 N-PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           +  P   K  +   N P+    L+ + L     ERP   +IL
Sbjct: 242 SLSPDLSKVRS---NCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 118/277 (42%), Gaps = 21/277 (7%)
Query: 6   TSKSGDKVQHNVDGNI-LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNK 63
           +SK G+ +  N    + +  +   + +GKG++G V  A  K      A+K +  +     
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64
Query: 64  TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILK 121
            D + T  E   L   + HP +  +   ++  +   L+ V E++     +  + + +   
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 181
           +   R+   ++ + L ++H   +++RDLK  N+L+D     K+ D G+ +    +     
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182
Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--L 239
            +  T  Y APEIL     Y   VD W++G +L EML     F   +     + I+N  +
Sbjct: 183 TFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
           V P   H            E+A  +L   +  NP+ R
Sbjct: 242 VYPTWLH------------EDATGILKSFMTKNPTMR 266

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKS 78
           ++Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79  FQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-ILKDVHIRYIMFQLCN 134
                  +I +LD ++  ++    ++ E  E   DL   I ++  L++   R   +Q+  
Sbjct: 64  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 135 GLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            + + H   V+HRD+K  NILID     +K+ D G    L D+    T++  TR Y  PE
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 179
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  +R +     +WSLG +L +M+     F      H  ++I   V         F+  
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQV---------FFR- 224
Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 225 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 115 SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K  F      +Q+  +  ++ PN      
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPN------ 284
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYV 288
               F + PE+ + D+L   L  +P +R    ++L H YV
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 33/299 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 115 SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K  F      +Q+  +  ++ PN      
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPN------ 284
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
               F + PE+ + D+L   L  +P +R    ++L H YV       TH + Q+   T 
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ----IQTHPVNQMAKGTT 339

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V E MEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 19  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 78
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 79  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 133
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 134 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 194 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 250
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP  RP   +I+
Sbjct: 251 DQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 70/134 (52%), Gaps = 12/134 (8%)
Query: 96  NNKDLYVVFEY-----MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK 150
           +N +LY+V EY     M + L ++ R     + H R+   Q+     Y+H+  +++RDLK
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 151 PSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
           P N+LID+   I++ D G A+ +      L     T    APEI++S + Y   VD W+L
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---GTPEALAPEIILS-KGYNKAVDWWAL 224
Query: 211 GCILAEMLQSKPLF 224
           G ++ EM    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 142/308 (46%), Gaps = 36/308 (11%)
Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREI 73
           +V G I   Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI
Sbjct: 5   SVKGRI---YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EI 58
Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-L 132
            +L   Q+H + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +
Sbjct: 59  AYLNKLQQHSDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 117
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYR 190
              +  IH   ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y 
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 191 APEIL--ISNRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
            PE +  +S+ R         +   D+WSLGCIL  M   K   P     +Q+  +  ++
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 234
Query: 241 RPNPPHADKFYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVI 299
            PN          F + PE+ + D+L   L  +P +R    ++L H YV       TH +
Sbjct: 235 DPN------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ----IQTHPV 284
Query: 300 PQVTPHTV 307
            Q+   T 
Sbjct: 285 NQMAKGTT 292

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 80  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL 194
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 195 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP  RP   +I+
Sbjct: 252 DQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 80  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HRDL   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 195 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP  RP   +I+
Sbjct: 252 DQP---------DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           TI + IG G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 25  TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 79
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCN----- 134
             HPNII +  +     +K + +V EYMEN       D  LK    ++ + QL       
Sbjct: 80  FDHPNIIHLEGV--VTKSKPVMIVTEYMENGS----LDTFLKKNDGQFTVIQLVGMLRGI 133
Query: 135 --GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRW 188
             G+ Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEML 218
             APE  I+ R++T   D+WS G ++ E++
Sbjct: 194 -TAPEA-IAFRKFTSASDVWSYGIVMWEVV 221

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 87  SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 146 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K   P     +Q+  +  ++ PN      
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPN------ 256
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYV 288
               F + PE+ + D+L   L  +P +R    ++L H YV
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 119/260 (45%), Gaps = 27/260 (10%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           K++G G +G V+  Y  NN   VA+K +          Q    E   +K+ Q       +
Sbjct: 18  KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHD----KL 69
Query: 89  LDIYKAVNNKD-LYVVFEYMEND--LNKVIRDKILKDVHIRYIMF--QLCNGLSYIHACK 143
           + +Y  V  ++ +Y++ E+M     L+ +  D+  K +  + I F  Q+  G++YI    
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEILISNRRY 201
            +HRDL+ +N+L+ +S   KI D GLAR + D++    E      +W  APE  I+   +
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEA-INFGCF 187
Query: 202 THHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           T   ++WS G +L E++   K  +PG + +  +  +    R             +N P+E
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYR---------MPRMENCPDE 238
Query: 261 AVDLLNQILVLNPSERPETD 280
             D++         ERP  D
Sbjct: 239 LYDIMKMCWKEKAEERPTFD 258

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I K IG G +G V     K     +  VAIK +   +   TD QR     E   +  F  
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY---TDKQRRDFLSEASIMGQFD- 73
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPNII +  +      K + ++ EYMEN  L+  +R  D     + +  ++  + +G+ Y
Sbjct: 74  HPNIIHLEGV--VTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAPEI 194
           +     +HRDL   NIL++ +   K+ D G++R L D  E         I  RW  APE 
Sbjct: 132 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPE- 189
Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R++T   D+WS G ++ E++
Sbjct: 190 AIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSF 79
           I + IG G +G V +   K     +  VAIK +   +   T+ QR  RE L     +  F
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY---TERQR--REFLSEASIMGQF 72
Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR--DKILKDVHIRYIMFQLCNGL 136
           + HPNII +  +    N+  + ++ E+MEN  L+  +R  D     + +  ++  + +G+
Sbjct: 73  E-HPNIIRLEGV--VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK------ECLTEYIATRWYR 190
            Y+     +HRDL   NIL++ +   K+ D GL+R L ++         L   I  RW  
Sbjct: 130 RYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW-T 188
Query: 191 APEILISNRRYTHHVDIWSLGCILAEML 218
           APE  I+ R++T   D WS G ++ E++
Sbjct: 189 APEA-IAFRKFTSASDAWSYGIVMWEVM 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 50/289 (17%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQY-----VAIKKIFEAFRNKTDAQRTY-REILFLKSFQRH 82
           + IG+GA+G V++A       Y     VA+K + E      D Q  + RE   +  F  +
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFD-N 109
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKIL--------KDVHIR------- 126
           PNI+ +L +      K + ++FEYM   DLN+ +R             D+  R       
Sbjct: 110 PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 127 ----------YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
                      I  Q+  G++Y+   K +HRDL   N L+ ++  +KI D GL+R++  +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 177 ---KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
              K    + I  RW   PE +  N RYT   D+W+ G +L E+  S  L P    +H  
Sbjct: 228 DYYKADGNDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIF-SYGLQPYYGMAH-- 282
Query: 234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
           + ++  VR          A  +N P E  +L+       P++RP    I
Sbjct: 283 EEVIYYVRDG-----NILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 70
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 71  SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 130 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K   P     +Q+  +  ++ PN      
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPN------ 240
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYV 288
               F + PE+ + D+L   L  +P +R    ++L H YV
Sbjct: 241 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     KN ++  A+K +  +E   R +T   R  R++L     Q
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGL 136
                IT L  Y   +   LY+V +Y +  DL  ++    DK+ +D+  R+ + ++   +
Sbjct: 135 ----WITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM-ARFYIGEMVLAI 188
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEIL 195
             IH    +HRD+KP N+L+D +  I++ D G    ++D     +   + T  Y +PEIL
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 196 ISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +      +Y    D WSLG  + EML  +  F   S       I+N       H ++F 
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HEERFQ 301
Query: 252 --AGFKNKPEEAVDLLNQILV 270
             +   +  EEA DL+ +++ 
Sbjct: 302 FPSHVTDVSEEAKDLIQRLIC 322

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     KN ++  A+K +  +E   R +T   R  R++L     Q
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVI---RDKILKDVHIRYIMFQLCNGL 136
                IT L  Y   +   LY+V +Y +  DL  ++    DK+ +D+  R+ + ++   +
Sbjct: 151 ----WITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM-ARFYIGEMVLAI 204
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY-IATRWYRAPEIL 195
             IH    +HRD+KP N+L+D +  I++ D G    ++D     +   + T  Y +PEIL
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 196 ISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
            +      +Y    D WSLG  + EML  +  F   S       I+N       H ++F 
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HEERFQ 317
Query: 252 --AGFKNKPEEAVDLLNQILV 270
             +   +  EEA DL+ +++ 
Sbjct: 318 FPSHVTDVSEEAKDLIQRLIC 338

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I K IG G +G V     K     +  VAIK +   +   TD QR     E   +  F  
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY---TDKQRRDFLSEASIMGQFD- 67
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPNII +  +      K + ++ EYMEN  L+  +R  D     + +  ++  + +G+ Y
Sbjct: 68  HPNIIHLEGV--VTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAPEI 194
           +     +HRDL   NIL++ +   K+ D G++R L D  E         I  RW  APE 
Sbjct: 126 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPE- 183
Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R++T   D+WS G ++ E++
Sbjct: 184 AIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 138/298 (46%), Gaps = 33/298 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 87  SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 146 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K   P     +Q+  +  ++ PN      
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPN------ 256
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT 306
               F + PE+ + D+L   L  +P +R    ++L H YV       TH + Q+   T
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ----IQTHPVNQMAKGT 310

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 29/280 (10%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 66
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 67  SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   + T  Y  PE +  +S
Sbjct: 126 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K   P     +Q+  +  ++ PN      
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPN------ 236
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYV 288
               F + PE+ + D+L   L  +P +R    ++L H YV
Sbjct: 237 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 102
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V E MEN  L+  +R  D     + +  ++  + +G+
Sbjct: 103 FDHPNIIRLEGV--VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 219
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 220 EA-IAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG+G++  VYK  D      VA  ++ +    K++ QR   E   LK  Q HPNI+   D
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ-HPNIVRFYD 92
Query: 91  IYKAV--NNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHACK--V 144
            +++     K + +V E   +   K    R K+ K   +R    Q+  GL ++H     +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 145 MHRDLKPSNILI-DKSCSIKIGDLGLA--RSLSDSKECLTEYIATRWYRAPEILISNRRY 201
           +HRDLK  NI I   + S+KIGDLGLA  +  S +K      I T  + APE      +Y
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFXAPEXY--EEKY 206
Query: 202 THHVDIWSLG-CILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
              VD+++ G C L       P     + +   + + + V+P
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKP 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 26  TIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR- 81
           +I K +G G +G V     K     +  VAIK +   +   T+ QR  R+ L   S    
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQR--RDFLGEASIMGQ 73
Query: 82  --HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             HPNII +  +     +K + +V E MEN  L+  +R  D     + +  ++  + +G+
Sbjct: 74  FDHPNIIRLEGV--VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAP 192
            Y+     +HRDL   NILI+ +   K+ D GL+R L D  E         I  RW  +P
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSP 190
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I+ R++T   D+WS G +L E++
Sbjct: 191 E-AIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 30  RIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           ++GKG +G V    Y     N    VA+K++     +  D QR + REI  LK+      
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSD-F 72
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNK--VIRDKILKDVHIRYIMF--QLCNGLSYIH 140
           I+    +      + L +V EY+ +   +  + R +   D   R +++  Q+C G+ Y+ 
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLG 131
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------WYRAP 192
           + + +HRDL   NIL++    +KI D GLA+ L   K    +Y   R        WY AP
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWY-AP 186
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E L S+  ++   D+WS G +L E+ 
Sbjct: 187 ESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 33/299 (11%)
Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKT-DAQRTYREILFLKSFQRH 82
           Y+I K+IG G    V++  ++  KQ  AIK +  E   N+T D+ R   EI +L   Q+H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-LCNGLSYIHA 141
            + I  L  Y+ + ++ +Y+V E    DLN  ++ K   D   R   ++ +   +  IH 
Sbjct: 115 SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--YIATRWYRAPEIL--IS 197
             ++H DLKP+N LI     +K+ D G+A  +      + +   +    Y  PE +  +S
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 198 NRR--------YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           + R         +   D+WSLGCIL  M   K  F      +Q+  +  ++ PN      
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPN------ 284
Query: 250 FYAGFKNKPEEAV-DLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
               F + PE+ + D+L   L  +P +R    ++L H YV       TH + Q+   T 
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ----IQTHPVNQMAKGTT 339

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 49/281 (17%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPNIITML 89
           +GKG +G   K   +   + + +K   E  R   + QRT+ +E+  ++  + HPN++  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMK---ELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFI 73
Query: 90  DI-YKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQ-------LCNGLSYIHA 141
            + YK   +K L  + EY++    +     I+K +  +Y   Q       + +G++Y+H+
Sbjct: 74  GVLYK---DKRLNFITEYIKGGTLR----GIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK---ECLTEY-----------IATR 187
             ++HRDL   N L+ ++ ++ + D GLAR + D K   E L              +   
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEML---QSKPLFPGASTSHQLQLIVNLVRPNP 244
           ++ APE +I+ R Y   VD++S G +L E++    + P +   +    L +   L R  P
Sbjct: 187 YWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           P          N P     +  +   L+P +RP   + LEH
Sbjct: 246 P----------NCPPSFFPITVRCCDLDPEKRPSFVK-LEH 275

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 30  RIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           ++GKG +G V    Y     N    VA+K++     +  D QR + REI  LK+      
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSD-F 73
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNK--VIRDKILKDVHIRYIMF--QLCNGLSYIH 140
           I+    +      + L +V EY+ +   +  + R +   D   R +++  Q+C G+ Y+ 
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLG 132
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------WYRAP 192
           + + +HRDL   NIL++    +KI D GLA+ L   K    +Y   R        WY AP
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWY-AP 187
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E L S+  ++   D+WS G +L E+ 
Sbjct: 188 ESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 14  QHNVDGNIL----AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT 69
           Q  +DG+ +     +  I ++IG G++G V++A  + +   VA+K + E   +       
Sbjct: 24  QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEF 81
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVH 124
            RE+  +K   RHPNI+  +       N  L +V EY+        L+K    + L +  
Sbjct: 82  LREVAIMKRL-RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 125 IRYIMFQLCNGLSYIHA--CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
              + + +  G++Y+H     ++HRDLK  N+L+DK  ++K+ D GL+R  +        
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX 198
Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 217
              T  + APE+L  +       D++S G IL E+
Sbjct: 199 AAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWEL 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 72
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGL 136
           H N++ +L +        LY+V EYM        L    R  +  D  +++ +  +C  +
Sbjct: 73  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAM 130
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE L 
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL- 186
Query: 197 SNRRYTHHVDIWSLGCILAEM 217
             ++++   D+WS G +L E+
Sbjct: 187 REKKFSTKSDVWSFGILLWEI 207

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 21  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 80
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 81  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 135
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HR+L   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 136 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 196 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 252
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP+ RP   +I+
Sbjct: 253 DQP---------DNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 30  RIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           ++GKG +G V    Y     N    VA+K++     +  D QR + REI  LK+      
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSD-F 85
Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNK--VIRDKILKDVHIRYIMF--QLCNGLSYIH 140
           I+    +      + L +V EY+ +   +  + R +   D   R +++  Q+C G+ Y+ 
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGMEYLG 144
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR--------WYRAP 192
           + + +HRDL   NIL++    +KI D GLA+ L   K    +Y   R        WY AP
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWY-AP 199
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E L S+  ++   D+WS G +L E+ 
Sbjct: 200 ESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I + IG G +G V   + K     + +VAIK +   +   T+ QR     E   +  F  
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD- 92
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPN+I +  +     +  + ++ E+MEN  L+  +R  D     + +  ++  +  G+ Y
Sbjct: 93  HPNVIHLEGV--VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 150
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS------KECLTEYIATRWYRAP 192
           +     +HRDL   NIL++ +   K+ D GL+R L D          L   I  RW  AP
Sbjct: 151 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAP 209
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I  R++T   D+WS G ++ E++
Sbjct: 210 EA-IQYRKFTSASDVWSYGIVMWEVM 234

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 244
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGL 136
           H N++ +L +        LY+V EYM        L    R  +  D  +++ +  +C  +
Sbjct: 245 HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAM 302
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE L 
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL- 358
Query: 197 SNRRYTHHVDIWSLGCILAEM 217
             ++++   D+WS G +L E+
Sbjct: 359 REKKFSTKSDVWSFGILLWEI 379

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL----FLKSFQR 81
           T+ + +G+G++G+VY+   ++  +  A  ++     N++ + R   E L     +K F  
Sbjct: 20  TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-------------KILKDVHIRY 127
           H +++ +L +      +   VV E M   DL   +R                L++  +  
Sbjct: 80  H-HVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
           +  ++ +G++Y++A K +HR+L   N ++    ++KIGD G+ R + ++   ++     +
Sbjct: 135 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             RW  APE L  +  +T   D+WS G +L E+  L  +P + G S    L+ +++    
Sbjct: 195 PVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYL 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
           + P          N PE   DL+      NP+ RP   +I+
Sbjct: 252 DQP---------DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 57
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGL 136
           H N++ +L +        LY+V EYM        L    R  +  D  +++ +  +C  +
Sbjct: 58  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAM 115
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE L 
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL- 171
Query: 197 SNRRYTHHVDIWSLGCILAEM 217
             ++++   D+WS G +L E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 26/268 (9%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +  + ++IG+G +G V+    + +   VA+K   E       A +  +E   LK +  HP
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYS-HP 172
Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIH 140
           NI+ ++ +      + +Y+V E ++  D    +R +   L+   +  ++     G+ Y+ 
Sbjct: 173 NIVRLIGV--CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEILIS 197
           +   +HRDL   N L+ +   +KI D G++R  +D     +     +  +W  APE L +
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPEAL-N 288
Query: 198 NRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGF 254
             RY+   D+WS G +L E   L + P +P  S     + +    R P P          
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEKGGRLPCPELC------- 340
Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQI 282
              P+    L+ Q     P +RP    I
Sbjct: 341 ---PDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 129/273 (47%), Gaps = 38/273 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           E T+ K +G G +G+V     K   QY VA+K I E   ++ +  +  + ++ L     H
Sbjct: 9   EITLLKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS----H 62
Query: 83  PNIITMLDIYKAVNNKD--LYVVFEYMEND-LNKVIRD--KILKDVHIRYIMFQLCNGLS 137
           P ++     +  V +K+  +Y+V EY+ N  L   +R   K L+   +  + + +C G++
Sbjct: 63  PKLVK----FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEI 194
           ++ + + +HRDL   N L+D+   +K+ D G+ R + D +      + T++   + APE+
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPEV 176
Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
                +Y+   D+W+ G ++ E+     +     T+ ++ L V+          + Y   
Sbjct: 177 F-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGHRLY--- 225
Query: 255 KNKPEEAVDLLNQILVLN----PSERPETDQIL 283
             +P  A D + QI+       P +RP   Q+L
Sbjct: 226 --RPHLASDTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 43/282 (15%)
Query: 31  IGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G+G +G V    Y     N  + VA+K + +            +EI  L++   H NI+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLY-HENIV 86
Query: 87  TMLDIYKAVNNKDLYVVFEYM-ENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHAC 142
               I        + ++ E++    L + +   ++KI     ++Y + Q+C G+ Y+ + 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYLGSR 145
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT----EYIATRWYRAPEILISN 198
           + +HRDL   N+L++    +KIGD GL +++   KE  T          WY APE L+ +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQS 204
Query: 199 RRYTHHVDIWSLGCILAEML-----QSKPL---FPGASTSHQLQLIVNLVR--------P 242
           + Y    D+WS G  L E+L      S P+         +H    +  LV         P
Sbjct: 205 KFYIAS-DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
            PP          N P+E   L+ +     PS R     ++E
Sbjct: 264 CPP----------NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 14  QHNVDGNIL----AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT 69
           Q  +DG+ +     +  I ++IG G++G V++A  + +   VA+K + E   +       
Sbjct: 24  QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEF 81
Query: 70  YREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVH 124
            RE+  +K   RHPNI+  +       N  L +V EY+        L+K    + L +  
Sbjct: 82  LREVAIMKRL-RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 125 IRYIMFQLCNGLSYIHA--CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
              + + +  G++Y+H     ++HR+LK  N+L+DK  ++K+ D GL+R  + +      
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 217
              T  + APE+L  +       D++S G IL E+
Sbjct: 199 AAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWEL 232

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 36/254 (14%)
Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
           G+ L E Y I   +G+G +G V +  D          KI +      +A R   EI  L+
Sbjct: 28  GDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARL--EINVLE 85
Query: 78  SF-QRHPN----IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVH-IRYIM 129
              ++ P+     + M D +    +  + + FE +       ++D   +   +H +R++ 
Sbjct: 86  KINEKDPDNKNLCVQMFDWFDY--HGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMA 143
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILI-------------------DKSCSIKIGDLGLA 170
           FQLC  + ++H  K+ H DLKP NIL                     KS ++++ D G  
Sbjct: 144 FQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG-- 201
Query: 171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
            S +   E  +  ++TR YRAPE+++    ++   D+WS+GCI+ E      LF      
Sbjct: 202 -SATFDHEHHSTIVSTRHYRAPEVILE-LGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNR 259
Query: 231 HQLQLIVNLVRPNP 244
             L ++  ++ P P
Sbjct: 260 EHLAMMERILGPIP 273

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 38/276 (13%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG G +G VYK   ++  +    ++  E+ +   + +     +    SF RHP++++++ 
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL----SFCRHPHLVSLIG 102
Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY-----IMFQLCNGLSYIHACKV 144
                N  ++ ++++YMEN +L + +    L  + + +     I      GL Y+H   +
Sbjct: 103 FCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI--ATRWYRAPEILISNRRYT 202
           +HRD+K  NIL+D++   KI D G+++  ++  +     +   T  Y  PE  I   R T
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKG-RLT 219
Query: 203 HHVDIWSLGCILAEML-------QSKP-----LFPGASTSHQLQLIVNLVRPNPPHADKF 250
              D++S G +L E+L       QS P     L   A  SH    +  +V PN   ADK 
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKI 277
Query: 251 YAGFKNKPE---EAVDLLNQILVLNPSERPETDQIL 283
                 +PE   +  D   + L L+  +RP    +L
Sbjct: 278 ------RPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 38/276 (13%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD 90
           IG G +G VYK   ++  +    ++  E+ +   + +     +    SF RHP++++++ 
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL----SFCRHPHLVSLIG 102
Query: 91  IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY-----IMFQLCNGLSYIHACKV 144
                N  ++ ++++YMEN +L + +    L  + + +     I      GL Y+H   +
Sbjct: 103 FCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI--ATRWYRAPEILISNRRYT 202
           +HRD+K  NIL+D++   KI D G+++  ++  +     +   T  Y  PE  I   R T
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKG-RLT 219
Query: 203 HHVDIWSLGCILAEML-------QSKP-----LFPGASTSHQLQLIVNLVRPNPPHADKF 250
              D++S G +L E+L       QS P     L   A  SH    +  +V PN   ADK 
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKI 277
Query: 251 YAGFKNKPE---EAVDLLNQILVLNPSERPETDQIL 283
                 +PE   +  D   + L L+  +RP    +L
Sbjct: 278 ------RPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 43/282 (15%)
Query: 31  IGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G+G +G V    Y     N  + VA+K + +            +EI  L++   H NI+
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLY-HENIV 74
Query: 87  TMLDIYKAVNNKDLYVVFEYM-ENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHAC 142
               I        + ++ E++    L + +   ++KI     ++Y + Q+C G+ Y+ + 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYLGSR 133
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT----EYIATRWYRAPEILISN 198
           + +HRDL   N+L++    +KIGD GL +++   KE  T          WY APE L+ +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQS 192
Query: 199 RRYTHHVDIWSLGCILAEML-----QSKPL---FPGASTSHQLQLIVNLVR--------P 242
           + Y    D+WS G  L E+L      S P+         +H    +  LV         P
Sbjct: 193 KFYIAS-DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 251
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
            PP          N P+E   L+ +     PS R     ++E
Sbjct: 252 CPP----------NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 4   NTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK 63
           + TS SG  +   V   +  + T+ + +GKG YG V++   +   + VA+K IF +    
Sbjct: 18  SCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQG--ENVAVK-IFSS---- 70
Query: 64  TDAQRTYREI-LFLKSFQRHPNIITML--DIYKAVNNKDLYVVFEYME-NDLNKVIRDKI 119
            D +  +RE  L+     RH NI+  +  D+    ++  L+++  Y E   L   ++   
Sbjct: 71  RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT 130
Query: 120 LKDVHIRYIMFQLCNGLSYIH--------ACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 171
           L  V    I+  + +GL+++H           + HRDLK  NIL+ K+    I DLGLA 
Sbjct: 131 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 190
Query: 172 SLSDSKECL----TEYIATRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEM 217
             S S   L       + T+ Y APE+L     +        VDIW+ G +L E+
Sbjct: 191 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            + ++IG+G +G V+    + +   VA+K   E       A +  +E   LK +  HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYS-HPNI 174
Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHAC 142
           + ++ +      + +Y+V E ++  D    +R +   L+   +  ++     G+ Y+ + 
Sbjct: 175 VRLIGV--CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT---EYIATRWYRAPEILISNR 199
             +HRDL   N L+ +   +KI D G++R  +D     +     +  +W  APE L +  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPEAL-NYG 290
Query: 200 RYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKN 256
           RY+   D+WS G +L E   L + P +P  S     + +    R P P            
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEKGGRLPCPELC--------- 340
Query: 257 KPEEAVDLLNQILVLNPSERPETDQI 282
            P+    L+ Q     P +RP    I
Sbjct: 341 -PDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 30  RIGKGAYGIV----YKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
           ++GKG +G V    Y     N    VA+K++     +  D QR + REI  LK+   H +
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKAL--HSD 68
Query: 85  IITMLDIYKAVN----NKDLYVVFEYMENDLNK--VIRDKILKDVHIRYIMF--QLCNGL 136
            I     Y+ V+      +L +V EY+ +   +  + R +   D   R +++  Q+C G+
Sbjct: 69  FIVK---YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDAS-RLLLYSSQICKGM 124
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAP 192
            Y+ + + +HRDL   NIL++    +KI D GLA+ L   K+        +    WY AP
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-AP 183
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E L S+  ++   D+WS G +L E+ 
Sbjct: 184 ESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-- 81
           I + IG G +G V     K        VAIK +   +   T+ QR  R+ L   S     
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGY---TEKQR--RDFLCEASIMGQF 101
Query: 82  -HPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HPN++ +  +      K + +V E+MEN  L+  +R  D     + +  ++  +  G+ 
Sbjct: 102 DHPNVVHLEGV--VTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAPE 193
           Y+     +HRDL   NIL++ +   K+ D GL+R + D  E +       I  RW  APE
Sbjct: 160 YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW-TAPE 218
Query: 194 ILISNRRYTHHVDIWSLGCILAEML 218
             I  R++T   D+WS G ++ E++
Sbjct: 219 A-IQYRKFTSASDVWSYGIVMWEVM 242

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 27  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 80
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 81  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 132
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +E   +      RW   PE
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW-SPPE 191
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 192 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 7/207 (3%)
Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML 89
           R+G G+YG V+K   K + +  A+K+    FR   D  R   E+   +   +HP  + + 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 90  DIYKAVNNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHR 147
             ++      LY+  E     L +        L +  +   +      L+++H+  ++H 
Sbjct: 124 QAWE--EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDI 207
           D+KP+NI +      K+GD GL   L  +     +    R Y APE+L  +  Y    D+
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS--YGTAADV 238
Query: 208 WSLGCILAEMLQSKPLFPGASTSHQLQ 234
           +SLG  + E+  +  L  G     QL+
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 135/309 (43%), Gaps = 64/309 (20%)
Query: 31  IGKGAYGIVYKAYDKNNKQYVAIK----KIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           +G G  G+V K   + +   +A K    +I  A RN+       RE+  L      P I+
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLHECN-SPYIV 77
Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-K 143
                +   ++ ++ +  E+M+   L++V+++ K + +  +  +   +  GL+Y+    +
Sbjct: 78  GFYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           +MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y APE L     Y+ 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMAPERL-QGTHYSV 192
Query: 204 HVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVRP------NPPHADKFYA---- 252
             DIWS+G  L E+   + P+ P    + +L+ I    RP        PH+         
Sbjct: 193 QSDIWSMGLSLVELAVGRYPIPP--PDAKELEAIFG--RPVVDGEEGEPHSISPRPRPPG 248
Query: 253 ------GFKNKPEEAV-------------------------DLLNQILVLNPSERPETDQ 281
                 G  ++P  A+                         + +N+ L+ NP+ER +   
Sbjct: 249 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 308
Query: 282 ILEHNYVSK 290
           +  H ++ +
Sbjct: 309 LTNHTFIKR 317

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 26  TIHKR-------IGKGAYGIV-YKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREIL 74
             HKR       +G+G +G V    YD  N    + VA+K + E    +  +    REI 
Sbjct: 5   VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIE 63
Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLC 133
            L++   H +I+      +    K + +V EY+    L   +    +    +     Q+C
Sbjct: 64  ILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC 122
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR------ 187
            G++Y+HA   +HR L   N+L+D    +KIGD GLA+++ +      EY   R      
Sbjct: 123 EGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSP 178
Query: 188 --WYRAPEILISNRRYTHHVDIWSLGCILAEML 218
             WY APE L   + Y +  D+WS G  L E+L
Sbjct: 179 VFWY-APECLKECKFY-YASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 26  TIHKR-------IGKGAYGIV-YKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREIL 74
             HKR       +G+G +G V    YD  N    + VA+K + E    +  +    REI 
Sbjct: 4   VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ-REIE 62
Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLC 133
            L++   H +I+      +    K + +V EY+    L   +    +    +     Q+C
Sbjct: 63  ILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC 121
Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR------ 187
            G++Y+HA   +HR L   N+L+D    +KIGD GLA+++ +      EY   R      
Sbjct: 122 EGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSP 177
Query: 188 --WYRAPEILISNRRYTHHVDIWSLGCILAEML 218
             WY APE L   + Y +  D+WS G  L E+L
Sbjct: 178 VFWY-APECLKECKFY-YASDVWSFGVTLYELL 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 25  YTIHK-RIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           +  H+ R+G+G++G V++  DK      A+KK+  E FR          E L   +    
Sbjct: 75  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA---------EELMACAGLTS 125
Query: 83  PNIITMLDIYKAVNNKDLYVVF-EYMEND-LNKVIRDK-ILKDVHIRYIMFQLCNGLSYI 139
           P I+ +   Y AV       +F E +E   L ++++++  L +    Y + Q   GL Y+
Sbjct: 126 PRIVPL---YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 182
Query: 140 HACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSD---SKECLT-EYI-ATRWYRAPE 193
           H+ +++H D+K  N+L+    S   + D G A  L      K+ LT +YI  T  + APE
Sbjct: 183 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 194 ILISNRRYTHHVDIWSLGCILAEML 218
           +++  R     VD+WS  C++  ML
Sbjct: 243 VVL-GRSCDAKVDVWSSCCMMLHML 266

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 63
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRYIMFQLCNGL 136
           H N++ +L +        LY+V EYM        L    R  +  D  +++ +  +C  +
Sbjct: 64  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAM 121
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE L 
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL- 177
Query: 197 SNRRYTHHVDIWSLGCILAEM 217
               ++   D+WS G +L E+
Sbjct: 178 REAAFSTKSDVWSFGILLWEI 198

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 25  YTIHK-RIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           +  H+ R+G+G++G V++  DK      A+KK+  E FR          E L   +    
Sbjct: 94  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA---------EELMACAGLTS 144
Query: 83  PNIITMLDIYKAVNNKDLYVVF-EYMEND-LNKVIRDK-ILKDVHIRYIMFQLCNGLSYI 139
           P I+ +   Y AV       +F E +E   L ++++++  L +    Y + Q   GL Y+
Sbjct: 145 PRIVPL---YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 201
Query: 140 HACKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSD---SKECLT-EYI-ATRWYRAPE 193
           H+ +++H D+K  N+L+    S   + D G A  L      K  LT +YI  T  + APE
Sbjct: 202 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 194 ILISNRRYTHHVDIWSLGCILAEML 218
           +++  R     VD+WS  C++  ML
Sbjct: 262 VVL-GRSCDAKVDVWSSCCMMLHML 285

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK---------ILKDV----HIRYI 128
            N++ +L          L V+ E+ +  +L+  +R K         + KD     H+   
Sbjct: 91  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIA 185
            FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +    + 
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +      
Sbjct: 210 LKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFXRRLK----- 261
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                +  A     PE    +L+      PS+RP   +++EH
Sbjct: 262 --EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 300

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 26  TIHKR-------IGKGAYGIV-YKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYR--- 71
             HKR       +G+G +G V    YD  N    + VA+K +      K DA   +R   
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADAGPQHRSGW 80
Query: 72  --EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYI 128
             EI  L++   H +II      +      L +V EY+    L   +    +    +   
Sbjct: 81  KQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 139
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIA 185
             Q+C G++Y+HA   +HRDL   N+L+D    +KIGD GLA+++ +  E      +  +
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
             ++ APE L    ++ +  D+WS G  L E+L
Sbjct: 200 PVFWYAPECL-KEYKFYYASDVWSFGVTLYELL 231

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-----------ILKDV----HIR 126
            N++ +L          L V+ E+ +  +L+  +R K           + KD     H+ 
Sbjct: 93  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---Y 183
              FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +    
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR 241
           +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +    
Sbjct: 212 LPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK--- 265
Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                  +  A     PE    +L+      PS+RP   +++EH
Sbjct: 266 ----EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 16/226 (7%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--FEAF-RNKTDAQRTYREILFLKSFQ 80
           ++ I K IG+GA+G V     KN  +  A+K +  +E   R +T   R  R++L      
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV----N 130
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
                IT L  Y   ++ +LY+V +Y +  DL  ++   +  L +   R+ + ++   + 
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLG-LARSLSDSKECLTEYIATRWYRAPEILI 196
            +H    +HRD+KP NIL+D +  I++ D G   + + D     +  + T  Y +PEIL 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 197 S----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
           +      RY    D WSLG  + EML  +  F   S       I+N
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 27  IHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I + IG G +G V   + K     + +VAIK +   +   T+ QR     E   +  F  
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD- 66
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPN+I +  +     +  + ++ E+MEN  L+  +R  D     + +  ++  +  G+ Y
Sbjct: 67  HPNVIHLEGV--VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS------KECLTEYIATRWYRAP 192
           +     +HR L   NIL++ +   K+ D GL+R L D          L   I  RW  AP
Sbjct: 125 LADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAP 183
Query: 193 EILISNRRYTHHVDIWSLGCILAEML 218
           E  I  R++T   D+WS G ++ E++
Sbjct: 184 EA-IQYRKFTSASDVWSYGIVMWEVM 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I K IG G  G V     +   Q    VAIK +   +   T+ QR     E   +  F  
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFD- 108
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPNII +  +      +   +V EYMEN  L+  +R  D     + +  ++  +  G+ Y
Sbjct: 109 HPNIIRLEGV--VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY----IATRWYRAPEI 194
           +     +HRDL   N+L+D +   K+ D GL+R L D  +         I  RW  APE 
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-APEA 225
Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R ++   D+WS G ++ E+L
Sbjct: 226 -IAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 26  TIHKR-------IGKGAYGIV-YKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYR--- 71
             HKR       +G+G +G V    YD  N    + VA+K +      K D    +R   
Sbjct: 10  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADCGPQHRSGW 63
Query: 72  --EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYI 128
             EI  L++   H +II      +    K L +V EY+    L   +    +    +   
Sbjct: 64  KQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 122
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR- 187
             Q+C G++Y+HA   +HR+L   N+L+D    +KIGD GLA+++ +      EY   R 
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVRE 178
Query: 188 -------WYRAPEILISNRRYTHHVDIWSLGCILAEML 218
                  WY APE L    ++ +  D+WS G  L E+L
Sbjct: 179 DGDSPVFWY-APECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 39/276 (14%)
Query: 31  IGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     HPNII +
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 89  LDIYKAVNNKD-LYVVFEY---------------MENDLNKVIRDKI---LKDVHIRYIM 129
           L    A  ++  LY+  EY               +E D    I +     L    + +  
Sbjct: 92  LG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
             +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R      +     +  RW 
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 208
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
               +  S   YT + D+WS G +L E+  L   P + G + +   + +    R   P  
Sbjct: 209 AIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLEKP-- 263
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                   N  +E  DL+ Q     P ERP   QIL
Sbjct: 264 -------LNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 39/276 (14%)
Query: 31  IGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     HPNII +
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 89  LDIYKAVNNKD-LYVVFEY---------------MENDLNKVIRDKI---LKDVHIRYIM 129
           L    A  ++  LY+  EY               +E D    I +     L    + +  
Sbjct: 82  LG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
             +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R      +     +  RW 
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 198
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
               +  S   YT + D+WS G +L E+  L   P + G + +   + +    R   P  
Sbjct: 199 AIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLEKP-- 253
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                   N  +E  DL+ Q     P ERP   QIL
Sbjct: 254 -------LNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 27  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 80
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 81  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 132
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +    +      RW   PE
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPE 191
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 192 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LF 75
           V   I  +  + K+IGKG YG V+    +  K  VA+K  F      T+    +RE  ++
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFF-----TTEEASWFRETEIY 83
Query: 76  LKSFQRHPNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQL 132
                RH NI+  +  DI    +   LY++ +Y EN  L   ++   L    +  + +  
Sbjct: 84  QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS 143
Query: 133 CNGLSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDLGLA-RSLSDSKEC---L 180
            +GL ++H           + HRDLK  NIL+ K+ +  I DLGLA + +SD+ E     
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 181 TEYIATRWYRAPEILISNRRYTHH-----VDIWSLGCILAEM 217
              + T+ Y  PE+L  +    H       D++S G IL E+
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 27  IHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
           I K IG G  G V     +   Q    VAIK +   +   T+ QR     E   +  F  
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFD- 108
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           HPNII +  +      +   +V EYMEN  L+  +R  D     + +  ++  +  G+ Y
Sbjct: 109 HPNIIRLEGV--VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYRAPEI 194
           +     +HRDL   N+L+D +   K+ D GL+R L D  +         I  RW  APE 
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEA 225
Query: 195 LISNRRYTHHVDIWSLGCILAEML 218
            I+ R ++   D+WS G ++ E+L
Sbjct: 226 -IAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK---------ILKDV----HIRYI 128
            N++ +L          L V+ E+ +  +L+  +R K         + KD     H+   
Sbjct: 91  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIA 185
            FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +    + 
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +      
Sbjct: 210 LKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK----- 261
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                +  A     PE    +L+      PS+RP   +++EH
Sbjct: 262 --EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 7   TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 60
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 61  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 112
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +    +      RW   PE
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPE 171
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 172 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           Q+ +GL ++H   +++RDLKP N+L+D   +++I DLGLA  L   +     Y  T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           APE+L+    Y   VD ++LG  L EM+ ++  F
Sbjct: 357 APELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK------------ILKDV----HI 125
            N++ +L          L V+ E+ +  +L+  +R K            + KD     H+
Sbjct: 92  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE--- 182
               FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLV 240
            +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +   
Sbjct: 211 RLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK-- 265
Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   +  A     PE    +L+      PS+RP   +++EH
Sbjct: 266 -----EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           Q+ +GL ++H   +++RDLKP N+L+D   +++I DLGLA  L   +     Y  T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           APE+L+    Y   VD ++LG  L EM+ ++  F
Sbjct: 357 APELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 18  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 71
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 72  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 123
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +    +      RW   PE
Sbjct: 124 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPE 182
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 183 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 235

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/327 (21%), Positives = 140/327 (42%), Gaps = 62/327 (18%)
Query: 8   KSGDKVQHNVDGNILAEYTIHKRI-GKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           KSG +++ N    I+ +Y +  ++ G G  G V + ++K  ++  A+K +        D 
Sbjct: 5   KSGLQIKKNA---IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDC 54
Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---IL 120
            +  RE+       + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+     
Sbjct: 55  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSK 177
            +     IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  +  K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF---PGASTSHQLQ 234
                                  Y    D+WSLG I+  +L   P F    G + S  ++
Sbjct: 175 -----------------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
Query: 235 LIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             + + +   PNP  ++          EE   L+  +L   P++R    + + H ++ + 
Sbjct: 212 TRIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ- 262
Query: 292 FPSATHVIPQVTPHTVVLDIDDNNQLE 318
               +  +PQ   HT  +  +D  + E
Sbjct: 263 ----STKVPQTPLHTSRVLKEDKERWE 285

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           Q+ +GL ++H   +++RDLKP N+L+D   +++I DLGLA  L   +     Y  T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           APE+L+    Y   VD ++LG  L EM+ ++  F
Sbjct: 357 APELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 11  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 64
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 65  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 116
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +    +      RW   PE
Sbjct: 117 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPE 175
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 176 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 228

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 12  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 65
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 66  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 117
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPE 193
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D +    +      RW   PE
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPPE 176
Query: 194 ILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
           +L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 177 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 40/238 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY-VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T  K +G G +G+V   Y K   QY VAIK I E   ++ +     + ++ L     H  
Sbjct: 12  TFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS----HEK 65
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQL-------CNG 135
           ++ +  +      + ++++ EYM N   LN       L+++  R+   QL       C  
Sbjct: 66  LVQLYGV--CTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEA 117
Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------Y 189
           + Y+ + + +HRDL   N L++    +K+ D GL+R + D      EY ++R       +
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSRGSKFPVRW 172
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPL--FPGASTSHQLQLIVNLVRPN 243
             PE+L+ + +++   DIW+ G ++ E+  L   P   F  + T+  +   + L RP+
Sbjct: 173 SPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 91  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 210 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 265
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 266 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           Q+ +GL ++H   +++RDLKP N+L+D   +++I DLGLA  L   +     Y  T  + 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLF 224
           APE+L+    Y   VD ++LG  L EM+ ++  F
Sbjct: 357 APELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 82  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 201 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 256
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 257 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 295

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 26  TIHKR-------IGKGAYGIV-YKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYR--- 71
             HKR       +G+G +G V    YD  N    + VA+K +      K D    +R   
Sbjct: 10  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADCGPQHRSGW 63
Query: 72  --EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYI 128
             EI  L++   H +II      +    K L +V EY+    L   +    +    +   
Sbjct: 64  KQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 122
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR- 187
             Q+C G++Y+H+   +HR+L   N+L+D    +KIGD GLA+++ +      EY   R 
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVRE 178
Query: 188 -------WYRAPEILISNRRYTHHVDIWSLGCILAEML 218
                  WY APE L    ++ +  D+WS G  L E+L
Sbjct: 179 DGDSPVFWY-APECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 110/264 (41%), Gaps = 69/264 (26%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
             Y + +++G G +  V+ ++D   K++VA+K +  A   +   +    EI  LKS +  
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNS 93
Query: 83  ----PN---IITMLDIYK--AVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMF 130
               PN   ++ +LD +K   VN   + +VFE + + L K I     + +    ++ I+ 
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 131 QLCNGLSYIHA-CKVMHRDLKPSNILID-------------------------------- 157
           Q+  GL Y+H  C+++H D+KP NIL+                                 
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 158 -----------------KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
                            +   +KI DLG A  +       TE I TR YR+ E+LI +  
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS-G 269
Query: 201 YTHHVDIWSLGCILAEMLQSKPLF 224
           Y    DIWS  C+  E+     LF
Sbjct: 270 YNTPADIWSTACMAFELATGDYLF 293

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 110/264 (41%), Gaps = 69/264 (26%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
             Y + +++G G +  V+ ++D   K++VA+K +  A   +   +    EI  LKS +  
Sbjct: 21  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNS 77
Query: 83  ----PN---IITMLDIYK--AVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMF 130
               PN   ++ +LD +K   VN   + +VFE + + L K I     + +    ++ I+ 
Sbjct: 78  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 137
Query: 131 QLCNGLSYIHA-CKVMHRDLKPSNILID-------------------------------- 157
           Q+  GL Y+H  C+++H D+KP NIL+                                 
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 158 -----------------KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
                            +   +KI DLG A  +       TE I TR YR+ E+LI +  
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS-G 253
Query: 201 YTHHVDIWSLGCILAEMLQSKPLF 224
           Y    DIWS  C+  E+     LF
Sbjct: 254 YNTPADIWSTACMAFELATGDYLF 277

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 91  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 210 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 265
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 266 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 82  LNVVNLLGACTKPGGP-LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 201 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 256
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 257 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 295

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 71
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 72  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGXLLDYVREH--KDNIGSQYLLNWCVQ 126
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 187 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 242
Query: 245 P 245
           P
Sbjct: 243 P 243

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FLKSFQRHPNI 85
           K +G GA+G VYK     + + V I    +  R  T + +  +EIL   ++ +    P +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYV 81
Query: 86  ITMLDIYKAVNNKDLYVVFEY-MENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
             +L I      + +  +  Y    D  +  R ++     + + M Q+  G+SY+   ++
Sbjct: 82  SRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCM-QIAKGMSYLEDVRL 140
Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY------IATRWYRAPEILISN 198
           +HRDL   N+L+     +KI D GLAR L D  E  TEY      +  +W     IL   
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDE--TEYHADGGKVPIKWMALESIL--R 195
Query: 199 RRYTHHVDIWSLGCILAEML 218
           RR+TH  D+WS G  + E++
Sbjct: 196 RRFTHQSDVWSYGVTVWELM 215

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 128 LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 247 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 302
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 303 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 341

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 115/276 (41%), Gaps = 39/276 (14%)
Query: 31  IGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     HPNII +
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 89  LDIYKAVNNKD-LYVVFEY---------------MENDLNKVIRDKI---LKDVHIRYIM 129
           L    A  ++  LY+  EY               +E D    I +     L    + +  
Sbjct: 89  LG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
             +  G+ Y+   + +HR+L   NIL+ ++   KI D GL+R      +     +  RW 
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 205
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
               +  S   YT + D+WS G +L E+  L   P + G + +   + +    R   P  
Sbjct: 206 AIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLEKP-- 260
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
                   N  +E  DL+ Q     P ERP   QIL
Sbjct: 261 -------LNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 91  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 210 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 265
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 266 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 93  LNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 212 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 267
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 268 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 306

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 70
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GXLLDYVREH--KDNIGSQYLLNWCVQI 126
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 187 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 242

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 74
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 75  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 129
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 190 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 245
Query: 245 P 245
           P
Sbjct: 246 P 246

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 71
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 72  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 126
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 187 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 242
Query: 245 P 245
           P
Sbjct: 243 P 243

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 72
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 73  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 127
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 188 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 243
Query: 245 P 245
           P
Sbjct: 244 P 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 82  LNVVNLLGACTKPGGP-LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 201 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 256
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 257 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 27  IHKRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-------------ILKDV----H 124
            N++ +L          L V+ E+ +  +L+  +R K             + KD     H
Sbjct: 82  LNVVNLLGACTKPGGP-LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
           +    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    + + +  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNL 239
             +  +W  APE  I +R YT   D+WS G +L E+  L + P +PG     +    +  
Sbjct: 201 ARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK- 256
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    +  A     PE    +L+      PS+RP   +++EH
Sbjct: 257 ------EGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 295

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 70
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 71  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 125
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 186 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 241
Query: 245 P 245
           P
Sbjct: 242 P 242

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 73
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 74  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 128
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 189 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 244
Query: 245 P 245
           P
Sbjct: 245 P 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFLKSFQRH 82
           + T+ + +GKG YG V++   +     VA+K IF +     D +  +RE  L+     RH
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGEN--VAVK-IFSS----RDEKSWFRETELYNTVMLRH 61
Query: 83  PNIITML--DIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            NI+  +  D+    ++  L+++  Y E   L   ++   L  V    I+  + +GL+++
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 140 H--------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATR 187
           H           + HRDLK  NIL+ K+    I DLGLA   S S   L       + T+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 188 WYRAPEIL-----ISNRRYTHHVDIWSLGCILAEM 217
            Y APE+L     +        VDIW+ G +L E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 65  DAQRTYREILFLKSFQR-HPNIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIRDK-IL 120
           +  R   E++ LK        +I +LD ++  ++    ++ E  E   DL   I ++  L
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGAL 154
Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKEC 179
           ++   R   +Q+   + + H C V+HRD+K  NILID     +K+ D G    L D+   
Sbjct: 155 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--V 212
Query: 180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 239
            T++  TR Y  PE +  +R +     +WSLG +L +M+     F      H  ++I   
Sbjct: 213 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQ 267
Query: 240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
           V         F+   +    E   L+   L L PS+RP  ++I  H ++
Sbjct: 268 V---------FFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 95
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 151
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 152 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 212 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 267

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 70
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 126
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 187 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 242

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 72
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 128
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 189 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 244

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 76
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 132
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 133 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 193 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 248

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 73
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 190 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 245

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 73
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 190 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 80
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 136
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 137 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 197 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 252

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 77
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 133
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 194 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 249

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREI-LFLKSFQRHPN 84
           T+ + +GKG YG V++   +   + VA+K IF +     D +  +RE  L+     RH N
Sbjct: 11  TLLECVGKGRYGEVWRGSWQG--ENVAVK-IFSS----RDEKSWFRETELYNTVMLRHEN 63
Query: 85  IITML--DIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH- 140
           I+  +  D+    ++  L+++  Y E   L   ++   L  V    I+  + +GL+++H 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 141 -------ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWY 189
                     + HRDLK  NIL+ K+    I DLGLA   S S   L       + T+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 190 RAPEIL-----ISNRRYTHHVDIWSLGCILAEM 217
            APE+L     +        VDIW+ G +L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 73
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 129
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 190 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 67
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 123
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 184 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 239

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T   R+G+G++G V++  DK      A+KK+  E FR          E L   +    P 
Sbjct: 77  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV---------EELVACAGLSSPR 127
Query: 85  IITMLDIYKAVNNKDLYVVF-EYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +   Y AV       +F E +E   L ++I+    L +    Y + Q   GL Y+H 
Sbjct: 128 IVPL---YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 184
Query: 142 CKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSD---SKECLT-EYI-ATRWYRAPEIL 195
            +++H D+K  N+L+    S   + D G A  L      K  LT +YI  T  + APE++
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 196 ISNRRYTHHVDIWSLGCILAEML 218
           +  +     VDIWS  C++  ML
Sbjct: 245 M-GKPCDAKVDIWSSCCMMLHML 266

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 64
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 120
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 181 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 70
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 126
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 187 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 242

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T   R+G+G++G V++  DK      A+KK+  E FR          E L   +    P 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV---------EELVACAGLSSPR 111
Query: 85  IITMLDIYKAVNNKDLYVVF-EYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
           I+    +Y AV       +F E +E   L ++I+    L +    Y + Q   GL Y+H 
Sbjct: 112 IVP---LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 142 CKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSD---SKECLT-EYI-ATRWYRAPEIL 195
            +++H D+K  N+L+    S   + D G A  L      K  LT +YI  T  + APE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 196 ISNRRYTHHVDIWSLGCILAEML 218
           +  +     VDIWS  C++  ML
Sbjct: 229 M-GKPCDAKVDIWSSCCMMLHML 250

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 69/263 (26%)
Query: 23  AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
             Y + +++G G +  V+  +D   K++VA+K +  A   +   +    EI  LK  +  
Sbjct: 31  GRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSA---QHYTETALDEIKLLKCVRES 87
Query: 83  ----PN---IITMLDIYK--AVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRY---IMF 130
               PN   ++ ++D +K   +N   + +VFE + + L K I     + + +R    I+ 
Sbjct: 88  DPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIR 147
Query: 131 QLCNGLSYIHA-CKVMHRDLKPSNILI--------------------------------- 156
           Q+  GL Y+H+ CK++H D+KP NIL+                                 
Sbjct: 148 QVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTA 207
Query: 157 ---------------DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
                          DK   +KI DLG A  +       TE I TR YR+ E+LI    Y
Sbjct: 208 PAADLLVNPLDPRNADK-IRVKIADLGNACWVHKH---FTEDIQTRQYRSIEVLI-GAGY 262
Query: 202 THHVDIWSLGCILAEMLQSKPLF 224
           +   DIWS  C+  E+     LF
Sbjct: 263 STPADIWSTACMAFELATGDYLF 285

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 118/249 (47%), Gaps = 30/249 (12%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           L+     + +G+  +G VYK +          Q VAIK + +  + +   +  +R    L
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD--KAEGPLREEFRHEAML 65
Query: 77  KSFQRHPNIITMLD----------IYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDV- 123
           ++  +HPN++ +L           I+   ++ DL  ++V     +D+     D+ +K   
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 124 ---HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKE 178
                 +++ Q+  G+ Y+ +  V+H+DL   N+L+    ++KI DLGL R +  +D  +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLI 236
            L   +    + APE ++   +++   DIWS G +L E+  S  L P    S+Q  +++I
Sbjct: 186 LLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVF-SYGLQPYCGYSNQDVVEMI 243
Query: 237 VNL-VRPNP 244
            N  V P P
Sbjct: 244 RNRQVLPCP 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHPN 84
           T   R+G+G++G V++  DK      A+KK+  E FR          E L   +    P 
Sbjct: 75  THQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV---------EELVACAGLSSPR 125
Query: 85  IITMLDIYKAVNNKDLYVVF-EYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
           I+    +Y AV       +F E +E   L ++I+    L +    Y + Q   GL Y+H 
Sbjct: 126 IVP---LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 182
Query: 142 CKVMHRDLKPSNILIDKSCS-IKIGDLGLARSLSD---SKECLT-EYI-ATRWYRAPEIL 195
            +++H D+K  N+L+    S   + D G A  L      K  LT +YI  T  + APE++
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 196 ISNRRYTHHVDIWSLGCILAEML 218
           +  +     VDIWS  C++  ML
Sbjct: 243 M-GKPCDAKVDIWSSCCMMLHML 264

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 116/244 (47%), Gaps = 31/244 (12%)
Query: 22  LAEYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           L+     + +G+  +G VYK +          Q VAIK + +  + +   +  +R    L
Sbjct: 25  LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD--KAEGPLREEFRHEAML 82
Query: 77  KSFQRHPNIITMLD----------IYKAVNNKDL--YVVFEYMENDLNKVIRDKILKDV- 123
           ++  +HPN++ +L           I+   ++ DL  ++V     +D+     D+ +K   
Sbjct: 83  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 124 ---HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKE 178
                 +++ Q+  G+ Y+ +  V+H+DL   N+L+    ++KI DLGL R +  +D  +
Sbjct: 143 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 202
Query: 179 CL-TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 237
            L    +  RW  APE ++   +++   DIWS G +L E+  S  L P    S+  Q +V
Sbjct: 203 LLGNSLLPIRWM-APEAIMYG-KFSIDSDIWSYGVVLWEVF-SYGLQPYCGYSN--QDVV 257
Query: 238 NLVR 241
            ++R
Sbjct: 258 EMIR 261

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 23/236 (9%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FLKSFQ 80
           E+   K +G GA+G VYK       + V I       R  T + +  +EIL   ++ +  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT-SPKANKEILDEAYVMASV 108
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQLCNGL 136
            +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+  G+
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQIAKGM 164
Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWYRAPE 193
           +Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W     
Sbjct: 165 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
           IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 225 IL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 276

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 29  KRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G VYK       +  K  VAIK + E    K + +    E L + S   HP+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPH 78
Query: 85  IITMLDIYKAVNNKDLY------VVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           ++ +L +  +   + +        + EY+        +D I   + + + + Q+  G+ Y
Sbjct: 79  LVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEH-----KDNIGSQLLLNWCV-QIAKGMMY 132
Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWYRAPEIL 195
           +   +++HRDL   N+L+     +KI D GLAR L  D KE   +   +  +W       
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 190
Query: 196 ISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
           I  R++TH  D+WS G  + E++    KP + G  T     L+    R P PP
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEKGERLPQPP 242

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 38/279 (13%)
Query: 29  KRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G V +A      K +       K+ ++  +  + +    E+  +    +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 85  IITMLDIYKAVNNKDLYVVFEY----------------MENDLNKVIRDKILKDVHIRYI 128
           I+ +L      +   + V+ EY                +E D    I +  L    + + 
Sbjct: 112 IVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIA 185
             Q+  G++++ +   +HRD+   N+L+      KIGD GLAR + +    + +    + 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPN 243
            +W  APE  I +  YT   D+WS G +L E+  L   P +PG   + +      LV+  
Sbjct: 230 VKW-MAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKF---YKLVKDG 283
Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              A   +A     P+    ++     L P+ RP   QI
Sbjct: 284 YQMAQPAFA-----PKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 29  KRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G V +A      K +       K+ ++  +  + +    E+  +    +H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 85  IITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-----------IRYIMFQL 132
           I+ +L      +   + V+ EY    DL   +R K   D+            + +   Q+
Sbjct: 104 IVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWY 189
             G++++ +   +HRD+   N+L+      KIGD GLAR + +    + +    +  +W 
Sbjct: 162 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW- 220
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
            APE  I +  YT   D+WS G +L E+  L   P +PG   + +      LV+     A
Sbjct: 221 MAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKF---YKLVKDGYQMA 275
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              +A     P+    ++     L P+ RP   QI
Sbjct: 276 QPAFA-----PKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 23/231 (9%)
Query: 29  KRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G VYK       +  K  VAIK + E    K + +    E L + S   HP+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPH 101
Query: 85  IITMLDIYKAVNNKDLYVVFEYMEND-LNKVI---RDKILKDVHIRYIMFQLCNGLSYIH 140
           ++ +L +     +  + +V + M +  L + +   +D I   + + + + Q+  G+ Y+ 
Sbjct: 102 LVRLLGV---CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-QIAKGMMYLE 157
Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWYRAPEILIS 197
             +++HRDL   N+L+     +KI D GLAR L  D KE   +   +  +W       I 
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIH 215
Query: 198 NRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
            R++TH  D+WS G  + E++    KP + G  T     L+    R P PP
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEKGERLPQPP 265

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 74
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 75  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 129
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D G A+ L ++ KE   E   +  +W
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 190 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 245
Query: 245 P 245
           P
Sbjct: 246 P 246

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 72
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 73  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 127
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D G A+ L ++ KE   E   +  +W
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 188 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 243
Query: 245 P 245
           P
Sbjct: 244 P 244

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 72
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 73  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 127
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D G A+ L ++ KE   E   +  +W
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 188 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 243
Query: 245 P 245
           P
Sbjct: 244 P 244

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 29  KRIGKGAYGIVYKA----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           K +G GA+G V +A      K +       K+ ++  +  + +    E+  +    +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 85  IITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDKILKDVH-----------IRYIMFQL 132
           I+ +L      +   + V+ EY    DL   +R K   D+            + +   Q+
Sbjct: 112 IVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWY 189
             G++++ +   +HRD+   N+L+      KIGD GLAR + +    + +    +  +W 
Sbjct: 170 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW- 228
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
            APE  I +  YT   D+WS G +L E+  L   P +PG   + +      LV+     A
Sbjct: 229 MAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKF---YKLVKDGYQMA 283
Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
              +A     P+    ++     L P+ RP   QI
Sbjct: 284 QPAFA-----PKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 115/244 (47%), Gaps = 48/244 (19%)
Query: 5   TTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT 64
           TTS SG  +   V   I     + + IGKG +G V++   K   + VA+K IF +   ++
Sbjct: 24  TTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVK-IFSSREERS 80
Query: 65  DAQRTYREI-LFLKSFQRHPNIITMLDIYKAVNNKD------LYVVFEYMEND-----LN 112
                +RE  ++     RH NI+  +    A +NKD      L++V +Y E+      LN
Sbjct: 81  ----WFREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 113 K--VIRDKILKDVHIRYIMFQLCNGLSYIHA--------CKVMHRDLKPSNILIDKSCSI 162
           +  V  + ++K      +     +GL+++H           + HRDLK  NIL+ K+ + 
Sbjct: 133 RYTVTVEGMIK------LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
Query: 163 KIGDLGLA---RSLSDSKECLTEY-IATRWYRAPEILISNRRYTH-----HVDIWSLGCI 213
            I DLGLA    S +D+ +    + + T+ Y APE+L  +    H       DI+++G +
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246
Query: 214 LAEM 217
             E+
Sbjct: 247 FWEI 250

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +  GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 77
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKD-VHIRYIM---FQ 131
            +   +P++  +L I        + ++ + M    L   +R+   KD +  +Y++    Q
Sbjct: 78  MASVDNPHVCRLLGI---CLTSTVQLIMQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 132
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRW 188
           +  G++Y+   +++HRDL   N+L+     +KI D GLA+ L ++ KE   E   +  +W
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNP 244
                IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P P
Sbjct: 193 MALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQP 248
Query: 245 P 245
           P
Sbjct: 249 P 249

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 115/240 (47%), Gaps = 31/240 (12%)
Query: 24  EYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREIL---FL 76
           E+   K +G GA+G VYK       +  K  VAIK++ EA   K +     +EIL   ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILDEAYV 72
Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD-VHIRYIM---FQL 132
            +   +P++  +L I      + +  +  +    L   +R+   KD +  +Y++    Q+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREH--KDNIGSQYLLNWCVQI 128
Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL-SDSKECLTE--YIATRWY 189
             G++Y+   +++HRDL   N+L+     +KI D G A+ L ++ KE   E   +  +W 
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPL--FPGASTSHQLQLIVNLVRPNPP 245
               IL  +R YTH  D+WS G  + E++   SKP    P +  S  L+    L  P PP
Sbjct: 189 ALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPP 244

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFE--AFRNKTDAQRTYREILFLKSFQ 80
            +++ +G+G +G VY+    N+K     VA+K   +     NK   ++   E + +K+  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLD 71
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFE---------YMENDLNKVIRDKILKDVHIRYIMFQ 131
            HP+I+ ++ I   +  +  +++ E         Y+E + N       LK + +     Q
Sbjct: 72  -HPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNS------LKVLTLVLYSLQ 121
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIATRW 188
           +C  ++Y+ +   +HRD+   NIL+     +K+GD GL+R + D    K  +T  +  +W
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR-LPIKW 180
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLF 224
             +PE  I+ RR+T   D+W     + E+L    +P F
Sbjct: 181 -MSPES-INFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFE--AFRNKTDAQRTYREILFLKSFQ 80
            +++ +G+G +G VY+    N+K     VA+K   +     NK   ++   E + +K+  
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLD 67
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFE---------YMENDLNKVIRDKILKDVHIRYIMFQ 131
            HP+I+ ++ I   +  +  +++ E         Y+E + N       LK + +     Q
Sbjct: 68  -HPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNS------LKVLTLVLYSLQ 117
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIATRW 188
           +C  ++Y+ +   +HRD+   NIL+     +K+GD GL+R + D    K  +T  +  +W
Sbjct: 118 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR-LPIKW 176
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLF 224
             +PE  I+ RR+T   D+W     + E+L    +P F
Sbjct: 177 -MSPES-INFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFE--AFRNKTDAQRTYREILFLKSFQ 80
            +++ +G+G +G VY+    N+K     VA+K   +     NK   ++   E + +K+  
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLD 83
Query: 81  RHPNIITMLDIYKAVNNKDLYVVFE---------YMENDLNKVIRDKILKDVHIRYIMFQ 131
            HP+I+ ++ I   +  +  +++ E         Y+E + N       LK + +     Q
Sbjct: 84  -HPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNS------LKVLTLVLYSLQ 133
Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYIATRW 188
           +C  ++Y+ +   +HRD+   NIL+     +K+GD GL+R + D    K  +T  +  +W
Sbjct: 134 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR-LPIKW 192
Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLF 224
             +PE  I+ RR+T   D+W     + E+L    +P F
Sbjct: 193 -MSPES-INFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 29  KRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDA---QRTYREILFLKSFQRHPN 84
           K +G GA+G V  A     +K  V+I+   +  + K D+   +    E+  +     H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 85  IITMLDIYKAVNNKDLYVVFEYM-ENDLNKVIRDK------------------------I 119
           I+ +L       +  +Y++FEY    DL   +R K                        +
Sbjct: 111 IVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS-LSDSKE 178
           L    +    +Q+  G+ ++     +HRDL   N+L+     +KI D GLAR  +SDS  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 179 CL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQL- 233
            +     +  +W  APE L     YT   D+WS G +L E+  L   P +PG        
Sbjct: 229 VVRGNARLPVKW-MAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFY 285
Query: 234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
           +LI N  + + P    FYA      EE   ++      +  +RP
Sbjct: 286 KLIQNGFKMDQP----FYA-----TEEIYIIMQSCWAFDSRKRP 320

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           ++T+ + +GKG +G V +A  K        VA+K +       +D +   RE   +K F 
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 81  RHPNIITMLDIYKAVNNKDL----YVVFEYME-NDLNKVIRDKILKD--------VHIRY 127
            HP++  ++ +      K       V+  +M+  DL+  +    + +          +R+
Sbjct: 84  -HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS---KECLTEYI 184
            M  +  G+ Y+ +   +HRDL   N ++ +  ++ + D GL+R +      ++     +
Sbjct: 143 -MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAE-MLQSKPLFPGASTSHQLQLIVNLVR-P 242
             +W  A E L  N  YT H D+W+ G  + E M + +  + G   +     ++   R  
Sbjct: 202 PVKWL-ALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP-------ETDQILEH 285
            PP             EE  DL+ Q    +P +RP       E + IL H
Sbjct: 260 QPPEC----------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 26  TIHKRIGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  K +G GA+G V +A      K++       K+ +   + T+ +    E+  L     
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIM--------- 129
           H NI+ +L     +    L +       DL   +R   D  +       IM         
Sbjct: 86  HMNIVNLLGAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 130 -------FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
                  +Q+  G++++ +   +HRDL   NIL+      KI D GLAR + +    + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 183 ---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIV 237
               +  +W  APE  I N  YT   D+WS G  L E+  L S P +PG     +   ++
Sbjct: 205 GNARLPVKW-MAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYKMI 261
Query: 238 --NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                  +P HA          P E  D++      +P +RP   QI++
Sbjct: 262 KEGFRMLSPEHA----------PAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 26  TIHKRIGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +  K +G GA+G V +A      K++       K+ +   + T+ +    E+  L     
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIM--------- 129
           H NI+ +L     +    L +       DL   +R   D  +       IM         
Sbjct: 109 HMNIVNLLGAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 130 -------FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
                  +Q+  G++++ +   +HRDL   NIL+      KI D GLAR + +    + +
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 183 ---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIV 237
               +  +W  APE  I N  YT   D+WS G  L E+  L S P +PG     +   ++
Sbjct: 228 GNARLPVKW-MAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYKMI 284
Query: 238 --NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                  +P HA          P E  D++      +P +RP   QI++
Sbjct: 285 KEGFRMLSPEHA----------PAEMYDIMKTCWDADPLKRPTFKQIVQ 323
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	404
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-134
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-129
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-125
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-125
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-124
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-124
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-123
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-123
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-123
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-122
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-120
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-120
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-108
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-106
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-104
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-103
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-100
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-99
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-95
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-94
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-92
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-91
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-90
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-80
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-72
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-72
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-71
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-69
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-69
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-68
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-67
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-64
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-64
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-64
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-63
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-61
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-60
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-60
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-58
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-57
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-56
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-56
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-55
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-55
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-55
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-55
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-54
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-54
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-53
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-53
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-53
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-53
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-53
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-52
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-52
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-52
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-52
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-52
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-51
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-51
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-51
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-51
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-51
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-51
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-51
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-51
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-50
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-50
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-50
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-50
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-49
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-49
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-49
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-49
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-49
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-48
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-48
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-48
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-48
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-48
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-48
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-48
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-47
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-47
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-47
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-47
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-46
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-46
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-46
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-46
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-45
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-45
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-44
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-44
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-39
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-37
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-35
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-34
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-34
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-32
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-31
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-30
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-29
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-29
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-29
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-29
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-28
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-28
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-27
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-27
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  388 bits (998), Expect = e-134
 Identities = 139/383 (36%), Positives = 223/383 (58%), Gaps = 71/383 (18%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
            VD ++L +Y + K++GKGAYGIV+K+ D+   + VA+KKIF+AF+N TDAQRT+REI+ 
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
           L     H NI+ +L++ +A N++D+Y+VF+YME DL+ VIR  IL+ VH +Y+++QL   
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---------------- 179
           + Y+H+  ++HRD+KPSNIL++  C +K+ D GL+RS  + +                  
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 180 -----LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
                LT+Y+ATRWYRAPEIL+ + +YT  +D+WSLGCIL E+L  KP+FPG+ST +QL+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 235 LIVNLV-------------------------RPNPPHADKFYAGFK------------NK 257
            I+ ++                         +     ++K     K            + 
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF-----PSATHVIPQVTPHTVVLDID 312
            EEA+DLL+++L  NP++R   +  L+H +VS +      P+          H + + I+
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNC--------DHIITIPIN 353

Query: 313 DNNQLEINDYQDKLYDIVKSCKK 335
           DN +  I+DY++ +Y  +   K+
Sbjct: 354 DNVKHSIDDYRNLVYSEISRRKR 376

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  375 bits (966), Expect = e-129
 Identities = 117/354 (33%), Positives = 185/354 (52%), Gaps = 49/354 (13%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           NI +++ +   +G+GAYG+V  A  K   + VAIKKI E F     A RT REI  LK F
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHF 66

Query: 80  QRHPNIITMLDIYKAV---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            +H NIIT+ +I +     N  ++Y++ E M+ DL++VI  ++L D HI+Y ++Q    +
Sbjct: 67  -KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC----------LTEYIAT 186
             +H   V+HRDLKPSN+LI+ +C +K+ D GLAR + +S             + E++AT
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP- 244
           RWYRAPE+++++ +Y+  +D+WS GCILAE+   +P+FPG    HQL LI  ++  P+  
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 245 ------------------PHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                             P          F     + +DLL ++LV +P++R    + LE
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 285 HNYVSKYF-----PSATHVIPQVTPHTVVLDID-DNNQLEINDYQDKLYDIVKS 332
           H Y+  Y      P    + P         + D     L   D +  +++ + S
Sbjct: 306 HPYLQTYHDPNDEPEGEPIPPS------FFEFDHYKEALTTKDLKKLIWNEIFS 353

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  366 bits (941), Expect = e-125
 Identities = 117/365 (32%), Positives = 182/365 (49%), Gaps = 48/365 (13%)

Query: 1   MTSNTTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF 57
           M+S   ++SG   +  V      + A Y   + +G GAYG V  A D      VAIKK++
Sbjct: 1   MSSPPPARSG-FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59

Query: 58  EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNK 113
             F+++  A+R YRE+  LK   RH N+I +LD++          D Y+V  +M  DL K
Sbjct: 60  RPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 118

Query: 114 VIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
           +++ + L +  I+++++Q+  GL YIHA  ++HRDLKP N+ +++ C +KI D GLAR  
Sbjct: 119 LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178

Query: 174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
                 +T Y+ TRWYRAPE++++  RYT  VDIWS+GCI+AEM+  K LF G+    QL
Sbjct: 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235

Query: 234 QLIVNLV-RPNP------------------PHADK--FYAGFKNKPEEAVDLLNQILVLN 272
           + I+ +   P                    P  +K  F +   N    AV+LL ++LVL+
Sbjct: 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 295

Query: 273 PSERPETDQILEHNYVSKYF-----PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLY 327
             +R    + L H Y          P                   D+    +++++   Y
Sbjct: 296 AEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF----------DDVDRTLDEWKRVTY 345

Query: 328 DIVKS 332
             V S
Sbjct: 346 KEVLS 350

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  364 bits (937), Expect = e-125
 Identities = 137/366 (37%), Positives = 199/366 (54%), Gaps = 48/366 (13%)

Query: 3   SNTTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA 59
            +  + +       V G    +   YT    IG+GAYG+V  AYD  NK  VAIKKI   
Sbjct: 4   HHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SP 62

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---NNKDLYVVFEYMENDLNKVIR 116
           F ++T  QRT REI  L  F RH NII + DI +A      KD+Y+V + ME DL K+++
Sbjct: 63  FEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK 121

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS-- 174
            + L + HI Y ++Q+  GL YIH+  V+HRDLKPSN+L++ +C +KI D GLAR     
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 175 -DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
            D    LTEY+ATRWYRAPEI+++++ YT  +DIWS+GCILAEML ++P+FPG     QL
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

Query: 234 QLIVNLV-RPNP------------------PHADK--FYAGFKNKPEEAVDLLNQILVLN 272
             I+ ++  P+                   PH +K  +   F N   +A+DLL+++L  N
Sbjct: 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301

Query: 273 PSERPETDQILEHNYVSKYF-----PSATHVIPQVTPHTVVLDID-DNNQLEINDYQDKL 326
           P +R E +Q L H Y+ +Y+     P A                D + + L     ++ +
Sbjct: 302 PHKRIEVEQALAHPYLEQYYDPSDEPIAEAPF----------KFDMELDDLPKEKLKELI 351

Query: 327 YDIVKS 332
           ++    
Sbjct: 352 FEETAR 357

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  361 bits (930), Expect = e-124
 Identities = 105/309 (33%), Positives = 151/309 (48%), Gaps = 41/309 (13%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++ + Y   K +G G  G+V+ A D +  + VAIKKI     +    +   REI  ++  
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRL 65

Query: 80  QRHPNIITMLDIYKAVNN------------KDLYVVFEYMENDLNKVIRDKILKDVHIRY 127
             H NI+ + +I     +              +Y+V EYME DL  V+    L + H R 
Sbjct: 66  -DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLS---DSKECLTEY 183
            M+QL  GL YIH+  V+HRDLKP+N+ I+ +   +KIGD GLAR +      K  L+E 
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
           + T+WYR+P +L+S   YT  +D+W+ GCI AEML  K LF GA    Q+QLI+  + P 
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI-PV 243

Query: 244 PPHAD---------------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
               D                                EAVD L QIL  +P +R   ++ 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 283 LEHNYVSKY 291
           L H Y+S Y
Sbjct: 304 LSHPYMSIY 312

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  363 bits (933), Expect = e-124
 Identities = 112/362 (30%), Positives = 178/362 (49%), Gaps = 49/362 (13%)

Query: 5   TTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR 61
           +  +     + +V+     +   Y     +G GAYG V  A DK + + VAIKK+   F+
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNKDLYVVFEYMENDLNKVIRD 117
           ++  A+R YRE+L LK   +H N+I +LD++       N  D Y+V  +M+ DL K++  
Sbjct: 63  SEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121

Query: 118 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
           K   +  I+Y+++Q+  GL YIH+  V+HRDLKP N+ +++ C +KI D GLAR      
Sbjct: 122 K-FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179

Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 237
             +T Y+ TRWYRAPE+++S   Y   VDIWS+GCI+AEML  K LF G     QL  I+
Sbjct: 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 238 NLV-RPNP------------------PHADK--FYAGFKNKPEEAVDLLNQILVLNPSER 276
            +   P                    P   +  F   F     +A DLL ++L L+  +R
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297

Query: 277 PETDQILEHNYVSKYF-----PSATHVIPQVTPHTVVLDID-DNNQLEINDYQDKLYDIV 330
               Q L H +   +        A              D   ++ +L +++++  +Y  +
Sbjct: 298 LTAAQALTHPFFEPFRDPEEETEAQQPF----------DDSLEHEKLTVDEWKQHIYKEI 347

Query: 331 KS 332
            +
Sbjct: 348 VN 349

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  361 bits (929), Expect = e-123
 Identities = 123/364 (33%), Positives = 189/364 (51%), Gaps = 42/364 (11%)

Query: 1   MTSNTTSKSGDK---VQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK 54
           M  +    S ++    +  ++     +   Y     +G GAYG V  A+D      VA+K
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60

Query: 55  KIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMEND 110
           K+   F++   A+RTYRE+  LK   +H N+I +LD++    +     D+Y+V   M  D
Sbjct: 61  KLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 119

Query: 111 LNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 170
           LN +++ + L D H++++++Q+  GL YIH+  ++HRDLKPSN+ +++ C +KI D GLA
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

Query: 171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
           R  +D    +T Y+ATRWYRAPEI+++   Y   VDIWS+GCI+AE+L  + LFPG    
Sbjct: 180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

Query: 231 HQLQLIVNLV-RPNP------------------PHADK--FYAGFKNKPEEAVDLLNQIL 269
            QL+LI+ LV  P                        K  F   F      AVDLL ++L
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296

Query: 270 VLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDID-DNNQLEINDYQDKLYD 328
           VL+  +R    Q L H Y ++Y        P   P     D   ++  L I++++   YD
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYH------DPDDEPVADPYDQSLESRDLLIDEWKSLTYD 350

Query: 329 IVKS 332
            V S
Sbjct: 351 EVIS 354

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  363 bits (933), Expect = e-123
 Identities = 117/415 (28%), Positives = 183/415 (44%), Gaps = 92/415 (22%)

Query: 1   MTSNTTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF 57
           M  +    SG +  +        +   Y I   IG+G+YG VY AYDKN ++ VAIKK+ 
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 58  EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---KDLYVVFEYMENDLNKV 114
             F +  D +R  REI  L    +   II + D+    +     +LY+V E  ++DL K+
Sbjct: 61  RMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKL 119

Query: 115 IRDKI-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
            +  I L + HI+ I++ L  G ++IH   ++HRDLKP+N L+++ CS+K+ D GLAR++
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 174 SDSKEC----------------------LTEYIATRWYRAPEILISNRRYTHHVDIWSLG 211
           +  K+                       LT ++ TRWYRAPE+++    YT  +DIWS G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 212 CILAEMLQS-----------KPLFPGASTS-----------------HQLQLIVNLV-RP 242
           CI AE+L              PLFPG+S                    QL +I N++  P
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299

Query: 243 NP------------------PHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                               PH         + +  ++ ++LL  +L  NP++R   DQ 
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359

Query: 283 LEHNYVSKYF-----PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
           L+H Y+           +           ++L  DD   L     +      V+S
Sbjct: 360 LDHPYLKDVRKKKLENFS--------TKKIILPFDDWMVLSETQLRYIFLKEVQS 406

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  360 bits (926), Expect = e-123
 Identities = 102/362 (28%), Positives = 155/362 (42%), Gaps = 49/362 (13%)

Query: 7   SKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---- 59
              G+    ++      + + YT+ + I  G+YG V    D      VAIK++F      
Sbjct: 3   QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDG 61

Query: 60  -----FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN---KDLYVVFEYMENDL 111
                  +    +R  REI  L  F  HPNI+ + DI+          LY+V E M  DL
Sbjct: 62  RTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL 120

Query: 112 NKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL 169
            +VI     ++   HI+Y M+ +  GL  +H   V+HRDL P NIL+  +  I I D  L
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180

Query: 170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 229
           AR  +      T Y+  RWYRAPE+++  + +T  VD+WS GC++AEM   K LF G++ 
Sbjct: 181 AREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

Query: 230 SHQLQLIVNL--------------------VRPNPPHADK--FYAGFKNKPEEAVDLLNQ 267
            +QL  IV +                    +R +  +     + A        A+DL+ +
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299

Query: 268 ILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDID-DNNQLEINDYQDKL 326
           +L  NP  R  T+Q L H Y    F       P      +      D +  ++ D     
Sbjct: 300 MLEFNPQRRISTEQALRHPYFESLFD------PLDLTEGLSERFHFDESVTDVYDMHKIF 353

Query: 327 YD 328
             
Sbjct: 354 TA 355

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  361 bits (928), Expect = e-122
 Identities = 114/434 (26%), Positives = 188/434 (43%), Gaps = 97/434 (22%)

Query: 2   TSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR 61
             +++  +    + + D  I   Y I   IG G+YG V +AYDK  K+ VAIKKI   F 
Sbjct: 32  QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91

Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYK---AVNNKDLYVVFEYMENDLNKVIRDK 118
           +  D +R  REI  L     H +++ +LDI          +LYVV E  ++D  K+ R  
Sbjct: 92  DLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP 150

Query: 119 I-LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
           + L ++HI+ +++ L  G+ Y+H+  ++HRDLKP+N L+++ CS+K+ D GLAR++   +
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210

Query: 178 EC---------------------------LTEYIATRWYRAPEILISNRRYTHHVDIWSL 210
                                        LT ++ TRWYRAPE+++    YT  +D+WS+
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270

Query: 211 GCILAEMLQS-----------KPLFPGAST--------------------SHQLQLIVNL 239
           GCI AE+L              PLFPG+S                       QL +I N+
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330

Query: 240 V-RPNP------------------PHADK--FYAGFKNKPEEAVDLLNQILVLNPSERPE 278
           +  P+                   P  +       F     +A+ LL ++LV NP++R  
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390

Query: 279 TDQILEHNYVSKYF-----PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSC 333
            ++ L H +  +        +A           V L  +D   ++    +      ++  
Sbjct: 391 INECLAHPFFKEVRIAEVETNA--------TEKVRLPFNDWMNMDEPQLRYAFVKEIQRY 442

Query: 334 KKKKSVKRLSKGNA 347
             +  + R S   A
Sbjct: 443 HPEIQLPRRSPNRA 456

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  356 bits (914), Expect = e-120
 Identities = 117/422 (27%), Positives = 205/422 (48%), Gaps = 47/422 (11%)

Query: 4   NTTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           + +          V  +   +L  Y   K IG GA GIV  AYD    + VAIKK+   F
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVIR 116
           +N+T A+R YRE++ +K    H NII++L+++         +D+Y+V E M+ +L +VI+
Sbjct: 100 QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
              L    + Y+++Q+  G+ ++H+  ++HRDLKPSNI++   C++KI D GLAR+   +
Sbjct: 159 -MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GT 216

Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 236
              +T Y+ TR+YRAPE+++    Y  +VDIWS+GCI+ EM++ K LFPG     Q   +
Sbjct: 217 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275

Query: 237 VNLV------------------------RPNPPHADKF--------YAGFKNKPEEAVDL 264
           +  +                                 F            K K  +A DL
Sbjct: 276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335

Query: 265 LNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQD 324
           L+++LV++P++R   D  L+H Y++ ++     V     P  +     D  +  I ++++
Sbjct: 336 LSKMLVIDPAKRISVDDALQHPYINVWY-DPAEVEAP--PPQIYDKQLDEREHTIEEWKE 392

Query: 325 KLYDIVKSCKKKKSVKRL-SKGNALDNTLRGHYKIKDAISSKYTSSEKENQQNNNNTAPS 383
            +Y  V + ++K     +  + +     +     +  + S    SS   +Q   ++T  S
Sbjct: 393 LIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSS 452

Query: 384 YK 385
            +
Sbjct: 453 LE 454

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  351 bits (903), Expect = e-120
 Identities = 109/376 (28%), Positives = 191/376 (50%), Gaps = 48/376 (12%)

Query: 3   SNTTSKSGDKVQHNVDGN---ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA 59
            + + +  +     +  +   +L  Y   K IG GA GIV  AYD   ++ VAIKK+   
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN----KDLYVVFEYMENDLNKVI 115
           F+N+T A+R YRE++ +K    H NII +L+++    +    +D+Y+V E M+ +L +VI
Sbjct: 62  FQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120

Query: 116 RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
           + + L    + Y+++Q+  G+ ++H+  ++HRDLKPSNI++   C++KI D GLAR+   
Sbjct: 121 QME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-G 178

Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
           +   +T Y+ TR+YRAPE+++    Y  +VDIWS+GCI+ EM++   LFPG     Q   
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237

Query: 236 IVNLV------------------------RPNPPHADKF--------YAGFKNKPEEAVD 263
           ++  +                                 F            K K  +A D
Sbjct: 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297

Query: 264 LLNQILVLNPSERPETDQILEHNYVSKYF-PSATHVIPQVTPHTVVLDIDDNNQLEINDY 322
           LL+++LV++ S+R   D+ L+H Y++ ++ PS      +  P  +     D  +  I ++
Sbjct: 298 LLSKMLVIDASKRISVDEALQHPYINVWYDPSE----AEAPPPKIPDKQLDEREHTIEEW 353

Query: 323 QDKLYDIVKSCKKKKS 338
           ++ +Y  V   +    
Sbjct: 354 KELIYKEVMDLEHHHH 369

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  322 bits (827), Expect = e-108
 Identities = 91/326 (27%), Positives = 157/326 (48%), Gaps = 45/326 (13%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           M+ N  + + ++ +  +D      + + +  G+G +G V    +K+    VAIKK+ +  
Sbjct: 6   MSLNAAAAADERSRKEMD-----RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-- 58

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD-----LYVVFEYMENDLNKVI 115
            +     R  + +  L     HPNI+ +   +  +  +D     L VV EY+ + L++  
Sbjct: 59  -DPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC 116

Query: 116 R-----DKILKDVHIRYIMFQLCNGLSYIHAC--KVMHRDLKPSNILIDKS-CSIKIGDL 167
           R           + I+  +FQL   +  +H     V HRD+KP N+L++++  ++K+ D 
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA 227
           G A+ LS   E    YI +R+YRAPE++  N+ YT  VDIWS+GCI AEM+  +P+F G 
Sbjct: 177 GSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235

Query: 228 STSHQLQLIVNL-----------VRPN-----------PPHADKFYAGFKNKPEEAVDLL 265
           +++ QL  IV +           + P+            P ++ F        +EA DLL
Sbjct: 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295

Query: 266 NQILVLNPSERPETDQILEHNYVSKY 291
           + +L   P ER +  + L H Y  + 
Sbjct: 296 SALLQYLPEERMKPYEALCHPYFDEL 321

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  319 bits (819), Expect = e-106
 Identities = 89/309 (28%), Positives = 148/309 (47%), Gaps = 43/309 (13%)

Query: 15  HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
              D      YT  K IG G++G+VY+A   ++ + VAIKK+ +      D +   RE+ 
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQ 99

Query: 75  FLKSFQRHPNIITMLDIYKAVNNK----DLYVVFEYMENDLNKVIRD-----KILKDVHI 125
            ++    H NI+ +   + +   K     L +V +Y+   + +V R      + L  +++
Sbjct: 100 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158

Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYI 184
           +  M+QL   L+YIH+  + HRD+KP N+L+D     +K+ D G A+ L    E    YI
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 217

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL----- 239
            +R+YRAPE++     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ +     
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277

Query: 240 ------VRPN---------PPH--ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
                 + PN           H     F       P EA+ L +++L   P+ R    + 
Sbjct: 278 REQIREMNPNYTEFKFPQIKAHPWTKVFR---PRTPPEAIALCSRLLEYTPTARLTPLEA 334

Query: 283 LEHNYVSKY 291
             H++  + 
Sbjct: 335 CAHSFFDEL 343

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  310 bits (797), Expect = e-104
 Identities = 91/309 (29%), Positives = 158/309 (51%), Gaps = 27/309 (8%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           ++ +Y    +IG+G+YG+V+K  +++  Q VAIKK  E+  +    +   REI  LK   
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL- 59

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSY 138
           +HPN++ +L++++    + L++VFEY ++ +   +    + + +  ++ I +Q    +++
Sbjct: 60  KHPNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
            H    +HRD+KP NILI K   IK+ D G AR L+   +   + +ATRWYR+PE+L+ +
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI---------------------V 237
            +Y   VD+W++GC+ AE+L   PL+PG S   QL LI                      
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
            +  P+P   +     F N    A+ LL   L ++P+ER   +Q+L H Y          
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN-IREIED 296

Query: 298 VIPQVTPHT 306
           +  +     
Sbjct: 297 LAKEHDKPA 305

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  309 bits (793), Expect = e-103
 Identities = 86/333 (25%), Positives = 150/333 (45%), Gaps = 69/333 (20%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
               +Y++ K +G G++GIV + +D  + +  A+KK+ +      D +   RE+  +K  
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVL 57

Query: 80  QRHPNIITMLDIY------------------------------------KAVNNKDLYVV 103
             H NII ++D +                                        NK L V+
Sbjct: 58  -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 104 FEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID- 157
            EY+ + L+KV++      + +    I   ++QL   + +IH+  + HRD+KP N+L++ 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 158 KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEM 217
           K  ++K+ D G A+ L    E    YI +R+YRAPE+++    YT  +D+WS+GC+  E+
Sbjct: 177 KDNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 218 LQSKPLFPGASTSHQLQLIVNLV---------RPNPPHADK---------FYAGFKNK-P 258
           +  KPLF G ++  QL  I+ ++         R NP + +          +        P
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
             A+DLL QIL   P  R    + + H +    
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  300 bits (771), Expect = e-100
 Identities = 90/306 (29%), Positives = 155/306 (50%), Gaps = 27/306 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y     +G+G+YG+V K  +K+  + VAIKK  E+  +K   +   REI  LK   RH 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHE 84

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHA 141
           N++ +L++ K    K  Y+VFE++++ +   +      L    ++  +FQ+ NG+ + H+
Sbjct: 85  NLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             ++HRD+KP NIL+ +S  +K+ D G AR+L+   E   + +ATRWYRAPE+L+ + +Y
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI---------------------VNLV 240
              VD+W++GC++ EM   +PLFPG S   QL  I                       + 
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
            P     +     +    E  +DL  + L ++P +RP   ++L H++       A     
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM-DGFAERFSQ 321

Query: 301 QVTPHT 306
           ++    
Sbjct: 322 ELQLKV 327

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  299 bits (768), Expect = 4e-99
 Identities = 91/295 (30%), Positives = 153/295 (51%), Gaps = 44/295 (14%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+V++A    + + VAIKK+ +      D +   RE+  ++   +HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ------DKRFKNRELQIMRIV-KHPN 93

Query: 85  IITMLDIYKAVNNK----DLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNG 135
           ++ +   + +  +K     L +V EY+   + +  R      + +  + I+  M+QL   
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 136 LSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D     +K+ D G A+ L  + E    YI +R+YRAPE+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYYRAPEL 212

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-----------VRPN 243
           +     YT ++DIWS GC++AE++Q +PLFPG S   QL  I+ +           + PN
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272

Query: 244 ---------PPH--ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                     PH  +  F       P +A+DL++++L   PS R    + L H +
Sbjct: 273 YMEHKFPQIRPHPFSKVFR---PRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  294 bits (756), Expect = 4e-98
 Identities = 82/307 (26%), Positives = 146/307 (47%), Gaps = 38/307 (12%)

Query: 15  HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           H V+     +Y + +++G+G Y  V++A +  N + V +K +          ++  REI 
Sbjct: 28  HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIK 82

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY-MENDLNKVIRDKILKDVHIRYIMFQLC 133
            L++ +  PNIIT+ DI K   ++   +VFE+    D  ++   + L D  IR+ M+++ 
Sbjct: 83  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEIL 140

Query: 134 NGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E     +A+R+++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 199

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLV----------R 241
           E+L+  + Y + +D+WSLGC+LA M+  K P F G     QL  I  ++          +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259

Query: 242 PNPPHADKFYAGFKNKP-----------------EEAVDLLNQILVLNPSERPETDQILE 284
            N     +F                          EA+D L+++L  +   R    + +E
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319

Query: 285 HNYVSKY 291
           H Y    
Sbjct: 320 HPYFYTV 326

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  286 bits (735), Expect = 9e-95
 Identities = 102/293 (34%), Positives = 145/293 (49%), Gaps = 38/293 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY---------REIL 74
            Y     +G+G +  VYKA DKN  Q VAIKKI      K   +            REI 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI------KLGHRSEAKDGINRTALREIK 64

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQL 132
            L+    HPNII +LD +   +  ++ +VF++ME DL  +I+D   +L   HI+  M   
Sbjct: 65  LLQEL-SHPNIIGLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             GL Y+H   ++HRDLKP+N+L+D++  +K+ D GLA+S        T  + TRWYRAP
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNP------- 244
           E+L   R Y   VD+W++GCILAE+L   P  PG S   QL  I   +  P         
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query: 245 --PHADKF--YAG------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
             P    F  + G      F    ++ +DL+  + + NP  R    Q L+  Y
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  283 bits (726), Expect = 7e-94
 Identities = 96/292 (32%), Positives = 157/292 (53%), Gaps = 38/292 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLK 77
           +Y   +++G+G YG+VYKA D    + VA+K+I      + DA+         REI  LK
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQG-RIVALKRI------RLDAEDEGIPSTAIREISLLK 74

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNG 135
               HPNI++++D+    + + L +VFE+ME DL KV+ +    L+D  I+  ++QL  G
Sbjct: 75  EL-HHPNIVSLIDVI--HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           +++ H  +++HRDLKP N+LI+   ++K+ D GLAR+        T  + T WYRAP++L
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL---------------- 239
           + +++Y+  VDIWS+GCI AEM+  KPLFPG +   QL  I ++                
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251

Query: 240 ----VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                         + +      +E +DLL+ +L  +P++R      + H Y
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  282 bits (723), Expect = 1e-93
 Identities = 89/292 (30%), Positives = 142/292 (48%), Gaps = 37/292 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLK 77
           +Y   ++IG+G YG V+KA ++   + VA+K++      + D           REI  LK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLK 56

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNG 135
              +H NI+ + D+    ++K L +VFE+ + DL K        L    ++  +FQL  G
Sbjct: 57  EL-KHKNIVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L + H+  V+HRDLKP N+LI+++  +K+ + GLAR+      C +  + T WYR P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR------------- 241
              + Y+  +D+WS GCI AE+  + +PLFPG     QL+ I  L+              
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 242 ------PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                 P  P                 DLL  +L  NP +R   ++ L+H Y
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  278 bits (714), Expect = 2e-92
 Identities = 104/291 (35%), Positives = 160/291 (54%), Gaps = 37/291 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLK 77
           +Y   ++IG+G YG+VYKA +    +  A+KKI      + + +       T REI  LK
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI------RLEKEDEGIPSTTIREISILK 55

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNG 135
              +H NI+ + D+      K L +VFE+++ DL K++      L+ V  +  + QL NG
Sbjct: 56  EL-KHSNIVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           ++Y H  +V+HRDLKP N+LI++   +KI D GLAR+        T  I T WYRAP++L
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNP---------P 245
           + +++Y+  +DIWS+GCI AEM+   PLFPG S + QL  I  ++  PN          P
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 246 HADKFYAGFKNKP---------EEAVDLLNQILVLNPSERPETDQILEHNY 287
             D  +  ++  P         E  +DLL+++L L+P++R    Q LEH Y
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  279 bits (715), Expect = 6e-92
 Identities = 100/296 (33%), Positives = 143/296 (48%), Gaps = 41/296 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLK 77
            Y    ++G+G YG VYKA D    + VAIK+I      + + +         RE+  LK
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLK 88

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI-LKDVHIRYIMFQLCNGL 136
              +H NII +  +    +N  L+++FEY ENDL K +     +    I+  ++QL NG+
Sbjct: 89  EL-QHRNIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 137 SYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRA 191
           ++ H+ + +HRDLKP N+L+  S +     +KIGD GLAR+        T  I T WYR 
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL------------ 239
           PEIL+ +R Y+  VDIWS+ CI AEML   PLFPG S   QL  I  +            
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265

Query: 240 --------VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                     P                +E +DLL  +L ++P +R      LEH Y
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  277 bits (711), Expect = 2e-91
 Identities = 90/307 (29%), Positives = 143/307 (46%), Gaps = 43/307 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-----RTYREILFLKS 78
            Y    ++G+G Y  VYK   K     VA+K+I      + + +        RE+  LK 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKD 56

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGL 136
             +H NI+T+ DI      K L +VFEY++ DL + + D   I+   +++  +FQL  GL
Sbjct: 57  L-KHANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
           +Y H  KV+HRDLKP N+LI++   +K+ D GLAR+ S   +     + T WYR P+IL+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL----------------- 239
            +  Y+  +D+W +GCI  EM   +PLFPG++   QL  I  +                 
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233

Query: 240 ---VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF---P 293
                     A+   +       +  DLL ++L      R   +  ++H     +F    
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH----PFFLSLG 289

Query: 294 SATHVIP 300
              H +P
Sbjct: 290 ERIHKLP 296

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  276 bits (707), Expect = 7e-91
 Identities = 97/300 (32%), Positives = 149/300 (49%), Gaps = 45/300 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR-----TYREILFLKS 78
           ++   +++G G Y  VYK  +K    YVA+K++      K D++        REI  +K 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKE 59

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDV-------HIRYIMFQ 131
             +H NI+ + D+        L +VFE+M+NDL K +  + + +         ++Y  +Q
Sbjct: 60  L-KHENIVRLYDVI--HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRA 191
           L  GL++ H  K++HRDLKP N+LI+K   +K+GD GLAR+        +  + T WYRA
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL------------ 239
           P++L+ +R Y+  +DIWS GCILAEM+  KPLFPG +   QL+LI ++            
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236

Query: 240 -----------VRPNPPHADKFYAGFKNK-PEEAVDLLNQILVLNPSERPETDQILEHNY 287
                       RP            K       +D L+ +L LNP  R    Q L H +
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  272 bits (698), Expect = 9e-90
 Identities = 95/298 (31%), Positives = 140/298 (46%), Gaps = 42/298 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR---------TYREIL 74
            Y     IG GAYG VYKA D ++  +VA+K +      +              T RE+ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV------RVPNGGGGGGGLPISTVREVA 63

Query: 75  FLK--SFQRHPNIITMLDIYKAVNNKD---LYVVFEYMENDLNKVIRD---KILKDVHIR 126
            L+      HPN++ ++D+           + +VFE+++ DL   +       L    I+
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT 186
            +M Q   GL ++HA  ++HRDLKP NIL+    ++K+ D GLAR  S     LT  + T
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVT 182

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPN-- 243
            WYRAPE+L+    Y   VD+WS+GCI AEM + KPLF G S + QL  I +L+  P   
Sbjct: 183 LWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 244 --------------PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                         P       +      E    LL ++L  NP +R    + L+H+Y
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  272 bits (698), Expect = 4e-89
 Identities = 88/304 (28%), Positives = 148/304 (48%), Gaps = 47/304 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQR------TYREILFLK 77
           +Y    +IG+G +G V+KA  +   Q VA+KK+        + ++        REI  L+
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKILQ 71

Query: 78  SFQRHPNIITMLDI------YKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIM 129
              +H N++ +++I              +Y+VF++ E+DL  ++ +         I+ +M
Sbjct: 72  LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS----LSDSKECLTEYIA 185
             L NGL YIH  K++HRD+K +N+LI +   +K+ D GLAR+     +      T  + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL------ 239
           T WYR PE+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L      
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250

Query: 240 --------------VRPNPPHADKFYAGFKN--KPEEAVDLLNQILVLNPSERPETDQIL 283
                         +        K     K   +   A+DL++++LVL+P++R ++D  L
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 284 EHNY 287
            H++
Sbjct: 311 NHDF 314

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  269 bits (690), Expect = 3e-88
 Identities = 101/315 (32%), Positives = 150/315 (47%), Gaps = 41/315 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQR------TYREILFL 76
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +           T RE+  L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVL 65

Query: 77  KSFQ--RHPNIITMLDI---YKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYI 128
           +  +   HPN++ + D+    +      L +VFE+++ DL   +       +    I+ +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           MFQL  GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S     LT  + T W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV-RPNP--- 244
           YRAPE+L+    Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++  P     
Sbjct: 185 YRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 245 -------------PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                          A        +  E   DLL + L  NP++R      L H Y    
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD- 302

Query: 292 FPSATHVIPQVTPHT 306
                  +    P +
Sbjct: 303 LERCKENLDSHLPPS 317

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  252 bits (644), Expect = 2e-80
 Identities = 88/314 (28%), Positives = 153/314 (48%), Gaps = 61/314 (19%)

Query: 30  RIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT 87
           ++G+G YG VYKA  K+ K  +  A+K+I     + +      REI  L+   +HPN+I+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS----ACREIALLREL-KHPNVIS 82

Query: 88  MLDIYKAVNNKDLYVVFEYMENDLNKVI----------RDKILKDVHIRYIMFQLCNGLS 137
           +  ++ +  ++ ++++F+Y E+DL  +I          +   L    ++ +++Q+ +G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 138 YIHACKVMHRDLKPSNILIDKSCS----IKIGDLGLARSLSDSKECLTEYIA---TRWYR 190
           Y+HA  V+HRDLKP+NIL+         +KI D+G AR  +   + L +      T WYR
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---------TSHQLQLIVNLV- 240
           APE+L+  R YT  +DIW++GCI AE+L S+P+F                QL  I N++ 
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 241 RPNP---------PHADKFYAGFKNKP------------------EEAVDLLNQILVLNP 273
            P           P        F+                      +A  LL ++L ++P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 274 SERPETDQILEHNY 287
            +R  ++Q ++  Y
Sbjct: 323 IKRITSEQAMQDPY 336

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  228 bits (583), Expect = 8e-73
 Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 22/282 (7%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
              +Y +   IG G+YG   K   K++ + +  K++      + + Q    E+  L+   
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL- 62

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQLCN 134
           +HPNI+   D      N  LY+V EY E  DL  VI     +  +     +  +M QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 135 GLSYIHACK-----VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            L   H        V+HRDLKP+N+ +D   ++K+GD GLAR L+        ++ T +Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            +PE + +   Y    DIWSLGC+L E+    P F   S   Q +L   +          
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKFRRIPY 238

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
            Y       +E  +++ ++L L    RP  ++ILE+  + ++
Sbjct: 239 RY------SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  228 bits (584), Expect = 1e-72
 Identities = 80/302 (26%), Positives = 137/302 (45%), Gaps = 19/302 (6%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFR 61
                +    ++ ++  N LA + I K+IG+G +  VY+A    +   VA+KK+      
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKIL 120
           +        +EI  LK    HPN+I     +  + + +L +V E  +  DL+++I+    
Sbjct: 72  DAKARADCIKEIDLLKQL-NHPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKHFKK 128

Query: 121 KDVH-----IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
           +        +     QLC+ L ++H+ +VMHRD+KP+N+ I  +  +K+GDLGL R  S 
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188

Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
                   + T +Y +PE  I    Y    DIWSLGC+L EM   +  F G   +    L
Sbjct: 189 KTTAAHSLVGTPYYMSPER-IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL 246

Query: 236 IVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
              + +   PP     Y       EE   L+N  +  +P +RP+   + +         +
Sbjct: 247 CKKIEQCDYPPLPSDHY------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300

Query: 295 AT 296
           ++
Sbjct: 301 SS 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  229 bits (585), Expect = 3e-72
 Identities = 80/289 (27%), Positives = 143/289 (49%), Gaps = 17/289 (5%)

Query: 7   SKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA 66
           S   D    N+    + +Y   ++IG+G++G         + +   IK+I  +  +  + 
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67

Query: 67  QRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKD 122
           + + RE+  L +  +HPNI+   + +    N  LY+V +Y E  DL K I  +   + ++
Sbjct: 68  EESRREVAVLANM-KHPNIVQYRESF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 123 VHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE 182
             I     Q+C  L ++H  K++HRD+K  NI + K  ++++GD G+AR L+ + E    
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184

Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP 242
            I T +Y +PEI   N+ Y +  DIW+LGC+L E+   K  F   S      L++ ++  
Sbjct: 185 CIGTPYYLSPEI-CENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISG 240

Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           + P     Y        +   L++Q+   NP +RP  + ILE  +++K 
Sbjct: 241 SFPPVSLHY------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  224 bits (573), Expect = 6e-71
 Identities = 60/287 (20%), Positives = 108/287 (37%), Gaps = 18/287 (6%)

Query: 6   TSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD 65
           T +S        +      +    R+G G+YG V+K   K + +  A+K+    FR   D
Sbjct: 40  TLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD 99

Query: 66  AQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDV 123
             R   E+   +   +HP  + +   ++      LY+  E     L +        L + 
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILYLQTELCGPSLQQHCEAWGASLPEA 157

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 183
            +   +      L+++H+  ++H D+KP+NI +      K+GD GL   L  +     + 
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ- 216

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
                Y APE+L     Y    D++SLG  + E+  +  L  G       QL    + P 
Sbjct: 217 EGDPRYMAPELL--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ--QLRQGYLPPE 272

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                           E   +L  +L  +P  R   + +L    + +
Sbjct: 273 FT---------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  220 bits (562), Expect = 1e-69
 Identities = 80/297 (26%), Positives = 130/297 (43%), Gaps = 41/297 (13%)

Query: 15  HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           H VD     ++   + IG G +G V+KA  + + +   IK++      K + ++  RE+ 
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVK 56

Query: 75  FLKSFQRHPNIITMLDIY--------------KAVNNKDLYVVFEYMEN-DLNKVI---R 116
            L     H NI+     +                   K L++  E+ +   L + I   R
Sbjct: 57  ALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
            + L  V    +  Q+  G+ YIH+ K+++RDLKPSNI +  +  +KIGD GL  SL + 
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 236
            +  T    T  Y +PE  IS++ Y   VD+++LG ILAE+L          TS     +
Sbjct: 176 GK-RTRSKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDL 231

Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
            +            +       ++   LL ++L   P +RP T +IL    V K  P
Sbjct: 232 RD--GIISDI----F------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  219 bits (561), Expect = 3e-69
 Identities = 72/310 (23%), Positives = 130/310 (41%), Gaps = 41/310 (13%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G  L ++   + +G+G +G+V++A +K +    AIK+I      +   ++  RE+  L  
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAK 59

Query: 79  FQRHPNIITMLDIYKAVNNKD----------LYVVFEYMEN-DLNKVIRDK----ILKDV 123
              HP I+   + +   N  +          LY+  +     +L   +  +      +  
Sbjct: 60  L-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC---- 179
              +I  Q+   + ++H+  +MHRDLKPSNI       +K+GD GL  ++   +E     
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 180 --------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH 231
                    T  + T+ Y +PE +     Y+H VDI+SLG IL E+L   P         
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY--PFSTQ---ME 232

Query: 232 QLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           +++ + ++     P        F  K      ++  +L  +P ERPE   I+E+      
Sbjct: 233 RVRTLTDVRNLKFPPL------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286

Query: 292 FPSATHVIPQ 301
                 V+ Q
Sbjct: 287 DFPGKTVLRQ 296

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  218 bits (557), Expect = 1e-68
 Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 40/300 (13%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
             +++     +G+GA+G V KA +  + +Y AIKKI      +        E++ L S  
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASL- 59

Query: 81  RHPNIITMLDIYKAVNNKD-----------LYVVFEYMEN-DLNKVIRDKILKD--VHIR 126
            H  ++     +    N             L++  EY EN  L  +I  + L        
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC------- 179
            +  Q+   LSYIH+  ++HRDLKP NI ID+S ++KIGD GLA+++  S +        
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 180 -------LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ 232
                  LT  I T  Y A E+L     Y   +D++SLG I  EM+   P   G    + 
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237

Query: 233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
           L+ + ++    PP  D       NK +    ++  ++  +P++RP    +L   ++    
Sbjct: 238 LKKLRSVSIEFPPDFD------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  214 bits (548), Expect = 3e-67
 Identities = 69/317 (21%), Positives = 118/317 (37%), Gaps = 29/317 (9%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           S+      + +           Y+I K+IG G    V++  ++   Q  AIK +     +
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEAD 66

Query: 63  KTDAQRTYREILFLKSFQRHPN--IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-I 119
                    EI +L    +  +  II + D      ++ +Y+V E    DLN  ++ K  
Sbjct: 67  NQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEI--TDQYIYMVMECGNIDLNSWLKKKKS 123

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SK 177
           +     +     +   +  IH   ++H DLKP+N LI     +K+ D G+A  +    + 
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTS 182

Query: 178 ECLTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEMLQSKPLFPGA 227
                 + T  Y  PE +              + +   D+WSLGCIL  M   K  F   
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

Query: 228 STSHQ-LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
                 L  I+     +P H  +F        ++  D+L   L  +P +R    ++L H 
Sbjct: 243 INQISKLHAII-----DPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 294

Query: 287 YVSKYFPSATHVIPQVT 303
           YV         +    T
Sbjct: 295 YVQIQTHPVNQMAKGTT 311

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  210 bits (536), Expect = 5e-65
 Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 29/297 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
            Y+I K+IG G    V++  ++   Q  AIK +     +         EI +L    +  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQH 67

Query: 84  N--IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIH 140
           +  II + D      ++ +Y+V E    DLN  ++ K  +     +     +   +  IH
Sbjct: 68  SDKIIRLYDYEI--TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILI-- 196
              ++H DLKP+N LI     +K+ D G+A  +            + T  Y  PE +   
Sbjct: 126 QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 197 --------SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHA 247
                   S  + +   D+WSLGCIL  M   K  F         L  I+     +P H 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-----DPNHE 239

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
            +F        ++  D+L   L  +P +R    ++L H YV         +    T 
Sbjct: 240 IEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  206 bits (527), Expect = 2e-64
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 43/300 (14%)

Query: 16  NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF 75
            +      E+   ++IG G +G V+K   + +    AIK+  +      D Q   RE+  
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIM 129
                +H +++     +    +  + +  EY     L   I +        K+  ++ ++
Sbjct: 64  HAVLGQHSHVVRYFSAW--AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSI-------------------KIGDLGLA 170
            Q+  GL YIH+  ++H D+KPSNI I ++                      KIGDLG  
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
             +S  +           + A E+L  N  +    DI++L   +     ++PL       
Sbjct: 182 TRISSPQVE----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP------ 231

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                   + +   P   +         +E  +LL  ++  +P  RP    +++H+ +  
Sbjct: 232 RNGDQWHEIRQGRLPRIPQVL------SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  206 bits (527), Expect = 4e-64
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 29/280 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   +++G+G +  V      ++  + A+K+I      + D +   RE    + F  HPN
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLF-NHPN 87

Query: 85  IITMLD--IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQLCNGL 136
           I+ ++   + +     + +++  + +   L   I     K        I +++  +C GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---------TR 187
             IHA    HRDLKP+NIL+       + DLG         E   + +          T 
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 188 WYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 245
            YRAPE+  + S+       D+WSLGC+L  M+  +  +           +    + + P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            + +  +           LLN ++ ++P +RP    +L  
Sbjct: 268 QSPRHSSALW-------QLLNSMMTVDPHQRPHIPLLLSQ 300

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  208 bits (531), Expect = 5e-64
 Identities = 35/310 (11%), Positives = 87/310 (28%), Gaps = 37/310 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSF---- 79
             + + +  G   +V+   D    +  A+K     A  ++++ +R +             
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 80  -------------------QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIR---- 116
                              Q  P    +          +  ++      DL  +      
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 117 ----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
                     + +  +  QL    + + +  ++H    P N+ I     + +GD+     
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 173 LSDSKECLTEYIATRWYRAPEILISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSH 231
           +       +       Y   E L ++   +TH ++ W LG  +  +      F   +   
Sbjct: 244 VGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 232 QLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           +       +R  P      +      P+    L+ + L  +   R    + +E     + 
Sbjct: 301 KGSWKRPSLRV-PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359

Query: 292 FPSATHVIPQ 301
               +  +  
Sbjct: 360 QNEISSSLST 369

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  206 bits (527), Expect = 4e-63
 Identities = 67/325 (20%), Positives = 116/325 (35%), Gaps = 37/325 (11%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
                         +         Y+I K+IG G    V++  ++   Q  AIK +    
Sbjct: 34  DLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEE 92

Query: 61  RNKTDAQRTYREILFLKSFQRHPN--IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK 118
            +         EI +L    +  +  II + D      ++ +Y+V E    DLN  ++ K
Sbjct: 93  ADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEI--TDQYIYMVMECGNIDLNSWLKKK 149

Query: 119 -ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-- 175
             +     +     +   +  IH   ++H DLKP+N LI     +K+ D G+A  +    
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 208

Query: 176 SKECLTEYIATRWYRAPEILI----------SNRRYTHHVDIWSLGCILAEMLQSKPLFP 225
           +       +    Y  PE +           S  + +   D+WSLGCIL  M   K  F 
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

Query: 226 GASTSHQLQLIVNLVRPN-----PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD 280
                +Q+  +  ++ PN     P              ++  D+L   L  +P +R    
Sbjct: 269 Q--IINQISKLHAIIDPNHEIEFPDIP----------EKDLQDVLKCCLKRDPKQRISIP 316

Query: 281 QILEHNYVSKYFPSATHVIPQVTPH 305
           ++L H YV         +    T  
Sbjct: 317 ELLAHPYVQIQTHPVNQMAKGTTEE 341

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  197 bits (503), Expect = 9e-61
 Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 22/292 (7%)

Query: 17  VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILF 75
           VD      Y   + +GKG +   ++  D + K+  A K +           ++   EI  
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLC 133
            +S   H +++     ++  +N  ++VV E      L ++  R K L +   RY + Q+ 
Sbjct: 69  HRSL-AHQHVVGFHGFFE--DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
            G  Y+H  +V+HRDLK  N+ +++   +KIGD GLA  +    E       T  Y APE
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           + +S + ++  VD+WS+GCI+  +L  KP F  +        I       P H       
Sbjct: 186 V-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI------ 238

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEH-----NYVSKYFPSATHVIP 300
                  A  L+ ++L  +P+ RP  +++L        Y+    P     IP
Sbjct: 239 ----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIP 286

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  198 bits (505), Expect = 1e-60
 Identities = 76/329 (23%), Positives = 138/329 (41%), Gaps = 23/329 (6%)

Query: 2   TSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAF 60
                  + +  +  VD      Y   + +GKG +   ++  D + K+  A K +     
Sbjct: 20  APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL 79

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDK 118
                 ++   EI   +S   H +++     ++  +N  ++VV E      L ++  R K
Sbjct: 80  LKPHQREKMSMEISIHRSL-AHQHVVGFHGFFE--DNDFVFVVLELCRRRSLLELHKRRK 136

Query: 119 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
            L +   RY + Q+  G  Y+H  +V+HRDLK  N+ +++   +KIGD GLA  +    E
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
                  T  Y APE+ +S + ++  VD+WS+GCI+  +L  KP F  +        I  
Sbjct: 197 RKKVLCGTPNYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255

Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH-----NYVSKYFP 293
                P H              A  L+ ++L  +P+ RP  +++L        Y+    P
Sbjct: 256 NEYSIPKHI----------NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 305

Query: 294 -SATHVIPQVTPHTVVLDIDDNNQLEIND 321
            +   + P+ +     LD  +   L + +
Sbjct: 306 ITCLTIPPRFSIAPSSLDPSNRKPLTVLN 334

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  199 bits (509), Expect = 4e-60
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 28/295 (9%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           S       ++    + G I   +     +G GA G +       + + VA+K+I      
Sbjct: 6   SLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI-----L 57

Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKIL 120
                   RE+  L+    HPN+I      K  + +  Y+  E     L + +  +D   
Sbjct: 58  PECFSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAIELCAATLQEYVEQKDFAH 115

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-----DKSCSIKIGDLGLARSLSD 175
             +    ++ Q  +GL+++H+  ++HRDLKP NILI            I D GL + L+ 
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175

Query: 176 ---SKECLTEYIATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
              S    +    T  + APE+L        T+ VDI+S GC+   ++       G S  
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            Q  +++     +  H +      K++   A +L+ +++ ++P +RP    +L+H
Sbjct: 236 RQANILLGACSLDCLHPE------KHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  197 bits (502), Expect = 5e-60
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 40/287 (13%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
             + + + +G +  VY+A D  + +  A+K++      +   +   +E+ F+K    HPN
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 85  IITMLD---IYKAVNNKDLYVVFEYME-------NDLNKVIRDKILKDVHIRYIMFQLCN 134
           I+       I K  ++          E         L K+     L    +  I +Q C 
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 135 GLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--------KECLTEYI 184
            + ++H  K  ++HRDLK  N+L+    +IK+ D G A ++S          +  L E  
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 185 ATR----WYRAPEI--LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
            TR     YR PEI  L SN       DIW+LGCIL  +   +  F   +   +L+ IVN
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA---KLR-IVN 263

Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                PPH D  Y  F         L+  +L +NP ER    +++  
Sbjct: 264 GKYSIPPH-DTQYTVFH-------SLIRAMLQVNPEERLSIAEVVHQ 302

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  192 bits (490), Expect = 1e-58
 Identities = 56/302 (18%), Positives = 106/302 (35%), Gaps = 38/302 (12%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                 + +   +G+GA   V++   K      AIK +F             RE   LK 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKK 63

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLC 133
              H NI+ +  I +    +   ++ E+     L  V+ +      L +     ++  + 
Sbjct: 64  L-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 134 NGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            G++++    ++HR++KP NI+     D     K+ D G AR L D ++ ++ Y  T  Y
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEY 181

Query: 190 RAPEIL-------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVR 241
             P++           ++Y   VD+WS+G            F       +  +++  ++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 242 PNPPHADKFYAGFKNKP------------------EEAVDLLNQILVLNPSERPETDQIL 283
             P  A       +N P                       +L  IL  +  +    DQ  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 284 EH 285
             
Sbjct: 302 AE 303

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  187 bits (477), Expect = 5e-57
 Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 18/280 (6%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + ++ +   +GKG++  VY+A   +    VAIK I  +A       QR   E+       
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL- 68

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI--RDKILKDVHIRYIMFQLCNGLS 137
           +HP+I+ + + ++  ++  +Y+V E   N ++N+ +  R K   +   R+ M Q+  G+ 
Sbjct: 69  KHPSILELYNYFE--DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+H+  ++HRDL  SN+L+ ++ +IKI D GLA  L    E       T  Y +PEI  +
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-AT 185

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
              +    D+WSLGC+   +L  +P F   +  + L  +V      P             
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL---------- 235

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
             EA DL++Q+L  NP++R     +L+H ++S+   + + 
Sbjct: 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  191 bits (486), Expect = 7e-57
 Identities = 86/288 (29%), Positives = 135/288 (46%), Gaps = 29/288 (10%)

Query: 14  QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQ 67
           Q      +  EY + K +G GA G V  A+++   + VAI+ I        + R    A 
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185

Query: 68  RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHI 125
               EI  LK    HP II + + +   + +D Y+V E ME  +L +KV+ +K LK+   
Sbjct: 186 NVETEIEILKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATC 241

Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTE 182
           +   +Q+   + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +  
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300

Query: 183 YIATRWYRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVN- 238
              T  Y APE+L  +    Y   VD WSLG IL   L   P F    T   L   I + 
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360

Query: 239 -LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                           +    E+A+DL+ ++LV++P  R  T++ L H
Sbjct: 361 KYNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  187 bits (478), Expect = 1e-56
 Identities = 82/319 (25%), Positives = 147/319 (46%), Gaps = 28/319 (8%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           M S++ ++S D++  +   +    + + + +G G YG VYK       Q  AIK +    
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIY----KAVNNKDLYVVFEYME----NDLN 112
             + + ++   EI  LK +  H NI T    +        +  L++V E+       DL 
Sbjct: 62  DEEEEIKQ---EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118

Query: 113 KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
           K  +   LK+  I YI  ++  GLS++H  KV+HRD+K  N+L+ ++  +K+ D G++  
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 173 LSDSKECLTEYIATRWYRAPEILISNRR----YTHHVDIWSLGCILAEMLQSKPLFPGAS 228
           L  +      +I T ++ APE++  +      Y    D+WSLG    EM +  P      
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---C 235

Query: 229 TSHQLQLIVNLVRPNPP--HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN 286
             H ++ +  + R   P   + K+   F+         +   LV N S+RP T+Q+++H 
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQ-------SFIESCLVKNHSQRPATEQLMKHP 288

Query: 287 YVSKYFPSATHVIPQVTPH 305
           ++    P+   V  Q+  H
Sbjct: 289 FIRDQ-PNERQVRIQLKDH 306

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  185 bits (472), Expect = 3e-56
 Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 19/269 (7%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
             IG+G++  VYK  D      VA  ++ +    K++ QR   E   LK  Q HPNI+  
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRF 90

Query: 89  LDIYKAVNNKD--LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK- 143
            D +++       + +V E M +  L   ++  K++K   +R    Q+  GL ++H    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 144 -VMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            ++HRDLK  NI I   + S+KIGDLGLA     S       I T  + APE+     +Y
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMY--EEKY 206

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA 261
              VD+++ G  + EM  S+  +     + Q+   V       P +       K    E 
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASFD-----KVAIPEV 259

Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSK 290
            +++   +  N  ER     +L H +  +
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  185 bits (471), Expect = 1e-55
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 29/282 (10%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREI 73
            +  EY + K +G GA G V  A+++   + VAIK I        + R    A     EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQ 131
             LK    HP II + + + A   +D Y+V E ME  +L +KV+ +K LK+   +   +Q
Sbjct: 67  EILKKL-NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +   + Y+H   ++HRDLKP N+L+   ++ C IKI D G ++ L ++   +     T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPT 181

Query: 189 YRAPEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVN--LVRPN 243
           Y APE+L  +    Y   VD WSLG IL   L   P F    T   L   I +       
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                     +    E+A+DL+ ++LV++P  R  T++ L H
Sbjct: 242 EV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  184 bits (469), Expect = 1e-55
 Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 35/299 (11%)

Query: 7   SKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-------FEA 59
           ++       +        Y   + +G+G   +V +   K   +  A+K I       F A
Sbjct: 1   TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK 118
              +   + T +E+  L+    HPNII + D Y+   N   ++VF+ M+  +L     D 
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGEL----FDY 114

Query: 119 ILKDVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
           + + V +     R IM  L   +  +H   ++HRDLKP NIL+D   +IK+ D G +  L
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 174 SDSKECLTEYIATRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
               E L E   T  Y APEI+      ++  Y   VD+WS G I+  +L   P F    
Sbjct: 175 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

Query: 229 TSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
               L++I+  N    +P         + +  +   DL+++ LV+ P +R   ++ L H
Sbjct: 234 QMLMLRMIMSGNYQFGSPE--------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  184 bits (468), Expect = 2e-55
 Identities = 75/267 (28%), Positives = 137/267 (51%), Gaps = 14/267 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++   ++PN
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMREN-KNPN 78

Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           I+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L ++H+ +
Sbjct: 79  IVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++ + Y  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGP 195

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
            VDIWSLG +  EM++ +P +   +    L LI     P   + +K  A F+       D
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-------D 248

Query: 264 LLNQILVLNPSERPETDQILEHNYVSK 290
            LN+ L ++  +R    ++L+H ++  
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLKI 275

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  187 bits (477), Expect = 2e-55
 Identities = 69/305 (22%), Positives = 127/305 (41%), Gaps = 43/305 (14%)

Query: 12  KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 71
               N + ++       K +G G+ G V        +  VA+K++               
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRM-----LIDFCDIALM 57

Query: 72  EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--------ILKDV 123
           EI  L     HPN+I          ++ LY+  E    +L  ++  K        + K+ 
Sbjct: 58  EIKLLTESDDHPNVIRYYCSET--TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-------------KSCSIKIGDLGLA 170
           +   ++ Q+ +G++++H+ K++HRDLKP NIL+              ++  I I D GL 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 171 RSLSDSKECLTEYIATR----WYRAPEIL------ISNRRYTHHVDIWSLGCILAEMLQS 220
           + L   +      +        +RAPE+L       + RR T  +DI+S+GC+   +L  
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 221 KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD 280
                G   S +     N++R      +      ++   EA DL++Q++  +P +RP   
Sbjct: 236 GKHPFGDKYSRE----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291

Query: 281 QILEH 285
           ++L H
Sbjct: 292 KVLRH 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  186 bits (474), Expect = 3e-55
 Identities = 56/302 (18%), Positives = 102/302 (33%), Gaps = 38/302 (12%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                 + +   +G+GA   V++   K      AIK +F             RE   LK 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKK 63

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLC 133
              H NI+ +  I +    +   ++ E+     L  V+ +      L +     ++  + 
Sbjct: 64  L-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 134 NGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            G++++    ++HR++KP NI+     D     K+ D G AR L D  E       T  Y
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEY 181

Query: 190 RAPEIL-------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVR 241
             P++           ++Y   VD+WS+G            F       +  +++  ++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 242 PNPPHADKFYAGFKNKP------------------EEAVDLLNQILVLNPSERPETDQIL 283
             P  A       +N P                       +L  IL  +  +    DQ  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 284 EH 285
             
Sbjct: 302 AE 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  181 bits (462), Expect = 9e-55
 Identities = 77/280 (27%), Positives = 134/280 (47%), Gaps = 29/280 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSF 79
           L ++ I + +GKG +G VY A +K +K  +A+K +F  +  +   + Q   RE+      
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHL 66

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLS 137
            RHPNI+ +   +   +   +Y++ EY     + + ++      +      + +L N LS
Sbjct: 67  -RHPNILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPE 193
           Y H+ +V+HRD+KP N+L+  +  +KI D G +     S+    C T +Y+       PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           + I  R +   VD+WSLG +  E L  KP F   +     + I  +    P         
Sbjct: 178 M-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV------ 230

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                E A DL++++L  NPS+RP   ++LEH +++    
Sbjct: 231 ----TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  182 bits (464), Expect = 1e-54
 Identities = 68/267 (25%), Positives = 135/267 (50%), Gaps = 14/267 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
              + +IG+G+ GIV  A +K++ + VA+K +    R +   +  + E++ ++ +Q H N
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQ-HFN 103

Query: 85  IITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK 143
           ++ M   Y  +  ++L+V+ E+++   L  ++    L +  I  +   +   L+Y+HA  
Sbjct: 104 VVEMYKSY--LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           V+HRD+K  +IL+     +K+ D G    +S         + T ++ APE+ IS   Y  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-ISRSLYAT 220

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVD 263
            VDIWSLG ++ EM+  +P +   S    ++ + +   P   ++ K     +       D
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR-------D 273

Query: 264 LLNQILVLNPSERPETDQILEHNYVSK 290
            L ++LV +P ER    ++L+H ++ +
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQ 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (461), Expect = 4e-54
 Identities = 54/270 (20%), Positives = 96/270 (35%), Gaps = 28/270 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
            T   R+G+G++G V++  DK      A+KK+  E FR          E++        P
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGL-SSP 110

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
            I+ +    +      + +  E +E   L ++I+    L +    Y + Q   GL Y+H 
Sbjct: 111 RIVPLYGAVR--EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 142 CKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIA-----TRWYRAPEIL 195
            +++H D+K  N+L+        + D G A  L       +         T  + APE+ 
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV- 227

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
           +  +     VDIWS  C++  ML     +           I +   P             
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC----- 282

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    + + L   P  R    ++   
Sbjct: 283 --APLTAQAIQEGLRKEPVHRASAMELRRK 310

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  181 bits (461), Expect = 4e-54
 Identities = 69/339 (20%), Positives = 123/339 (36%), Gaps = 82/339 (24%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--------------------------- 54
           L ++   + +G+G +G+V++A +K +    AIK                           
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 55  ---KIFEAFRNKTDAQRTYREILFLKSFQRHPNII-----------------------TM 88
              + F A+      +            +     +                       T+
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 89  LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV----HIRYIMFQLCNGLSYIHACK 143
             +  +     LY+  +     +L   +  +   +        +I  Q+   + ++H+  
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC------------LTEYIATRWYRA 191
           +MHRDLKPSNI       +K+GD GL  ++   +E              T  + T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY 251
           PE +     Y+H VDI+SLG IL E+L         ST  +   I+  VR       KF 
Sbjct: 245 PEQI-HGNNYSHKVDIFSLGLILFELLY------SFSTQMERVRIITDVRNL-----KFP 292

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
             F  K  +   ++  +L  +P+ERPE   I+E+     
Sbjct: 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  185 bits (471), Expect = 6e-54
 Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 29/301 (9%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G++   Y   K++G GAYG V    DK      AIK I +   + +   +   E+  LK 
Sbjct: 33  GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-----IRYIMFQL 132
              HPNI+ + D ++  + ++ Y+V E  +  +L     D+I+  +         I+ Q+
Sbjct: 93  LD-HPNIMKLYDFFE--DKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQV 145

Query: 133 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            +G++Y+H   ++HRDLKP N+L+   +K   IKI D GL+    + K+ + E + T +Y
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYY 204

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPHA 247
            APE+L   ++Y    D+WS+G IL  +L   P F G +    L+ +        +P   
Sbjct: 205 IAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-- 260

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
                 +KN  E A DL+ Q+L  +   R    Q LEH ++ +        I   +    
Sbjct: 261 ------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

Query: 308 V 308
           +
Sbjct: 315 I 315

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  184 bits (469), Expect = 1e-53
 Identities = 87/302 (28%), Positives = 140/302 (46%), Gaps = 29/302 (9%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
            G     Y I   +GKG++G V K  D+  +Q  A+K I +A     D     RE+  LK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-----IRYIMFQ 131
               HPNI+ + +I +  ++   Y+V E     +L     D+I+K           I+ Q
Sbjct: 77  KLD-HPNIMKLFEILE--DSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQ 129

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           + +G++Y+H   ++HRDLKP NIL+   +K C IKI D GL+     +   + + I T +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAY 188

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPH 246
           Y APE+L     Y    D+WS G IL  +L   P F G +    L+ +         P  
Sbjct: 189 YIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ- 245

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHT 306
                  ++   ++A DL+ ++L  +PS R    Q LEH ++ KY      +    +  +
Sbjct: 246 -------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLES 298

Query: 307 VV 308
            +
Sbjct: 299 AM 300

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  178 bits (454), Expect = 2e-53
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 29/300 (9%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
            +    S  +      G     Y I   +GKG++G V K  D+  +Q  A+K I +A   
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILK 121
             D     RE+  LK    HPNI+ + +I +  ++   Y+V E     +L     D+I+K
Sbjct: 62  NKDTSTILREVELLKKLD-HPNIMKLFEILE--DSSSFYIVGELYTGGEL----FDEIIK 114

Query: 122 DVH-----IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSL 173
                      I+ Q+ +G++Y+H   ++HRDLKP NIL+   +K C IKI D GL+   
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
             +   + + I T +Y APE+L     Y    D+WS G IL  +L   P F G +    L
Sbjct: 175 QQN-TKMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

Query: 234 QLIV--NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           + +         P         ++   ++A DL+ ++L  +PS R    Q LEH ++ KY
Sbjct: 232 KRVETGKYAFDLPQ--------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  178 bits (453), Expect = 2e-53
 Identities = 80/278 (28%), Positives = 126/278 (45%), Gaps = 25/278 (8%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
            G I   +   +++G GA+G V+   ++++     IK I +  R++   ++   EI  LK
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLK 75

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH-----IRYIMFQ 131
           S   HPNII + ++++  +  ++Y+V E  E  +L + I     +        +  +M Q
Sbjct: 76  SLD-HPNIIKIFEVFE--DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           + N L+Y H+  V+H+DLKP NIL         IKI D GLA      +   T    T  
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTAL 191

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           Y APE+    R  T   DIWS G ++  +L     F G S     Q             +
Sbjct: 192 YMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--------KE 241

Query: 249 -KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             +    +    +AVDLL Q+L  +P  RP   Q+L H
Sbjct: 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  180 bits (457), Expect = 2e-53
 Identities = 76/343 (22%), Positives = 136/343 (39%), Gaps = 65/343 (18%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF---EA 59
            +++ +     Q      +  +Y +   IG+G+YG+V  A +   +   AIK +      
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME----------- 108
             N  D +R   E+  +K    HPNI  + ++Y+  + + + +V E              
Sbjct: 66  QINPKDVERIKTEVRLMKKLH-HPNIARLYEVYE--DEQYICLVMELCHGGHLLDKLNVF 122

Query: 109 -------------------------------NDLNKVIRDKILKDVHIRYIMFQLCNGLS 137
                                              +   D + ++  I  IM Q+ + L 
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 138 YIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRA 191
           Y+H   + HRD+KP N L   +KS  IK+ D GL++            + T+    ++ A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 192 PEIL-ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHAD 248
           PE+L  +N  Y    D WS G +L  +L     FPG + +  +  ++   L   NP    
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN--- 299

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
                +      A DLL+ +L  N  ER +  + L+H ++S++
Sbjct: 300 -----YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  179 bits (455), Expect = 2e-53
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 19/290 (6%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + +      +G G  G V+K   +     +A+K++     NK + +R   ++  +     
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHD 82

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            P I+     +  + N D+++  E M    +  K      + +  +  +   +   L Y+
Sbjct: 83  CPYIVQCFGTF--ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 140 HAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL--- 195
                V+HRD+KPSNIL+D+   IK+ D G++  L D K           Y APE +   
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPP 199

Query: 196 -ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHADKFYAG 253
             +   Y    D+WSLG  L E+   +  +    T    L  ++    P  P    F   
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF--- 256

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
                 +    +   L  +  +RP+ +++LEH+++ +Y      V     
Sbjct: 257 ----SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  183 bits (466), Expect = 3e-53
 Identities = 89/306 (29%), Positives = 141/306 (46%), Gaps = 31/306 (10%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EA 59
           M  +  +  G  VQH+        Y   + +GKG++G V    DK   Q  A+K I    
Sbjct: 5   MMDHLHATPGMFVQHS-TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK 118
            + KTD +   RE+  LK    HPNI+ + + ++  +    Y+V E     +L     D+
Sbjct: 64  VKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFE--DKGYFYLVGEVYTGGEL----FDE 116

Query: 119 ILKDVH-----IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLA 170
           I+            I+ Q+ +G++Y+H  K++HRDLKP N+L+    K  +I+I D GL+
Sbjct: 117 IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
                SK+ + + I T +Y APE+L  +  Y    D+WS G IL  +L   P F GA+  
Sbjct: 177 THFEASKK-MKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 233

Query: 231 HQLQLIVN--LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
             L+ +         P         +K   E A DL+ ++L   PS R      L+H ++
Sbjct: 234 DILKKVEKGKYTFELPQ--------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

Query: 289 SKYFPS 294
             Y   
Sbjct: 286 QTYTKE 291

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  177 bits (452), Expect = 3e-53
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 24/298 (8%)

Query: 3   SNTTSKSGDKVQHNVDGN-ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR 61
           S  +++ GD     ++ +    E      +GKG YGIVY   D +N+  +AIK+I    R
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PER 58

Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRDK-- 118
           +   +Q  + EI   K   +H NI+  L  +    N  + +  E +    L+ ++R K  
Sbjct: 59  DSRYSQPLHEEIALHKHL-KHKNIVQYLGSFS--ENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 119 --ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSD 175
                +  I +   Q+  GL Y+H  +++HRD+K  N+LI+  S  +KI D G ++ L+ 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 176 SKECLTEYIATRWYRAPE-ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ 234
              C   +  T  Y APE I    R Y    DIWSLGC + EM   KP  P         
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQA 233

Query: 235 LI--VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            +  V + + +P   +           EA   + +    +P +R   + +L   ++  
Sbjct: 234 AMFKVGMFKVHPEIPESM-------SAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  178 bits (454), Expect = 8e-53
 Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 42/292 (14%)

Query: 12  KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR 71
           +  H         Y + + IG G+Y +  +   K      A+K I    ++K D      
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTE--- 64

Query: 72  EILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI----- 125
           EI  L  + +HPNIIT+ D+Y   + K +YVV E M+  +L     DKIL+         
Sbjct: 65  EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL----LDKILRQKFFSEREA 118

Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLT 181
             ++F +   + Y+HA  V+HRDLKPSNIL         SI+I D G A+ L      L 
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
               T  + APE+L   + Y    DIWSLG +L  ML     F         ++      
Sbjct: 179 TPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI------ 231

Query: 242 PNPPHADKFYAG---FKNKP-----EEAVDLLNQILVLNPSERPETDQILEH 285
                  +  +G             + A DL++++L ++P +R     +L H
Sbjct: 232 -----LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  177 bits (450), Expect = 9e-53
 Identities = 72/304 (23%), Positives = 143/304 (47%), Gaps = 18/304 (5%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           M  +        +Q N+  +    +T  ++IGKG++G V+K  D   ++ VAIK I +  
Sbjct: 1   MAHSPVQSGLPGMQ-NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLE 58

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
             + + +   +EI  L      P +      Y  + +  L+++ EY+       ++    
Sbjct: 59  EAEDEIEDIQQEITVLSQC-DSPYVTKYYGSY--LKDTKLWIIMEYLGGGSALDLLEPGP 115

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 179
           L +  I  I+ ++  GL Y+H+ K +HRD+K +N+L+ +   +K+ D G+A  L+D++  
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175

Query: 180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 239
              ++ T ++ APE+ I    Y    DIWSLG    E+ + +P     S  H ++++  +
Sbjct: 176 RNTFVGTPFWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLI 231

Query: 240 VRPNPPH-ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
            + NPP     +    K       + +   L   PS RP   ++L+H ++ +     +++
Sbjct: 232 PKNNPPTLEGNYSKPLK-------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284

Query: 299 IPQV 302
              +
Sbjct: 285 TELI 288

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  178 bits (453), Expect = 1e-52
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 40/307 (13%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---- 56
           +   +     +            +Y     IG+G   +V +   +      A+K +    
Sbjct: 72  LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 57  --FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNK 113
                 + +   + T RE   L+    HP+IIT++D Y+  ++  +++VF+ M   +L  
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--SSSFMFLVFDLMRKGEL-- 187

Query: 114 VIRDKILKDVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG 168
              D + + V +     R IM  L   +S++HA  ++HRDLKP NIL+D +  I++ D G
Sbjct: 188 --FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245

Query: 169 LARSLSDSKECLTEYIATRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEMLQSKPL 223
            +  L    E L E   T  Y APEIL      ++  Y   VD+W+ G IL  +L   P 
Sbjct: 246 FSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

Query: 224 FPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP-----EEAVDLLNQILVLNPSERPE 278
           F        L++I+           ++   F +           DL++++L ++P  R  
Sbjct: 305 FWHRRQILMLRMIM---------EGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353

Query: 279 TDQILEH 285
            +Q L+H
Sbjct: 354 AEQALQH 360

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  185 bits (470), Expect = 1e-52
 Identities = 76/340 (22%), Positives = 128/340 (37%), Gaps = 34/340 (10%)

Query: 10  GDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT 69
           G     ++       + + +R+G G +G V +   ++  + VAIK       +  + +R 
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERW 59

Query: 70  YREILFLKSFQRHPNIITMLDIY----KAVNNKDLYVVFEYMEN-DLNKVI----RDKIL 120
             EI  +K    HPN+++  ++     K   N    +  EY E  DL K +        L
Sbjct: 60  CLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSK 177
           K+  IR ++  + + L Y+H  +++HRDLKP NI++         KI DLG A+ L    
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG- 177

Query: 178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV 237
           E  TE++ T  Y APE+ +  ++YT  VD WS G +  E +     F       Q    V
Sbjct: 178 ELCTEFVGTLQYLAPEL-LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 238 NLVRPNPPHADKFYAGFKNKP--------------EEAVDLLNQILVLNPSERPETDQIL 283
                          G                    +    L  +L+ +  +R    Q  
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296

Query: 284 EHN----YVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEI 319
                    S        V+  V+       + +N  L+ 
Sbjct: 297 NVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQN 336

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  174 bits (444), Expect = 5e-52
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 28/296 (9%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                 Y + + +GKGA+ +V +   K      A K I     +  D Q+  RE    + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 132
            Q HPNI+ + D  +       Y+VF+ +   +L     + I+           + + Q+
Sbjct: 62  LQ-HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQI 114

Query: 133 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
              ++Y H+  ++HR+LKP N+L+    K  ++K+ D GLA  ++DS E    +  T  Y
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGY 173

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR--PNPPHA 247
            +PE+L     Y+  VDIW+ G IL  +L   P F           I       P+P   
Sbjct: 174 LSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-- 230

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
                 +     EA  L++ +L +NP +R   DQ L+  ++      A+ +  Q T
Sbjct: 231 ------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  180 bits (458), Expect = 6e-52
 Identities = 83/314 (26%), Positives = 139/314 (44%), Gaps = 42/314 (13%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-----------FEAFRNKTDAQ 67
           G I   Y   +++G GAYG V    +KN     AIK I            +    +   +
Sbjct: 32  GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 68  RTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVH-- 124
             Y EI  LKS   HPNII + D+++  + K  Y+V E+ E  +L     ++I+      
Sbjct: 92  EIYNEISLLKSLD-HPNIIKLFDVFE--DKKYFYLVTEFYEGGEL----FEQIINRHKFD 144

Query: 125 ---IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKE 178
                 IM Q+ +G+ Y+H   ++HRD+KP NIL+   +   +IKI D GL+   S   +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
            L + + T +Y APE+L   ++Y    D+WS G I+  +L   P F G +    ++ +  
Sbjct: 205 -LRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261

Query: 239 --LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
                            +KN  +EA +L+  +L  + ++R   ++ L   ++ KY  +  
Sbjct: 262 GKYYFDFND--------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY--ANN 311

Query: 297 HVIPQVTPHTVVLD 310
                       L 
Sbjct: 312 INKSDQKTLCGALS 325

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  174 bits (443), Expect = 7e-52
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 24/288 (8%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
             +      +G+GAYG+V K     + Q +A+K+I  A  N  + +R   ++        
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVD 64

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGL 136
            P  +T           D+++  E M+  L+K  +      + + +  +  I   +   L
Sbjct: 65  CPFTVTFYGAL--FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 137 SYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
            ++H+   V+HRD+KPSN+LI+    +K+ D G++  L D           + Y APE +
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAPERI 181

Query: 196 ISNRR---YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKF 250
                   Y+   DIWSLG  + E+   +  FP  S     Q +  +V    P   ADKF
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKF 239

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
                    E VD  +Q L  N  ERP   ++++H + + +    T V
Sbjct: 240 -------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  175 bits (445), Expect = 9e-52
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 39/305 (12%)

Query: 18  DGNILAEYTIH---KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           D      Y +    K +G+G++ I  K   K + Q  A+K I     +K     T +EI 
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEIT 57

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYI 128
            LK  + HPNI+ + +++   +    ++V E +   +L     ++I K  H       YI
Sbjct: 58  ALKLCEGHPNIVKLHEVFH--DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYI 111

Query: 129 MFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIA 185
           M +L + +S++H   V+HRDLKP N+L    + +  IKI D G AR      + L     
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP 245
           T  Y APE+L +   Y    D+WSLG IL  ML  +  F     S      V +      
Sbjct: 172 TLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI------ 224

Query: 246 HADKFYAG---FKNKP-----EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATH 297
              K   G   F+ +      +EA DL+  +L ++P++R +   +  + ++      +++
Sbjct: 225 -MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283

Query: 298 VIPQV 302
            +   
Sbjct: 284 PLMTP 288

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  173 bits (441), Expect = 1e-51
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 29/280 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSF 79
           + ++ I + +GKG +G VY A +K NK  +A+K +F  +  +   + Q   REI      
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHL 71

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLS 137
            RHPNI+ M + +   + K +Y++ E+    +L  ++ +     +      M +L + L 
Sbjct: 72  -RHPNILRMYNYFH--DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPE 193
           Y H  KV+HRD+KP N+L+     +KI D G +      +    C T +Y+       PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           + I  + +   VD+W  G +  E L   P F   S +   + IVN+    PP        
Sbjct: 183 M-IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL------ 235

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                + + DL++++L  +P +R     ++EH +V     
Sbjct: 236 ----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  176 bits (448), Expect = 2e-51
 Identities = 44/323 (13%), Positives = 94/323 (29%), Gaps = 52/323 (16%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-QRTYREILFLKSF-------- 79
             +G+       +A D+   +   +   +   R  ++A ++   E+L L+          
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 80  -QRHPNIITMLDIYKAVNNKDL---------------YVVFEYMENDLNKVIR------- 116
            + H   I   D+ K    K +               + ++  M+++L            
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 117 -DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD 175
             K L       +  Q+   L+ +H   ++H  L+P +I++D+   + +           
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 176 SKECL-TEYIATRWYRAPEILISNR----RYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
           S         A     A  +L   +      T   D W+LG  +  +  +       +  
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
              + I    +              N P+    LL   L     +R    Q +E     +
Sbjct: 324 GGSEWIFRSCK--------------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

Query: 291 YFPSATHVIPQVTPHTVVLDIDD 313
                +  +P             
Sbjct: 370 LRTELSAALPLYQTDGEPTREGG 392

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  172 bits (438), Expect = 3e-51
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 31/287 (10%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+I   YT+   IG+G++G V  A  K  +   A KKI        D  R  +EI  +KS
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMKS 62

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 132
              HPNII + + ++  +N D+Y+V E     +L     ++++            IM  +
Sbjct: 63  LD-HPNIIRLYETFE--DNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDV 115

Query: 133 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            + ++Y H   V HRDLKP N L         +K+ D GLA      K  +   + T +Y
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKVGTPYY 174

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPHA 247
            +P++L     Y    D WS G ++  +L   P F   + S  +  I       P     
Sbjct: 175 VSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-- 230

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                 + N   +A  L+ ++L  +P +R  + Q LEH +  K   S
Sbjct: 231 ------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  174 bits (443), Expect = 5e-51
 Identities = 80/314 (25%), Positives = 133/314 (42%), Gaps = 28/314 (8%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           MT       G +   N        Y + + +GKGA+ +V +   K      A K I    
Sbjct: 7   MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI 119
            +  D Q+  RE    +  Q HPNI+ + D  +       Y+VF+ +   +L     + I
Sbjct: 67  LSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL----FEDI 119

Query: 120 LKDVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLAR 171
           +           + + Q+   ++Y H+  ++HR+LKP N+L+    K  ++K+ D GLA 
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

Query: 172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH 231
            ++DS E    +  T  Y +PE+L     Y+  VDIW+ G IL  +L   P F       
Sbjct: 180 EVNDS-EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237

Query: 232 QLQLIVNLVR--PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
               I       P+P         +     EA  L++ +L +NP +R   DQ L+  ++ 
Sbjct: 238 LYAQIKAGAYDYPSPE--------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289

Query: 290 KYFPSATHVIPQVT 303
                A+ +  Q T
Sbjct: 290 NRERVASAIHRQDT 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  173 bits (440), Expect = 5e-51
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 20/293 (6%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
             +      IG+GAYG V K   K + Q +A+K+I  +  ++ + ++   ++  +     
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD------KILKDVHIRYIMFQLCNG 135
            P I+            D ++  E M    +K  +        ++ +  +  I       
Sbjct: 80  CPYIVQFYGAL--FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 136 LSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+++    K++HRD+KPSNIL+D+S +IK+ D G++  L DS    T     R Y APE 
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPER 196

Query: 195 LISNRR---YTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPPHADKF 250
           +  +     Y    D+WSLG  L E+   +  +P  ++   QL  +V      P  ++  
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSE 254

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
              F       ++ +N  L  + S+RP+  ++L+H ++  Y   A  V   V 
Sbjct: 255 EREF---SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVC 304

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  172 bits (439), Expect = 5e-51
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 28/274 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + +++G+G+YG VYKA  K   Q VAIK++      ++D Q   +EI  ++     P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQC-DSPH 85

Query: 85  IITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           ++     Y    N DL++V EY      +D+ ++ R+K L +  I  I+     GL Y+H
Sbjct: 86  VVKYYGSY--FKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLH 142

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
             + +HRD+K  NIL++     K+ D G+A  L+D+       I T ++ APE+ I    
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV-IQEIG 201

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----HADKFYAGFKN 256
           Y    DIWSLG    EM + KP +        + +I      NPP      + +   F  
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT----NPPPTFRKPELWSDNFT- 256

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                 D + Q LV +P +R    Q+L+H +V  
Sbjct: 257 ------DFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  175 bits (446), Expect = 7e-51
 Identities = 86/339 (25%), Positives = 141/339 (41%), Gaps = 75/339 (22%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFL 76
            + +A  Y + K IGKG++G V KAYD    Q+VA+K +    RN+    R    EI  L
Sbjct: 92  HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRIL 147

Query: 77  KSFQRHP-----NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIR 126
           +  ++       N+I ML+   ++      + + FE +  +L ++I+    +      +R
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFR----NHICMTFELLSMNLYELIKKNKFQGFSLPLVR 203

Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYI 184
                +   L  +H  +++H DLKP NIL+       IK+ D G +       + +  YI
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYI 260

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
            +R+YRAPE+++   RY   +D+WSLGCILAE+L   PL PG     QL  ++ L+    
Sbjct: 261 QSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319

Query: 245 PH-------ADKFYAG--------FKNKPEEA---------------------------- 261
                    A  F +              + +                            
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379

Query: 262 ------VDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                 +D L Q L  +P+ R    Q L H ++ +  P 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  172 bits (439), Expect = 8e-51
 Identities = 73/322 (22%), Positives = 136/322 (42%), Gaps = 51/322 (15%)

Query: 19  GNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
             +  +Y + K+ +G G  G V + + +   Q  A+K +        D+ +  +E+    
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHW 76

Query: 78  SFQRHPNIITMLDIY--KAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY------- 127
                P+I+ +LD+Y       + L ++ E ME  +L      +I +     +       
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAE 132

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYI 184
           IM  +   + ++H+  + HRD+KP N+L    +K   +K+ D G A+  + +   L    
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC 190

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
            T +Y APE+L    +Y    D+WSLG I+  +L   P F   +       +   +R   
Sbjct: 191 YTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--- 246

Query: 245 PHADKFYAG---FKNKP-----EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
                   G   F N       E+A  L+  +L  +P+ER    Q + H ++++      
Sbjct: 247 -------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS----- 294

Query: 297 HVIPQVTPHTVVLDIDDNNQLE 318
            V+PQ   HT  +  +D +  +
Sbjct: 295 MVVPQTPLHTARVLQEDKDHWD 316

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  172 bits (438), Expect = 9e-51
 Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 38/315 (12%)

Query: 18  DGNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
            G     Y + +  +G+GA+  V    +    Q  A+K I    +      R +RE+  L
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEML 64

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMF 130
              Q H N++ +++ ++       Y+VFE M    +       I K  H        ++ 
Sbjct: 65  YQCQGHRNVLELIEFFE--EEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQ 118

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKEC-------L 180
            + + L ++H   + HRDLKP NIL    ++   +KI D  L   +  + +C       L
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 181 TEYIATRWYRAPEIL----ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 236
                +  Y APE++         Y    D+WSLG IL  +L   P F G   S      
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

Query: 237 VNLVRPNPPH-ADKFYAG---FKNKP-----EEAVDLLNQILVLNPSERPETDQILEHNY 287
                       +    G   F +K        A DL++++LV +  +R    Q+L+H +
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298

Query: 288 VSKYFPSATHVIPQV 302
           V    P  T   P V
Sbjct: 299 VQGCAPENTLPTPMV 313

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  174 bits (441), Expect = 9e-51
 Identities = 39/321 (12%), Positives = 91/321 (28%), Gaps = 61/321 (19%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK-----------------------KIFEAF 60
                  +G+       +A D+   +   +                        ++    
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 61  RNKTDAQRTYREILFLKSFQR--HPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI--- 115
           +N+  A+   R I      +      +I +    + +     + ++  M+++L       
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 116 -----RDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 170
                  K L       +  Q+   L+ +H   ++H  L+P +I++D+   + +      
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 171 RSLSDSKECLTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEMLQS 220
                          +R +  PE+                 T   D W+LG ++  +  +
Sbjct: 254 VRDGARVVSSV----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 221 KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD 280
                  +     + I              +   KN P+    LL   L     +R    
Sbjct: 310 DLPITKDAALGGSEWI--------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 281 QILEHNYVSKYFPSATHVIPQ 301
           Q +E     +     +  +P 
Sbjct: 356 QAMETPEYEQLRTELSAALPL 376

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  172 bits (437), Expect = 1e-50
 Identities = 86/337 (25%), Positives = 151/337 (44%), Gaps = 27/337 (8%)

Query: 4   NTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK 63
           N+ +   D+  H      +  Y + K IGKG +  V  A      + VAIK I +   N 
Sbjct: 2   NSIASCADEQPH------IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP 55

Query: 64  TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILK 121
           T  Q+ +RE+  +K    HPNI+ + ++ +    K LY++ EY    ++ + ++    +K
Sbjct: 56  TSLQKLFREVRIMKIL-NHPNIVKLFEVIE--TEKTLYLIMEYASGGEVFDYLVAHGRMK 112

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 181
           +   R    Q+ + + Y H  +++HRDLK  N+L+D   +IKI D G +   +     L 
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLD 171

Query: 182 EYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV 240
            +     Y APE L   ++Y    VD+WSLG IL  ++     F G +     + ++   
Sbjct: 172 AFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
              P +             +  +LL + LVLNP +R   +QI++  +++        + P
Sbjct: 231 YRIPFYM----------STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED-ELKP 279

Query: 301 QVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKK 337
            V P   + D    + +    Y  +  +I +S  K K
Sbjct: 280 FVEPELDISDQKRIDIMVGMGYSQE--EIQESLSKMK 314

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  170 bits (434), Expect = 2e-50
 Identities = 74/277 (26%), Positives = 135/277 (48%), Gaps = 27/277 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L +   HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCD-HPY 77

Query: 85  IITMLDIYKAVNNKDLYVVFEYME----NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I+ +L  Y   ++  L+++ E+      + +     D+ L +  I+ +  Q+   L+++H
Sbjct: 78  IVKLLGAY--YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           + +++HRDLK  N+L+     I++ D G++     + +    +I T ++ APE+++    
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 201 ----YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---HADKFYAG 253
               Y +  DIWSLG  L EM Q +P  P     + +++++ + + +PP      K+   
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEP--PHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVE 251

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
           F+       D L   L  NP  RP   Q+LEH +VS 
Sbjct: 252 FR-------DFLKIALDKNPETRPSAAQLLEHPFVSS 281

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  170 bits (433), Expect = 3e-50
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 36/300 (12%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI--------------------- 56
           D   L +YT+   IGKG+YG+V  AY++N+  Y A+K +                     
Sbjct: 8   DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTR 67

Query: 57  ---FEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN 112
                  + +   ++ Y+EI  LK    HPN++ ++++    N   LY+VFE +    + 
Sbjct: 68  PAPGGCIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM 126

Query: 113 KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
           +V   K L +   R+    L  G+ Y+H  K++HRD+KPSN+L+ +   IKI D G++  
Sbjct: 127 EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 173 LSDSKECLTEYIATRWYRAPEILISNRRYTH--HVDIWSLGCILAEMLQSKPLFPGASTS 230
              S   L+  + T  + APE L   R+      +D+W++G  L   +  +  F      
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                I +            +    +  E+  DL+ ++L  NP  R    +I  H +V++
Sbjct: 247 CLHSKIKS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  171 bits (436), Expect = 4e-50
 Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 41/289 (14%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA---FRNKTDAQRTYREIL 74
           D      Y + + IGKG + +V +  ++   Q  A+K +  A          +   RE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-------- 125
                + HP+I+ +L+ Y   ++  LY+VFE+M+  DL      +I+K            
Sbjct: 79  ICHMLK-HPHIVELLETYS--SDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAV 131

Query: 126 -RYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLT 181
             + M Q+   L Y H   ++HRD+KP  +L+   + S  +K+G  G+A  L +S     
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR 241
             + T  + APE++     Y   VD+W  G IL  +L     F G  T  +L   +   +
Sbjct: 192 GRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGK 248

Query: 242 PNPPHADKFYAGFKNKP-----EEAVDLLNQILVLNPSERPETDQILEH 285
                          +      E A DL+ ++L+L+P+ER    + L H
Sbjct: 249 YK----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  171 bits (434), Expect = 6e-50
 Identities = 74/274 (27%), Positives = 139/274 (50%), Gaps = 26/274 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++  + IG G++G VY A D  N + VAIKK+ +   ++    Q   +E+ FL+   RHP
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 114

Query: 84  NIITMLDIYKAVNNKDLYVVFEYME---NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           N I     Y  +     ++V EY     +DL +V   K L++V I  +      GL+Y+H
Sbjct: 115 NTIQYRGCY--LREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  ++HRD+K  NIL+ +   +K+GD G A  ++ +      ++ T ++ APE++++   
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPEVILAMDE 227

Query: 201 --YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--HADKFYAGFKN 256
             Y   VD+WSLG    E+ + KP  P  +  + +  + ++ +   P   +  +   F+ 
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKP--PLFNM-NAMSALYHIAQNESPALQSGHWSEYFR- 283

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                 + ++  L   P +RP ++ +L+H +V +
Sbjct: 284 ------NFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  169 bits (431), Expect = 6e-50
 Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 31/298 (10%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
            NI   +   + +G GA+  V+    +   +  A+K I               EI  LK 
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKK 62

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 132
            + H NI+T+ DIY+  +    Y+V + +   +L     D+IL+           ++ Q+
Sbjct: 63  IK-HENIVTLEDIYE--STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQV 115

Query: 133 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            + + Y+H   ++HRDLKP N+L    +++  I I D GL++   +    ++    T  Y
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGY 173

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LVRPNPPHA 247
            APE+L + + Y+  VD WS+G I   +L   P F   + S   + I        +P   
Sbjct: 174 VAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF-- 230

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
                 + +  E A D +  +L  +P+ER   ++ L H ++         + P V+  
Sbjct: 231 ------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQ 282

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  170 bits (432), Expect = 7e-50
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 25/298 (8%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREI 73
              +   Y I + +G G + IV K  +K+     A K I      A R     +   RE+
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQ 131
             L+    H N+IT+ D+Y+  N  D+ ++ E +   +L + + + + L +      + Q
Sbjct: 67  SILRQVL-HHNVITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
           + +G++Y+H  K+ H DLKP NI++         IK+ D GLA  + D  E       T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTP 182

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPP 245
            + APEI+ +        D+WS+G I   +L     F G +    L  I  V+       
Sbjct: 183 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
                   F +  E A D + ++LV    +R    + L H +++        V  +  
Sbjct: 242 --------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  172 bits (439), Expect = 1e-49
 Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 27/296 (9%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                EY + + +GKGA+ +V +       Q  A   I     +  D Q+  RE    + 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHI-----RYIMFQL 132
            + HPNI+ + D          Y++F+ +   +L     + I+   +       + + Q+
Sbjct: 67  LK-HPNIVRLHDSIS--EEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQI 119

Query: 133 CNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
              + + H   V+HR+LKP N+L+    K  ++K+ D GLA  +   ++    +  T  Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPPHA 247
            +PE+L     Y   VD+W+ G IL  +L   P F         Q I       P+P   
Sbjct: 180 LSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE-- 236

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
                 +     EA DL+N++L +NPS+R    + L+H ++S     A+ +  Q T
Sbjct: 237 ------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  170 bits (433), Expect = 1e-49
 Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 25/298 (8%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREI 73
              +   Y I + +G G + IV K  +K+     A K I      A R     +   RE+
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQ 131
             L+    HPNIIT+ D+Y+  N  D+ ++ E +   +L + + + + L +      + Q
Sbjct: 67  SILRQVL-HPNIITLHDVYE--NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
           + +G++Y+H  K+ H DLKP NI++         IK+ D GLA  + D  E       T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTP 182

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPP 245
            + APEI+ +        D+WS+G I   +L     F G +    L  I  V+       
Sbjct: 183 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT 303
                   F    E A D + ++LV    +R    + L H +++        V  +  
Sbjct: 242 --------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  171 bits (435), Expect = 1e-49
 Identities = 69/311 (22%), Positives = 126/311 (40%), Gaps = 44/311 (14%)

Query: 18  DGNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
              I+ +Y +  + +G G  G V + ++K  ++  A+K +        D  +  RE+   
Sbjct: 56  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELH 108

Query: 77  KSFQRHPNIITMLDIY--KAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY------ 127
               + P+I+ ++D+Y       K L +V E ++  +L      +I       +      
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS 164

Query: 128 -IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 183
            IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  +     LT  
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTP 223

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
             T +Y APE+L    +Y    D+WSLG I+  +L   P F           +   +R  
Sbjct: 224 CYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282

Query: 244 PPHADKFYAGFKNKP-----EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
                     F N       EE   L+  +L   P++R    + + H ++ +        
Sbjct: 283 QYE-------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS-----TK 330

Query: 299 IPQVTPHTVVL 309
           +PQ   HT  +
Sbjct: 331 VPQTPLHTSRV 341

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  168 bits (428), Expect = 1e-49
 Identities = 77/318 (24%), Positives = 136/318 (42%), Gaps = 38/318 (11%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
             E  + + +G+GA+G+V KA  K   + VAIK+I     ++++ +    E+  L     
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRV-N 59

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGL 136
           HPNI+ +           + +V EY E   L  V+            H      Q   G+
Sbjct: 60  HPNIVKLY----GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 137 SYIHACK---VMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           +Y+H+ +   ++HRDLKP N+L+      +KI D G A  +      +T    +  + AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAP 172

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLIVNLVRPNPPHADKF 250
           E+      Y+   D++S G IL E++  +  F          +  + N  RP        
Sbjct: 173 EV-FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI----- 226

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH-NYVSKYFPSATHVIPQVTPHTVVL 309
               KN P+    L+ +    +PS+RP  ++I++   ++ +YFP A    P   P    L
Sbjct: 227 ----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA--DEPLQYPCQHSL 280

Query: 310 DIDDNNQLEINDYQDKLY 327
              ++ ++E      + Y
Sbjct: 281 PPGEDGRVEPYVDFAEFY 298

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  166 bits (424), Expect = 4e-49
 Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 25/278 (8%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILF 75
            +   Y + + +G G + IV K   K   +  A K I      + R     +   RE+  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLC 133
           L+  + HPNIIT+ DI++  N  D+ ++ E +   +L + +   + L +      + Q+ 
Sbjct: 62  LREIR-HPNIITLHDIFE--NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 134 NGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
           +G+ Y+H+ ++ H DLKP NI++      +  IK+ D G+A  +    E       T  +
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEF 177

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPPHA 247
            APEI+ +        D+WS+G I   +L     F G +    L  I  VN         
Sbjct: 178 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY-- 234

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                 F N  E A D + ++LV +P  R    Q LEH
Sbjct: 235 ------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  169 bits (431), Expect = 4e-49
 Identities = 76/376 (20%), Positives = 142/376 (37%), Gaps = 44/376 (11%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
              +   K   +      G++   Y I + +G GA+G+V++  +K   +    K I    
Sbjct: 29  FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--NT 86

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI 119
               D      EI  +     HP +I + D ++  +  ++ ++ E++   +L     D+I
Sbjct: 87  PYPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEMVLILEFLSGGEL----FDRI 139

Query: 120 LKDVH------IRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLAR 171
             + +      +   M Q C GL ++H   ++H D+KP NI+    K+ S+KI D GLA 
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH 231
            L+  +  +    AT  + APEI+        + D+W++G +   +L     F G     
Sbjct: 200 KLNPDEI-VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257

Query: 232 QLQLI--VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS 289
            LQ +   +               F +   EA D +  +L   P +R      LEH    
Sbjct: 258 TLQNVKRCDWEFDEDA--------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH---- 305

Query: 290 KYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSCKKKKSVKRLSKGNALD 349
                     P +      L     +       Q            + ++ R++  ++L 
Sbjct: 306 ----------PWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 355

Query: 350 NTLRGHYKIKDAISSK 365
                 Y+I D+   +
Sbjct: 356 KHRPQEYQIYDSYFDR 371

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  167 bits (425), Expect = 5e-49
 Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 21/283 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           +Y + + IG GA  +V  AY    K+ VAIK+I  E  + +T      +EI  +     H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQC-HH 72

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYME----NDLNKVI------RDKILKDVHIRYIMFQL 132
           PNI++    +  V   +L++V + +      D+ K I      +  +L +  I  I+ ++
Sbjct: 73  PNIVSYYTSF--VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-----YIATR 187
             GL Y+H    +HRD+K  NIL+ +  S++I D G++  L+   +         ++ T 
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
            + APE++   R Y    DIWS G    E+      +        L L +    P+    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            +     K   +    +++  L  +P +RP   ++L H +  K
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  166 bits (423), Expect = 9e-49
 Identities = 75/316 (23%), Positives = 126/316 (39%), Gaps = 30/316 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA--FRNKTDAQRTYREILFLKSFQRH 82
           Y +   +G+G+YG V +  D       A+K + +    R         +EI  L+   RH
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH 65

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND----LNKVIRDKILKDVHIRYIMF-QLCNGLS 137
            N+I ++D+      + +Y+V EY        L+ V   +        Y  F QL +GL 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY--FCQLIDGLE 123

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATR----WYRAPE 193
           Y+H+  ++H+D+KP N+L+    ++KI  LG+A +L        +   T      ++ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPAFQPPE 181

Query: 194 ILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           I      ++   VDIWS G  L  +      F G +     + I       P        
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC----- 236

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDID 312
                     DLL  +L   P++R    QI +H++  K  P A   +P           D
Sbjct: 237 -----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD---TKD 288

Query: 313 DNNQLEINDYQDKLYD 328
               + +  Y + L+ 
Sbjct: 289 RWRSMTVVPYLEDLHG 304

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (424), Expect = 1e-48
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 25/280 (8%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREI 73
             N+   Y   + +G G + +V K  +K+     A K I     ++ R     +   RE+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 74  LFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQ 131
             LK  Q HPN+IT+ ++Y+  N  D+ ++ E +   +L + +   + L +      + Q
Sbjct: 66  SILKEIQ-HPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
           + NG+ Y+H+ ++ H DLKP NI++         IKI D GLA  +    E       T 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTP 181

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPP 245
            + APEI+ +        D+WS+G I   +L     F G +    L  +  VN    +  
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   F N    A D + ++LV +P +R      L+H
Sbjct: 241 --------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  167 bits (426), Expect = 1e-48
 Identities = 79/337 (23%), Positives = 138/337 (40%), Gaps = 69/337 (20%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLK------ 77
           Y + +++G G +  V+ A D  N  +VA+K +    R           EI  L+      
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDAD 76

Query: 78  -SFQRHP---NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYI 128
            + +      +I+ +LD   +K  N   + +VFE +  +L  +I+    + +  ++++ I
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 129 MFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCS------IKIGDLGLARSLSDSKECLT 181
             QL  GL Y+H  C ++H D+KP N+L++   S      IKI DLG A       E  T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYT 193

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------HQLQL 235
             I TR YR+PE+L+    +    DIWS  C++ E++    LF              +  
Sbjct: 194 NSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 236 IVNLVRPNPPH-------ADKFYAG---------FKNKP----------------EEAVD 263
           I+ L+   P +          F+            K  P                +E  D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 264 LLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP 300
            L+ +L L+P +R +   ++ H ++          +P
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 349

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  168 bits (427), Expect = 2e-48
 Identities = 67/335 (20%), Positives = 113/335 (33%), Gaps = 67/335 (20%)

Query: 25  YTIHKRIGKGA--YGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           Y +   IGKG      V  A  K   +YV +++I     +         E+   K F  H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NH 85

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           PNI+     +  + + +L+VV  +M      DL        + ++ I YI+  +   L Y
Sbjct: 86  PNIVPYRATF--IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-------KECLTEYIATRWYRA 191
           IH    +HR +K S+ILI     + +  L    S+           +     +    + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 192 PEILISNRR-YTHHVDIWSLGCILAEMLQSKP----------LF---------------- 224
           PE+L  N + Y    DI+S+G    E+               L                 
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 225 -----------------PGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ 267
                               S +       N   P+ P+   F   F          + Q
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH-------HFVEQ 316

Query: 268 ILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
            L  NP  RP    +L H++  +    A+  +P++
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPEL 351

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  166 bits (423), Expect = 2e-48
 Identities = 74/331 (22%), Positives = 125/331 (37%), Gaps = 46/331 (13%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--- 57
           + SN ++              + +Y I + + +G +  +     + + ++ A+KK     
Sbjct: 9   ILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSL 66

Query: 58  ------------EAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFE 105
                       +    K+       E+  +    ++   +T   I    N  ++Y+++E
Sbjct: 67  LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT--NYDEVYIIYE 123

Query: 106 YMEN-----------DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK-VMHRDLKPSN 153
           YMEN            L+K     I   V    I   + N  SYIH  K + HRD+KPSN
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII-KSVLNSFSYIHNEKNICHRDVKPSN 182

Query: 154 ILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY-THHVDIWSLGC 212
           IL+DK+  +K+ D G +  + D K  +     T  +  PE   +   Y    VDIWSLG 
Sbjct: 183 ILMDKNGRVKLSDFGESEYMVDKK--IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

Query: 213 ILAEMLQSKPLFPGASTSHQL-QLIVN---------LVRPNPPHADKFYAGFKNKPEEAV 262
            L  M  +   F    +  +L   I                P    K          E +
Sbjct: 241 CLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300

Query: 263 DLLNQILVLNPSERPETDQILEHNYVSKYFP 293
           D L   L  NP+ER  ++  L+H +++    
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHEWLADTNI 331

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  165 bits (420), Expect = 3e-48
 Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 33/305 (10%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILF 75
              AEY +   +GKG +G V+  +   ++  VAIK I       +   +D+     E+  
Sbjct: 28  AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87

Query: 76  LK---SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIRDKILKDVHIRYIM 129
           L    +   HP +I +LD ++    +   +V E      DL + +     L +   R   
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRW 188
            Q+   + + H+  V+HRD+K  NILID +    K+ D G    L D     T++  TR 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRV 203

Query: 189 YRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
           Y  PE  IS  +Y      +WSLG +L +M+     F       + Q I+      P H 
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHV 256

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV 307
                       +   L+ + L   PS RP  ++IL   ++            +  P  +
Sbjct: 257 ----------SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPL 306

Query: 308 VLDID 312
              + 
Sbjct: 307 AWSLL 311

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  164 bits (417), Expect = 4e-48
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 21/281 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHP 83
           Y +   +G G +G V     +     VA+K +  +  R+     +  REI  LK F RHP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHP 71

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           +II +  +       D ++V EY+   +L + + +   ++++  R +  Q+ + + Y H 
Sbjct: 72  HIIKLYQVIS--TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
             V+HRDLKP N+L+D   + KI D GL+ ++    E L     +  Y APE+ IS R Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEV-ISGRLY 187

Query: 202 T-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
               VDIWS G IL  +L     F         + I   V   P +              
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL----------NRS 237

Query: 261 AVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQ 301
              LL  +L ++P +R     I EH +  +  PS  ++ P+
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS--YLFPE 276

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  165 bits (419), Expect = 6e-48
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 30/297 (10%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR 61
           S+      + +      N    Y +  + +G+G + +V +   K+  Q  A K + +  R
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67

Query: 62  NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKIL 120
            +        EI  L+  +  P +I + ++Y+  N  ++ ++ EY    ++        L
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NTSEIILILEYAAGGEI----FSLCL 121

Query: 121 KDVHIRY-------IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLA 170
            ++           ++ Q+  G+ Y+H   ++H DLKP NIL+        IKI D G++
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181

Query: 171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
           R +  + E L E + T  Y APEIL +    T   D+W++G I   +L     F G    
Sbjct: 182 RKIGHACE-LREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 231 HQLQLI--VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                I  VN+              F +  + A D +  +LV NP +RP  +  L H
Sbjct: 240 ETYLNISQVNVDYSEET--------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  164 bits (418), Expect = 6e-48
 Identities = 69/314 (21%), Positives = 117/314 (37%), Gaps = 31/314 (9%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI---- 56
           M       +           + ++Y +   +G G +G VY     ++   VAIK +    
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 57  FEAFRNKTDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVNNKDLYVVFEYMEN--DL-N 112
              +    +  R   E++ LK        +I +LD ++        ++ E  E   DL +
Sbjct: 81  ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RPDSFVLILERPEPVQDLFD 138

Query: 113 KVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLAR 171
            +     L++   R   +Q+   + + H C V+HRD+K  NILID     +K+ D G   
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198

Query: 172 SLSDSKECLTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTS 230
            L D+    T++  TR Y  PE  I   RY      +WSLG +L +M+     F      
Sbjct: 199 LLKDTV--YTDFDGTRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPF------ 249

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
              + I+                      E   L+   L L PS+RP  ++I  H ++  
Sbjct: 250 EHDEEIIRGQVFFRQRV----------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

Query: 291 YFPSATHVIPQVTP 304
                      +  
Sbjct: 300 VLLPQETAEIHLHS 313

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  163 bits (415), Expect = 8e-48
 Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 38/282 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTY----REILFLKS 78
           E    K+IGKG +G+V+K     +K  VAIK +       +T+    +    RE+  + +
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNG 135
              HPNI+ +      + +    +V E++   DL   + DK   +K      +M  +  G
Sbjct: 80  L-NHPNIVKLY----GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 136 LSYIHACK--VMHRDLKPSNILIDKS-----CSIKIGDLGLARSLSDSKECLTEYIATRW 188
           + Y+      ++HRDL+  NI +           K+ D GL++    S   ++  +    
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQ 191

Query: 189 YRAPEILI-SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV----RPN 243
           + APE +      YT   D +S   IL  +L  +  F   S   +++ I  +     RP 
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGLRPT 250

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            P         ++ P    +++      +P +RP    I++ 
Sbjct: 251 IP---------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  165 bits (419), Expect = 1e-47
 Identities = 85/356 (23%), Positives = 136/356 (38%), Gaps = 86/356 (24%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYR----- 71
           G+ L E Y I   +G+G +G V +  D    K  VA+K I    RN       YR     
Sbjct: 14  GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII----RNV----GKYREAARL 65

Query: 72  EILFLKSFQRH-----PNIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILK 121
           EI  LK  +          + M D   +       + + FE +  +  + +++   +   
Sbjct: 66  EINVLKKIKEKDKENKFLCVLMSDWFNFH----GHMCIAFELLGKNTFEFLKENNFQPYP 121

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-------------------DKSCSI 162
             H+R++ +QLC+ L ++H  ++ H DLKP NIL                     K+ SI
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 222
           ++ D G   S +   E  T  +ATR YR PE+ I    +    D+WS+GCIL E  +   
Sbjct: 182 RVADFG---SATFDHEHHTTIVATRHYRPPEV-ILELGWAQPCDVWSIGCILFEYYRGFT 237

Query: 223 LFPGASTSHQLQLIVNLVRPNPPH-------ADKFYAGFKNKPE---------------- 259
           LF        L ++  ++ P P H          FY G     E                
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297

Query: 260 -----------EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTP 304
                      +  DL+ ++L  +P++R    + L H + +   P          P
Sbjct: 298 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  163 bits (414), Expect = 2e-47
 Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 31/274 (11%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +  I ++IG G++G V++A  + +   VA+K + E   +        RE+  +K   RHP
Sbjct: 38  DLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP 94

Query: 84  NIITMLDIYKAVNNK-DLYVVFEYMEN-DLNKVIRDKILKDV----HIRYIMFQLCNGLS 137
           NI+       AV    +L +V EY+    L +++     ++         + + +  G++
Sbjct: 95  NIVLF---MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 138 YIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           Y+H     ++HR+LK  N+L+DK  ++K+ D GL+R  + +         T  + APE+ 
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV- 210

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV----RPNPPHADKFY 251
           + +       D++S G IL E+   +  +      +  Q++  +     R   P      
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNL---NPAQVVAAVGFKCKRLEIP------ 261

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              +N   +   ++       P +RP    I++ 
Sbjct: 262 ---RNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  164 bits (416), Expect = 2e-47
 Identities = 72/331 (21%), Positives = 132/331 (39%), Gaps = 32/331 (9%)

Query: 6   TSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEA 59
                 +     +G    +Y+    +G GA+G V+ A DK   + V +K I       + 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIR 116
           +       +   EI  L     H NII +LDI++  N     +V E   +  DL   + R
Sbjct: 67  WIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE--NQGFFQLVMEKHGSGLDLFAFIDR 123

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
              L +    YI  QL + + Y+    ++HRD+K  NI+I +  +IK+ D G A +  + 
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLER 182

Query: 177 KECLTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
            +    +  T  Y APE+ +    Y    +++WSLG  L  ++  +  F       +L+ 
Sbjct: 183 GKLFYTFCGTIEYCAPEV-LMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEE 235

Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA 295
            V      P              +E + L++ +L   P  R   ++++   +V++    A
Sbjct: 236 TVEAAIHPPYLV----------SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285

Query: 296 THVIPQVTPHTVV-LDIDDNNQLEINDYQDK 325
            +   +V         +     LE+ +    
Sbjct: 286 DYTWEEVFRVNKPESGVLSAASLEMGNRSLS 316

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  163 bits (415), Expect = 3e-47
 Identities = 78/296 (26%), Positives = 135/296 (45%), Gaps = 20/296 (6%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQRHP 83
           Y I + +G+G++G V  A     +Q VA+K I  +  +      R  REI +LK   RHP
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP 69

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           +II + D+       D+ +V EY   +L + ++  K + +   R    Q+   + Y H  
Sbjct: 70  HIIKLYDVIT--TPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           K++HRDLKP N+L+D + ++KI D GL+  ++D    L     +  Y APE+ I+ + Y 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV-INGKLYA 185

Query: 203 -HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA 261
              VD+WS G +L  ML  +  F      +  + + + V   P                A
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL----------SPGA 235

Query: 262 VDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQL 317
             L+ +++V +P +R    +I    + +   P   ++ P         D    ++L
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD--YLRPMEEVQGSYADSRIVSKL 289

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (410), Expect = 4e-47
 Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 29/294 (9%)

Query: 8   KSGDKVQHNVDGNILAEYTIH-------KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           K G    H+   +   ++ I        +RIG G++G VYK     +   VA+K +    
Sbjct: 2   KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA 58

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK- 118
                 Q    E+  L+   RH NI+             L +V ++ E   L   +    
Sbjct: 59  PTPQQLQAFKNEVGVLRKT-RHVNILLF---MGYSTAPQLAIVTQWCEGSSLYHHLHASE 114

Query: 119 -ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
              +   +  I  Q   G+ Y+HA  ++HRDLK +NI + +  ++KIGD GLA   S   
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174

Query: 178 ECLTEYIATRWYR--APEIL--ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
                   +      APE++    +  Y+   D+++ G +L E++  +  +   +   Q+
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

Query: 234 --QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              +    + P+            N P+    L+ + L     ERP   +IL  
Sbjct: 235 IEMVGRGSLSPDLSKVR------SNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  167 bits (424), Expect = 1e-46
 Identities = 65/292 (22%), Positives = 134/292 (45%), Gaps = 22/292 (7%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
              +   +   +       ++L  Y IH+ +G GA+G+V++  ++      A K +    
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MT 192

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDK 118
            +++D +   +EI  +   + HP ++ + D ++  ++ ++ +++E+M   +L  KV  + 
Sbjct: 193 PHESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDNEMVMIYEFMSGGELFEKVADEH 249

Query: 119 -ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSD 175
             + +      M Q+C GL ++H    +H DLKP NI+    +S  +K+ D GL   L D
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-D 308

Query: 176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL 235
            K+ +     T  + APE+    +   ++ D+WS+G +   +L     F G +    L+ 
Sbjct: 309 PKQSVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367

Query: 236 I--VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           +   +    +          F    E+  D + ++L+ +P+ R    Q LEH
Sbjct: 368 VKSCDWNMDDSA--------FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  161 bits (409), Expect = 2e-46
 Identities = 78/346 (22%), Positives = 138/346 (39%), Gaps = 86/346 (24%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYR----- 71
           G++L+  Y I   +G+GA+G V +  D K   ++VA+K +    +N       Y      
Sbjct: 9   GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV----KNV----DRYCEAARS 60

Query: 72  EILFLKSFQRH-----PNIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILK 121
           EI  L+             + ML+   +       + +VFE +       I++      +
Sbjct: 61  EIQVLEHLNTTDPNSTFRCVQMLEWFEHH----GHICIVFELLGLSTYDFIKENGFLPFR 116

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-------------------KSCSI 162
             HIR + +Q+C  ++++H+ K+ H DLKP NIL                      +  I
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKP 222
           K+ D G   S +   E  +  ++TR YRAPE+ I    ++   D+WS+GCIL E      
Sbjct: 177 KVVDFG---SATYDDEHHSTLVSTRHYRAPEV-ILALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 223 LFPGASTSHQLQLIVNLVRPNPPH-------ADKFYAGFKNKPEEA-------------- 261
           +FP   +   L ++  ++ P P H          F+    +  E +              
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 262 -------------VDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                         DL+ ++L  +P++R    + L+H +      S
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  161 bits (409), Expect = 3e-46
 Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 33/307 (10%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
              +      +  +    +   + +   +G+GA  IVY+   K  ++  A+K +    + 
Sbjct: 33  GTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KK 88

Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILK 121
             D +    EI  L     HPNII + +I++     ++ +V E +   +L     D+I++
Sbjct: 89  TVDKKIVRTEIGVLLRLS-HPNIIKLKEIFE--TPTEISLVLELVTGGEL----FDRIVE 141

Query: 122 DVHI-----RYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSL 173
             +         + Q+   ++Y+H   ++HRDLKP N+L         +KI D GL++ +
Sbjct: 142 KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201

Query: 174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL 233
                 +     T  Y APEIL     Y   VD+WS+G I   +L     F        +
Sbjct: 202 EHQ-VLMKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

Query: 234 QLIVNLVR---PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
              +        +P         +      A DL+ +++VL+P +R  T Q L+H +V+ 
Sbjct: 260 FRRILNCEYYFISPW--------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

Query: 291 YFPSATH 297
              +  H
Sbjct: 312 KAANFVH 318

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  159 bits (405), Expect = 3e-46
 Identities = 62/311 (19%), Positives = 115/311 (36%), Gaps = 65/311 (20%)

Query: 18  DGNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
              I+ +Y +  + +G G  G V + ++K  ++  A+K +        D  +  RE+   
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELH 64

Query: 77  KSFQRHPNIITMLDIY--KAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY------ 127
               + P+I+ ++D+Y       K L +V E ++  +L      +I       +      
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS 120

Query: 128 -IMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEY 183
            IM  +   + Y+H+  + HRD+KP N+L      +  +K+ D G               
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------- 166

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
                  A E      +Y    D+WSLG I+  +L   P F           +   +R  
Sbjct: 167 -------AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217

Query: 244 PPHADKFYAGFKNKP-----EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHV 298
                     F N       EE   L+  +L   P++R    + + H ++ +        
Sbjct: 218 QYE-------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS-----TK 265

Query: 299 IPQVTPHTVVL 309
           +PQ   HT  +
Sbjct: 266 VPQTPLHTSRV 276

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  160 bits (407), Expect = 7e-46
 Identities = 77/346 (22%), Positives = 129/346 (37%), Gaps = 92/346 (26%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYR-----E 72
           G +L   + + +++G G +G V      +NK+Y A+K +    RN     + Y      E
Sbjct: 30  GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNI----KKYTRSAKIE 81

Query: 73  ILFLKSFQRHP----NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDV 123
              LK  Q       NI+      +Y       + ++FE +   L ++I           
Sbjct: 82  ADILKKIQNDDINNNNIVKYHGKFMYY----DHMCLIFEPLGPSLYEIITRNNYNGFHIE 137

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI-------------------------DK 158
            I+    ++   L+Y+    + H DLKP NIL+                          K
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 159 SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
           S  IK+ D G     +   +     I TR YRAPE+++ N  +    D+WS GC+LAE+ 
Sbjct: 198 STGIKLIDFG---CATFKSDYHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELY 253

Query: 219 QSKPLFPGASTSHQLQLIVNLVRPNPPH--------ADKFY------------------- 251
               LF        L ++ ++++P P +            Y                   
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313

Query: 252 --AGFKNKP-------EEAVDLLNQILVLNPSERPETDQILEHNYV 288
                K  P       E   D L  IL ++P+ RP   ++L+H ++
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  160 bits (407), Expect = 1e-45
 Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 27/237 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT-YREILFLKSFQRHP 83
           Y I   IGKG++G V KAYD+  +++VAIK I    +NK         E+  L+   +H 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLLELMNKHD 111

Query: 84  -----NIITMLD--IYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLC 133
                 I+ +    +++      L +VFE +  +L  ++R+   + +     R    Q+C
Sbjct: 112 TEMKYYIVHLKRHFMFR----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 134 NGLSYIHA--CKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
             L ++      ++H DLKP NIL+   K  +IKI D G   S     + + +YI +R+Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFY 224

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           R+PE+ +    Y   +D+WSLGCIL EM   +PLF GA+   Q+  IV ++   P H
Sbjct: 225 RSPEV-LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  159 bits (404), Expect = 2e-45
 Identities = 74/309 (23%), Positives = 120/309 (38%), Gaps = 29/309 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   K IG G +G+     DK  K+ VA+K   E  R     +   REI+  +S  RHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVK-YIE--RGAAIDENVQREIINHRSL-RHPN 77

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+   ++        L ++ EY    +L  ++       +   R+   QL +G+SY H+ 
Sbjct: 78  IVRFKEVIL--TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135

Query: 143 KVMHRDLKPSNILIDKSCS--IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           ++ HRDLK  N L+D S +  +KI D G +   S         + T  Y APE+ +  + 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEV-LLRQE 193

Query: 201 YT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR------PNPPHADKFYAG 253
           Y     D+WS G  L  ML     F         +  +  +       P+          
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR------- 246

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD 313
                 E   L+++I V +P+ R    +I  H++  K  P+               +   
Sbjct: 247 ---ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303

Query: 314 NNQLEINDY 322
            +   I   
Sbjct: 304 QSLDTIMQI 312

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  156 bits (398), Expect = 2e-45
 Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 19/275 (6%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + + +G+GAYG V  A ++  ++ VA+K I +  R     +   +EI   K    H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML-NHEN 66

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           ++      +       Y+  EY    +L +++  D  + +   +    QL  G+ Y+H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISNRR 200
            + HRD+KP N+L+D+  ++KI D GLA        +  L +   T  Y APE+ +  R 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRRE 183

Query: 201 YT-HHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           +    VD+WS G +L  ML    P    + +  +            P        +K   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--------WKKID 235

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
              + LL++ILV NPS R     I +  + +K   
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  158 bits (402), Expect = 3e-45
 Identities = 65/305 (21%), Positives = 122/305 (40%), Gaps = 44/305 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++     +G G  G+V+K   K +   +A K I           +  RE+  L      P
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECN-SP 91

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND-LNKVIRD-KILKDVHIRYIMFQLCNGLSYIHA 141
            I+     +   ++ ++ +  E+M+   L++V++    + +  +  +   +  GL+Y+  
Sbjct: 92  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 142 -CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
             K+MHRD+KPSNIL++    IK+ D G++  L DS    + ++ TR Y +PE  +    
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS-FVGTRSYMSPER-LQGTH 206

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           Y+   DIWS+G  L EM   +   P         +    V  +                +
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 261 AV----------DLLNQI------------------------LVLNPSERPETDQILEHN 286
                       +LL+ I                        L+ NP+ER +  Q++ H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 287 YVSKY 291
           ++ + 
Sbjct: 327 FIKRS 331

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  156 bits (396), Expect = 1e-44
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 20/298 (6%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + + +G+GAYG V  A ++  ++ VA+K I +  R     +   +EI   K    H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKML-NHEN 66

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
           ++      +       Y+  EY    +L +++  D  + +   +    QL  G+ Y+H  
Sbjct: 67  VVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAPEILISNRR 200
            + HRD+KP N+L+D+  ++KI D GLA        +  L +   T  Y APE+ +  R 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRRE 183

Query: 201 YT-HHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           +    VD+WS G +L  ML    P    + +  +                 +   +K   
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------KKTYLNPWKKID 235

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQ 316
              + LL++ILV NPS R     I +  + +K         P+VT   V       ++
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR-PRVTSGGVSESPSGFSK 292

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  156 bits (396), Expect = 1e-44
 Identities = 62/277 (22%), Positives = 122/277 (44%), Gaps = 31/277 (11%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +  +Y I + +G+G +GIV++  + ++K+    K +       TD     +EI  L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIA 58

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKIL-KDVH-----IRYIMFQL 132
           + H NI+ + + ++  + ++L ++FE++   D+     ++I           I   + Q+
Sbjct: 59  R-HRNILHLHESFE--SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQV 111

Query: 133 CNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYR 190
           C  L ++H+  + H D++P NI+    +S +IKI + G AR L    +          Y 
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYY 170

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPPHAD 248
           APE+   +   +   D+WSLG ++  +L     F   +    ++ I              
Sbjct: 171 APEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--- 226

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                FK    EA+D ++++LV     R    + L+H
Sbjct: 227 -----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  155 bits (394), Expect = 2e-44
 Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 33/279 (11%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +  I + IGKG +G VY          VAI+ I     N+   +   RE++  +   RH 
Sbjct: 34  QLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHE 89

Query: 84  NIITMLDIYKAVNNK-DLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYI 139
           N++       A  +   L ++    +   L  V+RD   +L     R I  ++  G+ Y+
Sbjct: 90  NVVLF---MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-----SLSDSKECLTEYIATRWYRAPEI 194
           HA  ++H+DLK  N+  D    + I D GL            ++ L        + APEI
Sbjct: 147 HAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 195 L--------ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
           +             ++ H D+++LG I  E+   +  F        +  +   ++PN   
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                       +E  D+L         ERP   ++++ 
Sbjct: 266 IG--------MGKEISDILLFCWAFEQEERPTFTKLMDM 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  159 bits (403), Expect = 3e-44
 Identities = 84/318 (26%), Positives = 133/318 (41%), Gaps = 31/318 (9%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EA 59
           M          K+ H         Y +   +G G +G V     +     VA+K +  + 
Sbjct: 3   MAEKQKHDGRVKIGH---------YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK 53

Query: 60  FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRD 117
            R+     +  REI  LK F RHP+II +  +       D+++V EY+   +L + + ++
Sbjct: 54  IRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIS--TPSDIFMVMEYVSGGELFDYICKN 110

Query: 118 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
             L +   R +  Q+ +G+ Y H   V+HRDLKP N+L+D   + KI D GL+ ++    
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDG 169

Query: 178 ECLTEYIATRWYRAPEILISNRRYT-HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI 236
           E L     +  Y APE+ IS R Y    VDIWS G IL  +L     F         + I
Sbjct: 170 EFLRTSCGSPNYAAPEV-ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228

Query: 237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
            + +   P +               + LL  +L ++P +R     I EH +  +  P   
Sbjct: 229 CDGIFYTPQYL----------NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP--- 275

Query: 297 HVIPQVTPHTVVLDIDDN 314
             +    P      IDD 
Sbjct: 276 KYLFPEDPSYSSTMIDDE 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  153 bits (389), Expect = 3e-44
 Identities = 68/278 (24%), Positives = 108/278 (38%), Gaps = 34/278 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTY-REILFLKSFQR 81
           E T+ + IG G +G VY+A        VA+K    +   + +       +E        +
Sbjct: 8   ELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-K 64

Query: 82  HPNIITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNII +         +  L +V E+     LN+V+  K +    +     Q+  G++Y+
Sbjct: 65  HPNIIAL---RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121

Query: 140 HACK---VMHRDLKPSNILIDKSCS--------IKIGDLGLARSLSDSKECLTEYIATRW 188
           H      ++HRDLK SNILI +           +KI D GLAR    +            
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYA 179

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHA 247
           + APE+ I    ++   D+WS G +L E+L  +  F G         +    +    P  
Sbjct: 180 WMAPEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP-- 236

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                     PE    L+      +P  RP    IL+ 
Sbjct: 237 -------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  156 bits (395), Expect = 5e-44
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)

Query: 19  GNILAEYTIHKR--IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
           G + + YT+ K   +G G +G V+K  +      +A K I    R   D +    EI  +
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVM 140

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH------IRYIM 129
                H N+I + D ++  +  D+ +V EY++  +L     D+I+ + +          M
Sbjct: 141 NQL-DHANLIQLYDAFE--SKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFM 193

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATR 187
            Q+C G+ ++H   ++H DLKP NIL     +  IKI D GLAR     +E L     T 
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTP 252

Query: 188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV--NLVRPNPP 245
            + APE++ +    +   D+WS+G I   +L     F G + +  L  I+       +  
Sbjct: 253 EFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   F++  EEA + ++++L+   S R    + L+H
Sbjct: 312 --------FQDISEEAKEFISKLLIKEKSWRISASEALKH 343

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  153 bits (389), Expect = 8e-44
 Identities = 57/280 (20%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQRHPN 84
              + +GKG +G   K   +   + + +K++    R   + QRT+ +E+  ++    HPN
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELI---RFDEETQRTFLKEVKVMRCL-EHPN 68

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHA 141
           ++  + +     +K L  + EY++   L  +I+                 + +G++Y+H+
Sbjct: 69  VLKFIGV--LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--------------- 186
             ++HRDL   N L+ ++ ++ + D GLAR + D K       +                
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLIVNLVRPNP 244
            W  APE+ I+ R Y   VD++S G +L E++      P            +   +    
Sbjct: 187 YWM-APEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           P          N P     +  +   L+P +RP   ++  
Sbjct: 245 P---------PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  152 bits (386), Expect = 1e-43
 Identities = 41/273 (15%), Positives = 95/273 (34%), Gaps = 26/273 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
             +     ++ +   G ++K   +     + +K +     +   ++    E   L+ F  
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-S 65

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLS 137
           HPN++ +L   ++       ++  +M    L  V+ +    ++           +  G++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 138 YIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           ++H  +  +    L   +++ID+  + +I    +  S               W  APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV-APEAL 180

Query: 196 ISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYA 252
                       D+WS   +L E++  +  F   S       +    +RP  P       
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP------- 233

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                      L+   +  +P++RP+ D I+  
Sbjct: 234 --PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (363), Expect = 1e-39
 Identities = 69/320 (21%), Positives = 124/320 (38%), Gaps = 46/320 (14%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           +   TTS SG  +   V   I     + + IGKG +G V++   K   + VA+K      
Sbjct: 20  IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-- 75

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRD 117
           R +    R   EI       RH NI+  +  D         L++V +Y E+  L   +  
Sbjct: 76  REERSWFRE-AEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 133

Query: 118 KILKDVHIRYIMFQLCNGLSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDLGL 169
             +    +  +     +GL+++H           + HRDLK  NIL+ K+ +  I DLGL
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193

Query: 170 ARSLSDSKECLTEYIA----TRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEMLQS 220
           A     + + +         T+ Y APE+L     + +       DI+++G +  E+ + 
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 221 KP--------------LFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDL 264
                           L P   +  +++ +V    +RPN P+  +              +
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA----LRVMAKI 309

Query: 265 LNQILVLNPSERPETDQILE 284
           + +    N + R    +I +
Sbjct: 310 MRECWYANGAARLTALRIKK 329

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  143 bits (362), Expect = 2e-39
 Identities = 45/287 (15%), Positives = 97/287 (33%), Gaps = 45/287 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
              +H  +G+GA+  VY+A      D  NKQ   +K    A  N  +     + +  LK 
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-------DLNKVIRDKILKDVHIRYIMFQ 131
                  +     +  +      +V E           +L K   +K++    +     +
Sbjct: 124 -SMQHMFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 132 LCNGLSYIHACKVMHRDLKPSNILI-----------DKSCSIKIGDLGLARSLS--DSKE 178
           +   +  +H C+++H D+KP N ++           D S  + + DLG +  +       
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN 238
             T    T  ++  E+L SN+ + + +D + +   +  ML    +        + +    
Sbjct: 241 IFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-ECKPEGL 298

Query: 239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             R                 +   +  + +L +       +  +L  
Sbjct: 299 FRRL-------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  142 bits (359), Expect = 2e-39
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 28/239 (11%)

Query: 6   TSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD 65
                D    + +G     Y + + +G+G  G VY+A D   ++ VA+K + E   +  D
Sbjct: 17  RGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--D 74

Query: 66  AQRTYREILFLKSFQR---------HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVI 115
                    F    QR          P+++ + D      +  LYV    +   DL  ++
Sbjct: 75  PV-------FRTRMQREARTAGRLQEPHVVPIHDF--GEIDGQLYVDMRLINGVDLAAML 125

Query: 116 RDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS 174
           R +  L       I+ Q+ + L   HA    HRD+KP NIL+       + D G+A + +
Sbjct: 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185

Query: 175 DSKECLTE---YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
           D K  LT+    + T +Y APE   S    T+  DI++L C+L E L   P + G   S
Sbjct: 186 DEK--LTQLGNTVGTLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  142 bits (360), Expect = 3e-39
 Identities = 74/320 (23%), Positives = 127/320 (39%), Gaps = 46/320 (14%)

Query: 1   MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF 60
           +  + +S SG  +   V   I  +  + K+IGKG YG V+    K   + VA+K  F   
Sbjct: 15  IEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT-- 70

Query: 61  RNKTDAQRTYREILFLKSFQRHPNIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRD 117
             +    R   EI       RH NI+  +  DI    +   LY++ +Y EN  L   ++ 
Sbjct: 71  TEEASWFRE-TEIYQTVLM-RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128

Query: 118 KILKDVHIRYIMFQLCNGLSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDLGL 169
             L    +  + +   +GL ++H           + HRDLK  NIL+ K+ +  I DLGL
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 170 ARSLSDSKECLTEY----IATRWYRAPEIL-----ISNRRYTHHVDIWSLGCILAEMLQ- 219
           A         +       + T+ Y  PE+L      ++ +     D++S G IL E+ + 
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

Query: 220 -------------SKPLFPGASTSHQLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDL 264
                           L P   +   ++ IV    +RP+ P+             +   L
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC----LRQMGKL 304

Query: 265 LNQILVLNPSERPETDQILE 284
           + +    NP+ R    ++ +
Sbjct: 305 MTECWAHNPASRLTALRVKK 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (355), Expect = 6e-39
 Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 46/295 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+ + +GKG YG V++       + VA+K      R++    R   E+       RH NI
Sbjct: 11  TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFRE-TELYNTVML-RHENI 64

Query: 86  ITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA- 141
           +  +  D+    ++  L+++  Y E   L   ++   L  V    I+  + +GL+++H  
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 142 -------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL----TEYIATRWYR 190
                    + HRDLK  NIL+ K+    I DLGLA   S S   L       + T+ Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 191 APEIL-----ISNRRYTHHVDIWSLGCILAEMLQSKP--------------LFPGASTSH 231
           APE+L     +        VDIW+ G +L E+ +                 + P   +  
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 232 QLQLIV--NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
            ++ +V  +  RPN P+                 L+ +    NPS R    +I +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPT----LTSLAKLMKECWYQNPSARLTALRIKK 295

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  146 bits (370), Expect = 9e-39
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 38/270 (14%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQ---RTYREI 73
           G+I+A  Y +   I  G  G +Y A D+N N + V +K +     +  DA+       E 
Sbjct: 75  GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL----VHSGDAEAQAMAMAER 130

Query: 74  LFLKSFQRHPNIITMLDI---YKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIM 129
            FL     HP+I+ + +         +   Y+V EY+    L +    K+     I   +
Sbjct: 131 QFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA-YL 188

Query: 130 FQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
            ++   LSY+H+  +++ DLKP NI++ +   +K+ DLG    ++           T  +
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGF 243

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           +APEI+      T   DI+++G  LA +    P   G             +  + P    
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLK- 292

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPET 279
                    +    LL + +  +P +R  T
Sbjct: 293 -------TYDSYGRLLRRAIDPDPRQRFTT 315

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  135 bits (342), Expect = 6e-37
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 39/270 (14%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK-----KIFEAFRNKTDAQRTYREILFL 76
             ++   K +G+G++  V  A +    +  AIK      I +   NK       R+++  
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVM-- 84

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCN 134
            S   HP  + +   ++  +++ LY    Y +N +L K I +     +   R+   ++ +
Sbjct: 85  -SRLDHPFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-------CLT-EYIAT 186
            L Y+H   ++HRDLKP NIL+++   I+I D G A+ LS   +         T +Y+  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV-- 199

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
               +PE+L + +      D+W+LGCI+ +++   P F   +     Q I+ L    P  
Sbjct: 200 ----SPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
                        +A DL+ ++LVL+ ++R
Sbjct: 255 FF----------PKARDLVEKLLVLDATKR 274

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (332), Expect = 1e-35
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              +++GKG +G V          N  + VA+KK+    ++ T+       REI  LKS 
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEILKSL 68

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGL 136
            +H NI+    +  +   ++L ++ EY+    L   ++   + +  + +     Q+C G+
Sbjct: 69  -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+   + +HRDL   NIL++    +KIGD GL + L   KE    +           WY
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---FKVKEPGESPIFWY 184

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML 218
            APE  ++  +++   D+WS G +L E+ 
Sbjct: 185 -APES-LTESKFSVASDVWSFGVVLYELF 211

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  132 bits (335), Expect = 3e-35
 Identities = 63/275 (22%), Positives = 115/275 (41%), Gaps = 40/275 (14%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHP 83
            + ++IG+G +G V+    + +   VA+K   E         +    +E   LK +  HP
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEARILKQY-SHP 172

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIH 140
           NI+ ++ +      + +Y+V E ++  D    +R +   L+   +  ++     G+ Y+ 
Sbjct: 173 NIVRLIGV--CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--------RWYRAP 192
           +   +HRDL   N L+ +   +KI D G++R  +D       Y A+        +W  AP
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQVPVKWT-AP 284

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADK 249
           E  ++  RY+   D+WS G +L E     + P +P  S     + +    R P P     
Sbjct: 285 EA-LNYGRYSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEKGGRLPCPELC-- 340

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                   P+    L+ Q     P +RP    I +
Sbjct: 341 --------PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  131 bits (331), Expect = 3e-35
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQ 80
               ++GKG +G V          N    VA+K++     +  D QR + REI  LK+  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKAL- 81

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLS 137
               I+    +      + L +V EY+ +  L   ++     L    +     Q+C G+ 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+ + + +HRDL   NIL++    +KI D GLA+ L   K+    Y+          WY 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWY- 197

Query: 191 APEILISNRRYTHHVDIWSLGCILAEML 218
           APE  +S+  ++   D+WS G +L E+ 
Sbjct: 198 APES-LSDNIFSRQSDVWSFGVVLYELF 224

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (329), Expect = 4e-35
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 27/227 (11%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
            + L++ Y + + +G G    V+ A D  + + VA+K +        D         F  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPS-------FYL 57

Query: 78  SFQR---------HPNIITMLDIYKAVNNKDL--YVVFEYME-NDLNKVIRDK-ILKDVH 124
            F+R         HP I+ + D  +A        Y+V EY++   L  ++  +  +    
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117

Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-- 182
              ++   C  L++ H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+  
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 183 -YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS 228
             I T  Y +PE            D++SLGC+L E+L  +P F G S
Sbjct: 178 AVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (329), Expect = 5e-35
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              + +G+G +G V        +    + VA+K +     +     R+   +EI  L++ 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DAGPQHRSGWKQEIDILRTL 90

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
             H +II      +      L +V EY+    L   +    +    +     Q+C G++Y
Sbjct: 91  -YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRA 191
           +HA   +HRDL   N+L+D    +KIGD GLA+++ +  E    Y           WY A
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWY-A 205

Query: 192 PEILISNRRYTHHVDIWSLGCILAEML 218
           PE  +   ++ +  D+WS G  L E+L
Sbjct: 206 PEC-LKEYKFYYASDVWSFGVTLYELL 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (330), Expect = 5e-35
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              +++GKG +G V          N  + VA+KK+    ++ T+       REI  LKS 
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEILKSL 99

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGL 136
            +H NI+    +  +   ++L ++ EY+    L   ++   + +  + +     Q+C G+
Sbjct: 100 -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+   + +HRDL   NIL++    +KIGD GL + L   KE    Y           WY
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---YYKVKEPGESPIFWY 215

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML 218
            APE  ++  +++   D+WS G +L E+ 
Sbjct: 216 -APES-LTESKFSVASDVWSFGVVLYELF 242

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  135 bits (342), Expect = 5e-35
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 24/260 (9%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRH 82
           ++H+ IG+G +G VY     +  +  A+K + +     +         R +L L S    
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIH 140
           P I+ M   Y       L  + + M   DL+  + +  +  +  +R+   ++  GL ++H
Sbjct: 252 PFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT-EYIATRWYRAPEILI 196
              V++RDLKP+NIL+D+   ++I DLGLA   S  K      T  Y+      APE+L 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM------APEVLQ 363

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
               Y    D +SLGC+L ++L+    F    T  + ++    +       D F      
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------ 417

Query: 257 KPEEAVDLLNQILVLNPSER 276
              E   LL  +L  + + R
Sbjct: 418 -SPELRSLLEGLLQRDVNRR 436

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (327), Expect = 6e-35
 Identities = 72/229 (31%), Positives = 112/229 (48%), Gaps = 29/229 (12%)

Query: 16  NVDGNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL 74
           ++ G I+ E Y I  ++G G    VY A D      VAIK IF   R     +       
Sbjct: 3   HMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE--KEE------- 53

Query: 75  FLKSFQR---------HPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDK-ILKDV 123
            LK F+R         H NI++M+D+     +   Y+V EY+E   L++ I     L   
Sbjct: 54  TLKRFEREVHNSSQLSHQNIVSMIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD 111

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE- 182
                  Q+ +G+ + H  +++HRD+KP NILID + ++KI D G+A++LS++   LT+ 
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQT 169

Query: 183 --YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST 229
              + T  Y +PE            DI+S+G +L EML  +P F G + 
Sbjct: 170 NHVLGTVQYFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (322), Expect = 4e-34
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 25/209 (11%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              + +G+G +G V          N  + VA+K +                +EI  L++ 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP---ESGGNHIADLKKEIEILRNL 80

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGL 136
             H NI+    I        + ++ E++ +  L + +      +          Q+C G+
Sbjct: 81  -YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+ + + +HRDL   N+L++    +KIGD GL +++   KE    Y           WY
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---YYTVKDDRDSPVFWY 196

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEML 218
            APE  +   ++    D+WS G  L E+L
Sbjct: 197 -APEC-LMQSKFYIASDVWSFGVTLHELL 223

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  129 bits (326), Expect = 5e-34
 Identities = 83/366 (22%), Positives = 138/366 (37%), Gaps = 104/366 (28%)

Query: 19  GNILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL--F 75
           G++    Y + +++G G +  V+ ++D   K++VA+ K+ ++  + T+       +L   
Sbjct: 32  GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKSAEHYTETALDEIRLLKSV 90

Query: 76  LKSFQRHPN---IITMLDI--YKAVNNKDLYVVFEYMENDLNKVIR---DKILKDVHIRY 127
             S    PN   ++ +LD      VN   + +VFE + + L K I     + L    ++ 
Sbjct: 91  RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150

Query: 128 IMFQLCNGLSYIHA-CKVMHRDLKPSNILI------------------------------ 156
           I+ Q+  GL Y+H  C+++H D+KP NIL+                              
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 157 -------------------DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
                               +   +KI DLG A  +    +  TE I TR YR+ E+LI 
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLI- 266

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------HQLQLIVNLVRPNPPH----- 246
              Y    DIWS  C+  E+     LF   S          + LI+ L+   P       
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326

Query: 247 --ADKFY---AGFKNKP-------------------EEA---VDLLNQILVLNPSERPET 279
             + +F+      K+                     EEA    D L  +L L P +R   
Sbjct: 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386

Query: 280 DQILEH 285
            + L H
Sbjct: 387 AECLRH 392

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (320), Expect = 6e-34
 Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 42/276 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHPNL 71

Query: 86  ITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYI 139
           + +L     V       Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+
Sbjct: 72  VQLL----GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAP 192
                +HRDL   N L+ ++  +K+ D GL+R ++        Y A        +W  AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWT-AP 181

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADK 249
           E  ++  +++   D+W+ G +L E+      P +PG   S   +L+    R   P     
Sbjct: 182 ES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRMERPEGC-- 237

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   PE+  +L+      NPS+RP   +I + 
Sbjct: 238 --------PEKVYELMRACWQWNPSDRPSFAEIHQA 265

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  127 bits (322), Expect = 6e-34
 Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 41/278 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              K +G GA+G VYK       +  K  VAIK++ E     +         E   + S 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASV 74

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             +P++  +L I        + ++ + M    L   +R     +   ++     Q+  G+
Sbjct: 75  -DNPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RWYR 190
           +Y+   +++HRDL   N+L+     +KI D GLA+ L   ++   EY A       +W  
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWM- 186

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 247
           A E  I +R YTH  D+WS G  + E++   SKP + G   S    ++    R P PP  
Sbjct: 187 ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPPIC 244

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                       +   ++ +  +++   RP+  +++  
Sbjct: 245 ----------TIDVYMIMRKCWMIDADSRPKFRELIIE 272

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  127 bits (321), Expect = 7e-34
 Identities = 56/295 (18%), Positives = 108/295 (36%), Gaps = 42/295 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
              + +   +G +G V+KA   N  +YVA+K           + +   E+  L    +H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPI---QDKQSWQNEYEVYSLPGM-KHE 78

Query: 84  NIITML--DIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRY-IMFQLCNGLSYI 139
           NI+  +  +      + DL+++  + E   L+  ++  ++   +    I   +  GL+Y+
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV-SWNELCHIAETMARGLAYL 137

Query: 140 HAC----------KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL--TEYIATR 187
           H             + HRD+K  N+L+  + +  I D GLA      K        + TR
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 188 WYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
            Y APE+L       R     +D++++G +L E+        G    + L      +  +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF-EEEIGQH 256

Query: 244 PPHADKFYAGFKNK----------PEEAVDLLNQILVL----NPSERPETDQILE 284
           P   D        K              + +L + +      +   R     + E
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (310), Expect = 2e-32
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 36/281 (12%)

Query: 28  HKRIGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            K +G G +G V K Y +  K    VA+K +     +         E   ++    +P I
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYI 80

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK 143
           + M+ I      +   +V E  E   LNK ++  + +KD +I  ++ Q+  G+ Y+    
Sbjct: 81  VRMIGI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPEILI 196
            +HRDL   N+L+      KI D GL+++L   +     Y A        +WY APE  I
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWY-APEC-I 192

Query: 197 SNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
           +  +++   D+WS G ++ E      KP + G   S    ++    R   P         
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERMGCPAGC------ 245

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
               P E  DL+N     +   RP    +     +  Y+  
Sbjct: 246 ----PREMYDLMNLCWTYDVENRPGFAAV--ELRLRNYYYD 280

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (309), Expect = 2e-32
 Identities = 61/294 (20%), Positives = 122/294 (41%), Gaps = 45/294 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
            +++ +G+G +G VY+      K  K  VA+K   +   + T   +     E + +K+  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK---DCTLDNKEKFMSEAVIMKNL- 70

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HP+I+ ++ I   +  +  +++ E     +L   +      LK + +     Q+C  ++
Sbjct: 71  DHPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+ +   +HRD+   NIL+     +K+GD GL+R + D      +Y          +W  
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASVTRLPIKWM- 181

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 247
           +PE  I+ RR+T   D+W     + E+L    +P F        + ++    R P P   
Sbjct: 182 SPES-INFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVLEKGDRLPKPDLC 239

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQ 301
                     P     L+ +    +PS+RP   ++     +S  +     +  +
Sbjct: 240 ----------PPVLYTLMTRCWDYDPSDRPRFTEL--VCSLSDVYQMEKDIAME 281

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  122 bits (308), Expect = 2e-32
 Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 42/274 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T+ K +G G +G+V     K     VA+K I E           ++E   +     HP +
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKE---GSMSEDEFFQEAQTMMKL-SHPKL 65

Query: 86  ITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
           +        V      +Y+V EY+ N  L   +R   K L+   +  + + +C G++++ 
Sbjct: 66  VKFY----GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
           + + +HRDL   N L+D+   +K+ D G+ R + D      +Y+++       +W  APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKFPVKWS-APE 175

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
           +     +Y+   D+W+ G ++ E+      P +   + S  +  +    R   P  A   
Sbjct: 176 V-FHYFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKVSQGHRLYRPHLA--- 230

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                   +    ++       P +RP   Q+L 
Sbjct: 231 -------SDTIYQIMYSCWHELPEKRPTFQQLLS 257

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  122 bits (308), Expect = 2e-32
 Identities = 36/255 (14%), Positives = 62/255 (24%), Gaps = 37/255 (14%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y +    G       ++A D    + VA+  +  +        Q T    L L      P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KP 91

Query: 84  NIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC 142
            +  +LD+          VV E++    L +V        V     M  L       H  
Sbjct: 92  GVARVLDV--VHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRA 148

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
            V      PS + +     + +                                      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA--------N 180

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV 262
              DI  +G  L  +L ++   P A     L          P             P +  
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI---PFQIS 237

Query: 263 DLLNQILVLNPSERP 277
            +  + +  +   R 
Sbjct: 238 AVAARSVQGDGGIRS 252

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (305), Expect = 6e-32
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 45/287 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
            + + IG+G +G V++      +N    VAIK         +D+ R    +E L ++ F 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQF- 73

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HP+I+ ++ +   +    ++++ E     +L   ++     L    +    +QL   L+
Sbjct: 74  DHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+ + + +HRD+   N+L+  +  +K+GD GL+R + DS      Y          +W  
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWM- 184

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 247
           APE  I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R P PP+ 
Sbjct: 185 APES-INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPPNC 242

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                     P     L+ +    +PS RP   ++     +S     
Sbjct: 243 ----------PPTLYSLMTKCWAYDPSRRPRFTEL--KAQLSTILEE 277

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  121 bits (305), Expect = 8e-32
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTY-REILFLKSFQR 81
            + +++G G++G+V +            VA+K +     ++ +A   + RE+  + S   
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSY 138
           H N+I +  +   V    + +V E      L   +R          +     Q+  G+ Y
Sbjct: 80  HRNLIRLYGV---VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRA 191
           + + + +HRDL   N+L+     +KIGD GL R+L  + +    Y+          W  A
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD---HYVMQEHRKVPFAWC-A 192

Query: 192 PEILISNRRYTHHVDIWSLGCILAEML 218
           PE  +  R ++H  D W  G  L EM 
Sbjct: 193 PES-LKTRTFSHASDTWMFGVTLWEMF 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (304), Expect = 9e-32
 Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 42/275 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T  K +G G +G+V     +     VAIK I E             E   + +   H  +
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKE---GSMSEDEFIEEAKVMMNL-SHEKL 81

Query: 86  ITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
           + +      V    + ++++ EYM N  L   +R      +   +  +   +C  + Y+ 
Sbjct: 82  VQLY----GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
           + + +HRDL   N L++    +K+ D GL+R + D      EY ++       RW   PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----DEYTSSVGSKFPVRWS-PPE 191

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
           + +   +++   DIW+ G ++ E+      P +   + S   + I   +R   P  A   
Sbjct: 192 V-LMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHLA--- 246

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   E+   ++         ERP    +L +
Sbjct: 247 -------SEKVYTIMYSCWHEKADERPTFKILLSN 274

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  122 bits (308), Expect = 1e-31
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 28/262 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSF 79
           L ++   K +G G++G V     K +  + A+K     +  + K   + T  E   L++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAV 98

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLS 137
              P ++ +   +K  +N +LY+V EY+   ++   +R      + H R+   Q+     
Sbjct: 99  -NFPFLVKLEFSFK--DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAPEI 194
           Y+H+  +++RDLKP N+LID+   I++ D G A+ +       C T E +      APEI
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEI 209

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            I ++ Y   VD W+LG ++ EM    P F         + IV+     P H        
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS----- 263

Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +  DLL  +L ++ ++R
Sbjct: 264 -----DLKDLLRNLLQVDLTKR 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  125 bits (315), Expect = 1e-31
 Identities = 59/261 (22%), Positives = 107/261 (40%), Gaps = 23/261 (8%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRH 82
              + +G+G +G V+    K   +  A KK+ +     R         ++IL   +    
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL---AKVHS 244

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN--DL-----NKVIRDKILKDVHIRYIMFQLCNG 135
             I+++   Y      DL +V   M N  D+     N    +   ++    +   Q+ +G
Sbjct: 245 RFIVSL--AYAFETKTDLCLVMTIM-NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L ++H   +++RDLKP N+L+D   +++I DLGLA  L   +     Y  T  + APE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
                Y   VD ++LG  L EM+ ++  F       + + +   V          +    
Sbjct: 362 -LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF---- 416

Query: 256 NKPEEAVDLLNQILVLNPSER 276
                + D    +L  +P +R
Sbjct: 417 --SPASKDFCEALLQKDPEKR 435

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (313), Expect = 1e-31
 Identities = 64/276 (23%), Positives = 124/276 (44%), Gaps = 38/276 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHP 276

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYI 139
           N++ +L +         Y++ E+M   +L   +R+   + +  V + Y+  Q+ + + Y+
Sbjct: 277 NLVQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAP 192
                +HR+L   N L+ ++  +K+ D GL+R ++        Y A        +W  AP
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWT-AP 388

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADK 249
           E  ++  +++   D+W+ G +L E+      P +PG   S   +L+    R   P     
Sbjct: 389 ES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRMERPEGC-- 444

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                   PE+  +L+      NPS+RP   +I + 
Sbjct: 445 --------PEKVYELMRACWQWNPSDRPSFAEIHQA 472

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  121 bits (306), Expect = 1e-31
 Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 41/228 (17%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF----EAFRNKTDAQRTYREILFLK 77
           L    + + IG+G YG VYK     +++ VA+K       + F N+       + I  + 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINE-------KNIYRVP 62

Query: 78  SFQRHPNIITML--DIYKAVNNKD-LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLC 133
               H NI   +  D     + +    +V EY  N  L K +       V    +   + 
Sbjct: 63  LM-EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVT 121

Query: 134 NGLSYIHA---------CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 184
            GL+Y+H            + HRDL   N+L+    +  I D GL+  L+ ++       
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 185 A--------TRWYRAPEIL------ISNRRYTHHVDIWSLGCILAEML 218
                    T  Y APE+L               VD+++LG I  E+ 
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (308), Expect = 2e-31
 Identities = 63/264 (23%), Positives = 119/264 (45%), Gaps = 34/264 (12%)

Query: 27  IHKRIGKGAYGIVYKAYDKNNKQYVAIK-----KIFEAFRNKTDAQRTYREILFLKSFQR 81
           I + IGKG++G V      + K+  A+K     K  E  RN+        +I+       
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--RNEVRNVFKELQIM---QGLE 73

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYI 139
           HP ++ +   Y   + +D+++V + +   DL   + ++   K+  ++  + +L   L Y+
Sbjct: 74  HPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-----EYIATRWYRAPEI 194
              +++HRD+KP NIL+D+   + I D  +A  L    +  T      Y+      APE+
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM------APEM 185

Query: 195 LISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
             S +   Y+  VD WSLG    E+L+ +  +   S++   +++         +   +  
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW-- 243

Query: 253 GFKNKPEEAVDLLNQILVLNPSER 276
                 +E V LL ++L  NP +R
Sbjct: 244 -----SQEMVSLLKKLLEPNPDQR 262

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  119 bits (301), Expect = 2e-31
 Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 42/274 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
           T  + IG G +G+V+  Y   NK  VAIK I E        +    E   +     HP +
Sbjct: 11  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKL-SHPKL 65

Query: 86  ITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
           + +      V      + +V E+ME+  L+  +R    +     +  +   +C G++Y+ 
Sbjct: 66  VQLY----GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
              V+HRDL   N L+ ++  IK+ D G+ R + D      +Y ++       +W  +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWA-SPE 175

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
           +  S  RY+   D+WS G ++ E+      P +   S S  ++ I    R   P  A   
Sbjct: 176 V-FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRLYKPRLA--- 230

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                        ++N      P +RP   ++L 
Sbjct: 231 -------STHVYQIMNHCWRERPEDRPAFSRLLR 257

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (309), Expect = 2e-31
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 30/270 (11%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
              +  ++G+G +G V+        + VAIK +          +   +E   +K   RH 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVMKKL-RHE 239

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYI 139
            ++ +   Y  V+ + +Y+V EYM    L   ++    K L+   +  +  Q+ +G++Y+
Sbjct: 240 KLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWYRAPEILIS 197
                +HRDL+ +NIL+ ++   K+ D GLAR + D++    +      +W  APE    
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEA-AL 354

Query: 198 NRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGF 254
             R+T   D+WS G +L E+      P +PG      L  +    R P PP         
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMPCPPEC------- 406

Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILE 284
              PE   DL+ Q     P ERP  + +  
Sbjct: 407 ---PESLHDLMCQCWRKEPEERPTFEYLQA 433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  120 bits (303), Expect = 3e-31
 Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 41/278 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              K +G GA+G VYK       +  K  VAIK++ E     +         E   + S 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASV 74

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGL 136
             +P++  +L I        + ++ + M    L   +R     +   ++     Q+  G+
Sbjct: 75  -DNPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RWYR 190
           +Y+   +++HRDL   N+L+     +KI D GLA+ L   ++   EY A       +W  
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWM- 186

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHA 247
           A E  I +R YTH  D+WS G  + E++   SKP + G   S    ++    R P PP  
Sbjct: 187 ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPPIC 244

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                       +   ++ +  +++   RP+  +++  
Sbjct: 245 ----------TIDVYMIMVKCWMIDADSRPKFRELIIE 272

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  120 bits (303), Expect = 4e-31
 Identities = 80/301 (26%), Positives = 124/301 (41%), Gaps = 47/301 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
           T  K IG G +G VYK          +  VAIK +       T+ QR     E   +  F
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIMGQF 103

Query: 80  QRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCN 134
             H NII +      V    K + ++ EYMEN  L+K +R  D     + +  ++  +  
Sbjct: 104 -SHHNIIRLE----GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RW 188
           G+ Y+     +HRDL   NIL++ +   K+ D GL+R L D  E    Y  +      RW
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSGGKIPIRW 216

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
             APE  IS R++T   D+WS G ++ E++    +P +   S    ++ I +  R P P 
Sbjct: 217 T-APEA-ISYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAINDGFRLPTPM 273

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF--PSATHVIPQVT 303
                       P     L+ Q      + RP+   I   + + K    P +   +    
Sbjct: 274 DC----------PSAIYQLMMQCWQQERARRPKFADI--VSILDKLIRAPDSLKTLADFD 321

Query: 304 P 304
           P
Sbjct: 322 P 322

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  123 bits (311), Expect = 4e-31
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 20/259 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQR 81
           +  ++ +GKG +G V     +   +  A KK+ +     R         ++IL       
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL---EKVN 242

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLN---KVIRDKILKDVHIRYIMFQLCNGLS 137
              ++++   Y       L +V   M   DL      +      +    +   ++C GL 
Sbjct: 243 SRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
            +H  ++++RDLKP NIL+D    I+I DLGLA  + + +      + T  Y APE++  
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV-K 358

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
           N RYT   D W+LGC+L EM+  +  F       + + +  LV+  P    + +      
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF------ 412

Query: 258 PEEAVDLLNQILVLNPSER 276
             +A  L +Q+L  +P+ER
Sbjct: 413 SPQARSLCSQLLCKDPAER 431

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (310), Expect = 5e-31
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 30/270 (11%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
              +  ++G+G +G V+        + VAIK +          +   +E   +K   RH 
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVMKKL-RHE 322

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYI 139
            ++ +   Y  V+ + +Y+V EYM    L   ++    K L+   +  +  Q+ +G++Y+
Sbjct: 323 KLVQL---YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY--IATRWYRAPEILIS 197
                +HRDL+ +NIL+ ++   K+ D GLAR + D++    +      +W  APE    
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEA-AL 437

Query: 198 NRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGF 254
             R+T   D+WS G +L E+      P +PG      L  +    R P PP         
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMPCPPEC------- 489

Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILE 284
              PE   DL+ Q     P ERP  + +  
Sbjct: 490 ---PESLHDLMCQCWRKEPEERPTFEYLQA 516

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  119 bits (301), Expect = 5e-31
 Identities = 71/287 (24%), Positives = 111/287 (38%), Gaps = 46/287 (16%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
            I K IG G  G V              VAIK +       T+ QR     E   +  F 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMGQF- 107

Query: 81  RHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNG 135
            HPNII +      V    +   +V EYMEN  L+  +R  D     + +  ++  +  G
Sbjct: 108 DHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RW 188
           + Y+     +HRDL   N+L+D +   K+ D GL+R L D  +       T       RW
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD---AAYTTTGGKIPIRW 220

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPP 245
             APE  I+ R ++   D+WS G ++ E+L    +P +   +    +  +    R P P 
Sbjct: 221 T-APEA-IAFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSVEEGYRLPAPM 277

Query: 246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
                       P     L+      + ++RP   QI   + +    
Sbjct: 278 GC----------PHALHQLMLDCWHKDRAQRPRFSQI--VSVLDALI 312

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  120 bits (304), Expect = 8e-31
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 32/269 (11%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
             +Y + K IG+GA+G V     K+ ++  A+K + +     R+ +      R+I+   +
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM---A 124

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLS 137
           F   P ++ +   Y   +++ LY+V EYM   DL  ++ +  + +   R+   ++   L 
Sbjct: 125 FANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD 182

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------EYIATRWYR 190
            IH+   +HRD+KP N+L+DKS  +K+ D G    ++              +YI      
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236

Query: 191 APEILIS---NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA 247
           +PE+L S   +  Y    D WS+G  L EML     F   S       I+N         
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296

Query: 248 DKFYAGFKNKPEEAVDLLNQILVLNPSER 276
           D          +EA +L+   L  +   R
Sbjct: 297 DNDI------SKEAKNLICAFLT-DREVR 318

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  118 bits (299), Expect = 9e-31
 Identities = 72/303 (23%), Positives = 114/303 (37%), Gaps = 70/303 (23%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
           +  K +G GA+G V +A        +    VA+K +     +    +R     E+  L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSY 82

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK----------------- 118
              H NI+ +L              V+ EY    DL   +R K                 
Sbjct: 83  LGNHMNIVNLL----GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 119 --ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
              L    +    +Q+  G++++ +   +HRDL   NIL+      KI D GLAR + + 
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 177 KECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGA 227
                 Y+         +W  APE  I N  YT   D+WS G  L E+  L S P +PG 
Sbjct: 199 S----NYVVKGNARLPVKWM-APE-SIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGM 251

Query: 228 STSHQLQLIVNLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI 282
               +      +++      +P HA          P E  D++      +P +RP   QI
Sbjct: 252 PVDSKF---YKMIKEGFRMLSPEHA----------PAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 283 LEH 285
           ++ 
Sbjct: 299 VQL 301

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (302), Expect = 9e-31
 Identities = 77/300 (25%), Positives = 124/300 (41%), Gaps = 46/300 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
           +I K +G G +G V           +  VAIK +       T+ QR     E   +  F 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV---GYTEKQRRDFLGEASIMGQF- 103

Query: 81  RHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNG 135
            HPNII +      V   +K + +V EYMEN  L+  +R  D     + +  ++  + +G
Sbjct: 104 DHPNIIRLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT------RWY 189
           + Y+     +HRDL   NILI+ +   K+ D GL R L D  E    Y         RW 
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIPIRWT 217

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPH 246
            +PE  I+ R++T   D+WS G +L E++    +P +   S    ++ +    R P P  
Sbjct: 218 -SPEA-IAYRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAVDEGYRLPPPMD 274

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF--PSATHVIPQVTP 304
                      P     L+      + + RP+ +QI   + + K    P +  +I     
Sbjct: 275 C----------PAALYQLMLDCWQKDRNNRPKFEQI--VSILDKLIRNPGSLKIITSAAA 322

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (297), Expect = 9e-31
 Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 50/277 (18%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    RH N+
Sbjct: 24  KLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-RHSNL 76

Query: 86  ITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSY 138
           + +L     V       LY+V EYM    L   +R     +L    +      +C  + Y
Sbjct: 77  VQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRA 191
           +     +HRDL   N+L+ +    K+ D GL +                      +W  A
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---------ASSTQDTGKLPVKWT-A 182

Query: 192 PEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHAD 248
           PE  +  ++++   D+WS G +L E+      P +P       +  +    +   P    
Sbjct: 183 PEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAPDGC- 239

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                    P    +++     L+ + RP   Q+ E 
Sbjct: 240 ---------PPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  118 bits (299), Expect = 1e-30
 Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 41/284 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
           T+ + +GKG +G V +A    +  +   VA+K +       +D +   RE   +K F  H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DH 84

Query: 83  PNIITML----DIYKAVNNKDLYVVFEYMEN-DLNKVIR-------DKILKDVHIRYIMF 130
           P++  ++                V+  +M++ DL+  +           L    +   M 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 131 QLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT---- 186
            +  G+ Y+ +   +HRDL   N ++ +  ++ + D GL+R +         Y       
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----YYRQGCASK 200

Query: 187 ---RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVR 241
              +W  A E L ++  YT H D+W+ G  + E+      P + G   +     ++   R
Sbjct: 201 LPVKWL-ALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIGGNR 257

Query: 242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              P             EE  DL+ Q    +P +RP    +   
Sbjct: 258 LKQPP---------ECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  118 bits (298), Expect = 1e-30
 Identities = 61/327 (18%), Positives = 118/327 (36%), Gaps = 54/327 (16%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSF 79
              K +G G +G V+K       ++ K  V IK I +                +L + S 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED---KSGRQSFQAVTDHMLAIGSL 72

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGL 136
             H +I+ +L +        L +V +Y+    L   +R     L    +     Q+  G+
Sbjct: 73  -DHAHIVRLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWY 189
            Y+    ++HR+L   N+L+     +++ D G+A  L        + +         +W 
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQLLYSEAKTPIKWM 184

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPH 246
            A E  I   +YTH  D+WS G  + E++   ++P + G   +    L+    R   P  
Sbjct: 185 -ALES-IHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLLEKGERLAQPQI 241

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH---------NYVSKYFPSATH 297
                        +   ++ +  +++ + RP   ++             Y+     S   
Sbjct: 242 C----------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPG 291

Query: 298 VIPQVTPHTVVLDIDDNNQLEINDYQD 324
           + P   PH +     +  +LE     D
Sbjct: 292 IAPGPEPHGLTNKKLEEVELE--PELD 316

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  120 bits (302), Expect = 1e-30
 Identities = 63/273 (23%), Positives = 104/273 (38%), Gaps = 40/273 (14%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQR 81
           + I K IG+GA+  V     K   Q  A+K + +     R +    R  R++L       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL---VNGD 119

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLCNGL 136
              I  +   +   +   LY+V EY         L+K    + +     R+ + ++   +
Sbjct: 120 RRWITQLH--FAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAI 175

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------EYIATRWY 189
             +H    +HRD+KP NIL+D+   I++ D G    L       +       +Y+     
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 190 RAPEILIS------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN 243
            +PEIL +         Y    D W+LG    EM   +  F   ST+     IV+     
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
                      +  PEEA D + + L+  P  R
Sbjct: 290 S-----LPLVDEGVPEEARDFIQR-LLCPPETR 316

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  116 bits (294), Expect = 2e-30
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 42/275 (15%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            + +R+G G +G V+  Y   + + VA+K + +             E   +K   +H  +
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ---GSMSPDAFLAEANLMKQL-QHQRL 70

Query: 86  ITMLDIYKAVNNKD-LYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIH 140
           + +     AV  ++ +Y++ EYMEN  L   ++      L    +  +  Q+  G+++I 
Sbjct: 71  VRLY----AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
               +HRDL+ +NIL+  + S KI D GLAR + D      EY A        +W  APE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-----NEYTAREGAKFPIKWT-APE 180

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
             I+   +T   D+WS G +L E++     P +PG +    +Q +    R   P +    
Sbjct: 181 A-INYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMVRPDNC--- 235

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                  PEE   L+       P +RP  D +   
Sbjct: 236 -------PEELYQLMRLCWKERPEDRPTFDYLRSV 263

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (291), Expect = 6e-30
 Identities = 60/285 (21%), Positives = 109/285 (38%), Gaps = 42/285 (14%)

Query: 27  IHKRIGKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRH 82
               +G G +G V +     +  +  VAIK + +       A      RE   +     +
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQIMHQL-DN 69

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYI 139
           P I+ ++ +      + L +V E      L+K +    + +   ++  ++ Q+  G+ Y+
Sbjct: 70  PYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAP 192
                +HRDL   N+L+      KI D GL+++L         Y A        +WY AP
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWPLKWY-AP 182

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADK 249
           E  I+ R+++   D+WS G  + E L    KP +        +  I    R   PP    
Sbjct: 183 EC-INFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECPPEC-- 238

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                   P E   L++   +    +RP+   +     +   + S
Sbjct: 239 --------PPELYALMSDCWIYKWEDRPDFLTV--EQRMRACYYS 273

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (293), Expect = 8e-30
 Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 69/302 (22%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
            + K +G+GA+G V +A           + VA+K + E     T ++      E+  L  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIH 86

Query: 79  FQRHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD----------------- 117
              H N++ +L             L V+ E+ +  +L+  +R                  
Sbjct: 87  IGHHLNVVNLL----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 118 KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK 177
             L   H+    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 178 ECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAS 228
               +Y+         +W  APE +  +R YT   D+WS G +L E+  L + P +PG  
Sbjct: 203 ----DYVRKGDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

Query: 229 TSHQLQLIVNLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL 283
              +       ++       P +             E    +       PS+RP   +++
Sbjct: 256 IDEEF---CRRLKEGTRMRAPDYT----------TPEMYQTMLDCWHGEPSQRPTFSELV 302

Query: 284 EH 285
           EH
Sbjct: 303 EH 304

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  115 bits (291), Expect = 2e-29
 Identities = 74/262 (28%), Positives = 134/262 (51%), Gaps = 28/262 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK--KIFEAFRNKTDAQRTYREILFLKSF 79
           L ++ I + +G G++G V+    ++N +Y A+K  K     R K   + T  E L L   
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIV 63

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLS 137
             HP II M   ++  + + ++++ +Y+E  +L  ++R  +   +   ++   ++C  L 
Sbjct: 64  -THPFIIRMWGTFQ--DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLT-EYIATRWYRAPEI 194
           Y+H+  +++RDLKP NIL+DK+  IKI D G A+ + D     C T +YI      APE+
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEV 174

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
            +S + Y   +D WS G ++ EML     F  ++T    + I+N     PP  ++     
Sbjct: 175 -VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE----- 228

Query: 255 KNKPEEAVDLLNQILVLNPSER 276
                +  DLL++++  + S+R
Sbjct: 229 -----DVKDLLSRLITRDLSQR 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  117 bits (296), Expect = 2e-29
 Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 40/271 (14%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQRHP 83
            + + IGKG +G V     + NK  VA+K I      K DA       E   +    RH 
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCI------KNDATAQAFLAEASVMTQL-RHS 246

Query: 84  NIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGL 136
           N++ +L     V       LY+V EYM    L   +R     +L    +      +C  +
Sbjct: 247 NLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            Y+     +HRDL   N+L+ +    K+ D GL +  S +++  T  +  +W  APE  +
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWT-APEA-L 358

Query: 197 SNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG 253
             ++++   D+WS G +L E+      P +P       +  +    +   P         
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAPDGC------ 411

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               P    D++     L+ + RP   Q+ E
Sbjct: 412 ----PPAVYDVMKNCWHLDAATRPTFLQLRE 438

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  117 bits (296), Expect = 2e-29
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 40/273 (14%)

Query: 26  TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNI 85
            + K++G G +G V+ A    + + VA+K +          +    E   +K+  +H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKP---GSMSVEAFLAEANVMKTL-QHDKL 245

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHA 141
           + +   +  V  + +Y++ E+M    L   ++           +     Q+  G+++I  
Sbjct: 246 VKL---HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPEI 194
              +HRDL+ +NIL+  S   KI D GLAR + D+     EY A        +W  APE 
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-----EYTAREGAKFPIKWT-APEA 356

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKFY 251
            I+   +T   D+WS G +L E++     P +PG S    ++ +    R P P +     
Sbjct: 357 -INFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENC---- 410

Query: 252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                 PEE  +++ +     P ERP  + I  
Sbjct: 411 ------PEELYNIMMRCWKNRPEERPTFEYIQS 437

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  115 bits (290), Expect = 2e-29
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 63/299 (21%)

Query: 26  TIHKRIGKGAYGIVYKAY-------DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFL 76
           T+ K +G+GA+G V  A               VA+K + +   + T+   +    E+  +
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMM 94

Query: 77  KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR----------------- 116
           K   +H NII +L         +  LYV+ EY    +L + +R                 
Sbjct: 95  KMIGKHKNIINLL----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
           ++ +    +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++ 
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 177 KECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGA 227
                 Y  T       +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG 
Sbjct: 211 D----YYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGI 263

Query: 228 STSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                 +L+    R   P +             E   ++       PS+RP   Q++E 
Sbjct: 264 PVEELFKLLKEGHRMDKPANC----------TNELYMMMRDCWHAVPSQRPTFKQLVED 312

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (287), Expect = 4e-29
 Identities = 62/282 (21%), Positives = 117/282 (41%), Gaps = 46/282 (16%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
             ++ IG+G +G VY      +   K + A+K +          + +    E + +K F 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDF- 83

Query: 81  RHPNIITMLDIYKAVNNKD--LYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNG 135
            HPN++++L I       +    VV  YM++ DL   IR          +     Q+  G
Sbjct: 84  SHPNVLSLLGI---CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT--------- 186
           + Y+ + K +HRDL   N ++D+  ++K+ D GLAR + D      EY +          
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEYYSVHNKTGAKLP 195

Query: 187 -RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPN 243
            +W  A E  +  +++T   D+WS G +L E++   + P +P  +T      ++   R  
Sbjct: 196 VKWM-ALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLL 252

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            P            P+   +++ +        RP   +++  
Sbjct: 253 QPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  115 bits (290), Expect = 4e-29
 Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 34/286 (11%)

Query: 2   TSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF- 60
           T+NT SK  +    +     L ++     +GKG++G V  +  K   +  A+K + +   
Sbjct: 1   TTNTVSKFDNNGNRDRMK--LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 58

Query: 61  --RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIR 116
              +  +     + +L L    + P +  +           LY V EY+   DL   + +
Sbjct: 59  IQDDDVECTMVEKRVLALPG--KPPFLTQLH--SCFQTMDRLYFVMEYVNGGDLMYHIQQ 114

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
               K+ H  +   ++  GL ++ +  +++RDLK  N+++D    IKI D G+       
Sbjct: 115 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------C 168

Query: 177 KECLTEYIATRW------YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS 230
           KE + + + T+       Y APEI+ + + Y   VD W+ G +L EML  +  F G    
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
              Q I+      P              +EAV +   ++  +P +R
Sbjct: 228 ELFQSIMEHNVAYPKSM----------SKEAVAICKGLMTKHPGKR 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  115 bits (289), Expect = 4e-29
 Identities = 66/266 (24%), Positives = 114/266 (42%), Gaps = 33/266 (12%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKS 78
           + ++   K +GKG +G V    +K   +Y A+K   K     +++     T   +L    
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL---Q 60

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
             RHP +  +   Y    +  L  V EY    +L   + R+++  +   R+   ++ + L
Sbjct: 61  NTRHPFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YR 190
            Y+H+  V++RD+K  N+++DK   IKI D GL       KE +++    +       Y 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYL 172

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APE+L  +  Y   VD W LG ++ EM+  +  F         +LI+      P      
Sbjct: 173 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL--- 228

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
                    EA  LL  +L  +P +R
Sbjct: 229 -------SPEAKSLLAGLLKKDPKQR 247

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  116 bits (293), Expect = 4e-29
 Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 42/276 (15%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
             ++ I K IG+GA+G V     KN  +  A+K + +     R +T   R  R++L    
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL---V 129

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYME-----NDLNKVIRDKILKDVHIRYIMFQLC 133
                 I T+   Y   ++ +LY+V +Y         L+K   +  L +   R+ + ++ 
Sbjct: 130 NGDSKWITTLH--YAFQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMV 185

Query: 134 NGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT-------EYIAT 186
             +  +H    +HRD+KP NIL+D +  I++ D G    L +     +       +YI  
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI-- 243

Query: 187 RWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN--LV 240
               +PEIL +      RY    D WSLG  + EML  +  F   S       I+N    
Sbjct: 244 ----SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
              P              E A DL+ +++  +   R
Sbjct: 300 FQFPTQVTDV-------SENAKDLIRRLIC-SREHR 327

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  114 bits (287), Expect = 5e-29
 Identities = 53/283 (18%), Positives = 108/283 (38%), Gaps = 40/283 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
            + K +G+G +G V +     +      VA+K +     ++ + +    E   +K F  H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SH 95

Query: 83  PNIITMLDI---YKAVNNKDLYVVFEYMEN-DLNKVIR-------DKILKDVHIRYIMFQ 131
           PN+I +L +     +       V+  +M+  DL+  +         K +    +   M  
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT----- 186
           +  G+ Y+     +HRDL   N ++    ++ + D GL++ +         Y        
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----DYYRQGRIAKM 211

Query: 187 --RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQLIVNLVRP 242
             +W  A E L ++R YT   D+W+ G  + E+      P +PG         +++  R 
Sbjct: 212 PVKWI-AIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYLLHGHRL 268

Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             P          +  +E  +++      +P +RP    +   
Sbjct: 269 KQPE---------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (296), Expect = 5e-29
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 41/276 (14%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
            + + IG+G +G V++      +N    VAIK         +D+ R    +E L ++ F 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQF- 448

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLS 137
            HP+I+ ++ +   +    ++++ E     +L   ++     L    +    +QL   L+
Sbjct: 449 DHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYR 190
           Y+ + + +HRD+   N+L+  +  +K+GD GL+R + DS      Y          +W  
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWM- 559

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           APE  I+ RR+T   D+W  G  + E+L    KP F G   +  +  I N  R   P   
Sbjct: 560 APES-INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPP-- 615

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
                  N P     L+ +    +PS RP   ++  
Sbjct: 616 -------NCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  115 bits (289), Expect = 6e-29
 Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 63/299 (21%)

Query: 26  TIHKRIGKGAYGIVYKAY-------DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFL 76
           T+ K +G+G +G V  A               VA+K + +   + T+   +    E+  +
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMM 140

Query: 77  KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR----------------- 116
           K   +H NII +L         +  LYV+ EY    +L + +R                 
Sbjct: 141 KMIGKHKNIINLL----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
           ++ +    +    +QL  G+ Y+ + K +HRDL   N+L+ ++  +KI D GLAR +++ 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 177 KECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGA 227
                 Y  T       +W  APE L  +R YTH  D+WS G ++ E+  L   P +PG 
Sbjct: 257 D----YYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGI 309

Query: 228 STSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                 +L+    R   P +             E   ++       PS+RP   Q++E 
Sbjct: 310 PVEELFKLLKEGHRMDKPANC----------TNELYMMMRDCWHAVPSQRPTFKQLVED 358

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  114 bits (288), Expect = 6e-29
 Identities = 56/270 (20%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFL 76
           +  + + K +G GAYG V+   K    +  +  A+K + +A   +     + T  E   L
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCN 134
           +  ++ P ++T+   Y       L+++ +Y+   +L   + + +   +  ++  + ++  
Sbjct: 113 EHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------ 188
            L ++H   +++RD+K  NIL+D +  + + D GL      SKE + +     +      
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL------SKEFVADETERAYDFCGTI 224

Query: 189 -YRAPEILISNRR-YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
            Y AP+I+      +   VD WSLG ++ E+L     F      +    I   +  + P 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
             +           A DL+ ++L+ +P +R
Sbjct: 285 YPQEM------SALAKDLIQRLLMKDPKKR 308

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  113 bits (284), Expect = 7e-29
 Identities = 48/297 (16%), Positives = 110/297 (37%), Gaps = 48/297 (16%)

Query: 26  TIHKRIGKGAYGIVYKA-------YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
             ++ +G+G +  ++K        Y + ++  V +K + +A RN +++   +     +  
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSK 68

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNG 135
              H +++    +   V   +  +V E+++   L+  ++     +  +    +  QL   
Sbjct: 69  L-SHKHLVLNYGV--CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCS--------IKIGDLGLARSLSDSKECLTEY--IA 185
           + ++    ++H ++   NIL+ +           IK+ D G++ ++        +     
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQER 180

Query: 186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPN 243
             W   PE + + +      D WS G  L E+     KP      +  +LQ   +  +  
Sbjct: 181 IPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYEDRHQLP 238

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI---LEHNYVSKYFPSATH 297
            P A +             +L+N  +   P  RP    I   L   +     P  +H
Sbjct: 239 APKAAELA-----------NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  114 bits (287), Expect = 8e-29
 Identities = 76/264 (28%), Positives = 113/264 (42%), Gaps = 28/264 (10%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + ++ +HK +GKG++G V+ A  K   Q+ AIK +  +      D + T  E   L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSY 138
            HP +  M         ++L+ V EY+   DL   I            +   ++  GL +
Sbjct: 76  EHPFLTHMF--CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAP 192
           +H+  +++RDLK  NIL+DK   IKI D G+       KE +     T        Y AP
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGM------CKENMLGDAKTNTFCGTPDYIAP 187

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           EIL   ++Y H VD WS G +L EML  +  F G         I       P        
Sbjct: 188 EIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL----- 241

Query: 253 GFKNKPEEAVDLLNQILVLNPSER 276
                 +EA DLL ++ V  P +R
Sbjct: 242 -----EKEAKDLLVKLFVREPEKR 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  114 bits (287), Expect = 9e-29
 Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 32/266 (12%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
           +  +   + +GKG++G V  A  K      A+K + +      +  +   T + IL L  
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGL 136
              HP +  +           L+ V E++   DL   + + +   +   R+   ++ + L
Sbjct: 82  --NHPFLTQLF--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YR 190
            ++H   +++RDLK  N+L+D     K+ D G+       KE +   + T        Y 
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM------CKEGICNGVTTATFCGTPDYI 191

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APEIL     Y   VD W++G +L EML     F   +     + I+N     P      
Sbjct: 192 APEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL--- 247

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
                   E+A  +L   +  NP+ R
Sbjct: 248 -------HEDATGILKSFMTKNPTMR 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (284), Expect = 9e-29
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 51/228 (22%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
            + + +G+GA+G V+ A         +K  VA+K + +     T A R    RE   L +
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTN 73

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-----------------DK 118
            Q H +I+        V  +   L +VFEYM++ DLNK +R                   
Sbjct: 74  LQ-HEHIVKFY----GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 119 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
            L    + +I  Q+ +G+ Y+ +   +HRDL   N L+  +  +KIGD G++R +     
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS--- 185

Query: 179 CLTEYIAT--------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
             T+Y           RW   PE  I  R++T   D+WS G IL E+ 
Sbjct: 186 --TDYYRVGGHTMLPIRWM-PPES-IMYRKFTTESDVWSFGVILWEIF 229

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (284), Expect = 9e-29
 Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 44/281 (15%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH 82
              + IGKG +G+VY         N+   AIK +          +   RE L ++    H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGL-NH 81

Query: 83  PNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGL 136
           PN++ ++     +        +V+  YM + DL + IR   +      +     Q+  G+
Sbjct: 82  PNVLALI----GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT---------- 186
            Y+   K +HRDL   N ++D+S ++K+ D GLAR + D      EY +           
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----REYYSVQQHRHARLPV 192

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRPNP 244
           +W  A E L    R+T   D+WS G +L E+L   + P +           +    R   
Sbjct: 193 KWT-ALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFLAQGRRLPQ 249

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           P            P+    ++ Q    +P+ RP    ++  
Sbjct: 250 PE---------YCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (286), Expect = 1e-28
 Identities = 65/308 (21%), Positives = 107/308 (34%), Gaps = 75/308 (24%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
              K +G GA+G V  A             VA+K + E       ++R     E+  +  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREALMSELKMMTQ 104

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK----------------- 118
              H NI+ +L         +  +Y++FEY    DL   +R K                 
Sbjct: 105 LGSHENIVNLL----GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 119 -------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR 171
                  +L    +    +Q+  G+ ++     +HRDL   N+L+     +KI D GLAR
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 172 SLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKP 222
            +         Y+         +W  APE  +    YT   D+WS G +L E+  L   P
Sbjct: 221 DIMSDS----NYVVRGNARLPVKWM-APE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

Query: 223 LFPGASTSHQLQLIVNLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERP 277
            +PG            L++       P +A           EE   ++      +  +RP
Sbjct: 275 -YPGIPVDANF---YKLIQNGFKMDQPFYA----------TEEIYIIMQSCWAFDSRKRP 320

Query: 278 ETDQILEH 285
               +   
Sbjct: 321 SFPNLTSF 328

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (292), Expect = 2e-28
 Identities = 58/267 (21%), Positives = 105/267 (39%), Gaps = 36/267 (13%)

Query: 26  TIHKRIGKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
                +G G +G V +     +  +  VAIK + +      D +   RE   +     +P
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQL-DNP 396

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
            I+ ++ +      + L +V E      L+K +    + +   ++  ++ Q+  G+ Y+ 
Sbjct: 397 YIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 453

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------RWYRAPE 193
               +HR+L   N+L+      KI D GL+++L         Y A        +WY APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWPLKWY-APE 509

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVR-PNPPHADKF 250
             I+ R+++   D+WS G  + E L    KP +        +  I    R   PP     
Sbjct: 510 C-INFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECPPEC--- 564

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERP 277
                  P E   L++   +    +RP
Sbjct: 565 -------PPELYALMSDCWIYKWEDRP 584

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (281), Expect = 4e-28
 Identities = 71/294 (24%), Positives = 108/294 (36%), Gaps = 61/294 (20%)

Query: 26  TIHKRIGKGAYGIVYKAY--DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQR 81
                IG+G +G V KA       +   AIK++ E     +         E+  L     
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGH 84

Query: 82  HPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-----------------DKILK 121
           HPNII +L        +   LY+  EY  + +L   +R                    L 
Sbjct: 85  HPNIINLL----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT 181
              + +    +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R          
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------- 193

Query: 182 EYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQ 232
            Y+         RW  A E L     YT + D+WS G +L E+  L   P + G + +  
Sbjct: 194 VYVKKTMGRLPVRWM-AIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAEL 250

Query: 233 LQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            + +    R   P +            +E  DL+ Q     P ERP   QIL  
Sbjct: 251 YEKLPQGYRLEKPLNC----------DDEVYDLMRQCWREKPYERPSFAQILVS 294

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  115 bits (289), Expect = 4e-28
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 32/266 (12%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
           L ++     +GKG++G V  +  K   +  A+K + +      +  +     + +L L  
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGL 136
             + P +  +           LY V EY+   DL   + +    K+ H  +   ++  GL
Sbjct: 400 --KPPFLTQLH--SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YR 190
            ++ +  +++RDLK  N+++D    IKI D G+       KE + + + T+       Y 
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYI 509

Query: 191 APEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF 250
           APEI+ + + Y   VD W+ G +L EML  +  F G       Q I+      P      
Sbjct: 510 APEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM--- 565

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSER 276
                   +EAV +   ++  +P +R
Sbjct: 566 -------SKEAVAICKGLMTKHPGKR 584

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (279), Expect = 7e-28
 Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 64/295 (21%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
           T+ + +G+G++G+VY+           +  VAIK + E     +  +R     E   +K 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKE 84

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-----------DKILKDVH 124
           F    +++ +L     V    +   V+ E M   DL   +R                   
Sbjct: 85  F-NCHHVVRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 125 IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYI 184
           +  +  ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R + +     T+Y 
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----TDY- 193

Query: 185 ATRWYR------------APEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTS 230
               YR            +PE L  +  +T + D+WS G +L E+  L  +P + G S  
Sbjct: 194 ----YRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNE 247

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             L+ ++     + P          N P+   +L+      NP  RP   +I+  
Sbjct: 248 QVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (279), Expect = 7e-28
 Identities = 66/299 (22%), Positives = 112/299 (37%), Gaps = 66/299 (22%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
              K +G GA+G V +A       ++    VA+K +          ++     E+  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS---TAHADEKEALMSELKIMSH 105

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---------------IL 120
             +H NI+ +L        +   + V+ EY    DL   +R K                 
Sbjct: 106 LGQHENIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 121 KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
               + +   Q+  G++++ +   +HRD+   N+L+      KIGD GLAR + +     
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--- 218

Query: 181 TEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSH 231
             YI         +W  APE +  +  YT   D+WS G +L E+  L   P +PG   + 
Sbjct: 219 -NYIVKGNARLPVKWM-APESIF-DCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNS 274

Query: 232 QLQLIVNLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           +      LV+       P  A          P+    ++     L P+ RP   QI   
Sbjct: 275 KF---YKLVKDGYQMAQPAFA----------PKNIYSIMQACWALEPTHRPTFQQICSF 320

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 8e-28
 Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 63/299 (21%)

Query: 26  TIHKRIGKGAYGIVYKAY-------DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFL 76
            + K +G+GA+G V  A          N    VA+K +     + T+   +    E+  +
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMM 128

Query: 77  KSFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR----------------- 116
           K   +H NII +L         +  LYV+ EY    +L + ++                 
Sbjct: 129 KMIGKHKNIINLL----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 117 DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS 176
           ++ L    +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +   
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 177 KECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGA 227
                 Y  T       +W  APE L  +R YTH  D+WS G +L E+  L   P +PG 
Sbjct: 245 D----YYKKTTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGV 297

Query: 228 STSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                 +L+    R   P +             E   ++       PS+RP   Q++E 
Sbjct: 298 PVEELFKLLKEGHRMDKPSNC----------TNELYMMMRDCWHAVPSQRPTFKQLVED 346

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  112 bits (281), Expect = 8e-28
 Identities = 59/283 (20%), Positives = 117/283 (41%), Gaps = 48/283 (16%)

Query: 26  TIHKRIGKGAYGIVYKAY---DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKSFQ 80
             ++ IG+G +G VY      +   K + A+K +          + +    E + +K F 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDF- 147

Query: 81  RHPNIITMLDIYKAV---NNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCN 134
            HPN++++L     +   +     VV  YM++ DL   IR          +     Q+  
Sbjct: 148 SHPNVLSLL----GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT-------- 186
           G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D      E+ +         
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KEFDSVHNKTGAKL 258

Query: 187 --RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ--SKPLFPGASTSHQLQLIVNLVRP 242
             +W  A E  +  +++T   D+WS G +L E++   + P +P  +T      ++   R 
Sbjct: 259 PVKWM-ALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRL 315

Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             P            P+   +++ +        RP   +++  
Sbjct: 316 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  110 bits (278), Expect = 1e-27
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 37/270 (13%)

Query: 22  LAEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAF--RNKTDAQRTY--REIL 74
              + + + +GKG YG V+   K    N  +  A+K + +A   RN  D   T   R IL
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 75  FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQL 132
                 +HP I+ +  IY       LY++ EY+   +L  ++ R+ I  +    + + ++
Sbjct: 76  ---EEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130

Query: 133 CNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR-SLSDSKECLT-----EYIAT 186
              L ++H   +++RDLKP NI+++    +K+ D GL + S+ D     T     EY+  
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM-- 188

Query: 187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH 246
               APEIL     +   VD WSLG ++ +ML   P F G +    +  I+      PP+
Sbjct: 189 ----APEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243

Query: 247 ADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
                       +EA DLL ++L  N + R
Sbjct: 244 L----------TQEARDLLKKLLKRNAASR 263

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  110 bits (277), Expect = 1e-27
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 62/296 (20%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
            +   +G+GA+G V+ A       + +K  VA+K + EA    +++ R    RE   L  
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTM 99

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR----------------DKI 119
             +H +I+        V    + L +VFEYM + DLN+ +R                   
Sbjct: 100 L-QHQHIVRFF----GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154

Query: 120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC 179
           L    +  +  Q+  G+ Y+     +HRDL   N L+ +   +KIGD G++R +      
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---- 210

Query: 180 LTEY--------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAST 229
            T+Y        +  RW   PE  I  R++T   D+WS G +L E+     +P +   S 
Sbjct: 211 -TDYYRVGGRTMLPIRWM-PPES-ILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQLSN 266

Query: 230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           +  +  I        P            P E   ++       P +R     +   
Sbjct: 267 TEAIDCITQGRELERPR---------ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  110 bits (278), Expect = 2e-27
 Identities = 69/267 (25%), Positives = 116/267 (43%), Gaps = 34/267 (12%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKS 78
            +++   K IGKG++G V  A  K  + + A+K   K     + +     + R +L    
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN--DL-NKVIRDKILKDVHIRYIMFQLCNG 135
             +HP ++ +   +       LY V +Y+ N  +L   + R++   +   R+   ++ + 
Sbjct: 97  --KHPFLVGL--HFSFQTADKLYFVLDYI-NGGELFYHLQRERCFLEPRARFYAAEIASA 151

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------Y 189
           L Y+H+  +++RDLKP NIL+D    I + D GL       KE +     T        Y
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL------CKENIEHNSTTSTFCGTPEY 205

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            APE+L   + Y   VD W LG +L EML   P F   +T+     I+N      P+   
Sbjct: 206 LAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI-- 262

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER 276
                      A  LL  +L  + ++R
Sbjct: 263 --------TNSARHLLEGLLQKDRTKR 281

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  108 bits (273), Expect = 3e-27
 Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 60/296 (20%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
              + +G+  +G VYK +          Q VAIK + +         R     E +    
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD---KAEGPLREEFRHEAMLRAR 68

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR-----------------DK 118
             +HPN++ +L     V   ++ L ++F Y  + DL++ +                    
Sbjct: 69  L-QHPNVVCLL----GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 119 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
            L+     +++ Q+  G+ Y+ +  V+H+DL   N+L+    ++KI DLGL R +  +  
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-- 181

Query: 179 CLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGAST 229
               Y          RW  APE  I   +++   DIWS G +L E+     +P + G S 
Sbjct: 182 --DYYKLLGNSLLPIRWM-APEA-IMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSN 236

Query: 230 SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              +++I N      P          + P     L+ +     PS RP    I   
Sbjct: 237 QDVVEMIRNRQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  107 bits (270), Expect = 1e-26
 Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 35/268 (13%)

Query: 22  LAEYTIHKRIGKGAYGIVY---KAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFL 76
            +++ + K +G+G++G V+   K    + +Q  A+K + +A     D  RT   R+IL  
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL-- 80

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCN 134
                HP I+ +   Y       LY++ +++   DL  ++ ++ +  +  +++ + +L  
Sbjct: 81  -VEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------ 188
            L ++H+  +++RDLKP NIL+D+   IK+ D GL      SKE +              
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL------SKESIDHEKKAYSFCGTVE 191

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           Y APE++ + R +T   D WS G ++ EML     F G      + +I+      P    
Sbjct: 192 YMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL- 249

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSER 276
                      EA  LL  +   NP+ R
Sbjct: 250 ---------SPEAQSLLRMLFKRNPANR 268

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/267 (25%), Positives = 116/267 (43%), Gaps = 34/267 (12%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
           + E+   K +GKG +G V    +K   +Y A+K + +     +++     T   +L    
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL---Q 203

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDL-NKVIRDKILKDVHIRYIMFQLCNGL 136
             RHP +  +   Y    +  L  V EY    +L   + R+++  +   R+   ++ + L
Sbjct: 204 NSRHPFLTALK--YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 137 SYIHACK-VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------Y 189
            Y+H+ K V++RDLK  N+++DK   IKI D GL       KE + +    +       Y
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEY 315

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            APE+L  +  Y   VD W LG ++ EM+  +  F         +LI+      P     
Sbjct: 316 LAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL-- 372

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSER 276
                     EA  LL+ +L  +P +R
Sbjct: 373 --------GPEAKSLLSGLLKKDPKQR 391

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  107 bits (270), Expect = 2e-26
 Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 37/273 (13%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A+K +  E   +  D      E    +   
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +           L+ V EY+   DL   + R + L + H R+   ++   L+Y
Sbjct: 68  NHPFLVGLH--SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAP 192
           +H   +++RDLK  N+L+D    IK+ D G+       KE L     T        Y AP
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAP 179

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFP---------GASTSHQLQLIVNLVRPN 243
           EIL     Y   VD W+LG ++ EM+  +  F            +  +  Q+I+      
Sbjct: 180 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
           P               +A  +L   L  +P ER
Sbjct: 239 PRSL----------SVKAASVLKSFLNKDPKER 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (268), Expect = 2e-26
 Identities = 69/305 (22%), Positives = 114/305 (37%), Gaps = 70/305 (22%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
            + K +G+G +G V KA       +     VA+K + E   N + ++      E   LK 
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDLLSEFNVLKQ 82

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR------------------- 116
              HP++I +          +  L ++ EY +   L   +R                   
Sbjct: 83  VN-HPHVIKLY----GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 117 ------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 170
                 ++ L    +    +Q+  G+ Y+   K++HRDL   NIL+ +   +KI D GL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 171 RSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSK 221
           R + +       Y+         +W  A E L  +  YT   D+WS G +L E+  L   
Sbjct: 198 RDVYEED----SYVKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGN 251

Query: 222 PLFPGASTSHQLQLIVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETD 280
           P +PG        L+    R   P +            EE   L+ Q     P +RP   
Sbjct: 252 P-YPGIPPERLFNLLKTGHRMERPDNC----------SEEMYRLMLQCWKQEPDKRPVFA 300

Query: 281 QILEH 285
            I + 
Sbjct: 301 DISKD 305

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (266), Expect = 5e-26
 Identities = 66/291 (22%), Positives = 109/291 (37%), Gaps = 56/291 (19%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
           T+ + +G GA+G VY+       +  +   VA+K + E     ++        E L +  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISK 89

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--------DKILKDVHIRY 127
           F  H NI+  +     V   +   +++ E M   DL   +R           L  + + +
Sbjct: 90  F-NHQNIVRCI----GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLTEYI 184
           +   +  G  Y+     +HRD+   N L+         KIGD G+AR +         Y 
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----ASYY 199

Query: 185 AT--------RWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
                     +W   PE  +    +T   D WS G +L E+  L   P +P  S    L+
Sbjct: 200 RKGGCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLE 256

Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            + +  R +PP          N P     ++ Q     P +RP    ILE 
Sbjct: 257 FVTSGGRMDPPK---------NCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  107 bits (268), Expect = 7e-26
 Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 37/273 (13%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ + + IG+G+Y  V     K   +  A++ +  E   +  D      E    +   
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DL-NKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP ++ +           L+ V EY+   DL   + R + L + H R+   ++   L+Y
Sbjct: 111 NHPFLVGLH--SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW------YRAP 192
           +H   +++RDLK  N+L+D    IK+ D G+       KE L     T        Y AP
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAP 222

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFP---------GASTSHQLQLIVNLVRPN 243
           EIL     Y   VD W+LG ++ EM+  +  F            +  +  Q+I+      
Sbjct: 223 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSER 276
           P               +A  +L   L  +P ER
Sbjct: 282 PRSL----------SVKAASVLKSFLNKDPKER 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (261), Expect = 4e-25
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 56/291 (19%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
           T+ + +G GA+G VY+       +  +   VA+K + E     ++        E L +  
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISK 130

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR--------DKILKDVHIRY 127
           F  H NI+  +     V   +   +++ E M   DL   +R           L  + + +
Sbjct: 131 F-NHQNIVRCI----GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 128 IMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLSDSKECLTEY- 183
           +   +  G  Y+     +HRD+   N L+         KIGD G+AR +         Y 
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----AGYY 240

Query: 184 -------IATRWYRAPEILISNRRYTHHVDIWSLGCILAEM--LQSKPLFPGASTSHQLQ 234
                  +  +W   PE  +    +T   D WS G +L E+  L   P +P  S    L+
Sbjct: 241 RKGGCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLE 297

Query: 235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            + +  R +PP          N P     ++ Q     P +RP    ILE 
Sbjct: 298 FVTSGGRMDPPK---------NCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  102 bits (256), Expect = 1e-24
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 56/235 (23%)

Query: 26  TIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRT--YREILFLKS 78
              + IG+GA+G V++A             VA+K + E     +   +    RE   +  
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAE 106

Query: 79  FQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIR------------------- 116
           F  +PNI+ +L     V    K + ++FEYM   DLN+ +R                   
Sbjct: 107 F-DNPNIVKLL----GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161

Query: 117 ------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA 170
                    L       I  Q+  G++Y+   K +HRDL   N L+ ++  +KI D GL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 171 RSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEML 218
           R++  +      Y A        RW   PE +    RYT   D+W+ G +L E+ 
Sbjct: 222 RNIYSAD----YYKADGNDAIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIF 270

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 18/199 (9%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-RTYREILFLKSFQRHPNIITML 89
           +G+G +G VYK    +    VA+K++ E      + Q +T  E+  + S   H N++ + 
Sbjct: 38  LGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQT--EVEMI-SMAVHRNLLRLR 93

Query: 90  DIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRY-IMFQLCNGLSYIH-AC 142
                   + L  V+ YM N      L +    +   D   R  I      GL+Y+H  C
Sbjct: 94  GFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151

Query: 143 --KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-TRWYRAPEILISNR 199
             K++HRD+K +NIL+D+     +GD GLA+ +      +T  +  T  + APE L + +
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211

Query: 200 RYTHHVDIWSLGCILAEML 218
             +   D++  G +L E++
Sbjct: 212 S-SEKTDVFGYGVMLLELI 229

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 31  IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ-----RTYREILFLKSFQRHPNI 85
           IG G +G VYK   ++  + VA+K+     R    +Q      T  EI  L SF RHP++
Sbjct: 47  IGHGVFGKVYKGVLRDGAK-VALKR-----RTPESSQGIEEFET--EIETL-SFCRHPHL 97

Query: 86  ITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVH----IRY-IMFQLCNGLSYI 139
           ++++      N   L  +++YMEN +L + +    L  +      R  I      GL Y+
Sbjct: 98  VSLIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEI 194
           H   ++HRD+K  NIL+D++   KI D G+++  ++  +    +++T       Y  PE 
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEY 212

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKP 222
            I   R T   D++S G +L E+L ++ 
Sbjct: 213 FIKG-RLTEKSDVYSFGVVLFEVLCARS 239

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 83.8 bits (206), Expect = 4e-18
 Identities = 39/247 (15%), Positives = 78/247 (31%), Gaps = 60/247 (24%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI------FEAFRNKTDAQRTYREILFLK 77
           +    ++IG+G +G V++    +    VAIK I           ++   +    EI+  K
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 78  SFQ--------RHPNIITMLDIY----------------------------KAVNNKDLY 101
                      R    I +  ++                                +  L+
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 102 VVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKS 159
           +V E+       + +R K+      + I+ QL   L+    + +  HRDL   N+L+ K+
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198

Query: 160 CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ 219
              K+      +S           I +   +   I  +  R            +  ++  
Sbjct: 199 SLKKLHYTLNGKSS---------TIPSCGLQVSIIDYTLSRLE-----RDGIVVFCDVSM 244

Query: 220 SKPLFPG 226
            + LF G
Sbjct: 245 DEDLFTG 251

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 36/208 (17%)

Query: 30  RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQ--RTYR-EILFLKSFQRHPNII 86
           ++G+G +G+VYK Y  N    VA+KK+  A  + T  +  + +  EI  +   Q H N++
Sbjct: 38  KMGEGGFGVVYKGYVNN--TTVAVKKL-AAMVDITTEELKQQFDQEIKVMAKCQ-HENLV 93

Query: 87  TMLDIYKAVNNKDLYVVFEYMEND-----LNKVIRDKILKDVHIRY-IMFQLCNGLSYIH 140
            +L      ++  L  V+ YM N      L+ +     L   H+R  I     NG++++H
Sbjct: 94  ELLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPL-SWHMRCKIAQGAANGINFLH 150

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRW-----YRAPEIL 195
               +HRD+K +NIL+D++ + KI D GLAR+     +     + +R      Y APE  
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ---TVMTSRIVGTTAYMAPE-- 205

Query: 196 ISNRRY-----THHVDIWSLGCILAEML 218
                      T   DI+S G +L E++
Sbjct: 206 -----ALRGEITPKSDIYSFGVVLLEII 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + ++IG G++G +Y   D    + VAIK   E    KT   + + E    K  Q    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LE--CVKTKHPQLHIESKIYKMMQGGVG 66

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIH 140
           I T+   +         +V E +   L  +         LK V +  +  Q+ + + YIH
Sbjct: 67  IPTI--RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIH 122

Query: 141 ACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRW---YRAPEI 194
           +   +HRD+KP N L+    K   + I D GLA+   D++        T     YR  + 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR--------THQHIPYRENKN 174

Query: 195 LISNRRY----TH-------HVDIWSLGCILAEML 218
           L    RY    TH         D+ SLG +L    
Sbjct: 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + +RIG+G++G++++  +  N Q VAIK  FE    ++DA +   E    K       
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FE--PRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 85  IITMLDIYKAVNNKDLYVVFEYM----ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I  +   Y         +V + +    E+ L+   R   +K V +     Q+   +  IH
Sbjct: 68  IPNV--YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIH 123

Query: 141 ACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
              +++RD+KP N LI +  S     I + D G+ +   D      ++I    YR  + L
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIP---YREKKNL 178

Query: 196 ISNRRY----TH-------HVDIWSLGCILAEML 218
               RY    TH         D+ +LG +    L
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 33/214 (15%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + K+IG G +G +    +    +YVAIK   E    K+ A + + E  F K       
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LE--PMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIH 140
           I  +   Y     K   +V E +   L  +         LK V +  I  QL + + Y+H
Sbjct: 67  IPQV--YYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYVH 122

Query: 141 ACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           +  +++RD+KP N LI +  +     I I D  LA+   D +    ++I    YR  + L
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--KHIP---YREHKSL 177

Query: 196 ISNRRY----TH-------HVDIWSLGCILAEML 218
               RY    TH         D+ +LG +    L
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 31/212 (14%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + + ++IG G++G +Y   +    + VAIK   E    KT   +   E    +  Q    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LE--NVKTKHPQLLYESKIYRILQGGTG 64

Query: 85  IITMLDIYKAVNNKDLYVVFEYM----ENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I  +   +  V      +V + +    E+  N   R   LK V +  +  Q+ N + ++H
Sbjct: 65  IPNV--RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFVH 120

Query: 141 ACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           +   +HRD+KP N L+    ++  + I D GLA+   D+     ++I    YR  + L  
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIP---YRENKNLTG 175

Query: 198 NRRY----TH-------HVDIWSLGCILAEML 218
             RY    TH         D+ SLG +L   L
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)

Query: 106 YMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG 165
             E +  + +    L   H+    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI 
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 166 DLGLARSLSDSKECLTEYIAT-------RWYRAPEILISNRRYTHHVDIWSLGCILAEM- 217
           D GLAR +        +Y+         +W  APE +  +R YT   D+WS G +L E+ 
Sbjct: 236 DFGLARDIYKDP----DYVRKGDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIF 289

Query: 218 -LQSKPLFPGASTSHQLQLIVNLVR-----PNPPHADKFYAGFKNKPEEAVDLLNQILVL 271
            L + P +PG     +       ++       P +             E    +      
Sbjct: 290 SLGASP-YPGVKIDEEF---CRRLKEGTRMRAPDYT----------TPEMYQTMLDCWHG 335

Query: 272 NPSERPETDQILEH 285
            PS+RP   +++EH
Sbjct: 336 EPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 39/177 (22%), Positives = 67/177 (37%), Gaps = 9/177 (5%)

Query: 26  TIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
            + K +G+GA+G V +A     DK         K+ +     ++ +    E+  L     
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           H N++ +L          L V+ E+ +  +L+  +R K  + V  +    +   G  Y+ 
Sbjct: 85  HLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           A      DLK     I  S S         +SLSD +E        + +   E LI 
Sbjct: 144 AI---PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 31/174 (17%), Positives = 68/174 (39%), Gaps = 24/174 (13%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           ++ + K+IG G +G++Y A+  N  +  A   +  E      +    + E+ F +   + 
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE----YQENGPLFSELKFYQRVAKK 93

Query: 83  PNIITMLDIYK---------------AVNNKDLYV-VFEYMENDLNKVIR-DKILKDVHI 125
             I   ++  +                   +     V E +  DL K+   +   K   +
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV 153

Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSK 177
             +  ++ + L YIH  + +H D+K +N+L+       + + D GL+     + 
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 33/176 (18%), Positives = 63/176 (35%), Gaps = 25/176 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
            + +   IG+G +G +Y A   +++  V            +D    + E+ F +   +  
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 84  NIITMLDIYK---------------AVNNKDLYV-VFEYMENDLNKVIRDKI----LKDV 123
            I   +   K                 N K     + +   +DL K+          K V
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSK 177
               +  ++ + L YIH  + +H D+K SN+L++      + + D GLA       
Sbjct: 155 LQ--LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 26/181 (14%), Positives = 61/181 (33%), Gaps = 33/181 (18%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKN--------NKQYVAIKKIFEAFRNKTDAQRTYREILF 75
           ++ +     +   GI+Y+A   +         KQ  ++K   +A        R + E  F
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK--LDA-----KDGRLFNEQNF 95

Query: 76  LKSFQRHPNIITMLDIYKAVN-----------NKDLY--VVFEYMENDLNKVIRDKILKD 122
            +   +   +     +Y               ++D Y  +V   +   L   +       
Sbjct: 96  FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155

Query: 123 VHIR---YIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSK 177
           +  R    +  +L + L ++H  + +H ++   NI +  +    + +   G A     S 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 178 E 178
           +
Sbjct: 216 K 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 2e-11
 Identities = 52/363 (14%), Positives = 104/363 (28%), Gaps = 96/363 (26%)

Query: 36  YGIVYKAYDKNNKQYVAIKKIFEAFRNK--TDAQR-----TYREILF------LKSFQRH 82
           Y  +        +Q   + +++   R++   D Q        R   +      L   +  
Sbjct: 91  YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA 150

Query: 83  PNIIT--MLDIYKAVNNKDLYVVFEYMENDL-NKVIRDKILKDV---HIRYIMFQLCN-- 134
            N++   +L   K                 +   V     ++      I ++  + CN  
Sbjct: 151 KNVLIDGVLGSGKTW---------------VALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
                   K++++         D S +IK+        +   +  L   + ++ Y     
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKL-------RIHSIQAELRRLLKSKPY--ENC 246

Query: 195 LISNRRYTHHV--DIWSLGCILAEMLQSKPLFPGASTSHQLQLI--VNLVRPNPPHADKF 250
           L+        V  ++ +     A  L  K L     T+   Q+   ++         D  
Sbjct: 247 LL--------VLLNVQNAKAWNAFNLSCKILL----TTRFKQVTDFLSAATTTHISLDHH 294

Query: 251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLD 310
                  P+E   LL + L   P + P   ++L  N      P    +I +         
Sbjct: 295 SMTL--TPDEVKSLLLKYLDCRPQDLPR--EVLTTN------PRRLSIIAE-------SI 337

Query: 311 IDDNNQLE-INDYQ-DKLYDIVKSCKKKKSVKRLSKGNALDNTLRGHYK---I--KDA-I 362
            D     +       DKL  I++S     S+  L          R  +    +    A I
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIES-----SLNVLE-----PAEYRKMFDRLSVFPPSAHI 387

Query: 363 SSK 365
            + 
Sbjct: 388 PTI 390

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 57/420 (13%), Positives = 121/420 (28%), Gaps = 151/420 (35%)

Query: 67  QRTYREIL--FLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH 124
           Q  Y++IL  F  +F               V+N D   V +  ++ L+K   D I+    
Sbjct: 15  QYQYKDILSVFEDAF---------------VDNFDCKDVQDMPKSILSKEEIDHIIMSKD 59

Query: 125 ----IRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECL 180
                  + + L +               K   ++             +   L  + + L
Sbjct: 60  AVSGTLRLFWTLLS---------------KQEEMV----------QKFVEEVLRINYKFL 94

Query: 181 TEYIATRWYRAPEILIS------NRRYT-------HHV----DIWSLGCILAEMLQSKPL 223
              I T   R P ++        +R Y        ++V        L   L E+  +K +
Sbjct: 95  MSPIKTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153

Query: 224 F----PGASTSHQLQLIVNLVRPNPPHADKFYAGF------KNKPEEAVDLLNQI---LV 270
                 G+  +    + +++           +  F       N PE  +++L ++   + 
Sbjct: 154 LIDGVLGSGKT---WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210

Query: 271 LNPSERPETDQILEHN------YVSKYFPSATHVIPQVTPHT-VVLDIDDNNQLEINDYQ 323
            N + R +    ++         + +   S  +       +  +VL           + Q
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY------ENCLLVLL----------NVQ 254

Query: 324 DKLYDIVK----SCK-----KKKSVKRLSKGNALDNTLRGHYKIKD-----------AIS 363
           +           SCK     + K V      + L      H  +             ++ 
Sbjct: 255 NA--KAWNAFNLSCKILLTTRFKQVT-----DFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 364 SKYTSSEK-------------------ENQQNNNNTAPSYKNVNVNTTESVQRR--DKLE 402
            KY                        E+ ++   T  ++K+VN +   ++     + LE
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	404
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.91
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.05
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.97
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.35
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.3
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.15
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.97
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.7
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.03
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.84
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.12
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.35

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-65  Score=494.82  Aligned_cols=310  Identities=39%  Similarity=0.702  Sum_probs=256.7

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--   95 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--   95 (404)
                      .+.+.++|++++.||+|+||+||+|.++.+|+.||||++.+.........++.+|+.+|+.+. |||||++++++...  
T Consensus        49 ~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           49 TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSC
T ss_pred             CCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccc
Confidence            345667899999999999999999999999999999999877777777888999999999997 99999999998632  


Q ss_pred             --cCCeEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 --NNKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 --~~~~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                        +...+|||||||+|+|.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       128 ~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          128 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             cccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence              346899999999999999887 46799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC----CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC--
Q psy14434        173 LSDS----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH--  246 (404)
Q Consensus       173 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  246 (404)
                      +...    .....+.+||++|||||++.+...++.++||||+||++|||++|++||.+.+...++..+....+..+..  
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            6432    2334568999999999998766778999999999999999999999999999999999998876643321  


Q ss_pred             -------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcc
Q psy14434        247 -------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTV  307 (404)
Q Consensus       247 -------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~  307 (404)
                                         ...+...++.+++++.+||.+||.+||.+|||+.++|+||||+++..+...   +......
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~---p~~~~~~  364 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE---PDCAPPF  364 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGS---CCCSSCC
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccc---cCCCCCC
Confidence                               112233456789999999999999999999999999999999987654432   1111122


Q ss_pred             cccCCCCCcCCHHHHHHHHHHHHHh
Q psy14434        308 VLDIDDNNQLEINDYQDKLYDIVKS  332 (404)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~  332 (404)
                      ..++ +......+++++.+++.+..
T Consensus       365 ~~~~-~~~~~~~~~~k~~i~~ei~~  388 (398)
T 4b99_A          365 DFAF-DREALTRERIKEAIVAEIED  388 (398)
T ss_dssp             CCHH-HHSCCCHHHHHHHHHHHHHH
T ss_pred             CCcc-chhhcCHHHHHHHHHHHHHH
Confidence            1111 12345677888888777643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-65  Score=485.48  Aligned_cols=261  Identities=25%  Similarity=0.494  Sum_probs=231.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...+.|+++++||+|+||+||+|.++.+|+.||||++......  ....+.+|+.+|+.+. |||||+++++|.  +...
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~-HpnIV~l~~~~~--~~~~  145 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDE  145 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCC-CTTBCCEEEEEE--ETTE
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence            4456799999999999999999999999999999999654332  3345779999999997 999999999998  5778


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|||||||+| +|.+++..+.+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       146 ~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999995 899999988999999999999999999999999999999999999999999999999999998766656


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ...+.+||+.|||||++ .+..|+.++|||||||++|||++|++||.+.+....+..+.....+...       .+..+|
T Consensus       226 ~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-------~~~~~s  297 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-------NLHKVS  297 (346)
T ss_dssp             CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS-------CGGGSC
T ss_pred             cccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC-------ccccCC
Confidence            66788999999999998 5677999999999999999999999999998888887777665433222       224679


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      +++.+||.+||+.||.+|||+.|+|+||||++..+
T Consensus       298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            99999999999999999999999999999987554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.4e-66  Score=487.48  Aligned_cols=263  Identities=29%  Similarity=0.535  Sum_probs=228.6

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .++.+.-+++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|+++. |||||+++++|+ 
T Consensus        16 en~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~-   93 (350)
T 4b9d_A           16 ENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFE-   93 (350)
T ss_dssp             CCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred             cccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEE-
Confidence            345566678999999999999999999999999999999999877777777888999999999997 999999999998 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                       +...+|||||||+ |+|.+++..   ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus        94 -~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           94 -ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             -ETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             -ECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence             5778999999998 599999863   24799999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      +..........+.+||+.|||||++ .+..|+.++|||||||++|+|++|++||.+.+....+..+.....+..      
T Consensus       173 ~~~~~~~~~~~~~~GT~~YmAPE~l-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~------  245 (350)
T 4b9d_A          173 RVLNSTVELARACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV------  245 (350)
T ss_dssp             SCCCHHHHHHHHHHSCCTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------
T ss_pred             eeecCCcccccccCCCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC------
Confidence            8775443444667899999999998 567799999999999999999999999999988888887776544322      


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ...+|+++.+||.+||+.||.+|||+.++|+||||++
T Consensus       246 ---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          246 ---SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence               1467999999999999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-65  Score=469.66  Aligned_cols=259  Identities=31%  Similarity=0.503  Sum_probs=209.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      |..+++|++.+.||+|+||+||+|.++.+|+.||||++.+.... .....++.+|+.+++.+. ||||++++++|.  +.
T Consensus         9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~   85 (275)
T 3hyh_A            9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIK--SK   85 (275)
T ss_dssp             -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--EC
Confidence            56678999999999999999999999999999999999765433 334567889999999997 999999999997  57


Q ss_pred             CeEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         98 KDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        98 ~~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..+|||||||+|+|.+.+. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        86 ~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           86 DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            7899999999999988876 467999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                       ....+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+.......+.+.....+          ..
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----------~~  234 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----------KF  234 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----------TT
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----------CC
Confidence             3345678999999999986555567899999999999999999999999888777777766543322          35


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       235 ~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          235 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence            68999999999999999999999999999999753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-65  Score=474.57  Aligned_cols=261  Identities=25%  Similarity=0.460  Sum_probs=229.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+++. |||||+++++|+  +...
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~  106 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEK  106 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCE
Confidence            34679999999999999999999999999999999976532 3345677889999999997 999999999998  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-  176 (404)
                      +|||||||.| +|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... 
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999995 99998874 67999999999999999999999999999999999999999999999999999876533 


Q ss_pred             -CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        177 -KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       177 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .....+.+||+.|||||++ .+..|+.++|||||||++|+|++|++||.+.+....+..+.+.....+          .
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----------~  255 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----------E  255 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHH-HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----------T
T ss_pred             CcccccCcccCcccCCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------c
Confidence             2345678999999999998 466789999999999999999999999999988888888776543222          3


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHH------HHhccCCCCcCCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQ------ILEHNYVSKYFPSA  295 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~------ll~hp~~~~~~~~~  295 (404)
                      .+++++++||.+||+.||.+|||++|      +++||||+.+.+..
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence            56899999999999999999999987      68999999876654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-64  Score=487.17  Aligned_cols=262  Identities=26%  Similarity=0.500  Sum_probs=232.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +...+.|++++.||+|+||+||+|.++.+|+.||||++....  ......+.+|+.+|+.+. |||||+++++|.  +..
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~--~~~  221 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGD  221 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEE--ETT
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--ECC
Confidence            345578999999999999999999999999999999996543  233456789999999997 999999999998  467


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+|||||||.| +|.+++..+.+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            89999999995 89999999999999999999999999999999999999999999999999999999999999876665


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ....+.+||+.|||||++ .+..|+.++|||||||++|||++|++||.+.+....+..+.....+...       .+..+
T Consensus       302 ~~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~-------~~~~~  373 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK-------NLHKV  373 (423)
T ss_dssp             CCBCCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------CTTSS
T ss_pred             ccccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc-------ccccC
Confidence            666788999999999998 5677999999999999999999999999998888887777665433222       23567


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      |+++.+||.+||..||.+|||+.|+|+||||+...+
T Consensus       374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999999999999987544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-64  Score=470.54  Aligned_cols=258  Identities=26%  Similarity=0.451  Sum_probs=218.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++++.||+|+||+||+|++.   .+++.||||++.+.........++.+|+.+|+++. |||||+++++|+  +..
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQ--TEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEE--ETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECC
Confidence            468999999999999999999884   46889999999766544444556788999999997 999999999998  577


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|||||||+ |+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            8999999999 589988864 67999999999999999999999999999999999999999999999999999876655


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .....+.+||+.|||||++ .+..|+.++|||||||++|+|++|++||.+.+....+..+.+.....+          ..
T Consensus       180 ~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----------~~  248 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----------QF  248 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             CccccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----------Cc
Confidence            5556678999999999998 567799999999999999999999999999988888887776543322          35


Q ss_pred             CCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      +|+++.+||.+||+.||.+|||     ++++++||||+...+
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence            7999999999999999999998     589999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-62  Score=453.47  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=217.7

Q ss_pred             cCCe-EEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--cCC
Q psy14434         22 LAEY-TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNK   98 (404)
Q Consensus        22 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--~~~   98 (404)
                      .++| ++.+.||+|+||+||+|.+..++..||+|++...........++.+|+.+|++++ |||||+++++|...  ...
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence            3455 7888999999999999999999999999999877777777888999999999997 99999999998743  345


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcc-CCceEEecccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDK-SCSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~  173 (404)
                      .+|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++|  |+||||||+||||+. +|.+||+|||+|+..
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            6899999999 599998874 67999999999999999999999999  999999999999975 799999999999864


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ..  ....+.+||+.|||||++. + .|+.++|||||||++|+|+||++||.+......+....... ..+..      .
T Consensus       183 ~~--~~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~~------~  251 (290)
T 3fpq_A          183 RA--SFAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPAS------F  251 (290)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGG------G
T ss_pred             CC--CccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCCC------C
Confidence            33  3446679999999999983 3 58999999999999999999999998766554433322211 11111      1


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ...+++++.+||.+||..||.+|||+.++|+||||++
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            1456889999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-61  Score=452.97  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=214.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+.|++.+.||+|+||.||+|+++.+|+.||||++......       .+|+.+++.+. |||||+++++|.  +...+|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~-HpnIV~l~~~~~--~~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLS-SPRIVPLYGAVR--EGPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCC-CCCCCcEEEEEE--ECCEEE
Confidence            45699999999999999999999999999999999654222       36999999997 999999999987  577899


Q ss_pred             EEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||||+ |+|.++++. +.+++.+++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.+.....
T Consensus       127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999 599999974 6799999999999999999999999999999999999999987 699999999987654321


Q ss_pred             -----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        179 -----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       179 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                           .....+||+.|||||++ .+..|+.++|||||||++|+|++|++||.+.+.......+.....+       +...
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-------~~~~  278 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-------IREI  278 (336)
T ss_dssp             -------CCCCCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-------GGGS
T ss_pred             ccceecCCccccCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-------chhc
Confidence                 12346899999999998 4677999999999999999999999999987776666666553221       1122


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHH-------------HhccCCCCcC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQI-------------LEHNYVSKYF  292 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~l-------------l~hp~~~~~~  292 (404)
                      .+.+|+.+.+||.+||+.||.+|||+.|+             |+|||+..+.
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            35789999999999999999999999997             5799998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-59  Score=449.62  Aligned_cols=264  Identities=25%  Similarity=0.454  Sum_probs=215.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .+.++|++.+.||+|+||+||+|.++   .+++.||+|++.+.    ....++.+|+.+|+.+.+||||++++++|.  +
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~--~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR--K   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE--E
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE--E
Confidence            56678999999999999999999885   46789999998543    234567899999999977999999999998  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccccC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~~~  174 (404)
                      ...+|||||||+ |+|.+++.  .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            778999999998 58998884  59999999999999999999999999999999999999877 899999999997654


Q ss_pred             CCC----------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC-
Q psy14434        175 DSK----------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFP-  225 (404)
Q Consensus       175 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~-  225 (404)
                      ...                            ....+.+||++|||||++.+...|+.++||||+||++|+|++|+.||. 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            321                            122456899999999998766679999999999999999999999985 


Q ss_pred             CCCcHHHHHHHHHhhCCCC-------------------C-------------------------CcchhhcccCCCCHHH
Q psy14434        226 GASTSHQLQLIVNLVRPNP-------------------P-------------------------HADKFYAGFKNKPEEA  261 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~-------------------~-------------------------~~~~~~~~~~~~~~~~  261 (404)
                      +.+...++..+....+...                   .                         ........+..+|+++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            4555666666654332100                   0                         0001112345689999


Q ss_pred             HHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        262 VDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       262 ~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .|||.+||++||.+|||++|+|+||||++.
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-59  Score=437.89  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=201.6

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      |.+.++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+++. |||||+++++|...+. 
T Consensus         1 GR~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             CHHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred             CCcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence            456778999999999999999999999999999999996442 3445567889999999996 9999999999874332 


Q ss_pred             ---------CeEEEEEeccC-CcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceE
Q psy14434         98 ---------KDLYVVFEYME-NDLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        98 ---------~~~~lv~E~~~-~~L~~~l~~~~----l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vk  163 (404)
                               ..+|||||||. |+|.+++....    .++..++.++.||+.||+|||++||+||||||+||||+.+|.+|
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                     35799999998 58999998542    44566889999999999999999999999999999999999999


Q ss_pred             EeccccccccCCCCC------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q psy14434        164 IGDLGLARSLSDSKE------------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH  231 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  231 (404)
                      |+|||+|+.......            ..++.+||+.|||||++ .+..|+.++|||||||++|||++   ||.+.  .+
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~  232 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY---PFSTQ--ME  232 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHH-cCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cH
Confidence            999999987654221            22456899999999998 46789999999999999999996   77543  22


Q ss_pred             HHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        232 QLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ....+........+      ..+...++.+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus       233 ~~~~~~~~~~~~~p------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          233 RVRTLTDVRNLKFP------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHHHTTCCC------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHHHhcCCCC------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            33333333222111      111334678899999999999999999999999999987543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-58  Score=449.15  Aligned_cols=314  Identities=43%  Similarity=0.814  Sum_probs=251.8

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +...+.++|++++.||+|+||.||+|.+..+|+.||||++...........+..+|+.+++.+.+||||+++++++...+
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            44567889999999999999999999999999999999998777778888899999999999988999999999998656


Q ss_pred             CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC-
Q psy14434         97 NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-  175 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  175 (404)
                      ...+|+|||||+++|..++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             CCEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            6689999999999999999988999999999999999999999999999999999999999999999999999986532 


Q ss_pred             --------------------CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q psy14434        176 --------------------SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL  235 (404)
Q Consensus       176 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  235 (404)
                                          ........+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                112235578999999999986667899999999999999999999999999999998888


Q ss_pred             HHHhhCCCCCCcc------------------------hhhc-------------ccCCCCHHHHHHHHhccccCCCCCCC
Q psy14434        236 IVNLVRPNPPHAD------------------------KFYA-------------GFKNKPEEAVDLLNQILVLNPSERPE  278 (404)
Q Consensus       236 ~~~~~~~~~~~~~------------------------~~~~-------------~~~~~~~~~~~li~~~L~~dp~~Rpt  278 (404)
                      +............                        .+..             ....+++++.+||.+||+.||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            8776653321100                        0000             01267899999999999999999999


Q ss_pred             HHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCCCcCCHHHHHHHHHHHHHhh
Q psy14434        279 TDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKSC  333 (404)
Q Consensus       279 ~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (404)
                      ++++|+||||+.+..+..   .+..+.....++.++....+++|++.+++++...
T Consensus       323 ~~e~l~Hp~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (388)
T 3oz6_A          323 ANDALKHPFVSIFHNPNE---EPNCDHIITIPINDNVKHSIDDYRNLVYSEISRR  374 (388)
T ss_dssp             HHHHTTSTTTTTTCCGGG---CCCCSSCCCCC------CCHHHHHHHHHHHHHHH
T ss_pred             HHHHhCCHHHHHhcCCcc---CCCCCCCCCCCccccccCCHHHHHHHHHHHHHHh
Confidence            999999999998776554   3334444555667777889999999999988543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.3e-58  Score=463.41  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=214.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----hhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      -+++|++++.||+|+||.||+|+++.+|+.||||++.+....    .........++.+++.+. |||||+++++|.  +
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~--~  263 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFH--T  263 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEE--C
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEE--E
Confidence            357899999999999999999999999999999999764321    122222333455666665 999999999998  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...+|||||||. |+|..++. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            778999999999 48998886 4679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH---QLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ..  ...+.|||+.|||||++.++..|+.++|||||||++|+|++|.+||.+.+...   ....+.......        
T Consensus       344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~--------  413 (689)
T 3v5w_A          344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--------  413 (689)
T ss_dssp             SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC--------
T ss_pred             CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC--------
Confidence            43  34567999999999998656689999999999999999999999997653322   222222221111        


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFPS  294 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~~  294 (404)
                        ...+|+++.+||.+||+.||.+|++     ++++++||||+.+.+.
T Consensus       414 --p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             --CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             --CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence              1457999999999999999999998     7999999999986543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-57  Score=458.20  Aligned_cols=263  Identities=23%  Similarity=0.463  Sum_probs=230.6

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +.++++|++.+.||+|+||+||+|.++.+|+.||+|++...  .......+.+|+.+|+.++ ||||++++++|.  +..
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--~~~  227 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDN  227 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--CSS
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECC
Confidence            45678999999999999999999999999999999998543  3445667889999999997 999999999998  678


Q ss_pred             eEEEEEeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC--CceEEecccccccc
Q psy14434         99 DLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~--~~vkl~Dfg~a~~~  173 (404)
                      .+|||||||.| +|.+++.  .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+  |.+||+|||+|+.+
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            89999999984 8998885  3569999999999999999999999999999999999999854  89999999999987


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ... ......+||+.|||||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..+.......+.      ..
T Consensus       308 ~~~-~~~~~~~GT~~y~APEv~-~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~~  379 (573)
T 3uto_A          308 DPK-QSVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------SA  379 (573)
T ss_dssp             CTT-SEEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS------GG
T ss_pred             cCC-CceeeeEECccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc------cc
Confidence            643 345667899999999998 5677999999999999999999999999999988888877765443322      22


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      +..+|+++.+||.+||+.||.+|||+.++|+||||+....+
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            36789999999999999999999999999999999976543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4e-57  Score=421.74  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=207.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+++++.+.||+|+||+||+|....   .||||++.....+......+.+|+.++++++ |||||++++++.   ...+|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~---~~~~~  107 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMT---KDNLA  107 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE---CCeEE
Confidence            4679999999999999999997543   4999999766666777788999999999997 999999999864   34689


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC--
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--  176 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~--  176 (404)
                      ||||||+ |+|.+++..  +.+++.++..|+.||+.||+|||+++|+||||||+||||++++.+||+|||+|+.....  
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999 599999864  56999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .......+||+.|||||++.+  ...|+.++|||||||++|||+||+.||.+.+....+..+.......+.    .....
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~  263 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD----LSKLY  263 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC----STTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC----ccccc
Confidence            223455789999999999853  345899999999999999999999999988776655555443222211    11223


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+|+++.+||.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5679999999999999999999999987644

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.3e-57  Score=420.10  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=214.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|.+.+.||+|+||.||+|.+.     .++..||||++...  .....+++.+|+.+|++++ |||||++++++.  +
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~--~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--E   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEe--e
Confidence            357999999999999999999875     46889999999643  4556678899999999997 999999999987  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh--------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD--------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~--------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                      ...+|||||||+ |+|.+++..              ..+++.++..++.||+.||.|||+++|+||||||+||||++++.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            678999999999 599999964              25999999999999999999999999999999999999999999


Q ss_pred             eEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q psy14434        162 IKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  238 (404)
                      +||+|||+|+.......  .....+||+.|||||++. +..|+.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999986543322  223457999999999984 5679999999999999999998 8999999988888877777


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ...+..+         ..+|+++.+||.+||+.||.+|||+.++  |+|+..
T Consensus       246 ~~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          246 GRVLQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            6543332         4679999999999999999999999999  456654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-56  Score=422.58  Aligned_cols=249  Identities=25%  Similarity=0.441  Sum_probs=207.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|.+.++||+|+||+||+|...     .++..||||++..  .+....+.+.+|+.+|++++ |||||++++++.  +
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~--~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQ-HQHIVRFFGVCT--E  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--S
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--E
Confidence            357999999999999999999865     4688999999964  34556678899999999997 999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      ...+|||||||+ |+|.+++..                +.+++.++..|+.||+.||+|||+++|+||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            678999999999 599998864                358999999999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI  236 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  236 (404)
                      +.+||+|||+|+......  ......+||+.|||||++ .+..|+.++|||||||++|||+| |+.||.+.+....+..+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhh-cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998764332  223456799999999998 56779999999999999999998 99999999888888777


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .....+..+         ..+|+++.+|+.+||+.||++|||+.+++++
T Consensus       274 ~~g~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELERP---------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCCCCC---------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCCc---------ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            766543332         4679999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-56  Score=439.33  Aligned_cols=310  Identities=35%  Similarity=0.661  Sum_probs=241.5

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec-
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV-   95 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~-   95 (404)
                      ..+.+.++|++++.||+|+||+||+|.+..+++.||||++.+.........++.+|+.+|+.+. ||||+++++++... 
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD  125 (458)
T ss_dssp             SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence            3456778999999999999999999999999999999999877777778888999999999996 99999999998532 


Q ss_pred             --cCCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 --NNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 --~~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                        ....+|+||||++++|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       126 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             cccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence              3367999999999999999885 4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC---------------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh------
Q psy14434        173 LSDSK---------------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ------  219 (404)
Q Consensus       173 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~------  219 (404)
                      .....                           ......+||++|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            64221                           124567899999999987667789999999999999999998      


Q ss_pred             -----CCCCCCCCCc--------------------HHHHHHHHHhhCCCCC---------------------Ccchhhcc
Q psy14434        220 -----SKPLFPGAST--------------------SHQLQLIVNLVRPNPP---------------------HADKFYAG  253 (404)
Q Consensus       220 -----g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~---------------------~~~~~~~~  253 (404)
                           |+++|++.+.                    ..++..+.+..+....                     ....+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 7788877652                    3455555555443221                     11223344


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      ++..++++.+||.+||..||.+|||++++|+||||+.+.....   ++........++++....+.+++++.+++++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~---e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  439 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV---ETNATEKVRLPFNDWMNMDEPQLRYAFVKEI  439 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG---CCCCSSCCCCSSCTTSCCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc---CCCCCCCCCCCccccccCCHHHHHHHHHHHH
Confidence            5677999999999999999999999999999999999876554   2223333445566667788999999999887

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-55  Score=433.24  Aligned_cols=320  Identities=35%  Similarity=0.637  Sum_probs=258.1

Q ss_pred             CCCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceE
Q psy14434          9 SGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      .+...+.-....+.++|++.+.||+|+||.||+|.+..+++.||||++...........++.+|+.+|+.+. ||||+++
T Consensus        12 ~~~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l   90 (432)
T 3n9x_A           12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRL   90 (432)
T ss_dssp             CCCCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCE
T ss_pred             hhhhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceE
Confidence            444445555678889999999999999999999999999999999999877777778889999999999997 9999999


Q ss_pred             eeEEEeccC---CeEEEEEeccCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         89 LDIYKAVNN---KDLYVVFEYMENDLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        89 ~~~~~~~~~---~~~~lv~E~~~~~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      ++++.....   ..+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A           91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             EEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEE
Confidence            999864221   679999999999999999864 5999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCC----------------------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh---
Q psy14434        165 GDLGLARSLSDSK----------------------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ---  219 (404)
Q Consensus       165 ~Dfg~a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~---  219 (404)
                      +|||+++......                      ...+..+||++|+|||++.....++.++|||||||++|+|++   
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            9999998764322                      123667899999999997667789999999999999999998   


Q ss_pred             --------CCCCCCCCC-----------------cHHHHHHHHHhhCCCCC---------------------Ccchhhcc
Q psy14434        220 --------SKPLFPGAS-----------------TSHQLQLIVNLVRPNPP---------------------HADKFYAG  253 (404)
Q Consensus       220 --------g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~---------------------~~~~~~~~  253 (404)
                              |.++|++.+                 ...++..+.+..+....                     ....+...
T Consensus       251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (432)
T 3n9x_A          251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK  330 (432)
T ss_dssp             TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred             ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence                    556666654                 24555555555543221                     11122233


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCCCCcCCHHHHHHHHHHHHHh
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS  332 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (404)
                      ++.+++++.+||.+||..||.+|||++++|+||||+.......   ++..+.....++++...+..+++++.+++++..
T Consensus       331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~---e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~  406 (432)
T 3n9x_A          331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL---ENFSTKKIILPFDDWMVLSETQLRYIFLKEVQS  406 (432)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT---C---CCCCCCSSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc---CcCCCCCCCCChhhcccCCHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999876554   333344455566666788999999999998843

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-56  Score=417.85  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=213.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...+++++.+.||+|+||+||+|...     .+++.||||++... ........+.+|+.++++++ |||||++++++. 
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~-   99 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVT-   99 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCC-CCCCCCcceEEE-
Confidence            34568999999999999999999853     46789999999644 23344567889999999997 999999999986 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                       +...+|||||||+ |+|.+++..                 ..+++.++..++.||+.||.|||+++|+||||||+||||
T Consensus       100 -~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          100 -KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             -SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence             5677999999999 699999853                 348999999999999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL  233 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  233 (404)
                      ++++.+||+|||+|+......  ......+||+.|||||++. +..|+.++|||||||++|||+| |..||.+.+..+..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998654322  2334568999999999984 5679999999999999999998 89999999888877


Q ss_pred             HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+.+......+         ..+|+.+.+|+.+||+.||.+|||+.+++++
T Consensus       258 ~~i~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            777665443222         4679999999999999999999999999876

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-55  Score=421.22  Aligned_cols=306  Identities=35%  Similarity=0.652  Sum_probs=246.9

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+++.+. ||||+++++++....
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            3456788999999999999999999999999999999999777667777888999999999997 999999999986321


Q ss_pred             ----CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         97 ----NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        97 ----~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                          ...+|+||||++++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                2457999999988999999988899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      ...   .....+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+..+.       
T Consensus       178 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          178 ADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            543   2356789999999999866578999999999999999999999999999998888888776653322       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI  311 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  311 (404)
                                    ....+...+..+++.+.+||.+||..||.+|||+.++|+||||..+......   +... ....++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~---~~~~-~~~~~~  330 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE---PQVQ-KYDDSF  330 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---------CCC-CCCCC-
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC---CCCC-CCCCCh
Confidence                          1122334456789999999999999999999999999999999987655432   1111 112222


Q ss_pred             CCCCcCCHHHHHHHHHHHHH
Q psy14434        312 DDNNQLEINDYQDKLYDIVK  331 (404)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~  331 (404)
                       +......++|++.+++.+.
T Consensus       331 -~~~~~~~~~~~~~~~~~~~  349 (367)
T 1cm8_A          331 -DDVDRTLDEWKRVTYKEVL  349 (367)
T ss_dssp             -----CCHHHHHHHHHHHHH
T ss_pred             -hhhcCCHHHHHHHHHHHHH
Confidence             2235678899999888874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-55  Score=417.51  Aligned_cols=252  Identities=25%  Similarity=0.432  Sum_probs=211.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++... ........+.+|+.+|.++..|||||++++++.. .
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-T
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-c
Confidence            36799999999999999999998654     368999998643 3345567788999999999866999999999753 3


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      +..+|||||||+ |+|.++++.                 ..+++.++..++.||+.||+|||+++|+||||||+|||+++
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            556899999999 599999963                 23889999999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH-HHH
Q psy14434        159 SCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSH-QLQ  234 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-~~~  234 (404)
                      ++.+||+|||+|+.......  .....+||+.|||||++. +..|+.++|||||||++|||+| |..||.+..... ...
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999987654322  234568999999999984 5679999999999999999998 999999876444 444


Q ss_pred             HHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        235 LIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+.....+..+         ..+++++.+||.+||+.||.+|||+.++++|
T Consensus       300 ~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44444443332         4568999999999999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-54  Score=409.10  Aligned_cols=277  Identities=35%  Similarity=0.681  Sum_probs=229.3

Q ss_pred             ccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         13 VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ....-...+.++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+. ||||+++++++
T Consensus        11 ~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   88 (311)
T 3niz_A           11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVI   88 (311)
T ss_dssp             ----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE
Confidence            334445568889999999999999999999985 4889999999766555556677889999999996 99999999998


Q ss_pred             EeccCCeEEEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         93 KAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      .  +...+|+||||++++|.+.+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           89 H--SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             C--CSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             c--cCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCc
Confidence            7  56789999999999998888753  4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc---
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA---  247 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  247 (404)
                      .............+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+........+..   
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            87765444455668999999999986667789999999999999999999999999888888888777665332211   


Q ss_pred             -----------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        248 -----------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       248 -----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                                       ..+....+.+++++.+||.+||+.||.+|||+.++|+||||++..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                             1112233557889999999999999999999999999999997543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8e-55  Score=431.78  Aligned_cols=307  Identities=36%  Similarity=0.674  Sum_probs=242.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---   95 (404)
                      ..+.++|++++.||+|+||+||+|.+..+++.||||++.+.........++.+|+.+++.+. ||||++++++|...   
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence            35678999999999999999999999999999999999877777778888999999999996 99999999998632   


Q ss_pred             -cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       +...+|+||||++++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       137 ~~~~~~~lv~E~~~~~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          137 EEFQDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             ccCCeEEEEEeCCCCCHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             2357899999999988887765 49999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------  248 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  248 (404)
                      .. ......+||++|+|||++. +..++.++|||||||++|+|++|++||.+.+...++..+....+...+...      
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CC-cccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            43 3346678999999999985 567999999999999999999999999999999998888877664322100      


Q ss_pred             --------------hhhcccCC------------CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCC
Q psy14434        249 --------------KFYAGFKN------------KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV  302 (404)
Q Consensus       249 --------------~~~~~~~~------------~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~  302 (404)
                                    .+...++.            .++++.+||.+||..||.+|||++++|+||||+.+..+.....++ 
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~-  372 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP-  372 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCC-
Confidence                          00000010            146799999999999999999999999999999876544321111 


Q ss_pred             CCCcccccCCCCCcCCHHHHHHHHHHHHHh
Q psy14434        303 TPHTVVLDIDDNNQLEINDYQDKLYDIVKS  332 (404)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (404)
                       +...... .+..+..++++++.+++.+..
T Consensus       373 -~~~~~~~-~~~~~~~~~~~~~~~~~e~~~  400 (464)
T 3ttj_A          373 -PQIYDKQ-LDEREHTIEEWKELIYKEVMN  400 (464)
T ss_dssp             -------------CCCHHHHHHHHHHHHHC
T ss_pred             -CccCCcc-hhhccCCHHHHHHHHHHHHHH
Confidence             1111222 233556788999999887743

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-54  Score=418.36  Aligned_cols=309  Identities=38%  Similarity=0.686  Sum_probs=240.2

Q ss_pred             cccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         14 QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      .....+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+++.+. ||||+++++++.
T Consensus        20 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~   98 (367)
T 2fst_X           20 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFT   98 (367)
T ss_dssp             ETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEC
T ss_pred             ecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence            3445567889999999999999999999999999999999999777667777888999999999997 999999999986


Q ss_pred             ec----cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         94 AV----NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        94 ~~----~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      ..    ....+|+|||+++++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             SCSSGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             cCCccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            32    23668999999998999999888899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC----
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----  245 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  245 (404)
                      ++.....   ....+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+....    
T Consensus       179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   355789999999999866578999999999999999999999999999998888888776553221    


Q ss_pred             -----------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCccc
Q psy14434        246 -----------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVV  308 (404)
Q Consensus       246 -----------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~  308 (404)
                                       ....+...+...++.+.+||.+||..||.+|||+.++|+||||..+..+....   ..+ ...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~---~~~-~~~  331 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP---VAD-PYD  331 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC---CCC-CCC
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC---CCC-CCC
Confidence                             11122334456789999999999999999999999999999999877655421   111 122


Q ss_pred             ccCCCCCcCCHHHHHHHHHHHHH
Q psy14434        309 LDIDDNNQLEINDYQDKLYDIVK  331 (404)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~  331 (404)
                      .++ +......++|++.+++++.
T Consensus       332 ~~~-~~~~~~~~~~~~~~~~e~~  353 (367)
T 2fst_X          332 QSL-ESRDLLIDEWKSLTYDEVI  353 (367)
T ss_dssp             GGG-SSCCCCHHHHHHHHHHHHH
T ss_pred             cch-hhccCCHHHHHHHHHHHHH
Confidence            222 2346678899999999884

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.2e-54  Score=407.05  Aligned_cols=261  Identities=28%  Similarity=0.465  Sum_probs=231.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++.+.........++.+|+.+++.+. ||||+++++++.  ...
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~~   87 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIE--TEK   87 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECC
Confidence            44678999999999999999999999999999999999877777778888999999999997 999999999987  577


Q ss_pred             eEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+. ++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            8999999997 58988875 567999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                       ......+||++|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+          ..
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----------~~  236 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----------FY  236 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------CC
Confidence             3456678999999999986555556899999999999999999999999988877777766543322          24


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      +++++.+||.+||..||.+|||++++++||||+....
T Consensus       237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            5899999999999999999999999999999987554

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.6e-54  Score=400.22  Aligned_cols=269  Identities=32%  Similarity=0.631  Sum_probs=229.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++. ||||+++++++.  +...+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEE--eCCEEE
Confidence            36899999999999999999999999999999999776666666788889999999997 999999999987  577899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+++++...+..  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999999988777653  56999999999999999999999999999999999999999999999999999877655555


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCCCc-----------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPPHA-----------  247 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~-----------  247 (404)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+.......+...........           
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            56678999999999986556689999999999999999987755 677777777777776655322211           


Q ss_pred             --------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        248 --------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       248 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                              .......+.+++.+.+||.+||+.||.+|||++++|+||||+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                    1111223457899999999999999999999999999999998654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.1e-54  Score=414.20  Aligned_cols=285  Identities=24%  Similarity=0.457  Sum_probs=231.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.+. ||||++++++|.  +.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~   87 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQ--DE   87 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence            345678999999999999999999999999999999996543 23344567889999999996 999999999987  56


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            789999999985 89988875 4699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCCCCCcchh
Q psy14434        176 SKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  250 (404)
                      . ......+||+.|+|||++..  +..++.++|||||||++|+|++|..||......   .....+.......+      
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p------  240 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP------  240 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC------
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC------
Confidence            3 34466789999999999853  345899999999999999999999999754432   22222222221111      


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCC-HHHHHhccCCCCcCCCC---CCCCCCCCCCcccccCCCCCcC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPE-TDQILEHNYVSKYFPSA---THVIPQVTPHTVVLDIDDNNQL  317 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~hp~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  317 (404)
                          ..++..+.+||.+||+.||.+||+ ++++++||||....+..   ....|+..|.....++++....
T Consensus       241 ----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~~  307 (384)
T 4fr4_A          241 ----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFEL  307 (384)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCCS
T ss_pred             ----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccCh
Confidence                356899999999999999999998 89999999999865432   2334555555545555554443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.9e-53  Score=395.13  Aligned_cols=265  Identities=38%  Similarity=0.678  Sum_probs=221.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   76 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLV   76 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEc--cCCeEE
Confidence            36899999999999999999998 67889999999655444444567789999999997 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||+.++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999999999998874  56999999999999999999999999999999999999999999999999999876544444


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA------------  247 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------  247 (404)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+...........            
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            45567999999999986556789999999999999999999999999888888777776554221110            


Q ss_pred             -------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        248 -------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       248 -------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                             ..+......+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                   0111223467899999999999999999999999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-53  Score=408.21  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=221.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ..........+|..+++.+.+||||++++++|.  +...
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TPDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eCCE
Confidence            4578999999999999999999999999999999997542 233455667889999999877999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            9999999985 89888864 679999999999999999999999999999999999999999999999999998655444


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          ..+
T Consensus       179 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~  247 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----------TWL  247 (353)
T ss_dssp             -------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TTS
T ss_pred             ccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------CCC
Confidence            555677899999999998 456789999999999999999999999999988888887776543322          246


Q ss_pred             CHHHHHHHHhccccCCCCCCCH------HHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPET------DQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~------~~ll~hp~~~~~~~  293 (404)
                      ++.+.+||.+||+.||.+||++      .++++||||+...+
T Consensus       248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence            8999999999999999999999      89999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-52  Score=402.38  Aligned_cols=307  Identities=42%  Similarity=0.733  Sum_probs=246.7

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc-
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN-   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~-   96 (404)
                      ...+.++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++++. ||||+++++++.... 
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI   99 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCc
Confidence            345557999999999999999999999999999999998642 34455677889999999997 999999999986322 


Q ss_pred             --CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 --NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 --~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                        ...+|+||||++++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       100 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             TTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence              257899999999999999998899999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC------
Q psy14434        175 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP------  245 (404)
Q Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  245 (404)
                      ....   .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.........      
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3221   2345689999999999766677899999999999999999999999999888887777665543221      


Q ss_pred             ---------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCccccc
Q psy14434        246 ---------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLD  310 (404)
Q Consensus       246 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~  310 (404)
                                     ....+...++.+++++.+||.+||+.||.+|||+.++|+||||+.+..+.....+. .|  ...+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~-~~--~~~~  336 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAE-AP--FKFD  336 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCS-SC--CCCC
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCC-Cc--CCcc
Confidence                           11122233466789999999999999999999999999999999986554422111 11  1111


Q ss_pred             CCCCCcCCHHHHHHHHHHHH
Q psy14434        311 IDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~  330 (404)
                       .+......+++++.+++..
T Consensus       337 -~~~~~~~~~~~~~~~~~e~  355 (364)
T 3qyz_A          337 -MELDDLPKEKLKELIFEET  355 (364)
T ss_dssp             ------CCHHHHHHHHHHHT
T ss_pred             -cccccCCHHHHHHHHHHHH
Confidence             1223455667777777655

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-52  Score=399.74  Aligned_cols=258  Identities=25%  Similarity=0.447  Sum_probs=224.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+... .........+|+.+++.+. ||||++++++|.  ....+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~--~~~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSSEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEE--eCCEE
Confidence            5689999999999999999999999999999999965422 2344567789999999996 999999999987  56789


Q ss_pred             EEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.| +|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999985 8988886 45799999999999999999999999999999999999999999999999999987544444


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..++
T Consensus       161 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s  229 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----------RTLS  229 (337)
T ss_dssp             CBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TTSC
T ss_pred             cccccccChhhCChhhh-cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------CCCC
Confidence            55678899999999998 466789999999999999999999999998887777666655322211          3568


Q ss_pred             HHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        259 EEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      +++.+||.+||+.||.+||     ++.++++||||....+
T Consensus       230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999999999999999     9999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.3e-53  Score=395.31  Aligned_cols=261  Identities=28%  Similarity=0.505  Sum_probs=227.6

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+...++|++.+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.+++.+. ||||+++++++.  ..
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~   89 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK-NPNIVNYLDSYL--VG   89 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ET
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCC-CCCCCeEeEEEE--EC
Confidence            35667899999999999999999999999999999999865432  23456789999999996 999999999987  46


Q ss_pred             CeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..+|+||||+. ++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            78999999997 59999999888999999999999999999999999999999999999999999999999999877655


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.....+....       ...
T Consensus       170 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~  241 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------PEK  241 (297)
T ss_dssp             TCCBCCCCSCGGGCCHHHH-HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------GGG
T ss_pred             ccccCCccCCcCccChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------ccc
Confidence            5555667899999999998 46678999999999999999999999999888776666655544332221       135


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            68999999999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.6e-53  Score=402.18  Aligned_cols=276  Identities=36%  Similarity=0.582  Sum_probs=218.4

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ........++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++. 
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-  103 (329)
T 3gbz_A           26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIH-  103 (329)
T ss_dssp             ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEE-
T ss_pred             cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEe-
Confidence            344567788999999999999999999999999999999999765555555667789999999996 999999999987 


Q ss_pred             ccCCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-----cCCceEEeccc
Q psy14434         95 VNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-----KSCSIKIGDLG  168 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~-----~~~~vkl~Dfg  168 (404)
                       +...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++     ..+.+||+|||
T Consensus       104 -~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          104 -HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             -ETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             -cCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence             5778999999999999998875 4699999999999999999999999999999999999994     44569999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ++.............+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..+............
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            99876654444556789999999999865567899999999999999999999999999988888888776553322111


Q ss_pred             hhhc-------c-------------cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        249 KFYA-------G-------------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       249 ~~~~-------~-------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ....       .             ...+++++.+||.+||+.||.+|||+.++|+||||+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            0000       0             0116789999999999999999999999999999997543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-53  Score=401.40  Aligned_cols=271  Identities=35%  Similarity=0.667  Sum_probs=214.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELK-HENIVRLYDVIH--TENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEEC--CTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcC-CCCcceEEEEEE--ECCeEE
Confidence            468999999999999999999999999999999986442 2233456778999999996 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434        102 VVFEYMENDLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~-------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      +||||++++|.+++..       ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9999999999988864       248999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc-hh---
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-KF---  250 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~---  250 (404)
                      .........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+....... ..   
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            44444456689999999999865567899999999999999999999999999988888888776553221110 00   


Q ss_pred             --------------------hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        251 --------------------YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       251 --------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                                          ......++.++.+||.+||+.||.+|||+.++|+||||.+++..+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence                                0011257889999999999999999999999999999999876543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-52  Score=403.45  Aligned_cols=307  Identities=35%  Similarity=0.664  Sum_probs=247.5

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ....+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++..
T Consensus        34 ~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  112 (371)
T 4exu_A           34 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTP  112 (371)
T ss_dssp             TTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred             ccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheec
Confidence            344456788999999999999999999999999999999999876666677788899999999997 9999999999863


Q ss_pred             ccC----CeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         95 VNN----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        95 ~~~----~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      .+.    ..+|+||||+.++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          113 ASSLRNFYDFYLVMPFMQTDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CSSSTTCCCCEEEEECCCEEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             cCCcccceeEEEEEccccccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            222    13499999999999887754 4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-----
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-----  245 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  245 (404)
                      ......   ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.........     
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            865432   345679999999999865578999999999999999999999999999888887777665543221     


Q ss_pred             ----------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccc
Q psy14434        246 ----------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVL  309 (404)
Q Consensus       246 ----------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~  309 (404)
                                      ....+...++.+++.+.+||.+||+.||.+|||+.++|+||||+.+..+.... ....|  .. 
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~-~~~~~--~~-  344 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET-EAQQP--FD-  344 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCC-CCSSC--CC-
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccc-ccccC--cC-
Confidence                            11222333456799999999999999999999999999999999876544321 11111  11 


Q ss_pred             cCCCCCcCCHHHHHHHHHHHH
Q psy14434        310 DIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      ...+..+..++++++.+++.+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 4exu_A          345 DSLEHEKLTVDEWKQHIYKEI  365 (371)
T ss_dssp             CTTSSCCCCHHHHHHHHHHHH
T ss_pred             cchhhcccchHHHHHHHHHHH
Confidence            122345667889999988766

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.7e-52  Score=396.37  Aligned_cols=313  Identities=35%  Similarity=0.656  Sum_probs=250.0

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.+. ||||+++++++...
T Consensus         4 ~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFK-HENIITIFNIQRPD   81 (353)
T ss_dssp             TCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred             ccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccc
Confidence            34567788999999999999999999999999999999998532 34455667789999999997 99999999987531


Q ss_pred             ---cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 ---NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ---~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                         .....|+||||+.++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             CSTTCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence               23679999999999999999988999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        173 LSDSKE----------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       173 ~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ......          .....+||+.|+|||++.++..++.++|||||||++|+|++|.+||.+.+.......+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            643211          1233578999999999866678999999999999999999999999999888777776665443


Q ss_pred             CCCC----------------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCC
Q psy14434        243 NPPH----------------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIP  300 (404)
Q Consensus       243 ~~~~----------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~  300 (404)
                      ....                      ...+...++.+++++.+||.+||+.||.+|||+.++|+||||+....+......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  321 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG  321 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence            2210                      011222345789999999999999999999999999999999987765543323


Q ss_pred             CCCCCcccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        301 QVTPHTVVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      ...|.....-.........+++++.+++++
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          322 EPIPPSFFEFDHYKEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             CCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred             CCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence            333322222223345566777877777665

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-52  Score=400.29  Aligned_cols=263  Identities=27%  Similarity=0.426  Sum_probs=226.9

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.....    .....+.+|+.+++.+. ||||++++++|.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence            3567788999999999999999999999999999999996543322    23567889999999997 999999999987


Q ss_pred             eccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEecc
Q psy14434         94 AVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDL  167 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Df  167 (404)
                        +...+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        86 --~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           86 --NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             --CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             --eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence              5778999999997 589998874 5699999999999999999999999999999999999998877    7999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      |++...... ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+.  
T Consensus       164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  239 (361)
T 2yab_A          164 GLAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE--  239 (361)
T ss_dssp             SSCEECCTT-CCCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH--
T ss_pred             CCceEcCCC-CccccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc--
Confidence            999876543 234567899999999998 4667899999999999999999999999998888777776654433222  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                          ..+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus       240 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          240 ----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             ----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             ----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                1235679999999999999999999999999999999853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=410.70  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=229.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++.  +..
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~--~~~   83 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSIS--EEG   83 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEE--CSS
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEE--ECC
Confidence            34667899999999999999999999999999999999766555667778889999999996 999999999987  678


Q ss_pred             eEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---cCCceEEecccccccc
Q psy14434         99 DLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~---~~~~vkl~Dfg~a~~~  173 (404)
                      ..|+|||||.| +|.+.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            89999999985 8877776 46799999999999999999999999999999999999998   4578999999999877


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ..........+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+.      ..
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~~  236 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS------PE  236 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT------TT
T ss_pred             cCCCceeecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc------cc
Confidence            6655555667899999999998 4667899999999999999999999999999888888877766543332      12


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            3567999999999999999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-52  Score=403.63  Aligned_cols=306  Identities=36%  Similarity=0.660  Sum_probs=235.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++....   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccc
Confidence            5678999999999999999999999999999999999776666677788899999999996 999999999986322   


Q ss_pred             -CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         97 -NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        97 -~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                       ...+|+||||++++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          101 EFQDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             TCCEEEEEEECCSEEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cccceEEEEEcCCCCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             24789999999999988886 4599999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc-------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD-------  248 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  248 (404)
                      . ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+....+..+....+...+...       
T Consensus       180 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          180 S-FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             c-cccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            2 2334568999999999984 567899999999999999999999999999888777777655442211000       


Q ss_pred             -------------hhhcccC------------CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCC
Q psy14434        249 -------------KFYAGFK------------NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVT  303 (404)
Q Consensus       249 -------------~~~~~~~------------~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~  303 (404)
                                   .+...++            ..+..+.+||.+||..||.+|||++++|+||||+.+..+.....++. 
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~-  336 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP-  336 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCC-
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCC-
Confidence                         0000000            01467999999999999999999999999999998765443221111 


Q ss_pred             CCcccccCCCCCcCCHHHHHHHHHHHHHh
Q psy14434        304 PHTVVLDIDDNNQLEINDYQDKLYDIVKS  332 (404)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (404)
                       ...... .+..+..+++|++.++..+..
T Consensus       337 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          337 -KIPDKQ-LDEREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             -CCCTTT-TCCCCCCHHHHHHHHHHHHHH
T ss_pred             -CCCChh-hccccCcHHHHHHHHHHHHHH
Confidence             111112 234466889999999887743

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-52  Score=403.85  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=218.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-.++|++++.||+|+||.||+|+++.+++.||+|++.+.... ......+.+|..++.++.+||||++++++|.  +..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~  126 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TES  126 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSS
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECC
Confidence            3467899999999999999999999999999999999765433 3344557789999998867999999999987  577


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.| +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            89999999985 89888864 67999999999999999999999999999999999999999999999999999865444


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHhhCCCCCCc
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------SHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~  247 (404)
                      .......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.....         ......+.......+   
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l-~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---  282 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---  282 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC---
T ss_pred             CCccccccCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC---
Confidence            4556678999999999998 466789999999999999999999999964321         122233332221111   


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCH------HHHHhccCCCCcCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPET------DQILEHNYVSKYFP  293 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~hp~~~~~~~  293 (404)
                             ..+++++.+||.+||+.||.+||++      +++++||||....+
T Consensus       283 -------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          283 -------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             -------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             -------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                   3568999999999999999999985      79999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-52  Score=400.09  Aligned_cols=261  Identities=29%  Similarity=0.436  Sum_probs=224.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++.+.||+|+||.||+|.++.+|+.||||++.+... ..........|..++..+.+||||++++++|.  +..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eCC
Confidence            456799999999999999999999999999999999975421 22345567789999988856999999999987  577


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            8999999997 589988874 67999999999999999999999999999999999999999999999999999865444


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          ..
T Consensus       172 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------~~  240 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----------RW  240 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             CCcccCCCCCcccCChhhh-cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----------cc
Confidence            4445677899999999998 456789999999999999999999999999888777777655432221          34


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHH-HHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETD-QILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~-~ll~hp~~~~~~~  293 (404)
                      +++++.+||.+||..||.+||++. ++++||||....+
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence            689999999999999999999998 9999999998654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-52  Score=389.61  Aligned_cols=271  Identities=34%  Similarity=0.654  Sum_probs=222.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++++. ||||+++++++.  .....
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~   77 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFR--RKRRL   77 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheee--cCCeE
Confidence            357899999999999999999999999999999998766555556677889999999997 999999999987  57789


Q ss_pred             EEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ++||||+++ +|..++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999996 5767666 45699999999999999999999999999999999999999999999999999987765444


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+........+             
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            4556789999999999866677899999999999999999999999999888877776655442211             


Q ss_pred             --------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        246 --------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       246 --------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                              ........++.++..+.+||.+||+.||.+|||++++|+||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence                    1122223346789999999999999999999999999999999976543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-53  Score=402.79  Aligned_cols=262  Identities=28%  Similarity=0.453  Sum_probs=219.3

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-hHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-TDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .+...++|++.+.||+|+||.||+|.+..+++.||+|++.+..... .....+.+|+.+++.+. ||||+++++++.  .
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~   80 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVIT--T   80 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEE--C
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--e
Confidence            4567889999999999999999999999999999999996543222 22456789999999997 999999999987  5


Q ss_pred             CCeEEEEEeccCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         97 NKDLYVVFEYMENDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ...+|+||||++|+|.+.+. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             CCEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            67899999999988887775 56799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+....          .....
T Consensus       161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~----------~~~p~  229 (336)
T 3h4j_B          161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----------YVMPD  229 (336)
T ss_dssp             S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC----------CCCCT
T ss_pred             C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC----------CCCcc
Confidence            3 334567899999999998544445899999999999999999999998765432221111110          01123


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+++.+.+||.+||..||.+|||+.++++||||+...+
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            46899999999999999999999999999999987544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.3e-53  Score=393.96  Aligned_cols=257  Identities=21%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC--C
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN--K   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~--~   98 (404)
                      +..+|.+.+.||+|+||+||+|.+  +|+.||||++....   ........|+..+.+++ ||||+++++++...+.  .
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            346799999999999999999987  58899999985431   12222334666666776 9999999999875432  3


Q ss_pred             eEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEccCCceEEecccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~--------~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      .+|||||||+ |+|.++++...+++..+..++.|++.||+|||++        +|+||||||+||||+.++.+||+|||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            6899999999 6999999998999999999999999999999987        999999999999999999999999999


Q ss_pred             ccccCCCCC----cccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC------------
Q psy14434        170 ARSLSDSKE----CLTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQSKPLFPGAS------------  228 (404)
Q Consensus       170 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~------------  228 (404)
                      |+.......    .....+||+.|||||++.+..     .++.++|||||||++|||+||.+||....            
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            987654322    223468999999999985321     36789999999999999999987664221            


Q ss_pred             --cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        229 --TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ...............+.......  ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhcccCCCCCCcccc--chHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              11122221111111111100000  01123578899999999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-52  Score=398.09  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=225.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++++.||+|+||.||+|.++.+++.||||++.+... ..........|..++..+..||||++++++|.  +..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCC
Confidence            456799999999999999999999999999999999976432 23345667789999998867999999999987  567


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            89999999985 89988874 67999999999999999999999999999999999999999999999999999865444


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          ..
T Consensus       175 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------~~  243 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------KS  243 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             CcccccccCCccccChhhh-cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----------CC
Confidence            4445677899999999998 466789999999999999999999999999888877777766433222          35


Q ss_pred             CCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      +++++.+||.+||..||.+||+     +.++++||||....+
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence            6899999999999999999994     699999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-51  Score=393.76  Aligned_cols=260  Identities=24%  Similarity=0.410  Sum_probs=219.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -.++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..+++.+.+||||++++++|.  +...
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCCE
Confidence            45789999999999999999999999999999999976543 34556677899999998866999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999985 89888864 679999999999999999999999999999999999999999999999999998654444


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHHhhCCCCCCcc
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---------TSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||....         .......+.......+    
T Consensus       165 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  239 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  239 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----
T ss_pred             CcccccCCCccccCcccc-CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----
Confidence            445677899999999998 45678999999999999999999999997531         1222233332211111    


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCH------HHHHhccCCCCcCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPET------DQILEHNYVSKYFP  293 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~hp~~~~~~~  293 (404)
                            ..++..+.+||.+||+.||.+||++      .++++||||....+
T Consensus       240 ------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          240 ------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             ------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                  3568999999999999999999995      89999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=391.55  Aligned_cols=261  Identities=30%  Similarity=0.510  Sum_probs=217.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------------------------hhHHHHHHHHHHH
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------------------------KTDAQRTYREILF   75 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~E~~~   75 (404)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++......                        ......+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3467999999999999999999999999999999998644211                        1123567899999


Q ss_pred             HHhccCCCCcceEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q psy14434         76 LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNI  154 (404)
Q Consensus        76 l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NI  154 (404)
                      ++.+. ||||+++++++.......+|+||||+.+ +|.+++..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            99996 9999999999986567889999999984 777776677899999999999999999999999999999999999


Q ss_pred             EEccCCceEEeccccccccCCCCCcccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Q psy14434        155 LIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR--YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ  232 (404)
Q Consensus       155 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  232 (404)
                      |++.++.+||+|||++..............||+.|+|||++.+...  ++.++|||||||++|+|++|..||.+......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999877655444556789999999999854332  47899999999999999999999988776665


Q ss_pred             HHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ...+.......+.        ...+++.+.+||.+||+.||.+|||+.++++||||+
T Consensus       249 ~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPD--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCC--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            5555443222211        246789999999999999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5e-52  Score=399.30  Aligned_cols=263  Identities=27%  Similarity=0.456  Sum_probs=228.1

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ....+.++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.+. ||||+++++++.  +
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~   99 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--E   99 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--C
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--e
Confidence            3445667899999999999999999999999999999999776666677788899999999996 999999999987  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---CceEEecccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLAR  171 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---~~vkl~Dfg~a~  171 (404)
                      ....|+||||+.| +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            7789999999985 8888776 4569999999999999999999999999999999999999865   459999999998


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ..... ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+.      
T Consensus       180 ~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------  251 (362)
T 2bdw_A          180 EVNDS-EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------  251 (362)
T ss_dssp             CCTTC-CSCCCSCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------
T ss_pred             EecCC-cccccCCCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence            76543 334557899999999998 4667899999999999999999999999998887777777665443332      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..+..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            123567899999999999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=396.75  Aligned_cols=269  Identities=32%  Similarity=0.623  Sum_probs=219.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.  +...+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   76 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSLT   76 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCC-CTTBCCEEEEEE--CSSCEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcC-CCCCCeeeeEEe--eCCEEE
Confidence            3689999999999999999999999999999999854321 111123447999999997 999999999987  567899


Q ss_pred             EEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||||++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             EEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            9999999999988874  45999999999999999999999999999999999999999999999999999876554444


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-cc----------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-AD----------  248 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----------  248 (404)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+..... ..          
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            5566899999999998666778999999999999999999999999999988888888776633221 11          


Q ss_pred             ---------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        249 ---------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       249 ---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                               ......+.+++++.+||.+||+.||.+|||++++|+||||......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                     1112234678999999999999999999999999999999986544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=387.81  Aligned_cols=270  Identities=35%  Similarity=0.605  Sum_probs=219.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC---hhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN---KTDAQRTYREILFLKSFQ--RHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~   94 (404)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++......   ........+|+.+++.+.  .||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567999999999999999999999999999999998643211   112234456666666554  39999999999874


Q ss_pred             ccCC---eEEEEEeccCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccc
Q psy14434         95 VNNK---DLYVVFEYMENDLNKVIRDKI---LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG  168 (404)
Q Consensus        95 ~~~~---~~~lv~E~~~~~L~~~l~~~~---l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg  168 (404)
                      ....   .+++||||+.++|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            3322   589999999999999998543   8999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc-
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA-  247 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  247 (404)
                      ++...... ......+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+.......+... 
T Consensus       166 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          166 LARIYSYQ-MALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CTTTSTTC-CCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccCCC-cccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            99876543 3345678999999999984 56789999999999999999999999999999888888877665333211 


Q ss_pred             ----------------chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 ----------------DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 ----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                      .......+.+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                            11122335678999999999999999999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-52  Score=405.87  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=224.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+++.+. ||||++++++|.  +...
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~~~  143 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ--DDRY  143 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCE
Confidence            35689999999999999999999999999999999965321 1122334668999999996 999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|+|||||. |+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999997 5899999988899999999999999999999999999999999999999999999999999987654322


Q ss_pred             -cccccccccccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchhhcc
Q psy14434        179 -CLTEYIATRWYRAPEILISNR---RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKFYAG  253 (404)
Q Consensus       179 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  253 (404)
                       .....+||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+.......+..... ...+       .
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-------~  296 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-------D  296 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-------T
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-------C
Confidence             234678999999999985432   278999999999999999999999999988888888766432 1111       1


Q ss_pred             cCCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCcCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~~~~  294 (404)
                      ...+++++.+||.+||..+|.+  ||+++++++||||+...+.
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            1457899999999999999988  9999999999999986543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-51  Score=394.59  Aligned_cols=272  Identities=32%  Similarity=0.617  Sum_probs=228.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++..............+|+.+++.+. ||||+++++++....   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence            4568999999999999999999999999999999999766555555667789999999997 999999999987432   


Q ss_pred             ---CCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         97 ---NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        97 ---~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                         ...+|+||||++++|...+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence               457899999999998888874  469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC----CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        172 SLSDS----KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       172 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .....    .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.......++..
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            65422    12234567899999999986666789999999999999999999999999998888888877766443322


Q ss_pred             chhhcc---cC-------------------CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 DKFYAG---FK-------------------NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ~~~~~~---~~-------------------~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ......   +.                   ..++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            111100   00                   0267899999999999999999999999999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-51  Score=390.50  Aligned_cols=258  Identities=25%  Similarity=0.452  Sum_probs=224.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..   .......+.+|+.+++.+. ||||+++++++.  +...
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~   75 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIAR-HRNILHLHESFE--SMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCC-CCCCCeEeEEEe--cCCE
Confidence            356899999999999999999999999999999999853   2345566789999999996 999999999987  5678


Q ss_pred             EEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc--CCceEEeccccccccC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLS  174 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~~~  174 (404)
                      +|+||||+.| +|.+.+...  .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999985 899998753  5999999999999999999999999999999999999987  7899999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.........+.......+.      ..+
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------~~~  227 (321)
T 1tki_A          156 PG-DNFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------EAF  227 (321)
T ss_dssp             TT-CEEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------HHH
T ss_pred             CC-CccccccCChhhcCcHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh------hhh
Confidence            43 334556899999999998 4566899999999999999999999999998888777777665443322      223


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            5779999999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-51  Score=389.39  Aligned_cols=256  Identities=28%  Similarity=0.501  Sum_probs=222.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  +...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~   80 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQ   80 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEE--eCCE
Confidence            35789999999999999999999999999999999965432 2234556778999999996 999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999985 89998874 56999999999999999999999999999999999999999999999999999875432 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                        ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..+
T Consensus       160 --~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----------~~~  226 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----------PFF  226 (318)
T ss_dssp             --BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----------TTS
T ss_pred             --cccccCCccccCHhHh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------CCC
Confidence              3456899999999998 466789999999999999999999999998888777777765432222          346


Q ss_pred             CHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      ++++.+||.+||..||.+||     +++++++||||+...+
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence            89999999999999999999     9999999999997654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-51  Score=392.40  Aligned_cols=275  Identities=33%  Similarity=0.630  Sum_probs=225.9

Q ss_pred             ccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         13 VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ...++.+...++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   93 (331)
T 4aaa_A           15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVC   93 (331)
T ss_dssp             ----CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEe
Confidence            34457788899999999999999999999999999999999999766555666677889999999997 99999999998


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      .  +...+|+||||+.+ +|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        94 ~--~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           94 K--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             E--ETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             e--cCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence            7  57789999999997 4555554 456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-----
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-----  245 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  245 (404)
                      .............+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+........+     
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            876554444556789999999999865567899999999999999999999999999888777776655443221     


Q ss_pred             ----------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        246 ----------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       246 ----------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                                      ........++.+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                            111222233567899999999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4e-51  Score=391.81  Aligned_cols=305  Identities=35%  Similarity=0.659  Sum_probs=244.9

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ....+.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||+++++++....
T Consensus        18 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS   96 (353)
T ss_dssp             EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred             cccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence            3456778999999999999999999999999999999999776666667788899999999997 999999999986322


Q ss_pred             C----CeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         97 N----KDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        97 ~----~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .    ..+|+||||+.++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQTDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             SGGGCCCCEEEEECCSEEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             ccccceeEEEEeccccCCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            1    24699999999988877654 499999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      ....   ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+..+.       
T Consensus       176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            5432   345679999999999865577899999999999999999999999998887777777665432211       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI  311 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~  311 (404)
                                    ....+...++.+++.+.+||.+||+.||.+|||+.++|+||||..+..+.....   ...... ..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~---~~~~~~-~~  328 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE---AQQPFD-DS  328 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCC---CSSCCC-CT
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccccc---CCCCCc-cc
Confidence                          011222334567999999999999999999999999999999998765443211   111111 22


Q ss_pred             CCCCcCCHHHHHHHHHHHH
Q psy14434        312 DDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~  330 (404)
                      .+......++|+..+++.+
T Consensus       329 ~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          329 LEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             TTTCCCCHHHHHHHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHH
Confidence            3345677889998888766

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-51  Score=392.99  Aligned_cols=265  Identities=27%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.+++.+. ||||+++++++.  ...
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~   89 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLR-HPNIVRFKEVIL--TPT   89 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCC-CCCCCcEEEEEe--eCC
Confidence            3456789999999999999999999999999999999965332   2245678999999997 999999999987  577


Q ss_pred             eEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc--eEEeccccccccC
Q psy14434         99 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLGLARSLS  174 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~--vkl~Dfg~a~~~~  174 (404)
                      .+|+||||+. |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            8999999997 58988886 467999999999999999999999999999999999999987765  9999999997543


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-hCCCCCCcchhhcc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAG  253 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  253 (404)
                      .. ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+... .......     ..
T Consensus       170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----~~  243 (361)
T 3uc3_A          170 LH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI-----PD  243 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC-----CT
T ss_pred             cc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC-----CC
Confidence            22 22345679999999999865444455699999999999999999999875442222222221 1111110     01


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                      ...+++.+.+||.+||..||.+|||+.++++||||....+..
T Consensus       244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~  285 (361)
T 3uc3_A          244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPAD  285 (361)
T ss_dssp             TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchh
Confidence            135689999999999999999999999999999998765433

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-51  Score=395.44  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=216.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ....++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..++.+..+||||++++++|.  +.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~  111 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TA  111 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CS
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eC
Confidence            3456789999999999999999999999999999999976543 23345556677777433335999999999987  57


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            789999999985 89888864 6699999999999999999999999999999999999999999999999999987544


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      ........+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          .
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------~  260 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----------P  260 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----------S
T ss_pred             CCCccccccCCccccCHHHh-CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----------C
Confidence            44455678899999999998 466789999999999999999999999999888877777765432211          4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCH----HHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPET----DQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~hp~~~~~~~  293 (404)
                      .++..+.+||.+||+.||.+||++    .++++||||+...+
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence            568999999999999999999987    69999999997654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-51  Score=390.36  Aligned_cols=272  Identities=36%  Similarity=0.644  Sum_probs=222.6

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh---hHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK---TDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      +...++|++.+.||+|+||.||+|.+..+|+.||+|++.......   .....+.+|+.+++.+. ||||+++++++.  
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--   82 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG--   82 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC--
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEe--
Confidence            345678999999999999999999999999999999996532221   12345778999999997 999999999986  


Q ss_pred             cCCeEEEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      .....++||||++++|...+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            56779999999999999888754  5899999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC-cc----
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-AD----  248 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----  248 (404)
                      ..........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.......... ..    
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            6554555667899999999998655668999999999999999999999999999888888887765532211 11    


Q ss_pred             -------------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        249 -------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       249 -------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                                   .....+..++.++.+||.+||..||.+|||+.++|+||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence                         011123566899999999999999999999999999999987543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-51  Score=402.08  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=224.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.+... .......+.+|..++..+. ||||++++++|.  +...+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~--~~~~~  149 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQ--DDNNL  149 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEE--CSSEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--eCCEE
Confidence            4689999999999999999999999999999999965321 1122233678999999986 999999999987  57789


Q ss_pred             EEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |+|||||. |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999997 599999975  579999999999999999999999999999999999999999999999999998765433


Q ss_pred             C-ccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC--CCCCCcchh
Q psy14434        178 E-CLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR--PNPPHADKF  250 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  250 (404)
                      . .....+||+.|+|||++..    ...++.++|||||||++|||++|++||.+.+.......+.....  ..+.     
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----  304 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-----  304 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-----
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-----
Confidence            2 2344689999999999852    45689999999999999999999999999988888877765432  2221     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCC--CCCHHHHHhccCCCCcCCCCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSE--RPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                        ....+++++.+||.+||..+|++  |++++++++||||+...+...
T Consensus       305 --~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          305 --QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             --SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             --ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence              12457999999999999998888  999999999999998776554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-51  Score=394.15  Aligned_cols=260  Identities=27%  Similarity=0.452  Sum_probs=217.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++.....   .......+.+|+.+++.+. ||||+++++++.  +
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~   97 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS--S   97 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--E
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE--e
Confidence            455789999999999999999999999999999999864321   1224567889999999996 999999999987  4


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eEEecc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDL  167 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vkl~Df  167 (404)
                      ...+|+|||||. ++|.+.+..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence            678999999999 588777653     24899999999999999999999999999999999999987654   999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      |++.............+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.. ......+........+  
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~--  253 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP--  253 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH--
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHH-cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc--
Confidence            9998876554445567899999999998 45678999999999999999999999998753 3344444433222211  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                          ..+..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus       254 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          254 ----RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             ----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                123567999999999999999999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.8e-51  Score=390.50  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=224.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  +..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~  114 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNS  114 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--cCC
Confidence            456799999999999999999999999999999999965432 2234567789999999996 999999999987  577


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            8999999997 589988874 67999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                         ....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          ..
T Consensus       195 ---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------~~  260 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----------SH  260 (350)
T ss_dssp             ---BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             ---cccccCCccccCHHHh-cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----------CC
Confidence               3456899999999998 466789999999999999999999999998888777777766433222          35


Q ss_pred             CCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      +++++.+||.+||+.||.+||+     ++++++||||....+
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            6899999999999999999998     999999999987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-51  Score=405.90  Aligned_cols=259  Identities=26%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++.  ....
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~--~~~~  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--THDR  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEE--ETTE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEe--eCCE
Confidence            4578999999999999999999999999999999997543 23445566778999999997 999999999987  5678


Q ss_pred             EEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|+||||+.+ +|...+. .+.+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++.....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999985 8888876 4679999999999999999999998 99999999999999999999999999999875544


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+          ..
T Consensus       303 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------~~  371 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----------RT  371 (446)
T ss_dssp             ----CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             CcccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------cc
Confidence            4555678899999999998 567789999999999999999999999999888777776665433222          35


Q ss_pred             CCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      +++++.+||.+||+.||.+||     ++.++++||||....+
T Consensus       372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence            689999999999999999999     9999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.4e-51  Score=386.87  Aligned_cols=260  Identities=25%  Similarity=0.442  Sum_probs=212.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...++|++.+.||+|+||.||+|.+.   .+++.||+|++.+...  .......+.+|+.+++.+. ||||+++++++. 
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-   91 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQ-   91 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEE-
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEE-
Confidence            34578999999999999999999985   6889999999975432  2334556778999999997 999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       ....+|+||||+.| +|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        92 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 -TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             -CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence             56789999999984 8988887 45699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...........+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+        
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--------  241 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--------  241 (327)
T ss_dssp             --------CTTSSCCTTSCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             cccCCccccccCCCcCccCHhhC-cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            54444444567899999999998 456789999999999999999999999999888777777665433222        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                        ..++.++.+||.+||..||.+||     ++.++++||||....+
T Consensus       242 --~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          242 --PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             --TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             --CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence              34689999999999999999999     8999999999987643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-51  Score=386.22  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=223.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.+. ||||+++++++. 
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-   84 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE-   84 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE-
Confidence            346678999999999999999999999999999999996543221    24567889999999997 999999999987 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEeccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLG  168 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Dfg  168 (404)
                       +...+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence             5778999999997 599998864 5699999999999999999999999999999999999998887    89999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ++....... .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+.   
T Consensus       164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---  238 (326)
T 2y0a_A          164 LAHKIDFGN-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED---  238 (326)
T ss_dssp             TCEECCTTS-CCCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH---
T ss_pred             CCeECCCCC-ccccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc---
Confidence            998765432 33456799999999998 5667899999999999999999999999988877776666554332221   


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ..+..++..+.+||.+||..||.+|||+.++|+||||..
T Consensus       239 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          239 ---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             ---HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ---cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence               123567899999999999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.5e-51  Score=406.77  Aligned_cols=269  Identities=32%  Similarity=0.541  Sum_probs=229.8

Q ss_pred             ccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         13 VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      .+....|.+.++|++++.||+|+||+||+|.+..+++.||+|++.+..........+.+|+.+++++. ||||+++++++
T Consensus        12 ~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   90 (486)
T 3mwu_A           12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEIL   90 (486)
T ss_dssp             --CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEE
Confidence            34456688999999999999999999999999999999999999766555556778889999999996 99999999998


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---cCCceEEecc
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDL  167 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~---~~~~vkl~Df  167 (404)
                      .  +...+|+|||||.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        91 ~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           91 E--DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             E--CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             E--cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            7  57789999999985 8877665 56799999999999999999999999999999999999995   4567999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      |++...... ......+||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+.+....+..+.........  
T Consensus       169 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  243 (486)
T 3mwu_A          169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--  243 (486)
T ss_dssp             SCTTTBCCC-----CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS--
T ss_pred             CcCeECCCC-CccCCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            999876543 3345668999999999984  35899999999999999999999999998888877777665443222  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                          +.+..+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       244 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 ----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             ----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             ----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                223567999999999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-51  Score=396.41  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=222.8

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|..++..+. ||||++++++|.  +...
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~--~~~~  135 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQ--DENY  135 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEE--CSSE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEe--eCCE
Confidence            35789999999999999999999999999999999965321 2223344678999999986 999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|+||||+. |+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999997 599999875  36999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-ccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcc
Q psy14434        177 KE-CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHAD  248 (404)
Q Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  248 (404)
                      .. .....+||+.|+|||++..      ...++.++|||||||++|||++|++||.+.+.......+..... ...+.  
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--  293 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL--  293 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc--
Confidence            32 2234689999999999852      35689999999999999999999999999888887777765322 11110  


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCC---CCHHHHHhccCCCCcCCCCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSER---PETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~~ll~hp~~~~~~~~~~  296 (404)
                          ....+|+++.+||.+||. +|.+|   ++++++++||||+...+...
T Consensus       294 ----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          294 ----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             ----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                114579999999999999 99998   59999999999998766553

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-50  Score=389.97  Aligned_cols=262  Identities=25%  Similarity=0.448  Sum_probs=224.6

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.+. ||||+++++++.  +.
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~  120 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DK  120 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CS
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEE--eC
Confidence            356778999999999999999999999999999999998543  2334557789999999996 999999999987  57


Q ss_pred             CeEEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc--CCceEEeccccccc
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARS  172 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~  172 (404)
                      ..+|+||||+.| +|.+.+...  .+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++..
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            789999999984 899888643  6999999999999999999999999999999999999974  57899999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+.      .
T Consensus       201 ~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------~  272 (387)
T 1kob_A          201 LNPD-EIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------D  272 (387)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------S
T ss_pred             cCCC-cceeeeccCCCccCchhc-cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------c
Confidence            6543 233456799999999998 4667899999999999999999999999998887777766654332222      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      .+..+++++.+||.+||..||.+|||+.++|+||||....
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            2356799999999999999999999999999999998643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.1e-51  Score=394.42  Aligned_cols=272  Identities=23%  Similarity=0.307  Sum_probs=218.6

Q ss_pred             ccCCeEEeeeeccc--CceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         21 ILAEYTIHKRIGKG--AYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..++|++++.||+|  +||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||++++++|.  +..
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFI--ADN   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETT
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE--ECC
Confidence            45689999999999  9999999999999999999999877666777788889999999997 999999999987  567


Q ss_pred             eEEEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      .+|+|||||. ++|.+++..   +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            8999999998 589998875   569999999999999999999999999999999999999999999999999886542


Q ss_pred             CCC-------CcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-
Q psy14434        175 DSK-------ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-  245 (404)
Q Consensus       175 ~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  245 (404)
                      ...       ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+.....+... 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            211       112334799999999998543 57899999999999999999999999887665544333221110000 


Q ss_pred             -----------------------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        246 -----------------------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       246 -----------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                                                         ...........+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                               000001123457889999999999999999999999999999998


Q ss_pred             cCCCC
Q psy14434        291 YFPSA  295 (404)
Q Consensus       291 ~~~~~  295 (404)
                      .....
T Consensus       340 ~~~~~  344 (389)
T 3gni_B          340 IKRRA  344 (389)
T ss_dssp             C---C
T ss_pred             Hhhcc
Confidence            75443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3e-50  Score=374.25  Aligned_cols=264  Identities=31%  Similarity=0.482  Sum_probs=218.1

Q ss_pred             ccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         13 VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ......|++.++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.+. ||||+++++++
T Consensus        12 ~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   89 (285)
T 3is5_A           12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVF   89 (285)
T ss_dssp             -CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             ccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCC-CchHHhHHHhe
Confidence            345667899999999999999999999999999999999999986553 2334567889999999996 99999999998


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceE
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIK  163 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vk  163 (404)
                      .  +...+|+||||+.+ +|.+.+..     ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+|
T Consensus        90 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           90 E--DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             E--CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred             e--cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEE
Confidence            7  57789999999985 88887742     569999999999999999999999999999999999999   4568899


Q ss_pred             EeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q psy14434        164 IGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN  243 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  243 (404)
                      |+|||++...... .......||+.|+|||++  ...++.++|||||||++|+|++|..||.+.........+.......
T Consensus       168 l~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~--~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          168 IIDFGLAELFKSD-EHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             ECCCCCCCC-----------CTTGGGCCHHHH--TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EEeeecceecCCc-ccCcCcccccCcCChHHh--ccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            9999999765543 233456799999999997  3468999999999999999999999999887766555544332221


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..       ....+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus       245 ~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 AV-------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cc-------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            11       11346899999999999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-50  Score=370.47  Aligned_cols=263  Identities=27%  Similarity=0.447  Sum_probs=228.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++. ||||+++++++.  ....
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   79 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESF   79 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE--cCCE
Confidence            4567999999999999999999999999999999999877667777888899999999996 999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eEEeccccccccC
Q psy14434        100 LYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGLARSLS  174 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vkl~Dfg~a~~~~  174 (404)
                      .|+||||+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999985 7876665 566999999999999999999999999999999999999987655   9999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+.      ..+
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~  231 (284)
T 3kk8_A          160 DS-EAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------PEW  231 (284)
T ss_dssp             SS-CBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------TTT
T ss_pred             cC-ccccCCCCCcCCcCchhh-cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc------hhh
Confidence            43 233456799999999998 4667899999999999999999999999998887777776665443332      122


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ..+++++.+||.+||+.||.+|||+.++|+||||.....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            567899999999999999999999999999999987544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-50  Score=380.57  Aligned_cols=255  Identities=25%  Similarity=0.484  Sum_probs=221.3

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .|...+.||+|+||.||+|.+..+|+.||||++....  ......+.+|+.+++.+. ||||+++++++.  .....|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYL--VGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEEEEE
Confidence            4889999999999999999999999999999985432  334566789999999996 999999999987  46789999


Q ss_pred             EeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccc
Q psy14434        104 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE  182 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~  182 (404)
                      |||+.+ +|.+++....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++............
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            999985 8999998888999999999999999999999999999999999999999999999999999877654444556


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHH
Q psy14434        183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAV  262 (404)
Q Consensus       183 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (404)
                      .+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.....+...       ....+++.+.
T Consensus       201 ~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~  272 (321)
T 2c30_A          201 LVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-------NSHKVSPVLR  272 (321)
T ss_dssp             CCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-------TGGGSCHHHH
T ss_pred             ccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-------ccccCCHHHH
Confidence            7899999999998 4667899999999999999999999999888777666665544332211       1135689999


Q ss_pred             HHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        263 DLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       263 ~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +||.+||+.||.+|||+.++++||||.+.
T Consensus       273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          273 DFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            99999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9e-51  Score=384.69  Aligned_cols=263  Identities=26%  Similarity=0.385  Sum_probs=215.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.  +...
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~   79 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNI   79 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cCCe
Confidence            467899999999999999999999999999999999854321 223355778999999996 999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC-
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS-  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~-  176 (404)
                      .|+||||+.+ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999985 88888864 46999999999999999999999999999999999999999999999999999865322 


Q ss_pred             -CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        177 -KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       177 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+..................       ..+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~  232 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------NPWK  232 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------TTGG
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------Cccc
Confidence             22334568999999999986555558899999999999999999999987665432222222111111       1124


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+++.+.+||.+||..||.+|||+.++++||||.....
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            57899999999999999999999999999999987544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-50  Score=387.18  Aligned_cols=258  Identities=31%  Similarity=0.485  Sum_probs=215.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+....      ..+|+.++.++.+||||++++++|.  +..
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~--~~~   89 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYD--DGK   89 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEE--CSS
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEE--cCC
Confidence            45678899999999999999999999999999999999654322      2468888888867999999999987  577


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC----CceEEeccccccc
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS----CSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~----~~vkl~Dfg~a~~  172 (404)
                      .+|+|||||.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            89999999985 88888764 569999999999999999999999999999999999998543    3599999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHhhCCCCCCcch
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA---STSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ...........+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.   ........+.......+.    
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----  244 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG----  244 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS----
T ss_pred             CcCCCCceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc----
Confidence            765545556678999999999984 556889999999999999999999999863   333444444443322221    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                        ..+..+++++.+||.+||..||.+|||+.++++||||..+
T Consensus       245 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          245 --GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             --TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence              1235679999999999999999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3e-50  Score=398.98  Aligned_cols=261  Identities=28%  Similarity=0.458  Sum_probs=225.9

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.+. ||||+++++++.  ..
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~--~~   88 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIS--TP   88 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CS
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--EC
Confidence            4567899999999999999999999999999999999965432 2234567889999999997 999999999987  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            78999999997 589988874 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+.......+          .
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----------~  237 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----------Q  237 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----------T
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----------c
Confidence            3 3345678999999999986555558999999999999999999999999888877777765443222          3


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+++++.+||.+||..||.+|||+.++++||||....+
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            46899999999999999999999999999999987544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=378.79  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=212.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.++|++.+.||+|+||+||+|.+..+|+.||||++...............|+..+..+..||||+++++++.  +...+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~  132 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGIL  132 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEE
Confidence            4467999999999999999999999999999999987766666777777888888888867999999999987  57789


Q ss_pred             EEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||++++|.+.+..  ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus       133 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~  211 (311)
T 3p1a_A          133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G  211 (311)
T ss_dssp             EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence            99999999999888864  45999999999999999999999999999999999999999999999999999876543 2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      ......||+.|+|||++. + .++.++|||||||++|+|++|..||.+...   ...+....  .+.      .....++
T Consensus       212 ~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~------~~~~~~~  278 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPP------EFTAGLS  278 (311)
T ss_dssp             ---CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCH------HHHTTSC
T ss_pred             CCcccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCc------ccccCCC
Confidence            334567999999999984 3 689999999999999999999766654322   22222111  111      1124678


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +++.+||.+||+.||.+|||+.++|+||||++
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-50  Score=378.65  Aligned_cols=274  Identities=38%  Similarity=0.655  Sum_probs=222.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe----
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA----   94 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~----   94 (404)
                      ..+.++|++++.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++..    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCB
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccc
Confidence            45678999999999999999999999999999999998532  4556677889999999996 9999999998742    


Q ss_pred             --------ccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-cCCceEEe
Q psy14434         95 --------VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIG  165 (404)
Q Consensus        95 --------~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~-~~~~vkl~  165 (404)
                              .+...+|+||||++|+|.+++..+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence                    234688999999999999999988999999999999999999999999999999999999997 56799999


Q ss_pred             ccccccccCCC---CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        166 DLGLARSLSDS---KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       166 Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      |||++......   ........||+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.........+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999865432   122344568999999999866678999999999999999999999999998887777666554332


Q ss_pred             CCC--------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        243 NPP--------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       243 ~~~--------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                      ...                    .........+.++.++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            111                    01111223356899999999999999999999999999999999765443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=381.25  Aligned_cols=258  Identities=27%  Similarity=0.425  Sum_probs=202.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++...    .....+.+|+.+++.+. ||||+++++++.  +..
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~  121 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLS-HPNIIKLKEIFE--TPT  121 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCC-CCCCcceeeeEe--cCC
Confidence            45667899999999999999999999999999999998643    23455678999999997 999999999987  567


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEecccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg~a~~~  173 (404)
                      .+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            8999999998 589888864 56899999999999999999999999999999999999975   889999999999866


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCCCCcchhhc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..... ....+.........      .
T Consensus       202 ~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~------~  273 (349)
T 2w4o_A          202 EHQ-VLMKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS------P  273 (349)
T ss_dssp             ------------CGGGSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT------T
T ss_pred             Ccc-cccccccCCCCccCHHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC------c
Confidence            432 233456799999999998 45678999999999999999999999998776554 34444433222111      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .+..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            235678999999999999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-50  Score=390.34  Aligned_cols=264  Identities=32%  Similarity=0.617  Sum_probs=218.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe------
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------   94 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~------   94 (404)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++......      ..+|+.+++.+. ||||++++++|..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLD-HVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcC-CCCccchhheeeecCcccc
Confidence            456899999999999999999999999999999998543211      227999999996 9999999999853      


Q ss_pred             ------------------------------ccCCeEEEEEeccCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH
Q psy14434         95 ------------------------------VNNKDLYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYI  139 (404)
Q Consensus        95 ------------------------------~~~~~~~lv~E~~~~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~L  139 (404)
                                                    .+...+++||||++++|.+.+..     +.+++..++.++.||+.||+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                          23445899999999988777752     5699999999999999999999


Q ss_pred             HhCCCccCCCCCCcEEEc-cCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q psy14434        140 HACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML  218 (404)
Q Consensus       140 H~~~i~HrDlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  218 (404)
                      |++||+||||||+|||++ .++.+||+|||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            999999999999999998 6889999999999876543 23455679999999999866667999999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHhhCCCCCC------------------cchhhc-ccCCCCHHHHHHHHhccccCCCCCCCH
Q psy14434        219 QSKPLFPGASTSHQLQLIVNLVRPNPPH------------------ADKFYA-GFKNKPEEAVDLLNQILVLNPSERPET  279 (404)
Q Consensus       219 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~  279 (404)
                      +|.+||.+.+....+..+....+.....                  ...+.. ....+++++.+||.+||..||.+|||+
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999999999888888887765532210                  011111 123478899999999999999999999


Q ss_pred             HHHHhccCCCCcC
Q psy14434        280 DQILEHNYVSKYF  292 (404)
Q Consensus       280 ~~ll~hp~~~~~~  292 (404)
                      .++|+||||+...
T Consensus       317 ~e~l~hp~f~~~~  329 (383)
T 3eb0_A          317 YEAMAHPFFDHLR  329 (383)
T ss_dssp             HHHHTSGGGHHHH
T ss_pred             HHHhcCHHHHHHH
Confidence            9999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.6e-50  Score=394.91  Aligned_cols=266  Identities=30%  Similarity=0.519  Sum_probs=220.9

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc-----CCCCcceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-----RHPNIITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~l~~~~~   93 (404)
                      ..+..+|++++.||+|+||.||+|.+..+++.||||++..   .........+|+.+++.+.     +|+||+++++++.
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3566789999999999999999999999999999999853   2344556677888888774     4779999999987


Q ss_pred             eccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc--eEEeccc
Q psy14434         94 AVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--IKIGDLG  168 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~--vkl~Dfg  168 (404)
                        ....+|+||||+.++|.+++...   .+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||
T Consensus       170 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          170 --FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             --ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             --cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence              46789999999999999988754   3899999999999999999999999999999999999999987  9999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ++......   ....+||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+....+..+....+..+....
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceecCCc---ccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            99765432   34568999999999984 567899999999999999999999999999998888888776553332100


Q ss_pred             ------------------------------------------------hhhc-ccCCCCHHHHHHHHhccccCCCCCCCH
Q psy14434        249 ------------------------------------------------KFYA-GFKNKPEEAVDLLNQILVLNPSERPET  279 (404)
Q Consensus       249 ------------------------------------------------~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~  279 (404)
                                                                      .+.. .....++.+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                            0000 011237889999999999999999999


Q ss_pred             HHHHhccCCCCcCC
Q psy14434        280 DQILEHNYVSKYFP  293 (404)
Q Consensus       280 ~~ll~hp~~~~~~~  293 (404)
                      .++|+||||+...+
T Consensus       404 ~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          404 GQALRHPWLRRRLP  417 (429)
T ss_dssp             HHHHTSTTTC----
T ss_pred             HHHhCChhhccCCC
Confidence            99999999997544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.3e-50  Score=389.61  Aligned_cols=267  Identities=32%  Similarity=0.588  Sum_probs=218.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      ....+|++.+.||+|+||+||+|.+..+++ +|+|++......      ..+|+.+++.+. ||||++++++|....   
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVK-HPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCC-CTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCC-CCCcceEEEEEEecCCCC
Confidence            345679999999999999999999988777 888877432211      126999999997 999999999986422   


Q ss_pred             -CCeEEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-cCCceEEecccc
Q psy14434         97 -NKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGL  169 (404)
Q Consensus        97 -~~~~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~-~~~~vkl~Dfg~  169 (404)
                       ...+|+||||+.+++...+.     ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence             23488999999987765554     45699999999999999999999999999999999999999 799999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---  246 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  246 (404)
                      ++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+...++..+....+.....   
T Consensus       189 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98764432 33456899999999998666679999999999999999999999999999888888877765432210   


Q ss_pred             ---------------cchhhcc-cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        247 ---------------ADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       247 ---------------~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                                     ...+... ...+++++.+||.+||+.||.+|||+.++++||||+......
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence                           0111111 134789999999999999999999999999999999876544

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=392.83  Aligned_cols=271  Identities=31%  Similarity=0.586  Sum_probs=207.7

Q ss_pred             ccccCCeEEe-eeecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         19 GNILAEYTIH-KRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        19 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..+.+.|++. +.||+|+||.||+|.++  .+++.||||++.....    ...+.+|+.+|+.+. ||||++++++|...
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   90 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELK-HPNVISLQKVFLSH   90 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCC-CTTBCCCCEEEEET
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcC-CCCeeeEeeEEecC
Confidence            3455678884 57999999999999976  5688999999964322    235678999999997 99999999999766


Q ss_pred             cCCeEEEEEeccCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----ccCCc
Q psy14434         96 NNKDLYVVFEYMENDLNKVIRDK----------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCS  161 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~~~----------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----~~~~~  161 (404)
                      ....+|+||||+.++|.+++...          .+++..++.++.||+.||+|||++||+||||||+||||    +.++.
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            78899999999999988877521          39999999999999999999999999999999999999    67789


Q ss_pred             eEEeccccccccCCCC---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------
Q psy14434        162 IKIGDLGLARSLSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------  229 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------  229 (404)
                      +||+|||+++......   ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            9999999998764321   2234568999999999986556799999999999999999999999977654         


Q ss_pred             HHHHHHHHHhhCCCCCCcc-hhh---------------------------cccCCCCHHHHHHHHhccccCCCCCCCHHH
Q psy14434        230 SHQLQLIVNLVRPNPPHAD-KFY---------------------------AGFKNKPEEAVDLLNQILVLNPSERPETDQ  281 (404)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~  281 (404)
                      ..++..+....+....... .+.                           ......++.+.+||.+||..||.+|||+++
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            3666677766653332111 100                           001123678999999999999999999999


Q ss_pred             HHhccCCCCcCCC
Q psy14434        282 ILEHNYVSKYFPS  294 (404)
Q Consensus       282 ll~hp~~~~~~~~  294 (404)
                      +|+||||.....+
T Consensus       331 ~L~hp~f~~~~~~  343 (405)
T 3rgf_A          331 AMQDPYFLEDPLP  343 (405)
T ss_dssp             HHTSGGGTSSSCC
T ss_pred             HhcChhhccCCCC
Confidence            9999999875443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-49  Score=381.32  Aligned_cols=305  Identities=34%  Similarity=0.580  Sum_probs=234.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---------ChhHHHHHHHHHHHHHhccCCCCcceEe
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---------NKTDAQRTYREILFLKSFQRHPNIITML   89 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~~hpnIv~l~   89 (404)
                      ..+.++|++.+.||+|+||.||+|.+.. |..||||++.....         .......+.+|+.+++.+. ||||++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   95 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR   95 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence            3466899999999999999999998865 88999999865322         2233577889999999997 99999999


Q ss_pred             eEEEe---ccCCeEEEEEeccCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         90 DIYKA---VNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        90 ~~~~~---~~~~~~~lv~E~~~~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      +++..   .....+|+||||+.|+|.+.+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence            99864   234578999999999998888754  5999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        165 GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      +|||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+........
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999755433 2334567999999999986557799999999999999999999999999988888777766544322


Q ss_pred             C----------------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCC
Q psy14434        245 P----------------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV  302 (404)
Q Consensus       245 ~----------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~  302 (404)
                      .                      ....+....+..++.+.+||.+||+.||.+|||+.++|+||||+..+.+......  
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~--  332 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG--  332 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT--
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc--
Confidence            1                      1112223345678899999999999999999999999999999988665432111  


Q ss_pred             CCCcccccCCCCCcCCHHHHHHHHHHHHH
Q psy14434        303 TPHTVVLDIDDNNQLEINDYQDKLYDIVK  331 (404)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (404)
                      .+..  .. .+....+..++.+.+..++.
T Consensus       333 ~~~~--~~-~~~~~~~~~~~~~~~~~e~~  358 (362)
T 3pg1_A          333 LSER--FH-FDESVTDVYDMHKIFTAEVE  358 (362)
T ss_dssp             CCCC--CC-CCTTCCCHHHHHHHHHHHHH
T ss_pred             cccc--cC-hhhhhhhHHHHHHHHHHHHH
Confidence            1111  11 22245567777777776664

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-50  Score=381.99  Aligned_cols=272  Identities=25%  Similarity=0.430  Sum_probs=229.3

Q ss_pred             ccccccccccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeE
Q psy14434         13 VQHNVDGNILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI   91 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~   91 (404)
                      +.......+.++|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+..||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3344445677789998 899999999999999999999999999977666666677889999999999878999999999


Q ss_pred             EEeccCCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEE
Q psy14434         92 YKAVNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKI  164 (404)
Q Consensus        92 ~~~~~~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl  164 (404)
                      +.  +...+|+||||+.+ +|.+++..   +.+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||
T Consensus        98 ~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           98 YE--NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EE--CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EE--eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence            87  57789999999986 88888753   56999999999999999999999999999999999999987   789999


Q ss_pred             eccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        165 GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      +|||++...... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus       176 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          176 VDFGMSRKIGHA-CELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             CCGGGCEEC----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             eeCccccccCCc-cccccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            999999876543 223456799999999998 566789999999999999999999999999888777766665544332


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .      ..+..+++.+.+||.+||+.||.+|||++++|+||||+.+...
T Consensus       254 ~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          254 E------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             T------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             c------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            2      1225678999999999999999999999999999999986543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-50  Score=385.88  Aligned_cols=273  Identities=27%  Similarity=0.442  Sum_probs=223.0

Q ss_pred             cccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc---cChhHHHHHHHHHHHHHhccCCCCcceE
Q psy14434         12 KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      ..+......+.++|++.+.||+|+||.||+|.+..+++.||+|++....   ........+.+|+.+++.+. ||||+++
T Consensus        15 ~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~   93 (345)
T 3hko_A           15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARL   93 (345)
T ss_dssp             CCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCE
T ss_pred             cccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCccee
Confidence            3444444566789999999999999999999999999999999986542   24456678889999999997 9999999


Q ss_pred             eeEEEeccCCeEEEEEeccC-CcHHHHHHh-----------------------------------------cCCCHHHHH
Q psy14434         89 LDIYKAVNNKDLYVVFEYME-NDLNKVIRD-----------------------------------------KILKDVHIR  126 (404)
Q Consensus        89 ~~~~~~~~~~~~~lv~E~~~-~~L~~~l~~-----------------------------------------~~l~~~~~~  126 (404)
                      ++++.  +....|+||||+. |+|.+++..                                         ..+++..++
T Consensus        94 ~~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           94 YEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             EEEEE--CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             ehhhc--cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            99987  5778999999997 589888741                                         124677889


Q ss_pred             HHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC--ceEEeccccccccCCCC----Cccccccccccccccccccc-CC
Q psy14434        127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC--SIKIGDLGLARSLSDSK----ECLTEYIATRWYRAPEILIS-NR  199 (404)
Q Consensus       127 ~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~--~vkl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~  199 (404)
                      .++.||+.||+|||++||+||||||+|||++.++  .+||+|||++.......    .......||+.|+|||++.+ ..
T Consensus       172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            9999999999999999999999999999998776  89999999998653211    12345679999999999853 26


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCH
Q psy14434        200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPET  279 (404)
Q Consensus       200 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  279 (404)
                      .++.++|||||||++|+|++|..||.+.........+.......+.      ..+..+++.+.+||.+||..||.+|||+
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN------PNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS------GGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC------cccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            7899999999999999999999999998888777776665433222      1224568999999999999999999999


Q ss_pred             HHHHhccCCCCcCC
Q psy14434        280 DQILEHNYVSKYFP  293 (404)
Q Consensus       280 ~~ll~hp~~~~~~~  293 (404)
                      .++|+||||+.+..
T Consensus       326 ~~~l~hp~~~~~~~  339 (345)
T 3hko_A          326 MRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHSHHHHTTSS
T ss_pred             HHHhcChhhccChH
Confidence            99999999988654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-50  Score=416.06  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=227.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.++.+++.||||++.+.. ...........|..++..+..||+|+.++++|.  +...
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence            4678999999999999999999999999999999997542 223445667789999999877999999999987  5778


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999984 89988875 679999999999999999999999999999999999999999999999999998755444


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......+||+.|+|||++ .+..++.++|||||||++|||++|.+||.+.+.......+.......+          ..+
T Consensus       497 ~~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~  565 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----------KSM  565 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----------TTS
T ss_pred             cccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----------ccC
Confidence            555678999999999998 567789999999999999999999999999988888777765433222          356


Q ss_pred             CHHHHHHHHhccccCCCCCCCH-----HHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPET-----DQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~-----~~ll~hp~~~~~~~  293 (404)
                      ++++.+||.+||+.||.+||++     +++++||||....+
T Consensus       566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence            8999999999999999999997     99999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.3e-50  Score=382.24  Aligned_cols=258  Identities=29%  Similarity=0.470  Sum_probs=195.8

Q ss_pred             ccCCeEEe---eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         21 ILAEYTIH---KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        21 ~~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      +.++|++.   +.||+|+||.||+|.+..+++.||+|++.+.     ......+|+.+++.+.+||||+++++++.  +.
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~   78 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFH--DQ   78 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cC
Confidence            34578886   7899999999999999999999999998532     34566789999999988999999999987  57


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---ceEEeccccccc
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDLGLARS  172 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---~vkl~Dfg~a~~  172 (404)
                      ...|+||||+.+ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            789999999985 89988875 5699999999999999999999999999999999999998766   899999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHHhhCCCCC
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-------SHQLQLIVNLVRPNPP  245 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~  245 (404)
                      ...........+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.       ......+.......+.
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             cCCCCCcccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            66555555667899999999998 566789999999999999999999999976543       2223333222211111


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                            ..+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       238 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          238 ------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             ------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence                  12346799999999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.2e-50  Score=400.98  Aligned_cols=264  Identities=30%  Similarity=0.533  Sum_probs=222.4

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ...+.+.++|++++.||+|+||.||+|.++.++..||+|++.+..........+.+|+.+++.+. ||||++++++|.  
T Consensus        30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--  106 (494)
T 3lij_A           30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE--  106 (494)
T ss_dssp             CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE--
T ss_pred             cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--
Confidence            33455667899999999999999999999999999999999766555555677889999999996 999999999987  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---CceEEeccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGDLGLA  170 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---~~vkl~Dfg~a  170 (404)
                      +...+|+|||||.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            57789999999985 8877665 5679999999999999999999999999999999999999764   45999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ...... ......+||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+.........+.......+.     
T Consensus       187 ~~~~~~-~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  258 (494)
T 3lij_A          187 AVFENQ-KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS-----  258 (494)
T ss_dssp             EECBTT-BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-----
T ss_pred             eECCCC-ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence            876543 3345678999999999973  46899999999999999999999999999888887777765543332     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ..+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       259 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          259 -PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence             2246789999999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.1e-50  Score=383.56  Aligned_cols=262  Identities=28%  Similarity=0.459  Sum_probs=219.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc----CCCCcceEeeEEEe
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----RHPNIITMLDIYKA   94 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~l~~~~~~   94 (404)
                      ..+.++|++++.||+|+||.||+|.+..+++.||+|++..   ..........|+.+++.+.    .||||+++++++. 
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~-  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM-  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE-
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee-
Confidence            3456789999999999999999999999999999999853   2344556678999999886    5999999999987 


Q ss_pred             ccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-------------
Q psy14434         95 VNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-------------  158 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-------------  158 (404)
                       ....+|+||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.             
T Consensus       107 -~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 -YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             -ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             -ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence             46789999999988999999754   3999999999999999999999999999999999999975             


Q ss_pred             ------------CCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy14434        159 ------------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG  226 (404)
Q Consensus       159 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  226 (404)
                                  ++.+||+|||++......   ....+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        789999999999865432   34567999999999984 66789999999999999999999999999


Q ss_pred             CCcHHHHHHHHHhhCCCCCCcchhh---------------cc---------------------cCCCCHHHHHHHHhccc
Q psy14434        227 ASTSHQLQLIVNLVRPNPPHADKFY---------------AG---------------------FKNKPEEAVDLLNQILV  270 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~---------------------~~~~~~~~~~li~~~L~  270 (404)
                      .+.......+.....+.+.......               ..                     ....++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            8888888777776654442110000               00                     01124778899999999


Q ss_pred             cCCCCCCCHHHHHhccCCC
Q psy14434        271 LNPSERPETDQILEHNYVS  289 (404)
Q Consensus       271 ~dp~~Rpt~~~ll~hp~~~  289 (404)
                      .||.+|||+.++|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9e-50  Score=400.22  Aligned_cols=268  Identities=31%  Similarity=0.528  Sum_probs=226.2

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-----------hHHHHHHHHHHHHHhccCCC
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-----------TDAQRTYREILFLKSFQRHP   83 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~hp   83 (404)
                      ....+.+.++|++++.||+|+||.||+|.++.+++.||+|++.+.....           .....+.+|+.+++.+. ||
T Consensus        28 ~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp  106 (504)
T 3q5i_A           28 RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HP  106 (504)
T ss_dssp             CEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CT
T ss_pred             eccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CC
Confidence            3445678899999999999999999999999999999999996543221           34567889999999996 99


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-  160 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-  160 (404)
                      ||+++++++.  +...+|+|||||.| +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       107 niv~~~~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          107 NIIKLFDVFE--DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             TBCCEEEEEE--CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred             CCCeEEEEEE--cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence            9999999987  57789999999985 8877775 56799999999999999999999999999999999999998776 


Q ss_pred             --ceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q psy14434        161 --SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       161 --~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  238 (404)
                        .+||+|||++...... ......+||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       185 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence              6999999999876543 3345678999999999983  4689999999999999999999999999988887777766


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .....+.      ..+..+++++.+||.+||+.||.+|||+.++|+||||+.....
T Consensus       262 ~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          262 GKYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            5432221      2246789999999999999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-50  Score=377.78  Aligned_cols=269  Identities=25%  Similarity=0.427  Sum_probs=212.5

Q ss_pred             cccccccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         16 NVDGNILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...+.+.++|++. +.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++.++.+||||+++++++. 
T Consensus         5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-   81 (316)
T 2ac3_A            5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-   81 (316)
T ss_dssp             SSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             ccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-
Confidence            4456788899996 7899999999999999999999999998644  23345678899999999767999999999987 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eEEecccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDLGL  169 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vkl~Dfg~  169 (404)
                       +...+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+
T Consensus        82 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           82 -EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             -ETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             -eCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence             4678999999998 589988864 56999999999999999999999999999999999999988776   99999999


Q ss_pred             ccccCCCC-------Cccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------
Q psy14434        170 ARSLSDSK-------ECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---------  229 (404)
Q Consensus       170 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------  229 (404)
                      +.......       ......+||+.|+|||++..    ...++.++|||||||++|+|++|..||.+...         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            87653211       11234569999999999843    14578999999999999999999999987542         


Q ss_pred             ------HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        230 ------SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       230 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                            ......+.......+.      ..+..+++.+.+||.+||+.||.+|||+.++|+||||+...+.
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPD------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             cchhHHHHHHHHHhccCcccCc------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence                  1223333332221111      1224678999999999999999999999999999999976543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.4e-50  Score=392.72  Aligned_cols=265  Identities=31%  Similarity=0.587  Sum_probs=217.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec----cCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----NNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~----~~~   98 (404)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++.....      ...+|+.+++.+. ||||++++++|...    +..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcC-CCCccceeeEEeccCCCCcce
Confidence            469999999999999999999999999999999854321      1237999999997 99999999998532    223


Q ss_pred             eEEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccc
Q psy14434         99 DLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~  172 (404)
                      .+++||||+.++|...+.     ...+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            477999999998777664     3569999999999999999999999999999999999999965 5789999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------  246 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  246 (404)
                      ..... .....+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+.....      
T Consensus       207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            65432 23457899999999998655679999999999999999999999999998888887777654422110      


Q ss_pred             ------------cchhhcc-cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        247 ------------ADKFYAG-FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       247 ------------~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                                  ...+... ...+++++.+||.+||..||.+|||+.++++||||.......
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence                        0001111 135689999999999999999999999999999998876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-49  Score=381.19  Aligned_cols=257  Identities=28%  Similarity=0.496  Sum_probs=220.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...+.|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~  127 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--REH  127 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETT
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECC
Confidence            344569999999999999999999999999999999865432 2344567889999999997 999999999987  467


Q ss_pred             eEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..|+||||+.|+|.+.+.  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            899999999999888875  456999999999999999999999999999999999999999999999999999865432


Q ss_pred             CCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                          ...+||+.|+|||++..  ...++.++|||||||++|+|++|.+||.+.+.......+.....+...        .
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~  275 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------S  275 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--------C
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------C
Confidence                34679999999999842  457899999999999999999999999888777666655544332211        1


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            3568999999999999999999999999999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-49  Score=375.73  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=224.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.+. ||||+++++++. 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-   85 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE-   85 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe-
Confidence            456678999999999999999999999999999999996543222    23567889999999997 999999999987 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEeccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLG  168 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Dfg  168 (404)
                       +...+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++    .+||+|||
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           86 -NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence             5778999999997 599999875 4689999999999999999999999999999999999999887    79999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ++...... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+.   
T Consensus       165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---  239 (321)
T 2a2a_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE---  239 (321)
T ss_dssp             TCEECCTT-CCCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH---
T ss_pred             cceecCcc-ccccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh---
Confidence            99876543 233456799999999998 4667899999999999999999999999988877776666554332221   


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                         ..+..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       240 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          240 ---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             ---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence               1225678999999999999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=383.26  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=216.0

Q ss_pred             ccccCCeEE--eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         19 GNILAEYTI--HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        19 ~~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +.+.+.|++  .+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.+. ||||+++++++.  .
T Consensus        83 ~~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~  157 (373)
T 2x4f_A           83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLD-HANLIQLYDAFE--S  157 (373)
T ss_dssp             SCGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--C
T ss_pred             cccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--E
Confidence            345566777  67899999999999999999999999998543  2345667889999999996 999999999987  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE--ccCCceEEecccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLAR  171 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll--~~~~~vkl~Dfg~a~  171 (404)
                      ...+|+||||+++ +|.+.+..  ..+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||++.
T Consensus       158 ~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            6789999999984 88887764  359999999999999999999999999999999999999  566789999999998


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...... .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+....+..+.......+.      
T Consensus       238 ~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------  309 (373)
T 2x4f_A          238 RYKPRE-KLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------  309 (373)
T ss_dssp             ECCTTC-BCCCCCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS------
T ss_pred             ecCCcc-ccccccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh------
Confidence            765432 33456799999999998 5667899999999999999999999999998888777777665433222      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..+..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            223567999999999999999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-49  Score=368.19  Aligned_cols=262  Identities=29%  Similarity=0.499  Sum_probs=224.0

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.+.++|++.+.||+|+||.||+|.+..++..+|+|++.....  .....+.+|+.+++.+. ||||+++++++.  +.
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~   78 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLD-HPNIIRLYETFE--DN   78 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cC
Confidence            46678899999999999999999999999999999999965433  33567789999999996 999999999987  57


Q ss_pred             CeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEeccccccc
Q psy14434         98 KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARS  172 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~a~~  172 (404)
                      ...|+||||+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            789999999985 8888776 4569999999999999999999999999999999999999   7889999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .... .......||+.|+|||++.  ..++.++|||||||++|+|++|..||.+.........+.......+.      .
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~  229 (277)
T 3f3z_A          159 FKPG-KMMRTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE------K  229 (277)
T ss_dssp             CCTT-SCBCCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH------H
T ss_pred             ccCc-cchhccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------h
Confidence            6543 3345567999999999973  34899999999999999999999999998887777766655443322      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            22467899999999999999999999999999999986443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=374.80  Aligned_cols=279  Identities=28%  Similarity=0.475  Sum_probs=215.5

Q ss_pred             CCCCCCCCCCCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc
Q psy14434          1 MTSNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ   80 (404)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~   80 (404)
                      |++++...+.+.+.........++|++.+.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++.+.
T Consensus         2 ~~~~~~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~   78 (326)
T 2x7f_A            2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYS   78 (326)
T ss_dssp             --------------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhcc
Confidence            444444455555656666678889999999999999999999999999999999985432   23456778999999996


Q ss_pred             CCCCcceEeeEEEecc----CCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy14434         81 RHPNIITMLDIYKAVN----NKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS  152 (404)
Q Consensus        81 ~hpnIv~l~~~~~~~~----~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~  152 (404)
                      .||||+++++++....    ...+|+||||+.+ +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  158 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  158 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence            6999999999987532    5689999999986 99999874   46999999999999999999999999999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCCCccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS----NRRYTHHVDIWSLGCILAEMLQSKPLFPGAS  228 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  228 (404)
                      ||+++.++.+||+|||++..............||+.|+|||++..    +..++.++|||||||++|+|++|..||.+..
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999876543333455679999999999842    4568899999999999999999999998877


Q ss_pred             cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        229 TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .......+.....+..        ....++..+.+||.+||..||.+|||+.++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          239 PMRALFLIPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             HHHHHHHHHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             HHHHHHHhhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            7665554443322111        11456899999999999999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-49  Score=377.73  Aligned_cols=268  Identities=29%  Similarity=0.538  Sum_probs=217.2

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++..     .....+.+|+.+++.+.+||||+++++++.....
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            34456789999999999999999999999999999999853     2346678999999999889999999999986567


Q ss_pred             CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~~  175 (404)
                      ...++||||+.+ +|..++.  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             CceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            889999999995 7877764  389999999999999999999999999999999999999777 899999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCC------------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRP------------  242 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~------------  242 (404)
                      .. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||... .....+..+......            
T Consensus       184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            32 3345679999999999865577999999999999999999999998543 333333333322211            


Q ss_pred             -CCCC------------cchhh--cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        243 -NPPH------------ADKFY--AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       243 -~~~~------------~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                       ..+.            ...+.  .....+++++.+||.+||+.||.+|||++++|+||||+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence             0000            00000  011226899999999999999999999999999999997654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-50  Score=400.76  Aligned_cols=266  Identities=31%  Similarity=0.508  Sum_probs=228.9

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ......+.+|+.+++++. ||||+++++++. 
T Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~-   96 (484)
T 3nyv_A           19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFE-   96 (484)
T ss_dssp             CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEE-
T ss_pred             cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEE-
Confidence            34456778999999999999999999999999999999999655332 445677889999999996 999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEecccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGL  169 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~  169 (404)
                       +...+|+||||+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A           97 -DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             -eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence             57789999999984 8887776 4679999999999999999999999999999999999999   5678999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      +...... ......+||+.|+|||++. + .++.++|||||||++|+|++|.+||.+.+.......+.........    
T Consensus       176 a~~~~~~-~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  248 (484)
T 3nyv_A          176 STHFEAS-KKMKDKIGTAYYIAPEVLH-G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----  248 (484)
T ss_dssp             HHHBCCC-CSHHHHTTGGGTCCHHHHH-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----
T ss_pred             eEEcccc-cccccCCCCccccCceeec-C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence            9876543 3345568999999999984 3 5899999999999999999999999999888877777665443222    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                        +.+..+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       249 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          249 --PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             --GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence              223567999999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-49  Score=368.26  Aligned_cols=262  Identities=30%  Similarity=0.493  Sum_probs=224.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++. ||||+++++++.......
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCce
Confidence            3467999999999999999999999999999999999766666677788899999999996 999999999886656788


Q ss_pred             EEEEEeccCC-cHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcEEEccCCceEEeccc
Q psy14434        100 LYVVFEYMEN-DLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACK-----VMHRDLKPSNILIDKSCSIKIGDLG  168 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~-----~l~~~~~~~i~~qil~al~~LH~~~-----i~HrDlkp~NIll~~~~~vkl~Dfg  168 (404)
                      +|+||||+++ +|.+++...     .+++..++.++.||+.||.|||+.|     |+||||||+||+++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999985 899988642     3999999999999999999999999     9999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ++..............||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+........+   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---  237 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---  237 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHH-HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC---
T ss_pred             hheeeccccccccccCCCccccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC---
Confidence            998765443334456799999999998 4567899999999999999999999999988777666666554432221   


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                            ..++.++.+||.+||+.||.+|||+.++++|+|+....
T Consensus       238 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          238 ------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                  35689999999999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.8e-50  Score=389.03  Aligned_cols=258  Identities=25%  Similarity=0.467  Sum_probs=207.8

Q ss_pred             ccccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--c
Q psy14434         19 GNILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--V   95 (404)
Q Consensus        19 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~   95 (404)
                      +.+.++|.+. +.||+|+||+||+|.++.+|+.||||++..       .....+|+.++.++.+||||++++++|..  .
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            4677889997 789999999999999999999999999842       23456888888777679999999999863  2


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEeccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLG  168 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg  168 (404)
                      +...+|||||||.| +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            35678999999985 899999753   4999999999999999999999999999999999999987   7899999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHhhCCCC
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH----QLQLIVNLVRPNP  244 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~  244 (404)
                      +++..... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.....    ....+.......+
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          210 FAKETTSH-NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             TCEECC------------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccCCC-CccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            99876533 234567899999999998 56779999999999999999999999997654321    2233333222211


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .      ..+..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       288 ~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 N------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             T------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             C------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            1      1235679999999999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.5e-49  Score=372.93  Aligned_cols=274  Identities=36%  Similarity=0.589  Sum_probs=224.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc-CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEe--
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK-NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKA--   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~--   94 (404)
                      ...++|++.+.||+|+||.||+|.+. .+++.||+|++..............+|+.+++.+.  .||||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45578999999999999999999995 77899999998655433333334556777777663  49999999999862  


Q ss_pred             -ccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         95 -VNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        95 -~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                       .....+++||||+.++|.+++...   .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             245678999999999999998753   4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC----
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH----  246 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  246 (404)
                      ...... .......||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.........+..........    
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQ-MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCC-CCccccccccceeCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            765432 233456799999999998 45678999999999999999999999999998888887777654422110    


Q ss_pred             -------------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCC
Q psy14434        247 -------------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSA  295 (404)
Q Consensus       247 -------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~  295 (404)
                                   ..........++..+.+||.+||..||.+|||+.++++||||.......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence                         0111223356889999999999999999999999999999999875543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.5e-50  Score=384.05  Aligned_cols=276  Identities=31%  Similarity=0.543  Sum_probs=213.8

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      .......++|++.+.||+|+||.||+|.+..+|+.||||++....   .......+++..+..+. ||||++++++|...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcC-CCCcccHHHhhhcc
Confidence            334567789999999999999999999999999999999885432   22234556777788886 99999999998642


Q ss_pred             c-----CCeEEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCcEEEcc-CCce
Q psy14434         96 N-----NKDLYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIH--ACKVMHRDLKPSNILIDK-SCSI  162 (404)
Q Consensus        96 ~-----~~~~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH--~~~i~HrDlkp~NIll~~-~~~v  162 (404)
                      .     ...+++||||+.++|...+.     ...+++..++.++.||+.||.|||  +.||+||||||+|||++. ++.+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence            2     22388999999998766554     345899999999999999999999  999999999999999997 8999


Q ss_pred             EEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      ||+|||++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus       172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            999999998765432 3345679999999999866667899999999999999999999999999888888887765543


Q ss_pred             CCCCcc------------------hhh----cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        243 NPPHAD------------------KFY----AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       243 ~~~~~~------------------~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                      .+....                  .+.    ......++++.+||.+||+.||.+|||+.++|+||||+....+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            321000                  000    111225678999999999999999999999999999998765443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-49  Score=370.56  Aligned_cols=258  Identities=25%  Similarity=0.422  Sum_probs=198.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHH-HHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILF-LKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++........ ..+...|... ++.+ +||||+++++++.  +...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~-~h~~iv~~~~~~~--~~~~   80 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTV-DCPFTVTFYGALF--REGD   80 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTC-CCTTBCCEEEEEE--CSSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhC-CCCeEEEEeeeee--ccCC
Confidence            45689999999999999999999999999999999965533333 3344444444 5555 5999999999987  5678


Q ss_pred             EEEEEeccCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434        100 LYVVFEYMENDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      .|+||||++++|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999999988777653     4699999999999999999999998 9999999999999999999999999999866


Q ss_pred             CCCCCccccccccccccccccc---ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCCCcch
Q psy14434        174 SDSKECLTEYIATRWYRAPEIL---ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-SHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ... .......||+.|+|||++   ..+..++.++|||||||++|+|++|..||..... ............+...    
T Consensus       161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  235 (290)
T 3fme_A          161 VDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP----  235 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC----
T ss_pred             ccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc----
Confidence            543 223345799999999996   3456789999999999999999999999986433 3333333332222111    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                          ...+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       236 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          236 ----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                13568999999999999999999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5e-49  Score=369.00  Aligned_cols=264  Identities=26%  Similarity=0.472  Sum_probs=227.5

Q ss_pred             cccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         14 QHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        14 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ...+.....+.|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   90 (303)
T 3a7i_A           13 MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCD-SPYVTKYYGSYL   90 (303)
T ss_dssp             CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe
Confidence            344455677889999999999999999999999999999999865432 345677889999999996 999999999987


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                        +...+|+||||+++ +|.+++..+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus        91 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           91 --KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             --ETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --cCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccccee
Confidence              46789999999986 899999988899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ............||+.|+|||++ .+..++.++|||||||++|+|++|..||...........+.....+..        
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  239 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL--------  239 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------
T ss_pred             cCccccccCccCCCcCccCHHHH-hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC--------
Confidence            66544444567899999999998 466789999999999999999999999988777665555444322211        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ...++..+.+||.+||..||.+|||+.++++||||...
T Consensus       240 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence             14568999999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.2e-49  Score=366.46  Aligned_cols=267  Identities=28%  Similarity=0.458  Sum_probs=224.6

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc---C----hhHHHHHHHHHHHHHhccCCCCcceEee
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR---N----KTDAQRTYREILFLKSFQRHPNIITMLD   90 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~~hpnIv~l~~   90 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .    ......+.+|+.+++++.+||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            34677899999999999999999999999999999999864321   1    2234567799999999977999999999


Q ss_pred             EEEeccCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccc
Q psy14434         91 IYKAVNNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG  168 (404)
Q Consensus        91 ~~~~~~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg  168 (404)
                      ++.  .....|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus        92 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           92 TYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             EEE--CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eec--cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            987  5778999999998 589998875 579999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILI-----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN  243 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  243 (404)
                      ++...... .......||+.|+|||++.     ....++.++|||||||++|+|++|..||.+.........+.......
T Consensus       170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          170 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             chhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            99876543 2334567999999999974     24568899999999999999999999998888777666666544322


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      +.      ..+..++..+.+||.+||..||.+|||+.++++||||.+...
T Consensus       249 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          249 GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             Cc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            21      112456899999999999999999999999999999987643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-49  Score=397.69  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=219.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.+++.+. ||||++++++|.  ...
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~~~  258 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFE--TKT  258 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe--eCC
Confidence            4457899999999999999999999999999999999654322 234566789999999996 999999999987  567


Q ss_pred             eEEEEEeccC-CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+|+||||+. |+|..++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            8999999998 589888864     2599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCCCCCCcc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~  248 (404)
                      ...........+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+...    ......+.......+    
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l-~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----  413 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----  413 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----
T ss_pred             ccCCCcccccccCCccccChhhh-cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----
Confidence            76554444556899999999998 456789999999999999999999999987632    333333333222111    


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                            ..+++.+.+||.+||+.||.+||+     ++++++||||....+
T Consensus       414 ------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          414 ------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                  456899999999999999999996     589999999997643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-49  Score=366.49  Aligned_cols=257  Identities=29%  Similarity=0.514  Sum_probs=217.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.+. ||||+++++++.  +...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DATR   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEe--cCCE
Confidence            457899999999999999999999999999999998654322 223456778999999997 999999999987  5678


Q ss_pred             EEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .++||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999995 88888764 67999999999999999999999999999999999999999999999999998654432 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                       ......||+.|+|||.+ .+..++.++|||||||++|+|++|..||.+.........+.......+          ..+
T Consensus       163 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~  230 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----------DFV  230 (279)
T ss_dssp             ------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----------TTS
T ss_pred             -cccccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----------CcC
Confidence             23456799999999998 466789999999999999999999999998887777666655433322          346


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            889999999999999999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.8e-49  Score=374.74  Aligned_cols=262  Identities=26%  Similarity=0.464  Sum_probs=225.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.  +.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~  113 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--DN  113 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cC
Confidence            4456789999999999999999999999999999999865533 3455667889999999996 999999999987  57


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            78999999999 589888874 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .........||+.|+|||++ .+..++.++|||||||++|+|++|..||...........+.......+          .
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~  262 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----------K  262 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHH-HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----------T
T ss_pred             CcccccccCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----------c
Confidence            44444567799999999998 466789999999999999999999999988877666655554332211          3


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      .+++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            568899999999999999999999999999999875543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-49  Score=365.75  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=214.8

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++..............+|+..+..+..||||+++++++.  +
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~--~   82 (289)
T 1x8b_A            5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA--E   82 (289)
T ss_dssp             CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE--E
T ss_pred             ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee--c
Confidence            34566789999999999999999999999999999999997766666777888999999999956999999999987  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-----------
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-----------  159 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-----------  159 (404)
                      ...+++||||+++ +|.+++..     +.+++..++.++.||+.||.|||++||+||||||+|||++.+           
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            6789999999985 99998874     569999999999999999999999999999999999999844           


Q ss_pred             --------CceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q psy14434        160 --------CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH  231 (404)
Q Consensus       160 --------~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  231 (404)
                              ..+||+|||++......    ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....  
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             cccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                    47999999999876543    2345999999999986555677899999999999999999987754322  


Q ss_pred             HHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        232 QLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ...+.....+..         ...+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       237 -~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             233333222211         14578999999999999999999999999999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=370.96  Aligned_cols=266  Identities=24%  Similarity=0.402  Sum_probs=220.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....  .......+.+|+.+++.+. ||||+++++++...+.
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC--
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC
Confidence            356899999999999999999999999999999999965422  2345677889999999997 9999999999865566


Q ss_pred             CeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ..+|+||||+.++|.+++..   +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            78999999999888777763   569999999999999999999999999999999999999999999999999998764


Q ss_pred             CC--CCcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DS--KECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ..  ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+.......+       
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------  233 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP-------  233 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-------
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-------
Confidence            32  2223456799999999998432 2347899999999999999999999998877766666655432211       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                         ..+++.+.+||.+||..||.+|||+.++++||||....+...
T Consensus       234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence               356899999999999999999999999999999998765543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-50  Score=369.25  Aligned_cols=260  Identities=28%  Similarity=0.489  Sum_probs=195.5

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.  +
T Consensus         6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~   82 (278)
T 3cok_A            6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFE--D   82 (278)
T ss_dssp             HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEE--C
T ss_pred             cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEc--c
Confidence            35567889999999999999999999999999999999965422 2223467789999999997 999999999987  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ....|+||||+.+ +|.+++..  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            7789999999985 89998875  46999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ...........||+.|+|||.+ .+..++.++|||||||++|+|++|..||...........+..   ...       ..
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------~~  231 (278)
T 3cok_A          163 KMPHEKHYTLCGTPNYISPEIA-TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADY-------EM  231 (278)
T ss_dssp             C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---SCC-------CC
T ss_pred             cCCCCcceeccCCCCcCCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---ccc-------CC
Confidence            5443334456799999999998 456789999999999999999999999987665433322211   110       11


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ...++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            13468999999999999999999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-48  Score=363.45  Aligned_cols=256  Identities=29%  Similarity=0.419  Sum_probs=216.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--cCCeE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDL  100 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--~~~~~  100 (404)
                      ..|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.+. ||||+++++++...  +...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCceE
Confidence            4599999999999999999999999999999999877777777888999999999996 99999999998642  35678


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc-cCCceEEeccccccccCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILID-KSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~-~~~~vkl~Dfg~a~~~~~  175 (404)
                      |+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.|  |+||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999975 99999875 67999999999999999999999999  99999999999997 789999999999976543


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .  ......||+.|+|||++.  ..++.++|||||||++|+|++|..||.+................ +.      ....
T Consensus       185 ~--~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~------~~~~  253 (290)
T 1t4h_A          185 S--FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PA------SFDK  253 (290)
T ss_dssp             T--SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CG------GGGG
T ss_pred             c--ccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-cc------ccCC
Confidence            2  334567999999999873  45899999999999999999999999886655443332222111 11      1113


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            45789999999999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-49  Score=377.70  Aligned_cols=261  Identities=28%  Similarity=0.501  Sum_probs=221.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------hhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------KTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++......      ......+.+|+.+++.+.+||||+++++++. 
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-  170 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-  170 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe-
Confidence            446899999999999999999999999999999998654321      1224556789999999966999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       .....|+||||+.| +|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus       171 -~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          171 -SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             -BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             -eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence             57789999999985 89988874 5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .... ......+||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.........+.........  
T Consensus       250 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  326 (365)
T 2y7j_A          250 LEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS--  326 (365)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH--
T ss_pred             cCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            6543 23455789999999999843     235889999999999999999999999888777766666554332221  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                          ..+..++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus       327 ----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 ----PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ----HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                223567899999999999999999999999999999973

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.3e-49  Score=365.62  Aligned_cols=263  Identities=26%  Similarity=0.468  Sum_probs=225.4

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.  +
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~   86 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--D   86 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--C
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeec--c
Confidence            34566789999999999999999999999999999999866543 3445667789999999996 999999999987  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ....|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            778999999999 588888874 569999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ..........||+.|+|||.+ .+..++.++|||||||++|+|++|..||.+.........+.......+          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  235 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----------  235 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------
T ss_pred             cCccccccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----------
Confidence            444444556799999999998 466789999999999999999999999988877666555443322111          


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                      ..+++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            3568899999999999999999999999999999875443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-49  Score=375.13  Aligned_cols=260  Identities=26%  Similarity=0.370  Sum_probs=208.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC-CCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH-PNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+..| |||+++++++.  ....
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQY   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCE
Confidence            3457999999999999999999884 588899999976666667778888999999999732 99999999987  5778


Q ss_pred             EEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|+|||+.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus        84 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           84 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            999999888899998875 5699999999999999999999999999999999999996 67899999999987654322


Q ss_pred             --ccccccccccccccccccc----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCC
Q psy14434        179 --CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPP  245 (404)
Q Consensus       179 --~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  245 (404)
                        .....+||+.|+|||++.+          ...++.++|||||||++|+|++|..||.+.... .....+........ 
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  241 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-  241 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC-
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC-
Confidence              2345679999999999843          256899999999999999999999999875443 22222221111100 


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                             .....+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       242 -------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          242 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             -------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             -------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence                   0133468899999999999999999999999999998543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-49  Score=374.84  Aligned_cols=257  Identities=26%  Similarity=0.477  Sum_probs=206.9

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc---
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN---   96 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~---   96 (404)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++++. ||||++++++|....   
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            46678999999999999999999999999999999986443 3445677889999999996 999999999985422   


Q ss_pred             ----------------------------------------------------CCeEEEEEeccCC-cHHHHHHhcC----
Q psy14434         97 ----------------------------------------------------NKDLYVVFEYMEN-DLNKVIRDKI----  119 (404)
Q Consensus        97 ----------------------------------------------------~~~~~lv~E~~~~-~L~~~l~~~~----  119 (404)
                                                                          ...+|+|||||.+ +|.+++....    
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                1248999999985 8999998532    


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC------------Cccccccccc
Q psy14434        120 LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK------------ECLTEYIATR  187 (404)
Q Consensus       120 l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~gt~  187 (404)
                      .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......            ......+||+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5666789999999999999999999999999999999999999999999998765432            1234467999


Q ss_pred             ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHh
Q psy14434        188 WYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQ  267 (404)
Q Consensus       188 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  267 (404)
                      .|+|||++ .+..++.++|||||||++|+|++|..|+.     .....+........+      ..+...++.+.+||.+
T Consensus       241 ~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          241 LYMSPEQI-HGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFP------LLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             GGSCHHHH-HCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCC------HHHHHHCHHHHHHHHH
T ss_pred             CccChHHh-cCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCC------cccccCChhHHHHHHH
Confidence            99999998 46678999999999999999999876642     122222222221111      1112346788999999


Q ss_pred             ccccCCCCCCCHHHHHhccCCCC
Q psy14434        268 ILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       268 ~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ||+.||.+|||+.++|+||||++
T Consensus       309 ~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HccCCCCcCCCHHHHhhchhhhc
Confidence            99999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.9e-49  Score=381.19  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=209.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccC-CCCcceEeeEEEeccCCeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.+.. ||||+++++++.  ....+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~--~~~~~~  132 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY  132 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe--cCCEEE
Confidence            459999999999999999998865 8899999997666666777888999999999974 699999999987  567799


Q ss_pred             EEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC--
Q psy14434        102 VVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--  178 (404)
Q Consensus       102 lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--  178 (404)
                      +|||+..++|.+++.. +.+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.......  
T Consensus       133 lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          133 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            9999777899998875 5689999999999999999999999999999999999995 58999999999987654321  


Q ss_pred             ccccccccccccccccccc----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCCCCCCc
Q psy14434        179 CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  247 (404)
                      .....+||+.|+|||++.+          ...++.++|||||||++|+|++|..||.+.... ..+..+........   
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~---  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC---
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC---
Confidence            2345679999999999843          236899999999999999999999999876443 23333322111110   


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                           .....+..+.+||.+||..||.+|||+.++|+||||....
T Consensus       289 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          289 -----FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             -----CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             -----CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                 0123478899999999999999999999999999998543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-50  Score=379.67  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=215.5

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh------hHHHHHHHHHHHHHhccCCCCcceEe
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK------TDAQRTYREILFLKSFQRHPNIITML   89 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~~hpnIv~l~   89 (404)
                      ...+.+.++|++.+.||+|+||.||+|.+..+++.||+|++.......      .....+.+|+.+++.+. ||||++++
T Consensus        17 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~   95 (335)
T 3dls_A           17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVL   95 (335)
T ss_dssp             HHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEE
T ss_pred             cCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            345677889999999999999999999999999999999996543221      13445668999999996 99999999


Q ss_pred             eEEEeccCCeEEEEEeccC-C-cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         90 DIYKAVNNKDLYVVFEYME-N-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        90 ~~~~~~~~~~~~lv~E~~~-~-~L~~~l~~~-~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      +++.  +...+++||||+. | +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        96 ~~~~--~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A           96 DIFE--NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             EEEE--CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEe--eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence            9987  5778999999986 4 899888754 699999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||......         .....  
T Consensus       174 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~--  241 (335)
T 3dls_A          174 FGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAAI--  241 (335)
T ss_dssp             CTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTCC--
T ss_pred             cccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhhcc--
Confidence            9999876543 33455789999999999865554589999999999999999999999653211         11000  


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                           .....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       242 -----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          242 -----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                 1113468999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.2e-49  Score=367.14  Aligned_cols=263  Identities=28%  Similarity=0.459  Sum_probs=216.3

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .....++|++++.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++.  ..
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   88 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCD-HPYIVKLLGAYY--HD   88 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CC
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeee--eC
Confidence            346778999999999999999999999999999999998543  3345667889999999996 999999999987  46


Q ss_pred             CeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ..+|+||||+.+ +|..++..  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            789999999985 78887763  569999999999999999999999999999999999999999999999999976432


Q ss_pred             CCCCcccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        175 DSKECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ..........||+.|+|||++.    ....++.++|||||||++|+|++|..||...+.......+.....+...     
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  243 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-----  243 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-----
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC-----
Confidence            2212223457999999999974    3567889999999999999999999999988776665555544322211     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                        ....++..+.+||.+||..||.+|||+.++++||||....
T Consensus       244 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          244 --TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             --SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             --CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence              1134688999999999999999999999999999998643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-49  Score=396.35  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=216.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+|+.+. ||||++++++|.  +...
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~~~~  258 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TKDA  258 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe--eCCE
Confidence            45679999999999999999999999999999999965432 2234456779999999996 999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      +|+||||+. |+|..++...   .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999997 5899888743   399999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCCCCCCcchhh
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      . ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+...    ......+... ....       
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl-~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~-------  408 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEY-------  408 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHH-TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCC-------
T ss_pred             C-ccccccCCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccC-------
Confidence            3 234556899999999998 456789999999999999999999999987642    2222222221 1111       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                        ...+++++.+||.+||+.||.+||     ++.++++||||+...+
T Consensus       409 --p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          409 --SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             --CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence              145689999999999999999999     8999999999997543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-48  Score=378.50  Aligned_cols=265  Identities=32%  Similarity=0.564  Sum_probs=218.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC-----cceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-----IITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-----Iv~l~~~~~   93 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++..   .........+|+.+++.+..|++     |+.+++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            4567899999999999999999999999999999999853   23445667788888888865664     999999987


Q ss_pred             eccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCcEEEc--cCCceEEec
Q psy14434         94 AVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIH--ACKVMHRDLKPSNILID--KSCSIKIGD  166 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH--~~~i~HrDlkp~NIll~--~~~~vkl~D  166 (404)
                        ....+|+||||++++|.+++...   .+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+|
T Consensus       127 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          127 --FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             --ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             --cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence              46789999999999999998753   4899999999999999999999  57999999999999995  478899999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||+++.....   ....+||+.|+|||++. +..++.++|||||||++|+|++|++||.+.+....+..+.......+..
T Consensus       205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          205 FGSSCQLGQR---IYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccCceecccc---cccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999876432   34568999999999984 5678999999999999999999999999999888888887765533221


Q ss_pred             cch-------hhcccC-------------------------------------------C----CCHHHHHHHHhccccC
Q psy14434        247 ADK-------FYAGFK-------------------------------------------N----KPEEAVDLLNQILVLN  272 (404)
Q Consensus       247 ~~~-------~~~~~~-------------------------------------------~----~~~~~~~li~~~L~~d  272 (404)
                      ...       +....+                                           .    .++++.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence            100       000000                                           0    0137899999999999


Q ss_pred             CCCCCCHHHHHhccCCCCcC
Q psy14434        273 PSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       273 p~~Rpt~~~ll~hp~~~~~~  292 (404)
                      |.+|||+.++|+||||+...
T Consensus       361 P~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC--
T ss_pred             hhhCCCHHHHhcCcccccCC
Confidence            99999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.9e-49  Score=365.80  Aligned_cols=270  Identities=31%  Similarity=0.538  Sum_probs=229.6

Q ss_pred             cccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeE
Q psy14434         12 KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDI   91 (404)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~   91 (404)
                      .......+.+.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++. ||||++++++
T Consensus        11 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~   89 (287)
T 2wei_A           11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEI   89 (287)
T ss_dssp             HHHHHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             ccchhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEE
Confidence            344556788999999999999999999999999999999999999776666666778889999999996 9999999999


Q ss_pred             EEeccCCeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---CceEEec
Q psy14434         92 YKAVNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---CSIKIGD  166 (404)
Q Consensus        92 ~~~~~~~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---~~vkl~D  166 (404)
                      +.  +...+|+||||+. ++|.+.+. .+.+++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+|
T Consensus        90 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           90 LE--DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             EE--CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             Ee--CCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEec
Confidence            87  5778999999997 48877765 5679999999999999999999999999999999999999764   4699999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||++....... ......||+.|+|||.+.  ..++.++|||||||++|+|++|..||.+.........+......... 
T Consensus       168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  243 (287)
T 2wei_A          168 FGLSTCFQQNT-KMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-  243 (287)
T ss_dssp             TTGGGTBCCCS-SCSCHHHHHTTCCHHHHT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-
T ss_pred             cCcceeecCCC-ccccccCcccccChHHhc--CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence            99998765432 234557999999999984  34899999999999999999999999988877766666554332221 


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                           ..+..+++++.+||.+||..||.+|||+.++|+||||.++..
T Consensus       244 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             -----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             -----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                 123567899999999999999999999999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-48  Score=361.34  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=213.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   84 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIS--TPT   84 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSS
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEe--cCC
Confidence            355799999999999999999999999999999999865422 2234557789999999997 999999999987  567


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            8999999998 499998864 56999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                       .......||+.|+|||.+.+....+.++||||||+++|+|++|..||.+.........+.......+          ..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~  233 (276)
T 2h6d_A          165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----------EY  233 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TT
T ss_pred             -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----------hh
Confidence             2234567999999999985444457899999999999999999999988877766666554432221          34


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      ++..+.+||.+||+.||.+|||+.++++||||++..+
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            5889999999999999999999999999999987554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-48  Score=362.26  Aligned_cols=257  Identities=27%  Similarity=0.478  Sum_probs=220.2

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      -..++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+. ||||+++++++.  +..
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   87 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFH--DRK   87 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSS
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEE--cCC
Confidence            4457899999999999999999999999999999998654322 223456789999999997 999999999987  577


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .+|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            89999999985 89888864 56999999999999999999999999999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                        ......|++.|+|||++ .+..++.++|||||||++|+|++|..||...........+.......+          ..
T Consensus       168 --~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~  234 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMI-EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----------PF  234 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------TT
T ss_pred             --ccccccCCCCcCCHHHh-ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----------Cc
Confidence              23456799999999998 456789999999999999999999999988877766655554322211          34


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            689999999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-48  Score=366.97  Aligned_cols=262  Identities=21%  Similarity=0.362  Sum_probs=209.1

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ......++|++.+.||+|+||.||+|.+  +|..||+|++............+.+|+.+++++. ||||+++++++.  +
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~  105 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVT--Q  105 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--S
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--E
Confidence            3344567899999999999999999976  5888999999776666677788899999999997 999999999986  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCceEEecccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDKI----LKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~~----l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      ...+++||||+.+ +|.+++....    +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            6679999999985 9999997543    999999999999999999999999  99999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ++.............||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+.......+........     
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----  259 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-----  259 (309)
T ss_dssp             ----------------CCTTSCHHHH-TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC-----
T ss_pred             CccccccccccccCCCCccccChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence            98655443344567899999999998 466789999999999999999999999998877666555433222111     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh--ccCCCCcC
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE--HNYVSKYF  292 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--hp~~~~~~  292 (404)
                         ....+++.+.+||.+||+.||.+|||+.++++  .+++....
T Consensus       260 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          260 ---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence               11457899999999999999999999999988  56665543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-48  Score=365.52  Aligned_cols=259  Identities=26%  Similarity=0.430  Sum_probs=219.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....  ......+.+|+.+++.+. ||||+++++++.  +..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   79 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIK-HENIVTLEDIYE--STT   79 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCC-CCCeeehhhhcc--cCC
Confidence            456778999999999999999999999999999999986432  223456779999999996 999999999987  577


Q ss_pred             eEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEecccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~a~~~  173 (404)
                      .+|+||||+. ++|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            8999999998 48988776 5679999999999999999999999999999999999999   77889999999999764


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ..  ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+.      ..
T Consensus       160 ~~--~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------~~  230 (304)
T 2jam_A          160 QN--GIMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES------PF  230 (304)
T ss_dssp             CC--BTTHHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT------TT
T ss_pred             CC--CccccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc------cc
Confidence            43  223456799999999998 4667899999999999999999999999988887777776665433222      12


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            25678999999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-49  Score=385.46  Aligned_cols=261  Identities=32%  Similarity=0.514  Sum_probs=205.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------hhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------KTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+....      ......+.+|+.+++++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            44568999999999999999999999999999999999654321      122334678999999996 99999999998


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---ceEEecc
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---SIKIGDL  167 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---~vkl~Df  167 (404)
                      .   ....|+||||+.+ +|.+.+. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+||
T Consensus       210 ~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          210 D---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             E---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             e---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence            5   4558999999985 8877765 45699999999999999999999999999999999999997554   5999999


Q ss_pred             ccccccCCCCCccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHhhCCCC
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNP  244 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~  244 (404)
                      |+++..... ......+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+....... ..+........
T Consensus       287 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~  365 (419)
T 3i6u_A          287 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  365 (419)
T ss_dssp             STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred             ccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence            999876543 33456789999999999843  456789999999999999999999999875443222 23322222211


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +      ..+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus       366 ~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          366 P------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             H------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             c------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            1      223567999999999999999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.4e-49  Score=369.49  Aligned_cols=266  Identities=25%  Similarity=0.379  Sum_probs=215.8

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence            35677899999999999999999999999999999999976533 3345567789999999996 999999999987433


Q ss_pred             C--CeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         97 N--KDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        97 ~--~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .  ...|+||||+. ++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            3  24699999997 59999887 45699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        173 LSDSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       173 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      .....   ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.................+     
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----  239 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-----  239 (311)
T ss_dssp             ----------------CCTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-----
T ss_pred             ccccccccccccccCcCcccCCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-----
Confidence            54322   122345799999999998 466789999999999999999999999998877666555444322111     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ......++.++.+||.+||+.||.+||++.+++.|+|+...
T Consensus       240 -~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          240 -SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             -HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence             11235679999999999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.6e-49  Score=381.13  Aligned_cols=266  Identities=29%  Similarity=0.488  Sum_probs=214.3

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc-------CCCCcceEee
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-------RHPNIITMLD   90 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-------~hpnIv~l~~   90 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++..   .......+.+|+.+++.+.       +||||+++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            34456889999999999999999999999999999999853   2345567789999999985       2788999999


Q ss_pred             EEEec--cCCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCC----
Q psy14434         91 IYKAV--NNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSC----  160 (404)
Q Consensus        91 ~~~~~--~~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~----  160 (404)
                      +|...  +...+|+||||++++|.+.+..   +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++    
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             ceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            98632  4567999999999887777653   3599999999999999999999998 999999999999998775    


Q ss_pred             ---------------------------------------------ceEEeccccccccCCCCCccccccccccccccccc
Q psy14434        161 ---------------------------------------------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL  195 (404)
Q Consensus       161 ---------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  195 (404)
                                                                   .+||+|||++......   ....+||+.|+|||++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence                                                         7999999999876432   3456799999999998


Q ss_pred             ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHhhCCCCCCcc-------hhh-----------
Q psy14434        196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS------TSHQLQLIVNLVRPNPPHAD-------KFY-----------  251 (404)
Q Consensus       196 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~-------~~~-----------  251 (404)
                      . +..++.++|||||||++|+|++|+.||.+.+      ....+..+....+..+....       .+.           
T Consensus       266 ~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 I-GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             H-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             c-CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            4 5668999999999999999999999998655      34445555554443221000       000           


Q ss_pred             --------------cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        252 --------------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       252 --------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                                    ......+..+.+||.+||+.||.+|||+.++|+||||++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                          000112457889999999999999999999999999963

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-48  Score=359.71  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=216.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+. ||||+++++++.  +....
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcC-CCCceeeeeEEE--cCCEE
Confidence            4678999999999999999999999999999999986443 2344567789999999996 999999999987  56789


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      |+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999985 88888764 469999999999999999999999999999999999999999999999999997653221 


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-LQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+...... ...+...... .       ..+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-------~~~~  232 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-L-------NPWK  232 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-S-------TTGG
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-c-------Cchh
Confidence             2234567999999999985444457899999999999999999999987654322 2222221111 1       1124


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            57899999999999999999999999999999987543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=364.91  Aligned_cols=262  Identities=29%  Similarity=0.510  Sum_probs=213.3

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ..+.....++|++.+.||+|+||.||+|.+..+|+.||+|++...    .....+.+|+.+++.+. ||||+++++++. 
T Consensus        21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-   94 (314)
T 3com_A           21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCD-SPHVVKYYGSYF-   94 (314)
T ss_dssp             ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCC-CTTBCCEEEEEE-
T ss_pred             hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCC-CCCCccEEEEEE-
Confidence            344455667899999999999999999999999999999998643    23456788999999996 999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                       ....+|+||||+.+ +|.+++.  ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.
T Consensus        95 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           95 -KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             -ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             -eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence             46789999999986 8999886  4569999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .............||+.|+|||++ .+..++.++|||||||++|+|++|..||...........+.....+...      
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  246 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR------  246 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHH-SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS------
T ss_pred             hhhhhccccCccCCCCCccChhhc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC------
Confidence            766544444566799999999998 4567899999999999999999999999887766554444333221111      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                       ....++..+.+||.+||..||.+|||+.++++||||...
T Consensus       247 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          247 -KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             -CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence             113458899999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-48  Score=360.46  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=217.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.+. ||||+++++++.  +.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE--NK   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec--CC
Confidence            457999999999999999999999999999999986543222    23667889999999997 999999999987  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEecccccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGLAR  171 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Dfg~a~  171 (404)
                      ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++    .+||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            78999999997 589998864 5699999999999999999999999999999999999998877    89999999998


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+.......+.      
T Consensus       161 ~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  232 (283)
T 3bhy_A          161 KIEAGN-EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------  232 (283)
T ss_dssp             ECC---------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH------
T ss_pred             eccCCC-cccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc------
Confidence            765432 23456799999999998 4667899999999999999999999999988877666655443322211      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ..+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            12356789999999999999999999999999999998653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.6e-48  Score=367.31  Aligned_cols=263  Identities=27%  Similarity=0.519  Sum_probs=217.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEE-cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC------CcceEeeEE
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP------NIITMLDIY   92 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp------nIv~l~~~~   92 (404)
                      .+.++|++.+.||+|+||.||+|.+ ..+++.||+|++...   ........+|+.+++.+. |+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhh-hcCCCCceeeEeeeccc
Confidence            4557899999999999999999999 568899999998532   344566778999998886 54      599999998


Q ss_pred             EeccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-----------
Q psy14434         93 KAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-----------  158 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-----------  158 (404)
                      .  ....+|+||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus        87 ~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           87 E--HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             E--ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             c--cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            7  46789999999988999988754   4899999999999999999999999999999999999987           


Q ss_pred             --------CCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q psy14434        159 --------SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS  230 (404)
Q Consensus       159 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  230 (404)
                              ++.+||+|||++......   ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+..
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHh-hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    668999999999865432   3456799999999998 4667899999999999999999999999998888


Q ss_pred             HHHHHHHHhhCCCCCCcch----------------------------------hhcccCCCCHHHHHHHHhccccCCCCC
Q psy14434        231 HQLQLIVNLVRPNPPHADK----------------------------------FYAGFKNKPEEAVDLLNQILVLNPSER  276 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R  276 (404)
                      .....+.....+.+.....                                  +.......++.+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            7777766665543321100                                  000011224678999999999999999


Q ss_pred             CCHHHHHhccCCCCcC
Q psy14434        277 PETDQILEHNYVSKYF  292 (404)
Q Consensus       277 pt~~~ll~hp~~~~~~  292 (404)
                      ||+.++++||||+...
T Consensus       321 pt~~ell~hp~f~~~~  336 (339)
T 1z57_A          321 ITLREALKHPFFDLLK  336 (339)
T ss_dssp             CCHHHHTTSGGGGGGG
T ss_pred             cCHHHHhcCHHHHHHh
Confidence            9999999999998653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.2e-49  Score=367.84  Aligned_cols=267  Identities=25%  Similarity=0.428  Sum_probs=195.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.  .....|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   89 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCH-HPNIVSYYTSFV--VKDELW   89 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCC-CTTBCCEEEEEE--SSSCEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcC-CCCEeeEEEEEe--ecCCcE
Confidence            5689999999999999999999999999999999854321 234556778999999996 999999999987  466799


Q ss_pred             EEEeccC-CcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        102 VVFEYME-NDLNKVIRD---------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      +||||+. ++|.+++..         +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999997 589888863         458999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC-----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        172 SLSDSK-----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       172 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ......     .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+...............+....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            654321     122345799999999998544568999999999999999999999998877655544333322222111


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ..........++..+.+||.+||+.||.+|||+.++++||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            1111123356789999999999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-49  Score=377.67  Aligned_cols=260  Identities=22%  Similarity=0.391  Sum_probs=210.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+.   .+++.||||++.+...  .......+.+|+.+++.+..||||+++++++.  .
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--T  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--E
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe--e
Confidence            478999999999999999999984   5889999999865321  12233445678999999977999999999987  4


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            6789999999985 89988874 579999999999999999999999999999999999999999999999999998654


Q ss_pred             CC-CCcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhhCCCCCCcc
Q psy14434        175 DS-KECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       175 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~  248 (404)
                      .. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.....    ......+.....+.     
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  285 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-----  285 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC-----
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC-----
Confidence            32 2223456899999999998542 4578999999999999999999999975432    22222222211111     


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                           ...++..+.+||.+||..||.+||     |+.++++||||....+
T Consensus       286 -----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          286 -----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                 145689999999999999999999     9999999999997643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=369.02  Aligned_cols=263  Identities=19%  Similarity=0.298  Sum_probs=210.8

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++..... ........+|+.+++.+. ||||+++++++.......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceE
Confidence            44689999999999999999999999999999999965432 233556679999999997 9999999999886566689


Q ss_pred             EEEEeccC-CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----ccCCceEEecccccc
Q psy14434        101 YVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLAR  171 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----~~~~~vkl~Dfg~a~  171 (404)
                      |+||||+. ++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999998 5999999743    29999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCCCCccccccccccccccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILIS-------NRRYTHHVDIWSLGCILAEMLQSKPLFPGAST----SHQLQLIVNLV  240 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~  240 (404)
                      ...... ......||+.|+|||++..       +..++.++|||||||++|+|++|..||.....    ......+....
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            765433 3345679999999999742       46789999999999999999999999975332    33334443332


Q ss_pred             CCCCCC--------cchhh-------cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        241 RPNPPH--------ADKFY-------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       241 ~~~~~~--------~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      ......        ...+.       .....++..+.+||.+||+.||.+|||++++|+||
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            211000        00000       00112346789999999999999999999999997

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.5e-48  Score=360.74  Aligned_cols=262  Identities=28%  Similarity=0.385  Sum_probs=212.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..+.++|++++.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++++. ||||+++++++.  ..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~--~~   83 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE--ED   83 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE--CS
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee--eC
Confidence            355678999999999999999999999999999999985543 33455677889999999996 999999999987  57


Q ss_pred             CeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            789999999985 99998874 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CC-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        176 SK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       176 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......+||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+...............+  ..   .....
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~---~~~~~  237 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP--NV---TTDVR  237 (294)
T ss_dssp             -----------CCSSCCHHHH-HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC--CH---HHHSC
T ss_pred             ccccccCccccCccccCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC--Cc---chhcc
Confidence            32 223346799999999998 4667899999999999999999999999988766554333322111  11   11223


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ..+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            56789999999999999999999776777776654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.1e-50  Score=385.81  Aligned_cols=252  Identities=14%  Similarity=0.175  Sum_probs=201.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhcc--CCCCcceEe-------e
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQ--RHPNIITML-------D   90 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~-------~   90 (404)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.+.  .||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999999999999999999654 234456677889995555443  499999998       6


Q ss_pred             EEEeccC----------C-----eEEEEEeccCCcHHHHHHh-cCCCH-------HHHHHHHHHHHHHHHHHHhCCCccC
Q psy14434         91 IYKAVNN----------K-----DLYVVFEYMENDLNKVIRD-KILKD-------VHIRYIMFQLCNGLSYIHACKVMHR  147 (404)
Q Consensus        91 ~~~~~~~----------~-----~~~lv~E~~~~~L~~~l~~-~~l~~-------~~~~~i~~qil~al~~LH~~~i~Hr  147 (404)
                      ++...+.          .     ..|+||||++|+|.+++.. +.+++       ..++.++.||+.||+|||++||+||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            6653211          1     3789999999999999874 33555       7788899999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccC----------CCCCchhhHHHHHHHHHHH
Q psy14434        148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN----------RRYTHHVDIWSLGCILAEM  217 (404)
Q Consensus       148 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l  217 (404)
                      ||||+||||+.++.+||+|||+++....   .....+| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999986432   3345678 999999998543          2789999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        218 LQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       218 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ++|+.||.+........              ........+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       307 ltg~~Pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          307 WCADLPITKDAALGGSE--------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHSSCCC------CCSG--------------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHCCCCCcccccccchh--------------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999997654322111              111223567999999999999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.9e-48  Score=368.24  Aligned_cols=267  Identities=26%  Similarity=0.486  Sum_probs=218.5

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCC-eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC------cceEe
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNK-QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN------IITML   89 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn------Iv~l~   89 (404)
                      +...+.++|++.+.||+|+||.||+|.+..++ +.||+|++..   .......+.+|+.+++.+. |++      ++.++
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIK-EKDKENKFLCVLMS   88 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHh-hcCCCCceeEEEee
Confidence            34456689999999999999999999998776 7899999853   2344566778999999886 555      89999


Q ss_pred             eEEEeccCCeEEEEEeccCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----------
Q psy14434         90 DIYKAVNNKDLYVVFEYMENDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----------  156 (404)
Q Consensus        90 ~~~~~~~~~~~~lv~E~~~~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----------  156 (404)
                      +++.  ....+|+||||++++|.+.+...   .+++..++.++.||+.||+|||++||+||||||+|||+          
T Consensus        89 ~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           89 DWFN--FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEE--ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeee--eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            9887  46789999999998887777643   59999999999999999999999999999999999999          


Q ss_pred             ---------ccCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy14434        157 ---------DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA  227 (404)
Q Consensus       157 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  227 (404)
                               +.++.+||+|||++......   ....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                     66789999999999865432   34567999999999984 667899999999999999999999999998


Q ss_pred             CcHHHHHHHHHhhCCCCCCcch----------------------------------hhcccCCCCHHHHHHHHhccccCC
Q psy14434        228 STSHQLQLIVNLVRPNPPHADK----------------------------------FYAGFKNKPEEAVDLLNQILVLNP  273 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~L~~dp  273 (404)
                      ........+.....+.+.....                                  ........+..+.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            8887777776666544321100                                  000001123578899999999999


Q ss_pred             CCCCCHHHHHhccCCCCcCC
Q psy14434        274 SERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       274 ~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+|||+.++|+||||+...+
T Consensus       323 ~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          323 AQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             TTSCCHHHHTTSGGGGGCCH
T ss_pred             hhCcCHHHHhcChhhcCCCh
Confidence            99999999999999997643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8e-49  Score=378.40  Aligned_cols=268  Identities=13%  Similarity=0.125  Sum_probs=196.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhcc-CCCCcceEe-------e
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQ-RHPNIITML-------D   90 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-~hpnIv~l~-------~   90 (404)
                      .....|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. .||||++++       +
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            3445699999999999999999999999999999999765442 344555666755444443 499987755       5


Q ss_pred             EEEeccC---------------CeEEEEEeccCCcHHHHHHh--cCCCHHHH------HHHHHHHHHHHHHHHhCCCccC
Q psy14434         91 IYKAVNN---------------KDLYVVFEYMENDLNKVIRD--KILKDVHI------RYIMFQLCNGLSYIHACKVMHR  147 (404)
Q Consensus        91 ~~~~~~~---------------~~~~lv~E~~~~~L~~~l~~--~~l~~~~~------~~i~~qil~al~~LH~~~i~Hr  147 (404)
                      ++.....               ..+|+||||++++|.+++..  ..+++..+      ..++.||+.||+|||++||+||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            5543222               44899999999999999974  34555555      6777999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy14434        148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPG  226 (404)
Q Consensus       148 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~  226 (404)
                      ||||+||||+.+|.+||+|||+++.....   .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876432   2245677999999998431 5789999999999999999999999987


Q ss_pred             CCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        227 ASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ....... ......................+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       296 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          296 VTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            6432100 000000000000011112235779999999999999999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.9e-48  Score=366.24  Aligned_cols=261  Identities=32%  Similarity=0.510  Sum_probs=210.6

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc------ChhHHHHHHHHHHHHHhccCCCCcceEeeEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------NKTDAQRTYREILFLKSFQRHPNIITMLDIY   92 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~   92 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.....      .......+.+|+.+++.+. ||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence            4566789999999999999999999999999999999865421      1223345678999999996 99999999998


Q ss_pred             EeccCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eEEecc
Q psy14434         93 KAVNNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IKIGDL  167 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vkl~Df  167 (404)
                      ..   ...|+||||+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        85 ~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           85 DA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             ES---SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             cC---CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            63   348999999985 8888776 456999999999999999999999999999999999999987664   999999


Q ss_pred             ccccccCCCCCcccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCC
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNP  244 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~  244 (404)
                      |++...... .......||+.|+|||++.  +...++.++|||||||++|+|++|..||....... ....+........
T Consensus       162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            999876543 2234567999999999973  35678999999999999999999999997755432 2223333222211


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +      ..+..++..+.+||.+||..||.+|||+.++|+||||..
T Consensus       241 ~------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          241 P------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             H------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             c------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            1      123567899999999999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.5e-48  Score=369.93  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=214.2

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+++.+. ||||+++++++.  ...
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~  104 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDG  104 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE--ETT
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE--ECC
Confidence            34457899999999999999999999999999999998644 24455677889999999996 999999999987  567


Q ss_pred             eEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            89999999985 99998875 5799999999999999999999996 999999999999999999999999999975532


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh---------------
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLV---------------  240 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------  240 (404)
                      .  ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+....               
T Consensus       185 ~--~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             H--C----CCCCTTCCHHHH-TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c--cccCCCCCCCeECHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1  23456799999999998 46678999999999999999999999998766544322211000               


Q ss_pred             ------------------------CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        241 ------------------------RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       241 ------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                              ....+.     .....++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPK-----LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCC-----CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCC-----CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                    000000     0012368899999999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-48  Score=365.28  Aligned_cols=264  Identities=25%  Similarity=0.415  Sum_probs=212.6

Q ss_pred             CCCcccccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhcc-CCC
Q psy14434          9 SGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ-RHP   83 (404)
Q Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~-~hp   83 (404)
                      +...........+.++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++.+. .||
T Consensus        29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           29 ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             -----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             hhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            3333444455567788999999999999999999999999999999996553322    12244567899999997 379


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccC--CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-cC
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYME--NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KS  159 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~--~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~-~~  159 (404)
                      ||+++++++.  .....++|||++.  ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++ .+
T Consensus       109 ~i~~~~~~~~--~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          109 GVIRLLDWFE--RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             SBCCEEEEEE--CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred             CceEEEEEEe--cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence            9999999987  5678999999997  58998887 46799999999999999999999999999999999999999 78


Q ss_pred             CceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh
Q psy14434        160 CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL  239 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  239 (404)
                      +.+||+|||++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||.....      +...
T Consensus       187 ~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~  258 (320)
T 3a99_A          187 GELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG  258 (320)
T ss_dssp             TEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC
T ss_pred             CCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc
Confidence            99999999999876542  234567999999999986555568899999999999999999999965321      1111


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ...          ....+++++.+||.+||..||.+|||+.++++||||....
T Consensus       259 ~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          259 QVF----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccc----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            111          1145789999999999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-47  Score=368.63  Aligned_cols=252  Identities=28%  Similarity=0.467  Sum_probs=213.0

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc-------CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++.+.+||||+++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3468999999999999999999875       34578999999654 344566778899999999955999999999986


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                        ....+|+||||+.+ +|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          158 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             --cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence              56779999999985 999998753                 3789999999999999999999999999999999999


Q ss_pred             EccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14434        156 IDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ  232 (404)
Q Consensus       156 l~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  232 (404)
                      ++.++.+||+|||+++.......  ......||+.|+|||++ .+..++.++|||||||++|+|++ |..||.+......
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999986654321  22345678899999998 46679999999999999999999 9999998887776


Q ss_pred             HHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+........+         ..++..+.+||.+||+.||.+|||+.+++++
T Consensus       315 ~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6666554433222         4568999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-47  Score=361.48  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=205.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++.+.+||||+++++++.  .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~   80 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGP--CGKYN   80 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEE--ETTEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEe--cCCcc
Confidence            45689999999999999999999999999999999854322    2346789999999966999999999987  46789


Q ss_pred             EEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc-----eEEecccccccc
Q psy14434        101 YVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARSL  173 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~-----vkl~Dfg~a~~~  173 (404)
                      |+||||++++|.+++.  .+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.     +||+|||+++..
T Consensus        81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9999999889999998  467999999999999999999999999999999999999998887     999999999876


Q ss_pred             CCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCC
Q psy14434        174 SDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPN  243 (404)
Q Consensus       174 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  243 (404)
                      .....       .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+....   ..+..+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTH-LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHH-cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            44322       12456899999999998 4667899999999999999999999999875433   3333333322221


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +..     .....+| ++.+||..||..||.+||+++++++
T Consensus       240 ~~~-----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIE-----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHH-----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHH-----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            110     1112334 9999999999999999999988865

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-47  Score=363.12  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCe---EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..++|++.+.||+|+||.||+|.+..++.   .||+|++............+.+|+.+++.+. ||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeecccc
Confidence            34679999999999999999999887765   7999999776666677888999999999996 9999999999863222


Q ss_pred             ----CeEEEEEeccCC-cHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEe
Q psy14434         98 ----KDLYVVFEYMEN-DLNKVIRDK-------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG  165 (404)
Q Consensus        98 ----~~~~lv~E~~~~-~L~~~l~~~-------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~  165 (404)
                          ...++||||+.+ +|.+++...       .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence                124999999985 899888632       48999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCC
Q psy14434        166 DLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRP  242 (404)
Q Consensus       166 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  242 (404)
                      |||++........  ......+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+......
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~  258 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL  258 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             eccccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence            9999986543321  12234578899999998 45678999999999999999999 99999988887776666554432


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCC-------HHHHHhccCCCCcC
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPE-------TDQILEHNYVSKYF  292 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~~ll~hp~~~~~~  292 (404)
                      ..+         ..+++.+.+||.+||+.||.+|||       +++++.|||+....
T Consensus       259 ~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          259 KQP---------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCC---------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            222         456899999999999999999999       77888999998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.3e-48  Score=369.11  Aligned_cols=266  Identities=23%  Similarity=0.447  Sum_probs=187.0

Q ss_pred             ccccccccCCeEEee-eecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         15 HNVDGNILAEYTIHK-RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ......+.++|++.+ .||+|+||.||+|.+..+|+.||+|++...       ....+|+..+.+..+||||+++++++.
T Consensus        20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~   92 (336)
T 3fhr_A           20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYE   92 (336)
T ss_dssp             CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence            344467889999976 599999999999999999999999998532       122344444444446999999999987


Q ss_pred             ec--cCCeEEEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEE
Q psy14434         94 AV--NNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKI  164 (404)
Q Consensus        94 ~~--~~~~~~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl  164 (404)
                      ..  ....+|+||||+.| +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            42  24558999999986 999999754   5999999999999999999999999999999999999976   455999


Q ss_pred             eccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        165 GDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      +|||++......  .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..................
T Consensus       173 ~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (336)
T 3fhr_A          173 TDFGFAKETTQN--ALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ  249 (336)
T ss_dssp             CCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             eccccceecccc--ccccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence            999999865432  23456789999999998 566789999999999999999999999977654433221111111000


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      .  ..-...+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       250 ~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          250 Y--GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             c--ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            0  000012356799999999999999999999999999999998643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=358.10  Aligned_cols=260  Identities=23%  Similarity=0.419  Sum_probs=195.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHH-HHHhccCCCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREIL-FLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++....... ...+...|+. +++.+ +||||+++++++.  ...
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~--~~~   97 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSH-DCPYIVQCFGTFI--TNT   97 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTT-TCTTBCCEEEEEE--CSS
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhc-CCCceeeEEEEEe--cCC
Confidence            35678999999999999999999999999999999996553333 3334444444 55555 5999999999987  567


Q ss_pred             eEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+||||+++.+..+..  .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus        98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            899999999766666665  36799999999999999999999995 999999999999999999999999999976544


Q ss_pred             CCCcccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHhhCCCCCCcchh
Q psy14434        176 SKECLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      . .......||+.|+|||++.    ....++.++|||||||++|+|++|..||.... .......+.....+..+     
T Consensus       178 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  251 (318)
T 2dyl_A          178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-----  251 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-----
T ss_pred             C-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-----
Confidence            3 2234457999999999984    24568899999999999999999999998744 33444444433222211     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                        ....+++.+.+||.+||..||.+|||+.++++||||+.+
T Consensus       252 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          252 --GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             --SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             --ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence              124578999999999999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.2e-48  Score=367.69  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=216.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChh---------------HHHHHHHHHHHHHhccCCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKT---------------DAQRTYREILFLKSFQRHP   83 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~~hp   83 (404)
                      ....++|++.+.||+|+||.||+|.+  +++.||+|++........               ....+.+|+.+++.+. ||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~  103 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NE  103 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CC
Confidence            34568999999999999999999998  899999999965433221               1277889999999997 99


Q ss_pred             CcceEeeEEEeccCCeEEEEEeccCC-cHHHH------HH---hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCC
Q psy14434         84 NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKV------IR---DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPS  152 (404)
Q Consensus        84 nIv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~------l~---~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~  152 (404)
                      ||+++++++.  +...+|+||||+.+ +|.++      +.   ...+++..++.++.||+.||.|||+ .||+||||||+
T Consensus       104 ~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          104 YCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             TBCCCSEEEE--SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CcceEEEEEe--eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            9999999987  56789999999986 88887      54   3569999999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCc-H
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH-HVDIWSLGCILAEMLQSKPLFPGAST-S  230 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~-~  230 (404)
                      ||+++.++.+||+|||++......  ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+... .
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999999876443  3355679999999999854435655 99999999999999999999988776 5


Q ss_pred             HHHHHHHHhhCCCCCCcchh---------hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        231 HQLQLIVNLVRPNPPHADKF---------YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .....+.......+.....+         ......++..+.+||.+||+.||.+|||+.++++||||..
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            55555443322222111000         0111457899999999999999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=354.11  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=206.2

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|.....||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.+. ||||+++++++.  .....++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFS--ENGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEE--eCCcEEEE
Confidence            344445899999999999999999999999998543  3345567889999999996 999999999987  56789999


Q ss_pred             EeccC-CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-CCceEEeccccccccCCCC
Q psy14434        104 FEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-SCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       104 ~E~~~-~~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||+. ++|.+++...    .+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99997 5899988754    4678899999999999999999999999999999999988 8999999999998765544


Q ss_pred             CcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...................+.       ....
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~  250 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-------IPES  250 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC-------CCTT
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc-------cccc
Confidence            444556799999999998543 34789999999999999999999999765544322221111111111       1145


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +++.+.+||.+||+.||.+|||+.++|.||||+..
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            68999999999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=368.38  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=215.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEE-----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ....++|++.+.||+|+||.||+|.     +..++..||||++... ........+.+|+.+++++. ||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            3445789999999999999999999     4567889999998533 34555667889999999996 999999999986


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---c
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---S  161 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~~--------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---~  161 (404)
                        +....|+||||+.+ +|.+++...        .+++..++.++.||+.||+|||++||+||||||+|||++.+|   .
T Consensus       145 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             --cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence              56678999999975 999999753        489999999999999999999999999999999999999655   4


Q ss_pred             eEEeccccccccCCC--CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q psy14434        162 IKIGDLGLARSLSDS--KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  238 (404)
                      +||+|||+++.....  ........||+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754221  12233456899999999984 5678999999999999999998 9999999888877777665


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ......+         ..++..+.+||.+||+.||.+|||+.++++|.++..
T Consensus       302 ~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          302 GGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCC---------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            5443322         456899999999999999999999999999987754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.5e-47  Score=366.65  Aligned_cols=267  Identities=27%  Similarity=0.461  Sum_probs=211.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc----------CCCCcceEeeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----------RHPNIITMLDI   91 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hpnIv~l~~~   91 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..   .........+|+.+++.+.          +||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            4689999999999999999999999999999999853   2334556778888888875          27899999999


Q ss_pred             EEec--cCCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcc------C
Q psy14434         92 YKAV--NNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDK------S  159 (404)
Q Consensus        92 ~~~~--~~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~------~  159 (404)
                      +...  +...+++||||++++|.+++..   +.+++..++.++.||+.||+|||++ ||+||||||+|||++.      .
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            8743  2347899999998899998874   4599999999999999999999998 9999999999999954      3


Q ss_pred             CceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS------TSHQL  233 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~  233 (404)
                      +.+||+|||++......   ....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+..      ....+
T Consensus       175 ~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceEEEcccccccccCCC---CCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            47999999999876432   34457999999999984 5678999999999999999999999998654      33444


Q ss_pred             HHHHHhhCCCCCCcc----------------------------hhh----cccCCCCHHHHHHHHhccccCCCCCCCHHH
Q psy14434        234 QLIVNLVRPNPPHAD----------------------------KFY----AGFKNKPEEAVDLLNQILVLNPSERPETDQ  281 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~----------------------------~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~  281 (404)
                      ..+....+..+....                            ...    .....++.++.+||.+||+.||.+|||+.+
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            555554443322100                            000    000123568899999999999999999999


Q ss_pred             HHhccCCCCcCCCC
Q psy14434        282 ILEHNYVSKYFPSA  295 (404)
Q Consensus       282 ll~hp~~~~~~~~~  295 (404)
                      +|+||||+......
T Consensus       331 ll~hp~f~~~~~~~  344 (373)
T 1q8y_A          331 LVNHPWLKDTLGME  344 (373)
T ss_dssp             HHTCGGGTTCTTCT
T ss_pred             HhhChhhhcccCcc
Confidence            99999999865443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.5e-47  Score=355.58  Aligned_cols=258  Identities=29%  Similarity=0.485  Sum_probs=204.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec----
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV----   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~----   95 (404)
                      .+.++|++++.||+|+||.||+|.+..+++.||+|++..   .......+.+|+.+++.+. ||||+++++++...    
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            456789999999999999999999999999999999853   2345677889999999996 99999999987532    


Q ss_pred             -------cCCeEEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEe
Q psy14434         96 -------NNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIG  165 (404)
Q Consensus        96 -------~~~~~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~  165 (404)
                             ....+|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                   24678999999985 999999743  47889999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCC--------------CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cH
Q psy14434        166 DLGLARSLSDS--------------KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TS  230 (404)
Q Consensus       166 Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~  230 (404)
                      |||++......              ........||+.|+|||++.+...++.++|||||||++|+|++   ||.... ..
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            99999865421              1223456799999999998655578999999999999999998   554322 22


Q ss_pred             HHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .....+.......+..      .....+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPD------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHSTTCCCCTT------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHhccccccccCcc------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            2223332222222211      11456788999999999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-47  Score=355.75  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=208.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccC-CCCcceEeeEEEeccCC
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVNNK   98 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~l~~~~~~~~~~   98 (404)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++++.. ||||+++++++.  ...
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--CSS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--cCC
Confidence            34567999999999999999999885 48889999997665666677888999999999974 699999999987  567


Q ss_pred             eEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434         99 DLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      .+|+|||+..++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus       102 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            8999999877899999875 5699999999999999999999999999999999999996 4899999999998764432


Q ss_pred             C--ccccccccccccccccccc----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHhhCCCC
Q psy14434        178 E--CLTEYIATRWYRAPEILIS----------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-QLQLIVNLVRPNP  244 (404)
Q Consensus       178 ~--~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~  244 (404)
                      .  .....+||+.|+|||++.+          ...++.++|||||||++|+|++|..||....... ....+....... 
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  259 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-  259 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc-
Confidence            1  2234579999999999843          1468899999999999999999999997764432 222222111110 


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                             ......+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       260 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          260 -------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             -------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             -------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                   01134478999999999999999999999999999998644

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.5e-47  Score=363.51  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEE-----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..++|++.+.||+|+||.||+|.     +..+++.||||++... ........+.+|+.++.++..||||+++++++.. 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence            35789999999999999999998     4567799999999643 3445567788999999999779999999999863 


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHhcC-------------------------------------------------------
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRDKI-------------------------------------------------------  119 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~~~-------------------------------------------------------  119 (404)
                      ....+++||||+.+ +|.+++....                                                       
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            34568999999995 8999987432                                                       


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--Cccccccc
Q psy14434        120 ------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIA  185 (404)
Q Consensus       120 ------------l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~g  185 (404)
                                  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  .......|
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                        8899999999999999999999999999999999999999999999999998654322  22344678


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHh-hCCCCCCcchhhcccCCCCHHHHH
Q psy14434        186 TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNKPEEAVD  263 (404)
Q Consensus       186 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  263 (404)
                      |+.|+|||++. +..++.++|||||||++|+|++ |..||.+............. .....+         ..+++++.+
T Consensus       258 t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~  327 (359)
T 3vhe_A          258 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---------DYTTPEMYQ  327 (359)
T ss_dssp             CGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC---------TTCCHHHHH
T ss_pred             CceeEChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC---------CCCCHHHHH
Confidence            99999999984 5678999999999999999998 99999887654444333332 222221         346899999


Q ss_pred             HHHhccccCCCCCCCHHHHHhc
Q psy14434        264 LLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       264 li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +|.+||+.||.+|||+.++++|
T Consensus       328 li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHH
Confidence            9999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=362.90  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=214.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcC-------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..++|++.+.||+|+||.||+|.+..       .+..||+|++... ........+.+|+.+++.+.+||||+++++++.
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34689999999999999999999753       3467999998654 345566788899999999966999999999986


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                        ....+|+||||+.+ +|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       146 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 --QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             --cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence              56779999999985 999999753                 3899999999999999999999999999999999999


Q ss_pred             EccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14434        156 IDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ  232 (404)
Q Consensus       156 l~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  232 (404)
                      |+.++.+||+|||+++......  .......||+.|+|||++ .+..++.++|||||||++|+|++ |..||.+......
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998665432  223345678999999998 46778999999999999999999 9999999888777


Q ss_pred             HHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+........+         ..+++++.+||.+||+.||.+|||+.+++++
T Consensus       303 ~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6666655443322         4568999999999999999999999999886

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=346.53  Aligned_cols=247  Identities=26%  Similarity=0.463  Sum_probs=210.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++......   ...+.+|+.+++++. ||||+++++++.  +....|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCceE
Confidence            368999999999999999999987 4677999999654333   356789999999997 999999999986  567799


Q ss_pred             EEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        102 VVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      +||||+++ +|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999985 89999974  348999999999999999999999999999999999999999999999999998654321 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+|+.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+........+         ..
T Consensus       162 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  231 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------RL  231 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---------TT
T ss_pred             ccccCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---------Cc
Confidence            122344578889999998 45678999999999999999999 99999998888777776655433222         34


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +++.+.++|.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            58999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-46  Score=348.58  Aligned_cols=249  Identities=20%  Similarity=0.384  Sum_probs=209.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++......   ...+.+|+.+++.+. ||||+++++++.  +...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~   93 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS-HEKLVQLYGVCT--KQRP   93 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCC-CCCEeeEEEEEe--cCCC
Confidence            45578999999999999999999776 6778999999654333   355779999999997 999999999986  5678


Q ss_pred             EEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            999999997 589999975  56999999999999999999999999999999999999999999999999999865432


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      . .......+|+.|+|||++. +..++.++|||||||++|+|++ |..||...........+........+         
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  243 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------  243 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---------
T ss_pred             ccccccCCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---------
Confidence            1 1123345778899999984 5568999999999999999998 99999988887777776655443332         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...++.+.+||.+||+.||.+|||+.++++|
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          244 HLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            3458899999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-47  Score=362.64  Aligned_cols=263  Identities=26%  Similarity=0.452  Sum_probs=191.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+..+|+..+.+..+||||+++++++.  .....
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCce
Confidence            4578999999999999999999999999999999996442 33445566677774444445999999999987  56789


Q ss_pred             EEEEeccCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434        101 YVVFEYMENDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHAC-KVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~------~~~l~~~~~~~i~~qil~al~~LH~~-~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      |+||||+.++|.+++.      ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9999999998888776      45699999999999999999999999 9999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        174 SDSKECLTEYIATRWYRAPEILI---SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .... ......||+.|+|||++.   .+..++.++|||||||++|+|++|..||.+.....  ..+........+...  
T Consensus       177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~--  251 (327)
T 3aln_A          177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKGDPPQLS--  251 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCC--
T ss_pred             cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcCCCCCCC--
Confidence            5432 223447999999999973   34568999999999999999999999997654321  111111111111000  


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      ......+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            01124578999999999999999999999999999999754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=357.72  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=210.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..++|++.+.||+|+||.||+|.+..++   ..||||++... ........+.+|+.+++.+. ||||+++++++.  +.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVT--RG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--GG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence            4568999999999999999999998655   45999999643 24455677889999999996 999999999986  56


Q ss_pred             CeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ..+|+||||+.+ +|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            678999999975 99999964  469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        175 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ....   ......+|+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+     
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  276 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP-----  276 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC-----
T ss_pred             cCccceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC-----
Confidence            4322   12234567889999998 45678999999999999999999 99999998888777776655433222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ..+++.+.+||.+||..||.+|||+.++++.
T Consensus       277 ----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          277 ----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                4578999999999999999999999999863

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-46  Score=349.86  Aligned_cols=254  Identities=20%  Similarity=0.251  Sum_probs=209.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.+.+|+|++++++++.  ....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~   80 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLH   80 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCce
Confidence            45568999999999999999999999999999999985432    22346689999999977999999999986  5778


Q ss_pred             EEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc-----eEEeccccccc
Q psy14434        100 LYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS-----IKIGDLGLARS  172 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~-----vkl~Dfg~a~~  172 (404)
                      .|+||||++++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||++..
T Consensus        81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999999998899999984  45999999999999999999999999999999999999987776     99999999987


Q ss_pred             cCCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHhhCC
Q psy14434        173 LSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS---TSHQLQLIVNLVRP  242 (404)
Q Consensus       173 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~  242 (404)
                      ......       ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+..   .......+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            654321       23456799999999998 46678999999999999999999999998753   33333333332221


Q ss_pred             CCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+     .......+++.+.+||.+||+.||.+|||+.++++.
T Consensus       240 ~~-----~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TP-----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SC-----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cc-----HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11     111224678999999999999999999999998764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=373.05  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=193.8

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      +|++.+.||+|+||+|+. ....+++.||||++......     ...+|+.+++.+.+||||+++++++.  +...+|+|
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv   96 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEEE
Confidence            599999999999999764 34567889999998543221     24579999999966999999999987  57789999


Q ss_pred             EeccCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---C--CceEEeccccccccCCC
Q psy14434        104 FEYMENDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---S--CSIKIGDLGLARSLSDS  176 (404)
Q Consensus       104 ~E~~~~~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~--~~vkl~Dfg~a~~~~~~  176 (404)
                      ||||.|+|.+++....  +++..++.++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+++.....
T Consensus        97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9999999999998543  566678899999999999999999999999999999953   2  35789999999876533


Q ss_pred             C---Cccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        177 K---ECLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       177 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .   ......+||+.|+|||++.+  ...++.++|||||||++|+|++ |..||........ ..+..........    
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~----  251 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLH----  251 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSC----
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccC----
Confidence            2   22345679999999999853  3567889999999999999999 8999966544332 2221111111000    


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                        .....+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       252 --~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          252 --PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             --TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             --ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence              00122556899999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=351.78  Aligned_cols=245  Identities=20%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..  ........+.+|+.+++.+. ||||+++++++.  +....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLY--KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEe--cCCeeE
Confidence            4689999999999999999999999999999998843  35566778889999999997 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+.+ +|.+++..  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999985 99999985  5699999999999999999999999999999999999999999999999999987643322


Q ss_pred             cc--------------cccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHHh
Q psy14434        179 CL--------------TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-----QLQLIVNL  239 (404)
Q Consensus       179 ~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~  239 (404)
                      ..              ...+||+.|+|||++ .+..++.++|||||||++|+|++|..||.......     ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            11              146799999999998 56778999999999999999999999986533211     00111111


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .            ....+++.+.+||.+||+.||.+|||+.++++
T Consensus       243 ~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 Y------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             T------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0            11456889999999999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=357.52  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=212.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++... ........+.+|+.+++.+. ||||+++++++. 
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFD-NPNIVKLLGVCA-  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc-
Confidence            34578999999999999999999997     45589999999644 23445677889999999996 999999999986 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIRD-------------------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRD  148 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~~-------------------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrD  148 (404)
                       +...+|+||||+.+ +|.+++..                         ..+++.+++.++.||+.||.|||++||+|||
T Consensus       121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence             56779999999985 99999875                         4689999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy14434        149 LKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFP  225 (404)
Q Consensus       149 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~  225 (404)
                      |||+|||++.++.+||+|||++.......  .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            99999999999999999999997654321  1223456899999999984 5568999999999999999999 999999


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        226 GASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.........+........+         ..++..+.+||.+||+.||.+|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCChHHHHHHHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            88877766666544332221         4568999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-46  Score=350.88  Aligned_cols=256  Identities=23%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      -..++|++++.||+|+||.||+|.    +..+++.||+|++..  ........+.+|+.+++++. ||||+++++++...
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            345689999999999999999998    567899999999853  24555677889999999997 99999999998655


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      +...+++||||+. ++|.+++...  .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            5567899999997 5999999753  499999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------------HHHHHH
Q psy14434        173 LSDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH------------QLQLIV  237 (404)
Q Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~~~~~  237 (404)
                      ......   ......+++.|+|||.+. +..++.++|||||||++|+|++|..||.......            ....+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            643321   123345788899999984 5678999999999999999999999885432110            000111


Q ss_pred             Hhh-CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        238 NLV-RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ... .....      .....+++++.+||.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          243 ELLKNNGRL------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHTTCCC------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCcC------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            111 11000      1124678999999999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-47  Score=356.05  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhcc---CCCCcceEee
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ---RHPNIITMLD   90 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~---~hpnIv~l~~   90 (404)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++.......    .......+|+.++.++.   +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3456778999999999999999999999999999999996543221    22334457899998883   4999999999


Q ss_pred             EEEeccCCeEEEEEec-cC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-cCCceEEec
Q psy14434         91 IYKAVNNKDLYVVFEY-ME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGD  166 (404)
Q Consensus        91 ~~~~~~~~~~~lv~E~-~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~-~~~~vkl~D  166 (404)
                      ++.  .....++|||+ +. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus       106 ~~~--~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          106 WFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             EC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEe--cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            986  45678999999 55 589998874 5699999999999999999999999999999999999999 789999999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||++......  ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+......    
T Consensus       184 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~----  251 (312)
T 2iwi_A          184 FGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH----  251 (312)
T ss_dssp             CSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC----
T ss_pred             cchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC----
Confidence            9999876543  23456799999999998655555679999999999999999999996532      11221111    


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                            ....++..+.+||.+||+.||.+|||+.++++||||....
T Consensus       252 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          252 ------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                  1145689999999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.1e-46  Score=351.40  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=212.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...++|++.+.||+|+||.||+|.+.     .++..||+|++... ........+.+|+.+++.+. ||||+++++++. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-   96 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACS-   96 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe-
Confidence            34578999999999999999999983     45689999999643 34556678889999999996 999999999986 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHhc-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRDK-------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRD  148 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~~-------------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrD  148 (404)
                       +....|+||||+. ++|.+++...                         .+++..++.++.||+.||.|||++||+|||
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence             5677999999998 5999998742                         288999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q psy14434        149 LKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFP  225 (404)
Q Consensus       149 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~  225 (404)
                      |||+||+++.++.+||+|||++........  ......+|+.|+|||.+. +..++.++|||||||++|+|++ |..||.
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999986644322  123345788999999984 5668999999999999999999 999999


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        226 GASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.........+........+         ..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERP---------DNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            88876666555544332221         4578999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.6e-46  Score=349.07  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=199.7

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      ...+...++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+. ||||+++++++. 
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~-  104 (309)
T 2h34_A           27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGE-  104 (309)
T ss_dssp             -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE-
T ss_pred             cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEe-
Confidence            34577889999999999999999999999999999999999765433 344577889999999996 999999999987 


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       ....+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       105 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          105 -IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             -ETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             -eCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence             46789999999986 89998875 5699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCC-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        173 LSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       173 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ..... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.........+ ....+.+      .
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~------~  255 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRP------S  255 (309)
T ss_dssp             -------------CCGGGCCGGGT-CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCG------G
T ss_pred             ccccccccccccCCCcCccCHHHH-cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCc------c
Confidence            54432 223456799999999998 4667899999999999999999999999876654332222 2211111      1


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCC-CHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERP-ETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~~ll~  284 (404)
                      .....+++.+.+||.+||..||.+|| ++++++.
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            22356789999999999999999999 7877765

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5e-46  Score=342.32  Aligned_cols=248  Identities=22%  Similarity=0.407  Sum_probs=209.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.....   ....+.+|+.+++.+. ||||+++++++.  +....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~   78 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLS-HPKLVKFYGVCS--KEYPI   78 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCce
Confidence            3468999999999999999999776 567799999965433   2355789999999997 999999999986  56779


Q ss_pred             EEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |+||||++ ++|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999997 579998874  359999999999999999999999999999999999999999999999999998665432


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......+|+.|+|||.+ .+..++.++|||||||++|+|++ |..||...........+........+         .
T Consensus       159 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~  228 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---------H  228 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---------T
T ss_pred             hhcccCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---------C
Confidence            1 22334567789999998 45568999999999999999999 99999988887776666554433222         3


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..++.+.+||.+||+.||.+|||+.+++++
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            458899999999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.3e-46  Score=350.83  Aligned_cols=253  Identities=23%  Similarity=0.421  Sum_probs=212.4

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|++... ........+.+|+.+++.+. ||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence            345578999999999999999999887     46788999999643 23445667889999999996 999999999986


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRD-----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~-----------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                        +....|+||||+.+ +|.+++..           ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus        99 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           99 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             --cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence              56678999999985 99988864           35789999999999999999999999999999999999999999


Q ss_pred             eEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q psy14434        162 IKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVN  238 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  238 (404)
                      +||+|||++.......  .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........+..
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            9999999997654322  1223346789999999984 5668999999999999999999 8999988887766666554


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ......         ...++..+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          256 GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            332221         14678999999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-46  Score=345.80  Aligned_cols=250  Identities=23%  Similarity=0.406  Sum_probs=200.0

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|++... ........+.+|+.+++.+. ||||+++++++.   .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---E   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc---c
Confidence            456899999999999999999998654   567999998643 23455677889999999996 999999999974   4


Q ss_pred             CeEEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            568999999995 899998753  59999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        175 DSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       175 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .... ......+|+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........        
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~--------  238 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM--------  238 (281)
T ss_dssp             -----------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC--------
T ss_pred             cccccccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC--------
Confidence            4321 12334578899999998 45678999999999999999996 9999998887776666654433221        


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus       239 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          239 -PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             14678999999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-46  Score=341.46  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=198.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC--hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN--KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++......  ......+.+|+.+++.+. ||||+++++++.  ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCL--KEP   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--CC-
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe--cCC
Confidence            3578999999999999999999874  888999998654322  233567789999999997 999999999986  566


Q ss_pred             eEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEcc--------CCceEEec
Q psy14434         99 DLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK---VMHRDLKPSNILIDK--------SCSIKIGD  166 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~---i~HrDlkp~NIll~~--------~~~vkl~D  166 (404)
                      ..|+||||+. ++|.+++..+.+++..++.++.||+.||.|||++|   |+||||||+||+++.        ++.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            7899999998 48999998888999999999999999999999999   999999999999986        67899999


Q ss_pred             cccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC
Q psy14434        167 LGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH  246 (404)
Q Consensus       167 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  246 (404)
                      ||++.......  .....||+.|+|||.+. +..++.++|||||||++|+|++|..||.+.+.......+.......+  
T Consensus       160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  234 (271)
T 3dtc_A          160 FGLAREWHRTT--KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--  234 (271)
T ss_dssp             CCC---------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--
T ss_pred             CCccccccccc--ccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--
Confidence            99998665432  23457999999999984 56789999999999999999999999998877655554433222111  


Q ss_pred             cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        247 ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                            ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       235 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          235 ------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                  114568999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-45  Score=346.06  Aligned_cols=259  Identities=30%  Similarity=0.539  Sum_probs=200.1

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ........++|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.+. ||||+++++++.
T Consensus        24 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~  102 (310)
T 2wqm_A           24 PDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI  102 (310)
T ss_dssp             GGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred             CCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE
Confidence            344456778999999999999999999999999999999998653 234556677889999999996 999999999987


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecc
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                        .....++||||+.+ +|.+++..     ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus       103 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          103 --EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             --ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             --cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence              46789999999996 89888863     45899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHhhCCCCC
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNLVRPNPP  245 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~  245 (404)
                      |++..............|++.|+|||++ .+..++.++|||||||++|+|++|..||.+...  ......+.....+...
T Consensus       181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  259 (310)
T 2wqm_A          181 GLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP  259 (310)
T ss_dssp             ------------------CCSSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred             cceeeecCCCccccccCCCeeEeChHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence            9998765544444556799999999998 466789999999999999999999999976532  2222222222111111


Q ss_pred             CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        246 HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                              ...++.++.+||.+||..||.+|||+.+++++
T Consensus       260 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          260 --------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             --------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                    14568999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-46  Score=361.70  Aligned_cols=249  Identities=24%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+++.+. ||||+++++++.  ....+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~  188 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCT--QKQPIY  188 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEEC--SSSSCE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--cCCCcE
Confidence            46899999999999999999999999999999998643 23444556789999999996 999999999986  566799


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+. |+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999998 589998874  3599999999999999999999999999999999999999999999999999986543211


Q ss_pred             cc--cccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        179 CL--TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       179 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      ..  ....+++.|+|||++. ...++.++|||||||++|||++ |..||.+.........+........+         .
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~  338 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP---------E  338 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC---------T
T ss_pred             eecCCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------C
Confidence            11  1234577899999984 5568999999999999999998 99999988877666555544332221         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+++.+.+||.+||+.||.+|||+.++++
T Consensus       339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            56899999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-46  Score=354.15  Aligned_cols=261  Identities=24%  Similarity=0.412  Sum_probs=211.5

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEE-----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEee
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAY-----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLD   90 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~   90 (404)
                      .+.....++|++.+.||+|+||.||+|.     +..++..||+|++... ........+.+|+.+++.+. ||||+++++
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~  100 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFN-HQNIVRCIG  100 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCC-CCCCCeEEE
Confidence            3444566789999999999999999998     5567889999998633 34455667889999999996 999999999


Q ss_pred             EEEeccCCeEEEEEeccC-CcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC--
Q psy14434         91 IYKAVNNKDLYVVFEYME-NDLNKVIRDK--------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--  159 (404)
Q Consensus        91 ~~~~~~~~~~~lv~E~~~-~~L~~~l~~~--------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~--  159 (404)
                      ++.  .....|+||||+. ++|.+++...        .+++..++.++.||+.||.|||++||+||||||+|||++.+  
T Consensus       101 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A          101 VSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEC--SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEc--CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            986  5667899999996 5999999753        38999999999999999999999999999999999999844  


Q ss_pred             -CceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q psy14434        160 -CSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQL  235 (404)
Q Consensus       160 -~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  235 (404)
                       +.+||+|||++.......  .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence             469999999997543322  1223456899999999984 5568999999999999999998 9999998877766666


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +........+         ..++..+.+||.+||+.||.+|||+.++++|.|+..
T Consensus       258 ~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          258 VTSGGRMDPP---------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCCCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            6554333222         456899999999999999999999999999988753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.7e-46  Score=348.25  Aligned_cols=253  Identities=20%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC---CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++............+.+|+.+++++. ||||+++++++..... 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeecccc
Confidence            3579999999999999999998765   5668999999766666677788899999999997 9999999999874332 


Q ss_pred             --CeEEEEEeccCC-cHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecc
Q psy14434         98 --KDLYVVFEYMEN-DLNKVIRD-------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        98 --~~~~lv~E~~~~-~L~~~l~~-------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                        ...|+||||+.+ +|.+++..       ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence              256999999995 89988842       45899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCC
Q psy14434        168 GLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       168 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  244 (404)
                      |++.......  .......+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+........
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  270 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ  270 (313)
T ss_dssp             SCC----------------CCGGGSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred             CcceecccccccCcccccCCCccccCchhh-cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence            9998654332  112334578899999998 46778999999999999999999 8999998887776666655443222


Q ss_pred             CCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +         ..+++.+.+||.+||..||.+|||+.+++++
T Consensus       271 ~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          271 P---------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             B---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C---------ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2         4578999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-45  Score=341.05  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHH-----HHHHHHHHHHHhccCCCCcceEee
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDA-----QRTYREILFLKSFQRHPNIITMLD   90 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~~hpnIv~l~~   90 (404)
                      .......++|++.+.||+|+||.||+|.+..+++.||+|++..........     ..+.+|+.+++.+. ||||+++++
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~   90 (287)
T 4f0f_A           12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYG   90 (287)
T ss_dssp             CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred             hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhhe
Confidence            344455678999999999999999999999999999999986543332222     67889999999996 999999999


Q ss_pred             EEEeccCCeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCc----
Q psy14434         91 IYKAVNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCS----  161 (404)
Q Consensus        91 ~~~~~~~~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~----  161 (404)
                      ++..  ..  ++||||+. ++|.+.+..  ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.    
T Consensus        91 ~~~~--~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           91 LMHN--PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             EETT--TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             eecC--CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence            9752  22  79999998 589888753  46999999999999999999999999  999999999999988776    


Q ss_pred             -eEEeccccccccCCCCCccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH
Q psy14434        162 -IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ--LQLIV  237 (404)
Q Consensus       162 -vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~  237 (404)
                       +||+|||++.....   ......||+.|+|||++.. ...++.++|||||||++|+|++|..||........  ...+.
T Consensus       167 ~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             99999999975443   2345679999999999732 44578999999999999999999999987654433  22222


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .. ...+.       ....+++.+.+||.+||+.||.+|||+.++++.
T Consensus       244 ~~-~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          244 EE-GLRPT-------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             HS-CCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cc-CCCCC-------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            21 11111       114578999999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-45  Score=350.86  Aligned_cols=252  Identities=28%  Similarity=0.474  Sum_probs=211.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc-------CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++.+.+||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            3468999999999999999999986       45778999999644 344566778899999999956999999999986


Q ss_pred             eccCCeEEEEEeccCC-cHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         94 AVNNKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~~-~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                        ....+|+||||+.+ +|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       112 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             --SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             --cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence              56789999999985 999999753                 3889999999999999999999999999999999999


Q ss_pred             EccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q psy14434        156 IDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQ  232 (404)
Q Consensus       156 l~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  232 (404)
                      ++.++.+||+|||++........  ......+|+.|+|||++. +..++.++|||||||++|+|++ |..||.+......
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            99999999999999987654321  123345788999999984 5568999999999999999999 9999998887777


Q ss_pred             HHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        233 LQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+........+         ..++..+.+||.+||..||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          269 FKLLKEGHRMDKP---------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6666655433222         4568999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-46  Score=353.40  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--CC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--NK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--~~   98 (404)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||++...   ........+|+.+++++. ||||+++++++....  ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence            4468999999999999999999875  789999998543   234445567899999996 999999999987533  34


Q ss_pred             eEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCCcEEEccCCceEEecc
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC----------KVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~----------~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                      .+|+||||+.+ +|.+++..+.+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.+||+||
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            58999999985 999999988899999999999999999999999          9999999999999999999999999


Q ss_pred             ccccccCCCCC--cccccccccccccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----------
Q psy14434        168 GLARSLSDSKE--CLTEYIATRWYRAPEILISN----RRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-----------  230 (404)
Q Consensus       168 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------  230 (404)
                      |+++.......  .....+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....           
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99986654322  23346799999999998542    34567889999999999999999999764321           


Q ss_pred             ----HHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        231 ----HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          .............+.....+.  ....+.++.+||.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCcccccc--ccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                111111111111111110000  01124569999999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=352.87  Aligned_cols=251  Identities=24%  Similarity=0.417  Sum_probs=189.8

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe------cc
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA------VN   96 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~------~~   96 (404)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++.+||||+++++++..      ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4799999999999999999999999999999998432  445566788999999999779999999999842      24


Q ss_pred             CCeEEEEEeccCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCceEEeccccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ...+++||||+.|+|.+++..    +.+++..++.++.||+.||.|||+.|  |+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence            456899999999999888753    56999999999999999999999999  999999999999999999999999999


Q ss_pred             cccCCCCCc------------ccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q psy14434        171 RSLSDSKEC------------LTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI  236 (404)
Q Consensus       171 ~~~~~~~~~------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  236 (404)
                      .........            .....||+.|+|||++.  .+..++.++|||||||++|+|++|..||.+........  
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--  263 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN--  263 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc--
Confidence            876542211            12456999999999973  35568899999999999999999999997654432211  


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccC
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY  287 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~  287 (404)
                       .......         ....+..+.+||.+||+.||.+|||+.++++|-+
T Consensus       264 -~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          264 -GKYSIPP---------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---CCCCT---------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -CcccCCc---------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             1111111         1345678999999999999999999999998843

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-45  Score=346.73  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=209.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEE-----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++... ........+.+|+.+++++.+||||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT--I   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--c
Confidence            46899999999999999999985     457789999999644 234456778899999999955999999999986  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDK-------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~-------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                      ....++||||+.+ +|.+++...                   .+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            6678999999985 999998753                   38999999999999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL  233 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  233 (404)
                      +.++.+||+|||++........  ......||+.|+|||.+. +..++.++|||||||++|+|++ |..||.+.......
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999987654322  123456788999999984 5678999999999999999998 99999887655444


Q ss_pred             HHHHHhh-CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        234 QLIVNLV-RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ....... ....+         ..++..+.+||.+||..||.+|||+.+++++
T Consensus       258 ~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCCCCCCc---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4443322 22111         4568999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-45  Score=339.49  Aligned_cols=251  Identities=15%  Similarity=0.245  Sum_probs=211.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      +...++|++.+.||+|+||.||+|.+.  +..||+|++............+.+|+.+++++. ||||+++++++......
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCC
Confidence            345678999999999999999999885  888999999876666777788999999999996 99999999998754457


Q ss_pred             eEEEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         99 DLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+++||||+.+ +|.+++...   .+++..++.++.||+.||.|||++|  ++||||||+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            89999999984 999999864   3899999999999999999999999  99999999999999999999999988765


Q ss_pred             cCCCCCcccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ...     ....||+.|+|||++.+..  .++.++|||||||++|+|++|..||.+.........+........      
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------  231 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------  231 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------
Confidence            332     3356899999999985432  233489999999999999999999998877766555543322111      


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ....+++.+.+||.+||+.||.+|||+.++++.
T Consensus       232 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          232 --IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              114578999999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-45  Score=341.95  Aligned_cols=254  Identities=22%  Similarity=0.411  Sum_probs=209.0

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcC---CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..+...++|++.+.||+|+||.||+|.+..   ++..||+|++... ........+.+|+.+++.+. ||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCC-CCCcceEEEEEc
Confidence            335566789999999999999999998754   3457999998654 23455677889999999996 999999999975


Q ss_pred             eccCCeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccc
Q psy14434         94 AVNNKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                         ....|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        84 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           84 ---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             ---CCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence               345699999999 589998874  34999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        171 RSLSDSKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       171 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      ........ ......+|+.|+|||++ .+..++.++|||||||++|+|++ |+.||...........+........+   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---  236 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP---  236 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---
T ss_pred             cccccccccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---
Confidence            87654321 12334578899999998 45678999999999999999998 99999887776666665554332222   


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                            ..+++.+.+||.+||..||.+|||+.+++++
T Consensus       237 ------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 ------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                  3568999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-45  Score=343.40  Aligned_cols=249  Identities=25%  Similarity=0.492  Sum_probs=213.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++..   .......+.+|+.+++.+. ||||+++++++.  +...+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCCE
Confidence            45679999999999999999999999999999999853   3345677889999999997 999999999986  56779


Q ss_pred             EEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+. ++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999 599999874   34899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      . .......+|+.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.+.......+........+         
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  234 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------  234 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------
T ss_pred             ccccccCCccccCcCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC---------
Confidence            2 223345678899999998 45678999999999999999999 99999988877666665554333222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+++.+.+||.+||..||.+|||+.++++.
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            4568999999999999999999999999763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.7e-46  Score=358.10  Aligned_cols=259  Identities=15%  Similarity=0.181  Sum_probs=196.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-----CeEEEEEEcchhccChhH---------HHHHHHHHHHHHhccCCCCcce
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-----KQYVAIKKIFEAFRNKTD---------AQRTYREILFLKSFQRHPNIIT   87 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~~hpnIv~   87 (404)
                      .++|++.+.||+|+||.||+|.+..+     ++.||+|++.........         ......|+..+..+. ||||++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~  112 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVPK  112 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCCe
Confidence            34899999999999999999999765     578999998543211000         011234445556665 999999


Q ss_pred             EeeEEEecc--CCeEEEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--cCCc
Q psy14434         88 MLDIYKAVN--NKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCS  161 (404)
Q Consensus        88 l~~~~~~~~--~~~~~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~--~~~~  161 (404)
                      +++++....  ....||||||++++|.+++..  +.+++..++.++.||+.||+|||++||+||||||+|||++  .++.
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            999987432  256899999997799999975  5699999999999999999999999999999999999999  8899


Q ss_pred             eEEeccccccccCCCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHH
Q psy14434        162 IKIGDLGLARSLSDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAS-TSHQL  233 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~  233 (404)
                      +||+|||+++......       ......+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.. .....
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999997654321       112345699999999998 46668999999999999999999999998643 32222


Q ss_pred             HHHHHhhCCCCCCcchhhcc--cCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        234 QLIVNLVRPNPPHADKFYAG--FKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .............  .....  ...++.++.+||..||..||.+||++.++++
T Consensus       272 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIAS--LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHH--HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHH--HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2222111111100  00011  1467899999999999999999999998875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.7e-46  Score=366.99  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ....+.+.|.+.+.||+|+||+||.+ ...+|+.||||++...     ......+|+.+++.+.+||||+++++++.  +
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~   80 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSET--T   80 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEE--C
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEe--c
Confidence            34455667888899999999999875 4567899999998543     23456789999998866999999999986  5


Q ss_pred             CCeEEEEEeccCCcHHHHHHhcCC--------CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC---------
Q psy14434         97 NKDLYVVFEYMENDLNKVIRDKIL--------KDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS---------  159 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~~~~l--------~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~---------  159 (404)
                      ...+|+|||||+|+|.+++.....        ++..++.++.||+.||+|||++||+||||||+|||++.+         
T Consensus        81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            778999999999999999986432        233457799999999999999999999999999999754         


Q ss_pred             ----CceEEeccccccccCCCCC----ccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy14434        160 ----CSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAPEILIS------NRRYTHHVDIWSLGCILAEMLQ-SKPLF  224 (404)
Q Consensus       160 ----~~vkl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf  224 (404)
                          +.+||+|||++........    .....+||+.|+|||++.+      ...++.++|||||||++|+|++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                4899999999987654322    1234679999999999853      2568999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        225 PGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      .+.....  ..+.......+.. ..  .....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       241 ~~~~~~~--~~i~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          241 GDKYSRE--SNIIRGIFSLDEM-KC--LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CSTTTHH--HHHHHTCCCCCCC-TT--CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCchhhH--HHHhcCCCCcccc-cc--cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            7765443  2233322211110 00  001123578999999999999999999999999999964

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.5e-46  Score=351.50  Aligned_cols=250  Identities=22%  Similarity=0.373  Sum_probs=200.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeE----EEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.    ||+|.+... ........+.+|+.+++++. ||||+++++++..  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--   88 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--   88 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES--
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec--
Confidence            346799999999999999999999887765    477776432 23344567889999999997 9999999999873  


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                       ...++|+||+. |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence             34788999998 589988875  45999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        174 SDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .....  ......||+.|+|||.+. +..++.++|||||||++|+|++ |..||.+.........+........+     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  241 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-----  241 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-----
T ss_pred             cCCcccccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC-----
Confidence            44322  223345688999999984 5678999999999999999999 99999988776665555544332222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ..++..+.+++.+||+.||.+|||+.+++++
T Consensus       242 ----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 ----PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                3468899999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-45  Score=343.01  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.+..   .||+|++............+.+|+.+++.+. ||||++++++.   ....
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~~~~   93 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS---TAPQ   93 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---CSSS
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec---cCCc
Confidence            344579999999999999999997643   4999999776666777788899999999997 99999999964   3556


Q ss_pred             EEEEEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC-
Q psy14434        100 LYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-  175 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  175 (404)
                      .++||||+. ++|.+.+.  ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            899999998 58988885  34599999999999999999999999999999999999999999999999999976542 


Q ss_pred             -CCCcccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        176 -SKECLTEYIATRWYRAPEILI--SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       176 -~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                       .........||+.|+|||++.  .+..++.++|||||||++|+|++|..||.+.................+.    ...
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  249 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD----LSK  249 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----TTS
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----hhh
Confidence             122234467999999999984  2456788999999999999999999999887776655554443322211    111


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ....+++.+.+||.+||..||.+|||+.++++.
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            234678999999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-46  Score=353.35  Aligned_cols=252  Identities=23%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++.... .......+.+|+.+++++.+||||+++++++.  .
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~  120 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT--L  120 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--e
Confidence            467999999999999999999973     466789999996432 33445678899999999955999999999986  4


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhc------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDK------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKP  151 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~------------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp  151 (404)
                      ...+|+||||+.+ +|.+++...                        .+++..++.++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            6779999999984 999999743                        278999999999999999999999999999999


Q ss_pred             CcEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q psy14434        152 SNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAS  228 (404)
Q Consensus       152 ~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  228 (404)
                      +|||++.++.+||+|||++........  ......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+..
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999986543322  223456788999999984 5678999999999999999998 999998877


Q ss_pred             cHHHHHHHHHhh-CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        229 TSHQLQLIVNLV-RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       229 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      .......+.... ....+         ..+++.+.+||.+||+.||.+|||+.++++|-
T Consensus       280 ~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            554444433322 22111         34689999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-45  Score=342.69  Aligned_cols=256  Identities=21%  Similarity=0.261  Sum_probs=205.1

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +...+.++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.+. |++++..+..+.. .
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~   76 (296)
T 3uzp_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQ-GGVGIPTIRWCGA-E   76 (296)
T ss_dssp             --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHT-TSTTCCCEEEEEE-E
T ss_pred             ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhh-cCCCCCccccccC-C
Confidence            345677899999999999999999999999999999999854322    234678999999998 6666555555432 5


Q ss_pred             CCeEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEecccccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLAR  171 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~a~  171 (404)
                      ....++||||++++|.+++.  .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            77889999999889999997  4569999999999999999999999999999999999999   488999999999998


Q ss_pred             ccCCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHhhC
Q psy14434        172 SLSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST---SHQLQLIVNLVR  241 (404)
Q Consensus       172 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~  241 (404)
                      .......       ......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+...   ......+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            7654322       12456799999999998 466789999999999999999999999987432   222333332221


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+.     ......+|+.+.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 STPI-----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSCH-----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCch-----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1110     1112457899999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-46  Score=354.51  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=204.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeE----EEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQY----VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+.... .......+.+|+.+++.+. ||||+++++++.   .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP---G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC---B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc---C
Confidence            45899999999999999999999888775    6777664321 2223345668999999996 999999999875   4


Q ss_pred             CeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ...++||||+. |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56899999998 589888874  469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...  .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........+........+      
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  239 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP------  239 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC------
T ss_pred             cccccccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC------
Confidence            432  2234456888999999984 5668999999999999999999 99999988777666666554333222      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                         ..++..+.+||.+||..||.+|||+.++++|
T Consensus       240 ---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 ---QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               3357789999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-45  Score=347.13  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=209.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEE-----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++... ........+.+|+.++..+..||||+++++++.. 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence            456899999999999999999985     356789999999654 2344566788999999999769999999999863 


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRDKI-----------------LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID  157 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~~~-----------------l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~  157 (404)
                      .+..+|+||||+.+ +|.+++....                 +++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            34568999999995 9999997543                 78999999999999999999999999999999999999


Q ss_pred             cCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH-
Q psy14434        158 KSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL-  233 (404)
Q Consensus       158 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~-  233 (404)
                      .++.+||+|||++........  ......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+....... 
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            999999999999986644322  223456889999999984 5678999999999999999998 99999887644333 


Q ss_pred             HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+........+         ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       262 ~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCccCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333333222111         3468999999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.7e-46  Score=344.40  Aligned_cols=245  Identities=16%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCC-------eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNK-------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      ..++|++.+.||+|+||.||+|.+..++       ..||+|++...  .......+.+|+.+++.+. ||||+++++++.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   82 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLS-HKHLVLNYGVCV   82 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence            3568999999999999999999998877       57999998543  3345567889999999997 999999999987


Q ss_pred             eccCCeEEEEEeccC-CcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc--------e
Q psy14434         94 AVNNKDLYVVFEYME-NDLNKVIRDKI--LKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS--------I  162 (404)
Q Consensus        94 ~~~~~~~~lv~E~~~-~~L~~~l~~~~--l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~--------v  162 (404)
                        .....|+||||+. ++|.+++....  +++..++.++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        83 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           83 --CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             --CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             --eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence              4667899999998 59999997543  999999999999999999999999999999999999998887        9


Q ss_pred             EEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHhhC
Q psy14434        163 KIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~  241 (404)
                      ||+|||++......    ....||+.|+|||++.+...++.++|||||||++|+|++|. +||.......... ......
T Consensus       161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~  235 (289)
T 4fvq_A          161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH  235 (289)
T ss_dssp             EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC
T ss_pred             eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC
Confidence            99999999765332    34568999999999865477999999999999999999954 5555554443333 222222


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+          ...++++.+||.+||+.||.+|||+.++++|
T Consensus       236 ~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          236 QLP----------APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCC----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCC----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111          2347789999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=356.42  Aligned_cols=254  Identities=14%  Similarity=0.205  Sum_probs=202.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC--------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcce------
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN--------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIIT------   87 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~------   87 (404)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...       ..+.+|+.+++.+. ||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAA-KPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHC-CHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhc-ccchhhhhhhhc
Confidence            47899999999999999999999874        889999998543       35678999999997 999887      


Q ss_pred             ---------EeeEEEeccCCeEEEEEeccCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q psy14434         88 ---------MLDIYKAVNNKDLYVVFEYMENDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNIL  155 (404)
Q Consensus        88 ---------l~~~~~~~~~~~~~lv~E~~~~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIl  155 (404)
                               +++++.. +...+|+||||++++|.+++..   +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666543 4678999999997799999985   57999999999999999999999999999999999999


Q ss_pred             EccCC--ceEEeccccccccCCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q psy14434        156 IDKSC--SIKIGDLGLARSLSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG  226 (404)
Q Consensus       156 l~~~~--~vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  226 (404)
                      ++.++  .+||+|||+++.......       ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-KGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99998  999999999976543211       12345799999999998 466789999999999999999999999987


Q ss_pred             CC-cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        227 AS-TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       227 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .. ...............+.........+..+++.+.+||.+||..||.+|||+.++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            64 333333333222211111111112234578999999999999999999999998763

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.6e-45  Score=341.85  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             cCCeEEee-eecccCceeEEEEEE--cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHK-RIGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+ .||+|+||.||+|.+  ..+++.||+|++............+.+|+.+++.+. ||||+++++++.   ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---SS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEC---CC
Confidence            46899998 999999999999954  567889999999766555566778889999999996 999999999984   55


Q ss_pred             eEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ..|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            6899999998 589998875 45999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...   .....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.+.........+.....+..+       
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  242 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-------  242 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-------
T ss_pred             CCcccccccCCCCceeeChHHh-ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence            221   1223467889999998 45568899999999999999999 99999988877666655544332221       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       243 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 --AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              457899999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6e-46  Score=346.37  Aligned_cols=256  Identities=21%  Similarity=0.265  Sum_probs=199.4

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +...+.++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.+. |++++..+..+.. .
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~   76 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQ-GGVGIPTIRWCGA-E   76 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHT-TSTTCCCEEEEEE-E
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhc-CCCCCCeeeeecC-C
Confidence            34566789999999999999999999999999999999874332    2234678999999998 6666655555432 5


Q ss_pred             CCeEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEecccccc
Q psy14434         97 NKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLAR  171 (404)
Q Consensus        97 ~~~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~a~  171 (404)
                      ....++||||++++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            77889999999889999997  4579999999999999999999999999999999999999   788999999999998


Q ss_pred             ccCCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhC
Q psy14434        172 SLSDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVR  241 (404)
Q Consensus       172 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~  241 (404)
                      .......       ......||+.|+|||.+ .+..++.++|||||||++|+|++|..||.+....   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHh-cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7654321       22356799999999998 4667899999999999999999999999875432   22222222211


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+     .......+++.+.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 STP-----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSC-----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cch-----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            111     11122456899999999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-45  Score=345.07  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=201.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ...+|++.+.||+|+||.||+|.    +..+++.||+|++.... .......+.+|+.+++.+. ||||+++++++....
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            34569999999999999999998    56789999999996443 3344567889999999997 999999999998655


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ...+++||||+.+ +|.+++..  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            5779999999985 99999853  46999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------HHHHHHHHHh
Q psy14434        174 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST-----------SHQLQLIVNL  239 (404)
Q Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~  239 (404)
                      .....   ......||+.|+|||++. +..++.++|||||||++|+|++|..|+.....           ......+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            54332   233456888999999984 55688999999999999999999987632210           0011111111


Q ss_pred             h-CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        240 V-RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      . .....      .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          256 LKEGKRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhccCCC------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            1 11100      112467899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-45  Score=336.88  Aligned_cols=247  Identities=26%  Similarity=0.450  Sum_probs=209.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++......   ...+.+|+.+++.+. ||||+++++++.  +....|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCCCeE
Confidence            368999999999999999999986 5778999999654332   356789999999996 999999999986  566799


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-  177 (404)
                      +||||+. ++|.+++..  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            9999998 589999875  458999999999999999999999999999999999999999999999999998654321 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .......+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+         ..
T Consensus       160 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------~~  229 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------RL  229 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---------TT
T ss_pred             cccccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---------cc
Confidence            112334578899999998 45678999999999999999999 89999988877776666554332222         34


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ++..+.++|.+||+.||.+|||+.+++++
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            58899999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-45  Score=344.98  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=199.3

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHh--ccCCCCcceEeeEEEec
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS--FQRHPNIITMLDIYKAV   95 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~~hpnIv~l~~~~~~~   95 (404)
                      ...+.++|++.+.||+|+||.||+|.+  +++.||+|++...     ......+|..++..  +. ||||+++++++...
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~   74 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLR-HENILGFIASDMTS   74 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhcc-CcCeeeEEEeeccc
Confidence            345678999999999999999999987  6889999998532     33445566666665  54 99999999987532


Q ss_pred             --cCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCcEEEccCCceEE
Q psy14434         96 --NNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH--------ACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        96 --~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH--------~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                        ....+|+||||+.+ +|.++++...+++..++.++.||+.||+|||        +.||+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              34568999999985 9999999888999999999999999999999        999999999999999999999999


Q ss_pred             eccccccccCCCCCc----ccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q psy14434        165 GDLGLARSLSDSKEC----LTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQS----------KPLFP  225 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~pf~  225 (404)
                      +|||+++........    ....+||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765433221    23347999999999985432     345799999999999999999          88886


Q ss_pred             CCC----cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        226 GAS----TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       226 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...    ...............+.......  ....+..+.+||.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWF--SDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGG--GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhc--cCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            532    22222332222221111111100  12245789999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=340.51  Aligned_cols=250  Identities=21%  Similarity=0.372  Sum_probs=210.4

Q ss_pred             cCCeEEee-eecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHK-RIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++... ........+.+|+.+++.+. ||||+++++++.   ..
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---AE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEec---CC
Confidence            45788887 9999999999999864  56888999999654 34556778889999999996 999999999984   45


Q ss_pred             eEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..++||||+.+ +|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            68999999996 89998863  4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        176 SKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...   ......||+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+.....+..+      
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~------  235 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP------  235 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC------
T ss_pred             CcceeeccccccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC------
Confidence            322   12234568999999998 45668999999999999999998 99999988877766666554332221      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                         ..+++.+.+||.+||..||.+||++.++++|.
T Consensus       236 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          236 ---PECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ---CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               46789999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-45  Score=350.32  Aligned_cols=253  Identities=28%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEE--EEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYV--AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..-.++|++.+.||+|+||.||+|.+..++..+  |+|.+... ........+.+|+.+++++.+||||+++++++.  +
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~   97 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--H   97 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE--E
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee--e
Confidence            344578999999999999999999999998865  99988532 234455667899999999956999999999987  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK  158 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~  158 (404)
                      ...+|+||||+++ +|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            6789999999974 999998753                 5899999999999999999999999999999999999999


Q ss_pred             CCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q psy14434        159 SCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIV  237 (404)
Q Consensus       159 ~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  237 (404)
                      ++.+||+|||++...... .......+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus       178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CCeEEEcccCcCcccccc-ccccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            999999999999753321 122334578899999998 45668999999999999999998 999999888776665554


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .......+         ..+++.+.+||.+||..||.+|||+.+++++
T Consensus       256 ~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43322211         3568999999999999999999999999886

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.6e-46  Score=356.96  Aligned_cols=249  Identities=26%  Similarity=0.446  Sum_probs=199.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+.||+|+||.||+|.+.   .++..||||++.... .......+.+|+.+++++. ||||+++++++.  +..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVT--KSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--SSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCC
Confidence            457999999999999999999887   467789999996542 4455677889999999996 999999999986  567


Q ss_pred             eEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+||||+. ++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            7999999997 5999999753  599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        176 SKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       176 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ....   .....+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+      
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~------  272 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP------  272 (373)
T ss_dssp             --------------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC------
T ss_pred             CCccceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence            3221   1223457789999998 45678999999999999999997 99999988877776666554432222      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                         ..++..+.+||.+||+.||.+||++.++++
T Consensus       273 ---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          273 ---MDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence               356889999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=349.44  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=201.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEE----EEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYV----AIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..++|++++.||+|+||.||+|.+..+++.+    |+|.+... ........+.+|+.+++.+. ||||+++++++..  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--   88 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--   88 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES--
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec--
Confidence            3468999999999999999999998888755    56655422 23445677889999999997 9999999999873  


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                       ...++||||+. |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             -CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence             34788999988 589888874  45999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        174 SDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      .....  ......||+.|+|||.+. +..++.++|||||||++|+|++ |..||.+.........+........+     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  241 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-----  241 (327)
T ss_dssp             ------------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-----
T ss_pred             cCccccccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence            43221  223345788999999984 5678999999999999999999 99999988777666655544332222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ..++.++.+||.+||..||.+|||+.++++.
T Consensus       242 ----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          242 ----PICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                4468899999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=344.79  Aligned_cols=251  Identities=27%  Similarity=0.413  Sum_probs=204.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCC----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..++|++.+.||+|+||.||+|.+..++    ..||+|++... ........+.+|+.+++.+. ||||+++++++.  .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~  117 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS--K  117 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--S
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe--c
Confidence            4568999999999999999999887553    46999998643 24455667889999999996 999999999986  5


Q ss_pred             CCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ...+++||||+.+ +|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            6789999999986 89999875  46999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        174 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      .....   ......+|+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+    
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~----  272 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP----  272 (333)
T ss_dssp             -------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC----
T ss_pred             ccccccccccCCCCccccccCchhc-ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc----
Confidence            54321   11223467889999998 46678999999999999999998 99999888877766666554332221    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                           ..++..+.+||.+||+.||.+||++.+++++
T Consensus       273 -----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          273 -----MDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 3568999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-45  Score=348.35  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             CCeEEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ++|++.+.||+|+||.||+|.    +..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCCc
Confidence            579999999999999999998    5678999999998543  4455667889999999996 99999999998766778


Q ss_pred             eEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+||||++ ++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            8999999996 589999874  4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----------HHHHHHhhC
Q psy14434        176 SKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQ-----------LQLIVNLVR  241 (404)
Q Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----------~~~~~~~~~  241 (404)
                      ...   ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........           ...+.....
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            322   22335688899999998 456689999999999999999999999865432210           011111111


Q ss_pred             -CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 -PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ....      .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          259 EGQRL------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCC------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1000      1124678999999999999999999999999755

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-45  Score=347.46  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             cccCCe-EEeeeecccCceeEEEEEE----cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         20 NILAEY-TIHKRIGKGAYGIVYKAYD----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        20 ~~~~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .+.++| ++++.||+|+||.||++..    ..+++.||+|++... ........+.+|+.+++.+. ||||+++++++..
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED  104 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence            345565 9999999999999988753    457899999999654 34456677889999999997 9999999999986


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      .....+++||||+.+ +|.+++....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            556789999999985 9999999888999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHHHHHh
Q psy14434        174 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH-----------QLQLIVNL  239 (404)
Q Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~  239 (404)
                      .....   ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......           ....+...
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            54322   223456888999999984 5568899999999999999999999986532210           01111111


Q ss_pred             hC-CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        240 VR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .. ....      .....++..+.+||.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 LERGERL------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcccCC------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11 1110      112457899999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=359.33  Aligned_cols=262  Identities=20%  Similarity=0.300  Sum_probs=207.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++..... ........+|+.+++.+. ||||+++++++...+....
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCee
Confidence            45689999999999999999999999999999999965422 233556679999999997 9999999999986566689


Q ss_pred             EEEEeccCC-cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----ccCCceEEecccccc
Q psy14434        101 YVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI----DKSCSIKIGDLGLAR  171 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll----~~~~~vkl~Dfg~a~  171 (404)
                      |+||||+.+ +|.+++...    .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999984 899998743    29999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCCCCccccccccccccccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHhh
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILIS-------NRRYTHHVDIWSLGCILAEMLQSKPLFPGA----STSHQLQLIVNLV  240 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~  240 (404)
                      ..... ......+||+.|+|||++.+       ...++.++|||||||++|+|++|+.||...    ........+....
T Consensus       165 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          165 ELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             ECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             EccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            76543 23345679999999999743       146788999999999999999999999643    2333444443322


Q ss_pred             CCCCCC--------cchhh-------cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        241 RPNPPH--------ADKFY-------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       241 ~~~~~~--------~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ......        ...+.       .....++..+.+||.+||..||.+|||+.+++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            111000        00000       0011234678899999999999999999998654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=351.59  Aligned_cols=262  Identities=17%  Similarity=0.198  Sum_probs=198.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcC---CCeEEEEEEcchhccChh---------HHHHHHHHHHHHHhccCCCCcceE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKN---NKQYVAIKKIFEAFRNKT---------DAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~---------~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      ..++|++.+.||+|+||.||+|.+..   ++..+|+|++........         ....+.+|+..++.+. ||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            34679999999999999999999987   788999999864321110         1123457788888886 9999999


Q ss_pred             eeEEEe--ccCCeEEEEEeccCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC--ceE
Q psy14434         89 LDIYKA--VNNKDLYVVFEYMENDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC--SIK  163 (404)
Q Consensus        89 ~~~~~~--~~~~~~~lv~E~~~~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~--~vk  163 (404)
                      ++++..  .+...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+|
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             ecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            999874  22678999999997799999874 4799999999999999999999999999999999999999887  999


Q ss_pred             EeccccccccCCCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHH
Q psy14434        164 IGDLGLARSLSDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQL  235 (404)
Q Consensus       164 l~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~  235 (404)
                      |+|||+++......       .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+. ........
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999997654321       112456799999999998 4667899999999999999999999999653 22222222


Q ss_pred             HHHhhC-CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        236 IVNLVR-PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...... ..+...... .....+++++.+||.+||..||.+|||+.++++.
T Consensus       273 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          273 AKTNLLDELPQSVLKW-APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHTTTHHHHHH-SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhhcccccHHHHhh-ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            222222 222111110 0012678999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.4e-45  Score=345.66  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=208.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCe-----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQ-----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ..++|++.+.||+|+||.||+|.+..++.     .||+|++.... .......+.+|+.+++.+.+||||+++++++.  
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT--  120 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence            34679999999999999999999977664     79999986432 34456778899999999955999999999986  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHh---------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRD---------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~---------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      ....+|+||||+.+ +|.+++..               ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            56779999999985 99988863               247999999999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q psy14434        160 CSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLI  236 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  236 (404)
                      +.+||+|||++........  ......||+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........+
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            9999999999986543221  223456788999999984 5678999999999999999998 99999887665554444


Q ss_pred             HHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        237 VNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .........        ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus       280 ~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          280 VKDGYQMAQ--------PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCC--------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            433221111        13458899999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.3e-45  Score=338.54  Aligned_cols=252  Identities=29%  Similarity=0.428  Sum_probs=208.4

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe-
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA-   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~-   94 (404)
                      .+...+.++|++++.||+|+||.||+|.+..+++.||+|++....      ..+.+|+.+++.+. ||||+++++++.. 
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   76 (284)
T 2a19_B            4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLD-HVNIVHYNGCWDGF   76 (284)
T ss_dssp             CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCC-CTTBCCEEEEEEEE
T ss_pred             cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCC-CCCEEEEeeeEecc
Confidence            344567789999999999999999999999999999999985432      24568999999997 9999999999853 


Q ss_pred             -------------ccCCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q psy14434         95 -------------VNNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID  157 (404)
Q Consensus        95 -------------~~~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~  157 (404)
                                   .....+|+||||+.+ +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV  156 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence                         124568999999995 99999964   4699999999999999999999999999999999999999


Q ss_pred             cCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q psy14434        158 KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIV  237 (404)
Q Consensus       158 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  237 (404)
                      .++.+||+|||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...  ......+.
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~  232 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR  232 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHH-HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred             CCCCEEECcchhheeccccc-cccccCCcccccChhhh-ccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence            99999999999998765432 23456799999999998 4667899999999999999999999887421  11111111


Q ss_pred             HhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                         ....         ...++..+.+||.+||+.||.+|||+.++++|.+.-.
T Consensus       233 ---~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 ---DGII---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ---TTCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ---cccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               1111         1346889999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-44  Score=338.48  Aligned_cols=260  Identities=26%  Similarity=0.430  Sum_probs=210.9

Q ss_pred             ccccccccccCCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEe
Q psy14434         13 VQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITML   89 (404)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~   89 (404)
                      ++..+.+....+|++.+.||+|+||.||+|.+..+   +..+|+|.+.. .........+.+|+.+++++. ||||++++
T Consensus        15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   92 (298)
T 3f66_A           15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS-HPNVLSLL   92 (298)
T ss_dssp             HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCC-CTTBCCCC
T ss_pred             hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCC-CCCEeeee
Confidence            34444556667899999999999999999987543   34689999864 234456677889999999997 99999999


Q ss_pred             eEEEeccCCeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEec
Q psy14434         90 DIYKAVNNKDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGD  166 (404)
Q Consensus        90 ~~~~~~~~~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~D  166 (404)
                      +++.. .....|+||||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A           93 GICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             EEECC-SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECS
T ss_pred             eEEEc-CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECc
Confidence            98643 45678999999986 99999974  4589999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhC
Q psy14434        167 LGLARSLSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       167 fg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      ||++.......    .......||+.|+|||.+ .+..++.++|||||||++|+|++ |.+||.+.........+.....
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             ccccccccccchhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            99998654322    122345678899999998 45678999999999999999999 6788887776666555555443


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+         ..++..+.++|.+||+.||.+|||+.++++.
T Consensus       251 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          251 LLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3222         3468899999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-45  Score=365.76  Aligned_cols=248  Identities=25%  Similarity=0.485  Sum_probs=211.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      ..+|++.+.||+|+||.||+|.++.++..||||++....   .....+.+|+.+++++. ||||+++++++.  ....+|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--~~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcC-CCCEeeEEEEEe--cCCcEE
Confidence            467999999999999999999999999999999996432   23567889999999997 999999999986  567799


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||||+. |+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999998 599999974   358999999999999999999999999999999999999999999999999998764432


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .......+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+.......+........+         .
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~  442 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------E  442 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------T
T ss_pred             eeecCCCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------C
Confidence             1223345678899999984 5678999999999999999999 99999988877666655544332221         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+++.+.+||.+||+.||.+|||+.++++.
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            578999999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-44  Score=357.95  Aligned_cols=246  Identities=24%  Similarity=0.424  Sum_probs=209.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+. ++..||||++....   .....+.+|+.+++.+. ||||+++++++.   ...+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~---~~~~  257 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT---KEPI  257 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSC
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe---CCcc
Confidence            4467999999999999999999886 46779999996532   34567889999999997 999999999975   4568


Q ss_pred             EEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+. |+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999998 599999874   36899999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      . .......+|+.|+|||++ ....++.++|||||||++|||++ |..||.+.+.......+........+         
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------  407 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP---------  407 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC---------
T ss_pred             ceeccCCCcccccccCHHHh-ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence            1 112234567889999998 45678999999999999999999 99999998888777777665443222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+++.+.+||.+||..||.+|||+.+++.
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            457899999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-44  Score=335.24  Aligned_cols=246  Identities=26%  Similarity=0.452  Sum_probs=207.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.....   ....+.+|+.+++.+. ||||+++++++.   ....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~   82 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQ-HQRLVRLYAVVT---QEPI   82 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCC-CcCcceEEEEEc---CCCc
Confidence            3468999999999999999999875 567899999865432   3456789999999996 999999999875   4458


Q ss_pred             EEEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+. ++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999997 5999998743   6999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+         
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  232 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---------  232 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------
T ss_pred             ccccccCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc---------
Confidence            21 22334578899999998 45668999999999999999999 99999988877766666554332221         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+++.+.+||.+||..||.+|||+.++++
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            456899999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=335.33  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=205.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe---EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .-.|++.+.||+|+||.||+|.+..++.   .||+|++.. .........+.+|+.+++.+. ||||+++++++.. ...
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~   96 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLP-PEG   96 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC-SSS
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEec-CCC
Confidence            3468888999999999999999765544   799999864 234456677889999999996 9999999999863 344


Q ss_pred             eEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..++||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            4589999997 699999975  5689999999999999999999999999999999999999999999999999976543


Q ss_pred             CC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        176 SK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       176 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ..    .......+|+.|+|||.+ .+..++.++|||||||++|+|++ |.+||...+.......+........+     
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-----  250 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP-----  250 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC-----
T ss_pred             CcccccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC-----
Confidence            21    222345688999999998 56678999999999999999999 55666666665555555444332222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ..+++.+.+||.+||+.||.+|||+.++++.
T Consensus       251 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          251 ----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----ccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                4568999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-44  Score=357.72  Aligned_cols=243  Identities=24%  Similarity=0.440  Sum_probs=204.9

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||++...    .....+.+|+.+++++. ||||+++++++.. ....+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCC-CTTBCCEEEEEEC-TTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEc-CCCce
Confidence            3568999999999999999999875  779999998643    24567889999999997 9999999999753 34479


Q ss_pred             EEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+.+ +|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999984 999999753   2799999999999999999999999999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                         .....+++.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+         .
T Consensus       343 ---~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p---------~  409 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------D  409 (450)
T ss_dssp             -------CCCTTTSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC---------T
T ss_pred             ---ccCCCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------C
Confidence               1233678899999998 46679999999999999999998 99999988777666666554433222         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+++.+.+||.+||+.||.+|||+.+++.
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67899999999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=343.37  Aligned_cols=253  Identities=24%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--cCC
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNK   98 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--~~~   98 (404)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..  ........+.+|+.+++.+. ||||+++++++...  ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCc
Confidence            34679999999999999999999999999999999854  34556677889999999996 99999999998632  345


Q ss_pred             eEEEEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ..|+||||+.+ +|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            78999999996 89888864     5699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC---------cccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHh
Q psy14434        173 LSDSKE---------CLTEYIATRWYRAPEILISNR--RYTHHVDIWSLGCILAEMLQSKPLFPGAST--SHQLQLIVNL  239 (404)
Q Consensus       173 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~  239 (404)
                      ......         ......||+.|+|||++....  .++.++|||||||++|+|++|..||.....  ......+...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            432111         012345799999999984322  368899999999999999999999953110  0111111111


Q ss_pred             hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        240 VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ... +        ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       264 ~~~-~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 LSI-P--------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --C-C--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-C--------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            111 1        114568999999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-44  Score=335.21  Aligned_cols=243  Identities=23%  Similarity=0.420  Sum_probs=197.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+.  |+.||+|++...    .....+.+|+.+++.+. ||||+++++++.. ....+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc-CCCce
Confidence            4578999999999999999999774  889999998532    35567889999999997 9999999998743 34578


Q ss_pred             EEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+.+ +|.+++...   .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999986 999988743   3899999999999999999999999999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                         .....+++.|+|||.+ .+..++.++|||||||++|+|++ |..||...........+........         ..
T Consensus       171 ---~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~  237 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---------PD  237 (278)
T ss_dssp             --------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---------CT
T ss_pred             ---ccCCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---------cc
Confidence               2234678999999998 45678999999999999999998 9999988776665555443322211         14


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+++.+.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            57899999999999999999999999876

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.9e-45  Score=342.13  Aligned_cols=243  Identities=23%  Similarity=0.445  Sum_probs=193.9

Q ss_pred             cccccCCeEEe-eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--
Q psy14434         18 DGNILAEYTIH-KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--   94 (404)
Q Consensus        18 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--   94 (404)
                      .+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++..       .....+|+.++.++.+||||+++++++..  
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            47888999998 789999999999999999999999999842       23456888888666679999999999863  


Q ss_pred             ccCCeEEEEEeccCC-cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEecc
Q psy14434         95 VNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDL  167 (404)
Q Consensus        95 ~~~~~~~lv~E~~~~-~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Df  167 (404)
                      .+...+|+||||+.+ +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            235678999999985 999999753   5999999999999999999999999999999999999998   788999999


Q ss_pred             ccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        168 GLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       168 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      |++....                       +..++.++|||||||++|+|++|..||.+...................  
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--  219 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--  219 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC--
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc--
Confidence            9986432                       234678999999999999999999999776543321111111110000  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      ......+..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            000112256789999999999999999999999999999998643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-44  Score=358.28  Aligned_cols=254  Identities=18%  Similarity=0.262  Sum_probs=205.9

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++......    ..+.+|+.+++.+..|++|..+..++.  ...
T Consensus         3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~   76 (483)
T 3sv0_A            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGV--EGD   76 (483)
T ss_dssp             CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEE--ETT
T ss_pred             CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEe--eCC
Confidence            45678999999999999999999999999999999987543322    246789999999985566666665544  577


Q ss_pred             eEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---ccCCceEEecccccccc
Q psy14434         99 DLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSL  173 (404)
Q Consensus        99 ~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll---~~~~~vkl~Dfg~a~~~  173 (404)
                      ..+|||||+.++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++..
T Consensus        77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            899999999889999997  5679999999999999999999999999999999999999   68899999999999876


Q ss_pred             CCCCC-------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCC
Q psy14434        174 SDSKE-------CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPN  243 (404)
Q Consensus       174 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  243 (404)
                      .....       .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+....   ..+..+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             cCCccccccccccccccCCCccccCHHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            54322       12256899999999998 4667899999999999999999999999875542   2233332221111


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                           ........++.++.+||.+||..||.+||++.++++
T Consensus       236 -----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          236 -----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             -----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                 111222567899999999999999999999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-45  Score=346.01  Aligned_cols=261  Identities=24%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             ccccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhc-cCCCCcceEeeEEE
Q psy14434         15 HNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF-QRHPNIITMLDIYK   93 (404)
Q Consensus        15 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~~hpnIv~l~~~~~   93 (404)
                      ......+.++|++.+.||+|+||.||+|.+.  ++.||+|++...     ......+|..++..+ ..||||+++++++.
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            3455667789999999999999999999875  889999998432     233444555555544 24999999999987


Q ss_pred             eccC--CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEccCCce
Q psy14434         94 AVNN--KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC--------KVMHRDLKPSNILIDKSCSI  162 (404)
Q Consensus        94 ~~~~--~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~--------~i~HrDlkp~NIll~~~~~v  162 (404)
                      ....  ..+|+||||+.+ +|.+++....+++..++.++.||+.||.|||+.        ||+||||||+|||++.++.+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            4322  689999999985 999999988999999999999999999999999        99999999999999999999


Q ss_pred             EEeccccccccCCCCCc----ccccccccccccccccccCCCCCc------hhhHHHHHHHHHHHHhC----------CC
Q psy14434        163 KIGDLGLARSLSDSKEC----LTEYIATRWYRAPEILISNRRYTH------HVDIWSLGCILAEMLQS----------KP  222 (404)
Q Consensus       163 kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~~DiwslG~il~~l~~g----------~~  222 (404)
                      ||+|||++.........    ....+||+.|+|||++.+ ..+..      ++|||||||++|+|++|          ..
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            99999999765443221    124579999999999843 33333      49999999999999999          67


Q ss_pred             CCCCCC----cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        223 LFPGAS----TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       223 pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ||....    ...............+.....+  ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW--SSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccc--hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            775432    2222222222211111111110  012346789999999999999999999999886

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=349.11  Aligned_cols=250  Identities=24%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..|++.+.||+|+||.||+|.+..+   +..||+|.+... ........+.+|+.+++++. ||||+++++++.. ....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~-~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECC-CSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEc-CCCC
Confidence            3589999999999999999987543   346899998642 34456778889999999996 9999999998643 3557


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      .|+||||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            8999999985 99999975  35889999999999999999999999999999999999999999999999999865432


Q ss_pred             C----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        177 K----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       177 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      .    .......+|+.|+|||++ .+..++.++|||||||++|+|++ |.+||.+.........+........+      
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p------  318 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------  318 (373)
T ss_dssp             ------------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC------
T ss_pred             ccccccccCCCCCcccccChHHh-cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence            1    112345678899999998 45678999999999999999999 78899887665555555444332222      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                         ..++..+.++|.+||..||.+|||+.+++++
T Consensus       319 ---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          319 ---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               4568999999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4e-44  Score=367.47  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             eEEe-eeecccCceeEEEEEE--cCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         25 YTIH-KRIGKGAYGIVYKAYD--KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        25 y~~~-~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +.+. +.||+|+||.||+|.+  +.+++.||||++............+.+|+.+++++. ||||+++++++.   ...++
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~---~~~~~  445 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AESWM  445 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SSSEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCCEE
Confidence            4443 4799999999999955  456789999999876666667788999999999997 999999999986   34589


Q ss_pred             EEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        102 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      +|||||.+ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... 
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999985 89998875 4599999999999999999999999999999999999999999999999999987654321 


Q ss_pred             --cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        179 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       179 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                        ......||+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+         .
T Consensus       526 ~~~~~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---------~  595 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---------A  595 (635)
T ss_dssp             ---------CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------T
T ss_pred             cccccCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------C
Confidence              22334578899999998 46678999999999999999998 99999998888777766655443222         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .++.++.+||.+||+.||.+|||+.++++
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            57899999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-45  Score=348.00  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=204.8

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.+. ||||+++++++.  ...
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCR-HPHLVSLIGFCD--ERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECC--CTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--CCC
Confidence            346689999999999999999999864 6889999998543  3445677889999999997 999999999976  567


Q ss_pred             eEEEEEeccC-CcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~-----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ..|+||||+. ++|.+++...     .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            8999999998 4898888643     489999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHhh--CCCCC
Q psy14434        173 LSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL---QLIVNLV--RPNPP  245 (404)
Q Consensus       173 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~--~~~~~  245 (404)
                      .....  .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.......   .......  .....
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             cccccccccccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            54321  2234456999999999984 557899999999999999999999999765432211   1111111  00000


Q ss_pred             Cc-chh-hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        246 HA-DKF-YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       246 ~~-~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                      .. ... .......+..+.+++.+||+.||.+|||+.+++++.
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            00 000 001122356799999999999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=332.52  Aligned_cols=241  Identities=28%  Similarity=0.476  Sum_probs=192.7

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      -.++|++.+.||+|+||.||+|.+.  ++.||+|++..    ......+.+|+.+++++. ||||+++++++.    ...
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~   74 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVN-HPNIVKLYGACL----NPV   74 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT----TTT
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----CCc
Confidence            3568999999999999999999874  78899999852    345667889999999996 999999999864    237


Q ss_pred             EEEEeccCC-cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCcEEEccCCc-eEEecccccc
Q psy14434        101 YVVFEYMEN-DLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHA---CKVMHRDLKPSNILIDKSCS-IKIGDLGLAR  171 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~---~~i~HrDlkp~NIll~~~~~-vkl~Dfg~a~  171 (404)
                      |+||||+.+ +|.+++...    .++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            999999984 999999753    37899999999999999999999   89999999999999998886 7999999997


Q ss_pred             ccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHhhCCCCCCcch
Q psy14434        172 SLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSH--QLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  249 (404)
                      .....   .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......  ....+.....+  .    
T Consensus       155 ~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~----  224 (307)
T 2eva_A          155 DIQTH---MTNNKGSAAWMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--P----  224 (307)
T ss_dssp             -------------CCTTSSCHHHH-TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC--C----
T ss_pred             ccccc---cccCCCCCceEChhhh-CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC--C----
Confidence            65432   2345699999999998 46678999999999999999999999997654322  11122211111  1    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                         ....++..+.+||.+||+.||.+|||+.+++++
T Consensus       225 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          225 ---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             ---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence               124678999999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-44  Score=354.28  Aligned_cols=251  Identities=25%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++.....   ....+.+|+.+++++. ||||+++++++.   ...+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---~~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCC-CCCEeeEEEEEc---CCce
Confidence            34679999999999999999999875 45699999965432   2456789999999997 999999999975   3568


Q ss_pred             EEEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      |+||||+. |+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999998 599999863   45999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      . .......+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.........+........+         
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------  403 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------  403 (452)
T ss_dssp             ---------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------
T ss_pred             ceecccCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence            2 1223345778999999984 5678999999999999999999 99999998887777666554432222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc--cCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH--NYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h--p~~~  289 (404)
                      ..+++.+.+||.+||+.||.+|||+.++++.  .++.
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            4578999999999999999999999999873  4444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-44  Score=333.43  Aligned_cols=252  Identities=22%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcC-CC--eEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKN-NK--QYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..++|++.+.||+|+||.||+|.+.. ++  ..||+|++..... .......+.+|+.+++.+. ||||+++++++..  
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--   92 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT--   92 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS--
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcc--
Confidence            34689999999999999999998643 33  3689999865432 3456677889999999996 9999999999863  


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                       ...++||||+. ++|.+.+..  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        93 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence             34899999998 589988874  45999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        174 SDSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      .....   ......+|+.|+|||++. +..++.++|||||||++|+|++ |..||.+.........+.......+     
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  245 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-----  245 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-----
T ss_pred             cccccchhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC-----
Confidence            54322   122346788999999984 5568899999999999999999 9999998887766665544322111     


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                         ....++..+.++|.+||..||.+|||+.+++++
T Consensus       246 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          246 ---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               114578999999999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-45  Score=355.69  Aligned_cols=250  Identities=16%  Similarity=0.157  Sum_probs=195.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchh-ccChhHHHHHHHHHHHHHhccCC-CCcc-------------
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEA-FRNKTDAQRTYREILFLKSFQRH-PNII-------------   86 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h-pnIv-------------   86 (404)
                      ...|.+.+.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+++.+. | +|..             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchh
Confidence            34588999999999999999999999999999998633 222233566788999998886 4 3211             


Q ss_pred             --------eEeeEEEec---cCCeEEEEEeccCCcHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy14434         87 --------TMLDIYKAV---NNKDLYVVFEYMENDLNKVIR--------DKILKDVHIRYIMFQLCNGLSYIHACKVMHR  147 (404)
Q Consensus        87 --------~l~~~~~~~---~~~~~~lv~E~~~~~L~~~l~--------~~~l~~~~~~~i~~qil~al~~LH~~~i~Hr  147 (404)
                              .+..++...   ....++++|+++.++|.++++        .+.+++..+..++.||+.||+|||++||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    111111111   133578999999999998885        3347888899999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccc---------cCCCCCchhhHHHHHHHHHHHH
Q psy14434        148 DLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI---------SNRRYTHHVDIWSLGCILAEML  218 (404)
Q Consensus       148 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~l~  218 (404)
                      ||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999998865432   345678 9999999983         3456788999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        219 QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       219 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +|+.||.+........              ........+|+.+.+||.+||+.||.+|||+.++++||||..
T Consensus       312 tg~~Pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          312 CADLPNTDDAALGGSE--------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HSSCCCCTTGGGSCSG--------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HCCCCCCCcchhhhHH--------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999997765322111              112223467899999999999999999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=340.39  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++............+.+|+.+++.+. ||||+++++++.  +...
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~  103 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACM--SPPH  103 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEE--CSSC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEe--cCCc
Confidence            445789999999999999999998864   3999999765444444556678999999996 999999999987  5667


Q ss_pred             EEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC-
Q psy14434        100 LYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD-  175 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~-  175 (404)
                      +++||||+. ++|.+++...  .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++..... 
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999998 4899999754  499999999999999999999999999999999999998 67999999999875432 


Q ss_pred             ----CCCccccccccccccccccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCC
Q psy14434        176 ----SKECLTEYIATRWYRAPEILIS--------NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPN  243 (404)
Q Consensus       176 ----~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  243 (404)
                          .........||+.|+|||++..        ...++.++|||||||++|+|++|..||.+.........+.....+.
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                1122234569999999999853        2457899999999999999999999999888776666555443322


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..        ...++.++.+||.+||..||.+|||+.++++.
T Consensus       263 ~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          263 LS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            21        13468899999999999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-44  Score=342.52  Aligned_cols=263  Identities=21%  Similarity=0.338  Sum_probs=201.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.+. ||||+++++++.  ....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~  101 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCM--TPTE  101 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCC-CTTBCCCCEEEC--CSSC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhcc-CCCccceEEEEe--cCCc
Confidence            45678999999999999999999754 6888999998654221 12225778999999997 999999999986  5667


Q ss_pred             EEEEEeccCC-cHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEccCCceEEeccccc
Q psy14434        100 LYVVFEYMEN-DLNKVIRDK-----ILKDVHIRYIMFQLCNGLSYIHAC---KVMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~-----~l~~~~~~~i~~qil~al~~LH~~---~i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      .++||||+.+ +|.+++...     .+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            8999999985 999999743     389999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----CCcHHHHHHHHHhhCCCC
Q psy14434        171 RSLSDSK-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPG-----ASTSHQLQLIVNLVRPNP  244 (404)
Q Consensus       171 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-----~~~~~~~~~~~~~~~~~~  244 (404)
                      ....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||..     .........+........
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             cccCcccccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            8765332 2234456999999999984 55689999999999999999999999952     111111112111111110


Q ss_pred             C-Cc--chhh-cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        245 P-HA--DKFY-AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       245 ~-~~--~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      . ..  .... ......+..+.+|+.+||+.||.+|||+.++++|-.-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0 00  0000 0001124679999999999999999999999998653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=360.15  Aligned_cols=247  Identities=21%  Similarity=0.381  Sum_probs=203.3

Q ss_pred             CCeEEee-eecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHK-RIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +++.+.+ .||+|+||.||+|.+.  .++..||||++... ........+.+|+.+|+.+. ||||+++++++..   ..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES---SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc---CC
Confidence            4566666 8999999999999876  35677999999654 23445677889999999996 9999999999862   45


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|+|||||.+ +|.+++..  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999985 89998863  45999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...   .....+|+.|+|||++ .+..++.++|||||||++|||++ |..||.+.........+........+       
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-------  561 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-------  561 (613)
T ss_dssp             ------------CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC-------
T ss_pred             CceeeeccCCCCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence            211   1223456889999998 45678999999999999999998 99999998888777776655433222       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                        ..+++++.+||.+||..||.+||++.++++
T Consensus       562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             --CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              457899999999999999999999998753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-43  Score=337.36  Aligned_cols=261  Identities=21%  Similarity=0.327  Sum_probs=201.8

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhc-cCCCCcceEeeEEEe
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF-QRHPNIITMLDIYKA   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~~hpnIv~l~~~~~~   94 (404)
                      .....+.++|++.+.||+|+||.||+|.+  +++.||+|++..     .......+|+.++..+ ..||||+++++++..
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33445678999999999999999999987  589999999853     2345667888888873 259999999999874


Q ss_pred             ccC--CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCcEEEccCCceE
Q psy14434         95 VNN--KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH--------ACKVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        95 ~~~--~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH--------~~~i~HrDlkp~NIll~~~~~vk  163 (404)
                      ...  ..+|+||||+.+ +|.+++....+++..++.++.||+.||.|||        +.||+||||||+|||++.++.+|
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            322  379999999995 9999999888999999999999999999999        89999999999999999999999


Q ss_pred             EeccccccccCCCCC----cccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHhC----------CCCC
Q psy14434        164 IGDLGLARSLSDSKE----CLTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQS----------KPLF  224 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~pf  224 (404)
                      |+|||++........    ......||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            999999986654322    224457999999999985432     233789999999999999999          7788


Q ss_pred             CCCCc----HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        225 PGAST----SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       225 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .....    ..............+.....+  ....++..+.+||.+||+.||.+|||+.++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            65422    222222211111111111100  001234679999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=339.96  Aligned_cols=263  Identities=22%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHH--HHHHHHHhccCCCCcceEeeEEEe--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQRHPNIITMLDIYKA--   94 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--~E~~~l~~l~~hpnIv~l~~~~~~--   94 (404)
                      ....++|++.+.||+|+||.||+|.+  +++.||+|++...     ......  .|+..+..+. ||||+++++.+..  
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLME-HDNIARFIVGDERVT   80 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhcc-Ccchhhheecccccc
Confidence            34567999999999999999999966  6899999998533     222233  3333344465 9999999986642  


Q ss_pred             -ccCCeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCcEEEccCCceE
Q psy14434         95 -VNNKDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC---------KVMHRDLKPSNILIDKSCSIK  163 (404)
Q Consensus        95 -~~~~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~---------~i~HrDlkp~NIll~~~~~vk  163 (404)
                       .....+|+||||++ |+|.+++....+++..++.++.||+.||.|||+.         ||+||||||+|||++.++.+|
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             23446789999997 5999999988889999999999999999999999         999999999999999999999


Q ss_pred             EeccccccccCCCC--------CcccccccccccccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCC-CCCC
Q psy14434        164 IGDLGLARSLSDSK--------ECLTEYIATRWYRAPEILISN------RRYTHHVDIWSLGCILAEMLQSKPLF-PGAS  228 (404)
Q Consensus       164 l~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~g~~pf-~~~~  228 (404)
                      |+|||++.......        ......+||+.|+|||++.+.      ..++.++|||||||++|+|++|..|| .+..
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998654321        122345799999999998532      35667899999999999999996554 3322


Q ss_pred             c----------------HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHH------hcc
Q psy14434        229 T----------------SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQIL------EHN  286 (404)
Q Consensus       229 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll------~hp  286 (404)
                      .                ..............+. ..........+++.+.+||.+||+.||.+|||+.+++      -++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK-FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC-CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCC-CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1                1111111111111111 1111111112345799999999999999999999995      456


Q ss_pred             CCCC
Q psy14434        287 YVSK  290 (404)
Q Consensus       287 ~~~~  290 (404)
                      |-.+
T Consensus       320 ~~~~  323 (336)
T 3g2f_A          320 WERN  323 (336)
T ss_dssp             CCC-
T ss_pred             HHhc
Confidence            6554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=337.02  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEE----EcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAY----DKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      ..++|++++.||+|+||.||+|.    +..+++.||+|++..  ........+.+|+.+++.+. ||||+++++++...+
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence            45679999999999999999998    467899999999864  24556677889999999996 999999999986545


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      ...+++||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            5578999999985 999999753  4999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCc---ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------------HHHHHHHH
Q psy14434        174 SDSKEC---LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------------HQLQLIVN  238 (404)
Q Consensus       174 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------------~~~~~~~~  238 (404)
                      ......   .....++..|+|||.+. +..++.++|||||||++|+|++|..||......            .....+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            543221   22345778899999984 556899999999999999999999888542111            11111111


Q ss_pred             hhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        239 LVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .......     ......++..+.+||.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 LLKNNGR-----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTTCC-----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhcCCC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1110000     0112457899999999999999999999999975

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.6e-44  Score=335.78  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=199.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc--cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .|...+.||+|+||.||+|.+  +++.||+|++....  ........+.+|+.+++.+. ||||+++++++.  +....+
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~  106 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSS--DGDDLC  106 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEe--cCCceE
Confidence            355568999999999999975  57889999986432  23445677889999999996 999999999986  567799


Q ss_pred             EEEeccC-CcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        102 VVFEYME-NDLNKVIRD----KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~----~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +||||+. ++|.+++..    ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            9999997 589988862    35999999999999999999999999999999999999999999999999999865432


Q ss_pred             CC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh---
Q psy14434        177 KE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY---  251 (404)
Q Consensus       177 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  251 (404)
                      ..  ......||+.|+|||++.  ..++.++|||||||++|+|++|.+||.+.........+.............+.   
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK  264 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred             cccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence            21  123457999999999873  35799999999999999999999999876543322222222111111000000   


Q ss_pred             --cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        252 --AGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       252 --~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              0011234678999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=356.73  Aligned_cols=247  Identities=25%  Similarity=0.436  Sum_probs=208.0

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++.....   ....+.+|+.+|+.+. ||||+++++++.   ...+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~---~~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCC-CCCEeeEEEEEe---eccc
Confidence            34679999999999999999999875 45699999965432   2456789999999997 999999999975   3568


Q ss_pred             EEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      ||||||+.+ +|.+++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999985 99999863   45999999999999999999999999999999999999999999999999999866432


Q ss_pred             C-CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 K-ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      . .......++..|+|||++. ...++.++|||||||++|+|++ |..||.+.........+........+         
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---------  486 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------  486 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------
T ss_pred             ceecccCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence            1 1122345678899999984 5578999999999999999999 99999998887777666554432221         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..++..+.+||.+||+.||.+|||+.+++..
T Consensus       487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          487 PECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4578999999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.7e-45  Score=371.68  Aligned_cols=272  Identities=25%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             cccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe-
Q psy14434         16 NVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA-   94 (404)
Q Consensus        16 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~-   94 (404)
                      ...+...++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.+. ||||+++++++.. 
T Consensus         7 ~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~   84 (676)
T 3qa8_A            7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGL   84 (676)
T ss_dssp             ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTT
T ss_pred             CCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccc
Confidence            44566778999999999999999999999999999999998643 34556677889999999996 9999999998652 


Q ss_pred             ---ccCCeEEEEEeccC-CcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc---eE
Q psy14434         95 ---VNNKDLYVVFEYME-NDLNKVIRDK----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS---IK  163 (404)
Q Consensus        95 ---~~~~~~~lv~E~~~-~~L~~~l~~~----~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~---vk  163 (404)
                         ......|+||||+. ++|.+++...    .+++..++.++.||+.||+|||+.||+||||||+||+++.++.   +|
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence               23667899999997 5999999752    4899999999999999999999999999999999999997765   99


Q ss_pred             EeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH------H
Q psy14434        164 IGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLI------V  237 (404)
Q Consensus       164 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------~  237 (404)
                      |+|||++...... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+..........      .
T Consensus       165 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          165 IIDLGYAKELDQG-ELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE  242 (676)
T ss_dssp             ECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred             Ecccccccccccc-cccccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence            9999999876543 233556899999999998 4667899999999999999999999999775433221000      0


Q ss_pred             HhhC-CCCC-------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        238 NLVR-PNPP-------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       238 ~~~~-~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .... ....       ...........+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            0000 0000       0000001112356889999999999999999999999999999764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=341.66  Aligned_cols=242  Identities=17%  Similarity=0.247  Sum_probs=190.1

Q ss_pred             CCeEEeeeecccCceeEEEE-----EEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccC--CCCcceEeeEEEec
Q psy14434         23 AEYTIHKRIGKGAYGIVYKA-----YDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR--HPNIITMLDIYKAV   95 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~l~~~~~~~   95 (404)
                      ++|++.+.||+|+||.||+|     .+..+++.||+|++...     ....+.+|+.+++.+..  |+||+.+++++.  
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~--  137 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL--  137 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE--
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee--
Confidence            56999999999999999999     46778999999998532     23345566666666642  899999999987  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc----------
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIR------DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK----------  158 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~------~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~----------  158 (404)
                      .....|+|||||. |+|.+++.      .+.+++..++.++.||+.||+|||++||+||||||+||||+.          
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            5677999999998 59999986      346999999999999999999999999999999999999998          


Q ss_pred             -CCceEEeccccccccC--CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q psy14434        159 -SCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQL  235 (404)
Q Consensus       159 -~~~vkl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  235 (404)
                       ++.+||+|||+++...  .........+||+.|+|||++ .+..++.++|||||||++|+|++|+.||........   
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-cCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence             8999999999997543  223344567899999999998 456699999999999999999999999855432100   


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhcc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHN  286 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp  286 (404)
                         ......       .. ...++.+.+++..||..+|.+|++..+.+.+.
T Consensus       294 ---~~~~~~-------~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          294 ---KPEGLF-------RR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ---EECSCC-------TT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ---eechhc-------cc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence               000000       00 12356789999999999999997665555543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-44  Score=341.70  Aligned_cols=251  Identities=17%  Similarity=0.223  Sum_probs=194.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc------ChhHHHHHHHHHHHHHhcc--------CCCCcce
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR------NKTDAQRTYREILFLKSFQ--------RHPNIIT   87 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~--------~hpnIv~   87 (404)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++.....      .......+.+|+.+++.+.        .||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999988  689999999975432      2334567889999998886        5888888


Q ss_pred             EeeEEEec----------------------------cCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHH
Q psy14434         88 MLDIYKAV----------------------------NNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSY  138 (404)
Q Consensus        88 l~~~~~~~----------------------------~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~  138 (404)
                      +.+++...                            +...+|||||||.+ ++.+.+..+.+++..++.++.||+.||.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            88775311                            26789999999974 45555555779999999999999999999


Q ss_pred             HH-hCCCccCCCCCCcEEEccCC--------------------ceEEeccccccccCCCCCccccccccccccccccccc
Q psy14434        139 IH-ACKVMHRDLKPSNILIDKSC--------------------SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS  197 (404)
Q Consensus       139 LH-~~~i~HrDlkp~NIll~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  197 (404)
                      || ++||+||||||+||||+.++                    .+||+|||+|+.....     ..+||+.|+|||++. 
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~-  250 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT-  250 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC-
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc-
Confidence            99 99999999999999999987                    8999999999876532     457999999999985 


Q ss_pred             CCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCc-HHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCC
Q psy14434        198 NRRYTHHVDIWSLGCI-LAEMLQSKPLFPGAST-SHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSE  275 (404)
Q Consensus       198 ~~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  275 (404)
                      +.. +.++||||||++ .++++.|..||.+... ......+............   ..+..+++++.+||.+||+.|   
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT---PAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCS---HHHHHHHHHHHHHHHHGGGSS---
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccch---hhhhhcCHHHHHHHHHHhccC---
Confidence            333 899999998777 7778899999844211 1122222222221111111   112346789999999999977   


Q ss_pred             CCCHHHHH-hccCCC
Q psy14434        276 RPETDQIL-EHNYVS  289 (404)
Q Consensus       276 Rpt~~~ll-~hp~~~  289 (404)
                        |+.++| +||||+
T Consensus       324 --sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --SATDLLCQHSLFK  336 (336)
T ss_dssp             --SHHHHHHHCGGGC
T ss_pred             --CHHHHHhcCCCcC
Confidence              999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-42  Score=357.34  Aligned_cols=249  Identities=24%  Similarity=0.431  Sum_probs=207.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+.||+|+||.||+|.+..+   +..||+|.+... ........+.+|+.+++.+. ||||+++++++.   ..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~  463 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---EN  463 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe---cC
Confidence            46799999999999999999998643   567999998543 34455677889999999996 999999999974   45


Q ss_pred             eEEEEEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+||||+. |+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999998 5999999754  589999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcc
Q psy14434        176 SKE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG  253 (404)
Q Consensus       176 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (404)
                      ... ......+|+.|+|||++ .+..++.++|||||||++|+|++ |..||.+.........+........+        
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------  614 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP--------  614 (656)
T ss_dssp             ----------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC--------
T ss_pred             CcceeccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence            321 12334578899999998 45678999999999999999997 99999998888777777665443222        


Q ss_pred             cCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        254 FKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       254 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                       ..+++.+.+||.+||..||.+|||+.++++.
T Consensus       615 -~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          615 -PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -ccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             4678999999999999999999999999763

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-42  Score=323.11  Aligned_cols=229  Identities=16%  Similarity=0.092  Sum_probs=186.6

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+..+..+. ||||+++++++.  ....
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~--~~~~  105 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVH--TRAG  105 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEE--ECCc
Confidence            457899999999999999999999999999999999765443 455677889999999996 999999999987  4678


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      .|+||||+.| +|.++++.+ ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|          
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            9999999985 899999766 4666788999999999999999999999999999999999999998543          


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                                |++        .++.++|||||||++|+|++|+.||.+.+....+..........   ..........++
T Consensus       175 ----------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 ----------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ---PIEPADIDRDIP  233 (286)
T ss_dssp             ----------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC---BCCHHHHCTTSC
T ss_pred             ----------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC---CCChhhcccCCC
Confidence                      233        26899999999999999999999998765532110000001111   111112235679


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.+.+||.+||+.||.+| |+.++++.
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999999 99999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-42  Score=358.29  Aligned_cols=244  Identities=23%  Similarity=0.376  Sum_probs=198.4

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcC-CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKN-NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      .+.++|++.+.||+|+||.||+|.+.. +++.||||++... ........+.+|+.++.++. ||||+++++++...+. 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTT
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCC
Confidence            345899999999999999999999976 7899999998643 23445567789999999997 9999999999875332 


Q ss_pred             --CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 --KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 --~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                        ...||||||++| +|.+.+.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence              127999999985 78777665 79999999999999999999999999999999999999885 89999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ..    ...+||+.|+|||++.++  ++.++|||||||++|+|++|.+||.+....           ..+.. ..    .
T Consensus       233 ~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~-~~----~  290 (681)
T 2pzi_A          233 SF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPED-DP----V  290 (681)
T ss_dssp             CC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTT-CH----H
T ss_pred             cC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccc-cc----c
Confidence            43    456799999999998433  489999999999999999999988653211           00000 00    0


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      ...++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            12367899999999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.3e-36  Score=305.78  Aligned_cols=186  Identities=14%  Similarity=0.088  Sum_probs=135.4

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhc--------cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF--------RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ...+.|+.|.+..++....|+.||+|++.+..        ..+....++.+|+.+|+++..|+||++++++++  ++..+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~  317 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSG  317 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEE
Confidence            34678888888888888889999999996542        123445678899999999988999999999988  68889


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||||++| +|.+++.. +.+++.   .|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            999999997 89999985 456654   4789999999999999999999999999999999999999999998766656


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK  221 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  221 (404)
                      ...+.+||+.|||||++.  +.+..++|+||+|+++++|.+|.
T Consensus       395 ~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             cccCceechhhccHHHhC--CCCCCcccccccccchhhhcccc
Confidence            667789999999999984  34678899999999998876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.3e-29  Score=249.97  Aligned_cols=186  Identities=21%  Similarity=0.233  Sum_probs=140.9

Q ss_pred             EEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ...+.||+|+||.||+|  ...+..+++|+.......      .....++.+|+.+++++. ||||+++..++.  ....
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--~~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDV--DLDN  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEE--ETTT
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEE--eCCc
Confidence            34568999999999999  445677899986432221      122455789999999997 999994444433  3445


Q ss_pred             EEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      .||||||++ ++|.+++..       +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++.......
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            699999998 599988876       6689999999999999999999999999999998  999999999998754322


Q ss_pred             c-------cccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q psy14434        179 C-------LTEYIATRWYRAPEILIS-NRRYTHHVDIWSLGCILAEMLQSKPLFP  225 (404)
Q Consensus       179 ~-------~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~  225 (404)
                      .       ....+||+.|||||++.. ...|+..+|+||.++-..+-+.++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1       246789999999999843 1457888899999999999888887763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.4e-26  Score=210.82  Aligned_cols=141  Identities=18%  Similarity=0.198  Sum_probs=112.3

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----------------hHHHHHHHHHHHHHhccCCCCcceEee
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----------------TDAQRTYREILFLKSFQRHPNIITMLD   90 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~~hpnIv~l~~   90 (404)
                      +.+.||+|+||.||+|.+ .+|+.||+|++.......                .....+.+|+.+++.+. |   +++++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v~~  168 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAVPK  168 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSSCC
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCcCe
Confidence            339999999999999999 889999999985432111                13556789999999997 4   55555


Q ss_pred             EEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccc
Q psy14434         91 IYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGL  169 (404)
Q Consensus        91 ~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~  169 (404)
                      ++..   ...|+||||++| +|.+ +     .......++.||+.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus       169 ~~~~---~~~~lvmE~~~g~~L~~-l-----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          169 VYAW---EGNAVLMELIDAKELYR-V-----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEEE---ETTEEEEECCCCEEGGG-C-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             EEec---cceEEEEEecCCCcHHH-c-----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            5542   346999999986 7876 3     2234567999999999999999999999999999999 99999999999


Q ss_pred             ccccCCCCCccccccccccccccccc
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEIL  195 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~  195 (404)
                      ++.             +..++|||.+
T Consensus       239 a~~-------------~~~~~a~e~l  251 (282)
T 1zar_A          239 SVE-------------VGEEGWREIL  251 (282)
T ss_dssp             CEE-------------TTSTTHHHHH
T ss_pred             CeE-------------CCCCCHHHHH
Confidence            863             3446899987

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.8e-22  Score=182.98  Aligned_cols=138  Identities=17%  Similarity=0.179  Sum_probs=108.3

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeE--EEEEEcchhccCh----------------------hHHHHHHHHHHHHHhcc
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNK----------------------TDAQRTYREILFLKSFQ   80 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~   80 (404)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++.......                      .....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            88999999999999999999778988  9999874321110                      11235678999999997


Q ss_pred             CCCCc--ceEeeEEEeccCCeEEEEEeccC--C----cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCC
Q psy14434         81 RHPNI--ITMLDIYKAVNNKDLYVVFEYME--N----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKP  151 (404)
Q Consensus        81 ~hpnI--v~l~~~~~~~~~~~~~lv~E~~~--~----~L~~~l~~~~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp  151 (404)
                       |+++  +.++++      ...+|||||++  |    .|.+....  .++..+..++.||+.||.||| +.||+||||||
T Consensus       129 -~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          129 -EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             -HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             -hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence             7754  444432      13589999995  2    56665432  345678899999999999999 99999999999


Q ss_pred             CcEEEccCCceEEecccccccc
Q psy14434        152 SNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus       152 ~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.8e-18  Score=164.58  Aligned_cols=138  Identities=15%  Similarity=0.152  Sum_probs=98.0

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC------------hhH------H--HHHHHHHHHHHhccCCCC
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN------------KTD------A--QRTYREILFLKSFQRHPN   84 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~------~--~~~~~E~~~l~~l~~hpn   84 (404)
                      |++.+.||.|++|.||+|.+. +|+.||||++......            ...      .  ....+|...|.++. +.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g  174 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG  174 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence            999999999999999999885 6889999987532111            000      1  11235677777774 333


Q ss_pred             cceEeeEEEeccCCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC---
Q psy14434         85 IITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC---  160 (404)
Q Consensus        85 Iv~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~---  160 (404)
                      +. ....+.. ..  .+|||||++| .|..+     ........++.||+.+|.+||++||+||||||.|||++++|   
T Consensus       175 v~-vp~p~~~-~~--~~LVME~i~G~~L~~l-----~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          175 FP-VPEPIAQ-SR--HTIVMSLVDALPMRQV-----SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CS-CCCEEEE-ET--TEEEEECCSCEEGGGC-----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CC-CCeeeec-cC--ceEEEEecCCccHhhh-----cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            32 2222211 11  3799999997 55332     22334567889999999999999999999999999998876   


Q ss_pred             -------ceEEecccccccc
Q psy14434        161 -------SIKIGDLGLARSL  173 (404)
Q Consensus       161 -------~vkl~Dfg~a~~~  173 (404)
                             .+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=2.7e-13  Score=123.38  Aligned_cols=142  Identities=14%  Similarity=0.132  Sum_probs=111.1

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++.|++...+|.|+.+.||++...  +..+++|+......  .....+.+|+.+++.+..+..++++++++.  ..+.
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~   84 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGW   84 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe--cCCc
Confidence            45678999999999999999999643  67899999864321  112357789999999976778889998876  4678


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA-------------------------------------  141 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~-------------------------------------  141 (404)
                      .|+|||+++| +|....    .+......++.+++.+|+.||+                                     
T Consensus        85 ~~lv~e~i~G~~l~~~~----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEECCSSEEHHHHC----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             eEEEEEecCCeehhhcc----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999999998 666542    1223345788899999999998                                     


Q ss_pred             ----------------------CCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        142 ----------------------CKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       142 ----------------------~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                                            ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876556799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=7e-12  Score=113.49  Aligned_cols=139  Identities=14%  Similarity=0.105  Sum_probs=99.1

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC-cceEeeEEEeccC
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN-IITMLDIYKAVNN   97 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-Iv~l~~~~~~~~~   97 (404)
                      ......|.+....+.|..+.||++.. .+|..+++|+....     ....+.+|+.+++.+..+.- +++++++..  ..
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~   87 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EA   87 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CS
T ss_pred             HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CC
Confidence            44556788766555777799999954 45677999987432     12345688999988875522 566888765  45


Q ss_pred             CeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACK---------------------------------  143 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~---------------------------------  143 (404)
                      +..++||||++| +|.  .  ....   ...++.+++.+|..||+..                                 
T Consensus        88 ~~~~~v~e~i~G~~l~--~--~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S--SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             SCEEEEEECCSSEETT--T--SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             CCCEEEEEecCCcccC--c--CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            668999999998 552  1  1111   2356677777788887643                                 


Q ss_pred             -------------------------CccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        144 -------------------------VMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       144 -------------------------i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                                               ++|+|++|.||+++.++.+.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                     99999999999998776667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=9.8e-11  Score=111.48  Aligned_cols=144  Identities=11%  Similarity=0.114  Sum_probs=102.5

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcc--hhccChhHHHHHHHHHHHHHhccC-CCCcceEeeEEEecc-CCeE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF--EAFRNKTDAQRTYREILFLKSFQR-HPNIITMLDIYKAVN-NKDL  100 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~l~~~~~~~~-~~~~  100 (404)
                      ...++.|+.|.++.||++...  +..+++|+..  ... .......+.+|..+++.+.. +..+++++.++...+ .+..
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            345678999999999999654  4568888874  221 11223466789999998864 345788888765321 1457


Q ss_pred             EEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q psy14434        101 YVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--------------------------------------  141 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~--------------------------------------  141 (404)
                      |+||||++| .+.+.. -..++..+...++.+++.+|+.||+                                      
T Consensus       117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999997 342211 1236788888899999999999997                                      


Q ss_pred             --------------------CCCccCCCCCCcEEEccCCc--eEEeccccccc
Q psy14434        142 --------------------CKVMHRDLKPSNILIDKSCS--IKIGDLGLARS  172 (404)
Q Consensus       142 --------------------~~i~HrDlkp~NIll~~~~~--vkl~Dfg~a~~  172 (404)
                                          .+++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                36899999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=4.2e-11  Score=111.35  Aligned_cols=183  Identities=17%  Similarity=0.172  Sum_probs=118.9

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCC--cceEeeEEEecc-CCeEEEEE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN--IITMLDIYKAVN-NKDLYVVF  104 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn--Iv~l~~~~~~~~-~~~~~lv~  104 (404)
                      ++.++.|..+.||++.     ..+++|+...    ......+.+|..+++.+..+..  ++.++......+ ....|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4569999999999873     3488998632    2345677899999988854433  344444322111 12348999


Q ss_pred             eccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy14434        105 EYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA------------------------------------------  141 (404)
Q Consensus       105 E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~------------------------------------------  141 (404)
                      ++++| .+..... ..++..+...++.+++..++.||+                                          
T Consensus        96 ~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           96 TKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             ECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99998 4543222 347777888888888888888886                                          


Q ss_pred             ----------------CCCccCCCCCCcEEEcc--CCceEEeccccccccCCCCCccccccccccc---ccccccc---c
Q psy14434        142 ----------------CKVMHRDLKPSNILIDK--SCSIKIGDLGLARSLSDSKECLTEYIATRWY---RAPEILI---S  197 (404)
Q Consensus       142 ----------------~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y---~aPE~~~---~  197 (404)
                                      ..++|+|++|.||+++.  .+.+.|+||+.+.......    .......+   ..|+...   .
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHHHHHHH
Confidence                            13699999999999998  4567899999986532211    00011111   1222110   0


Q ss_pred             C-C---------CCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        198 N-R---------RYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       198 ~-~---------~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                      . +         ......+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0 0         0122368999999999999998766

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=3.3e-07  Score=83.14  Aligned_cols=137  Identities=20%  Similarity=0.214  Sum_probs=94.0

Q ss_pred             eEEeeeecccCce-eEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         25 YTIHKRIGKGAYG-IVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        25 y~~~~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      |+.. .+..|..| .||+.....++..+++|+-..     .....+.+|...|+.+..+--+.+++.+..  +.+..|+|
T Consensus        27 ~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~--~~~~~~lv   98 (272)
T 4gkh_A           27 YRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIR--TPDDAWLL   98 (272)
T ss_dssp             CEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEE
T ss_pred             CeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEE--ECCeEEEE
Confidence            4433 34445554 699998877788899998632     345567789999998876555778888765  45678999


Q ss_pred             EeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q psy14434        104 FEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC----------------------------------------  142 (404)
Q Consensus       104 ~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~----------------------------------------  142 (404)
                      ||+++| ++.+.....   ......+..++...|..||+.                                        
T Consensus        99 me~l~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             EECCCSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             EEeeCCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            999998 555443321   112223444455555555521                                        


Q ss_pred             ------------------CCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        143 ------------------KVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       143 ------------------~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                                        .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              278999999999998877677999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.70  E-value=2.5e-07  Score=85.77  Aligned_cols=135  Identities=19%  Similarity=0.200  Sum_probs=91.7

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC--CcceEeeEEEeccCCeEEEEEe
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP--NIITMLDIYKAVNNKDLYVVFE  105 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--nIv~l~~~~~~~~~~~~~lv~E  105 (404)
                      ++.++.|....||++     +..+++|+..    .......+.+|..+|+.+..+-  .+++.+.+.. ...+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEe
Confidence            456889999999998     4558888852    2234567789999999997442  2556666543 24566789999


Q ss_pred             ccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q psy14434        106 YMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHAC------------------------------------------  142 (404)
Q Consensus       106 ~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~------------------------------------------  142 (404)
                      +++| .+....- ..++..+...++.++...|+.||+.                                          
T Consensus        94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            9998 4544211 1244444555555555555555532                                          


Q ss_pred             ------------------CCccCCCCCCcEEEcc---CCce-EEecccccccc
Q psy14434        143 ------------------KVMHRDLKPSNILIDK---SCSI-KIGDLGLARSL  173 (404)
Q Consensus       143 ------------------~i~HrDlkp~NIll~~---~~~v-kl~Dfg~a~~~  173 (404)
                                        .++|+|++|.||+++.   ++.+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              3599999999999987   4565 89999988653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=5.4e-07  Score=86.69  Aligned_cols=79  Identities=19%  Similarity=0.253  Sum_probs=49.3

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc--C---hhHHHHHHHHHHHHHhccCC-C-CcceEeeEEEeccCCe
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR--N---KTDAQRTYREILFLKSFQRH-P-NIITMLDIYKAVNNKD   99 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~~h-p-nIv~l~~~~~~~~~~~   99 (404)
                      -.+.||.|..+.||++....+++.+++|.......  .   .....+...|..+++.+..+ | .+++++.+  +  ...
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEM  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCc
Confidence            35679999999999997666677899998642211  0   01233456788888877533 3 34456643  2  233


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                      .++|||+++|
T Consensus       110 ~~lvmE~l~g  119 (397)
T 2olc_A          110 AVTVMEDLSH  119 (397)
T ss_dssp             TEEEECCCTT
T ss_pred             cEEEEEeCCC
Confidence            5899999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=2.2e-06  Score=81.09  Aligned_cols=85  Identities=9%  Similarity=0.034  Sum_probs=53.4

Q ss_pred             eEEeeee-cccCceeEEEEEEc--C----CCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEe
Q psy14434         25 YTIHKRI-GKGAYGIVYKAYDK--N----NKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRH--PNIITMLDIYKA   94 (404)
Q Consensus        25 y~~~~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~   94 (404)
                      ....+.| +.|..+.+|++...  .    ++..+++|+...... .......+.+|..+++.+..+  -.+++++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3446778 88999999998653  1    156789998643220 000113456788888887644  356777776542


Q ss_pred             cc-CCeEEEEEeccCC
Q psy14434         95 VN-NKDLYVVFEYMEN  109 (404)
Q Consensus        95 ~~-~~~~~lv~E~~~~  109 (404)
                      .+ .+..|+|||+++|
T Consensus       102 ~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             STTTSSCEEEEECCCC
T ss_pred             CCccCCceEEEEecCC
Confidence            11 1456899999986

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=3e-05  Score=72.40  Aligned_cols=30  Identities=23%  Similarity=0.292  Sum_probs=27.4

Q ss_pred             CCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            679999999999999888899999999774

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.05  E-value=2.5e-05  Score=75.54  Aligned_cols=79  Identities=11%  Similarity=0.087  Sum_probs=47.5

Q ss_pred             HhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccccccc--ccccccccccccCC--CCCchhhHHHHHHHHH
Q psy14434        140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA--TRWYRAPEILISNR--RYTHHVDIWSLGCILA  215 (404)
Q Consensus       140 H~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~  215 (404)
                      +...++|+|++|.|||++.++ +.|+||+.+......-. ......  ...|.+|+......  ......++.+++..++
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            356799999999999998876 99999998865321111 111111  13456665542110  1122345557777777


Q ss_pred             HHHhC
Q psy14434        216 EMLQS  220 (404)
Q Consensus       216 ~l~~g  220 (404)
                      ..+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.97  E-value=0.00017  Score=62.18  Aligned_cols=120  Identities=13%  Similarity=0.124  Sum_probs=79.3

Q ss_pred             cHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCcccccccc
Q psy14434        110 DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH-ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIAT  186 (404)
Q Consensus       110 ~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH-~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt  186 (404)
                      +|.++++  ..+++++++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|.+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            6999997  578999999999999999988762 22222334567999999999988764 2111            122


Q ss_pred             cccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHH
Q psy14434        187 RWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLN  266 (404)
Q Consensus       187 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  266 (404)
                      ..+.|||..  ....+.+.=|||||+++|.-+--..|-..                           -..+|+.+.+||.
T Consensus       101 ~~~~~pe~~--~~~~te~~~IysLG~tLY~ALDygL~e~e---------------------------E~eLS~~LE~LL~  151 (229)
T 2yle_A          101 PPPVAGKLG--YSQCMETEVIESLGIIIYKALDYGLKENE---------------------------ERELSPPLEQLID  151 (229)
T ss_dssp             ------CCS--SSSSCHHHHHHHHHHHHHHHHTTTCCTTE---------------------------EECCCHHHHHHHH
T ss_pred             cCCCChhhc--cccchHHHHHHHHHHHHHHHhhcCCCccc---------------------------chhhCHHHHHHHH
Confidence            345688875  34557889999999999998742222100                           0346888888888


Q ss_pred             hcccc
Q psy14434        267 QILVL  271 (404)
Q Consensus       267 ~~L~~  271 (404)
                      .|..-
T Consensus       152 ~Mt~~  156 (229)
T 2yle_A          152 HMANT  156 (229)
T ss_dssp             HHTTC
T ss_pred             HHHhc
Confidence            88755

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.89  E-value=4.8e-05  Score=70.04  Aligned_cols=69  Identities=10%  Similarity=0.038  Sum_probs=43.5

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEecc
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYM  107 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~  107 (404)
                      ++.|+.|....+|++      ..+++|+......   ......+|...++.+..+.-.++++.+.    ...-++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~----~~~~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD----PATGVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC----TTTCCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE----CCCCEEEEeec
Confidence            788999999999999      3488888743211   1112235777777765443335666542    22347899999


Q ss_pred             -CC
Q psy14434        108 -EN  109 (404)
Q Consensus       108 -~~  109 (404)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             65

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00016  Score=66.83  Aligned_cols=74  Identities=14%  Similarity=0.109  Sum_probs=55.2

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEeccCCeEEEEE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKDLYVVF  104 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~~~~~~~~lv~  104 (404)
                      -.+.|+.|....+|++..  ++..+++|+....     ....+.+|...|+.+..+  ..+++++.+..  ..+..|+||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~--~~g~~~lvm  110 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGN--SQGHSFLLL  110 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE--CSSEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee--cCCceEEEE
Confidence            357799999999999964  4667889986432     345667888888888543  56778887754  456789999


Q ss_pred             eccCC
Q psy14434        105 EYMEN  109 (404)
Q Consensus       105 E~~~~  109 (404)
                      |+++|
T Consensus       111 e~l~G  115 (312)
T 3jr1_A          111 EALNK  115 (312)
T ss_dssp             ECCCC
T ss_pred             EeccC
Confidence            99986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.66  E-value=0.00015  Score=67.63  Aligned_cols=32  Identities=22%  Similarity=0.243  Sum_probs=27.6

Q ss_pred             CCCccCCCCCCcEEEccC----CceEEecccccccc
Q psy14434        142 CKVMHRDLKPSNILIDKS----CSIKIGDLGLARSL  173 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~----~~vkl~Dfg~a~~~  173 (404)
                      ..++|+|+.|.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    67999999988653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.00011  Score=69.82  Aligned_cols=136  Identities=10%  Similarity=0.111  Sum_probs=82.7

Q ss_pred             eeeecccCceeEEEEEEcC-------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         28 HKRIGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ++.|..|-...+|++....       ++..+++|+....   ........+|..+++.+..+.-.+++++++.  +    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----
Confidence            4568888899999997642       3567999986321   1234455589999888875555577777653  2    


Q ss_pred             EEEEeccCC-cH-----------H---HHHH---hc--C----CC--HHHHHHHHHHHHH-------------------H
Q psy14434        101 YVVFEYMEN-DL-----------N---KVIR---DK--I----LK--DVHIRYIMFQLCN-------------------G  135 (404)
Q Consensus       101 ~lv~E~~~~-~L-----------~---~~l~---~~--~----l~--~~~~~~i~~qil~-------------------a  135 (404)
                      .+||||++| .|           .   ..+.   .-  .    ..  ..++..++.++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            399999986 21           1   1111   11  1    11  3455656554422                   2


Q ss_pred             HHHHH----h----CCCccCCCCCCcEEEccC----CceEEeccccccc
Q psy14434        136 LSYIH----A----CKVMHRDLKPSNILIDKS----CSIKIGDLGLARS  172 (404)
Q Consensus       136 l~~LH----~----~~i~HrDlkp~NIll~~~----~~vkl~Dfg~a~~  172 (404)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33332    2    259999999999999876    7899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.52  E-value=0.00031  Score=68.07  Aligned_cols=73  Identities=12%  Similarity=0.166  Sum_probs=50.0

Q ss_pred             EeeeecccCceeEEEEEEcC-------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         27 IHKRIGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -++.|+.|....||++....       ++..+++|+....  ..  ...+.+|..+++.+..+.-.+++++.+.   +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~---~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFS---G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEET---T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--
Confidence            35678999999999997653       2567899987321  11  1344478888888865544467777643   2  


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                       .+|+||++|
T Consensus       148 -g~v~e~l~G  156 (429)
T 1nw1_A          148 -GRLEEYIPS  156 (429)
T ss_dssp             -EEEECCCCE
T ss_pred             -CEEEEEeCC
Confidence             389999986

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.42  E-value=0.00025  Score=65.62  Aligned_cols=141  Identities=12%  Similarity=0.059  Sum_probs=76.3

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEEE----eccCCe
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYK----AVNNKD   99 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~~----~~~~~~   99 (404)
                      ..-++.|+.|....+|++... +| .+++|+....    .....+..|..+++.+..+. .+++++..-.    ....+.
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            344567888988999999754 33 5889987542    11223446777777665331 1333332100    001356


Q ss_pred             EEEEEeccCCc-H-----H------HHH----Hh-cCC--------CHHHHHH---------------HHHHHHHHHHHH
Q psy14434        100 LYVVFEYMEND-L-----N------KVI----RD-KIL--------KDVHIRY---------------IMFQLCNGLSYI  139 (404)
Q Consensus       100 ~~lv~E~~~~~-L-----~------~~l----~~-~~l--------~~~~~~~---------------i~~qil~al~~L  139 (404)
                      .+++|++++|. +     .      ..+    .. ..+        ....-..               +...+...+..+
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            78999999862 1     0      111    10 011        1000000               001133445555


Q ss_pred             Hh-------CCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        140 HA-------CKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       140 H~-------~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      ..       .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            42       369999999999999887656899998775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.35  E-value=0.00042  Score=65.61  Aligned_cols=73  Identities=15%  Similarity=0.130  Sum_probs=43.7

Q ss_pred             eeeecccCceeEEEEEEcC--------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         28 HKRIGKGAYGIVYKAYDKN--------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++.|+.|....+|++....        .+..+++|+.....   ........|..+++.+..+.-++++++.+   .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF---NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec---CC--
Confidence            5668888899999997653        13678899874321   11112356788888776443355676553   22  


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                       ++||||++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             689999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.0032  Score=57.25  Aligned_cols=78  Identities=12%  Similarity=0.039  Sum_probs=52.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC--CcceEeeEEEeccCCeE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP--NIITMLDIYKAVNNKDL  100 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--nIv~l~~~~~~~~~~~~  100 (404)
                      .+..-++.+|.|..+.||++.. .+|+.|++|+-.....  .....+.+|...|+.+....  -+++++.+  + .   -
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~---~   85 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D---R   85 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T---T
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C---c
Confidence            4567789999999999999975 4678899998643211  11234557888888885332  34555544  2 1   2


Q ss_pred             EEEEeccCC
Q psy14434        101 YVVFEYMEN  109 (404)
Q Consensus       101 ~lv~E~~~~  109 (404)
                      ++|||++.+
T Consensus        86 ~lv~e~l~~   94 (288)
T 3f7w_A           86 TLAMEWVDE   94 (288)
T ss_dssp             EEEEECCCC
T ss_pred             eEEEEeecc
Confidence            789999874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.30  E-value=0.0023  Score=62.35  Aligned_cols=74  Identities=15%  Similarity=0.078  Sum_probs=48.3

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      -++.|+.|-...+|++....++..+++|+......   ......+|..+++.|..+.-.+++++++.   +   .+||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence            35678899999999998765457889998743211   11112478888888875544567777652   2   359999


Q ss_pred             cCC
Q psy14434        107 MEN  109 (404)
Q Consensus       107 ~~~  109 (404)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            986

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.07  E-value=0.002  Score=59.62  Aligned_cols=75  Identities=12%  Similarity=0.135  Sum_probs=45.2

Q ss_pred             eeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEEEe----ccCCeEEEE
Q psy14434         29 KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKA----VNNKDLYVV  103 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~~~----~~~~~~~lv  103 (404)
                      ..|+ |....||++... +|+.+++|.......   ....+..|..+++.+..+. .+++++.. ..    ...+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence            4566 888899988543 455689998753211   2334556777777775331 13444432 10    024567899


Q ss_pred             EeccCC
Q psy14434        104 FEYMEN  109 (404)
Q Consensus       104 ~E~~~~  109 (404)
                      |++++|
T Consensus       106 ~~~i~G  111 (328)
T 1zyl_A          106 FPSVGG  111 (328)
T ss_dssp             EECCCC
T ss_pred             EEecCC
Confidence            999986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.97  E-value=0.0032  Score=58.84  Aligned_cols=31  Identities=26%  Similarity=0.290  Sum_probs=27.7

Q ss_pred             CCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.70  E-value=0.0046  Score=59.49  Aligned_cols=74  Identities=8%  Similarity=0.029  Sum_probs=48.6

Q ss_pred             EeeeecccCceeEEEEEEcCC-------CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNN-------KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      -++.|..|-...+|++.....       +..+++++.....   .......+|..+++.+..+.-.+++++.+.   +  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP---E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET---T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---C--
Confidence            456688888999999987531       5678999864321   111223467888877765544566776432   2  


Q ss_pred             EEEEEeccCC
Q psy14434        100 LYVVFEYMEN  109 (404)
Q Consensus       100 ~~lv~E~~~~  109 (404)
                       ++||||++|
T Consensus       146 -~~I~efI~G  154 (424)
T 3mes_A          146 -GRIEEFIDG  154 (424)
T ss_dssp             -EEEEECCCS
T ss_pred             -CEEEEEeCC
Confidence             789999987

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.03  E-value=0.03  Score=53.45  Aligned_cols=29  Identities=21%  Similarity=0.332  Sum_probs=24.8

Q ss_pred             CccCCCCCCcEEE------ccCCceEEeccccccc
Q psy14434        144 VMHRDLKPSNILI------DKSCSIKIGDLGLARS  172 (404)
Q Consensus       144 i~HrDlkp~NIll------~~~~~vkl~Dfg~a~~  172 (404)
                      ++|+|+.+.|||+      ++++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3457799999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.84  E-value=1.3  Score=38.00  Aligned_cols=121  Identities=12%  Similarity=0.150  Sum_probs=78.4

Q ss_pred             HHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEeccCC--cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy14434         71 REILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRD  148 (404)
Q Consensus        71 ~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~~~~--~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrD  148 (404)
                      .|+..|..  .||+++.. .+-+  ....+.+.++.-+.  ++.. +  +.++....++++.+|+....+++  .=+|--
T Consensus        35 ~el~LL~~--~~~~Fl~~-~I~e--~eD~v~~~y~~~~~~~~f~~-i--k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~  104 (215)
T 4ann_A           35 HLMYLLEQ--HSPYFIDA-ELTE--LRDSFQIHYDINDNHTPFDN-I--KSFTKNEKLRYLLNIKNLEEVNR--TRYTFV  104 (215)
T ss_dssp             GGGGGGGS--CCTTBCCE-EEEE--CSSEEEEEECCCTTSEEGGG-G--GGSCHHHHHHHHHHGGGGGGGGG--SSEECC
T ss_pred             HHHHHHhc--cCCcccce-EEEE--cccEEEEEEEcCcccCCHHH-H--HhcCHHHHHHHHHHHHHHHHHhc--CceEEE
Confidence            34444443  37988877 3432  45566666665542  3443 2  33778888999999988774443  347888


Q ss_pred             CCCCcEEEccCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        149 LKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       149 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                      |.|+||+++.++.+++.--|+-..+                 +|..      .+...=+-..=|++..+++|+..|
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~l-----------------~P~~------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNVV-----------------DPLP------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTTB-----------------SCCC------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EecceEEEcCCCCEEEEEccCccCC-----------------CCCC------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999999999877764332                 2221      122222334668888889888776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.12  E-value=0.053  Score=52.79  Aligned_cols=64  Identities=11%  Similarity=0.050  Sum_probs=18.3

Q ss_pred             EEeeeecccCceeEEEEEEcCCCeEEEE------EEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEE
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNKQYVAI------KKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYK   93 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~   93 (404)
                      .+.+.||   ||.||++.......+||+      |..............+.+|..+++.+. |||+++.+.+-.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccccccccccccccccccccc-ccccCCCcceEE
Confidence            4455666   999999988765567888      666543444455566778888888886 999999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.35  E-value=4.1  Score=34.89  Aligned_cols=112  Identities=13%  Similarity=0.179  Sum_probs=73.2

Q ss_pred             CCCCcceEeeEEEeccCCeEEEEEeccCC--cHHHHHHhcCCCHHHHHHHHHHHHHHHH-HHHhCCCccCCCCCCcEEEc
Q psy14434         81 RHPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLS-YIHACKVMHRDLKPSNILID  157 (404)
Q Consensus        81 ~hpnIv~l~~~~~~~~~~~~~lv~E~~~~--~L~~~l~~~~l~~~~~~~i~~qil~al~-~LH~~~i~HrDlkp~NIll~  157 (404)
                      .||++ . ..+  ..+++.+.+.++.-.+  ++..+   +.++..+.++++.+|+.... ++  ..-+|--|.|+||+++
T Consensus        48 ~~~~f-~-~~I--~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCI-V-RDI--DVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSS-E-EEE--EECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred             cCCCC-C-eEE--EEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence            37888 2 222  2256667777776643  55544   34788888888888887655 33  4557888999999999


Q ss_pred             cCCceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy14434        158 KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLF  224 (404)
Q Consensus       158 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  224 (404)
                      .++.++|.-.|+-..+                 +|..+      +...=+-++=|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~l-----------------pP~e~------~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKESL-----------------PPDEW------DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTTB-----------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCcccC-----------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999887764332                 22221      22222234667888888877665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	404
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-72
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-72
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-71
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-71
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-69
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-68
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-67
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-66
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-66
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-65
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-65
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-64
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-64
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-64
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-64
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-63
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-62
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-61
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-61
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-59
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-59
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-58
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-58
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-56
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-53
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-49
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-25

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 5e-74
 Identities = 78/285 (27%), Positives = 143/285 (50%), Gaps = 16/285 (5%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           G+   +YT  ++IG+GA G VY A D    Q VAI+++    + +   +    EIL ++ 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRE 73

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLS 137
             ++PNI+  LD Y  +   +L+VV EY+    L  V+ +  + +  I  +  +    L 
Sbjct: 74  N-KNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           ++H+ +V+HRD+K  NIL+    S+K+ D G    ++  +   +  + T ++ APE+ ++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VT 189

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            + Y   VDIWSLG +  EM++ +P +   +    L LI     P   + +K        
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------- 242

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNY--VSKYFPSATHVIP 300
                D LN+ L ++  +R    ++L+H +  ++K   S T +I 
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 6e-74
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 22/276 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           +Y +   IG G+YG   K   K++ + +  K++      + + Q    E+  L+   +HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 63

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLS 137
           NI+   D      N  LY+V EY E  DL  VI       + L +  +  +M QL   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 138 YIH-----ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
             H        V+HRDLKP+N+ +D   ++K+GD GLAR L+        ++ T +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E + +   Y    DIWSLGC+L E+    P F   S       I        P+      
Sbjct: 184 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY------ 236

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV 288
                 +E  +++ ++L L    RP  ++ILE+  +
Sbjct: 237 ---RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 6e-72
 Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 19/276 (6%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           + I   +G GA+G VYKA +K      A K I    +++ + +    EI  L S   HPN
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASC-DHPN 70

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGLSYIHA 141
           I+ +LD +      +L+++ E+        +    ++ L +  I+ +  Q  + L+Y+H 
Sbjct: 71  IVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN--- 198
            K++HRDLK  NIL      IK+ D G++   + + +    +I T ++ APE+++     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 199 -RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R Y +  D+WSLG  L EM + +P     +    L  I     P      ++       
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW------- 241

Query: 258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
                D L + L  N   R  T Q+L+H +V+    
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 8e-72
 Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 15/274 (5%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++ + + +G+GAYG V  A ++  ++ VA+K + +  R     +   +EI   K    H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKML-NHE 63

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIHA 141
           N++      +       Y+  EY       +++  D  + +   +    QL  G+ Y+H 
Sbjct: 64  NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILISNR 199
             + HRD+KP N+L+D+  ++KI D GLA      + +  L +   T  Y APE+L    
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
            +   VD+WS G +L  ML  +  +   S S Q        +       K          
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-------DS 234

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
             + LL++ILV NPS R     I +  + +K   
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 9e-72
 Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 17/271 (6%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           L ++ I + +GKG +G VY A +K +K  +A+K +F+A   K   +   R  + ++S  R
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQLCNGLSYI 139
           HPNI+ +   +   +   +Y++ EY        ++ +     +      + +L N LSY 
Sbjct: 65  HPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
           H+ +V+HRD+KP N+L+  +  +KI D G +     S+        T  Y  PE+ I  R
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEM-IEGR 179

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
            +   VD+WSLG +  E L  KP F   +     + I  +    P              E
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV----------TE 229

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            A DL++++L  NPS+RP   ++LEH +++ 
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  225 bits (574), Expect = 3e-71
 Identities = 75/348 (21%), Positives = 155/348 (44%), Gaps = 31/348 (8%)

Query: 19  GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
            ++L  Y IH+ +G GA+G+V++  ++      A K +     +++D +   +EI  +  
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSV 79

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNG 135
             RHP ++ + D ++  ++ ++ +++E+M   +L + + D+   + +      M Q+C G
Sbjct: 80  L-RHPTLVNLHDAFE--DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 136 LSYIHACKVMHRDLKPSNILI--DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPE 193
           L ++H    +H DLKP NI+    +S  +K+ D GL   L   +        T  + APE
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPE 195

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           +    +   ++ D+WS+G +   +L     F G +    L+ + +        A      
Sbjct: 196 V-AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------ 248

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD 313
           F    E+  D + ++L+ +P+ R    Q LEH +++              P +    I D
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR---DSQIPSSRYTKIRD 305

Query: 314 NNQLEINDYQDKLYDIVKSCKKKKSVKRLSKGNALDNTLRGHYKIKDA 361
           + + + + + + L            + R+S  ++L       Y I+DA
Sbjct: 306 SIKTKYDAWPEPL----------PPLGRISNYSSLRKHRPQEYSIRDA 343

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  222 bits (568), Expect = 9e-71
 Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 20/277 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++  + IG G++G VY A D  N + VAIKK+ +   ++    Q   +E+ FL+   RHP
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKV--IRDKILKDVHIRYIMFQLCNGLSYIHA 141
           N I     Y  +     ++V EY     + +  +  K L++V I  +      GL+Y+H+
Sbjct: 76  NTIQYRGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL--ISNR 199
             ++HRD+K  NIL+ +   +K+GD G A  ++ +      ++ T ++ APE++  +   
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEG 189

Query: 200 RYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPE 259
           +Y   VD+WSLG    E+ + KP     +    L  I     P             +  E
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--------GHWSE 241

Query: 260 EAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT 296
              + ++  L   P +RP ++ +L+H +V +  P   
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  219 bits (558), Expect = 1e-69
 Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 25/282 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-------FEAFRNKTDAQRTYREILFLK 77
           Y   + +G+G   +V +   K   +  A+K I       F A   +   + T +E+  L+
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-LKDVHIRYIMFQLCNG 135
               HPNII + D Y+   N   ++VF+ M+  +L   + +K+ L +   R IM  L   
Sbjct: 65  KVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           +  +H   ++HRDLKP NIL+D   +IK+ D G +  L D  E L E   T  Y APEI+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 181

Query: 196 -----ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADK 249
                 ++  Y   VD+WS G I+  +L   P F        L++I++   +   P  D 
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           +        +   DL+++ LV+ P +R   ++ L H +  +Y
Sbjct: 242 Y-------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 4e-68
 Identities = 100/297 (33%), Positives = 148/297 (49%), Gaps = 27/297 (9%)

Query: 29  KRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTD---AQRTYREILFLKSFQRHPNI 85
             +G+G +  VYKA DKN  Q VAIKKI    R++      +   REI  L+    HPNI
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 86  ITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACK 143
           I +LD +   +  ++ +VF++ME DL  +I+D   +L   HI+  M     GL Y+H   
Sbjct: 63  IGLLDAFG--HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 144 VMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTH 203
           ++HRDLKP+N+L+D++  +K+ D GLA+S        T  + TRWYRAPE+L   R Y  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 204 HVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH----------------- 246
            VD+W++GCILAE+L   P  PG S   QL  I   +                       
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 247 -ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY-FPSATHVIPQ 301
                +  F    ++ +DL+  + + NP  R    Q L+  Y S    P+    +P+
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (552), Expect = 5e-68
 Identities = 130/336 (38%), Positives = 190/336 (56%), Gaps = 33/336 (9%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           ++   YT    IG+GAYG+V  AYD  NK  VAIKKI   F ++T  QRT REI  L  F
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF 63

Query: 80  QRHPNIITMLDIYKA---VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGL 136
            RH NII + DI +A      KD+Y+V   M  DL K+++ + L + HI Y ++Q+  GL
Sbjct: 64  -RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYRAPE 193
            YIH+  V+HRDLKPSN+L++ +C +KI D GLAR      +    LTEY+ATRWYRAPE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
           I+++++ YT  +DIWS+GCILAEML ++P+FPG     QL  I+ ++             
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 254 ---------------------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
                                F N   +A+DLL+++L  NP +R E +Q L H Y+ +Y+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

Query: 293 PSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYD 328
             +   I +  P    +++DD   L     ++ +++
Sbjct: 303 DPSDEPIAEA-PFKFDMELDD---LPKEKLKELIFE 334

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  216 bits (550), Expect = 1e-67
 Identities = 77/353 (21%), Positives = 145/353 (41%), Gaps = 32/353 (9%)

Query: 18  DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
            G++   Y I + +G GA+G+V++  +K   +    K I   +    D      EI  + 
Sbjct: 24  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMN 81

Query: 78  SFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI--RDKILKDVHIRYIMFQLCN 134
               HP +I + D ++  +  ++ ++ E++   +L   I   D  + +  +   M Q C 
Sbjct: 82  QL-HHPKLINLHDAFE--DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138

Query: 135 GLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAP 192
           GL ++H   ++H D+KP NI+ +  K+ S+KI D GLA  L+   E +    AT  + AP
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAP 197

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           EI +       + D+W++G +   +L     F G      LQ +          A     
Sbjct: 198 EI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----- 251

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDID 312
            F +   EA D +  +L   P +R      LEH ++     + T  IP  + +  +    
Sbjct: 252 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS-SRYNKIRQKI 309

Query: 313 DNNQLEINDYQDKLYDIVKSCKKKKSVKRLSKGNALDNTLRGHYKIKDAISSK 365
                +                 + ++ R++  ++L       Y+I D+   +
Sbjct: 310 KEKYADWP-------------APQPAIGRIANFSSLRKHRPQEYQIYDSYFDR 349

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-66
 Identities = 103/300 (34%), Positives = 148/300 (49%), Gaps = 29/300 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           +   ++IG+G YG+VYKA +K   + VA+KKI      +       REI  LK    HPN
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 62

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVH---IRYIMFQLCNGLSYIHA 141
           I+ +LD+        LY+VFE++  DL K +    L  +    I+  +FQL  GL++ H+
Sbjct: 63  IVKLLDVIH--TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 142 CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRY 201
            +V+HRDLKP N+LI+   +IK+ D GLAR+        T  + T WYRAPEIL+  + Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 202 THHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA-------------- 247
           +  VDIWSLGCI AEM+  + LFPG S   QL  I   +                     
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 248 -----DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV 302
                  F        E+   LL+Q+L  +P++R      L H     +F   T  +P +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTKPVPHL 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 44/305 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           ++     +G G  G+V+K   K +   +A K I    +      +  RE+  L      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHEC-NSP 64

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIH- 140
            I+     +   ++ ++ +  E+M+   L++V+ +   + +  +  +   +  GL+Y+  
Sbjct: 65  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
             K+MHRD+KPSNIL++    IK+ D G++  L DS      ++ TR Y +PE L     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-QGTH 179

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK--- 257
           Y+   DIWS+G  L EM   +   P         +    V  +                 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 258 -------------------------------PEEAVDLLNQILVLNPSERPETDQILEHN 286
                                            E  D +N+ L+ NP+ER +  Q++ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 287 YVSKY 291
           ++ + 
Sbjct: 300 FIKRS 304

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-66
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 35/301 (11%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y    +IG+G +G V+KA  +   Q VA+KK+      +       REI  L+   +H N
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHEN 70

Query: 85  IITMLDIYKA------VNNKDLYVVFEYMENDLNKVIRDKILKDVH--IRYIMFQLCNGL 136
           ++ +++I +            +Y+VF++ E+DL  ++ + ++K     I+ +M  L NGL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYIATRWYRAP 192
            YIH  K++HRD+K +N+LI +   +K+ D GLAR+ S +K       T  + T WYR P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
           E+L+  R Y   +D+W  GCI+AEM    P+  G +  HQL LI  L     P       
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 253 GFK----------------------NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
            ++                       +   A+DL++++LVL+P++R ++D  L H++   
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

Query: 291 Y 291
            
Sbjct: 311 D 311

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  209 bits (534), Expect = 9e-66
 Identities = 72/291 (24%), Positives = 131/291 (45%), Gaps = 17/291 (5%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
           +I   Y     +G GA+  V  A DK  ++ VAIK I +             EI  L   
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKI 64

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLS 137
            +HPNI+ + DIY+  +   LY++ + +   +L   I +K    +     ++FQ+ + + 
Sbjct: 65  -KHPNIVALDDIYE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 138 YIHACKVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           Y+H   ++HRDLKP N+L    D+   I I D GL++ + D    L+    T  Y AP  
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAP-E 179

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           +++ + Y+  VD WS+G I   +L   P F   + +   + I+                +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY------W 233

Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPH 305
            +  + A D +  ++  +P +R   +Q L+H +++       ++   V+  
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (531), Expect = 1e-65
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 21/289 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   ++IG+G YG V+KA ++   + VA+K++     ++       REI  LK   +H N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKN 62

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKV 144
           I+ + D+  +     L   F   +        +  L    ++  +FQL  GL + H+  V
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHH 204
           +HRDLKP N+LI+++  +K+ + GLAR+      C +  + T WYR P++L   + Y+  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 205 VDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLVR-------------------PNP 244
           +D+WS GCI AE+  +  PLFPG     QL+ I  L+                    P  
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
           P                 DLL  +L  NP +R   ++ L+H Y S + P
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 2e-65
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 21/271 (7%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
                 IG+G++  VYK  D      VA  ++ +    K++ QR   E   LK   +HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPN 69

Query: 85  IITMLDIYKAV--NNKDLYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           I+   D +++     K + +V E M +      + R K++K   +R    Q+  GL ++H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 141 ACK--VMHRDLKPSNILI-DKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
                ++HRDLK  NI I   + S+KIGDLGLA     S       I T  + APE+   
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY-- 185

Query: 198 NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYAGFKN 256
             +Y   VD+++ G  + EM  S+  +     + Q+ + + + V+P            K 
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--------KV 237

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEHNY 287
              E  +++   +  N  ER     +L H +
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 8e-65
 Identities = 64/278 (23%), Positives = 127/278 (45%), Gaps = 19/278 (6%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           +  +Y I + +G+G +GIV++  + ++K+    K +       TD     +EI  L    
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIA- 58

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLS 137
           RH NI+ + + ++  + ++L ++FE++   D+ + I      L +  I   + Q+C  L 
Sbjct: 59  RHRNILHLHESFE--SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 138 YIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           ++H+  + H D++P NI+    +S +IKI + G AR L         + A  +Y      
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH- 175

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
             +   +   D+WSLG ++  +L     F   +    ++ I+N        A      FK
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------FK 228

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP 293
               EA+D ++++LV     R    + L+H ++ +   
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 1e-64
 Identities = 112/333 (33%), Positives = 173/333 (51%), Gaps = 34/333 (10%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   + +G GAYG V  A D      VAIKK++  F+++  A+R YRE+  LK   RH N
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHEN 78

Query: 85  IITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           +I +LD++      D     Y+V  +M  DL K+++ + L +  I+++++Q+  GL YIH
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           A  ++HRDLKP N+ +++ C +KI D GLAR        +T Y+ TRWYRAPE++++  R
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMR 195

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-------------- 246
           YT  VDIWS+GCI+AEM+  K LF G+    QL+ I+ +    P                
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 247 -------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVI 299
                     F +   N    AV+LL ++LVL+  +R    + L H Y      +     
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED--E 313

Query: 300 PQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
           PQV  +    D  D+    +++++   Y  V S
Sbjct: 314 PQVQKYD---DSFDDVDRTLDEWKRVTYKEVLS 343

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-64
 Identities = 116/338 (34%), Positives = 176/338 (52%), Gaps = 34/338 (10%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +   Y     +G GAYG V  A+D      VA+KK+   F++   A+RTYRE+  LK  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 80  QRHPNIITMLDIYKA----VNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
            +H N+I +LD++          D+Y+V   M  DLN +++ + L D H++++++Q+  G
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           L YIH+  ++HRDLKPSN+ +++ C +KI D GLAR   D     T Y+ATRWYRAPEI+
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 190

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG-- 253
           ++   Y   VDIWS+GCI+AE+L  + LFPG     QL+LI+ LV        K  +   
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 254 -------------------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS 294
                              F      AVDLL ++LVL+  +R    Q L H Y ++Y   
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 295 ATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
               +      +      ++  L I++++   YD V S
Sbjct: 311 DDEPVADPYDQSF-----ESRDLLIDEWKSLTYDEVIS 343

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 4e-64
 Identities = 60/270 (22%), Positives = 122/270 (45%), Gaps = 19/270 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           ++   K +G+G++  V  A +    +  AIK +       +       RE   +     H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
           P  + +   ++  +++ LY    Y +N   L  + +     +   R+   ++ + L Y+H
Sbjct: 68  PFFVKLYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISN 198
              ++HRDLKP NIL+++   I+I D G A+ LS   +      ++ T  Y +PE+ ++ 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTE 184

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           +      D+W+LGCI+ +++   P F   +     Q I+ L    P              
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF----------F 234

Query: 259 EEAVDLLNQILVLNPSERPETDQILEHNYV 288
            +A DL+ ++LVL+ ++R   +++  +  +
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 5e-64
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 18/269 (6%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + T+ +RIG G++G VYK     +   VA+K +          Q    E+  L+   RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHV 64

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR--DKILKDVHIRYIMFQLCNGLSYIH 140
           NI+  +          L +V ++ E   L   +   +   + + +  I  Q   G+ Y+H
Sbjct: 65  NILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEIL--I 196
           A  ++HRDLK +NI + +  ++KIGD GLA   S         +   +  + APE++   
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
               Y+   D+++ G +L E++  +  +   +   Q+  +V     +P  +        N
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV----RSN 237

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEH 285
            P+    L+ + L     ERP   QIL  
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-63
 Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 17/271 (6%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRH 82
           ++ +HK +GKG++G V+ A  K   Q+ AIK +  +      D + T  E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 83  PNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGLSYIH 140
           P +  M   +     ++L+ V EY+   DL   I+           +   ++  GL ++H
Sbjct: 63  PFLTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  +++RDLK  NIL+DK   IKI D G+ +           +  T  Y APEI +  ++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI-LLGQK 179

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           Y H VD WS G +L EML  +  F G         I       P              +E
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL----------EKE 229

Query: 261 AVDLLNQILVLNPSERPET-DQILEHNYVSK 290
           A DLL ++ V  P +R      I +H    +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-63
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 21/282 (7%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILF 75
           N+   Y   + +G G + +V K  +K+     A K I     ++ R     +   RE+  
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 76  LKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLC 133
           LK   +HPN+IT+ ++Y+  N  D+ ++ E +      + +   + L +      + Q+ 
Sbjct: 67  LKEI-QHPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 134 NGLSYIHACKVMHRDLKPSNILIDK----SCSIKIGDLGLARSLSDSKECLTEYIATRWY 189
           NG+ Y+H+ ++ H DLKP NI++         IKI D GLA  +    E       T  +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182

Query: 190 RAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
            APEI ++        D+WS+G I   +L     F G +    L  +  +          
Sbjct: 183 VAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY-- 239

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
               F N    A D + ++LV +P +R      L+H ++   
Sbjct: 240 ----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 8e-63
 Identities = 69/310 (22%), Positives = 132/310 (42%), Gaps = 26/310 (8%)

Query: 19  GNILAEYTIHKR-IGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLK 77
             I+ +Y +  + +G G  G V + ++K  ++  A+K +        D  +  RE+    
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHW 59

Query: 78  SFQRHPNIITMLDIYKAV--NNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQ 131
              + P+I+ ++D+Y+ +    K L +V E ++  +L   I+D+      +     IM  
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119

Query: 132 LCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLSDSKECLTEYIATRW 188
           +   + Y+H+  + HRD+KP N+L      +  +K+ D G A+  +      T    T +
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPY 178

Query: 189 YRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD 248
           Y APE+L    +Y    D+WSLG I+  +L   P F           +   +R       
Sbjct: 179 YVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVV 308
                +    EE   L+  +L   P++R    + + H ++ +        +PQ   HT  
Sbjct: 238 NPE--WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK-----VPQTPLHTSR 290

Query: 309 LDIDDNNQLE 318
           +  +D  + E
Sbjct: 291 VLKEDKERWE 300

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-62
 Identities = 86/296 (29%), Positives = 150/296 (50%), Gaps = 37/296 (12%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           YT  K IG G++G+VY+A   ++ + VAIKK+        D +   RE+  ++    H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKL-DHCN 74

Query: 85  IITMLDIYKAVNNKD----LYVVFEYMENDLNKVIRDKI-----LKDVHIRYIMFQLCNG 135
           I+ +   + +   K     L +V +Y+   + +V R        L  ++++  M+QL   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSI-KIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           L+YIH+  + HRD+KP N+L+D   ++ K+ D G A+ L   +  ++ YI +R+YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 193

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRP---------NPP 245
           +     YT  +D+WS GC+LAE+L  +P+FPG S   QL  I+ ++           NP 
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 246 HADKFYAGFKNKP----------EEAVDLLNQILVLNPSERPETDQILEHNYVSKY 291
           + +  +   K  P           EA+ L +++L   P+ R    +   H++  + 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  198 bits (503), Expect = 2e-61
 Identities = 100/287 (34%), Positives = 155/287 (54%), Gaps = 25/287 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y   ++IG+G YG+VYKA +   +   A+KKI     ++     T REI  LK   +H N
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKEL-KHSN 61

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I+ + D+      K L +VFE+++ DL K++   +  L+ V  +  + QL NG++Y H  
Sbjct: 62  IVKLYDVIH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 143 KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYT 202
           +V+HRDLKP N+LI++   +KI D GLAR+        T  I T WYRAP++L+ +++Y+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 203 HHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP----------------- 245
             +DIWS+GCI AEM+   PLFPG S + QL  I  ++                      
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 246 --HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK 290
                 + +  K   E  +DLL+++L L+P++R    Q LEH Y  +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  198 bits (503), Expect = 5e-61
 Identities = 83/315 (26%), Positives = 151/315 (47%), Gaps = 38/315 (12%)

Query: 3   SNTTSKSGDKVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN 62
           ++   +  D   H V+     +Y + +++G+G Y  V++A +  N + V +K +      
Sbjct: 15  THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----K 69

Query: 63  KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILK 121
               ++  REI  L++ +  PNIIT+ DI K   ++   +VFE++ N D  ++   + L 
Sbjct: 70  PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLT 127

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSKECL 180
           D  IR+ M+++   L Y H+  +MHRD+KP N++ID +   +++ D GLA      +E  
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 181 TEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNL 239
              +A+R+++ PE+L+  + Y + +D+WSLGC+LA M+  K P F G     QL  I  +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 240 VRPNPPHADKFYAGFKNKP---------------------------EEAVDLLNQILVLN 272
           +     +        +  P                            EA+D L+++L  +
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 273 PSERPETDQILEHNY 287
              R    + +EH Y
Sbjct: 307 HQSRLTAREAMEHPY 321

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 6e-61
 Identities = 96/290 (33%), Positives = 143/290 (49%), Gaps = 28/290 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYD-KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ-- 80
           +Y     IG+GAYG V+KA D KN  ++VA+K++      +     T RE+  L+  +  
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 81  RHPNIITMLDIYKAVNNKD---LYVVFEYMEND---LNKVIRDKILKDVHIRYIMFQLCN 134
            HPN++ + D+           L +VFE+++ D       + +  +    I+ +MFQL  
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           GL ++H+ +V+HRDLKP NIL+  S  IK+ D GLAR  S      T  + T WYRAPE+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEV 186

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH-------- 246
            +    Y   VD+WS+GCI AEM + KPLF G+S   QL  I++++              
Sbjct: 187 -LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 247 ---------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNY 287
                    A        +  E   DLL + L  NP++R      L H Y
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  191 bits (487), Expect = 3e-59
 Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 16/269 (5%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSFQRHP 83
           Y + + +G G    V+ A D    + VA+K +  +  R+ +   R  RE     +   HP
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 67

Query: 84  NIITMLDIYKAVNNKD--LYVVFEYMENDL--NKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            I+ + D  +A        Y+V EY++     + V  +  +       ++   C  L++ 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE---YIATRWYRAPEILI 196
           H   ++HRD+KP+NI+I  + ++K+ D G+AR+++DS   +T+    I T  Y +PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA- 186

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
                    D++SLGC+L E+L  +P F G S        V      P    +       
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL----- 241

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEH 285
              +   ++ + L  NP  R +T   +  
Sbjct: 242 -SADLDAVVLKALAKNPENRYQTAAEMRA 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 26/269 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           + E  + + IGKG +G V     + NK  VA+K I    +N   AQ    E   +    R
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI----KNDATAQAFLAEASVMTQL-R 58

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK---ILKDVHIRYIMFQLCNGLS 137
           H N++ +L +        LY+V EYM    L   +R +   +L    +      +C  + 
Sbjct: 59  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+     +HRDL   N+L+ +    K+ D GL +  S ++           + APE L  
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEAL-R 173

Query: 198 NRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
            ++++   D+WS G +L E+    +  +P       +  +    + + P           
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------DG 224

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEH 285
            P    +++     L+ + RP   Q+ E 
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 7e-59
 Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 29/278 (10%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKI----FEAFRNKTDAQRTYREILFLKSF 79
           +Y +   +G G +G VY     ++   VAIK +       +    +  R   E++ LK  
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 80  Q-RHPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDK-ILKDVHIRYIMFQLCNG 135
                 +I +LD ++        ++ E  E   DL   I ++  L++   R   +Q+   
Sbjct: 65  SSGFSGVIRLLDWFE--RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 136 LSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEI 194
           + + H C V+HRD+K  NILID +   +K+ D G    L D+    T++  TR Y  PE 
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEW 180

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF 254
           +  +R +     +WSLG +L +M+     F       + Q+                   
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------- 224

Query: 255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF 292
           +    E   L+   L L PS+RP  ++I  H ++    
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 21/276 (7%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF---RNKTDAQRTYREILFLKS 78
           + ++++H+ IG+G +G VY     +  +  A+K + +     +         R +L L S
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-ILKDVHIRYIMFQLCNGL 136
               P I+ M   +       L  + + M   DL+  +    +  +  +R+   ++  GL
Sbjct: 63  TGDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILI 196
            ++H   V++RDLKP+NIL+D+   ++I DLGLA   S  K      + T  Y APE+L 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQ 178

Query: 197 SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
               Y    D +SLGC+L ++L+    F    T  + ++    +       D F      
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------ 232

Query: 257 KPEEAVDLLNQILVLNPSERPET-----DQILEHNY 287
              E   LL  +L  + + R         ++ E  +
Sbjct: 233 -SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 3e-58
 Identities = 113/349 (32%), Positives = 187/349 (53%), Gaps = 43/349 (12%)

Query: 20  NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
            +L  Y   K IG GA GIV  AYD    + VAIKK+   F+N+T A+R YRE++ +K  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 80  QRHPNIITMLDIYKAVN----NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNG 135
             H NII++L+++         +D+Y+V E M+ +L +VI+ ++  +  + Y+++Q+  G
Sbjct: 74  -NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-RMSYLLYQMLCG 131

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEIL 195
           + ++H+  ++HRDLKPSNI++   C++KI D GLAR+   S   +T Y+ TR+YRAPE+ 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEV- 189

Query: 196 ISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LVRPNPPHADKFYAGF 254
           I    Y  +VDIWS+GCI+ EM++ K LFPG     Q   ++  L  P P    K     
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 255 KN-------------------------------KPEEAVDLLNQILVLNPSERPETDQIL 283
           +N                               K  +A DLL+++LV++P++R   D  L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 284 EHNYVSKYFPSATHVIPQVTPHTVVLDIDDNNQLEINDYQDKLYDIVKS 332
           +H Y++ ++  A     +  P  +     D  +  I ++++ +Y  V +
Sbjct: 310 QHPYINVWYDPAE---VEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  189 bits (481), Expect = 8e-58
 Identities = 70/277 (25%), Positives = 131/277 (47%), Gaps = 25/277 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++ I + +G G++G V+    ++N +Y A+K +  E        + T  E L L    
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 61

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEN--DLNKVIRDKILKDVHIRYIMFQLCNGLSY 138
            HP II M   +   + + ++++ +Y+E     + + + +   +   ++   ++C  L Y
Sbjct: 62  THPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H+  +++RDLKP NIL+DK+  IKI D G A+ + D          T  Y APE++ S 
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVV-ST 175

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           + Y   +D WS G ++ EML     F  ++T    + I+N     PP             
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF----------N 225

Query: 259 EEAVDLLNQILVLNPSERPET-----DQILEHNYVSK 290
           E+  DLL++++  + S+R        + +  H +  +
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 9e-58
 Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 22/266 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
              + +R+G G +G V+  Y   + + VA+K +    +          E   +K   +H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK---QGSMSPDAFLAEANLMKQL-QHQ 68

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            ++ +  +      + +Y++ EYMEN    D  K      L    +  +  Q+  G+++I
Sbjct: 69  RLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
                +HRDL+ +NIL+  + S KI D GLAR + D++    E             I+  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 200 RYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
            +T   D+WS G +L E++   +  +PG +    +Q +    R   P          N P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---------DNCP 236

Query: 259 EEAVDLLNQILVLNPSERPETDQILE 284
           EE   L+       P +RP  D +  
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRS 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 65/279 (23%), Positives = 116/279 (41%), Gaps = 26/279 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
              +  ++G+G +G V+        + VAIK +          +   +E   +K   RH 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHE 72

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYI 139
            ++ +  +    + + +Y+V EYM      D  K    K L+   +  +  Q+ +G++Y+
Sbjct: 73  KLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-YIATRWYRAPEILISN 198
                +HRDL+ +NIL+ ++   K+ D GLAR + D++    +       + APE     
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALY 188

Query: 199 RRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK 257
            R+T   D+WS G +L E+    +  +PG      L  +    R   P            
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------PEC 239

Query: 258 PEEAVDLLNQILVLNPSERPETDQILE--HNYVSKYFPS 294
           PE   DL+ Q     P ERP  + +     +Y +   P 
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 22/274 (8%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           + ++   K +GKG +G V    +K   +Y A+K +  E    K +   T  E   L++  
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMEND--LNKVIRDKILKDVHIRYIMFQLCNGLSY 138
           RHP +  +   +    +  L  V EY         + R+++  +   R+   ++ + L Y
Sbjct: 63  RHPFLTALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISN 198
           +H+  V++RD+K  N+++DK   IKI D GL +        +  +  T  Y APE+L  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-ED 179

Query: 199 RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
             Y   VD W LG ++ EM+  +  F         +LI+      P              
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL----------S 229

Query: 259 EEAVDLLNQILVLNPSERPET-----DQILEHNY 287
            EA  LL  +L  +P +R         +++EH +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-55
 Identities = 51/267 (19%), Positives = 101/267 (37%), Gaps = 22/267 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + T  K +G G +G+V     +     VAIK I E             E   + +   H 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKE---GSMSEDEFIEEAKVMMNL-SHE 59

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
            ++ +  +      + ++++ EYM N              +   +  +   +C  + Y+ 
Sbjct: 60  KLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-CLTEYIATRWYRAPEILISNR 199
           + + +HRDL   N L++    +K+ D GL+R + D +            +  PE+L    
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-MYS 176

Query: 200 RYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           +++   DIW+ G ++ E+    K  +   + S   + I   +R   PH            
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---------LAS 227

Query: 259 EEAVDLLNQILVLNPSERPETDQILEH 285
           E+   ++         ERP    +L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 62/267 (23%), Positives = 114/267 (42%), Gaps = 22/267 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           E T  + IG G +G+V+  Y  N  + VAIK I E        +    E   +     HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIRE---GAMSEEDFIEEAEVMMKL-SHP 60

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKILKDV--HIRYIMFQLCNGLSYIH 140
            ++ +  +   +    + +VFE+ME+  L+  +R +        +  +   +C G++Y+ 
Sbjct: 61  KLVQLYGVC--LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA-TRWYRAPEILISNR 199
              V+HRDL   N L+ ++  IK+ D G+ R + D +   +        + +PE+  S  
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFS 177

Query: 200 RYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           RY+   D+WS G ++ E+  + K  +   S S  ++ I    R   P         +   
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------RLAS 228

Query: 259 EEAVDLLNQILVLNPSERPETDQILEH 285
                ++N      P +RP   ++L  
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-54
 Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 22/265 (8%)

Query: 29  KRIGKGAYGIVYKAYDKNNK--QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII 86
           K +G G +G V K Y +  K  + VA+K +     +         E   ++    +P I+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIV 71

Query: 87  TMLDIYKAVNNKDLYVVFEYMEN-DLNKVI-RDKILKDVHIRYIMFQLCNGLSYIHACKV 144
            M+ I +    +   +V E  E   LNK + +++ +KD +I  ++ Q+  G+ Y+     
Sbjct: 72  RMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 145 MHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYRAPEILISNRRY 201
           +HRDL   N+L+      KI D GL+++L   +      T       + APE + +  ++
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-NYYKF 187

Query: 202 THHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           +   D+WS G ++ E     +  + G   S    ++    R   P            P E
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---------AGCPRE 238

Query: 261 AVDLLNQILVLNPSERPETDQILEH 285
             DL+N     +   RP    +   
Sbjct: 239 MYDLMNLCWTYDVENRPGFAAVELR 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-54
 Identities = 61/296 (20%), Positives = 106/296 (35%), Gaps = 47/296 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQ-----YVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                K +G GA+G V  A      +      VA+K + E   + ++ +    E+  +  
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQ 96

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK------------------- 118
              H NI+ +L       +  +Y++FEY    DL   +R K                   
Sbjct: 97  LGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 119 -----ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL 173
                +L    +    +Q+  G+ ++     +HRDL   N+L+     +KI D GLAR +
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 174 SDSKECLTEYIA--TRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTS 230
                 +    A     + APE L     YT   D+WS G +L E+       +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 231 HQLQLIV-NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                ++ N  + + P             EE   ++      +  +RP    +   
Sbjct: 274 ANFYKLIQNGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 3e-54
 Identities = 56/266 (21%), Positives = 112/266 (42%), Gaps = 20/266 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP 83
           + T+  ++G G YG VY+   K     VA+K + E   +  + +   +E   +K   +HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI-KHP 73

Query: 84  NIITMLDIYKAVNNKDLYVVFEYMENDLNKVI----RDKILKDVHIRYIMFQLCNGLSYI 139
           N++ +L +         Y++ E+M              + +  V + Y+  Q+ + + Y+
Sbjct: 74  NLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 140 HACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNR 199
                +HRDL   N L+ ++  +K+ D GL+R ++                     ++  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 200 RYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP 258
           +++   D+W+ G +L E+       +PG   S   +L+    R   P         +  P
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------EGCP 242

Query: 259 EEAVDLLNQILVLNPSERPETDQILE 284
           E+  +L+      NPS+RP   +I +
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 51/272 (18%), Positives = 102/272 (37%), Gaps = 22/272 (8%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKI-FEAFRNKTDAQRTYREILFLKSF 79
           +  + +++G G++G+V +            VA+K +  +            RE+  + S 
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMEN---DLNKVIRDKILKDVHIRYIMFQLCNGL 136
             H N+I +  +        + +V E                      +     Q+  G+
Sbjct: 69  -DHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEI 194
            Y+ + + +HRDL   N+L+     +KIGD GL R+L  + +   + E+    +      
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 195 LISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAG 253
            +  R ++H  D W  G  L EM    +  + G + S  L  I       P         
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP------- 237

Query: 254 FKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            ++ P++  +++ Q     P +RP    + + 
Sbjct: 238 -EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  175 bits (445), Expect = 9e-53
 Identities = 49/280 (17%), Positives = 97/280 (34%), Gaps = 24/280 (8%)

Query: 20  NILAE-YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           N++   Y + +RIG+G++G++++  +  N Q VAIK        ++DA +   E    K 
Sbjct: 1   NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKL 56

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGL 136
                 I  +    +        +V + +   L  ++    +      +     Q+   +
Sbjct: 57  LAGCTGIPNVYYFGQ--EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 137 SYIHACKVMHRDLKPSNILIDKSC-----SIKIGDLGLARSLSDSKE-------CLTEYI 184
             IH   +++RD+KP N LI +        I + D G+ +   D                
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNP 244
            T  Y +       R  +   D+ +LG +    L+    + G   +   Q    +     
Sbjct: 175 GTARYMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 245 PHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
               +        PEE    ++    L     P+ D +  
Sbjct: 234 STPLREL--CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (445), Expect = 9e-53
 Identities = 57/284 (20%), Positives = 99/284 (34%), Gaps = 24/284 (8%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
           Y + ++IG G++G +Y   D    + VAIK        KT   + + E    K  Q    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVG 64

Query: 85  IITMLDIYKAVNNKDLYVVFEYMENDLNKVI--RDKILKDVHIRYIMFQLCNGLSYIHAC 142
           I T+             +V E +   L  +     +      +  +  Q+ + + YIH+ 
Sbjct: 65  IPTIRWCG--AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 143 KVMHRDLKPSNILI---DKSCSIKIGDLGLARSLSDSKE-------CLTEYIATRWYRAP 192
             +HRD+KP N L+    K   + I D GLA+   D++               T  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
                    +   D+ SLG +L         + G   + + Q    +         +   
Sbjct: 183 NT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL- 240

Query: 253 GFKNKPEEAVDLLNQILVLNPSERP---ETDQILEHNYVSKYFP 293
             K  P E    LN    L   ++P      Q+  + +  + F 
Sbjct: 241 -CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (440), Expect = 6e-52
 Identities = 61/276 (22%), Positives = 111/276 (40%), Gaps = 26/276 (9%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           ++   I + IG G +G V   + K   +   +VAIK +   +  K   +    E   +  
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQ 83

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNG 135
           F  HPN+I +  +     +  + ++ E+MEN          D     + +  ++  +  G
Sbjct: 84  F-DHPNVIHLEGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 136 LSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTE-----YIATRWYR 190
           + Y+     +HRDL   NIL++ +   K+ D GL+R L D     T            + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 191 APEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADK 249
           APE  I  R++T   D+WS G ++ E++   +  +   +    +  I    R  PP    
Sbjct: 201 APEA-IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP---- 255

Query: 250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
                 + P     L+      + + RP+  QI+  
Sbjct: 256 -----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 27/271 (9%)

Query: 31  IGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITM 88
           +G G +G V +   +    +  VAIK + +    K D +   RE   +     +P I+ +
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL-DNPYIVRL 74

Query: 89  LDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVM 145
           + + +A     L +V E      L+K +  K   +   ++  ++ Q+  G+ Y+     +
Sbjct: 75  IGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 146 HRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIA---TRWYRAPEILISNRRYT 202
           HRDL   N+L+      KI D GL+++L       T   A      + APE + + R+++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFS 190

Query: 203 HHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEA 261
              D+WS G  + E L   +  +        +  I    R   P            P E 
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---------PECPPEL 241

Query: 262 VDLLNQILVLNPSERP---ETDQILEHNYVS 289
             L++   +    +RP     +Q +   Y S
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 3e-51
 Identities = 56/269 (20%), Positives = 107/269 (39%), Gaps = 21/269 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQY---VAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
              + + IG+G +G V++    + +     VAIK       +    ++  +E L ++ F 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQF- 65

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKI---LKDVHIRYIMFQLCNGLS 137
            HP+I+ ++ +        ++++ E       +         L    +    +QL   L+
Sbjct: 66  DHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 138 YIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILIS 197
           Y+ + + +HRD+   N+L+  +  +K+GD GL+R + DS                   I+
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 198 NRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN 256
            RR+T   D+W  G  + E+L      F G   +  +  I N  R   P          N
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---------PN 233

Query: 257 KPEEAVDLLNQILVLNPSERPETDQILEH 285
            P     L+ +    +PS RP   ++   
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 35/283 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNN--KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQR 81
           +      IG+G +G V KA  K +  +   AIK++ E + +K D +    E+  L     
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGH 69

Query: 82  HPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDKI-----------------LKDV 123
           HPNII +L   +  +   LY+  EY  + +L   +R                    L   
Sbjct: 70  HPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 124 HIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEY 183
            + +    +  G+ Y+   + +HRDL   NIL+ ++   KI D GL+R   +     T  
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 186

Query: 184 IATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRP 242
                + A E L +   YT + D+WS G +L E++      + G + +   + +    R 
Sbjct: 187 RLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245

Query: 243 NPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
             P          N  +E  DL+ Q     P ERP   QIL  
Sbjct: 246 EKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 25/272 (9%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNN----KQYVAIKKIFEAFRNKTDAQRTYREILFLKSF 79
             T  K IG G +G VYK   K +    +  VAIK +   +  K        E   +  F
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQF 66

Query: 80  QRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHIRYIMFQLCNGL 136
             H NII +  +      K + ++ EYMEN         +D     + +  ++  +  G+
Sbjct: 67  -SHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 137 SYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLTEYIATRWYRAPE 193
            Y+     +HRDL   NIL++ +   K+ D GL+R L D  E     +       + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 194 ILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQL-QLIVNLVRPNPPHADKFYA 252
             IS R++T   D+WS G ++ E++          ++H++ + I +  R   P       
Sbjct: 184 A-ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP------- 235

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
              + P     L+ Q      + RP+   I+ 
Sbjct: 236 --MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (434), Expect = 2e-50
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 21/275 (7%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIF-EAFRNKTDAQRTYREILFLKSFQ 80
           L ++   K +G G++G V     K +  + A+K +  +        + T  E   L++  
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV- 98

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
             P ++ +   +K  +N  + + +       + + R     + H R+   Q+     Y+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRR 200
           +  +++RDLKP N+LID+   I++ D G A+ +            T    APEI+  ++ 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEII-LSKG 214

Query: 201 YTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE 260
           Y   VD W+LG ++ EM    P F         + IV+     P H             +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF----------SSD 264

Query: 261 AVDLLNQILVLNPSERPET-----DQILEHNYVSK 290
             DLL  +L ++ ++R        + I  H + + 
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 4e-50
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 41/290 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDK-------NNKQYVAIKKIFEAFRNKTDAQRTYREILFL 76
              + K +G+GA+G V  A          N    VA+K +      K D      E+  +
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMM 72

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIR-----------------DK 118
           K   +H NII +L       +  LYV+ EY    +L + ++                 ++
Sbjct: 73  KMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 119 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
            L    +    +Q+  G+ Y+ + K +HRDL   N+L+ +   +KI D GLAR +     
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 179 CLT--EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQL 235
                       + APE L  +R YTH  D+WS G +L E+       +PG       +L
Sbjct: 191 YKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           +    R + P          N   E   ++       PS+RP   Q++E 
Sbjct: 250 LKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-50
 Identities = 53/270 (19%), Positives = 104/270 (38%), Gaps = 21/270 (7%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIK---KIFEAFRNKTDAQRTYREILFLKSFQ 80
           E+   K +G GA+G VYK       + V I    K      +    +    E   + S  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV- 68

Query: 81  RHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKD--VHIRYIMFQLCNGLSY 138
            +P++  +L I   + +    +        L   +R+        ++     Q+  G++Y
Sbjct: 69  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 139 IHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIATRWYRAPEILI 196
           +   +++HRDL   N+L+     +KI D GLA+ L   + +           + A E  I
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-I 185

Query: 197 SNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK 255
            +R YTH  D+WS G  + E++      + G   S    ++    R   P          
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---------P 236

Query: 256 NKPEEAVDLLNQILVLNPSERPETDQILEH 285
               +   ++ +  +++   RP+  +++  
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (426), Expect = 8e-50
 Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 46/294 (15%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
                + IG+GA+G V++A             VA+K + E            RE   +  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAE 72

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK------------------- 118
           F  +PNI+ +L +      K + ++FEYM   DLN+ +R                     
Sbjct: 73  F-DNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 119 ------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS 172
                  L       I  Q+  G++Y+   K +HRDL   N L+ ++  +KI D GL+R+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 173 L-SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTS 230
           + S          A      P   I   RYT   D+W+ G +L E+       + G +  
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 231 HQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
             +  + +      P         +N P E  +L+       P++RP    I  
Sbjct: 250 EVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 7e-49
 Identities = 62/285 (21%), Positives = 120/285 (42%), Gaps = 24/285 (8%)

Query: 12  KVQHNVDGNILAEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQR 68
            VQH V G        ++ IG+G +G VY     +N   K + A+K +     +  +  +
Sbjct: 16  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ 74

Query: 69  TYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVI---RDKILKDVHI 125
              E + +K F  HPN++++L I    +     VV  YM++   +              +
Sbjct: 75  FLTEGIIMKDF-SHPNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132

Query: 126 RYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLT 181
                Q+  G+ ++ + K +HRDL   N ++D+  ++K+ D GLAR + D +       T
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192

Query: 182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEML-QSKPLFPGASTSHQLQLIVNLV 240
                  + A E L   +++T   D+WS G +L E++ +  P +P  +T      ++   
Sbjct: 193 GAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251

Query: 241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
           R   P         +  P+   +++ +        RP   +++  
Sbjct: 252 RLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 52/284 (18%), Positives = 119/284 (41%), Gaps = 22/284 (7%)

Query: 22  LAEYTIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEA--FRNKTDAQRTYREILFL 76
           +  + + K +G GAYG V+     +     +  A+K + +A   +     + T  E   L
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 77  KSFQRHPNIITMLDIYKAVNNKDLYVVFEYME-NDLNKVIRDKI-LKDVHIRYIMFQLCN 134
           +  ++ P ++T+   ++      L+++ +Y+   +L   +  +    +  ++  + ++  
Sbjct: 83  EHIRQSPFLVTLHYAFQ--TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 135 GLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD--SKECLTEYIATRWYRAP 192
            L ++H   +++RD+K  NIL+D +  + + D GL++      ++          +    
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 193 EILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA 252
            +   +  +   VD WSLG ++ E+L     F      +    I   +  + P   +   
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM- 259

Query: 253 GFKNKPEEAVDLLNQILVLNPSERPET-----DQILEHNYVSKY 291
                   A DL+ ++L+ +P +R        D+I EH +  K 
Sbjct: 260 -----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 42/290 (14%)

Query: 24  EYTIHKRIGKGAYGIVYKAYD-----KNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
             +  K +G GA+G V +A        +    VA+K + +   + T+ +    E+  L  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSY 82

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK------------------- 118
              H NI+ +L            V+ EY    DL   +R K                   
Sbjct: 83  LGNHMNIVNLLGAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 119 ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE 178
            L    +    +Q+  G++++ +   +HRDL   NIL+      KI D GLAR + +   
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 179 --CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQL 235
                       + APE  I N  YT   D+WS G  L E+       +PG     +   
Sbjct: 201 YVVKGNARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 236 IV-NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE 284
           ++    R   P         ++ P E  D++      +P +RP   QI++
Sbjct: 260 MIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-48
 Identities = 57/297 (19%), Positives = 111/297 (37%), Gaps = 40/297 (13%)

Query: 21  ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ 80
           I     + + IGKG +G V++   +   + VA+K       +  + +  +RE    ++  
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIF-----SSREERSWFREAEIYQTVM 53

Query: 81  -RHPNIITMLDIYKAVNN--KDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGL 136
            RH NI+  +      N     L++V +Y E+  L   +    +    +  +     +GL
Sbjct: 54  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113

Query: 137 SYIHAC--------KVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE----CLTEYI 184
           +++H           + HRDLK  NIL+ K+ +  I DLGLA     + +         +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 185 ATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNL 239
            T+ Y APE+L       +       DI+++G +  E+ +   +             +  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 240 VRPNPPHADKFYAGFKNKP------------EEAVDLLNQILVLNPSERPETDQILE 284
             P+     K     K +P                 ++ +    N + R    +I +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-47
 Identities = 61/282 (21%), Positives = 123/282 (43%), Gaps = 34/282 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
           + T+ + +G+G++G+VY+   K       +  VAIK + EA   + +      E   +K 
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKE 79

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-----------ILKDVHIR 126
           F    +++ +L +      +   V+ E M   DL   +R                   + 
Sbjct: 80  F-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 127 YIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL--SDSKECLTEYI 184
            +  ++ +G++Y++A K +HRDL   N ++ +  ++KIGD G+ R +  +D      + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 185 ATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPN 243
               + +PE L  +  +T + D+WS G +L E+   ++  + G S    L+ ++     +
Sbjct: 197 LPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255

Query: 244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
            P          N P+   +L+      NP  RP   +I+  
Sbjct: 256 KP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 7e-46
 Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 37/288 (12%)

Query: 24  EYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKS 78
              + K +G+GA+G V +A           + VA+K + E   +  + +    E+  L  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIH 72

Query: 79  FQRHPNIITMLDIYKAVNNKDLYVVFEYMENDLNKVIRDK-----------------ILK 121
              H N++ +L          + +V      +L+  +R K                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 122 DVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE--C 179
             H+    FQ+  G+ ++ + K +HRDL   NIL+ +   +KI D GLAR +    +   
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL-QLIV 237
             +      + APE  I +R YT   D+WS G +L E+       +PG     +  + + 
Sbjct: 193 KGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 238 NLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH 285
              R   P              E    +       PS+RP   +++EH
Sbjct: 252 EGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (383), Expect = 5e-43
 Identities = 73/347 (21%), Positives = 132/347 (38%), Gaps = 67/347 (19%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ---- 80
           Y + +++G G +  V+ A D  N  +VA+K +     +K   +    EI  L+       
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 71

Query: 81  ------RHPNIITMLDIYKAVNNKDLYVVFEYMEN-----DLNKVIRDKILKDVHIRYIM 129
                    +I+ +LD +       ++VV  +         L K    + +  ++++ I 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 130 FQLCNGLSYI-HACKVMHRDLKPSNILIDKS------CSIKIGDLGLARSLSDSKECLTE 182
            QL  GL Y+   C ++H D+KP N+L++          IKI DLG A    +       
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188

Query: 183 YIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS------HQLQLI 236
            I TR YR+PE+L     +    DIWS  C++ E++    LF              +  I
Sbjct: 189 SIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 237 VNLVRPNPPHADKF--------------------------------YAGFKNKPEEAVDL 264
           + L+   P +  +                                 Y   K++ +E  D 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 265 LNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDI 311
           L+ +L L+P +R +   ++ H ++          +P    +    DI
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.3 bits (244), Expect = 8e-25
 Identities = 26/200 (13%), Positives = 63/200 (31%), Gaps = 18/200 (9%)

Query: 25  YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPN 84
             I K +G+G    V+  Y +   +   +K       +    +          S     +
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 85  IITMLDIYKAVNNKDLYVVFEYMEN----DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH 140
                   + +    +  V+ +  N    +L        ++  +   ++  +   ++  +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 141 ACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS--DSKECLTEYIA--TRWYRAPEILI 196
              ++H DL   N+L+ +   I I D   +  +     +E L   +     ++       
Sbjct: 121 HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS------ 173

Query: 197 SNRRYTHHVDIWSLGCILAE 216
             R Y    DI S    + +
Sbjct: 174 --RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	404
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.36
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.5
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.41
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.03

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-62  Score=454.46  Aligned_cols=258  Identities=28%  Similarity=0.507  Sum_probs=227.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      +..++|++++.||+|+||+||+|.++.+|+.||||++.....  ...+.+.+|+.+++.+. ||||++++++|.  +...
T Consensus        17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~   91 (293)
T d1yhwa1          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK-NPNIVNYLDSYL--VGDE   91 (293)
T ss_dssp             CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTE
T ss_pred             CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCC-CCCEeeEeEEEE--ECCE
Confidence            345689999999999999999999999999999999865433  33467889999999997 999999999998  4678


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|||||||.| +|.+++..+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999985 899999888999999999999999999999999999999999999999999999999999998765555


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.....+....       ...+|
T Consensus       172 ~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~s  243 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------PEKLS  243 (293)
T ss_dssp             CBCCCCSCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSS-------GGGSC
T ss_pred             cccccccCCCccChhhh-cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------cccCC
Confidence            56677899999999998 46678999999999999999999999999988877776666554433221       14578


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-62  Score=448.66  Aligned_cols=256  Identities=30%  Similarity=0.514  Sum_probs=213.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..........+.+.+|+.+++++. ||||+++++++.+.....+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            46899999999999999999999999999999999877777777888899999999997 99999999998755567899


Q ss_pred             EEEeccCC-cHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcEEEccCCceEEeccccc
Q psy14434        102 VVFEYMEN-DLNKVIRD-----KILKDVHIRYIMFQLCNGLSYIHACK-----VMHRDLKPSNILIDKSCSIKIGDLGLA  170 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-----~~l~~~~~~~i~~qil~al~~LH~~~-----i~HrDlkp~NIll~~~~~vkl~Dfg~a  170 (404)
                      ||||||++ +|.+++..     +.+++..++.++.||+.||+|||+.|     |+||||||+|||++.+|.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999985 89988852     46999999999999999999999876     999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        171 RSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       171 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      +............+||+.|||||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.+...+..+     
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~-----  235 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-----  235 (269)
T ss_dssp             HHC-----------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC-----
T ss_pred             eecccCCCccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence            9876655555678899999999998 5677999999999999999999999999998888777777665433222     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                          ..+|+++.+||.+||+.||.+|||++++|+|||+
T Consensus       236 ----~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 ----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                4578999999999999999999999999999995

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-62  Score=449.84  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=216.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.++++++ ||||+++++++.  +...+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~--~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCC-CCCEeeEeeeec--cCceeE
Confidence            5789999999999999999999999999999999865422 223456789999999997 999999999987  577899


Q ss_pred             EEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC--C
Q psy14434        102 VVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--K  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~--~  177 (404)
                      ||||||.| +|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  .
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999985 89888864 56999999999999999999999999999999999999999999999999999876432  2


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......+||+.|||||++.+...++.++|||||||++|+|++|++||.+..................       ..+..+
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~  232 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------NPWKKI  232 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------TTGGGS
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------CccccC
Confidence            3345678999999999986555567899999999999999999999987655433333322222111       112567


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      |+++.+||.+||+.||.+|||++++|+||||++..
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            89999999999999999999999999999998644

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-62  Score=443.88  Aligned_cols=253  Identities=30%  Similarity=0.529  Sum_probs=221.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++.+.||+|+||+||+|+++.+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++.  +...+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DATRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEE--ECCEE
Confidence            4689999999999999999999999999999999975532 2334566789999999996 999999999987  57789


Q ss_pred             EEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+|||||+ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......  
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            99999999 589988874 67999999999999999999999999999999999999999999999999999876543  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+||+.|||||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.+.....+          ..+|
T Consensus       160 ~~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s  228 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----------DFVT  228 (263)
T ss_dssp             CCEETTEEGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------TTSC
T ss_pred             cccccCCCCcccCHHHH-cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------ccCC
Confidence            33567899999999998 466789999999999999999999999999888777766655432222          3468


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        259 EEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      +++.+||.+||+.||.+|||++++|+||||+.
T Consensus       229 ~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         229 EGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999999999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-61  Score=444.96  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=222.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      -+.|++++.||+|+||+||+|+++.+|+.||+|++...  .....+.+.+|+.+|++++ ||||+++++++.  +...+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCD-HPNIVKLLDAFY--YENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCCeEE
Confidence            35799999999999999999999999999999998643  3445567889999999997 999999999987  567899


Q ss_pred             EEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +|||||.| +|..++.+  +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999985 88888753  5699999999999999999999999999999999999999999999999999976544333


Q ss_pred             cccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        179 CLTEYIATRWYRAPEILI----SNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .....+||+.|||||++.    ....|+.++|||||||++|+|++|++||.+.+....+..+.....+....       .
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------~  238 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-------P  238 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS-------G
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc-------c
Confidence            345678999999999974    24568999999999999999999999999988877777766554322221       2


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            457899999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-61  Score=442.52  Aligned_cols=259  Identities=25%  Similarity=0.462  Sum_probs=221.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+.+++++. ||||++++++|.  +...+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~~   83 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEKL   83 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEE--CSSEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEE--ECCEE
Confidence            367999999999999999999999999999999997543 23345567889999999997 999999999987  57789


Q ss_pred             EEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC--
Q psy14434        101 YVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--  176 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~--  176 (404)
                      |+|||||+| +|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.+...  
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999995 8988876 567999999999999999999999999999999999999999999999999999876532  


Q ss_pred             CCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        177 KECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      .....+.+||+.|||||++ .+..++.++|||||||++|+|++|..||.+.+.......+.+.....+          ..
T Consensus       164 ~~~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----------~~  232 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----------EK  232 (288)
T ss_dssp             ------CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----------TT
T ss_pred             ccccccccCCccccCceee-ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----------cc
Confidence            2233457899999999998 566789999999999999999999999999888777777665432221          35


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHH------HHhccCCCCcCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQ------ILEHNYVSKYFPS  294 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~------ll~hp~~~~~~~~  294 (404)
                      +++++.+||.+||+.||.+|||++|      +++||||+...+.
T Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence            7899999999999999999999987      5889999987544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-60  Score=447.52  Aligned_cols=257  Identities=25%  Similarity=0.447  Sum_probs=227.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.+. ||||++++++|.  +...+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSSEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeec--ccccc
Confidence            5689999999999999999999999999999999976532 3345677889999999997 999999999998  57789


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+|||||.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999995 88888874 6799999999999999999999999999999999999999999999999999997765555


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+.......+.......+          ..+|
T Consensus       161 ~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----------~~~s  229 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----------RTLS  229 (337)
T ss_dssp             CBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TTSC
T ss_pred             ccccceeCHHHhhhhhc-cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----------ccCC
Confidence            66778999999999998 566789999999999999999999999999988877776665433222          4579


Q ss_pred             HHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~  292 (404)
                      +++.+||.+||++||.+|++     ++++++||||....
T Consensus       230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence            99999999999999999994     89999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-60  Score=431.62  Aligned_cols=252  Identities=29%  Similarity=0.442  Sum_probs=214.8

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec--cCCeEEE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV--NNKDLYV  102 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~--~~~~~~l  102 (404)
                      |++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.+|++++ ||||++++++|...  ....+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEE
Confidence            47888999999999999999999999999999877667777888899999999997 99999999998743  3467899


Q ss_pred             EEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc-cCCceEEeccccccccCCCC
Q psy14434        103 VFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACK--VMHRDLKPSNILID-KSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       103 v~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~--i~HrDlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      |||||++ +|.+++.. +.+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+....  
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence            9999985 89988864 57999999999999999999999999  99999999999997 478999999999986543  


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQ-LIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                      ....+.+||+.|||||++. + .++.++|||||||++|+|++|+.||.+......+. .+.....  +..      ....
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~-~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~------~~~~  237 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PAS------FDKV  237 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGG------GGGC
T ss_pred             CccCCcccCccccCHHHhC-C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--Ccc------cCcc
Confidence            2345678999999999983 3 58999999999999999999999998766554433 3322211  111      1245


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCC
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVS  289 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~  289 (404)
                      +++++.+||.+||+.||++|||++|+|+||||+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            689999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-60  Score=444.13  Aligned_cols=259  Identities=27%  Similarity=0.472  Sum_probs=208.0

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++.++|++.+.||+|+||+||+|.++.+|+.||||++.+..... ....+.+|+.+|+.+. ||||++++++|.  ++..
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~   81 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIK-HPNIVALDDIYE--SGGH   81 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCC-CTTBCCEEEEEE--CSSE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence            46678999999999999999999999999999999996543322 2355678999999996 999999999987  5788


Q ss_pred             EEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---cCCceEEeccccccccC
Q psy14434        100 LYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID---KSCSIKIGDLGLARSLS  174 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~---~~~~vkl~Dfg~a~~~~  174 (404)
                      +|||||||+ |+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999998 599998864 5799999999999999999999999999999999999995   57899999999998665


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ....+.+||+.|||||++ .+..|+.++|||||||++|+|++|.+||.+.........+.......+.      ...
T Consensus       162 ~~-~~~~~~~GT~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~  233 (307)
T d1a06a_         162 PG-SVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------PYW  233 (307)
T ss_dssp             ------------CTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT------TTT
T ss_pred             CC-CeeeeeeeCccccCcHHH-cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC------ccc
Confidence            43 334567899999999998 4667899999999999999999999999998888777777665443222      123


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                      ..+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus       234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            567999999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.1e-60  Score=447.87  Aligned_cols=263  Identities=23%  Similarity=0.465  Sum_probs=229.4

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.++++|++++.||+|+||.||+|.++.+|+.||||++...  .......+.+|+.+|++++ ||||++++++|.  +.
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~   95 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DD   95 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--ET
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--EC
Confidence            357889999999999999999999999999999999999643  3445677889999999997 999999999987  57


Q ss_pred             CeEEEEEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc--CCceEEeccccccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK--SCSIKIGDLGLARS  172 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~--~~~vkl~Dfg~a~~  172 (404)
                      ..+|||||||. |+|.+.+.  .+.+++..++.++.||+.||+|||++||+||||||+|||++.  +|.+||+|||+++.
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            78999999998 58999885  356999999999999999999999999999999999999964  58899999999987


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .... ......+||+.|||||++ .+..++.++|||||||++|+|++|+.||.+.+....+..+.......+.      .
T Consensus       176 ~~~~-~~~~~~~gT~~Y~aPEv~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~  247 (350)
T d1koaa2         176 LDPK-QSVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------S  247 (350)
T ss_dssp             CCTT-SCEEEECSCTTTCCHHHH-HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC------G
T ss_pred             cccc-cccceecCcccccCHHHH-cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------c
Confidence            7643 334567899999999998 4667899999999999999999999999998888888877765543322      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                      .+..+|+++.+||.+||+.||.+|||++++|+||||+....
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            23567999999999999999999999999999999987543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-59  Score=446.31  Aligned_cols=262  Identities=26%  Similarity=0.448  Sum_probs=228.9

Q ss_pred             cccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         18 DGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        18 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.+.++|++++.||+|+||+||+|.+..+|+.||||++...  .......+.+|+.+|+++. ||||++++++|.  ++
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~   98 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DK   98 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CS
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--EC
Confidence            466788999999999999999999999999999999998653  2344567789999999996 999999999997  57


Q ss_pred             CeEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--cCCceEEeccccccc
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILID--KSCSIKIGDLGLARS  172 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~--~~~~vkl~Dfg~a~~  172 (404)
                      ..+|||||||+ |+|.+.+..  ..+++.+++.++.||+.||+|||++||+||||||+||||+  .++.+||+|||+|..
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence            88999999999 589887753  3599999999999999999999999999999999999997  578999999999988


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      .... ......+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+.+....+..+.......+.      .
T Consensus       179 ~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------~  250 (352)
T d1koba_         179 LNPD-EIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------D  250 (352)
T ss_dssp             CCTT-SCEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------S
T ss_pred             cCCC-CceeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------c
Confidence            7653 334567899999999998 5677999999999999999999999999999888888877765543332      1


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                      .+..+|+++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            2356799999999999999999999999999999998743

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=437.48  Aligned_cols=268  Identities=37%  Similarity=0.636  Sum_probs=227.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++++. ||||++++++|.  +...+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~--~~~~~~   77 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKLY   77 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccc--ccccee
Confidence            36899999999999999999999999999999999765544455677889999999997 999999999998  577899


Q ss_pred             EEEeccCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      +||||+.+++...+.   .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            999999987666654   34599999999999999999999999999999999999999999999999999988766656


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------------  246 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  246 (404)
                      .....+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+..........            
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            66677899999999998666777999999999999999999999999998888877776655432211            


Q ss_pred             -------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 -------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 -------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                             ...+......+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                   1111223346789999999999999999999999999999998764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-59  Score=443.82  Aligned_cols=303  Identities=35%  Similarity=0.665  Sum_probs=244.0

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--   96 (404)
                      +.+.++|++++.||+|+||+||+|.++.+|+.||||++.+...+......+.+|+.+|+++. ||||++++++|...+  
T Consensus        14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence            44778999999999999999999999999999999999877777777888999999999996 999999999986322  


Q ss_pred             --CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         97 --NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        97 --~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                        ...+|+|||||+++|..+++.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        93 ~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence              236799999998899999988899999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---------  245 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  245 (404)
                      ..   .+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.......+.         
T Consensus       173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            32   356789999999999876677899999999999999999999999999888777776665543221         


Q ss_pred             ------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCC
Q psy14434        246 ------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD  313 (404)
Q Consensus       246 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (404)
                                  ....+.....++++++.+||.+||..||.+|||+.++|+||||+........   +..+ ....+. +
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~---~~~~-~~~~~~-~  324 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE---PQVQ-KYDDSF-D  324 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---------CCC-CCCCC---
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc---ccCC-CCCCch-h
Confidence                        1222334456789999999999999999999999999999999987654431   1111 111122 2


Q ss_pred             CCcCCHHHHHHHHHHHH
Q psy14434        314 NNQLEINDYQDKLYDIV  330 (404)
Q Consensus       314 ~~~~~~~~~~~~~~~~~  330 (404)
                      ....+.+++++.+++++
T Consensus       325 ~~~~~~~e~k~~~~~e~  341 (346)
T d1cm8a_         325 DVDRTLDEWKRVTYKEV  341 (346)
T ss_dssp             ---CCHHHHHHHHHHHH
T ss_pred             hhhcCHHHHHHHHHHHh
Confidence            33467889998888877

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=438.66  Aligned_cols=262  Identities=37%  Similarity=0.662  Sum_probs=219.9

Q ss_pred             EeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh---hHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEE
Q psy14434         27 IHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK---TDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVV  103 (404)
Q Consensus        27 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv  103 (404)
                      .++.||+|+||+||+|.++.+|+.||||++.......   .....+.+|+.+++++. ||||++++++|.  ++..+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~--~~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG--HKSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC--CTTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeec--cCCceeeh
Confidence            4688999999999999999999999999996543322   22356789999999997 999999999987  56779999


Q ss_pred             EeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCccc
Q psy14434        104 FEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKECLT  181 (404)
Q Consensus       104 ~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~  181 (404)
                      ||||.+++...+.  .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence            9999986555444  34699999999999999999999999999999999999999999999999999987766555556


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC---------------
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH---------------  246 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  246 (404)
                      ..+||+.|+|||++.....|+.++|||||||++|+|++|.+||.+.+..+++..+.+..+.....               
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            67899999999998767778999999999999999999999999999999888888766532211               


Q ss_pred             ---cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        247 ---ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       247 ---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                         ...+...++.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence               011122335678999999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-59  Score=437.73  Aligned_cols=255  Identities=28%  Similarity=0.483  Sum_probs=219.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC-hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN-KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      .+.|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|+++. ||||++++++|.  +...+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~   90 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL--REHTA   90 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEE--ECCEE
Confidence            34699999999999999999999999999999999765433 345567889999999997 999999999987  46789


Q ss_pred             EEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+|||||.+ +|..++. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....   
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999996 4554443 56799999999999999999999999999999999999999999999999999986543   


Q ss_pred             ccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        179 CLTEYIATRWYRAPEILIS--NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                       ....+||+.|||||++.+  ...|+.++|||||||++|+|++|..||.+......+..+.....+...        ...
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------~~~  238 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------SGH  238 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--------CTT
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--------CCC
Confidence             245679999999999853  346899999999999999999999999988887777666655443222        145


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +|+++.+||.+||+.||.+|||++++|+||||...
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            68999999999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-59  Score=434.37  Aligned_cols=261  Identities=26%  Similarity=0.433  Sum_probs=225.5

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----hhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      ++.++|++.+.||+|+||+||+|+++.+|+.||||++.+....    ....+.+.+|+.+|++++ ||||++++++|.  
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--   83 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--   83 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--
Confidence            4567899999999999999999999999999999999654322    234677889999999997 999999999997  


Q ss_pred             cCCeEEEEEeccC-CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC----ceEEecccc
Q psy14434         96 NNKDLYVVFEYME-NDLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC----SIKIGDLGL  169 (404)
Q Consensus        96 ~~~~~~lv~E~~~-~~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~----~vkl~Dfg~  169 (404)
                      +...+|||||||. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            5788999999998 589998864 5799999999999999999999999999999999999998776    599999999


Q ss_pred             ccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        170 ARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       170 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      +...... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+....+..+.......+.    
T Consensus       164 a~~~~~~-~~~~~~~~t~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  237 (293)
T d1jksa_         164 AHKIDFG-NEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED----  237 (293)
T ss_dssp             CEECTTS-CBCSCCCCCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH----
T ss_pred             hhhcCCC-ccccccCCCCcccCHHHH-cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc----
Confidence            9877543 334567899999999998 4667899999999999999999999999998888777776654433222    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                        ...+.+|+.+.+||.+||+.||.+|||++++|+||||+..
T Consensus       238 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             --hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence              1235679999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-60  Score=444.01  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=212.5

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.... ......++.+|+.+|+.++ ||||++++++|.  +...+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEE
Confidence            457999999999999999999999999999999986542 3455677889999999997 999999999998  577899


Q ss_pred             EEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        102 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      ||||||.| +|.+++. .+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+....  .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--S  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--H
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--C
Confidence            99999995 8998886 4679999999999999999999997 5999999999999999999999999999987643  2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-hh-----------------
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVN-LV-----------------  240 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-----------------  240 (404)
                      ...+.+||++|||||++. +..|+.++|||||||++|||++|+.||.+.+.......... ..                 
T Consensus       159 ~~~~~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            335678999999999984 66799999999999999999999999987654322111000 00                 


Q ss_pred             ---------------------CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        241 ---------------------RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       241 ---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                                           ...++..     ....+|.++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCC-----CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                 0000000     002357899999999999999999999999999999863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-58  Score=426.15  Aligned_cols=261  Identities=28%  Similarity=0.464  Sum_probs=226.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh-------hHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK-------TDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....       .....+.+|+.+++++..||||++++++|. 
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-   80 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence            478999999999999999999999999999999996653221       223457799999999987999999999997 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       ++..+|||||||+ |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 -~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          81 -TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             -cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence             6788999999998 59999986 56799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILIS-----NRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      .... ......+||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+.......+.+.....+.  
T Consensus       160 ~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  236 (277)
T d1phka_         160 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS--  236 (277)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             ccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence            7653 33456789999999999852     345789999999999999999999999999888877777765433222  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                          ..+.++|+++.+||.+||+.||.+|||++++|+||||+++
T Consensus       237 ----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         237 ----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                1225679999999999999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-59  Score=437.91  Aligned_cols=255  Identities=28%  Similarity=0.506  Sum_probs=224.1

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+++.+. ||||+++++++.  +...+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~   79 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQI   79 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEe--eCCee
Confidence            4689999999999999999999999999999999975432 3344667889999999996 999999999987  57889


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+|||||.| +|..++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....  
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999995 77777764 56899999999999999999999999999999999999999999999999999876543  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                       ....+||+.|||||++ .+..|+.++|||||||++|+|++|+.||.+.+.......+.......+          +.++
T Consensus       158 -~~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s  225 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----------PFFN  225 (316)
T ss_dssp             -BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----------TTSC
T ss_pred             -cccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----------CCCC
Confidence             3457899999999998 566789999999999999999999999999988888777766543322          3568


Q ss_pred             HHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcCC
Q psy14434        259 EEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYFP  293 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~~  293 (404)
                      +++.++|.+||..||.+|+     |++++++||||++..+
T Consensus       226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence            9999999999999999996     9999999999998644

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-58  Score=439.03  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=223.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+. ||||++++++|.  +...+
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNSNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccc--ccccc
Confidence            478999999999999999999999999999999996543 23345667889999999996 999999999987  57789


Q ss_pred             EEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |+||||+.| +|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999995 7877775 467999999999999999999999999999999999999999999999999999887543  


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                       ....+||+.|||||++ .+..++.++|||||||++|+|++|.+||.+.+.......+.......+          ..++
T Consensus       195 -~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s  262 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----------SHFS  262 (350)
T ss_dssp             -BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TTCC
T ss_pred             -cccccCccccCCHHHH-cCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----------ccCC
Confidence             3457899999999998 466789999999999999999999999999888877777766543222          4578


Q ss_pred             HHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                      +++.+||.+||+.||.+|+     |++++++||||+...
T Consensus       263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            9999999999999999995     999999999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=433.01  Aligned_cols=258  Identities=29%  Similarity=0.453  Sum_probs=223.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhc-cChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-RNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ..........+|+.++....+||||++++++|.  +...+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCce
Confidence            468999999999999999999999999999999997543 233445666778887765445999999999988  57789


Q ss_pred             EEEEeccCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC
Q psy14434        101 YVVFEYMEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE  178 (404)
Q Consensus       101 ~lv~E~~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~  178 (404)
                      |||||||.| +|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++++|++||+|||+++.......
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999995 89998864 5699999999999999999999999999999999999999999999999999987766555


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKP  258 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (404)
                      .....+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+.......+          ..+|
T Consensus       159 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----------~~~s  227 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----------RWLE  227 (320)
T ss_dssp             CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------TTSC
T ss_pred             cccccCCCCCcCCHHHH-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------ccCC
Confidence            56677899999999998 466789999999999999999999999999888877777665432211          3568


Q ss_pred             HHHHHHHHhccccCCCCCCCHH-HHHhccCCCCcC
Q psy14434        259 EEAVDLLNQILVLNPSERPETD-QILEHNYVSKYF  292 (404)
Q Consensus       259 ~~~~~li~~~L~~dp~~Rpt~~-~ll~hp~~~~~~  292 (404)
                      +++.+||.+||+.||.+|||+. ++++||||++..
T Consensus       228 ~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence            9999999999999999999995 899999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.8e-58  Score=438.46  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=215.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----hhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----KTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      +++|++.+.||+|+||.||+|+++.+|+.||||++.+....    .....+..+++.+++.+. ||||++++++|.  +.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~--~~   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFH--TP   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEE--CS
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEE--EC
Confidence            56899999999999999999999999999999999654321    122223334566666665 999999999987  56


Q ss_pred             CeEEEEEeccC-CcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+|+|||||. |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            78999999999 58998886 45699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        176 SKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      .  .....+||+.|+|||++..+..|+.++|||||||++|+|++|+.||.+...................       ...
T Consensus       160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~  230 (364)
T d1omwa3         160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------LPD  230 (364)
T ss_dssp             S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC-------CCS
T ss_pred             C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------CCC
Confidence            3  2355689999999999866677999999999999999999999999876554433333222222221       124


Q ss_pred             CCCHHHHHHHHhccccCCCCCCC-----HHHHHhccCCCCcCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPE-----TDQILEHNYVSKYFP  293 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~hp~~~~~~~  293 (404)
                      .+|+++.+||.+||+.||.+|||     ++++++||||+...+
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            67999999999999999999999     799999999987643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.2e-58  Score=424.73  Aligned_cols=265  Identities=38%  Similarity=0.682  Sum_probs=222.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||+||+|+++ +|+.||||++...........++.+|+.+|+++. ||||++++++|.  +....|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~   76 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLV   76 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecc--cCCcee
Confidence            468999999999999999999986 7789999999766555555678889999999997 999999999987  577899


Q ss_pred             EEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      ++||++.+++...+.  .+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+.........
T Consensus        77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            999999986655554  456999999999999999999999999999999999999999999999999999887655555


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------------  245 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  245 (404)
                      .....|++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.........              
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            566689999999999977778899999999999999999999999999888888877765553221              


Q ss_pred             -----CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCC
Q psy14434        246 -----HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSK  290 (404)
Q Consensus       246 -----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~  290 (404)
                           ...........+++.+.|||.+||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                 011112223567899999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-58  Score=430.37  Aligned_cols=258  Identities=24%  Similarity=0.447  Sum_probs=224.7

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++...   ..+...+.+|+.+|+.++ ||||++++++|+  +...
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~   75 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIAR-HRNILHLHESFE--SMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCE
Confidence            4678999999999999999999999999999999999643   234456779999999997 999999999998  5678


Q ss_pred             EEEEEeccCC-cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC--CceEEeccccccccC
Q psy14434        100 LYVVFEYMEN-DLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS--CSIKIGDLGLARSLS  174 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~--~~vkl~Dfg~a~~~~  174 (404)
                      +|||||||.| +|.+.+...  .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++...
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            9999999995 899999743  59999999999999999999999999999999999999854  589999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......+||+.|+|||.+ .+..++.++|||||||++|+|++|..||.+.+....+..+.+.....+.      ..+
T Consensus       156 ~~-~~~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~  227 (321)
T d1tkia_         156 PG-DNFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------EAF  227 (321)
T ss_dssp             TT-CEEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------HHH
T ss_pred             cC-Ccccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh------hhc
Confidence            43 334557899999999997 5677899999999999999999999999999888888887765443322      223


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      +.+|+++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            5679999999999999999999999999999999753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=427.61  Aligned_cols=276  Identities=45%  Similarity=0.769  Sum_probs=229.3

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc--
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN--   96 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~--   96 (404)
                      +++.++|++++.||+|+||+||+|.+..+|+.||||++.+. .......++.+|+.+|+++. ||||+++++++....  
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence            56778999999999999999999999999999999999643 24556677889999999996 999999999986322  


Q ss_pred             -CCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         97 -NKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        97 -~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                       ...+|++|++++|+|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             TCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence             2457788777778999999988999999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC-------
Q psy14434        176 SK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP-------  245 (404)
Q Consensus       176 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  245 (404)
                      ..   ......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+.................       
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            22   22355689999999999866778899999999999999999999999998877766665544332211       


Q ss_pred             --------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCC
Q psy14434        246 --------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSAT  296 (404)
Q Consensus       246 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~  296 (404)
                                    ....+...++++++++.+||.+||+.||.+|||+.++|+||||.....+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD  306 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence                          112233445678899999999999999999999999999999998766544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-57  Score=423.43  Aligned_cols=269  Identities=36%  Similarity=0.609  Sum_probs=221.9

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCC-CeEEEEEEcchhccChhHHHHHHHHHHHHHhcc--CCCCcceEeeEEEec---
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNN-KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ--RHPNIITMLDIYKAV---   95 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~l~~~~~~~---   95 (404)
                      .++|++++.||+|+||+||+|++..+ ++.||||++..............+|+.+++.+.  .||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999999655 778999999765555444455667888777663  499999999998632   


Q ss_pred             cCCeEEEEEeccCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 NNKDLYVVFEYMENDLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 ~~~~~~lv~E~~~~~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      ....+|++|||+.+++.....   ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            345789999999986544443   34699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCC------
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPH------  246 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  246 (404)
                      .... ......+||+.|+|||++ .+..|+.++|||||||++|+|++|.+||.+.+....+..+..........      
T Consensus       166 ~~~~-~~~~~~~gT~~Y~APE~~-~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         166 YSFQ-MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hccc-ccCCCcccChhhcCcchh-cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            5432 344567899999999998 46779999999999999999999999999999888888887765432210      


Q ss_pred             -----------cchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        247 -----------ADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       247 -----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                                 ..........+++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                       1111223356789999999999999999999999999999998753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=429.29  Aligned_cols=303  Identities=38%  Similarity=0.695  Sum_probs=245.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---   95 (404)
                      +++.++|++++.||+|+||+||+|++..+|+.||||++.+...+.....++.+|+.+|+++. ||||++++++|...   
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSST
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccc
Confidence            56778999999999999999999999999999999999877777778888999999999997 99999999998632   


Q ss_pred             -cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       +...+++++++++|+|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence             2334566666656799999998899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC---------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP---------  245 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  245 (404)
                      .   ...+..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.........         
T Consensus       173 ~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         173 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             G---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             c---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence            2   3455679999999999866677899999999999999999999999999888887777666543221         


Q ss_pred             ------------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCCCCCcccccCCC
Q psy14434        246 ------------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQVTPHTVVLDIDD  313 (404)
Q Consensus       246 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (404)
                                  ....+...+.++++++.+||.+||+.||.+|||+.|+|+||||+++..+.......    ....+ ..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~----~~~~~-~~  324 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD----PYDQS-FE  324 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC----CCCCG-GG
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC----CCCCc-cc
Confidence                        11122233456899999999999999999999999999999999876544321111    11111 22


Q ss_pred             CCcCCHHHHHHHHHHHH
Q psy14434        314 NNQLEINDYQDKLYDIV  330 (404)
Q Consensus       314 ~~~~~~~~~~~~~~~~~  330 (404)
                      ......+++++.+++++
T Consensus       325 ~~~~~~~~~k~~~~~e~  341 (348)
T d2gfsa1         325 SRDLLIDEWKSLTYDEV  341 (348)
T ss_dssp             GCCCCHHHHHHHHHHHH
T ss_pred             chhcCHHHHHHHHHHHh
Confidence            34667788888887765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-58  Score=431.68  Aligned_cols=262  Identities=24%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             ccccCCeEEee-eecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe--c
Q psy14434         19 GNILAEYTIHK-RIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA--V   95 (404)
Q Consensus        19 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~--~   95 (404)
                      ..++++|++++ .||+|+||+||+|.+..+++.||||++.+       .....+|+.++.++.+||||++++++|++  .
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            45778999986 59999999999999999999999999853       23466899988777669999999999974  2


Q ss_pred             cCCeEEEEEeccCC-cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEeccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLG  168 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg  168 (404)
                      ....+|||||||+| +|.+++..   ..+++.+++.++.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence            35678999999985 99999975   35999999999999999999999999999999999999975   5679999999


Q ss_pred             cccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        169 LARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      +|+..... ......+||+.|||||++ .+..|+.++|||||||++|+|+||.+||.+.+.......+............
T Consensus       160 ~a~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         160 FAKETTSH-NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TCEECCCC-CCCCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             eeeeccCC-CccccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99876553 334567899999999998 5667999999999999999999999999887665544444333221111000


Q ss_pred             hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        249 KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                        ...+..+|+++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       238 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         238 --NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             --TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             --CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence              01123578999999999999999999999999999999753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=430.18  Aligned_cols=305  Identities=36%  Similarity=0.672  Sum_probs=234.7

Q ss_pred             ccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec---
Q psy14434         19 GNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV---   95 (404)
Q Consensus        19 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~---   95 (404)
                      +++.++|++++.||+|+||+||+|+++.+|+.||||++.+...+.....++.+|+.++++++ ||||++++++|...   
T Consensus        13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence            35778999999999999999999999999999999999877777777888999999999996 99999999999632   


Q ss_pred             -cCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       ....+|+|||||.+++...+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ccCceeEEEEeccchHHHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence             347899999999988777664 459999999999999999999999999999999999999999999999999988665


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD------  248 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  248 (404)
                      .. ......+||+.|+|||++. +..++.++||||+||++|+|++|++||.+.+.......+........+...      
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TS-FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cc-cccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            43 3445678999999999984 568899999999999999999999999999888877777655443211000      


Q ss_pred             --------------hhh------------cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCCCCCCCCCC
Q psy14434        249 --------------KFY------------AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPSATHVIPQV  302 (404)
Q Consensus       249 --------------~~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~  302 (404)
                                    ...            ......++++.+||++||..||++|||++|||+||||+...++...  +..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~--~~~  326 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV--EAP  326 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH--TCC
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc--cCC
Confidence                          000            0001135679999999999999999999999999999987653331  222


Q ss_pred             CCCcccccCCCCCcCCHHHHHHHHHHHH
Q psy14434        303 TPHTVVLDIDDNNQLEINDYQDKLYDIV  330 (404)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (404)
                      .|.......+ +..+..++|++.++.++
T Consensus       327 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~  353 (355)
T d2b1pa1         327 PPQIYDKQLD-EREHTIEEWKELIYKEV  353 (355)
T ss_dssp             CC-------C-CCCCCHHHHHHHHHHHH
T ss_pred             CCCCCCcchh-hhhcCHHHHHHHHHHHh
Confidence            2333333333 35778889999988765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=417.39  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=211.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccCh----hHHHHHHHHHHHHHhcc-CCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNK----TDAQRTYREILFLKSFQ-RHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~-~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.+.....    ....++.+|+.+++++. .||||++++++|.  +
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--R   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--C
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--e
Confidence            468999999999999999999999999999999997543322    12234568999999986 4899999999987  5


Q ss_pred             CCeEEEEEeccCC--cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC-CceEEeccccccc
Q psy14434         97 NKDLYVVFEYMEN--DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS-CSIKIGDLGLARS  172 (404)
Q Consensus        97 ~~~~~lv~E~~~~--~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~-~~vkl~Dfg~a~~  172 (404)
                      ...+|+||||+.+  ++..++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            7789999999974  6777765 5679999999999999999999999999999999999999854 7999999999986


Q ss_pred             cCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        173 LSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...  ...++.+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      .+.......         
T Consensus       161 ~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~---------  223 (273)
T d1xwsa_         161 LKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF---------  223 (273)
T ss_dssp             CCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC---------
T ss_pred             ccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC---------
Confidence            543  334567899999999998666666888999999999999999999997532      222221111         


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYF  292 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~  292 (404)
                       ...+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       224 -~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         224 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence             145799999999999999999999999999999998653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=411.93  Aligned_cols=270  Identities=31%  Similarity=0.602  Sum_probs=229.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      +++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+++.+. ||||++++++|.  +....+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~--~~~~~~   77 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccc--ccccee
Confidence            46899999999999999999999999999999999776666677888999999999997 999999999987  577899


Q ss_pred             EEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCCc
Q psy14434        102 VVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKEC  179 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~  179 (404)
                      +||+++.+ +|..++. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++........
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99999997 5555555 456999999999999999999999999999999999999999999999999999987665555


Q ss_pred             ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCC-------------
Q psy14434        180 LTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPP-------------  245 (404)
Q Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~-------------  245 (404)
                      .....+++.|+|||++.....++.++|||||||++|+|++|+.| |.+.+.......+.........             
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            55667889999999986666789999999999999999999877 5566666666666665543221             


Q ss_pred             ------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        246 ------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       246 ------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                            ...........+++.+.+||.+||+.||.+|||++|+|+||||+++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence                  1112222334568899999999999999999999999999999987653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=417.43  Aligned_cols=270  Identities=33%  Similarity=0.606  Sum_probs=221.5

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec-----
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV-----   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~-----   95 (404)
                      -+++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++ ||||+++++++...     
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            468999999999999999999999999999999999776666666777889999999997 99999999998532     


Q ss_pred             -cCCeEEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434         96 -NNKDLYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus        96 -~~~~~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                       ....+|+||||+.+++.....  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence             245689999999976665554  34699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCC----CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcc
Q psy14434        173 LSDSK----ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHAD  248 (404)
Q Consensus       173 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  248 (404)
                      .....    ....+.+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+............
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            54321    22344679999999999876678999999999999999999999999999988888888777654332111


Q ss_pred             hhhcc----------------------cCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCc
Q psy14434        249 KFYAG----------------------FKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKY  291 (404)
Q Consensus       249 ~~~~~----------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~  291 (404)
                      .....                      ....++.+.|||.+||+.||++|||+.|+|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00000                      00136788999999999999999999999999999853

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=422.34  Aligned_cols=263  Identities=32%  Similarity=0.573  Sum_probs=218.9

Q ss_pred             CeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe----ccCCe
Q psy14434         24 EYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA----VNNKD   99 (404)
Q Consensus        24 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~----~~~~~   99 (404)
                      +|+.++.||+|+||+||+|+++.+|+.||||++.+....      ..+|+.+|++++ ||||++++++|..    .+..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceE
Confidence            799999999999999999999999999999999643221      237999999996 9999999999853    23456


Q ss_pred             EEEEEeccCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEecccccccc
Q psy14434        100 LYVVFEYMENDLNKVIR-----DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSL  173 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~-----~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~  173 (404)
                      +|||||||++++...+.     ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999987655443     34699999999999999999999999999999999999999875 8999999999876


Q ss_pred             CCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCC--------
Q psy14434        174 SDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPP--------  245 (404)
Q Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  245 (404)
                      ... ....+.+||+.|+|||.+.+...++.++|||||||++|||++|.+||.+.+...++..+.+..+....        
T Consensus       174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            543 33456789999999999876778999999999999999999999999999888888777665442211        


Q ss_pred             -----------CcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCCC
Q psy14434        246 -----------HADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFPS  294 (404)
Q Consensus       246 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~~  294 (404)
                                 ............++++.+||.+||..||.+|||+.|+|+||||+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                       0000111224578999999999999999999999999999999886543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=404.69  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=208.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|...   ..||||++.....+......+.+|+.++++++ ||||++++++..   ...+|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~---~~~~~   79 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST---APQLA   79 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe---ccEEE
Confidence            467999999999999999999653   35999999877667777888999999999996 999999999854   45689


Q ss_pred             EEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC--
Q psy14434        102 VVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS--  176 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~--  176 (404)
                      ||||||+ |+|.+++..  +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....  
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999 599998863  45999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CCcccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KECLTEYIATRWYRAPEILISN--RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      ........||+.|||||++...  ..|+.++|||||||++|||+||+.||.+.+...............+.    .....
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~  235 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----LSKVR  235 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----GGGSC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc----chhcc
Confidence            2233556899999999998532  35899999999999999999999999988776665555443322221    11223


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .++|+++.+||.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5678999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.1e-55  Score=411.06  Aligned_cols=269  Identities=29%  Similarity=0.527  Sum_probs=217.8

Q ss_pred             ccccccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         17 VDGNILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        17 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      +.....++|++++.||+|+||+||+|+++.+|+.||||++...     ...++.+|+.+|+.+.+||||++++++|....
T Consensus        29 ~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~  103 (328)
T d3bqca1          29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV  103 (328)
T ss_dssp             CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             cCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence            3344567899999999999999999999999999999998532     34567899999999977999999999998766


Q ss_pred             CCeEEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCC-ceEEeccccccccC
Q psy14434         97 NKDLYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSC-SIKIGDLGLARSLS  174 (404)
Q Consensus        97 ~~~~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~-~vkl~Dfg~a~~~~  174 (404)
                      ...+|+|||||.+ +|....  +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+...
T Consensus       104 ~~~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             CCceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            7789999999995 665543  4699999999999999999999999999999999999998765 69999999998765


Q ss_pred             CCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHhhCC-----------
Q psy14434        175 DSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS-HQLQLIVNLVRP-----------  242 (404)
Q Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-----------  242 (404)
                      .. ......+||+.|+|||.+.+...++.++||||+||++|+|++|..||...... .+...+....+.           
T Consensus       182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         182 PG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            43 33456789999999999876677899999999999999999999999765543 333333222110           


Q ss_pred             --CCC---------C---cc--hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCCCCcCC
Q psy14434        243 --NPP---------H---AD--KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYVSKYFP  293 (404)
Q Consensus       243 --~~~---------~---~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~~~~~~  293 (404)
                        ...         .   ..  ........+++++.+||.+||.+||.+|||++|+|+||||+...+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence              000         0   00  000112346889999999999999999999999999999987543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.3e-55  Score=402.47  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=210.8

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.+... +......+.+|+.+++.+. ||||+++++++...+. 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            345689999999999999999999999999999999976544 3445667889999999996 9999999999875433 


Q ss_pred             -CeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 -KDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 -~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                       ..+|||||||+| +|...+. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence             458999999995 8887775 5679999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        175 DSK---ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       175 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...   ......+||+.|+|||++ .+..++.++|||||||++|+|+||.+||.+.+.......+.......+.      
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~------  235 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------  235 (277)
T ss_dssp             ----------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG------
T ss_pred             cccccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc------
Confidence            322   234556899999999998 4667899999999999999999999999988877766665544322211      


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHhccCC
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILEHNYV  288 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~hp~~  288 (404)
                      .....+|+++.+||.+||+.||.+||+..+.+.|+|.
T Consensus       236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            2235789999999999999999999955455556664

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-55  Score=402.02  Aligned_cols=247  Identities=25%  Similarity=0.482  Sum_probs=207.8

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||+||+|.++.+++.||||++....   ...+++.+|+.+|++++ ||||+++++++.  +...+|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCC-CCCEecCCccEe--eCCeeE
Confidence            368999999999999999999999999999999986543   34556889999999997 999999999986  567899


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      ||||||. |+|..++..   ..+++..+..++.||+.||+|||++||+||||||+||||++++.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999999 589888864   458999999999999999999999999999999999999999999999999998765433


Q ss_pred             C-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 E-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPL-FPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                      . ......||+.|+|||++. +..++.++|||||||++|||++|..| |.+.+.......+.....+..+         .
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~---------~  239 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---------E  239 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---------T
T ss_pred             ceeeccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC---------c
Confidence            2 233456899999999984 56789999999999999999996655 5555555444444443332222         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      .+|+++.+||.+||+.||.+|||++++++
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            67899999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=395.55  Aligned_cols=246  Identities=26%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.....   ....+.+|+.++++++ ||||+++++++.  ....+|+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~g~~~--~~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcC-CCCcccccceec--cCCceEE
Confidence            58999999999999999999986 567899999965432   3356789999999997 999999999986  5667999


Q ss_pred             EEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC-
Q psy14434        103 VFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE-  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-  178 (404)
                      |||||. |+|.+++..  ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++....... 
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            999998 589998864  4589999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......||+.|+|||++ .+..++.++|||||||++|||+| |.+||...+.......+........+         ..+
T Consensus       158 ~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---------~~~  227 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------RLA  227 (263)
T ss_dssp             -------CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---------TTS
T ss_pred             eecceecCcccCChHHh-cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---------ccc
Confidence            23346789999999998 46679999999999999999999 57778777777777777665543332         356


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ++++.+||.+||+.||.+|||++++++|
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-54  Score=402.61  Aligned_cols=250  Identities=24%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCe---EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQ---YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      .++|++.+.||+|+||+||+|.++.+++   .||||.+... ......+.+.+|+.+|++++ |||||++++++.  ...
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~--~~~  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVT--KST  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--SSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEe--eCC
Confidence            5689999999999999999999987664   6899988543 34455677899999999996 999999999986  567


Q ss_pred             eEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+|+|||||.+ +|.+++..  +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            79999999995 89888774  4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcch
Q psy14434        176 SKE-----CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADK  249 (404)
Q Consensus       176 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  249 (404)
                      ...     ......||+.|||||.+ .+..++.++|||||||++|||+| |.+||.+.........+.....+..+    
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  255 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP----  255 (299)
T ss_dssp             ---------------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC----
T ss_pred             CCCcceeeecccccCCccccCHHHH-hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence            321     11234679999999998 46679999999999999999998 89999998888777777665443332    


Q ss_pred             hhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        250 FYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                           ..+++++.+||.+||+.||.+|||+.+++++
T Consensus       256 -----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 -----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                 4578999999999999999999999998765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-55  Score=401.14  Aligned_cols=246  Identities=25%  Similarity=0.416  Sum_probs=204.4

Q ss_pred             eeecccCceeEEEEEEc--CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEEEEec
Q psy14434         29 KRIGKGAYGIVYKAYDK--NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYVVFEY  106 (404)
Q Consensus        29 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~lv~E~  106 (404)
                      ++||+|+||.||+|.+.  .+++.||||++.....+.....++.+|+.+|++++ ||||+++++++.   ....||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~---~~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---SSSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEec---cCCEEEEEEc
Confidence            47999999999999865  45678999999766556666778899999999996 999999999985   3457999999


Q ss_pred             cCC-cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCCC---ccc
Q psy14434        107 MEN-DLNKVIRD-KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSKE---CLT  181 (404)
Q Consensus       107 ~~~-~L~~~l~~-~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~---~~~  181 (404)
                      |++ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   ...
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            984 89998875 5699999999999999999999999999999999999999999999999999987654322   123


Q ss_pred             ccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCCCHH
Q psy14434        182 EYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNKPEE  260 (404)
Q Consensus       182 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (404)
                      ...||+.|||||++. +..++.++|||||||++|||++ |.+||.+.+..+....+.+...+..+         ..+|++
T Consensus       169 ~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p---------~~~~~~  238 (277)
T d1xbba_         169 HGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---------AGCPRE  238 (277)
T ss_dssp             --CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------TTCCHH
T ss_pred             ccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------cccCHH
Confidence            356899999999984 5678999999999999999997 89999998887776666654443322         467899


Q ss_pred             HHHHHHhccccCCCCCCCHHHH---HhccCC
Q psy14434        261 AVDLLNQILVLNPSERPETDQI---LEHNYV  288 (404)
Q Consensus       261 ~~~li~~~L~~dp~~Rpt~~~l---l~hp~~  288 (404)
                      +.+||.+||+.||.+|||++++   |+|+|+
T Consensus       239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999999999999998   466665

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=399.15  Aligned_cols=252  Identities=22%  Similarity=0.376  Sum_probs=213.6

Q ss_pred             CCeEEeee-ecccCceeEEEEEEcC--CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKR-IGKGAYGIVYKAYDKN--NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++|.+.+. ||+|+||.||+|.++.  ++..||||++... .......++.+|+.+|++++ ||||+++++++.   ...
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~---~~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---AEA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SSS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeec---cCe
Confidence            46888885 9999999999998754  4568999998644 34556778899999999997 999999999986   345


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|||||||++ +|.+++..  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999995 89998753  46999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        177 KE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ..   ......||+.|+|||++. +..++.++|||||||++|||+| |..||.+.+..+....+.+...+..+       
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-------  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-------  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC-------
T ss_pred             ccccccccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence            22   223456899999999984 5678999999999999999998 99999998888777777665543332       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHH---HhccCCC
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQI---LEHNYVS  289 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l---l~hp~~~  289 (404)
                        +.+|+++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       235 --~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         235 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              4679999999999999999999999887   6788875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=398.35  Aligned_cols=250  Identities=25%  Similarity=0.458  Sum_probs=210.7

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.++ ++..||||++....   .....+.+|+.++++++ ||||+++++++.   ...+|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~---~~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT---QEPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCC-CCCEeEEEeeec---cCCeE
Confidence            368999999999999999999976 57789999996543   23456889999999996 999999999864   34579


Q ss_pred             EEEeccC-CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRD---KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~---~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|||||. |+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+|+......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999 588876652   359999999999999999999999999999999999999999999999999998775432


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .......||+.|||||++. +..++.++|||||||++|||+|| .+||...........+.....+..+         .
T Consensus       164 ~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---------~  233 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---------D  233 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------T
T ss_pred             cccccccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---------c
Confidence             2234567899999999984 56789999999999999999995 5667777776666666655443332         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh--ccCCC
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE--HNYVS  289 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--hp~~~  289 (404)
                      .+++++.+||.+||+.||++|||++++++  |+||+
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            57899999999999999999999999998  78875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=408.49  Aligned_cols=250  Identities=24%  Similarity=0.409  Sum_probs=207.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCC-----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNK-----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++.+.||+|+||+||+|.+..++     ..||+|.+.... .......+.+|+.++.++.+|||||++++++.  +.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT--LS  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--eC
Confidence            68999999999999999999987654     369999886432 33445677899999999966999999999987  56


Q ss_pred             CeEEEEEeccC-CcHHHHHHhc------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRDK------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPS  152 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~~------------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~  152 (404)
                      ..+|+|||||+ |+|.+++...                        .+++..++.++.||+.||+|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            77999999998 5999998643                        3889999999999999999999999999999999


Q ss_pred             cEEEccCCceEEeccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q psy14434        153 NILIDKSCSIKIGDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGAST  229 (404)
Q Consensus       153 NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  229 (404)
                      |||++.++.+||+|||+|+.......  ...+..||+.|||||++. +..++.++|||||||++|||++ |.+||.+.+.
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999986544322  234567899999999984 5678999999999999999997 8999998776


Q ss_pred             HHHHHHHHHhh-CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        230 SHQLQLIVNLV-RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ...+..+.... .+..+         ..+|+++.+||.+||+.||++|||++++++|
T Consensus       273 ~~~~~~~~~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCC---------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            65555544432 22221         4578999999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=390.30  Aligned_cols=246  Identities=21%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      ++|++.+.||+|+||+||+|+++ ++..||||++.+....   ...+.+|+.+++++. ||||+++++++.  +...+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~-HpnIv~~~g~~~--~~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS-HEKLVQLYGVCT--KQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCC-CTTBCCEEEEEC--CSSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcC-CCceeeEEEEEe--eCCceEE
Confidence            58999999999999999999985 7888999999754333   356789999999997 999999999986  5677999


Q ss_pred             EEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC-C
Q psy14434        103 VFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK-E  178 (404)
Q Consensus       103 v~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~-~  178 (404)
                      ||||+. |+|..++.  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            999998 57887765  4569999999999999999999999999999999999999999999999999998664432 2


Q ss_pred             cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCCC
Q psy14434        179 CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKNK  257 (404)
Q Consensus       179 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (404)
                      ......||+.|+|||++. +..++.++|||||||++|||+| |+.||.+.+..+....+.+......+         ..+
T Consensus       157 ~~~~~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---------~~~  226 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------HLA  226 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---------TTC
T ss_pred             eecccCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---------ccc
Confidence            233467999999999984 5678999999999999999998 89999999888877777765554333         456


Q ss_pred             CHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        258 PEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       258 ~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ++++.+||.+||+.||++|||++++++|
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=405.86  Aligned_cols=263  Identities=22%  Similarity=0.394  Sum_probs=216.3

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEc---CCCeEEEEEEcchhcc--ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEec
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDK---NNKQYVAIKKIFEAFR--NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAV   95 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~   95 (404)
                      -+++|++++.||+|+||+||+|.+.   .+|+.||||++.+...  +......+.+|+.+++++..||||+++++++.  
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--   99 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--   99 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec--
Confidence            3578999999999999999999874   4789999999975432  23345567799999999985589999999987  


Q ss_pred             cCCeEEEEEeccCC-cHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEecccccccc
Q psy14434         96 NNKDLYVVFEYMEN-DLNKVIR-DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSL  173 (404)
Q Consensus        96 ~~~~~~lv~E~~~~-~L~~~l~-~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~  173 (404)
                      +...+|++|||+.+ +|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            46789999999994 8988886 457899999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-CCcccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhC-CCCCCcchh
Q psy14434        174 SDS-KECLTEYIATRWYRAPEILISN-RRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVR-PNPPHADKF  250 (404)
Q Consensus       174 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  250 (404)
                      ... ........|++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.........+..... ..++     
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-----  254 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-----  254 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-----
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-----
Confidence            432 2234557899999999998543 3578899999999999999999999988765544444444332 1111     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCC-----CHHHHHhccCCCCcC
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERP-----ETDQILEHNYVSKYF  292 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~hp~~~~~~  292 (404)
                        ....+++++.+||.+||++||.+||     |++|+++||||++..
T Consensus       255 --~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         255 --YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             --CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence              1145799999999999999999999     589999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=389.00  Aligned_cols=248  Identities=24%  Similarity=0.424  Sum_probs=200.7

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC---CeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN---KQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ++|++.+.||+|+||.||+|.+..+   +..||||.+... ........+.+|+.++++++ ||||+++++++.   ...
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~~   81 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT---ENP   81 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---SSS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCe
Confidence            5899999999999999999998654   457899988543 34455677889999999996 999999999985   456


Q ss_pred             EEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCC
Q psy14434        100 LYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDS  176 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~  176 (404)
                      +|+|||||.+ +|..++..  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            8999999995 78777653  45899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        177 KE-CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                      .. ......||+.|+|||++ .+..++.++|||||||++|||++ |.+||.+.+.......+.+...+..+         
T Consensus       162 ~~~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~---------  231 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---------  231 (273)
T ss_dssp             ---------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------
T ss_pred             cceeccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence            22 23445689999999998 45678999999999999999997 89999998888777777665443222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +++|+++.+||.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5679999999999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=388.37  Aligned_cols=252  Identities=25%  Similarity=0.445  Sum_probs=205.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.++.+ ..||||++.....   ....+.+|+.++++++ ||||+++++++.   ...+|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~-h~nIv~~~g~~~---~~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcc-cCCEeEEEEEEe---cCCeE
Confidence            46899999999999999999998765 5699999965433   3456889999999997 999999999975   34579


Q ss_pred             EEEeccCC-cHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYMEN-DLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~~-~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +|||||.+ +|..++.   .+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999994 7777765   3469999999999999999999999999999999999999999999999999998664332


Q ss_pred             -CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccC
Q psy14434        178 -ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFK  255 (404)
Q Consensus       178 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (404)
                       .......||+.|+|||.+. ...++.++|||||||++|||++| .+||.+......+..+........+         .
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~---------~  237 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---------P  237 (285)
T ss_dssp             --------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---------T
T ss_pred             ceeeccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---------c
Confidence             2234467999999999984 66789999999999999999995 5666666666666666654433222         4


Q ss_pred             CCCHHHHHHHHhccccCCCCCCCHHHHHh--ccCCCCc
Q psy14434        256 NKPEEAVDLLNQILVLNPSERPETDQILE--HNYVSKY  291 (404)
Q Consensus       256 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--hp~~~~~  291 (404)
                      .+++++.+||.+||+.||++|||++++++  ++||...
T Consensus       238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            67899999999999999999999999988  8888754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=384.97  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=200.0

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC----eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK----QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      .+.|++.+.||+|+||.||+|.++.++    ..||||++... ........+.+|+.++++++ ||||+++++++.  +.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~--~~   81 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS--KY   81 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe--cC
Confidence            357999999999999999999987655    47999998643 34445567889999999997 999999999986  56


Q ss_pred             CeEEEEEeccCC-cHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccC
Q psy14434         98 KDLYVVFEYMEN-DLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLS  174 (404)
Q Consensus        98 ~~~~lv~E~~~~-~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~  174 (404)
                      ..+++|||||.+ ++.+.+..  +.+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            779999999996 67776653  469999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhCCCCCCcchh
Q psy14434        175 DSKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVRPNPPHADKF  250 (404)
Q Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (404)
                      ....   ......||+.|||||++ .+..++.++|||||||++|||++| .+||.+.+.......+.....+..+     
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~-----  235 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP-----  235 (283)
T ss_dssp             ------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-----
T ss_pred             CCCccceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc-----
Confidence            4321   22345689999999998 567899999999999999999995 5556666666666666555443322     


Q ss_pred             hcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        251 YAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       251 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                          ..++..+.+||.+||+.||++|||+.++++
T Consensus       236 ----~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 ----MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                456899999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=393.34  Aligned_cols=248  Identities=23%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCe----EEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQ----YVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+... ......+.+.+|+.++++++ ||||+++++++..   .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~---~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD-NPHVCRLLGICLT---S   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES---S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---C
Confidence            579999999999999999999988876    5788877543 23345667889999999997 9999999999862   3


Q ss_pred             eEEEEEeccC-CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      ..+++||++. ++|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            4677777777 688777763  4699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhc
Q psy14434        176 SKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYA  252 (404)
Q Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (404)
                      ...  ......||+.|+|||++. +..++.++|||||||++|||+| |.+||.+.+.......+.....+..+       
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p-------  235 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-------  235 (317)
T ss_dssp             TCC--------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC-------
T ss_pred             ccccccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence            322  223456899999999985 5578999999999999999998 89999988877776666665543332       


Q ss_pred             ccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        253 GFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       253 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                        ..+++.+.+||.+||+.||.+|||+.+++.|
T Consensus       236 --~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         236 --PICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence              4568999999999999999999999999988

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=387.84  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=200.6

Q ss_pred             CCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNN   97 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~   97 (404)
                      ++|++.+.||+|+||.||+|.+..     +++.||||++... ........+.+|+..+.++..|+||+.+++++.. .+
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CC
Confidence            679999999999999999999754     4578999998643 3345566778899999999879999999998753 45


Q ss_pred             CeEEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccC
Q psy14434         98 KDLYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKS  159 (404)
Q Consensus        98 ~~~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~  159 (404)
                      ..+++|||||+ |+|.+++..                 ..+++.++..++.||+.||.|||++||+||||||+||||+.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            67899999999 589998863                 238899999999999999999999999999999999999999


Q ss_pred             CceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHH-
Q psy14434        160 CSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQL-  235 (404)
Q Consensus       160 ~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~-  235 (404)
                      +.+||+|||+|+......  ......+||+.|+|||++. +..++.++|||||||++|||++| .+||.+......+.. 
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999998654332  2234567999999999984 56789999999999999999986 578887765544433 


Q ss_pred             HHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        236 IVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +.....+..+         ..+++++.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3333333222         4568999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=379.31  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=197.4

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCC-C--eEEEEEEcchhcc-ChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCC
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNN-K--QYVAIKKIFEAFR-NKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNK   98 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~   98 (404)
                      ++|++.+.||+|+||.||+|....+ +  ..||||++.+... .....+.+.+|+.+|++++ ||||+++++++.   ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~---~~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL---TP   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe---ec
Confidence            5799999999999999999986533 3  4689999876543 3345677889999999996 999999999986   24


Q ss_pred             eEEEEEeccC-CcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCC
Q psy14434         99 DLYVVFEYME-NDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSD  175 (404)
Q Consensus        99 ~~~lv~E~~~-~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~  175 (404)
                      .+++|||||. |++.+.+.  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            5799999998 57777665  35699999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhh
Q psy14434        176 SKE---CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFY  251 (404)
Q Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (404)
                      ...   ......|+..|+|||++. +..++.++|||||||++|||++ |.+||.+.+.......+.......+       
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------  235 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-------  235 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-------
T ss_pred             CCCcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-------
Confidence            322   223356788999999984 5678999999999999999998 8999999888887776654322111       


Q ss_pred             cccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        252 AGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       252 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                       ....+|+.+.+||.+||..||++|||+.++++
T Consensus       236 -~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 -RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             12567899999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=381.39  Aligned_cols=250  Identities=28%  Similarity=0.473  Sum_probs=208.4

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCC-------eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNK-------QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKA   94 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~   94 (404)
                      .++|++.+.||+|+||.||+|++..++       ..||||++... ........+.+|+..+.++.+||||+++++++. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence            468999999999999999999876554       47999999654 345566788899999999967999999999987 


Q ss_pred             ccCCeEEEEEeccC-CcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q psy14434         95 VNNKDLYVVFEYME-NDLNKVIRDK-----------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILI  156 (404)
Q Consensus        95 ~~~~~~~lv~E~~~-~~L~~~l~~~-----------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll  156 (404)
                       ++..+|+|||||. |+|.+++...                 .+++..++.++.||+.||+|||+.||+||||||+|||+
T Consensus        90 -~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          90 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             -SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence             5678999999999 5899998633                 38999999999999999999999999999999999999


Q ss_pred             ccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q psy14434        157 DKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQL  233 (404)
Q Consensus       157 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  233 (404)
                      +.++.+||+|||+++......  .......||+.|+|||.+. +..|+.++|||||||++|||++ |.+||.+.+.....
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            999999999999998765432  2234467899999999984 5679999999999999999998 79999888887776


Q ss_pred             HHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        234 QLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      ..+.+...+..+         ..+++++.+||.+||+.||.+|||+.++++
T Consensus       248 ~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            666655443332         467899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-51  Score=381.98  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=210.3

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||+||+|+.+.     +++.||||++... .......++.+|+.++++++ ||||+++++++.  .
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~--~   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFD-NPNIVKLLGVCA--V   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--S
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcC-CCCcccceeeec--c
Confidence            4579999999999999999998753     5688999998643 34445677899999999996 999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHhc-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRDK-------------------------ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLK  150 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~~-------------------------~l~~~~~~~i~~qil~al~~LH~~~i~HrDlk  150 (404)
                      ...++++|||+. |+|.+++...                         .+++..+..++.||+.||+|||++||+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            678999999998 5899888632                         37889999999999999999999999999999


Q ss_pred             CCcEEEccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCC
Q psy14434        151 PSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGA  227 (404)
Q Consensus       151 p~NIll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~  227 (404)
                      |+|||++.++.+||+|||+|+......  .......||+.|+|||.+. +..++.++|||||||++|||++|. +||.+.
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            999999999999999999998654322  2234567899999999984 667999999999999999999985 789888


Q ss_pred             CcHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        228 STSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +..+....+.+...+..+         ..+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~e~~~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         247 AHEEVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CHHHHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888877777655443222         467899999999999999999999999965

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=375.92  Aligned_cols=243  Identities=23%  Similarity=0.438  Sum_probs=199.6

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEE
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLY  101 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~  101 (404)
                      .++|++.+.||+|+||.||+|.++  |..||||++..    ....+.+.+|+.++++++ ||||+++++++.. +...+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN----DATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC----CC--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEe-cCCcEE
Confidence            457999999999999999999874  77899999953    334567889999999996 9999999998742 345589


Q ss_pred             EEEeccC-CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC
Q psy14434        102 VVFEYME-NDLNKVIRDK---ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK  177 (404)
Q Consensus       102 lv~E~~~-~~L~~~l~~~---~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~  177 (404)
                      +||||++ |+|.+++...   .+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999998 5899988643   4899999999999999999999999999999999999999999999999999875432 


Q ss_pred             CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhCCCCCCcchhhcccCC
Q psy14434        178 ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPLFPGASTSHQLQLIVNLVRPNPPHADKFYAGFKN  256 (404)
Q Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (404)
                        .....+|+.|+|||++. +..++.++|||||||++|||+| |++||.+.+..+....+.+...+..+         ..
T Consensus       157 --~~~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~---------~~  224 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------DG  224 (262)
T ss_dssp             -------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC---------TT
T ss_pred             --CccccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---------cc
Confidence              23456899999999985 5678999999999999999998 79999888877777776655443322         45


Q ss_pred             CCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        257 KPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       257 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      +++++.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            68999999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=382.28  Aligned_cols=250  Identities=28%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcCCCeE--EEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKNNKQY--VAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .++|++.+.||+|+||.||+|.++.+|..  ||||.+... ......+.+.+|+.+|.++.+||||+++++++.  ++..
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~   85 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGY   85 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETTE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe--cCCe
Confidence            36899999999999999999999988864  677776432 233455678899999999966999999999987  5778


Q ss_pred             EEEEEeccC-CcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCc
Q psy14434        100 LYVVFEYME-NDLNKVIRD-----------------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCS  161 (404)
Q Consensus       100 ~~lv~E~~~-~~L~~~l~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~  161 (404)
                      +|+||||++ |+|.+++..                 ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence            999999999 589998863                 35899999999999999999999999999999999999999999


Q ss_pred             eEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHhh
Q psy14434        162 IKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSK-PLFPGASTSHQLQLIVNLV  240 (404)
Q Consensus       162 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~  240 (404)
                      +||+|||+++..... .......||+.|+|||.+. +..++.++|||||||++|||++|. +||.+.+.......+.+..
T Consensus       166 ~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         166 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EEECCTTCEESSCEE-CCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEcccccccccccc-ccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            999999999865432 2223457999999999984 567899999999999999999965 6788888777766665544


Q ss_pred             CCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        241 RPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      .+..+         ..+++++.+||.+||+.||++|||+.++++|
T Consensus       244 ~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 RLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43322         4568999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=375.37  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=214.0

Q ss_pred             ccccccccc-cCCeEEeeeecccCceeEEEEEEc-----CCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcc
Q psy14434         13 VQHNVDGNI-LAEYTIHKRIGKGAYGIVYKAYDK-----NNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNII   86 (404)
Q Consensus        13 ~~~~~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv   86 (404)
                      +.+...+.+ .++|++.+.||+|+||.||+|.+.     .+++.||||++.... .......+.+|+.+++.+.+||||+
T Consensus        12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv   90 (311)
T d1t46a_          12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIV   90 (311)
T ss_dssp             SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEE
Confidence            333444443 478999999999999999999863     467899999996543 4556667889999999997799999


Q ss_pred             eEeeEEEeccCCeEEEEEeccCC-cHHHHHHhc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy14434         87 TMLDIYKAVNNKDLYVVFEYMEN-DLNKVIRDK-------------------ILKDVHIRYIMFQLCNGLSYIHACKVMH  146 (404)
Q Consensus        87 ~l~~~~~~~~~~~~~lv~E~~~~-~L~~~l~~~-------------------~l~~~~~~~i~~qil~al~~LH~~~i~H  146 (404)
                      ++++++.  +...+|+|||||++ +|..++...                   .+++..+..++.||+.||+|||++|++|
T Consensus        91 ~~~g~~~--~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          91 NLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             CEEEEEC--SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEEEe--eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            9999986  56679999999984 888888643                   4889999999999999999999999999


Q ss_pred             CCCCCCcEEEccCCceEEeccccccccCCCC--CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q psy14434        147 RDLKPSNILIDKSCSIKIGDLGLARSLSDSK--ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQ-SKPL  223 (404)
Q Consensus       147 rDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~p  223 (404)
                      |||||+||+++.++.+||+|||+++......  ......+||+.|+|||++. ...++.++|||||||++|||+| |.+|
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765432  2234468999999999984 5678999999999999999998 6777


Q ss_pred             CCCCCcHHHHHHHHHh-hCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        224 FPGASTSHQLQLIVNL-VRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       224 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      |.+......+..+... ..+..+         ..+++++.+||.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         248 YPGMPVDSKFYKMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             STTCCSSHHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8777766655554433 322222         356899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-50  Score=376.24  Aligned_cols=262  Identities=20%  Similarity=0.245  Sum_probs=203.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.....    ..++.+|+.+++.+..|++|+.+.+++.  +...
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~--~~~~   77 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA--EGDY   77 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE--ETTE
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe--cCCE
Confidence            456789999999999999999999999999999999864322    2346789999999984455555565544  5778


Q ss_pred             EEEEEeccCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc---CCceEEeccccccccC
Q psy14434        100 LYVVFEYMENDLNKVIR--DKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK---SCSIKIGDLGLARSLS  174 (404)
Q Consensus       100 ~~lv~E~~~~~L~~~l~--~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~---~~~vkl~Dfg~a~~~~  174 (404)
                      .++||||+++++...+.  .+.+++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+...
T Consensus        78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99999999998877765  456999999999999999999999999999999999999854   4579999999998765


Q ss_pred             CCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhCCCCCCc
Q psy14434        175 DSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTSHQLQLIVNLVRPNPPHA  247 (404)
Q Consensus       175 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  247 (404)
                      ...       ......+||+.|||||++ .+..++.++|||||||++|||++|..||.+.........+.........  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--  234 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--  234 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred             ccccccceeccccCCcCCCccccCHHHH-hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--
Confidence            432       123456899999999998 4667999999999999999999999999876655443333222110000  


Q ss_pred             chhhcccCCCCHHHHHHHHhccccCCCCCCCHH---HHHhccCCCC
Q psy14434        248 DKFYAGFKNKPEEAVDLLNQILVLNPSERPETD---QILEHNYVSK  290 (404)
Q Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---~ll~hp~~~~  290 (404)
                      ........++|+++.+||.+||+.||++||+++   ++|+|+|...
T Consensus       235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            001122356799999999999999999999987   4577887654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=376.70  Aligned_cols=249  Identities=24%  Similarity=0.442  Sum_probs=212.2

Q ss_pred             cCCeEEeeeecccCceeEEEEEEcC-----CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEecc
Q psy14434         22 LAEYTIHKRIGKGAYGIVYKAYDKN-----NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVN   96 (404)
Q Consensus        22 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~   96 (404)
                      .++|++.+.||+|+||.||+|.+..     ++..||||++... ........+.+|+.+++++. ||||+++++++.  .
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--~   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS--Q   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC--S
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEe--c
Confidence            4789999999999999999998853     3578999999754 34556667889999999997 999999999986  5


Q ss_pred             CCeEEEEEeccC-CcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEE
Q psy14434         97 NKDLYVVFEYME-NDLNKVIRD-----------KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKI  164 (404)
Q Consensus        97 ~~~~~lv~E~~~-~~L~~~l~~-----------~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl  164 (404)
                      ....++|||||. |+|.+++..           ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            667999999998 588887752           13688999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCC--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHhhC
Q psy14434        165 GDLGLARSLSDSKE--CLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQS-KPLFPGASTSHQLQLIVNLVR  241 (404)
Q Consensus       165 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~  241 (404)
                      +|||+++.......  ......||+.|+|||.+ .+..++.++|||||||++|||+|| .+||.+.+....+..+.+...
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l-~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHH-ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999986644322  22345789999999998 466789999999999999999998 588988888888777776554


Q ss_pred             CCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        242 PNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +..+         ..+++.+.+||.+||+.||++|||+.++++
T Consensus       254 ~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         254 LDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3332         467899999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=368.34  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=199.7

Q ss_pred             EEeeeecccCceeEEEEEEcCCC---eEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeEEE
Q psy14434         26 TIHKRIGKGAYGIVYKAYDKNNK---QYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        26 ~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~~l  102 (404)
                      .+.+.||+|+||+||+|.+..++   ..||||++.+ ..+.....++.+|+.+|++++ ||||+++++++.. .+..+++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEE-TTTEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEe-cCCceEE
Confidence            44678999999999999986543   4699999864 345667788999999999997 9999999998753 4567999


Q ss_pred             EEeccC-CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccccccccCCCC--
Q psy14434        103 VFEYME-NDLNKVIRDK--ILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLGLARSLSDSK--  177 (404)
Q Consensus       103 v~E~~~-~~L~~~l~~~--~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~~~~~~--  177 (404)
                      |||||+ |+|.+++...  .+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++......  
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999 5888888743  47788899999999999999999999999999999999999999999999998764432  


Q ss_pred             --CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHhhCCCCCCcchhhccc
Q psy14434        178 --ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGA-STSHQLQLIVNLVRPNPPHADKFYAGF  254 (404)
Q Consensus       178 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (404)
                        .......||+.|+|||.+. ...++.++|||||||++|||++|..||... +.......+.....+..+         
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p---------  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---------  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---------
T ss_pred             cceecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---------
Confidence              1223456899999999984 567899999999999999999977666543 333444444444433222         


Q ss_pred             CCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        255 KNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       255 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                      ..+++++.+||.+||+.||++|||+.|+++|
T Consensus       257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4568999999999999999999999999988

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-49  Score=366.90  Aligned_cols=252  Identities=19%  Similarity=0.257  Sum_probs=205.2

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++....    ....+.+|+..++.+..|+|++.+++++.  .....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~   76 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHN   76 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCcc
Confidence            4578999999999999999999999999999999885432    22345678888999987799999999976  57789


Q ss_pred             EEEEeccCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcc-----CCceEEecccccccc
Q psy14434        101 YVVFEYMENDLNKVIRD--KILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDK-----SCSIKIGDLGLARSL  173 (404)
Q Consensus       101 ~lv~E~~~~~L~~~l~~--~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~-----~~~vkl~Dfg~a~~~  173 (404)
                      |+||||++++|.+++..  +.++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+..
T Consensus        77 ~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          77 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99999999999988864  46999999999999999999999999999999999999974     578999999999876


Q ss_pred             CCCC-------CcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHhhCCC
Q psy14434        174 SDSK-------ECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGASTS---HQLQLIVNLVRPN  243 (404)
Q Consensus       174 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  243 (404)
                      ....       ......+||+.|||||++ .+..++.++|||||||++|+|++|..||.+....   .....+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHh-cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            4321       123456899999999998 4677999999999999999999999999865433   2233333222111


Q ss_pred             CCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHh
Q psy14434        244 PPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILE  284 (404)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  284 (404)
                      +     ......++|+++.+++..|+..+|++||+++.+.+
T Consensus       236 ~-----~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 P-----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             C-----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             C-----hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1     11223567899999999999999999999876643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=364.43  Aligned_cols=255  Identities=21%  Similarity=0.311  Sum_probs=191.1

Q ss_pred             ccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHH--HHHHHHHhccCCCCcceEeeEEEeccC-
Q psy14434         21 ILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTY--REILFLKSFQRHPNIITMLDIYKAVNN-   97 (404)
Q Consensus        21 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--~E~~~l~~l~~hpnIv~l~~~~~~~~~-   97 (404)
                      +..+|.+.+.||+|+||.||+|+.  +|+.||||++...     ......  .|+..+.++. ||||+++++++...+. 
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            356899999999999999999975  6889999998532     222333  4555556675 9999999999875332 


Q ss_pred             -CeEEEEEeccC-CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCCcEEEccCCceEEecc
Q psy14434         98 -KDLYVVFEYME-NDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHA--------CKVMHRDLKPSNILIDKSCSIKIGDL  167 (404)
Q Consensus        98 -~~~~lv~E~~~-~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~--------~~i~HrDlkp~NIll~~~~~vkl~Df  167 (404)
                       ..+|+|||||. |+|..++++..+++..+..++.|++.||.|||+        +||+||||||+||||+.++.+||+||
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence             36899999998 599999998889999999999999999999996        59999999999999999999999999


Q ss_pred             ccccccCCCCC----cccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC----------
Q psy14434        168 GLARSLSDSKE----CLTEYIATRWYRAPEILISNR-----RYTHHVDIWSLGCILAEMLQSKPLFPGAS----------  228 (404)
Q Consensus       168 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~----------  228 (404)
                      |+++.......    .....+||+.|+|||++....     .++.++|||||||++|||+||.+||....          
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            99987644322    234568999999999984321     25778999999999999999988763321          


Q ss_pred             ----cHHHHHHHHHhhCCCCCCcchhhcccCCCCHHHHHHHHhccccCCCCCCCHHHHHhc
Q psy14434        229 ----TSHQLQLIVNLVRPNPPHADKFYAGFKNKPEEAVDLLNQILVLNPSERPETDQILEH  285 (404)
Q Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  285 (404)
                          ...............+.......  ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGG--GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccC--ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                11122222111111111111100  01123468999999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-47  Score=364.26  Aligned_cols=265  Identities=28%  Similarity=0.467  Sum_probs=201.9

Q ss_pred             CCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhcc----------CCCCcceEeeEE
Q psy14434         23 AEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQ----------RHPNIITMLDIY   92 (404)
Q Consensus        23 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hpnIv~l~~~~   92 (404)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.   ........+|+.+++.+.          +|+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            4699999999999999999999999999999999643   233455678888888774          368899999998


Q ss_pred             EeccCCeEEEEEeccCC--cHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEccCC------
Q psy14434         93 KAVNNKDLYVVFEYMEN--DLNKVIR---DKILKDVHIRYIMFQLCNGLSYIHA-CKVMHRDLKPSNILIDKSC------  160 (404)
Q Consensus        93 ~~~~~~~~~lv~E~~~~--~L~~~l~---~~~l~~~~~~~i~~qil~al~~LH~-~~i~HrDlkp~NIll~~~~------  160 (404)
                      ........+++|+++..  +......   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++      
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            76566677777777763  3333332   3468999999999999999999998 8999999999999998765      


Q ss_pred             ceEEeccccccccCCCCCcccccccccccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHH
Q psy14434        161 SIKIGDLGLARSLSDSKECLTEYIATRWYRAPEILISNRRYTHHVDIWSLGCILAEMLQSKPLFPGAST------SHQLQ  234 (404)
Q Consensus       161 ~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~  234 (404)
                      .++++|||.+......   ....+||+.|+|||++. ...++.++|+||+||++++|++|+.||...+.      ...+.
T Consensus       170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc---cccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            3999999999865432   34567999999999985 56789999999999999999999999975432      22333


Q ss_pred             HHHHhhCCCCCCcc--------------------------------hhhcccCCCCHHHHHHHHhccccCCCCCCCHHHH
Q psy14434        235 LIVNLVRPNPPHAD--------------------------------KFYAGFKNKPEEAVDLLNQILVLNPSERPETDQI  282 (404)
Q Consensus       235 ~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l  282 (404)
                      ......+..+....                                .........++++.+||.+||.+||.+|||++||
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            33333332111000                                0000011235689999999999999999999999


Q ss_pred             HhccCCCCcCCC
Q psy14434        283 LEHNYVSKYFPS  294 (404)
Q Consensus       283 l~hp~~~~~~~~  294 (404)
                      |+||||+.....
T Consensus       326 L~Hp~f~~~~~~  337 (362)
T d1q8ya_         326 VNHPWLKDTLGM  337 (362)
T ss_dssp             HTCGGGTTCTTC
T ss_pred             hcCcccCCCCCc
Confidence            999999965543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.8e-26  Score=199.07  Aligned_cols=171  Identities=15%  Similarity=0.123  Sum_probs=121.9

Q ss_pred             eEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccC----------------hhHHHHHHHHHHHHHhccCCCCcceE
Q psy14434         25 YTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRN----------------KTDAQRTYREILFLKSFQRHPNIITM   88 (404)
Q Consensus        25 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~~hpnIv~l   88 (404)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++.....                ........+|...+.++. |++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            468899999999999999885 6889999987532111                111233456888899996 8999998


Q ss_pred             eeEEEeccCCeEEEEEeccCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEccCCceEEeccc
Q psy14434         89 LDIYKAVNNKDLYVVFEYMENDLNKVIRDKILKDVHIRYIMFQLCNGLSYIHACKVMHRDLKPSNILIDKSCSIKIGDLG  168 (404)
Q Consensus        89 ~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~l~~~~~~~i~~qil~al~~LH~~~i~HrDlkp~NIll~~~~~vkl~Dfg  168 (404)
                      +++..      .+++|||+++...     ..++...+..++.||+.||+|||++||+||||||+|||++++ .++|+|||
T Consensus        80 ~~~~~------~~lvme~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          80 YAWEG------NAVLMELIDAKEL-----YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEEET------TEEEEECCCCEEG-----GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             EEecC------CEEEEEeeccccc-----cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            87632      2799999997421     225666778899999999999999999999999999999865 49999999


Q ss_pred             cccccCCCCCccccccc-ccccccccccccCCCCCchhhHHHHHHHH
Q psy14434        169 LARSLSDSKECLTEYIA-TRWYRAPEILISNRRYTHHVDIWSLGCIL  214 (404)
Q Consensus       169 ~a~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il  214 (404)
                      .|.....+..  ..+.. ... .-.+.+  ...|+.++|+||+.--+
T Consensus       148 ~a~~~~~~~~--~~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGW--REILERDVR-NIITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTH--HHHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCc--HHHHHHHHH-HHHHHH--cCCCCCcccHHHHHHHH
Confidence            9976543211  11100 000 001222  34678899999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=8.8e-08  Score=84.37  Aligned_cols=143  Identities=15%  Similarity=0.146  Sum_probs=91.6

Q ss_pred             cccCCeEEeeeecccCceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCe
Q psy14434         20 NILAEYTIHKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKD   99 (404)
Q Consensus        20 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~   99 (404)
                      ..++.|++++..+.++.+.||++.  .++..+++|+......  .....+.+|...+..+..+--+.+++.+..  +++.
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~   84 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGW   84 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCc
Confidence            456788998887767778999884  4556678888754322  122345678888888865555677887765  4677


Q ss_pred             EEEEEeccCC-cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy14434        100 LYVVFEYMEN-DLNKVIRDKILKDVHIRYIMFQLCNGLSYIH--------------------------------------  140 (404)
Q Consensus       100 ~~lv~E~~~~-~L~~~l~~~~l~~~~~~~i~~qil~al~~LH--------------------------------------  140 (404)
                      .|+||++++| .+......    ......++.++...++.||                                      
T Consensus        85 ~~lv~~~l~G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             eEEEEEecccccccccccc----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            8999999987 44322211    0111112222222222222                                      


Q ss_pred             ---------------h------CCCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        141 ---------------A------CKVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       141 ---------------~------~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                                     .      ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                           1      1279999999999998776667999988753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.36  E-value=6.7e-07  Score=83.62  Aligned_cols=78  Identities=18%  Similarity=0.192  Sum_probs=49.3

Q ss_pred             eeeecccCceeEEEEEEcCCCeEEEEEEcchhc-----cChhHHHHHHHHHHHHHhccCC--CCcceEeeEEEeccCCeE
Q psy14434         28 HKRIGKGAYGIVYKAYDKNNKQYVAIKKIFEAF-----RNKTDAQRTYREILFLKSFQRH--PNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~E~~~l~~l~~h--pnIv~l~~~~~~~~~~~~  100 (404)
                      .+.||.|....||++.+..+++.+++|.-....     .......+...|...|+.+..+  ..+++++.+  +  ....
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d--~~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c--CCCC
Confidence            557999999999999888888889999643211     0112334556788888777543  345666654  2  3345


Q ss_pred             EEEEeccCC
Q psy14434        101 YVVFEYMEN  109 (404)
Q Consensus       101 ~lv~E~~~~  109 (404)
                      ++|||++++
T Consensus       107 ~lvmE~L~~  115 (392)
T d2pula1         107 VTVMEDLSH  115 (392)
T ss_dssp             EEEECCCTT
T ss_pred             EEEEeccCC
Confidence            789999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=2.2e-05  Score=67.98  Aligned_cols=139  Identities=15%  Similarity=0.165  Sum_probs=78.8

Q ss_pred             eEEeeeecccC-ceeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeEEEeccCCeEEE
Q psy14434         25 YTIHKRIGKGA-YGIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDIYKAVNNKDLYV  102 (404)
Q Consensus        25 y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~~~~~~~~~~~l  102 (404)
                      ++.. .+..|. .+.||++.. .++..+++|.....     ....+..|...++.+..+. .+++++.+..  +.+..++
T Consensus        13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~   83 (255)
T d1nd4a_          13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWL   83 (255)
T ss_dssp             CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEE
T ss_pred             CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEE
Confidence            4443 344444 467898865 34666888876322     2223556777777665332 2666777654  5667899


Q ss_pred             EEeccCC-cHH--------------HHHHh-cC-------CCH--HH-HHH----H---------------HHHHHHHHH
Q psy14434        103 VFEYMEN-DLN--------------KVIRD-KI-------LKD--VH-IRY----I---------------MFQLCNGLS  137 (404)
Q Consensus       103 v~E~~~~-~L~--------------~~l~~-~~-------l~~--~~-~~~----i---------------~~qil~al~  137 (404)
                      ||++++| ++.              ..+.+ ..       +..  .. ...    +               .......+.
T Consensus        84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             EEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            9999986 221              11110 00       000  00 000    0               000122333


Q ss_pred             HHHhC-------CCccCCCCCCcEEEccCCceEEeccccccc
Q psy14434        138 YIHAC-------KVMHRDLKPSNILIDKSCSIKIGDLGLARS  172 (404)
Q Consensus       138 ~LH~~-------~i~HrDlkp~NIll~~~~~vkl~Dfg~a~~  172 (404)
                      .+...       .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            33332       379999999999999876678999988753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.50  E-value=0.00022  Score=65.95  Aligned_cols=72  Identities=13%  Similarity=0.175  Sum_probs=51.2

Q ss_pred             eeeecccCceeEEEEEEcC-------CCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCCCcceEeeEEEeccCCeE
Q psy14434         28 HKRIGKGAYGIVYKAYDKN-------NKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHPNIITMLDIYKAVNNKDL  100 (404)
Q Consensus        28 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~l~~~~~~~~~~~~  100 (404)
                      ++.|+.|-.-.+|++....       ..+.|.+++....    .......+|..+++.+..+.-.+++++++.   +   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS---G---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---T---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcC---C---
Confidence            4679999999999998753       2456777776421    123345688999998876655678888764   2   


Q ss_pred             EEEEeccCC
Q psy14434        101 YVVFEYMEN  109 (404)
Q Consensus       101 ~lv~E~~~~  109 (404)
                      ++||||+.|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            789999986

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.41  E-value=0.0089  Score=53.11  Aligned_cols=69  Identities=13%  Similarity=0.127  Sum_probs=39.9

Q ss_pred             eeEEEEEEcCCCeEEEEEEcchhccChhHHHHHHHHHHHHHhccCCC-CcceEeeE---EEeccCCeEEEEEeccCC
Q psy14434         37 GIVYKAYDKNNKQYVAIKKIFEAFRNKTDAQRTYREILFLKSFQRHP-NIITMLDI---YKAVNNKDLYVVFEYMEN  109 (404)
Q Consensus        37 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~l~~~---~~~~~~~~~~lv~E~~~~  109 (404)
                      -.||++.. .+|..|++|+......+   ..++..|...+..|..+. -++.....   -.....+..+.+++++.|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            57999965 46778999987543322   344556777777775221 11111110   001135567889999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.03  E-value=0.0077  Score=53.12  Aligned_cols=30  Identities=23%  Similarity=0.190  Sum_probs=26.9

Q ss_pred             CCCccCCCCCCcEEEccCCceEEecccccc
Q psy14434        142 CKVMHRDLKPSNILIDKSCSIKIGDLGLAR  171 (404)
Q Consensus       142 ~~i~HrDlkp~NIll~~~~~vkl~Dfg~a~  171 (404)
                      .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999875